concept,cuis,hasMesh,number
heart failure ( class l - lll ),C0018801;C0456387;C1261077;C1518526;C1705943;C0018802;C4554158,true;false;false;false;false;true;false,0/22402
duration of hypertension  n ( % ),C0449238;C0020538;C1963138;C2926735,false;true;false;false,1/22402
type $nmbr$ diabetes 一 no . ( % ),C1320657,false,2/22402
tofacitinib $nmbr$ mg bid [ n = $nmbr$ |,C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3/22402
high - density lipoprotein cholesterol mean ( mg / dl ± sd ),C0023822;C0444504;C0439269;C2699239;C2347634;C2348143,true;false;false;false;false;false,4/22402
temporary discontinuation of study drug,C0205374;C0457454;C0013175;C1444662;C4552847;C1548539;C3245481,false;false;true;false;false;false;false,5/22402
death  mi  idr  st  or any timi bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,6/22402
race and ss at baseline,C0034510;C1706779;C3853635,true;false;false,7/22402
high intensity,C4081854,false,8/22402
prior percutaneous coronary intervention  n ( % ),C0332152;C1532338;C2826257,false;true;false,9/22402
pre - randomization pci,C0332152;C0034656;C4049621;C0740175;C2257086;C3669034,false;true;false;false;false;false,10/22402
p  subgroup *,C0369773;C1079230;C1515021;C2603361,false;false;false;false,11/22402
hosji fcrhypoglycemia,,,12/22402
apixaban vs . placebo,C1831808,true,13/22402
medication use — no . ( % ),C0013227;C3244316;C4284232,true;false;false,14/22402
second prior mi,C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false;false,15/22402
subarachnoid hemorrhage,C0038525,true,16/22402
total invasive cancer,C0439175;C0677898;C0439810,false;false;false,17/22402
acute stent thrombosis,C0205178;C3897493,false;false,18/22402
alteplase ( n = $nmbr$ ),C0032143,true,19/22402
relative decrease > $nmbr$ %,C0080103;C0392756;C0547047;C0205345;C1547039,true;false;false;false;false,20/22402
$nmbr$ th - $nmbr$ th percentiles,C0039725;C1264641;C0039738;C1420718;C4282123;C4285344,true;false;true;false;false;false,21/22402
number of ( % ) females,C0237753;C0086287;C0449788,false;true;false,22/22402
emphysema ( % ),C0013990;C0034067,true;true,23/22402
argentina,C0003761;C1504311,true;false,24/22402
ccq score § §,,,25/22402
vents / patients,C0030705,true,26/22402
number of patients with,C2360800,false,27/22402
concomitant mtx —,C0521115;C0025677;C1417487,false;true;false,28/22402
europe / lsrael,C0015176,true,29/22402
thromboaspiration — no . ( % ),,,30/22402
cardiac - biomarker status — no . / total no . ( % ) $,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,31/22402
receiving insulin therapy,C1514756;C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,false;true;true;true;false;false;false;false,32/22402
pulmonary embolism ± deep vein thrombosis,C0852030;C0226514;C0034065;C0149871,false;false;true;true,33/22402
abdominal or perianal fistula at baseline  n ( % ),C0000726,true,34/22402
cyclosporine ( n = $nmbr$ ),C0010592;C0010594,true;true,35/22402
geographic region - europe,C0017446;C0015176,true;true,36/22402
indian ( indian subcontinent ),C0454693,false,37/22402
percutaneous coronary intervention,C1532338,true,38/22402
antiplatelet or anticoagulant therapy,,,39/22402
lesion length  mean ( sd )  mm,C0221198;C1444754;C0444504;C2699239;C4330985;C4554674;C2347634;C2348143;C1706316;C1546698,false;false;false;false;false;false;false;false;false;false,40/22402
non - q wave,C1518422;C0429089;C1305738,false;false;false,41/22402
continued thienopyridine n = $nmbr$ subjects,C0549178;C1120149,false;true,42/22402
weight ( kg / m $nmbr$ ) [ median ( $nmbr$ th to $nmbr$ th percentile ) ],C0552346;C1532718;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;false;false;false;false;false;false,43/22402
left ventricular ejection fraction  % af history,C0428772;C0344434;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049859;C0488728,false;false;true;true;false;false;false;false;false;false,44/22402
single - vessel disease  n ( % ),C0037179;C0042373;C0087136;C0205171,true;true;true;false,45/22402
geographic region — no . ( % ),C0017446,true,46/22402
pad lower extremities,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,47/22402
bmi > $nmbr$ kg / m $nmbr$ ( % ),C0578022;C1532718,false;false,48/22402
total gadolinium - enhancing lesion count  no . ( % ),C0439175;C1333400;C0439810,false;false;false,49/22402
fatigue,C0015672;C3463815;C4050243;C4554645,true;false;false;false,50/22402
$nmbr$ to < $nmbr$ kg / m $nmbr$,C1532718,false,51/22402
st - elevation mi,C0520886;C3810814,false;false,52/22402
azathioprine ( n = $nmbr$ ),C0004482,true,53/22402
serum uric acid ( mg / dl ),C0455272;C0439269;C0700634,false;false;false,54/22402
baseline mean ( sd )  % [ mmol / mol ],C0168634;C0444504;C2699239;C3829066;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,55/22402
cv death  ml  or stroke,C3538987;C0011065;C0439526;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;false;true;false,56/22402
atenolol ( « = $nmbr$ $nmbr$ ),C0004147,true,57/22402
previous antiarrhythmic treatment — no . ( % ),C0205156;C0003195;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3537142;C1552607,false;true;true;true;false;false;false;false;false;false;false,58/22402
drugs used in diabetes  n ( % ),C0013227;C3687832,true;false,59/22402
after pci,C4049621,false,60/22402
secukinumab,C3179547,true,61/22402
mean a ± sem ( % ),C0444504;C2347634;C2348143,false;false;false,62/22402
ppi but no aspirin,C0358591;C0871125;C3811894,true;true;false,63/22402
$nmbr$ mg / kg ( n = $nmbr$ ),C0439272,false,64/22402
family history of cad ( diagnosed at < $nmbr$ yr of age ) — no . ( % ) cigarette smoker — no . ( % ),C0241889;C1504769;C2239547;C3813548;C4284121,true;true;false;false;false,65/22402
trend / het . test,C1521798;C4554533,false;false,66/22402
cv death + hf hospitalization,C3538987;C0011065;C0018488;C0019993;C1313497;C1538440;C3273279;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;true;true;true;false;false;false;false;false;true;false,67/22402
mepolizumab  $nmbr$ mg ( n = $nmbr$ ),C0969324;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,68/22402
medical therapy only ( n = $nmbr$ ),C0418981;C0205171;C1720467,false;false;false,69/22402
caucasian ethnicity,C0007457;C0015031;C0243103;C0043157,true;true;true;true,70/22402
crcl at baseline < $nmbr$ ml / min,C1846718;C0168634;C0439445;C1442488,false;true;false;false,71/22402
elevated hscrp > $nmbr$ mg / l  n ( % ),C0205250;C0439268;C3163633,false;false;false,72/22402
seizure types reported during baseline  n ( % ) a,C0036572;C0332307;C1959629;C4553401,true;false;false;false,73/22402
median total cholesterol  mmol / l,C0549183;C0201950;C1532563;C0543421;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,74/22402
mean ± sd bmi  kg / m $nmbr$,C0444504;C2699239;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false;false,75/22402
first mace,C0205435;C0349381;C0949745;C1445339;C1279901,false;false;true;false;false,76/22402
disease duration $nmbr$ to b $nmbr$ years ( n = $nmbr$ ),C0872146;C0439234,false;false,77/22402
history of amputation — no . ( % ),C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,78/22402
lipid - lowering medication ( % ),C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,79/22402
previous hf hospitalization  n ( % ),C0205156;C0018488;C0019993;C1313497;C1538440;C3273279;C1552607,false;true;true;true;false;false;false,80/22402
mean lipid values  mg / dl,C0444504;C0023779;C0042295;C0439269;C2347634;C2348143,false;true;false;false;false;false,81/22402
prior years taking warfarin,C0332152;C0439234;C2826257,false;false;false,82/22402
bnp  median ( iqr )  pg / ml,C0054015;C0549183;C0439297;C0876920;C2347635;C2348144;C2939193;C1095989;C1417808;C2982014,true;false;false;false;false;false;false;false;false;false,83/22402
hba $nmbr$ ca  % ( mmol / mol ),C0019016;C3887642;C3829066;C1825777;C3538758,true;true;false;false;false,84/22402
latin america hr ( $nmbr$ % cl ),C0023122;C0596019,true;false,85/22402
current atrial fibrillation or flutter on ecg,C0521116;C0004238;C0344434;C1963067;C1705970,false;true;false;false;false,86/22402
invasive,C0205281;C1334278,false;false,87/22402
estimated glomerular filtration,C0750572;C0232809,false;false,88/22402
pasi score ! * *,C4528685;C0449820;C4050231,false;false;false,89/22402
amiodarone  n ( % ),C0002598,true,90/22402
american indian or alaska,C0002460,true,91/22402
pooled simvastatin factorial studies,C1709595;C0074554;C2826344;C2349200;C4522255,false;true;false;false;false,92/22402
implantable cardioverter - defibrillator,C0162589;C2825184,true;false,93/22402
varespladib ( n = $nmbr$ ),C2713485,true,94/22402
acute coronary event,C0205178;C0741923,false;false,95/22402
ntpro - cnp ( ng / ml ),C3889729;C0439275,false;false,96/22402
useofmedical therapyathospitaldischarge,,,97/22402
coenzyme q $nmbr$  ^ g / ml #,C0041536;C1300565,true;false,98/22402
dyspnoea - mmrc grade  n ( % ),C0013404;C3826977;C0441800;C0919553;C3244287;C1963100,true;false;false;false;false;false,99/22402
triglycerides — mmol / liter,C0041004;C0439190;C0475211,true;false;false,100/22402
baseline ecrcl,C0168634;C1442488,true;false,101/22402
cardiovascular history,C1880008,false,102/22402
with placebo ( n $nmbr$ $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,103/22402
cardiovascular medications,C0007220,true,104/22402
after bronchodilation,C1371299;C3537072,false;false,105/22402
mean $nmbr$ mwd *  m ( sd ),C0444504;C0369637;C2699239;C0441923;C2347634;C2348143,false;false;false;false;false;false,106/22402
angiotensin - converting enzyme inhibitors / angiotensin receptor blockers,C0003015;C0597357;C2757044,true;false;false,107/22402
medication taken alone or in combination,C0013227;C3244316;C4284232,true;false;false,108/22402
etoricoxib dose,C0972314;C0178602;C0869039;C1114758,true;false;false;false,109/22402
ischemic cerebrovascular disease  n ( % ),C0475224;C0007820,false;true,110/22402
bare metal stent  n ( % ),C2825200,false,111/22402
mean age ( years ) ( s . d . ),C0444504;C1510829;C2347634;C2348143,false;false;false;false,112/22402
das $nmbr$ ( esr )  mean ( sd ),C0051767;C3811131;C0444504;C2699239;C2347634;C2348143;C0057671,true;false;false;false;false;false;true,113/22402
absolute  litres,C0205344;C0475211,false;false,114/22402
wml load at follow - up mri,C1550025;C0589120;C0024485;C1824234;C3890166;C1522577;C1704685;C3274571;C1704782;C1708715,false;false;true;false;false;false;false;false;false;false,115/22402
clopidogrel ( n = $nmbr$  $nmbr$ ),C0070166,true,116/22402
ancestry ( % ) f,C0016327,true,117/22402
no p - blocker intake at randomisation ( n = $nmbr$ ),C0369773;C1512806;C0034656;C2603361,false;false;true;false,118/22402
valsartan / hctz  n / n ( % ),C0216784;C0020261,true;true,119/22402
> $nmbr$ oral agents,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,120/22402
total chol  mg / dl,C0439175;C0201950;C0439269;C0439810,false;false;false;false,121/22402
calcium channel blockers  n ( % ),C0006684;C2757014,true;false,122/22402
bsa > $nmbr$ %  n ( % ) t,,,123/22402
benralizumab $nmbr$ mg q $nmbr$ w ( n = $nmbr$ ),C2982078;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,124/22402
blood pressure  mean ( sd ) [ range ]  mm hg,C0428886;C2699239;C1514721;C0439475;C2348147;C3542016,true;false;false;false;false;false,125/22402
atenolol n = $nmbr$,C0004147,true,126/22402
type of mi ( % ),C0332307;C3810814;C1547052,false;false;false,127/22402
mtx + non - mtx,C0025677;C1518422;C1417487,true;false;false,128/22402
concomitant corticosteroid use  n ( % ),C0521115;C0239126,false;false,129/22402
estimated glomerular filtration rate ( mdrd )  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C3811844;C3839656;C0439445;C0369637;C0441923,false;false;false;false;false,130/22402
mild impairment ( $nmbr$ to < $nmbr$ ),C2945599;C0221099;C0684336,false;false;false,131/22402
years since menopause,C0439234,false,132/22402
major cvd /,C0205082;C0007222;C0205164;C4318856;C4521762,false;true;false;false;false,133/22402
medical therapy ( n = $nmbr$ ),C0418981,false,134/22402
no . of tnfi among non - tnfi naive,,,135/22402
use of ace inhibitor,C1524063;C0003015;C4541021,false;true;false,136/22402
haemorrhagic,C0333275,false,137/22402
stroke ( vs tia ),C0038454;C4554100,true;false,138/22402
detemir / insulin glargine  %,C0537270;C0907402,true;true,139/22402
screening prebronchodilator fev $nmbr$  l,C0220908;C2599602;C3714541;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;true;false;false;false;false;false,140/22402
stent plus placebo,C0038257;C0332287;C0032042;C1696465;C1706408,true;false;true;false;false,141/22402
coronary revascularization $nmbr$ days after randomization,C0877341;C0439228;C0034656,false;false;true,142/22402
sacubitril / valsartan,C4033631,true,143/22402
no . of prior bdmards,C0332152;C2826257,false;false,144/22402
mean prebronchodilator fev $nmbr$ ( sd )  % predicted,C0444504;C2599602;C3714541;C2699239;C2347634;C2348143,false;false;true;false;false;false,145/22402
paracetamol,C0000970,true,146/22402
aspirin / other antiplatelet agents  n ( % ),C0004057,true,147/22402
randomized to receive beta carotene,C0034656;C3815594,true;false,148/22402
bsa  % *,,,149/22402
erosion score,C0333307;C0449820;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false,150/22402
peripheral arterial disease  n ( % ),C0085096;C1704436,true;true,151/22402
primary end point  no . of events / total no . ( % ),C2986535,false,152/22402
lvdd ( mm ),C4330985;C4554674,false;false,153/22402
draining cutaneous fistula at baseline  n ( % ),C0013103;C0180499;C4265177,true;false;false,154/22402
tg < $nmbr$  hdl > $nmbr$ ( n = $nmbr$ ),C0337445;C3715113,false;false,155/22402
comorbidities other than diabetes,C0009488;C0011847;C0011849,true;false;true,156/22402
toast classification of qualifying stroke,C1710306;C1514624;C0038454;C4554100;C4521230,false;false;true;false;false,157/22402
rasagiline  $nmbr$ mg / day,C0525678;C0439422,true;false,158/22402
metabolic syndrome $nmbr$ baseline lipids  mg / dl,C0524620;C0168634;C0023779;C0439269;C1442488,true;true;true;false;false,159/22402
crude analysis  n ( % ),C0002778;C0936012;C1524024,false;false;true,160/22402
bypass surgery,C1536078,false,161/22402
missing — number / n ( % ),C1551393;C0237753;C0449788;C1705492;C3272743,false;false;false;false;false,162/22402
cholesterol  ( . $nmbr$ . $nmbr$ mmol / l )  n ( % ),C0008377;C1532563,true;false,163/22402
right coronary,C0225808,false,164/22402
health habits,C0679786,false,165/22402
blood pressure,C0005823;C1271104;C1272641,true;false;true,166/22402
homa . % b  median ( ql  q $nmbr$ )  %,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,167/22402
severity of copd  ( gold $nmbr$ )  %,C0439793;C0024117;C0018026;C1304897;C1412502;C3714496;C0522510,false;true;true;false;false;false;false,168/22402
prior myocardial infarction,C0155668,false,169/22402
both ptca and cabg,C2936173,true,170/22402
major cerebrovascular,C0205082;C1880018;C0205164;C4318856;C4521762,false;false;false;false;false,171/22402
hazard ratio ( $nmbr$ % cl ) $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ),C2985465;C0596019,false;false,172/22402
diastolic blood pressure ( mm hg ) medications,C0428883;C0439475;C0013227;C0802604;C2598133;C4284232;C1305849,true;false;true;false;false;false;false,173/22402
iglar dose at randomization ( u / day ),C0178602;C0034656;C0456683;C0869039;C1114758,false;true;false;false;false,174/22402
prior cv event at randomization !,C0332152;C3538987;C0441471;C0034656;C4019010;C4048877;C4318503;C2826257,false;false;false;true;false;true;false;false,175/22402
mean ± sd waist circumference  cm,C0444504;C2699239;C0455829;C2347634;C2348143,false;false;true;false;false,176/22402
risk of bleeding,C3251812,false,177/22402
cv medication  % of patients,C3538987;C0013227;C0030705;C3244316;C4284232;C4048877;C4318503,false;true;true;false;false;true;false,178/22402
total updrs score ( range  $nmbr$ - $nmbr$ ) 卞,C0439175;C3639721;C0439810,false;true;false,179/22402
atrial fibrillation  duration — no . ( % ),C0004238;C0449238;C2926735;C0344434;C1963067,true;false;false;false;false,180/22402
known duration of diabetes  yr,C0205309;C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;false;true;false,181/22402
$nmbr$ % < hba $nmbr$ c < = $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,182/22402
dactylitis count,C0239161;C0750480;C1705566,false;false;false,183/22402
previous disease :,C0205156;C0012634;C1552607,false;true;false,184/22402
previous dmards use  n ( % ),C0205156;C0242708;C1552607,false;true;false,185/22402
gly $nmbr$ . $nmbr$ gg b . i . d n / n ( % ),C1415124;C0017454;C0152277;C0018370,false;true;false;true,186/22402
previous percutaneous coronary intervention,C0205156;C1532338;C1552607,false;true;false,187/22402
unfractionated heparin before randomisation,C0019134;C0034656;C2825026,true;true;false,188/22402
oad plus insulin,C0021641;C1533581;C1579433;C3714501,true;false;false;false,189/22402
diabetes with target organ disease *,C0011847;C1521840;C0178784;C0012634;C2986546;C0011849,false;false;false;true;false;true,190/22402
unknown type,C0439673;C0332307;C1547052;C3541433;C4050014,false;false;false;false;false,191/22402
beta - blocker — no . ( % ),C0001645,true,192/22402
cognitive functioning,C0392334;C0392335,false;false,193/22402
( % ) $nmbr$ - $nmbr$,,,194/22402
history of hyperlipidemia ( % ),C4695788,false,195/22402
evenls per $nmbr$  $nmbr$ palienl - years,C0439234,false,196/22402
fasting free fatty acids ( ^ mol / liter ),C0015663,true,197/22402
treatment after admission,C0039798;C0184666;C0809949;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,198/22402
rarertd antocagibtcn before andorrtzafon,,,199/22402
intestinal area involved  n ( % ) $,C0021853;C0017446;C0205146,true;true;false,200/22402
ethnicity ( % ),C0015031;C0243103,true;true,201/22402
all cardiovascular,C0007226;C3887460,true;false,202/22402
smoking in the past year,C0037369;C4086728;C0453996;C1881674,true;false;true;false,203/22402
diskus only  n,C1553480;C0205171;C1720467,false;false;false,204/22402
jsn score  mean $nmbr$ sd,C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false,205/22402
number omega - $nmbr$ number placeb fatty acid,C0237753;C1719844;C0015684;C0449788,false;false;true;false,206/22402
high - intensity statin vs medium - or low - intensity statin at randomization,C4081854;C0360714,false;true,207/22402
score on nih stroke scale — median ( iqr ),C0449820;C1697238;C0549183;C0876920;C2347635;C2348144;C2939193;C3484372;C4050231,false;false;false;false;false;false;false;false;false,208/22402
initiation of insulin,C0589507;C0021641;C1533581;C1579433;C3714501;C1158830;C1704686,false;true;false;false;false;false;false,209/22402
$nmbr$ nd > $nmbr$ . $nmbr$ / < $nmbr$ . $nmbr$,,,210/22402
cad and abi < $nmbr$ - $nmbr$ §,C1504769;C2239547;C3813548;C4284121,true;false;false;false,211/22402
pioglitazone events / n ( % ),C0071097;C0441471;C3541888,true;false;false,212/22402
acecoumarol  no . ( % ),,,213/22402
cigarette users,C0677453;C1706077;C1704760;C3890423,true;false;false;false,214/22402
gfr ( mdrd ) ( ml / min / $nmbr$ - $nmbr$ m $nmbr$ ),C0017654;C3839656;C0439445;C0369637;C0441923;C1424601,true;false;false;false;false;false,215/22402
bmi ( kg / m $nmbr$ ) cardiac parameters,C0578022;C1532718;C0018787;C0449381;C1522601,false;false;true;false;false,216/22402
ace inhibitor or arb at last follow - up,C0003015;C4541021,true;false,217/22402
blood urea nitrogen ( mg / dl ),C0005845;C0439269;C0600137,true;false;false,218/22402
grip strength ( kg ),C0429271;C0022718;C0439209;C4054209;C2598165,false;true;false;false;false,219/22402
current smoker — no . of patients ( % ),C3173209;C3241966,false;false,220/22402
one - third radius,C0205447;C0205437;C0034627;C1306504,false;false;true;false,221/22402
psychosocial risk factors,C0033963;C0035647;C4552904;C0542298;C0035648;C1553898;C1458132,true;true;false;false;true;false;false,222/22402
bursitis,C0006444,true,223/22402
non - hdl - c in $nmbr$ classes,C1518422;C3715113;C0456387;C1518526;C1705943;C4019422,false;false;false;false;false;false,224/22402
family history ol diabetes ?,C1313937,false,225/22402
age ( years ) : $nmbr$ - < $nmbr$,C1510829,false,226/22402
digital clubbing  n ( % ),C0009080;C0149651,true;false,227/22402
death or myocardial infarction,C0011065;C1306577;C4082313;C4552775,true;false;false;false,228/22402
risk reduction  %,C1137094,true,229/22402
a mini - mental state examination  omega - $nmbr$ fatty acids vs placebo,C0451306;C1719844;C0015684,true;false;true,230/22402
pain vas  $nmbr$ - $nmbr$ mm,C0042815;C4330985;C4554674,true;false;false,231/22402
smoking : ex - smoker,C0037369;C0453996;C1881674,true;true;false,232/22402
statin treatment,C0360714;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,233/22402
pre - bronchodilator fev $nmbr$ / fvc ratio *,C2599602;C3714541;C0456603;C1547037,false;true;false;false,234/22402
prior stroke or transient ischemic attack,C0332152;C0038454;C4554100;C2826257,false;true;false;false,235/22402
czp $nmbr$ mg ( n $nmbr$ $nmbr$ ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,236/22402
microvascular eye diseased,C0443258;C0015392;C0700042,false;true;false,237/22402
extent of disease  %,C0449279;C4553144,false;false,238/22402
mean ( $nmbr$ % ci ) difference vs saxa + dapa + met,C0444504;C0008107;C1705241;C1705242;C3259781;C2347634;C2348143,false;true;false;false;false;false;false,239/22402
urgent coronary revascularization,C0439609;C0877341;C3272275,false;false;false,240/22402
caucasian simva,C0007457;C0043157,true;true,241/22402
full analysis set,C0443225;C0002778;C0036849;C1442518;C1705195;C0936012;C1524024,false;false;true;false;false;false;true,242/22402
serious ae,C0205404;C3887670,false;false,243/22402
smoking history ( ever ),C1519384;C3887636,false;false,244/22402
uncodable,,,245/22402
no pah therapy,C0030123;C0039798;C0087111;C1363945;C3203102;C4284467,true;true;true;false;true;false,246/22402
standard ( n = $nmbr$ ),C1442989;C2828392,false;false,247/22402
patent foramen ovale,C0016522;C0344724,true;true,248/22402
laboratory values,C0022877;C0042295;C3244292;C4283904,true;false;false;false,249/22402
years  mean ( sd ),C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,250/22402
hscrp < $nmbr$ . $nmbr$ mga . $nmbr$ ( $nmbr$ . $nmbr$ x $nmbr$ ( $nmbr$ . $nmbr$ ),C0065879,true,251/22402
physician ' s judgment that vka,C0031831;C0022423;C0804815,true;true;false,252/22402
calcium - channel blocker ( ratelowering ),C0006684;C3536851;C4521885,true;false;false,253/22402
left ventricular hypertrophy ( % ),C0149721;C3484363,true;false,254/22402
randomized to aspirin use,C0034656;C0004057;C0042153;C0457083;C1947944;C3815594,true;true;true;false;false;false,255/22402
antihypertensive  antianginal  and other cardiovascular medications,C0003364;C1874267;C3537168,true;false;false,256/22402
glp - $nmbr$ receptor agonist ( other than study drug ),C0018301;C4543206;C0013175;C1422069;C1425391;C1539338;C2350813,true;false;true;false;false;false;true,257/22402
primary renal endpoint or death,C2986535;C0022646,false;true,258/22402
metabolic syndrome characteristics  n ( % ),C0524620;C1521970,true;false,259/22402
mean duration of disease  years,C0444504;C0872146;C0439234;C2347634;C2348143,false;false;false;false;false,260/22402
other oral hypoglycemic drug ( s ),C0359086,false,261/22402
> $nmbr$ additional cv risk factors $nmbr$,C1524062;C3538987;C0035648;C1553898;C4048877;C4318503,false;false;true;false;true;false,262/22402
pancolitis,C0868908,false,263/22402
death from any cause,C0007465,true,264/22402
high - density lipoprotein cholesterol  mg / l,C0023822;C0439268,true;false,265/22402
diabetes mellitus status,C1317301,false,266/22402
fibrinolysis primary pci ( n = $nmbr$ ) ( n = $nmbr$ ) no . of patients / total no . ( % ),C0016017;C0205225;C4049621;C0439612;C0439631;C1305868,true;false;false;false;false;false,267/22402
stool frequency subscore,C0015733;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0183622,true;true;false;false;false;false;false;false;false,268/22402
psap - b ( ng / ml ),C1418975;C0439275;C1420002;C1425004,false;false;false;false,269/22402
no use of $nmbr$ - asa compounds,C1524063;C0004057;C0205198;C1706082;C3853627,false;true;false;false;false,270/22402
visit $nmbr$ ldl cholesterol strata,C0545082;C0023824;C0202117;C1512346;C2826704,false;true;false;false;false,271/22402
endothelin $nmbr$ ( pg / ml ),C0079284;C0439297,true;false,272/22402
normal ( egfr > $nmbr$ ),C0205307;C1739039;C3811844;C3812682;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,273/22402
py = $nmbr$ . $nmbr$ ),C0030428;C3538810,true;false,274/22402
fibrinogen,C0016006;C1167394;C2587184;C3540039,true;false;false;false,275/22402
total haq  $nmbr$ - $nmbr$,C0439175;C0102923;C0451208;C0439810,false;true;false;false,276/22402
mean baseline ibdq score ( sd ) § crp concentration  mg / l,C3533236;C0168634;C2699239;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285;C1442488,false;true;false;false;true;false;false;false;false;false,277/22402
dipyridamole,C0012582,true,278/22402
aspirin and other antiplatelet,C0004057,true,279/22402
positive,C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false,280/22402
age [ years ] ( interaction : p = $nmbr$ . $nmbr$ ),C1510829;C1704675,false;false,281/22402
decreased appetite,C0232462,false,282/22402
beta - blocker ( except sotalol ),C0001645;C0037707,true;true,283/22402
geometric mean crp concentration ( mg / l ),C2986759;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285,false;false;true;false;false;false;false,284/22402
duration of morning,C0449238;C0332170;C2926735,false;false;false,285/22402
hr ( enl vs lcz ) ( $nmbr$ % cl ),,,286/22402
rf positive — number ( % ),C0035448;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false,287/22402
selected medications — no . ( % ),C1707391;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,288/22402
no peripheral revascularization ( n = $nmbr$  $nmbr$ ),C0205100;C0581603,false;false,289/22402
white / european,C0007457;C0239307;C1535514;C0043157;C0220938,true;false;false;true;false,290/22402
at least $nmbr$ flare,,,291/22402
time to admission  min,C3854258;C0702093;C1524029;C3813700;C3854259,false;false;false;false;false,292/22402
octave sustain,,,293/22402
lm bifurcation not treated,C1261082;C0184906;C3146289;C1551056,false;false;false;false,294/22402
radial access,C0442038;C0444454;C1554204;C0920847,false;false;false;false,295/22402
history of peripheral artery disease,C0683519;C0489868;C0730226;C0850708;C0944983,false;false;false;false;false,296/22402
baseline fev  ( l ),C0168634;C3714541;C1442488,true;true;false,297/22402
combined trials,C0205195;C0008976,false;true,298/22402
negative,C0205160;C1513916;C2825415;C2825491;C3853545,false;false;false;false;false,299/22402
severe dysfunction,C3274777,false,300/22402
fasting c - peptide  ng / ml,C0015663;C0006558;C0439275,true;true;false,301/22402
aggressive ( n = $nmbr$ ),C0001807;C0580822,true;false,302/22402
aldosterone blocker  %,C0002006,true,303/22402
management of event — no . ( % ),C0001554;C0441471;C4019010;C0376636;C1273870;C3273539,true;false;false;true;false;false,304/22402
> $nmbr$ mg / dl chd status,C0439269;C0280604;C0449438;C3542407,false;false;false;false,305/22402
serum albumin  g $nmbr$ $nmbr$,C0036773;C0439267;C0728877,true;false;false,306/22402
intraperitoneal,C0442120,false,307/22402
headache,C0018681;C4553197,true;false,308/22402
left main artery,C0205091;C0205225;C0003842;C0226004;C1542147;C0443246;C1552822,false;false;true;false;false;false;false,309/22402
> $nmbr$ to < $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ a,C0040363;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0041260;C1883351,true;true;false;false;false;false;false;true;false,310/22402
established,C0443211;C1272684,false;false,311/22402
gender ( % ) male / female,C0079399;C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1522384,true;true;true;true;false;false;false;false;false;true,312/22402
chondroitin sulfate ( n = $nmbr$ ),C0008466,true,313/22402
unstable angina ( biomarker negative ),C0002965;C0005516;C0205160;C1513916;C2825415;C2825491;C3853545,true;true;false;false;false;false;false,314/22402
american indian or native alaskan,C0002460,true,315/22402
symptom onset to start of reperfusion treatment : tenecteplase or arterial sheath insertion !,C4086878,false,316/22402
age ( years ) [ median ( $nmbr$ th to $nmbr$ th percentile ) ],C1510829;C0549183;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false;false,317/22402
formoterol $nmbr$ gg bid,C0060657;C0017454;C0018370,true;true;true,318/22402
race or ethnic group ( % ),C0034510;C1706779;C3853635,true;false;false,319/22402
dihydropyridine,C0012315;C0220821,true;true,320/22402
canakinumab,C2718773,true,321/22402
lev status  n ( % ),C0023556;C0449438,true;false,322/22402
steroids § §,C0038317,true,323/22402
normal / mild ckd,C0205307;C2945599;C1561643;C0231683;C0439166;C2347086;C4553972,false;false;true;false;false;false;false,324/22402
number of stent = $nmbr$,C0237753;C0038257;C0449788,false;true;false,325/22402
previous medications  n ( % ),C0205156;C0013227;C0802604;C2598133;C4284232;C1552607,false;true;false;false;false;false,326/22402
nyha class $nmbr$ - $nmbr$ : no { n = llll ),C1882083,false,327/22402
tofacitinib $nmbr$ mg twice daily n = $nmbr$,C2930696;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,328/22402
verapamil sr n = $nmbr$ no . ( % ),C1527129,false,329/22402
no prior ml or stroke,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,330/22402
stent length per lesion  mm,C0038257;C1444754;C0221198;C4330985;C4554674;C1546698;C1706316,true;false;false;false;false;false;false,331/22402
chf history,C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,332/22402
anti - ccp antibody positive,C4318437;C0741132,true;false,333/22402
oral medications,C0304289,false,334/22402
no antidiabetic drug,C0935929,true,335/22402
tofacitinib $nmbr$ mg two times a day,C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,336/22402
no . of $nmbr$ - mg acetaminophen tablets / day,C0439422;C1243102,false;false,337/22402
acpa positive  %,C1525410;C0439178;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false,338/22402
timi major / minor,C4441842,false,339/22402
severity of airflow limitation ( gold $nmbr$ - $nmbr$ )  n ( % ),C0439793;C0231999;C0443288;C0018026;C1304897;C0449295;C0522510,false;false;false;true;false;false;false,340/22402
pooled simva,C1709595;C2349200;C4522255,false;false;false,341/22402
timi risk score — no . ( % ) : t,C0035647;C0449820;C4050231;C4552904,true;false;false;false,342/22402
baseline dyspnea index  mean total score,C1511069;C3533236;C0439175;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false;false,343/22402
number ( % ) of patients with event,C2360800,false,344/22402
atrial fibrillation onset,C0004238;C0206132;C0332162;C0344434;C1963067,true;true;false;false;false,345/22402
infarct characteristics,C0021308;C1521970,true;false,346/22402
caucasian simva ( „ = $nmbr$ },C0007457;C0043157,true;true,347/22402
ticagrelor $nmbr$ mg $nmbr$ yr km %,C1999375;C0024671;C0439234;C3887676;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;true;false;false;false;false;false,348/22402
galectin - $nmbr$ ( ng / ml ),C0607430;C0439275,true;false,349/22402
hctz = hydrochlorothiazide . * based on wilcoxon $nmbr$ - sample rank - sum tests for age and body mass index  t tests for systolic and diastolic blood and ' / $nmbr$ tests for categorical variables . t data were missing for some patients .,C0020261;C0001779;C0012000;C0005767;C0005768;C0229664;C1551393;C0030705;C1705492;C3272743,true;false;true;true;true;false;false;true;false;false,350/22402
$nmbr$ mg clopidogrel load,C0024671;C0070166;C1550025;C1704782;C1708715;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,351/22402
intravenous dobutamine,C0348016;C0012963,false;true,352/22402
family history of diabetes — no . ( % ),C1313937,false,353/22402
primary prevention subgroup,C0033144;C1079230;C1515021,true;false;false,354/22402
telmisartan ( n = $nmbr$  $nmbr$ ),C0248719,true,355/22402
ppi use ( p = $nmbr$ - $nmbr$ t ),C0358591;C0871125;C3811894,true;true;false,356/22402
large mi,C0549177;C3810814,false;false,357/22402
never / rarely,C2003901;C0522498,false;false,358/22402
medication adherence,C2364172,true,359/22402
no concomitant cortcosteroid use,C0521115;C0042153;C0457083;C1947944,false;true;false;false,360/22402
severity of hypertensionb,C0439793;C0522510,false;false,361/22402
clopidogrel  %,C0070166,true,362/22402
fev $nmbr$ percent predicted ( sd ),C3714541;C0439165,true;false,363/22402
antidiabetic medication | |,C0935929,true,364/22402
gad positive — no . ( % ) ^,C0270549;C0439178;C1446409;C1514241;C2825490;C3812269;C1414925,false;false;false;false;false;false;false,365/22402
intravenous vasodilators ( % ),C0443081,false,366/22402
european trial,C0239307;C0008976;C1535514,false;true;false,367/22402
systemic corticosteroid use,C4053960;C0042153;C0457083;C1947944;C0205373;C0239126,false;true;false;false;false;false,368/22402
weight  median ( interquartile range )  kg,C0005910;C0549183;C1711350;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;false;false;true;false;false,369/22402
indacaterol $nmbr$ ug versus placebo,C1722260;C0041573;C0439211,true;true;false,370/22402
crohn ’ s disease related surgery,C0010346,true,371/22402
peripheral arterial disease — no . ( % ) §,C0085096;C1704436,true;true,372/22402
mases ( $nmbr$ - $nmbr$ )  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,373/22402
duration of coronary artery disease — yr,C0449238;C0018787;C0852949;C0439234;C2926735,false;true;false;false;false,374/22402
hba $nmbr$ c  mean ( sd )  % [ mmol / mol ],C0019016;C0444504;C2699239;C3829066;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false;false,375/22402
total cholesterol ( week $nmbr$ ),C0201950;C0332174;C0439230;C0543421,false;false;false;false,376/22402
at least $nmbr$ severe flare,C0205082;C1517205;C3540542;C4050465;C4050466,false;false;false;false;false,377/22402
baseline / concomitant therapies,C0168634;C1707479;C1442488,true;false;false,378/22402
chd eze / simva ( n = $nmbr$ ],C0280604;C3542407,false;false,379/22402
heart failure criteria met,C0018801;C0243161;C0018802;C4554158,true;true;true;false,380/22402
left atrial diameter,C0225860;C1301886;C0225861,true;false;false,381/22402
pulmonary function tests  % of predicted,C0024119;C0681842;C1882327;C2598152,true;false;false;false,382/22402
other nsaids,C0003211,true,383/22402
rheumatic heart disease,C0035439,true,384/22402
coronary angiography and intervention,C0085532;C1548829,true;false,385/22402
time of qualifying ecg to balloon inflation ( hrs ),C0040223;C1514624;C1623258;C3541383,true;false;true;false,386/22402
time from symptoms to treatment,C0040223;C0683368;C1457887;C3541383,true;true;false;false,387/22402
ratio fp / sal : sal ( $nmbr$ % ci ),C0456603;C0016704;C0036140;C0008107;C3259781;C0037494;C0206136;C1419068;C1419906;C3541238;C3541412;C1547037,false;true;true;true;false;true;true;false;false;false;false;false,388/22402
coexisting conditions — no . ( % ),,,389/22402
clopidogrel  ticlopidine  or prasugrel,C0070166;C0040207,true;true,390/22402
crp ( mg / dl ) < $nmbr$ . $nmbr$,C3890735;C0439269;C4048285,false;false;false,391/22402
mean ± s . d . duration of diabetes  years,C0444504;C0449238;C0011847;C0439234;C0011849;C2926735;C2347634;C2348143,false;false;false;false;true;false;false;false,392/22402
russia / georgia ( n = $nmbr$ ),C0035970;C0017452;C0017454,true;true;true,393/22402
fatal and nonfatal ml,C1302234;C1705232,false;false,394/22402
hypertension ( n 二 $nmbr$ ),C0020538;C1963138,true;false,395/22402
cv event  years,C3538987;C0441471;C0439234;C4019010;C4048877;C4318503,false;false;false;false;true;false,396/22402
oxidative stress,C0242606,true,397/22402
age ( yrs ) < $nmbr$,C0001779,false,398/22402
no . of previous anti - tnf drugs — no . ( % ),C0205156;C1448177;C0013227;C3687832;C1552607,false;true;true;false;false,399/22402
< $nmbr$ . $nmbr$ mmol / liter apob : apoa - l ratio,C1532563;C0475211;C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,false;false;true;true;false;false;false;false;false;true,400/22402
former smoker  n ( % ),C0337671,false,401/22402
less than $nmbr$ %,C0439092,false,402/22402
hispanic ( n = $nmbr$ ),C0086409,true,403/22402
ischemic tvr,C0475224,false,404/22402
any albuminuria — no . ( % ),C0001925,true,405/22402
baseline ics use  n ( % ),C0168634;C0815320;C4551720;C1442488,true;false;true;false,406/22402
bosentan ( n = $nmbr$ ),C0252643,true,407/22402
nitrates ( oral or topical ),C0028125;C0699857;C3848573,true;false;false,408/22402
left - sided disease only,C3842976;C0012634,false;true,409/22402
third heart sound  n ( % ),C0232237;C0232278,false;false,410/22402
other antiarrhythmics ^,C0003195,true,411/22402
psa duration  years,C3810537;C0449238;C0439234;C2926735;C3813209,false;false;false;false;false,412/22402
low molecular weight ( lmw ) heparin before randomisation,C0019139;C0034656;C3536766,true;true;false,413/22402
interval study drug to pci,C1272706;C0013175;C4049621;C1552654;C1552713,false;true;false;false;false,414/22402
atrial fibrillation / atrial flutter  %,C0155709,false,415/22402
a $nmbr$ + ez n = $nmbr$,C0206578,true,416/22402
initial aspirin — no . ( % ),C0205265;C0004057;C1279901;C1555582;C1705685,false;true;false;false;false,417/22402
symbol digit score,C0679214;C0582802;C0449820;C4050231;C3241971;C1698987,false;false;false;false;false;false,418/22402
time from qualifying event to randomization,C0040223;C1514624;C0441471;C4019010;C3541383,true;false;false;false;false,419/22402
serum hdl cholesterol ( mmol / l )  mean ( sd ),C0428472;C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,420/22402
pav  mean ( $nmbr$ % ci ),C0058890;C0444504;C0008107;C3259781;C2347634;C2348143,true;false;true;false;false;false,421/22402
events treatment ( $nmbr$ ),C0441471;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3541888,false;true;true;false;false;false;false;false;false,422/22402
annt or bnnh ( $nmbr$ % ci ),,,423/22402
geographic region  %,C0017446,true,424/22402
drug - related teaes $nmbr$,C0013227;C0439849;C0445223;C1254351,true;false;false;false,425/22402
atorvastatin dose,C0286651;C0178602;C0869039;C1114758,true;false;false;false,426/22402
ldl - cihdl - c  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,427/22402
prior biologic therapy ( including anti - tnfs ),C0278947,false,428/22402
left ventricular ejection fraction within previous $nmbr$ mo |,C0428772;C0205156;C0026544;C0332177;C1552607;C0488728,false;false;true;false;false;false,429/22402
cabg or pci,C0010055,true,430/22402
ace inhibitor monotherapy,C0003015;C4541021,true;false,431/22402
treated with cabg — no . / total no . ( % ),C0332293;C0010055,false;true,432/22402
psoriatic arthritis pain ],C4317006;C0003872;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;true;false;false;false;false;false;false;false;false,433/22402
erythrocyte sedimentation rate — mm / hr | |,C1176468;C4330985;C4554674;C1619634,false;false;false;true,434/22402
dose of aspirin,C4696290,false,435/22402
p - val . ( $nmbr$ ),C0369773;C0042285;C0523975;C2603361,false;true;false;false,436/22402
small - artery occlusion ( lacune ),C0226001;C0001168;C0241970;C0011382;C0028778;C0441597;C1110554;C1947917;C0700321;C0264995,false;false;false;true;false;false;false;false;false;false,437/22402
atorvastatin  n ( % ),C0286651,true,438/22402
baseline heart rate,C0168634;C0018810;C1442488,true;true;false,439/22402
apo b ( mg / dl ) - mean ± sd,C0003593;C0439269;C0444504;C2699239;C2347634;C2348143;C3252643,true;false;false;false;false;false;true,440/22402
peak procedural act — sec,C0444505;C0025664;C0184661;C2700391;C3274430;C3538935;C3539779,false;true;true;false;false;false;false,441/22402
extended - duration enoxaparin  n / n ( % ),C0231448;C0449238;C0206460;C2926735;C0231449;C0439792,false;false;true;false;false;false,442/22402
total stent length,C0439175;C0038257;C1444754;C1706316;C0439810,false;true;false;false;false,443/22402
triglycerides  median ( range ),C0041004;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false;false;false,444/22402
efficacy,C1280519;C1707887,false;false,445/22402
non - stemi,C3537184,false,446/22402
mri substudy ( n = $nmbr$ ),C0024485;C1824234;C3890166,true;false;false,447/22402
lv mass index ( g / m $nmbr$ - $nmbr$ ),C0455825;C0600653;C0456715;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;false;false,448/22402
all with coenzyme q $nmbr$ ( n = $nmbr$  $nmbr$ ),C0041536,true,449/22402
serum total cholesterol  mmol / l ( sd ),C0587184;C1532563;C2699239;C1287371,false;false;false;false,450/22402
visits $nmbr$ e $nmbr$,C0545082;C1512346;C2826704,false;false;false,451/22402
week $nmbr$ ( itt population ),C0332174;C0032659;C1257890;C0439230,false;true;true;false,452/22402
puerperium,C0034042;C0086839;C1879329,true;true;false,453/22402
gold group d — no . ( % ) | |,C0018026;C0441838;C1304897,true;false;false,454/22402
atv $nmbr$ mg study protocol,C0210243;C0024671;C1507394;C2348563;C2599718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0674679;C1145759;C1334862,true;true;false;false;true;true;false;false;false;false;false;true;true;false,455/22402
aml / val $nmbr$ / $nmbr$ mg,C0023465;C0042285;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0523975;C0023467,true;true;true;true;false;false;false;false;false;false;true,456/22402
median albumin / creatinine ratio ( g / mg ),C0549183;C0486293;C0439267;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1318293;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;false;false;false;false;false;false;false;false;false,457/22402
smoking ( a ),C0037369;C0453996;C1881674,true;true;false,458/22402
tirofiban ( n = $nmbr$ ),C0247025,true,459/22402
time from acs to randomization ( median  iqr ),C0040223;C0742343;C4318612;C3541383,true;true;false;false,460/22402
smoking pack - years,C0037369;C1277691;C0453996;C1881674,true;false;true;false,461/22402
serum creatinine > $nmbr$ mmol / l  n ( % ),C0201976;C1532563;C0600061,false;false;false,462/22402
nonaspirin antiplatelet agent,C0722138;C0085826,false;true,463/22402
use of concomitant lipid - modifying therapy,C1524063;C1707479;C0023779;C0392747,false;false;true;false,464/22402
% stenosis  as assessed by investigator,C0678234;C1261287;C2632116,false;true;false,465/22402
parenteral anticoagulalion before randomization,C0030547;C0034656;C4522267,true;true;false,466/22402
lesions b $nmbr$ / c,C0221198;C1546698,false;false,467/22402
median fasting insulin ( iqr ) — pu per milliliter,C0549183;C0015663;C0021641;C0018387;C0439242;C1533581;C1579433;C3714501;C0876920;C2347635;C2348144;C2939193,false;true;true;true;false;false;false;false;false;false;false;false,468/22402
death or stent thrombosis,C0011065;C1306577;C4082313;C4552775,true;false;false;false,469/22402
measured at home with automated device,C0444706;C3541902,false;false,470/22402
atenolol *,C0004147,true,471/22402
neuropilin ( ng / ml ),C0287275;C0439275,true;false,472/22402
individuals with diabetes  n = $nmbr$,C0027361;C0011847;C0011849;C0237401,true;false;true;false,473/22402
basal insulin analogue : insulin,C0650607;C0243071;C0205112;C2825028,false;false;false;false,474/22402
mean pulse pressure  mmhg ( s . d . ) “,C0445074;C0232117;C2347155;C0391850;C1947910;C0444504;C0949236;C2347634;C2348143,false;true;false;false;false;false;true;false;false,475/22402
oral hypoglycemic drug,C0359086,false,476/22402
antihypertensive treatment,C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,477/22402
patients with > $nmbr$ exacerbations resulting in hospital admission,C0030705;C4086268,true;false,478/22402
ranolazine ( n = $nmbr$  $nmbr$ ),C0073633,true,479/22402
final timi flow grade post - ppci,C0205088;C3272266;C0441800;C0687676;C1704687;C3469826;C0919553;C3244287;C1546485;C3853528,false;false;false;false;false;false;false;false;false;false,480/22402
duration of disease  median,C0872146;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,481/22402
ace inhibitor or arb at enrollment,C0003015;C4541021,true;false,482/22402
psoriasis duration  yrs *,C0033860;C0449238;C2926735,true;false;false,483/22402
$nmbr$ to < $nmbr$ . $nmbr$ %,C0040363;C0041260;C1883351,true;true;false,484/22402
simvastatin monotherapy ( n = $nmbr$  $nmbr$ * ),C0074554,true,485/22402
timi major bleeding,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,486/22402
small - artery occlusion,C0226001;C0001168;C0011382;C0028778;C0441597;C1110554;C1947917;C0700321;C0264995,false;false;true;false;false;false;false;false;false,487/22402
left ventricular hypertrophy — no . ( % ),C0149721;C3484363,true;false,488/22402
laboratory findings,C0587081,false,489/22402
crp  nmol / l  median ( range ),C3890735;C0439282;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false;false;false,490/22402
bivariate frailty model ( statin users vs non - users ),C0424594;C3161035;C0360714;C1706077;C3274659;C3714583;C3853906,true;false;true;false;false;false;false,491/22402
resection performed  %,C0015252;C0728940,false;false,492/22402
liraglutide $nmbr$ . $nmbr$ mg ls means ( n ),C1456408;C0024671;C0023668;C1704970;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,493/22402
ada ifg,C1060325;C1334085;C1708411;C3811629,false;false;false;false,494/22402
median change  %,C0549183;C0392747;C0443172;C1705241;C4319952;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,495/22402
sita $nmbr$ + pio $nmbr$,C0030800;C2347712,true;false,496/22402
combined estimated gfr and albuminuria status,C0205195,false,497/22402
neoplasia,C0027651;C1882062,true;false,498/22402
venous graft,C0042449;C0181074;C0332835;C1961139;C0348013,true;false;true;false;false,499/22402
mean age  y  median ( range ),C0444504;C0001779;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false,500/22402
body - mass index ( kg / mj ) previous diagnosis,C0005893;C0022718;C0439254;C0332132;C4284025;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;true,501/22402
antihyperglycemic,C0020616,true,502/22402
duration of ra ( time from symptom onset )  years,C0449238;C3538806;C0040223;C3541383;C4048756;C2926735,false;false;true;false;false;false,503/22402
grouped region,C0439745;C0017446;C0205147;C4319846,false;true;false;false,504/22402
nitrate — no . ( % ),C0028125;C0699857;C3848573,true;false;false,505/22402
shs  mean $nmbr$ sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,506/22402
oral antidiabetes monotherapya  n ( % ),C0442027;C4521986,false;false,507/22402
patients without ra  as  or psa ( n = $nmbr$  $nmbr$ ),C0030705;C3538806;C4048756,true;false;false,508/22402
treatmentofpulmonary embolismpriorto randomization,C0034656,true,509/22402
renin - angiotensin inhibitors,C2917241;C0003018;C4521302;C3653375,false;true;false;false,510/22402
fev $nmbr$  litres ( post - salbutamol )  mean ( sd ),C3714541;C0475211;C0687676;C0001927;C0444504;C2699239;C2347634;C2348143;C1704687;C3469826,true;false;false;true;false;false;false;false;false;false,511/22402
upper respiratory tract infection $nmbr$ ( $nmbr$ . $nmbr$ ),C0041912,true,512/22402
age at diagnosis  y,C1828181;C3173302,false;false,513/22402
change in mtss ( mean ),C0392747;C0444504;C2347634;C2348143;C0443172;C1705241;C4319952,false;false;false;false;false;false;false,514/22402
aliskiren ( n = $nmbr$ ),C1120110,true,515/22402
number of exacerbations in last $nmbr$ months,C0237753;C4086268;C0449788,false;false;false,516/22402
p  all vs all,C0369773;C2603361,false;false,517/22402
fasting plasma insulin — mu / liter,C0015663;C0857690;C0028971;C0475211;C0347978;C3714918,true;false;true;false;false;false,518/22402
baseline albumin / creatinine ratio in $nmbr$ classes,C0168634;C0486293;C0456387;C1518526;C1705943;C4019422;C1318293;C1442488,true;false;false;false;false;false;false;false,519/22402
cvd risk factors ( age > $nmbr$ ),C0007222;C0035648;C0001779;C1553898;C0035647;C0001783;C4552904,true;true;false;false;true;true;false,520/22402
former smoker ( n = $nmbr$ ),C0337671,false,521/22402
prior use of biologics  n ( % ),C0332152;C1524063;C0005515;C0005522;C4553887;C2826257,false;false;true;true;true;false,522/22402
amlodipine $nmbr$ mg / v = $nmbr$,C0051696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,523/22402
moderate or less airflow limitation,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,524/22402
ethnic group — no . ( % ) ',C0015031;C1879937,true;false,525/22402
any event,C0441471;C4019010,false;false,526/22402
pain in extremity,C0030196;C4553007,false;false,527/22402
hospitalized for asthma  n ( % ) *,C0701159;C0004096;C2984299,false;true;false,528/22402
sex : male ( n = $nmbr$ ),C0086582,true,529/22402
apolipoprotein b ^,C0003593,true,530/22402
abnormal angiogram,C0205161;C0002978;C1548816;C3891555;C4255126;C2347472;C2699333,false;true;false;false;true;false;false,531/22402
three or more drugs,C0205449,false,532/22402
data missing,C1511726;C3245479;C3714741,false;false;false,533/22402
heart failure nyha ii - iii,C0018801;C1275491;C1710602;C0439070;C1705160;C4082587;C0018802;C4554158,true;false;false;false;false;false;true;false,534/22402
cerebrovascular disease  n ( % ),C0007820,true,535/22402
western europe hr ( $nmbr$ % cl ),C0043129;C0596019,true;false,536/22402
biologic agents,C0005515,true,537/22402
ls mean difference ± seb,C0023668;C0444504;C1705241;C0059386;C1309881;C1423585;C3815268;C1705242;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false,538/22402
factor xa inhibitor,C2825027;C4553708,false;false,539/22402
mean bmi  kg / m $nmbr$ ( s . d . ),C0444504;C0578022;C0022718;C1512018;C0439209;C4054209;C2347634;C2348143,false;false;true;false;false;false;false;false,540/22402
anti - ischaemia agents *,C0040616;C0022116;C4321499,true;true;false,541/22402
exposure,C0274281;C0332157,false;false,542/22402
mycophenolate mofetil,C0209368,true,543/22402
age when diabetes first diagnosed — yr,C0001779,false,544/22402
randomization to placebo or telmisartan,C0034656;C0032042;C1696465;C1706408,true;true;false;false,545/22402
aspirin $nmbr$ clopidogrel,C0004057;C0070166,true;true,546/22402
chd risk equivalents  n ( % ),C1282512;C0439185;C4049980,false;false;false,547/22402
systolic blood pressure [ mmhg ] ( interaction : p = $nmbr$ . $nmbr$ ),C0488055;C0439475;C1704675;C0871470;C1306620,false;false;false;true;false,548/22402
clinical history,C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,549/22402
ezetimibe + simvastatin ( n = $nmbr$ * ),C1532737,true,550/22402
duration of psoriasis  years,C0449238;C0033860;C0439234;C2926735,false;true;false;false,551/22402
procedures for index event,C0025664;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C0184661;C2700391;C3538935,true;true;false;false;true;false;false;false;true;false;false,552/22402
killip class at admission — no . / total no . ( % ),C1881332;C0184666;C0809949,false;false;false,553/22402
other lipid parameters,C0023779;C0449381,true;false,554/22402
tc / hdl - c ratio,C0039411;C3715113;C0456603;C1547037;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;true;true;true;false;false;false,555/22402
ct or mr scan of the brain *,C0007673;C3540513;C3813556;C3888140,true;false;false;false,556/22402
peri - or postmenopausal,C0347985,false,557/22402
indeterminate or unknown,C0205258,false,558/22402
ratet ( $nmbr$ % cl ),C0596019,false,559/22402
> $nmbr$ % stenosis of coronary  carotid  or lower extremity arteries,C0242231;C0741968;C0018787;C0007282,true;false;true;true,560/22402
atrial fibrillation / flutter  n ( % ),C0155709,false,561/22402
hypertension — no . ( % ) hypercholesterolemia — no . ( % ),C0020538;C1963138,true;false,562/22402
pulmonary disease,C0024115,true,563/22402
region of enrollment  n ( % ) +,C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,564/22402
baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$,C0168634;C0578022;C1532718;C1442488,true;false;false;false,565/22402
statin + ezetimibe  n ( % ),C0360714;C1142985,true;true,566/22402
ldl - c ( calculated ) *,,,567/22402
evaluable for acr $nmbr$ at week $nmbr$  n,C1516986;C1412134;C1515941,false;false;false,568/22402
tertile $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ pg / ml ) n = $nmbr$,C0439297,false,569/22402
ez / simva n = $nmbr$ n ( % ),C0206578,true,570/22402
event rates  %,C0441471;C0871208;C1521828;C4019010,false;false;false;false,571/22402
baseline $nmbr$ - h ppg,C0168634;C0033727;C1418888;C0369286;C0441932;C0564385;C4528284;C1442488,true;true;false;false;false;false;false;false,572/22402
nontrial ppi,C0358591;C0871125;C3811894,true;true;false,573/22402
cardiac resynchronization therapy,C1167956,true,574/22402
nyha class iii or iv ( n = $nmbr$ ),C1882086,false,575/22402
oral agents use,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,576/22402
recurrent ischemia - urgent revascularization,C1455761;C0022116;C0439609;C0581603;C3272275;C4321499;C2945760,false;true;false;false;false;false;false,577/22402
rheumatoid factor positive §  n ( % ),C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,578/22402
serum p $nmbr$ np ( ^ g / liter ),C0229671;C0065827;C0439267;C0475211;C1706141;C3887659;C1546774;C1550100,true;true;false;false;false;false;false;false,579/22402
investigator - reported hypoglycaemia *,C0035173,true,580/22402
diuretic — no . / total no . ( % ),C0012798,true,581/22402
interleukin - $nmbr$ ( ng / l ),C0021764;C0439297;C1527200,true;false;false,582/22402
non - caucasian eze / simva ( „ = $nmbr$ },C1518422;C0007457;C0043157,false;true;true,583/22402
median ( q $nmbr$ : q $nmbr$ ) tgs,C0549183;C1156212;C1537574;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,584/22402
indacaterol $nmbr$ ug versus indacaterol $nmbr$ ug,C1722260;C0041573;C0439211,true;true;false,585/22402
score of > $nmbr$ . $nmbr$ — %,C0449820;C4050231,false;false,586/22402
weight  median ( $nmbr$ th — $nmbr$ th percentiles )  kg,C0552346;C0549183;C0039725;C0022718;C0439209;C4054209;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;true;false;false;true;false;false;false;false;false;false;false,587/22402
$nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ ),C0369718;C0441922,false;false,588/22402
anti - cholinergics ( short - acting ) a,C0242896,true,589/22402
north america n z $nmbr$,C0028405,true,590/22402
diabetes durationa < median,C0011847;C0549183;C0876920;C2347635;C2348144;C2939193;C0011849,false;false;false;false;false;false;true,591/22402
discontinuations,C0457454,false,592/22402
available baseline blood specimen n,C0470187;C0168634;C0178913;C1442488,false;true;false;false,593/22402
quicki,,,594/22402
ratio of women to men — %,C0456603;C0043210;C1547037,false;true;false,595/22402
randomization to arterial sheath insertion,C0034656;C0003842;C0227952;C0021107;C0441587;C1512796;C1883719;C0221464,true;true;true;false;false;true;false;false,596/22402
p value versus placebo,C1709380,false,597/22402
history of cardiac arrhythmia,C3494593,false,598/22402
n analysed,C0369718;C0441922,false;false,599/22402
body mass  kg,C0518010;C0022718;C0439209;C4054209,false;true;false;false,600/22402
mean cdai score,C0444504;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false,601/22402
placebo plus aspirin,C0032042;C0332287;C0004057;C1696465;C1706408,true;false;true;false;false,602/22402
ii - iv ( % ),C1710602;C0022326;C4265176;C4082587,false;true;false;false,603/22402
previous bowel resection performed — no . of patients ( % ),C0205156;C0741614;C1552607,false;false;false,604/22402
left anterior descending  n ( % ),C0441998;C0205386;C1547177,false;false;false,605/22402
postmenopausal hormone use,C0232970;C0019932;C0042153;C0457083;C1947944;C4521914,false;true;true;false;false;false,606/22402
femoral neck,C0015815,true,607/22402
standard control ( n = $nmbr$ ) no . of patients ( percent ),C1442989;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C2828392,false;true;false;false;false;false;false;false,608/22402
other asian,C0078988,true,609/22402
measurements,C0242485,false,610/22402
antithrombotic / coagulant,C0009117,true,611/22402
myocardial infarction within the previous $nmbr$ yr,C0027051;C0205156;C0439234;C1552607;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false;false;false;false,612/22402
receiving concomitant nsaids and / or cox - $nmbr$ inhibitors,C1514756,false,613/22402
b digit symbol substitution  omega - $nmbr$ fatty acids vs placebo,C0582802;C0679214;C1555721;C1719844;C0015684;C1706204;C1698987;C3241971,false;false;false;false;true;false;false;false,614/22402
post - bronchodilator ratio of fev $nmbr$ to fvc — %,C2599594;C0456603;C3714541;C1547037,false;false;true;false,615/22402
statin with niacin,C0360714;C0027996;C1142562,true;true;false,616/22402
neither glucocorticoids nor immunosuppressive agents,C0017710;C3540777;C3540778,true;false;false,617/22402
anti - inflammatory drugs,C0003209,true,618/22402
i & ii : fev $nmbr$ > $nmbr$ % predicted,C0021966;C1710602;C3714541;C4082587;C0221138,true;false;true;false;false,619/22402
interval clopidogrel to pci,C1272706;C0070166;C4049621;C1552654;C1552713,false;true;false;false;false,620/22402
procedure,C0184661;C2700391;C3274430;C3539779,true;false;false;false,621/22402
electrophysiological study — no . ( % ) weight — ibj,C0850293,false,622/22402
montelukast ( n = $nmbr$ ),C0298130,true,623/22402
$nmbr$ - h pmg ( mg / dl ),C0033727;C0439269;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false;false,624/22402
phenytoin,C0031507;C0202454,true;false,625/22402
enact - $nmbr$ trial rerandomization to natalizumab ( n = $nmbr$ ),,,626/22402
$nmbr$ bmi  kg / m,C0578022;C1532718,false;false,627/22402
baseline ldl cholesterol,C0168634;C0023824;C0202117;C1442488,true;true;false;false,628/22402
iglar ( insulin glargine l $nmbr$ u ),C0907402;C0439148,true;false,629/22402
llv wlalil $nmbr$ statin,C0360714,true,630/22402
number of prior csdmards  n ( % ),C0237753;C0332152;C2826257;C0449788,false;false;false;false,631/22402
efficacy and safety : net adverse clinical events *,C1280519;C1707887,false;false,632/22402
glucocorticoids and immunosuppressants,C0017710;C3540777;C3540778,true;false;false,633/22402
heart disease risk factors,C0741920,false,634/22402
statin use at baseline,C0360714;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,635/22402
current smoker : ex - smoker ( % ),C3173209;C3241966,false;false,636/22402
aspirin but no ppi,C0004057,true,637/22402
nsaid use — no . / total no . ( % ),C0003211;C3536840,true;false,638/22402
dx at presentation  n ( % ),C3538936;C0449450,false;false,639/22402
recent surgery or trauma,C0332185;C0038894;C0038895;C0543467;C1274039,false;false;true;true;true,640/22402
left anterior descending,C0441998;C0205386;C1547177,false;false;false,641/22402
ezetimibe $nmbr$ mg + statin ( n = $nmbr$  $nmbr$ ),C1142985;C0024671;C0360714;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,642/22402
coumadin,C0699129,true,643/22402
device group,C1706365,false,644/22402
glargine,C0907402,true,645/22402
safety population  n ( % ),C0036043;C0032659;C1257890;C1705187,true;true;true;false,646/22402
pef  post - bronchodilator  % predicted normal,C0030771;C1518922;C1542834,true;false;false,647/22402
all randomized patients ( range ),C0034656;C0030705;C1514721;C2348147;C3542016;C3815594,true;true;false;false;false;false,648/22402
permanent,C0205355,false,649/22402
tocilizumab,C1609165,true,650/22402
$nmbr$ = help needed  still independent,C1269765;C1552861,false;false,651/22402
non - metsyn,C1518422,false,652/22402
hemoglobin  g $nmbr$ $nmbr$,C1319312,false,653/22402
level of renal impairment,C0441889;C1565489;C0456079;C1547707;C2946261,false;true;false;false;false,654/22402
soe or sue,,,655/22402
previous stroke ortransient ischaemic attack ( % ),C0205156;C0038454;C0745413;C4554100;C1552607,false;true;false;false;false,656/22402
clopidogrel / ticlopidine,C0070166;C0040207,true;true,657/22402
selexipag,C2000145,true,658/22402
mi type unknown ( % ),C3810814;C0332307;C1547052,false;false;false,659/22402
crohn ' s disease,C0010346,true,660/22402
high - sensitivity crp — mg / liter | |,C1441604;C3890735;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;false;true;false;true;false;false;false;false;false;false,661/22402
prior coronary revascularization,C0332152;C0877341;C2826257,false;false;false,662/22402
severe teaes,C0205082;C4050465;C4050466,false;false;false,663/22402
any statin + other llt,C0360714,true,664/22402
arb at last follow - up,C3888198;C0589120;C1522577;C1704685;C3274571,false;false;false;false;false,665/22402
ml without st - segment elevation !,C0439526;C0520886;C1705224;C3887665,false;false;false;false,666/22402
hydralazine,C0020223,true,667/22402
multivessel pci,C4049621,false,668/22402
oral anticoagulant — no . / total no . ( % ),C0354604,false,669/22402
notable abnormalities,C4288581;C0000768;C0000769,false;true;true,670/22402
contrast nephropathy risk score,C0009924;C0022658;C0035647;C0449820;C4050231;C4552904;C1979874,true;true;true;false;false;false;false,671/22402
aspirin at last follow - up,C0004057;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,672/22402
physical component,C0031809;C0449432;C1705248;C0205485;C1509143,true;false;false;false;false,673/22402
indacaterol $nmbr$ gg qd,C1722260;C0017454;C0332173;C0018370,true;true;false;true,674/22402
elderly ( > $nmbr$ years ),C0001792;C0439234;C1999167,true;false;false,675/22402
odds ratio versus placebo ( $nmbr$ % ci ),C0028873,true,676/22402
geographic region - north america,C0017446;C0028405,true;true,677/22402
all patients with fistulas ( n = $nmbr$ ),C0030705;C0016169,true;true,678/22402
fev $nmbr$ / fvc ( post - albuterol ),C3714541,true,679/22402
prior medications,C0332152;C0013227;C0802604;C2598133;C4284232;C2826257,false;true;false;false;false;false,680/22402
location of ml,C0450429;C0439526;C1705224;C3887665;C1515974;C4284930;C4284931,false;false;false;false;false;false;false,681/22402
use of hormone replacement therapy ( a ),C1524063;C0282402,false;true,682/22402
versus tiotropium $nmbr$ . $nmbr$ pg,,,683/22402
prior coronary revascularization  n ( % ),C0332152;C0877341;C2826257,false;false;false,684/22402
duration of infusion — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,685/22402
beta - blocker at last follow - up |,C0001645;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,686/22402
rentrop score,C0449820;C4050231,false;false,687/22402
randomisation visit ( baseline ),C0034656;C0545082;C0168634;C1442488;C1512346;C2826704,true;false;true;false;false;false,688/22402
gastrointestinal area involved — no . / total no . ( % ),C0521362;C0017446;C0205146,false;true;false,689/22402
baseline pulmonary medication  n ( % ),C0168634;C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false,690/22402
median serum periostin  ng / mla,C0549183;C0229671;C0219433;C0017887;C0599973;C0028074;C1424662;C3812270;C1546774;C1550100;C0876920;C2347635;C2348144;C2939193,false;true;true;true;true;true;false;false;false;false;false;false;false;false,691/22402
multiple tnfi *,C0439064,false,692/22402
diet + pravastatin ( n = $nmbr$ ),C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,693/22402
prior coronary artery bypass graft surgery,C0332152;C0010055;C2826257,false;true;false,694/22402
c - peptide  median ( ql  q $nmbr$ )  nmol / l,C0006558;C0549183;C0439282;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,695/22402
enoxaparin,C0206460,true,696/22402
vorapaxar placebo $nmbr$ - yr %,C2974521;C0032042;C0439234;C1696465;C1706408,true;true;false;false;false,697/22402
missing data,C4684714,false,698/22402
risk reduction ( %  $nmbr$ % ci ),C1137094;C0008107;C3259781,true;true;false,699/22402
fastest third,C0015663;C0205437;C0456962;C2985769,true;false;false;false,700/22402
gemfibrozil,C0017245,true,701/22402
cha $nmbr$ ds $nmbr$ - vasc,C1420648;C3714751,false;false,702/22402
ezetimibe / simvastatin $nmbr$ / $nmbr$ mg ( n = $nmbr$ ),C1532737;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,703/22402
( $nmbr$ % ci ] $nmbr$,C0008107;C3259781,true;false,704/22402
triglycerides mean ( mg / dl ± sd ),C0041004;C0444504;C0439269;C2699239;C2347634;C2348143,true;false;false;false;false;false,705/22402
incidence rate,C1708485,false,706/22402
urinary albumin / creatinine ratio  median mg / g ( range ),C0455271;C0549183;C1300563;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1318330,false;false;false;false;false;false;false;false;false;false;false,707/22402
minimum stent diameter,C4054490;C0038257,false;true,708/22402
nt - probnp pg / mla ( iqr ),C0669479;C0030827;C0599973;C0072225;C1266240;C0754710,true;true;true;true;false;true,709/22402
body mass index ( bmi )  kg / m $nmbr$,C0005893;C0578022;C1532718;C1305855,false;false;false;true,710/22402
diet plus pravastatin group ( n = $nmbr$ ),C0012155;C0332287;C0085542;C0441848;C0012159;C1519433;C2983588;C3668949,true;false;true;false;true;false;false;false,711/22402
duration of clopidogrel pretreatment 一 hr median,C0449238;C0070166;C1550147;C0549183;C0876920;C2347635;C2348144;C2939193;C2709094;C3539075;C3539076;C2926735,false;true;false;false;false;false;false;false;false;false;false;false,712/22402
family history of coronary artery disease,C2317524,false,713/22402
sex  n ( % ) male,C0086582,true,714/22402
cv risk factor - no . ( % ),C3538987;C0035648;C4048877;C4318503,false;true;true;false,715/22402
valvular disease ( % ),C3258293,false,716/22402
no corticosteroid + no imm  n,C0001617;C3536709,true;false,717/22402
antimalarials only,C0003374;C0205171;C1720467,true;false;false,718/22402
tnl ultrapositive > $nmbr$ . $nmbr$ pg / l  $nmbr$ = $nmbr$,C1540071;C0439278,false;false,719/22402
dactylitis count ( $nmbr$ - $nmbr$ )  mean ( sd ),C0239161;C0750480;C0444504;C2699239;C2347634;C2348143;C1705566,false;false;false;false;false;false;false,720/22402
nasal polyps,C0027430,true,721/22402
verapamil sr n = $nmbr$,C1527129,false,722/22402
continued thienopyridine n ( % ),C0549178;C1120149,false;true,723/22402
disease - progression composite outcome !,C0679250;C0242656;C0205199;C1547335;C0449258;C3542417;C1274040;C1335499;C1947900;C4552808,false;true;false;false;false;false;false;false;false;false,724/22402
egfrmdrd < $nmbr$ ml - min - $nmbr$ - $nmbr$ . $nmbr$ m - $nmbr$  n ( % ),C0439445;C0369637;C0441923,false;false;false,725/22402
diarrhea,C0011991;C1963091;C3641756;C4084784;C4084802;C4085317,true;false;false;false;false;false,726/22402
uric acid ( mg / dl ),C0041980;C0439269,true;false,727/22402
pasi score  mean ± sd,C4528685;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,728/22402
theophylline compound,C0039771;C0205198;C1706082,true;false;false,729/22402
heterogeneity / trend test,C0019409;C1521798;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4554533;C0242960,false;false;false;false;false;false;false;false;false;false;true,730/22402
disease,C0012634,true,731/22402
hispanic / latin american,C0019576,true,732/22402
isolated pulmonary embolism,C0205409;C0034065;C1548221,false;true;false,733/22402
middle tertile ( range  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / dl  mean ± sd  $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ mg / dl ),C0444598;C1514721;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016;C0549183;C1552826,false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false;false;false,734/22402
total cholesterol ( mg / dl )  mean + sd  available for $nmbr$ patients,C0201950;C0439269;C0444504;C2699239;C2347634;C2348143;C0543421,false;false;false;false;false;false;false,735/22402
geometric mean of baseline,C2986759;C0168634;C1442488,false;true;false,736/22402
baseline fvc  l,C0168634;C3714541;C1442488,true;true;false,737/22402
csf $nmbr$ s - hydroxy -,C3540512;C3889436,false;false,738/22402
mean annualized exacerbation rate,C0444504;C4086268;C0871208;C1521828;C2347634;C2348143,false;false;false;false;false;false,739/22402
placebo no . / total ( % ),C0032042;C1696465;C1706408,true;false;false,740/22402
not reported / unknown,C1518422,false,741/22402
prior therapy with tnf antagonist  n ( % ),C1514463;C1448177;C0231491;C0332152;C0279936;C2826257,false;true;false;false;false;false,742/22402
difference from baselinea,C1705241;C1705242,false;false,743/22402
age at randomization ( years ),C1510829;C0034656,false;true,744/22402
never used lev,C2003901;C1273517;C0023556,false;false;true,745/22402
single vessel coronary artery disease *,C0581374,false,746/22402
non - sulfonylurea secretagogues,C1518422;C0038766;C4704833;C3536898,false;true;true;false,747/22402
index event asymptomatic or unconfirmed,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,748/22402
baseline medical therapy,C0168634;C0418981;C1442488,true;false;false,749/22402
prior corticosteroid failure only,C0332152;C0001617;C0231174;C0205171;C1720467;C0680095;C3536709;C2826257,false;true;false;false;false;false;false;false,750/22402
one or more blood pressure medications  n ( % ),C0205447,false,751/22402
evomab ( n = $nmbr$ ),,,752/22402
baseline post - bronchodilator % predicted fev  < $nmbr$ %,C0168634;C1442488,true;false,753/22402
cardiovascular hospitalization,C0007226;C0019993;C3887460,true;true;false,754/22402
crohn ' s disease activity index score ],C0451071;C0449820;C4050231,false;false;false,755/22402
prior use of biologic agents,C0332152;C1524063;C0005515;C2826257,false;false;true;false,756/22402
relative risk reduction ( $nmbr$ % cl ),C0242492;C0301630;C0596019;C0392756;C1293152;C4551656;C0080103;C1137094;C0205345;C1547039,true;false;false;false;false;false;true;true;false;false,757/22402
hba $nmbr$ c distribution,C0019016;C0520511;C1704711;C1825777;C3538758,true;false;true;false;false,758/22402
diuretic agent,C0012798;C0450442;C1254351;C1521826,true;false;false;false,759/22402
patients treated with insulin,C0030705,true,760/22402
estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ) ^ |,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,761/22402
$nmbr$ - aminosalicylic compounds — no . ( % ),C0205198;C1706082,false;false,762/22402
iwqol - lite physical score ( arbitrary units ),C4483112;C0439183,false;false,763/22402
bdi total score ( baseline ),C0006448;C2964552;C0168634;C1442488;C0451022;C3714938;C3889415,true;false;true;false;false;false;false,764/22402
estimated * creatinine clearance < $nmbr$ mlvmin  %,C0750572;C0812399,false;false,765/22402
low - density lipoprotein cholesterol  %,C0023824,true,766/22402
education  high school or higher,C0683862,false,767/22402
partial mayo clinic scored,C0728938;C0454788;C0002424;C0442592;C1077578;C1550516,false;false;true;false;false;false,768/22402
prior lipid - modifying therapy,C1514463;C0023779;C0392747,false;true;false,769/22402
cv risk factor,C3538987;C0035648;C4048877;C4318503,false;true;true;false,770/22402
mets w / o t $nmbr$ dm,C0812270;C0011816;C3250443;C1705694;C2939420,false;true;false;false;false,771/22402
other countries,C0454664,false,772/22402
smoking history — no . ( % ),C1519384,false,773/22402
other vascular disease — no . ( % ),C0042373,true,774/22402
mean — g / dl,C0444504;C0439267;C2347634;C2348143,false;false;false;false,775/22402
outcome,C1274040,false,776/22402
ccbs  ( % ),C0006684,true,777/22402
sfc $nmbr$ / $nmbr$ | ig bid n = $nmbr$,C4521536;C0021027;C0305052;C0360506,false;true;false;false,778/22402
cangrelor  %,C1121991,true,779/22402
losartan n = $nmbr$,C0126174,true,780/22402
laba + ics,C0815320;C4551720,false;true,781/22402
short - acting anticholinergics,C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;true;false;false;false;true;false;false;false;false,782/22402
> $nmbr$ vessels with > $nmbr$ % stenosis,C0679403,false,783/22402
concomitant antihyperglycaemic drugs  n ( % ),C0521115;C0020616;C0013227;C3687832,false;true;true;false,784/22402
losmapimod,C3272847,true,785/22402
history of myocardial infarction ( % ),C1275835,false,786/22402
$nmbr$ - $nmbr$ with cv disease ( n = $nmbr$ ),C0007222,true,787/22402
severely impaired,C0205082,false,788/22402
estimated creatinine clearance < $nmbr$ ml / min *,C0750572;C0812399;C0439445,false;false;false,789/22402
anticyclic citrullinated peptide positive ^  n ( % ),C1320283;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,790/22402
wrist fracture,C0435630;C4553927,false;false,791/22402
mtx exposure ( mg / week ),C0025677;C0274281;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0332157;C1417487,true;false;true;false;false;true;false;false;false;false;false;false;false,792/22402
ischaemic  n ( % ),C0475224,false,793/22402
atenolol n = $nmbr$ no . ( % ),C0004147,true,794/22402
vascular disordersb,C0005847;C1558950;C1801960,true;false;false,795/22402
adjusted mean change from baseline ( $nmbr$ % ci )  % [ mmol / mol ],C0456081;C0444504;C0392747;C0168634;C0008107;C3829066;C3259781;C1442488;C0443172;C1705241;C4319952;C0439190;C0948922;C2347634;C2348143,false;false;false;true;true;false;false;false;false;false;false;false;false;false;false,796/22402
< $nmbr$ . $nmbr$ mmol / liter triglyceride level,C0439190;C0475211;C0428475,false;false;false,797/22402
previous myocardial infarction — no . ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,798/22402
time since diagnosis of diabetesa  n ( % ),C0040223;C3541383,true;false,799/22402
fev $nmbr$ / fvc  %  mean ( sd ) $nmbr$,C3714541;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,800/22402
> $nmbr$ . $nmbr$ mmol / l ( n = $nmbr$ ),C1532563,false,801/22402
serum albumin  g / dl,C0036773;C0439267;C0728877,true;false;false,802/22402
classification of af  no . ( % ),C0008902;C0344434;C4049859;C0008903;C0678229,true;false;false;true;false,803/22402
age at screening,C0001779;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,804/22402
change in sbp ( $nmbr$ months ),C0392747;C0085805;C0439231;C0443172;C1705241;C4319952,false;true;false;false;false;false,805/22402
bronchitis,C0006277,true,806/22402
left ventricular ef  mean ( sd )  %,C0225897;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,807/22402
pde $nmbr$ inhibitor monotherapy,C0031638,true,808/22402
ischemic heart disease  %,C0010054;C0151744,true;true,809/22402
neither pbo + statin eze + statin,C0031962;C0360714,true;true,810/22402
impaired fasting glucose level ( n = $nmbr$ ),C1272092;C0441889;C0456079;C1547707;C2946261;C0221099;C0202045,false;false;false;false;false;false;false,811/22402
cancer ( n = $nmbr$ ),C0006826;C0998265;C1306459,true;false;false,812/22402
selected clinical characteristics  n ( % ),C1707391;C0683325,false;false,813/22402
lumbar spine,C0024091;C3887615,true;false,814/22402
reversibility of fev $nmbr$ ( % ),C0449261;C3714541,false;true,815/22402
missing data — no . / total no . ( % ),C4684714,false,816/22402
insulin ( pmol / l ) t vital signs,C0021641;C0439284;C0150404;C0518766;C1533581;C1579433;C3714501,true;false;false;true;false;false;false,817/22402
glucose - lowering therapies,C0017725;C0441994;C0087111;C2003888,true;false;true;false,818/22402
baseline heart failure severity nyha class i,C0168634;C0018801;C0439793;C1882084;C0522510;C0018802;C4554158;C1442488,true;true;false;false;false;true;false;false,819/22402
selected baseline medications,C1707391;C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,false;true;true;false;false;false;false,820/22402
endovascular — no . ( % ),C0524425,false,821/22402
aspirin - erdp ( n = $nmbr$  $nmbr$ ),C0004057,true,822/22402
previous treatment with tnf antagonist — no . ( % ) §,C0205156;C0039798;C1448177;C0231491;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;true;false;false;false;false;false;false,823/22402
zotarolimus - eluting,C1700035,true,824/22402
change in nt - probnp at $nmbr$ months ( log - transformed ),C0392747;C0669479;C0754710;C0443172;C1705241;C4319952,false;true;true;false;false;false,825/22402
low - molecular - weight,C0041667;C1521991;C0205251;C0026385;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;false;true;false;false;false;false;false,826/22402
heart rate ( b . p . m . )  mean ± sd,C0018810;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923,true;false;false;false;false;false;false,827/22402
vorapaxar group ( n = $nmbr$ ),C2974521;C0441848,true;false,828/22402
glucose test,C0337438;C0595310,false;false,829/22402
number of concomitant aeds  n ( % ),C0237753;C0521115;C0180309;C0449788,false;false;true;false,830/22402
mean number of exacerbations ( per patient - year [ $nmbr$ % ci ] ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,831/22402
use $nmbr$ - asa compounds,C0042153;C0004057;C0205198;C1706082;C3853627;C0457083;C1947944,true;true;false;false;false;false;false,832/22402
glycemic drugs,C0005802;C0013227;C3687832,true;true;false,833/22402
balloon angioplasty — no . ( % ),C0002996;C0002997,true;true,834/22402
prior history of cardiovascular disease  n ( % ),C0332152;C0455539;C2826257,false;false;false,835/22402
accp bleeding risk at inclusion  no . ( % ) f,C3251812;C0007637;C1512693,false;true;false,836/22402
angina pectoris — no . ( % ),C0002962,true,837/22402
history of systemic hypertension,C0455527;C0205373,false;false,838/22402
angiography — no . ( % ),C0002978,true,839/22402
prasugrel,C1620287,true,840/22402
cardiovascular disease,C0007222,true,841/22402
prior congestive heart failure,C0332152;C0018802;C2826257,false;true;false,842/22402
post - bronchodilator reversibility fev $nmbr$ ( % ) mean ( sd ),C2599594;C0449261;C3714541;C0444504;C2699239;C2347634;C2348143,false;false;true;false;false;false;false,843/22402
diabetes therapy  n ( % ),C3274787;C3539002,false;false,844/22402
low - dose aspirin use at baseline yes,C2608320;C0042153;C0168634;C1549445;C1705108;C1710701;C1442488;C0457083;C1947944,false;true;true;false;false;false;false;false;false,845/22402
medication at enrollment — no . ( % ),C0013227;C1516879;C1696073;C3888021;C3244316;C4284232,true;false;false;false;false;false,846/22402
age  yrs  median ( $nmbr$ th  $nmbr$ th ),C0001779;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;true;false;false;false;false;false;false;false,847/22402
no . of predictors of cardiovascular risk,C2698872;C0007226;C0035647;C4552904;C3887460,false;true;true;false;false,848/22402
mean ( s . d . ) free pcsk $nmbr$  ng / ml,C0444504;C0332296;C0439275;C1880497;C1996904;C2347634;C2348143,false;false;false;false;false;false;false,849/22402
enrollment in lmwh,C1516879;C0019139;C3536766;C1696073;C3888021,false;true;false;false;false,850/22402
coronary angiography during the index hospital stay,C0085532;C0600653;C3489408;C0918012;C1552854;C1637833;C2986546;C1548829;C0428776;C0002978,true;true;true;true;false;false;false;false;false;true,851/22402
primary pci ( n = $nmbr$ ),C0205225;C4049621;C0439612;C0439631,false;false;false;false,852/22402
versus tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ pg,,,853/22402
long - acting or short - acting nitrates,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,854/22402
cardiovascular and respiratory,C0007226;C3887460,true;false,855/22402
hispanic ethnic group — no . ( % ) f,C0086409;C0015031;C1879937,true;true;false,856/22402
placebo  n ( rate ),C0032042;C0871208;C1521828;C1696465;C1706408,true;false;false;false;false,857/22402
calcium antagonists  n ( % ),C0006684,true,858/22402
egfr  ml / min / m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,859/22402
lipid lowering medication use,C0023779;C0441994;C0240320;C2003888,true;false;false;false,860/22402
opg  ( ng / ml ),C1262886;C0439275;C1336645;C1412836;C1710303,false;false;false;false;false,861/22402
final timi flow,C0205088;C3272266;C1546485;C3853528,false;false;false;false,862/22402
patient ' s global assessment of disease activity  mean ( sd ),C4054228;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,863/22402
with revascularisation,C0581603,false,864/22402
antihypertensive medication or,C0003364,true,865/22402
level $nmbr$ immobility § | |,C0441889;C0231441;C0456079;C1547707;C2946261,false;false;false;false;false,866/22402
serum creatinine  limo $nmbr$ $nmbr$,C0201976;C0600061,false;false,867/22402
central / eastern europe / russia,C0682369;C1707877;C0035970;C0205099;C0015177;C1879652,false;false;true;false;true;false,868/22402
role physical,C0035820;C0031809;C0205485;C1509143;C1705810;C3871154,true;true;false;false;false;false,869/22402
hba $nmbr$ c category  n ( % ),C0019016;C0683312;C3889287;C1825777;C3538758,true;false;false;false;false,870/22402
not reported in ecrf,C1518422,false,871/22402
beta - blockers ( all )  n ( % ),C0001645,true,872/22402
laba users,C1706077,false,873/22402
creatinine clearance at admission ( ml / min ),C0184666;C0151280;C0809949,false;false;false,874/22402
egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$  $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,875/22402
other anticoagulant,C0003280;C0848112;C3536711,true;false;false,876/22402
severe impairment ( < $nmbr$ ),C0205082;C0221099;C0684336;C4050465;C4050466,false;false;false;false;false,877/22402
pre - bronchodilator fev $nmbr$ ( % predicted normal ),C2599602;C3714541,false;true,878/22402
insulin + oad,C0021641;C1533581;C1579433;C3714501,true;false;false;false,879/22402
clopidogrel ( n = $nmbr$ ),C0070166,true,880/22402
first - generation stentt,C0205435;C0079411;C3146294;C1279901,false;true;false;false,881/22402
crp  mg / l : median ( range ),C3890735;C0439268;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false;false;false,882/22402
least square mean ( se ),C0023189;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,883/22402
preoperative heart rate ( beats per minute ),C0445204;C0018810,false;true,884/22402
angiography during index hospitalization,C0002978;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,true;true;true;true;false;false;false,885/22402
allhat - llt,C2347090,false,886/22402
prior cardiovascular event — no . ( % ) - j -,C0332152;C1320716;C2826257,false;false;false,887/22402
baseline killip class,C0168634;C1881332;C1442488,true;false;false,888/22402
score on modified rankin scale — no . ( % ) §,C0449820;C2984908;C3854213;C4050231,false;false;false;false,889/22402
energy / fatigue,C0424589;C0015672;C3463815;C4050243;C4554645;C0542479;C1442080;C4330907,false;true;false;false;false;false;false;false,890/22402
atrial flutter,C0004239;C0344423;C1963068,true;false;false,891/22402
subjects randomized,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,892/22402
active a,C0205177;C3853793;C3888249,false;false;false,893/22402
rec . ischemia leading to hasp,C1424025;C0022116;C4321499;C2606415,false;true;false;true,894/22402
history of cabg surgery  n ( % ),C0455610;C0010055,false;true,895/22402
western europe and other,C0043129,true,896/22402
qualifying mi type,C1514624;C3810814;C0332307;C1547052,false;false;false;false,897/22402
potassium - sparing at last follow - up,C0032821;C0589120;C1522577;C1704685;C3274571;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false,898/22402
congestive heart failure  n ( % ),C0018802,true,899/22402
score distribution : < $nmbr$,C0449820;C0520511;C1704711;C4050231,false;false;true;false,900/22402
candesartan $nmbr$ / $nmbr$,C0717550,true,901/22402
planned treatment strategy,C0599880;C0679199,false;false,902/22402
/ ’ - value $nmbr$ ’,C1522609,false,903/22402
parental history of myocardial infarction before $nmbr$ yr of age ( % ),C0030551;C1275835,true;false,904/22402
hba $nmbr$ c distribution at baseline  n ( % ),C0019016;C0520511;C0168634;C1442488;C1704711;C1825777;C3538758,true;false;true;false;true;false;false,905/22402
change in haq - di ( mean ) t,C0392747;C3826998;C0444504;C2347634;C2348143;C4321476;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false;false,906/22402
normoalbuminuria at baseline ( $nmbr$ % of patients treated ),C0168634;C0030705;C1442488,true;true;false,907/22402
previous deep - vein thrombosis or pulmonary embolism,C0205156;C0149871;C1552607,false;true;false,908/22402
placebo mean ( n ),C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,true;false;false;false;false;false,909/22402
previous coronary revascularization — no . ( % ),C0205156;C0877341;C1552607,false;false;false,910/22402
medical history and risk factors — no . ( % ),C0262926;C1704706,false;false,911/22402
rankin grade,C0441800;C0919553;C3244287,false;false;false,912/22402
previous heart failure,C0205156;C0018801;C0018802;C4554158;C1552607,false;true;true;false;false,913/22402
ptca or pci,C2936173,true,914/22402
inflammatory disease,C1290884,false,915/22402
exacerbations,C4086268,false,916/22402
statin ( open ),C0360714,true,917/22402
glyburide ( n = $nmbr$ ),C0017628,true,918/22402
history of cardiovascular disease — no . ( % ) ^ |,C0455539,false,919/22402
heart failure — no . ( % ),C0018801;C0018802;C4554158,true;true;false,920/22402
normoglycemic $nmbr$,C0580545,false,921/22402
fevi  % predicted  mean ( sd ) $nmbr$,C0849974;C1561566;C4528367,false;false;false,922/22402
cardiac failure  n ( % ),C0018801;C0018802,true;true,923/22402
previous vascular disease,C0205156;C0042373;C1552607,false;true;false,924/22402
ethnic origin  n ( % ),C0015031,true,925/22402
abatacept monotherapy ( n = $nmbr$ ),C1619966,true,926/22402
calcium channel antagonists  n ( % ),C0006684;C2757014,true;false,927/22402
high potencyc,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,928/22402
ra symptom duration — year,C3538806;C1457887;C0449238;C0439234;C0439508;C2926735;C3854129;C4048756,false;false;false;false;false;false;false;false,929/22402
previous myocardial infarction ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,930/22402
post - bronchodilator fvc ( l ) a,C2599594;C3714541,false;true,931/22402
moderate risk,C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,932/22402
< $nmbr$ . $nmbr$ mm hg diastolic blood pressure,C0439475;C0428883;C1305849,false;true;false,933/22402
$nmbr$ mg cohort,C0024671;C0009247;C0599755;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,934/22402
exercise times per week  ( minimum,C0015259;C0456698;C1524031;C1552614;C2826545;C1522704,true;false;false;false;false;false,935/22402
other ( $nmbr$ . $nmbr$ % ) t,C2603360,false,936/22402
medical conditions  no . ( % ),C0199168;C0012634;C0348080;C1705253;C3864998;C0205476,false;true;false;false;false;false,937/22402
smoking status at screening  n ( % ),C1519386;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0037369;C0421330;C0453996;C1881674,false;true;true;false;false;false;false;false;true;false;true;false,938/22402
low - dose rivaroxaban + aspirin ( n / n ),C2608320;C1739768,false;true,939/22402
revascularization,C0581603,false,940/22402
hoehn and yahr stage ( range  $nmbr$ - $nmbr$ ),C0205390;C1514721;C2348147;C3542016;C1300072;C1306673,false;false;false;false;false;false,941/22402
blood leukocyte count ( $nmbr$ cells per l ),C0023508;C0347983;C0023516;C0427512,true;false;true;false,942/22402
low risk and fewer symptoms ( group a ),C3272281;C3538919,false;false,943/22402
alt and / or ast > $nmbr$ times uln consecutive #,C1266129;C4553172,false;false,944/22402
$nmbr$ yr km % ( n ),C0439234;C3887676,false;false,945/22402
history of symptomatic,C0019664;C0231220;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,946/22402
time of symptom onset to balloon inflation ( hrs ),C1320528,false,947/22402
statin potency stratum  n ( % ),C0360714;C3245505,true;false,948/22402
no dysglycaemia or mets,C1960636,false,949/22402
weight $ $nmbr$ . $nmbr$ kg  < $nmbr$ . $nmbr$ kg  n,C0005910;C1319635;C0043100;C1305866;C1705104,true;false;true;false;false,950/22402
race or ethnic group,C0034510;C1706779;C3853635,true;false;false,951/22402
moderate impairment ( $nmbr$ to < $nmbr$ ),C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false,952/22402
ascvd including tia,C3665365,false,953/22402
receiving concomitant corticosteroids,C1514756,false,954/22402
laba + ics ( free or fixed - dose combination ),C0815320;C4551720,false;true,955/22402
fc - ldl - c  friedewald - calculated,C2983605,false,956/22402
egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ n = $nmbr$ ( $nmbr$ . $nmbr$ % ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,957/22402
receptor blockers  n ( % ) baseline lipid and apolipoprotein levels,C0597357;C0168634;C0023779;C1442488,false;true;true;false,958/22402
hyperkalemia ( > $nmbr$ . $nmbr$ meq / l ),C0020461;C0439375;C4552983,true;false;false,959/22402
region of enrollment  no . ( % ),C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,960/22402
mean score on haq - di §,C3533236;C3826998;C4321476,false;false;false,961/22402
medications at randomization,C0013227;C0034656;C0802604;C2598133;C4284232,true;true;false;false;false,962/22402
$nmbr$  $nmbr$ / $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ ),,,963/22402
history of cardiovascular disease,C0455539,false,964/22402
> $nmbr$ yr warfarin experience,C0439234;C0043031;C0237607;C0596545,false;true;false;false,965/22402
intervention in complex lesions,C1292781;C0221198,false;false,966/22402
peak creatine kinase - mb  u / l,C0444505;C0010290;C0439339;C0523584,false;true;false;false,967/22402
secondary ( change in total updrs score from baseline to final visit in phase $nmbr$ ),C0027627;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0175668;C0205436,true;false;false;true;false;false;false;false;false;false,968/22402
leflunomide ( mean dose : $nmbr$ . $nmbr$ mg / day ),C0063041;C0444504;C0178602;C0439422;C0869039;C1114758;C2347634;C2348143,true;false;false;false;false;false;false;false,969/22402
antithrombotic agents  n ( % ),C1704311,true,970/22402
leisure,C0086542,true,971/22402
angiotensin receptor blocker and / or ace,C0034787;C1622222,true;true,972/22402
type of treatment  n ( % ),C0455708,false,973/22402
pancreatic cancer,C0235974;C0346647;C2984259,true;true;false,974/22402
mean iglar dose ± sd ( u / day ),C0444504;C0178602;C2699239;C0456683;C0869039;C1114758;C2347634;C2348143,false;false;false;false;false;false;false;false,975/22402
int . p *,C3272375,false,976/22402
hawaiian / pacific,C0337920,true,977/22402
aspirin at any dose,C4696290,false,978/22402
baseline fpg,C0168634;C1442488,true;false,979/22402
crp ( mg / l ) : < $nmbr$,C3890735;C0439268;C4048285,false;false;false,980/22402
large - artery atherosclerosis,C0226003;C0003850;C0004153,false;true;true,981/22402
antihyperglycemic medication usage,C0020616;C0013227;C0457083;C3244316;C4284232,true;true;false;false;false,982/22402
carotid,C0741968,false,983/22402
western european includinq australia  israel  and south africa,C0043128;C0239307;C0022271;C1535514;C0239312;C0004340,true;false;true;false;false;true,984/22402
low density lipoprotein cholesterol  mg / dl * *,C0023824;C0439269,true;false,985/22402
blood eosinophil count ( $nmbr$ cells per l ),C0200638,false,986/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mdrd ),C1739039;C0439445;C0369637;C3839656;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,987/22402
placebo n = $nmbr$ subjects,C0032042;C1696465;C1706408,true;false;false,988/22402
treatment with candesartan,C0039798;C0717550;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,989/22402
hba $nmbr$ c $nmbr$ - < = $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,990/22402
eze / simva $nmbr$ / $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,991/22402
pulmonary rales,C0034642,true,992/22402
loop at last follow - up,C0445022;C0589120;C1522577;C1704685;C3274571,false;false;false;false;false,993/22402
modified rankin scale score,C2984908;C0449820;C4050231;C3854213,false;false;false;false,994/22402
qualifying event — no . ( % ),C1514624;C0441471;C4019010,false;false;false,995/22402
claudication ( fontaine class > $nmbr$ ),C0021775;C0456387;C1518526;C1705943;C0311395;C1456822,true;false;false;false;false;false,996/22402
steroid use at baseline  n ( % ),C0281991;C0168634;C1442488,false;true;false,997/22402
metabolic syndrome ( > $nmbr$ of $nmbr$ characteristics ),C0524620;C1521970,true;false,998/22402
killip class,C1881332,false,999/22402
respiratory medication ( % ),C0418986,false,1000/22402
concomitant lipid - lowering therapy  n ( % ),C0521115;C0585943,false;false,1001/22402
duration of t $nmbr$ dm,C0449238;C0011816;C3250443;C2926735,false;true;false;false,1002/22402
egfr  ml min $nmbr$ $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,1003/22402
smoking status ( % ),C1519386,false,1004/22402
bare - metal stent — no . ( % ),C2825200,false,1005/22402
rate / $nmbr$ patient - years,C0871208;C0030705;C0439234;C1521828,false;true;false;false,1006/22402
> $nmbr$ servings / wk ( n = $nmbr$ ),C1519269;C0332174;C0439230,false;false;false,1007/22402
key secondary end point : st,C4528314;C0036056;C3272372,false;true;false,1008/22402
no . of risk factors ( % ) | |,C0035648;C1553898,true;false,1009/22402
prior antihypertensive medication  n ( % ),C0332152;C0003364;C2826257,false;true;false,1010/22402
mean yearly decline,C0444504;C2347634;C2348143,false;false;false,1011/22402
standard therapy,C2936643,true,1012/22402
phosphorus  mmol $nmbr$ $nmbr$,C0031705;C0439190;C0080014;C3714498,true;false;true;false,1013/22402
lipid levels — mg / dl,C0428460;C0439269,false;false,1014/22402
smoking habit  n ( % ),C4505437,true,1015/22402
open triple ( n = $nmbr$ ),C0175566,false,1016/22402
no prior hf hospitalization ( n = $nmbr$  $nmbr$ ),C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,1017/22402
glyburide,C0017628,true,1018/22402
mean ( sd ) extent of exposure  days,C0444504;C2699239;C0439792;C0274281;C0439228;C0332157;C2347634;C2348143,false;false;false;false;false;false;false;false,1019/22402
triple therapy use at screening  n ( % ),C2121434;C0039798;C0042153;C0457083;C1947944;C0087111;C1363945,false;true;true;false;false;true;false,1020/22402
europe $nmbr$ ( n = $nmbr$ ),C0015176,true,1021/22402
ankle - brachial index < $nmbr$ . $nmbr$ — no . ( % ),C1328319;C3888326,true;false,1022/22402
number of subjects,C0237753;C0681850;C1550501;C1706203;C2349001;C2697811;C0449788,false;false;false;false;false;false;false,1023/22402
fasting insulin,C0015663;C0021641;C1533581;C1579433;C3714501,true;true;false;false;false,1024/22402
ace - i or arb use,C1452534;C0021966;C0221138;C4284014,true;true;false;false,1025/22402
pfo closure group ( n = $nmbr$ ),C0185003;C0441848;C1521802,false;false;false,1026/22402
median ( q $nmbr$ : q $nmbr$ ) duration of insulin use  years,C0549183;C1881378;C0021641;C0439234;C1533581;C1579433;C3714501;C2826775;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false;false,1027/22402
control group ( n = $nmbr$ ),C0243148;C0441848;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false;false,1028/22402
normal troponin,C0205307;C0041199;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false,1029/22402
ind / gly $nmbr$ / $nmbr$ pg o . d . n = $nmbr$,C4049864;C0017890;C2827928;C0523677,false;true;false;false,1030/22402
traditional chinese medicine for respiratory disease — no . ( % ),C0025124;C0035204;C0035242;C1515884,true;true;true;false,1031/22402
baseline copd exacerbation history  * n ( % ),C0168634;C0740304;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1442488,true;false;true;true;false;false;false;false;false,1032/22402
european union,C0015179,true,1033/22402
blood pressure - lowering treatment,C0596197;C0033095;C0441994;C2003888;C0460139;C1306345;C4284008;C0005823;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1271104;C1272641,false;true;false;false;false;false;false;true;true;true;false;false;false;false;false;false;true,1034/22402
ezetimibe,C1142985,true,1035/22402
fish oil,C0016157,true,1036/22402
cardiovascular inclusion criteriat,C0007226;C0007637;C1512693;C3887460,true;true;false;false,1037/22402
median duration of study - drug administration,C0549183;C2348354;C0013175;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false,1038/22402
psoriasis body surface area > $nmbr$ %,C0033860;C0005902,true;true,1039/22402
exenatide,C0167117,true,1040/22402
cardiovascular risk factors — no . / total no . ( % ),C0850624,false,1041/22402
( $nmbr$ % ci ) p value,C0008107;C1709380;C3259781,true;false;false,1042/22402
time from symptom onset to randomization,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,1043/22402
percentage difference ( $nmbr$ % cl ),C0439165;C1705241;C0596019;C1705242;C1549488;C1561533,false;false;false;false;false;false,1044/22402
fpg ( mmol / l )  mean ( sd ) 、,C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,1045/22402
apo a $nmbr$ ( g / l ),C0003592;C0439294;C0456615;C0523508;C4553344;C4553379,true;false;false;false;false;false,1046/22402
fibrinolysis ( n = $nmbr$ ),C0016017;C1305868,true;false,1047/22402
ticagrelor $nmbr$ mg vs . placebo hr ( $nmbr$ % ci ),C1999375;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1048/22402
combined n = $nmbr$,C0205195,false,1049/22402
simplified disease activity index,C3869582,false,1050/22402
ratio of ldl to hdl,C0456603;C1547037,false;false,1051/22402
st ( arc definite only ),C0036056;C0439544;C0205171;C1720467;C1704787;C3272372,true;false;false;false;false;false,1052/22402
duration of diabetes mellitus  y,C0449238;C0011849;C2926735,false;true;false,1053/22402
sex  male / female  %,C0086287;C0086582;C1706180;C1706428;C1706429;C0043210;C1705497;C1705498,true;true;false;false;false;true;false;false,1054/22402
total study population ( n = $nmbr$  $nmbr$ ),C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,1055/22402
sita / pio $nmbr$ / $nmbr$,C0030800;C2347712,true;false,1056/22402
blood eosinophils count,C0014467,true,1057/22402
who / idf ifg,C1334085;C1708411,false;false,1058/22402
cardiovascular history 一 no . ( % ),C1880008,false,1059/22402
ace inhibitor at last follow - up,C0003015;C0589120;C1522577;C1704685;C3274571;C4541021,true;false;false;false;false;false,1060/22402
prior cardiac surgery  n ( % ),C0455610;C0018787;C1522601;C0332152;C0018821;C0524727;C2826257,false;true;false;false;true;true;false,1061/22402
ischemic aetiology  n ( % ),C0475224;C0015127;C1314792;C1524003,false;true;true;false,1062/22402
placebo $nmbr$ year km ( % ),C0032042;C0439234;C3887676;C0439508;C1696465;C1706408,true;false;false;false;false;false,1063/22402
vorapaxar n = $nmbr$,C2974521,true,1064/22402
postmenopausal  never or past hormone therapy use,C0232970;C2003901,false;false,1065/22402
difference vs placebo  % [ $nmbr$ % cl ]  p,C1705241;C1705242,false;false,1066/22402
urinary albumin - to - creatinine ratio ^,C0455271;C1318330,false;false,1067/22402
percent change,C0439165;C0392747;C0443172;C1705241;C4319952,false;false;false;false;false,1068/22402
standard care ( n = $nmbr$ ),C1442989;C1947933;C2828392,false;false;false,1069/22402
cerebrovascular disorders  n ( % ),C0007820,true,1070/22402
ace inhibitor — no . ( % ),C0003015;C4541021,true;false,1071/22402
location of treatment center,C0039798;C0205099;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,1072/22402
indacaterol $nmbr$ ug ( n = $nmbr$ ),C1722260;C0041573;C0439211,true;true;false,1073/22402
history of peripheral arterial disease ( % ),C0683519;C0205100;C0003842;C0221464;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,1074/22402
creatinine  mean ( sd )  mg / dl,C0010294;C0444504;C2699239;C0439269;C2347634;C2348143;C1561535,true;false;false;false;false;false;false,1075/22402
sf $nmbr$ - pcs,C0037712;C1864389;C1882368,true;false;true,1076/22402
randomization groups $nmbr$ and $nmbr$,C0034656;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429,true;false;false;true;false;false;false;false,1077/22402
presence of honeycombing  $nmbr$ n ( % ),C0150312;C0332468;C0349384;C0392148;C3854307,false;false;false;false;false,1078/22402
very severe n z $nmbr$,C3641272;C4050419,false;false,1079/22402
years since pah diagnosis,C0439234,false,1080/22402
partial mayo score $ | |,C0728938;C0454788;C0449820;C4050231;C1077578;C1550516,false;false;false;false;false;false,1081/22402
rosuvastain + fenofibric acid $nmbr$ = $nmbr$,C0060179,true,1082/22402
severity n ( % ),C0439793;C0522510,false;false,1083/22402
history of hypercholesterolemia,C1533076,false,1084/22402
> $nmbr$ years education,C0439234;C0013621;C0013622;C0013658;C0039401,false;true;true;true;true,1085/22402
angiographic complications  site - reported — no . / total no . ( % ),C0002978;C0009566;C0205145;C1515974;C2825164;C1171258,true;false;false;false;false;true,1086/22402
acute coronary syndrome $nmbr$,C0948089,true,1087/22402
asastoppedat randomization  n,C0034656,true,1088/22402
mean blood pressure  mmhg ( s . d . j,C0428886;C2347155;C0488053,true;false;false,1089/22402
baseline lipids  mean ± sd ( mmol / l ),C0168634;C0023779;C0444504;C2699239;C1532563;C2347634;C2348143;C1442488,true;true;false;false;false;false;false;false,1090/22402
philippines,C0031529,true,1091/22402
active cancer at randomization  n ( % ),C0205177;C0006826;C0034656;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false,1092/22402
current (  $nmbr$ cigs / day ),C0521116;C1570610;C0332173;C0439228;C0439505;C1705970,false;true;false;false;false;false,1093/22402
aspirin and ppi,C0004057,true,1094/22402
screening % reversibility fev $nmbr$,C0220908;C0449261;C3714541;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;true;false;false;false;false;false,1095/22402
prior pci or cabg surgery,C0332152;C4049621;C2826257,false;false;false,1096/22402
lower - limb arterial — no . ( % ),C0023216,true,1097/22402
baseline disease and quality - of - life scores,C0168634;C0012634;C1442488,true;true;false,1098/22402
index event  %,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,1099/22402
endoscopy subscore,C0014245,true,1100/22402
intended clopidogrel dose $nmbr$ mg,C1283828;C0070166;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C1551357,false;true;false;true;true;false;false;false;false;false;false;false;false,1101/22402
placebo + mtx,C0032042;C0025677;C1417487;C1696465;C1706408,true;true;false;false;false,1102/22402
celecoxib ( n = $nmbr$ ),C0538927,true,1103/22402
oral hypoglycemic agent,C0359086,false,1104/22402
death  mi  idr  or st,C0011065;C3810814;C1306577;C4082313;C4552775,true;false;false;false;false,1105/22402
unacceptable adverse events,C1883420;C0877248;C1705413,false;false;false,1106/22402
tolal choleslerol - lo - hdl choleslerol ralio,C0206579;C3715113;C1232424,true;false;false,1107/22402
median ( days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,1108/22402
ldl particle size ( week $nmbr$ ),C3641256;C0332174;C0439230,false;false;false,1109/22402
gold $nmbr$ groups,C0018026;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C1304897,true;false;false;true;false;false;false;false;false,1110/22402
parameter,C0549193;C1704769;C2350001,false;false;false,1111/22402
vascular intervention,C0005847;C0184661;C0886296;C1273869;C1558950;C1801960,true;true;false;false;false;false,1112/22402
a $nmbr$ + ezio a $nmbr$ ( n = $nmbr$ ) ( n = $nmbr$ ),,,1113/22402
amlodipine / vaisartan ( n = $nmbr$ ),C0051696,true,1114/22402
ldl cholesterol — mg / dl | |,C0023824;C0439269;C0202117,true;false;false,1115/22402
week $nmbr$ ( geometric mean  cv ),C0332174;C2986759;C3538987;C4048877;C4318503;C0439230,false;false;false;true;false;false,1116/22402
triglycerides ( week $nmbr$ ) a,C0041004;C0332174;C0439230,true;false;false,1117/22402
cause of heart failure,C0015127;C0018801;C0018802;C4554158;C1524003,true;true;true;false;false,1118/22402
copd or asthma,C0024117;C1412502;C3714496,true;false;false,1119/22402
latin and north america,,,1120/22402
comorbid diseasesa diabetesb,C0009488,true,1121/22402
cardiac rhythm,C0232187,false,1122/22402
proactive intervention ( n = $nmbr$ a ),C0184661;C0886296;C1273869,true;false;false,1123/22402
$nmbr$ = minor symptoms  no limitations,C0026193;C0683368;C1457887;C0205165,true;true;false;false,1124/22402
patients ' characteristics age ( years )  mean + sd,C0815172;C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,1125/22402
history of hypercholesterolemia  n ( % ),C1533076,false,1126/22402
acc / aha lesion class b $nmbr$ or c  n ( % ),C4072694;C0221198;C0456387;C1518526;C1705943;C1546698,false;false;false;false;false;false,1127/22402
enact - $nmbr$ trial,,,1128/22402
fasting insulin — / tiu / ml §,C0015663;C0021641;C0439526;C1705224;C3887665;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false,1129/22402
biomarker low ( periostin < $nmbr$ ng / ml or blood eosinophils < $nmbr$ cells per pl )  na,C0005516;C0205251;C0219433;C0439275;C1424662;C3812270;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;true;false;false;false;false;false;false;false;false,1130/22402
age  mean years  [ sd ],C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,1131/22402
lipoprotein ( a ) ( mg / dl ),C0065058;C0439269;C0125953;C1096202;C1439335,true;false;true;false;false,1132/22402
any pulmonary medication,C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268,true;true;false;false;false;false;false,1133/22402
non - study ppi use,C1518422;C0557651;C0358591;C0871125;C3811894;C2603343,false;false;true;true;false;false,1134/22402
> $nmbr$ : obese class iii,C1319441,false,1135/22402
acute dvt study,C0205178;C0149871;C0557651;C2603343;C2926618;C3899446,false;true;false;false;false;false,1136/22402
high subgroup,C0205250;C1079230;C1515021;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,1137/22402
mean ( sd ) body mass index  kg / m $nmbr$,C0444504;C2699239;C0005893;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;false;true;false;false,1138/22402
diuretic drugs,C0012798;C0013227;C3687832,true;true;false,1139/22402
gallbladder - related aes,C0016976;C0439849;C1412268;C2699274;C0445223,true;false;false;false;false,1140/22402
rivastigmine ( n = $nmbr$ ),C0649350,true,1141/22402
vitamin e,C0042874;C3714803,true;false,1142/22402
jvp > $nmbr$ cm,,,1143/22402
family history of venous thromboembolism ( % ),C0241889;C1997614;C0015576;C0455533;C0042449;C0348013;C1704727,true;false;true;false;true;false;false,1144/22402
post - bronchodilator fev $nmbr$ ( % predicted * ),C2599594;C3714541,false;true,1145/22402
creatinine clearance by c - g ( ml / min ),C0439267;C0151280,false;false,1146/22402
associated with hiv infection,C0332281;C0019693,false;true,1147/22402
muscle spasms,C0037763,true,1148/22402
copd severity ( gold stage ),C0024117;C0439793;C0018026;C0205390;C1300072;C1306673;C1304897;C0522510;C1412502;C3714496,true;false;true;false;false;false;false;false;false;false,1149/22402
rivaroxaban $nmbr$ mg,C1739768;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1150/22402
baseline cardiac biomarkers elevated,C0168634;C2735101;C2735102;C1442488,true;false;false;false,1151/22402
mental component score ( mcs ),C0229992;C0449432;C0449820;C4050231;C1705248,false;false;false;false;false,1152/22402
combined end points,C0205195;C2349179,false;false,1153/22402
death  large mi,C0011065;C0549177;C3810814;C1306577;C4082313;C4552775,true;false;false;false;false;false,1154/22402
race  white  n ( % ),C0034510;C1706779;C3853635,true;false;false,1155/22402
elevated tg,C0205250;C0337445;C3163633,false;false;false,1156/22402
baseline scales  median ( range ),C0168634;C1442488,true;false,1157/22402
formal education  years,C0681344;C0439234,false;false,1158/22402
tiotropium $nmbr$ gg qd,C0213771;C0017454;C0332173;C0018370,true;true;false;true,1159/22402
thrombocytopenia,C0040034;C0392386,true;false,1160/22402
presence of mets,C0150312;C0812270;C1705694;C2939420;C0392148;C3854307,false;false;false;false;false;false,1161/22402
treatment at randomization — no . ( % ),C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,1162/22402
other biologic agent,C0005515,true,1163/22402
hdl < $nmbr$ / $nmbr$ mg / dl ( $nmbr$ . $nmbr$ / $nmbr$ . $nmbr$ mmol / l ) for men / women,C3715113;C3642216;C3898312;C0025266;C0043210,false;false;false;true;true,1164/22402
baseline systolic bp,C0168634;C0871470;C1442488,true;true;false,1165/22402
angina class iii or iv prior myocardial infarction,C0264677,false,1166/22402
mucolytic agent,C0026698,true,1167/22402
acenocoumaroi,,,1168/22402
multiple,C0439064,false,1169/22402
emotional well - being,C2984554;C3641833,false;false,1170/22402
$nmbr$ ( fev $nmbr$ < $nmbr$ % pred ),C3714541,true,1171/22402
rec . ischemia due worsening angina,C1424025;C0022116;C0678226;C0002965;C3146286;C4321499;C2606415,false;true;false;true;false;false;true,1172/22402
current ( $nmbr$ + cigs / day ),C0521116;C1570610;C0332173;C0439228;C0439505;C1705970,false;true;false;false;false;false,1173/22402
prior surgery : no,C0455610,false,1174/22402
carotid stenosis,C0007282,true,1175/22402
smoking history  pack - years  mean ( sd ),C1519384;C1277691;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,1176/22402
ever smoked ( current / former ),,,1177/22402
estimated gfr  ml min - $nmbr$ $nmbr$ . $nmbr$ m - $nmbr$ ( sd ) a,C0750572;C0017654;C0439445;C0369637;C2699239;C0441923;C1424601,false;true;false;false;false;false;false,1178/22402
isolated systolic hypertension  n ( % ) “,C0745133,false,1179/22402
feno placebo ( lsm ),C0032042;C1696465;C1706408,true;false;false,1180/22402
no . of prior tnfi,C0332152;C2826257,false;false,1181/22402
non - fatal myocardial infarction,C1518422;C1302234;C0027051;C0428953;C2926063;C3810814;C4552959;C1705232,false;false;true;false;false;false;false;false,1182/22402
involved intestinal area  n ( % ),C1879646;C0021853,false;true,1183/22402
normal fasting glucose level ( n = $nmbr$ ),C0522082;C0015663;C0205307;C0202045;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,1184/22402
saxa + dapa + met n = $nmbr$,,,1185/22402
joint damage outcomes ( mitt population ),C0022417;C0010957;C1274040;C0032659;C1257890;C1883709;C0392905;C1706309,true;false;false;true;true;false;false;false,1186/22402
discontinuations teaes,C0457454,false,1187/22402
aldosterone inhibitor,C0002007,true,1188/22402
adverse outcome,C1274040,false,1189/22402
etoricoxib $nmbr$ mg n = $nmbr$ n ( % ),C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1190/22402
asia - pacific hr ( $nmbr$ % cl ),C0003980;C0596019,true;false,1191/22402
left bundle - branch block,C0023211;C0344420;C2828132,true;false;false,1192/22402
any prior anti - tnf treatment failure,C1514463;C1448177;C0231174;C0680095;C0332152;C0162643;C0235828;C0521983;C1547544;C2826257,false;true;false;false;false;true;false;false;false;false,1193/22402
pioglitazone pts / n ( % ),C0071097;C1419129;C2698747,true;false;false,1194/22402
central / eastern europe and russia hr ( $nmbr$ % cl ),C0682369;C1707877;C0205099;C0015177;C1879652,false;false;false;true;false,1195/22402
copd - rosuvastatin ( n = $nmbr$ ),C0024117;C0965129;C1412502;C3714496,true;true;false;false,1196/22402
abatacept / open - label abatacept,C1619966;C1709323,true;false,1197/22402
nonblack race — no . ( % ) - j -,,,1198/22402
prior ischemic stroke,C0332152;C0948008;C2826257,false;false;false,1199/22402
ff / vi $nmbr$ / $nmbr$ gg ( n = $nmbr$  $nmbr$ ),C4554348;C0205999;C0017454;C0018370,false;true;true;true,1200/22402
baseline nihss score ( % ) #,C0168634;C1697238;C1442488,true;false;false,1201/22402
free fatty acids ( mmol / l ),C0015688;C1532563,true;false,1202/22402
laba or lama ’ versus ind / gly lsm difference ( $nmbr$ % cl ),,,1203/22402
change from baseline in hba $nmbr$ c ( % ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1204/22402
aspirin group ( n = $nmbr$ $nmbr$ ) ( $nmbr$ $nmbr$ person years ),C0004057;C0441848;C0027361;C0439234;C2347489,true;false;true;false;false,1205/22402
angiogenin ( ng / ml ),C0051844;C0439275;C1367482,true;false;false,1206/22402
weight  mean ± sd ( kg ),C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,1207/22402
race / ethnicity  %,C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,1208/22402
etanercept ( n = $nmbr$ ),C0717758,true,1209/22402
serum creatinine — pmol / liter,C0201976;C0439192;C0475211;C0600061,false;false;false;false,1210/22402
prior carotid intervention,C0332152;C0741968;C0184661;C0886296;C1273869;C2826257,false;false;true;false;false;false,1211/22402
abx - facil . pci,C4049621,false,1212/22402
antiplatelet — no . / total no . ( % ),,,1213/22402
other lipid - modifying drug use at study entry  n ( % ),C0023779;C0392747;C0242510;C0557651;C1705654;C2603343;C0042153;C0013175;C0457083;C1947944;C0013227;C0869040;C1254351,true;false;false;false;false;false;true;true;false;false;true;false;false,1214/22402
without dm ( n = $nmbr$ i $nmbr$ * ),C0011816;C3250443,true;false,1215/22402
potassium,C0032821;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false,1216/22402
difference ( tiotropium - placebo ) ml ( $nmbr$ % ci ),C1705241;C0213771;C0032042;C0439526;C0008107;C3259781;C1705224;C3887665;C1696465;C1706408;C1705242,false;true;true;false;true;false;false;false;false;false;false,1217/22402
any relevant infarct,C2347946;C0021308,false;true,1218/22402
baricitinib  $nmbr$ mg daily ( n = $nmbr$ ),C4044947;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,1219/22402
ls mean % change from baseline _ se,C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false,1220/22402
established ascvd or > $nmbr$ cv risk factors,C0443211;C3665365;C1272684,false;false;false,1221/22402
fasting plasma glucose  mg / dl  mean ( sd ) b,C0015663;C0202042;C0439269;C0444504;C2699239;C2347634;C2348143;C0455280,true;false;false;false;false;false;false;false,1222/22402
e $nmbr$ + a $nmbr$ -,,,1223/22402
filtration rate $nmbr$ - $nmbr$,C0016107;C0871208;C1521828,true;false;false,1224/22402
placebo secukinumab $nmbr$ mg,C0032042;C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1696465;C1706408,true;true;true;true;false;false;false;false;false;false;false,1225/22402
sf - $nmbr$ physical component summaryjj,C0037712;C0031809;C0449432;C1705248;C0205485;C1509143,true;true;false;false;false;false,1226/22402
angiographic data,C0002978;C1511726;C3245479;C3714741,true;false;false;false,1227/22402
community hospital ( % ),C0020003,true,1228/22402
death or absolute fvc decrease > $nmbr$ %,C0011065;C1306577;C4082313;C4552775,true;false;false;false,1229/22402
indacaterol $nmbr$ mg [ n z $nmbr$ ],C1722260;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1230/22402
other statin,C0360714,true,1231/22402
median ( iqr ) age  years,C0549183;C1510829;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,1232/22402
estimated glomerular filtration rate < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ : i : §,C3811844;C0023806;C0702093;C0369637;C0441923;C1524029;C3813700;C0439445;C0021966;C0221138,false;true;false;false;false;false;false;false;true;false,1233/22402
homa_ % b tx difference vs pbo  median change from baseline ( se ) $nmbr$,C0041403;C1705241;C1705242,true;false;false,1234/22402
tim $nmbr$ nsk score,C1313407;C0449820;C4050231;C3541335;C3711667;C3827754;C3890185;C4319633,true;false;false;false;true;false;false;false,1235/22402
indication for pci,C0392360;C4049621;C3146298,false;false;false,1236/22402
percutaneous coronary intervention or coronary artery bypass graft surgery  n ( % ),C1532338,true,1237/22402
$nmbr$ - aminosalicylates ’ i  i ‘,C0368663;C0021966;C0221138,false;true;false,1238/22402
native latin,C0302891,false,1239/22402
left atrial diameter  mm ( sd ),C0225860;C1301886;C4330985;C2699239;C4554674;C0225861,true;false;false;false;false;false,1240/22402
patient history of disease,C0030705;C0683519;C0730226;C0850708;C0944983,true;false;false;false;false,1241/22402
copd severity : severe / very severe,C0024117;C0439793;C0442824;C2984081;C0522510;C1412502;C3714496,true;false;false;false;false;false;false,1242/22402
mean platelet volume  fl,C0200665;C1300812;C1708024;C0344388,true;false;false;false,1243/22402
in ibdq total score at week $nmbr$  mean [ se ],C2964552;C0332174;C0444504;C0036919;C2347634;C2348143;C0439230;C0439175;C3533236;C0439810,false;false;false;true;false;false;false;false;false;false,1244/22402
baseline ezetimibe usec,C0168634;C1142985;C0439224;C1442488,true;true;false;false,1245/22402
ics use at screening  n ( % ),C0815320;C4551720,false;true,1246/22402
mdi / hfa  n,C0993596;C0015458;C1839839;C4049613,true;true;true;false,1247/22402
moderate or severe exacerbations in the previous year ( range ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,1248/22402
mixed chronic bronchitis and emphysema,C0205430;C0008677;C3160715,false;true;false,1249/22402
triple - vessel disease  n ( % ),C0856738,false,1250/22402
mean ( sd ) crp  mg / l *,C0444504;C2699239;C3890735;C0439268;C4048285;C2347634;C2348143,false;false;false;false;false;false;false,1251/22402
epa / aa ratio,C0282379;C0456603;C1547037;C1235746;C1882141;C4554792,true;false;false;false;false;false,1252/22402
one or more requiring hospitalization in $nmbr$ mo before screening — no . ( % ) $nmbr$,C0205447,false,1253/22402
health state index score  uk algorithm,C0683314;C0600653;C0449820;C0041700;C0002045;C1553907;C4050231;C0918012;C1552854;C1637833;C2986546,false;true;false;true;true;false;false;true;false;false;false,1254/22402
time from onset of pain to randomization  median ( iqr )  h,C0449244;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;false;false;false;false;false;false;false;false,1255/22402
homajr tx difference vs pbo  median change from baseline ( se ) $nmbr$ lipid parameters,C0041403;C1705241;C1705242,true;false;false,1256/22402
ticagrelor  $nmbr$ mg ( n = $nmbr$ ),C1999375;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1257/22402
dpp - $nmbr$ inhibitor therapy,C1414174;C1999216;C0039798;C0087111;C1363945,false;false;true;true;false,1258/22402
median cardiac troponin t ( iqr ) — pg / ml,C0549183;C3538889;C0439297;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1259/22402
> $nmbr$ ( ml ) additional angiography,C0439526;C1524062;C0002978;C1705224;C3887665,false;false;true;false;false,1260/22402
sbp < $nmbr$ mmhg and dbp < $nmbr$ mmhg,C0085805;C0439475,true;false,1261/22402
insulin and oral hypoglycemic drugs,C0021641;C1533581;C1579433;C3714501,true;false;false;false,1262/22402
other antiplatelet,,,1263/22402
use of ics,C1524063;C0815320;C4551720,false;false;true,1264/22402
mean hscrp  mg / l ( sd ),C0444504;C0439268;C2699239;C2347634;C2348143,false;false;false;false;false,1265/22402
carotid revascularization,C0741968;C0581603,false;false,1266/22402
time from onset to randomization  h  mean ± sd,C0449244,false,1267/22402
beta - adrenergic blocker,C0001645;C2757061;C3536830,true;false;false,1268/22402
class l / ll heart failure,C0456387;C1518526;C1705943,false;false;false,1269/22402
rerandomization to placebo ( n = $nmbr$ ) f,C0032042;C0016327;C1696465;C1706408,true;true;false;false,1270/22402
triglycerides > $nmbr$ mg / dl,C0041004;C0439269,true;false,1271/22402
history of cabg surgery,C0455610;C0010055,false;true,1272/22402
vomiting,C0042963;C1963281;C3898969;C4084766;C4084767;C4084768;C4084769,true;false;false;false;false;false;false,1273/22402
thoracic cage fractures,C0222762,true,1274/22402
baseline sgrq score,C0168634;C1442488,true;false,1275/22402
usa and canada,C0041703,true,1276/22402
obesity ( body mass index > $nmbr$ kg / m $nmbr$ ),C0028754;C0005893;C1532718;C0578022;C1305855;C1963185,true;false;false;false;true;false,1277/22402
clopidogrel plus aspirin ( n = $nmbr$ ),C0070166;C0332287;C0004057,true;false;true,1278/22402
intent of early invasive strategy  %,C0162425;C1279919;C0205281;C0679199;C1334278;C1283828;C1550453,true;false;false;false;false;false;false,1279/22402
mean fev $nmbr$  l ( sd ),C0444504;C3714541;C2699239;C2347634;C2348143,false;true;false;false;false,1280/22402
heavy calcification,C0439539;C0006660;C0006663;C0175895;C1533591;C1879982;C2242558,false;true;true;false;false;false;false,1281/22402
cardiovascular medications  %,C0007220,true,1282/22402
only peripheral artery disease,C0205171;C1704436;C4025272;C1720467,false;true;false;false,1283/22402
inhaled anticholinergic §,C0004048;C0242896;C3537004,true;true;false,1284/22402
$nmbr$ - h plasma glucose during ogtt ( mmol / l ),C2827804;C0202042;C0029161;C0455280,false;false;true;false,1285/22402
uacra  mg / g  n ( % ),C1300563,false,1286/22402
western europe and israel,C0043129,true,1287/22402
sglt - $nmbr$ inhibitors ^,C3665045,false,1288/22402
myocardial infarction — no . ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,1289/22402
united states,C0041703,true,1290/22402
number of antidiabetes drugs at screening  n ( % ),C0237753;C0013227;C3687832;C0449788,false;true;false;false,1291/22402
any type  according to daily dose * *,C0332307;C0680240;C2348070;C1547052,false;false;false;false,1292/22402
glucocorticoids plus immunosuppressive agents,C0017710;C0021081;C3540777;C3540778,true;true;false;false,1293/22402
left anterior descending artery  n ( % ),C0226032,false,1294/22402
albuterol reversibility  %,C0001927;C0449261,true;false,1295/22402
rivaroxaban + aspirin,C1739768;C0004057,true;true,1296/22402
anyantianginal agent,C0450442;C1254351;C1521826,false;false;false,1297/22402
patients with diabetic nephropathy,C0030705;C0011881;C1442864,true;true;false,1298/22402
hba $nmbr$ c in patients with baseline hba $nmbr$ c > $nmbr$ % to < $nmbr$ % ( > $nmbr$ to < $nmbr$ mmol / mol )  % [ mmol / mol ]  la  n baseline ( sd ) adjusted mean change ( $nmbr$ % ci ) placebo subtracted change ( se ),C0019016;C0030705;C0168634;C1442488;C1825777;C3538758;C3829066;C0023031;C0168634;C2699239;C1442488;C0023749;C0230347;C2346906;C4553351;C0392747;C0008107;C0032042;C1719767;C0036919;C2348589;C1696465;C1706408;C3259781;C0443172;C1705241;C4319952,true;true;true;false;false;false;false;true;true;false;false;true;false;false;false;false;true;true;false;true;false;false;false;false;false;false;false,1299/22402
health - related quality of life,C4279947,true,1300/22402
risk factors  %,C0035648;C1553898,true;false,1301/22402
concomitant therapy  no . ( % ),C1707479,false,1302/22402
any cardiovascular disease history  n ( % ),C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,1303/22402
cardiac history  %,C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1522601,true;true;true;false;false;false;false;false,1304/22402
subgroup by treatment interaction p - value,C1079230;C0039798;C1704675;C1709380;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1515021,false;true;false;false;true;false;false;false;false;false;false,1305/22402
a $nmbr$ + ez $nmbr$ a $nmbr$ ( n = $nmbr$ ) ( n = $nmbr$ ),C0206578,true,1306/22402
dpi ( other than diskus )  n,C1553480,false,1307/22402
previous copd treatment  n ( % ) *,C0205156;C0024117;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1412502;C3714496;C1552607,false;true;true;true;false;false;false;false;false;false;false;false,1308/22402
body mass index ( kg / m $nmbr$ ) - mean ± sd,C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,1309/22402
positive for anti - cyclic citrullinated peptide antibody — no . ( % ) f,C0741132;C1320283,false;false,1310/22402
psoriasis duration  mean ± sd  years,C0033860;C0449238;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735,true;false;false;false;false;false;false;false,1311/22402
fevi  l *,C0429706;C0849974;C1561566;C4528367,false;false;false;false,1312/22402
ldl cholesterol at baseline ( mmol / l ) * ldl cholesterol at screening,C0023824;C0168634;C1532563;C1442488;C0202117,true;true;false;false;false,1313/22402
black race,C0005680,true,1314/22402
lp ( a )  mean ( sd ),C0065058;C0444504;C2699239;C2347634;C2348143;C1439335;C4553379,true;false;false;false;false;false;false,1315/22402
previous transient ischaemic attack / ischaemic stroke previous warfarin use,C0205156;C0007787;C0038454;C0043031;C0042153;C0457083;C1947944;C4554100;C0917805;C1552607,false;true;true;true;true;false;false;false;true;false,1316/22402
calculated ldl - c in $nmbr$ classes,C0444686;C0456387;C1518526;C1705943;C4019422;C1441506,false;false;false;false;false;false,1317/22402
rosiglitazone,C0289313,true,1318/22402
without revascularsation,,,1319/22402
odds ratio,C0028873,true,1320/22402
body mass index  kg / m $nmbr$  median ( q $nmbr$  q $nmbr$ ),C0005893;C1532718;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;false;true,1321/22402
exenatide n = $nmbr$,C0167117,true,1322/22402
total score on the sgrq - c  i,C2964552;C3826872;C0021966;C0221138,false;false;true;false,1323/22402
elevated creatinine ( > $nmbr$ pmol / l ),C0151578;C0439284;C0700225,false;false;false,1324/22402
valsartan / hctz,C0216784;C0020261,true;true,1325/22402
baseline : < $nmbr$ . $nmbr$ meq / l eos : > $nmbr$ . $nmbr$ or < $nmbr$ . $nmbr$ meq / l,C0168634;C0439375;C1623465;C1861303;C1442488,true;false;false;true;false,1326/22402
history of currently treated hypertension  n ( % ),C0455527;C0521116;C1522326,false;false;false,1327/22402
tg  mmol / l [ mg / dl ],C0337445;C3898312;C3642216,false;false;false,1328/22402
terminal ileum,C0227327,false,1329/22402
das $nmbr$ - esr lda,C0051767;C3811131;C4553195;C0057671,true;false;false;true,1330/22402
prior tnfi  n ( % ),C0332152;C2826257,false;false,1331/22402
liraglutide $nmbr$ . $nmbr$ mg / day ( n = $nmbr$ ),C1456408;C0439422,true;false,1332/22402
established ascvd,C0443211;C3665365;C1272684,false;false;false,1333/22402
depressed and low perceived social support,C0344315;C0549249,false;true,1334/22402
limb ( sd ),C0015385;C2699239,true;false,1335/22402
emergent / urgent surgery,C0750573;C2188405,false;false,1336/22402
laboratory measurements,C0681902,false,1337/22402
simva n = $nmbr$ n ( % ),,,1338/22402
czp $nmbr$ mg  % ( n / n ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,1339/22402
fibrinogen ( pmol / l ) c,C0016006;C0439284;C1167394;C2587184;C3540039,true;false;false;false;false,1340/22402
frailty status,C0424594;C0449438,true;false,1341/22402
basal insulin dose at run - in ( u / day ),C0650607;C0178602;C3274438;C0456683;C0869039;C1114758;C0205112;C0366513,false;false;false;false;false;false;false;false,1342/22402
worsening angina,C0002965,true,1343/22402
use of parenteral antithrombotic,C1524063;C0030547;C4522267,false;true;false,1344/22402
cvd or mi,C0007222,true,1345/22402
screening bmi ( kg / m $nmbr$ ),C0220908;C0578022;C1532718;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;true;false;false;false;false;false,1346/22402
atherosclerosis ^  n ( % ),C0003850;C0004153,true;true,1347/22402
none ( cdmard - naive or past use at baseline ),,,1348/22402
tender joint count ( $nmbr$ - $nmbr$ ),C0451530,false,1349/22402
hba $nmbr$ c  %  n ( % ) b,C0019016;C1825777;C3538758,true;false;false,1350/22402
ldl - c < $nmbr$ . $nmbr$ mmol / l,C1532563,false,1351/22402
duration of last qualifying episode of atrial fibrillation > $nmbr$ days,C0449238;C1514624;C0332189;C0004238;C0439228;C0344434;C1963067;C2926735,false;false;false;true;false;false;false;false,1352/22402
saxagliptin $nmbr$ . $nmbr$ mg ( n = $nmbr$  $nmbr$ ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1353/22402
years [ range ],C0439234;C1514721;C2348147;C3542016,false;false;false;false,1354/22402
potassium - sparing at enrollment,C0032821;C1516879;C1696073;C3888021;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false,1355/22402
body mass index > $nmbr$ kg / m $nmbr$  n ( % ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,1356/22402
modmy al randcnxzaton,C0202311,false,1357/22402
additional investigations,C2359834,false,1358/22402
peri - op amiodarone : no ( n = $nmbr$ ),C0347985;C0002598,false;true,1359/22402
ejection fraction  % nyha class  n ( % ),C0489482;C1882083;C2700378,false;false;false,1360/22402
class i or iii aad use in $nmbr$ months before enrollment,C0441885;C1319793;C2698967,false;false;false,1361/22402
intravenous anticoagulant during hospitalization,C0348016;C0003280;C0019993;C0848112;C3536711,false;true;true;false;false,1362/22402
high density lipoprotein cholesterol  mg / dl ^,C0023822;C0439269,true;false,1363/22402
functional assessment of chronic illness,C0278372;C0008679,false;true,1364/22402
hormonal status,C0458083;C0449438,false;false,1365/22402
postmenopausal  current hormone,C0232970;C0521116;C0019932;C4521914;C1705970,false;false;true;false;false,1366/22402
spironolactone ( n = $nmbr$ ),C0037982,true,1367/22402
any disease,C0012634,true,1368/22402
endothelin - receptor antagonists plus phosphodiesterase type $nmbr$ inhibitors,C1134681;C0031638;C0332307;C1547052;C1656262;C3539996;C2266875,true;true;false;false;false;false;false,1369/22402
bolus administered — no . ( % ),C1186706;C1511237;C1705509;C3812160,false;false;false;false,1370/22402
tofacitinib  $nmbr$ mg ( n = $nmbr$ ),C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1371/22402
medical history — no . / total no . ( % ),C0262926;C1704706,false;false,1372/22402
tobacco use ( % ),C0040335;C0543414;C0841002;C3853727,false;true;false;false,1373/22402
infliximab - naive ( n = $nmbr$ ),C0666743,true,1374/22402
week $nmbr$ mean 士 sd,C0332174;C0444504;C2699239;C2347634;C2348143;C0439230,false;false;false;false;false;false,1375/22402
hr ( $nmbr$ % ci ) p value for interaction *,C0008107;C1709380;C1704675;C3259781,true;false;false;false,1376/22402
history of congestive heart failure,C0455531;C0742742,false;false,1377/22402
events  no .,C0441471;C3541888,false;false,1378/22402
event / total,C0441471;C0439175;C0439810;C4019010,false;false;false;false,1379/22402
serum cholesterol — mmol / liter,C0587184;C0439190;C0475211,false;false;false,1380/22402
pooled empagliflozin ( n = $nmbr$ ),C1709595;C3490348;C2349200;C4522255,false;true;false;false,1381/22402
statin monotherapy,C0360714,true,1382/22402
total comparators  patients with events / total patients,C0439175;C1707454;C0030705;C0441471;C3541888;C4553389;C4553390;C0439810,false;false;true;false;false;false;false;false,1383/22402
( % ) control ( $nmbr$ ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,1384/22402
hypertension : no ( n = $nmbr$ ),C0020538;C1963138,true;false,1385/22402
angiotensin - converting enzyme inhibitor or angiotensin receptor blocker,C0003015;C2757044;C3536837;C4541021,true;false;false;false,1386/22402
bdmard - ir,C0022065;C0022071;C1448132,true;true;true,1387/22402
estimated glomerular filtration rate,C3811844,false,1388/22402
periprocedural medications — no . / total no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,1389/22402
proportion of predicted normal fev $nmbr$ value   §,C1709707;C0681842;C0086715;C3714541;C0520835;C1522609;C1882327,false;false;true;true;false;false;false,1390/22402
mellitus,,,1391/22402
amiodarone,C0002598,true,1392/22402
permanently stopped study drug because of adverse events,C1272691;C0557651;C0041755;C2603343,false;false;true;false,1393/22402
median ( q $nmbr$ : q $nmbr$ ) tg - rich lipoprotein cholesterol,C0549183;C0337445;C0699759;C0065055;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false,1394/22402
apolipoproiein a $nmbr$ ( tng / $nmbr$ ),,,1395/22402
metformin dose  mg,C0025598;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,true;false;true;true;false;false;false;false;false;false;false,1396/22402
placebo no . of events / total no . ( % ),C0032042;C1696465;C1706408,true;false;false,1397/22402
hba $nmbr$ c $nmbr$ % - < $nmbr$ % ( n - $nmbr$ ),C0019016;C1825777;C3538758,true;false;false,1398/22402
hypoglycaemic agents,C0020616,true,1399/22402
apremilast $nmbr$ mg bid n = $nmbr$,C1678805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1400/22402
duration  mean ( sd )  years,C0449238;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735,false;false;false;false;false;false;false,1401/22402
patient global assessment of disease activity ( vas $nmbr$ - $nmbr$ mm ),C4054228;C0042815;C4330985;C4554674;C3536884;C3827561,false;true;false;false;true;false,1402/22402
intermittent claudication,C0021775,true,1403/22402
myocardial ischaemia,C0010054;C0151744,true;true,1404/22402
arb at enrollment,C3888198;C1516879;C1696073;C3888021,false;false;false;false,1405/22402
rosuvastatin of patients ( rate ),C0965129;C0030705;C0871208;C1521828,true;true;false;false,1406/22402
recent cardioversion ( within $nmbr$ days before randomization ) —,C0332185;C0013778;C0439228,false;true;false,1407/22402
denosumab ( n = $nmbr$ ),C1690432,true,1408/22402
genotyping,C1285573,false,1409/22402
remission  n ( % ),C0544452;C0687702,false;false,1410/22402
radius fracture,C0034628,true,1411/22402
clopidogrel dose on / before pci,C0070166;C0178602;C4049621;C0869039;C1114758,true;false;false;false;false,1412/22402
enoxaparin / vka,C0206460,true,1413/22402
sf - $nmbr$ score,C0037712;C0449820;C4050231,true;false;false,1414/22402
seropositivity,C0521143,false,1415/22402
interval pain onset to admission,C1272706;C1507009;C0184666;C0809949;C1552654;C1552713,false;false;false;false;false;false,1416/22402
metrex modified intention - to - treat population with an eosinophilic phenotypey,,,1417/22402
number of previous anti - tnf treatments for psoriatic arthritis,C0237753;C0205156;C1448177;C0087111;C1552607;C0449788,false;false;true;true;false;false,1418/22402
serum creatinine  mean ( sd )  pmol / l,C0201976;C0444504;C2699239;C0439284;C2347634;C2348143;C0600061,false;false;false;false;false;false;false,1419/22402
coronary heart disease ( % ),C0010054;C0010068;C1956346,true;true;true,1420/22402
bmi ( kg / m $nmbr$ ) < $nmbr$,C0578022;C1532718,false;false,1421/22402
abdominal aortic — no . ( % ),C0003484,true,1422/22402
mean weight  kg ( sd ),C0444504;C0005910;C0022718;C2699239;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;false;true;false;false;false;false,1423/22402
severe hyperkalemiac,C0205082;C4050465;C4050466,false;false;false,1424/22402
history of bone disease ( predefined )  n ( % ),C0683519;C0262950;C0730226;C0850708;C0944983;C0019664;C0005940;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;false;false;true;true;true;false;false;false;false,1425/22402
abrupt vessel closure,C1276802;C0005847;C0185003;C1521802,false;true;false;false,1426/22402
/ j - valuc ! l,,,1427/22402
> $nmbr$ days warfarin,C0439228;C0043031,false;true,1428/22402
non - hdl - c ( mmol / l  mean ),C1518422;C3715113;C1532563;C0444504;C2347634;C2348143,false;false;false;false;false;false,1429/22402
yes  non - insulin - treated,C1549445;C1705108;C1710701,false;false;false,1430/22402
$nmbr$ - $nmbr$ . $nmbr$ kg / m $nmbr$,C1532718,false,1431/22402
baseline lp ( a ) in $nmbr$ classes,C0168634;C0065058;C0456387;C1518526;C1705943;C4019422;C1439335;C4553379;C1442488,true;true;false;false;false;false;false;false;false,1432/22402
primary + gusto moderate or severe bleeding,C0205225;C0439612;C0439631,false;false;false,1433/22402
dyspepsia,C0013395;C4552968,true;false,1434/22402
south asian,C1519427,false,1435/22402
claudication,C0021775;C0311395;C1456822,true;false;false,1436/22402
anticoagulant therapy,C0150457,false,1437/22402
dactylitis  n ( % ),C0239161,false,1438/22402
prior immunnosupressive failure but no anti - tnf failure,C0332152;C0231174;C0680095;C2826257,false;false;false;false,1439/22402
sf - $nmbr$ v $nmbr$ domain scores  mean [ sd ],C0037712;C1880389;C1883221;C3541951,true;false;false;false,1440/22402
reversibility ( b $nmbr$ - agonist )  %  mean ( sd ) $nmbr$,C0449261;C2987634;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,1441/22402
icd therapy vs . placebo no . hazard ratio ( $nmbr$ . $nmbr$ % cl ),C0021122;C0039798;C0087111;C1363945,true;true;true;false,1442/22402
fev  at baseline,C3714541;C0168634;C1442488,true;true;false,1443/22402
low - density lipoprotein cholesterol  mg / dl,C0023824;C0439269,true;false,1444/22402
qualifying type of atherosclerosis — no . ( % ),C1514624;C0332307;C0003850;C0004153;C1547052,false;false;true;true;false,1445/22402
white : black : other,C0007457;C0005680;C0027567;C0085756;C0439541;C0043157;C0220938,true;true;true;true;false;true;false,1446/22402
placebo estimated mean,C0032042;C1696465;C1706408,true;false;false,1447/22402
salmeterol - fluticasone group,C0939232;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1448/22402
impaired glucose tolerance or impaired fasting glucose — no . ( % ),C0271650,true,1449/22402
duration of t $nmbr$ dm ( % ),C0449238;C0011816;C3250443;C2926735,false;true;false;false,1450/22402
therapy ( asa $nmbr$  $nmbr$ / placebo $nmbr$ ),C0039798;C0004057;C0032042;C1696465;C1706408;C3853627;C0087111;C1363945,true;true;true;false;false;false;true;false,1451/22402
antihyperglycemic oral agent therapy,C0020616;C0442027;C0450442;C0039798;C0087111;C1363945;C1254351;C1521826;C4521986,true;false;false;true;true;false;false;false;false,1452/22402
gender  % of patients,C0079399;C0030705;C1522384,true;true;true,1453/22402
planned thienopyridine at baseline,C1301732;C1120149;C0168634;C1442488,false;true;true;false,1454/22402
medical history,C0262926;C1704706,false;false,1455/22402
medium - or low - intensity statin,C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false,1456/22402
current / past,C0521116;C1444637;C4284302;C1705970,false;false;false;false,1457/22402
rosuvastatin n = $nmbr$,C0965129,true,1458/22402
pulse rate ( bpm ),C0232117,true,1459/22402
anti - cholinergics ( long - acting ),C0242896,true,1460/22402
primary + gusto severe bleeding,C0205225;C0205082;C0019080;C4050465;C4050466;C0439612;C0439631,false;false;true;false;false;false;false,1461/22402
mean age  years ( $nmbr$ % ci ),C0444504;C1510829;C0008107;C3259781;C2347634;C2348143,false;false;true;false;false;false,1462/22402
vertebrobasilar infarct,C0545733;C0021308,false;true,1463/22402
alathosterol ( % ),,,1464/22402
blood oxygenation  mean ± sd,C0005767;C0231940;C0444504;C2699239;C2347634;C2348143;C0282636;C0005768;C0229664,true;false;false;false;false;false;true;true;false,1465/22402
rf positive  %,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,1466/22402
sf - $nmbr$ ( health transition score ),C0037712;C0376627;C0449820;C4050231,true;true;false;false,1467/22402
time since diagnosis of osteoarthritis — yr,C0040223;C3541383,true;false,1468/22402
no . of days to homa - ir testing — median ( iqr ),C0439228,false,1469/22402
certolizumab group ( n = $nmbr$ ),C1872109;C0441848,true;false,1470/22402
$nmbr$ - $nmbr$ / week,C0332174;C0439230,false;false,1471/22402
p $nmbr$ y $nmbr$ inhibitor,C0369773;C1999216;C2603361,false;false;false,1472/22402
previous cardiovascular disease !,C0205156;C0007222;C1552607,false;true;false,1473/22402
acute and delayed reaction,C0205178,false,1474/22402
atenolol strategy,C0004147;C0679199,true;false,1475/22402
nationality,C0027473,true,1476/22402
bl updrs : high,C0005918;C3639721;C0006413;C1552663;C2827109,true;true;true;false;false,1477/22402
history of paroxysmal atrial fibrillation  n ( % ),C0729790;C0205311,false;false,1478/22402
biomarker status,C0449442,false,1479/22402
nicotine pack - years,C0028040;C1277691,true;false,1480/22402
congestive heart failure — no . ( % ) | |,C0018802,true,1481/22402
fibrin - specific,C0015982,true,1482/22402
≥ $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ years,C0439234,false,1483/22402
duration of hypertension ( years ),C0449238;C0020538;C0439234;C1963138;C2926735,false;true;false;false;false,1484/22402
therapy ( asa $nmbr$ / placebo $nmbr$ ),C0039798;C0004057;C0032042;C1696465;C1706408;C3853627;C0087111;C1363945,true;true;true;false;false;false;true;false,1485/22402
$nmbr$ prolonged antithrombotic pretreatment ( n = $nmbr$ ),C0439590;C1550147;C2709094;C3539075;C3539076,false;false;false;false;false,1486/22402
isolated igt,C0205409;C1548221,false;false,1487/22402
pasi < $nmbr$ *,C4528685,false,1488/22402
$nmbr$ locf ),C2825507,false,1489/22402
uacr ( mgg - $nmbr$ ),,,1490/22402
vorapaxar placebo $nmbr$ - yr . km % rate,C2974521;C0032042;C0439234;C3887676;C0871208;C1521828;C1696465;C1706408,true;true;false;false;false;false;false;false,1491/22402
change from baseline  adjusted mean ( $nmbr$ % ci )  %,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1492/22402
paclitaxel - eluting,C0144576,true,1493/22402
distal anastomosis ( % ),C0448964,false,1494/22402
< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ — no . ( % ),C0439445;C0369637;C0441923,false;false;false,1495/22402
atrial fibrillation  n ( % ),C0004238;C0344434;C1963067,true;false;false,1496/22402
uacr  mg / mmol ( interquartile range ) b,C0567349;C1711350;C2348885,false;false;false,1497/22402
fasting glucose  mmol / l  mean ± sd,C0015663;C0017725;C1532563;C0444504;C2699239;C2347634;C2348143,true;true;false;false;false;false;false,1498/22402
coronary artery bypass surgery,C0010055,true,1499/22402
prior cardiovascular event — no . ( % ),C0332152;C1320716;C2826257,false;false;false,1500/22402
concomitant atorvastatin dose  mg,C0521115;C0286651;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,false;true;false;true;true;false;false;false;false;false;false;false,1501/22402
n ( indacaterol $nmbr$ ug / indacaterol $nmbr$ ug / placebo ),C0369718;C1722260;C1319635;C0032042;C1696465;C1706408;C0441922,false;true;false;true;false;false;false,1502/22402
etanercept,C0717758,true,1503/22402
aortic stenosis  n ( % ),C0003507,true,1504/22402
pretreatment / concomitant treatment,C1550147;C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2709094;C3539075;C3539076,false;false;true;true;false;false;false;false;false;false;false;false,1505/22402
circumflex,C1880089,false,1506/22402
diuretic drugs  n ( % ),C0012798;C0013227;C3687832,true;true;false,1507/22402
baseline median ( iq range ),C0168634;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false;false;false,1508/22402
serum sodium — meq / liter,C0523891;C0439152;C0475211,false;false;false,1509/22402
pacific islander,C0242191,true,1510/22402
hbalc > = $nmbr$ % ( n - $nmbr$ ),,,1511/22402
hba $nmbr$ c ( % ) all countries,C0019016;C0454664;C1825777;C3538758,true;false;false;false,1512/22402
prior diabetes,C0332152;C0011847;C0011849;C2826257,false;false;true;false,1513/22402
number of events / patients,C4330837;C0030705;C2360800;C0441471;C3541888,false;true;false;false;false,1514/22402
coronary heart disease,C0010054;C0010068;C1956346,true;true;true,1515/22402
mean sgrq total score ( sd ),C3533236;C0439175;C2699239;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false;false,1516/22402
managed medically — no . / total no . ( % ),C1273870,false,1517/22402
postoperative glucocorticoid use,C0032790;C0017710;C0042153;C0457083;C1947944,true;true;true;false;false,1518/22402
losartan + placebo,C0126174;C0032042;C1696465;C1706408,true;true;false;false,1519/22402
geographical region ( % ),C0017446,true,1520/22402
serum haemoglobin a $nmbr$ c concentration ( % )  mean ( sd ),C0683149;C0019020;C0444504;C2699239;C2347634;C2348143;C3889898,false;true;false;false;false;false;false,1521/22402
creatinine ≥ $nmbr$ . $nmbr$ mg / dl,C0010294;C0439269;C1561535,true;false;false,1522/22402
previous balloon angioplasty  n ( % ),C0205156;C0002996;C0002997;C1552607,false;true;true;false,1523/22402
thrombolytic treatment before randomization,C0016018;C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0520997,true;true;true;true;false;false;false;false;false;false,1524/22402
apixaban,C1831808,true,1525/22402
urgent cor revasc,C0439609;C0018787;C0378365;C0056331;C3272275,false;true;true;true;false,1526/22402
diabetic treatments !,C0241863;C0087111,false;true,1527/22402
primary ep ( cvd / mi / ri ),C0205225;C1880476;C0007222;C3810814;C0035487;C1826843;C4321526;C0439612;C0439631,false;false;true;false;true;false;false;false;false,1528/22402
cv death / mi / stroke,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,1529/22402
ticlopidine ( n = $nmbr$ ),C0040207,true,1530/22402
alt  ast  or both > $nmbr$ x uln,C3831581,false,1531/22402
qualifying nstemi  n ( % ),C1514624;C3537184;C4255010,false;false;true,1532/22402
baseline nihss score  median ( range ),C0168634;C1697238;C1442488,true;false;false,1533/22402
scr  gmol / l,C1539487;C4050416,false;false,1534/22402
baseline cardiovascular medication  c n ( % ),C0168634;C0007220;C1442488,true;true;false,1535/22402
thienopyridine drug at start of open - label period,C1120149;C2348346;C1709323;C0439531;C1948053,true;false;false;false;false,1536/22402
egfr ( mumin / $nmbr$ . $nmbr$ m $nmbr$ ),C1739039;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false,1537/22402
median ( sd )  mg / mmol,C0549183;C2699239;C0567349;C2348885;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,1538/22402
double - vessel disease  n ( % ),C0205173;C0042373;C1705764;C1705765,false;true;false;false,1539/22402
lipid profile,C0023779;C1979963;C2003903,true;false;false,1540/22402
chronic obstructive pulmonary disease,C0024117,true,1541/22402
treatment difference  ml,C0039798;C1705241;C0439526;C1705224;C3887665;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;false;false;true;false;false;false;false;false,1542/22402
homa - ir  median ( q $nmbr$  q $nmbr$ ),C0022065;C0549183;C0876920;C2347635;C2348144;C2939193;C0022071;C1448132,true;false;false;false;false;false;true;true,1543/22402
$nmbr$ placebo n = $nmbr$,C0032042;C1696465;C1706408,true;false;false,1544/22402
concomitant mtx use  n ( % ),C0521115;C0025677;C0042153;C0457083;C1947944;C1417487,false;true;true;false;false;false,1545/22402
atorvastatin ls means difference $nmbr$ mg ( $nmbr$ % ci ) a ( n = $nmbr$ ),C0286651;C0023668;C1704970;C1705241;C0024671;C0008107;C3259781;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1705242,true;true;false;false;true;true;false;true;false;false;false;false;false;false,1546/22402
dmard | |,C0242708,true,1547/22402
calculated ldl cholesterol ( week $nmbr$ ),C0444686;C0023824;C0332174;C0439230;C0202117;C1441506,false;true;false;false;false;false,1548/22402
median ( q $nmbr$ : q $nmbr$ ) total daily insulin dose $nmbr$,C0549183;C2348070;C0021641;C1533581;C1579433;C3714501;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false,1549/22402
hematologic,C0018943;C0205488,true;false,1550/22402
physician global assessment ( $nmbr$ - $nmbr$ mm vas ),C4050369;C4330985;C0042815;C3536884;C3827561;C4554674,false;false;true;true;false;false,1551/22402
ipf - related,C0034069;C1800706,true;true,1552/22402
history of major bleeding,C0019664;C0205082;C0019080;C0205164;C4318856;C4521762;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;true;false;false;false;false,1553/22402
fpg  mean ( sd )  mmol / l,C0444504;C2699239;C1532563;C2347634;C2348143,false;false;false;false;false,1554/22402
ldl - c ( bq ) ( mg / dl ) - mean ± sd,C2346983;C3642216;C0444504;C2699239;C2347634;C2348143;C0560038;C0439269;C3541236,false;false;false;false;false;false;false;false;false,1555/22402
body - mass index  !  waist - to - hip ratio,C0005893;C0205682;C0578022;C1305855,false;true;false;true,1556/22402
hba  % $nmbr$ c,C0019016;C1825777;C3538758,true;false;false,1557/22402
current tobacco abuse  n ( % ),C0521116;C0040336;C1705970,false;true;false,1558/22402
hormone therapy,C0279025,false,1559/22402
total group ( n = $nmbr$ ),C0439175;C0441848;C0439810,false;false;false,1560/22402
smoking pack year ( years ) fl,C0037369;C1277691;C0439234;C1300812;C1708024;C0439508;C0453996;C1881674,true;false;false;false;false;false;true;false,1561/22402
( $nmbr$ % ell ' ll  * non - hdl - c,C1427925;C3273466,false;false,1562/22402
terol  hdl - c  high - density lipoprotein cholesterol,C0023822,true,1563/22402
age at first seizure  years  mean ( sd ),C1510829;C0205435;C0036572;C0444504;C2699239;C2347634;C2348143;C1959629;C4553401;C1279901,false;false;true;false;false;false;false;false;false;false,1564/22402
glomerular,C0022663;C0268731,true;false,1565/22402
median blood eosinophil count  cells per pla,C0549183;C0200638;C0456170;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1566/22402
cv death or first hhf,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,1567/22402
balloon angioplasty plus abciximab,C0002996;C0332287;C0288672;C0002997,true;false;true;true,1568/22402
lipoprotein ( a )  median ( ql  q $nmbr$ )  nmol / l,C0065058;C0549183;C0439282;C0876920;C2347635;C2348144;C2939193;C0125953;C1096202;C1439335,true;false;false;false;false;false;false;true;false;false,1569/22402
osteoporosis,C0029456;C4554622,true;false,1570/22402
acute rheumatic disorders,C0001314,true,1571/22402
intensive control,C0162425;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C0522510;C1283828;C1550453,true;true;false;false;false;false;false;false;false;false,1572/22402
treatment duration  days,C0444921;C0439228;C3259042,false;false;false,1573/22402
warfarin ( n = $nmbr$ ),C0043031,true,1574/22402
reported hypertension *,C0684224;C0020538;C1963138;C0700287;C4319718,true;true;false;false;false,1575/22402
before bronchodilation,C1371299;C3537072,false;false,1576/22402
ccv history / condition at baseline,C0683519;C0168634;C1442488,false;true;false,1577/22402
ivabradine ( n = $nmbr$ ),C0257190,true,1578/22402
bmi ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ),C0578022,false,1579/22402
physical function ( $nmbr$ - $nmbr$  short form - $nmbr$ subscale ),C0597240;C0031843;C1282927;C1806781;C2350002;C0542341;C0700205;C1705273;C0700329;C0516981;C0348078;C0376315;C1522492;C4255237;C2964478;C4049916,false;true;false;false;false;false;false;false;false;false;false;true;false;false;false;false,1580/22402
prior cerebrovascular disease,C0332152;C0007820;C2826257,false;true;false,1581/22402
reason for enrollment in active a — no . ( % ),C0392360;C1516879;C1696073;C3888021,false;false;false;false,1582/22402
medical characteristics,C0199168;C1521970;C0205476,false;false;false,1583/22402
medication use at baseline — no . ( % ),C0240320;C0168634;C1442488,false;true;false,1584/22402
age < $nmbr$ years — no . ( % ),C1510829,false,1585/22402
planned valve surgery  n ( % ),C1301732;C0184252;C0038894;C0038895;C0543467;C1274039;C1186983;C1704414;C3888056,false;false;false;true;true;true;false;false;false,1586/22402
time from randomization to pci ( st - elevation mi )  min,C0040223;C0034656;C3541383,true;true;false,1587/22402
haq - di score ( $nmbr$ - $nmbr$ ),C3826998;C0449820;C4050231;C4321476,false;false;false;false,1588/22402
mean ( sd ) das $nmbr$ - $nmbr$ ( esr ) *,C0444504;C2699239;C0051767;C3811131;C0057671;C2347634;C2348143,false;false;true;false;true;false;false,1589/22402
randomised treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,1590/22402
v alsartan / hctz  n ( % ),C0020261,true,1591/22402
$nmbr$ year or more,C0439234;C0439508,false;false,1592/22402
crcb - ( ml / min )  mean ( s . e . ),C0439390;C0702093;C0444504;C2347634;C2348143;C1524029;C3813700;C0439445,false;false;false;false;false;false;false;false,1593/22402
three - vessel disease,C3272265,false,1594/22402
st - segment depression > $nmbr$ . $nmbr$ mv on admission  %,C0520887;C1454484;C1705503;C4281602,false;true;false;false,1595/22402
planned treatment duration  n ( % ),C4528394,false,1596/22402
z\tonastaiin,,,1597/22402
inadequate response / intolerance to prior therapy  %,C0205412;C0871261;C0231199;C0332152;C0039798;C0087111;C1363945;C1744706;C2355652;C1704632;C1706817;C2911692;C0439856,false;false;false;false;true;true;false;false;false;false;false;false;false,1598/22402
change from baseline in das $nmbr$ - esr  mean $nmbr$ sd,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,1599/22402
cause of heart failure — no . ( % ),C0015127;C0018801;C0018802;C4554158;C1524003,true;true;true;false;false,1600/22402
predominant type of heparin,C1542147;C0332307;C0019134;C0770546;C1547052,false;false;true;false;false,1601/22402
western europe / australia / israel,C0043128;C0015176;C0022271;C0043129;C0004340,true;true;true;true;true,1602/22402
preoperative blood pressure ( mm hg ) patients fulfilling eligibility criteria,C0445204;C0005823;C0439475;C0030705;C1271104;C1272641,false;true;false;true;false;true,1603/22402
glucose  mmol / l,C0017725;C1532563,true;false,1604/22402
aspirin + clopidogrel ( n = $nmbr$ ) $nmbr$ . $nmbr$,C0004057;C0070166,true;true,1605/22402
retinopathy — %,C0035309;C1962966,true;false,1606/22402
pulmonary embolism,C0034065,true,1607/22402
mild or moderate copd,C2945599,false,1608/22402
prior ml ( before index acs ),C0332152;C0439526;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1705224;C3887665;C2826257,false;false;true;true;false;true;false;false;false;false;false;false,1609/22402
diabetes duration ( known )  % of patients,C0011847;C0449238;C2926735;C0011849,false;false;false;true,1610/22402
creatinine clearance ， : : $nmbr$ ml / min  %,C0812399;C0439445,false;false,1611/22402
baseline hb < $nmbr$ g $nmbr$ $nmbr$ n = $nmbr$,C0168634;C0062408;C0439267;C1442488,true;true;false;false,1612/22402
joint swelling,C0152031,false,1613/22402
$nmbr$ mwd decrease > $nmbr$ m,C0392756;C0369637;C0441923;C0547047,false;false;false;false,1614/22402
profound thrombocytopenia ( < $nmbr$ x $nmbr$ / l ),C0439808;C0040034;C0392386,false;true;false,1615/22402
body mass index  median  ( $nmbr$ th — $nmbr$ th percentiles )  kg / m $nmbr$,C0005893;C0549183;C0039725;C1264641;C1532718;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;true;false;false;true;false;false;false;false;false;false;false;false;true,1616/22402
associated with connective tissue disease,C0332281;C0009782,false;true,1617/22402
postbronchodilator lung function at screening,C2599594;C0035245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;true;false;false;false;false;false,1618/22402
non – small - cell lung cancer,C0007131;C2984258;C3539721,true;false;false,1619/22402
prior anti - tnf therapy — no . ( % ),C0332152;C0281481;C2826257,false;false;false,1620/22402
all rosuva,,,1621/22402
peripheral edema,C0085649,false,1622/22402
insulin - na ' ive,C0021641;C0597484;C3435805;C4554334;C1272460;C1546968;C1879645;C4049872;C4552882;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false;false;false,1623/22402
gender  women n  % ),C0079399;C0043210;C1522384,true;true;true,1624/22402
mean ( sd ) swollen joint count *,C0444504;C2699239;C0451521;C2347634;C2348143,false;false;false;false;false,1625/22402
diuretic drugs ( excluding antialdosterone ),C0012798;C0013227;C3687832,true;true;false,1626/22402
hfpef ( ef n $nmbr$ )  ( % ),,,1627/22402
extent of disease  n ( % ),C0449279;C4553144,false;false,1628/22402
tendonitis,C0039503,true,1629/22402
previous hypertension,C0205156;C0020538;C1963138;C1552607,false;true;false;false,1630/22402
oral contraceptives,C0009905,true,1631/22402
syncope — no . ( % ),C0039070;C3541349;C4554644,true;false;false,1632/22402
anatomic complexity characteristics,C0502371;C0439855;C1704241,false;false;false,1633/22402
conventional treatment,C2945704,false,1634/22402
left circumflex,C0205091;C1880089;C0443246;C1552822,false;false;false;false,1635/22402
amiodarone vs . placebo no . hazard ratio ( $nmbr$ . $nmbr$ % cl ),C0002598,true,1636/22402
number of pack - years,C0237753;C1277691;C0449788,false;false;false,1637/22402
baseline cardiac biomarkers,C0168634;C2735101;C2735102;C1442488,true;false;false;false,1638/22402
type $nmbr$ diabetes duration  mean ( sd )  years,C1320657;C0449238;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735,false;false;false;false;false;false;false;false,1639/22402
oral study drug administered — no . / total no . ( % ),C0442027;C0013175;C4521986,false;true;false,1640/22402
diltiazem or verapamil,C0012373,true,1641/22402
major bleeding ( statin use vs non - use ),C0205082;C0019080;C0360714;C0042153;C0457083;C1947944;C0205164;C4318856;C4521762,false;true;true;true;false;false;false;false;false,1642/22402
placebo secukinumab pooled,C0032042;C3179547;C1696465;C1706408,true;true;false;false,1643/22402
bilateral disease ( % ) ' j ' ' j ',C1511113,false,1644/22402
pathological q waves,C0429090,false,1645/22402
leukocytes  $nmbr$ / nl,C0023516;C0027778;C0560008;C3892223,true;true;false;false,1646/22402
lipid - lowering agents ( % ),C0086440,true,1647/22402
history of second prior mi,C0019664;C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;false;false;true;false;false;false;false,1648/22402
study medication — no . ( % ),C0557651;C0013227;C3244316;C4284232;C2603343,false;true;false;false;false,1649/22402
laboratory data  mean ( sd ),C0022877;C1511726;C0444504;C2699239;C2347634;C2348143;C3245479;C3714741;C3244292;C4283904,true;false;false;false;false;false;false;false;false;false,1650/22402
p value ( men versus women ),C1709380;C0025266,false;true,1651/22402
former n z $nmbr$,C0205156;C0750523,false;false,1652/22402
insulin : glucose ratio,C0021641;C0017725;C0456603;C1547037;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,1653/22402
t $nmbr$ dm duration ( years ),C2603360;C0011816;C0449238;C0439234;C2926735;C3250443,false;true;false;false;false;false,1654/22402
serum creatinine > $nmbr$ pmol / l . n ( % ) |,C0201976;C0439284;C0600061,false;false;false,1655/22402
kellgren and lawrence radiographic reading grade $nmbr$ — no . ( % ),,,1656/22402
data missing or no drug given,C1511726;C1551393;C1705492;C3272743;C3245479;C3714741,false;false;false;false;false;false,1657/22402
gpiib / iiia receptor inhibitor,C0016011;C0597357;C1999216,true;false;false,1658/22402
ethnic origin,C0015031,true,1659/22402
supine after $nmbr$ minutes change from baseline,C0038846;C0439232;C0700321;C0702093;C1282918;C2347166,true;false;false;false;false;false,1660/22402
omega - $nmbr$ fatty acid ( n = $nmbr$ ),C1719844;C0015684,false;true,1661/22402
pulmonary rales  n ( % ),C0034642,true,1662/22402
< $nmbr$ months  n ( % ),C0439231,false,1663/22402
fibrinogen  g / l,C0016006;C0439294;C0456615;C1167394;C2587184;C3540039,true;false;false;false;false;false,1664/22402
right ventriculardysfunction atinclusion,C0205090;C0444532,false;false,1665/22402
nace ( primary endpoint ),C2986535,false,1666/22402
micro - / macro - albuminuria  ckd and / or retinopathy,C0085672;C2984010;C0001925;C1561643;C1553035;C3811161;C4049106,false;false;true;true;false;false;false,1667/22402
interaction : treatment by psoriasis p value $nmbr$,C1704675;C3258078;C1709380,false;false;false,1668/22402
score > $nmbr$ %  % of patients,C0449820;C0030705;C4050231,false;true;false,1669/22402
any aes  n ( % ),C1412268;C2699274,false;false,1670/22402
ace inhibitors or angiotensin ii,C0003015,true,1671/22402
des ( % previous stenting ),C0011702;C0205156;C0038257;C2348535;C1552607;C4551552,true;false;true;false;false;true,1672/22402
comparison with placebo ( mean,C1707455;C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,false;true;false;false;false;false;false,1673/22402
mean ( s . d . ) hbalc  %,C0444504;C2347634;C2348143,false;false;false,1674/22402
exercise,C0015259;C1522704,true;false,1675/22402
vascular territory # $nmbr$,C0005847;C1301808;C2983136;C1558950;C1801960,true;false;false;false;false,1676/22402
native hawaiian or other pacific islander,C0337920,true,1677/22402
control baseline ( n - $nmbr$ ),C0243148;C0168634;C1442488;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false;false,1678/22402
rando . in na * *,C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false,1679/22402
estimated glomerular filtration rate - ml / min  median ( iqr ) ',C3811844;C0439445;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1680/22402
nyha class within past month — no . / total no . ( % ),C1882083;C4331910,false;false,1681/22402
aspirin group,C0004057;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1682/22402
non - hdl - c ( mg / dl ) - mean ± sd,C1518422;C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false;false,1683/22402
fibrinolytic for qualifying event,C0040044;C1514624;C0441471;C4019010,true;false;false;false,1684/22402
$nmbr$ degree of ica stenosis 丰,C0201519;C4034225,false;false,1685/22402
calcium - channel blockers ( % ),C0006684;C2757014,true;false,1686/22402
duration of ra ( years ),C0449238;C3538806;C0439234;C4048756;C2926735,false;false;false;false;false,1687/22402
min  max,C0702093;C1524029;C3813700,false;false;false,1688/22402
estimated gfr  < $nmbr$ ml min - $nmbr$ $nmbr$ . $nmbr$ m - $nmbr$  n ( % ) a,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,1689/22402
ctn - l  ng / ml,C0917591;C0439275,true;false,1690/22402
chd + cerebral infarction,C0280604;C0007785;C3542407,false;true;false,1691/22402
fenofibric acid + moderate - dose statin,C0060179;C1709056;C0360714,true;false;true,1692/22402
highest tg tertile,C1522410;C0337445,false;false,1693/22402
days of study - drug administration ( % ) * * $nmbr$ day,C2826182;C0150270;C3469597,false;false;false,1694/22402
emotional role,C0013987;C0035820;C1705810;C3871154;C0849912,true;true;false;false;false,1695/22402
antithrombotic therapy,C0039798;C0087111;C1363945,true;true;false,1696/22402
periprocedural medications — no . / total no .,C0013227;C0802604;C2598133;C4284232,true;false;false;false,1697/22402
kim $nmbr$ ( pg / ml ),C0439297,false,1698/22402
mi or cad,C3810814,false,1699/22402
d - dimer levelsatinclusion,C0060323,true,1700/22402
any immunosuppressive agent,C0021081,true,1701/22402
tender joint count  of $nmbr$,C0451530,false,1702/22402
increased waist circumference,C0205217;C0455829;C0442805,false;true;false,1703/22402
cross - damp time : < l : llhrs : min ( n = $nmbr$ ),C2828360;C0205381;C0040223;C0702093;C1524029;C3813700;C3541383;C3891560,false;false;true;false;false;false;false;true,1704/22402
aspirin only ( n = $nmbr$  $nmbr$ ),C0004057;C0205171;C1720467,true;false;false,1705/22402
high risk with atherosclerotic vascular disease *,C0332167;C0004153;C3272283;C4050568;C4319571,false;true;false;false;false,1706/22402
metrex overall modified intention - to - treat population ? :,C0282416;C0392747;C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C3889737;C1561607,true;false;true;true;true;true;false;false;false;false;false,1707/22402
basmi ( linear )  mean ( sd ),C0205132;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,1708/22402
cor revasc,C0018787;C0378365;C0056331,true;true;true,1709/22402
high ( > $nmbr$ ) ( n = $nmbr$  $nmbr$  $nmbr$ % ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,1710/22402
adl subscale ( range  $nmbr$ - $nmbr$ ) *,C0001288;C1514721;C2348147;C3542016;C1420005,true;false;false;false;false,1711/22402
baseline statin usec,C0168634;C0360714;C0439224;C1442488,true;true;false;false,1712/22402
unbound pcsk $nmbr$ ( nmol / l ),C0439282,false,1713/22402
months from mi — median ( iqr ),C0439231;C3810814;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,1714/22402
enthesitis count,C1282952;C0750480;C1705566,false;false;false,1715/22402
enalapril,C0014025,true,1716/22402
history of alcohol use,C0551571;C0552479,false;false,1717/22402
initiation of dialysis  renal transplantation  or creatinine . $nmbr$ . $nmbr$ mg / dl ( $nmbr$ mmol / l ),C0589507;C0011946;C0040732;C0040733;C0019004;C4551529;C0011945;C0022671;C1059964;C1158830;C1704686,false;false;true;true;true;true;true;true;false;false;false,1718/22402
female race / ethnicity,C0043210;C0034510;C0015031;C0243103;C1706779;C3853635;C0086287;C1705497;C1705498,true;true;true;true;false;false;true;false;false,1719/22402
bsa affected  mean ± sd  %,,,1720/22402
timing of clopidogrel loading dose,C0449243;C0070166;C3714444;C1704250,false;true;false;false,1721/22402
week $nmbr$ fpg  mean ( s . e . ),C0332174;C0444504;C2347634;C2348143;C0439230,false;false;false;false;false,1722/22402
crohn ' s disease - related medication at baseline  n ( % ),C0010346,true,1723/22402
post - menopausal ( a ),C0232970,false,1724/22402
saxagliptin $nmbr$ mg ( n z $nmbr$ ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1725/22402
weight ( range ) ( kg ),C0005910;C1514721;C0022718;C0439209;C4054209;C2348147;C3542016;C0043100;C1305866;C1705104,true;false;true;false;false;false;false;true;false;false,1726/22402
monotherapy,,,1727/22402
small vessel,C0225988,false,1728/22402
history of microvascular disease — no . ( % ),C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,1729/22402
baseline sitosterol,C0168634;C0037215;C0220914;C1442488,true;true;true;false,1730/22402
hypertension and left ventricular hypertrophy,C0020538;C1963138,true;false,1731/22402
ls mean ( s . e . ) primary endpoint : % change from baseline to week $nmbr$,C0023668;C0444504;C2986535;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;true;false;false;false;false;false;false,1732/22402
severe n z $nmbr$,C0205082;C4050465;C4050466,false;false;false,1733/22402
arthritis,C0003864;C4552845,true;false,1734/22402
concurrent treatment of crohn ' s disease at study entry — no . of patients ( % ) ff,C0205420;C0039798;C0010346;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;true;false;false;false;false;false,1735/22402
extensive,C0205231,false,1736/22402
baseline corticosteroids *,C0168634;C0001617;C3539185;C3540725;C3540726;C3540727;C1442488,true;true;false;false;false;false;false,1737/22402
lv hypertrophy  n ( % ),C0149721,true,1738/22402
sex ( interaction : p = $nmbr$ . $nmbr$ ),C0009253;C1704675;C0036864;C0079399;C0804628;C1314687;C1522384,true;false;true;true;false;false;true,1739/22402
native hawaiian / other,C0337920,true,1740/22402
pain ( $nmbr$ - $nmbr$ mm vas ),C0042815;C4330985;C4554674,true;false;false,1741/22402
randomized,C0034656;C3815594,true;false,1742/22402
$nmbr$ baseline mean,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,1743/22402
fc - ldl - c  mg / dl,C2983605;C0439269,false;false,1744/22402
patients with previous loss of response to and intolerance of infliximab *,C0030705;C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,true;false;false;false;false;false;false;false,1745/22402
other glp - $nmbr$ receptor agonist,C0018301;C4543206;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,1746/22402
baseline hematocrit  median ( iqr ),C0168634;C0018935;C0549183;C0876920;C2347635;C2348144;C2939193;C0518014;C1442488,true;true;false;false;false;false;false;false;false,1747/22402
placebo event rate ( n = $nmbr$ )  %,C0032042;C0441471;C0871208;C1521828;C4019010;C1696465;C1706408,true;false;false;false;false;false;false,1748/22402
history of amputation,C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,1749/22402
low - dose rivaroxaban + aspirin group,C2608320;C1739768;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;true;false;false;true;false;false;false,1750/22402
documented asymptomatic cardiac ischemiac,C1301725;C0231221;C0018787;C1522601;C1609436,false;false;true;false;false,1751/22402
seropositive ( rf + ve and / or acpa + ve ) subgroup,C0521143;C0035448;C0042469;C3714652;C4321495;C0201660;C0748398;C1547111,false;true;true;false;false;false;false;false,1752/22402
| ? ) - blocker  %,,,1753/22402
metabolizer phenotype ( % ) §,C0031437;C1285572,true;false,1754/22402
disease location / type : terminal ileum,C0457464;C0450429;C0227327;C1515974;C4284930;C4284931,false;false;false;false;false;false,1755/22402
selexipag ( n = $nmbr$ ),C2000145,true,1756/22402
clinical presentation,C2708283,false,1757/22402
patients not receiving corticosteroids at baseline,C0030705,true,1758/22402
alteplase group ( n = $nmbr$ ),C0032143;C0441848,true;false,1759/22402
obesity  % *,C0028754;C1963185,true;false,1760/22402
cardiovascular history — no . / total no . ( % ),C1880008,false,1761/22402
cardiac therapy  n ( % ) d,C3654025,false,1762/22402
femoral access — no . / total no . ( % ),C0015811,true,1763/22402
laboratory data,C0022877;C1511726;C3245479;C3714741;C3244292;C4283904,true;false;false;false;false;false,1764/22402
other drugs,C0013227;C3687832,true;false,1765/22402
apob : apoa - $nmbr$ ratio,C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;false;false;true,1766/22402
length of stay ( randomization to discharge  h ),C0023303;C0034656,true;true,1767/22402
$nmbr$ - aminosalicylates | | | |,C0368663,false,1768/22402
peripheral - artery disease ( % ),C1704436;C4025272,true;false,1769/22402
severity of the disease ( gold $nmbr$ )  n ( % ),C0521117;C0018026;C1304897,false;true;false,1770/22402
apixaban  $nmbr$ . $nmbr$ mg,C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,1771/22402
coronary bypass graft,C1260596,false,1772/22402
vascular disease indicator no ( n = $nmbr$ ),C0042373;C0021212;C1235732;C1522602,true;true;false;false,1773/22402
laboratory values at randomization ( median and iqr ),C0022877;C0042295;C0034656;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904,true;false;true;false;false;false;false;false;false;false,1774/22402
acr  mg / mmol,C1412134;C0567349;C2348885;C1515941,false;false;false;false,1775/22402
tc / hdl - c,C0039411;C3715113;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,1776/22402
hba $nmbr$ c at baseline  %,C0019016;C0168634;C1442488;C1825777;C3538758,true;true;false;false;false,1777/22402
indication for stent,C0392360;C0038257;C3146298,false;true;false,1778/22402
history of intermittent claudication and abi < $nmbr$ - $nmbr$ or substantial peripheral arterial stenosis > $nmbr$ %,C2315493;C0205267,false;false,1779/22402
months since ra was first diagnosed  mean ( sd ),C0439231,false,1780/22402
hemorrhagic stroke ( n = $nmbr$ ),C0553692,true,1781/22402
mini - mental state examination,C0451306,true,1782/22402
number of stents implanted,C0237753;C0038257;C0449788,false;true;false,1783/22402
risk score category ( points ),C0035647;C0449820;C0683312;C3889287;C4050231;C4552904,true;false;false;false;false;false,1784/22402
microvascular complications  n ( % ) ’,C0443258;C0009566;C1171258,false;false;true,1785/22402
erosion score  median ( min  max ),C0333307;C0449820;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false;false;false;false;false;false;false;false;false,1786/22402
fev $nmbr$ / fvc ( post salbutamol ),C3714541;C0687676;C0001927;C1704687;C3469826,true;false;true;false;false,1787/22402
type $nmbr$ diabetes,C1320657,false,1788/22402
% predicted pre - bronchodilator fev $nmbr$  % *,C0681842;C2599602;C3714541;C1882327,false;false;true;false,1789/22402
patients receiving corticosteroids at baseline,C0030705,true,1790/22402
odds ratio adj ( $nmbr$ % cl ),C0028873;C0001552;C0596019;C2826286,true;true;false;false,1791/22402
no statin vs statin alone vs any statin plus other llt,C0360714,true,1792/22402
general and lumbar epidural,C0205246;C3812897;C3891294;C4521767,false;false;false;false,1793/22402
rf and acpa negative $nmbr$,C0035448;C0201660;C0748398;C1547111,true;false;false;false,1794/22402
hispanic,C0086409,true,1795/22402
onsetofaf  no . ( % ),,,1796/22402
percentage with disease duration < $nmbr$ years,C0439165;C0872146;C0439234;C1549488;C1561533,false;false;false;false;false,1797/22402
doubling of creatinine †,C0205173;C0010294;C1561535;C1705764,false;true;false;false,1798/22402
diameter stenosis  mean ( sd )  %,C0552409;C0678234;C2699239;C1261287;C2632116,false;false;false;true;false,1799/22402
biologic naive,C0005515;C0205460,true;false,1800/22402
systemic corticosteroids  n ( % ) a,C4053960,false,1801/22402
europe ( non - eu ),C0015176;C1518422;C0015179;C3665627,true;false;true;false,1802/22402
fasting blood glucose ( mg / dl ),C0428568;C0439269;C1261430,false;false;false,1803/22402
fev $nmbr$ reversibilityz ( pre / post ipratropium )  %,C3714541;C0332152;C0687676;C0027235;C1704687;C3469826;C0740175;C2257086;C3669034,true;false;false;true;false;false;false;false;false,1804/22402
mean eosinophil count  per ml,C0444504;C0200638;C0439526;C1705224;C3887665;C0750879;C2347634;C2348143,false;false;false;false;false;false;false;false,1805/22402
men  total ( n 二 $nmbr$ ),C0025266;C0439175;C0439810,true;false;false,1806/22402
rhabdomyolysis  myopathy  or myalgia with ck elevation > $nmbr$ x uln,C0035410;C0026848;C4552660,true;true;false,1807/22402
rf positive  n ( % ),C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,1808/22402
without insulin or insulin - modifying therapy,C0021641;C1533581;C1579433;C3714501,true;false;false;false,1809/22402
hospitalized for heart failure during that time period,C0701159;C0018801;C0018802;C4554158,false;true;true;false,1810/22402
phospholipid omega - $nmbr$ levels : < $nmbr$ % ( n = $nmbr$ ),C0031676;C1719844;C0441889;C0202177,true;false;false;false,1811/22402
clinical and laboratory measurements,C0205210,false,1812/22402
current medication — no . ( % ),C0746467,false,1813/22402
infliximab $nmbr$ mg / kg,C0666743;C0439272,true;false,1814/22402
randomization - to -,C0034656,true,1815/22402
low hdl cholesterol,C0151691,false,1816/22402
history of chronic hf,C0019664;C0205191;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;true;false;false;false;false,1817/22402
race - non - white ( n = $nmbr$  $nmbr$ ),C0034510;C1706779;C3853635,true;false;false,1818/22402
moderate teaes,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,1819/22402
sfc $nmbr$ / $nmbr$ mg twice daily ( n = $nmbr$ ),C4521536;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;true;false;false;false;false;false,1820/22402
time since diagnosis of type $nmbr$ diabetes,C0040223;C3541383,true;false,1821/22402
riva roxa ban n / n { % ) $nmbr$ ( $nmbr$ . $nmbr$ ),C0683610;C4553947,false;false,1822/22402
disease and quality - of - life scores,C0012634,true,1823/22402
laba / ics use at screening  n ( % ),C0815320;C4551720,false;true,1824/22402
mean change in radiographic end points,C0444504;C0392747;C0444708;C2349179;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false,1825/22402
screening % predicted fev $nmbr$,C0220908;C0681842;C3714541;C1882327;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;true;false;true;false;false;false;false;false,1826/22402
lntensityd,,,1827/22402
steroid use at baseline,C0281991;C0168634;C1442488,false;true;false,1828/22402
angina class at baseline,C0002962;C0456387;C0168634;C1442488;C1518526;C1705943,true;false;true;false;false;false,1829/22402
emotional status,C0013987;C0449438;C0849912,true;false;false,1830/22402
albuminuria ( g / g ),C0001925;C1319635,true;false,1831/22402
concomitant therapy,C1707479,false,1832/22402
thrombophilia,C0398623,true,1833/22402
mean — mg / dl level — no . ( % ),C0444504;C0439269;C0441889;C0456079;C1547707;C2946261;C2347634;C2348143,false;false;false;false;false;false;false;false,1834/22402
urine albumin - to - creatinine ratio - no . ( % ) § §,C0455271;C1318330,false;false,1835/22402
mean a ± sd ( mmhg ),C0444504;C2347634;C2348143,false;false;false,1836/22402
hdl cholesterol ( week $nmbr$ ) a,C0023822;C0332174;C0439230;C0392885,true;false;false;false,1837/22402
low - dose rivaroxaban plus aspirin ( n = $nmbr$ ),C2608320;C1739768;C0332287,false;true;false,1838/22402
clinical criteria $nmbr$,C0205210;C0243161,false;true,1839/22402
abatacept ( n = $nmbr$ * ),C1619966,true,1840/22402
ind $nmbr$ gg q . d . n / n ( % ),C4049864;C0017454;C0018370,false;true;true,1841/22402
lvef ( % )  mean ± sd,C0428772;C0444504;C2699239;C2347634;C2348143;C0488728,false;false;false;false;false;false,1842/22402
menopausal status and use of hrt ( % ) y,C1513126,false,1843/22402
renin inhibitor ( e . g . aliskerin ),C1960108;C3537174;C4521920,false;false;false,1844/22402
urine albumin - to - creatinine ratio,C0455271;C1318330,false;false,1845/22402
total n = $nmbr$ n ( % ),C0439175;C0439810,false;false,1846/22402
chronic heart failure,C0018802;C0264716,true;false,1847/22402
type $nmbr$ diabetes mellitus ’,C1320657,false,1848/22402
mean score on das $nmbr$ - $nmbr$ ( crp ) ^,C3533236;C0051767;C3890735;C4048285;C0057671,false;true;false;false;true,1849/22402
orthostatic hypotension,C0020651,true,1850/22402
previous oral glucose - lowering agents  % of patients,C0205156;C1955477;C0441994;C0600419;C2003888;C1552607,false;false;false;true;false;false,1851/22402
aortic stenosis,C0003507,true,1852/22402
no . of patients / total no . ( % ),C0030705,true,1853/22402
any dose reduction,C0178602;C0301630;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;false;false;false;false;false,1854/22402
hazard ratio for event ( $nmbr$ % ci ),C2985465;C0441471;C0008107;C3259781;C4019010,false;false;true;false;false,1855/22402
prior implantable cardiodefibrillator  n ( % ),C0332152;C0021102;C2826257,false;false;false,1856/22402
crp ( mg / l )  median ( min  max ),C3890735;C0439268;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false;false;false,1857/22402
gold $nmbr$ groups  n ( % ),C0018026;C1304897,true;false,1858/22402
enalapril + aliskiren dm = $nmbr$ non - dm = $nmbr$,C0014025;C1120110;C0011816;C3250443,true;true;true;false,1859/22402
ics  mg / day,C0815320;C0439422;C4551720,false;false;true,1860/22402
psoriasis covering > $nmbr$ % bsa  n ( % ) §,C0033860;C0180153;C0439844,true;false;false,1861/22402
antihypertensive drug  %,C0003364,true,1862/22402
mean ( sd ) post - bronchodilator fev $nmbr$ reversibility  %,C0444504;C2699239;C2599594;C3714541;C0449261;C2347634;C2348143,false;false;false;true;false;false;false,1863/22402
$nmbr$ - $nmbr$ ( severe ),C0205082;C4050465;C4050466,false;false;false,1864/22402
stroke or pvd  ( % ),C0038454;C4554100,true;false,1865/22402
cabg > $nmbr$ month ago,C0010055;C0332177;C0439231,true;false;false,1866/22402
history of percutaneous coronary intervention,C1320647;C4554713,false;false,1867/22402
current or previous atrial fibrillation,C0521116;C1705970,false;false,1868/22402
ace - inhibitor use,C0003015;C0042153;C0457083;C1947944;C4541021,true;true;false;false;false,1869/22402
anemia — no . ( % ) | |,C0002871;C1000483;C4554633,true;false;false,1870/22402
low - dose corticosteroid user,C0445550;C0001617;C1548600;C1706077;C3536709;C1708745,false;true;false;false;false;false,1871/22402
upper gastrointestinal,C3203348,true,1872/22402
cad history and risk factors  n ( % ),C1504769;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C2239547;C3813548;C4284121,true;true;true;false;false;false;false;false;false;false,1873/22402
das - $nmbr$ ( crp ) < $nmbr$ . $nmbr$  n ( % ),C0051767;C3890735;C4048285;C0057671,true;false;false;true,1874/22402
repaired chd,C0205340;C0280604;C3542407,false;false;false,1875/22402
gusto - defined bleeding,,,1876/22402
peripheral vasodilators,C0724804,false,1877/22402
mean ( sd ) number of albuterol per day  puff,C0444504;C2699239;C0237753;C0001927;C0449788;C2347634;C2348143,false;false;false;true;false;false;false,1878/22402
liraglutide ( n = $nmbr$  $nmbr$ ),C1456408,true,1879/22402
angiotensin - converting enzyme or angiotensin receptor blocker,C0022709;C1452534,true;true,1880/22402
perianal or anus,C0442158,false,1881/22402
framingham $nmbr$ - year cv risk score,C3166866;C0439234;C3538987;C0035647;C0449820;C4050231;C4552904;C4048877;C4318503;C0439508,false;false;false;true;false;false;false;true;false;false,1882/22402
native coronary - artery lesions,C0302891;C0205042;C0221198,false;true;false,1883/22402
current drinker,C0556297,false,1884/22402
placebo ls means ( n ),C0032042;C0023668;C1704970;C1696465;C1706408,true;true;false;false;false,1885/22402
( %  $nmbr$ % cl ),C0596019,false,1886/22402
duration of disease  years,C0872146;C0439234,false;false,1887/22402
musculoskeletal,C0497254;C2707260,false;false,1888/22402
severe ( gold $nmbr$ ),C0205082;C0018026;C1304897;C4050465;C4050466,false;true;false;false;false,1889/22402
moderate thrombocytopenia ( < $nmbr$ x $nmbr$ / l ),C0205081;C0040034;C0392386;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,1890/22402
st change > $nmbr$ mm,C0036056;C0392747;C4330985;C4554674;C0443172;C1705241;C4319952;C3272372,true;false;false;false;false;false;false;false,1891/22402
received an oral aha within $nmbr$ weeks prior to screening,C1514756,false,1892/22402
stiffness subscale,C0427008,false,1893/22402
egfr < $nmbr$  n ( % ),C1739039;C3811844;C3812682,true;false;false,1894/22402
rec . ischemia requiring revasc,C1424025;C0022116;C0378365;C4321499;C2606415,false;true;true;false;true,1895/22402
type of concomitant statin,C0332307;C0521115;C0360714;C1547052,false;false;true;false,1896/22402
bmi ( kg / m $nmbr$ ) [ median ( $nmbr$ th to $nmbr$ th percentile ) ],C2923536;C1532718;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;false;false;false;false;false;false,1897/22402
moderate ( $nmbr$ risk factor ),C0205081;C0035648;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,1898/22402
timi risk score $nmbr$ - $nmbr$,C0035647;C0449820;C4050231;C4552904,true;false;false;false,1899/22402
chronic obstructive pulmonary disease  n ( % ),C0024117,true,1900/22402
glycopyrronium $nmbr$ mg ( n = $nmbr$ ),C3814772;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,1901/22402
history of microvascular eye disease 本  n ( % ),C0683519;C0443258;C0015392;C0700042;C0730226;C0850708;C0944983;C0019664;C0015397;C0019665;C0262512;C0262926;C1705255;C2004062,false;false;true;false;false;false;false;true;true;true;false;false;false;false,1902/22402
oral aminosalicylates,C0442027;C0368663;C4521986,false;false;false,1903/22402
bmi kg - m - $nmbr$,C0578022;C1532718,false;false,1904/22402
mean ± sd triglycerides  mg / dl,C0444504;C2699239;C0041004;C0439269;C2347634;C2348143,false;false;true;false;false;false,1905/22402
type of des,C0332307;C0011702;C4551552;C1547052,false;true;true;false,1906/22402
white  n ( % ),C0007457;C0043157;C0220938,true;true;false,1907/22402
aspirin / antiplatelet,C0004057,true,1908/22402
any peripheral arterial disease,C0085096;C1704436,true;true,1909/22402
ldl cholesterol mean ( mg / dl ± sd ),C0023824;C0444504;C0439269;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,1910/22402
index event — no . ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,1911/22402
hospital factor # $nmbr$,C0019994;C1521761;C2827422;C1510665,true;false;false;false,1912/22402
baseline tobacco use,C0168634;C0040335;C0543414;C0841002;C3853727;C1442488,true;false;true;false;false;false,1913/22402
persistent anemia bsl hb < $nmbr$ g i - $nmbr$  yr $nmbr$ < $nmbr$ g i $nmbr$,C0741008;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138,false;false;true;false;true;false;false,1914/22402
previously taken tnfi  %,,,1915/22402
troponin t,C0077404;C1420827,true;false,1916/22402
exacerbations in the previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,1917/22402
omega - $nmbr$ fatty acid,C1719844;C0015684,false;true,1918/22402
stroke risk score,C1277291;C0449820;C4050231,false;false;false,1919/22402
daily insulin dose  mean ( sd )  iu,C2348070;C0021641;C0444504;C2699239;C0049272;C0439453;C0694756;C2347634;C2348143;C1533581;C1579433;C3714501;C0332173;C0366513,false;true;false;false;true;false;false;false;false;false;false;false;false;false,1920/22402
former or never,C0205156;C0750523,false;false,1921/22402
type $nmbr$ diabetes duration  years,C1320657;C0449238;C0439234;C2926735,false;false;false;false,1922/22402
ccv history / condition,C0683519,false,1923/22402
microalbuminuria or proteinuria,C0730345,false,1924/22402
absolute risk difference ( ci )  % *,C1549031;C0035647;C0008107;C3259781;C4552904;C1519101;C1705241;C1705242,false;true;true;false;false;false;false;false,1925/22402
elevated at wk $nmbr$ — no . ( % ) $nmbr$,C0205250;C0332174;C0439230;C3163633,false;false;false;false,1926/22402
proctosigmoiditis,C0033252,true,1927/22402
mean age ( years ) race,C0444504;C1510829;C2347634;C2348143,false;false;false;false,1928/22402
cat total score,C0007450;C2964552;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;true;false;false;false;false,1929/22402
$nmbr$ no . of events,C0441471;C3541888,false;false,1930/22402
intervention group ( n = $nmbr$ ),C0184661;C0441848;C0886296;C1273869,true;false;false;false,1931/22402
( $nmbr$ % cl ) interaction,C0596019;C1704675,false;false,1932/22402
apoa - $nmbr$  g / l,C0003592;C0439294;C0456615;C0523508;C4553344;C4553379,true;false;false;false;false;false,1933/22402
yes  insulin - treated,C1549445;C0021641;C1533581;C1579433;C3714501;C1705108;C1710701,false;true;false;false;false;false;false,1934/22402
epa treatment ( n = $nmbr$ ),C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,1935/22402
responders of three - item end point at $nmbr$ weeks *,C0205449;C1551338;C2349179;C2826544;C4554251,false;false;false;false;false,1936/22402
systemic glucocorticoid use at randomisation,C0205373;C0017710;C0042153;C0034656;C0457083;C1947944,false;true;true;true;false;false,1937/22402
duration of t $nmbr$ dm  y,C0449238;C0011816;C3250443;C2926735,false;true;false;false,1938/22402
ace inhibitors or angiotensin ii blockers,C0003015,true,1939/22402
physician ' s global assessment of dis -,C4050369;C0451119;C1444662;C1970187,false;false;false;true,1940/22402
clopidogrel no . of patients % ),C0070166,true,1941/22402
duration of crohn ' s disease ( yrs ),C0449238;C0010346;C2926735,false;true;false,1942/22402
multivessel intervention  n ( % ),C0184661;C0886296;C1273869,true;false;false,1943/22402
tertile $nmbr$,,,1944/22402
cabg surgery,C0010055;C0038894;C0038895;C0543467;C1274039,true;false;true;true;true,1945/22402
crp concentration > $nmbr$ . $nmbr$ mg / dl ( $nmbr$ mg / l )  n ( % ),C3890735;C0086045;C2827881;C3642216;C1446561;C3827302;C4048285,false;true;false;false;false;false;false,1946/22402
fatal and nonfatal stroke,C1302234;C1705232,false;false,1947/22402
angiotensin - converting - enzyme inhibitor or angiotensin - receptor blocker §,C0003015;C2757044;C3536837;C4541021,true;false;false;false,1948/22402
ace - i / arb  ( % ),C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,1949/22402
gliclazide ( modified release ) 一 no . ( % ) ^,C0017631,true,1950/22402
conventional treatment ( n = $nmbr$ ),C2945704,false,1951/22402
currentother ( notpredefined ) medical conditions,C0199168;C0012634;C0348080;C1705253;C3864998;C0205476,false;true;false;false;false;false,1952/22402
history of coronary revascularization,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,1953/22402
concomitant conventional dmard use,C0521115;C0439858;C0242708;C0042153;C0457083;C1947944,false;false;true;true;false;false,1954/22402
dual antiplatelet,C0205173;C1554184,false;false,1955/22402
digitalis,C0012252;C0304520,true;false,1956/22402
active or previous cancer,C0205177;C3853793;C3888249,false;false;false,1957/22402
therapy at discharge,C0039798;C0012621;C0030685;C2926602;C0087111;C1363945,true;false;true;false;true;false,1958/22402
north america hr ( $nmbr$ % cl ),C0028405;C0596019,true;false,1959/22402
intermediate ( $nmbr$ ) ( n = $nmbr$  $nmbr$  $nmbr$ % ),C0205103;C1550465;C2827755;C3889971,false;false;false;false,1960/22402
male sex — no . ( % ) race — no . ( % ) ) :,C0086582,true,1961/22402
primary end point kaplan - meier rate  %,C2986535;C0871208;C1521828,false;false;false,1962/22402
all ~ cause mort / hf hosp .,C0015127;C3815322;C0018488;C1313497;C1538440;C3273279;C1524003,true;false;true;true;false;false;false,1963/22402
haemodynamics and lv function,C0019010;C4281788,true;false,1964/22402
duration of study - drug infusion,C0449238;C0557651;C0392877;C2603343;C2926735,false;false;false;false;false,1965/22402
salmeterol $nmbr$ gg bid,C0073992;C0017454;C0018370,true;true;true,1966/22402
p value for adjusted hr,C1709380;C0456081,false;false,1967/22402
vitamin k antagonist ( e . g . warfarin / coumarol ),C1096489;C2267235,false;false,1968/22402
a / v ( n = $nmbr$ ),C1272460,false,1969/22402
unknown,C0439673;C3541433;C4050014,false;false;false,1970/22402
ff / vi $nmbr$ / $nmbr$ pg od,C4554348;C0205999;C0030827;C0229089;C0439164;C1512019;C3273373;C3665488;C0072225;C1266240,false;true;true;false;false;false;true;true;true;false,1971/22402
ivabradine group,C0257190;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,1972/22402
comparison with baseline ( mean,C1707455;C0168634;C0444504;C2347634;C2348143;C1442488,false;true;false;false;false;false,1973/22402
irofiban,,,1974/22402
laba / lama,C0999593;C1416775,false;false,1975/22402
< $nmbr$ years eze / simva,C0439234,false,1976/22402
placebo ( dm - vs . dm + ),C0032042;C0011816;C3250443;C1696465;C1706408,true;true;false;false;false,1977/22402
o total randomized,C0483204;C0439175;C0439810,false;false;false,1978/22402
cabgorptca,,,1979/22402
total patients n = $nmbr$,C0439175;C0030705;C0439810,false;true;false,1980/22402
left circumflex artery,C0226037,false,1981/22402
lebrikizumab ( n = $nmbr$ ),C2981360,true,1982/22402
disease duration  median ( range ) years,C0872146;C0549183;C1514721;C0439234;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,1983/22402
bl updrs : low,C0005918;C3639721;C0006413;C1552663;C2827109,true;true;true;false;false,1984/22402
fev $nmbr$ % reversibility,C3714541;C0449261,true;false,1985/22402
lipoprotein ( a ) tx difference vs pbo  ls mean % change from baseline ( se ),C0065058;C0041403;C1705241;C1705242;C0125953;C1096202;C1439335,true;true;false;false;true;false;false,1986/22402
( $ $nmbr$ mg / dl [ $nmbr$ . $nmbr$ mmol / l ] ),C0439269;C1532563,false;false,1987/22402
very high risk,C0442804;C0035647;C4552904;C4321397;C0442824;C0332167;C3272283;C4050568;C4319571;C2984081,false;true;false;false;false;false;false;false;false;false,1988/22402
location of crohn ' s disease  %,C0450429;C0010346;C1515974;C4284930;C4284931,false;true;false;false;false,1989/22402
baseline diabetes,C0168634;C0011847;C0011849;C1442488,true;false;true;false,1990/22402
number of vessels disease,C0237753;C0042373;C0449788,false;true;false,1991/22402
patient history of disease n ( % ),C0030705;C0683519;C0730226;C0850708;C0944983,true;false;false;false;false,1992/22402
tocilizumab ( n = $nmbr$ ),C1609165,true,1993/22402
mean ( sd ) duration of smoking  pack years,C0444504;C2699239;C0449238;C0037369;C1277691;C0453996;C1881674;C2926735;C2347634;C2348143,false;false;false;true;false;true;false;false;false;false,1994/22402
difference ( a ) vs placebo ( $nmbr$ % cl ),C1705241;C1705242,false;false,1995/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,1996/22402
demographic characteristics,C0683970,false,1997/22402
ezetimibe use,C1142985;C0042153;C0457083;C1947944,true;true;false;false,1998/22402
subset of patients on metformin,C1515021;C0030705,false;true,1999/22402
$nmbr$ vessels or left main,C0005847,true,2000/22402
congenital shunts,C0009678;C0232180;C0542331;C1442858;C1744681,true;false;false;false;false,2001/22402
eze / simva gender,C0079399;C1522384,true;true,2002/22402
methotrexate dose at baseline,C0025677;C0178602;C0168634;C1442488;C0869039;C1114758,true;false;true;false;false;false,2003/22402
neoplasia  n ( % ),C0027651;C1882062,true;false,2004/22402
mesothelin ( ng / ml ),C0380162;C0439275;C1334533,true;false;false,2005/22402
non - smoker ( n = $nmbr$  $nmbr$ ),C0337672;C0425293;C4554605,false;false;true,2006/22402
amlodipine / valsartan $nmbr$ / $nmbr$ mg / v = $nmbr$,C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2007/22402
> $nmbr$ . $nmbr$ hdl cholesterol level,C0023822;C0441889;C0456079;C1547707;C2946261;C0392885;C3715113;C0201950;C0428466,true;false;false;false;false;false;false;false;false,2008/22402
past or current angina pectoris,C1444637;C4284302,false;false,2009/22402
history of peripheral vascular disease,C1881056,false,2010/22402
group — no . ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,2011/22402
number of treated vessels ( per patient ),C0237753;C1522326;C0005847;C0449788,false;false;true;false,2012/22402
ranolazine  n = i $nmbr$ i $nmbr$,C0073633;C0021966;C0221138,true;true;false,2013/22402
prior failure of anti - tnf therapy — no . ( % ),C0332152;C0231174;C0281481;C0680095;C2826257,false;false;false;false;false,2014/22402
concomitant medications for ulcerative colitis — no . ( % ),C0521115;C0013227;C0009324;C0802604;C2598133;C4284232,false;true;true;false;false;false,2015/22402
lipid - lowering therapy,C0585943,false,2016/22402
dlqi  $nmbr$ - $nmbr$ *,C3899393,false,2017/22402
patients treated for > $nmbr$ weeks ( % ),C0030705,true,2018/22402
immunomodulatory agents,C0005525,true,2019/22402
endothelin - receptor antagonists,C1134681;C2266875,true;false,2020/22402
nt - probnp  median ( iqr )  pg / ml,C0669479;C0549183;C0439297;C0876920;C2347635;C2348144;C2939193;C0754710,true;false;false;false;false;false;false;true,2021/22402
hosp . for hf,C0018488;C1313497;C1538440;C3273279,true;true;false;false,2022/22402
alcohol use ( > $nmbr$ drink / wk ),C0556297;C0042153;C0332174;C0439230;C0457083;C1947944;C0001948;C0452428,false;true;false;false;false;false;true;false,2023/22402
st - segment elevation mi,C0520886;C3810814,false;false,2024/22402
history of dyspepsia,C0019664;C0013395;C4552968;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,2025/22402
ncep risk category at study entry  n ( % ),C0035647;C2983287;C1705654;C2983669;C4552904,true;false;false;false;false,2026/22402
treated hypertension :,C1522326;C0020538;C1963138,false;true;false,2027/22402
presence of dactylitis  n ( % ),C0150312;C0239161;C0392148;C3854307,false;false;false;false,2028/22402
placebo every $nmbr$ weeks ( n = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,2029/22402
heart rate  mean ± sd ( b . p . m . ),C0018810;C0444504;C2699239;C0369637;C0441923;C2347634;C2348143,true;false;false;false;false;false;false,2030/22402
post - bronchodilator fev $nmbr$  reversibility percentage of baseline value,C2599594;C3714541;C0449261;C0439165;C0168634;C1522609;C1442488;C1549488;C1561533,false;true;false;false;true;false;false;false;false,2031/22402
intense physical activity,C0522510;C0015259;C0026606,false;true;true,2032/22402
concomitant drugs,C0521115;C0013227;C3687832,false;true;false,2033/22402
cholesterol absorption inhibitor ( ezetimibe ),C0003277;C0000854;C1142985;C2347023;C2347080;C2698776;C2825050;C2945742;C1999216,true;false;true;true;false;false;false;false;false,2034/22402
cha $nmbr$ ds $nmbr$ - vasc score ( median  iqr ),C1420648;C3714751;C0449820;C0549183;C0876920;C2347635;C2348144;C2939193;C4050231,false;false;false;false;false;false;false;false;false,2035/22402
serum potassium — mmol / liter,C0302353;C0439190;C0475211;C0543465,false;false;false;false,2036/22402
nadroparin vs control,C0206232,true,2037/22402
type of event — no . ( % ),C1561488,false,2038/22402
stroke or tia — no . ( % ),C0038454;C4554100,true;false,2039/22402
previous major bleeding,C0205156;C0205082;C0019080;C0205164;C4318856;C4521762;C1552607,false;false;true;false;false;false;false,2040/22402
coexisting conditions,C0679225,false,2041/22402
characteristics of pulmonary embolism at inclusion,C1521970;C0034065,false;true,2042/22402
time of symptom onset to randomization ( hrs ),C1320528,false,2043/22402
recurrent heart failure,C1455761;C0018801;C0018802;C4554158;C2945760,false;true;true;false;false,2044/22402
all completers ( n $nmbr$ $nmbr$ ),,,2045/22402
qualifying hba $nmbr$ c ( % ),C1514624;C0019016;C1825777;C3538758,false;true;false;false,2046/22402
medically important infectionsa,C3898777;C4084912,false;false,2047/22402
three arm,C0205449;C0446516;C3715044;C4553528,false;true;false;false,2048/22402
after $nmbr$ h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,2049/22402
fev $nmbr$ % pred,C3714541,true,2050/22402
copd assessment test ( cat ) score,C4284282;C0007450;C0449820;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461,false;true;false;false;false;true;false;false;false,2051/22402
aspirin use ( > $nmbr$ mg ),C0004057;C0042153;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0457083;C1947944,true;true;true;true;false;false;false;false;false;false;false,2052/22402
moderate ( gold $nmbr$ ),C0205081;C0018026;C1304897;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,2053/22402
no ascvd + additional cv risk factors  n ( % ),C3665365;C1524062;C3538987;C0035648;C1553898;C4048877;C4318503,false;false;false;true;false;true;false,2054/22402
arb / ace,C3888198;C1452534;C4284014,false;true;false,2055/22402
hypertension serum lipid values,C0020538;C0428462;C0042295;C1963138,true;false;false;false,2056/22402
measured at clinic visit with usual device,C0444706;C0008952;C3541902,false;true;false,2057/22402
average maximum cimt ( mm ),C1510992;C0806909;C4330985;C4554674;C1552615;C2826546;C2825518,false;false;false;false;false;false;false,2058/22402
thrombophilia  no . ( % ) e,C0398623,true,2059/22402
health assessment questionnaire - disability index,C4321476,false,2060/22402
median ( q $nmbr$ : q $nmbr$ ) lp ( a )  mg / dl,C0549183;C0065058;C0439269;C1439335;C4553379;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,2061/22402
any clinical ae,C0205210;C3887670,false;false,2062/22402
mean ( sd ) feno  ppb,C0444504;C2699239;C1415800;C2347634;C2348143,false;false;false;false;false,2063/22402
cdai score §,C0683448;C1413248;C3273706,false;false;false,2064/22402
unfractionated,,,2065/22402
physical and cognitive examination : ! :,C0031809;C0205485;C1509143,true;false;false,2066/22402
syst . bp ( mmhg ),C0037623;C0439475;C1415692;C1708288;C4318478,true;false;false;false;false,2067/22402
medications at discharge or day $nmbr$  if earlier ( % ),C0806915,false,2068/22402
drug discontinuation not due to death,C0013227;C0457454;C1444662;C4552847;C1254351,true;false;false;false;false,2069/22402
congestive heart failure ( < $nmbr$ wk ),C0018802;C0332174;C0439230,true;false;false,2070/22402
aliskiren,C1120110,true,2071/22402
physician global assessment of disease activity ( vas $nmbr$ - $nmbr$ mm ),C4050369;C0042815;C4330985;C4554674;C3536884;C3827561,false;true;false;false;true;false,2072/22402
baseline dlco . mmol kpa - ’ -,C0168634;C1516251;C0439190;C0263428;C0439474;C1442488,true;false;false;true;false;false,2073/22402
role emotional,C0035820;C0013987;C0849912;C1705810;C3871154,true;true;false;false;false,2074/22402
baseline ( geometric mean  cv ),C0168634;C2986759;C3538987;C4048877;C4318503;C1442488,true;false;false;true;false;false,2075/22402
pah classification,C0030123;C0008902;C0008903;C0678229;C3203102;C4284467,true;true;true;false;true;false,2076/22402
days without albuterol use  * %,C0439228;C0001927;C0042153;C0457083;C1947944,false;true;true;false;false,2077/22402
simva ( % ),,,2078/22402
treatment with open - label perindopril,C3640652;C0136123,false;true,2079/22402
new diabetes — no . ( % ),C0205314;C0011847;C0011849,false;false;true,2080/22402
adjusted change from baseline mean ( s . e . ),C0456081;C0392747;C0168634;C0444504;C2347634;C2348143;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false;false;false;false,2081/22402
$ $nmbr$ and  $nmbr$ years,,,2082/22402
fpg ( range ) ( mmol / l ),C1514721;C1532563;C2348147;C3542016,false;false;false;false,2083/22402
arterial graft,C0450140,false,2084/22402
any established coronary artery disease,C0443211;C0010054;C0010068;C1956346;C1272684,false;true;true;true;false,2085/22402
time to treatment ( min ) t,C3494202;C0702093;C1524029;C3813700,true;false;false;false,2086/22402
serum potassium : < $nmbr$ . $nmbr$ mmol / l ( n = $nmbr$ ),C0302353;C1532563;C0543465,false;false;false,2087/22402
hemoglobin concentration — g / liter,C1319312;C0086045;C0475211;C1446561;C3827302;C0019029;C0439267;C1314664;C1318517,false;true;false;false;false;false;false;false;false,2088/22402
clopidogrel + aspirin ( n = $nmbr$ ),C0070166;C0004057,true;true,2089/22402
previous metformin use  %,C0205156;C0025598;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,2090/22402
current ( % ),C0521116;C1705970,false;false,2091/22402
ecg findings at baseline — no . ( % ),C0438154;C0168634;C1442488,false;true;false,2092/22402
concomitant therapies n ( % ),C1707479,false,2093/22402
baseline therapy,C0168634;C0039798;C0087111;C1363945;C1442488,true;true;true;false;false,2094/22402
hba $nmbr$ c $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ % ( $nmbr$ - $nmbr$ mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,2095/22402
history of recurrent venous thromboembolism,C0455533;C1455761;C0042449;C0348013;C2945760,false;false;true;false;false,2096/22402
magnetic resonance angiography,C0243032,true,2097/22402
free fatty acids — mmol / liter,C0015688;C0439190;C0475211,true;false;false,2098/22402
baseline post - bronchodilator % predicted fev  > $nmbr$ % and no concurrent tiotropium,C0168634;C1442488,true;false,2099/22402
id genotype,C0009450;C0017431;C0600091;C1441613,true;true;false;false,2100/22402
major coronary,C0205082;C0018787;C0205164;C4318856;C4521762,false;true;false;false;false,2101/22402
cardiac rhythm disorders,C0264886,true,2102/22402
previous ischemic stroke  n ( % ),C0205156;C0948008;C1552607,false;false;false,2103/22402
apolipoprotein b tx difference vs pbo  ls mean % change from baseline ( se ),C0003593;C0041403;C1705241;C1705242,true;true;false;false,2104/22402
history of macroalbuminuriat  n ( % ),C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,2105/22402
high ( > $nmbr$ risk factor ),C0332167;C1521761;C2827422;C3272283;C4050568;C4319571;C0205250;C0035648;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;true;false;false;false;false;false;false,2106/22402
psoriasis affecting > $nmbr$ % of body - surface,C0033860;C0392760;C0489451;C1314939,true;false;false;false,2107/22402
asthma duration ( sd )  years,C0004096;C0449238;C2699239;C0439234;C2926735;C2984299,true;false;false;false;false;false,2108/22402
glucose metabolism,C0596620,false,2109/22402
glycated hemoglobin  median ( iqr ),C0017853;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,2110/22402
blood pressure  mean ± sd mm hg,C0428886;C2699239;C0439475,true;false;false,2111/22402
fpi  mean ( sd )  pu / mlt,C0444504;C2699239;C0018387;C4553833;C2347634;C2348143,false;false;true;false;false;false,2112/22402
secondary # $nmbr$,C0027627;C0175668;C0205436,true;false;false,2113/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ kg / m $nmbr$,C1532718,false,2114/22402
primary pci no .,C0205225;C4049621;C0439612;C0439631,false;false;false;false,2115/22402
rectum and sigmoid colon only,C0034896,true,2116/22402
radial access — no . / total no . ( % ),C0442038;C0920847,false;false,2117/22402
oral blood glucose - lowering,C0442027;C0005802;C0441994;C2003888;C4521986,false;true;false;false;false,2118/22402
age $nmbr$ + yrs,C0001779,false,2119/22402
> $nmbr$ . $nmbr$ pmol / liter hscrp level,C0439192;C0475211;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false;false,2120/22402
other ischaemic heart disease ( non - infarction ),C0010054;C1518422;C0021308;C0151744,true;false;true;true,2121/22402
calcium supplements,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,2122/22402
a mini - mental state examination  insulin glargine vs standard care,C0451306;C0907402,true;true,2123/22402
country : argentina ( n = $nmbr$ ),C0454664;C0003761;C1504311;C1511538,false;true;false;false,2124/22402
estimated gfr — no . ( % ) $nmbr$,C0750572;C0017654;C1424601,false;true;false,2125/22402
received > $nmbr$ prior anti - tnf therapies  n,C1514756;C0332152;C0432633;C0279936;C2826257,false;false;false;false;false,2126/22402
$nmbr$ placebo ( n = $nmbr$ $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,2127/22402
standard care n ( % ),C1442989;C1947933;C2828392,false;false;false,2128/22402
interval from clopidogrel loading  h,C1272706;C0070166;C1708715;C0033727;C0369286;C0441932;C0564385;C4528284;C1552654;C1552713,false;true;false;true;false;false;false;false;false;false,2129/22402
severity of copd *  n ( % ),C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,2130/22402
acr deciles,C1412134;C1515941,false;false,2131/22402
change at week $nmbr$,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,2132/22402
europe  israel  or australia,C0015176;C0022271,true;true,2133/22402
low density lipoprotein cholesterol - mg / dltt,C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2134/22402
other dmard use,C0242708;C0042153;C0457083;C1947944,true;true;false;false,2135/22402
duration of hypercholesterolemia ( yr ),C0449238;C0020443;C0439234;C1522133;C2926735,false;true;false;false;false,2136/22402
personal relationships,C1552027,false,2137/22402
heart failure or lvef < $nmbr$ % associated with index acs event,C0018801;C0018802;C4554158,true;true;false,2138/22402
previous venous thromboembolism — no . ( % ),C0205156;C1861172;C1552607,false;true;false,2139/22402
prior biologic exposure,C0332152;C0005515;C0274281;C0332157;C0205460;C2826257,false;true;false;false;false;false,2140/22402
need for urgent coronary - artery bypass grafting,C0027552;C0439609;C0010055;C3272275;C0686904,true;false;true;false;false,2141/22402
egfr ( ml / min / $nmbr$ - $nmbr$ mz ),C1739039;C0439445;C0026655;C1705291;C3811844;C3812682,true;false;true;false;false;false,2142/22402
egfr ( mdrd )  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C3839656;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,2143/22402
previous stroke  n ( % ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,2144/22402
alpha $nmbr$ blockers,C0001641,true,2145/22402
moderate dysfunction,C3274776,false,2146/22402
tnf - r $nmbr$ a ( ng / ml ),C1363984;C1706001,false;false,2147/22402
jejunum,C0022378,true,2148/22402
neither ace - i nor arb use,C1452534;C0021966;C0221138;C4284014,true;true;false;false,2149/22402
history of vte * *,C0019664;C0630906;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,2150/22402
d - dimer level  mean ( sd )  ng / mld,C0060323;C0441889;C0444504;C2699239;C0017887;C0023522;C1539265;C3539688;C3539689;C0028074;C2347634;C2348143;C0456079;C1547707;C2946261,true;false;false;false;true;true;false;false;false;true;false;false;false;false;false,2151/22402
gfr ( ml / min per $nmbr$ . $nmbr$ nr ),C0017654;C0439445;C0027496;C3844738;C1424601,true;false;true;false;false,2152/22402
diastolic fmmhff ' ),C0012000,true,2153/22402
diabetes duration  median ( iqr )  years,C0011847;C0449238;C0549183;C0439234;C0876920;C2347635;C2348144;C2939193;C2926735;C0011849,false;false;false;false;false;false;false;false;false;true,2154/22402
$nmbr$ . $nmbr$ ( $nmbr$ $nmbr$ . $nmbr$ ),,,2155/22402
plaque score ( $nmbr$ - $nmbr$ ),C0429153,false,2156/22402
prior disease,C0332152;C0012634;C2826257,false;true;false,2157/22402
mean sd fpg  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,2158/22402
serum ctx ( ng / ml ),C0229671;C0010377;C0439275;C0631180;C3539598;C1546774;C1550100,true;true;false;true;false;false;false,2159/22402
baseline triglycerides in $nmbr$ classes,C0168634;C0041004;C0456387;C1518526;C1705943;C4019422;C1442488,true;true;false;false;false;false;false,2160/22402
ff / vi $nmbr$ mg / $nmbr$ mg ( n = $nmbr$ ),C4554348;C0205999;C1319635,false;true;false,2161/22402
previous anti - tnf therapy  n [ % ],C0205156;C0432633;C0279936;C1552607,false;false;false;false,2162/22402
dronedarone ( n = $nmbr$ ),C0766326,true,2163/22402
standard ( $nmbr$ ),C1442989;C2828392,false;false,2164/22402
age  median ( interquartile range )  y,C0001779;C0549183;C1711350;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2165/22402
one or more copd exacerbations ( n / n [ % ] ),C0205447,false,2166/22402
peripheral embolism,C0205100;C0013922;C1704212,false;true;true,2167/22402
arterial blood pressure  mm hg,C1272641;C0439475,true;false,2168/22402
co - morbidities  a n ( % ),C0009488,true,2169/22402
oral hypoglycemic drugs only,C0359086;C0205171;C1720467,false;false;false,2170/22402
p value ( on vs off omt ),C1709380,false,2171/22402
mucocutaneous,,,2172/22402
any new anti - hyperglycemic rx,C0205314;C1425688;C1521941;C2709207,false;false;false;false,2173/22402
metsyn with ldl > $nmbr$ . $nmbr$ mg / dl,C0439269,false,2174/22402
severe or worse airflow limitation,C0205082;C4050465;C4050466,false;false;false,2175/22402
periprocedural anticoagulant,C0003280;C0848112;C3536711,true;false;false,2176/22402
lsms difference ( $nmbr$ % ci ) $nmbr$,C1705241;C0008107;C3259781;C1705242,false;true;false;false,2177/22402
age  y sex  no . ( % ),C0001779;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,false;true;true;true;false;false;true,2178/22402
blood eosinophil,C0014467,true,2179/22402
pah classification — no . ( % ),C0030123;C0008902;C0008903;C0678229;C3203102;C4284467,true;true;true;false;true;false,2180/22402
short - acting b $nmbr$ - agonists,C1282927;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;true;false;false;true;false;false;false;false,2181/22402
fev $nmbr$ reversibility  pre - / post - albuterol  %,C3714541;C0449261;C0332152;C0687676;C0001927;C1704687;C3469826;C0740175;C2257086;C3669034,true;false;false;false;true;false;false;false;false;false,2182/22402
ischemia on cecg ( n = $nmbr$  $nmbr$ ),C0022116;C4321499,true;false,2183/22402
ularitide n / n ( % ),C0077910,true,2184/22402
three of seven risk factors,C0205449;C0205453;C0035648;C1553898,false;false;true;false,2185/22402
moderately high risk without atherosclerotic vascular disease *,C0205081;C0332167;C0004153;C3272283;C4050568;C4319571;C1881878;C4085643;C4321491,false;false;true;false;false;false;false;false;false,2186/22402
randomised to canakinumab $nmbr$ mg,,,2187/22402
ff $nmbr$ pgod,C4554348,false,2188/22402
fev $nmbr$ post - bronchodilator  % predicted normal,C3714541,true,2189/22402
migraine — no . ( % ) $,C0149931,true,2190/22402
hypertension — no . / total no . ( % ),C0020538;C1963138,true;false,2191/22402
randomized to active yitamin e,C0034656;C0205177;C3853793;C3888249;C3815594,true;false;false;false;false,2192/22402
low risk and more symptoms ( group b ),C3272281;C3538919,false;false,2193/22402
high risk,C0332167;C3272283;C4050568;C4319571,false;false;false;false,2194/22402
carotid artery diseaset,C0007272;C0162859,true;true,2195/22402
cholesterol — mmol / liter,C0008377;C0439190;C0475211,true;false;false,2196/22402
fasting plasma glucose,C0015663;C0202042;C0455280,true;false;false,2197/22402
daily activities,C0871707,false,2198/22402
extended - duration enoxaparin ( n = $nmbr$ ),C0231448;C0449238;C0206460;C2926735;C0231449;C0439792,false;false;true;false;false;false,2199/22402
das $nmbr$ - $nmbr$ ( esr ),C0051767;C3811131;C0057671,true;false;true,2200/22402
associated with corrected - congenital shunts,C0332281;C0205202;C0009678;C0232180;C0542331;C1442858;C1744681,false;false;true;false;false;false;false,2201/22402
traditional nsaid use,C3897349;C0003211;C3536840,false;true;false,2202/22402
baseline albumin : < $nmbr$,C0168634;C0001924;C1442488,true;true;false,2203/22402
high - risk cvd  n ( % ),C0332167;C0007222;C3272283;C4050568;C4319571,false;true;false;false;false,2204/22402
pro / pro homozygotes,C1120626;C0019904,true;true,2205/22402
sulfasalazine ( mean dose : $nmbr$ . $nmbr$ g / day ),C0036078;C0444504;C0178602;C0439417;C0869039;C1114758;C2347634;C2348143,true;false;false;false;false;false;false;false,2206/22402
> $nmbr$ years eze / simva baseline ldl - c,C0439234;C0168634;C1442488,false;true;false,2207/22402
< $nmbr$ % predicted arr ( n = $nmbr$  $nmbr$ ),C0681842;C2170357;C4084934;C1882327,false;false;false;false,2208/22402
pe associated with dvt at diagnosis,C0070939;C1880476;C4284304,true;false;false,2209/22402
baseline hba $nmbr$ c,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,2210/22402
renal function < $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0232804;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,false;true;false;false;false;false;false,2211/22402
blood eosinophil concentration  $nmbr$ cells per l,C0014467;C0086045;C0347983;C1446561;C3827302;C0427728;C0699870;C1313904,true;true;false;false;false;false;false;false,2212/22402
less severe $nmbr$,C0439092;C0205082;C4050465;C4050466;C0547044,false;false;false;false;false,2213/22402
cardiovascular risk,C0007226;C0035647;C4552904;C3887460,true;true;false;false,2214/22402
prehospital ticagrelor ( n = $nmbr$ ),C1999375,true,2215/22402
symptoms of atrial fibrillation in the $nmbr$ months before randomiza -,C0683368;C0004238;C0344434;C1963067;C1457887,true;true;false;false;false,2216/22402
perindopril,C0136123,true,2217/22402
tiotropium / olodaterol $nmbr$ / $nmbr$ mg ( n = $nmbr$ ),C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2218/22402
symptom onset to hospital admission,C4086878;C0184666,false;false,2219/22402
ldl - c ( measured ) *,,,2220/22402
rerapamil - sr strategy ( n = $nmbr$ ),C0753208;C0679199;C1709991;C3813610;C3890900;C3891546,true;false;false;false;false;false,2221/22402
erosion score  mean $nmbr$ sd,C0333307;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false;false;false;false;false,2222/22402
valve surgery  n ( % ),C0184252;C0038894;C0038895;C0543467;C1274039;C1186983;C1704414;C3888056,false;false;true;true;true;false;false;false,2223/22402
ticagrelor $nmbr$ mg $nmbr$ year km ( % ),C1999375;C0024671;C0439234;C3887676;C0439508;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,2224/22402
north america ( plus australia and new zealand ),C0028405;C0332287;C0004340,true;false;true,2225/22402
calcium antagonist — no . ( % ),C0006684,true,2226/22402
penetrating disease  %,C0205321;C0012634,false;true,2227/22402
non - drug - eluting stent,C1518422;C1322815,false;true,2228/22402
number of exacerbations in the past $nmbr$ months,C0237753;C4086268;C0449788,false;false;false,2229/22402
potassium supplement,C0304475,false,2230/22402
age group,C0027362;C2348001,true;false,2231/22402
congestive heart failure ( chf ) ( in past $nmbr$ weeks ),C0018802;C2987125,true;false,2232/22402
platelet count  x $nmbr$ mm $nmbr$,C0032181;C4330985;C4554674;C1287267,true;false;false;false,2233/22402
other supraventricular tachycardia,C0039240;C1963244;C3815188,true;false;false,2234/22402
egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ [ mdrdequation ] ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,2235/22402
mean bmi  kg / m $nmbr$,C0444504;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false,2236/22402
* * * unstable angina,C0002965,true,2237/22402
rate ratio,C0871208;C0456603;C1547037;C1521828,false;false;false;false,2238/22402
recurrent vte ( statin use vs non - use ),C1455761;C0630906;C0360714;C0042153;C0457083;C1947944;C2945760,false;true;true;true;false;false;false,2239/22402
saxagliptin $nmbr$ mg ( n = $nmbr$  $nmbr$ ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2240/22402
irregular or ulcerated ica p ) laque : [ :,C0205271,false,2241/22402
extreme tortuosity,C0205403;C0333076;C3641272;C4085555,false;false;false;false,2242/22402
angina status — no . ( % ),C0002962;C0449438,true;false,2243/22402
p value $nmbr$ . $nmbr$,C1709380,false,2244/22402
nonaspirin antiplatelet,C0722138,false,2245/22402
antihyperglycemictherapies  %,,,2246/22402
geographic distribution - no . ( % ),C0681686,false,2247/22402
conventional synthetic dmard use at baseline,C0439858;C1883254;C0242708;C0042153;C0168634;C1442488;C0457083;C1947944,false;false;true;true;true;false;false;false,2248/22402
statins 一 no . ( % ),C0360714,true,2249/22402
at six weeks,C0205452;C0439230,false;false,2250/22402
angiographic data and treatment :,C0002978;C1511726;C3245479;C3714741,true;false;false;false,2251/22402
clinical indication at the index procedure  n ( % ),C0205210;C2315323;C0600653;C0918012;C1552854;C1637833;C2986546;C2347896,false;false;true;true;false;false;false;false,2252/22402
mean bdi focal score ( sd ),C3533236;C0006448;C0205234;C2699239;C0451022;C3714938;C3889415,false;true;false;false;false;false;false,2253/22402
cabg during index hospitalization,C0010055;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,true;true;true;true;false;false;false,2254/22402
pci for index event,C4049621;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,2255/22402
concomitant drug treatment,C0521115;C0150270;C3469597,false;false;false,2256/22402
third primary ( change in updrs score / wk  wk $nmbr$ - $nmbr$ ),C0205437;C0205225;C0392747;C3639721;C0443172;C1705241;C4319952;C0439612;C0439631,false;false;false;true;false;false;false;false;false,2257/22402
implanted pacemaker,C0848753,false,2258/22402
concomitant asthma medications  n ( % ),C0521115;C0004096;C0013227;C0802604;C2598133;C4284232;C2984299,false;true;true;false;false;false;false,2259/22402
hba $nmbr$ c $ $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,2260/22402
uacr not available,,,2261/22402
ret / abx - facil . pci,C0389252;C4049621,true;false,2262/22402
severity of copd  airflow limitation  n ( % ),C0439793;C0024117;C0231999;C0443288;C0449295;C1412502;C3714496;C0522510,false;true;false;false;false;false;false;false,2263/22402
claudication only,C0021775;C0205171;C1720467;C0311395;C1456822,true;false;false;false;false,2264/22402
mean % predicted dlco * ( sd ),C0444504;C2347634;C2348143,false;false;false,2265/22402
titre ( u / ml ) t,C0475208;C0439340;C1880521;C2945590,false;false;false;false,2266/22402
treatment before admission ( % ),C0039798;C0184666;C0809949;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,2267/22402
overall quality of life,C3641830,false,2268/22402
no baseline corticosteroids,C0168634;C0001617;C3539185;C3540725;C3540726;C3540727;C1442488,true;true;false;false;false;false;false,2269/22402
high on - treatment platelet reactivity *,C0205250;C0039798;C0005821;C0443286;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,2270/22402
potassium ( meql )  mean + sd  available for $nmbr$ patients,C0032821;C0444504;C2699239;C2347634;C2348143;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false,2271/22402
all patients with opg n - $nmbr$,C0030705;C1262886;C1336645;C1412836;C1710303,true;false;false;false;false,2272/22402
urinary albumin : creatinine ratio ( pg / mg )  median ( iqr ),C0455271;C1627892;C0549183;C0876920;C2347635;C2348144;C2939193;C1318330,false;false;false;false;false;false;false;false,2273/22402
cardiac rhythm disorder at baseline yes,C0264886;C0168634;C1549445;C1705108;C1710701;C1442488,true;true;false;false;false;false,2274/22402
islander,,,2275/22402
left circumflex coronary artery,C0226037,false,2276/22402
risk category ( points ),C0035647;C0683312;C3889287;C4552904,true;false;false;false,2277/22402
nihss at randomization  $nmbr$ - $nmbr$,C1697238;C0034656,false;true,2278/22402
cilostazol,C0055729,true,2279/22402
creatinine clearance category  ml / min  no . ( % ) b,C0812399;C0683312;C0439445;C3889287,false;false;false;false,2280/22402
tg > $nmbr$ mg / dl  n ( ° / o ),C0337445;C0439269,false;false,2281/22402
chf on losartan ( % ),C0018802;C0126174,true;true,2282/22402
comorbidities  %,C0009488,true,2283/22402
prior lipid - lowering agent use,C0332152;C0086440;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,2284/22402
iwqol - lite total score ( arbitrary units ) #,C2964552;C0439183,false;false,2285/22402
absolute change,C1549031,false,2286/22402
gusto moderate / severe,,,2287/22402
ls mean difference ( se ) vs placebo,C0023668;C0444504;C1705241;C0036919;C1705242;C2347634;C2348143,true;false;false;true;false;false;false,2288/22402
stent implanted — no . ( % ),C0522776,false,2289/22402
eze / simva ( „ = $nmbr$ },,,2290/22402
low eosinophil subgroup (  $nmbr$ / ml ) ( n = $nmbr$ ),C0205251;C0014467;C1079230;C0439526;C1705224;C3887665;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false;false;false,2291/22402
alaska native,C0682125,true,2292/22402
| interactior $nmbr$ p,,,2293/22402
number ( s ) of features present,C0237753;C1521970;C1706388;C2346469;C2348519;C0449788,false;false;false;false;false;false,2294/22402
extent of disease — no . / total no . ( % ) § ^ |,C0449279;C4553144,false;false,2295/22402
eze / simva $nmbr$ / $nmbr$ mg n = $nmbr$,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,2296/22402
bivalirudin,C0168273,true,2297/22402
two arm,C0205448;C0446516;C3715044;C4553528,false;true;false;false,2298/22402
metreo modified intention - to - treat population §,C0392747;C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C3889737,false;true;true;true;true;false;false;false;false,2299/22402
any blood pressure medications ( % ),C0849164;C0033095;C0460139;C1306345;C4284008;C0005823;C0013227;C0802604;C2598133;C4284232;C1271104;C1272641,false;true;false;false;false;true;true;false;false;false;false;true,2300/22402
p  net difference,C0369773;C1456447;C1705241;C1705242;C3853572;C3887809;C3890893;C2603361,false;true;false;false;false;false;false;false,2301/22402
statin users ( n = $nmbr$ ),C0360714;C1706077,true;false,2302/22402
simplified disease activity index score ( $nmbr$ - $nmbr$ ),C3869582;C0449820;C4050231,false;false;false,2303/22402
calcium channel,C0006685,true,2304/22402
level — no . ( % ),C0441889;C0456079;C1547707;C2946261,false;false;false;false,2305/22402
no regular consumption,C0205272;C0009830;C1947907,false;true;false,2306/22402
$nmbr$ / $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ ),,,2307/22402
time from randomization to pci ( non - st - elevation mi )  h,C0040223;C0034656;C3541383,true;true;false,2308/22402
$nmbr$ e < $nmbr$ %  n ( % ),,,2309/22402
prior pacemaker  n ( % ),C0332152;C0030163;C0810633;C1546728;C3275122;C3853703;C2826257,false;true;false;false;false;false;false,2310/22402
non - detectable / unknown  n ( % ),C1518422;C3830527;C0439673;C3541433;C4050014,false;false;false;false;false,2311/22402
individuals without diabetes  n = $nmbr$  $nmbr$,C0027361;C0011847;C0011849;C0237401,true;false;true;false,2312/22402
post - fibrinolysis angioplasty ( n = $nmbr$ ),C0687676;C0016017;C0162577;C1548817;C1305868;C1704687;C3469826,false;true;true;false;false;false;false,2313/22402
aerobic activity,C0001701,true,2314/22402
pulse pressure,C0949236,true,2315/22402
laboratory measures,C0022877;C3244292;C4283904,true;false;false,2316/22402
deep - vein thrombosis ( % ),C0149871,true,2317/22402
cardiovascu lar subg roup,C1419115;C0276828;C3814448,false;false;false,2318/22402
greater than or equal to $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439093,false,2319/22402
statin  n ( % ),C0360714,true,2320/22402
location of infarction,C0450429;C0021308;C1515974;C4284930;C4284931,false;true;false;false;false,2321/22402
infliximab - experienced ( n = $nmbr$ ),C0666743,true,2322/22402
time since first copd diagnosis ( years ),C0040223;C3541383,true;false,2323/22402
potassium — mmol / liter,C0032821;C0439190;C0475211;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false,2324/22402
rivaroxaban ( n = $nmbr$ ),C1739768,true,2325/22402
investigator - determined myocardial infarction,C0035173,true,2326/22402
time from first eval,C0040223;C0205435;C1707957;C2698624;C1279901;C3541383,true;false;false;false;false;false,2327/22402
diagnosis of heterozygous familial hypercholester,C0011900;C0019425;C0015576;C0241888;C1704338;C1704656,true;true;true;false;true;false,2328/22402
baseline crp ( mg / dl ),C0168634;C3890735;C0439269;C4048285;C1442488,true;false;false;false;false,2329/22402
average of maximum far wall cimt ( mm ),C1510992;C0806909;C0205108;C0677535;C4330985;C4554674;C1552615;C2826546;C2825518,false;false;false;false;false;false;false;false;false,2330/22402
hispanic ethnicity,C0086409;C0015031;C0243103,true;true;true,2331/22402
other vasodilator,C0042402;C3537240,true;false,2332/22402
maintenance dose,C3714445,false,2333/22402
thienopyridine type,C1120149;C0332307;C1547052,true;false;false,2334/22402
perfusion defectsatinclusion,C0031001;C4281794,true;false,2335/22402
das $nmbr$ - esr remission,C0051767;C3811131;C0544452;C0687702;C0057671,true;false;false;false;true,2336/22402
no . of panents . total no . $nmbr$ % ),,,2337/22402
disease activity outcomes ( itt population ) week $nmbr$,C1292728;C1274040;C0032659;C0332174;C0439230;C1257890;C0679250;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939;C3542417,false;false;true;false;false;true;false;false;false;false;false;false;false;false;false,2338/22402
fluticasone furoate and vilanterol ( n = $nmbr$ ),C1948374,true,2339/22402
any infarct,C0021308,true,2340/22402
apolipoprotein a - i *,C0085201;C1677784,true;true,2341/22402
current smoking — no . / total no . ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,2342/22402
miami k antagonist received,C1551421;C0597277;C0231491;C1708601,false;false;false;false,2343/22402
rivastigmine,C0649350,true,2344/22402
europa ( n = $nmbr$ l $nmbr$ ),C0242751,true,2345/22402
lung function  mean,C0035245;C0444504;C2347634;C2348143,true;false;false;false,2346/22402
physician ' s global assessment of disease activity ( $nmbr$ - $nmbr$ mm vas )  mean ( sd ),C4050369;C4330985;C0042815;C0444504;C2699239;C2347634;C2348143;C3536884;C3827561;C4554674,false;false;true;false;false;false;false;true;false;false,2347/22402
$nmbr$ - $nmbr$ ( very severe ),C3641272;C4050419,false;false,2348/22402
high - risk clinical features,C0332167;C0683325;C3272283;C4050568;C4319571,false;false;false;false;false,2349/22402
second primary composite outcome,C0205436;C0205225;C0205199;C1274040;C1547335;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false;false;false;false;false,2350/22402
baseline % predicted fev $nmbr$,C0168634;C1442488,true;false,2351/22402
treatment characteristics,C0039798;C1521970;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,2352/22402
digoxin at last follow - up,C0012265;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,2353/22402
both impaired glucose tolerance and impaired fasting glucose tolerance — no .,C0271650,true,2354/22402
ez / simva < % >,C0206578,true,2355/22402
sbp indicates systolic blood pressure  dbp  diastolic blood pressure  aa  arachidonic acid  epa  eicosapentaenoic acid . values for age  bmi  total cholesterol  ldl cholesterol  hdl cholesterol  sbp  dbp  aa  epa  and epa / aa ratio represent the mean values represent the median ( interquartile range ) . p values are for the differences between the no epa and epa groups .,C0085805;C0003695;C0000545;C0439632;C0578022;C0439175;C0439810;C2316832;C2699193;C0085805;C0536221;C0282379;C1235746;C1882141;C4554792;C3813197;C4281799;C0282379;C0456603;C1547037;C1235746;C1882141;C4554792;C1711350;C1709380,true;true;true;false;false;false;false;false;false;true;true;true;false;false;false;false;false;true;false;false;false;false;false;false;false,2356/22402
# of prior bdmards,C0332152;C2826257,false;false,2357/22402
acute reaction,C0205178;C0443286,false;false,2358/22402
ulcers / gangrene,C0041582;C0017086,true;true,2359/22402
fasting plasma glucose ( mmol / l ),C0015663;C0202042;C1532563;C0455280,true;false;false;false,2360/22402
other teaes,,,2361/22402
alcohol intake,C0001948,true,2362/22402
change from baseline ( % ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,2363/22402
ileum only,C0020885;C0205171;C1720467,true;false;false,2364/22402
anti - tnf - ir patients,C1448177;C0022065;C0030705;C0022071;C1448132,true;true;true;true;true,2365/22402
north america plus australia and new zealand,C0028405;C0332287;C0004340,true;false;true,2366/22402
medial - distal - diag,C0205098;C0205108;C0348026;C4522154,false;false;false;false,2367/22402
bw at $nmbr$ weeks  kg +,C0005910;C0439230;C0022718;C0439209;C4054209;C0006041;C2986891,true;false;true;false;false;true;false,2368/22402
haemoglobin ( mmol / l ),C0635222;C0439190;C0019046;C1532563,true;false;true;false,2369/22402
severity ofcopd ( gold $nmbr$ )  n ( % ),C0439793;C0018026;C1304897;C0522510,false;true;false;false,2370/22402
prior stroke — no . ( % ),C0332152;C2826257,false;false,2371/22402
adalimumab ( n = $nmbr$ ),C1122087,true,2372/22402
aliskiren dm = $nmbr$ non - dm = $nmbr$,C1120110;C0011816;C3250443,true;true;false,2373/22402
previous cabg ( before index acs ) *,C0205156;C0010055;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1552607,false;true;true;true;false;true;false;false;false;false,2374/22402
number of patients ( % ) or mean 士 sd,C2360800,false,2375/22402
severity of copd  n ( % ) ( gold $nmbr$ ) : moderate,C0439793;C0024117;C0018026;C1304897;C1412502;C3714496;C0522510,false;true;true;false;false;false;false,2376/22402
western friroce,C1705493,false,2377/22402
baseline lipids  mean ± sd ( mmol / $nmbr$ ),C0168634;C0023779;C0444504;C2699239;C0439190;C2347634;C2348143;C1442488,true;true;false;false;false;false;false;false,2378/22402
baseline calcium yes,C0168634;C0006675;C1549445;C1705108;C1710701;C0006726;C2936886;C3540037;C3714611;C1442488,true;true;false;false;false;true;false;false;false;false,2379/22402
cardiac mediations,C0018787;C0680727;C1522601,true;true;false,2380/22402
large vessel,C0225990,false,2381/22402
no . of treated vessels,C1522326;C0005847,false;true,2382/22402
sinus rhythm at baseline,C0232201;C0168634;C1442488,false;true;false,2383/22402
ipah / hpah,C0152171;C0340543;C0637939;C1150929,false;true;true;false,2384/22402
ccs class §,C1879987,false,2385/22402
antithrombotic and anticoagulant medications,,,2386/22402
ixeq $nmbr$ w  n = $nmbr$,,,2387/22402
warfarin group ( n = $nmbr$ ),C0043031;C0441848,true;false,2388/22402
white - cell count — x $nmbr$ _ $nmbr$ / liter,C0023508;C0475211;C0427512,true;false;false,2389/22402
mean % predicted fvc ( sd ),C0444504;C2347634;C2348143,false;false;false,2390/22402
only cerebrovascular disease,C0205171;C0007820;C1720467,false;true;false,2391/22402
three or more agents,C0205449,false,2392/22402
msfc timed $nmbr$ - foot walk test  median seconds,,,2393/22402
mean ( sd ) baseline scores,C0444504;C2699239;C0168634;C1442488;C2347634;C2348143,false;false;true;false;false;false,2394/22402
patients with > $nmbr$ % ■ $nmbr$ ml increase in fev $nmbr$ post - bronchodilator ( % ),C0030705;C0439526;C0442805;C1705224;C3887665,true;false;false;false;false,2395/22402
meglitinide,C0065880,true,2396/22402
prior tobacco use  n ( % ),C0332152;C0040335;C0543414;C0841002;C3853727;C2826257,false;false;true;false;false;false,2397/22402
graft occlusionsa,C0181074;C0332835;C1961139,false;true;false,2398/22402
ascot - lla,C0718674,false,2399/22402
cortical only,C0001613;C0205171;C1720467;C0007776;C0022655,true;false;false;true;true,2400/22402
key : tc = triglyceride  hs - crp = ldl - c = low - density lipoprotein fc = fasting glucose  ncep atp * this category did not include ar to have > _ $nmbr$ of the indicated char least - square means  except tc an note : all treatment by subgroup,C0039411;C0041004;C3890735;C0023823;C4048285;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C2983605;C0015663;C0017725;C2744579;C4552600;C1436327;C2986463;C3884535;C4521369;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;false;true;false;true;true;true;false;false;false;false;true;true;true;false;true;false;true;false;true;true;true;true;false;false;false,2401/22402
prior disease - modifying drugs resulting in inadequate response — mean no . / patient,C0332152;C0012634;C0392747;C0013227;C3687832;C2826257,false;true;false;true;false;false,2402/22402
extent of disease,C0449279;C4553144,false;false,2403/22402
candesartan group ( n = $nmbr$ ),C0717550;C0441848,true;false,2404/22402
rivaroxaban alone ( n = $nmbr$ ),C1739768;C0205171;C0439044;C0679994,true;false;false;false,2405/22402
body mass index  mean ( sd ) [ range ] a,C0005893;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;false;false;true,2406/22402
baseline antihyperglycemic medications  n ( % ),C0168634;C0020616;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;true;false;false;false;false,2407/22402
fasting lipid levels  mmol / l,C0015663;C0428460;C1532563,true;false;false,2408/22402
proximal gastrointestinal tract,C0205107;C0017189;C0521362;C4489236,false;true;false;false,2409/22402
diabetes mellitus ( type $nmbr$ or $nmbr$ ),C1320657,false,2410/22402
heart failure ( hf )  ( % ),C0018801;C0018488;C1313497;C1538440;C3273279;C0018802;C4554158,true;true;true;false;false;true;false,2411/22402
platelet  $nmbr$ / l,C0456525,false,2412/22402
hba $nmbr$ c < $nmbr$ % ( n - $nmbr$ ),C0019016;C1825777;C3538758,true;false;false,2413/22402
spironolactone  n ( % ),C0037982,true,2414/22402
b digit symbol substitution  insulin glargine vs standard care,C0291665;C0582802;C0679214;C1555721;C0907402;C1706204;C1698987;C3241971,true;false;false;false;true;false;false;false,2415/22402
proteinuria $nmbr$ ( g / day ),C0033687;C0439417;C1962972;C4554346,true;false;false;false,2416/22402
elevated blood pressure,C0020538;C0497247,true;false,2417/22402
ldl - c ( mg / dl ) < $nmbr$,C0439269,false,2418/22402
laser or vitrectomy,C0023089;C0458142;C1023865;C1706315,true;false;false;false,2419/22402
total study population ( n = $nmbr$ ),C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,2420/22402
presenting diagnosis,C0449450;C0011900;C1704338;C1704656,false;true;true;false,2421/22402
duration of type $nmbr$ diabetes ( years ),C0449238;C1320657;C0439234;C2926735,false;false;false;false,2422/22402
alt ( units / l ),C1266129;C0439339;C4553172,false;false;false,2423/22402
severity of airflow limitation,C0439793;C0231999;C0443288;C0449295;C0522510,false;false;false;false;false,2424/22402
patient ' s global assessment of disease,C4054229;C0012634,false;true,2425/22402
daily dose $nmbr$ - $nmbr$ mg n = $nmbr$,C2348070;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,2426/22402
in - stent restenosis of des,C3272317;C0011702;C4551552,false;true;true,2427/22402
baseline hba $nmbr$ c  mean ( s . e . ),C0168634;C0019016;C0444504;C2347634;C2348143;C1825777;C3538758;C1442488,true;true;false;false;false;false;false;false,2428/22402
predicted normal ( % ),C0681842;C0205307;C0231683;C0439166;C2347086;C4553972;C1882327,false;false;false;false;false;false;false,2429/22402
killip class — no . ( % ) i,C1881332,false,2430/22402
prior ml or abnormal angiogram,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,2431/22402
placebo + mtx ( n = $nmbr$ ),C0032042;C0025677;C1417487;C1696465;C1706408,true;true;false;false;false,2432/22402
baseline corticosteroid use ( mg ),C0168634;C0239126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488,true;false;true;true;false;false;false;false;false;false,2433/22402
ind / gly $nmbr$ / $nmbr$ mg once daily ( n = $nmbr$  $nmbr$ ),C4049864;C0017890;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0523677,false;true;true;false;true;false;false;false;false;false;false,2434/22402
patients who received positive results on test for antibodies to infliximabt,C0030705,true,2435/22402
ptca < $nmbr$ h,C2936173;C0033727;C0369286;C0441932;C0564385;C4528284,true;true;false;false;false;false,2436/22402
verapamil - sr ( « = $nmbr$ $nmbr$ ),C1527129,false,2437/22402
simvastatin ( $nmbr$ / $nmbr$ mg / d ),C0074554;C0439422,true;false,2438/22402
insulin 一 no . ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,2439/22402
duration of type $nmbr$ diabetes mellitus ( years ),C0449238;C1320657;C0439234;C2926735,false;false;false;false,2440/22402
central america and south america,C0007674,true,2441/22402
hip circumference — cm,C0562350,false,2442/22402
r $nmbr$ + ezio ( n = $nmbr$ ),C0687673,true,2443/22402
male sex — no . of patients ( % ),C0086582,true,2444/22402
stents per lesion  n,C0038257;C0221198;C1546698,true;false;false,2445/22402
infliximab ( n = $nmbr$ ),C0666743,true,2446/22402
dose of rosuvastatin,C0178602;C0965129;C0869039;C1114758,false;true;false;false,2447/22402
lvef < $nmbr$ %  n = $nmbr$ $nmbr$ ) “,C0428772;C0488728,false;false,2448/22402
n - terminal pro - brain natriuretic peptide  pg / ml,C3272900;C0439297,false;false,2449/22402
bmi — mean ( sd ) ( kg / m $nmbr$ ),C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,2450/22402
vorapaxar event rate ( n = $nmbr$ )  %,C2974521;C0441471;C0871208;C1521828;C4019010,true;false;false;false;false,2451/22402
death or $nmbr$ mwd decrease > $nmbr$ m,C0011065;C1306577;C4082313;C4552775,true;false;false;false,2452/22402
associated with transient or reversible risk factor,C0332281;C0040704;C0205374,false;true;false,2453/22402
europe and australia,C0015176,true,2454/22402
all countries,C0454664,false,2455/22402
urinary protein : creatinine ratioa ( mg / mg ),C0042027;C0369901;C1319635;C0428627;C1524119,true;false;false;false;false,2456/22402
serum cholesterol  median ( iqr )  mg / dl,C0587184;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2457/22402
intermediate risk ( ri = $nmbr$ ),C3640764;C0035487;C1826843,false;true;false,2458/22402
cangrelor,C1121991,true,2459/22402
baseline cdai score  mean ( s . d . ),C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,2460/22402
major bleeding events *,C0205082;C0019080;C0441471;C3541888;C0205164;C4318856;C4521762,false;true;false;false;false;false;false,2461/22402
baseline  mm hg,C0168634;C0439475;C1442488,true;false;false,2462/22402
white / caucasian,C0043157,true,2463/22402
body mass index  mean ± sd ( kg / m $nmbr$ ),C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,2464/22402
recurrent ischemia,C1455761;C0022116;C4321499;C2945760,false;true;false;false,2465/22402
index event not confirmed,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,2466/22402
non - hdl cholesterol ( mg / dl ),C0729627;C0439269;C1535899,false;false;false,2467/22402
comparison with placebo,C1707455;C0032042;C1696465;C1706408,false;true;false;false,2468/22402
current use of an ace inhibitor,C0521116;C1524063;C0003015;C4541021;C1705970,false;false;true;false;false,2469/22402
mean total serum ige ( sd )  iu / ml,C0444504;C0439175;C0229671;C2699239;C0439458;C1546774;C1550100;C0439810;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,2470/22402
af or atrial flutter 卞,C0344434;C4049859,false;false,2471/22402
pain subscale,C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,true;false;false;false;false;false;false;false;false,2472/22402
ejection fraction based on local reading,C0489482;C2700378,false;false,2473/22402
cardiac and echocardiography parameters,C0018787;C1522601,true;false,2474/22402
albuterol use ( sd )  puffs / day,C0001927;C0042153;C2699239;C1533107;C0332173;C0439228;C0439505;C0457083;C1947944,true;true;false;false;false;false;false;false;false,2475/22402
white race — number ( % ),C0007457;C0237753;C0449788;C0043157,true;false;false;true,2476/22402
stable angina ( n - $nmbr$  $nmbr$ ),C0340288,true,2477/22402
weight  kg  median ( $nmbr$ th  $nmbr$ th ),C0005910;C0022718;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;true;true;false;false;false;false;false;false;false;false;false;true;false;false,2478/22402
long - term aspirin,C0443252;C0004057,false;true,2479/22402
moderately impaired,C0205081;C1881878;C4085643;C4321491,false;false;false;false,2480/22402
left side only,C3842976,false,2481/22402
past or never,C1444637;C4284302,false;false,2482/22402
gastroesophageal reflux disease,C0017168;C4553201,true;false,2483/22402
anticoagulant — no . ( % ),C0003280;C0848112;C3536711,true;false;false,2484/22402
region  asia / paafic,C0017446;C0003980;C0205147,true;true;false,2485/22402
arteriosclerosis,C0003850,true,2486/22402
fasting plasma glucose $nmbr$ medan,C0015663;C0202042;C0455280,true;false;false,2487/22402
age mean ( yrs ± sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,2488/22402
chronic renal failure,C0022661;C1561643;C2316810,true;true;false,2489/22402
peripheral artery,C0489868,false,2490/22402
neither t $nmbr$ dm nor mets,C2603360;C0011816;C3250443,false;true;false,2491/22402
time since first af diagnosis  yrs,C0040223;C3541383,true;false,2492/22402
anti - hypertensive therapy - no . ( % ),C0585941,false,2493/22402
pacemaker,C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,2494/22402
infarct ion w ithin previous $nmbr$ day s,C0021308;C0022023;C0205156;C0332173;C0439228;C0439505;C1552607;C1700702,true;true;false;false;false;false;false;false,2495/22402
cardiac death,C0376297,true,2496/22402
interval between clinical evaluation and initiation oftreatment — no . ( % ),C1272706;C1261322;C4084924;C1552654;C1552713;C0205210;C2826267,false;false;false;false;false;false;false,2497/22402
apolipoprotein b  mean ( sd )  g / l,C0003593;C0444504;C2699239;C0439294;C0456615;C2347634;C2348143,true;false;false;false;false;false;false,2498/22402
no . of participants with events ( % ),C0679646,false,2499/22402
mean a ± sd  mg / dl ( mmol / $nmbr$ ),C0444504;C2347634;C2348143,false;false;false,2500/22402
homa - ir ( mu / l ^ mmol / l ),C0022065;C0439342;C0439190;C0022071;C1448132,true;false;false;true;true,2501/22402
> $nmbr$ months ( n = $nmbr$  $nmbr$ ),C0439231,false,2502/22402
elevated troponin ( > $nmbr$ . $nmbr$ mg / l )  %,C0205250;C0041199;C0439268;C3163633,false;true;false;false,2503/22402
mean weight ( sd )  kg,C0444504;C0005910;C2699239;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;false;true;false;false;true;false;false;false;false,2504/22402
europe ( zone $nmbr$ ),C0015176;C1710706,true;false,2505/22402
cox bsl onlyc,C1565830;C1549954,true;false,2506/22402
number resulting in ed visit,C0237753;C0449788,false;false,2507/22402
left ventricular systolic or diastolic dysfunction,C0225897;C0039155,true;true,2508/22402
any other llts ( other than statin ),,,2509/22402
other blood - pressure drug,C0003364,true,2510/22402
both ace inhibitor and arb,C0003015;C4541021,true;false,2511/22402
tg  median ( sdy rng / cjl,C0337445;C0549183;C1424906;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2512/22402
statin at last follow - up,C0360714;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,2513/22402
p - value ( lnteraction ),C1709380,false,2514/22402
mild dysfunction or normal,C3274775,false,2515/22402
recurrent infections ( > $nmbr$ per year ),C0239998;C0439234;C0439508,false;false;false,2516/22402
estimated glomerular filtration rate < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$,C3811844;C0439445;C0369637;C0441923,false;false;false;false,2517/22402
median ( q $nmbr$ : q $nmbr$ ) duration of diabetes  years,C0549183;C0449238;C0011847;C0439234;C0011849;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false,2518/22402
$nmbr$ l $nmbr$ mmhg,C0439394;C0439475;C1706495;C3642217,false;false;false;false,2519/22402
chronic non - steroidal antiinflammatory drugs,C0205191;C0003211,false;true,2520/22402
european subcategories,C0239307;C1515010;C1535514,false;false;false,2521/22402
placebo + $nmbr$ mg / d of simvastatin ( n = $nmbr$ ),C0032042;C0439422;C0074554;C1696465;C1706408,true;false;true;false;false,2522/22402
median c - reactive protein — mg / dl ^,C0549183;C0006560;C0439269;C1413716;C4048285;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,2523/22402
use of other medications — no . ( % ),C0240320,false,2524/22402
total - c : hdl - c,C0439175;C3715113;C0439810,false;false;false,2525/22402
pre - bronchodilator fev $nmbr$ / fvc ( % ),C2599602;C3714541,false;true,2526/22402
reversibility ( % predicted fev $nmbr$ ) *,C0449261,false,2527/22402
conversion to sinus rhythm in < $nmbr$ days,C1321500,false,2528/22402
stent implanted,C0522776,false,2529/22402
median weight  kg ( iqr ),C0549183;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;true;false;false;false;false;false;false,2530/22402
saxagliptin ( % ),C1611934,true,2531/22402
salmeterol - fluticasone group ( n = $nmbr$ ),C0939232;C0441848,true;false,2532/22402
abciximab,C0288672,true,2533/22402
vein bypass graft stented,C0398147,false,2534/22402
mean age ( sd )  years,C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,2535/22402
prior treatment,C1514463,false,2536/22402
bivalirudin used during pci,C0168273,true,2537/22402
mean ( s . d . ) ldl particle number  nmol / l,C0444504;C2612459;C0237753;C0439282;C0449788;C2347634;C2348143,false;false;false;false;false;false;false,2538/22402
pad symptoms ( % ),C0182158;C0683368;C1457887;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,2539/22402
number of treated lesions,C0449791;C1522326,false;false,2540/22402
infliximab ( combined $nmbr$ mg / kg and $nmbr$ mg / kg )  n ( % ),C0666743;C0205195;C0439272,true;false;false,2541/22402
high dose statin ( n = $nmbr$  $nmbr$ ),C0444956;C0360714,false;true,2542/22402
any recurrent stroke,C2242682,false,2543/22402
distal one - third of radius,C0450168;C0205447;C0034627;C1306504;C0588207;C0205437,false;false;true;false;false;false,2544/22402
mean mayo score ( sd ),C3533236;C0454788;C2699239;C1077578,false;false;false;false,2545/22402
diagnosis at presentation,C0011900;C0449450;C1704338;C1704656,true;false;true;false,2546/22402
median disease duration — yr,C0549183;C0872146;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,2547/22402
events / control group,C0441471;C0009932;C3541888,false;true;false,2548/22402
lowest tg tertile,C1708760;C0337445,false;false,2549/22402
other antihyperglycemic agents  not listed,C0020616,true,2550/22402
index stroke > $nmbr$ days before randomization — no . ( % ),C0456712;C0439228;C0034656,false;false;true,2551/22402
renal fmclicn : creatntoe clearance,C0232813;C0699829,false;false,2552/22402
prior mi ( n - $nmbr$  $nmbr$ ),C0332152;C3810814;C2826257,false;false;false,2553/22402
losartan plus placebo ( n = $nmbr$ ),C0126174;C0332287;C0032042;C1696465;C1706408,true;false;true;false;false,2554/22402
anti - ccp positive ( > $nmbr$ u / ml )  n ( % ),C0432633;C1525410;C0439178;C0439340;C1880521;C2945590;C1446409;C1514241;C2825490;C3812269;C1704514,false;false;false;false;false;false;false;false;false;false;false,2555/22402
total occlusion  n ( % ),C0439175;C0001168;C0011382;C0028778;C0441597;C1110554;C1947917;C0439810,false;false;true;false;false;false;false;false,2556/22402
male sex — no . ( % ) risk factors,C0086582,true,2557/22402
multiple tnfi and other bdmards §,C0439064,false,2558/22402
stiffness ( min ),C0427008;C0702093;C1524029;C3813700,false;false;false;false,2559/22402
rosuvastatin $nmbr$ - $nmbr$ mg ( n = $nmbr$ ),C0965129;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2560/22402
randomization to angiography,C0034656;C0002978,true;true,2561/22402
thienopyridine n = $nmbr$,C1120149,true,2562/22402
treatment difference,C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,2563/22402
absolute reversibility in fev $nmbr$  ml *,C0205344;C0449261;C3714541;C0439526;C1705224;C3887665,false;false;true;false;false;false,2564/22402
time to treatment,C3494202,true,2565/22402
duration of initial anticoagulation  mean ( sd )  mo,C0449238;C0205265;C0003281;C0444504;C2699239;C0026544;C0332177;C2347634;C2348143;C2917212;C2919015;C3537050;C1279901;C1555582;C1705685;C2926735,false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false,2566/22402
undetermined etiology,C0478157,false,2567/22402
ace inhibitors through hospital discharge or day $nmbr$ — %,C0003015;C0586003,true;false,2568/22402
patient ' s global assessment ( vas ),C4054229;C0042815;C3536884;C3827561,false;true;true;false,2569/22402
triglycerides ( mg / dl )  mean + sd  available for $nmbr$ patients,C0041004;C0439269;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,2570/22402
qualifying type of atherosclerosis  n ( % ),C1514624;C0332307;C0003850;C0004153;C1547052,false;false;true;true;false,2571/22402
patient ' s preference not to take vka  only reason,C0376409,true,2572/22402
probable,C0033204;C0332148,true;false,2573/22402
at least two cardiovascular risk factors,C0205448;C0850624,false;false,2574/22402
surgical technique post - randomisation characteristic * *,C0683469;C0687676;C0034656;C1521970;C1704687;C3469826,false;false;true;false;false;false,2575/22402
age group  no . ( % )  y,C0027362;C2348001,true;false,2576/22402
disease location ( % ) *,C0012634;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,2577/22402
previous oad ( % ),C0205156;C1552607,false;false,2578/22402
hdl cholesterol — mg / dl triglycerides — mg / dl,C0023822;C0024671;C3539687;C0041004;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0392885,true;true;false;true;true;false;false;false;false;false;false,2579/22402
< $nmbr$ months in - $nmbr$ kill,C0439231;C0162388;C0681205;C1550555,false;true;false;false,2580/22402
antialdosterone agents,C0450442;C1254351;C1521826,false;false;false,2581/22402
risk factors bmi ( kg / m $nmbr$ )  mean + sd,C0035648;C0578022;C1532718;C0444504;C2699239;C2347634;C2348143;C1553898,true;false;false;false;false;false;false;false,2582/22402
ex - smoker / current,C0337671;C0521116;C1705970;C4555205,false;false;false;true,2583/22402
at goal,C0018017;C1571704,true;false,2584/22402
history of heart failure — no . ( % ),C0455531,false,2585/22402
diabetes duration subgroups,C0011847;C0449238;C1079230;C2926735;C0011849,false;false;false;false;true,2586/22402
western europe ( including south africa ),C0043129,true,2587/22402
randomization stratum,C0034656,true,2588/22402
death  mi  idr  st or gusto severe bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,2589/22402
clopidogrel / total no . of patients % %,C0070166;C0439175;C0439810,true;false;false,2590/22402
corticosteroid ( without imm ),C0001617;C0205470;C3536709,true;false;false,2591/22402
creatinine ratio $nmbr$ - $nmbr$,C0010294;C0456603;C1547037;C1561535,true;false;false;false,2592/22402
overall pad,C0282416;C1561607,true;false,2593/22402
steroids ( other ),C0038317,true,2594/22402
mean ± s . d . weight  kg,C0444504;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;true;false;false;false;false,2595/22402
amlodipine ( n = $nmbr$ ),C0051696,true,2596/22402
previous infliximab therapy — no . of patients ( % ) * *,C0205156;C4076075;C1552607,false;false;false,2597/22402
anti - tnf - naive  n ( % ),C0432633;C1448177,false;true,2598/22402
previous acute hypersensitivity reaction to infliximab — no . of patients ( % ),C0205156;C0413234;C0666743;C1552607,false;false;true;false,2599/22402
non - elderly ( < $nmbr$ years ),C1518422;C0001792;C0439234;C1999167,false;true;false;false,2600/22402
pravastatin ( n = $nmbr$ >,C0085542,true,2601/22402
week $nmbr$ ( mean  sd ),C0332174;C0444504;C2699239;C2347634;C2348143;C0439230,false;false;false;false;false;false,2602/22402
factor v leiden ( % ),C0380964;C0584960;C1414509;C3542419,true;false;false;false,2603/22402
tender joint count ( $nmbr$ - $nmbr$ possible joints ),C0240094;C4554549;C4696258,false;false;false,2604/22402
male sex — no . / total no . ( % ),C0086582,true,2605/22402
insulin glargine n ( x ),C0907402,true,2606/22402
time since randomization,C0040223;C3541383,true;false,2607/22402
post - bronchodilator fev $nmbr$ ( % predicted normal ) a,C2599594;C3714541,false;true,2608/22402
vessel size  mean ( sd )  mm,C0005847;C0456389;C0444504;C2699239;C4330985;C4554674;C2347634;C2348143,true;false;false;false;false;false;false;false,2609/22402
hs - crp ( median  iqr )  mg / l,C3890735;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,2610/22402
insulin - requiring,C0021641;C1533581;C1579433;C3714501,true;false;false;false,2611/22402
homa . ir  median ( ql  q $nmbr$ )  % / $nmbr$,C0022065;C0549183;C0876920;C2347635;C2348144;C2939193;C0022071;C1448132,true;false;false;false;false;false;true;true,2612/22402
baseline short - acting anticholinergics,C0168634;C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002;C1442488,true;false;true;true;false;false;false;true;false;false;false;false;false,2613/22402
multivitamin use ( current ),C0301532;C0042153;C0521116;C1705970;C0457083;C1947944,false;true;false;false;false;false,2614/22402
apob : apoal,C0003593;C3252643,true;true,2615/22402
cardiac stretch,C0018787;C0600080;C1522601,true;false;false,2616/22402
hospitalization for heart failure within $nmbr$ mo,C3898876,false,2617/22402
lv ejection fraction  mean ( sd ) [ range ]  %,C0023128;C0489482;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143;C2700378;C0731033;C1881413,true;false;false;false;false;false;false;false;false;false;true;false,2618/22402
pasi score  $nmbr$ - $nmbr$ *,C4528685;C0449820;C4050231,false;false;false,2619/22402
patients with event / patients analyzed,C0030705;C0441471;C4019010,true;false;false,2620/22402
mean ( sd ) periostin  ng / ml,C0444504;C2699239;C0219433;C0439275;C1424662;C3812270;C2347634;C2348143,false;false;true;false;false;false;false;false,2621/22402
any blood transfusion,C0005841;C0281867,true;false,2622/22402
low molecular weight heparin,C0019139;C3536766,true;false,2623/22402
yes ( stopped for trial ),C1549445;C1705108;C1710701,false;false;false,2624/22402
previous chronic use of antiplatelet drugs,C0205156;C0205191;C1524063;C0085826;C2963157;C1552607,false;false;false;true;false;false,2625/22402
aspirin - erdp clopidogrel no . of patients / total no .,C0004057;C0070166,true;true,2626/22402
denosumab,C1690432,true,2627/22402
patients randomized,C0030705,true,2628/22402
days with asthma symptoms / week,C0677547;C0004096;C0683368;C1457887;C2984299,false;true;true;false;false,2629/22402
statin with fibrate,C0360714,true,2630/22402
delayed - start group ( n = $nmbr$ ),C0205421;C0439659;C0441848;C1545665;C3272602,false;false;false;false;false,2631/22402
fev $nmbr$ % predicted ( post salbutamol ),C3714541,true,2632/22402
intended durat - sm of antccagubficn,C1283828;C0036154;C4553627;C1551357,false;true;false;false,2633/22402
baseline dmard use  n ( % ),C0168634;C0242708;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,2634/22402
creatinine — mg / dl urinary albumin - to - creatinine ratio §,C0010294;C0439269;C2362049;C0456603;C1547037;C1561535,true;false;false;false;false;false,2635/22402
companion : wake - up stroke,C0031268;C1170730;C0038454;C4554100;C0335343;C0682323,true;false;true;false;true;false,2636/22402
placebo events / n ( % ),C0032042;C0441471;C3541888;C1696465;C1706408,true;false;false;false;false,2637/22402
cdai score < $nmbr$,C0683448;C1413248;C3273706,false;false;false,2638/22402
baseline ibdq total score  mean,C0168634;C2964552;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false;false,2639/22402
positive for rheumatoid factor  anti - cyclic citrullinated peptide antibodies  or both — % ff,C0741132;C0035448;C1320283;C0201660;C0439178;C0003241;C4505301;C0439596;C1511572;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;true;true;false;false;false;false;false;false,2640/22402
current alcohol use  n ( % ),C0521116;C0001948;C1705970,false;true;false,2641/22402
cardiac medications at discharge  %,C0018787;C0806915;C1522601,true;false;false,2642/22402
medical management only,C0199168;C0001554;C0205171;C1720467;C0376636;C1273870;C3273539;C0205476,false;true;false;false;true;false;false;false,2643/22402
shoulder pain,C0037011,true,2644/22402
hbalc  mean ( s . d . ),C0444504;C2347634;C2348143,false;false;false,2645/22402
$nmbr$ . $nmbr$ mg bid,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,2646/22402
pci during index hospitalization,C4049621;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,2647/22402
history of cv disease,C0683519;C3538987;C4048877;C4318503;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,2648/22402
complex lesions ^,C0439855;C0221198;C1704241,false;false;false,2649/22402
level $nmbr$ immobility ^,C0441889;C0231441;C0456079;C1547707;C2946261,false;false;false;false;false,2650/22402
asia / pacific / other,C0003980,true,2651/22402
calcium  mmol $nmbr$ $nmbr$,C0006675;C0439190;C0006726;C2936886;C3540037;C3714611,true;false;true;false;false;false,2652/22402
race  % caucasian,C0034510;C1706779;C3853635,true;false;false,2653/22402
mtss cfb mean ± sd,C0009002;C0444504;C2699239;C2347634;C2348143;C1824728,true;false;false;false;false;false,2654/22402
study end concentration,C0557651;C0444930;C0086045;C1446561;C3827302;C2746065;C2603343,false;false;true;false;false;false;false,2655/22402
potassium  mean ( sd )  meq / l,C0032821;C0444504;C2699239;C0439375;C2347634;C2348143;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false;false,2656/22402
naive to antihyperglycemic agent therapy,C0020616;C0450442;C0039798;C0087111;C1363945;C1254351;C1521826,true;false;true;true;false;false;false,2657/22402
swollen joint count  of $nmbr$,C0451521,false,2658/22402
hemispheric tia n = $nmbr$,C0205139;C0007787;C0917805;C1054154,false;true;true;false,2659/22402
c - peptide tx difference vs pbo  median change from baseline ( se ) $nmbr$,C0006558;C0041403;C1705241;C1705242,true;true;false;false,2660/22402
severity of airflow limitation ( gold $nmbr$ )  n ( % ),C0439793;C0231999;C0443288;C0018026;C1304897;C0449295;C0522510,false;false;false;true;false;false;false,2661/22402
other atherosclerotic event,C0333482;C0441471;C4019010,false;false;false,2662/22402
retinopathy ( stage $nmbr$ / $nmbr$ / $nmbr$ / $nmbr$ ),C0035309;C0205390;C1300072;C1306673;C1962966,true;false;false;false;false,2663/22402
mean — ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0444504;C0439445;C0369637;C0441923;C2347634;C2348143,false;false;false;false;false;false,2664/22402
fev $nmbr$ ( % predicted normal ),C3714541,true,2665/22402
baseline total cholesterol,C0168634;C0201950;C0543421;C1442488,true;false;false;false,2666/22402
egfr category  n ( % ),C1739039;C0683312;C3889287;C3811844;C3812682,true;false;false;false;false,2667/22402
rhabdomyolysis,C0035410;C4552660,true;false,2668/22402
any other antihyperglycaemic drugs,,,2669/22402
any risk factor for stent thrombosis,C0035648;C3897493,true;false,2670/22402
copd severity : mild / moderate,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,2671/22402
medications taken at time of randomization statins,C0013227;C0802604;C2598133;C4284232,true;false;false;false,2672/22402
neither n = $nmbr$  $nmbr$,C0369718;C0441922,false;false,2673/22402
exercise at least weekly ( a ),C0015259;C1522704,true;false,2674/22402
patients with previous intolerance of infliximab,C0030705;C0205156;C0231199;C0666743;C1744706;C2355652;C1552607,true;false;false;true;false;false;false,2675/22402
mayo clinic score §,C0454788;C0002424;C0449820;C4050231;C0442592;C1077578,false;true;false;false;false;false,2676/22402
nob systolic blood pressure ( mm hg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,2677/22402
geographic region - other,C0017446,true,2678/22402
months since first ra symptom  mean ( sd ) f,C0439231,false,2679/22402
continuation ( n = $nmbr$ ),,,2680/22402
timi - defined bleeding,,,2681/22402
glycosylated hemoglobin  %,C0017853,true,2682/22402
omeprazole,C0028978,true,2683/22402
in - hospital ticagrelor ( n = $nmbr$ ),C0019994;C1999375;C1510665,true;true;false,2684/22402
mean bmi ( $nmbr$ % ci ),C0444504;C0578022;C0008107;C3259781;C2347634;C2348143,false;false;true;false;false;false,2685/22402
physiological measures,C0205463;C0079809;C1879489,false;true;false,2686/22402
atrial fibrillation pattern,C0004238;C0449774;C0344434;C1963067,true;false;false;false,2687/22402
corticosteroid + imm,C0001617;C0205470;C3536709,true;false;false,2688/22402
thiazide at enrollment,C0541746;C1516879;C1696073;C3888021,true;false;false;false,2689/22402
nasopharyngitis,C0027441,true,2690/22402
established atherosclerotic,C0443211;C0333482;C1272684,false;false;false,2691/22402
overall effect,C0282416;C1280500;C1518681;C2348382;C1561607,true;false;false;false;false,2692/22402
omega - $nmbr$ fa,C1719844,false,2693/22402
ejection fraction : < $nmbr$ % ( n = $nmbr$ ),C0489482;C2700378,false;false,2694/22402
< $nmbr$ mm hg heart rate,C0439475;C0018810,false;true,2695/22402
lv ejection fraction ( % ),C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,2696/22402
cangrelor clopidogrel no . of events / total no . ( % ),C1121991;C0070166,true;true,2697/22402
killip at baseline,C0168634;C1442488,true;false,2698/22402
time since asthma diagnosis ( years ),C0040223;C3541383,true;false,2699/22402
$nmbr$ placebo,C0032042;C1696465;C1706408,true;false;false,2700/22402
carbamazepine,C0006949;C0006950;C0682993,true;false;false,2701/22402
postmenopausal  current hormone therapy use,C0232970;C2827774;C0019932;C0042153;C0457083;C1947944;C4521914;C0521116;C0279025;C1705970,false;false;true;true;false;false;false;false;false;false,2702/22402
known duration of type $nmbr$ diabetes ( years ),C0205309;C0449238;C1320657;C0439234;C2926735,false;false;false;false;false,2703/22402
beta - blocker at enrollment,C0001645;C1516879;C1696073;C3888021,true;false;false;false,2704/22402
number of exacerbations $nmbr$ months before randomisation,C0237753;C4086268;C0439231;C0449788,false;false;false;false,2705/22402
week $nmbr$ hba $nmbr$ c  mean ( s . e . ),C0332174;C0019016;C0444504;C2347634;C2348143;C1825777;C3538758;C0439230,false;true;false;false;false;false;false;false,2706/22402
tertile $nmbr$ ( n = $nmbr$ ),,,2707/22402
mean ( sd ) duration of copd  years,C0444504;C2699239;C0449238;C0024117;C0439234;C1412502;C3714496;C2926735;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false,2708/22402
ci - aki risk score,C0008107;C0022660;C0035647;C0449820;C4050231;C4552904;C0330978;C3259781,true;true;true;false;false;false;true;false,2709/22402
risk factors for stroke  no . ( % ),C0035648;C1553898,true;false,2710/22402
esr ( mm / h )  median ( min  max ),C3811131;C3642211;C0033727;C0549183;C0876920;C2347635;C2348144;C2939193;C0369286;C0441932;C0564385;C4528284;C0456680;C0702093;C1524029;C3813700,false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false,2711/22402
units per week  mean ( sd ),C0560588;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,2712/22402
c - reactive protein — mg / literj,C0006560;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,true;true;true;false;false;false;false;false;false;false,2713/22402
non - u . s .,C1518422,false,2714/22402
acuity - defined bleeding,C0750509,false,2715/22402
vedolizumab,C2742797,true,2716/22402
other / multiracial,C1881928,false,2717/22402
time since qualifying event,C0040223;C3541383,true;false,2718/22402
> $nmbr$ vessels treated,C0005847,true,2719/22402
statin use  n ( % ),C0360714;C0042153;C0457083;C1947944,true;true;false;false,2720/22402
previous coronary - artery bypass grafting,C2144990,false,2721/22402
median ( min  max ),C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,2722/22402
intensive control ( n = $nmbr$ ) no . of patients ( percent ),C0162425;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C0522510;C1283828;C1550453,true;true;false;false;false;false;false;false;false;false,2723/22402
arterial hypertension  n ( % ),C0020538,true,2724/22402
ranolazine ( n = $nmbr$ ) placebo ( n = $nmbr$ ),C0073633;C0032042;C1696465;C1706408,true;true;false;false,2725/22402
large shunt,C0549177;C0232180;C0542331;C1442858,false;false;false;false,2726/22402
history of hypertension  n ( % ),C0455527,false,2727/22402
age y  median ( range ),C0001779;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,2728/22402
companion : $nmbr$ - $nmbr$ hours,C0031268;C0439227;C0335343;C0682323,true;false;true;false,2729/22402
nt - pro bnp,C0669479;C0754710,true;true,2730/22402
lipid difference ( mg / dl ),C0023779;C1705241;C0439269;C1705242,true;false;false;false,2731/22402
other determined etiology,C0521095;C0015127;C1314792;C1524003,false;true;true;false,2732/22402
baseline pasi score,C0168634;C4528685;C0449820;C4050231;C1442488,true;false;false;false;false,2733/22402
mean ( sd ) total asthma symptom scores,C0444504;C2699239;C3533163;C0004096;C2984299;C2347634;C2348143,false;false;false;true;false;false;false,2734/22402
time since pah diagnosisc ( years ),C0040223;C3541383,true;false,2735/22402
alpha receptor antagonist,C0439095;C4543207;C2003941;C2350010,false;false;false;false,2736/22402
esrd on losartan ( % ),C0022661;C0126174;C0035078;C2316810,true;true;true;false,2737/22402
stroke at entry ( vs transient ischemic attack ),C0038454;C1705654;C4554100,true;false;false,2738/22402
medical history and risk factors ( % ),C0262926;C1704706,false;false,2739/22402
placebo monthly ( n = $nmbr$ ),C0032042;C0332177;C1696465;C1706408,true;false;false;false,2740/22402
intravenous inotropes or vasopressors ( % ),C0348016;C1258199,false;true,2741/22402
overall a phase population,C0282416;C1561607,true;false,2742/22402
symptom onset to first medical contact : ambulance or emergency department,C4086878;C0205435;C0199168;C0332158;C0002422;C3846685;C0337611;C1705415;C3812666;C0205476;C1279901,false;false;false;false;true;false;false;false;false;false;false,2743/22402
any glucocorticoid *,C0017710,true,2744/22402
mean ( sd ) post - bronchodilator fev $nmbr$ percentage predicted,C0444504;C2699239;C2599594;C3714541;C0439165;C1549488;C1561533;C2347634;C2348143,false;false;false;true;false;false;false;false;false,2745/22402
insulin ( mu / ml ),C0021641;C0439339;C1533581;C1579433;C3714501,true;false;false;false;false,2746/22402
creatinine clearance < $nmbr$ ml / min,C0812399;C0439445,false;false,2747/22402
nihss at randomization,C1697238;C0034656,false;true,2748/22402
elevated serum potassium  > $nmbr$ . $nmbr$ mmol / l,C0553704;C1532563,false;false,2749/22402
concordant stress test abnormalities,C4553529;C0015260;C0000768;C0000769;C3494508,false;true;true;true;true,2750/22402
eos serum k +  meq / l,C1623465;C0302353;C0439375;C1861303,false;false;false;true,2751/22402
duration of diabetes,C0449238;C0011847;C0011849;C2926735,false;false;true;false,2752/22402
arterial revascularization,C0003842;C0581603;C0221464,true;false;false,2753/22402
endpoint rate,C2349179;C0871208;C1521828;C2826544,false;false;false;false,2754/22402
highest tertile ( range  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / dl  mean ± sd  $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ mg / dl ),C1522410;C1514721;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016,false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false,2755/22402
p interaction women vs men,C0369773;C1704675;C0043210;C2603361,false;false;true;false,2756/22402
malaysia,C0024552,true,2757/22402
populations :,C0032659;C1257890,true;true,2758/22402
serum creatinine  弘 mol 儿 | |,C0201976;C0027960;C0324740;C0439189;C1456781;C1824986;C3665593;C0600061,false;true;true;false;false;false;false;false,2759/22402
index pci performed,C0600653;C4049621;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false,2760/22402
retinopathy,C0035309;C1962966,true;false,2761/22402
history of nicotine use,C0019664;C0028040;C1524063;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,2762/22402
insulin glargine n ( % ) / $nmbr$ py,C0907402;C0030428;C3538810,true;true;false,2763/22402
no chd simva ( n = $nmbr$ ],C0280604;C3542407,false;false,2764/22402
treated with insulin,C0332293;C0021641;C1533581;C1579433;C3714501,false;true;false;false;false,2765/22402
previous ischemic stroke ortia,C0205156;C0948008;C1552607,false;false;false,2766/22402
iglarlixi,,,2767/22402
previous cabg surgery,C0205156;C0010055;C0038894;C0038895;C0543467;C1274039;C1552607,false;true;false;true;true;true;false,2768/22402
statin alone,C0360714,true,2769/22402
study drug loading days ( actual ) : $nmbr$ ( n = $nmbr$ ),C0013175;C1708715;C0439228;C0237400,true;false;false;false,2770/22402
lumbar epidural,C0581283,false,2771/22402
periprocedural medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,2772/22402
mean age  y  mean = sd,C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,2773/22402
group dif . ( $nmbr$ ),C0441833;C0812246;C1710304;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;false;false;true;false;false;false,2774/22402
prior cardiac resynchronization therapy  n ( % ),C0332152;C1167956;C2826257,false;true;false,2775/22402
cardiac risk,C0018787;C0035647;C4552904;C1522601,true;true;false;false,2776/22402
albuterol use,C0001927;C0042153;C0457083;C1947944,true;true;false;false,2777/22402
no . of events / total,C0441471;C3541888,false;false,2778/22402
no . of participants per $nmbr$ patient - yr,C0679646,false,2779/22402
estimated glomerular filtration rate < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ — no . / total no . ( % ) §,C3811844;C0439445;C0369637;C0441923,false;false;false;false,2780/22402
established atherosclerotic disease,C0443211;C0333482;C0012634;C1272684,false;false;true;false,2781/22402
ukraine,C0041580,true,2782/22402
negative for helicobacter pylori — no . / total no . ( % ),C4688581,false,2783/22402
other medical history — no . / total no . ( % ),C0262926;C1704706,false;false,2784/22402
left atrial anteroposterior diameter — mm,C0225860;C1301886;C4330985;C4554674;C0225861,true;false;false;false;false,2785/22402
any established peripheral arterial disease,C0443211;C0085096;C1704436;C1272684,false;true;true;false,2786/22402
serum k + level and drug treatment,C0302353;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false,2787/22402
chronic inflammatory disease,C1290886,false,2788/22402
randomization to arrival in catheterization laboratory,C0034656;C1555577;C1706079,true;false;false,2789/22402
rituximab,C0393022,true,2790/22402
hemoglobin,C0019046,true,2791/22402
high risk ( receiving treatment for ) :,C0332167;C1514756;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3272283;C4050568;C4319571,false;false;true;true;false;false;false;false;false;false;false;false,2792/22402
c - reactive protein  median ( iqr )  mg / l,C0006560;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1413716;C4048285,true;false;false;false;false;false;false;false;false,2793/22402
anti - tnf - naive patients,C1448177;C0030705,true;true,2794/22402
lipids  mean ( sd )  mg / dlt,C0023779;C0444504;C2699239;C0024671;C1413248;C3273706;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,true;false;false;true;false;false;true;false;false;false;false;false;false;false,2795/22402
high - dose statin use at screening *,C0444956;C0360714;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,false;true;true;true;true;false;false;false;false;false;false;false,2796/22402
second primary ( estimated change in total updrs score from baseline to wk $nmbr$ ),C0205436;C0205225;C0750572;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false,2797/22402
abciximab no . / total ( % ),C0288672,true,2798/22402
no . of non - tnfi,C1518422,false,2799/22402
current cvd / diabetes  n ( % ),C0521116;C0007222;C0011847;C0011849;C1705970,false;true;false;true;false,2800/22402
cv mortality,C3538987;C0026565;C0026566;C4048877;C4318503,false;true;true;true;false,2801/22402
duration of dementia symptoms  months,C0436359;C0011265;C0439231;C0497327,false;true;false;true,2802/22402
no pad baseline,C0182158;C0168634;C1442488;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,2803/22402
pre ' rtous eptscde ( s } d dvt / pe,C0332152;C0149871;C0070939;C1880476;C4284304;C2926618;C3899446;C0740175;C2257086;C3669034,false;true;true;false;false;false;false;false;false;false,2804/22402
prior coronary artery bypass surgery,C0332152;C0010055;C2826257,false;true;false,2805/22402
interaction p - value $nmbr$,C1704675;C1709380,false;false,2806/22402
ipah  hpah  hiv  drug or toxin induced,C0152171;C0340543;C0019682;C0013227;C1254351;C0019699;C0637939;C1150929,false;true;true;true;false;true;true;false,2807/22402
< $nmbr$ mg / dl simva ( n = $nmbr$ ],C0439269,false,2808/22402
location of disease  n ( % ),C0450429;C0012634;C1515974;C4284930;C4284931,false;true;false;false;false,2809/22402
mtx ( mean dose : $nmbr$ . $nmbr$ mg / wk ),C0366550;C0444504;C1881833;C2347634;C2348143,false;false;false;false;false,2810/22402
labs at the index acs event,C0587081;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false;true;false;false;false,2811/22402
black race ( n = $nmbr$ vs $nmbr$ ),C0005680,true,2812/22402
treatment with any bp lowering drugs,C3469597;C0037623;C0441994;C2003888;C1415692;C1708288;C4318478,false;true;false;false;false;false;false,2813/22402
placebo $nmbr$ / $nmbr$,C0032042;C1696465;C1706408,true;false;false,2814/22402
diagnosed  y,C0011900,true,2815/22402
peri - op statins : no ( n = $nmbr$ ),C0347985;C0360714,false;true,2816/22402
region  europe,C0017446;C0015176;C0205147,true;true;false,2817/22402
copd disease severity,C0024117;C0521117;C1412502;C3714496,true;false;false;false,2818/22402
baseline dyslipidemia,C0168634;C0242339;C1442488,true;true;false,2819/22402
difference in ls means ( $nmbr$ % ci ) $nmbr$,C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,2820/22402
male gender  n ( % ),C0086582;C1706180,true;false,2821/22402
( $nmbr$ - $nmbr$ - cm vas ),C0042815;C3536884;C3827561,true;true;false,2822/22402
screening absolute reversibility fev $nmbr$  ml,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,2823/22402
k - m %,C0597277;C0369637;C0441923;C1708601,false;false;false;false,2824/22402
type of surgery,C0332307;C0038894;C0038895;C0543467;C1274039;C1547052,false;false;true;true;true;false,2825/22402
hosp . worsening hf,C0332271;C0018488;C1313497;C1538440;C3273279;C1457868;C1546960,false;true;true;false;false;false;false,2826/22402
rest of the world,C0035253;C2700280;C1622890,true;false;false,2827/22402
placebo no . / total no .,C0032042;C1696465;C1706408,true;false;false,2828/22402
azathioprine / $nmbr$ - mercaptopurine,C0004482;C0000618,true;true,2829/22402
duration of diabetes  mean ( sd )  y,C0449238;C0011847;C0444504;C2699239;C2347634;C2348143;C0011849;C2926735,false;false;false;false;false;false;true;false,2830/22402
cox - $nmbr$ selective nsaid,C1565830;C0036576;C0003211;C3536840;C1707391,true;true;true;false;false,2831/22402
total ( n = $nmbr$  $nmbr$ ) - -,C0439175;C0439810,false;false,2832/22402
laboratory variables,C0022877;C0439828;C3244292;C4283904,true;false;false;false,2833/22402
baseline anti - hyperglycemic medications,C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,2834/22402
ivabradine group ( n = $nmbr$ ),C0257190;C0441848,true;false,2835/22402
undergoing major vascular surgery,,,2836/22402
< $nmbr$ baseline killip class,C0168634;C1881332;C1442488,true;false;false,2837/22402
statin intensity $nmbr$ * $nmbr$,C0360714;C0522510,true;false,2838/22402
multivitamin use,C0301532;C0042153;C0457083;C1947944,false;true;false;false,2839/22402
baseline body weight quartile,C1303013;C2828255,false;false,2840/22402
baseline fpg  mean ( s . e . ),C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,2841/22402
primary pci n = $nmbr$,C0205225;C4049621;C0439612;C0439631,false;false;false;false,2842/22402
prior tnfi treatment,C1514463,false,2843/22402
multiple ( > $nmbr$ ) chd risk factors that confer a $nmbr$ - year risk of chd > $nmbr$ %,C0439064;C0280604;C0035648;C1553898;C3542407,false;false;true;false;false,2844/22402
pctindopnl - indapamide ( n = $nmbr$ ),C0021186,true,2845/22402
history of impaired renal function,C0019664;C1565489;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,2846/22402
stroke of any etiology,C0038454;C0015127;C1314792;C1524003;C4554100,true;true;true;false;false,2847/22402
fasting insulin ( pmol / l ),C0015663;C0021641;C0439284;C1533581;C1579433;C3714501,true;true;false;false;false;false,2848/22402
total body ( without head ),C0229960;C0018670;C1706305,false;true;false,2849/22402
fatty acid composition,C0015684;C0486616;C1555710,true;false;false,2850/22402
cerebral hemorrhage,C2937358,true,2851/22402
pasi $nmbr$ response },C4528685;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,2852/22402
nonglycemic cardiovascular risk factors systolic blood pressure — mmhg,C0850624;C0488055;C0439475;C0871470;C1306620,false;false;false;true;false,2853/22402
duration of diabetes ( months ),C0449238;C0011847;C0439231;C0011849;C2926735,false;false;false;true;false,2854/22402
alpha - glucosidase inhibitors,C1299007;C2756986;C3539108,true;false;false,2855/22402
anthropometry : mean ( sd ),C0003188;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,2856/22402
white ethnicity,C0007457;C0015031;C0243103;C0043157;C0220938,true;true;true;true;false,2857/22402
vascular history  %,C0005847;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1558950;C1801960,true;true;true;false;false;false;false;false;false,2858/22402
time from qualifying myocardial infarction,C0040223;C1514624;C0027051;C0428953;C2926063;C3810814;C4552959;C3541383,true;false;true;false;false;false;false;false,2859/22402
$nmbr$ — $nmbr$ nlmw,,,2860/22402
postoperative glucocorticoid use post - randomisation characteristic * *,C0032790;C0017710;C0042153;C0687676;C0034656;C1521970;C1704687;C3469826;C0457083;C1947944,true;true;true;false;true;false;false;false;false;false,2861/22402
sinus rhythm,C0232201,false,2862/22402
united states or canada,C0041703,true,2863/22402
heparin  ‘ ondaparinux or brvalirudin use between rxjex event,C0019134;C0770546,true;false,2864/22402
community hospital  n ( % ),C0020003,true,2865/22402
patient - reported outcome measures,C4277735,true,2866/22402
> $nmbr$ . $nmbr$ mg / liter antiplatelet agents,C0024671;C0475211;C0085826;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,2867/22402
ara functional class — no . ( % ),C0325983;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C2316832;C3890184;C4282437;C4321455,false;false;false;false;false;false;false;false;false;false;false,2868/22402
left ventricular ejection fraction,C0428772;C0488728,false;false,2869/22402
restenotic vessel,C0333186;C0005847,false;true,2870/22402
mean $nmbr$ - year cvd risk *,C0444504;C0439234;C0007222;C0035647;C4552904;C0439508;C2347634;C2348143,false;false;true;true;false;false;false;false,2871/22402
^ median > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,2872/22402
ace inhibitors / sartans,C0003015;C1563745,true;true,2873/22402
duration of hypertension  y,C0449238;C0020538;C1963138;C2926735,false;true;false;false,2874/22402
history of pci — no . / total no . ( % ) : t,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,2875/22402
current cigarette smoker or within past year,C3173209;C0677453;C1704760;C3890423;C3241966;C0521116;C0337667;C1705970,false;true;false;false;false;false;false;false,2876/22402
time to randomization from symptom onset,C0040223;C0034656;C3541383,true;true;false,2877/22402
motor weakness,C1513492;C3714552;C1705994,false;false;false,2878/22402
hospitalization for hf previous year  ( % ),C0019993;C0018488;C0205156;C0439234;C0439508;C1552607;C1313497;C1538440;C3273279,true;true;false;false;false;false;true;false;false,2879/22402
st - segment depression < $nmbr$ . $nmbr$ mv  %,C0520887;C1454484;C1705503;C4281602,false;true;false;false,2880/22402
ab / ff $nmbr$ / $nmbr$ pg ( n = $nmbr$ ),C4554348;C0030827;C0072225;C1266240,false;true;true;false,2881/22402
severity of airflow obstruction,C0439793;C0231999;C0028778;C1882136;C0522510,false;false;false;false;false,2882/22402
tender - joint count ( of $nmbr$ joints ),C0451530,false,2883/22402
tenecteplase,C0872913,true,2884/22402
median duration of symptoms ( range )  yr,C0549183;C0436359;C1514721;C0439234;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,2885/22402
history of pci / ptca,C0019664;C4049621;C2936173;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,2886/22402
only dvt,C0205171;C0149871;C2926618;C3899446;C1720467,false;true;false;false;false,2887/22402
glucose - lowering drug,C0017725;C0441994;C0013227;C1254351;C2003888,true;false;true;false;false,2888/22402
age group ( years ),C1510829;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0027362;C0439234;C2348001,false;false;false;true;false;false;false;true;false;false,2889/22402
renal events,C0022646;C0441471;C3541888,true;false;false,2890/22402
blood leucocyte concentration ( $nmbr$ cells per l ),C0023516;C0086045;C0347983;C1446561;C3827302;C0427728;C0699870;C1313904,true;true;false;false;false;false;false;false,2891/22402
baricitinib $nmbr$ mg,C4044947;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2892/22402
etd ( % ) [ $nmbr$ % ci ],C1180255;C0008107;C3259781,false;true;false,2893/22402
ranolazine ( n = $nmbr$ ),C0073633,true,2894/22402
below - knee popliteal,C0542339;C0022742;C0442037;C0022745;C1963703;C1552829,false;true;false;true;false;false,2895/22402
uacr ( mg / g ),C1300563,false,2896/22402
geographic location,C0017446,true,2897/22402
albuminuria,C0001925,true,2898/22402
angina  n ( % ),C0002962,true,2899/22402
acr $nmbr$ response,C1412134;C0871261;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false,2900/22402
dyslipidemia $nmbr$,C0242339,true,2901/22402
past or current,C1444637;C4284302,false;false,2902/22402
interval from randomization to angiography,C1272706;C0034656;C1552654;C1552713,false;true;false;false,2903/22402
enthesitis,C1282952,false,2904/22402
previous treatment,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,2905/22402
non - tnf inhibitors,C1518422;C1448177;C0243077,false;true;true,2906/22402
any blood - pressure - lowering drug 一 no . ( % ),C0003364,true,2907/22402
previous stroke — no . ( % ),C0205156;C1552607,false;false,2908/22402
proximal to the splenic flexure,C0205107;C0227387;C4489236,false;true;false,2909/22402
high eosinophil subgroup ( > $nmbr$ / ml ) ( n = $nmbr$ ),C0014457;C1079230;C0439526;C1705224;C3887665;C1515021,true;false;false;false;false;false,2910/22402
patients with egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n,C0030705;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;true;false;false;false;false;false,2911/22402
slo days,C1416602;C0439228;C3539661,false;false;false,2912/22402
cardiovascular mortality,C0007226;C0026565;C0026566;C3887460,true;true;true;false,2913/22402
m $nmbr$ subgroup,C0369637;C1079230;C1515021;C0441923,false;false;false;false,2914/22402
valsartan ( n = $nmbr$ ),C0216784,true,2915/22402
japan n = $nmbr$,C0022341,true,2916/22402
modified se - adl scale,C0392747;C0036919;C0001288;C0175659;C0349674;C1947916;C1420005;C3889737,false;true;true;true;false;false;false;false,2917/22402
corticosteroids only,C0001617;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false;false;false,2918/22402
p - value interaction,C1709380;C1704675,false;false,2919/22402
undetermined  other  or cardioembolism,C0205258;C3536725;C4082977,false;false;false,2920/22402
percentage patients reaching target,C0439165;C0030705;C1549488;C1561533,false;true;false;false,2921/22402
hispanic  n ( % ),C0086409,true,2922/22402
modified has - bled,C0392747;C3889737,false;false,2923/22402
insulin alone,C0021641;C1533581;C1579433;C3714501,true;false;false;false,2924/22402
statin only  n ( % ),C0360714;C0205171;C1720467,true;false;false,2925/22402
body - mass index categories — no . ( % ) : c,C0005893;C0683312;C0578022;C1305855,false;false;false;true,2926/22402
monocytes  $nmbr$ / nl,C0026473;C0027778;C0560008;C3892223,true;true;false;false,2927/22402
criteria for subcortical vad ( by mri )  %,C0243161;C0815275;C0077973,true;false;true,2928/22402
crp mean ( mg / dl ± sd ),C3890735;C0444504;C0439269;C2699239;C2347634;C2348143;C4048285,false;false;false;false;false;false;false,2929/22402
angiographic features,C0002978;C1521970;C1706388;C2346469;C2348519,true;false;false;false;false,2930/22402
> $nmbr$ years to < $nmbr$ years ( n = $nmbr$ ),C0439234,false,2931/22402
pathologic q waves  n ( % ),C0429090,false,2932/22402
duration of metformin therapy ( months ),C0444917;C0025598;C0439231,false;true;false,2933/22402
baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$ change from baseline to $nmbr$ weeks,C0168634;C0578022;C1532718;C0392747;C0443172;C1705241;C4319952;C1442488,true;false;false;false;false;false;false;false,2934/22402
lesion location,C0221198;C0450429;C1515974;C4284930;C4284931;C1546698,false;false;false;false;false;false,2935/22402
patients treated with statins ( n = $nmbr$ ),C0030705,true,2936/22402
copd exacerbations during the previous year,C0740304;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,2937/22402
biasp $nmbr$,,,2938/22402
insulin — iu,C0021641;C0049272;C0439453;C0694756;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,2939/22402
subject characteristics,C0681884;C1519021;C1706465,false;false;false,2940/22402
primary composite outcome,C0205225;C0205199;C1274040;C1547335;C0439612;C0439631,false;false;false;false;false;false,2941/22402
category $nmbr$ and $nmbr$,C0683312;C3889287,false;false,2942/22402
race or ethnic background — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,2943/22402
renal function subgroups,C0232804;C1079230,false;false,2944/22402
percent of patients,C0439165;C0030705,false;true,2945/22402
placebo / simvastatin,C0032042;C0074554;C1696465;C1706408,true;true;false;false,2946/22402
% of predicted normal value *,C0681842;C0086715;C1882327,false;true;false,2947/22402
body - mass index ( kg / m $nmbr$ )  mean ( sd ),C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,2948/22402
rolofylline dose,C0166128;C0178602;C0869039;C1114758,true;false;false;false,2949/22402
canagliflozin dose,C2974540;C0178602;C0869039;C1114758,true;false;false;false,2950/22402
pbo + statin $nmbr$,C0031962;C0360714,true;true,2951/22402
orthopaedic,C0029355,true,2952/22402
geographic region — number ( % ),C0017446;C0237753;C0449788,true;false;false,2953/22402
black race — no . / total no . ( % ) f,C0005680;C0027567;C0085756;C0439541,true;true;true;false,2954/22402
versus olodaterol $nmbr$ pg,,,2955/22402
antihypertensive agents  n ( % ),C0003364,true,2956/22402
baseline cardiovascular medication,C0168634;C0007220;C1442488,true;true;false,2957/22402
alpha - blocker,C0001641,true,2958/22402
modified total sharp score * *,C0392747;C2964552;C1444775;C1539835;C3890003;C3889737,false;false;false;false;false;false,2959/22402
beta - blocker use at baseline,C0001645;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,2960/22402
all - cause,C0015127;C1524003,true;false,2961/22402
class $nmbr$ or no symptoms,C0456387;C1518526;C1705943,false;false;false,2962/22402
laboratory variables at baseline,C0022877;C0439828;C0168634;C1442488;C3244292;C4283904,true;false;true;false;false;false,2963/22402
pneumonia in past year,C0032285;C4086728,true;false,2964/22402
apixaban  $nmbr$ mg ( n = $nmbr$ ),C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2965/22402
chd men,C0280604;C0025266;C3542407,false;true;false,2966/22402
calcium antagonist strategy ( cas ) ( events / n ),C0006684;C0679199;C0441471;C3541888,true;false;false;false,2967/22402
muscle twitching,C0015644;C0231530,true;false,2968/22402
other medication usage,C0013227;C0457083;C3244316;C4284232,true;false;false;false,2969/22402
qva $nmbr$ $nmbr$ / $nmbr$ | ig od n = $nmbr$,C0021027;C0229089;C0439164;C1512019;C3273373;C3665488;C0305052;C0360506,true;false;false;false;true;true;false;false,2970/22402
female sex — number ( % ),C0086287;C0237753;C0449788,true;false;false,2971/22402
heart rate  beats / min  mean ± sd,C0018810,true,2972/22402
mitral insufficiency  n ( % ),C0026266,true,2973/22402
from baseline ( $nmbr$ % ci ),C0168634;C0008107;C3259781;C1442488,true;true;false;false,2974/22402
compression stockings,C0038348,true,2975/22402
baseline triglycerides < $nmbr$ mg / dl,C0168634;C0041004;C0439269;C1442488,true;true;false;false,2976/22402
apo b / apo a - l,C1447574;C0003592;C0523508;C4553344;C4521365,true;true;false;false;false,2977/22402
beta - carotene ( n = $nmbr$  $nmbr$ ),C0053396;C0696105,true;false,2978/22402
> $nmbr$ years baseline ldl - c,C0439234;C0168634;C1442488,false;true;false,2979/22402
prevalence of each metabolic syndrome criterion,C0033105;C0524620;C0243161;C0220900,true;true;true;true,2980/22402
sex  men / women  %,C0009253;C0025266;C0043210;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;true;false;false;true,2981/22402
high - dose statin use  n ( % ) e,C0444956;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,2982/22402
fasting glucose ( mmol / l ),C0015663;C0017725;C1532563,true;true;false,2983/22402
fistula at baseline  n ( % ),C0016169;C0168634;C1442488,true;true;false,2984/22402
dizziness,C0012833;C0042571;C1963093;C4084788;C4085547;C4085548;C4085549;C4553830,true;true;false;false;false;false;false;false,2985/22402
coronary angiography — no . ( % ),C0085532;C1548829,true;false,2986/22402
presenting signs and symptoms,C0449450;C0220912;C0220913;C0311392,false;true;false;false,2987/22402
moderate copdb [ n z $nmbr$ ],C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,2988/22402
planned conservative therapy subgroup,C1301732;C0459914;C1079230;C1515021,false;true;false;false,2989/22402
sonti amenca,,,2990/22402
clopidogrel  $nmbr$ mg *,C0070166;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,2991/22402
methotrexate,C0025677,true,2992/22402
hs - crp ( mg / l  median ),C3890735;C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,2993/22402
previously taken dmards other than methotrexate  %,,,2994/22402
non - ischaemic ( n = $nmbr$ o $nmbr$ ),C1518422;C0475224,false;false,2995/22402
progestins,C0033306,true,2996/22402
fasting serum glucose ( mg / dl )  median ( iqr ),C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3534430,true;false;false;false;false;false;false;false;false,2997/22402
normalized,C1882115,false,2998/22402
time from hospital admission to pci  h  median ( q $nmbr$  q $nmbr$ ),C0040223;C0019994;C1959907;C1510665;C3541383,true;true;false;false;false,2999/22402
known t ' rc - iitoji cccndilon,C0205309;C1167159;C1419366,false;false;false,3000/22402
ii or iii,,,3001/22402
left ventricular ejection,C2733342,false,3002/22402
left ventricular ejection fraction — no . / total no . ( % ),C0428772;C0488728,false;false,3003/22402
previous loss of response to and intolerance of infliximab  n ( % ) *,C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,false;false;false;false;false;false;false,3004/22402
reported diabetes mellitus,C0684224;C0011849;C0700287;C4319718,true;true;false;false,3005/22402
other / missing,C1551393;C1705492;C3272743,false;false;false,3006/22402
severe or moderate,C0205082;C4050465;C4050466,false;false;false,3007/22402
coronary bypass  n ( % ),C0010055,true,3008/22402
new zealand,C0027978;C0324547,true;true,3009/22402
cox - $nmbr$ selective nsaid use,C1565830;C0036576;C0003211;C0042153;C0457083;C1947944;C3536840;C1707391,true;true;true;true;false;false;false;false,3010/22402
heart failure cause,C0018801;C0015127;C1524003;C0018802;C4554158,true;true;false;true;false,3011/22402
sbp ( mmhg ) < $nmbr$,C0085805;C0439475,true;false,3012/22402
past smoker  n ( % ),C1444637;C0337664;C4284302,false;true;false,3013/22402
previous stroke — no . ( % ) concomitant treatment — no . ( % ),C0205156;C1552607,false;false,3014/22402
mean ( s . d . ) hdl cholesterol,C0444504;C0023822;C0392885;C2347634;C2348143,false;true;false;false;false,3015/22402
amiodarone ( n = $nmbr$ ),C0002598,true,3016/22402
previous disease — no . ( % ) f,C0205156;C0012634;C1552607,false;true;false,3017/22402
esrd on placebo ( % ),C0022661;C0032042;C1696465;C1706408;C0035078;C2316810,true;true;false;false;true;false,3018/22402
acute respiratory insufficiency,C0865850,false,3019/22402
> $nmbr$ % predicted arr ( n = $nmbr$ ),C0681842;C2170357;C4084934;C1882327,false;false;false;false,3020/22402
associated with drug or toxin exposure,C0332281;C0013227;C1254351,false;true;false,3021/22402
ls mean change ± sea,C0023668;C0444504;C0392747;C0036493;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false,3022/22402
reversible ( % ),C0205343,false,3023/22402
left atrial dimension  cm,C2950135;C0018792;C0439534,false;true;false,3024/22402
aspirin alone ( n = $nmbr$ ) $nmbr$ . $nmbr$,C0004057;C0205171;C0439044;C0679994,true;false;false;false,3025/22402
diuretics ( % ),C0012798,true,3026/22402
ldl cholesterohhdl cholesterol ratio,C0023824;C0456603;C1547037;C0202117,true;false;false;false,3027/22402
renal insufficiency $nmbr$,C0035078;C1565489,true;true,3028/22402
> $nmbr$ : $nmbr$ hrs : min ( n = $nmbr$ ),C1568891;C0702093;C1524029;C3813700,true;false;false;false,3029/22402
sr ii b $nmbr$ - cjl $nmbr$,C0753208;C1710602;C4082587;C1709991;C3813610;C3890900;C3891546,true;false;false;false;false;false;false,3030/22402
csdmards + mtx ( n = $nmbr$ ),C0025677;C1417487,true;false,3031/22402
uc duration  y  mean ( range ),C0449238;C0444504;C1514721;C2348147;C3542016;C2347634;C2348143;C2926735,false;false;false;false;false;false;false;false,3032/22402
ejection fraction category,C0489482;C0683312;C3889287;C2700378,false;false;false;false,3033/22402
high - probability ventilation / perfusion lung scanning,C4699572;C0560738;C0024109,false;true;true,3034/22402
mmse $nmbr$ - $nmbr$,C0451306,true,3035/22402
use oforal glucose - lowering agent — no . ( % ),C0042153;C0457083;C1947944,true;false;false,3036/22402
baseline sgrq total score,C0168634;C2964552;C1442488,true;false;false,3037/22402
min - max age,C0702093;C0001779;C1524029;C3813700,false;false;false;false,3038/22402
baseline gfr < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C0168634;C0017654;C0439445;C0369637;C0441923;C1424601;C1442488,true;true;false;false;false;false;false,3039/22402
ischemic stroke,C0948008,false,3040/22402
medications at discharge,C0806915,false,3041/22402
multiracial  n ( % ),C1881928,false,3042/22402
q $nmbr$ : $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ kg ( n = $nmbr$ vs $nmbr$ ),C0022718;C0439209;C4054209,true;false;false,3043/22402
heart rate,C0018810,true,3044/22402
self - reported disease severity  $nmbr$ - $nmbr$ scale *,C0681906;C0521117;C0175659;C0349674;C1947916;C2700446,false;false;true;false;false;true,3045/22402
concomitant aedsa,C0521115,false,3046/22402
immunosuppressant use  %,C0021081;C0042153;C0457083;C1947944,true;true;false;false,3047/22402
moderately high risk,C0205081;C0332167;C3272283;C4050568;C4319571;C1881878;C4085643;C4321491,false;false;false;false;false;false;false;false,3048/22402
triglycerides  median ( ql  q $nmbr$ )  mmol / l,C0041004;C0549183;C1532563;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,3049/22402
$nmbr$ = some restrictions  no help needed,C0443288,false,3050/22402
$nmbr$ or $nmbr$ high - risk categories,,,3051/22402
calcium antagonist strategy ( n = $nmbr$ $nmbr$ ),C0006684;C0679199,true;false,3052/22402
time to balloon / needle  min *,C0040223;C0336867;C0027551;C0702093;C1524029;C3813700;C1882041;C0441144;C3541383,true;false;true;false;false;false;false;false;false,3053/22402
no - diuretics group ( n = $nmbr$ ),C0012798;C0441848,true;false,3054/22402
egfr . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$  $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,3055/22402
patients with any clinical,C0030705;C0205210,true;false,3056/22402
squamous cell carcinoma,C0007137;C1302853,true;false,3057/22402
( pg / mg ),C1627892,false,3058/22402
phosphodiesterase type $nmbr$ inhibitors,C0031638;C0332307;C1547052;C1656262;C3539996,true;false;false;false;false,3059/22402
history of stroke ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3060/22402
age ^ $nmbr$ yrs  n ( % ),C0001779,false,3061/22402
cangrelor ( n = $nmbr$ ),C1121991,true,3062/22402
previous cabg ( % total ),C0205156;C0010055;C0439175;C0439810;C1552607,false;true;false;false;false,3063/22402
baseline composite mayo clinic score,C0168634;C4055211;C0454788;C0002424;C0442592;C1077578;C1442488,true;false;false;true;false;false;false,3064/22402
ticlopidine after completion of study drug,C0040207;C2348557;C0013227;C1254351;C0205197;C0013175;C1554962,true;false;true;false;false;true;false,3065/22402
admission for hf in previous year  n ( % ),C0184666;C0018488;C1313497;C1538440;C3273279;C0809949,false;true;true;false;false;false,3066/22402
time since diagnosis — mo,C0040223;C3541383,true;false,3067/22402
left main coronary artery,C1261082,false,3068/22402
other llt at randomization,C2347090;C0034656,false;true,3069/22402
other anti - hypertensives,C0003364,true,3070/22402
a ngina > $nmbr$ day s previously *,C0332173;C0439228;C0439505,false;false;false,3071/22402
% predicted,C0681842;C1882327,false;false,3072/22402
use of antihypertensive drugs,C1524063;C0003364,false;true,3073/22402
total cholesterol ( median  iqr )  mg / dl,C0201950;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193;C0543421,false;false;false;false;false;false;false;false,3074/22402
hr ( $nmbr$ % ci ) p   value,C0008107;C1709380;C3259781,true;false;false,3075/22402
loop or thiazide diuretic : ! :,C0445022,false,3076/22402
monitoring group ( n = $nmbr$ ),C0150369;C0441848;C1283169,false;false;false,3077/22402
ischemic coronary artery disease,C0852149,false,3078/22402
blood eosinophil count > $nmbr$ / mm $nmbr$ at screening — no . ( % ),C1511226;C0200638;C4330985;C4554674;C0750879,false;false;false;false;false,3079/22402
no known frtrontxtfufoc cond aon,C0205309,false,3080/22402
mssbp / msdbp,,,3081/22402
devices for heart failure at screening visit,C0025078;C0018787;C2024216;C0231174;C0680095;C0025080;C0018801;C0018802;C4554158;C0220819;C0699733,true;true;false;false;false;true;true;true;false;true;true,3082/22402
interleukin $nmbr$ ( pg / ml ),C0021764;C0439297;C1527200,true;false;false,3083/22402
priorvascular disease  %,C0012634,true,3084/22402
planned thienopyridine at enrollment,C1709561;C1120149,false;true,3085/22402
background csdmard category,C1706907;C0683312;C3889287,false;false;false,3086/22402
relative risk ( $nmbr$ % ci ) ofprimary end point,C0242492;C0008107;C2349179;C2826544;C3259781,true;true;false;false;false,3087/22402
history of gi bleeding or ulcer — no . / total no . ( % ),C0019664;C0017181;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,3088/22402
non - fibrin - specific,C0205370;C0015982,false;true,3089/22402
gly $nmbr$ . $nmbr$ mg b . i . d . n = $nmbr$,C1415124;C0024671;C0152277;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;true;false;false;false;false;false,3090/22402
previous coronary angioplasty  n ( % ),C2114427,false,3091/22402
mean ± sd egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0444504;C2699239;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,3092/22402
octave induction $nmbr$ and $nmbr$,C0205263;C0857127,false;false,3093/22402
single vessel coronary artery disease $nmbr$,C0581374,false,3094/22402
greater than or equal to $nmbr$ %,C0439093,false,3095/22402
baseline nih stroke scale — no . ( % ) ^,C0168634;C1697238;C3484372;C1442488,true;false;false;false,3096/22402
history of stroke or tia — no . ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3097/22402
chd + cerebrovascular disease men $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ),C0280604;C0007820;C0025266;C3542407,false;true;true;false,3098/22402
albumin ( mg / dl ),C0001924;C0439269,true;false,3099/22402
lp ( a ) ( pmol / l ),C0065058;C0439284;C1439335;C4553379,true;false;false;false,3100/22402
st - segment depression,C0520887,false,3101/22402
statin — no . / total no . ( % ),C0360714,true,3102/22402
> $nmbr$ episodes of atrial fibrillation in previous $nmbr$ mo,C0332189;C0004238;C0344434;C1963067,false;true;false;false,3103/22402
ascvd as per protocol,C3665365;C1698058,false;false,3104/22402
oral antidiabetes combination therapy without insulina  n ( % ),C0442027;C0009429;C0556895;C4521986,false;true;false;false,3105/22402
interquartile range — yr,C1711350;C0439234,false;false,3106/22402
beta - blockers through hospital discharge or day $nmbr$ — %,C0001645;C0586003,true;false,3107/22402
korea  republic of,C0022773,true,3108/22402
corticosteroid ( without imm )  n,C0001617;C0205470;C3536709,true;false;false,3109/22402
index event subtype,C0600653;C0441471;C0449560;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;false;true;false;false;false,3110/22402
residual perfusion defect > $nmbr$ % on lung scan  no . ( % ),C1609982;C1457869;C1518040,false;false;false,3111/22402
antiplatelet agent or anticoagulant,C0085826,true,3112/22402
atorvastatin monotherapy ( n = $nmbr$ * ),C0286651,true,3113/22402
glycoprotein ilb / iiia inhibitor before pci ],C0017968;C4697913;C1999216;C4049621,true;false;false;false,3114/22402
extensive disease other,C0849867,false,3115/22402
catheter access site,C0449652;C0444454;C1554204;C0085590;C0589360,false;false;false;true;false,3116/22402
number of individuals,C1549735,false,3117/22402
congenital heart disease,C0152021,false,3118/22402
ff $nmbr$ gg ( n = $nmbr$  $nmbr$ ),C4554348;C0017454;C0018370,false;true;true,3119/22402
time from event to randomization — days,C0040223;C0441471;C4019010;C3541383,true;false;false;false,3120/22402
clinical,C0205210,false,3121/22402
presence of mets ( % ) a,C0150312;C0812270;C1705694;C2939420;C0392148;C3854307,false;false;false;false;false;false,3122/22402
parental history of mii,C0030551;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,3123/22402
fasting serum glucose  mg / dl,C0015663;C0202041;C0439269;C3534430,true;false;false;false,3124/22402
treatment at randomization,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,3125/22402
glomerular filtration rate ( ml / min / $nmbr$ . $nmbr$ ma,C0017654;C0439445;C0024443;C3887485;C1561549,true;false;true;false;false,3126/22402
qrs duration > $nmbr$ ms  n ( % ),C0429025;C2349943;C3539704;C3713294;C0488377,false;false;false;true;false,3127/22402
median time to first exacerbation ( months [ $nmbr$ % ci ] ),C0549183;C0205435;C4086268;C0556969;C0008107;C3259781;C1279901;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false;false,3128/22402
fasting c - peptide ( nmol / l ) c,C0015663;C0006558;C0439282,true;true;false,3129/22402
tender joint count ( $nmbr$ joints ),C0451530,false,3130/22402
all - cause hospitalization,C0015127;C0019993;C1524003,true;true;false,3131/22402
duration of full - dose warfarin therapy before enrollment ( mo ),C0444917;C0443225;C0366686,false;false;false,3132/22402
severe or very severe copd,C0205082;C4050465;C4050466,false;false;false,3133/22402
$nmbr$ mg vs placebo,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3134/22402
$nmbr$ mwd  m,C0369637;C0441923,false;false,3135/22402
proportion ( $nmbr$ % ci ) adjusted for baseline hba $nmbr$ c  %,C1709707;C0008107;C3259781,false;true;false,3136/22402
waist ( cm ),C0230097,false,3137/22402
qualifying diagnosis,C1514624;C0011900;C1704338;C1704656,false;true;true;false,3138/22402
mean disease duration  y ( sd ),C0444504;C0872146;C2699239;C2347634;C2348143,false;false;false;false;false,3139/22402
daily activities / social functioning,C0871707;C0037395,false;true,3140/22402
saxa $nmbr$ . $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3141/22402
rosuva $nmbr$ mg n = $nmbr$,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3142/22402
bmi group — no . ( % ),C0578022;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;false;true;false;false;false,3143/22402
lv mass,C0455825,false,3144/22402
hours from clopidogrel loading  mean ( sd ),C0439227;C0070166;C1708715;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false;false,3145/22402
non - ischaemic,C1518422;C0475224,false;false,3146/22402
omega $nmbr$ allocation,C1719844;C1706778,false;false,3147/22402
adjusted $nmbr$ risk reduction losartan vs placebo ( $nmbr$ % cl ),C0456081;C1137094;C0126174,false;true;true,3148/22402
n - $nmbr$ pufa,C0369718;C0032615;C0441922,false;true;false,3149/22402
combined ( n = $nmbr$ ),C0205195,false,3150/22402
lamotrigine,C0064636;C0524166,true;false,3151/22402
maximal diameter stenosis,C0205289;C1301886;C0678234;C1261287;C2632116;C0806909;C4049713,false;false;false;true;false;false;false,3152/22402
hispanic ethnic group  n ( % ),C0086409;C0015031;C0441848;C0680174,true;true;false;false,3153/22402
multivessel coronary artery disease — no . / total no . ( % ),C0010054;C0010068;C1956346,true;true;true,3154/22402
history,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,3155/22402
patient ' s global assessment of disease activity ( $nmbr$ - $nmbr$ mm vas )  mean ( sd ),C4054228;C4330985;C0042815;C0444504;C2699239;C2347634;C2348143;C3536884;C3827561;C4554674,false;false;true;false;false;false;false;true;false;false,3156/22402
prior cardiovascular event  ',C0332152;C1320716;C2826257,false;false;false,3157/22402
no . with event / total no . { % ),C0441471;C0439175;C0439810;C4019010,false;false;false;false,3158/22402
ras - aldosterone inhibitor ^,C1514727;C0002006;C0034678;C0002007;C0525678,false;true;true;true;true,3159/22402
mean ( sd ) post - bronchodilator fev $nmbr$ / fvc  %,C0444504;C2699239;C2599594;C3714541;C2347634;C2348143,false;false;false;true;false;false,3160/22402
non - hispanic white,C1518424;C0007457;C0043157;C0220938,false;true;true;false,3161/22402
ethacrynic acid,C0014963,true,3162/22402
aqlq ( s ) score,C4055434;C0449820;C4050231,false;false;false,3163/22402
patients who received negative results on test for antibodies to infliximabt,C0030705,true,3164/22402
non - hdl ( mg / dl ) < $nmbr$,C1518422;C3715113;C0439269,false;false;false,3165/22402
all completers,,,3166/22402
mean difference = seb,C0444504;C1705241;C0059386;C1309881;C1423585;C3815268;C1705242;C2347634;C2348143,false;false;true;true;false;false;false;false;false,3167/22402
> $nmbr$  n ( % ) gender  n ( % ),C0369718;C0079399;C1522384;C0441922,false;true;true;false,3168/22402
prior use of $ $nmbr$ systemic therapies,C1514463;C1524063;C0205373;C0332152;C1515119;C2826257,false;false;false;false;false;false,3169/22402
health assessment questionnaire ( $nmbr$ - $nmbr$ range ),C0451208;C1514721;C2348147;C3542016,false;false;false;false,3170/22402
low - molecular - weight heparin,C0019139;C3536766,true;false,3171/22402
non - hdl cholesterol ( mmol / l ),C0729627;C1532563;C1535899,false;false;false,3172/22402
previous medication for respiratory disease — no . ( % ),C0205156;C0418986;C0012634;C0013227;C0035204;C0035242;C3244316;C4284232;C1552607,false;false;true;true;true;true;false;false;false,3173/22402
characteristics of the index ml,C1521970;C0600653;C0439526;C1705224;C3887665;C0918012;C1552854;C1637833;C2986546,false;true;false;false;false;true;false;false;false,3174/22402
history of heart failure,C0455531,false,3175/22402
prior cardiovascular history,C0332152;C1880008;C2826257,false;false;false,3176/22402
metabolic syndrome $nmbr$ *,C0524620,true,3177/22402
consistency of effect,C0332529;C1280500;C1518681;C2348382;C1547017,false;false;false;false;false,3178/22402
fondaparinux,C1098510,true,3179/22402
other lipid - modifying drug 一 no . ( % ),C0023779;C0392747;C0013227;C1254351,true;false;true;false,3180/22402
initial timi flow,C0205265;C3272266;C1279901;C1555582;C1705685,false;false;false;false;false,3181/22402
overall $nmbr$,C0282416;C1561607,true;false,3182/22402
absolute decrease > $nmbr$ %,C0205344;C0392756;C0547047,false;false;false,3183/22402
recurrent hf hospitalization,C1455761;C0018488;C0019993;C1313497;C1538440;C3273279;C2945760,false;true;true;true;false;false;false,3184/22402
intrathoracic or intraperitoneal surgery,C0595836,false,3185/22402
former or never diabetes,C0205156;C0750523,false;false,3186/22402
geographic site  %,C0017446,true,3187/22402
history of high cholesterol ( a ) $nmbr$,C0019664;C0020443;C1522133;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3188/22402
history of heart failure  n ( % ),C0455531,false,3189/22402
sco . ’ ita ' rojs dvt . ' pe,C2986561;C0022277;C0149871;C0070939;C1880476;C4284304;C2926618;C3899446,false;true;true;true;false;false;false;false,3190/22402
general health vas  $nmbr$ - $nmbr$ mm,C0424575;C0042815;C4330985;C4554674;C3536884;C3827561;C4018875,false;true;false;false;true;false;false,3191/22402
placebo / open - label abatacept,C0032042;C1709323;C1619966;C1696465;C1706408,true;false;true;false;false,3192/22402
prior known stenosis > $nmbr$ %,C0332152;C0205309;C0678234;C1261287;C2632116;C2826257,false;false;false;true;false;false,3193/22402
ras antagonist  %,C0034678;C0231491;C0525678,true;false;true,3194/22402
cancer medications,C0006826;C0013227;C0802604;C2598133;C4284232;C0998265;C1306459,true;true;false;false;false;false;false,3195/22402
current other ( predefined ) medical conditions,C0521116;C1705970,false;false,3196/22402
center location,C0205099,false,3197/22402
time from qualifying stroke to randomization,C0040223;C1514624;C0038454;C4554100;C3541383,true;false;true;false;false,3198/22402
geographical region  n ( % ),C0017446,true,3199/22402
priorbone disease,C0012634,true,3200/22402
laba - inhaled glucocorticoid use at screening,,,3201/22402
main concomitant treatments  no . ( % ),C0205225;C0521115;C0087111;C1542147,false;false;true;false,3202/22402
use of rescue medication,C0240320,false,3203/22402
p vs placebo,C0369773;C2603361,false;false,3204/22402
cardiac troponin t level > $nmbr$ . $nmbr$ pg / l,C3538889;C0441889;C0439278;C0456079;C1547707;C2946261,false;false;false;false;false;false,3205/22402
aspirin < $nmbr$ day,C0004057;C0332173;C0439228;C0439505,true;false;false;false,3206/22402
native coronary,C0302891;C0018787,false;true,3207/22402
arthralgia,C0003862;C4551938,true;false,3208/22402
other bdmards ( no tnfi taken ) t  n ( % ),,,3209/22402
hmgcoa rl,C0047420;C1419337;C3539667,true;false;false,3210/22402
egfrmdrd  ml - min - $nmbr$ - $nmbr$ . $nmbr$ m - $nmbr$,C0439445;C0369637;C0441923,false;false;false,3211/22402
prior angioplasty,C0332152;C0162577;C1548817;C2826257,false;true;false;false,3212/22402
anti - ccp antibody ( u /,C0003242;C1525410;C0439148;C1704514;C4318437;C0003241;C0021027;C1167408;C3665580,true;false;false;false;true;true;true;false;false,3213/22402
mean baseline ldl - c ( mmol / l ),C0444504;C0168634;C1532563;C1442488;C2347634;C2348143,false;true;false;false;false;false,3214/22402
composite events,C0205199;C0441471;C3541888;C1547335,false;false;false;false,3215/22402
foot fracture,C0272774,false,3216/22402
non - caucasian simva ( „ = $nmbr$ },C1518422;C0007457;C0043157,false;true;true,3217/22402
tc  mean ( sd )  rrig / dl,C0039411;C0444504;C2699239;C3642216;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;false;true;true;true;false;false;false,3218/22402
high risk and fewer symptoms ( group c ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,3219/22402
type $nmbr$ diabetes history  n ( % ),C1320657;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,3220/22402
total cholesterol / hdl - c,C0201950;C3715113;C0543421;C0439175;C0023822;C0439810,false;false;false;false;true;false,3221/22402
hypertension absent,C0020538;C1963138,true;false,3222/22402
warfarin,C0043031,true,3223/22402
moderate  n ( % ) a,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3224/22402
urine acr ( mg / g ),C0042036;C1412134;C1300563;C1515941;C0042037;C2963137,true;false;false;false;true;false,3225/22402
baseline systolic blood pressure,C4274438,false,3226/22402
hr $nmbr$ and $nmbr$ % cl,,,3227/22402
ventricular tachyarrhythmias,C3827656,false,3228/22402
sulfonylurea based,C0038766;C3536898,true;false,3229/22402
medication use — no . ( % ) ^ |,C0013227;C3244316;C4284232,true;false;false,3230/22402
bivalirudin ( n = $nmbr$ ),C0168273,true,3231/22402
p - blockers  n ( % ),C0369773;C2603361,false;false,3232/22402
acarbose 一 no . ( % ),C0050393,true,3233/22402
unfractionated heparin,C0019134;C2825026,true;false,3234/22402
all patients n = $nmbr$,C0030705,true,3235/22402
sitagliptin no . / total no .,C1565750,true,3236/22402
% anti - ccp + ( > $nmbr$ units ),C4318437;C0439148;C1519795;C3853603,true;false;false;false,3237/22402
septal anomaly — no . ( % ),C0442004;C0332447;C1704258,false;false;false,3238/22402
intensified ( n 二 $nmbr$ ),,,3239/22402
long - acting b $nmbr$ - agonists,C0205166;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;true;false;false;false,3240/22402
bodily pain,C3890602,false,3241/22402
mmrc grade,C3826977;C0441800;C0919553;C3244287,false;false;false;false,3242/22402
alcohol consumption > once weekly,C0001948,true,3243/22402
p - value for trend *,C1709380;C1521798;C4554533,false;false;false,3244/22402
blood eosinophil count > $nmbr$ / mm $nmbr$ in $nmbr$ months before screening — no . ( % ),C0014467;C0750480;C4330985;C0439231;C4554674;C1705566;C0005767;C0200638;C0750879;C0005768;C0229664,true;false;false;false;false;false;true;false;false;true;false,3245/22402
at entry,C1705654,false,3246/22402
tiotropium group ( n = $nmbr$ ),C0213771;C0441848,true;false,3247/22402
$nmbr$ - $nmbr$ months ( n = $nmbr$ ),C0439231,false,3248/22402
dapagliflozin $nmbr$ mg group ( n = $nmbr$ ),C2353951;C0024671;C0441848;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,3249/22402
p value ( aged > $nmbr$ vs . < $nmbr$ years ),C1709380;C0001779;C0001792;C1999167,false;false;true;false,3250/22402
valvular disease,C3258293,false,3251/22402
prior angina,C0332152;C0002962;C2826257,false;true;false,3252/22402
japan and south korea,C0022341,true,3253/22402
postoperative nsaid or glucocorticoid use post - randomisation characteristic * *,C0032790;C0003211;C3536840,true;true;false,3254/22402
all randomized patients,C0034656;C0030705;C3815594,true;true;false,3255/22402
pack - years  mean ( sd ),C1277691;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,3256/22402
epa hr events ( % ),C0441471;C3541888,false;false,3257/22402
type of myocardial infarction — no . ( % ),C0332307;C0027051;C0428953;C2926063;C3810814;C4552959;C1547052,false;true;false;false;false;false;false,3258/22402
pciperformed for qualifying event,C1514624;C0441471;C4019010,false;false;false,3259/22402
nonsustained ventricular tachycardia — no . ( % ) - j -,C0750194;C2919575,false;false,3260/22402
ventricular tachycardia or fibrillation,C0042514;C0344428;C1963247;C4554446,true;false;false;false,3261/22402
percutaneous intervention,C0522523;C0184661;C0886296;C1273869,false;true;false;false,3262/22402
hazard ratio for cardiovascular death  stroke  or myocardial infarction ( $nmbr$ % ci ),C2985465;C0027051;C0011065;C1306577;C4082313;C4552775,false;true;true;false;false;false,3263/22402
hypercholesterolemia  n ( % ),C0020443;C1522133,true;false,3264/22402
diclofenac,C0012091,true,3265/22402
$nmbr$ week to $nmbr$ month,C0332174;C0332177;C0439231;C0439230,false;false;false;false,3266/22402
gp llb / llla inhibitors,C1705010;C0243077;C3811116,false;true;false,3267/22402
current  n ( % ),C0521116;C1705970,false;false,3268/22402
syndesmophyte present  n ( % ),C0221690;C0150312;C0449450,false;false;false,3269/22402
angiographic findings | |,C0002978;C2607943;C2926606;C3539655,true;true;false;false,3270/22402
apixaban  $nmbr$ mg,C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3271/22402
bypass graft,C0185098,false,3272/22402
bm $nmbr$ ( kg / m $nmbr$ ),C0006416;C1532718,true;false,3273/22402
$nmbr$ = no symptoms,C0683368;C1457887,true;false,3274/22402
prior brachytherapy,C0332152;C0006098;C2826257,false;true;false,3275/22402
time since cessation of full - dose warfarin therapy,C0040223;C3541383,true;false,3276/22402
history of or current cardiac disorders  %,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,3277/22402
impaired glucose tolerance or impaired fasting glucose,C0271650,true,3278/22402
severe  n ( % ) b,C0205082;C4050465;C4050466,false;false;false,3279/22402
hospitalization for heart failure within previous $nmbr$ mo — no . ( % ),C3898876,false,3280/22402
diuretics  n ( % ),C0012798,true,3281/22402
mmse ( points ),C0451306,true,3282/22402
apixaban ( n = $nmbr$ ),C1831808,true,3283/22402
corticosteroid ( with or without immunosuppressants ),C0001617;C3536709,true;false,3284/22402
congestive heart failure,C0018802,true,3285/22402
chf on placebo ( % ),C0018802;C0032042;C1696465;C1706408,true;true;false;false,3286/22402
overall hr ( $nmbr$ % cl ),C0282416;C0596019;C1561607,true;false;false,3287/22402
hyperlipidemia — no . ( % ),C0020473;C0428465;C4555212,true;false;false,3288/22402
p value for trend across tertiles,C1709380;C1521798;C4554533,false;false;false,3289/22402
$nmbr$ - $nmbr$ drinks / wk,C0452428,false,3290/22402
> $nmbr$ mg / dl — %,C0439269,false,3291/22402
diagnosis of allergic rhinitis,C0011900;C1334103;C2607914;C4552864;C1704338;C1704656,true;false;true;false;true;false,3292/22402
refractory to such therapy — no . ( % ),C0205269;C0039798;C0087111;C1363945,false;true;true;false,3293/22402
lymphocytes  $nmbr$ / + il,C0024264;C0020898;C0021764;C0022271;C4018897,true;true;true;true;false,3294/22402
adjusted * or ( $nmbr$ % ci ) p value,C0456081,false,3295/22402
fev $nmbr$ % pred . ( post - albuterol )  %,C3714541;C0032952;C0687676;C0001927;C1704687;C3469826;C0044955,true;true;false;true;false;false;true,3296/22402
known thrombophilia — no . ( % ),C0205309;C0398623,false;true,3297/22402
$nmbr$ - $nmbr$ ( mild ),C2945599,false,3298/22402
simvastatin  n ( % ),C0074554,true,3299/22402
age  mean ( sd ) [ range ]  y,C0001779;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false;false,3300/22402
copd exacerbation history  n ( % ),C0740304;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,3301/22402
atio - pla,C0456170,false,3302/22402
cardiac troponin t level  median ( iqr )  pg / l,C3538889;C0441889;C0549183;C0439278;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261,false;false;false;false;false;false;false;false;false;false;false,3303/22402
estimated glomerular filtration rate  ml / min per $nmbr$ . $nmbr$ m $nmbr$,C3811844;C0439445;C0369637;C0441923,false;false;false;false,3304/22402
toast classification of qualifying stroke ( % ),C1710306;C1514624;C0038454;C4554100;C4521230,false;false;true;false;false,3305/22402
duration of diabetes by tertiles,C0449238;C0011847;C0011849;C2926735,false;false;true;false,3306/22402
on drug treatment ( % ),C0150270;C3469597,false;false,3307/22402
triglyceride ( median  mg / dl ) - $nmbr$ [ $nmbr$ - $nmbr$ percentile |,C0041004;C0549183;C0439269;C1264641;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false;false,3308/22402
pre - specified hr ( $nmbr$ % cl ),C2826245,false,3309/22402
cardiac medications during indexhospitalization and / or discharge,C0018787;C0013227;C0802604;C2598133;C4284232;C1522601,true;true;false;false;false;false,3310/22402
neither corticosteroid nor immunosuppressant,C0001617;C3536709,true;false,3311/22402
albumin / creatinine ratio  n ( % ),C0486293;C1318293,false;false,3312/22402
score on modified rankin scale — median ( iqr ),C0449820;C2984908;C0549183;C0876920;C2347635;C2348144;C2939193;C3854213;C4050231,false;false;false;false;false;false;false;false;false,3313/22402
placebo group,C0032042;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408,true;false;false;true;false;false;false;false;false,3314/22402
discontinuations due to ae,C0457454;C0678226;C3887670,false;false;false,3315/22402
creatinine clearance  n ( % ),C0812399,false,3316/22402
multi vessel ( or left main ),C0439064;C0005847;C3266262,false;true;true,3317/22402
infarct location,C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,3318/22402
elevated hscrp,C0205250;C3163633,false;false,3319/22402
laba + ics n = $nmbr$,C0815320;C4551720,false;true,3320/22402
renal function  severe,C0232804,false,3321/22402
high - density lipoprotein cholesterol  median  ( $nmbr$ th — $nmbr$ th percentiles )  mg / dl,C0023822;C0549183;C0039725;C1264641;C0439269;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,true;false;true;false;false;true;false;false;false;false;false;false;false,3322/22402
mean ± sd fasting insulin  uu / ml,C0444504;C2699239;C0015663;C0021641;C0439342;C1533581;C1579433;C3714501;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false,3323/22402
at least $nmbr$ / mo,C0026544;C0332177,true;false,3324/22402
atrial fibrillation — no . / total no . ( % ),C0004238;C0344434;C1963067,true;false;false,3325/22402
ls - mean between - group difference ( $nmbr$ % ci ),C0023668;C2347634;C1705241;C0008107;C3259781;C1705242,true;false;false;true;false;false,3326/22402
all others  n ( % ),C1955473;C3539125,false;false,3327/22402
joint swelling  effusion  or both on clinical examination — no . ( % ),C1253936;C0013604;C0038999;C1963136;C4554335;C0152031;C0013687;C2317432,true;true;false;false;false;false;false;false,3328/22402
median age ( $nmbr$ %  $nmbr$ % )  y,C0549183;C0001779;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3329/22402
history of cerebrovascular disease,C0585890,false,3330/22402
laba or lama ’,,,3331/22402
metformin ( n = $nmbr$ ),C0025598,true,3332/22402
prior cabg ( before index acs ),C0332152;C0010055;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C2826257,false;true;true;true;false;true;false;false;false;false,3333/22402
anti - tnf - experienced patients,C1448177;C0030705,true;true,3334/22402
digoxin / digitalis glycoside,C0012265;C0012253,true;true,3335/22402
body mass index ( range ) ( kg / m $nmbr$ ),C0005893;C1514721;C1532718;C2348147;C3542016;C0578022;C1305855,false;false;false;false;false;false;true,3336/22402
patients with previous loss of response to infliximab,C0030705;C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,true;false;false;false;false;false;false;false,3337/22402
treatment group,C0039798;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;true;false;false;false;false;false,3338/22402
haq - di  mean ( sd ),C3826998;C0444504;C2699239;C2347634;C2348143;C4321476,false;false;false;false;false;false,3339/22402
duration of copd ( years )  mean ( sd ),C0449238;C0024117;C0439234;C0444504;C2699239;C2347634;C2348143;C1412502;C3714496;C2926735,false;true;false;false;false;false;false;false;false;false,3340/22402
egfr < $nmbr$  ml / min / m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,3341/22402
carotid infarct,C0741968;C0021308,false;true,3342/22402
negative ( < $nmbr$ . $nmbr$ )  n ( % ),C0205160;C1513916;C2825415;C2825491;C3853545,false;false;false;false;false,3343/22402
endpoint week $nmbr$,C2349179;C0332174;C0439230;C2826544,false;false;false;false,3344/22402
homa - ir  mean ( sd ) ( mu / l $ mmol / l ) b,C0022065;C0444504;C2699239;C0439342;C0439190;C2347634;C2348143;C0022071;C1448132,true;false;false;false;false;false;false;true;true,3345/22402
lipid and lipoprotein values ( mg / dl ),C0023779,true,3346/22402
placebo no . of events / no .,C0032042;C1696465;C1706408,true;false;false,3347/22402
for treatment of index event,C0039798;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;true;false;false;false;true;false;false;false;false;false,3348/22402
mild ( > $nmbr$ to < $nmbr$ ),C2945599,false,3349/22402
heterogeneity p value,C0019409;C1709380;C0242960,false;false;true,3350/22402
number of stents ( per patient ),C0237753;C0038257;C0449788,false;true;false,3351/22402
preoperative serum creatinine > $nmbr$ pmol / l,C0445204;C0201976;C0439284;C0600061,false;false;false;false,3352/22402
sacubitril / valsartan ( n = $nmbr$ ),C4033631,true,3353/22402
mean ( s . d . ) apoc - ll $nmbr$  mg / dl,C0444504;C0003594;C2347634;C2348143,false;true;false;false,3354/22402
implanted cardioverter - defibrillator,C0021102;C0810516;C2828363,false;false;false,3355/22402
swollen joint count ( n / $nmbr$ ),C0451521,false,3356/22402
postmenopausal ( % ),C0232970,false,3357/22402
coronary disease,C0010068;C1956346,true;true,3358/22402
prior lev treatment,C1514463;C0023556,false;true,3359/22402
rsg $nmbr$ mg / day,C0439422,false,3360/22402
former or current smokers ( % ),C0205156;C0750523,false;false,3361/22402
topiramate,C0076829,true,3362/22402
hydrochlorothiazide,C0020261,true,3363/22402
toast classification of qualifying stroke  no . ( % ),C1710306;C1514624;C4521230,false;false;false,3364/22402
class $nmbr$ antiarrhythmic agents,C0456387;C0003195;C0301380;C1518526;C1705943,false;true;false;false;false,3365/22402
age  mean $nmbr$ sd years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,3366/22402
concomitant methotrexate  n ( % ),C0521115;C0025677,false;true,3367/22402
corticosteroids . immunosuppressants . and antimalarials,C0001617;C0021081;C3539185;C3540725;C3540726;C3540727,true;true;false;false;false;false,3368/22402
bl mean  mg / dl ( mmol / $nmbr$ ),C0005918;C0444504;C0567349;C3642216;C2348885;C0439269;C0439190;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;false;false;false;false;false;true;false;false,3369/22402
history of diabetes mellitus  n ( % ),C0455488,false,3370/22402
median ( iqr ) admission data,C0549183;C0184666;C1511726;C3245479;C3714741;C0809949;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,3371/22402
not provided,C1518422,false,3372/22402
current bone disease,C0521116;C0005940;C1705970,false;true;false,3373/22402
triglyceride ( median : mg / dl ) a [ $nmbr$ - $nmbr$ percentile ],C0041004;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,3374/22402
stent plus abciximab,C0038257;C0332287;C0288672,true;false;true,3375/22402
systolic blood pressure < $nmbr$ mm hg and diastolic blood pressure < $nmbr$ mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,3376/22402
vasoprotectives,C0304533,false,3377/22402
associatedproximaldeep - veinthrombosisatdiagnosis  no . ( % ),,,3378/22402
discharge medication  n ( % ),C0012621;C0013227;C3244316;C4284232;C0030685;C2926602,false;true;false;false;true;false,3379/22402
other cardiac surgery  n ( % ),C0018821;C0524727,true;true,3380/22402
induction - trial group assignment — no . ( % ),C0205263;C1320290;C1516050;C0857127,false;false;false;false,3381/22402
bw  mean ( sd )  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0006041;C2986891,true;false;false;true;false;false;false;false;true;false,3382/22402
first procedure,C0205435;C0184661;C2700391;C3274430;C3539779;C1279901,false;true;false;false;false;false,3383/22402
prior af ablation  n ( % ),C0332152;C0344434;C0547070;C1261381;C4049859;C2826257,false;false;false;false;false;false,3384/22402
fev $nmbr$ reversibilityz ( pre / post salbutamol )  %,C3714541;C0332152;C0687676;C0001927;C1704687;C3469826;C0740175;C2257086;C3669034,true;false;false;true;false;false;false;false;false,3385/22402
second - generation stent,C0205436;C0079411;C0038257;C3146294;C0457385;C0565930;C1561503;C1705190,false;true;true;false;false;false;false;false,3386/22402
msasss  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,3387/22402
total cholesterohhdl cholesterol ratio,C0201950;C0456603;C1547037;C0543421,false;false;false;false,3388/22402
primary safety end point : severe / life - threatening,C2986535;C0036043;C0205082;C1546953;C2826244;C3537125;C4050465;C4050466;C1705187,false;true;false;false;false;false;false;false;false,3389/22402
nt - probnp ( pg / ml ) ( q $nmbr$ - q $nmbr$ ),C0669479;C0439297;C0754710,true;false;true,3390/22402
remodeling,,,3391/22402
smoking past,C0037369;C1444637;C4284302;C0453996;C1881674,true;false;false;true;false,3392/22402
cigarette smoking status,C0239059;C0449438;C0700219;C0677453;C1519386;C1704760;C3890423,false;false;true;true;false;false;false,3393/22402
use of concomitant lipid - lowering therapy - no . ( % ),C1524063;C0521115;C0585943,false;false;false,3394/22402
prior arrhythmias  n ( % ),C0332152;C0003811;C2826257,false;true;false,3395/22402
thienopyridine at enrollment,C1120149;C1516879;C1696073;C3888021,true;false;false;false,3396/22402
coronary risk factors — no . ( % ),C2024776,false,3397/22402
cardiovascular risk factors,C0850624,false,3398/22402
less than $nmbr$ year,C0439092;C0439234;C0439508,false;false;false,3399/22402
anti - arthritic medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,3400/22402
some physical activity,C0015259;C0026606,true;true,3401/22402
first medical contact — no . ( % ) §,C0205435;C0199168;C0205476;C1279901,false;false;false;false,3402/22402
premature cad among family members,C0151526;C1504769;C0086282;C2239547;C3813548;C4284121;C0205252;C4018905,true;true;true;false;false;false;false;false,3403/22402
ppci in - $nmbr$,,,3404/22402
overall n = $nmbr$  $nmbr$,C0282416;C1561607,true;false,3405/22402
fev $nmbr$ % predicted  post - albuterol  %,C3714541,true,3406/22402
medical therapy only,C0418981;C0205171;C1720467,false;false;false,3407/22402
aspirin and thienopyridine therapy,C0004057,true,3408/22402
heart rate  mean ( sd )  beats / min,C0018810;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,3409/22402
tg  median ( interquartile range ),C0337445;C0549183;C1711350;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,3410/22402
non - hispanic black,C1518424;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,3411/22402
normal renal function,C0232805,false,3412/22402
renal parameters,C0022646;C0449381,true;false,3413/22402
fasting blood glucose — mmol / liter,C0428568;C0439190;C0475211;C1261430,false;false;false;false,3414/22402
glycoprotein iib / iiiareceptorinhibitor,C0017968,true,3415/22402
plaque ( n  % ),C0011389;C0241148;C0332461;C0333463;C4316797,true;false;false;true;false,3416/22402
coronary angiography,C0085532;C1548829,true;false,3417/22402
age  mean ( min - max ) ( yrs ),C0001779;C0444504;C0702093;C1524029;C3813700;C2347634;C2348143,false;false;false;false;false;false;false,3418/22402
evolocumab $nmbr$ mg every $nmbr$ weeks ( n = $nmbr$ ),C3529352;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3419/22402
patients not receiving immunosuppressive agents at baseline,C0030705,true,3420/22402
no . ( % ) with event [ incidence rate per $nmbr$ patient - y ],C0441471;C1708485;C0030705;C4019010,false;false;true;false,3421/22402
screening hba $nmbr$ c ( % ),C0220908;C0019016;C1825777;C3538758;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;true;false;false;false;false;false,3422/22402
modified rankin scale — no . ( % ) |,C2984908;C3854213,false;false,3423/22402
previous cancer  n ( % ),C0205156;C0006826;C0998265;C1306459;C1552607,false;true;false;false;false,3424/22402
penetrating,C0205321,false,3425/22402
more than $nmbr$ vessels stented,C0205172;C0005847,false;true,3426/22402
changes ( a ) in metabolic syndrome parameters hdl cholesterol,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3427/22402
baseline acq - $nmbr$ score,C0168634;C2919686;C1442488,true;false;false,3428/22402
dm medication  n ( % ) c,C0011816;C0013227;C3244316;C4284232;C3250443,true;true;false;false;false,3429/22402
left main disease,C0205091;C0205225;C0012634;C1542147;C0443246;C1552822,false;false;true;false;false;false,3430/22402
> $nmbr$ lesions per vessel,C0221198;C0005847,false;true,3431/22402
xanthines $nmbr$,C0043318;C3541955,true;false,3432/22402
tg ( mmol / l  median ),C0337445;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,3433/22402
verapamil sr strategy ( n = $nmbr$  $nmbr$ ),C1527129;C0679199,false;false,3434/22402
aspirin ( asa ) ( » = $nmbr$ $nmbr$ ),C0004057;C3853627,true;false,3435/22402
weight  mean $nmbr$ sd kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,3436/22402
hispanic black,C0086409;C0005680;C0027567;C0085756;C0439541,true;true;true;true;false,3437/22402
atrial fibrillation or flutter — no . ( % ),C0004238;C0344434;C1963067,true;false;false,3438/22402
on - treatment,C4684449,false,3439/22402
killip class i — no . ( % ),C2697844,false,3440/22402
killip class ( interaction : p = $nmbr$ . $nmbr$ ),C1881332;C1704675,false;false,3441/22402
adjusted hr ( enl vs lcz ) ( $nmbr$ % cl ),C0456081,false,3442/22402
total basdai  mean ( sd ),C0439175;C1998004;C0444504;C2699239;C2347634;C2348143;C0439810,false;false;false;false;false;false;false,3443/22402
placebo + statin ( n = $nmbr$  $nmbr$ ),C0032042;C0360714;C1696465;C1706408,true;true;false;false,3444/22402
thrombus aspiration,C0087086;C0220787;C0349707;C0700198;C2712334;C2827071;C0302148;C3146237,true;false;false;false;false;false;false;false,3445/22402
marital status  married,C0024819;C1716536;C3172566,true;false;false,3446/22402
no . of days to randomization — median ( iqr ),C0439228,false,3447/22402
exacerbations in previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,3448/22402
pain ( $nmbr$ mm vas ),C0042815;C4330985;C4554674,true;false;false,3449/22402
angiogenesis,C0302600;C1519670,false;false,3450/22402
non - fatal mi,C1518422;C1302234;C3810814;C1705232,false;false;false;false,3451/22402
who functional class — no . ( % ) : c,C0205245;C0456387;C1518526;C1705943;C0542341;C2700217,false;false;false;false;false;false,3452/22402
diabetic patients,C0241863;C0030705,false;true,3453/22402
type $nmbr$  n ( % ),C0332307;C1547052,false;false,3454/22402
abatacept $nmbr$ / — $nmbr$ mg / kg ( n = $nmbr$ ),C1619966;C0439272,true;false,3455/22402
black race and ss < $nmbr$ ( n = $nmbr$ vs $nmbr$ ) ■ -,C0005680,true,3456/22402
baseline treatments  n ( % ) a,C0168634;C0087111;C1442488,true;true;false,3457/22402
imm ( without corticosteroid ),C0205470;C0001617;C3536709,false;true;false,3458/22402
mean ( sd ) number of exacerbations *,C0444504;C2699239;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false;false,3459/22402
s . e .,C0565930;C2603362,false;false,3460/22402
spiralcomputedtomographyangiography,,,3461/22402
p ( losartan versus placebo ),C0369773;C0126174;C2603361,false;true;false,3462/22402
apo b / apo a - l ratio ( mean ),C1447574;C0003592;C0456603;C0444504;C2347634;C2348143;C1547037;C0523508;C4553344;C4521365,true;true;false;false;false;false;false;false;false;false,3463/22402
mean ( s . d . ) non - hdl cholesterol,C0444504;C0729627;C1535899;C2347634;C2348143,false;false;false;false;false,3464/22402
secukinumab $nmbr$ mg,C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3465/22402
early - start group ( n = $nmbr$ ),C1279919,false,3466/22402
p interaction ( rx arm * sex ),C0369773;C1704675;C1425688;C0446516;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C3715044;C4553528;C1521941;C2709207;C2603361,false;false;false;true;true;true;true;false;false;true;false;false;false;false;false,3467/22402
left ventricular hypertrophy  n ( % ),C0149721;C3484363,true;false,3468/22402
af pattern,C0344434;C0449774;C4049859,false;false;false,3469/22402
severity of copd,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,3470/22402
post - bronchodilator fev   % predicted,C2599594;C3714541,false;true,3471/22402
copd or asthma  ( % ),C0024117;C1412502;C3714496,true;false;false,3472/22402
body - mass index — no . ( % ) $,C0005893;C0578022;C1305855,false;false;true,3473/22402
waist - to - hip ratio,C0205682,true,3474/22402
$nmbr$ years or older,C0439234,false,3475/22402
years since myocardial infarction,C0439234,false,3476/22402
with alogliptin $nmbr$ mg ( n $nmbr$ $nmbr$ ),C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3477/22402
hoehn and yahr stage,C0205390;C1300072;C1306673,false;false;false,3478/22402
elevated cardiac markers — no . ( % ) : t,C0205250;C1271630;C3163633,false;false;false,3479/22402
scores for global and pain assessments §,C0449820;C0205246;C2348867,false;false;false,3480/22402
documented coronary artery disease,C1301725;C0010054;C0010068;C1956346;C1609436,false;true;true;true;false,3481/22402
large vessel atherosclerosis,C0225990;C0003850;C0004153,false;true;true,3482/22402
hbalc < $nmbr$ % ( < $nmbr$ mmol / mol )  n ( % ),C3829066,false,3483/22402
copd severity,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,3484/22402
geometric mean,C2986759,false,3485/22402
assoc  with connective tissue disease,C0009782,true,3486/22402
chronic kidney disease stage : egfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C1561643;C1739039;C0439445;C0007591;C0456533;C3811844;C3812682;C4553188,true;true;false;true;false;false;false;false,3487/22402
haq - di ( $nmbr$ - $nmbr$ )  mean ( sd ),C3826998;C0444504;C2699239;C2347634;C2348143;C4321476,false;false;false;false;false;false,3488/22402
egfr crcl < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C1846718;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,3489/22402
baseline weight  kg,C1303013;C0022718;C0439209;C4054209,false;true;false;false,3490/22402
bifurcation  n ( % ),C0184906;C3146289,false;false,3491/22402
pe ( with or without dvt ),C0070939;C1880476;C4284304,true;false;false,3492/22402
difference $nmbr$,C1705241;C1705242,false;false,3493/22402
dilatative  n ( % ),C0002940;C0012359;C0700124;C1322279,true;true;false;true,3494/22402
arterial access,C0003842;C0444454;C1554204;C0221464,true;false;false;false,3495/22402
serum cholesterol ( mg / l ) *,C0587184;C0439268,false;false,3496/22402
cerebral thrombosis,C0079102;C0151945;C0795687,true;false;false,3497/22402
rosuva $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,3498/22402
dose of atorvastatin,C0178602;C0286651;C0869039;C1114758,false;true;false;false,3499/22402
mean ( sd ) weight  kg,C0444504;C2699239;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;false;true;true;false;false;true;false;false;false;false,3500/22402
congestive heart failure — %,C0018802,true,3501/22402
no prior ms therapies,C1514463;C2349943;C3539704;C3713294,false;false;false;true,3502/22402
glucocorticoids only,C0017710;C0205171;C1720467;C3540777;C3540778,true;false;false;false;false,3503/22402
background aha therapy at screening  n ( % ),C1706907;C0050451;C0039798;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0087111;C1363945;C0772110,false;true;true;true;true;false;false;false;false;false;true;false;false,3504/22402
established atherosclerotic cv disease §,C0443211;C0333482;C0007222;C1272684,false;false;true;false,3505/22402
angina symptoms ^,C0858277,false,3506/22402
pain ( vas ),C0042815,true,3507/22402
stroke subtype  n ( % ),C0038454;C0449560;C4554100,true;false;false,3508/22402
with placebo,C0032042;C1696465;C1706408,true;false;false,3509/22402
relative risk ( $nmbr$ % confidence interval ),C0242492;C0009667,true;true,3510/22402
r $nmbr$ mg + fa ( « = $nmbr$ ),C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,3511/22402
previous pci or cabg,C0205156;C4049621;C1552607,false;false;false,3512/22402
total pack - yrs,C0439175;C1968515;C2825051;C2828395;C0439810,false;false;false;false;false,3513/22402
baseline trl - c by quintiles,C0168634;C1508496;C1442488,true;false;false,3514/22402
mtx > $nmbr$ and £ $nmbr$ mg / week,C0025677;C1417487,true;false,3515/22402
ff / vi $nmbr$ / $nmbr$ | ig ( n = $nmbr$ ),C4554348;C0205999;C0021027;C0305052;C0360506,false;true;true;false;false,3516/22402
( $nmbr$ % ell ' ll,C1427925;C3273466,false;false,3517/22402
corticosteroids and immunosuppressants only,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,3518/22402
number of vessels treated  index pci,C0237753;C0005847;C0449788,false;true;false,3519/22402
mra ( spironolactone or eplerenone ),C0243032;C0037982;C1609165;C3891069,true;true;true;false,3520/22402
peripheral artery occlusive disease,C1306889,false,3521/22402
baseline value,C0168634;C1522609;C1442488,true;false;false,3522/22402
chronic cvd,C0205191;C0007222,false;true,3523/22402
established ( n = $nmbr$ ),C0443211;C1272684,false;false,3524/22402
known thrombophilia,C0205309;C0398623,false;true,3525/22402
normal > $nmbr$ - $nmbr$,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,3526/22402
estimated gfr renal function stage,C0750572;C0017654;C0232804;C0205390;C1300072;C1306673;C1424601,false;true;false;false;false;false;false,3527/22402
tg  mmol / l ( mg / dl ) [ median ],C0337445;C3898312;C3642216;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,3528/22402
clinical characteristics,C0683325,false,3529/22402
interval after index event,C1272706;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C1552654;C1552713,false;true;false;false;true;false;false;false;false;false,3530/22402
country  n ( % ),C0454664;C1511538,false;false,3531/22402
fractures ( site not specified ),C0016658,true,3532/22402
number of previous dmards,C0237753;C0205156;C0242708;C1552607;C0449788,false;false;true;false;false,3533/22402
non - hispanic,C1518424,false,3534/22402
proportion of patients in corticosteroid - free clinical remission at week $nmbr$,C1709707;C0030705,false;true,3535/22402
pramlintide,C0537551,true,3536/22402
height  inches,C0489786;C0439204,false;false,3537/22402
antithrombotic agents,C1704311,true,3538/22402
ambulance  n ( % ),C0002422;C3846685,true;false,3539/22402
chd risk - no . ( % ),C0280604;C3542407,false;false,3540/22402
infusion administered — no . / total no . ( % ),C0574032;C1827465,false;false,3541/22402
non - hdl cholesterol ( week $nmbr$ ),C0729627;C0332174;C0439230;C1535899,false;false;false;false,3542/22402
inhaled glucocorticoid use at screening,C0004048;C0017710;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;true;true;false;false;false;false;false;false;false,3543/22402
type of vessel involved,C1282017,false,3544/22402
oral blood glucose - lowering drug $nmbr$ ( $nmbr$ . $nmbr$ ),C0442027;C0018938;C0017725;C0441994;C2003888;C0005802;C0013227;C1254351;C4521986,false;true;true;false;false;true;true;false;false,3545/22402
baseline pos frequency per $nmbr$ days  median ( min  max ),C0168634;C1262869;C0585290;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C3496112;C3496399;C1442488,true;true;false;false;false;false;false;false;false;false;false;false;false;false,3546/22402
mean ( sd ) mtx dose  mg / week,C0444504;C2699239;C0366550;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;false;true;false;false;true;false;false;false;false;false;false;false,3547/22402
laboratory ae  n ( % },C0022877;C3887670;C3244292;C4283904,true;false;false;false,3548/22402
use of concomitant lipid - lowering treatment,C1524063;C0521115;C0023779;C0441994;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2003888,false;false;true;false;true;true;false;false;false;false;false;false,3549/22402
age ( y )  median ( iqr ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3550/22402
heart failure  lvef < $nmbr$ %  or both,C0018801;C0428772;C0488728;C0018802;C4554158,true;false;false;true;false,3551/22402
omalizumab ( lsm ),C0966225,true,3552/22402
baseline cv medications  n ( % ),C0168634;C3538987;C0013227;C0802604;C2598133;C4284232;C4048877;C4318503;C1442488,true;false;true;false;false;false;true;false;false,3553/22402
$nmbr$ or $nmbr$ high cardiovascular risk categories,,,3554/22402
pack - years smoked,C1277691,false,3555/22402
exenatide lar,C0167117,true,3556/22402
concomitant treatment,C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,3557/22402
score on the minnesota living with heart failure scaled,C0449820;C0026183;C0595998;C4520849;C4551704;C4050231,false;true;false;false;false;false,3558/22402
eosinophil count ( cells per pl ),C0200638;C0007584;C3897966;C4049765;C0007634;C0750879,false;true;false;false;true;false,3559/22402
disease duration ( yr )  mean ± sd,C0872146;C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,3560/22402
baseline total pcsk $nmbr$ level by median,C0168634;C0439175;C0441889;C0549183;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261;C0439810;C1442488,true;false;false;false;false;false;false;false;false;false;false;false;false,3561/22402
antiplatelet agents ( % ),C0085826,true,3562/22402
peripheral vascular disease  n ( % ),C0085096,true,3563/22402
duration of disease — yr : t,C0872146;C0439234,false;false,3564/22402
infarction $nmbr$ - $nmbr$ days,C0021308;C0439228,true;false,3565/22402
estimated difference ( $nmbr$ % ci ),C0750572;C1705241;C0008107;C3259781;C1705242,false;false;true;false;false,3566/22402
non - st - elevation myocardial infarction,C1536221;C1536222;C3537184;C4255010,false;false;false;true,3567/22402
aspirin i clopidogrel ( n = $nmbr$  $nmbr$ ),C0004057;C0021966;C0070166;C0221138,true;true;true;false,3568/22402
pulmonary disease — no . ( % ),C0024115,true,3569/22402
etn $nmbr$ mg + mtx n = $nmbr$,C0014758;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0717758,true;true;true;false;true;false;false;false;false;false;true,3570/22402
all stroke,C0038454;C4554100,true;false,3571/22402
previous respiratory disease other than copd — no . ( % ),C0205156;C0035204;C0024117;C1412502;C3714496;C0035242;C1552607,false;true;true;false;false;true;false,3572/22402
history of stroke or transient ischemic attack,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,3573/22402
pelvic fractures,C0149531,false,3574/22402
standard care allocation,C1442989;C1947933;C1706778;C2828392,false;false;false;false,3575/22402
ra duration ( months ) *,C3538806;C0449238;C0439231;C2926735;C4048756,false;false;false;false;false,3576/22402
other drugs — no . ( % ),C0013227;C3687832,true;false,3577/22402
atherosclerotic disease *,C0333482;C0012634,false;true,3578/22402
angiography and revascularization,C0002978,true,3579/22402
unfractionated heparin ( n = $nmbr$ ),C0019134;C2825026,true;false,3580/22402
demographic and clinical characteristics,C0011298,true,3581/22402
mean lixi dose ± sd ( lg / day ),C0444504;C0178602;C2699239;C0023128;C0332173;C0439228;C0439505;C0694651;C0869039;C1114758;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false;false,3582/22402
number ( % ),C0237753;C0449788,false;false,3583/22402
age subgroups,C0001779;C1079230,false;false,3584/22402
ind / gly $nmbr$ / $nmbr$ mg once daily ( n = $nmbr$ ),C4049864;C0017890;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0523677,false;true;true;false;true;false;false;false;false;false;false,3585/22402
glycated hemoglobin  mean ( sd )  %,C0017853;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,3586/22402
no . of events / no . of patients,C0441471;C3541888,false;false,3587/22402
carotid artery intervention *,C0007272;C0184661;C0886296;C1273869;C0162859;C0741968;C0397581,true;true;false;false;true;false;false,3588/22402
hope patients with coronary - artery disease ( n = $nmbr$ ),C0392347;C0030705;C0010054;C0010068;C1956346,true;true;true;true;true,3589/22402
linagliptin / metformin,C3264599,false,3590/22402
ultrasound carotid arteries,C0948945,false,3591/22402
pci or cabg surgery for index event,C4049621,false,3592/22402
das $nmbr$ - $nmbr$ ( esr ) $nmbr$,C0051767;C3811131;C0057671,true;false;true,3593/22402
cardiac therapy §,C3654025,false,3594/22402
low - dose statin,C0445550;C0360714;C1708745,false;true;false,3595/22402
oral anticoagulant  n ( % ),C0354604,false,3596/22402
p - value for interaction $nmbr$ . $nmbr$,C1709380;C1704675,false;false,3597/22402
> $nmbr$ des type,C0011702;C0332307;C1547052;C4551552,true;false;false;true,3598/22402
placebo patients with events / total,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,3599/22402
average age ( year ),C1510992;C0001779;C0439234;C0439508;C2825518,false;false;false;false;false,3600/22402
placebo + $nmbr$ mg / d of simvastatin,C0032042;C0439422;C0074554;C1696465;C1706408,true;false;true;false;false,3601/22402
baseline hb $nmbr$ g i $nmbr$ n = $nmbr$,C0168634;C0062408;C0086706;C1442488,true;true;true;false,3602/22402
type of end point,C0332307;C2349179;C2826544;C1547052,false;false;false;false,3603/22402
copd medication at study entry,C0024117;C0013175;C1705654;C1412502;C3714496,true;true;false;false;false,3604/22402
emphysema,C0013990;C0034067,true;true,3605/22402
mean ( sd ) esr  mm / h *,C0444504;C2699239;C3811131;C0456680;C2347634;C2348143,false;false;false;false;false;false,3606/22402
vilanterol  n = $nmbr$,C2935023,true,3607/22402
latin america ( n = $nmbr$ ),C0023122,true,3608/22402
third heart sound,C0232237;C0232278,false;false,3609/22402
tnfi naive,,,3610/22402
continued thienopyridine ( n = $nmbr$ ),C0549178;C1120149,false;true,3611/22402
total intravenous loop diuretic ( mg ) median,C0439175;C0348016;C0354100;C0024671;C0549183;C0876920;C2347635;C2348144;C2939193;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C3536704;C0439810,false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;false;false,3612/22402
mild to moderate,C1299392,false,3613/22402
median n - terminal probnp ( iqr ) — pg / ml,C0549183;C0669479;C0439297;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,3614/22402
degree of stenosis  % of diameter,C4034225;C1301886,false;false,3615/22402
diagnostic angiography,C0002978,true,3616/22402
left ventricular hypertrophy on echo,C0149721;C0058928;C1655045;C3484363,true;true;false;false,3617/22402
fasting serum glucose  median ( sd )  mg / dl,C0015663;C0202041;C0549183;C2699239;C0439269;C0876920;C2347635;C2348144;C2939193;C3534430,true;false;false;false;false;false;false;false;false;false,3618/22402
abatacept plus mtx ( n = $nmbr$ ),C1619966;C0025677;C1417487,true;true;false,3619/22402
baseline measurements,C0168634;C0242485;C1442488,true;false;false,3620/22402
non - compliance,C0376405;C0457432,true;false,3621/22402
duration of pre - randomization anticoagulant therapy,C2711563;C0332152;C0034656;C0740175;C2257086;C3669034,false;false;true;false;false;false,3622/22402
bmi at baseline ( kg / m $nmbr$ ),C0578022;C0168634;C1532718;C1442488,false;true;false;false,3623/22402
average maximum common and bifurcation cimt ( mm ),C1510992;C0806909;C1552615;C2826546;C2825518,false;false;false;false;false,3624/22402
location,C0450429;C1515974;C4284930;C4284931,false;false;false;false,3625/22402
kheeatne index dvt,C0600653;C0149871;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,true;true;false;false;true;false;false;false,3626/22402
osteitis,C0029400,true,3627/22402
$nmbr$ - $nmbr$ months fn = $nmbr$ . $nmbr$ ),C0439231;C1570610,false;true,3628/22402
glinide 一 no . ( % ),C2266929,false,3629/22402
below - knee popliteal crural,C0542339;C0022742;C0442037;C0023216;C1140621;C0022745;C1963703;C1552829,false;true;false;true;true;true;false;false,3630/22402
pre - enrollment antihyperglycemic therapy,C1882440;C1516879;C0020616;C1696073;C3888021,false;false;true;false;false,3631/22402
symptom duration,C1457887;C0449238;C2926735;C3854129,false;false;false;false,3632/22402
% patients with no progression,C0030705;C0242656;C0449258,true;true;false,3633/22402
measured at clinic visit with automated device §,C0444706;C0008952;C3541902,false;true;false,3634/22402
previous episode of heart failure,C0205156;C0332189;C0018801;C0018802;C4554158;C1552607,false;false;true;true;false;false,3635/22402
liraglutide ( n = $nmbr$ ),C1456408,true,3636/22402
hba $nmbr$ c  % ( sd ),C0019016;C2699239;C1825777;C3538758,true;false;false;false,3637/22402
post - bronchodilator fev $nmbr$ — liters,C2599594;C3714541;C0475211,false;true;false,3638/22402
renal insufficiency,C0035078;C1565489,true;true,3639/22402
lvef within $nmbr$ mo  %,C0428772;C0026544;C0332177;C0488728,false;true;false;false,3640/22402
ldl cholesterol  mmol / l  mean ± sd,C0023824;C1532563;C0444504;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,3641/22402
history of hypertension for $nmbr$ mo or more,C0455527,false,3642/22402
fish oil ( n = $nmbr$ ),C0016157,true,3643/22402
digitalis glycoside,C0012253,true,3644/22402
baseline mean,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,3645/22402
no previous dmard therapy,C0205156;C0242708;C0039798;C0087111;C1363945;C1552607,false;true;true;true;false;false,3646/22402
hba $nmbr$ c at $nmbr$ weeks *,C0019016;C0439230;C1825777;C3538758,true;false;false;false,3647/22402
glycated hemoglobin,C0017853,true,3648/22402
elevated fasting glucose,C0205250;C3163633,false;false,3649/22402
no adk / e cancer,C1412243;C0006826;C0998265;C1306459,false;true;false;false,3650/22402
indacaterol + tiotropium ( n [ $nmbr$ ),C1722260;C0213771,true;true,3651/22402
ras % target dose,C0034678;C1521840;C0178602;C0869039;C1114758;C2986546;C0525678,true;false;false;false;false;false;true,3652/22402
history of upper gastrointestinal event,C0019664;C3203348;C0441471;C4019010;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,3653/22402
ibdq score |,,,3654/22402
first primary ( change in updrs score / wk  wk $nmbr$ - $nmbr$ ),C0205435;C0205225;C0392747;C3639721;C0443172;C1705241;C4319952;C0439612;C0439631;C1279901,false;false;false;true;false;false;false;false;false;false,3655/22402
overweight ( $nmbr$ to < $nmbr$ kg / m $nmbr$ ),C0497406;C1532718,true;false,3656/22402
symptom onset - to -,C4086878,false,3657/22402
median ( iqr ) cholesterol,C0549183;C0008377;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false,3658/22402
week $nmbr$ mean ( se ),C0332174;C0444504;C0036919;C2347634;C2348143;C0439230,false;false;true;false;false;false,3659/22402
western europe  israel  australia  or south africa,C0043128;C0015176;C0022271;C0043129;C0004340,true;true;true;true;true,3660/22402
imm + corticosteroid  n,C0205470;C0001617;C3536709,false;true;false,3661/22402
t $nmbr$ dm duration  y,C2603360;C0011816;C0449238;C2926735;C3250443,false;true;false;false;false,3662/22402
previous myocardial infarction  n ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,3663/22402
no . ( % ) of participants,C0679646,false,3664/22402
previous tnf antagonist exposure  n ( % ),C0205156;C1448177;C0231491;C0274281;C0332157;C1552607,false;true;false;false;false;false,3665/22402
pharmacotherapy,C0013216;C0013217,true;true,3666/22402
ulcerative colitis,C0009324,true,3667/22402
received $nmbr$ prior anti - tnf therapy  n,C1514756;C0332152;C0432633;C0279936;C2826257,false;false;false;false;false,3668/22402
placebo n ( rate ) *,C0032042;C0871208;C1521828;C1696465;C1706408,true;false;false;false;false,3669/22402
low - density lipoprotein,C0023823,true,3670/22402
family history ^,C0241889,true,3671/22402
fvc ( % predicted ),C3714541,true,3672/22402
clinical ae  n ( % },C0205210;C3887670,false;false,3673/22402
dietary epa - dha intake ( mg / day ) *,C1286104;C0142831;C0439422;C2348308,false;true;false;false,3674/22402
other llt use,C2347090;C0042153;C0457083;C1947944,false;true;false;false,3675/22402
ada $nmbr$ / $nmbr$ n [ $nmbr$,C1060325;C3811629,false;false,3676/22402
serious adverse events,C1519255,false,3677/22402
change from baseline at week $nmbr$,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,3678/22402
medications at coronary angiography,C0013227;C0085532;C1548829;C0802604;C2598133;C4284232,true;true;false;false;false;false,3679/22402
$nmbr$ $nmbr$ years  n ( % ),C0439234,false,3680/22402
no . of subjects,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,3681/22402
fpg  mean ( sd )  mg / dl [ mmol / l ],C0444504;C2699239;C0439269;C1532563;C2347634;C2348143,false;false;false;false;false;false,3682/22402
acr $nmbr$ response  n / n ( % ),C1412134;C0871261;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false,3683/22402
sfc $nmbr$ / $nmbr$ mg twice daily ( n = $nmbr$  $nmbr$ ),C4521536;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;true;false;false;false;false;false,3684/22402
geometric mean blood eosinophil count ( sd on a loge scale ) — cells / mm $nmbr$,C2986759;C0200638;C2699239;C2697934;C0175659;C4330985;C4554674;C0349674;C1947916,false;false;false;false;true;false;false;false;false,3685/22402
copd - placebo ( n = $nmbr$ ),C0024117;C0032042;C1696465;C1706408;C1412502;C3714496,true;true;false;false;false;false,3686/22402
pga subscore,C0016410;C3541266;C4050369,true;false;false,3687/22402
mafcaiancy at randorrtzaton,,,3688/22402
$nmbr$ . $nmbr$ mg / dl triglycerides ^,C0439269;C0041004,false;true,3689/22402
antiplatelet within $nmbr$ mo before randomization,C0026544;C0332177,true;false,3690/22402
lesion characteristics,C1286326,false,3691/22402
handihaler and diskus  n,,,3692/22402
baseline dyspnea index score,C1511069;C0449820;C4050231,false;false;false,3693/22402
creatinine clearance — no . ( % ),C0812399,false,3694/22402
any oral hypoglycemic drug 一 no . ( % ),C0359086,false,3695/22402
sfc $nmbr$ / $nmbr$ pg b . i . d . n = $nmbr$,C4521536;C2827928;C0021966;C0221138;C0030827;C0152277;C0072225;C1266240,false;false;true;false;true;false;true;false,3696/22402
infarct related artery location,C0021308;C0439849;C0003842;C0450429;C1515974;C4284930;C4284931;C0226004;C0445223,true;false;true;false;false;false;false;false;false,3697/22402
pen - label empagliflozin $nmbr$ mg ( baseline hba $nmbr$ c > $nmbr$ % ),C1424886;C0181496;C3490348;C0024671;C0168634;C0019016;C1825777;C3538758;C1442488;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2827499;C4522130;C4551445;C3273588;C4319659,false;false;true;true;true;true;false;false;false;true;false;false;false;false;false;false;false;false;false;false,3698/22402
other vasculars,,,3699/22402
patients who received indeterminate results on test for antibodies to infliximabt,C0030705,true,3700/22402
history of diabetes requiring drugs,C0019664;C0020616;C0019665;C0262512;C0262926;C1705255;C2004062;C0011847;C1553893;C0011849,true;true;true;false;false;false;false;false;false;true,3701/22402
coronary intervention,C0018787;C0184661;C0886296;C1273869,true;true;false;false,3702/22402
elevated at wk $nmbr$ — no . ( % ) !,C0205250;C0332174;C0439230;C3163633,false;false;false;false,3703/22402
body mass index category  no . ( % ) l,C0005893;C0683312;C3889287;C0578022;C1305855,false;false;false;false;true,3704/22402
liraglutide $nmbr$ . $nmbr$ mg mean ( n ),C1456408;C0024671;C0444504;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,3705/22402
hab $nmbr$ c ( mean ± sem )  %,C0444504;C2347634;C2348143,false;false;false,3706/22402
low risk ( $nmbr$ - $nmbr$ ),C3272281;C3538919,false;false,3707/22402
gfr as assessed by mdrd,C0017654;C1424601,true;false,3708/22402
history of ischemic stroke,C0019664;C0948008;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,3709/22402
$nmbr$ - minute walk distance — m,C0439232;C0429886;C0369637;C0441923;C0700321;C0702093;C1282918;C2347166,false;false;false;false;false;false;false;false,3710/22402
male / female  %,C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429,true;true;true;false;false;false;false;false,3711/22402
current inhaler +,C0521116;C0021461;C1881212;C4319647;C1705970,false;true;false;false;false,3712/22402
phosphate ( mmol / l ),C0031603;C1532563;C0031701;C1601799,true;false;true;false,3713/22402
established cardiovascular disease,C0443211;C0007222;C1272684,false;true;false,3714/22402
smoker ( current / former ),C0337664;C0521116;C0205156;C0750523;C1705970,true;false;false;false;false,3715/22402
total cholesterol - to - hdl cholesterol ratio,C0428619,false,3716/22402
oral anticoagulant drugs  n ( % ),C0354604,false,3717/22402
definite,C0439544;C1704787,false;false,3718/22402
abciximab - facilitated pci ( n = $nmbr$ ),C0288672;C4049621,true;false,3719/22402
computed tomographic angiography,C1536105,true,3720/22402
distribution — no . ( % ),C0520511;C1704711,false;true,3721/22402
intravenous heparin,C0354566,false,3722/22402
$nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ % ( $nmbr$ to < $nmbr$ mmol / mol ),C0040363;C3829066;C0041260;C1883351,true;false;true;false,3723/22402
$nmbr$ - month follow - up median ( iq range ),C0332177;C0589120;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1522577;C1704685;C3274571;C0439231,false;false;false;false;false;false;false;false;false;false;false;false;false;false,3724/22402
biventricular pacemaker,C1719274,false,3725/22402
warfarin group,C0043031;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,3726/22402
$nmbr$ aspirin ( n = $nmbr$ $nmbr$ ),C0004057,true,3727/22402
short form $nmbr$ ( sf - $nmbr$ ),C2964478;C0037712,false;true,3728/22402
individual intended study duration — no . ( % ),C0027361;C1283828;C0489652;C1551357;C0237401,true;false;false;false;false,3729/22402
male nyha class,C0086582;C1882083;C1706180;C1706428;C1706429,true;false;false;false;false,3730/22402
metoprolol group ( n = $nmbr$ ),C0025859;C0441848,true;false,3731/22402
fenofibric acid,C0060179,true,3732/22402
warfarin at enrollment,C0043031;C1516879;C1696073;C3888021,true;false;false;false,3733/22402
global ischemia,C0205246;C0022116;C4321499;C2348867,false;true;false;false,3734/22402
p value § ( < $nmbr$ vs . > = $nmbr$ years ),C1709380,false,3735/22402
hf or lvef < $nmbr$ % associated with index event,C0018488;C1313497;C1538440;C3273279,true;true;false;false,3736/22402
subject completion status  n ( % ),C3891295;C0205197;C1554962;C2348577;C0449438;C0681850;C0805732;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false;false;false;false;false,3737/22402
egfr — ml / min / $nmbr$ . $nmbr$ m * *,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,3738/22402
coronary angioplasty or stenting,C0002997;C0190211,true;false,3739/22402
death from cardiovascular causes,C0007465;C0007226;C3887460,true;true;false,3740/22402
$nmbr$ mg / dl ldl cholesterol | |,C0439269;C0023824;C0202117,false;true;false,3741/22402
femur fracture,C0015802,true,3742/22402
erythrocyte sedimentation rate  mm / hour,C1176468;C4330985;C0439227;C0564385;C4554674;C1619634,false;false;false;false;false;true,3743/22402
insulin sensitivity — % §,C0920563;C4049919,true;false,3744/22402
anti - tnf agent ( s ),C0221141;C1448177;C0450442;C1254351;C1521826;C0313162,false;true;false;false;false;false,3745/22402
medication after enrolment,C0013227;C1516879;C1696073;C3888021;C3244316;C4284232,true;false;false;false;false;false,3746/22402
number insulin glargine,C0237753;C0907402;C0449788,false;true;false,3747/22402
asian ( $nmbr$ . $nmbr$ % ),C0078988,true,3748/22402
lifestyle modifications,C0870811;C2960841,false;false,3749/22402
change from,C0392747;C0443172;C1705241;C4319952,false;false;false;false,3750/22402
% change  $nmbr$ % ci ),C0392747;C0008107;C3259781;C0443172;C1705241;C4319952,false;true;false;false;false;false,3751/22402
< $nmbr$ nwrrtn,,,3752/22402
moderate renal impairment,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3753/22402
major diabetic eye disease  n ( % ),C0205082;C0342245;C0205164;C4318856;C4521762,false;false;false;false;false,3754/22402
all participants,C0679646,false,3755/22402
history of atrial fibrillation / flutter  ( % ),C0729790;C0016385;C2242390;C1998417;C0232197,false;false;false;false;false,3756/22402
apixaban dose ( or matching placebo ),C1831808;C0178602;C0869039;C1114758,true;false;false;false,3757/22402
symptom onset,C4086878,false,3758/22402
prosthetic,,,3759/22402
disease hare . no . ( % ) i,C0012634,true,3760/22402
treatment by egfr stage,C0815181;C1739039;C3811844;C3812682,false;true;false;false,3761/22402
hormonal therapy — no . ( % ),C0279025,false,3762/22402
angina pectoris  ( % ),C0002962,true,3763/22402
type of stent at index procedure,C0332307;C0038257;C1547052,false;true;false,3764/22402
blood pressure lowering medication use,C0005823;C0441994;C0240320;C2003888;C1271104;C1272641,true;false;false;false;false;true,3765/22402
gpi used during pci,C1415351,false,3766/22402
lowzmedium intensity,C0522510,false,3767/22402
antihypertensive therapy  n ( % ),C0585941,false,3768/22402
any medication,C0013227;C3244316;C4284232,true;false;false,3769/22402
mean — mm hg level — no . ( % ),C0444504;C0439475;C0441889;C0456079;C1547707;C2946261;C2347634;C2348143,false;false;false;false;false;false;false;false,3770/22402
chd simva $nmbr$ = $nmbr$ ],C0280604;C3542407,false;false,3771/22402
diabetic history ( years ) x,C0241863;C0019664;C0439234;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;true;false;false;false;false,3772/22402
urine albumin / creatinine ratio ( mg / g ),C0455271;C1300563;C1318330,false;false;false,3773/22402
extensive colitis or pancolitis,C0205231;C0009319;C1963084,false;true;false,3774/22402
moderate ckd at randomization,C0205081;C1561643;C0034656;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false,3775/22402
less than the median,C0439092;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,3776/22402
qualifying cv event  n ( % ),C1514624;C3538987;C0441471;C4019010;C4048877;C4318503,false;false;false;false;true;false,3777/22402
peripheral artery occlusive disease ( stage $nmbr$ / $nmbr$ / $nmbr$ / $nmbr$ / $nmbr$ ),C1306889;C0205390;C1300072;C1306673,false;false;false;false,3778/22402
or placebo treatment,,,3779/22402
diabetes $nmbr$ ( % ),C0011847;C0011849,false;true,3780/22402
continued thienopyridine ( n $nmbr$ $nmbr$ ),C0549178;C1120149,false;true,3781/22402
saxagliptin $nmbr$ . $nmbr$ mg,C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3782/22402
patients with ra  as  or psa ( n = $nmbr$ ),C0030705;C3538806;C4048756,true;false;false,3783/22402
chronic bronchitis ( % ),C0008677,true,3784/22402
reduction in risk ( $nmbr$ % ci ) %,C1137094;C0008107;C3259781;C0035647;C0520870;C4552904,true;true;false;true;false;false,3785/22402
moderate disease activity : > $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$  n ( % ),C1513375;C0012634;C3833417;C0205081;C1292728;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false;false;false,3786/22402
age $nmbr$ years or more,C1510829,false,3787/22402
valsartan / hctz ( n = $nmbr$ ),C0216784;C0020261,true;true,3788/22402
ics users  n ( % ),C0815320;C1706077;C4551720,false;false;true,3789/22402
since onset,,,3790/22402
diabetes at randomization,C0011847;C0034656;C0011849,false;true;true,3791/22402
treated with pci — no . / total no . ( % ),C0332293;C4049621,false;false,3792/22402
device group ( n = $nmbr$ ),C0025080;C0441848;C0699733,true;false;true,3793/22402
left main coronary artery  n ( % ),C1261082,false,3794/22402
statin use at study entry  n ( % ),C0360714;C0869040;C1705654,true;false;false,3795/22402
lipid disorder,C0154251,true,3796/22402
history of atrial fibrillation  type 一 no . ( % ),C0729790;C0332307;C1547052,false;false;false,3797/22402
total diuretic dose ( iv + oral ) on day $nmbr$  mg,C2986497;C0012798;C0022326;C4265176,false;true;true;false,3798/22402
enthesitis  n ( % ),C1282952,false,3799/22402
immobazaton,,,3800/22402
digit symbol substitution,C0582802;C0679214;C1555721;C1706204;C1698987;C3241971,false;false;false;false;false;false,3801/22402
prior coronary revascularization ( pci or cabg ),C0332152;C0877341;C4049621;C2826257,false;false;false;false,3802/22402
hbalc  median ( ql  q $nmbr$ )  %,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,3803/22402
fasting cholesterol — mg / dl,C0015663;C0008377;C0439269,true;true;false,3804/22402
idiopathic,C0332240,false,3805/22402
mean ( sd ) [ range ],C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,3806/22402
inhaled corticosteroids,C0004048;C0001617;C3539185;C3540725;C3540726;C3540727,true;true;false;false;false;false,3807/22402
fasting insulin — pmol / liter,C0015663;C0021641;C0439192;C0475211;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,3808/22402
watchman ( n = $nmbr$ ),C0335390,false,3809/22402
apixaban  $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3810/22402
primary renal endpoint,C2986535;C0022646,false;true,3811/22402
hgb  g / dl,C0019029;C0439267;C0019046;C0518015;C1424337,false;false;true;false;false,3812/22402
normal ( > $nmbr$ ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,3813/22402
type of des at index procedure,C0332307;C0011702;C4551552;C1547052,false;true;true;false,3814/22402
$nmbr$ vitamin e ( n = $nmbr$ $nmbr$ ),C0042874;C3714803,true;false,3815/22402
persistent wrf ( n = $nmbr$ ),C0205322;C0332996,false;false,3816/22402
estonia,C0014908,true,3817/22402
score on modified rankin scale ( ' % / ',C0449820;C2984908;C3854213;C4050231,false;false;false;false,3818/22402
atrial fibrillation or flutter ( ecg ) §,C0004238;C0344434;C1963067,true;false;false,3819/22402
adcs - adl score *,C3641947;C0449820;C4050231,false;false;false,3820/22402
mean sf $nmbr$ score ( $nmbr$ % ci ),C3533236;C0037712;C0008107;C3259781,false;true;true;false,3821/22402
qrs > $nmbr$ ms  n ( % )  available for $nmbr$ patients,C2349943;C3539704;C3713294,false;false;true,3822/22402
baseline high - sensitivity crp,C0168634;C1441604;C3890735;C4048285;C1442488,true;false;false;false;false,3823/22402
heart rates ( beats / minutes ),C0018810,true,3824/22402
insulin glargine allocation,C0907402;C1706778,true;false,3825/22402
left side of colon,C0227388,false,3826/22402
left ventricular hypertrophy,C0149721;C3484363,true;false,3827/22402
non - cortical,C1518422;C0001613;C0007776;C0022655,false;true;true;true,3828/22402
low - density lipoprotein cholesterol  median  ( $nmbr$ th — $nmbr$ th percentiles )  mg / dl,C0023824;C0549183;C0039725;C1264641;C0439269;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,true;false;true;false;false;true;false;false;false;false;false;false;false,3829/22402
unsuccessful procedure,C1272705;C0184661;C2700391;C3274430;C3539779,false;true;false;false;false,3830/22402
previous angina  n ( % ),C0205156;C0002962;C1552607,false;true;false,3831/22402
$nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ( % ),C0040363;C0041260;C1883351,true;true;false,3832/22402
nt - pro - bnp — pmol / liter - j -,C0669479;C0439192;C0475211;C0754710,true;false;false;true,3833/22402
sirukumab $nmbr$ mg q $nmbr$ w,C3254570;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3834/22402
baseline post - bronchodilator % predicted fev  > $nmbr$ % and concurrent tiotropium use,C0168634;C1442488,true;false,3835/22402
euroscore additive  median ( $nmbr$ th  $nmbr$ th % ) §,C3164744;C0442796;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193;C1550602,false;false;false;true;true;false;false;false;false;false;false;false;false,3836/22402
lev - naive,C0023556,true,3837/22402
clinical disease activity index score ( $nmbr$ - $nmbr$ ),C3869583;C0449820;C4050231,false;false;false,3838/22402
black / african - american ( $nmbr$ . $nmbr$ % ),C0085756,true,3839/22402
chronic cox $nmbr$ inhibitors,C0205191;C0085387,false;true,3840/22402
no . of coronary vessels with > $nmbr$ % diameter stenosis,C0010075,true,3841/22402
history of claudication,C2315493,false,3842/22402
seated sbp at $nmbr$ weeks  mmhg +,C0277814;C0085805;C0439230;C0439475;C1283233,true;true;false;false;false,3843/22402
ended > $nmbr$ days before trial entry,C1272693;C0439228;C0008976;C1705654;C2746065,false;false;true;false;false,3844/22402
rope score * *,C1563164;C0449820;C4050231,false;false;false,3845/22402
inter p - value,C0205103;C1548610,false;false,3846/22402
risk factor profile index event,C0035648;C1979963;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C2003903,true;false;true;false;false;true;false;false;false;false,3847/22402
use of ace inhibitor  arb  or both — no . ( % ),C1524063;C0003015;C3888198;C4541021,false;true;false;false,3848/22402
clopidogrel  $nmbr$ mg loading dose !,C0070166;C4086581;C1708715;C0024671;C3714444;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;true;false;false;false;false;false,3849/22402
adverse eventy,,,3850/22402
discontinued,C1444662,false,3851/22402
duration of osteoarthritis symptoms — yr,C0436359;C0029408;C0439234,false;true;false,3852/22402
total cholesterol - mg / dl * *,C0201950;C0439269;C0543421,false;false;false,3853/22402
peripheral revascularization ( n = $nmbr$ ),C0205100;C0581603,false;false,3854/22402
smoking in past yr,C0037369;C1444637;C0439234;C4284302;C0453996;C1881674,true;false;false;false;true;false,3855/22402
percentage of patients using ics or ics / laba on entry,C0439165;C0030705;C1549488;C1561533,false;true;false;false,3856/22402
mean change,C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false,3857/22402
neither ics nor laba,C0815320;C4551720,false;true,3858/22402
combination - facilitated pci ( n = $nmbr$ ),C0205195;C1947911;C3811910,false;false;false,3859/22402
bifurcation,C0184906;C3146289,false;false,3860/22402
coronary heart disease death,C0010054;C0011065;C1306577;C4082313;C4552775;C0010068;C1956346,true;true;false;false;false;true;true,3861/22402
< $nmbr$ mg / dl eze / simva ( n = $nmbr$ },C0439269,false,3862/22402
a / v ( n = $nmbr$ ) v ( n = $nmbr$ ),C0560268;C1272460;C3887614,false;false;false,3863/22402
hypertrophic cardiomyopathy,C0007194;C4551472,true;true,3864/22402
median body mass index  kg / m $nmbr$ ( iqr ),C0549183;C0005893;C1532718;C0578022;C1305855;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false,3865/22402
$nmbr$ - year framingham chd risk ( % ) $nmbr$ mean / sd ),C0439234;C3166866;C1282512;C0444504;C2699239;C2347634;C2348143;C0439508,false;false;false;false;false;false;false;false,3866/22402
ecrcl  ml / min,C0439445,false,3867/22402
time from longest event to randomisation,C0040223;C1522425;C0441471;C4019010;C3541383,true;false;false;false;false,3868/22402
no prior hf hospitalization,C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,3869/22402
conservative,,,3870/22402
serum creatinine ( pmol / l )  mean ( sd ),C0201976;C0439284;C0444504;C2699239;C2347634;C2348143;C0600061,false;false;false;false;false;false;false,3871/22402
any cv history / risk factors  n ( % ),C3538987;C0019664;C0035648;C1553898;C0019665;C0262512;C0262926;C1705255;C2004062;C4048877;C4318503,false;true;true;false;true;false;false;false;false;true;false,3872/22402
vte at day $nmbr$ +,C0630906;C0332173;C0439228;C0439505,true;false;false;false,3873/22402
age of completion of highest education  years ( sd ),C1510829;C0205197;C1522410;C0013621;C2699239;C0013622;C0013658;C0039401;C1554962,false;false;false;true;false;true;true;true;false,3874/22402
pfo + asa,C0004057;C3853627,true;false,3875/22402
$nmbr$ mg / day - placebo,C0439422;C0032042;C1696465;C1706408,false;true;false;false,3876/22402
mtss cfb,C0009002;C1824728,true;false,3877/22402
mental component summary,C0229992;C0449432;C1552616;C1706244;C1705248,false;false;false;false;false,3878/22402
low - density lipoprotein cholesterol tx difference vs pbo  ls mean % change from baseline ( se ),C0023824;C0041403;C1705241;C1705242,true;true;false;false,3879/22402
dihydropyridine calcium - channel blocker,C2945601,false,3880/22402
germany,C0017480,true,3881/22402
high sensitivity c - reactive protein ( mg / l ),C1441604;C0006560;C0439268;C1413716;C4048285,false;true;false;false;false,3882/22402
azathioprine,C0004482,true,3883/22402
high risk ( ri ≥ $nmbr$ ),C0332167;C0035487;C1826843;C3272283;C4050568;C4319571,false;true;false;false;false;false,3884/22402
egfr ( ml / min per $nmbr$ - $nmbr$ m ' ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,3885/22402
ez / simva $nmbr$ mg,C0206578;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,3886/22402
patients receiving immunosuppressive agents at baseline,C0030705,true,3887/22402
demographics age  years  mean ( sd ),C0011298;C1510829;C0444504;C2699239;C2347634;C2348143;C1704791,true;false;false;false;false;false;false,3888/22402
previous aorta - femoral or lower extremity bypass surgery  pta of iliac  or infrainguinal artery,C0205156;C0003483;C1552607,false;true;false,3889/22402
fracture,C0016658,true,3890/22402
clopidogrel loading dose $nmbr$ mg,C0070166;C3714444;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,3891/22402
renal insufficiency — no . ( % ),C0035078;C1565489,true;true,3892/22402
caucasian eze / simva ( „ = $nmbr$ },C0007457;C0043157,true;true,3893/22402
tg mg / dl  median ( sd ),C0337445;C0439269;C0549183;C2699239;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,3894/22402
locafon of index dvt,C0600653;C0149871;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,true;true;false;false;true;false;false;false,3895/22402
baseline nihss,C0168634;C1697238;C1442488,true;false;false,3896/22402
clinical details,C0205210;C1522508,false;false,3897/22402
limited i -,C0439801;C0021966;C0221138;C2674459;C3542948;C4050251,false;true;false;false;false;false,3898/22402
intracranial disease of major artery 寸,C0524466;C0852949;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false;false,3899/22402
mean bp ( mmhg ),C0444504;C0037623;C0439475;C1415692;C1708288;C4318478;C2347634;C2348143,false;true;false;false;false;false;false;false,3900/22402
no chd eze / simva $nmbr$ = $nmbr$ },C0280604;C3542407,false;false,3901/22402
heart rate  b . p . m . mean ± sd,C0018810;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923,true;false;false;false;false;false;false,3902/22402
estimated glomerular filtration rate - no . ( % ) : :,C3811844,false,3903/22402
moderate n z $nmbr$,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,3904/22402
central nervous system,C3540014;C3714787,false;true,3905/22402
drug - eluting stent implanted — no . ( % ),C1322815,true,3906/22402
elevated bnp ( $nmbr$ pg / ml )  %,C0205250;C0054015;C0439297;C1095989;C1417808;C2982014;C3163633,false;true;false;false;false;false;false,3907/22402
verapamil - sr strategy,C1527129;C0679199,false;false,3908/22402
baseline steroids,C0168634;C0038317;C1442488,true;true;false,3909/22402
c - reactive protein  median ( q $nmbr$  q $nmbr$ ),C0006560;C0549183;C0876920;C2347635;C2348144;C2939193;C1413716;C4048285,true;false;false;false;false;false;false;false,3910/22402
albumin measurements ^ ^,C0201838,false,3911/22402
dactylitis,C0239161,false,3912/22402
no hypertension ( n = $nmbr$ ),C0020538;C1963138,true;false,3913/22402
history of other medical conditions  n ( % ),C0262926;C0012634;C0348080;C1705253;C3864998,false;true;false;false;false,3914/22402
placebo allocation,C0032042;C1706778;C1696465;C1706408,true;false;false;false,3915/22402
cyclosporin,C0010592;C0010594,true;true,3916/22402
symptom onset to hospital arrival  hours,C4086878;C0019994;C1555577;C0439227;C1706079;C1510665,false;true;false;false;false;false,3917/22402
before amendment,C0680532;C2346732,false;false,3918/22402
baseline erosion,C0168634;C0333307;C1880549;C1959609;C3887524;C1442488,true;false;false;false;false;false,3919/22402
minimal important change threshold ( improvement ) a,C3845594;C3898777;C0449864;C2986411;C4084912,false;false;false;false;false,3920/22402
digoxin,C0012265,true,3921/22402
left ventricular ejection fraction  mean ( sd )  %,C0428772;C0444504;C2699239;C2347634;C2348143;C0488728,false;false;false;false;false;false,3922/22402
new york heart association congestive heart failure class,C1882083;C0018802,false;true,3923/22402
haemoglobin ( g / dl )  mean + sd  available for $nmbr$ patients,C1319312;C3642216;C0444504;C2699239;C2347634;C2348143;C0019046;C0439267,false;false;false;false;false;false;true;false,3924/22402
peripheral arterial revascularization,C0205100;C0003842;C0581603;C0221464,false;true;false;false,3925/22402
median daily dose - iu ™,C0549183;C2348070;C0049272;C0439453;C0694756;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false,3926/22402
hla - b $nmbr$ positive  n ( % ),C1426226;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,3927/22402
renal function ( egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C0232804;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,false;true;false;false;false;false;false,3928/22402
ldl particle numbers ( week $nmbr$ ),C2612459;C0237753;C0332174;C0439230;C0449788,false;false;false;false;false,3929/22402
serum ldl cholesterol,C0428474,false,3930/22402
all grafts,,,3931/22402
stroke thought due to atherothrombotic disease,C0038454;C4554100,true;false,3932/22402
first hhf,C0205435;C1279901,false;false,3933/22402
primary angioplasty ( n = $nmbr$ ),C0205225;C0162577;C1548817;C0439612;C0439631,false;true;false;false;false,3934/22402
atenolol strategy ( n = $nmbr$ ),C0004147;C0679199,true;false,3935/22402
prothrombin mutation ( % ),C1610621,false,3936/22402
cardiovascular risk factors and medical history,C0850624,false,3937/22402
valsartan  n ( % ),C0216784,true,3938/22402
qrs > $nmbr$ msec $nmbr$ - min walk test,C0439223;C0702093;C4277740;C1524029;C3813700,false;false;true;false;false,3939/22402
immobilization at randomization  n ( % ),C0020944;C0034656;C4048292,true;true;false,3940/22402
difference,C1705241;C1705242,false;false,3941/22402
participants n,C0679646,false,3942/22402
left ventricular ejection fraction  median ( iqr )  %,C0428772;C0549183;C0876920;C2347635;C2348144;C2939193;C0488728,false;false;false;false;false;false;false,3943/22402
associated with corrected,C0332281;C0205202,false;false,3944/22402
ckd ( egfr < $nmbr$ b ),C1561643;C1739039;C3811844;C3812682,true;true;false;false,3945/22402
lowering drugs,C0441994;C0013227;C3687832;C2003888,false;true;false;false,3946/22402
concomitant cardiovascular therapy ( taken > $nmbr$ days ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,3947/22402
post - bronchodilator fev $nmbr$ / fvc ( % ) a,C2599594;C3714541,false;true,3948/22402
no . evenls,,,3949/22402
medical treatment,C0679624,false,3950/22402
previous angina pectoris,C0205156;C0002962;C1552607,false;true;false,3951/22402
indeterminate ! !,C0205258,false,3952/22402
select lipids and lipoproteins,C1707391,false,3953/22402
$nmbr$ - year framingham chd risk,C0439234;C3166866;C1282512;C0439508,false;false;false;false,3954/22402
> q $nmbr$ ( $nmbr$ . $nmbr$ ) - q $nmbr$ ( $nmbr$ ) — number / n ( % ),C0237753;C0449788,false;false,3955/22402
egfr ( ckd - epi  cystatin c )  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C1561643;C0162734;C0071744;C0439445;C0369637;C0441923;C1413772;C4281721;C3811844;C3812682,true;true;true;true;false;false;false;false;false;false;false,3956/22402
previous receipt of therapy against tnf - a — no . ( % ),C0205156;C0039798;C0087111;C1363945;C1552607,false;true;true;false;false,3957/22402
prior to index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,3958/22402
race  % of patients,C0034510;C0030705;C1706779;C3853635,true;true;false;false,3959/22402
apo a - i  mg / dl,C0085201;C0439269;C1677784,true;false;true,3960/22402
vessel treated  n,C0005847,true,3961/22402
non - smokers receiving lipid - lowering drugs  p blockers,C0337672;C4554605,false;true,3962/22402
estrogen therapy,C0279494,false,3963/22402
haq - di total score  mean ( sd ),C3826998;C2964552;C0444504;C2699239;C2347634;C2348143;C4321476,false;false;false;false;false;false;false,3964/22402
high density lipoprotein cholesterol - mg / dl * *,C0023822;C0439269,true;false,3965/22402
systolic pulmonary arterial pressure  mean ( sd )  mm hg,C0871470;C0024109;C0444504;C2699239;C0439475;C2347634;C2348143;C2707265;C2709248;C4522268;C0039155;C1168098,true;true;false;false;false;false;false;false;false;false;true;false,3966/22402
> q $nmbr$ ( $nmbr$ ) - q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % ),C0237753;C0449788,false;false,3967/22402
das - $nmbr$ ( crp )  mean ( sd ),C0051767;C3890735;C0444504;C2699239;C2347634;C2348143;C4048285;C0057671,true;false;false;false;false;false;false;true,3968/22402
blood transfusion,C0005841;C0281867,true;false,3969/22402
partial evolving to secondarily generalized ( ic ),C0728938;C0332253;C0205246;C0020750;C4554818;C1550516,false;false;false;true;false;false,3970/22402
hscrp > $nmbr$ to < $nmbr$ mg / l,C0439268,false,3971/22402
ra symptom duration < $nmbr$ months — number ( % ),C3538806;C1457887;C0449238;C0439231;C0237753;C0449788;C2926735;C3854129;C4048756,false;false;false;false;false;false;false;false;false,3972/22402
ldl - c < $nmbr$ mg / dl,C0439269,false,3973/22402
ace / arb medication ( % ),C1452534;C3888198;C0013227;C3244316;C4284232;C4284014,true;false;true;false;false;false,3974/22402
positive family history of type $nmbr$ diabetes ( % ),C0439178;C1313937;C0332307;C1547052;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false;false;false,3975/22402
urinary albumimcreatinine ratio,C1273442,false,3976/22402
diabetes treatment,C0011847;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0011849,false;true;true;false;false;false;false;false;true,3977/22402
mucolytics,C0026698,true,3978/22402
pooled analysis,C1709595;C0002778;C0936012;C1524024;C2349200;C4522255,false;false;false;true;false;false,3979/22402
infliximab,C0666743,true,3980/22402
iduration of symptoms > $nmbr$ min,C0683368;C0702093;C1524029;C3813700;C1457887,true;false;false;false;false,3981/22402
estrogens,C0014939;C3537250;C3541386;C3714615,true;false;false;false,3982/22402
$nmbr$ mg twice daily n = $nmbr$,C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,3983/22402
major gastro - intestinal bleeding,C0205082;C0017181;C0205164;C4318856;C4521762,false;true;false;false;false,3984/22402
anti - ccp antibody positive  n ( % ),C0432633;C1525410;C0741132;C1704514,false;false;false;false,3985/22402
egfrmdrd  ml / min / $nmbr$ . $nmbr$ m $nmbr$ bsa,C0439445;C0369637;C0441923,false;false;false,3986/22402
weight > $nmbr$ kg  n ( % ),C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,3987/22402
multiple diagnoses,C0439064;C0011900,false;true,3988/22402
cholecystitis chronic,C0008325;C1963083;C4553186,true;false;false,3989/22402
baseline % bsa involvement,C0168634;C1314939;C1442488,true;false;false,3990/22402
> $nmbr$ corticosteroids or immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,3991/22402
history of atrial arrhythmia  n ( % ),C0019664;C0085611;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,3992/22402
chronic pulmonary disease,C0746102,false,3993/22402
> $nmbr$  obesity class $nmbr$,C0028754;C0456387;C1518526;C1705943;C1963185,true;false;false;false;false,3994/22402
congestive heart failure ( definite ),C0018802,true,3995/22402
average dose ( mg / week ),C1510992;C0178602;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C2825518,false;false;true;false;false;true;false;false;false;false;false;false;false;false,3996/22402
urinary albumin : creatinine ratio *,C0455271;C1318330,false;false,3997/22402
previous pci ( % total ),C0205156;C4049621;C0439175;C0439810;C1552607,false;false;false;false;false,3998/22402
highest killip classiciation pre - pci,C1522410,false,3999/22402
edss stratification  no . ( % ),C0451246;C1514983;C3887783,false;false;false,4000/22402
exenatide no . of events / total no . ( % ),C0167117,true,4001/22402
method used to diagnose the incident pulmonary embolism  no . ( % ),C0025663;C0449851;C0871511,true;false;false,4002/22402
blood glucose,C0005802,true,4003/22402
rf or acpa positive,C0035448;C0201660;C0748398;C1547111,true;false;false;false,4004/22402
congestive heart failure — no . ( % ),C0018802,true,4005/22402
mean ucsd - sobq score * ( sd ),C3533236;C2699239,false;false,4006/22402
morphine use for index event / pci,C0242000;C0600653;C0441471;C4049621;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;false;true;false;false;false,4007/22402
albumin - to - creatinine ratio,C0486293;C1318293,false;false,4008/22402
region  north america,C0017446;C0028405;C0205147,true;true;false,4009/22402
medical therapy alone,C0418981,false,4010/22402
continuation,,,4011/22402
$nmbr$ ( fevi $nmbr$ - < $nmbr$ % pred ),C0849974;C1561566;C4528367,false;false;false,4012/22402
a $nmbr$ s - hydroxy -,C0700307,false,4013/22402
qrs interval > $nmbr$ msec — no . ( % ),C0520880;C0439223,false;false,4014/22402
streptokinase,C0038418,true,4015/22402
haq - di improvement > $nmbr$ . $nmbr$,C3826998;C2986411;C4321476,false;false;false,4016/22402
baseline cv treatment  n ( % ) y,C0168634;C3538987;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4048877;C4318503;C1442488,true;false;true;true;false;false;false;false;false;true;false;false,4017/22402
adalimumab croup  n / n ( % ),C1122087;C0010380,true;true,4018/22402
apob ( week $nmbr$ ),C0003593;C0332174;C0439230;C3252643,true;false;false;true,4019/22402
systemic arterial hypertension  n ( % ),C0020538,true,4020/22402
reversibility to salbutamol  %,C1271924,false,4021/22402
overall  male : female,C0282416;C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1561607,true;true;true;true;false;false;false;false;false;false,4022/22402
$nmbr$ p value,C1709380,false,4023/22402
evolocumab ( $nmbr$ mg ),C3529352;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4024/22402
bifurcation lesion,C0184906;C0221198;C1546698;C3146289,false;false;false;false,4025/22402
time from onset of symptoms to randomization — days,C1320528,false,4026/22402
thiazide at last follow - up,C0541746;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,4027/22402
% change median baseline crp > $nmbr$ mg / l,C0392747;C0443172;C1705241;C4319952,false;false;false;false,4028/22402
blood pressure systolic  mm hg,C0005823;C0039155;C0439475;C1271104;C1272641,true;true;false;false;true,4029/22402
hf hospitalizations  median ( iqr ),C0018488;C0019993;C0549183;C0876920;C2347635;C2348144;C2939193;C1313497;C1538440;C3273279,true;true;false;false;false;false;false;true;false;false,4030/22402
history of carotid artery disease,C0019664;C0007273;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,4031/22402
history of diabetes mellitus,C0455488,false,4032/22402
prior treatment history $nmbr$,C1514463;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,4033/22402
patients with bw decrease of $ $nmbr$ % in patients with baseline bmi of $ $nmbr$ kg / m $nmbr$ +,C0030705;C0005910;C0392756;C0547047;C0006041;C2986891,true;true;false;false;true;false,4034/22402
interaction $nmbr$,C1704675,false,4035/22402
no history of migraine,C0455512,false,4036/22402
mild ( gold $nmbr$ ),C2945599;C0018026;C1304897,false;true;false,4037/22402
iii : fev $nmbr$ > $nmbr$ % - < $nmbr$ % predicted,C0439070;C3714541;C1705160,false;true;false,4038/22402
cat score category,C0007450;C0449820;C0683312;C3889287;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;false;false;false;true;false;false;false;false,4039/22402
baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$,C0168634;C0578022;C1532718;C1442488,true;false;false;false,4040/22402
statin only,C0360714;C0205171;C1720467,true;false;false,4041/22402
drug therapy at admission 一 no . ( % ) aspirin,C0013216;C0184666;C0809949;C0013217,true;false;false;true,4042/22402
fatty acid profile,C0015684;C1979963;C2003903,true;false;false,4043/22402
residual deep - vein thrombosis  no . ( % ),C1609982;C0149871,false;true,4044/22402
unstable angina  n ( % ),C0002965,true,4045/22402
completed trial,C0205197;C0008976;C3854010,false;true;false,4046/22402
duration of symptoms  h,C0436359;C0033727;C0369286;C0441932;C0564385;C4528284,false;true;false;false;false;false,4047/22402
% predicted ” fev  at baseline  % *,C0681842;C3714541;C0168634;C1442488;C1882327,false;true;true;false;false,4048/22402
aspirin dose at randomization,C4696290;C0034656,false;true,4049/22402
normoglycemia ^,C0580545,false,4050/22402
race / ethnicity,C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,4051/22402
oral antidiabetic drugs,C0029167;C0935929;C0175795;C0304289;C0442027;C4521986,true;true;false;false;false;false,4052/22402
ef $nmbr$ - $nmbr$ % hfmref ( n = $nmbr$  $nmbr$ % ),,,4053/22402
cerebral embolism,C0007780,true,4054/22402
fev $nmbr$ / fvc prebronchodilatort,C3714541,true,4055/22402
previous use of antiplatelet drugs,C0205156;C1524063;C0085826;C2963157;C1552607,false;false;true;false;false,4056/22402
laba non - users,C1518422;C1706077,false;false,4057/22402
thiazolidinedione based,C0289779;C1257987;C3537039,true;true;false,4058/22402
chronic respiratory failure,C0264492,false,4059/22402
coronary artery disease history,C0010054;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0010068;C1956346,true;true;true;false;false;false;false;true;true,4060/22402
current prescribed medications,C0521116;C3166216;C3202967;C1705970,false;false;false;false,4061/22402
current weekly alcohol use ( % ),C0521116;C0332174;C0001948;C1705970,false;false;true;false,4062/22402
calcium ( mmol / l ),C0006675;C1532563;C0006726;C2936886;C3540037;C3714611,true;false;true;false;false;false,4063/22402
region ( pooled ),C0017446;C0205147,true;false,4064/22402
bdmard - naive,,,4065/22402
general andthoracic epidural,C0205246;C0228134;C0812144;C3812897;C3891294;C4521767,false;true;false;false;false;false,4066/22402
first co - primary outcome,C0205435;C3245499;C0205225;C1274040;C0439612;C0439631;C1279901,false;true;false;false;false;false;false,4067/22402
cvd  mi  stroke  or recurrent ischemia - urgent revascularization  or hospitalization for unstable angina,C0007222;C3810814;C0038454;C4554100,true;false;true;false,4068/22402
age at enrolment  years,C1510829;C1516879;C1696073;C3888021,false;false;false;false,4069/22402
not available,C0686905,false,4070/22402
use of antiplatelet agents ^,C1524063;C0085826,false;true,4071/22402
aspirin or thienopyridines ( % ),C0004057,true,4072/22402
baseline trig > $nmbr$ millycerides g / dl,C0168634;C0202236;C0439267;C1519533;C1442488,true;false;false;false;false,4073/22402
baseline anti - hypertensive usea,C0168634;C0003364;C1442488,true;true;false,4074/22402
intent - to - treat population  n ( % ),C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C1550453,true;true;true;true;false;false;false;false,4075/22402
dyslipidaemia and hypertension  n ( % ),C0242339,true,4076/22402
saxa $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,4077/22402
estimated response rate and odds ratio,C0750572;C0237629,false;false,4078/22402
first loading dose,C0205435;C3714444;C1279901,false;false;false,4079/22402
ex - smokers $nmbr$,C0337671;C4555205,false;true,4080/22402
atrial fibrillation ldl cholesterol level,C0004238;C0023824;C0441889;C0456079;C1547707;C2946261;C0202117;C0344434;C1963067,true;true;false;false;false;false;false;false;false,4081/22402
duration of,C0449238;C2926735,false;false,4082/22402
weight ab  %,C0005910;C0043100;C1305866;C1705104,true;true;false;false,4083/22402
race or ethnic group — no . / total no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,4084/22402
loop at enrollment,C0445022;C1516879;C1696073;C3888021,false;false;false;false,4085/22402
current cigarette use  n ( % ),C0521116;C0694535;C1705970,false;false;false,4086/22402
central europe,C0682369,false,4087/22402
atopic ( based on phadiatop test ),C0392707,false,4088/22402
baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$ change from baseline to $nmbr$ weeks,C0168634;C0578022;C1532718;C0392747;C0443172;C1705241;C4319952;C1442488,true;false;false;false;false;false;false;false,4089/22402
kccq ( $nmbr$ months ),C3476798;C0439231,false;false,4090/22402
mean eq - $nmbr$ d response ( $nmbr$ % ci ),C0444504;C0205163;C0871261;C0008107;C3259781;C1704632;C1706817;C2911692;C0439185;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,4091/22402
tp vs no tp,C0036183;C3541334,true;false,4092/22402
mitral insufficiency,C0026266,true,4093/22402
r $nmbr$ mg + fa,C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,4094/22402
total study population,C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,4095/22402
subacute ( $nmbr$ - $nmbr$ days ),C0205365;C0439228,false;false,4096/22402
assoc  with corrected congenital shunts,C0205202;C0009678;C0232180;C0542331;C1442858;C1744681,false;true;false;false;false;false,4097/22402
spinal fractures,C0080179;C0518450,true;false,4098/22402
multivessel disease  n ( % ),C0012634,true,4099/22402
normoalbuminuria or microalbuminuria,,,4100/22402
low ( no risk factor ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,4101/22402
hospitalisation for chf within $nmbr$ years of randomisation,C0019993;C0018802,true;true,4102/22402
rec . ischemia due to ecg changes,C1424025;C0022116;C0678226;C1623258;C4321499;C2606415,false;true;false;true;false;true,4103/22402
event / patients ( $nmbr$ / pt - y ),C0441471;C0030705;C0032743;C0699718;C4019010,false;true;true;false;false,4104/22402
calcium - channel antagonists,C0006684;C2757014,true;false,4105/22402
angiotensin receptor,C0034787;C1622222,true;true,4106/22402
dbp  mean ( sd )  mm hg glycaemic parameters,C0536221;C0444504;C2699239;C0439475;C0005802;C0449381;C2347634;C2348143;C3813197;C4281799,true;false;false;false;true;false;false;false;false;false,4107/22402
priorother ( predefined ) medical conditions,,,4108/22402
t $nmbr$ lesion volume  mm $nmbr$,C2603360;C0221198;C0449468;C4330985;C4554674;C1690016;C1705102;C2700258;C1546698,false;false;false;false;false;false;false;false;false,4109/22402
african - american / african heritage ( n = $nmbr$ ),C0085756;C2986513,true;false,4110/22402
new anti - anginal therapy,C3242274;C1874267;C3537168,false;false;false,4111/22402
smoking : current smoker,C0037369;C0453996;C1881674,true;true;false,4112/22402
total cataract,C3665439,false,4113/22402
no . of patients ( % ),C0030705,true,4114/22402
ami $nmbr$ mg n = $nmbr$,C4319936;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,4115/22402
baseline lvef,C0168634;C0428772;C0488728;C1442488,true;false;false;false,4116/22402
change from baseline stage $nmbr$ ckd,C0168634;C0597205;C1561643;C0679846;C1442488,true;false;true;false;false,4117/22402
indacaterol group ( n = $nmbr$ ),C1722260;C0441848,true;false,4118/22402
iv : fev $nmbr$ < $nmbr$ % predicted,C0022326;C3714541;C4265176,true;true;false,4119/22402
education $nmbr$ - $nmbr$ years,C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,4120/22402
waist circumference,C0455829,true,4121/22402
hispanic — no . ( % ),C0086409,true,4122/22402
> $nmbr$ . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,4123/22402
rituximab  n = $nmbr$,C0393022,true,4124/22402
stroke  n ( % ),C0038454;C4554100,true;false,4125/22402
family history of premature,C0241889;C0151526;C0205252;C4018905,true;true;false;false,4126/22402
change in bp  mm hg,C1268766;C0439475,false;false,4127/22402
nonfatal ischemic stroke,C0948008,false,4128/22402
pci delay due to low risk,C4049621,false,4129/22402
prior percutaneous coronary intervention,C0332152;C1532338;C2826257,false;true;false,4130/22402
oral anticoagulant agent,C0354604,false,4131/22402
alcohol intake ( a ),C0001948,true,4132/22402
hba $nmbr$ c subgroups,C0019016;C1079230;C1825777;C3538758,true;false;false;false,4133/22402
history of atherosclerotic vascular disease — no . ( % ) §,C0683519;C0333482;C0005847;C1558950;C1801960;C0730226;C0850708;C0944983,false;false;true;false;false;false;false;false,4134/22402
renal function : creatinine clearance,C0232804;C0812399,false;false,4135/22402
mercaptopurine,C0000618,true,4136/22402
transient monocular blindness,C0149793,true,4137/22402
nyha functional class  n ( % ),C1882083;C0205245;C0542341;C2700217,false;false;false;false,4138/22402
entire cohort gender,C0439751;C0009247;C0079399;C1522384;C0599755;C0444667,false;true;true;true;false;false,4139/22402
inhaled §,C0004048,true,4140/22402
patient global assessment of pain ( vas $nmbr$ - $nmbr$ mm ),C4054229;C0042815;C4330985;C4554674,false;true;false;false,4141/22402
rituximab ( $nmbr$ x $nmbr$ mg ) + mtx ( n = $nmbr$ ),C0393022;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,4142/22402
peripheral artery revascularization without amputation,C0489868;C0581603;C0002688;C0332840;C1546539,false;false;true;false;false,4143/22402
other cause  n ( % ),C0015127;C1524003,true;false,4144/22402
immunosuppressants and antimalarials only,C0021081,true,4145/22402
* * positive stress test,C0439178;C0015260;C3494508;C1446409;C1514241;C2825490;C3812269,false;true;true;false;false;false;false,4146/22402
aspirin use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,4147/22402
randomisation scheme,C0034656;C1519193,true;false,4148/22402
ala carriers,C0523459;C0007294;C3888236,false;true;false,4149/22402
arterial hypertension — no . ( % ),C0020538,true,4150/22402
bmi ( median  iqr )  kg / m $nmbr$,C0578022;C0549183;C1532718;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,4151/22402
alternative disability,C1523987;C0231170,false;false,4152/22402
non - hdl cholesterol / apob ( ratio ),C0729627;C0003593;C0456603;C1547037;C3252643;C1535899;C1518422;C2938854,false;true;false;false;true;false;false;false,4153/22402
other risk factors,C0035648;C1553898,true;false,4154/22402
hf hospitalization or cardiovascular death,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,4155/22402
no revascularization for index acs event,C0581603;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false;true;false;false;false,4156/22402
p - value for variance,C1709380;C1711260;C2348152,false;false;false,4157/22402
apo b  mean ( sd )  mg / dl,C0003593;C0444504;C2699239;C0439269;C2347634;C2348143;C3252643,true;false;false;false;false;false;true,4158/22402
at ldl - c ( bq ) goal * at baseline - no . ( % ),C0560038;C0018017;C0168634;C1442488;C1571704;C3541236,false;true;true;false;false;false,4159/22402
missing data initial diagnosis — no .,C4684714;C0205265;C0011900;C1704338;C1704656;C1279901;C1555582;C1705685,false;false;true;true;false;false;false;false,4160/22402
aspirin at enrollment,C0004057;C1516879;C1696073;C3888021,true;false;false;false,4161/22402
prespecified analysis,C0002778;C0936012;C1524024,false;false;true,4162/22402
k ( rate ),C0597277;C0871208;C1521828;C1708601,false;false;false;false,4163/22402
r | r ' ' ' ( $nmbr$ % ci ),C0205090;C0008107;C3259781;C0684010;C2603358,false;true;false;true;false,4164/22402
glyburide dose duringthe study ( mg ),C0017628;C0178602;C0557651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2603343;C0869039;C1114758,true;false;false;true;true;false;false;false;false;false;false;false;false,4165/22402
ptca / cabg,C2936173;C0010055,true;true,4166/22402
score  %,C0449820;C4050231,false;false,4167/22402
seizure types reported during baseline  b n ( % ),C0036572;C0332307;C1959629;C4553401,true;false;false;false,4168/22402
biologic therapeutic failure,C0005515;C0087111;C0231174;C0680095;C0302350;C0205460,true;true;false;false;false;false,4169/22402
simva ( „ = $nmbr$ },,,4170/22402
partial mayo score  mean ( sd ),C0728938;C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578;C1550516,false;false;false;false;false;false;false;false;false;false,4171/22402
selected clinical characteristics — no . / total no . ( % ),C1707391;C0683325,false;false,4172/22402
. $nmbr$ . $nmbr$ ml / s / m $nmbr$ ( $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  n ( % ),C0439445;C0369637;C0441923,false;false;false,4173/22402
prior use of conventional dmards only ( biologic - nai ' ve )  n ( % ),C0332152;C1524063;C0439858;C0205171;C4055380;C3537218;C0042469;C3714652;C4321495;C1720467;C2826257,false;false;false;false;false;false;true;false;false;false;false,4174/22402
family history  n ( % ),C0241889,true,4175/22402
patients with diabetes mellitus,C0030705;C0011849,true;true,4176/22402
thiazolidinedione ( includes pioglitazone ),C0289779;C1257987;C3537039,true;true;false,4177/22402
corticosteroids and antimalarials only,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,4178/22402
total pack - years mean ( sd ),C0439175;C1277691;C0444504;C2699239;C2347634;C2348143;C0439810,false;false;false;false;false;false;false,4179/22402
medications at study entry — no . / total no . ( % ),C0013175;C1705654,true;false,4180/22402
gold iii - iv,C0018026;C0439070;C0022326;C4265176;C1705160;C1304897,true;false;true;false;false;false,4181/22402
reason for enrollment in active a,C0392360;C1516879;C1696073;C3888021,false;false;false;false,4182/22402
asia / australia / new zealand,C0003980;C4289954,true;false,4183/22402
octave induction $nmbr$,C0205263;C0857127,false;false,4184/22402
tachyarrhythmias  n ( % ),C0080203,true,4185/22402
europe n z $nmbr$,C0015176,true,4186/22402
atrial fibrillation alone ),C0004238;C0344434;C1963067,true;false;false,4187/22402
supraventricular tachyarrhythmias ( incl . atrial,C1698480;C3853833,false;false,4188/22402
previous cerebrovascular event,C0205156;C1880018;C0441471;C4019010;C1552607,false;false;false;false;false,4189/22402
stroke — no . ( % ),C0038454;C4554100,true;false,4190/22402
bronchodilator response  ml,C0006280;C0871261;C0439526;C1705224;C3887665;C1704632;C1706817;C2911692,true;false;false;false;false;false;false;false,4191/22402
$nmbr$ ( fevi ^ $nmbr$ % pred ),C0849974;C1561566;C4528367,false;false;false,4192/22402
mental component,C0229992;C0449432;C1705248,false;false;false,4193/22402
apo a - l ( g / l ),C0628062,true,4194/22402
veflonzumao,,,4195/22402
pfo with large shunt and atrial septal aneurysm,C0549177;C0232180;C0542331;C1442858,false;false;false;false,4196/22402
classification of index venous thromboembolism — no . ( % ),C0008902;C0600653;C1997614;C0918012;C1552854;C1637833;C2986546;C0008903;C0678229,true;true;false;true;false;false;false;true;false,4197/22402
fev $nmbr$ at baseline,C3714541;C0168634;C1442488,true;true;false,4198/22402
incidence rate per $nmbr$ person - years,C1708485;C0027361;C0439234;C2347489,false;true;false;false,4199/22402
time of randomization ( interaction : p = $nmbr$ . $nmbr$ ),C0040223;C0034656;C1704675;C3541383,true;true;false;false,4200/22402
chronic renal failure  n ( % ),C0022661;C1561643;C2316810,true;true;false,4201/22402
both deep - vein thrombosis and pulmonary embolism,C0149871,true,4202/22402
myocardial infarction without st - segment elevation — no . ( % ),C1536220,true,4203/22402
pooled eze / simva,C1709595;C2349200;C4522255,false;false;false,4204/22402
other sglt - $nmbr$ inhibitor,C1999216,false,4205/22402
clavicle fracture,C0159658,false,4206/22402
ecg abnormality ( resting )  %,C1623258;C1704258,true;false,4207/22402
musculoskeletal stiffness,C0497254;C0427008;C2707260,false;false;false,4208/22402
psoriatic arthritis  %,C0003872,true,4209/22402
medication prior to admission  ( % ),C0013227;C0332152;C0184666;C0809949;C3244316;C4284232,true;false;false;false;false;false,4210/22402
death / st,C0011065;C0036056;C3272372;C1306577;C4082313;C4552775,true;true;false;false;false;false,4211/22402
bdi focal score,C0006448;C0205234;C0449820;C4050231;C0451022;C3714938;C3889415,true;false;false;false;false;false;false,4212/22402
time to randomisation [ hours ] ( interaction : p = $nmbr$ . $nmbr$ ),C0040223;C0034656;C0439227;C1704675;C3541383,true;true;false;false;false,4213/22402
laboratory examination,C0260877,false,4214/22402
placebo patients with events,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,4215/22402
organ system involvement  no . ( % ),C0460002;C1314939,false;false,4216/22402
enalapril lcz $nmbr$ ( n = $nmbr$ ) ( n = $nmbr$ ),C0014025,true,4217/22402
high - dose statin,C0444956;C0360714,false;true,4218/22402
peripheral,C0205100,false,4219/22402
ldl cholesicrol ( minol / l ),,,4220/22402
hispanic / latino ethnicity  n ( % ),C0086409;C0086528;C0015031;C0243103,true;true;true;true,4221/22402
$nmbr$ - $nmbr$ drinks,C0452428,false,4222/22402
aborted cardiac arrest,C1550015;C1609614;C4085625;C4318470,false;false;false;false,4223/22402
baseline crp < $nmbr$ mg / l,C0168634;C3890735;C0439268;C4048285;C1442488,true;false;false;false;false,4224/22402
relative risk reduction ( $nmbr$ % cl ) percent,C0242492;C0301630;C0596019;C0439165;C0392756;C1293152;C4551656;C0080103;C1137094;C0205345;C1547039,true;false;false;false;false;false;false;true;true;false;false,4225/22402
unprotected left main stented,C0205091;C0205225;C0038257;C1542147;C0443246;C1552822,false;false;true;false;false;false,4226/22402
catheterization performed for qualifying event,C0007430,true,4227/22402
fraction ( % ),C1264633;C1554103,false;false,4228/22402
$nmbr$ % ci for difference,C0008107;C1705241;C1705242;C3259781,true;false;false;false,4229/22402
index event to randomization  median ( iqr )  h,C0600653;C0441471;C0034656;C0549183;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;true;false;true;false;false;false;false;false;false;false;false;false;true;false;false;false,4230/22402
inclusion criteria — no . ( % ),C1512693,false,4231/22402
normal hscrp,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,4232/22402
^ $nmbr$ - cell function — % §,C0007613,true,4233/22402
previous tnf - antagonist use  n ( % ),C0205156;C1448177;C0231491;C0042153;C0457083;C1947944;C1552607,false;true;false;true;false;false;false,4234/22402
depressed only,C0344315;C0549249,false;true,4235/22402
acute infection without septic shock,C0275518;C0036983,false;true,4236/22402
mtss units,C0439148;C1519795;C3853603,false;false;false,4237/22402
previous statin use,C0205156;C0360714;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,4238/22402
mean ( s . d . ) calculated ldl cholesterol,C0444504;C2347634;C2348143,false;false;false,4239/22402
$nmbr$ % confidence interval,C0009667,true,4240/22402
type of concomitant statin by daily dose,C0332307;C0521115;C0360714;C1547052,false;false;true;false,4241/22402
statin with ezetimibe,C0360714;C1142985,true;true,4242/22402
history of ml or ischemic stroke,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,4243/22402
within $nmbr$ h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,4244/22402
placebo n = $nmbr$ n ( % ),C0032042;C1696465;C1706408,true;false;false,4245/22402
nyha class not reported,C1882083,false,4246/22402
neither uh or lmw heparin,,,4247/22402
fpg tx difference vs pbo  median change from baseline ( se ) $nmbr$,C0041403;C1705241;C1705242,true;false;false,4248/22402
iglarlixi ( fixed - ratio combination ),C0443218;C0456603;C0205195;C1947911;C3811910;C1547037;C2827483;C3714578,false;false;false;false;false;false;false;false,4249/22402
previous congestive heart failure,C0205156;C0018802;C1552607,false;true;false,4250/22402
periostin ( ng / ml ),C0219433;C0439275;C1424662;C3812270,true;false;false;false,4251/22402
belimumab $nmbr$ mg sc ( n $nmbr$ ),C1723401;C0024671;C0282380;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,4252/22402
glycatedhemoglobin category  %,C0683312;C3889287,false;false,4253/22402
canvas - r,C3281223;C0205090;C0684010;C2603358,false;false;true;false,4254/22402
waist circumference  cm mean ( sd ),C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,4255/22402
tg > $nmbr$ . hdl < $nmbr$ ( mg / dl ) ( / ? = $nmbr$ ),C0337445;C3715113;C0439269,false;false;false,4256/22402
africa  asia  or the middle east,C0001737;C0003980,true;true,4257/22402
history of gestational diabetes mellitus — no . ( % of women ),C2183115,false,4258/22402
non - black race ( n = $nmbr$ vs $nmbr$ ),C1518422;C0005680,false;true,4259/22402
community hospital,C0020003,true,4260/22402
not - japan n = $nmbr$  $nmbr$,C1518422;C0022341,false;true,4261/22402
stage > $nmbr$ chronic kidney disease ( % ),C0205390;C1300072;C1306673,false;false;false,4262/22402
$nmbr$ - hr plasma glucose — mg / dl,C0202042;C0439269;C0455280,false;false;false,4263/22402
not at goal,C1518422;C0018017;C1571704,false;true;false,4264/22402
concomitant aminosalicylates  n [ % ] concomitant corticosteroids  n [ % ] mayo score  mean [ sd ],C0521115;C0368663;C0001617;C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578;C3539185;C3540725;C3540726;C3540727,false;false;true;false;false;false;false;false;false;false;false;false;false;false;false,4265/22402
baseline fecal caicrctectin,C0168634;C0015733;C1442488,true;true;false,4266/22402
hospitalization for unstable angina,C0019993;C0002965,true;true,4267/22402
patients having exacerbation,C0030705,true,4268/22402
regular alcohol consumption per week  no . ( % ),C0205272;C0001948;C0332174;C0439230,false;true;false;false,4269/22402
improving anemia bsl hb < $nmbr$ g i - $nmbr$  yr $nmbr$ > $nmbr$ g i - $nmbr$,C1272745;C0002871;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138;C1000483;C4554633,false;true;false;true;false;true;false;false;false;false,4270/22402
qualifying peripheral arterial disease,C1514624,false,4271/22402
previous bypass surgery  n ( % ),C0205156;C1536078;C1552607,false;false;false,4272/22402
anthropometric characteristics,C0003188;C1521970,true;false,4273/22402
baseline fev $nmbr$  l *,C0168634;C3714541;C1442488,true;true;false,4274/22402
$nmbr$ - lead ecg heart rate  beats / min,C0179504;C0018810,false;true,4275/22402
aspirin + dipyridamole ( n = $nmbr$ ),C0732279,true,4276/22402
patients entering pt period n = $nmbr$,C0030705,true,4277/22402
surgical technique,C0683469,false,4278/22402
psoriatic arthropathy,C0003872,true,4279/22402
with alogliptin $nmbr$ mg,C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4280/22402
revascularisation but no antiplatelets  lipid - lowering agents  or p blockers,C0581603,false,4281/22402
pfo with large shunt without atrial septal aneurysm,C0549177;C0232180;C0542331;C1442858,false;false;false;false,4282/22402
clinical and patient - reported characteristics at baseline and randomization,C0205210,false,4283/22402
or ( unadjusted ),,,4284/22402
unknown or missing,C0439673;C3541433;C4050014,false;false;false,4285/22402
reported high cholesterol ' !,C0684224;C0020443;C1522133;C0700287;C4319718,true;true;false;false;false,4286/22402
syndecan - $nmbr$ ( ng / ml ),C0075691;C0439275;C1419891,true;false;false,4287/22402
long - acting,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,4288/22402
use of antiarrhythmic agent,C1524063;C0003195;C0301380,false;true;false,4289/22402
egfr using cg / mdrd formulae  % of patients,C1739039;C3811844;C3812682,true;false;false,4290/22402
baseline body mass index,C0168634;C0005893;C0578022;C1305855;C1442488,true;false;false;true;false,4291/22402
swollen - joint count ( of $nmbr$ joints ),C0451521,false,4292/22402
region  n ( % ),C0017446;C0205147,true;false,4293/22402
> $nmbr$ - $nmbr$ mg / week,C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;false;false;false;false,4294/22402
hypertension $nmbr$ ( % ),C0020538;C1963138,true;false,4295/22402
psa - modified total shs,C3810537;C3813209,false;false,4296/22402
minor ischaemic stroke,C0026193;C0948008;C0205165,true;false;false,4297/22402
annualized rate ind / gly sfc,C0871208;C4049864;C0017890;C4521536;C0523677;C1521828,false;false;true;false;false;false,4298/22402
sulfasalazine,C0036078,true,4299/22402
mean change at week $nmbr$,C0444504;C0392747;C0332174;C0439230;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false,4300/22402
acpa positive ( > $nmbr$ iu / ml )  n ( % ),C1525410;C0439178;C0439458;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false;false,4301/22402
history of stroke $nmbr$,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4302/22402
long - term warfarin ( n - $nmbr$ ),C0443252;C0043031,false;true,4303/22402
crp ( mg / l )  median ± sd,C3890735;C0439268;C0549183;C2699239;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false;false,4304/22402
obese ( > $nmbr$ kg / m $nmbr$ ),C0028754;C1532718,true;false,4305/22402
facit - fatigue . mean $nmbr$ sd ( range $nmbr$ - $nmbr$ ),C3476791;C0015672;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143;C3463815;C4050243;C4554645,false;true;false;false;false;false;false;false;false;false;false;false,4306/22402
infarct location ( interactsn $ : p = $nmbr$ . $nmbr$ ),C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,4307/22402
not hospitalized for heart failure in the year prior to study enrollment,C1518422,false,4308/22402
calcification  n ( % ),C0006660;C0006663;C0175895;C1533591;C1879982;C2242558,true;true;false;false;false;false,4309/22402
all ischemic stroke,C0948008,false,4310/22402
rosuvastatin  n ( % ),C0965129,true,4311/22402
hormone replacement therapy use,C0282402;C0042153;C0457083;C1947944,true;true;false;false,4312/22402
older than $nmbr$ years,C0580836;C0439234,false;false,4313/22402
rolofylline,C0166128,true,4314/22402
apo a - $nmbr$  mean ( sd )  mg / dl,C0003592;C0444504;C2699239;C0439269;C2347634;C2348143;C0523508;C4553344;C4553379,true;false;false;false;false;false;false;false;false,4315/22402
long - term antiplatelet therapy,C0443252;C1096021,false;false,4316/22402
prior bypass graft surgery,C0455610;C0185098,false;false,4317/22402
bone erosion ( judged by physician )  n ( % ),C0587240,false,4318/22402
triglyceride ( mm,C0041004;C4330985;C4554674,true;false;false,4319/22402
cigarettesmoking  %,,,4320/22402
pentraxin - $nmbr$ ( ng / ml ),C0439275,false,4321/22402
tnfi exposed,,,4322/22402
history of atrial fibrillation  n ( % ),C0729790,false,4323/22402
asa or antiplatelet agent,C0004057;C3853627,true;false,4324/22402
ischemic stroke ( vs . tia ),C0948008,false,4325/22402
men : women ( % ),C0025266;C0043210,true;true,4326/22402
patients not treated with statins ( n = $nmbr$ ),C0030705,true,4327/22402
severe renal impairment,C0205082;C1565489;C4050465;C4050466,false;true;false;false,4328/22402
om $nmbr$ mg / aml $nmbr$ mg / hctz $nmbr$ mg,C0028971;C1319635;C0023465;C0020261;C0023467;C1705272,true;false;true;true;true;false,4329/22402
history of atrial fibrillation,C0729790,false,4330/22402
corticosteroid use at baseline,C0239126;C0168634;C1442488,false;true;false,4331/22402
sedentary,C0205254,false,4332/22402
no . of patients ( indacaterol / placebo ),C0030705;C1722260;C0032042;C1696465;C1706408,true;true;true;false;false,4333/22402
insulin plus oral,C0021641;C0442027;C4521986;C1533581;C1579433;C3714501,true;false;false;false;false;false,4334/22402
> $nmbr$ . $nmbr$  n ( % ),C0369718;C0441922,false;false,4335/22402
ics use  %,C0815320;C4551720,false;true,4336/22402
age category ( years )  n ( % ),C1510829;C0683312;C3889287,false;false;false,4337/22402
atherosclerotic disease ( % ),C0333482;C0012634,false;true,4338/22402
copd duration  y,C0024117;C0449238;C2926735;C1412502;C3714496,true;false;false;false;false,4339/22402
thrombolytic therapy,C0040044,true,4340/22402
acpa positive  n ( % ),C1525410;C0439178;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false,4341/22402
baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$ change from baseline to $nmbr$ weeks,C0168634;C0578022;C1532718;C0392747;C0443172;C1705241;C4319952;C1442488,true;false;false;false;false;false;false;false,4342/22402
acei vs . non - acei,,,4343/22402
risk factors for atherosclerosis,C0035648;C0003850;C0004153;C1553898,true;true;true;false,4344/22402
bifurcation lesion with side branch $ $nmbr$ . $nmbr$ mm stented,C0184906;C0221198;C0441987;C0205384;C4330985;C4554674;C1253959;C1881507;C2700383;C2826234;C1546698;C3146289,false;false;false;false;false;false;false;false;false;false;false;false,4345/22402
fevi  % predicted *,C0849974;C1561566;C4528367,false;false;false,4346/22402
heart rate at rest in the supine position ( beats / min ),C0018810;C0035253;C1622890,true;true;false,4347/22402
feno $nmbr$ mg / eze $nmbr$ mg ( n = $nmbr$ ),C1319635,false,4348/22402
mean ( s . d . ) total pcsk $nmbr$  ng / ml,C0444504;C0439175;C0439275;C0439810;C2347634;C2348143,false;false;false;false;false;false,4349/22402
baseline cdai score  mean ( sd ),C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,4350/22402
severity of copd  combined assessment  n ( % ),C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,4351/22402
ambulance ( % ),C0002422;C3846685,true;false,4352/22402
estimated means and difference,C0750572;C1704970,false;false,4353/22402
concomitant medication ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,4354/22402
qualifying atherosclerosis,C1514624;C0003850;C0004153,false;true;true,4355/22402
ada impaired fasting glucose,C1060325;C1272092;C3811629,false;false;false,4356/22402
death  q wave mi or ischemia - driven revasc,C0011065;C0861151;C1306577;C4082313;C4552775,true;false;false;false;false,4357/22402
stented vessels,C0183521,false,4358/22402
diabetes duration  n ( % ),C0011847;C0449238;C2926735;C0011849,false;false;false;true,4359/22402
tender - joint count  of $nmbr$ joints examined,C0451530,false,4360/22402
verapamil sr,C1527129,false,4361/22402
thiazolidinedione 一 no . ( % ),C0289779;C1257987;C3537039,true;true;false,4362/22402
difference  % median,C1705241;C0549183;C0876920;C2347635;C2348144;C2939193;C1705242,false;false;false;false;false;false;false,4363/22402
edema  ( % ),C0013604;C1717255,true;false,4364/22402
medications on admission  %,C0013227;C0802604;C2598133;C4284232,true;false;false;false,4365/22402
rf positive ( > $nmbr$ iu / ml )  n ( % ),C0035448;C0439178;C0439458;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false;false,4366/22402
worsening heart failure,C0332271;C0018801;C0018802;C4554158;C1457868;C1546960,false;true;true;false;false;false,4367/22402
previous limb or foot amputation,C0205156;C0015385;C1552607,false;true;false,4368/22402
alcohol consumption ( % ),C0001948,true,4369/22402
uacr  mgg $nmbr$ ( gm ),C0017480;C3854019,true;true,4370/22402
om $nmbr$ / aml $nmbr$ /,C0028971;C0023465;C0023467;C1705272,true;true;true;false,4371/22402
hypertension history,C0020538;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1963138,true;true;true;false;false;false;false;false,4372/22402
swollen - joint count  of $nmbr$ joints examined,C0451521,false,4373/22402
racial group  n ( % ),C0034510;C0441848;C1706779;C3669213;C3853635,true;false;false;false;false,4374/22402
$nmbr$ to < $nmbr$ ml per $nmbr$ - $nmbr$ m $nmbr$,C0439526;C0369637;C0441923;C1705224;C3887665,false;false;false;false;false,4375/22402
risk factors,C0035648;C1553898,true;false,4376/22402
deep vein thrombosis only,C0149871;C0205171;C1720467,true;false;false,4377/22402
within last $nmbr$ d,C1517741,false,4378/22402
egfr at baseline  $nmbr$ ml / min ( % ) b,C1739039;C0168634;C0439445;C1442488;C3811844;C3812682,true;true;false;false;false;false,4379/22402
low - density lipoprotein cholesterol  mean ( sd )  mmol / l,C0023824;C0444504;C2699239;C1532563;C2347634;C2348143,true;false;false;false;false;false,4380/22402
intermediate,C0205103;C1550465;C2827755;C3889971,false;false;false;false,4381/22402
duration of hypertension ( months ),C0449238;C0020538;C0439231;C1963138;C2926735,false;true;false;false;false,4382/22402
wap $nmbr$ c ( ng / ml ),C0439275,false,4383/22402
left circumflex artery  n ( % ),C0226037,false,4384/22402
fpg  median ( ql  q $nmbr$ )  mmol / l,C0549183;C1532563;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4385/22402
ischaemic cause,C0475224;C0015127;C1524003,false;true;false,4386/22402
total cholesterol > $nmbr$ mg / dl,C0201950;C0439269;C0543421,false;false;false,4387/22402
intention - to - treat,C0162425;C1283828,true;false,4388/22402
enoxaparin / vka n / n ( % ) $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ),C0206460,true,4389/22402
in - stent restenosis,C3272317,false,4390/22402
high risk without atherosclerotic vascular disease +,C0332167;C0004153;C3272283;C4050568;C4319571,false;true;false;false;false,4391/22402
priorother ( not predefined ) medical conditions,,,4392/22402
reteplase / abciximab - facilitated pci ( n = $nmbr$ ),C0256103;C0288672;C4049621,true;true;false,4393/22402
established atherosclerotic disease  n ( % ),C0443211;C0333482;C0012634;C1272684,false;false;true;false,4394/22402
concomitant drugs  %,C0521115;C0013227;C3687832,false;true;false,4395/22402
after amendment ( % ),C0680532;C2346732,false;false,4396/22402
antianginal medications,C1874267;C0013227;C0802604;C2598133;C4284232;C3537168,false;true;false;false;false;false,4397/22402
eular good response,C0205170;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,4398/22402
ls means difference ( $nmbr$ % ci ) $nmbr$,C0023668;C1704970;C1705241;C0008107;C3259781;C1705242,true;false;false;true;false;false,4399/22402
prior stroke ( before index event ),C0332152;C0456712;C0441471;C4019010;C2826257,false;false;false;false;false,4400/22402
interval from onset of symptoms,C1272706;C4086878;C1552654;C1552713,false;false;false;false,4401/22402
low risk ( ri = $nmbr$ - $nmbr$ ),C3272281;C0035487;C1826843;C3538919,false;true;false;false,4402/22402
patients with prior copd - related,C0030705;C0332152;C0024117;C0439849;C0445223;C1412502;C3714496;C2826257,true;false;true;false;false;false;false;false,4403/22402
duration of ra  mean ( min - max ) ( yrs ),C0449238;C3538806;C0444504;C0702093;C1524029;C3813700;C2347634;C2348143;C4048756;C2926735,false;false;false;false;false;false;false;false;false;false,4404/22402
myocardial infarction / cabg / pci < $nmbr$ years,C0027051;C0010055;C4049621;C0439234;C0428953;C2926063;C3810814;C4552959,true;true;false;false;false;false;false;false,4405/22402
dilatative,C0002940;C0012359;C0700124;C1322279,true;true;false;true,4406/22402
ncep atp iii risk factors,C2744579;C0439070;C0035648;C1553898;C1705160;C4552600,true;false;true;false;false;false,4407/22402
change from baseline  adjusted mean ( $nmbr$ % ci ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,4408/22402
antiarrhythmic therapy,C0003195;C0039798;C0087111;C1363945;C3537142,true;true;true;false;false,4409/22402
mean ( sd ) tender joint count *,C0444504;C2699239;C0451530;C2347634;C2348143,false;false;false;false;false,4410/22402
• ? sd ml / min,C2699239;C0439445,false;false,4411/22402
renal function ( egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  according to mdrd )  n ( % ),C0232804;C1739039;C0439445;C0369637;C0680240;C3839656;C0441923;C3811844;C3812682,false;true;false;false;false;false;false;false;false,4412/22402
serum creatinine,C0201976;C0600061,false;false,4413/22402
first - recorded event  no . ( and % ) of patients,C0205435;C1279901,false;false,4414/22402
fevi  l  mean ( sd ) $nmbr$,C0429706;C0444504;C2699239;C2347634;C2348143;C0849974;C1561566;C4528367,false;false;false;false;false;false;false;false,4415/22402
male / female,C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429,true;true;true;false;false;false;false;false,4416/22402
unknown ( none of the above ),C0439673;C3541433;C4050014,false;false;false,4417/22402
baseline creatinine clearance,C0168634;C0812399;C1442488,true;false;false,4418/22402
drug - eluting stent — no . ( % ),C1322815,true,4419/22402
mean disease duration  years,C0444504;C0872146;C0439234;C2347634;C2348143,false;false;false;false;false,4420/22402
spacer use during the study,C0221874;C0869040,false;false,4421/22402
non - end - stage renal dysfunction,C1518422;C0205088;C1565489;C3279454,false;false;true;false,4422/22402
duration of epilepsy  years  mean ( sd ),C0449238;C0014544;C0439234;C0444504;C2699239;C2347634;C2348143;C2926735,false;true;false;false;false;false;false;false,4423/22402
blood pressure control,C0005823;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1271104;C1272641,true;true;false;false;false;false;false;false;true,4424/22402
medications through day $nmbr$,C0013227;C0332173;C0439228;C0439505;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,4425/22402
nyha class ii ( n = $nmbr$ l $nmbr$ ),C1882085,false,4426/22402
nadroparin,C0206232,true,4427/22402
past smoking,C1444637;C0037369;C0453996;C1881674;C4284302,false;true;true;false;false,4428/22402
$nmbr$ - min walk distance ( m ),C0702093;C0429886;C0369637;C0441923;C1524029;C3813700,false;false;false;false;false;false,4429/22402
biologics user,C0005515;C1548600;C1706077;C0005522;C4553887,true;false;false;true;true,4430/22402
other medical history — no . ( % ),C0262926;C1704706,false;false,4431/22402
blood pressure ( % ),C0005823;C1271104;C1272641,true;false;true,4432/22402
sfc $nmbr$ mg / $nmbr$ mg,C4521536;C1319635,false;false,4433/22402
cardioversion in previous $nmbr$ wk,C0013778;C0205156;C0332174;C0439230;C1552607,true;false;false;false;false,4434/22402
$nmbr$ - $nmbr$ ( low risk ),C3272281;C3538919,false;false,4435/22402
hypercholesterolemia ( > $nmbr$ mg / dl ),C0020443;C0439269;C1522133,true;false;false,4436/22402
use of medication at baseline — no . ( % ),C1524063;C0013227;C3244316;C4284232,false;true;false;false,4437/22402
revascularization during index hospitalization  %,C0581603;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,4438/22402
gender  %,C0079399;C1522384,true;true,4439/22402
brv dosage  mg / d,C0155502;C0178602;C0439422;C2986497,true;false;false;false,4440/22402
not rando . in na *,C1518422;C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false;false,4441/22402
age  median ( iqr )  years,C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4442/22402
oral antidiabetic drugs / insulin ( % / % ),C0029167;C0935929;C0021641;C1533581;C1579433;C3714501;C0175795;C0304289;C0442027;C4521986,true;true;true;false;false;false;false;false;false;false,4443/22402
risk factors specified as inclusion criteria — no . ( % ) f,C0035648;C1553898,true;false,4444/22402
asian or pacific islander,C0078988,true,4445/22402
reversibility : > $nmbr$ - < $nmbr$ %,C0449261,false,4446/22402
average daily dose ( % of target ) *,C1510992;C2348070;C1521840;C2986546;C2825518,false;false;false;false;false,4447/22402
target - vessel revascularization,C0449618;C0581603,false;false,4448/22402
severity of copd — no . ( % ) f,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,4449/22402
lvef  %  median ( iqr ),C0428772;C0549183;C0876920;C2347635;C2348144;C2939193;C0488728,false;false;false;false;false;false;false,4450/22402
fev $nmbr$ / fvc  post - albuterol  %,C3714541,true,4451/22402
esrd saxa $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C0022661;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0035078;C2316810,true;true;true;false;false;false;false;false;true;false,4452/22402
time since diagnosis of pah — yrf,C0040223;C3541383,true;false,4453/22402
right coronary artery  n ( % ),C1261316,false,4454/22402
younger patients ( aged $nmbr$ years ),C0332239;C0030705,false;true,4455/22402
fvc ( l ) proportion taking pulmonary medications ( % ) b,C3714541;C1709707,true;false,4456/22402
vein graft stented,C0042449;C0181074;C0332835;C1961139,true;false;true;false,4457/22402
qualifying stroke,C1514624;C0038454;C4554100,false;true;false,4458/22402
difference vs . pbof mean ( s . e . ) t,C1705241;C1705242,false;false,4459/22402
oral hypoglycaemics only,C0359086;C0205171;C1720467,false;false;false,4460/22402
baseline history of vascular disease ( % ),C0168634;C0683519;C0005847;C1558950;C1801960;C0730226;C0850708;C0944983;C1442488,true;false;true;false;false;false;false;false;false,4461/22402
prednisone - equivalent dose — mg,C0032952;C0205163;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C0439185,true;false;false;true;true;false;false;false;false;false;false;false;false,4462/22402
aspirin alone group no of events / total n ( % ),C0004057;C2826346,true;false,4463/22402
known thrombophilic condition — no . ( % ),C0205309;C0398623;C0012634;C0348080;C1705253;C3864998,false;true;true;false;false;false,4464/22402
blood eosinophil proportion ( % ),C0014467;C1709707,true;false,4465/22402
( a ) demographics,C0011298;C1704791,true;false,4466/22402
cox bsl + yr $nmbr$ hbd,C1565830;C1549954;C0439234,true;false;false,4467/22402
direct thrombin inhibitors,C0003440;C3541936,true;false,4468/22402
body - mass index - kg / m $nmbr$  median ( iqr ),C0005893;C1532718;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;false;true,4469/22402
acute coronary syndrome,C0948089,true,4470/22402
waist circumference  cm ( sd ),C0455829;C2699239,true;false,4471/22402
moderate impairment ( egfr $nmbr$ - $nmbr$ ),C0205081;C0221099;C1739039;C3811844;C3812682;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;false;false;false;false;false;false;false;false,4472/22402
use of supplemental oxygen  n ( % ),C4067893;C4554557,false;false,4473/22402
unadjusted or ( $nmbr$ % ci ) p value,C1439367,false,4474/22402
rarely / never,C4035880,false,4475/22402
st - elevation myocardial infarction,C1536220;C3538872,true;false,4476/22402
woscops,,,4477/22402
age ( yrs )  mean *,C0001779;C0444504;C2347634;C2348143,false;false;false;false,4478/22402
non - ischaemic cardiomyopathy,C1518422;C0349782,false;false,4479/22402
history of myocardial infarction  n ( % ),C1275835,false,4480/22402
cardiac catheterization,C0018795,true,4481/22402
estimated glomerular filtration rate  n ( % ),C3811844,false,4482/22402
no aspirin or ppi,C0004057,true,4483/22402
inadequate response,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,4484/22402
drinking  n ( % ),C0001948;C0684271,true;true,4485/22402
non - ics +,C1518422;C0815320;C4551720,false;false;true,4486/22402
endovascular,C0524425,false,4487/22402
sbp ( mmhg )  mean ± sd,C0085805;C0439475;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,4488/22402
hormone - refractory prostate carcinoma,C1328504,false,4489/22402
drug - eluting stent implanted ( at least one ),C1322815,true,4490/22402
pah origin / cause,C1418251;C0015127;C1524003,false;true;false,4491/22402
experience,C0237607;C0596545,false;false,4492/22402
chinese subgroup,C0008120;C1079230;C1515021;C0152035,false;false;false;true,4493/22402
history of cardiovascular events,C1880008;C0441471;C3541888;C0019664;C1320716;C0019665;C0262512;C0262926;C1705255;C2004062,false;false;false;true;false;true;false;false;false;false,4494/22402
disease duration : < baseline mean,C0872146;C0168634;C0444504;C2347634;C2348143;C1442488,false;true;false;false;false;false,4495/22402
physician ' s global assessment . mean $nmbr$ sd,C4050369;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,4496/22402
glycated hemoglobin < median,C0017853;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,4497/22402
% stenosis  as assessed by core laboratory,C0678234;C1261287;C2632116,false;true;false,4498/22402
upper respiratory tract infection,C0041912,true,4499/22402
antibiotics * *,C0003232;C0003237;C3540704;C3540705;C3540706;C3540707;C3540708;C3540709;C3540710,true;true;false;false;false;false;false;false;false,4500/22402
normoalbuminuria — no . / total no . ( % ),,,4501/22402
aggressive ( $nmbr$ ),C0001807;C0580822,true;false,4502/22402
patients with specific disease characteristics,C0030705;C0205369;C0599878;C1552740,true;false;false;false,4503/22402
work and school,C0043227,true,4504/22402
activity ( $nmbr$ - $nmbr$ vas ),C0205177;C0042815;C3536884;C3827561;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;true;true;false;false;false;false;false;false;false,4505/22402
age ( yrs ) $nmbr$ - $nmbr$,C0001779,false,4506/22402
afcaps /,,,4507/22402
clinical presentation of vte at initial diagnosis — no . ( % ),C2708283;C0630906,false;true,4508/22402
aspirin < $nmbr$ hours,C0004057;C0439227,true;false,4509/22402
glucosamine ( n = $nmbr$ ),C0017718,true,4510/22402
neither ace inhibitor nor arb,C0003015;C4541021,true;false,4511/22402
previous coronary intervention,C0205156;C0018787;C0184661;C0886296;C1273869;C1552607,false;true;true;false;false;false,4512/22402
time since diagnosis of diabetes — no . ( % ),C0040223;C3541383,true;false,4513/22402
egfr ( ckd - epi  cystatinc )  ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C1739039;C1561643;C0162734;C0439445;C0369637;C0441923;C4281721;C3811844;C3812682,true;true;true;false;false;false;false;false;false,4514/22402
dyslipidaemia and hypertensiont,C0242339,true,4515/22402
presence of erosions  n ( % ),C0150312;C0333307;C1959609;C0392148;C3854307,false;false;false;false;false,4516/22402
sitting pulse  bpma,C0277814;C0232117;C0391850;C1947910;C2584297;C4050224,true;true;false;false;true;false,4517/22402
post - cabg,C0687676;C0010055;C1704687;C3469826,false;true;false;false,4518/22402
cigarette smoking  mean pack - years ( sd ),C1303175;C0037369;C0444504;C2699239;C2347634;C2348143;C0453996;C1881674,false;true;false;false;false;false;true;false,4519/22402
> $nmbr$ - $nmbr$ ( moderate risk ),C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,4520/22402
triglycerides tx difference vs pbo  ls mean % change from baseline ( se ),C0041004;C0041403;C1705241;C1705242,true;true;false;false,4521/22402
$nmbr$ - $nmbr$ / $nmbr$ - $nmbr$ mm hg,C0439475,false,4522/22402
body mass indexa < median,C0518010;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,4523/22402
dmard user,C0242708;C1548600;C1706077,true;false;false,4524/22402
admission for hf in previous year,C0184666;C0018488;C1313497;C1538440;C3273279;C0809949,false;true;true;false;false;false,4525/22402
duplex ultrasonography,C3825392,false,4526/22402
all of the colon,C0009368;C3888384,true;false,4527/22402
$nmbr$ - $nmbr$ - $nmbr$  obesity class $nmbr$,C0028754;C0456387;C1518526;C1705943;C1963185,true;false;false;false;false,4528/22402
coronary artery disease — no . / total no . ( % ),C0010054;C0010068;C1956346,true;true;true,4529/22402
body mass index  mean + sd ( kg / m ),C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,4530/22402
> $nmbr$ previous venous thromboembolisms ( % ),C0205156;C1997614;C1552607,false;false;false,4531/22402
remission at maintenance - trial entry — no . ( % ),C0544452;C0024501;C0008976;C1705654;C0687702,false;true;true;false;false,4532/22402
improved,C0184511;C0332272;C1561611;C4084203,false;false;false;false,4533/22402
treatment stratum ^ :,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,4534/22402
red blood cell counting  $nmbr$ / l,C0332575;C0005767;C0022827;C0750480;C1705566;C0005768;C0229664;C1260956;C4049926,false;true;true;false;false;true;false;false;false,4535/22402
$nmbr$ - wk kaplan - meier rate  %,C0332174;C0871208;C1521828;C0439230,false;false;false;false,4536/22402
continuous variables  mean ( sd ),C0549178;C0439828;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,4537/22402
intensified $nmbr$ months ( n - $nmbr$ ),C0439231,false,4538/22402
elevated troponin,C0205250;C0041199;C3163633,false;true;false,4539/22402
smoking history : current smoker,C1519384;C3173209;C3241966,false;false;false,4540/22402
jbs - $nmbr$ primary prevention only $nmbr$,C0175692;C0033144;C0205171;C1720467;C0795841;C1416527,true;true;false;false;true;false,4541/22402
( se ] tf hdl - c,C0036919;C4048299;C3715113;C4048587,true;false;false;false,4542/22402
baseline hs - crp tertiles ( mg / i ],C0168634;C3890735;C0024671;C0021966;C0221138;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285;C1442488,true;false;true;true;false;true;false;false;false;false;false;false;false,4543/22402
not reported,C1518422,false,4544/22402
diabetes and currently on an oral hypoglycaemic agent orinsulin,C0011847;C0011849,false;true,4545/22402
standard care n ( % ) / $nmbr$ py,C1442989;C1947933;C0030428;C3538810;C2828392,false;false;true;false;false,4546/22402
apremilast,C1678805,true,4547/22402
anterior myocardial infarction — no . ( % ),C0340293,true,4548/22402
oxcarbazepine,C0069751,true,4549/22402
mildly impaired,C0750532;C2945599,false;false,4550/22402
incidence [ n / n ( rate per $nmbr$ person - years ) ],C1708485;C0027361;C0439234;C2347489,false;true;false;false,4551/22402
blood pressure at target level ( % ) §,C0005823;C1521840;C0441889;C0456079;C1547707;C2946261;C2986546;C1271104;C1272641,true;false;false;false;false;false;false;false;true,4552/22402
egfrmdrd ， ml - min - $nmbr$ - $nmbr$ . $nmbr$ m_ $nmbr$,C0439445;C0369637;C0441923,false;false;false,4553/22402
benign prostatic hyperplasia,C1704272,true,4554/22402
> $nmbr$ erosion  n ( % ),C0333307;C1880549;C1959609;C3887524,false;false;false;false,4555/22402
body - mass index > $nmbr$,C0005893;C0578022;C1305855,false;false;true,4556/22402
alcohol consumption  n ( % ),C0001948,true,4557/22402
rhabdomyolysis or myopathy,C0035410;C4552660,true;false,4558/22402
treatment arm,C1522541,false,4559/22402
concomitant therapies at hospital discharge,C1707479;C0586003,false;false,4560/22402
hba $nmbr$ c in patients with baseline hba $nmbr$ c > $nmbr$ % ( > $nmbr$ mmol / mol )  % [ mmol / mol ]  la  n baseline ( sd ) adjusted mean change ( $nmbr$ % ci ) placebo - subtracted change ( se ),C0019016;C0030705;C0168634;C3829066;C1442488;C1825777;C3538758;C3829066;C0023031;C0168634;C2699239;C1442488;C0023749;C0230347;C2346906;C4553351;C0032042;C1719767;C0392747;C0036919;C0443172;C1705241;C4319952;C2348589;C1696465;C1706408,true;true;true;false;false;false;false;false;true;true;false;false;true;false;false;false;true;false;false;true;false;false;false;false;false;false,4561/22402
specific risk of bleeding ^,C0205369;C3251812;C1552740,false;false;false,4562/22402
number resulting in emergency department visit,C0237753;C0449788,false;false,4563/22402
elevated troponin ( > $nmbr$ . $nmbr$ pg / l ),C0205250;C0041199;C0439278;C3163633,false;true;false;false,4564/22402
hi ) ah ( % ),C0018619;C1836672;C0239849;C1412082;C1412316;C1431594;C4552857,true;true;true;false;false;true;false,4565/22402
number of exacerbations,C0237753;C4086268;C0449788,false;false;false,4566/22402
cpk > $nmbr$ times uln,C0040223;C1519815;C1632851,true;false;false,4567/22402
glucosamine + chondroitin sulfate ( n = $nmbr$ ),C0017720;C0008454;C0876712;C0038720;C0474702;C0475337;C3536965;C0017718;C0008466,true;true;false;true;false;false;false;true;true,4568/22402
serum trap - $nmbr$ b ( u / liter ),C0229671;C0184047;C0439148;C0475211;C1336677;C1566918;C1706005;C1710330;C3887583;C1546774;C1550100,true;false;false;false;false;true;false;false;false;false;false,4569/22402
sex ( male ) ethnic origin,C0086582;C0015031,true;true,4570/22402
no corticosteroids or immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,4571/22402
lvef within $nmbr$ months  %,C0428772;C0439231;C0488728,false;false;false,4572/22402
ls mean change from baseline $nmbr$,C0023668;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false;false,4573/22402
uric acid ( mg / dl ) creatinine clearance ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C0041980;C0439269;C0151280;C0369637;C0441923;C0024671;C3642208;C0026410;C1960952;C2346927;C4321396;C4521761,true;false;false;false;false;true;false;true;false;false;false;false,4574/22402
weight — kg ( median ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,4575/22402
non - black,C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,4576/22402
myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,4577/22402
duration of assigned regimen before surgery,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,4578/22402
asian / black / white / hispanic / other ( % ) clinical parameters,C0078988;C1533017;C0007457;C0043157;C0220938;C1533018;C0005680;C1533020;C1533021;C0027567;C0085756;C0439541,true;false;true;true;false;false;true;false;false;true;true;false,4579/22402
> $nmbr$ mg / dl eze / simva $nmbr$ = $nmbr$ },C0439269,false,4580/22402
risk factors for pad,C0035648;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C1553898,true;false;false;false;false;false;false;false,4581/22402
baseline hemoglobin  median ( iqr  g / dl ),C0168634;C1319312;C0549183;C3642216;C0876920;C2347635;C2348144;C2939193;C0019046;C0439267;C1442488,true;false;false;false;false;false;false;false;true;false;false,4582/22402
insulin  iu / ml  median ( q $nmbr$  q $nmbr$ ),C0021641;C0439458;C0549183;C0876920;C2347635;C2348144;C2939193;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,4583/22402
prior percutaneous coronary intervention — no . ( % ),C0332152;C1532338;C2826257,false;true;false,4584/22402
other bdmard §,,,4585/22402
icd therapy ( n =,C0021122;C0039798;C0087111;C1363945,true;true;true;false,4586/22402
apo a - l ( mg / dl ) - mean ± sd,C1447574;C0439269;C0444504;C2699239;C2347634;C2348143;C4521365,true;false;false;false;false;false;false,4587/22402
with alogliptin $nmbr$ . $nmbr$ mg ( n $nmbr$ $nmbr$ ),C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4588/22402
symptomatic pad of lower extremities *,C0231220;C0182158;C0023216;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;true;false;false;false;false;false,4589/22402
pfor heterogeneity,C1151635;C0019409;C0242960,false;false;true,4590/22402
severe impairment ( egfr < $nmbr$ ),C0205082;C0221099;C1739039;C3811844;C3812682;C0684336;C4050465;C4050466,false;false;true;false;false;false;false;false,4591/22402
previous use of amiodarone,C0205156;C1524063;C0002598;C1552607,false;false;true;false,4592/22402
levetiracetam,C0377265;C3693636,true;false,4593/22402
peri - op beta - blockers : no ( n = $nmbr$ ),C0347985;C0001645,false;true,4594/22402
patient global assessment ( $nmbr$ - $nmbr$ mm vas ),C4054229;C4330985;C0042815;C3536884;C3827561;C4554674,false;false;true;true;false;false,4595/22402
background treatment  n ( % ),C1706907;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,4596/22402
high titre ( > $nmbr$ times of uln )  n ( % ),C0205250;C0475208;C0040223;C1519815;C1632851;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false;false,4597/22402
no corticosteroid  no imm,C0001617;C3536709,true;false,4598/22402
greater than or equal to $nmbr$ mm hg,C0439093,false,4599/22402
antiarrhythmic agent,C0003195;C0301380,true;false,4600/22402
white not of hispanic origin,C0007457;C0043157;C0220938,true;true;false,4601/22402
cause of dvt or pe — no . ( % ),C0015127;C0149871;C2926618;C3899446;C1524003,true;true;false;false;false,4602/22402
sulfonylurea — no . ( % ),C0038766;C3536898,true;false,4603/22402
mean preoperative abpi of the index,C0444504;C0445204;C0600653;C0918012;C1552854;C1637833;C2986546;C2347634;C2348143,false;false;true;true;false;false;false;false;false,4604/22402
met criterion at finalt,C0428210;C0243161;C1550543;C4317104,false;true;false;false,4605/22402
orthopnea  ( % ),C0085619,false,4606/22402
total mortality,C0439175;C0026565;C0026566;C0439810,false;true;true;false,4607/22402
pace  no . ( $nmbr$ ),C0287990;C1552930;C4048252,true;false;false,4608/22402
non - caucasian simva,C1518422;C0007457;C0043157,false;true;true,4609/22402
high periostin subgroup ( > $nmbr$ ng / ml ) ( n = $nmbr$ ),C0205250;C0219433;C1079230;C0439275;C1515021;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false;false;false;false;false,4610/22402
overall population,C0282416;C0032659;C1257890;C1561607,true;true;true;false,4611/22402
all randomized women,C0034656;C0043210;C3815594,true;true;false,4612/22402
respiratory - related ^,C0521346;C0439849;C0445223;C1546767,false;false;false;false,4613/22402
treated vessel - native coronary,C1522326;C0005847;C0302891;C0018787,false;true;false;true,4614/22402
< $nmbr$ . $nmbr$ mmol / liter estimated gfr,C0439190;C0475211,false;false,4615/22402
prior ms treatment with ifn - beta or,C1514463;C2349943;C0015980;C3539704;C3713294,false;false;true;false;true,4616/22402
no hemoconcentration hemoconcentration,C0549409;C0854379,false;false,4617/22402
clopidogrel  $nmbr$ - mg loading dose,C0070166;C4086581;C1708715;C0024671;C3714444;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;true;false;false;false;false;false,4618/22402
body weight ( kg )  mean ( s . d . ),C0005910;C1275571;C0444504;C2347634;C2348143;C1305866,true;false;false;false;false;false,4619/22402
das $nmbr$ ( c - reactive protein ),C0051767;C0006560;C1413716;C4048285;C0057671,true;true;false;false;true,4620/22402
blood pressure  pbo y patients with diabe teristics ( ncep atp i,C0005823;C0031962;C0030705;C2744579;C0021966;C0221138;C4552600;C1271104;C1272641,true;true;true;true;true;false;false;false;true,4621/22402
patients with normoalbuminuria at baseline,C0030705,true,4622/22402
stenting plus medical therapy ( n = $nmbr$ ),C0038257;C0418981;C2348535,true;false;false,4623/22402
mean - sd change in pre - bronchodilator fev $nmbr$  l,C0444504;C2699239;C0392747;C2599602;C3714541;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;true;false;false;false;false;false,4624/22402
change from baseline in % predicted fev $nmbr$,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,4625/22402
patients with uncomplicated events ( p = o - $nmbr$ 十 ),C0030705;C0443334;C0441471;C3541888,true;false;false;false,4626/22402
post - bronchodilator percent of predicted fev $nmbr$  % ( sd ),C2599594;C1882327;C3714541;C2699239,false;false;true;false,4627/22402
comparison with baseline,C1707455;C0168634;C1442488,false;true;false,4628/22402
previous ml ( interaction : p = $nmbr$ . $nmbr$ ),C0205156;C0439526;C1704675;C1705224;C3887665;C1552607,false;false;false;false;false;false,4629/22402
cardiac glycosides,C0007158,true,4630/22402
previously taken any other dmards  n ( % ),,,4631/22402
crp ( normal range : $nmbr$ - $nmbr$ . $nmbr$ )  mg / dl  mean ( sd ),C3890735;C0086715;C0439269;C0444504;C2699239;C2347634;C2348143;C4048285,false;true;false;false;false;false;false;false,4632/22402
modified rankin score,C0392747;C0449820;C4050231;C3889737,false;false;false;false,4633/22402
a a ( $nmbr$ ( % ),,,4634/22402
mean involved bsa  % ( $nmbr$ % ci ),C0444504;C2347634;C2348143,false;false;false,4635/22402
other defined,C1704788;C3539106,false;false,4636/22402
without ( n = $nmbr$ $nmbr$ ),C0369718;C0441922,false;false,4637/22402
treatment with drugeluting stent,C0039798;C1322815;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,4638/22402
$nmbr$ - $nmbr$ ( moderate ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,4639/22402
angiography,C0002978,true,4640/22402
sbp / dbp $ $nmbr$ / $ $nmbr$ mmhg,C0085805;C0536221;C0439475;C3813197;C4281799,true;true;false;false;false,4641/22402
non - extensive,C1518422;C0205231,false;false,4642/22402
electrocardiographic findings — no . ( % ),C0438154,false,4643/22402
beta receptor antagonist,C0330390;C4543207;C0439096;C2004068,false;false;false;false,4644/22402
baseline triglycerides by quintiles,C0168634;C0041004;C1508496;C1442488,true;true;false;false,4645/22402
median albumin - to - creatinine ratio ( interquartile range ),C0549183;C0486293;C1711350;C1318293;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4646/22402
< $nmbr$ regardless of historical count,C1552658;C0750480;C1705566;C1552723;C2004062,false;false;false;false;false,4647/22402
stent type,C0038257;C0332307;C1547052,true;false;false,4648/22402
$nmbr$ vessel pci,C0005847;C4049621,true;false,4649/22402
body mass index subgroups,C0005893;C1079230;C0578022;C1305855,false;false;false;true,4650/22402
pioglitazone,C0071097,true,4651/22402
b - agonists ( long - acting ) a,C0243192;C2987634,true;false,4652/22402
tg ( mg / dl )  median ± sd,C0337445;C0439269;C0549183;C2699239;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4653/22402
risk factors for recurrent vte — no . ( % ) f,C0035648;C1455761;C0630906;C2945760;C1553898,true;false;true;false;false,4654/22402
caucasian eze / simva,C0007457;C0043157,true;true,4655/22402
$nmbr$ - < $nmbr$ mvmin,,,4656/22402
pioglitazone ( n = $nmbr$  $nmbr$ ),C0071097,true,4657/22402
time from onset to medication  h  mean ± sd,C0449244,false,4658/22402
baseline insulin daily dose / kg,C0168634;C0366513;C0332173;C0022718;C0439209;C4054209;C0021641;C2348070;C1533581;C1579433;C3714501;C1442488,true;false;false;true;false;false;true;false;false;false;false;false,4659/22402
mean — ml / min / $nmbr$ . $nmbr$ m $nmbr$ of body - surface area,C0444504;C0439445;C0369637;C0489451;C0017446;C0205146;C0441923;C2347634;C2348143,false;false;false;false;true;false;false;false;false,4660/22402
telmisartan group ( n = $nmbr$ ),C0248719;C0441848,true;false,4661/22402
total cholesterol ( mmo $nmbr$ / $nmbr$ ),C0201950;C0543421,false;false,4662/22402
african - latin american,C0085756,true,4663/22402
more than $nmbr$ lesions per vessel,C0205172,false,4664/22402
fpg  mg / dl ( mmol / l ),C0439269;C1532563,false;false,4665/22402
> = $nmbr$ % and < $nmbr$ % ( > = $nmbr$ and < $nmbr$ mmol / mol ),,,4666/22402
no . of events / total no . ( % ),C0441471;C3541888,false;false,4667/22402
ind $nmbr$ mg q . d . n = $nmbr$,C4049864;C0439422,false;false,4668/22402
smoking history : ex - smoker,C1519384;C0337664,false;true,4669/22402
troponin level,C0041199;C0441889;C0456079;C1547707;C2946261,true;false;false;false;false,4670/22402
duration of copd — days ^,C0449238;C0024117;C0439228;C1412502;C3714496;C2926735,false;true;false;false;false;false,4671/22402
other antiplatelet agents  n ( % ),C0085826,true,4672/22402
thienopyridine at randomization,C1120149;C0034656,true;true,4673/22402
bmi ( kg / m $nmbr$ ) cardiovascular history,C0578022;C1532718;C1880008,false;false;false,4674/22402
controlled $nmbr$ — no . ( % ),C2587213;C2911690,false;false,4675/22402
sulfonylurea derivatives,C0038766,true,4676/22402
score $nmbr$ - $nmbr$,C0449820;C4050231,false;false,4677/22402
radial access site,C0442038;C0589360;C0920847,false;false;false,4678/22402
use of parenteral antithrombotic agents — no . ( % ),C1524063;C0030547;C1704311;C4522267,false;true;true;false,4679/22402
immunosuppressant ( with or without corticosteroid ),C0021081,true,4680/22402
ml with st - segment elevation,C0439526;C0520886;C1705224;C3887665,false;false;false;false,4681/22402
remission in overall population,C0544452;C0282416;C0032659;C1257890;C1561607;C0687702,false;true;true;true;false;false,4682/22402
v / hctz,C0020261,true,4683/22402
pulse ( beats / min ) cholesterol ( mmol / l ),C0232117;C0391850;C1947910,true;false;false,4684/22402
number of participants,C0237753;C0679646;C0449788,false;false;false,4685/22402
beta - carotene,C0053396;C0696105,true;false,4686/22402
hemispheric stroke n = $nmbr$,C0205139;C0038454;C4554100,false;true;false,4687/22402
pci for index mi ( % ),C4049621;C0600653;C3810814;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;false;false,4688/22402
absolute fvc decrease > $nmbr$ %,C0205344;C3714541;C0392756;C0547047,false;true;false;false,4689/22402
hemoglobin ( gl ' ),C0019046;C0018229;C1423073;C1427674,true;true;false;false,4690/22402
low ( $nmbr$ - $nmbr$ ) ( n = $nmbr$  $nmbr$  $nmbr$ % ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,4691/22402
> $nmbr$ % and < $nmbr$ % predicted arr ( n = $nmbr$  $nmbr$ ),,,4692/22402
duration from hospital admission to pci  h ( median  iqr ),C0449238;C0019994;C1959907;C1510665;C2926735,false;true;false;false;false,4693/22402
prednisone,C0032952,true,4694/22402
enalapril dm = $nmbr$ non - dm = $nmbr$,C0014025;C0011816;C3250443,true;true;false,4695/22402
entire cohort,C0439751;C0009247;C0599755;C0444667,false;true;false;false,4696/22402
intravenous loop diuretics !,C0348016;C0354100,false;true,4697/22402
peripheral revascularization,C0205100;C0581603,false;false,4698/22402
no ischemia ( n = $nmbr$  $nmbr$ ),C0022116;C4321499,true;false,4699/22402
fp / sal $nmbr$ / $nmbr$ pg ( n = $nmbr$ ),C0016704;C0036140;C0030827;C0072225;C1266240;C0037494;C0206136;C1419068;C1419906;C3541238;C3541412,true;true;true;true;false;true;true;false;false;false;false,4700/22402
antithrombotic use,C0042153;C0457083;C1947944,true;false;false,4701/22402
p lace of randomization ( interaction : p = $nmbr$ . $nmbr$ ),C0369773;C0280109;C0034656;C1704675;C0453991;C2603361,false;false;true;false;false;false,4702/22402
km event rate ( % ),C3887676;C0441471;C0871208;C1521828;C4019010,false;false;false;false;false,4703/22402
revascularisation + antiplatelets + lipid - lowering agents + p blockers,C0581603;C0086440,false;true,4704/22402
beta $nmbr$ selective,C0330390;C0439096;C2004068,false;false;false,4705/22402
iii and iv ejection fraction,C0439070;C1705160,false;false,4706/22402
antiarrhythmic drug,C0003195;C0301380,true;false,4707/22402
median time since diagnosis * ( range )  yr,C0549183;C0040223;C3541383;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,4708/22402
bmi  kg / m $nmbr$ uac  no . ( % ),C0578022;C1532718,false;false,4709/22402
high - density lipoprotein cholesterol  mean ( sd )  mmol / l,C0023822;C0444504;C2699239;C1532563;C2347634;C2348143,true;false;false;false;false;false,4710/22402
serum potassium ( mmol / l ),C0302353;C1532563;C0543465,false;false;false,4711/22402
gissi prevention $nmbr$ / $nmbr$ - $nmbr$ / $nmbr$,C0199176;C1706420;C2700409,false;false;true,4712/22402
nyha class $nmbr$ or higher,C1882083,false,4713/22402
concomitant medication — no . ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,4714/22402
history of major cardiovascular disease  n ( % ),C0455539;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false,4715/22402
versus tiotropium $nmbr$ pg,,,4716/22402
nyha functional class at screening,C1882083;C0205245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0542341;C2700217,false;false;true;true;false;false;false;false;false;false;false,4717/22402
time from most recent qualifying,C0040223;C0332185;C1514624;C3541383,true;false;false;false,4718/22402
use of loop diuretics  n ( % ),C1524063;C0354100,false;true,4719/22402
glycemia  mg / dl,C0005802;C0439269,true;false,4720/22402
duration of asthma  years,C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,4721/22402
bisphosphonates,C0012544;C3541401,true;false,4722/22402
cardiovascular disease history,C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,4723/22402
no pci or cabg — no . ( % ),C4049621,false,4724/22402
any statin ( with / without llt ),C0360714,true,4725/22402
associated with drug / toxin,C0332281;C0013221,false;true,4726/22402
non - diabetic patients,C1829939;C0241863,false;false,4727/22402
baseline hba $nmbr$ c in $nmbr$ classes,C0168634;C0019016;C0456387;C1518526;C1705943;C4019422;C1825777;C3538758;C1442488,true;true;false;false;false;false;false;false;false,4728/22402
coronary artery disease — no . ( % ) : ! :,C0010054;C0010068;C1956346,true;true;true,4729/22402
patients with egfr $nmbr$ > $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n,C0030705;C1739039;C3811844;C3812682,true;true;false;false,4730/22402
baseline corticosteroidst ( mean dose : $nmbr$ . $nmbr$ mg / day )  n ( % ),C0168634;C0444504;C0178602;C0439422;C0869039;C1114758;C2347634;C2348143;C1442488,true;false;false;false;false;false;false;false;false,4731/22402
vka  only reason,,,4732/22402
reported in ecrf,C0684224;C4551412;C0700287;C4319718,true;false;false;false,4733/22402
evidence or thombus  n ( % ),C3887511,false,4734/22402
prior aortocoronary bypass surgery 一 no . ( % ),C0455610;C0010055,false;true,4735/22402
regional anaesthesia,C0002911,true,4736/22402
events / n,C0441471;C3541888,false;false,4737/22402
anti - coagulants - no . ( % ),C0848112,false,4738/22402
other antihypertensive,C0003364,true,4739/22402
thrombus - containing lesion,C0087086;C0332256;C0221198;C1546698;C2700400;C0302148;C3146237,true;false;false;false;false;false;false,4740/22402
sgrq total score ( week,C2964552;C0332174;C0439230,false;false;false,4741/22402
americas ( n = $nmbr$ ),C0002454;C0596070,true;false,4742/22402
placebo - adjusted mean difference in % hba $nmbr$ c ( $nmbr$ % ci  [ p value ] ),C0032042;C1696465;C1706408,true;false;false,4743/22402
serum total cholesterol ( mmol / l )  mean ( sd ),C0587184;C1532563;C0444504;C2699239;C2347634;C2348143;C1287371,false;false;false;false;false;false;false,4744/22402
creatinine level,C0428279,false,4745/22402
heart rate  mean ( sd ) [ range ]  beats / min,C0018810;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143,true;false;false;false;false;false;false;false,4746/22402
cv death / mi / stroke / ucr,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,4747/22402
irbesartan,C0288171,true,4748/22402
time from acs to randomization,C0040223;C0742343;C4318612;C3541383,true;true;false;false,4749/22402
time intervals  h,C0872291;C0033727;C0369286;C0441932;C0564385;C4528284,false;true;false;false;false;false,4750/22402
history of stroke or tia,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4751/22402
medications at timing of randomization  n ( % ),C2359859;C0034656,false;true,4752/22402
cv death or hf hospitalization n,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,4753/22402
cvd events,C0007222;C0441471;C3541888,true;false;false,4754/22402
$nmbr$ - point mace,C1552961;C2347617;C3714763,false;false;false,4755/22402
low - dose aspirin use,C2608320;C0042153;C0457083;C1947944,false;true;false;false,4756/22402
moderate / severe exacerbations  itt population  n ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,4757/22402
lp ( a ) §,C0065058;C1439335;C4553379,true;false;false,4758/22402
hba $nmbr$ c levels,C0019016;C0441889;C1825777;C3538758,true;false;false;false,4759/22402
weekly,C0332174,false,4760/22402
> $nmbr$ ( high risk ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,4761/22402
percentage of time in therapeutic inr range  mean ( sd ),C0439165;C0040223;C3541383;C1549488;C1561533,false;true;false;false;false,4762/22402
> $nmbr$ prior myocardial infarction — no . ( % ),C0155668,false,4763/22402
threatened abrupt vessel closure,C1276802;C0005847;C0185003;C1521802,false;true;false;false,4764/22402
prior therapy  %,C1514463,false,4765/22402
duration of pci ( min )  median n ( iqr ),C0449238;C4049621;C0702093;C0549183;C0876920;C2347635;C2348144;C2939193;C1524029;C3813700;C2926735,false;false;false;false;false;false;false;false;false;false;false,4766/22402
age > $nmbr$ y  n ( % ),C0001779,false,4767/22402
van der heijde mtss  mean ( sd ),C0557775;C1511780;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,4768/22402
form / bud,C0348078;C2700462;C2945744;C0376315;C1522492;C4255237,false;false;false;true;false;false,4769/22402
no . of patients ind / gly sfc,C0030705;C4049864;C0017890;C4521536;C0523677,true;false;true;false;false,4770/22402
missing hb at yr $nmbr$,C1551393;C0019046;C0439234;C1705492;C3272743,false;true;false;false;false,4771/22402
within $nmbr$ h after,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,4772/22402
left ventricular ejection fraction < $nmbr$ %,C0428772;C0488728,false;false,4773/22402
mestizos,C0682082,false,4774/22402
ankle - brachial index < $nmbr$ . $nmbr$,C1328319;C3888326,true;false,4775/22402
p - value ( anova ),C1709380;C0753802,false;true,4776/22402
patients with > $nmbr$ exacerbations resulting in emergency department visit,C0030705;C4086268,true;false,4777/22402
difference in change,C1705241;C0392747;C0443172;C4319952;C1705242,false;false;false;false;false,4778/22402
established atherosclerotic cardiovascular disease,C0443211;C0004153;C1272684,false;true;false,4779/22402
other vascular disease,C0042373,true,4780/22402
black race and ss > $nmbr$ ( n = $nmbr$ vs $nmbr$ ),C0005680,true,4781/22402
qualifying mi : stemi,C1514624;C3810814;C1536220;C3538872,false;false;true;false,4782/22402
coenzyme q $nmbr$,C0041536,true,4783/22402
history of a transient ischaemic attack,C0455536,false,4784/22402
known tiromtcch * c ccndifeon,C0205309,false,4785/22402
total patients,C0439175;C0030705;C0439810,false;true;false,4786/22402
periprocedural medications  n ( % ) clopidogrel  $nmbr$ mg *,C0013227;C0070166;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0802604;C2598133;C4284232,true;true;true;true;false;false;false;false;false;false;false;false,4787/22402
swollen joint count ( $nmbr$ - $nmbr$ possible joints ),C0451521;C0332149;C1705910;C2362652,false;false;false;false,4788/22402
prior amputation,C0332152;C0002688;C0332840;C1546539;C2826257,false;true;false;false;false,4789/22402
weight  kg  median ( range ),C0005910;C0022718;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;false;false;false;true;false;false,4790/22402
arterial area ( mm $nmbr$ ),C0003842;C0017446;C4330985;C4554674;C0205146;C0221464,true;true;false;false;false;false,4791/22402
statin + fibrate or,C0360714,true,4792/22402
presence of enthesitis  n ( % ),C0150312;C1282952;C0392148;C3854307,false;false;false;false,4793/22402
nyha class ( when patient was last in stable condition before admission )  %,C1882083,false,4794/22402
history of second prior mi  n ( % ),C0019664;C0205436;C0332152;C3810814;C2826257;C0457385;C0565930;C1561503;C1705190;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;false;false;true;false;false;false;false,4795/22402
ischaemic ( n = $nmbr$ l $nmbr$ ),C0475224,false,4796/22402
sbp > $nmbr$ mmhg and / or dbp > $nmbr$ mmhg,C0085805;C0439475,true;false,4797/22402
caucasian  n ( % ),C0007457;C0043157,true;true,4798/22402
use of cardiac medication *,C1524063;C0018787;C0013227;C3244316;C4284232;C1522601,false;true;true;false;false;false,4799/22402
pioglitazone ( n = $nmbr$ ),C0071097,true,4800/22402
hdl cholesterol < $nmbr$ ( men ) or < $nmbr$ mg / dl ( women ),C0023822;C0025266;C0392885,true;true;false,4801/22402
cardiac valvular disease,C0018824,true,4802/22402
randomized to receive vitamin e,C0034656;C3815594,true;false,4803/22402
indication for index procedure,C2315323;C0600653;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false,4804/22402
total c ( mmol / l  mean ),C0439175;C1532563;C0444504;C2347634;C2348143;C0439810,false;false;false;false;false;false,4805/22402
left ventricular ejection fraction — %,C0428772;C0488728,false;false,4806/22402
non - reversible ( % ),C1518422;C0205343,false;false,4807/22402
peripheral neuropathy,C0031117,true,4808/22402
acuity major,C0750509,false,4809/22402
standard therapyy ( n = $nmbr$ ),C1442989;C2828392,false;false,4810/22402
acq $nmbr$ score,C2919686,false,4811/22402
baseline cardiovascular disease,C0168634;C0007222;C1442488,true;true;false,4812/22402
myalgia,C0231528;C4552646,true;false,4813/22402
time since as diagnosis  mean ( sd ) years,C0040223;C3541383,true;false,4814/22402
albumin / creatinine ratio - mg / mmol  median ( iqr ),C0486293;C0567349;C0549183;C0876920;C2347635;C2348144;C2939193;C2348885;C1318293,false;false;false;false;false;false;false;false;false,4815/22402
change in das $nmbr$ - esr ( mean ) i physical function outcomes week $nmbr$,C0392747;C0051767;C3811131;C0444504;C0021966;C0516981;C1274040;C0332174;C0439230;C4049916;C0221138;C2347634;C2348143;C0057671;C0443172;C1705241;C4319952,false;true;false;false;true;false;false;false;false;false;false;false;false;true;false;false;false,4816/22402
venous insufficiency,C0042485,true,4817/22402
pdqol scale,C0175659;C0349674;C1947916,true;false;false,4818/22402
baseline $nmbr$ - asa,C0168634;C0004057;C3853627;C1442488,true;true;false;false,4819/22402
current medication  n ( % ),C0746467,false,4820/22402
baseline pulmonary medication,C0168634;C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false,4821/22402
median ( range ),C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,4822/22402
mean ( sd ) aqlq,C0444504;C2699239;C4055434;C2347634;C2348143,false;false;false;false;false,4823/22402
humerus fracture,C0020162,true,4824/22402
high - density lipoprotein cholesterol tx difference vs pbo  ls mean % change from baseline ( se ),C0023822;C0041403;C1705241;C1705242,true;true;false;false,4825/22402
clopidogrel pretreatment duration,C0070166;C1550147;C0449238;C2926735;C2709094;C3539075;C3539076,true;false;false;false;false;false;false,4826/22402
lower than normal range — % ^,C0441994;C0086715;C1548802;C2003888,false;true;false;false,4827/22402
months ( log - transformed ),C0439231,false,4828/22402
saba reversibility,C0449261,false,4829/22402
previous stroke or tia,C0205156;C0038454;C4554100;C1552607,false;true;false;false,4830/22402
high disease activity : > $nmbr$ . $nmbr$  n ( % ),C4699623;C0012634;C0205250;C1292728;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false;false,4831/22402
alcohol use ( % ),C0001948,true,4832/22402
americas  excluding us,C0002454;C0596070,true;false,4833/22402
acitretin,C0050559,true,4834/22402
stratification variables,C1514983;C0439828,false;false,4835/22402
factor v leiden or prothrombin mutation,C0380964;C0584960;C1414509;C3542419,true;false;false;false,4836/22402
simplified disease activity index score,C3869582;C0449820;C4050231,false;false;false,4837/22402
diabetic kidney disease,C0011881,true,4838/22402
prior coronary artery disease yes,C0332152;C0010054;C1549445;C1705108;C1710701;C0010068;C1956346;C2826257,false;true;false;false;false;true;true;false,4839/22402
intravenous nitrates,C0348016;C0028125,false;true,4840/22402
toast classification,C1710306;C4521230,false;false,4841/22402
£ $nmbr$ . $nmbr$ % * *,,,4842/22402
yes previous revascularization,C1549445;C0205156;C0581603;C1552607;C1705108;C1710701,false;false;false;false;false;false,4843/22402
no . / $nmbr$ person - yr,C0027361;C0439234;C2347489,true;false;false,4844/22402
p - blocker intake at randomisation ( n = $nmbr$ o ),C0369773;C1512806;C0034656;C2603361,false;false;true;false,4845/22402
> l : $nmbr$ hrs : min ( n = $nmbr$ ),C0439393;C1568891,false;true,4846/22402
oral glucocorticoid use at baseline — no . ( % ) : t,C1527415;C0017710;C0168634;C1442488,false;true;true;false,4847/22402
adjusted mean change,C0456081;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false,4848/22402
age at completion of highest level of,C0001779;C0205197;C4321237;C1554962,false;false;false;false,4849/22402
age group 一 ％,C0027362;C2348001,true;false,4850/22402
combined macro + micro,C0205195;C2984010;C0085672;C1553035;C3811161;C4049106,false;false;false;false;false;false,4851/22402
race / ethnicity chinese,C0034510;C0015031;C0008120;C0152035;C0243103;C1706779;C3853635,true;true;false;true;true;false;false,4852/22402
history of more than $nmbr$ prior mi ( % ),C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,4853/22402
physical activity §,C0015259;C0026606,true;true,4854/22402
systolic blood pressure  mm hg < $nmbr$,C0488055;C0439475;C0871470;C1306620,false;false;true;false,4855/22402
diagnoses / risk factors  n ( % ),C0011900;C0035648;C1553898,true;true;false,4856/22402
medication effects,C1319171,false,4857/22402
insulin glargine,C0907402,true,4858/22402
mean age  years ( sd ),C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,4859/22402
diuretic thiazide,C0012802,true,4860/22402
paclitaxel,C0144576,true,4861/22402
total back pain  mean ( sd ),C0439175;C0004604;C0444504;C2699239;C2347634;C2348143;C1963071;C4553945;C0439810,false;true;false;false;false;false;false;false;false,4862/22402
previous intolerance of infliximab  n ( % ) *,C0205156;C0231199;C0666743;C1744706;C2355652;C1552607,false;false;true;false;false;false,4863/22402
uae ( p  g / min ),C1519789;C0560021,false;false,4864/22402
any statin versus no statin at randomization,C0360714,true,4865/22402
adalimumab group ( n = $nmbr$ ) t,C1122087;C0036669,true;true,4866/22402
hgb  g / dl < $nmbr$ men  < $nmbr$ women,C0019029;C0439267;C0025266;C0043210;C0019046;C0518015;C1424337,false;false;true;true;true;false;false,4867/22402
fracture during follow - up,C0016658;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,4868/22402
biguanides,C0005382;C0360396;C3540012,true;false;false,4869/22402
> $nmbr$ . $nmbr$ kg / m $nmbr$ hypertension :,C1532718;C0020538;C1963138,false;true;false,4870/22402
values are expressed as percentages unless otherwise indicated . bmi  body mass index  cabg  coronary artery bypass ischemic attack  nsaids  nonsteroidal anti - inflammatory drugs  sbp  systolic bp  dbp  diastolic bp . * history of or currently taking antidiabetic or lipid - lowering medications .,C0042295;C0577559;C0600653;C0010055;C0745413;C0003211;C0918012;C1552854;C1637833;C2986546;C0577573;C1096155;C1306372;C3152252;C3539882;C4283905;C0003209;C0085805;C0871470;C0536221;C0012000;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3813197;C4281799,false;false;true;true;false;true;true;false;false;false;false;true;false;false;false;false;true;true;true;true;true;true;true;false;false;false;false;false;false,4871/22402
aminosalicylates,C0368663,false,4872/22402
prediabetes — no . ( % ) $nmbr$,C0362046,true,4873/22402
history of pci with stenting,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,4874/22402
brain volume  cm $nmbr$,C1113695,false,4875/22402
swollen joint count ( $nmbr$ - $nmbr$ ),C0451521,false,4876/22402
no . of strokes ( % ),C0038454,true,4877/22402
demographic and medical variables,C0011298,true,4878/22402
australia / nz,C0004340;C0027978,true;true,4879/22402
no . of events / patients,C0441471;C0030705;C3541888,false;true;false,4880/22402
chd history  n ( % ),C0280604;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3542407,false;true;true;false;false;false;false;false,4881/22402
jsn score ( $nmbr$ - $nmbr$ ),C0449820;C4050231,false;false,4882/22402
ascvdor > $nmbr$ cv risk factors,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,4883/22402
previous transient ischemic attack,C0205156;C0007787;C0917805;C1552607,false;true;true;false,4884/22402
number of stent = l or $nmbr$ or $nmbr$,C0237753;C0038257;C0449788,false;true;false,4885/22402
ischemic stroke with hemnrrhnaic cnnversinn,C0948008,false,4886/22402
chronic stable angina,C0340288,true,4887/22402
fenofibric acid + low - dose statin,C0060179;C0445550;C0360714;C1708745,true;false;true;false,4888/22402
daily iglar dose at week $nmbr$ ( u ),C2348070;C0560588,false;false,4889/22402
anticholinergic,C0242896;C3537004,true;false,4890/22402
contrast volume,C0009924;C0449468;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false,4891/22402
rituximab ( $nmbr$ x $nmbr$ mg ) + mtx,C0393022;C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,4892/22402
> $nmbr$ mg / dl simva $nmbr$ = $nmbr$ ],C0439269,false,4893/22402
glucagon - like peptide - $nmbr$ agonist,C0014361;C2987634,true;false,4894/22402
acr $nmbr$ response at week $nmbr$  n ( % ),C1412134;C0871261;C0332174;C0439230;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false;false;false,4895/22402
alcohol intake ( + ) ( % ),C0001948,true,4896/22402
# of prior tnfi among non - tnfi naive,C0332152;C1518422;C2826257,false;false;false,4897/22402
remission,C0544452;C0687702,false;false,4898/22402
triglycerides ( median  iqr )  mg / dl,C0041004;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,4899/22402
total antihypertensive use,C0439175;C0003364;C0042153;C0457083;C1947944;C0439810,false;true;true;false;false;false,4900/22402
a $nmbr$ c distribution ( % ),C0520511;C1704711,false;true,4901/22402
middle third,C0442050,false,4902/22402
symptom score ( sd ),C3476546;C2699239,false;false,4903/22402
atorvastatin factorial study,C0286651;C2826344,true;false,4904/22402
former / non - drinker,C0205156;C0457801;C0750523,false;false;false,4905/22402
electrocardiographic findings at randomization,C0438154;C0034656,false;true,4906/22402
lumbar spine bmd t - score,C0024091;C0449820;C4050231;C3887615,true;false;false;false,4907/22402
multiple ( $nmbr$ + ) chd risk,C0439064;C1282512,false;false,4908/22402
hyperlipidemia  n ( % ),C0020473;C0428465;C4555212,true;false;false,4909/22402
place of randomization,C0442504;C0034656;C1533810;C1704765;C1882509,false;true;false;false;false,4910/22402
beta - blocker % target dose,C0001645;C1521840;C0178602;C0869039;C1114758;C2986546,true;false;false;false;false;false,4911/22402
left circumflex  n ( % ),C0205091;C1880089;C0443246;C1552822,false;false;false;false,4912/22402
ranolazine vs . placebo km failure rate,C0073633,true,4913/22402
biomarker high ( periostin > $nmbr$ ng / ml or blood eosinophils > $nmbr$ cells per pl )  na,C0005516;C0205250;C0219433;C0439275;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,true;false;true;false;false;false;false;false;false;false;false;false,4914/22402
at or above the median,,,4915/22402
indacaterol - glycopyrronium group ( n = $nmbr$ ),C1722260;C3814772;C0441848,true;false;false,4916/22402
infarct on brain imaging 丰,C0751955,true,4917/22402
baseline laboratory values  median ( iqr ) d,C0168634;C0022877;C0042295;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904;C1442488,true;true;false;false;false;false;false;false;false;false;false,4918/22402
timi major or minor bleeding,,,4919/22402
olodaterol $nmbr$ mg ( n = $nmbr$ ),C2934193;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,4920/22402
race / ethnicity white,C0034510;C0015031;C0007457;C0043157;C0220938;C0243103;C1706779;C3853635,true;true;true;true;false;true;false;false,4921/22402
tnfi ( no other bdmard taken ) t  n ( % ),,,4922/22402
patients treated,C0030705,true,4923/22402
distribution time,C0520511;C0040223;C3541383;C1704711,false;true;false;true,4924/22402
previous treatment failure — no . ( % ) § * *,C0205156;C0162643;C0235828;C0521983;C1547544;C1552607,false;true;false;false;false;false,4925/22402
median body weight — kg,C3821165;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0549183;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;true;false;false;false;false;false;false;false,4926/22402
raas inhibitor use,C1999216;C0042153;C0457083;C1947944,false;true;false;false,4927/22402
previous cardiovascular event at randomization,C0205156;C1320716;C0034656;C1552607,false;false;true;false,4928/22402
aspirin alone ( n = $nmbr$ ),C0004057;C0205171;C0439044;C0679994,true;false;false;false,4929/22402
wml load at baseline mri,C1550025;C0168634;C0024485;C1824234;C3890166;C1442488;C1704782;C1708715,false;true;true;false;false;false;false;false,4930/22402
clopidogrel plus aspirin,C0070166;C0332287;C0004057,true;false;true,4931/22402
alanine aminotransferase or aspartate aminotransferase > $nmbr$ x upper limit of normal ( n = $nmbr$ ),C0001899;C0057041;C1415274;C3887708,true;true;false;false,4932/22402
non - endstage renal dysfunction *,C1518422;C0205088;C1565489;C3279454,false;false;true;false,4933/22402
active inflammatory bowel disease,C0205177;C0021390;C3853793;C3888249,false;true;false;false,4934/22402
current alcohol use — no . / total no . ( % ),C0521116;C0001962;C0001975;C1705970,false;true;true;false,4935/22402
complex partial ( ib ),C0439855;C0728938;C2744579;C3890035;C4283819;C1550516;C1704241,false;false;true;false;false;false;false,4936/22402
saxagliptin ( n = $nmbr$  $nmbr$ ),C1611934,true,4937/22402
low subgroup,C0205251;C1079230;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,4938/22402
high - dose statin pretreatment ( n = $nmbr$ ),C0444956;C0360714;C1550147;C2709094;C3539075;C3539076,false;true;false;false;false;false,4939/22402
common study baseline,C0205214;C0557651;C0168634;C1442488;C2603343;C1522138;C3245511,false;false;true;false;false;false;false,4940/22402
lm bifurcation treated,C1261082;C0184906;C3146289;C1551056,false;false;false;false,4941/22402
renal impairment  n ( % ),C1565489,true,4942/22402
> $nmbr$ failure,C0231174;C0680095,false;false,4943/22402
coronary revascularization procedure,C0877341,false,4944/22402
intensified baseline ( n - $nmbr$ ),C0168634;C1442488,true;false,4945/22402
time from onset of qualifying stroke to randomization,C0449244;C1514624;C0038454;C4554100,false;false;true;false,4946/22402
statin non - users ( n = $nmbr$ ),C0360714;C1518422;C1706077,true;false;false,4947/22402
barc $nmbr$ - $nmbr$,,,4948/22402
laba use  % patients,C0042153;C0030705;C0457083;C1947944,true;true;false;false,4949/22402
enoxaparin ( n = $nmbr$ ),C0206460,true,4950/22402
who / idf impaired fasting glucose,C1272092,false,4951/22402
dip involvement  ! n ( % ),C3539618;C1314939,false;false,4952/22402
copd severity ( gold $nmbr$ ),C0024117;C0439793;C0018026;C1304897;C0522510;C1412502;C3714496,true;false;true;false;false;false;false,4953/22402
erosion score ( $nmbr$ - $nmbr$ ),C0333307;C0449820;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false,4954/22402
st - segment depression > $nmbr$ . $nmbr$ mv,C0520887;C1454484;C1705503;C4281602,false;true;false;false,4955/22402
fasting tgs §,C0015663;C1156212;C1537574,true;false;false,4956/22402
total cataract extraction,C3665439;C0185115;C0684295;C0439175;C0007389;C0439810,false;false;false;false;true;false,4957/22402
$nmbr$ mg / day early - start,C0439422,false,4958/22402
$nmbr$ - $nmbr$ with cv risk but not disease ( n = $nmbr$ ),C3538987;C0035647;C4552904;C4048877;C4318503,false;true;false;true;false,4959/22402
oral treprostinil ( n = $nmbr$ ),C0442027;C1145760;C4521986,false;true;false,4960/22402
acute ( < $nmbr$ hr ),C0205178,false,4961/22402
total ldl - c *,C0439175;C0439810,false;false,4962/22402
obese patients  ! n ( % ),C0028754;C0030705,true;true,4963/22402
baseline aspirin dose < $nmbr$ mg,C0168634;C4696290;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488,true;false;true;true;false;false;false;false;false;false,4964/22402
immunologic,C0152036;C0205470,true;false,4965/22402
high - dose aspirin,C0444956;C0004057,false;true,4966/22402
a - glucosidase inhibitor,C1512211,false,4967/22402
history of stroke  n ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,4968/22402
crusade bleeding score,C0019080;C0449820;C4050231,true;false;false,4969/22402
% with haq - di decrease > $nmbr$ . $nmbr$,C3826998;C0392756;C0547047;C4321476,false;false;false;false,4970/22402
= $nmbr$ ’ ),,,4971/22402
simple partial ( ia ),C0205352;C0728938;C0020980;C0694634;C1947960;C1550516,false;false;true;false;false;false,4972/22402
monitoring ( n = $nmbr$ ),C0150369;C1283169,false;false,4973/22402
crp median ( se )  rng / l,C3890735;C0549183;C0036919;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;true;false;false;false;false;false,4974/22402
no . of previous venous thromboembolic events,C0205156;C1861172;C1997614;C3160733;C1552607,false;true;false;false;false,4975/22402
d / mi / idr / st,C0073187;C3810814;C0036056;C3272372;C0332173;C4484261,true;false;true;false;false;false,4976/22402
smoking ( % ) laboratory parameters,C0037369;C0022877;C0449381;C3244292;C4283904;C0453996;C1881674,true;true;false;false;false;true;false,4977/22402
female sex  n ( % ) race  n ( % ),C0086287;C0034510;C1706779;C3853635,true;true;false;false,4978/22402
hypertension  treated,C0020538;C1963138,true;false,4979/22402
no . in the $nmbr$ mo before screening,C0026544;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0332177,true;true;true;false;false;false;false;false;false,4980/22402
severity of copd  n ( % ) *,C0439793;C0024117;C1412502;C3714496;C0522510,false;true;false;false;false,4981/22402
reduced ef,C0392756,false,4982/22402
disease duration  years : median ( range ),C0872146;C0439234;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,4983/22402
absent ( < $nmbr$ mg / dl ),C0332197;C0439269;C4285062,false;false;false,4984/22402
sgrq total score * *,C2964552,false,4985/22402
black race  n ( % ),C0005680,true,4986/22402
indication for index pci,C0392360;C0600653;C4049621;C0918012;C1552854;C1637833;C2986546;C3146298,false;true;false;true;false;false;false;false,4987/22402
forearm fracture,C1305215,false,4988/22402
clinical copd phenotype ^,C0205210;C0024117;C0031437;C1285572;C1412502;C3714496,false;true;true;false;false;false,4989/22402
symptoms and feelings,C0683368;C1457887,true;false,4990/22402
extent of index event,C0439792;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,4991/22402
gold stage — no . ( % ) * *,C0018026;C1304897,true;false,4992/22402
drugs used in diabetes,C0013227;C3687832,true;false,4993/22402
baseline short - acting anticholinergics  n ( % ),C0168634;C1282927;C0079613;C0242896;C3537307;C3540711;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002;C1442488,true;false;true;true;false;false;false;true;false;false;false;false;false,4994/22402
stent plus medical therapy,C0038257;C0418981,true;false,4995/22402
significant worsening in kccq clinical score ( > $nmbr$ ) at $nmbr$ months $nmbr$,C0332271;C3476798;C2826293;C0449820;C4050231;C1457868;C1546960,false;false;false;false;false;false;false,4996/22402
diet + pravastatin,C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,4997/22402
doubling of serum creatinine,C0205173;C0201976;C0600061;C1705764,false;false;false;false,4998/22402
before index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,4999/22402
global ischemia ( % ) * *,C0205246;C0022116;C4321499;C2348867,false;true;false;false,5000/22402
il - $nmbr$  ng / l,C0020898;C0439297;C0021764;C0022271,true;false;true;true,5001/22402
> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mu / l $ mmol / l,C0439342;C0439190,false;false,5002/22402
glycoprotein llb / llla inhibitors,C0017968;C0243077,true;true,5003/22402
statin intolerance $nmbr$  n ( % ),C0360714;C0231199;C1744706;C2355652,true;false;false;false,5004/22402
ccsc at $nmbr$ month before enrollment,C1516705;C0332177;C0439231,false;false;false,5005/22402
fevi auc $nmbr$ - $nmbr$ l,C0429706;C0376690;C0849974;C1561566;C4528367,false;true;false;false;false,5006/22402
total  adjusted weight of $nmbr$ . $nmbr$ for gastrointestinal bleeding,C0439175;C0456081;C0005910;C0043100;C1305866;C1705104;C0439810,false;false;true;true;false;false;false,5007/22402
indacaterol n = $nmbr$,C1722260,true,5008/22402
cv risk factors  % of patients,C3538987;C0035648;C0030705;C1553898;C4048877;C4318503,false;true;true;false;true;false,5009/22402
egfr  median ( sd )  ml / min,C1739039;C0549183;C2699239;C0439445;C0876920;C2347635;C2348144;C2939193;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,5010/22402
% rf +,C0035448;C0201660;C0748398;C1547111,true;false;false;false,5011/22402
moderate or severe copd exacerbations,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,5012/22402
beta - blocker use at randomization,C0001645;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,5013/22402
hscrp > $nmbr$ mg / l,C0439268,false,5014/22402
exacerbation rate in the previous year ( range ),C4086268;C0871208;C0205156;C0439234;C1514721;C2348147;C3542016;C0439508;C1552607;C1521828,false;false;false;false;false;false;false;false;false;false,5015/22402
bdp / ff / g ( n = $nmbr$ ),C0004906;C4554348;C0439267;C1422585;C1538710,true;false;false;false;false,5016/22402
high density lipoprotein ( mg / dl ),C0023821;C0439269,true;false,5017/22402
dose ( n ),C0178602;C0869039;C1114758,false;false;false,5018/22402
hormone replacement therapy,C0282402,true,5019/22402
europe ( eu ),C0015176;C0015179;C3665627,true;true;false,5020/22402
events / statin group,C0441471;C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888,false;true;false;false;true;false;false;false;false,5021/22402
site of disease — no . ( % ),C2945843;C0012634,false;true,5022/22402
proximal - mainleft,C0205107;C4489236,false;false,5023/22402
pharmaco - invasive n = $nmbr$,C0205281;C1334278,false;false,5024/22402
$nmbr$ % c . i .,C1547546,false,5025/22402
metformin : no / yes  %,C0025598,true,5026/22402
laba or lamab n = $nmbr$,,,5027/22402
physical role,C0031809;C0035820;C1705810;C3871154;C0205485;C1509143,true;true;false;false;false;false,5028/22402
colorectal cancer,C0009402;C0346629;C1527249;C2984278;C3542412,true;false;true;false;false,5029/22402
estimated odds ratio,C0750572;C0028873,false;true,5030/22402
secukinumab intravenous $nmbr$ mg ( n = $nmbr$ ),C3179547;C0348016;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,5031/22402
clopidogrel dose,C0070166;C0178602;C0869039;C1114758,true;false;false;false,5032/22402
ex - smoker / smoker  %,C0337671;C4555205,false;true,5033/22402
moderate ( > $nmbr$ to < $nmbr$ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,5034/22402
stroke of undetermined cause,C0038454;C0015127;C1524003,true;true;false,5035/22402
screening visit,C0220908;C0545082;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;false;true;false;false;false;false;false,5036/22402
medications before admission,C0013227;C0184666;C0809949;C0802604;C2598133;C4284232,true;false;false;false;false;false,5037/22402
antiplatelet therapy dual,C1096021,false,5038/22402
fenofibric acid $nmbr$ = $nmbr$,C0060179,true,5039/22402
asia / pacific ( % ),C0003980,true,5040/22402
number of patients with fractures,C2360800,false,5041/22402
before amendment ( % ),C0680532;C2346732,false;false,5042/22402
( haq - di  $nmbr$ - $nmbr$ ),C3826998;C4321476,false;false,5043/22402
race or ethnic group — no . f,C0034510;C1706779;C3853635,true;false;false,5044/22402
loss of response : ! : : ! :,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,5045/22402
post - bronchodilator fev $nmbr$ — % of predicted value,C2599594;C3714541;C0681842;C1522609;C1882327,false;true;false;false;false,5046/22402
medical history duration of heart failure ( years ) primary cause of heart failure,C0199168;C0455531;C0449238;C0439234;C0205225;C0015127;C1524003;C0439612;C0439631;C2926735;C0205476,false;false;false;false;false;true;false;false;false;false;false,5047/22402
major cardiovascular,C0205082;C0007226;C3887460;C0205164;C4318856;C4521762,false;true;false;false;false;false,5048/22402
bmi > $nmbr$ ( % ),C0578022,false,5049/22402
high risk ( $nmbr$ - $nmbr$ ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,5050/22402
seronegative ( rf - ve and acpa - ve ) subgroup,C0521144;C0035448;C0042469;C3714652;C4321495;C0201660;C0748398;C1547111,false;true;true;false;false;false;false;false,5051/22402
functional outcome ( mrs $nmbr$ - $nmbr$ ),C0205245;C1274040;C1522706;C2349188;C3714939;C3854213;C0542341;C2700217,false;false;false;false;false;false;false;false,5052/22402
previous balloon angioplasty,C0205156;C0002996;C0002997;C1552607,false;true;true;false,5053/22402
mean number of exacerbations in previous $nmbr$ months ( sd ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,5054/22402
duration from clopidogrel / placebo to pci  min ( median  iqr ),C0449238;C0070166;C0032042;C1696465;C1706408;C2926735,false;true;true;false;false;false,5055/22402
( ci ) b,C0008107;C3259781,true;false,5056/22402
hispanic ethnic group — no . / total no . ( % ) ‘ j ‘,C0086409;C0015031;C1879937,true;true;false,5057/22402
age  y . o .,C0001779,false,5058/22402
serum triglycerides  mg / dle,C0542495;C0024671;C0024138;C3542918;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;true;false;false;false;false;false,5059/22402
post - acute ischemic stroke,C0687676;C0751956;C0475224;C0205178;C0948008;C1704687;C3469826,false;true;false;false;false;false;false,5060/22402
death / mi / idr / st / gusto - defined moderate or severe bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,5061/22402
use of rescue albuterol  puffs / day *,C1524063;C0001927;C1533107;C0332173;C0439228;C0439505,false;true;false;false;false;false,5062/22402
intent of conservative strategy  %,C0162425;C0679199;C1283828;C1550453,true;false;false;false,5063/22402
> < $nmbr$ . $nmbr$  < $nmbr$ . $nmbr$  r < mmse = mini - mental,C0205090;C0451306;C0684010;C2603358,false;true;true;false,5064/22402
estimated gfr,C0750572;C0017654;C1424601,false;true;false,5065/22402
stenosis > $nmbr$ %,C0678234;C1261287;C2632116,false;true;false,5066/22402
$nmbr$ - year rates in placebo groups,C0439234;C0871208;C0032042;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C1696465;C1706408;C1521828;C0439508,false;false;true;false;false;true;false;false;false;false;false;false;false;false,5067/22402
previously on acei + arb,C3888198,false,5068/22402
peripheral artery disease details,C1704436;C4025272,true;false,5069/22402
egfr ( median  iqr )  ml / min / $nmbr$  $nmbr$ m $nmbr$,C1739039;C0549183;C0439445;C0369637;C0441923;C0876920;C2347635;C2348144;C2939193;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false;false,5070/22402
dipeptidyl peptidase - $nmbr$ inhibitor,C0003015;C2757044;C3536837,true;false;false,5071/22402
body mass index $nmbr$,C0005893;C0578022;C1305855,false;false;true,5072/22402
traditional nsaid,C0443324;C0003211;C3536840;C1548559,false;true;false;false,5073/22402
menopausal status and use of ht,C1513126,false,5074/22402
standard care,C1442989;C1947933;C2828392,false;false;false,5075/22402
non - european trial,C1518422;C0239307;C0008976;C1535514,false;false;true;false,5076/22402
patient ' s assessment of pain ( $nmbr$ - $nmbr$ vas ),C0679830;C0042815,false;true,5077/22402
tdi total score ( week $nmbr$,C0205976;C2964552;C0332174;C0439230;C2674784;C3714807,true;false;false;false;false;false,5078/22402
p  treatment - by - region interaction,C0369773;C0039798;C0017446;C1704675;C0205147;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2603361,false;true;true;false;false;true;false;false;false;false;false;false,5079/22402
insulin only,C0021641;C0205171;C1720467;C1533581;C1579433;C3714501,true;false;false;false;false;false,5080/22402
catscorecategory  n ( % ),,,5081/22402
anacetrapib ( n = $nmbr$  $nmbr$ ),C2604745,true,5082/22402
control $nmbr$ months ( n - $nmbr$ ),C0243148;C0439231;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false;false,5083/22402
no immomtedion,,,5084/22402
delayed reaction,C0205421;C0443286;C1545665;C3272602,false;false;false;false,5085/22402
disease site — no . of patients ( % ) |,C0012634;C0205145;C1515974;C2825164,true;false;false;false,5086/22402
$nmbr$ . $nmbr$ - < $nmbr$,,,5087/22402
sgrq total score ( units ) : ! :,C2964552;C0439148;C1519795;C3853603,false;false;false;false,5088/22402
qualifying myocardial infarction,C1514624,false,5089/22402
psoriasis,C0033860,true,5090/22402
no glucocorticoids or immunosuppressants,C0017710;C3540777;C3540778,true;false;false,5091/22402
mean ± s . d . hba $nmbr$ c,C0444504;C0019016;C1825777;C3538758;C2347634;C2348143,false;true;false;false;false;false,5092/22402
time from last dose of p $nmbr$ y $nmbr$ inhibitor  days,C0946444;C1999216;C0439228,false;false;false,5093/22402
s $nmbr$ gallop  n ( % ),C2986823,true,5094/22402
any condition,C0012634;C0348080;C1705253;C3864998,true;false;false;false,5095/22402
sitagliptin n = $nmbr$,C1565750,true,5096/22402
mean weight  kg  mean = sd,C0444504;C0005910;C0022718;C2699239;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;false;true;false;false;false;false,5097/22402
abciximab ( n = $nmbr$ ),C0288672,true,5098/22402
antiplatelet — no . ( % ),,,5099/22402
ischemic heart disease indicator no ( n = $nmbr$ l ),C0010054;C0021212;C1235732;C1522602;C0151744,true;true;false;false;true,5100/22402
ifg / prediabetes ^,C1334085;C0362046;C1708411,false;true;false,5101/22402
no . of target vessels,C0449618,false,5102/22402
adjusted mean ± se ( $nmbr$ % ci ),C0456081;C0444504;C0036919;C0008107;C3259781;C2347634;C2348143,false;false;true;true;false;false;false,5103/22402
albuminuria < $nmbr$ gram / gram cr,C0001925;C1319635;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337,true;false;false;false;true;false;false;false,5104/22402
nyha lll - iv,C1275491;C1261077;C0022326;C4265176,false;false;true;false,5105/22402
chronic kidney disease  n ( % ),C1561643;C4553188,true;false,5106/22402
patients with fistulas at baseline,C0030705;C0016169,true;true,5107/22402
standard control,C1442989;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C2828392,false;true;false;false;false;false;false;false,5108/22402
cvd  mi  stroke  or recurrent ischemia - urgent revascularization,C0007222;C3810814;C0038454;C4554100,true;false;true;false,5109/22402
white race  %,C0007457;C0043157,true;true,5110/22402
> $nmbr$ / tmol / liter — no . ( % ),C0475211,false,5111/22402
renin inhibitors,C2917241;C3653375,false;false,5112/22402
not localized,C1518422,false,5113/22402
ischemic stroke without hemorrhagic conversior,C0948008;C0333275;C0475224;C0553692,false;false;false;true,5114/22402
constitutional,C1511487,false,5115/22402
smoking status  n ( % ) former,C1519386,false,5116/22402
crp ( mg / dl ) * *,C3890735;C0439269;C4048285,false;false;false,5117/22402
ularitide ( n = $nmbr$ ),C0077910,true,5118/22402
vorapaxar placebo $nmbr$ - yr . km %,C2974521;C0032042;C0439234;C3887676;C1696465;C1706408,true;true;false;false;false;false,5119/22402
cv death  ml  ischemic stroke  hosp . for hf  cor . revasc .  ua,C3538987;C0011065;C0439526;C0948008;C0018488;C0018787;C0378365;C0041580;C0042014;C0056331;C1313497;C1538440;C3273279;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;true;true;true;true;true;true;true;false;false;false;false;false;false;false;true;false,5120/22402
prior anti - tnf therapy,C0332152;C0281481;C2826257,false;false;false,5121/22402
reinfarction,,,5122/22402
sgrq total score,C2964552,false,5123/22402
first primary composite outcome,C0205435;C0205225;C0205199;C1274040;C1547335;C0439612;C0439631;C1279901,false;false;false;false;false;false;false;false,5124/22402
score on modified mini - mental state examination — median ( iqr ),C4304091;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5125/22402
hormone replacement,C0282402,true,5126/22402
composite endpoint of doubling of serum creatinine  esrd,C0205199;C2349179;C0205173;C0201976;C0022661;C0035078;C2316810;C0600061;C1705764;C2826544;C1547335,false;false;false;false;true;true;false;false;false;false;false,5127/22402
exercise ( % ),C0015259;C1522704,true;false,5128/22402
history of ischemic heart disease — no . ( % ),C0683519;C0475224;C0018787;C0730226;C0850708;C0944983,false;false;true;false;false;false,5129/22402
statin therapy,C1278454,false,5130/22402
stratified analyses,C0205363;C0002778;C0936012;C1524024,false;false;false;true,5131/22402
seated sbp at $nmbr$ weeks  mmhg + * *,C0277814;C0085805;C0439230;C0439475;C1283233,true;true;false;false;false,5132/22402
former / current smoker  n ( % ),C0337671;C0521116;C1705970;C0205156;C3173209;C3241966;C0750523,false;false;false;false;false;false;false,5133/22402
( sd )  mg / dl,C2699239;C0439269,false;false,5134/22402
primary trial end point,C2986535;C0008976,false;true,5135/22402
fasting blood glucose,C0428568;C1261430,false;false,5136/22402
number ( % ) reporting migraine on $nmbr$ - month questionnaire,C0237753;C0700287;C0149931;C0332177;C0034394;C0439231;C0449788,false;false;true;false;true;false;false,5137/22402
concomitant corticosteroid use,C0521115;C0239126,false;false,5138/22402
elevated bun ( > $nmbr$ . $nmbr$ meq / l ),C0151539;C0439375,false;false,5139/22402
slowest third,C0439834;C0205437,false;false,5140/22402
clinical features of hf,C0683325;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,5141/22402
tertile $nmbr$ index pci performed,C0600653;C4049621;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false,5142/22402
risk factor ( predefined ) for falling at screening  n ( % ),C0035648,true,5143/22402
left ventricular dysfunction,C0242698,true,5144/22402
serum cholesterol  mg / dld,C0587184;C0024671;C1414063;C2826331;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;true;false;false;false;false;false,5145/22402
acs treatment,C0742343;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4318612,true;true;true;false;false;false;false;false;false,5146/22402
< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ nt - pro - bnp,C0439445;C0369637;C0669479;C0754710;C0441923,false;false;true;true;false,5147/22402
prednisone use  %,C0032952;C0042153;C0457083;C1947944,true;true;false;false,5148/22402
actual treatment strategy,C0237400;C0039798;C0679199;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;true;false;false;false;false;false,5149/22402
other antiplatelet agent 一 no . ( % ),C0085826,true,5150/22402
% change from baseline ls means ( se ),C0392747;C0168634;C0023668;C1704970;C0036919;C1442488;C0443172;C1705241;C4319952,false;true;true;false;true;false;false;false;false,5151/22402
use of blood pressure lowering medication *,C1524063;C0020649;C0013227;C3244316;C4284232,false;true;true;false;false,5152/22402
multivessel disease 一 no . ( % ),C0012634,true,5153/22402
patients using concurrent tiotropium,C0030705,true,5154/22402
time since copd diagnosis ( yrs ),C0040223;C3541383,true;false,5155/22402
use of medications for pah — no . ( % ),C1524063;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,5156/22402
ace - i or arb use at baseline,C1452534;C0021966;C0221138;C4284014,true;true;false;false,5157/22402
medical history of diabetic retinopathy §,C0262926;C0011884,false;true,5158/22402
a $nmbr$ + ez n = $nmbr$ a $nmbr$ n = $nmbr$,C0206578,true,5159/22402
anti - tnf - naive patients $nmbr$,C1448177;C0030705,true;true,5160/22402
total patients  n,C0439175;C0030705;C0439810,false;true;false,5161/22402
heterogeneity test,C0019409;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0242960,false;false;false;false;false;false;false;false;true,5162/22402
infarction  date not reported,C0021308;C0011008;C2348077,true;true;true,5163/22402
rates per $nmbr$ patient - years,C0871208;C0030705;C0439234;C1521828,false;true;false;false,5164/22402
% difference  $nmbr$ % ci ),C1705241;C0008107;C3259781;C1705242,false;true;false;false,5165/22402
tofacitinib $nmbr$ mg bid,C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5166/22402
smoking index — pack - yr §,C0037369;C0600653;C1968515;C0439234;C2825051;C2828395;C0918012;C1552854;C1637833;C2986546;C0453996;C1881674,true;true;false;false;false;false;true;false;false;false;true;false,5167/22402
body weight ( kg )  n ( % ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,5168/22402
spironolactone,C0037982,true,5169/22402
non - frail,C1518422;C0871754,false;false,5170/22402
$nmbr$ vitamin e,C0042874;C3714803,true;false,5171/22402
low potencyc,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,5172/22402
osteopontin ( ng / ml ),C0069676;C0439275;C1420369;C1505427;C4084879,true;false;false;true;false,5173/22402
pvaluefor any mi versus no mi,,,5174/22402
prerandomization statin therapy,C1278454,false,5175/22402
multivessel cad  n ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5176/22402
glomerular filtration rate §,C0017654;C1561549,true;false,5177/22402
$nmbr$ mg sirukumab every $nmbr$ weeks ( n = $nmbr$ ),C0024671;C3254570;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5178/22402
baseline lvef  %,C0168634;C0428772;C0488728;C1442488,true;false;false;false,5179/22402
hypertension ( % ) : t,C0020538;C1963138,true;false,5180/22402
previous loss of response to infliximab  n ( % ) *,C0205156;C1517945;C0871261;C1704632;C1706817;C2911692;C1552607,false;false;false;false;false;false;false,5181/22402
number of treated vessels,C0237753;C1522326;C0005847;C0449788,false;false;true;false,5182/22402
extracranial carotid stenosis  n ( % ),C0580586;C0007282,false;true,5183/22402
coronary artery disease  n ( % ),C0010054;C0010068;C1956346,true;true;true,5184/22402
telmisartan,C0248719,true,5185/22402
physician,C0031831;C0804815,true;false,5186/22402
black and other,C0005680;C0027567;C0085756;C0439541,true;true;true;false,5187/22402
diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . . ( . % . . ) . . . . . . . . . . . . . . . . .,C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5188/22402
smokers ( at baseline ),C0337664;C0168634;C1442488,true;true;false,5189/22402
baseline use of hormone therapy ( % ),C0168634;C1524063;C0279025;C1442488,true;false;false;false,5190/22402
high hdl - c ( for men ≥ $nmbr$   mg / dl / for women ≥ $nmbr$   mg / dl ),C0205250;C3715113;C0025266;C0439269;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false,5191/22402
myocardial infarction or angina,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,5192/22402
exposed ( n = $nmbr$ ),C0332157,false,5193/22402
primary composite end point,C2986535;C0205199;C1547335,false;false;false,5194/22402
fasting insulin ( giu / ml ),C0015663;C0021641;C0439526;C1705224;C3887665;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false,5195/22402
met criterion at final ( n [ % ] ),C0428210;C0243161;C0205088;C1546485;C3853528;C1550543;C4317104,false;true;false;false;false;false;false,5196/22402
mean ( sd ) bmi ( kg / m $nmbr$ ),C0444504;C2699239;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false;false,5197/22402
mean body weight ( sd )  kg,C0444504;C0005910;C2699239;C0022718;C0439209;C4054209;C1305866;C2347634;C2348143,false;true;false;true;false;false;false;false;false,5198/22402
lean ( < $nmbr$ kg / m $nmbr$ ),C1532718,false,5199/22402
previous treatment with a laba and / or lama  n ( % ) c,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,5200/22402
new des ( n = $nmbr$ ),C0205314;C0011702;C4551552,false;true;true,5201/22402
homa - ir index — median ( iqr ),C0022065;C0600653;C0549183;C0876920;C2347635;C2348144;C2939193;C0918012;C1552854;C1637833;C2986546;C0022071;C1448132,true;true;false;false;false;false;false;true;false;false;false;true;true,5202/22402
timi risk score ( interaction : p = $nmbr$ . $nmbr$ ),C0035647;C0449820;C1704675;C4050231;C4552904,true;false;false;false;false,5203/22402
prior use of systemic,C0332152;C1524063;C0205373;C2826257,false;false;false;false,5204/22402
all randomized,,,5205/22402
obesity ( % ) §,C0028754;C1963185,true;false,5206/22402
diabetes therapy,C3274787;C3539002,false;false,5207/22402
balloon angioplasty,C0002996;C0002997,true;true,5208/22402
ibdq domain scores  mean [ sd ],C1880389;C1883221;C3541951,false;false;false,5209/22402
rosiglitazone ( n = $nmbr$ ),C0289313,true,5210/22402
smoking ( ever ),C0037369;C0453996;C1881674,true;true;false,5211/22402
patella fracture,C0159849,false,5212/22402
screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,5213/22402
medical history and risk factors,C0262926;C1704706,false;false,5214/22402
ineffective therapy,C3242229;C0039798;C0087111;C1363945,false;true;true;false,5215/22402
risk group,C0242444,true,5216/22402
hdl - c ( mg / dl ) - mean ± sd,C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,5217/22402
very severe ( gold $nmbr$ ),C3641272;C0018026;C1304897;C4050419,false;true;false;false,5218/22402
glycated hemoglobin  n ( % ),C3666909;C0062408,false;true,5219/22402
antihypertensive therapy — no . ( % ),C0585941,false,5220/22402
non - ischaemic cause,C1518422;C0475224;C0015127;C1524003,false;false;true;false,5221/22402
low periostin subgroup (  $nmbr$ ng / ml ) ( n = $nmbr$ ),C0205251;C0219433;C1079230;C0439275;C1515021;C1424662;C3812270;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false;false;false,5222/22402
infarct location — no . / total no . ( % ),C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,5223/22402
enrollment by region  no . ( % ),C1516879;C0017446;C0205147;C1696073;C3888021,false;true;false;false;false,5224/22402
fixed triple ( n = $nmbr$ ),C0443218;C0205174;C2827483;C3714578,false;false;false;false,5225/22402
multivessel stenting,C0038257;C2348535,true;false,5226/22402
estimated creatinine clearance < $nmbr$ rmb ' mint,C0750572;C0812399;C0452249;C0522467;C1337213;C1576800;C3890003,false;false;false;true;false;false;false,5227/22402
event rate,C0441471;C0871208;C1521828;C4019010,false;false;false;false,5228/22402
fev $nmbr$  litres ( pre salbutamol )  mean ( sd ),C3714541;C0475211;C0332152;C0001927;C0444504;C2699239;C2347634;C2348143;C0740175;C2257086;C3669034,true;false;false;true;false;false;false;false;false;false;false,5229/22402
gpifeellla inhibitor use before angography,C1999216;C0042153;C0457083;C1947944,false;true;false;false,5230/22402
gender  female  n ( % ),C0079399;C0043210;C0086287;C1705497;C1705498;C1522384,true;true;true;false;false;true,5231/22402
latin america or south africa,C0023122,true,5232/22402
patients with complicated events ( p = $nmbr$ - $nmbr$ 十 ),C0030705;C0231242;C0441471;C3541888,true;false;false;false,5233/22402
triglycerides $ $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l ),C0041004;C0439269;C1532563,true;false;false,5234/22402
patients with > $nmbr$ exacerbations resulting in ed visit,C0030705;C4086268,true;false,5235/22402
use of statins,C1524063;C0360714,false;true,5236/22402
time between cessation of full - dose warfarin therapy and enrollment ( mo ),C1880019;C0682295;C0366686;C0039798;C0087111;C1363945;C0178602;C4303340;C0869039;C1114758,false;false;false;true;true;false;false;false;false;false,5237/22402
egfr $nmbr$ - $nmbr$,C1739039;C3811844;C3812682,true;false;false,5238/22402
egfr > = $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ n = $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ % ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,5239/22402
peri - op ace - inhibitors / arbs : no ( n = $nmbr$ ),C0347985;C0003015;C3888198,false;true;false,5240/22402
cangrelor ( n = $nmbr$ ) n / n ( % ),C1121991,true,5241/22402
baseline fev $nmbr$ % predicted,C0168634;C3714541;C1442488,true;true;false,5242/22402
age ( range ) ( years ),C1510829;C1514721;C2348147;C3542016,false;false;false;false,5243/22402
mean — yr age group — no . ( % ),C0444504;C0439234;C0027362;C2348001;C2347634;C2348143,false;false;true;false;false;false,5244/22402
history of atrial fibrillation or flutter treatment at randomisation,C0729790,false,5245/22402
previous stenting ( % previous pci ),C0205156;C0038257;C4049621;C2348535;C1552607,false;true;false;false;false,5246/22402
bivalirudin only,C0168273;C0205171;C1720467,true;false;false,5247/22402
medical history ( % ),C0262926;C1704706,false;false,5248/22402
clopidogrel given before procedure,C0070166,true,5249/22402
ezetimibe + simvastatin ( n = $nmbr$  $nmbr$ * ),C1532737,true,5250/22402
aliskiren / valsartan ( n = $nmbr$ ),C2733073,false,5251/22402
urinary protein - to - creatinine ratio | |,C1096054,false,5252/22402
cerebrovascular accident,C0038454,true,5253/22402
male sex — no . ( % ) weight — no . ( % ),C0086582,true,5254/22402
weight — no . ( % ),C0005910;C0043100;C1305866;C1705104,true;true;false;false,5255/22402
$nmbr$ non - mtx,C1518422;C0025677;C1417487,false;true;false,5256/22402
fasting triglycerides — mg / dl,C0015663;C0041004;C0439269,true;true;false,5257/22402
concomitant csdmards other than methotrexate  n ( % ),C0521115;C0025677,false;true,5258/22402
( b ) concomitant respiratory medications [ n ( % ) ],C0521115;C0418986,false;false,5259/22402
copd population ( n = $nmbr$ ),C0024117;C0032659;C1257890;C1412502;C3714496,true;true;true;false;false,5260/22402
ibdq score  mean ( sd ),C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false,5261/22402
lifestyle,C0023676,true,5262/22402
disease location  %,C0012634;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,5263/22402
haq - di  number ( % ),C3826998;C0237753;C0449788;C4321476,false;false;false;false,5264/22402
cardiac pacemaker — no . ( % ),C0030163;C0037189,true;true,5265/22402
patient ' s preference not to take,C0376409,true,5266/22402
tofacitinib  $nmbr$ mg twice daily,C2930696;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,5267/22402
diet + pravastatin group,C0012155;C0085542;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0012159;C1519433;C2983588;C3668949,true;true;false;false;true;false;false;false;true;false;false;false,5268/22402
glycated hemoglobin level,C0202054,false,5269/22402
asthma population ( n = $nmbr$ ),C0004096;C0032659;C1257890;C2984299,true;true;true;false,5270/22402
albumin creatinine ratio,C0486293;C1318293,false;false,5271/22402
apolipoproiein b ( mij / $nmbr$ ),,,5272/22402
aliskiren ( dm - vs . dm + ),C1120110;C0011816;C3250443,true;true;false,5273/22402
regadenoson,C1698215,true,5274/22402
change in erosion score ( mean ),C0392747;C0333307;C3533236;C1880549;C1959609;C3887524;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false;false,5275/22402
fecal calprotectin — pg / g * *,C0015733;C0950624;C1638318;C1335798;C1366582,true;true;false;false;false,5276/22402
infarction before age $nmbr$ ( a ),C0021308;C0001779,true;false,5277/22402
patients  no . / total no . ( % ),C0030705,true,5278/22402
prior biologic use,C0332152;C0005515;C0042153;C0457083;C1947944;C0205460;C2826257,false;true;true;false;false;false;false,5279/22402
time since diagnosis of type $nmbr$ diabetes - no . ( % ),C0040223;C3541383,true;false,5280/22402
metabolic syndrome visit $nmbr$ low - density lipoprotein cholesterol strata,C0524620,true,5281/22402
nonbiologic disease - modifying drug other than methotrexate : :,C0392747;C4036059;C0025677,false;false;true,5282/22402
moderate risk ( $nmbr$ - $nmbr$ ),C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,5283/22402
csf a ( $nmbr$ ( pm ),C3540512;C3889436,false;false,5284/22402
combination - facilitated pci ( % ),C0205195;C4049621;C1947911;C3811910,false;false;false;false,5285/22402
time since psa diagnosis ( years )  mean ( sd ),C0040223;C3541383,true;false,5286/22402
deep - vein thrombosis,C0149871,true,5287/22402
> $nmbr$ to < $nmbr$ - $nmbr$ mg / week,C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;false;false;false;false,5288/22402
aspirin alone ( n / n ),C0004057;C0205171;C0439044;C0679994,true;false;false;false,5289/22402
prior treatment — %,C1514463,false,5290/22402
homa - ir ( % ) b,C0022065;C0022071;C1448132,true;true;true,5291/22402
duration of diabetes  median ( iqr ),C0449238;C0011847;C0549183;C0876920;C2347635;C2348144;C2939193;C0011849;C2926735,false;false;false;false;false;false;false;true;false,5292/22402
interquartile range height — cm,C1711350;C0489786,false;false,5293/22402
mild thrombocytopenia ( < $nmbr$ x $nmbr$ / l ),C1856453,false,5294/22402
reversibility ( anticholinergic )  %  mean ( sd ) $,C0449261;C0242896;C0444504;C2699239;C2347634;C2348143;C3537004,false;true;false;false;false;false;false,5295/22402
number of exacerbation in the previous $nmbr$ months  n ( % ),C0237753;C4086268;C0449788,false;false;false,5296/22402
established cvd ( age > $nmbr$ ),C0443211;C0007222;C0001779;C1272684,false;true;false;false,5297/22402
crci > $nmbr$ - < $nmbr$,,,5298/22402
who functional class ii / iii,C0205245;C0441887;C1710602;C4082587;C2698969;C0441886;C0439070;C1705160;C2698968;C0542341;C2700217,false;false;false;false;false;false;false;false;false;false;false,5299/22402
( n $nmbr$ $nmbr$ ),C0369718;C0441922,false;false,5300/22402
cigarette smoking in the past year,C0239059;C4086728;C0700219,false;false;true,5301/22402
candesartan,C0717550,true,5302/22402
previous pci / cabg  n ( % ),C0205156;C4049621;C0010055;C1552607,false;false;true;false,5303/22402
coronary angiography during the index hospitalization,C0085532;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546;C1548829;C0428776;C0002978,true;true;true;true;false;false;false;false;false;true,5304/22402
baseline free pcsk $nmbr$ level by median,C0168634;C0332296;C0441889;C0549183;C0876920;C2347635;C2348144;C2939193;C0456079;C1547707;C2946261;C1880497;C1996904;C1442488,true;false;false;false;false;false;false;false;false;false;false;false;false;false,5305/22402
( se ] tf total - c,C0036919;C4048299;C0439175;C0439810;C4048587,true;false;false;false;false,5306/22402
continued thienopyridine %,C0549178;C1120149,false;true,5307/22402
before pci,C4049621,false,5308/22402
glomerular filtration rate  $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0017654;C0439445;C0369637;C0441923;C1561549,true;false;false;false;false,5309/22402
elevated troponin t ( > $nmbr$ . $nmbr$ / xg / l ),C0205250;C0077404;C0017209;C1292284;C1421532;C1420827;C3163633,false;true;true;false;false;false;false,5310/22402
rivaroxaban,C1739768,true,5311/22402
prior history ml or stroke,C0332152;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;false;false;true;false;false;false;false;false,5312/22402
atorvastatin $nmbr$ mg ( n = $nmbr$  $nmbr$ ),C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5313/22402
alcohol  % with > $nmbr$ drink / d,C0001948;C0556297,true;false,5314/22402
western europe and lebanon,C0043129,true,5315/22402
body mass index  kg / m $nmbr$ ( sd ),C0005893;C1532718;C2699239;C0578022;C1305855,false;false;false;false;true,5316/22402
current smoker ( > $nmbr$ cigarettes / day ) — no . ( % ),C3173209;C0677453;C0332173;C0439228;C0439505;C3241966,false;true;false;false;false;false,5317/22402
atorvastatin $nmbr$ mg ( n = $nmbr$ ),C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5318/22402
unstable angina > $nmbr$ mo ago,C0002965;C0026544;C0332177,true;true;false,5319/22402
amlodipine / valsartan $nmbr$ / $nmbr$ vs $nmbr$ / $nmbr$ mg,C1962523,true,5320/22402
mean ( s . d . ) apob  mg / dl,C0444504;C0003593;C0439269;C3252643;C2347634;C2348143,false;true;false;true;false;false,5321/22402
tobacco use — no . ( % ),C0040335;C0543414;C0841002;C3853727,false;true;false;false,5322/22402
previousdistaldeep - veinthrombosisorsuperficial - vein thrombosis,C0042487,true,5323/22402
dapagliflozin $nmbr$ mg / day ( n = $nmbr$ ),C2353951;C0439422,true;false,5324/22402
edema  peripheral,C0013604;C1717255,true;false,5325/22402
peripheral vascular disease,C0085096,true,5326/22402
angina ( past $nmbr$ weeks ),C0002962;C2987125,true;false,5327/22402
drug - eluting stent implanted,C1322815,true,5328/22402
rhabdomyolysis ( n = $nmbr$ ),C0035410;C4552660,true;false,5329/22402
hospitalizations  n,C0019993,true,5330/22402
baseline heart failure severity amongthose with priorheartfailure  %,C0168634;C0018801;C0439793;C0522510;C0018802;C4554158;C1442488,true;true;false;false;true;false;false,5331/22402
patients with end point,C0030705;C2349179;C2826544,true;false;false,5332/22402
us resident,C1320928;C1549439;C2347958;C3835651,false;false;false;false,5333/22402
less than $nmbr$ mm hg,C0439092;C0439475,false;false,5334/22402
p value for mra vs no mra,C1709380;C0243032;C1609165;C3891069,false;true;true;false,5335/22402
insulin - treated diabetes,C0021641;C1533581;C1579433;C3714501,true;false;false;false,5336/22402
$nmbr$ rrmnl ),,,5337/22402
metastatic disease,C0027627;C2939419;C2939420,true;false;false,5338/22402
no stroke n = $nmbr$ $nmbr$,C0038454;C4554100,true;false,5339/22402
physical component score ( pcs ),C4483112;C0449432;C1864389;C1882368;C1705248,false;false;false;true;false,5340/22402
bmi > $nmbr$ — no . ( % ) f,C0578022,false,5341/22402
oral contraceptive pills — no . / total no . ( % ),C0009905;C0009906;C0029151,true;true;false,5342/22402
renal function  moderate,C0232804,false,5343/22402
$nmbr$ - yr risk of coronary heart disease ( % ) ^ |,C0439234;C1277690,false;false,5344/22402
llt other than statin at randomization,C2347090;C0360714,false;true,5345/22402
other antihypertensive agents,C0003364,true,5346/22402
ace inhibitor at enrollment,C0003015;C1516879;C1696073;C3888021;C4541021,true;false;false;false;false,5347/22402
b - agonists ( short - acting ) a,C0243192;C2987634,true;false,5348/22402
egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ n = $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ % ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,5349/22402
hemoglobin a $nmbr$ c  mean ( sd )  % b,C0062248;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,5350/22402
duration of ulcerative colitis,C0449238;C0009324;C2926735,false;true;false,5351/22402
positive for rheumatoid factor — no . ( % ) : t,C0439178;C0035448;C0201660;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false,5352/22402
euroscore logistic  median ( $nmbr$ th  $nmbr$ th % ) £,C3164744;C0242415;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;true;false;true;true;false;false;false;false;false;false;false,5353/22402
simvastatin $nmbr$ mg plus fenofibrate $nmbr$ mg ( n = $nmbr$ /,C0074554;C1319635;C0332287;C0033228,true;false;false;true,5354/22402
age — mean ( sd ) ( years ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5355/22402
cerebrovascular or peripheral arterial disease  n ( % ),C1880018,false,5356/22402
low feno subgroup (  $nmbr$ . $nmbr$ ppb ) ( n = $nmbr$ ),C0205251;C1079230;C1415800;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false;false,5357/22402
blood - pressure medications at randomization — no . / total no . ( % ),C0849164;C0033095;C0034656;C0460139;C1306345;C4284008;C0005823;C0013227;C0802604;C2598133;C4284232;C1271104;C1272641,false;true;true;false;false;false;true;true;false;false;false;false;true,5358/22402
index event  n ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,5359/22402
other or missing data,,,5360/22402
number of copd exacerbations in the previous year  n ( % ),C0237753;C0740304;C0449788,false;false;false,5361/22402
rivaroxaban plus aspirin ( n = $nmbr$ ),C1739768;C0332287;C0004057,true;false;true,5362/22402
diuretics * *,C0012798,true,5363/22402
one vessel,C0205447;C0005847,false;true,5364/22402
intended duration of anticoagulation,C1283828;C0449238;C0003281;C2917212;C2919015;C3537050;C2926735;C1551357,false;false;false;false;false;false;false;false,5365/22402
non - stenotic vessels  n ( % ),C1518422;C0679403,false;false,5366/22402
gusto severe,,,5367/22402
> $nmbr$ . $nmbr$ bpm current smoker,C3173209;C3241966,false;false,5368/22402
patients with any clinical event,C0030705;C0205210;C0441471;C4019010,true;false;false;false,5369/22402
previous diabetes,C0205156;C0011847;C0011849;C1552607,false;false;true;false,5370/22402
mmrc dyspnea scale  n ( % ),C3826977;C0013404;C0175659;C0349674;C1947916;C1963100,false;true;true;false;false;false,5371/22402
brv $nmbr$ mg / day ( n = $nmbr$ ),C0155502;C0439422,true;false,5372/22402
urinary tract infection,C0042029;C0262655;C4554638,true;false;false,5373/22402
baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$,C0168634;C0578022;C1532718;C1442488,true;false;false;false,5374/22402
hospitalization for heart failure,C3898876,false,5375/22402
any history of congestive heart failure,C0455531;C0742742,false;false,5376/22402
time from study drug administration to coronary revascularization  median ( iqr )  h,C0040227;C0150270;C3469597;C0206209;C0013175;C2349982,true;false;false;true;true;false,5377/22402
heart failure ( class i — iii ),C0018801;C0441887;C0021966;C0221138;C2698969;C0441885;C0439070;C1705160;C1319793;C2698967;C0018802;C4554158,true;false;true;false;false;false;false;false;false;false;true;false,5378/22402
c - reactive protein — mg / liter * *,C0006560;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,true;true;false;true;false;false;false;false;false;false;false,5379/22402
liraglutide $nmbr$ . $nmbr$ mg  n = $nmbr$  $nmbr$,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5380/22402
placebo $nmbr$ yr km %,C0032042;C0439234;C3887676;C1696465;C1706408,true;false;false;false;false,5381/22402
prebronchodilator fev $nmbr$ ( % predicted normal ) t,C2599602;C3714541,false;true,5382/22402
rest of world,C0035253;C2700280;C1622890,true;false;false,5383/22402
mean age ( sd )  y,C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,5384/22402
low - molecular weight heparin or intravenous unfractionated heparin,C0019139;C3536766,true;false,5385/22402
$nmbr$ early intervention ( n = $nmbr$ ),C0242687;C1964029,true;false,5386/22402
no statin ( + / - llt ),C0360714;C2347090,true;false,5387/22402
treatment satisfaction,C3476649,false,5388/22402
pathologic q waves — no . ( % ),C0429090,false,5389/22402
total periventricular wml score  mean ( sd ),C2964552;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5390/22402
laboratory values at admission ( median and iqr ),C0022877;C0042295;C0184666;C0549183;C0876920;C2347635;C2348144;C2939193;C0809949;C3244292;C4283904,true;false;false;false;false;false;false;false;false;false;false,5391/22402
corticosteroid use  $nmbr$ n ( % ),C0239126,false,5392/22402
use of inhaled glucocorticoids at screening — no . ( % ),C1524063;C0004048;C0017710;C3540777;C3540778,false;true;true;false;false,5393/22402
comorbidity score  mean ( sd ) t,C0009488;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,true;false;false;false;false;false;false,5394/22402
non - smokers ( at baseline ),C0337672;C0168634;C1442488;C4554605,false;true;false;true,5395/22402
tender joint count ( n / $nmbr$ ),C0451530,false,5396/22402
total intravenous loop diuretics  mg,C0439175;C0348016;C0354100;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439810,false;false;true;true;true;false;false;false;false;false;false,5397/22402
atorvastatin $nmbr$ mg + ezetimibe $nmbr$ mg ( n = $nmbr$ ),C0286651;C1319635;C1142985,true;false;true,5398/22402
angiotensin ll - receptor antagonist — no . ( % ),C0003018;C4521302,true;false,5399/22402
mean serum glucose  mg / dl  mean = sd,C0444504;C0202041;C0439269;C2699239;C3534430;C2347634;C2348143,false;false;false;false;false;false;false,5400/22402
gold stage ( % ) f,C0018026;C0205390;C0016327;C1300072;C1306673;C1304897,true;false;true;false;false;false,5401/22402
non - hdl - c / hdl - c,C1518422;C3715113,false;false,5402/22402
multivessel ( two vessel  three vessel  or left main ),C4012475;C0205449;C4037954,false;false;false,5403/22402
body weight index ( kg / m $nmbr$ ),C0005910;C0600653;C1532718;C0918012;C1552854;C1637833;C2986546;C1305866,true;true;false;true;false;false;false;false,5404/22402
triglycerides  mmolt $nmbr$ ( gm * ),C0041004;C0017480;C3854019,true;true;true,5405/22402
procalcitonin ( ng / ml ),C0072027;C0439275,true;false,5406/22402
fasting blood glucose > $nmbr$ mg / dl,C0428568;C0439269;C1261430,false;false;false,5407/22402
category $nmbr$,C0683312;C3889287,false;false,5408/22402
type of event,C1561488,false,5409/22402
quality of life,C0034380;C0518214,true;false,5410/22402
diagnosis ( y )  mean ( sd ),C0011900;C0444504;C2699239;C2347634;C2348143;C1704338;C1704656,true;false;false;false;false;true;false,5411/22402
persistent or permanent immobilization,C0205322;C0332996,false;false,5412/22402
modified rankin scale at screening  $nmbr$ - $nmbr$,C2984908;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3854213,false;true;true;false;false;false;false;false;false,5413/22402
placebo $nmbr$ . $nmbr$ pt yrs,C0032042;C0032743;C0699718;C1696465;C1706408,true;true;false;false;false,5414/22402
diet controlled or no,C0743195,false,5415/22402
body weight,C0005910;C1305866,true;false,5416/22402
cvd  mi  or stroke,C0007222;C3810814,true;false,5417/22402
no . of patients / no . of events,C0030705,true,5418/22402
intravenous study drug administered — no . ( % ),C0683092;C0557651;C2603343;C0348016;C0013175,false;false;false;false;true,5419/22402
number of females n ( % ),C0237753;C0086287;C0449788,false;true;false,5420/22402
> $nmbr$ . $nmbr$ % and ≤ $nmbr$ . $nmbr$ %,,,5421/22402
treatment with statins,C0039798;C0360714;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,5422/22402
prior heart failure  n ( % ),C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,5423/22402
systemic symptoms,C0205373;C0683368;C1457887,false;true;false,5424/22402
persistent or paroxysmal,C0205322;C0332996,false;false,5425/22402
metabolic syndrome w / o t $nmbr$ dm,C0524620;C0011816;C3250443,true;true;false,5426/22402
stroke — no . / total no . ( % ),C0038454;C4554100,true;false,5427/22402
nice primary prevention onlyb,C4087029;C0033144,false;true,5428/22402
cv death  mi  ischemic stroke  hospitalization for hf  coronary revascularization  ua,C3538987;C0011065;C3810814;C0948008;C0019993;C0018488;C0877341;C0041580;C0042014;C1313497;C1538440;C3273279;C1306577;C0376297;C0581603;C4082313;C4552775;C4048877;C4318503,false;true;false;false;true;true;false;true;true;true;false;false;false;true;false;false;false;true;false,5429/22402
change from pre - to,C0392747;C0332152;C0740175;C2257086;C3669034;C0443172;C1705241;C4319952,false;false;false;false;false;false;false;false,5430/22402
any lipid - lowering agent,C0086440,true,5431/22402
abatacept,C1619966,true,5432/22402
indacaterol - glycopyrronium group,C1722260;C3814772;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;false;true;false;false;false,5433/22402
warfarin naive,C0043031,true,5434/22402
prior or new diabetes,C0332152;C2826257,false;false,5435/22402
tender and swollen joints — mean no . : :,C0234234,false,5436/22402
systolic blood pressure > $nmbr$ mm hg or diastolic blood pressure > $nmbr$ mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,5437/22402
rolofylline ( n = $nmbr$  $nmbr$ ),C0166128,true,5438/22402
total stent length ( mm )  mean ± sd,C0439175;C0038257;C1444754;C4330985;C0444504;C2699239;C2347634;C2348143;C4554674;C1706316;C0439810,false;true;false;false;false;false;false;false;false;false;false,5439/22402
swollen joint count ( $nmbr$ joints ),C0451521,false,5440/22402
mean $nmbr$ sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,5441/22402
previously taken methotrexate  %,,,5442/22402
gusto moderate,,,5443/22402
procedure * *,C0184661;C2700391;C3274430;C3539779,true;false;false;false,5444/22402
hormone replacement ! !,C0282402,true,5445/22402
other cardiovascular risk factors,C0850624,false,5446/22402
severe copdc [ n z $nmbr$ ],C0205082;C4050465;C4050466,false;false;false,5447/22402
cardiac biomarker status !,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,5448/22402
$nmbr$ - mercaptopurine,C0000618,true,5449/22402
patient presentation,C0030705;C0449450,true;false,5450/22402
baseline serum k +  meq / l,C0168634;C0302353;C0439375;C1442488,true;false;false;false,5451/22402
other sulfonylurea 一 no . ( % ),C0038766;C3536898,true;false,5452/22402
hctz * ( n = $nmbr$ ),C0020261,true,5453/22402
cardiometabolic syndrome  ^ n ( % ),C0039082,true,5454/22402
carotid artery — no . ( % ),C0007272;C0162859,true;true,5455/22402
cardiac valve surgery : no ( n = $nmbr$ ),C0018821;C0184252;C1186983;C1704414;C3888056;C0524727;C0018826;C0038894;C0038895;C0543467;C1274039,true;false;false;false;false;true;true;false;true;true;true,5456/22402
other cause,C0015127;C1524003,true;false,5457/22402
beyond popliteal pedal,C0442037;C0016504;C0687080,false;true;false,5458/22402
> $nmbr$ cv risk factors 咐 or established atherosclerotic cv disease,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,5459/22402
oral anticoagulant drugs,C0354604,false,5460/22402
fracture history ( predefined )  n ( % ),C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,5461/22402
any coronary revascularization,C0877341,false,5462/22402
ex - / current smoker,C0337671;C0521116;C1705970;C4555205;C1704625;C3173209;C3241966,false;false;false;true;false;false;false,5463/22402
vorapaxar $nmbr$ - y,C2974521,true,5464/22402
fluindione  no . ( % ),C0117899,true,5465/22402
current n z $nmbr$,C0521116;C1705970,false;false,5466/22402
concomitant oral corticosteroids  n ( % ) * *,C0521115;C0442027;C0001617;C3539185;C3540725;C3540726;C3540727;C4521986,false;false;true;false;false;false;false;false,5467/22402
anaesthesia / analgesia,C0002905,true,5468/22402
local eosinophil count ( cells per pl ) t,C0205276;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879,false;false;true;false;false;true;false,5469/22402
age ( years )  mean ( s . d . ),C1510829;C0444504;C2347634;C2348143,false;false;false;false,5470/22402
ethnic group ( % ),C0015031;C1879937,true;false,5471/22402
physician ' s global assessment ( vas ),C4050369;C0042815;C3536884;C3827561,false;true;true;false,5472/22402
antihypertensive drugs,C0003364,true,5473/22402
median age — yr §,C0549183;C0001779;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,5474/22402
cad and / or crvd ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5475/22402
chronic obstructive lung disease,C0024117,true,5476/22402
exercise category ( % ),C3669314,false,5477/22402
prior congestive heart failure yes,C0332152;C0018802;C1549445;C1705108;C1710701;C2826257,false;true;false;false;false;false,5478/22402
secondary prevention subgroup,C0679699;C1079230;C1515021,true;false;false,5479/22402
aspirin $nmbr$ mg ( n = $nmbr$ ),C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5480/22402
night - time awakenings / week,C0860510;C0332174;C0439230,false;false;false,5481/22402
non - hdl - c  mean ( sd )  rng / dl,C1518422;C3715113;C0444504;C2699239;C3642216;C2347634;C2348143,false;false;false;false;false;false;false,5482/22402
laa closure ( n - $nmbr$ ),C0185003;C1521802,false;false,5483/22402
p - value * ' ',C1709380,false,5484/22402
known prothrombotic genotype,C0205309;C0017431,false;true,5485/22402
> $nmbr$ concomitant medication,C0521115;C0013227;C3244316;C4284232,false;true;false;false,5486/22402
function subscale,C0031843;C0542341;C0700205;C1705273,true;false;false;false,5487/22402
high risk and more symptoms ( group d ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,5488/22402
white ( $nmbr$ . $nmbr$ % ),C0007457;C0043157;C0220938,true;true;false,5489/22402
osteoarthritis,C0029408,true,5490/22402
age ( y )  median ( $nmbr$ th to $nmbr$ th percentiles ),C0001779;C0549183;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false;false,5491/22402
history of microalbuminuria — no . ( % ),C3532606,false,5492/22402
tender joint count ( $nmbr$ joints )  mean ( sd ),C0451530;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5493/22402
$nmbr$ mg / day delayed - start,C0439422,false,5494/22402
documented symptomatic chdb,C1301725;C0231220;C1609436,false;false;false,5495/22402
c - reactive protein,C0006560;C1413716;C4048285,true;false;false,5496/22402
ejection fraction  percent ( sd ),C0489482;C0439165;C2699239;C2700378,false;false;false;false,5497/22402
previous pneumonia,C0205156;C0032285;C1552607,false;true;false,5498/22402
das $nmbr$ - esr remission  %,C0051767;C3811131;C0544452;C0687702;C0057671,true;false;false;false;true,5499/22402
budesonide — no . ( % ),C0054201,true,5500/22402
linagliptin  patients with events / total patients,C2746078;C0030705;C0441471;C0439175;C0439810;C3541888,true;true;false;false;false;false,5501/22402
middle tg tertile,C0444598;C0337445;C0549183;C1552826,false;false;false;false,5502/22402
density lipoprotein  csf =,C0178587;C0023820;C3540512;C3889436,false;true;false;false,5503/22402
hscrp  median ( min  max )  mg / l,C0549183;C2827895;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5504/22402
concomitant medication after randomisation,C0521115;C0013227;C0034656;C3244316;C4284232,false;true;true;false;false,5505/22402
non - black ( n = $nmbr$ ),C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,5506/22402
dmard or corticosteroid,C0242708,true,5507/22402
non - epa number of <,C1518422;C0237753;C0449788,false;false;false,5508/22402
hbalc tx difference vs pbo  median change from baseline ( se ) $nmbr$,C0041403;C1705241;C1705242,true;false;false,5509/22402
trough fevi l,C0444506;C0429706;C0849974;C1561566;C4528367,false;false;false;false;false,5510/22402
eq - $nmbr$ d ( visual analog score ),C0205163;C0234621;C0243071;C0449820;C4050231;C0439185,false;false;false;false;false;false,5511/22402
antihypertensive medication  open - label  no . ( % ),C0003364,true,5512/22402
mer ’ s disease assessment,C0673013;C0012634;C1261322;C1516048;C3810521;C4281714,true;true;false;false;false;false,5513/22402
baseline ldl - c strata  n ( ° / o ),C0168634;C1442488,true;false,5514/22402
with alogliptin $nmbr$ . $nmbr$ mg,C1958126;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5515/22402
anacetrapib ( n = $nmbr$ ),C2604745,true,5516/22402
secondary dvt . ' fe,C0027627;C0149871;C3848561;C2926618;C3899446;C0175668;C0205436,true;true;false;false;false;false;false,5517/22402
with laba  n ( % ) pretreatment,C1550147;C2709094;C3539075;C3539076,false;false;false;false,5518/22402
basal insulin analogue dose * ( coefficient,C0650607;C0243071;C0178602;C1707429;C0869039;C1114758;C0205112;C0366513;C2825028,false;false;false;false;false;false;false;false;false,5519/22402
theophyllines,C0039771,true,5520/22402
angina class iii or iv — no . ( % ),C0264677,false,5521/22402
n ( $nmbr$ yr km event rate  % ),C0369718;C0439234;C3887676;C0441471;C0871208;C1521828;C4019010;C0441922,false;false;false;false;false;false;false;false,5522/22402
age — year ( median ),C0001779;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C0439508,false;false;false;false;false;false;false;false,5523/22402
tnt and ideal ( pooled ),,,5524/22402
cabg or ptca / pci,C0010055,true,5525/22402
ex - smoker ( n z $nmbr$ ),C0337671;C4555205,false;true,5526/22402
event rate ( % ) of primary endpoints,C0441471;C0871208;C2986535;C1521828;C4019010,false;false;false;false;false,5527/22402
insulin - dependent diabetes,C0011854,true,5528/22402
malignancy at randomization,C0006826;C0034656;C1306459;C4282132,true;true;false;false,5529/22402
short - acting,C1282927;C0079613;C1704930;C1869853;C3890007;C4048375;C1806781;C2350002,false;true;false;true;false;false;false;false,5530/22402
serum potassium  meq / l,C0302353;C0439375;C0543465,false;false;false,5531/22402
rest of world n z $nmbr$,C0035253;C2700280;C1622890,true;false;false,5532/22402
never smoked  n ( % ),C2003901;C0037366;C0439994;C1881674,false;true;false;false,5533/22402
seizure worry,C0036572;C0233481;C1959629;C4553401,true;false;false;false,5534/22402
placebo group ( n = $nmbr$ $nmbr$ ) ( $nmbr$ $nmbr$ person years ),C0032042;C0441848;C0027361;C0439234;C2347489;C1696465;C1706408,true;false;true;false;false;false;false,5535/22402
rest - of - world ( n = $nmbr$ ),C0035253;C2700280;C1622890,true;false;false,5536/22402
no use ofdiabetes drugs — no . ( % ),C0240320,false,5537/22402
no estimate,C0750572,false,5538/22402
baseline ( n ),C0168634;C1442488,true;false,5539/22402
pci > $nmbr$ month ago,C4049621;C0332177;C0439231,false;false;false,5540/22402
swollen joint count ( $nmbr$ joints )  mean ( sd ),C0451521;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5541/22402
> $nmbr$ years $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ),C0439234,false,5542/22402
time in therapeutic range before inclusion,C1554109;C0087111;C0302350;C0040223;C0460097;C3541383,false;true;false;true;false;false,5543/22402
initial diagnosis — no . ( % ),C0205265;C0011900;C1704338;C1704656;C1279901;C1555582;C1705685,false;true;true;false;false;false;false,5544/22402
angiotension converting enzyme - inhibitor,C0014432;C0919438;C4521603,true;false;false,5545/22402
xanthines,C0043318;C3541955,true;false,5546/22402
management distribution medical treatment,C0030677;C0520511;C0199168;C0205476;C1704711;C0001554;C0679624;C0376636;C1273870;C3273539,true;false;false;false;true;true;false;true;false;false,5547/22402
pharmaco - invasive ( n = $nmbr$ ),C0205281;C1334278,false;false,5548/22402
estrogen - containing hormones,C0014939;C0332256;C0019932;C2700400;C2936882;C4542544,true;false;true;false;false;false,5549/22402
uac $nmbr$ - $nmbr$ mg / g,C1300563,false,5550/22402
$nmbr$ % < hba $nmbr$ c < = $nmbr$ % ( n $nmbr$ $nmbr$ ),C0019016;C1825777;C3538758,true;false;false,5551/22402
mean ( s . d . ) measured ldl cholesterol,C0444504;C2347634;C2348143,false;false;false,5552/22402
history of hypertension — no . ( % ),C0455527,false,5553/22402
prior cv history  n ( % ),C0332152;C3538987;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4048877;C4318503;C2826257,false;false;true;true;false;false;false;false;true;false;false,5554/22402
time to end - of - study ivus  median ( iqr )  days,C0439548;C0444930;C0557651;C1456025;C0549183;C0876920;C2347635;C2348144;C2939193;C2603343;C2746065,false;false;false;false;false;false;false;false;false;false;false,5555/22402
steroids ( inhaled ) a,C0038317,true,5556/22402
> q $nmbr$ ( $nmbr$ . $nmbr$ ) - q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % ),C0237753;C0449788,false;false,5557/22402
previous angioplasty  n ( % ),C0205156;C0162577;C1548817;C1552607,false;true;false;false,5558/22402
time since diagnosis of diabetes,C0040223;C3541383,true;false,5559/22402
uric acid tertile $nmbr$ ( $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mg / dl ),C0041980;C0439269,true;false,5560/22402
major hypoglycemia,C0205082;C0020615;C4553659;C0205164;C4318856;C4521762,false;true;false;false;false;false,5561/22402
prosper,,,5562/22402
dyspnea at rest ( nyha iv )  ( % ),C0743330;C1275491;C0022326;C4265176,false;false;true;false,5563/22402
czech republic,C0206578,true,5564/22402
gusto moderate or severe bleeding,,,5565/22402
baseline cdai,C0168634;C0683448;C1413248;C3273706;C1442488,true;false;false;false;false,5566/22402
% change from baseline  mean ( s . e . ),C0392747;C0168634;C0444504;C2347634;C2348143;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false;false;false;false,5567/22402
enalapril + aliskiren ( n = $nmbr$ ),C0014025;C1120110,true;true,5568/22402
non - calcium antagonist strategy ( n = $nmbr$ $nmbr$ ),C1518422;C0006684;C0679199,false;true;false,5569/22402
ankle fracture,C0159877;C4552974,true;false,5570/22402
number standard care,C0237753;C1442989;C1947933;C2828392;C0449788,false;false;false;false;false,5571/22402
digitalis  n ( % ),C0012252;C0304520,true;false,5572/22402
warfarin at last follow - up,C0043031;C0589120;C1522577;C1704685;C3274571,true;false;false;false;false,5573/22402
pci data,C4049621;C1511726;C3245479;C3714741,false;false;false;false,5574/22402
end of follow - up,C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,5575/22402
handihaler only  n,C0205171;C1720467,false;false,5576/22402
certolizumab pegol ( n = $nmbr$ ),C1872109,true,5577/22402
mean — ml / min / $nmbr$ . $nmbr$ m $nmbr$ level — no . ( % ),C0444504;C0439445;C0369637;C0441889;C0456079;C1547707;C2946261;C0441923;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false,5578/22402
egfr via mdrd ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C1739039;C3839656;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,5579/22402
core laboratory percent stenosis,C0444669;C0022877;C0439165;C0678234;C1261287;C2632116;C3244292;C4283904;C1167518;C1706352;C1882467;C3274653,false;true;false;false;true;false;false;false;false;false;false;false,5580/22402
native american / alaskan,C0682125;C0596070;C0282204;C0238611;C1515945,true;false;true;false;false,5581/22402
mean cdai score ( sd ),C0444504;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false,5582/22402
insulin glargine vs standard care least - squares mean ( $nmbr$ % cl ),C0907402,true,5583/22402
difference in ls mean $nmbr$ ( $nmbr$ % cl ),C1705241;C0023668;C0444504;C0596019;C2347634;C2348143;C1705242,false;true;false;false;false;false;false,5584/22402
prior diagnosis - no . ( % ),C0332132,false,5585/22402
moderate - dose statin,C1709056;C0360714,false;true,5586/22402
tnf - alpha ( pg / ml ),C1448177;C0439297;C1456820;C1522669,true;false;true;false,5587/22402
antithrombotic drug use at time of event,C0013227;C1524063;C0040223;C0441471;C4019010;C3541383;C1254351,true;false;true;false;false;false;false,5588/22402
jbs - $nmbr$ secondary prevention only $nmbr$,C0175692;C0679699;C0205171;C1720467;C0795841;C1416527,true;true;false;false;true;false,5589/22402
full cohort,C0443225;C0009247;C0599755,false;true;false,5590/22402
c - peptide,C0006558,true,5591/22402
immobilization,C0020944;C4048292,true;false,5592/22402
death  mi  idr  st  or gusto moderate / severe bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,5593/22402
thienopyridine ( n = $nmbr$ ),C1120149,true,5594/22402
$nmbr$ - year framingham chd risk  %,C0439234;C3166866;C1282512;C0439508,false;false;false;false,5595/22402
etoricoxib,C0972314,true,5596/22402
previous coronary artery disease  n ( % ),C0205156;C0010054;C0010068;C1956346;C1552607,false;true;true;true;false,5597/22402
elevated cardiac markers,C0205250;C1271630;C3163633,false;false;false,5598/22402
ifx + aza ( n = $nmbr$ ),C0020823;C0004482,true;true,5599/22402
open - label clopidogrel after completion of study drug,C1709323;C0070166;C0205197;C0013227;C1254351;C1554962,false;true;false;true;false;false,5600/22402
baseline low - density lipoprotein cholesterol ( mg / dl ),C0168634;C0023824;C0439269;C1442488,true;true;false;false,5601/22402
symptom onset to randomization,C4086878;C0034656,false;true,5602/22402
stricturing,C1261287,true,5603/22402
insulin tx difference vs pbo  median change from baseline ( se ) $nmbr$,C0021641;C0041403;C1705241;C1705242;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,5604/22402
duration of rheumatoid arthritis ( years ),C0449238;C0003873;C0439234;C2926735,false;true;false;false,5605/22402
beta - blocker — no . / total no . ( % ),C0001645,true,5606/22402
second loading dose,C0205436;C3714444;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,5607/22402
trochanter,C0162370,true,5608/22402
low perceived social support only,C0205251;C0030971;C0037438;C0205171;C1720467;C0748877;C1540833;C3669642;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;true;false;false;true;false;false;false;false;false;false;false,5609/22402
white / other,C0007457;C0043157;C0220938,true;true;false,5610/22402
treatment groups [ n / nb ( % ) ],C0039798;C0441848;C0028101;C0919442;C1705347;C4553907;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;true;false;false;false;false;false,5611/22402
cardiovascular medication usage,C0007220;C0457083,true;false,5612/22402
non - calcium antagonist strategy ( ncas ) ( events / n ),C1518422;C0006684;C0679199;C1413309;C0441471;C3541888;C3813543,false;true;false;false;false;false;false,5613/22402
simvastatin ( $nmbr$ / $nmbr$ mg / d ) ( n = $nmbr$ ),C0074554;C0439422,true;false,5614/22402
baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$,C0168634;C0578022;C1532718;C1442488,true;false;false;false,5615/22402
n / n $nmbr$ / $nmbr$,C0369718;C0441922,false;false,5616/22402
not - japan,C1518422;C0022341,false;true,5617/22402
previous cardiovascular events,C0205156;C1320716;C1552607,false;false;false,5618/22402
trigl yeerides * ( m mol / l ),C0456616;C0027960;C0324740;C0439189;C1456781;C1824986;C3665593;C0369637;C0347982;C0441923,false;true;true;false;false;false;false;false;false;false,5619/22402
total cholesterol : hdl - c ratio,C0439175;C0523558;C0439810,false;false;false,5620/22402
proadm ( ng / ml ),C0439275,false,5621/22402
interact !,,,5622/22402
older des ( n = $nmbr$ ),C0580836;C0011702;C4551552,false;true;true,5623/22402
second co - primary outcome,C0205436;C3245499;C0205225;C1274040;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190,false;true;false;false;false;false;false;false;false;false,5624/22402
pe ± dvt,C0070939;C0149871;C2926618;C3899446;C1880476;C4284304,true;true;false;false;false;false,5625/22402
previous warfarin use  no . ( % ),C0205156;C0043031;C1552607,false;true;false,5626/22402
nice secondary prevention onlyb,C4087029;C0679699,false;true,5627/22402
ankle / brachial index,C1328319;C3888326,true;false,5628/22402
non - caucasian eze / simva,C1518422;C0007457;C0043157,false;true;true,5629/22402
use of compression stockings  no . ( % ),C1524063;C0038348,false;true,5630/22402
prior angiography showing stenosis > $nmbr$ %  n = $nmbr$ °,C0332152;C0002978;C2826257,false;true;false,5631/22402
previous use of antiarrhythmic drugs,C0205156;C1524063;C0003195;C1552607,false;false;true;false,5632/22402
location  n ( % ),C0450429;C1515974;C4284930;C4284931,false;false;false;false,5633/22402
associated with ctd,C0332281;C1335071;C1442905,false;false;false,5634/22402
clopidogrel ( n = $nmbr$ ) n / n ( % ),C0070166,true,5635/22402
physical exam oedema,C0031809;C0013604;C1717255,true;true;false,5636/22402
triglyceride ( mmol / l ) * blood pressure,C0041004;C1532563;C0005823;C1271104;C1272641,true;false;true;false;true,5637/22402
valproate,C0080356,true,5638/22402
ls - mean change from baseline ( $nmbr$ % ci ),C0023668;C0444504;C0392747;C0168634;C0008107;C3259781;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false;false,5639/22402
median age ( iqr  years ),C0549183;C1510829;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5640/22402
cardiac medications during index hospital stay and / or discharge,C0428776;C0013227;C3489408;C0802604;C2598133;C4284232,false;true;true;false;false;false,5641/22402
cardiac medications during index hospitalization  %,C0428776;C0013227;C0019993;C0802604;C2598133;C4284232,false;true;true;false;false;false,5642/22402
no ipst ( n = $nmbr$  $nmbr$ ),,,5643/22402
non high dose statin ( n = $nmbr$  $nmbr$ ),C1518422;C0444956;C0360714,false;false;true,5644/22402
gall bladder adverse event ( n = $nmbr$ ),C0016976;C0877248,true;false,5645/22402
elevated crp ( > ulnt )  n ( % ),C0742906,false,5646/22402
liraglutide,C1456408,true,5647/22402
type of drug - eluting stent  n ( % ),C0457591;C0038257;C0332307;C1322815;C1547052,false;true;false;true;false,5648/22402
ratio of fev $nmbr$ to fvc,C0456603;C3714541;C1547037,false;true;false,5649/22402
infarct localization  n ( % ),C0021308;C0475264;C1744691,true;false;false,5650/22402
racial category *,C0034510;C0683312;C3889287;C1706779;C3669213;C3853635,true;false;false;false;false;false,5651/22402
inhaled j $nmbr$ - agonist §,C0004048;C2987634,true;false,5652/22402
nonwhite race — no . ( % ) ejection fraction,,,5653/22402
theophylline use at screening,C0241361;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,5654/22402
history of omalizumab treatment,C0019664;C0966225;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;true;false;false;false;false;false;true;false;false;false;false,5655/22402
symptom onset to arrival in catheterization laboratory,C4086878;C1555577;C1706079,false;false;false,5656/22402
omega - $nmbr$ fatty acid vs placebo least - squares mean ( $nmbr$ % cl ),C1719844;C0015684,false;true,5657/22402
tnfi and other bdmardst  n ( % ),,,5658/22402
atenolol strategy ( n = $nmbr$  $nmbr$ ),C0004147;C0679199,true;false,5659/22402
left atrial diameter : < $nmbr$ mm ( n = $nmbr$ ),C0225860;C1301886;C4330985;C4554674;C0225861,true;false;false;false;false,5660/22402
ethnic group,C0015031;C1879937,true;false,5661/22402
baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$ change from baseline to $nmbr$ weeks,C0168634;C0578022;C1532718;C0392747;C0443172;C1705241;C4319952;C1442488,true;false;false;false;false;false;false;false,5662/22402
rf ( iu / ml ),C0035448;C0439458;C0201660;C0748398;C1547111,true;false;false;false;false,5663/22402
coronary heart disease risk equivalents  n ( % ) c,C1277690;C0439185;C4049980,false;false;false,5664/22402
medical history of hypertension,C0262926;C0020538;C1963138;C0199168;C0455527;C0205476,false;true;false;false;false;false,5665/22402
mepolizumab group,C0969324;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,5666/22402
microalbuminuria or macroalbuminuria,C0730345,false,5667/22402
baseline ldl - c > $nmbr$ mg / dl,C0168634;C0439269;C1442488,true;false;false,5668/22402
combination therapy * *,C0009429;C0556895,true;false,5669/22402
uac > $nmbr$ mg / g,C1300563,false,5670/22402
health assessment questionnaire score,C2960025,false,5671/22402
age at onset  y,C0206132;C3870509,true;false,5672/22402
antidiabetes drug usage [ % ( n ) ],C0242510,false,5673/22402
ibdq total score  mean [ sd ],C2964552;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,5674/22402
fenofibric,,,5675/22402
era and pde $nmbr$ inhibitors,C1521863;C3495919,true;false,5676/22402
allogliptin,,,5677/22402
current smoker ( n = $nmbr$  $nmbr$ ),C3173209;C3241966,false;false,5678/22402
weight ( kg )  mean ( s . d . ),C0005910;C1275571;C0444504;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;false;false;true;false;false,5679/22402
previous stroke or tia ( % ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,5680/22402
average of maximum common carotid cimt ( mm ),C1510992;C0806909;C0205214;C0741968;C4330985;C4554674;C1522138;C3245511;C1552615;C2826546;C2825518,false;false;false;false;false;false;false;false;false;false;false,5681/22402
new or suspected thrombus,C0205314,false,5682/22402
lacosamide,C0893761,true,5683/22402
natalizumab ( n = $nmbr$ ) f,C1172734;C0016327,true;true,5684/22402
family history of coronary disease,C0850707;C0018787,false;true,5685/22402
multivessel cad ( % ),C1504769;C2239547;C3813548;C4284121,true;false;false;false,5686/22402
long - acting bronchodilator use at screening,C0205166;C0079613;C0006280;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;true;true;true;false;false;false;false;false;false;false;false;true;false;false;false,5687/22402
fev $nmbr$ / fvc ratio  % ( sd ),C3714541;C0456603;C2699239;C1547037,true;false;false;false,5688/22402
mild impairment ( egfr $nmbr$ - $nmbr$ ),C2945599;C0221099;C1739039;C3811844;C3812682;C0684336,false;false;true;false;false;false,5689/22402
all randomly assigned,,,5690/22402
diet and exercise,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,5691/22402
diabetesduration  mean ( sd )  y,C0444504;C2699239;C2347634;C2348143,false;false;false;false,5692/22402
median feno  ppba,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5693/22402
non - detectable / unknown,C1518422;C3830527;C0439673;C3541433;C4050014,false;false;false;false;false,5694/22402
primary enrollment diagnoses  n ( % ),C0332137;C1516879;C1696073;C3888021;C0801658,false;false;false;false;false,5695/22402
low hdl - c ( for men < $nmbr$   mg / dl / for women < $nmbr$   mg / dl ),C0151691;C0025266;C0439269,false;true;false,5696/22402
mean body mass index ( sd )  kg / m $nmbr$,C0444504;C0005893;C2699239;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;false;true;false;false,5697/22402
ace inhibitor or angiotensin ii receptor,C0003015;C4541021,true;false,5698/22402
diet diet + pravastatin,C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,5699/22402
unspecified,C0205370;C1549663;C2983689;C4048188,false;false;false;false,5700/22402
atherosclerotic cardiovascular disease,C0004153,true,5701/22402
dilated cardiomyopathy,C0007193;C2984282,true;false,5702/22402
participation in phase a,C0679823;C0205390;C1710475,false;false;false,5703/22402
region of enrollment,C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,5704/22402
white race  n ( % ),C0007457;C0043157,true;true,5705/22402
after amendment,C0680532;C2346732,false;false,5706/22402
laba + ics versus indzgly lsm difference ( $nmbr$ % cl ),C0815320;C4551720,false;true,5707/22402
number of patients > $nmbr$ years ( % ),C2360800;C0439234,false;false,5708/22402
hypoglycemia,C0020615;C4553659,true;false,5709/22402
gold stage [ n ( % ) ],C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,5710/22402
not treated,C1518422,false,5711/22402
motor subscale ( range  $nmbr$ - $nmbr$ ),C1513492;C1514721;C2348147;C3542016;C1705994,false;false;false;false;false,5712/22402
feno + eze,,,5713/22402
total group,C0439175;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0439810,false;false;false;true;false;false;false;false,5714/22402
asthma control test score at baseline,C2733224;C0168634;C1442488,false;true;false,5715/22402
lipid values  mmol / l,C0023779;C0042295;C1532563,true;false;false,5716/22402
esr  $nmbr$ - $nmbr$ mm / hour,C3811131;C4330985;C0439227;C0564385;C4554674,false;false;false;false;false,5717/22402
europe and canada,C0015176,true,5718/22402
total mayo score $ | |,C2964552;C0454788;C1077578,false;false;false,5719/22402
egfr  $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,5720/22402
as - needed inhalations / day,C1879745;C0004048;C0332173;C0439228;C0439505;C0354922;C1883728,false;true;false;false;false;false;false,5721/22402
warfarin  no . ( % ),C0043031,true,5722/22402
habitual fish intake : < $nmbr$ servings / wk ( n = $nmbr$ ),C0205353;C0556216;C1519269;C0332174;C0439230,false;false;false;false;false,5723/22402
number resulting in hospital admission,C0237753;C0449788,false;false,5724/22402
infarction > $nmbr$ days previously,C0021308;C0439228,true;false,5725/22402
pasi score ( $nmbr$ - $nmbr$ ) t  mean ( sd ),C4528685;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,5726/22402
index mi ( n - $nmbr$  $nmbr$ ),C0600653;C3810814;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false,5727/22402
> $nmbr$ % coronary stenosis,C0242231,true,5728/22402
mean ( s . d . ) egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0444504;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C2347634;C2348143,false;true;false;false;false;false;false;false;false,5729/22402
triglycerides  mmol / l  mean ± sd,C0041004;C1532563;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,5730/22402
losartan + lisinopril,C0126174;C0065374,true;true,5731/22402
male  n / n ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,5732/22402
isolated deep - vein thrombosis,C0205409;C0149871;C1548221,false;true;false,5733/22402
esrd or death,C0022661;C0035078;C2316810,true;true;false,5734/22402
tiotropium $nmbr$ . $nmbr$ mg,C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5735/22402
other major risk factors,C0205082;C0035648;C1553898;C0205164;C4318856;C4521762,false;true;false;false;false;false,5736/22402
csf lathosterol ( | jlg / cll ),C3540512;C0064673;C0023434;C3889436,false;true;true;false,5737/22402
diagnosis at presentation — no . ( % ),C0011900;C0449450;C1704338;C1704656,true;false;true;false,5738/22402
number of concomitant csdmards  n ( % ),C0237753;C0521115;C0449788,false;false;false,5739/22402
radiographic characteristics at baseline and randomization,C0444708;C4684572,false;false,5740/22402
probability  of event %,C0033204;C0441471;C4019010,true;false;false,5741/22402
d - dimer ( ng / ml ),C0060323;C0439275,true;false,5742/22402
insulin  median ( ql  q $nmbr$ )  pmol / l,C0021641;C0549183;C0439284;C0876920;C2347635;C2348144;C2939193;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,5743/22402
cerebrovascular,C1880018,false,5744/22402
methotrexate use at randomisation,C0025677;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,5745/22402
method of identification ofstenosis ( % ),C1301921,false,5746/22402
treatment of the index ml,C0039798;C0600653;C0439526;C1705224;C3887665;C0918012;C1552854;C1637833;C2986546;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;true;false;false;false;true;false;false;false;false;false,5747/22402
saba puffs per day at baseline,C1533107;C0332173;C0439228;C0439505,false;false;false;false,5748/22402
joint space narrowing score,C1859695;C0449820;C4050231,false;false;false,5749/22402
evolocumab $nmbr$ mg monthly ( n = $nmbr$ ),C3529352;C0024671;C0332177;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,5750/22402
intent - to - treatb,C0162425;C1283828;C1550453,true;false;false,5751/22402
ace - i or angiotensin receptor blocker,C1452534;C0021966;C0221138;C4284014,true;true;false;false,5752/22402
body mass index > $nmbr$ — no . ( % ) f,C0005893;C0578022;C1305855,false;false;true,5753/22402
mean change  % ( se ),C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,5754/22402
prebronchodilator fev $nmbr$ / fvc,C2599602;C3714541,false;true,5755/22402
less than $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439092;C0439445;C0369637;C0441923,false;false;false;false,5756/22402
previous tia or stroke,C0205156;C0007787;C0917805;C1054154;C1552607,false;true;true;false;false,5757/22402
non - ischaemic aetiology,C1518422;C0475224;C0015127;C1314792;C1524003,false;false;true;true;false,5758/22402
stroke n = $nmbr$,C0038454;C4554100,true;false,5759/22402
crp concentration > $nmbr$ mg / l  n ( % ) \,C3890735;C0086045;C0439268;C1446561;C3827302;C4048285,false;true;false;false;false;false,5760/22402
european quality of life - $nmbr$ dimensions - $nmbr$ level ( eq - $nmbr$ d ),C0239307;C0034380;C0439534;C0441889;C0205163;C0439185;C0456079;C1547707;C2946261;C0518214;C1535514,false;true;false;false;false;false;false;false;false;false;false,5761/22402
major clinical response,C0205082;C4055223;C0205164;C4318856;C4521762,false;false;false;false;false,5762/22402
mean ham - d score ( $nmbr$ % ci ),C3533236;C1570167;C0008107;C3259781;C3853311,false;true;true;false;false,5763/22402
bowel function,C0011135,true,5764/22402
laa ostium,C0444567,false,5765/22402
bnp o $nmbr$ pg / ml or nt pro - bnp o $nmbr$ pg / ml  n ( % ),C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,5766/22402
laa length,C1444754;C1706316,false;false,5767/22402
patient ' s preference not to take vka  only reason * *,C0376409,true,5768/22402
risk factors and immobility level  n ( % ),C0035648;C1553898,true;false,5769/22402
pasi score > $nmbr$ *,C4528685;C0449820;C4050231,false;false;false,5770/22402
cardiac history,C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1522601,true;true;true;false;false;false;false;false,5771/22402
drug - eluting stent  n ( % ),C1322815,true,5772/22402
copd — no . ( % ) medication use,C0024117;C1412502;C3714496,true;false;false,5773/22402
interquartile range,C1711350,false,5774/22402
acute stroke of other determined cause,C0751956;C0521095;C0015127;C1524003,true;false;true;false,5775/22402
severe exacerbations  itt population  n ( % ),C0205082;C4086268;C0032659;C1257890;C4050465;C4050466,false;false;true;true;false;false,5776/22402
europe $nmbr$,C0015176,true,5777/22402
male gender ( % ),C0086582;C1706180,true;false,5778/22402
no . of vessels,C0005847,true,5779/22402
n - $nmbr$ fatty acids - placebo lsm ( $nmbr$ % cl ),C0369718;C0015684;C0032042;C0596019;C1696465;C1706408;C0441922,false;true;true;false;false;false;false,5780/22402
rheumatoid arthritis,C0003873,true,5781/22402
> $nmbr$ % focal seizure frequency responders,C0751495;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775,true;true;false;false;false;false;false;false;false;false,5782/22402
medication within $nmbr$ days before enrolment,C0013227;C0439228;C3244316;C4284232,true;false;false;false,5783/22402
sex ( male ) - no . ( % ),C0086582,true,5784/22402
worsened,C1457868;C4084902,false;false,5785/22402
digoxin at enrollment,C0012265;C1516879;C1696073;C3888021,true;false;false;false,5786/22402
prostate cancer,C0376358;C0600139;C2984325;C3541264,true;false;false;false,5787/22402
pre - bronchodilator fvc ( l ),C2599602;C3714541,false;true,5788/22402
creatinine clearance,C0812399,false,5789/22402
no . of treated lesions,C1522326;C0221198,false;false,5790/22402
cholecystectomy ( n = $nmbr$ ),C0008320,true,5791/22402
# of prior non - tnfi bdmards *,C0332152;C1518422;C2826257,false;false;false,5792/22402
immunosuppressive agents only,C0021081;C0205171;C1720467,true;false;false,5793/22402
enalapril ( n = $nmbr$ ),C0014025,true,5794/22402
deep - vein thrombosis or pulmonary embolism — no . ( % ),C0149871,true,5795/22402
age - years  median ( iqr ),C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,5796/22402
total no . of patients,C0439175;C0439810,false;false,5797/22402
n - $nmbr$ fatty acids ( n = $nmbr$ ),C0369718;C0015684;C0441922,false;true;false,5798/22402
baseline cv treatment,C0168634;C3538987;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4048877;C4318503;C1442488,true;false;true;true;false;false;false;false;false;true;false;false,5799/22402
selena - sledai ( range u - $nmbr$ u $nmbr$ ) t,C0451528;C1514721;C0439148;C2348147;C3542016,false;false;false;false;false,5800/22402
bnp > $nmbr$ pg / ml  n = $nmbr$,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,5801/22402
ms & ng,C2349943;C0017887;C0028074;C3539704;C3713294,false;true;true;false;true,5802/22402
global assessment of disease status score,C0281858;C3176928;C0449820;C4050231,false;false;false;false,5803/22402
all patients ( n = $nmbr$ ),C0030705,true,5804/22402
isolated impaired glucose tolerance — no .,C0205409;C1548221,false;false,5805/22402
angiographic extent of disease,C0002978;C0449279;C4553144,true;false;false,5806/22402
type of concomitant statin by daily dose - no . ( % ),C0332307;C0521115;C0360714;C1547052,false;false;true;false,5807/22402
postoperative nsaid or glucocorticoid use,C0032790;C0003211;C3536840,true;true;false,5808/22402
airflow reversibility — no . ( % ) |,C0231999;C0449261,false;false,5809/22402
devices,C0025080;C0220819;C0699733,true;true;true,5810/22402
age at enrollment ( years ),C1510829;C1516879;C1696073;C3888021,false;false;false;false,5811/22402
mean ( sd ) disease duration  years,C0444504;C2699239;C0872146;C0439234;C2347634;C2348143,false;false;false;false;false;false,5812/22402
race - white ( n = $nmbr$  $nmbr$ ),C0034510;C1706779;C3853635,true;false;false,5813/22402
fluticasone furoate  n = $nmbr$,C1948374,true,5814/22402
baseline hba $nmbr$ c  n ( % ),C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,5815/22402
aldosterone antagonists ( e . g . spironolactone ),C0002007;C2757004,true;false,5816/22402
pci duration in min ( median  iqr ),C4049621;C0449238;C0702093;C0549183;C0876920;C2347635;C2348144;C2939193;C1524029;C3813700;C2926735,false;false;false;false;false;false;false;false;false;false;false,5817/22402
age > $nmbr$ years  n ( % ),C1510829,false,5818/22402
active cancer — no . ( % ),C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,5819/22402
insulina  n ( % ),,,5820/22402
skull  and facial bone fractures,C0037303;C2951888,true;false,5821/22402
$nmbr$ - aminosalicylates {,C0368663,false,5822/22402
hemorrhagic stroke,C0553692,true,5823/22402
immy ( without corticosteroid )  n,C0001617;C3536709,true;false,5824/22402
renal function  normal - mild,C0232804;C0205307;C2945599;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false,5825/22402
log rank p - value,C1708728;C0667477;C1709380;C0699794;C2986775,false;true;false;false;false,5826/22402
prior myocardial infarction  n ( % ),C0155668,false,5827/22402
high - density lipoprotein,C0023821,true,5828/22402
antibodies to infliximab  n ( % ) * *,C3533054,false,5829/22402
safety : non - cabg - related bleeding,C0036043;C1518422;C0010055;C1705187,true;false;true;false,5830/22402
diabetes mellitus — no . ( % ),C0011849,true,5831/22402
mmrc grade  n ( % ),C3826977;C0441800;C0919553;C3244287,false;false;false;false,5832/22402
inspiratory capacity ( l ),C0021610;C0802663,true;false,5833/22402
hf  lvd  or both,C0018488;C1313497;C1538440;C3273279,true;true;false;false,5834/22402
percent of predicted fev $nmbr$,C1882327;C3714541,false;true,5835/22402
ace inhibitor or angiotensin - receptor blocker — no . / total no . ( % ),C0003015;C4541021,true;false,5836/22402
diuretics group ( n = $nmbr$ ),C0012798;C0441848,true;false,5837/22402
prior aortocoronary bypass surgery,C0455610;C0010055,false;true,5838/22402
neutrophils  $nmbr$ / nl,C0027950;C0027778;C0560008;C3892223,true;true;false;false,5839/22402
antiplatelet or anti - inflammatory drugs,,,5840/22402
presentation of index event,C0449450;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;false;true;false;false;false,5841/22402
statin at enrollment,C0360714;C1516879;C1696073;C3888021,true;false;false;false,5842/22402
ethnicitya hispanic or latino,C0086409,true,5843/22402
waist circumference s $nmbr$ ( men ) or > $nmbr$ cm ( women ),C0455829;C0025266,true;true,5844/22402
baseline mssbp / msdbp  mm hg,C0168634;C0439475;C1442488,true;false;false,5845/22402
hispanic american,C0019576,true,5846/22402
hba ] c ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,5847/22402
men / women,C0025266;C0043210,true;true,5848/22402
pbo ( n $nmbr$ $nmbr$ ),C0031962,true,5849/22402
creatinine clearance < $nmbr$ ml / min ( % ),C0812399;C0439445,false;false,5850/22402
total comparators ( n = $nmbr$ ),C0439175;C1707454;C4553389;C4553390;C0439810,false;false;false;false;false,5851/22402
heart rate ( b . p . m . ),C0018810;C0369637;C0441923,true;false;false,5852/22402
smoking history  n ( % ),C1519384,false,5853/22402
disease duration  mean yr ( sd ),C0872146;C0444504;C0439234;C2699239;C2347634;C2348143,false;false;false;false;false;false,5854/22402
high feno subgroup ( > $nmbr$ . $nmbr$ ppb ) ( n = $nmbr$ ),C0205250;C1079230;C1415800;C1515021;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false;false,5855/22402
hba $nmbr$ c in patients with baseline hba $nmbr$ c < $nmbr$ % ( < $nmbr$ mmol / l )  % [ mmol / mol ]  la  n baseline ( sd ) adjusted mean change ( $nmbr$ % ci ) placebo - subtracted change ( se ),C0019016;C0030705;C0168634;C1532563;C1442488;C1825777;C3538758;C3829066;C0023031;C0168634;C2699239;C1442488;C0023749;C0230347;C2346906;C4553351;C0032042;C1719767;C0392747;C0036919;C0443172;C1705241;C4319952;C2348589;C1696465;C1706408,true;true;true;false;false;false;false;false;true;true;false;false;true;false;false;false;true;false;false;true;false;false;false;false;false;false,5856/22402
overall event rate,C0282416;C0441471;C0871208;C1521828;C4019010;C1561607,true;false;false;false;false;false,5857/22402
prior biologic therapeutic failures  n ( % ),C0332152;C0005515;C0087111;C0231174;C0680095;C0302350;C0205460;C2826257,false;true;true;false;false;false;false;false,5858/22402
losartan plus lisinopril ( n = $nmbr$ ),C0126174;C0332287;C0065374,true;false;true,5859/22402
us site of enrollment,C2945843;C1516879;C1696073;C3888021,false;false;false;false,5860/22402
killip class lll - iv,C2697847;C1261077,false;false,5861/22402
coronary artery osteochondrosis,C0205042;C0029376;C0029429;C0729346,true;true;true;false,5862/22402
time from onset of pain to randomization  median ( $nmbr$ th — $nmbr$ th percentiles )  n,C0449244;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;false;false;false;false;false;false;false;false,5863/22402
subset of patients not on metformin,C1515021;C0030705,false;true,5864/22402
no persistent wrf ( n = $nmbr$  $nmbr$ ),C0205322;C0332996,false;false,5865/22402
clopidogrel plus aspirin % / yr,C0070166;C0332287;C0004057;C0439234,true;false;true;false,5866/22402
percutaneous coronary revascularization,C1532338,true,5867/22402
plus metformin,C0332287;C0025598,false;true,5868/22402
calcium - channel inhibitor,C0006685;C1999216,true;false,5869/22402
uacra  mg / g  gmean = gcv,C1300563;C0017066,false;true,5870/22402
cure trial,C1880198;C0008976,false;true,5871/22402
ratio ( $nmbr$ % ci ) *,C0456603;C0008107;C3259781;C1547037,false;true;false;false,5872/22402
baseline pre - bronchodilator fev $nmbr$  l,C0168634;C2599602;C3714541;C1442488,true;false;true;false,5873/22402
physical component summary,C0031809;C0449432;C1552616;C1706244;C1705248;C0205485;C1509143,true;false;false;false;false;false;false,5874/22402
placebo croup  n / n ( % ),C0032042;C0010380;C1696465;C1706408,true;true;false;false,5875/22402
smoking status at screening,C1519386;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0037369;C0421330;C0453996;C1881674,false;true;true;false;false;false;false;false;true;false;true;false,5876/22402
copd medication taken for at least $nmbr$ months before st,C0024117;C0013227;C3244316;C4284232;C1412502;C3714496,true;true;false;false;false;false,5877/22402
st - segment - elevation myocardial infarction — no . ( % ),C1536220,true,5878/22402
ada $nmbr$ / $nmbr$ ( n [ $nmbr$ ),C1060325;C3811629,false;false,5879/22402
previous segmental resection — no . ( % ),C0205156;C2987624;C1552607,false;false;false,5880/22402
older patients ( aged > $nmbr$ years ),C0580836;C0030705,false;true,5881/22402
pre - operative cardiac medications *,C2347660;C1882154;C0018787;C1522601,false;false;true;false,5882/22402
other forms of,C0348078;C0376315,false;true,5883/22402
mean ( s . d . ) hbalc  mmol / mol,C0444504;C3829066;C2347634;C2348143,false;false;false;false,5884/22402
number of ( % ) patients > $nmbr$ years,C2360800;C0439234,false;false,5885/22402
ck - mb  ng / ml,C0010290;C0439275,true;false,5886/22402
prior cardiovascular disease,C0332152;C0007222;C2826257,false;true;false,5887/22402
current / past smoker,C3173209;C1444637;C4284302;C3241966,false;false;false;false,5888/22402
on - pump time : < l : $nmbr$ hrs : min ( n = $nmbr$ ),C3842462;C0040223;C1568891;C0702093;C1524029;C3813700;C3541383,false;true;true;false;false;false;false,5889/22402
diuretic — no . ( % ) surgery,C0012798,true,5890/22402
< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C0439445;C0369637;C0441923,false;false;false,5891/22402
types of fibrinolytic agent,C0332307;C0016018,false;true,5892/22402
u » c » ( mg / g ),C1532633;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2608091;C1638407;C0439267;C0439148;C1300563,false;true;true;false;false;false;false;false;false;false;false;false;false,5893/22402
anticoagulant group ( n = $nmbr$ ),C0003280;C0441848;C0848112;C3536711,true;false;false;false,5894/22402
< $nmbr$ yr of education — no . ( % ),C0439234;C0013621;C0013622;C0013658;C0039401,false;true;true;true;true,5895/22402
non - colorectal cancer,C1518422;C0009402;C0346629;C1527249;C2984278;C3542412,false;true;false;true;false;false,5896/22402
all bleeding,,,5897/22402
hbalc ( % )  mean ( sd ) ^,C0444504;C2699239;C2347634;C2348143,false;false;false;false,5898/22402
simvastatin $nmbr$ mg ( n = $nmbr$  $nmbr$ ),C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,5899/22402
losmapimod ( n = $nmbr$ ),C3272847,true,5900/22402
number of e,C0237753;C0449788,false;false,5901/22402
region  europe union,C0017446;C0015179;C0205147,true;true;false,5902/22402
hydochlorothiazide ( n = $nmbr$ ),,,5903/22402
continued treatment study,C0549178;C3161471,false;false,5904/22402
death / q - wave mi / idr,C0011065;C0861151;C1306577;C4082313;C4552775,true;false;false;false;false,5905/22402
p value for trend,C1709380;C1521798;C4554533,false;false;false,5906/22402
time since diagnosis of heart failure,C0040223;C3541383,true;false,5907/22402
mean ( s . d . ) ldl particle size  nm,C0444504;C3641256;C0203634;C0312860;C3890923;C2347634;C2348143,false;false;false;false;false;false;false,5908/22402
single vessel pci,C0037179;C0005847;C4049621;C0087136;C0205171,true;true;false;true;false,5909/22402
pfo with mild - to - moderate shunt and atrial septal aneurysm,C1299392;C0232180;C0542331;C1442858,false;false;false;false,5910/22402
obesity ( bmi > $nmbr$ kg / m $nmbr$ )  %,C0028754;C0578022;C1532718;C1963185,true;false;false;false,5911/22402
colon only,C0009368;C0205171;C1720467;C3888384,true;false;false;false,5912/22402
lp ( a ) ( week $nmbr$ ),C0065058;C0332174;C0439230;C1439335;C4553379,true;false;false;false;false,5913/22402
n - $nmbr$ pufa events / patients ( % ),C0369718;C0032615;C0441471;C0030705;C3541888;C0441922,false;true;false;true;false;false,5914/22402
arthritis type *,C0003864;C0332307;C1547052;C4552845,true;false;false;false,5915/22402
aml / val  $nmbr$ / $nmbr$ mg rr = $nmbr$ *,C0023465;C0042285;C0024671;C4554402;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0523975;C0023467,true;true;true;false;true;false;false;false;false;false;false;true,5916/22402
in emergency department before ambulance transfer,C0562508;C0002422;C0040671;C1705822;C4319192;C3846685,true;true;true;false;false;false,5917/22402
gold d,C0018026;C1304897,true;false,5918/22402
saaca,,,5919/22402
ecg,C1623258,true,5920/22402
之 $nmbr$,,,5921/22402
total ( n = $nmbr$ ),C0439175;C0439810,false;false,5922/22402
race  %,C0034510;C1706779;C3853635,true;false;false,5923/22402
race — no . ( % ) |,C0034510;C1706779;C3853635,true;false;false,5924/22402
% $nmbr$ - $nmbr$,,,5925/22402
severe,C0205082;C4050465;C4050466,false;false;false,5926/22402
pbo  n = $nmbr$,C0031962,true,5927/22402
bnp,C0054015;C1095989;C1417808;C2982014,true;false;false;false,5928/22402
male sex  ( % ),C0086582,true,5929/22402
females  %,C0086287,true,5930/22402
< $nmbr$ mm,C4330985;C4554674,false;false,5931/22402
s $nmbr$ %,C0565930;C2603362,false;false,5932/22402
age ' ^ $nmbr$ yrs,C0001779,false,5933/22402
atv $nmbr$ mg ( n = $nmbr$ ),C0210243;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0674679;C1145759;C1334862,true;true;true;false;false;false;false;false;true;true;false,5934/22402
female  no . ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,5935/22402
> $nmbr$ mo,C0026544;C0332177,true;false,5936/22402
male sex — %,C0086582,true,5937/22402
lvh,C0149721,true,5938/22402
stent,C0038257,true,5939/22402
acr $nmbr$,C1412134;C1515941,false;false,5940/22402
diet,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,5941/22402
cg / ld,C0043444;C0694649;C1567075;C3540479,true;false;true;false,5942/22402
age ( years ) *,C1510829,false,5943/22402
nonsmoker,C0337672;C0425293;C4554605,false;false;true,5944/22402
ics use,C0815320;C4551720,false;true,5945/22402
no ( % ),,,5946/22402
lips,C0023759,true,5947/22402
≤ $nmbr$,,,5948/22402
ocs,,,5949/22402
tg < = $nmbr$ . $nmbr$,C0337445,false,5950/22402
vka,,,5951/22402
rate * ( n ),C0871208;C1521828,false;false,5952/22402
statin ( n - $nmbr$ ),C0360714,true,5953/22402
« s $nmbr$ - $nmbr$,C0565930;C2603362,false;false,5954/22402
$nmbr$ to < $nmbr$ mmhg,C0439475,false,5955/22402
males ( % ),C0086582,true,5956/22402
三 $nmbr$ to < $nmbr$,C0040363;C0041260;C1883351,true;true;false,5957/22402
cough,C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,5958/22402
> median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5959/22402
smoking *,C0037369;C0453996;C1881674,true;true;false,5960/22402
etd ( $nmbr$ % ci ),C1180255;C0008107;C3259781,false;true;false,5961/22402
% ( se ),C0036919,true,5962/22402
pm  n ( % ),C0030266;C4049155,true;false,5963/22402
placebo  n ( % ),C0032042;C1696465;C1706408,true;false;false,5964/22402
n ( % ),C0369718;C0441922,false;false,5965/22402
> $nmbr$ beds,C0004916,true,5966/22402
number,C0237753;C0449788,false;false,5967/22402
male  no ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,5968/22402
> $nmbr$ years ( n = $nmbr$ ),C0439234,false,5969/22402
femaleb,,,5970/22402
< $nmbr$ hr,,,5971/22402
> $nmbr$ to < $nmbr$ mm hg,C0439475,false,5972/22402
deaths,C0011065;C1306577,true;false,5973/22402
uvb,C0454530;C0564461,false;false,5974/22402
asian ( n — $nmbr$ ),C0078988,true,5975/22402
bms,,,5976/22402
p - int,C0369773;C3272375;C2603361,false;false;false,5977/22402
l ’ - value ’,C0439394;C1522609;C1706495;C3642217,false;false;false;false,5978/22402
abnormal,C0205161;C2347472;C2699333,false;false;false,5979/22402
placebo,C0032042;C1696465;C1706408,true;false;false,5980/22402
crt,,,5981/22402
sex :,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,5982/22402
icd,C0021122,true,5983/22402
cabg,C0010055,true,5984/22402
≤ median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,5985/22402
$nmbr$ - $nmbr$ ft,C1881534;C3890579,false;false,5986/22402
lad,,,5987/22402
$nmbr$ yrs,,,5988/22402
hs - crp,C3890735;C4048285,false;false,5989/22402
no prior llt,C0332152;C2347090;C2826257,false;false;false,5990/22402
range,C1514721;C2348147;C3542016,false;false;false,5991/22402
phi ( n = $nmbr$ ),C1333690;C1704947;C1706536;C2975867;C4084801,false;false;false;true;false,5992/22402
> $nmbr$ h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,5993/22402
women ( n = $nmbr$ ),C0043210,true,5994/22402
> $nmbr$ - < $nmbr$ years,C0439234,false,5995/22402
men ( % ),C0025266,true,5996/22402
> $nmbr$ ug / g,C0439272,false,5997/22402
cdai,C0683448;C1413248;C3273706,false;false;false,5998/22402
age $nmbr$,C0001779,false,5999/22402
age > = $nmbr$ years,C1510829,false,6000/22402
hbalc < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6001/22402
arr ( $nmbr$ % ci ),C2170357;C0008107;C3259781;C4084934,false;true;false;false,6002/22402
msdbp,,,6003/22402
ato $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6004/22402
redon,,,6005/22402
daily,C0332173,false,6006/22402
placebo n / n ( % ),C0032042;C1696465;C1706408,true;false;false,6007/22402
statin ( n = $nmbr$ ),C0360714,true,6008/22402
white,C0007457;C0043157;C0220938,true;true;false,6009/22402
blockers,,,6010/22402
idr,,,6011/22402
p - valuec,C0369773;C2603361,false;false,6012/22402
$nmbr$ ( > $nmbr$ % ),,,6013/22402
≥ $nmbr$ . $nmbr$ years,C0439234,false,6014/22402
men  %,C0025266,true,6015/22402
a $nmbr$ n = $nmbr$,C0369718;C0441922,false;false,6016/22402
p valued,C0369773;C2603361,false;false,6017/22402
study,C0557651;C2603343,false;false,6018/22402
> $nmbr$ % $nmbr$,,,6019/22402
no pci,C4049621,false,6020/22402
igm,,,6021/22402
ex - smoker,C0337671;C4555205,false;true,6022/22402
etn  no,C0014758;C0717758,true;true,6023/22402
rales  n ( % ),C0034642;C0240859,true;false,6024/22402
pooled,C1709595;C2349200;C4522255,false;false;false,6025/22402
total,C0439175;C0439810,false;false,6026/22402
female sex ( % ),C0086287,true,6027/22402
acs,C0742343;C4318612,true;false,6028/22402
$nmbr$ . $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,6029/22402
motor,C1513492;C1705994,false;false,6030/22402
apo bt,,,6031/22402
age  years,C1510829,false,6032/22402
asian  n ( % ),C0078988,true,6033/22402
age < $nmbr$ yr,C0001779;C0439234,false;false,6034/22402
hr $nmbr$ % cl,C0596019,false,6035/22402
sal $nmbr$ mg,C0036140;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0037494;C0206136,true;true;true;false;false;false;false;false;true;true,6036/22402
frail,C0871754,false,6037/22402
> l $nmbr$ years,C0439394;C0439234;C1706495;C3642217,false;false;false;false,6038/22402
iv ( n z $nmbr$ ),C0022326;C4265176,true;false,6039/22402
( $nmbr$ % cl ),C0596019,false,6040/22402
* p value,C1709380,false,6041/22402
arb,C3888198,false,6042/22402
oad,,,6043/22402
fema le,C0023190;C0439090;C1423767;C2697858,true;false;false;false,6044/22402
$nmbr$ e $nmbr$ years,C0439234,false,6045/22402
black ( n = $nmbr$ ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,6046/22402
missing,C1551393;C1705492;C3272743,false;false;false,6047/22402
single,C0037179;C0087136;C0205171,true;true;false,6048/22402
events ( % ),C0441471;C3541888,false;false,6049/22402
> $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,6050/22402
s,C0565930;C2603362,false;false,6051/22402
< $nmbr$ ng / ml,C0439275,false,6052/22402
rr ( $nmbr$ % ci ),C4554402;C0008107;C3259781,false;true;false,6053/22402
result,C1274040;C1546471;C2825142,false;false;false,6054/22402
age > $nmbr$ years  %,C1510829,false,6055/22402
patients n,C0030705,true,6056/22402
placebo [ n = $nmbr$ |,C0032042;C1696465;C1706408,true;false;false,6057/22402
$nmbr$ % cl,C0596019,false,6058/22402
$nmbr$ $nmbr$,,,6059/22402
> $nmbr$ %,,,6060/22402
hbak < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6061/22402
yes,C1549445;C1705108;C1710701,false;false;false,6062/22402
> $nmbr$ yr sex,C0439234;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,false;true;true;true;false;false;true,6063/22402
< $nmbr$,,,6064/22402
> = $nmbr$ years,C0439234,false,6065/22402
$nmbr$ mg / g,C1300563,false,6066/22402
ascvd  n ( % ),C3665365,false,6067/22402
lgm ( n = $nmbr$ ),,,6068/22402
mace,C0349381;C0949745;C1445339,false;true;false,6069/22402
neither,,,6070/22402
> = $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,6071/22402
( se ) t *,C0036919,true,6072/22402
esrd,C0022661;C0035078;C2316810,true;true;false,6073/22402
placebo n [ $nmbr$,C0032042;C1696465;C1706408,true;false;false,6074/22402
death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,6075/22402
mtx,C0025677;C1417487,true;false,6076/22402
loop,C0445022,false,6077/22402
japanese,C0376247;C1556094,false;true,6078/22402
chda,,,6079/22402
> $nmbr$ lb,,,6080/22402
age ( years ) +,C1510829,false,6081/22402
l ( % ),C0439394;C1706495;C3642217,false;false;false,6082/22402
chads $nmbr$,C0007928;C1413373,true;false,6083/22402
( n = $nmbr$ ),C0369718;C0441922,false;false,6084/22402
new om,C0205314;C0028971;C1705272,false;true;false,6085/22402
$nmbr$ % $nmbr$,,,6086/22402
former  n ( % ),C0205156;C0750523,false;false,6087/22402
b lack,C0332268,false,6088/22402
median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6089/22402
$nmbr$ — < $nmbr$ years,C0439234,false,6090/22402
hdl - cd,C3715113;C0007928;C0034283;C4552032,false;true;true;false,6091/22402
low,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,6092/22402
> $nmbr$ ( n — $nmbr$ ),C0369718;C0441922,false;false,6093/22402
rr *,,,6094/22402
iii / iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6095/22402
pla,C0456170,false,6096/22402
hr,,,6097/22402
bmi < $nmbr$,C0578022,false,6098/22402
$nmbr$ . $nmbr$ yrs,,,6099/22402
plac,C0048838,true,6100/22402
women  n ( % ),C0043210,true,6101/22402
other  n ( % ),C0369718;C0441922,false;false,6102/22402
lmwh,C0019139;C3536766,true;false,6103/22402
mexico,C0025885,true,6104/22402
lcz $nmbr$ ( n = $nmbr$ ),,,6105/22402
$nmbr$ % cit,C0008864;C0523573;C1427027;C4553421,true;false;false;false,6106/22402
black ( n — $nmbr$ ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,6107/22402
< $nmbr$ yr,C0439234,false,6108/22402
< $nmbr$ » < $nmbr$ y,,,6109/22402
hba „ ( % ),C0019016;C1825777;C3538758,true;false;false,6110/22402
htn,C0020538,true,6111/22402
p for i,C0369773;C0021966;C0221138;C2603361,false;true;false;false,6112/22402
af,C0344434;C4049859,false;false,6113/22402
# $nmbr$ year,C0439234;C0439508,false;false,6114/22402
beta - blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6115/22402
naive ( n = $nmbr$ ),,,6116/22402
change $nmbr$,C0392747;C0443172;C1705241;C4319952,false;false;false;false,6117/22402
< l $nmbr$ years,C0439394;C0439234;C1706495;C3642217,false;false;false;false,6118/22402
treated,C1522326,false,6119/22402
t $nmbr$ d,C2603360,false,6120/22402
mtx n = $nmbr$,C0025677;C1417487,true;false,6121/22402
white ( n — $nmbr$ ),C0007457;C0043157;C0220938,true;true;false,6122/22402
pasi *,C4528685,false,6123/22402
aged ^ $nmbr$ years,C0001779;C0439234;C0001792;C1999167,false;false;true;false,6124/22402
> $nmbr$ - < $nmbr$ mmhg,C0439475,false,6125/22402
copd ( n = $nmbr$ ),C0024117;C1412502;C3714496,true;false;false,6126/22402
$nmbr$ +,,,6127/22402
< $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,6128/22402
< $nmbr$ ( n — $nmbr$ ),C0369718;C0441922,false;false,6129/22402
bmi > $nmbr$,C0578022,false,6130/22402
lsm ( $nmbr$ % ci ),C0008107;C3259781,true;false,6131/22402
dd,C3538867;C3814791,false;false,6132/22402
x / n,,,6133/22402
age yrs,C0001779,false,6134/22402
diet alone,C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,6135/22402
sfc ( n [ $nmbr$ ),C4521536,false,6136/22402
> $nmbr$ / > $nmbr$ mm hg,C0439475,false,6137/22402
former,C0205156;C0750523,false;false,6138/22402
< $nmbr$ ft,C1881534;C3890579,false;false,6139/22402
■ $nmbr$ years,C0439234,false,6140/22402
$nmbr$ - $nmbr$ years,C0439234,false,6141/22402
p value *,C1709380,false,6142/22402
beta blocker,C0001645,true,6143/22402
< $nmbr$ years ( n = $nmbr$ ),C0439234,false,6144/22402
beta - blocker  %,C0001645,true,6145/22402
race ( % ) $,C0034510;C1706779;C3853635,true;false;false,6146/22402
fibrate,,,6147/22402
primary pci,C0205225;C4049621;C0439612;C0439631,false;false;false;false,6148/22402
egfr,C1739039;C3811844;C3812682,true;false;false,6149/22402
colon,C0009368;C3888384,true;false,6150/22402
n,C0369718;C0441922,false;false,6151/22402
arb  n ( % ),C3888198,false,6152/22402
aphasia,C0003537,true,6153/22402
heparin,C0019134;C0770546,true;false,6154/22402
white  %,C0007457;C0043157;C0220938,true;true;false,6155/22402
low ’,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,6156/22402
f emale,C0016327,true,6157/22402
igm ( n = $nmbr$ ),C1706005,false,6158/22402
> $nmbr$ $nmbr$,,,6159/22402
< $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6160/22402
ics : yes,C0815320;C1549445;C1705108;C1710701;C4551720,false;false;false;false;true,6161/22402
< $nmbr$ ml,C0439526;C1705224;C3887665,false;false;false,6162/22402
placebo ( n = $nmbr$,C0032042;C1696465;C1706408,true;false;false,6163/22402
unprovoked,,,6164/22402
strategy,C0679199,false,6165/22402
asia ( n = $nmbr$ ),C0003980,true,6166/22402
region  %,C0017446;C0205147,true;false,6167/22402
cse ] +,,,6168/22402
age > $nmbr$ y * *,C0001779,false,6169/22402
i % $nmbr$,C0021966;C0221138,true;false,6170/22402
mca,C0149566,true,6171/22402
taci ( n = $nmbr$ ),C0666480;C1425349;C4284230,true;false;false,6172/22402
hdl - c,C3715113,false,6173/22402
medium,C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false,6174/22402
placebo ( n = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,6175/22402
women men,C0043210;C0025266,true;true,6176/22402
both,,,6177/22402
rca  n ( % ),,,6178/22402
events,C0441471;C3541888,false;false,6179/22402
patients  n,C0030705,true,6180/22402
italy,C0022277,true,6181/22402
$nmbr$,,,6182/22402
> $nmbr$ - $nmbr$ years,C0439234,false,6183/22402
s $nmbr$,C0565930;C2603362,false;false,6184/22402
chf,C0018802,true,6185/22402
^ - blockers,,,6186/22402
$nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,6187/22402
ale,C0678386;C2632076,false;false,6188/22402
p valuea,C0369773;C2603361,false;false,6189/22402
age ( yrs ),C0001779,false,6190/22402
≤ $nmbr$ %,,,6191/22402
$nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6192/22402
placebo n = $nmbr$,C0032042;C1696465;C1706408,true;false;false,6193/22402
anemia,C0002871;C1000483;C4554633,true;false;false,6194/22402
eze,,,6195/22402
mean *,C0444504;C2347634;C2348143,false;false;false,6196/22402
atv $nmbr$ mg,C0210243;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0674679;C1145759;C1334862,true;true;true;false;false;false;false;false;true;true;false,6197/22402
ef $nmbr$ - $nmbr$ %,,,6198/22402
open — no . ( % ),C0175566,false,6199/22402
oriental,C0078988;C0699027,true;false,6200/22402
\ $nmbr$ %,,,6201/22402
anakinra,C0245109,true,6202/22402
of patients,C0030705,true,6203/22402
arb  %,C3888198,false,6204/22402
sex  men ( % ),C0009253;C0025266;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;false;false;true,6205/22402
sedbp,,,6206/22402
£ $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,6207/22402
japan,C0022341,true,6208/22402
> $nmbr$ hrs,C1568891,true,6209/22402
female ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6210/22402
hbak > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6211/22402
aspirin  n ( % ),C0004057,true,6212/22402
other — no . ( % ),,,6213/22402
male ( n z $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6214/22402
dm absent,C0011816;C3250443,true;false,6215/22402
vora,,,6216/22402
* $nmbr$ to < $nmbr$ y,,,6217/22402
male,C0086582;C1706180;C1706428;C1706429,true;false;false;false,6218/22402
never smoking,C2003901,false,6219/22402
female sex — no . ( % ),C0086287,true,6220/22402
( gm ),C0017480;C3854019,true;true,6221/22402
st +,C0036056;C3272372,true;false,6222/22402
≥ $nmbr$ to < $nmbr$ %,C0040363;C0041260;C1883351,true;true;false,6223/22402
aqe i $nmbr$,C0021966;C0221138,true;false,6224/22402
n / pyr,C0369718;C0441922,false;false,6225/22402
apobe,,,6226/22402
age : > $nmbr$ years,C1510829,false,6227/22402
crci > $nmbr$,,,6228/22402
$nmbr$ mg bid,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6229/22402
psa ( n = $nmbr$ ),C3810537;C3813209,false;false,6230/22402
ldl *,,,6231/22402
pin /,C0175718;C1168556;C1704584,true;false;false,6232/22402
overall,C0282416;C1561607,true;false,6233/22402
( se ] tf,C0036919;C4048299;C4048587,true;false;false,6234/22402
oa,C0029408;C3887876,true;false,6235/22402
grade $nmbr$,C0441800;C0919553;C3244287,false;false;false,6236/22402
off omt,,,6237/22402
gold a,C0018026;C1304897,true;false,6238/22402
no ascvd,C3665365,false,6239/22402
mean bmi,C0444504;C0578022;C2347634;C2348143,false;false;false;false,6240/22402
female sex,C0086287,true,6241/22402
serum,C0229671;C1546774;C1550100,true;false;false,6242/22402
othersc,,,6243/22402
eze $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6244/22402
crt - p,,,6245/22402
itherchdt,,,6246/22402
dm present,C0011816;C0150312;C0449450;C3250443,true;false;false;false,6247/22402
non - smoker,C0337672;C0425293;C4554605,false;false;true,6248/22402
> = $nmbr$ - < $nmbr$ mmhg,C0439475,false,6249/22402
$nmbr$ or $nmbr$ days,,,6250/22402
group d,C0441838,false,6251/22402
age  $nmbr$ years,C1510829,false,6252/22402
placebo pts / n ( % ),C0032042;C1419129;C2698747;C1696465;C1706408,true;false;false;false;false,6253/22402
= s $nmbr$,C0565930;C2603362,false;false,6254/22402
$nmbr$ - $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,6255/22402
ii ( n = $nmbr$ ),C1710602;C4082587,false;false,6256/22402
rectum,C0034896,true,6257/22402
age  yrs *,C0001779,false,6258/22402
total *,C0439175;C0439810,false;false,6259/22402
< $nmbr$ . $nmbr$ %,,,6260/22402
cana $nmbr$ mg ( n = $nmbr$ ),C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,6261/22402
mae,C0286540;C4085238,true;false,6262/22402
$nmbr$ % - $nmbr$ %,,,6263/22402
^ $nmbr$ - $nmbr$,,,6264/22402
on omt,,,6265/22402
race — no . ( % ),C0034510;C1706779;C3853635,true;false;false,6266/22402
age : < $nmbr$ years,C1510829,false,6267/22402
hdl - cy,C3715113;C0010622;C0332298;C2239193,false;true;false;false,6268/22402
≥ $nmbr$ %,,,6269/22402
africa,C0001737,true,6270/22402
cardiac,C0018787;C1522601,true;false,6271/22402
feno $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6272/22402
lvef < $nmbr$ %,C0428772;C0488728,false;false,6273/22402
pa,C0030428;C3541314,true;false,6274/22402
hr ( $nmbr$ % ci ),C0008107;C3259781,true;false,6275/22402
nsaid,C0003211;C3536840,true;false,6276/22402
pe,C0070939;C1880476;C4284304,true;false;false,6277/22402
white ( n = $nmbr$ ),C0007457;C0043157;C0220938,true;true;false,6278/22402
placebo n ( % ),C0032042;C1696465;C1706408,true;false;false,6279/22402
egfr > $nmbr$,C1739039;C3811844;C3812682,true;false;false,6280/22402
other *,,,6281/22402
> $nmbr$ . $nmbr$ yrs,,,6282/22402
past,C1444637;C4284302,false;false,6283/22402
< $nmbr$ mm hg,C0439475,false,6284/22402
> $nmbr$ % to < $nmbr$ %,C0040363;C0041260;C1883351,true;true;false,6285/22402
known chd,C0205309;C0280604;C3542407,false;false;false,6286/22402
sex  n ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6287/22402
nnt,C1417750,false,6288/22402
all ( n = $nmbr$ f ),C0369718;C0016327;C0441922,false;true;false,6289/22402
tia,C0007787;C0917805;C1054154,true;true;false,6290/22402
$nmbr$ / $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6291/22402
mmse < $nmbr$,C0451306,true,6292/22402
> $nmbr$ - $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,6293/22402
< $nmbr$ . $nmbr$ bpm,,,6294/22402
placebo ( n z $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,6295/22402
locf ),C2825507,false,6296/22402
< $nmbr$ days,C0439228,false,6297/22402
erosion,C0333307;C1880549;C1959609;C3887524,false;false;false;false,6298/22402
smokers  %,C0337664,true,6299/22402
weight,C0005910;C0043100;C1305866;C1705104,true;true;false;false,6300/22402
iiiv,,,6301/22402
( i - blocker,C0021966;C0221138,true;false,6302/22402
das $nmbr$,C0051767;C0057671,true;true,6303/22402
all ( n = $nmbr$ ),C0369718;C0441922,false;false,6304/22402
placebo  n = $nmbr$,C0032042;C1696465;C1706408,true;false;false,6305/22402
no htn,C0020538,true,6306/22402
sex  no . ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6307/22402
race ( % ),C0034510;C1706779;C3853635,true;false;false,6308/22402
vitality,C0424589,false,6309/22402
us,,,6310/22402
pain,C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,true;false;false;false;false;false;false;false;false,6311/22402
age — y £,C0001779,false,6312/22402
< $nmbr$ week,C0332174;C0439230,false;false,6313/22402
hbalc  %,,,6314/22402
open,C0175566,false,6315/22402
> $nmbr$ y,,,6316/22402
avm ( n = $nmbr$ ),C0003857;C0279476,true;false,6317/22402
mild,C2945599,false,6318/22402
ami $nmbr$ mg,C4319936;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,6319/22402
$nmbr$ mg / day,C0439422,false,6320/22402
ever - smoker,C3887636;C0337664,false;true,6321/22402
no . ( % ),,,6322/22402
lateral,C0205093,false,6323/22402
placebo  n / n ( % ),C0032042;C1696465;C1706408,true;false;false,6324/22402
region — no . ( % ),C0017446;C0205147,true;false,6325/22402
age ^ $nmbr$,C0001779,false,6326/22402
pvd,C0085096;C4521226,true;false,6327/22402
> $nmbr$ mm hg,C0439475,false,6328/22402
romania,C0035826,true,6329/22402
$nmbr$ < - $nmbr$,,,6330/22402
< $nmbr$ mg / dl,C0439269,false,6331/22402
patients,C0030705,true,6332/22402
n / n ( % ),C0369718;C0441922,false;false,6333/22402
> = median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6334/22402
> $nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,6335/22402
$nmbr$ — $nmbr$ years,C0439234,false,6336/22402
> $nmbr$ % and < $nmbr$ %,,,6337/22402
cancer,C0006826;C0998265;C1306459,true;false;false,6338/22402
macce,,,6339/22402
£ $nmbr$ to < $nmbr$ years,C0439234,false,6340/22402
or $nmbr$ % ci,,,6341/22402
> i,C0021966;C0221138,true;false,6342/22402
any use,C0042153;C0457083;C1947944,true;false;false,6343/22402
never,C2003901,false,6344/22402
p - blocker,C0369773;C2603361,false;false,6345/22402
age > $nmbr$,C0001779,false,6346/22402
period i,C0439531;C0021966;C0221138;C1948053,false;true;false;false,6347/22402
$nmbr$ to < $nmbr$ hr,,,6348/22402
swollen,C0038999,false,6349/22402
rrr ( $nmbr$ % cl ),C0596019,false,6350/22402
≤ $nmbr$ . $nmbr$ %,,,6351/22402
hscrp,,,6352/22402
$nmbr$ % ci,C0008107;C3259781,true;false,6353/22402
second ( n = $nmbr$ ),C0205436;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false,6354/22402
chd death,C0280604;C0011065;C1306577;C4082313;C4552775;C3542407,false;true;false;false;false;false,6355/22402
pbo ( n = $nmbr$ ),C0031962,true,6356/22402
mean — kg,C0444504;C0022718;C0439209;C4054209;C2347634;C2348143,false;true;false;false;false;false,6357/22402
ab $nmbr$ pg ( n = $nmbr$ ),C0030827;C0072225;C1266240,true;true;false,6358/22402
p +,C0369773;C2603361,false;false,6359/22402
yes *,C1549445;C1705108;C1710701,false;false;false,6360/22402
age,C0001779,false,6361/22402
ageadj,,,6362/22402
aqc < $nmbr$,,,6363/22402
rr ^ ( $nmbr$ % ci ),C4554402;C0008107;C3259781,false;true;false,6364/22402
$nmbr$ mmhg,C0439475,false,6365/22402
$nmbr$ - $nmbr$ mo,C0026544;C0332177,true;false,6366/22402
> $nmbr$ mg / dl,C0439269,false,6367/22402
age - years,C1510829,false,6368/22402
statin usage,C0360714;C0457083,true;false,6369/22402
age $nmbr$ y,C0001779,false,6370/22402
race — no . ( % ) 卞,C0034510;C1706779;C3853635,true;false;false,6371/22402
> $nmbr$ / day,C0332173;C0439228;C0439505,false;false;false,6372/22402
des,C0011702;C4551552,true;true,6373/22402
< median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6374/22402
$nmbr$ - < $nmbr$ yrs,,,6375/22402
taiwan,C0039260,true,6376/22402
$nmbr$ - $nmbr$ yrs,,,6377/22402
some,,,6378/22402
≥ $nmbr$ years,C0439234,false,6379/22402
> $nmbr$ to < $nmbr$ years,C0439234,false,6380/22402
female  no ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6381/22402
cabg — no . ( % ),C0010055,true,6382/22402
women - no . ( % ),C0043210,true,6383/22402
paci,C1165245,false,6384/22402
a $nmbr$ c,,,6385/22402
age :,C0001779,false,6386/22402
vldl,C0523560,false,6387/22402
lvef ( % ),C0428772;C0488728,false;false,6388/22402
$nmbr$ - $nmbr$ hr,,,6389/22402
mi,C3810814,false,6390/22402
ls mean,C0023668;C0444504;C2347634;C2348143,true;false;false;false,6391/22402
n *,C0369718;C0441922,false;false,6392/22402
ldl,,,6393/22402
risk *,C0035647;C4552904,true;false,6394/22402
present,C0150312;C0449450,false;false,6395/22402
age > $nmbr$ y  %,C0001779,false,6396/22402
sex,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6397/22402
bid,,,6398/22402
pci,C4049621,false,6399/22402
statin use,C0360714;C0042153;C0457083;C1947944,true;true;false;false,6400/22402
month $nmbr$,C0332177;C0439231,false;false,6401/22402
primary,C0205225;C0439612;C0439631,false;false;false,6402/22402
placebo ( n = $nmbr$ o ),C0032042;C1696465;C1706408,true;false;false,6403/22402
< $nmbr$ years,C0439234,false,6404/22402
niacini,,,6405/22402
dm,C0011816;C3250443,true;false,6406/22402
$nmbr$ to < $nmbr$ yr,C0439234,false,6407/22402
edge,C0205154;C2697523,false;false,6408/22402
spoke,,,6409/22402
bmi < = $nmbr$,C0578022,false,6410/22402
epa ( n = $nmbr$ ),,,6411/22402
mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,6412/22402
cdmard,,,6413/22402
sd,C2699239,false,6414/22402
$nmbr$ mo to $nmbr$ yr,C0026544;C0439234;C0332177,true;false;false,6415/22402
pfor,C1151635,false,6416/22402
$nmbr$ - < $nmbr$ %,,,6417/22402
alert,C0239110;C2004580;C3665546;C3669039;C4084853;C4553014,false;false;false;false;false;false,6418/22402
lvef,C0428772;C0488728,false;false,6419/22402
$ $nmbr$,,,6420/22402
apo - b,C0003593;C3252643,true;true,6421/22402
cohort,C0009247;C0599755,true;false,6422/22402
ali,,,6423/22402
ace,C1452534;C4284014,true;false,6424/22402
woman,C0043210;C4281745,true;false,6425/22402
apob,C0003593;C3252643,true;true,6426/22402
$nmbr$ to < $nmbr$ mm hg,C0439475,false,6427/22402
£ median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6428/22402
ckd,C1561643,true,6429/22402
or ( $nmbr$ % cl ),,,6430/22402
af alone,C0344434;C4049859,false;false,6431/22402
region,C0017446;C0205147,true;false,6432/22402
nsclc,C0007131,true,6433/22402
other ( n  % ),C0369718;C0441922,false;false,6434/22402
monthly,C0332177,false,6435/22402
beta - blockers,C0001645,true,6436/22402
race  n ( % ),C0034510;C1706779;C3853635,true;false;false,6437/22402
australasia,C0282279;C1257882,true;true,6438/22402
fp $nmbr$ mg,C0016704;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1419068;C1419906;C3541238;C3541412,true;true;true;false;false;false;false;false;false;false;false;false,6439/22402
mean ( se ),C0444504;C0036919;C2347634;C2348143,false;true;false;false,6440/22402
iii - iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6441/22402
$nmbr$ or $nmbr$,,,6442/22402
or [ $nmbr$ % ci ],,,6443/22402
asian,C0078988,true,6444/22402
itt,,,6445/22402
id ( n = $nmbr$ ),C0009450;C0600091;C1441613,true;false;false,6446/22402
state,C1301808;C1442792;C3148680,false;false;false,6447/22402
a $nmbr$,,,6448/22402
hub,C0063034;C1414372;C1708389,true;false;false,6449/22402
> $nmbr$ hr,,,6450/22402
lsm ( $nmbr$ % cl ),C0596019,false,6451/22402
pci  n ( % ),C4049621,false,6452/22402
no . ( % ) *,,,6453/22402
≥ $nmbr$ to < $nmbr$ years,C0439234,false,6454/22402
wssng,,,6455/22402
f,C0016327,true,6456/22402
fp ( n [ $nmbr$ ),C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,6457/22402
» $nmbr$ yr,C0439234,false,6458/22402
mean — yr,C0444504;C0439234;C2347634;C2348143,false;false;false;false,6459/22402
prior dm,C0332152;C0011816;C3250443;C2826257,false;true;false;false,6460/22402
pre - h,C0332152;C0033727;C0369286;C0441932;C0564385;C4528284;C0740175;C2257086;C3669034,false;true;false;false;false;false;false;false;false,6461/22402
acid,C0001128;C0202406,true;false,6462/22402
hctz,C0020261,true,6463/22402
r $nmbr$,C0205090;C0684010;C2603358,false;true;false,6464/22402
korean,C1556095,true,6465/22402
placebo %,C0032042;C1696465;C1706408,true;false;false,6466/22402
. $nmbr$,,,6467/22402
age < median,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,6468/22402
nste - acs,C0742343;C4318612,true;false,6469/22402
age £ $nmbr$,C0001779,false,6470/22402
w,,,6471/22402
p - value *,C1709380,false,6472/22402
stent ( n = $nmbr$ ),C0038257,true,6473/22402
value *,C1522609,false,6474/22402
sso - $nmbr$,,,6475/22402
id,C0009450;C0600091;C1441613,true;false;false,6476/22402
iorii ( n z $nmbr$ ),,,6477/22402
belgium,C0004950,true,6478/22402
hbalca median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6479/22402
use,C0042153;C0457083;C1947944,true;false;false,6480/22402
male sex ( % ),C0086582,true,6481/22402
> $nmbr$ yrs sex :,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6482/22402
female ( n z $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6483/22402
pci ( % ),C4049621,false,6484/22402
or ( $nmbr$ % ci ),,,6485/22402
( e - blocker,,,6486/22402
nsteacs,,,6487/22402
other ',,,6488/22402
bmi ^,C0578022,false,6489/22402
smoking,C0037369;C0453996;C1881674,true;true;false,6490/22402
race n ( % ),C0034510;C1706779;C3853635,true;false;false,6491/22402
risk,C0035647;C4552904,true;false,6492/22402
homa,,,6493/22402
africa *,C0001737,true,6494/22402
sex ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6495/22402
jvp  ( % ),,,6496/22402
r $nmbr$ ( n = $nmbr$ ),C0687673,true,6497/22402
py = $nmbr$ ),C0030428;C3538810,true;false,6498/22402
a - blocker,,,6499/22402
p blocker,C0369773;C2603361,false;false,6500/22402
hba  c ( % ),C0019016;C1825777;C3538758,true;false;false,6501/22402
r $nmbr$ mg,C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,6502/22402
female sex  n ( % ),C0086287,true,6503/22402
> $nmbr$,,,6504/22402
> $nmbr$ to < $nmbr$,C0040363;C0041260;C1883351,true;true;false,6505/22402
rales  ( % ),C0034642;C0240859,true;false,6506/22402
tion — no . ( % ),,,6507/22402
p trend,C0369773;C1521798;C4554533;C2603361,false;false;false;false,6508/22402
ada  no,C1060325;C3811629,false;false,6509/22402
macce ( % ),,,6510/22402
nonwhite,,,6511/22402
pt,C0032743;C0699718,true;false,6512/22402
apo b *,C0003593;C3252643,true;true,6513/22402
% ( $nmbr$ % ci ),C0008107;C3259781,true;false,6514/22402
^ - blocker,,,6515/22402
no betablocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6516/22402
age  ( years ),C1510829,false,6517/22402
> $nmbr$ type,C0332307;C1547052,false;false,6518/22402
female,C0043210;C0086287;C1705497;C1705498,true;true;false;false,6519/22402
us ( n = $nmbr$ ),C0369718;C0441922,false;false,6520/22402
tzd,,,6521/22402
$nmbr$ - < $nmbr$,,,6522/22402
peace ( n = $nmbr$ ),C0680443,false,6523/22402
< $nmbr$ lb,,,6524/22402
< $nmbr$ mg / g,C1300563,false,6525/22402
non - mtx,C1518422;C0025677;C1417487,false;true;false,6526/22402
age  year,C0001779;C0439234;C0439508,false;false;false,6527/22402
py *,C0030428;C3538810,true;false,6528/22402
feno,,,6529/22402
mental,C0229992,false,6530/22402
smokers,C0337664,true,6531/22402
> $nmbr$ ft,C1881534;C3890579,false;false,6532/22402
women  %,C0043210,true,6533/22402
mssbp,,,6534/22402
uac =,,,6535/22402
acei,,,6536/22402
usa,C0041703,true,6537/22402
class > $nmbr$,C0456387;C1518526;C1705943,false;false;false,6538/22402
europe ii,C0015176;C1710602;C4082587,true;false;false,6539/22402
/ ’ - value,C1522609,false,6540/22402
sabaa,,,6541/22402
prior mi,C0332152;C3810814;C2826257,false;false;false,6542/22402
no statin,C0360714,true,6543/22402
cv death,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,6544/22402
age > = $nmbr$,C0001779,false,6545/22402
$nmbr$ §,,,6546/22402
alone,C0205171;C0439044;C0679994,false;false;false,6547/22402
r,C0205090;C0684010;C2603358,false;true;false,6548/22402
ultra,C0728475,false,6549/22402
paci ( n = $nmbr$ ),C1165245,false,6550/22402
age < $nmbr$,C0001779,false,6551/22402
stage $nmbr$,C0205390;C1300072;C1306673,false;false;false,6552/22402
laba alone,,,6553/22402
eze $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6554/22402
no prior ml,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,6555/22402
$nmbr$ ( < $nmbr$ % ),,,6556/22402
statin,C0360714,true,6557/22402
n $nmbr$ yrs,C0369718;C0441922,false;false,6558/22402
male ( n = $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6559/22402
psa,C3810537;C3813209,false;false,6560/22402
$nmbr$ / $nmbr$,,,6561/22402
region - no . ( % ),C0017446;C0205147,true;false,6562/22402
placebo ( n = $nmbr$ l ),C0032042;C1696465;C1706408,true;false;false,6563/22402
otherz,,,6564/22402
$nmbr$ years,C0439234,false,6565/22402
$nmbr$ yr,C0439234,false,6566/22402
asp,C0206293;C0206298;C1332656;C1528298;C3541260;C3890396;C4048238;C4321307;C4553371,false;true;false;true;false;false;false;false;false,6567/22402
aqe < $nmbr$,,,6568/22402
n = $nmbr$,C0369718;C0441922,false;false,6569/22402
fh ii,C1854107,true,6570/22402
overallb,,,6571/22402
nitrate,C0028125;C0699857;C3848573,true;false;false,6572/22402
age > $nmbr$ y,C0001779,false,6573/22402
black,C0005680;C0027567;C0085756;C0439541,true;true;true;false,6574/22402
new dm,C0205314;C0011816;C3250443,false;true;false,6575/22402
< $nmbr$ mon ( n = $nmbr$ ),,,6576/22402
lower,C0441994;C1548802;C2003888,false;false;false,6577/22402
age  mean,C0001779;C0444504;C2347634;C2348143,false;false;false;false,6578/22402
dvt,C0149871;C2926618;C3899446,true;false;false,6579/22402
m,C0369637;C0441923,false;false,6580/22402
black  n ( % ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,6581/22402
obesity,C0028754;C1963185,true;false,6582/22402
women,C0043210,true,6583/22402
il - $nmbr$,C0020898;C0021764;C0022271,true;true;true,6584/22402
< $nmbr$ y ( n = $nmbr$ ),,,6585/22402
placebo r %,C0032042;C0205090;C0684010;C2603358;C1696465;C1706408,true;false;true;false;false;false,6586/22402
mg / dl,C0439269,false,6587/22402
ml c,C0439526;C1705224;C3887665,false;false;false,6588/22402
tg +,C0337445,false,6589/22402
sotalol,C0037707,true,6590/22402
cdai < $nmbr$ t,C0683448;C1413248;C3273706,false;false;false,6591/22402
$nmbr$ ( $nmbr$ % ),,,6592/22402
mmse > $nmbr$,C0451306,true,6593/22402
tg §,C0337445,false,6594/22402
v ( n = $nmbr$ ),,,6595/22402
= $nmbr$,,,6596/22402
p,C0369773;C2603361,false;false,6597/22402
race  no . ( % ),C0034510;C1706779;C3853635,true;false;false,6598/22402
fa $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6599/22402
none,,,6600/22402
no smoking,C0037369;C0453996;C1881674,true;true;false,6601/22402
usa ( n = $nmbr$ ),C0041703,true,6602/22402
rate *,C0871208;C1521828,false;false,6603/22402
gender,C0079399;C1522384,true;true,6604/22402
male ( n - $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6605/22402
austria,C0004348,true,6606/22402
$ $nmbr$ years,C0439234,false,6607/22402
fh $nmbr$,,,6608/22402
no ?,,,6609/22402
dd ( n = $nmbr$ ),C3538867;C3814791,false;false,6610/22402
lu / kg,C0024171;C0022718;C0439209;C4054209;C0024176;C2697939,true;true;false;false;true;false,6611/22402
no ststm,,,6612/22402
st -,C0036056;C3272372,true;false,6613/22402
p - valuea,C0369773;C2603361,false;false,6614/22402
yes ( n = $nmbr$ ),C1549445;C1705108;C1710701,false;false;false,6615/22402
abi < $nmbr$ . $nmbr$,C1328319;C3888326,true;false,6616/22402
iv,C0022326;C4265176,true;false,6617/22402
sama,C1075468,false,6618/22402
latvia,C0023128,true,6619/22402
mra,C0243032;C1609165;C3891069,true;true;false,6620/22402
asian *,C0078988,true,6621/22402
bm i < $nmbr$,C0006416;C0021966;C0221138,true;true;false,6622/22402
age > $nmbr$ yrs,C0001779,false,6623/22402
chf ( % ),C0018802,true,6624/22402
ef  %,,,6625/22402
vi $nmbr$ mg ( n = $nmbr$ ),C0205999;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,6626/22402
< $nmbr$ % ( n = $nmbr$ ),C0369718;C0441922,false;false,6627/22402
hbaic ( % ),,,6628/22402
tjc,,,6629/22402
cvd,C0007222,true,6630/22402
> $nmbr$ ml,C0439526;C1705224;C3887665,false;false;false,6631/22402
$nmbr$ to < $nmbr$,C0040363;C0041260;C1883351,true;true;false,6632/22402
obese,C0028754,true,6633/22402
gold  n ( % ),C0018026;C1304897,true;false,6634/22402
age $ $nmbr$ yrs,C0001779,false,6635/22402
placebo ( % ),C0032042;C1696465;C1706408,true;false;false,6636/22402
rr ( $nmbr$ % cl ),C4554402;C0596019,false;false,6637/22402
« $nmbr$ - $nmbr$,,,6638/22402
whitea,C1021495,false,6639/22402
age > : $nmbr$,C0001779,false,6640/22402
stroke,C0038454;C4554100,true;false,6641/22402
median ( iqr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6642/22402
sjc,,,6643/22402
< $nmbr$ h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6644/22402
pbo,C0031962,true,6645/22402
$nmbr$ - $nmbr$ yr,C0439234,false,6646/22402
< $nmbr$ %,,,6647/22402
chads $nmbr$ ^,C0007928;C1413373,true;false,6648/22402
p blockers,C0369773;C2603361,false;false,6649/22402
£ $nmbr$ years,C0439234,false,6650/22402
> $nmbr$ / week,C0332174;C0439230,false;false,6651/22402
$nmbr$ - < $nmbr$ y,,,6652/22402
non - c,C1518422,false,6653/22402
group a,C0441835;C4522145,false;false,6654/22402
< $nmbr$ - $nmbr$,,,6655/22402
ldu - c,,,6656/22402
$ $nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,6657/22402
≥ $nmbr$ mg / dl,C0439269,false,6658/22402
> $nmbr$ % ( n = $nmbr$ ),C0369718;C0441922,false;false,6659/22402
rca,,,6660/22402
age  n ( % ),C0001779,false,6661/22402
nyha ii,C1275491;C1710602;C4082587,false;false;false,6662/22402
$nmbr$ . $nmbr$,,,6663/22402
£ $nmbr$ yo ( n = $nmbr$ ),C1413296,false,6664/22402
ni,C0028075;C2348274;C3869926;C3869927,true;false;false;false,6665/22402
noneh,,,6666/22402
» $nmbr$ y,,,6667/22402
saba §,,,6668/22402
cabg  n ( % ),C0010055,true,6669/22402
nitrates,C0028125;C0699857;C3848573,true;false;false,6670/22402
sita $nmbr$,,,6671/22402
a $nmbr$ + ez $nmbr$,C0206578,true,6672/22402
male sex  %,C0086582,true,6673/22402
laaca,,,6674/22402
> $nmbr$ mmhg,C0439475,false,6675/22402
age > $nmbr$ yr,C0001779;C0439234,false;false,6676/22402
bmi,C0578022,false,6677/22402
stemi ( % ),C1536220;C3538872,true;false,6678/22402
cabg ( % ),C0010055,true,6679/22402
european,C0239307;C1535514,false;false,6680/22402
pvalue,,,6681/22402
lll - iv,C1261077;C0022326;C4265176,false;true;false,6682/22402
bmi > = $nmbr$,C0578022,false,6683/22402
o $nmbr$,C0483204,false,6684/22402
fp ( n = $nmbr$ ),C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,6685/22402
crt - d,,,6686/22402
severity,C0439793;C0522510,false;false,6687/22402
normal,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,6688/22402
age > $nmbr$ yrs  %,C0001779,false,6689/22402
patients ( n ),C0030705,true,6690/22402
hr  $nmbr$ % cl,C0596019,false,6691/22402
sdai < $nmbr$ t,C3871128,false,6692/22402
no *,,,6693/22402
age years,C1510829,false,6694/22402
row,C1552840;C1552846,false;false,6695/22402
beta blockers,C0001645,true,6696/22402
lvmi ( $nmbr$,,,6697/22402
care,C1947933,false,6698/22402
egfr -,C1739039;C3811844;C3812682,true;false;false,6699/22402
prior om,C0332152;C0028971;C1705272;C2826257,false;true;false;false,6700/22402
n %,C0369718;C0441922,false;false,6701/22402
early ( n = $nmbr$ ),C1279919,false,6702/22402
$nmbr$ to < $nmbr$ cells,C0007584;C0007634,true;true,6703/22402
mm hg,C0439475,false,6704/22402
any death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,6705/22402
> $nmbr$ < $nmbr$,,,6706/22402
cl $nmbr$ %,C0596019,false,6707/22402
poci ( n = $nmbr$ ),,,6708/22402
pbo n ( % ),C0031962,true,6709/22402
$ $nmbr$ years ( n = $nmbr$ ),C0439234,false,6710/22402
all patients,C0030705,true,6711/22402
laba ',,,6712/22402
< $nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,6713/22402
smoking  %,C0037369;C0453996;C1881674,true;true;false,6714/22402
male  %,C0086582;C1706180;C1706428;C1706429,true;false;false;false,6715/22402
level $nmbr$,C0441889;C0456079;C1547707;C2946261,false;false;false;false,6716/22402
placebo  n = i $nmbr$,C0032042;C1696465;C1706408,true;false;false,6717/22402
< $nmbr$ mmhg,C0439475,false,6718/22402
no psa,C3810537;C3813209,false;false,6719/22402
$nmbr$ e $nmbr$,,,6720/22402
placebo [ n z $nmbr$ ],C0032042;C1696465;C1706408,true;false;false,6721/22402
ls mean ( se ),C0023668;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,6722/22402
prior stemi,C0332152;C1536220;C3538872;C2826257,false;true;false;false,6723/22402
betablocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6724/22402
aml $nmbr$ /,C0023465;C0023467,true;true,6725/22402
acr,C1412134;C1515941,false;false,6726/22402
\ $nmbr$,,,6727/22402
homa > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6728/22402
p - blocker yes,C0369773;C1549445;C1705108;C1710701;C2603361,false;false;false;false;false,6729/22402
> = $nmbr$ mmhg,C0439475,false,6730/22402
no dm ( n = $nmbr$ ),C0011816;C3250443,true;false,6731/22402
otherx,,,6732/22402
age — yrf,C0001779,false,6733/22402
fragile,C0302113,false,6734/22402
no beta - blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,6735/22402
n o,C0369718;C0441922,false;false,6736/22402
asa > $nmbr$ mg,C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C3853627,true;true;true;false;false;false;false;false;false,6737/22402
mra  ( % ),C0243032;C1609165;C3891069,true;true;false,6738/22402
india,C0021201;C2700456,true;false,6739/22402
gold $nmbr$,C0018026;C1304897,true;false,6740/22402
csf,C3540512;C3889436,false;false,6741/22402
$nmbr$ mo,C0026544;C0332177,true;false,6742/22402
sites,C0205145,false,6743/22402
aspirin ( n = $nmbr$ ),C0004057,true,6744/22402
< $nmbr$ days ( n = $nmbr$ ),C0439228,false,6745/22402
first ( n = $nmbr$ ),C0205435;C1279901,false;false,6746/22402
age > $nmbr$  y,C0001779,false,6747/22402
sesbp,,,6748/22402
( se ] t *,C0036919,true,6749/22402
value,C1522609,false,6750/22402
ics usage,C0815320;C0457083;C4551720,false;false;true,6751/22402
> $nmbr$ to < $nmbr$ yr,C0439234,false,6752/22402
< $nmbr$ beds,C0004916,true,6753/22402
ptca,C2936173,true,6754/22402
≥ $nmbr$ bpm ( n = $nmbr$ ),,,6755/22402
no beta - blocker,C0001645,true,6756/22402
age < $nmbr$ y,C0001779,false,6757/22402
fa $nmbr$ mg ( « = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6758/22402
p value 十,C1709380,false,6759/22402
spinal,C0521329,false,6760/22402
arr,C2170357;C4084934,false;false,6761/22402
acm,C0001143;C1549040,true;false,6762/22402
age > $nmbr$ yrs *,C0001779,false,6763/22402
orc ( $nmbr$ % cl ),C1167125;C0596019,false;false,6764/22402
saba,,,6765/22402
in - h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6766/22402
males,C0086582,true,6767/22402
female  n ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6768/22402
brachial,C0445456,false,6769/22402
age ( yr ),C0001779;C0439234,false;false,6770/22402
italy ( n = $nmbr$ ),C0022277,true,6771/22402
$nmbr$ - $nmbr$,,,6772/22402
hiv,C0019682;C0019699,true;true,6773/22402
ale < $nmbr$,C0678386;C2632076,false;false,6774/22402
chd *  n ( % ),C0280604;C3542407,false;false,6775/22402
iglar,,,6776/22402
arbs,C3888198,false,6777/22402
age in years,C1510829,false,6778/22402
l / ll,C0439394;C1706495;C3642217,false;false;false,6779/22402
> $nmbr$ yrs,,,6780/22402
tg ’,C0337445,false,6781/22402
age < $nmbr$ yrs,C0001779,false,6782/22402
ff $nmbr$ pg ( n = $nmbr$ ),C4554348;C0030827;C0072225;C1266240,false;true;true;false,6783/22402
pad,C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,6784/22402
arr ( $nmbr$ % cl ),C2170357;C0596019;C4084934,false;false;false,6785/22402
americas,C0002454;C0596070,true;false,6786/22402
st,C0036056;C3272372,true;false,6787/22402
hctz *,C0020261,true,6788/22402
> $nmbr$ . $nmbr$ mm hg,C0439475,false,6789/22402
placebo ( n - $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,6790/22402
gold ii,C0018026;C1710602;C4082587;C1304897,true;false;false;false,6791/22402
lama,C0999593;C1416775,false;false,6792/22402
chd,C0280604;C3542407,false;false,6793/22402
median  iqr,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,6794/22402
cv death n,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,6795/22402
ldl  - c,,,6796/22402
p - value,C1709380,false,6797/22402
edge ii,C0205154;C1710602;C4082587;C2697523,false;false;false;false,6798/22402
$nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,6799/22402
both ( % ),,,6800/22402
ml,C0439526;C1705224;C3887665,false;false;false,6801/22402
cad,C1504769;C2239547;C3813548;C4284121,true;false;false;false,6802/22402
all,,,6803/22402
age > $nmbr$ years,C1510829,false,6804/22402
sa,C0036243;C0038702;C1539696;C1825840;C3539736;C4521691,true;true;false;false;false;false,6805/22402
racea,,,6806/22402
male sex  n ( % ),C0086582,true,6807/22402
others,C1955473;C3539125,false;false,6808/22402
reqion,,,6809/22402
m / f,C1306057,false,6810/22402
cat > $nmbr$,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,6811/22402
atv n ( % ),C0210243;C0674679;C1145759;C1334862,true;true;true;false,6812/22402
< $nmbr$ y,,,6813/22402
> $nmbr$ days,C0439228,false,6814/22402
ebria,C1917247,false,6815/22402
other,,,6816/22402
no pa,C0030428;C3541314,true;false,6817/22402
poland,C0032356,true,6818/22402
prior pci,C0332152;C4049621;C2826257,false;false;false,6819/22402
b - blocker,,,6820/22402
( n = $nmbr$,C0369718;C0441922,false;false,6821/22402
abi # $nmbr$ . $nmbr$,C1328319;C3888326,true;false,6822/22402
oradj ( $nmbr$ % cl ),C0596019,false,6823/22402
labaa,,,6824/22402
hr $nmbr$ % ci,C0008107;C3259781,true;false,6825/22402
minor,C0026193;C0205165,true;false,6826/22402
ufh,,,6827/22402
dm ( n = $nmbr$ ),C0011816;C3250443,true;false,6828/22402
never smoked,C2003901,false,6829/22402
copd,C0024117;C1412502;C3714496,true;false;false,6830/22402
v total ( n = $nmbr$ ),C0439175;C0439810,false;false,6831/22402
egfr < $nmbr$,C1739039;C3811844;C3812682,true;false;false,6832/22402
other !,,,6833/22402
hba < median,C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,6834/22402
event ( % ),C0441471;C4019010,false;false,6835/22402
general,C0205246;C3812897;C3891294;C4521767,false;false;false;false,6836/22402
≤ $nmbr$ ug / g,C0439272,false,6837/22402
rr ( $nmbr$ % ci ) *,C4554402;C0008107;C3259781,false;true;false,6838/22402
yes ( % ),C1549445;C1705108;C1710701,false;false;false,6839/22402
post - mi,C0856742,false,6840/22402
laba,,,6841/22402
$nmbr$ years ( n = $nmbr$ ),C0439234,false,6842/22402
sdai,C3871128,false,6843/22402
> $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6844/22402
p value,C1709380,false,6845/22402
stemi,C1536220;C3538872,true;false,6846/22402
< $nmbr$ ( n z $nmbr$ ),C0369718;C0441922,false;false,6847/22402
age > $nmbr$  %,C0001779,false,6848/22402
area,C0017446;C0205146,true;false,6849/22402
male sex — no . ( % ),C0086582,true,6850/22402
teaes,,,6851/22402
sex — no . ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,6852/22402
age  y,C0001779,false,6853/22402
male ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,6854/22402
cvd death,C0007222;C0011065;C1306577;C4082313;C4552775,true;true;false;false;false,6855/22402
chinese,C0008120;C0152035,false;true,6856/22402
nstemi,C3537184;C4255010,false;true,6857/22402
qmi,,,6858/22402
$nmbr$ - $nmbr$ h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,6859/22402
apo b,C0003593;C3252643,true;true,6860/22402
> $nmbr$ mm ( n = $nmbr$ ),C4330985;C4554674,false;false,6861/22402
female sex  %,C0086287,true,6862/22402
all n = $nmbr$,C0369718;C0441922,false;false,6863/22402
abi,C1328319;C3888326,true;false,6864/22402
any statin,C0360714,true,6865/22402
tg > $nmbr$ . $nmbr$,C0337445,false,6866/22402
$nmbr$ y,,,6867/22402
race — no . ( % ) : c,C0034510;C1706779;C3853635,true;false;false,6868/22402
e,,,6869/22402
angina,C0002962,true,6870/22402
ns,C0038944;C1112705;C1705982,true;false;false,6871/22402
age  yr,C0001779;C0439234,false;false,6872/22402
oretal,,,6873/22402
no smo king,C1311076;C1364142;C1423784,true;false;false,6874/22402
women  n ( % ) *,C0043210,true,6875/22402
p value c,C1709380,false,6876/22402
mets,C0812270;C1705694;C2939420,false;false;false,6877/22402
pbo ( n = $nmbr$ ) vs,C0031962,true,6878/22402
race — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,6879/22402
lipid,C0023779,true,6880/22402
females,C0086287,true,6881/22402
$nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,6882/22402
ada  yes,C1060325;C1549445;C1705108;C1710701;C3811629,false;false;false;false;false,6883/22402
placebo [ n = $nmbr$ ],C0032042;C1696465;C1706408,true;false;false,6884/22402
< $nmbr$ mo,C0026544;C0332177,true;false,6885/22402
$ $nmbr$ %,,,6886/22402
> = $nmbr$ . $nmbr$,,,6887/22402
< $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,6888/22402
no .,,,6889/22402
hbaic — %,,,6890/22402
n .,C0369718;C0441922,false;false,6891/22402
russia,C0035970,true,6892/22402
race *,C0034510;C1706779;C3853635,true;false;false,6893/22402
< $nmbr$ hrs,C1568891,true,6894/22402
hps,C0242994,true,6895/22402
patients ( ft ),C0030705,true,6896/22402
prior stent,C0332152;C0038257;C2826257,false;true;false,6897/22402
$nmbr$ — < $nmbr$,,,6898/22402
all ( n = $nmbr$ * ),C0369718;C0441922,false;false,6899/22402
asa < $nmbr$ mg,C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C3853627,true;true;true;false;false;false;false;false;false,6900/22402
< $nmbr$ year,C0439234;C0439508,false;false,6901/22402
stage $nmbr$ b,C0441781,false,6902/22402
iv nitrates,C0022326;C4265176,true;false,6903/22402
pio $nmbr$,C0030800;C2347712,true;false,6904/22402
beta - blocker !,C0001645,true,6905/22402
femoral,C0015811,true,6906/22402
australia,C0004340,true,6907/22402
placeboa,,,6908/22402
pint,C0560012;C3811619;C3890014;C3890556,false;false;false;false,6909/22402
hdl,C3715113,false,6910/22402
$nmbr$ / week,C0332174;C0439230,false;false,6911/22402
> $nmbr$ y ( n = $nmbr$ ),,,6912/22402
phi ( n - $nmbr$ ),C1333690;C1704947;C1706536;C2975867;C4084801,false;false;false;true;false,6913/22402
iii & iv,C0439070;C0022326;C4265176;C1705160,false;true;false;false,6914/22402
aqe ^ $nmbr$,,,6915/22402
region ( % ),C0017446;C0205147,true;false,6916/22402
$nmbr$ to < $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,6917/22402
age # $nmbr$ yrs,C0001779,false,6918/22402
placebo ( n $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,6919/22402
anemia ( % ),C0002871;C1000483;C4554633,true;false;false,6920/22402
pbo ( n $nmbr$ ),C0031962,true,6921/22402
ckdc  n ( % ),,,6922/22402
provoked,C1444748,false,6923/22402
race,C0034510;C1706779;C3853635,true;false;false,6924/22402
mtx ( n = $nmbr$ ),C0025677;C1417487,true;false,6925/22402
> $nmbr$ years,C0439234,false,6926/22402
upper,C1282910,false,6927/22402
mean a ± sdt,C0444504;C2347634;C2348143,false;false;false,6928/22402
no prior mi,C0332152;C3810814;C2826257,false;false;false,6929/22402
mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,6930/22402
female ( n — $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,6931/22402
tics — no . ( % ),C0040188;C0278076;C2169806;C3889970,true;true;false;false,6932/22402
apo a - i,C0085201;C1677784,true;true,6933/22402
ascvd,C3665365,false,6934/22402
glipizide,C0017642,true,6935/22402
years,C0439234,false,6936/22402
stage $nmbr$ a,C0205390;C1300072;C1306673,false;false;false,6937/22402
asian ( n = $nmbr$ ),C0078988,true,6938/22402
ics alone,C0815320;C4551720,false;true,6939/22402
i / ii,C0021966;C1710602;C4082587;C0221138,true;false;false;false,6940/22402
%,,,6941/22402
lesions,C0221198,false,6942/22402
total c,C0439175;C0439810,false;false,6943/22402
> $nmbr$ mon ( n = $nmbr$ ),,,6944/22402
nstemi ( % ),C3537184;C4255010,false;true,6945/22402
ppci ( n = $nmbr$ ),,,6946/22402
women  no . ( % ),C0043210,true,6947/22402
no ipst,,,6948/22402
( n = ms ),C0369718;C2349943;C3539704;C3713294;C0441922,false;false;false;true;false,6949/22402
uti,C0042029;C0077906;C1412376,true;true;false,6950/22402
obesityj,,,6951/22402
asia,C0003980,true,6952/22402
p [ int ],C0369773;C3272375;C2603361,false;false;false,6953/22402
rarely,C0522498,false,6954/22402
tc,C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;true;true;false;false;false,6955/22402
qd,C0332173,false,6956/22402
age  yrs,C0001779,false,6957/22402
age ( year ),C0001779;C0439234;C0439508,false;false;false,6958/22402
age  years *,C1510829,false,6959/22402
> $nmbr$ mm,C4330985;C4554674,false;false,6960/22402
europe,C0015176,true,6961/22402
≥ $nmbr$,,,6962/22402
$nmbr$ min,C0702093;C1524029;C3813700,false;false;false,6963/22402
statins,C0360714,true,6964/22402
canvas,C3281223,false,6965/22402
niacin,C0027996;C1142562,true;false,6966/22402
study $nmbr$,C0557651;C2603343,false;false,6967/22402
graft  n ( % ),C0181074;C0332835;C1961139,false;true;false,6968/22402
c,,,6969/22402
ipst ( n = $nmbr$ ),,,6970/22402
f * >,C0016327,true,6971/22402
high  %,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,6972/22402
ml ),C0439526;C1705224;C3887665,false;false;false,6973/22402
male sex 一 no . ( % ),C0086582,true,6974/22402
£ $nmbr$ %,,,6975/22402
no po,C0032729;C0442027,true;false,6976/22402
y es,C0013754;C0205944,true;true,6977/22402
ff - blocker,C4554348,false,6978/22402
no prior stemi,C0332152;C1536220;C3538872;C2826257,false;true;false;false,6979/22402
< $nmbr$ . $nmbr$ years,C0439234,false,6980/22402
african,C0027567,true,6981/22402
fibrates,C1449704;C3540783,true;false,6982/22402
canada,C0006823,true,6983/22402
venous,C0042449;C0348013,true;false,6984/22402
$nmbr$ - < $nmbr$ ( % ),,,6985/22402
total n = $nmbr$,C0439175;C0439810,false;false,6986/22402
mate,C0682323;C1260875,false;false,6987/22402
i,C0021966;C0221138,true;false,6988/22402
met ( n = $nmbr$ ),C0428210;C1550543;C4317104,false;false;false,6989/22402
nausea,C0027497;C1963179;C2984057;C3829611;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767,true;false;false;false;false;false;false;false;false;false;false;false,6990/22402
other chd,C0280604;C3542407,false;false,6991/22402
lda  %,C4553195,false,6992/22402
ics : no,C0815320;C4551720,false;true,6993/22402
aspirin,C0004057,true,6994/22402
age ( years ),C1510829,false,6995/22402
rrr,,,6996/22402
$nmbr$ - $nmbr$ days,C0439228,false,6997/22402
hr ( $nmbr$ % cl ),C0596019,false,6998/22402
etn  yes,C0014758;C1549445;C1705108;C1710701;C0717758,true;false;false;false;true,6999/22402
> $nmbr$ and < $nmbr$ %,,,7000/22402
male sex — no . ( % ) f,C0086582,true,7001/22402
n $nmbr$,C0369718;C0441922,false;false,7002/22402
ipst,,,7003/22402
age > = $nmbr$ yrs,C0001779,false,7004/22402
m being,C0369637;C0441923,false;false,7005/22402
oral,C0442027;C4521986,false;false,7006/22402
race  zz ( % ),C0034510;C1706779;C3853635,true;false;false,7007/22402
> $nmbr$ - < $nmbr$,,,7008/22402
tgt,C1421391;C1428265;C4321338,false;false;false,7009/22402
sfc ( n = $nmbr$ ),C4521536,false,7010/22402
prior llt,C0332152;C2347090;C2826257,false;false;false,7011/22402
> = $nmbr$ y,,,7012/22402
non - white,C1518422;C0007457;C0043157;C0220938,false;true;true;false,7013/22402
ldl - c,,,7014/22402
( $nmbr$ % ci ] h,C0008107;C0033727;C0369286;C0441932;C0564385;C4528284;C3259781,true;true;false;false;false;false;false,7015/22402
gold b,C0018026;C1304897,true;false,7016/22402
men  n ( % ),C0025266,true,7017/22402
hbalc ( % ),,,7018/22402
never smoker,C0425293,false,7019/22402
men,C0025266,true,7020/22402
≥ $nmbr$ mg / g,C1300563,false,7021/22402
≥ $nmbr$ ng / ml,C0439275,false,7022/22402
no psa ( n = $nmbr$ ),C3810537;C3813209,false;false,7023/22402
$nmbr$ - i,C0021966;C0221138,true;false,7024/22402
low  %,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,7025/22402
haq,C0102923;C0451208,true;false,7026/22402
beta - blocker,C0001645,true,7027/22402
urti,,,7028/22402
renal,C0022646,true,7029/22402
lama +,C0999593;C1416775,false;false,7030/22402
( sem ),,,7031/22402
primary *,C0205225;C0439612;C0439631,false;false;false,7032/22402
no mi,C3810814,false,7033/22402
statini,,,7034/22402
n_,C0369718;C0441922,false;false,7035/22402
metsyn,,,7036/22402
< $nmbr$ / < $nmbr$ mm hg,C0439475,false,7037/22402
no use,C0042153;C0457083;C1947944,true;false;false,7038/22402
> $nmbr$ . $nmbr$ %,,,7039/22402
tvr,,,7040/22402
laa,,,7041/22402
om $nmbr$ /,C0028971;C1705272,true;false,7042/22402
arm,C0446516;C3715044;C4553528,true;false;false,7043/22402
r $nmbr$ mg ( « = $nmbr$ ),C0205090;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0684010;C2603358,false;true;true;false;false;false;false;false;true;false,7044/22402
female  %,C0043210;C0086287;C1705497;C1705498,true;true;false;false,7045/22402
cancer §,C0006826;C0998265;C1306459,true;false;false,7046/22402
hbalc > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7047/22402
men ( n = $nmbr$ ),C0025266,true,7048/22402
crcl < $nmbr$,C1846718,false,7049/22402
chd  n ( % ),C0280604;C3542407,false;false,7050/22402
age — yr,C0001779;C0439234,false;false,7051/22402
gold c,C0018026;C1304897,true;false,7052/22402
mean = sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,7053/22402
avr,C0449217,false,7054/22402
epa,,,7055/22402
l $nmbr$,C0439394;C1706495;C3642217,false;false;false,7056/22402
treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,7057/22402
< $nmbr$ yo ( n = $nmbr$ ),C1413296,false,7058/22402
wegu,,,7059/22402
hba $nmbr$ c,C0019016;C1825777;C3538758,true;false;false,7060/22402
( se ] +,C0036919,true,7061/22402
cards,C2930619;C3275277,true;false,7062/22402
$nmbr$ mg / dl,C0439269,false,7063/22402
hdl *,C3715113,false,7064/22402
year $nmbr$,C0439234;C0439508,false;false,7065/22402
p - blockers,C0369773;C2603361,false;false,7066/22402
< $nmbr$ yrs,,,7067/22402
( se ] t,C0036919,true,7068/22402
no prior pci,C0332152;C4049621;C2826257,false;false;false,7069/22402
$nmbr$ . $nmbr$ %,,,7070/22402
diet ( n 二 $nmbr$ ),C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,7071/22402
pnorpci,,,7072/22402
hr ( $nmbr$ % cl ) *,C0596019,false,7073/22402
iu,C0049272;C0439453;C0694756,true;false;false,7074/22402
^ median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7075/22402
> $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,7076/22402
$nmbr$ to < $nmbr$ mo,C0026544;C0332177,true;false,7077/22402
> = $nmbr$ yea ' s,,,7078/22402
median — yr,C0549183;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,7079/22402
$nmbr$ to < $nmbr$ years,C0439234,false,7080/22402
no des,C0011702;C4551552,true;true,7081/22402
> $nmbr$ mg / g,C1300563,false,7082/22402
> $nmbr$ . $nmbr$,,,7083/22402
hrqol,C4279947;C4300252,true;false,7084/22402
p values,C1709380,false,7085/22402
no acs,C0742343;C4318612,true;false,7086/22402
other $nmbr$,,,7087/22402
> $nmbr$ to $nmbr$ years,C0439234,false,7088/22402
cat < $nmbr$,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,7089/22402
age > $nmbr$ yr 十,C0001779;C0439234,false;false,7090/22402
smoker,C0337664,true,7091/22402
oads  n ( % ),,,7092/22402
paod,,,7093/22402
$nmbr$ or more,,,7094/22402
site,C0205145;C1515974;C2825164,false;false;false,7095/22402
> = $nmbr$ years ( n = $nmbr$ ),C0439234,false,7096/22402
ifg,C1334085;C1708411,false;false,7097/22402
cancer * *,C0006826;C0998265;C1306459,true;false;false,7098/22402
race — no . ( % ) ' (,C0034510;C1706779;C3853635,true;false;false,7099/22402
aged < $nmbr$ years,C0001779;C0439234;C0001792;C1999167,false;false;true;false,7100/22402
( ri = $nmbr$ ),C0035487;C1826843,true;false,7101/22402
x / n *,,,7102/22402
s £ $nmbr$,C0565930;C2603362,false;false,7103/22402
aml,C0023465;C0023467,true;true,7104/22402
age ( years ) :,C1510829,false,7105/22402
htn hx,C0020538;C0262926;C3814444,true;false;false,7106/22402
lvef > $nmbr$ %,C0428772;C0488728,false;false,7107/22402
non - dm,C1518422;C0011816;C3250443,false;true;false,7108/22402
group b,C4522078,false,7109/22402
total hip,C0439175;C0019552;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;true;true;false;false;false,7110/22402
obesity t,C0028754;C1963185,true;false,7111/22402
b,,,7112/22402
no,,,7113/22402
total  n = $nmbr$,C0439175;C0439810,false;false,7114/22402
race - no . ( % ),C0034510;C1706779;C3853635,true;false;false,7115/22402
< $nmbr$ . $nmbr$,,,7116/22402
r $nmbr$ mg ( n = $nmbr$ ),C0687673;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7117/22402
ics # #,C0815320;C4551720,false;true,7118/22402
off pump,C1518543;C0182537,false;false,7119/22402
china,C0008115,true,7120/22402
abi > $nmbr$ . $nmbr$,C1328319;C3888326,true;false,7121/22402
male  n ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,7122/22402
female ( n = $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,7123/22402
age  ya,C0001779,false,7124/22402
adl,C0001288;C1420005,true;false,7125/22402
ii - iv,C1710602;C0022326;C4265176;C4082587,false;true;false;false,7126/22402
any,,,7127/22402
ff $nmbr$ | ig ( n = $nmbr$ ),C4554348;C0021027;C0305052;C0360506,false;true;false;false,7128/22402
crp,C3890735;C4048285,false;false,7129/22402
nste - mi,C3537184;C4255010,false;true,7130/22402
n =,C0369718;C0441922,false;false,7131/22402
korea,C0022771,true,7132/22402
ckd  n ( % ) t,C1561643,true,7133/22402
icd  n ( % ),C0021122,true,7134/22402
poba  n ( % ),,,7135/22402
no aspirin,C0004057,true,7136/22402
yes  n ( % ),C1549445;C1705108;C1710701,false;false;false,7137/22402
placebo $nmbr$,C0032042;C1696465;C1706408,true;false;false,7138/22402
no chd,C0280604;C3542407,false;false,7139/22402
sfc,C4521536,false,7140/22402
asthma,C0004096;C2984299,true;false,7141/22402
[ $nmbr$ % cl ],C0596019,false,7142/22402
$nmbr$ to < $nmbr$ ( % ),C0040363;C0041260;C1883351,true;true;false,7143/22402
lvef  %,C0428772;C0488728,false;false,7144/22402
> = $nmbr$,,,7145/22402
y $nmbr$,,,7146/22402
age < $nmbr$ years,C1510829,false,7147/22402
n / n,C0369718;C0441922,false;false,7148/22402
race $nmbr$,C0034510;C1706779;C3853635,true;false;false,7149/22402
placebo ( n [ $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,7150/22402
vdhmtss,,,7151/22402
poci,,,7152/22402
> $nmbr$ . $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,7153/22402
placebo ( n = $nmbr$ * ),C0032042;C1696465;C1706408,true;false;false,7154/22402
aicd  ( % ),C0972395;C2611803;C3537205;C3546309,false;false;false;false,7155/22402
hscrp §,,,7156/22402
major,C0205082;C0205164;C4318856;C4521762,false;false;false;false,7157/22402
prior,C0332152;C2826257,false;false,7158/22402
ccb,C0006684,true,7159/22402
male - no . ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,7160/22402
b - blockers,,,7161/22402
placebo ( lsm ),C0032042;C1696465;C1706408,true;false;false,7162/22402
median — vr,C0549183;C3476815;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,7163/22402
ileum,C0020885,true,7164/22402
no ( n = $nmbr$ ),C0369718;C0441922,false;false,7165/22402
> $nmbr$ - $nmbr$,,,7166/22402
no statin use,C0360714;C0042153;C0457083;C1947944,true;true;false;false,7167/22402
absent,C0332197;C4285062,false;false,7168/22402
age $ $nmbr$ years § *,C1510829,false,7169/22402
ics,C0815320;C4551720,false;true,7170/22402
laci,C1420705;C3273314;C4281721,false;false;false,7171/22402
< $nmbr$ bpm ( n = $nmbr$ ),,,7172/22402
% pred,C0032952;C0044955,true;true,7173/22402
prior ml,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,7174/22402
> $nmbr$ yr,C0439234,false,7175/22402
on $nmbr$,,,7176/22402
tg,C0337445,false,7177/22402
on pump,C3842462,false,7178/22402
t $nmbr$ dm,C2603360;C0011816;C3250443,false;true;false,7179/22402
others  n ( % ),C1955473;C3539125,false;false,7180/22402
mean,C0444504;C2347634;C2348143,false;false;false,7181/22402
high,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,7182/22402
hazard,C0598697,false,7183/22402
p valuey,C0369773;C2603361,false;false,7184/22402
cana $nmbr$ mg,C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,7185/22402
age ( y ),C0001779,false,7186/22402
( $nmbr$ % ci ),C0008107;C3259781,true;false,7187/22402
age ( yij,C0001779,false,7188/22402
ssi - $nmbr$,,,7189/22402
« = $nmbr$,,,7190/22402
ucr,,,7191/22402
tender,C0234234,false,7192/22402
p *,C0369773;C2603361,false;false,7193/22402
iii ( n z $nmbr$ ),C0439070;C1705160,false;false,7194/22402
cyclo,C1172566,true,7195/22402
hbalc < medan,,,7196/22402
non - hdl,C1518422;C3715113,false;false,7197/22402
sodium,C0037473;C0597484;C3541959;C3714642,true;false;false;false,7198/22402
£ $nmbr$,,,7199/22402
simva,,,7200/22402
laci ( n = $nmbr$ ),C1420705;C3273314;C4281721,false;false;false,7201/22402
puva,C0853073;C1704892,false;false,7202/22402
icsa,,,7203/22402
ua,C0041580;C0042014,true;true,7204/22402
hr ( $nmbr$ % ci ) “,C0008107;C3259781,true;false,7205/22402
asa,C0004057;C3853627,true;false,7206/22402
ng,C0017887;C0028074,true;true,7207/22402
patient,C0030705,true,7208/22402
rr,,,7209/22402
race ( % ) ) ',C0034510;C1706779;C3853635,true;false;false,7210/22402
> $nmbr$ to $nmbr$,C0040363;C0041260;C1883351,true;true;false,7211/22402
ii,,,7212/22402
otherb,,,7213/22402
ldl - cz,C0206578,true,7214/22402
( a blocker,,,7215/22402
event,C0441471;C4019010,false;false,7216/22402
iii,C0439070;C1705160,false;false,7217/22402
^ $nmbr$,,,7218/22402
ef < $nmbr$ %,,,7219/22402
israel,C0022271,true,7220/22402
glinide,C2266929,false,7221/22402
brazil,C0006137,true,7222/22402
pasi ^ i,C4528685;C0021966;C0221138,false;true;false,7223/22402
indian,C1524069,false,7224/22402
europe i,C0015176;C0021966;C0221138,true;true;false,7225/22402
male sex,C0086582,true,7226/22402
ifx ( n = $nmbr$ ),C0020823,true,7227/22402
week $nmbr$,C0332174;C0439230,false;false,7228/22402
right,C0205090;C0444532,false;false,7229/22402
tg *,C0337445,false,7230/22402
sama $nmbr$,C1075468,false,7231/22402
high *,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,7232/22402
hope ( n = $nmbr$ ),C0392347,true,7233/22402
active ( n = $nmbr$ ),C0205177;C3853793;C3888249,false;false;false,7234/22402
> $nmbr$  < $nmbr$,,,7235/22402
group c,C0441837,false,7236/22402
ex - smokers,C0337671;C4555205,false;true,7237/22402
male sex  no . ( % ),C0086582,true,7238/22402
with ( n = $nmbr$ ),C0369718;C0441922,false;false,7239/22402
poor,C0032854;C0542537;C2700379,true;false;false,7240/22402
radial,C0442038;C0920847,false;false,7241/22402
n $nmbr$ / n $nmbr$,C0369718;C0441922,false;false,7242/22402
ef > $nmbr$ %,,,7243/22402
stalin,,,7244/22402
> = $nmbr$ yr,C0439234,false,7245/22402
race  n ( % ) b,C0034510;C1706779;C3853635,true;false;false,7246/22402
ra,C3538806;C4048756,false;false,7247/22402
sal $nmbr$ pg ( n = $nmbr$ ),C0036140;C0030827;C0072225;C1266240;C0037494;C0206136,true;true;true;false;true;true,7248/22402
pci — no . ( % ),C4049621,false,7249/22402
hrt,C0282402,true,7250/22402
mtss,,,7251/22402
$nmbr$ e < $nmbr$ %,,,7252/22402
yes ',C1549445;C1705108;C1710701,false;false;false,7253/22402
ratio,C0456603;C1547037,false;false,7254/22402
sal ( n = $nmbr$ ),C0036140;C0037494;C0206136,true;true;true,7255/22402
nyhaii,,,7256/22402
women — no . ( % ),C0043210,true,7257/22402
smoking status  no . ( % ),C1519386,false,7258/22402
smoking status  n ( % ),C1519386,false,7259/22402
smoking status — no . ( % ),C1519386,false,7260/22402
systolic bp  mm hg,C0871470;C0439475,true;false,7261/22402
systolic bp ( mm hg ),C0871470;C0439475,true;false,7262/22402
diastolic ( mmhg ),C0012000;C0439475,true;false,7263/22402
systolic — mm hg,C0039155;C0439475,true;false,7264/22402
diastolic ( mm hg ),C0012000;C0439475,true;false,7265/22402
systolic bp ( mmhg ),C0871470;C0439475,true;false,7266/22402
systolic ( mm hg ),C0039155;C0439475,true;false,7267/22402
diastolic bp  mm hg,C0428883;C0439475,true;false,7268/22402
systolic ( mmhg ),C0039155;C0439475,true;false,7269/22402
diastolic bp ( mmhg ),C0428883;C0439475,true;false,7270/22402
diastolic — mm hg,C0012000;C0439475,true;false,7271/22402
diastolic bp ( mm hg ),C0428883;C0439475,true;false,7272/22402
das $nmbr$ ( esr ),C0051767;C3811131;C0057671,true;false;true,7273/22402
das $nmbr$ - crp §,C0051767;C3890735;C4048285;C0057671,true;false;false;true,7274/22402
das $nmbr$ - hscrp,C0051767;C0057671,true;true,7275/22402
das $nmbr$ ( crp ),C0051767;C3890735;C4048285;C0057671,true;false;false;true,7276/22402
das $nmbr$ - crp,C0051767;C3890735;C4048285;C0057671,true;false;false;true,7277/22402
das $nmbr$ - esr,C0051767;C3811131;C0057671,true;false;true,7278/22402
unadjusted,C1439367,false,7279/22402
unadjusted hr,C1439367,false,7280/22402
unadjusted irr,C1439367;C4082285,false;true,7281/22402
adjusted,C0456081,false,7282/22402
unadjusted hr .,C1439367,false,7283/22402
ejection fraction,C0489482;C2700378,false;false,7284/22402
lv ejection fraction,C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,7285/22402
apolipoprotein a $nmbr$ ( g / l ),C0003592;C0439294;C0456615;C0523508,true;false;false;false,7286/22402
apolipoprotein a $nmbr$ ( mg / dl ),C0003592;C0439269;C0523508,true;false;false,7287/22402
fpg  mmol / l,C1532563,false,7288/22402
fpg ( mmol / l ),C1532563,false,7289/22402
tg ( mmol / l ) c,C0337445;C1532563,false;false,7290/22402
na ( mmol / l ),C0597484;C1532563;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false;false,7291/22402
k ( mmol / l ),C0597277;C1532563;C1708601,false;false;false,7292/22402
ldl ( mmol / l ),C1532563,false,7293/22402
bun  mmol / l,C1532563,false,7294/22402
tc ( mmol / l ),C0039411;C1532563;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,7295/22402
tg ( mmol / l ),C0337445;C1532563,false;false,7296/22402
ffa ( mmol / l ),C0015688;C1532563,true;false,7297/22402
fpg  mmol / lt,C0439190;C0023376;C0230426;C3887647;C4521399,false;true;false;false;false,7298/22402
mdg ( mmol / l ),C0024443;C1532563;C1417239;C2986643,true;false;false;false,7299/22402
ppg  mmol / l,C1418888;C1532563,false;false,7300/22402
hdl ( mmol / l ),C3715113;C1532563,false;false,7301/22402
mssbp  mm hg,C0439475,false,7302/22402
dbp ( mmhg ),C0536221;C0439475;C3813197;C4281799,true;false;false;false,7303/22402
sbp ( mm hg ),C0085805;C0439475,true;false,7304/22402
sbp  mmhg,C0085805;C0439475,true;false,7305/22402
dbp  mm hg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,7306/22402
sbp ( mmhg ),C0085805;C0439475,true;false,7307/22402
dbp  mmhg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,7308/22402
msdbp  mm hg,C0439475,false,7309/22402
msdbp  mm hga,C4330985;C4554674,false;false,7310/22402
mssbp  mm hga,C4330985;C4554674,false;false,7311/22402
sbp  mm hg,C0085805;C0439475,true;false,7312/22402
dbp ( mm hg ),C0536221;C0439475;C3813197;C4281799,true;false;false;false,7313/22402
map ( mmhg ),C0024779;C0439475;C1706473;C4050322,true;false;false;false,7314/22402
cvd subjects,C0007222,true,7315/22402
all subjects,,,7316/22402
mrf subjects,C0312443;C1412879,false;false,7317/22402
c - reactive protein ( mg / l ),C0006560;C0439268;C1413716;C4048285,true;false;false;false,7318/22402
c - reactive protein ( mg / dl ),C0006560;C0439269;C1413716;C4048285,true;false;false;false,7319/22402
c - reactive protein  mg / l,C0006560;C0439268;C1413716;C4048285,true;false;false;false,7320/22402
c - reactive protein  * mg / l,C0006560;C0439268;C1413716;C4048285,true;false;false;false,7321/22402
c - reactive protein ( mg / dl_ ),C0006560;C0439269;C1413716;C4048285,true;false;false;false,7322/22402
body - mass index ( kg / m $nmbr$ ) t,C0005893;C1532718;C0578022;C1305855,false;false;false;true,7323/22402
body mass index - kg / m $nmbr$ t,C0005893;C1532718;C0578022;C1305855,false;false;false;true,7324/22402
body mass index ( kg / m $nmbr$ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,7325/22402
body mass index  kg / m $nmbr$,C0005893;C1532718;C0578022;C1305855,false;false;false;true,7326/22402
body mass index ( kg / nr ),C0005893;C0022718;C0027496;C3844738;C0439209;C4054209;C0578022;C1305855,false;true;true;false;false;false;false;true,7327/22402
body - mass index ( kg / m $nmbr$ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,7328/22402
bodymass index ( kg / m $nmbr$ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,7329/22402
body mass index ( kg / m $nmbr$ ) * ',C0005893;C1532718;C0578022;C1305855,false;false;false;true,7330/22402
body mass index  * kg / m $nmbr$,C0005893;C1532718;C0578022;C1305855,false;false;false;true,7331/22402
comorbidities  n ( % ) a,C0009488,true,7332/22402
comorbidites  n ( % ),,,7333/22402
controls ( n = $nmbr$ ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7334/22402
control ( n z $nmbr$ ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7335/22402
control ( nz $nmbr$ ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7336/22402
control ( n = $nmbr$ ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7337/22402
control ( n - $nmbr$ ),C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,7338/22402
african - american,C0085756,true,7339/22402
african american,C0085756,true,7340/22402
african americans,C0085756,true,7341/22402
african america,C0085756,true,7342/22402
history of hypertension ( n = $nmbr$ ),C0455527,false,7343/22402
no history of hypertension ( n = $nmbr$ ),C0455527,false,7344/22402
egfr ( ml / min ),C1739039;C0439445;C3811844;C3812682,true;false;false;false,7345/22402
egfr  ml / min,C1739039;C0439445;C3811844;C3812682,true;false;false;false,7346/22402
- ics / + laba n z $nmbr$,C0815320;C4551720,false;true,7347/22402
+ ics / + laba nz $nmbr$,C0815320;C0027978;C4551720,false;true;true,7348/22402
baseline mean ( se ),C0168634;C0444504;C0036919;C2347634;C2348143;C1442488,true;false;true;false;false;false,7349/22402
baseline ( mean  sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,7350/22402
baseline  mean ( sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,7351/22402
no current smoking,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7352/22402
current smoker  %,C3173209;C3241966,false;false,7353/22402
current smokers,C3173209;C3241966,false;false,7354/22402
current smokers ( % ),C3173209;C3241966,false;false,7355/22402
current smoker ( % ),C3173209;C3241966,false;false,7356/22402
current smoker,C3173209;C3241966,false;false,7357/22402
current non - smoker,C0425311,false,7358/22402
current smoking,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7359/22402
current smokers  %,C3173209;C3241966,false;false,7360/22402
current smokers *,C3173209;C3241966,false;false,7361/22402
current smoking *,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7362/22402
current nonsmoker,C0521116;C0337672;C0425293;C4554605;C1705970,false;false;false;true;false,7363/22402
current smoker yes,C3173209;C1549445;C1705108;C1710701;C3241966,false;false;false;false;false,7364/22402
current nonsmokers,C0521116;C0337672;C4554605;C1705970,false;false;true;false,7365/22402
prior ptca or pci,C0332152;C2936173;C2826257,false;true;false,7366/22402
prior ptca / pci,C0332152;C2936173;C4049621;C2826257,false;true;false;false,7367/22402
interactior p - value,C1709380,false,7368/22402
interaction p - value,C1704675;C1709380,false;false,7369/22402
interaction p value 中,C1704675;C1709380,false;false,7370/22402
interaction p value §,C1704675;C1709380,false;false,7371/22402
interaction p value,C1704675;C1709380,false;false,7372/22402
duration of copd ( yr ),C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7373/22402
duration of copd  y,C0449238;C0024117;C1412502;C3714496;C2926735,false;true;false;false;false,7374/22402
duration of copd — yr,C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7375/22402
duration of copd  yr,C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7376/22402
duration of copd  years,C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7377/22402
duration of pd  y,C0449238;C4553228;C4553229;C2926735,false;false;false;false,7378/22402
duration of copd,C0449238;C0024117;C1412502;C3714496;C2926735,false;true;false;false;false,7379/22402
duration of copd ( years ),C0449238;C0024117;C0439234;C1412502;C3714496;C2926735,false;true;false;false;false;false,7380/22402
multivariate p - value,C1709380,false,7381/22402
univariate p - value,C1709380,false,7382/22402
group b ( n = $nmbr$ ),C0441848,false,7383/22402
group c ( n = $nmbr$ ),C0441848,false,7384/22402
group a ( n = $nmbr$ ),C0441848,false,7385/22402
rage ( ng / ml ),C0034634;C0439275;C3539760;C3815186,true;false;false;false,7386/22402
ltbr ( ng / ml ),C1416931;C0439275,false;false,7387/22402
pigr ( ng / ml ),C1418569;C0439275,false;false,7388/22402
vegfr ( ng / ml ),C1568520;C0439275,true;false,7389/22402
imt ( $nmbr$ ),C0334121;C1704614;C4318736,true;false;false,7390/22402
imt ( mm ),C0334121;C4330985;C4554674;C1704614;C4318736,true;false;false;false;false,7391/22402
haq - di *,C3826998;C4321476,false;false,7392/22402
haq - di,C3826998;C4321476,false;false,7393/22402
haq - di * *,C3826998;C4321476,false;false,7394/22402
non - fatal stroke,C1518422;C1302234;C0038454;C4554100;C1705232,false;false;true;false;false,7395/22402
nonfatal stroke,C0038454;C4554100,true;false,7396/22402
antiplatelet or anticoagulant,,,7397/22402
antiplatelets or anticoagulants,,,7398/22402
hypercholesterolemia — no . ( % ) *,C0020443;C1522133,true;false,7399/22402
hypercholesterolemia — no . ( % ),C0020443;C1522133,true;false,7400/22402
hypercholesterolemia 一 no . ( % ),C0020443;C1522133,true;false,7401/22402
pre - menopausal without hormone replacement,C0206158;C0282402,true;true,7402/22402
post - menopausal with hormone replacement,C0019930,true,7403/22402
pre - menopausal with hormone replacement,C0206158;C0282402,true;true,7404/22402
post - menopausal without hormone replacement,C0019930,true,7405/22402
bumetanide,C0006376,true,7406/22402
budesonide,C0054201,true,7407/22402
$nmbr$ - hour madbp  mm hg,C0439227;C0439475;C0564385,false;false;false,7408/22402
$nmbr$ - hour masbp  mm hg,C0439227;C0439475;C0564385,false;false;false,7409/22402
no prior heart failure,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7410/22402
prior heart failure,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7411/22402
prior cancer,C0332152;C0006826;C0998265;C1306459;C2826257,false;true;false;false;false,7412/22402
no prior cancer,C0332152;C0006826;C0998265;C1306459;C2826257,false;true;false;false;false,7413/22402
$nmbr$ to < $nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,7414/22402
$ $nmbr$ to  $nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,7415/22402
$nmbr$ to < $nmbr$ ( n z $nmbr$ ),C0369718;C0441922,false;false,7416/22402
ace - i or arb,C1452534;C0021966;C0221138;C4284014,true;true;false;false,7417/22402
no ace - i / arb,C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,7418/22402
ace - lorarb,C1452534;C4284014,true;false,7419/22402
ace - i / arb,C1452534;C0021966;C3888198;C0221138;C4284014,true;true;false;false;false,7420/22402
acei or arb,,,7421/22402
ace - l / arbs,C1452534;C3888198;C4284014,true;false;false,7422/22402
aceis / arbs,C3888198,false,7423/22402
acei / arb,C3888198,false,7424/22402
triglycerides,C0041004,true,7425/22402
triglyceride a,C0041004,true,7426/22402
triglycerides *,C0041004,true,7427/22402
triglycerides * *,C0041004,true,7428/22402
triglyceride,C0041004,true,7429/22402
fluvastatin ( n = $nmbr$ ),C0082608,true,7430/22402
simvastatin ( n = $nmbr$ ),C0074554,true,7431/22402
rosuvastatin ( n = $nmbr$ ),C0965129,true,7432/22402
diabetic yes,C0241863;C1549445;C1705108;C1710701,false;false;false;false,7433/22402
diabetes,C0011847;C0011849,false;true,7434/22402
antidiabetic,C0935929,true,7435/22402
diabetes $nmbr$,C0011847;C0011849,false;true,7436/22402
nondiabetic,,,7437/22402
prediabetes  %,C0362046,true,7438/22402
diabetic no,C0241863,false,7439/22402
non - diabetic,C1518422;C0241863,false;false,7440/22402
diabetes ( % ),C0011847;C0011849,false;true,7441/22402
diuretics,C0012798,true,7442/22402
diuretic use,C0012798;C0042153;C0457083;C1947944,true;true;false;false,7443/22402
diabetic $nmbr$,C0241863,false,7444/22402
diabetesf,,,7445/22402
diabetes  %,C0011847;C0011849,false;true,7446/22402
prediabeticb,,,7447/22402
diureticff,,,7448/22402
n o diabetes,C0369718;C0011847;C0011849;C0441922,false;false;true;false,7449/22402
diabetes *,C0011847;C0011849,false;true,7450/22402
dabetes,,,7451/22402
non - diabetes,C1518422;C0011847;C0011849,false;false;true,7452/22402
non - diabetics,C1518422;C0241863,false;false,7453/22402
diabetics,C0241863,false,7454/22402
diuretic,C0012798,true,7455/22402
no diabetes,C0011847;C0011849,false;true,7456/22402
diurciic,,,7457/22402
diabetic,C0241863,false,7458/22402
diabeticb,,,7459/22402
stage $nmbr$ a : egfr > = $nmbr$ and < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$,C0205390;C1300072;C1306673,false;false;false,7460/22402
stage $nmbr$ b : egfr > = $nmbr$ and < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$,C0441781;C1739039;C3811844;C3812682,false;true;false;false,7461/22402
pm pef ( sd )  l / min,C0030266;C0030771;C2699239;C0702093;C1524029;C3813700;C1518922;C1542834;C4049155,true;true;false;false;false;false;false;false;false,7462/22402
am pef ( sd )  l / min,,,7463/22402
fev $nmbr$ : fvc ratio,C3714541;C0456603;C1547037,true;false;false,7464/22402
fev $nmbr$ / fvc ratio *,C3714541;C0456603;C1547037,true;false;false,7465/22402
egfr  * ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,7466/22402
egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,7467/22402
egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,7468/22402
egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ) §,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,7469/22402
dyslipidaemiat,,,7470/22402
dyslipidaemia,C0242339,true,7471/22402
dyslipidaemia 本,C0242339,true,7472/22402
dyslipidemia,C0242339,true,7473/22402
$nmbr$ st < $nmbr$ . $nmbr$,C0036056;C3272372,true;false,7474/22402
$nmbr$ / $nmbr$ ( $nmbr$ ),,,7475/22402
$nmbr$ ( $nmbr$  $nmbr$ ),,,7476/22402
$nmbr$ ( $nmbr$ . $nmbr$ % ),,,7477/22402
$nmbr$ ( $nmbr$ e < $nmbr$ % ),,,7478/22402
> $nmbr$ - $nmbr$ - $nmbr$,,,7479/22402
$nmbr$ rd > $nmbr$ . $nmbr$,C0694666;C4553350,false;false,7480/22402
$nmbr$ - $nmbr$ . $nmbr$,,,7481/22402
$nmbr$ ( $nmbr$ . $nmbr$ ),,,7482/22402
$nmbr$ . $nmbr$ % ( $nmbr$ ),,,7483/22402
$nmbr$ - < $nmbr$ . $nmbr$,,,7484/22402
oral hypoglycemic,C0359086,false,7485/22402
oral hypoglycemics,C0359086,false,7486/22402
north america ( % ),C0028405,true,7487/22402
south america ( % ),C0037713,true,7488/22402
sitagliptin $nmbr$ mg n = $nmbr$,C1565750;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,7489/22402
disease activity ],C1292728,false,7490/22402
disease activity,C1292728,false,7491/22402
ease activity ],C1331418;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false,7492/22402
class i,C0441885;C1319793;C2698967,false;false;false,7493/22402
class ia,C0456387;C0020980;C0694634;C1947960;C1518526;C1705943,false;true;false;false;false;false,7494/22402
class iii,C0441887;C2698969,false;false,7495/22402
class ii,C0441886;C2698968,false;false,7496/22402
class ib,C0456387;C2744579;C3890035;C4283819;C1518526;C1705943,false;true;false;false;false;false,7497/22402
class ic,C0456387;C0020750;C4554818;C1518526;C1705943,false;true;false;false;false,7498/22402
class iv,C0441888;C2698970,false;false,7499/22402
nt - probnp  pg / mlt,C0669479;C0030827;C4553833;C0072225;C1266240;C0754710,true;true;false;true;false;true,7500/22402
nt - probnp ( pg / ml ) h,C0669479;C2827929;C0439526;C1705224;C3887665;C0439297;C0033727;C0369286;C0441932;C0564385;C4528284;C0030827;C0439391;C0072225;C1266240;C0754710,true;false;false;false;false;false;true;false;false;false;false;true;false;true;false;true,7501/22402
nt - probnp ( pg / ml ),C0669479;C0439297;C0754710,true;false;true,7502/22402
nt - probnp — pg / ml * *,C0669479;C0439297;C0754710,true;false;true,7503/22402
nt - probnp  pg / ml,C0669479;C0439297;C0754710,true;false;true,7504/22402
drug - eluting stent,C1322815,true,7505/22402
drug eluting stent,C1322815,true,7506/22402
race : non - white,C0034510;C1706779;C3853635,true;false;false,7507/22402
race  nonwhite,C0034510;C1706779;C3853635,true;false;false,7508/22402
race - non - white,C0034510;C1706779;C3853635,true;false;false,7509/22402
race nonwhitet,C0034510;C1706779;C3853635,true;false;false,7510/22402
race  % nonwhite,C0034510;C1706779;C3853635,true;false;false,7511/22402
race  non - white,C0034510;C1706779;C3853635,true;false;false,7512/22402
smoking status *,C1519386,false,7513/22402
smokinq status,C0449438,false,7514/22402
smoking status,C1519386,false,7515/22402
nyha iii or iv,C1275491;C0439070;C1705160,false;false;false,7516/22402
nyhaiiioriv,,,7517/22402
csf cholesterol,C3540512;C0008377;C3889436,false;true;false,7518/22402
hdl - cholesterol,C0023822;C0392885,true;false,7519/22402
vldl cholesterol,C0023826;C0523560,true;false,7520/22402
ldl cholesterolt,,,7521/22402
ldl - cholesterol (,C0023824;C0202117,true;false,7522/22402
hdl cholesterol §,C0023822;C0392885,true;false,7523/22402
ldl cholesterol,C0023824;C0202117,true;false,7524/22402
tolal choleslerol,,,7525/22402
total cholesterol *,C0201950;C0543421,false;false,7526/22402
hdl cholesterol *,C0023822;C0392885,true;false,7527/22402
total cholesterol  %,C0201950;C0543421,false;false,7528/22402
total cholesterol,C0201950;C0543421,false;false,7529/22402
hdl choleslerol,C3715113,false,7530/22402
ldl choleslerol,,,7531/22402
aldl cholesterol,C0008377,true,7532/22402
hdl cholesterol,C0023822;C0392885,true;false,7533/22402
ldl - cholesterol,C0023824;C0202117,true;false,7534/22402
medical therapy,C0418981,false,7535/22402
medical therapies,C0418981,false,7536/22402
topical therapy,C0332237;C0039798;C0087111;C1363945,false;true;true;false,7537/22402
hba $nmbr$ c ( n ),C0019016;C1825777;C3538758,true;false;false,7538/22402
> $nmbr$  no . ( % ),,,7539/22402
> $nmbr$ h  n ( % ),C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,7540/22402
> $nmbr$ days ( % ),C0439228,false,7541/22402
< $nmbr$ h  n ( % ),C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,7542/22402
< $nmbr$ %  n ( % ),C0369718;C0441922,false;false,7543/22402
> $nmbr$ ( % ),,,7544/22402
a $nmbr$ c ( % ),,,7545/22402
> $nmbr$ y  no . ( % ),,,7546/22402
hba $nmbr$ c  %,C0019016;C1825777;C3538758,true;false;false,7547/22402
hba $nmbr$ c  % §,C0019016;C1825777;C3538758,true;false;false,7548/22402
> $nmbr$ %  n ( % ),C0369718;C0441922,false;false,7549/22402
hba $nmbr$ c ( % ),C0019016;C1825777;C3538758,true;false;false,7550/22402
> $nmbr$ yr — no . ( % ),C0439234,false,7551/22402
< $nmbr$ vr — no . ( % ),C3476815,false,7552/22402
$ $nmbr$ %  n ( % ),C0369718;C0441922,false;false,7553/22402
> $nmbr$  n ( % ),C0369718;C0441922,false;false,7554/22402
< $nmbr$ { % ),,,7555/22402
< $nmbr$ y  n ( % ),,,7556/22402
^ $nmbr$ y  n ( % ),,,7557/22402
aab $nmbr$ ( % ),,,7558/22402
< $nmbr$ yr — no . ( % ),C0439234,false,7559/22402
< $nmbr$ ( % ),,,7560/22402
> = $nmbr$ * ( % ),,,7561/22402
> $nmbr$ yr ( % ),C0439234,false,7562/22402
> = $nmbr$ ( % ),,,7563/22402
> $nmbr$ y  n ( % ),,,7564/22402
< $nmbr$ days ( % ),C0439228,false,7565/22402
> $nmbr$ y . n ( % ),,,7566/22402
< $nmbr$  n ( % ),C0369718;C0441922,false;false,7567/22402
£ median ( $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7568/22402
> median ( $nmbr$ % ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7569/22402
> median ( $nmbr$ kg ),C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false,7570/22402
> median ( $nmbr$ mm ),C0549183;C4330985;C4554674;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7571/22402
> median ( $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7572/22402
< median ( $nmbr$ kg ),C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false,7573/22402
women < $nmbr$ years,C0043210;C0439234,true;false,7574/22402
women > $nmbr$ years,C0043210;C0439234,true;false,7575/22402
diclofenac ( n = $nmbr$  $nmbr$ ),C0012091,true,7576/22402
diclofenac ( n = $nmbr$ $nmbr$ ),C0012091,true,7577/22402
previous mi — no . ( % ),C0205156;C3810814;C1552607,false;false;false,7578/22402
previous vte — no . ( % ),C0205156;C0630906;C1552607,false;true;false,7579/22402
previous chf — no . ( % ),C0205156;C0018802;C1552607,false;true;false,7580/22402
bl h / y : bilateral,C0005918;C0033727;C0369286;C0441932;C0564385;C4528284;C0006413;C1552663;C2827109,true;true;false;false;false;false;true;false;false,7581/22402
bl h / y : unilateral,C0005918;C0033727;C0369286;C0441932;C0564385;C4528284;C0006413;C1552663;C2827109,true;true;false;false;false;false;true;false;false,7582/22402
diabetes status,C1317301,false,7583/22402
diabetic status,C0241863;C0449438,false;false,7584/22402
mean ( sd ) age in years,C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7585/22402
mean ( sd ) age  yr,C0444504;C2699239;C0001779;C0439234;C2347634;C2348143,false;false;false;false;false;false,7586/22402
mean ( sd ) age  years,C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7587/22402
mean ( sd ) age ( years ),C0444504;C2699239;C1510829;C2347634;C2348143,false;false;false;false;false,7588/22402
no symptoms,C0683368;C1457887,true;false,7589/22402
symptoms,C0683368;C1457887,true;false,7590/22402
age at randomization,C0001779;C0034656,false;true,7591/22402
age at randomisation,C0001779;C0034656,false;true,7592/22402
vadas score *,,,7593/22402
mmse score *,C0451306;C0449820;C4050231,true;false;false,7594/22402
mean acrn,C0444504;C2347634;C2348143,false;false;false,7595/22402
rope score,C1563164;C0449820;C4050231,false;false;false,7596/22402
cat score,C0007450;C0449820;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;false;true;false;false;false;false,7597/22402
sss score,C0037052;C0723181,true;false,7598/22402
gds score *,C0451184;C1149049;C1418244,false;false;false,7599/22402
mmse score,C0451306;C0449820;C4050231,true;false;false,7600/22402
edss score,C0451246;C3887783,false;false,7601/22402
chads score,C0007928;C1413373,true;false,7602/22402
mean score,C3533236,false,7603/22402
mhis score,C0449820;C4050231,false;false,7604/22402
cat scoreff,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,7605/22402
kccq score,C3476798,false,7606/22402
aqlq score,C4055434,false,7607/22402
accp score,C0449820;C4050231,false;false,7608/22402
baseline sbp ( mm hg ),C0168634;C0085805;C0439475;C1442488,true;true;false;false,7609/22402
baseline dbp ( mm hg ),C0168634;C0536221;C0439475;C3813197;C4281799;C1442488,true;true;false;false;false;false,7610/22402
itt population,C0032659;C1257890,true;true,7611/22402
mitt population,C0032659;C1257890,true;true,7612/22402
tiotropium + placebo ( n [ $nmbr$ ),C0213771;C0032042;C1696465;C1706408,true;true;false;false,7613/22402
tiotropium + placeb ( n [ $nmbr$ ),C0213771,true,7614/22402
myocardial infarction  n ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,7615/22402
myocardial infarction  ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,7616/22402
sinusitis,C0037199;C4553555,true;false,7617/22402
synovitis,C0039103,true,7618/22402
no history of tia / stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7619/22402
history of tia or stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7620/22402
history of tia / stroke,C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,7621/22402
heart rate ( beats per min ),C0018810,true,7622/22402
heart rate  beats / min,C0018810,true,7623/22402
heart rate  beats per min,C0018810,true,7624/22402
heart rate — beats / min,C0018810,true,7625/22402
heart rate ( beats / min ),C0018810,true,7626/22402
heart rate ( beats per minute ),C0018810,true,7627/22402
pga  $nmbr$ - $nmbr$,C0016410;C3541266;C4050369,true;false;false,7628/22402
tjc  $nmbr$ - $nmbr$,,,7629/22402
sjc  $nmbr$ - $nmbr$,,,7630/22402
ptga  $nmbr$ - $nmbr$,,,7631/22402
region latin american,C0017446;C0205147,true;false,7632/22402
region  latin america,C0017446;C0023122;C0205147,true;true;false,7633/22402
calcium - channel blockers,C0006684;C2757014,true;false,7634/22402
calcium channel blockers,C0006684;C2757014,true;false,7635/22402
calcium - channel blocker,C0006684;C3536851;C4521885,true;false;false,7636/22402
calcium channel blocker,C0006684;C3536851;C4521885,true;false;false,7637/22402
calcium - channel blockerf,C0006685,true,7638/22402
baseline median [ mg / l ],C0168634;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7639/22402
baseline median  mg / dl,C0168634;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7640/22402
baseline mean  mg / dl,C0168634;C0444504;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false,7641/22402
baseline mean ( mg / dl ],C0168634;C0444504;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false,7642/22402
baseline median  mg / l,C0168634;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,7643/22402
baseline mean mtss,C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,7644/22402
baseline mean 士 sd,C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,7645/22402
glucocorticoids,C0017710;C3540777;C3540778,true;false;false,7646/22402
glucocorticoid,C0017710,true,7647/22402
glucocorticoids *,C0017710;C3540777;C3540778,true;false;false,7648/22402
esr ( mm / h ),C3811131;C0456680,false;false,7649/22402
esr  mm / hour,C3811131;C4330985;C0439227;C0564385;C4554674,false;false;false;false;false,7650/22402
esr — mm / hr,C3811131;C4330985;C4554674,false;false;false,7651/22402
esr ( mm / hour ) git config - - global user . name  your name,C3811131;C4330985;C0439227;C1418224;C2827597;C0205246;C1548600;C1706077;C2348867;C0564385;C4554674,false;false;false;false;false;false;false;false;false;false;false,7652/22402
ns cardiac cisease,C0038944;C0018787;C1522601;C1112705;C1705982,true;true;false;false;false,7653/22402
cardiac disease,C0018799,true,7654/22402
no cardiac disease,C0018799,true,7655/22402
education < $nmbr$ years,C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,7656/22402
education > $nmbr$ years,C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,7657/22402
triglyceride ( mmol / l ),C0041004;C1532563,true;false,7658/22402
triglyceride ( mmol / l ) t,C0041004;C1532563,true;false,7659/22402
triglyceride  mmol / l,C0041004;C1532563,true;false,7660/22402
triglycerides ( mmol / l ) :,C0041004;C1532563,true;false,7661/22402
triglycerides ( mmol / l ),C0041004;C1532563,true;false,7662/22402
triglycerides  mg / l,C0041004;C0439268,true;false,7663/22402
triglycerides  mmol / l §,C0041004;C1532563,true;false,7664/22402
triglycerides * ( mg / dl ),C0041004;C0439269,true;false,7665/22402
triglycerides  mg / dl,C0041004;C0439269,true;false,7666/22402
triglyceride ( mg / dl ) d,C0041004;C0439422;C3642216,true;false;false,7667/22402
triglycerides — mg / dl,C0041004;C0439269,true;false,7668/22402
triglycerides ( mg / dl ),C0041004;C0439269,true;false,7669/22402
triglycerides  mg / dl ^,C0041004;C0439269,true;false,7670/22402
triglycerides  mmol / l,C0041004;C1532563,true;false,7671/22402
triglyceride ( mg / dl ),C0041004;C0439269,true;false,7672/22402
triglycerides  mmol / lf,C0041004;C0439190;C1416933;C2986618;C4554443,true;false;false;false;false,7673/22402
patients without diabetesb,C0030705,true,7674/22402
patients with diabetesb,C0030705,true,7675/22402
no prior heart failure ( n = $nmbr$  $nmbr$ ),C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7676/22402
prior heart failure ( n = $nmbr$  $nmbr$ ),C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,7677/22402
prior lev use,C0332152;C0023556;C2826257,false;true;false,7678/22402
prior asa use,C0332152;C0004057;C0042153;C0457083;C1947944;C3853627;C2826257,false;true;true;false;false;false;false,7679/22402
postmenopausal,C0232970,false,7680/22402
premenopausal,C0279752,false,7681/22402
hs - crp ( mg / l ),C3890735;C0439268;C4048285,false;false;false,7682/22402
apob  mg / dl,C0003593;C0439269;C3252643,true;false;true,7683/22402
fpg  mg / dl,C0439269,false,7684/22402
bnp ( pg / ml ),C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,7685/22402
fpg ( mg / dl ),C0439269,false,7686/22402
hs - crp  mg / l,C3890735;C0439268;C4048285,false;false;false,7687/22402
bun  mg / dl,C0439269,false,7688/22402
crp — mg / l,C3890735;C0439268;C4048285,false;false;false,7689/22402
crp ( ng / ml ),C3890735;C0439275;C4048285,false;false;false,7690/22402
hscrp  mg / l,C0439268,false,7691/22402
apob  g / l,C0003593;C0439294;C0456615;C3252643,true;false;false;true,7692/22402
bun ( mg / dl ),C0439269,false,7693/22402
tgs ( mg / dl ),C1156212;C0439269;C1537574,false;false;false,7694/22402
hdl ( mg / dl ),C3715113;C0439269,false;false,7695/22402
ppg  mg / dl,C1418888;C0439269,false;false,7696/22402
bnp  pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,7697/22402
apo b ( g / l ),C0003593;C0439294;C0456615;C3252643,true;false;false;true,7698/22402
crp ( mg / dl ),C3890735;C0439269;C4048285,false;false;false,7699/22402
apoal  mg / dl,C0439269,false,7700/22402
mpo ( ng / ml ),C0439275,false,7701/22402
hscrp ( mg / l ),C0439268,false,7702/22402
hscrp  mg / dl,C0439269,false,7703/22402
hscrp ( mg / l ) c,C0439268,false,7704/22402
apo b  mg / dl,C0003593;C0439269;C3252643,true;false;true,7705/22402
hscrp ( nmol / l ),C0439282,false,7706/22402
troy ( ng / ml ),C1420811;C0439275;C1883402,false;false;false,7707/22402
apob ( mg / dl ),C0003593;C0439269;C3252643,true;false;true,7708/22402
bnp ( pg / ml ) h,C0054015;C2827929;C0439526;C1705224;C3887665;C0439297;C0033727;C0369286;C0441932;C0564385;C4528284;C0030827;C0439391;C0072225;C1266240;C1095989;C1417808;C2982014,true;false;false;false;false;false;true;false;false;false;false;true;false;true;false;false;false;false,7709/22402
crp  mg / l,C3890735;C0439268;C4048285,false;false;false,7710/22402
bnp  pg / mlt,C0054015;C0030827;C4553833;C0072225;C1266240;C1095989;C1417808;C2982014,true;true;false;true;false;false;false;false,7711/22402
triglycerides $nmbr$  d third,C0041004;C0205437,true;false,7712/22402
triglycerides $nmbr$ st third,C0041004;C0036056;C0205437;C3272372,true;true;false;false,7713/22402
triglycerides $nmbr$ nd third,C0041004;C0205437,true;false,7714/22402
no multivessel disease,C0012634,true,7715/22402
multivessel disease,C0012634,true,7716/22402
fastng plasma glucose < median,C0202042;C0549183;C0876920;C2347635;C2348144;C2939193;C0455280,false;false;false;false;false;false;false,7717/22402
fascng plasma glucose a medan,C0202042;C0455280,false;false,7718/22402
fasting plasma glucose < median,C0015663;C0202042;C0549183;C0876920;C2347635;C2348144;C2939193;C0455280,true;false;false;false;false;false;false;false,7719/22402
caucasian  %,C0007457;C0043157,true;true,7720/22402
caucasian ( % ),C0007457;C0043157,true;true,7721/22402
caucasiana ( % ),,,7722/22402
concomitant cardiovascular therapies — no . ( % ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,7723/22402
concomitant cardiovascular therapy — no . ( % ),C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,7724/22402
dissatisfied with / stopped $ $nmbr$ prior systemic therapies because of side effects,C0870433;C1272691;C1514463;C0205373;C0332152;C1515119;C2826257;C4085546,false;false;false;false;false;false;false;false,7725/22402
dissatisfied with / stopped $ $nmbr$ prior systemic therapy because of side effects,C0870433;C1272691;C1514463;C0205373;C0332152;C1515119;C2826257;C4085546,false;false;false;false;false;false;false;false,7726/22402
linagliptin ( n z $nmbr$ ),C2746078,true,7727/22402
vildagliptin ( n = $nmbr$ ),C1570906,true,7728/22402
linagliptin ( n = $nmbr$ ),C2746078,true,7729/22402
sitagliptin ( n = $nmbr$ ),C1565750,true,7730/22402
smoking — current,C0037369;C0521116;C1705970;C0453996;C1881674,true;false;false;true;false,7731/22402
smoking  % current,C0037369;C0521116;C1705970;C0453996;C1881674,true;false;false;true;false,7732/22402
current smoking — no . ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7733/22402
current smoking  n ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,7734/22402
current smoker 一 no . ( % ),C3173209;C3241966,false;false,7735/22402
current smokers  n ( % ),C3173209;C3241966,false;false,7736/22402
current smoker — no . ( % ),C3173209;C3241966,false;false,7737/22402
current smoker  n ( % ),C3173209;C3241966,false;false,7738/22402
current smoker  no ( % ),C3173209;C3241966,false;false,7739/22402
without t $nmbr$ dm n = $nmbr$,C2986835;C0011816;C3250443,false;true;false,7740/22402
with t $nmbr$ dm n = $nmbr$,C2986835;C0011816;C3250443,false;true;false,7741/22402
val / hctz ( n = $nmbr$ ),C0042285;C0020261;C0523975,true;true;false,7742/22402
v / hctz ( n = $nmbr$ ),C0020261,true,7743/22402
aml / hctz ( n = $nmbr$ ),C0023465;C0020261;C0023467,true;true;true,7744/22402
ind / gly,C4049864;C0017890;C0523677,false;true;false,7745/22402
indzgly,,,7746/22402
gdf - $nmbr$ ( ng / ml ),C1418244;C0439275,false;false,7747/22402
mmp - $nmbr$ ( ng / ml ),C0623362;C0439275;C0919336,true;false;false,7748/22402
st - $nmbr$ ( ng / ml ),C0036056;C0439275;C3272372,true;false;false,7749/22402
mmp - $nmbr$ ( ng / ml ) *,C0623362;C0439275;C0919336,true;false;false,7750/22402
il - $nmbr$ ( pg / ml ),C0020898;C0439297;C0021764;C0022271,true;false;true;true,7751/22402
diabetes  n ( % ),C0011847;C0011849,false;true,7752/22402
diabetes — no . ( % ),C0011847;C0011849,false;true,7753/22402
diabetes  no . ( % ),C0011847;C0011849,false;true,7754/22402
diabetes  * n ( % ),C0011847;C0011849,false;true,7755/22402
prediabetes  n ( % ),C0362046,true,7756/22402
unstable angina — no . ( % ),C0002965,true,7757/22402
stable angina — no . ( % ),C0340288,true,7758/22402
a $nmbr$ c < $nmbr$ . $nmbr$ % ( median ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7759/22402
a $nmbr$ = $nmbr$ . $nmbr$ % ( median ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,7760/22402
hazard ratio ( $nmbr$ % cl ),C2985465;C0596019,false;false,7761/22402
hazard ratio ( $nmbr$ % ci ) *,C2985465;C0008107;C3259781,false;true;false,7762/22402
hazard ratio ( $nmbr$ % ci ),C2985465;C0008107;C3259781,false;true;false,7763/22402
hazard ratio * ( $nmbr$ % ci ),C2985465;C0008107;C3259781,false;true;false,7764/22402
hazard ratiof ( $nmbr$ % ci ),C0598697;C0008107;C3259781,false;true;false,7765/22402
lipid - lowering agent §,C0086440,true,7766/22402
lipid - lowering agents,C0086440,true,7767/22402
lipid - lowering agent,C0086440,true,7768/22402
zotarolimus,C1700035,true,7769/22402
zotarolimust,,,7770/22402
pci orcabg,C4049621,false,7771/22402
prior cabg,C0332152;C0010055;C2826257,false;true;false,7772/22402
no prior cabg,C0332152;C0010055;C2826257,false;true;false,7773/22402
pnorcabg,,,7774/22402
diastolic blood pressure  mm hg  median ( range ),C0428883;C0439475;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1305849,true;false;false;false;false;false;false;false;false;false;false,7775/22402
systolic blood pressure  mm hg  median ( range ),C0488055;C0439475;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C0871470;C1306620,false;false;false;false;false;false;false;false;false;false;true;false,7776/22402
very severe,C3641272;C4050419,false;false,7777/22402
more severe ^,C0205172;C0205082;C4050465;C4050466,false;false;false;false,7778/22402
less severe,C0439092;C0205082;C4050465;C4050466;C0547044,false;false;false;false;false,7779/22402
more severe,C0205172;C0205082;C4050465;C4050466,false;false;false;false,7780/22402
cholesterol ( mg / dl ),C0008377;C0439269,true;false,7781/22402
cholesterol — mg / dl,C0008377;C0439269,true;false,7782/22402
treatment difference ( $nmbr$ % cl ),C0039798;C1705241;C0596019;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,7783/22402
treatment difference ( $nmbr$ % ci ),C0039798;C1705241;C0008107;C3259781;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;true;false;false;false;false;false,7784/22402
insulin,C0021641;C1533581;C1579433;C3714501,true;false;false;false,7785/22402
insulina,,,7786/22402
> median ( $nmbr$ ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7787/22402
< median ( $nmbr$ ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,7788/22402
baseline mssbp ( mmhg )  mean ± sd,C0168634;C0439475;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,7789/22402
baseline msdbp ( mmhg )  mean ± sd,C0168634;C0439475;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,7790/22402
age range ( years ),C1510829;C1514721;C2348147;C3542016,false;false;false;false,7791/22402
age range  years,C1510829;C1514721;C2348147;C3542016,false;false;false;false,7792/22402
inflammation,C0021368,true,7793/22402
inflammatory,C0333348,false,7794/22402
hispanic or latino,C0086409,true,7795/22402
hispanic / latino,C0086409;C0086528,true;true,7796/22402
< $nmbr$ cells / pl,C0007584;C3897966;C4049765;C0007634,true;false;false;true,7797/22402
> $nmbr$ cells / pl,C0007584;C3897966;C4049765;C0007634,true;false;false;true,7798/22402
american indian,C0002460,true,7799/22402
american indian /,C0002460,true,7800/22402
with an sfua,,,7801/22402
without an sfua,,,7802/22402
men  > $nmbr$ cm,C0025266,true,7803/22402
men  < $nmbr$ cm,C0025266,true,7804/22402
women  < $nmbr$ cm,C0043210,true,7805/22402
women  > $nmbr$ cm,C0043210,true,7806/22402
sulphonylureas,C0038766,true,7807/22402
sulphonylurea,C0038766;C3536898,true;false,7808/22402
on sulfonylurea,C0038766;C3536898,true;false,7809/22402
sulfonylureaa,,,7810/22402
sulfonylurea,C0038766;C3536898,true;false,7811/22402
pbo + mtx,C0031962;C0025677;C1417487,true;true;false,7812/22402
czp + mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,7813/22402
caucasians,C0007457;C0043157,true;true,7814/22402
caucasian,C0007457;C0043157,true;true,7815/22402
noncaucasian,,,7816/22402
non - caucasian,C1518422;C0007457;C0043157,false;true;true,7817/22402
ldl cholesterol ( mg / dl )  mean + sd  available for $nmbr$ patients,C0023824;C0439269;C0444504;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,7818/22402
hdl cholesterol ( mg / dl )  mean + sd  available for $nmbr$ patients,C0023822;C0439269;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;false;false;false;false;false,7819/22402
previous or current use of im or cs : no,C0205156;C1552607,false;false,7820/22402
previous or current use of im and cs : no,C0205156;C1552607,false;false,7821/22402
$nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,7822/22402
$nmbr$ to o $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0483204;C0439445;C0369637;C0441923,false;false;false;false,7823/22402
≥ $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,7824/22402
without psoriasis ( zi = $nmbr$ ),C0033860;C0043476,true;true,7825/22402
with psoriasis ( n = $nmbr$ ),C0033860,true,7826/22402
with psoriasis ( zi = $nmbr$ ),C0033860;C0043476,true;true,7827/22402
placebo events / patients ( % ),C0032042;C0441471;C0030705;C3541888;C1696465;C1706408,true;false;true;false;false;false,7828/22402
placebo  events / patients ( % ),C0032042;C0441471;C0030705;C3541888;C1696465;C1706408,true;false;true;false;false;false,7829/22402
ldl - cholesterol ( mg / dl ),C0023824;C0439269;C0202117,true;false;false,7830/22402
ldl cholesterol  mg / dl,C0023824;C0439269;C0202117,true;false;false,7831/22402
hdl cholesterol ( mg / dl ),C0023822;C0439269;C0392885,true;false;false,7832/22402
ldl cholesterol — mg / dl,C0023824;C0439269;C0202117,true;false;false,7833/22402
i idl cholesterol ( mg / dl ),C0619865;C0523559;C0439269;C0021966;C0123167;C0221138,true;false;false;true;true;false,7834/22402
hdl cholesterol — mg / dl,C0023822;C0439269;C0392885,true;false;false,7835/22402
hdl cholesterol  mg / dl,C0023822;C0439269;C0392885,true;false;false,7836/22402
ldl cholesterol ( mg / dl ),C0023824;C0439269;C0202117,true;false;false,7837/22402
hdl - cholesterol ( mg / dl ),C0023822;C0439269;C0392885,true;false;false,7838/22402
baseline ldl - c,C0168634;C1442488,true;false,7839/22402
baseline ldl - c :,C0168634;C1442488,true;false,7840/22402
who fc ii symptoms at baseline,C2983605;C1710602;C0683368;C0168634;C1442488;C1457887;C4082587,false;false;true;true;false;false;false,7841/22402
who fc iii symptoms at baseline,C2983605;C0439070;C0683368;C0168634;C1442488;C1457887;C1705160,false;false;true;true;false;false;false,7842/22402
$nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$,,,7843/22402
> $nmbr$ - $nmbr$ - $nmbr$ - $nmbr$,,,7844/22402
$nmbr$ - $nmbr$ - $nmbr$ - $nmbr$,,,7845/22402
$nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ %,C0040363;C0041260;C1883351,true;true;false,7846/22402
> $nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$,,,7847/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$,,,7848/22402
$nmbr$ . $nmbr$ + $nmbr$ . $nmbr$,,,7849/22402
$nmbr$ $nmbr$ ( $nmbr$ . $nmbr$ ),,,7850/22402
$nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ %,,,7851/22402
$nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ ),,,7852/22402
$nmbr$  $nmbr$ - < $nmbr$ . $nmbr$,,,7853/22402
$nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ),,,7854/22402
$nmbr$ . $nmbr$ to $nmbr$ . $nmbr$,C0040363;C0041260;C1883351,true;true;false,7855/22402
> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$,C0040363;C0041260;C1883351,true;true;false,7856/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ),,,7857/22402
> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ %,C0040363;C0041260;C1883351,true;true;false,7858/22402
$nmbr$ . $nmbr$ % - $nmbr$ . $nmbr$ %,,,7859/22402
no mra at baseline,C0243032;C0168634;C1442488;C1609165;C3891069,true;true;false;true;false,7860/22402
mra at baseline,C0243032;C0168634;C1442488;C1609165;C3891069,true;true;false;true;false,7861/22402
ss at baseline,C2699257;C0168634;C1442488;C3891295;C4551874,false;true;false;false;false,7862/22402
mmrc at baseline,C3826977;C0168634;C1442488,false;true;false,7863/22402
pad at baseline,C0182158;C0168634;C1442488;C0332568;C3540603;C3669270;C3814046;C4319657,false;true;false;false;false;false;false;false,7864/22402
nihss at baseline,C1697238;C0168634;C1442488,false;true;false,7865/22402
aspirin dose,C4696290,false,7866/22402
aspirin alone,C0004057,true,7867/22402
aspirin use,C0004057;C0042153;C0457083;C1947944,true;true;false;false,7868/22402
arrhythmia,C0003811,true,7869/22402
arrhythmia !,C0003811,true,7870/22402
arrhythmias,C0003811,true,7871/22402
hypertensive,C0857121,false,7872/22402
hypertensiont,,,7873/22402
hypertension  n ( % ),C0020538;C1963138,true;false,7874/22402
hypertension 本,C0020538;C1963138,true;false,7875/22402
hypotension,C0020649;C3163620,true;false,7876/22402
hypertension  * n ( % ),C0020538;C1963138,true;false,7877/22402
hyper - tension,C0020538;C1963138,true;false,7878/22402
hypertension,C0020538;C1963138,true;false,7879/22402
hypertension  %,C0020538;C1963138,true;false,7880/22402
hypertension ( % ),C0020538;C1963138,true;false,7881/22402
hypertension  ( % ),C0020538;C1963138,true;false,7882/22402
no hypertension,C0020538;C1963138,true;false,7883/22402
hyperlension,,,7884/22402
hypertension *,C0020538;C1963138,true;false,7885/22402
hypertensive  n ( % ),C0857121,false,7886/22402
hypertension §,C0020538;C1963138,true;false,7887/22402
hypertension !,C0020538;C1963138,true;false,7888/22402
unstable angina *,C0002965,true,7889/22402
unstable angina age,C0002965;C0001779,true;false,7890/22402
unstable angina §,C0002965,true,7891/22402
unstable anginad,C0443343;C1883468,false;false,7892/22402
unstableangina,,,7893/22402
stable angina,C0340288,true,7894/22402
unstable anginat,C0443343;C1883468,false;false,7895/22402
unstable angina,C0002965,true,7896/22402
arb monotherapy,C3888198,false,7897/22402
era monotherapy,C1521863;C3495919,true;false,7898/22402
cardioembolism,,,7899/22402
cardioembolic,,,7900/22402
age category >,C0001779;C0683312;C3889287,false;false;false,7901/22402
bmi category,C0578022;C0683312;C3889287,false;false;false,7902/22402
age category,C0001779;C0683312;C3889287,false;false;false,7903/22402
aspirin or other antiplatelet agents,C0004057,true,7904/22402
aspirin or other antiplatelet agent,C0004057,true,7905/22402
mean ( sd ) pga vas *,C0444504;C2699239;C0016410;C0042815;C3536884;C3827561;C3541266;C4050369;C2347634;C2348143,false;false;true;true;true;false;false;false;false;false,7906/22402
mean ( sd ) ptga vas *,C0444504;C2699239;C0042815;C3536884;C3827561;C2347634;C2348143,false;false;true;true;false;false;false,7907/22402
mean ( sd ) pain vas *,C0444504;C2699239;C0042815;C2347634;C2348143,false;false;true;false;false,7908/22402
previous ml ( before index acs ),C0205156;C0439526;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1705224;C3887665;C1552607,false;false;true;true;false;true;false;false;false;false;false;false,7909/22402
previous pci ( before index acs ),C0205156;C4049621;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C1552607,false;false;true;true;false;true;false;false;false;false,7910/22402
fibula fracture,C0149699,false,7911/22402
tibia fracture,C0040185,true,7912/22402
weight in kg  mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7913/22402
weight  kg  mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7914/22402
weight  kg : mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7915/22402
weight ( kg )  mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7916/22402
weight ( kg )  mean ± sd,C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,7917/22402
serum creatinine  umol / lf,C0201976;C0439194;C1416933;C2986618;C4554443;C0600061,false;false;false;false;false;false,7918/22402
serum creatinine  gmol / l |,C0201976;C0600061,false;false,7919/22402
serum creatinine ( gmol / ),C0201976;C0600061,false;false,7920/22402
serum creatinine ( mmol / l ),C0201976;C1532563;C0600061,false;false;false,7921/22402
serum creatinine  ^ mol / l,C0201976;C0347982;C0600061,false;false;false,7922/22402
> $nmbr$ years eze / simva ( „ = $nmbr$ },C0439234,false,7923/22402
< $nmbr$ years eze / simva ( n = $nmbr$ },C0439234,false,7924/22402
im use : no,,,7925/22402
cs use : no,C0010182;C0271160;C3540510;C4085345,true;false;false;false,7926/22402
stent diameter < $nmbr$ mm,C0038257;C1301886;C4330985;C4554674,true;false;false;false,7927/22402
stent diameter $ $nmbr$ mm,C0038257;C1301886;C4330985;C4554674,true;false;false;false,7928/22402
overall ( n = $nmbr$  $nmbr$ ),C0282416;C1561607,true;false,7929/22402
overall ( n = $nmbr$ vs $nmbr$ ),C0282416;C1561607,true;false,7930/22402
leukotriene receptor antagonists,C0595726;C2757015;C3542962,true;false;false,7931/22402
leukotriene - receptor antagonist,C0595726;C3537183;C4521995,true;false;false,7932/22402
high - sensitivity c - reactive protein  mg / ltt,C1441604;C0006560;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,false;true;true;true;false;false;false;false;false;false;false,7933/22402
high - sensitivityc - reactive protein  mg / l,C0205250;C0205332;C0033684;C0439268;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false,7934/22402
etn + mtx ( n = $nmbr$ ),C0014758;C0025677;C1417487;C0717758,true;true;false;true,7935/22402
hcq + mtx ( n = $nmbr$ ),C0020336;C0025677;C1417487,true;true;false,7936/22402
ssz + mtx ( n = $nmbr$ ),C0025677;C1417487,true;false,7937/22402
lef + mtx ( n = $nmbr$ ),C0025677;C1417487,true;false,7938/22402
> $nmbr$ drinks,C0452428,false,7939/22402
$nmbr$ drinks,C0452428,false,7940/22402
glucose ( mg / dl ),C0017725;C0439269,true;false,7941/22402
glucose — mg / dl,C0017725;C0439269,true;false,7942/22402
thienopyridine,C1120149,true,7943/22402
+ thienopyridine,C1120149,true,7944/22402
no thienopyridine,C1120149,true,7945/22402
- thienopyridine,C1120149,true,7946/22402
acholesterol ( % ),,,7947/22402
cholesterol ( % ),C0008377,true,7948/22402
< $nmbr$ . $nmbr$ mg / dl,C0439269,false,7949/22402
> $nmbr$ . $nmbr$ mg / mmol,C0567349;C2348885,false;false,7950/22402
> $nmbr$ . $nmbr$ - g / l,C0439294;C0456615,false;false,7951/22402
$nmbr$ - $nmbr$ mg / g,C1300563,false,7952/22402
$nmbr$ $nmbr$ mg / dl,C0439269,false,7953/22402
≥ $nmbr$ to < $nmbr$ mg / g,C1300563,false,7954/22402
> $nmbr$ . $nmbr$ mg / l,C0439268,false,7955/22402
> $nmbr$ . $nmbr$ mmol / l,C1532563,false,7956/22402
≥ $nmbr$ to < $nmbr$ mg / dl,C0439269,false,7957/22402
< $nmbr$ . $nmbr$ mmol / l,C1532563,false,7958/22402
< $nmbr$ . $nmbr$ mg / mmol,C0567349;C2348885,false;false,7959/22402
> $nmbr$ & < $nmbr$ mg / dl,C0439269,false,7960/22402
> $nmbr$ and < $nmbr$ mg / dl,,,7961/22402
> $nmbr$ to $nmbr$ mg / g,C1300563,false,7962/22402
> $nmbr$ but < $nmbr$ mg / dl,,,7963/22402
< $nmbr$ . $nmbr$ ng / ml,C0439275,false,7964/22402
> $nmbr$ + $nmbr$ mmol / l,C1532563,false,7965/22402
$nmbr$ - $nmbr$ mg / dl,C0439269,false,7966/22402
. $nmbr$ . $nmbr$ mg / mmol,C0567349;C2348885,false;false,7967/22402
< $nmbr$ - $nmbr$ mmol / l,C1532563,false,7968/22402
$nmbr$ . $nmbr$ mg / mmol,C0567349;C2348885,false;false,7969/22402
$nmbr$ to $nmbr$ mg / g,C1300563,false,7970/22402
$nmbr$ to < $nmbr$ mg / dl,C0439269,false,7971/22402
> $nmbr$ . $nmbr$ mg / dl,C0439269,false,7972/22402
> $nmbr$  < $nmbr$ mg / dl,C0439269,false,7973/22402
< $nmbr$ . $nmbr$ l - g / l,C3539687;C0439267,false;false,7974/22402
> $nmbr$ . $nmbr$ ng / ml,C0439275,false,7975/22402
> $nmbr$ ' $nmbr$ mmol / l,C1532563,false,7976/22402
> $nmbr$ - $nmbr$ mmol / l,C1532563,false,7977/22402
< $nmbr$ . $nmbr$ mg / l,C0439268,false,7978/22402
cerebral vascular disease,C0007820,true,7979/22402
cerebrovascular disease,C0007820,true,7980/22402
linagliptin,C2746078,true,7981/22402
vildagliptin,C1570906,true,7982/22402
sitagliptin,C1565750,true,7983/22402
saxagliptin,C1611934,true,7984/22402
mean ( s . e . ),C0444504;C2347634;C2348143,false;false;false,7985/22402
mean ( s . e . ) t,C0444504;C2347634;C2348143,false;false;false,7986/22402
mean ( s . d . ),C0444504;C2347634;C2348143,false;false;false,7987/22402
mean bmi  kg / m $nmbr$ ( sd ),C0444504;C0578022;C1532718;C2699239;C2347634;C2348143,false;false;false;false;false;false,7988/22402
mean bmi ( kg / m $nmbr$ ) ( sd ),C0444504;C0578022;C1532718;C2699239;C2347634;C2348143,false;false;false;false;false;false,7989/22402
tiotropium ( nz $nmbr$ ),C0213771;C0027978,true;true,7990/22402
tiotropium ( n z $nmbr$ ),C0213771,true,7991/22402
tiotropium ( n = $nmbr$ ),C0213771,true,7992/22402
gastroduodenum,C0391900,false,7993/22402
gastroduodenal,C0450199,false,7994/22402
primary endpoint,C2986535,false,7995/22402
primary end point,C2986535,false,7996/22402
dyslipidemia — no . ( % ),C0242339,true,7997/22402
dyslipidemia — no . ( % ) |,C0242339,true,7998/22402
tjc ( $nmbr$ - $nmbr$ )  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,7999/22402
sjc ( $nmbr$ - $nmbr$ )  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,8000/22402
non cv mortality,C1518422;C3538987;C0026565;C0026566;C4048877;C4318503,false;false;true;true;true;false,8001/22402
non - cv mortality,C1518422;C3538987;C0026565;C0026566;C4048877;C4318503,false;false;true;true;true;false,8002/22402
patients with prevalent kidney disease at baseline,C0030705;C0022646;C0683921;C0227665,true;true;false;false,8003/22402
patients without prevalent kidney disease at baseline,C0030705;C0022646;C0683921;C0227665,true;true;false;false,8004/22402
mean ( s . d . ) age  years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,8005/22402
mean ± s . d . age  years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,8006/22402
$nmbr$ mg / day early - start - delayed - start,C0439422,false,8007/22402
$nmbr$ mg / day early - start - delayed start,C0439422,false,8008/22402
£ $nmbr$ kg / m $nmbr$,C1532718,false,8009/22402
a $nmbr$ kg / m $nmbr$,C1532718,false,8010/22402
< $nmbr$ kg / m $nmbr$,C1532718,false,8011/22402
> $nmbr$ kg / m $nmbr$,C1532718,false,8012/22402
s $nmbr$ kg / m $nmbr$,C0565930;C1532718;C2603362,false;false;false,8013/22402
≥ $nmbr$ kg / m $nmbr$,C1532718,false,8014/22402
hypokalemia ‡   ( potassium < $nmbr$ . $nmbr$ mmol / l ),C0020621;C0032821;C1532563;C0202194;C0304475;C0597277;C3714637;C4553966,true;true;false;false;false;false;false;false,8015/22402
hyperkalemia ‡   ( potassium ≥ $nmbr$ . $nmbr$ mmol / l ),C0020461;C0032821;C1532563;C0202194;C0304475;C0597277;C3714637;C4552983,true;true;false;false;false;false;false;false,8016/22402
heparin only,C0019134;C0205171;C1720467;C0770546,true;false;false;false,8017/22402
aspirin only,C0004057;C0205171;C1720467,true;false;false,8018/22402
mitral regurgitation  n ( % ),C0026266,true,8019/22402
mitral regurgitation  ( % ),C0026266,true,8020/22402
< $nmbr$ years n z $nmbr$,C0439234,false,8021/22402
> $nmbr$ years n z $nmbr$,C0439234,false,8022/22402
age < $nmbr$ y ( n = $nmbr$ ),C0001779,false,8023/22402
age ' $nmbr$ y ( n $nmbr$ ),C0001779,false,8024/22402
age > $nmbr$ y ( n = $nmbr$ ),C0001779,false,8025/22402
ace inhibitor  %,C0003015;C4541021,true;false,8026/22402
ace inhibitor,C0003015;C4541021,true;false,8027/22402
ace inhibitors,C0003015,true,8028/22402
tnf inhibitors,C1448177;C0243077,true;true,8029/22402
tnf inhibitor,C1448177;C1999216,true;false,8030/22402
ace inhibitor yes,C0003015;C1549445;C1705108;C1710701;C4541021,true;false;false;false;false,8031/22402
body - mass index : ! :,C0005893;C0578022;C1305855,false;false;true,8032/22402
body - mass index  !,C0005893;C0578022;C1305855,false;false;true,8033/22402
change from baseline to eos  uu / ml,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8034/22402
change from baseline to eos  mg / dl,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8035/22402
right coronary artery,C1261316,false,8036/22402
r ight coronar y artery,C0205090;C0003842;C0226004;C0684010;C2603358,false;true;false;true;false,8037/22402
duration of t $nmbr$ dm > $nmbr$ years,C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,8038/22402
duration of t $nmbr$ dm < $nmbr$ years,C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,8039/22402
time to randomization,C0040223;C0034656;C3541383,true;true;false,8040/22402
time of randomization,C0040223;C0034656;C3541383,true;true;false,8041/22402
p value ( cangrelor versus clopidogrel in men ),C1709380;C1121991,false;true,8042/22402
p value ( cangrelor versus clopidogrel in women ),C1709380;C1121991,false;true,8043/22402
weight ( kg ),C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8044/22402
weight  kg *,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8045/22402
height — cm,C0489786,false,8046/22402
w eight ( k g ),C0205454;C0597277;C0439267;C1708601,false;false;false;false,8047/22402
weight  lbs,C0005910;C0439219;C3161851;C0043100;C1305866;C1705104,true;false;false;true;false;false,8048/22402
weight  kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8049/22402
height  cm,C0489786,false,8050/22402
weight 一 kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8051/22402
height ( cm ),C0489786,false,8052/22402
weight — kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8053/22402
weight - kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,8054/22402
height  cm *,C0489786,false,8055/22402
ldl - c  mmol / l ( mg / dl ),C3898312;C3642216,false;false,8056/22402
hdl - c  mmol / l ( mg / dl ),C3715113;C3898312;C3642216,false;false;false,8057/22402
body - mass index ) -,C0005893;C0578022;C1305855,false;false;true,8058/22402
body mass index  %,C0005893;C0578022;C1305855,false;false;true,8059/22402
body - mass indexj,C0518010,false,8060/22402
body - mass indexf,C0518010,false,8061/22402
body - mass index ),C0005893;C0578022;C1305855,false;false;true,8062/22402
body - mass index *,C0005893;C0578022;C1305855,false;false;true,8063/22402
body - mass index §,C0005893;C0578022;C1305855,false;false;true,8064/22402
body mass index *,C0005893;C0578022;C1305855,false;false;true,8065/22402
body - mass index $,C0005893;C0578022;C1305855,false;false;true,8066/22402
body mass indexc,C0518010,false,8067/22402
body mass index +,C0005893;C0578022;C1305855,false;false;true,8068/22402
body mass index,C0005893;C0578022;C1305855,false;false;true,8069/22402
body mass index :,C0005893;C0578022;C1305855,false;false;true,8070/22402
body - mass index,C0005893;C0578022;C1305855,false;false;true,8071/22402
family history of premature chd,C0241889;C0151526;C0280604;C3542407;C0205252;C4018905,true;true;false;false;false;false,8072/22402
family history of premature chdj,C0241889;C0151526;C0205252;C4018905,true;true;false;false,8073/22402
abatacept $nmbr$ mg / kg ( n = $nmbr$ ),C1619966;C0439272,true;false,8074/22402
abatacept ~ $nmbr$ mg / kg ( n = $nmbr$ ),C1619966;C0439272,true;false,8075/22402
prior tnf antagonist failure - no,C0332152;C1448177;C0231491;C0231174;C0680095;C2826257,false;true;false;false;false;false,8076/22402
prior tnf antagonist failure - yes,C0332152;C1448177;C0231491;C0231174;C1549445;C1705108;C1710701;C0680095;C2826257,false;true;false;false;false;false;false;false;false,8077/22402
previous cabg,C0205156;C0010055;C1552607,false;true;false,8078/22402
previous mi,C0205156;C3810814;C1552607,false;false;false,8079/22402
previous ptca,C0205156;C2936173;C1552607,false;true;false,8080/22402
previous pci,C0205156;C4049621;C1552607,false;false;false,8081/22402
previous hf,C0205156;C0018488;C1313497;C1538440;C3273279;C1552607,false;true;true;false;false;false,8082/22402
previous tia,C0205156;C0007787;C0917805;C1054154;C1552607,false;true;true;false;false,8083/22402
previous ml,C0205156;C0439526;C1705224;C3887665;C1552607,false;false;false;false;false,8084/22402
previous chf,C0205156;C0018802;C1552607,false;true;false,8085/22402
previous cad,C0205156;C1504769;C2239547;C3813548;C4284121;C1552607,false;true;false;false;false;false,8086/22402
previous ami,C0205156;C4319936;C1552607,false;false;false,8087/22402
previously,,,8088/22402
previous,C0205156;C1552607,false;false,8089/22402
w event ( rate ),C0441471;C0871208;C1521828;C4019010,false;false;false;false,8090/22402
n event ( rate ),C0369718;C0441471;C0871208;C1521828;C4019010;C0441922,false;false;false;false;false;false,8091/22402
type $nmbr$ diabetes ( n = $nmbr$  $nmbr$ ),C1320657,false,8092/22402
no type $nmbr$ diabetes ( n = $nmbr$  $nmbr$ ),C1320657,false,8093/22402
family history of vte,C0241889;C0630906,true;true,8094/22402
family history of cad,C0241889;C1504769;C2239547;C3813548;C4284121,true;true;false;false;false,8095/22402
with p blockers,C0369773;C2603361,false;false,8096/22402
without p blockers,C0369773;C2603361,false;false,8097/22402
triglycerides < $nmbr$ - $nmbr$ mmol / l,C0041004;C1532563,true;false,8098/22402
triglycerides > $nmbr$ - $nmbr$ mmol / l,C0041004;C1532563,true;false,8099/22402
non - hdl - c  mg / dl,C1518422;C3715113;C0439269,false;false;false,8100/22402
non - hdl - c ( mg / dl ),C1518422;C3715113;C0439269,false;false;false,8101/22402
lipid - lowering medications ^,C0023779;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,8102/22402
lipid - lowering medications,C0023779;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,8103/22402
lipid - lowering medication,C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,8104/22402
history of cad,C0019664;C1504769;C2239547;C3813548;C4284121;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;true;false;false;false;false,8105/22402
no history of af,C0019664;C0344434;C4049859;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8106/22402
history of pci,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8107/22402
history of copd,C0019664;C0024117;C1412502;C3714496;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,8108/22402
history pci,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8109/22402
history of mi,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8110/22402
history of vte,C0019664;C0630906;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8111/22402
history of chf,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8112/22402
history of chd,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8113/22402
history of cabg,C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8114/22402
no history of chf,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8115/22402
history of pad,C0019664;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;false;false;true;false;false;false;false,8116/22402
history of ml,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,8117/22402
history of hf,C0019664;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;true;false;false;false;false,8118/22402
history of af,C0019664;C0344434;C4049859;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8119/22402
lesion length $ $nmbr$ mm,C0221198;C1444754;C4330985;C4554674;C1706316;C1546698,false;false;false;false;false;false,8120/22402
lesion length > $nmbr$ mm,C0221198;C1444754;C4330985;C4554674;C1706316;C1546698,false;false;false;false;false;false,8121/22402
male gender,C0086582;C1706180,true;false,8122/22402
female gender,C0086287,true,8123/22402
ratio of hrs ( $nmbr$ % cl )  p for sex interaction,C0456603;C1568891;C0596019;C1547037,false;true;false;false,8124/22402
ratio of hrs ( $nmbr$ % ci )  p for sex interaction,C0456603;C1568891;C0008107;C3259781;C1547037,false;true;true;false;false,8125/22402
statins / ezetimibe,C0360714;C1142985,true;true,8126/22402
statin or ezetimibe,C0360714,true,8127/22402
> median ( $nmbr$ . $nmbr$ ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,8128/22402
< median ( $nmbr$ . $nmbr$ ) — number / n ( % ),C0549183;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,8129/22402
renal impairment,C1565489,true,8130/22402
renal impairmentt,C0022646,true,8131/22402
antiplatelet drugs,C0085826;C2963157,true;false,8132/22402
antiplatelet drug,C0085826,true,8133/22402
cha $nmbr$ ds $nmbr$ - vasc $ $nmbr$,C1420648;C3714751,false;false,8134/22402
cha $nmbr$ ds $nmbr$ - vasc # $nmbr$,C1420648;C3714751,false;false,8135/22402
cha $nmbr$ ds $nmbr$ - vasc > $nmbr$,C1420648;C3714751,false;false,8136/22402
reversibility to,C0449261,false,8137/22402
reversibility ( % ) t,C0449261,false,8138/22402
reversibility *,C0449261,false,8139/22402
reversibility,C0449261,false,8140/22402
reversibility  %,C0449261,false,8141/22402
reversibility ( % ),C0449261,false,8142/22402
reversibility %,C0449261,false,8143/22402
present ( £ $nmbr$ mg / dl ),C0150312;C0439269;C0449450,false;false;false,8144/22402
present ( > $nmbr$ mg / dl ),C0150312;C0439269;C0449450,false;false;false,8145/22402
hba $nmbr$ c < = $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,8146/22402
hba $nmbr$ c < $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,8147/22402
hba $nmbr$ c > $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,8148/22402
hba $nmbr$ c > = $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,8149/22402
metformin 一 no . ( % ),C0025598,true,8150/22402
metformin — no . ( % ),C0025598,true,8151/22402
women / men [ % ],C0043210;C0025266,true;true,8152/22402
women / men  %,C0043210;C0025266,true;true,8153/22402
$nmbr$ . $nmbr$ to # $nmbr$ . $nmbr$ mg / mmol,C0567349;C2348885,false;false,8154/22402
$nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ mg / mmol,C0567349;C2348885,false;false,8155/22402
baseline tav - > = median ( n = $nmbr$  $nmbr$ ),C0168634;C0279686;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,8156/22402
baseline pav - > = median ( n = $nmbr$  $nmbr$ ),C0168634;C0058890;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;false;false;false;false;false,8157/22402
baseline tav - < median ( n = $nmbr$  $nmbr$ ),C0168634;C0279686;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false,8158/22402
baseline pav - < median ( n = $nmbr$  $nmbr$ ),C0168634;C0058890;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;false;false;false;false;false,8159/22402
ifg / igt,C1334085;C1708411,false;false,8160/22402
ifg and igt,C1334085;C1708411,false;false,8161/22402
< $nmbr$ % ( < $nmbr$ mmol / mol ),C3829066,false,8162/22402
> $nmbr$ % ( > $nmbr$ mmol / mol ),C3829066,false,8163/22402
> = $nmbr$ % ( $nmbr$ mmol / mol ),C3829066,false,8164/22402
< $nmbr$ % ( $nmbr$ mmol / mol ),C3829066,false,8165/22402
no mi ( n - $nmbr$  $nmbr$ ),C3810814,false,8166/22402
pad ( n - $nmbr$  $nmbr$ ),C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,8167/22402
no mvd ( n - $nmbr$  $nmbr$ ),C1417507;C3272839,false;false,8168/22402
acs ( n - $nmbr$  $nmbr$ ),C0742343;C4318612,true;false,8169/22402
mvd ( n - $nmbr$  $nmbr$ ),C1417507;C3272839,false;false,8170/22402
any mi ( n - $nmbr$  $nmbr$ ),C3810814,false,8171/22402
no pad ( n - $nmbr$  $nmbr$ ),C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,8172/22402
total cholesterol > $nmbr$ - $nmbr$ mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,8173/22402
total cholesterol < $nmbr$ $nmbr$ mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,8174/22402
total cholesterol < $nmbr$ - $nmbr$ mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,8175/22402
total cholesterol > $nmbr$ ' $nmbr$ mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,8176/22402
body mass index  mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8177/22402
body mass index  mean ( sd ) t,C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8178/22402
body massindex  mean ( sd ) a,C0242821;C0444504;C2699239;C2347634;C2348143;C0460148;C1268086;C4082212,true;false;false;false;false;false;false;false,8179/22402
body - mass index  mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8180/22402
body mass index  mean ( sd ) d,C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,8181/22402
change from baseline *,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8182/22402
change from baseline,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8183/22402
% change from baseline,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,8184/22402
rectal bleeding subscore {,C0018932;C0267596,true;false,8185/22402
rectal bleeding subscore,C0018932;C0267596,true;false,8186/22402
ldl - c ( mmol / l ),C1532563,false,8187/22402
ldl - c  mmol / l,C1532563,false,8188/22402
hdl - c  mmol / l,C3715113;C1532563,false;false,8189/22402
hdl - c ( mmol / l ),C3715113;C1532563,false;false,8190/22402
ldl - c * ( mmol / l ),C1532563,false,8191/22402
insulin - dependent,C0021641;C0429964;C0429986;C0851827;C1701901;C3244310;C4321395;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,8192/22402
insulin dependentc,C0021641;C1533581;C1579433;C3714501,true;false;false;false,8193/22402
antihypertensive therapy,C0585941,false,8194/22402
anti - hypertensive therapy,C0585941,false,8195/22402
ace inhibitors or angiotensin - receptor blockers ^,C0003015,true,8196/22402
ace inhibitor or angiotensin receptor blocker,C0003015;C4541021,true;false,8197/22402
ace inhibitor or angiotensin ii receptor blocker,C0003015;C4541021,true;false,8198/22402
ace inhibitors or angiotensin receptor blockers,C0003015,true,8199/22402
diabetes duration  years,C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,8200/22402
diabetes duration ( years ),C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,8201/22402
age ( years ) mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8202/22402
age  y  mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8203/22402
cdai  mean ( sd ),C0683448;C0444504;C2699239;C2347634;C2348143;C1413248;C3273706,false;false;false;false;false;false;false,8204/22402
age  years ( sd ),C1510829;C2699239,false;false,8205/22402
age  years  mean + sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8206/22402
age  yr mean ( sd ),C0001779;C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8207/22402
age  mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8208/22402
bmi  mean ( sd ),C0578022;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8209/22402
age ( years ) mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8210/22402
age ( years ) ( mean  sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8211/22402
tc  mean ( sd ),C0039411;C0444504;C2699239;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;true;true;true;false;false;false,8212/22402
bmi  mean ( sd ) b,C0578022;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8213/22402
ibdq  mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,8214/22402
age ( years )  mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8215/22402
age  y  mean ± sd,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8216/22402
age  years  mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8217/22402
bmi  mean ± sd,C0578022;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8218/22402
age  yr  mean ( sd ),C0001779;C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8219/22402
sdai  mean ( sd ),C3871128;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8220/22402
age  mean ± sd,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8221/22402
age ( yrs )  mean ± sd,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8222/22402
age ( years )  mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8223/22402
age  years  mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8224/22402
age  mean yr ( sd ),C0001779;C0444504;C0439234;C2699239;C2347634;C2348143,false;false;false;false;false;false,8225/22402
basfi  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,8226/22402
age in years  mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8227/22402
age ( years ) - mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8228/22402
age  yrs  mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8229/22402
one of the above,C0205447,false,8230/22402
two of the above,C0205448,false,8231/22402
all of the above,C1282910;C1552828,false;false,8232/22402
none of the above,C1282910;C1552828,false;false,8233/22402
any of the above,C1282910;C1552828,false;false,8234/22402
asian or oriental,C0078988,true,8235/22402
asian / oriental,C0078988;C0699027,true;false,8236/22402
no . of stents,C0038257,true,8237/22402
no . of events,C0441471;C3541888,false;false,8238/22402
no . of patients,C0030705,true,8239/22402
serum creatinine — mg / dl §,C0201976;C0439269;C0600061,false;false;false,8240/22402
serum creatinine ( mg / dl ),C0201976;C0439269;C0600061,false;false;false,8241/22402
serum creatinine — mg / dl,C0201976;C0439269;C0600061,false;false;false,8242/22402
serum creatinine  mg / dlb,C0201976;C0024671;C0752347;C3890365;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0600061,false;true;true;false;true;false;false;false;false;false;false,8243/22402
serum creatinine  mg / dl,C0201976;C0439269;C0600061,false;false;false,8244/22402
no diabetes ( n - $nmbr$  $nmbr$ ),C0011847;C0011849,false;true,8245/22402
diabetes ( n - $nmbr$  $nmbr$ ),C0011847;C0011849,false;true,8246/22402
final median  mg / l,C0205088;C0549183;C0439268;C0876920;C2347635;C2348144;C2939193;C1546485;C3853528,false;false;false;false;false;false;false;false;false,8247/22402
final mean  mg / dl,C0205088;C0444504;C0439269;C2347634;C2348143;C1546485;C3853528,false;false;false;false;false;false;false,8248/22402
nonwhite race !,C0034510;C1706779;C3853635,true;false;false,8249/22402
nonwhite race,C0034510;C1706779;C3853635,true;false;false,8250/22402
white race,C0007457;C0043157,true;true,8251/22402
non - white race,C1518422;C0007457;C0043157,false;true;true,8252/22402
non - white raceb,C1518422;C0007457;C0043157;C0220938,false;true;true;false,8253/22402
> $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8254/22402
> $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ a,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8255/22402
current cigarette smoker,C3173209;C0677453;C1704760;C3890423;C3241966;C0521116;C0337667;C1705970,false;true;false;false;false;false;false;false,8256/22402
current cigarette smoking,C0521116;C0239059;C0700219;C1705970,false;false;true;false,8257/22402
at home systolic pressure > $nmbr$ mm hg,C4534363;C0871470;C0439475,false;true;false,8258/22402
at home diastolic pressure < $nmbr$ mm hg,C4534363;C0428883;C0439475,false;true;false,8259/22402
at home diastolic pressure > $nmbr$ mm hg,C4534363;C0428883;C0439475,false;true;false,8260/22402
at home systolic pressure < $nmbr$ mm hg,C4534363;C0871470;C0439475,false;true;false,8261/22402
hx stroke / tia,C0262926;C0038454;C0007787;C0917805;C1054154;C4554100;C3814444,false;true;true;true;false;false;false,8262/22402
stroke or tia,C0038454;C4554100,true;false,8263/22402
stroke ortiab,C0038454;C4554100,true;false,8264/22402
stroke / tia,C0038454;C0007787;C0917805;C1054154;C4554100,true;true;true;false;false,8265/22402
no stroke / tia,C0038454;C0007787;C0917805;C1054154;C4554100,true;true;true;false;false,8266/22402
clinical history — no . ( % ),C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,8267/22402
clinical history  no . ( % ),C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,8268/22402
clinical history  n ( % ),C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,8269/22402
combination therapy ( n = $nmbr$ ),C0009429;C0556895,true;false,8270/22402
combination therapy  n = $nmbr$,C0009429;C0556895,true;false,8271/22402
a $nmbr$ c at baseline < $nmbr$ . $nmbr$ %,C0168634;C1442488,true;false,8272/22402
a $nmbr$ c at baseline ≥ $nmbr$ . $nmbr$ %,C0168634;C1442488,true;false,8273/22402
native american,C0282204;C1515945,true;false,8274/22402
latin american,C1553378,false,8275/22402
latin america,C0023122,true,8276/22402
liraglutide $nmbr$ . $nmbr$ mg,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8277/22402
medical history  no . ( % ),C0262926;C1704706,false;false,8278/22402
medical history — no . ( % ),C0262926;C1704706,false;false,8279/22402
medical history  n ( % ),C0262926;C1704706,false;false,8280/22402
diabetes mellitus :,C0011849,true,8281/22402
diabetes mellitus,C0011849,true,8282/22402
no diabetes mellitus,C0011849,true,8283/22402
diabetes mellitus  n ( % ),C0011849,true,8284/22402
diabetes mellitus !,C0011849,true,8285/22402
diabetes mellitus  § n ( % ),C0011849,true,8286/22402
diabetes mellitus  %,C0011849,true,8287/22402
diabetes mellitus ( % ),C0011849,true,8288/22402
diabetes mellitus  ( % ),C0011849,true,8289/22402
since diagnosis,,,8290/22402
index diagnosis,C0600653;C0011900;C1704338;C1704656;C0918012;C1552854;C1637833;C2986546,true;true;true;false;true;false;false;false,8291/22402
> $nmbr$ months  mean ( sd ),C0439231;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8292/22402
< $nmbr$ months  mean ( sd ),C0439231;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8293/22402
placebo ( n = $nmbr$ $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,8294/22402
placebo ( n = $nmbr$  $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,8295/22402
placebo ( n - $nmbr$ . $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,8296/22402
placebo ( n $nmbr$ $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,8297/22402
second mi,C0205436;C3810814;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,8298/22402
no second mi,C0205436;C3810814;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false,8299/22402
controlled,C2587213;C2911690,false;false,8300/22402
coronary,C0018787,true,8301/22402
country,C0454664;C1511538,false;false,8302/22402
controlld,,,8303/22402
uncontrolled,C0205318,false,8304/22402
control,C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,8305/22402
diabetes status  n ( % ),C1317301,false,8306/22402
diabetes status  no . ( % ),C1317301,false,8307/22402
ezetimibe $nmbr$ mg ( n = $nmbr$ * ),C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8308/22402
ezetimibe $nmbr$ mg ( n = $nmbr$ ),C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8309/22402
chads $nmbr$ score,C0007928;C1413373,true;false,8310/22402
chads $nmbr$ score *,C0007928;C1413373,true;false,8311/22402
chads $nmbr$ scoreb,C0007928;C1413373,true;false,8312/22402
age  mean = sd  years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8313/22402
age  mean ± sd ( year ),C0001779;C0444504;C2699239;C0439234;C0439508;C2347634;C2348143,false;false;false;false;false;false;false,8314/22402
age  mean ± sd years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8315/22402
age  mean ( sd ) years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8316/22402
age  mean ( sd )  years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8317/22402
age  mean ( sd )  y,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8318/22402
age  mean ( sd )  yrs,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8319/22402
age  mean ± sd  years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,8320/22402
aiirocumab ( n = $nmbr$ ),,,8321/22402
alirocumab ( n = $nmbr$ ),C3491162,true,8322/22402
< $nmbr$ enroll,,,8323/22402
> $nmbr$ enroll,,,8324/22402
das $nmbr$ - crp  ls mean change from baseline ( se ) ¥,C0051767;C3890735;C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143;C4048285;C0057671,true;false;true;false;false;true;true;false;false;false;false;false;false;false;true,8325/22402
das $nmbr$ - crp  ls mean change from baseline ( se ) §,C0051767;C3890735;C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143;C4048285;C0057671,true;false;true;false;false;true;true;false;false;false;false;false;false;false;true,8326/22402
anacetrapib $nmbr$ mg ( n = $nmbr$ ),C2604745;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8327/22402
anacetrapib $nmbr$ mg ( n - $nmbr$ ),C2604745;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8328/22402
current,C0521116;C1705970,false;false,8329/22402
currently,C0521116,false,8330/22402
total stent length - mm,C0439175;C0038257;C1444754;C4330985;C4554674;C1706316;C0439810,false;true;false;false;false;false;false,8331/22402
total stent length  mm,C0439175;C0038257;C1444754;C4330985;C4554674;C1706316;C0439810,false;true;false;false;false;false;false,8332/22402
body mass index > $nmbr$ kg / m $nmbr$ *,C0005893;C1532718;C0578022;C1305855,false;false;false;true,8333/22402
body mass index < $nmbr$ kg / m $nmbr$,C0005893;C1532718;C0578022;C1305855,false;false;false;true,8334/22402
p inleraclion,C0369773;C2603361,false;false,8335/22402
p $nmbr$ interaction,C0369773;C1704675;C2603361,false;false;false,8336/22402
p for interaction,C0369773;C1704675;C2603361,false;false;false,8337/22402
pfor interaction,C1151635;C1704675,false;false,8338/22402
p interaction,C0369773;C1704675;C2603361,false;false;false,8339/22402
pinteraction,,,8340/22402
p  interaction !,C0369773;C1704675;C2603361,false;false;false,8341/22402
p for interaction *,C0369773;C1704675;C2603361,false;false;false,8342/22402
interaction p,C1704675,false,8343/22402
age - interaction,C0001779;C1704675,false;false,8344/22402
interaction - p,C1704675,false,8345/22402
p - interaction,C0369773;C1704675;C2603361,false;false;false,8346/22402
p . interaction,C0369773;C1704675;C2603361,false;false;false,8347/22402
p : interaction,C0369773;C1704675;C2603361,false;false;false,8348/22402
p - interactio n,C0369773;C2603361,false;false,8349/22402
angiotensin receptor blockers,C0521942;C0815017,true;true,8350/22402
angiotensin receptor blocker yes,C0034787;C1549445;C1705108;C1710701;C1622222,true;false;false;false;true,8351/22402
angiotensin ii receptor blocker,C0521942;C3536793,true;false,8352/22402
angiotensin - receptor blocker,C0034787;C1622222,true;true,8353/22402
angiotensin receptor blocker,C0034787;C1622222,true;true,8354/22402
angiotensin ll - receptor blocker,C0003018;C4521302,true;false,8355/22402
creatinine — mg / dl,C0010294;C0439269;C1561535,true;false;false,8356/22402
creatinine  mg / dl_,C0010294;C0439269;C1561535,true;false;false,8357/22402
creatinine ( mg / dl ),C0010294;C0439269;C1561535,true;false;false,8358/22402
creatinine  mg / dl,C0010294;C0439269;C1561535,true;false;false,8359/22402
baseline post - bronchodilator % predicted fev  > $nmbr$ % and no prior ics use,C0168634;C1442488,true;false,8360/22402
baseline post - bronchodilator % predicted fev  > $nmbr$ % and prior ics use,C0168634;C1442488,true;false,8361/22402
fev $nmbr$ ( % predicted ),C3714541,true,8362/22402
fev $nmbr$  % predicted,C3714541,true,8363/22402
fev $nmbr$  % predicteda,C3714541,true,8364/22402
fev $nmbr$ % predicted,C3714541,true,8365/22402
fev $nmbr$  l *,C3714541,true,8366/22402
fev $nmbr$  l,C3714541,true,8367/22402
fev $nmbr$  la,C3714541;C0023031;C0023749;C0230347;C2346906;C4553351,true;true;true;false;false;false,8368/22402
fev $nmbr$ ( l ),C3714541,true,8369/22402
mean sitting sbp ( mmhg ),C0444504;C0277814;C0085805;C0439475;C2584297;C4050224;C2347634;C2348143,false;true;true;false;true;false;false;false,8370/22402
mean sitting dbp ( mmhg ),C0444504;C0277814;C0536221;C0439475;C3813197;C4281799;C2584297;C4050224;C2347634;C2348143,false;true;true;false;false;false;true;false;false;false,8371/22402
potassium ( mmol / l ),C0032821;C1532563;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,8372/22402
potassium ( meq / l ),C0032821;C0439375;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,8373/22402
potassium  mmol / l,C0032821;C1532563;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,8374/22402
£ $nmbr$ ( men ) / £ $nmbr$ ( women ),C0025266;C0043210,true;true,8375/22402
< $nmbr$ ( men ) / < $nmbr$ ( women ),C0025266;C0043210,true;true,8376/22402
creat clearance < $nmbr$ ml / min,C0201975;C0449297;C0439445;C1382187;C2825073;C4554548,false;false;false;false;false;false,8377/22402
creat clearance > $nmbr$ ml / min,C0201975;C0449297;C0439445;C1382187;C2825073;C4554548,false;false;false;false;false;false,8378/22402
pre - bronchodilator,C2599602,false,8379/22402
prebronchodilator,C2599602,false,8380/22402
post - bronchodilator,C2599594,false,8381/22402
postbronchodilator,C2599594,false,8382/22402
heritable,C0439660,false,8383/22402
variable,C0439828;C4553760,false;false,8384/22402
apolipoprotein b ( mg / dl ),C0003593;C0439269,true;false,8385/22402
apolipoprotein b ( g / l ),C0003593;C0439294;C0456615,true;false;false,8386/22402
tiotropiumc,,,8387/22402
tiotropium,C0213771,true,8388/22402
no prior statin use,C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,8389/22402
prior statin use,C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,8390/22402
nyha iv  n ( % ),C1275491;C0022326;C4265176,false;true;false,8391/22402
nyha ii  n ( % ),C1275491;C1710602;C4082587,false;false;false,8392/22402
nyha iii  n ( % ),C1275491;C0439070;C1705160,false;false;false,8393/22402
metabolic syndrome,C0524620,true,8394/22402
metabolic syndrome *,C0524620,true,8395/22402
tiotropium $nmbr$ mg,C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8396/22402
tiotropium $nmbr$ m g,C0213771;C0456715,true;false,8397/22402
pitavastatin $nmbr$ mg,C1101838;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8398/22402
pravastatin $nmbr$ mg,C0085542;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8399/22402
rosuvastatin $nmbr$ mg,C0965129;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8400/22402
simvastatin $nmbr$ mg,C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8401/22402
atorvastatin $nmbr$ mg,C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8402/22402
fluvastatin $nmbr$ mg,C0082608;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8403/22402
lovastatin $nmbr$ mg,C0024027;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8404/22402
stage $nmbr$ b : $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0441781;C0439445;C0369637;C0441923,false;false;false;false,8405/22402
stage $nmbr$ a : $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0205390;C1300072;C1306673,false;false;false,8406/22402
stage $nmbr$ : $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0456533;C0439445,false;false,8407/22402
readmission ( n = $nmbr$ ),C1548168;C4489276,false;false,8408/22402
no readmission ( n = $nmbr$ ),C1548168;C4489276,false;false,8409/22402
nyha class iii,C1882086,false,8410/22402
nyha class iv,C1882087,false,8411/22402
nyha class,C1882083,false,8412/22402
nyha class ii,C1882085,false,8413/22402
nyha class > ii,C1882085,false,8414/22402
nyha class i,C1882084,false,8415/22402
no prior cv event,C0332152;C3538987;C0441471;C4019010;C4048877;C4318503;C2826257,false;false;false;false;true;false;false,8416/22402
prior lgi event,C0332152;C0441471;C4019010;C2826257,false;false;false;false,8417/22402
prior ugi event,C0332152;C0560042;C0441471;C4019010;C2826257,false;false;false;false;false,8418/22402
no prior ugi event,C0332152;C0560042;C0441471;C4019010;C2826257,false;false;false;false;false,8419/22402
prior cv event,C0332152;C3538987;C0441471;C4019010;C4048877;C4318503;C2826257,false;false;false;false;true;false;false,8420/22402
major cv event,C0205082;C3538987;C0441471;C4019010;C4048877;C4318503;C0205164;C4318856;C4521762,false;false;false;false;true;false;false;false;false,8421/22402
no prior lgi event,C0332152;C0441471;C4019010;C2826257,false;false;false;false,8422/22402
prior peripheralarterialdisease,C0332152;C2826257,false;false,8423/22402
prior peripheral arterial disease,C0332152;C0085096;C1704436;C2826257,false;true;true;false,8424/22402
pre - bronchodilator fev $nmbr$ ( l ),C2599602;C3714541,false;true,8425/22402
post - bronchodilator fev $nmbr$  l,C2599594;C3714541,false;true,8426/22402
post - bronchodilator fev $nmbr$  l *,C2599594;C3714541,false;true,8427/22402
postbronchodilator fev $nmbr$  l,C2599594;C3714541,false;true,8428/22402
prebronchodilator fev $nmbr$ ( l ) t,C2599602;C3714541,false;true,8429/22402
post - bronchodilator fev $nmbr$ ( l ) a,C2599594;C3714541,false;true,8430/22402
post - bronchodilator fev $nmbr$ ( l ) *,C2599594;C3714541,false;true,8431/22402
prebronchodilator fev $nmbr$ ( l ),C2599602;C3714541,false;true,8432/22402
prebronchodilator fev $nmbr$  l,C2599602;C3714541,false;true,8433/22402
post - bronchodilator fev $nmbr$ ( l ),C2599594;C3714541,false;true,8434/22402
pre - bronchodilator fev $nmbr$  l *,C2599602;C3714541,false;true,8435/22402
amlodipine / valsartan $nmbr$ / $nmbr$ mg ( n = $nmbr$ ),C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8436/22402
amlodipine / valsartan $nmbr$ / $nmbr$ mg ( n = $nmbr$ i ),C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8437/22402
noncardiovascular,,,8438/22402
cardiovascular,C0007226;C3887460,true;false,8439/22402
etoricoxib ( n = $nmbr$  $nmbr$ ),C0972314,true,8440/22402
etoricoxib ( n = $nmbr$ $nmbr$ ),C0972314,true,8441/22402
no previous cv event,C0205156;C3538987;C0441471;C4019010;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,8442/22402
previous cv event,C0205156;C3538987;C0441471;C4019010;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,8443/22402
asa use at baseline  n ( % ),C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,8444/22402
ics use at baseline  n ( % ),C0815320;C4551720,false;true,8445/22402
ics users at baseline  n ( % ),C0815320;C1706077;C0168634;C1442488;C4551720,false;false;true;false;true,8446/22402
icsusers atbaseline  n ( % ),,,8447/22402
mean fvc ± sd,C0444504;C3714541;C2699239;C2347634;C2348143,false;true;false;false;false,8448/22402
mean dlco ± sd,C0444504;C1516251;C2699239;C2347634;C2348143,false;false;false;false;false,8449/22402
saphenous vein graft,C0729538,false,8450/22402
saphenous - vein graft,C0729538,false,8451/22402
hypercholesterolemia,C0020443;C1522133,true;false,8452/22402
hypercholesterolemia *,C0020443;C1522133,true;false,8453/22402
hypercholesterolemiat,,,8454/22402
hypercholesterolaemia,C0020443;C1522133,true;false,8455/22402
one tnfi and,C0205447,false,8456/22402
one tnfi *,C0205447,false,8457/22402
with stent ^ l,C0038257,true,8458/22402
with stent,C0038257,true,8459/22402
without stent,C0038257,true,8460/22402
postmenopausal and current hrt,C0232970,false,8461/22402
postmenopausal and current ht,C0232970,false,8462/22402
postmenopausal  current hrt,C0232970;C0521116;C0282402;C1705970,false;false;true;false,8463/22402
end point,C2349179;C2826544,false;false,8464/22402
endpoint,C2349179;C2826544,false;false,8465/22402
end points,C2349179,false,8466/22402
endpointc,,,8467/22402
telmisartan ( n = $nmbr$ ),C0248719,true,8468/22402
irbesartan ( n = $nmbr$ ),C0288171,true,8469/22402
olmesartan ( n = $nmbr$ ),C1098320,true,8470/22402
duration of rheumatoid arthritis  year,C0449238;C0003873;C0439234;C0439508;C2926735,false;true;false;false;false,8471/22402
duration of rheumatoid arthritis — yr,C0449238;C0003873;C0439234;C2926735,false;true;false;false,8472/22402
dyslipidaemia  n ( % ),C0242339,true,8473/22402
dyslipidemia  n ( % ),C0242339,true,8474/22402
heart failure $nmbr$ mo before admission,C0018801;C0026544;C0184666;C0809949;C0332177;C0018802;C4554158,true;true;false;false;false;true;false,8475/22402
heart failure $nmbr$ month before admission,C0018801;C0332177;C0184666;C0809949;C0439231;C0018802;C4554158,true;false;false;false;false;true;false,8476/22402
no anemia bsl hb > $nmbr$ g i - $nmbr$  yr $nmbr$ > $nmbr$ g i - $nmbr$,C0002871;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138;C1000483;C4554633,true;false;true;false;true;false;false;false;false,8477/22402
new anemia bsl hb > $nmbr$ g i - $nmbr$  yr $nmbr$ < $nmbr$ g i - $nmbr$,C0205314;C0002871;C1549954;C0019046;C1319635;C0021966;C0439234;C0221138;C1000483;C4554633,false;true;false;true;false;true;false;false;false;false,8478/22402
no previous myocardial infarction,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,8479/22402
previous myocardial infarction,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,8480/22402
peripheral artery disease,C1704436;C4025272,true;false,8481/22402
peripheral arterial disease,C0085096;C1704436,true;true,8482/22402
peripheral - artery disease,C1704436;C4025272,true;false,8483/22402
peripheral artery disease *,C1704436;C4025272,true;false,8484/22402
peripheral artery diseasef,C0489868,false,8485/22402
history of pvd  n ( % ),C4534349,false,8486/22402
history of chd  n ( % ),C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,8487/22402
history of mi  n ( % ),C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8488/22402
history of chf  n ( % ),C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8489/22402
history of tia  n ( % ),C0019664;C0007787;C0917805;C1054154;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,8490/22402
history of pci  n ( % ),C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,8491/22402
history of cabg  n ( % ),C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,8492/22402
white race — no . / total no . ( % ) $,C0007457;C0043157;C0220938,true;true;false,8493/22402
white race — no . / total no . ( % ) f,C0007457;C0043157;C0220938,true;true;false,8494/22402
aspirin $nmbr$,C0004057,true,8495/22402
aspirin $nmbr$ mg,C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8496/22402
total cholesterol  mmol / l,C0201950;C1532563;C0543421,false;false;false,8497/22402
total cholesterol ( mmol / l ),C0201950;C1532563;C0543421,false;false;false,8498/22402
total cholesterol  mmol / l 本,C0201950;C1532563;C0543421,false;false;false,8499/22402
total cholesterol ( mmol / l ) :,C0201950;C1532563;C0543421,false;false;false,8500/22402
no myocardial infarction at presentation ( n = $nmbr$ ),C0027051;C0449450;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false;false,8501/22402
myocardial infarction at presentation ( n = $nmbr$ ),C0027051;C0449450;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false;false,8502/22402
< $nmbr$ mmol / l,C1532563,false,8503/22402
> $nmbr$ mmol / l,C1532563,false,8504/22402
black / african american,C0085756,true,8505/22402
black or african - american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,8506/22402
black / african - american,C0085756,true,8507/22402
black or african american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,8508/22402
black or african america,C0005680;C0027567;C0085756;C0439541,true;true;true;false,8509/22402
black / african american *,C0085756,true,8510/22402
saxagliptin $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8511/22402
saxagliptin $nmbr$ . $nmbr$ mg ( n z $nmbr$ ),C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8512/22402
bmi ( kg / m $nmbr$ )  mean ± sd,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8513/22402
bmi ( kg / m $nmbr$ ) mean ± sd,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8514/22402
bmi ( kg / m $nmbr$ )  mean ( sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8515/22402
bmi  kg / m $nmbr$  mean + sd,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8516/22402
bmi  kg / m $nmbr$  mean ( sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8517/22402
bmi  kg / m $nmbr$  mean ± sd,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8518/22402
bmi in kg / m $nmbr$  mean ( sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8519/22402
bmi ( kg / m $nmbr$ ) mean ( sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,8520/22402
> $nmbr$ years  n ( % ),C0439234,false,8521/22402
< $nmbr$ years  n ( % ),C0439234,false,8522/22402
hazard ratio or difference $nmbr$ * ( $nmbr$ % cl ) p - value,C2985465,false,8523/22402
hazard ratio or difference $nmbr$ ( $nmbr$ % cl ) p - value,C2985465,false,8524/22402
history of hypertension ( a ) c,C0455527,false,8525/22402
history of hypertension ( % ),C0455527,false,8526/22402
women ( n = $nmbr$ )  n / n ( % ),C0043210,true,8527/22402
men ( n = $nmbr$ )  n / n ( % ),C0025266,true,8528/22402
aldosterone antagonists,C0002007;C2757004,true;false,8529/22402
aldosterone antagonist,C0002007;C2757004;C3536833,true;false;false,8530/22402
diastolic blood pressure  mm hg  mean ± sd,C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,8531/22402
diastolic blood pressure ( mm hg )  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,8532/22402
systolic blood pressure  mm hg  mean ± sd,C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,8533/22402
systolic blood pressure ( mm hg )  mean ( sd ),C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,8534/22402
systolic blood pressure  mm hg  mean ( sd ),C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,8535/22402
diastolic blood pressure  mm hg  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,8536/22402
length of stent > median,C0449462;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8537/22402
length of stent < median,C0449462;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8538/22402
£ median ( $nmbr$ . $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,8539/22402
< median ( $nmbr$ . $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,8540/22402
> median ( $nmbr$ . $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,8541/22402
with previous surgery,C0205156;C0038894;C0038895;C0543467;C1274039;C1552607,false;false;true;true;true;false,8542/22402
without previous surgery,C0205156;C0038894;C0038895;C0543467;C1274039;C1552607,false;false;true;true;true;false,8543/22402
corticosteroids,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,8544/22402
corticosteroid use,C0239126,false,8545/22402
no corticosteroid,C0001617;C3536709,true;false,8546/22402
corticosteroidsa,,,8547/22402
corticosteroid,C0001617;C3536709,true;false,8548/22402
full population,C0443225;C0032659;C1257890,false;true;true,8549/22402
full po pulatio n,C0443225;C0946289,false;false,8550/22402
no epa group n = $nmbr$,C0441848,false,8551/22402
epa group n = $nmbr$,C0441848,false,8552/22402
coronary artery disease — %,C0010054;C0010068;C1956346,true;true;true,8553/22402
coronary artery disease ( % ),C0010054;C0010068;C1956346,true;true;true,8554/22402
olodaterol $nmbr$ m g,C2934193;C0456715,true;false,8555/22402
olodaterol $nmbr$ mg,C2934193;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8556/22402
baseline : > $nmbr$ . $nmbr$ meq / l eos : < $nmbr$ . $nmbr$ meq / l,C0168634;C0439375;C1623465;C1861303;C1442488,true;false;false;true;false,8557/22402
baseline : > $nmbr$ . $nmbr$ meq / l eos : > $nmbr$ . $nmbr$ meq / l,C0168634;C0439375;C1623465;C1861303;C1442488,true;false;false;true;false,8558/22402
digoxin  ( % ),C0012265,true,8559/22402
digoxin  n ( % ),C0012265,true,8560/22402
vitamin k antagonists,C3653316,false,8561/22402
vitamin k antagonist,C1096489;C2267235,false;false,8562/22402
off omt ( n = $nmbr$ ),,,8563/22402
on omt ( n = $nmbr$ ),,,8564/22402
ticlopidine,C0040207,true,8565/22402
ticlopidin,,,8566/22402
type $nmbr$ diabetes  n ( % ),C1320657,false,8567/22402
type $nmbr$ diabetes  n ( % ) d,C1320657,false,8568/22402
laba use at screening  n ( % ),C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;false;false;false;false;false;false;false,8569/22402
lama use at screening  n ( % ),C0999593;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1416775,false;true;true;true;false;false;false;false;false;false;false;false,8570/22402
das $nmbr$ - $nmbr$ ( esr ) < $nmbr$ . $nmbr$ *,C0051767;C3811131;C0057671,true;false;true,8571/22402
das $nmbr$ - $nmbr$ ( esr ) < $nmbr$ . $nmbr$ t,C0051767;C3811131;C0057671,true;false;true,8572/22402
modified acc / aha lesion class b $nmbr$ / c,C0392747;C0101856;C0050451;C0221198;C0456387;C1518526;C1705943;C1546698;C0772110;C3889737,false;true;true;false;false;false;false;false;false;false,8573/22402
modified acc - aha lesion class b $nmbr$ or c,C0392747;C4072694;C0221198;C0456387;C1518526;C1705943;C1546698;C3889737,false;false;false;false;false;false;false;false,8574/22402
modified acc / aha lesion class b $nmbr$ or cj,C0392747;C4072694;C0221198;C0456387;C1518526;C1705943;C1546698;C3889737,false;false;false;false;false;false;false;false,8575/22402
modified acc or aha lesion class b $nmbr$ or c,C0392747;C0175754;C0282160;C3541413;C3889737,false;true;true;false;false,8576/22402
mtss ( $nmbr$ - $nmbr$ ),,,8577/22402
vas ( $nmbr$ - $nmbr$ ),C0042815;C3536884;C3827561,true;true;false,8578/22402
oad only,C0205171;C1720467,false;false,8579/22402
diet only,C0012155;C0205171;C1720467;C0012159;C1519433;C2983588;C3668949,true;false;false;true;false;false;false,8580/22402
past only,C1444637;C0205171;C1720467;C4284302,false;false;false;false,8581/22402
cabg only,C0010055;C0205171;C1720467,true;false;false,8582/22402
dvt only,C0149871;C0205171;C1720467;C2926618;C3899446,true;false;false;false;false,8583/22402
ptca only,C2936173;C0205171;C1720467,true;false;false,8584/22402
ics only,C0815320;C0205171;C1720467;C4551720,false;false;false;true,8585/22402
< $nmbr$ ml / min per $nmbr$ - $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,8586/22402
> $nmbr$ ml / min per $nmbr$ - $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,8587/22402
gold stage,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,8588/22402
gold stage  %,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,8589/22402
gold stage ii,C0018026;C0441767;C1304897,true;false;false,8590/22402
gold stage iv,C0018026;C0205390;C0022326;C4265176;C1300072;C1306673;C1304897,true;false;true;false;false;false;false,8591/22402
gold stage iii,C0018026;C0441771;C1304897,true;false;false,8592/22402
gold stage #,C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,8593/22402
austrafca and new zealand,,,8594/22402
australia / new zealand,C4289954,false,8595/22402
australia and new zealand,C0004340,true,8596/22402
simvastatin,C0074554,true,8597/22402
pravastatin,C0085542,true,8598/22402
subjects $ $nmbr$ years of age  n ( % ),C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,8599/22402
subjects  $nmbr$ years of age  n ( % ),C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,8600/22402
previous mi  n ( % ),C0205156;C3810814;C1552607,false;false;false,8601/22402
previous ami  n ( % ),C0205156;C4319936;C1552607,false;false;false,8602/22402
previous cabg  n ( % ),C0205156;C0010055;C1552607,false;true;false,8603/22402
previous pci  n ( % ),C0205156;C4049621;C1552607,false;false;false,8604/22402
$nmbr$ - $nmbr$ vr — no . ( % ),C3476815,false,8605/22402
$nmbr$ - $nmbr$ yr — no . ( % ),C0439234,false,8606/22402
$nmbr$ = $nmbr$ yr — no . ( % ),C0439234,false,8607/22402
ldl cholesterol  mmol / l 丰,C0023824;C1532563;C0202117,true;false;false,8608/22402
hdl cholesterol  mmol / 冲,C0023822;C0439190;C0392885,true;false;false,8609/22402
hdl cholesterol ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,8610/22402
ldl - cholesterol ( mmol / ),C0023824;C0439190;C0202117,true;false;false,8611/22402
hdl cholesterol ( mmol / l ) :,C0023822;C1532563;C0392885,true;false;false,8612/22402
hdl cholesterol  mmol / l,C0023822;C1532563;C0392885,true;false;false,8613/22402
kdl cholesterol ( mmol / ),C0008377;C0439190,true;false,8614/22402
ldl - cholesterol ( mmol / l ),C0023824;C1532563;C0202117,true;false;false,8615/22402
hdl cholesterol  ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,8616/22402
ldl cholesterol ( mmol / l ) :,C0023824;C1532563;C0202117,true;false;false,8617/22402
hdl cholesterol  mmol / l *,C0023822;C1532563;C0392885,true;false;false,8618/22402
ldl cholesterol ( mmol / l ),C0023824;C1532563;C0202117,true;false;false,8619/22402
ldl cholesterol  mmol / l,C0023824;C1532563;C0202117,true;false;false,8620/22402
ldl cholesterol  mmol / l *,C0023824;C1532563;C0202117,true;false;false,8621/22402
hdl - cholesterol ( mmol / l ),C0023822;C1532563;C0392885,true;false;false,8622/22402
no renal dysfunction,C1565489;C3279454,true;false,8623/22402
renal dysfunction,C1565489;C3279454,true;false,8624/22402
renal function,C0232804,false,8625/22402
prebronchodilator fev $nmbr$  % predicted,C2599602;C3714541,false;true,8626/22402
postbronchodilator fev $nmbr$  % predicted,C2599594;C3714541,false;true,8627/22402
post - bronchodilator fev $nmbr$  % predicted,C2599594;C3714541,false;true,8628/22402
< q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % ),C0237753;C0449788,false;false,8629/22402
> q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % ),C0237753;C0449788,false;false,8630/22402
p value $nmbr$,C1709380,false,8631/22402
p value * $nmbr$,C1709380,false,8632/22402
eze / simva - $nmbr$ yr km rale ( % ),C0439234;C3887676;C0034642,false;false;true,8633/22402
pbo / simva - $nmbr$ yr km rale ( % ),C0031962;C0439234;C3887676;C0034642,true;false;false;true,8634/22402
age  median ( iqr ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8635/22402
bmi  median ( iqr ),C0578022;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,8636/22402
inter .,C0205103;C1548610,false;false,8637/22402
intense,C0522510,false,8638/22402
< $nmbr$ . $nmbr$ kg / m $nmbr$,C1532718,false,8639/22402
$nmbr$ - $nmbr$ kg / m $nmbr$,C1532718,false,8640/22402
> $nmbr$ . $nmbr$ kg / m $nmbr$,C1532718,false,8641/22402
thiazide,C0541746,true,8642/22402
thiazides,C0541746,true,8643/22402
antiplatelet agents,C0085826,true,8644/22402
antiplatelet agent,C0085826,true,8645/22402
hemoglobin  g / dl,C1319312;C3642216;C0019046;C0439267,false;false;true;false,8646/22402
haemoglobin ( g / dl ),C1319312;C3642216;C0019046;C0439267,false;false;true;false,8647/22402
haemoglobin ( g / l ),C0635222;C0439267;C0019046;C0439294;C0456615,true;false;true;false;false,8648/22402
hemoglobin ( g / dl ),C1319312;C3642216;C0019046;C0439267,false;false;true;false,8649/22402
hemoglobin ( gm / dl ),C0019046;C0017480;C3642216;C3854019,true;true;false;true,8650/22402
hemoglobin  mg / dl,C0019046;C0439269,true;false,8651/22402
hemoglobin  g / l,C0635222;C0439267;C0019046;C0439294;C0456615,true;false;true;false;false,8652/22402
haemoglobin  mg / dl,C0019046;C0439269,true;false,8653/22402
hemoglobin — g / dl,C1319312;C3642216;C0019046;C0439267,false;false;true;false,8654/22402
hemoglobin  g / dlf,C1319312,false,8655/22402
usual care ( n = $nmbr$ la ),C3538928;C1947933;C0023031;C0023749;C0230347;C2346906;C4553351,false;false;true;true;false;false;false,8656/22402
usual care ( n = $nmbr$ a ),C3538928;C1947933,false;false,8657/22402
usual care ( n = $nmbr$ ),C3538928;C1947933,false;false,8658/22402
ace - inhibitors  n ( % ),C0003015,true,8659/22402
ace inhibitor  n ( % ),C0003015;C4541021,true;false,8660/22402
total ho population ( n = $nmbr$ ),C3258257;C0019905;C1832110;C3889614,false;true;false;false,8661/22402
total population ( n = $nmbr$ ),C3258257,false,8662/22402
mean age  years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,8663/22402
mean age ( years ),C0444504;C1510829;C2347634;C2348143,false;false;false;false,8664/22402
mean age  yrs,C0444504;C0001779;C2347634;C2348143,false;false;false;false,8665/22402
mean age ( yrs ),C0444504;C0001779;C2347634;C2348143,false;false;false;false,8666/22402
mean age — yr,C0444504;C0001779;C0439234;C2347634;C2348143,false;false;false;false;false,8667/22402
waist - to - hip  female,C0230097;C0019552;C0043210;C0086287;C1705497;C1705498;C0022122;C1505163;C3538851;C4284725,false;true;true;true;false;false;true;true;false;false,8668/22402
waist - to - hip  male,C0230097;C0019552;C0086582;C1706180;C1706428;C1706429;C0022122;C1505163;C3538851;C4284725,false;true;true;false;false;false;true;true;false;false,8669/22402
at index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,8670/22402
index acs event,C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;true;false;false;false,8671/22402
chronic bronchitis !,C0008677,true,8672/22402
chronic bronchitis,C0008677,true,8673/22402
post - bronchodilation fev $nmbr$,C0439576;C3714541,false;true,8674/22402
pre - bronchodilation fev $nmbr$,C0439566;C3714541,false;true,8675/22402
pre - bronchodilator fev $nmbr$,C2599602;C3714541,false;true,8676/22402
lama use at screening,C0999593;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944;C1416775,false;true;true;true;false;false;false;false;false;false;false;false,8677/22402
laba use at screening,C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;false;false;false;false;false;false;false,8678/22402
exetimibe / simvastatin,C0074554,true,8679/22402
ezetimibe / simvastatin,C1532737,true,8680/22402
cv death  ml  ischemic stroke,C3538987;C0011065;C0439526;C0948008;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;false;false;true;false,8681/22402
cv death  mi  ischemic stroke,C3538987;C0011065;C3810814;C0948008;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;true;false,8682/22402
cv death  mi  or ischemic stroke,C3538987;C0011065;C3810814;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;true;false,8683/22402
proton pump inhibitors,C0358591;C1384478;C3540020,true;false;false,8684/22402
proton - pump inhibitors,C0358591;C1384478;C3540020,true;false;false,8685/22402
proton - pump inhibitor,C0358591;C3536754;C4521480,true;false;false,8686/22402
proton pump inhibitor use,C0358591;C0042153;C0457083;C1947944;C3536754;C4521480,true;true;false;false;false;false,8687/22402
duration of t $nmbr$ dm ( years ),C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,8688/22402
duration of t $nmbr$ dm  years,C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,8689/22402
duration of t $nmbr$ d ( years ),C0449238;C0439234;C2926735,false;false;false,8690/22402
anti platelet therapy,C0005821;C0039798;C0087111;C1363945,true;true;true;false,8691/22402
anti - platelet therapy,C0005821;C0039798;C0087111;C1363945,true;true;true;false,8692/22402
no antiplatelet therapy,C1096021,false,8693/22402
antiplatelet therapy,C1096021,false,8694/22402
antiplatelet therapy §,C1096021,false,8695/22402
diastolic blood pressurea  mmhg,C0012000;C0005767;C0439475;C0005768;C0229664,true;true;false;true;false,8696/22402
systolic blood pressure — mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8697/22402
diastolic blood pressure ( mm hg ),C0428883;C0439475;C1305849,true;false;false,8698/22402
systolic blood pressure  mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8699/22402
systolic blood pressure ( mmhg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,8700/22402
diastolic blood pressure ( mm hg ) :,C0428883;C0439475;C1305849,true;false;false,8701/22402
systolic blood pressurea  mm hg,C0039155;C0005767;C0439475;C0005768;C0229664,true;true;false;true;false,8702/22402
diastolic blood pressure  mm hg,C0428883;C0439475;C1305849,true;false;false,8703/22402
systolic blood pressure ( mm hg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,8704/22402
diastolic blood pressure  mmhg,C0428883;C0439475;C1305849,true;false;false,8705/22402
diastolic blood pressure - mmhg,C0428883;C0439475;C1305849,true;false;false,8706/22402
diastolic blood pressure ( mmhg ),C0428883;C0439475;C1305849,true;false;false,8707/22402
systolic blood pressure - mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8708/22402
systolic blood pressure  mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,8709/22402
diastolic blood pressure — mm hg,C0428883;C0439475;C1305849,true;false;false,8710/22402
mineralocorticoid receptor antagonist,C1579268,true,8711/22402
mineralocorticoid receptor antagonists,C1373021;C1579268,false;true,8712/22402
diet group ( n = $nmbr$ ),C0012155;C0441848;C0012159;C1519433;C2983588;C3668949,true;false;true;false;false;false,8713/22402
stent group ( n = $nmbr$ ),C0038257;C0441848,true;false,8714/22402
haq - di scoreff,C3826998;C4321476,false;false,8715/22402
haq - di scored,C3826998;C4321476,false;false,8716/22402
haq - di score,C3826998;C0449820;C4050231;C4321476,false;false;false;false,8717/22402
sirolimus,C0072980,true,8718/22402
everolimus,C0541315,true,8719/22402
ambulance,C0002422;C3846685,true;false,8720/22402
in ambulance,C0002422;C3846685,true;false,8721/22402
p value for heterogeneity,C1709380;C0019409;C0242960,false;false;true,8722/22402
pvalue for heterogeneity,C0019409;C0242960,false;true,8723/22402
race  while,C0034510;C1706779;C3853635,true;false;false,8724/22402
racea white,C0007457;C0043157;C0220938,true;true;false,8725/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / l,C0439268,false,8726/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mmol / l,C1532563,false,8727/22402
macroalbuminuria  n ( % ),,,8728/22402
microalbuminuria  n ( % ),C0730345,false,8729/22402
womac score,C0449820;C4050231,false;false,8730/22402
total score,C2964552,false,8731/22402
lacunar,C0241970;C1459585,false;false,8732/22402
vascular,C0005847;C1558950;C1801960,true;false;false,8733/22402
dbp  mm hg  mean ± sdc,C0536221;C0439475;C0444504;C1419891;C3273112;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false;false,8734/22402
sbp  mm hg  mean ± sdc,C0085805;C0439475;C0444504;C1419891;C3273112;C2347634;C2348143,true;false;false;false;false;false;false,8735/22402
sbp  mm hg  mean + sdc,C0085805;C0439475;C0444504;C1419891;C3273112;C2347634;C2348143,true;false;false;false;false;false;false,8736/22402
mean dlqi score ( $nmbr$ % ci ),C0444504;C3899393;C2347634;C2348143,false;false;false;false,8737/22402
mean pasi score ( $nmbr$ % ci ),C3533236;C4528685;C0008107;C3259781,false;false;true;false,8738/22402
tc  mmol / l ( mg / dl ),C0039411;C3898312;C3642216;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;true;true;true;false;false;false,8739/22402
fpg  mmol / l ( mg / dl ),C3898312;C3642216,false;false,8740/22402
body weight  mean ± sd  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C1305866,true;false;false;true;false;false;false;false;false,8741/22402
body weight  mean = sd  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C1305866,true;false;false;true;false;false;false;false;false,8742/22402
race / ethnicity n ( % ),C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,8743/22402
race / ethnicity  n ( % ),C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,8744/22402
race / ethnicity  no . ( % ),C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,8745/22402
race or ethnicity  n ( % ),C0034510;C1706779;C3853635,true;false;false,8746/22402
arial flutter or fibrillation,C0016385;C2242390,false;false,8747/22402
atrial flutter / fibrillation,C0155709,false,8748/22402
current smoker ( n z $nmbr$ ),C3173209;C3241966,false;false,8749/22402
current smoker ( n = $nmbr$ ),C3173209;C3241966,false;false,8750/22402
waist circumference  mean ( sd )  cm,C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,8751/22402
waist circumference  mean ( sd )  in,C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,8752/22402
empagliflozin,C3490348,true,8753/22402
dapagliflozint,,,8754/22402
canagliflozin,C2974540,true,8755/22402
coronary - artery bypass grafting,C0010055,true,8756/22402
coronary artery bypass grafting,C0010055,true,8757/22402
coronary artery bypass graft,C0010055;C1260596,true;false,8758/22402
sex : male,C0086582,true,8759/22402
sex  male,C0086582,true,8760/22402
sex  % female,C0086287,true,8761/22402
sexa male,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8762/22402
sex : female,C0086287,true,8763/22402
sex  female,C0086287,true,8764/22402
sex ( female ),C0086287,true,8765/22402
dbp  mean ( sd )  mm hg,C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,8766/22402
sbp  mean ( sd )  mmhg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8767/22402
dbp  mean ( sd )  mmhg,C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,8768/22402
sbp  mean ( sd )  mm hg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8769/22402
sbp  mean = sd  mmhg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,8770/22402
contrast volume ( ml ),C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,8771/22402
contrast volume  ml,C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,8772/22402
crp — mg / liter ^,C3890735;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;true;false;true;false;false;false;false;false;false,8773/22402
hscrp — mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,8774/22402
omega - $nmbr$ fa intake $nmbr$ nd third,C1719844;C1512806;C0205437,false;false;false,8775/22402
omega - $nmbr$ fa intake $nmbr$ st third,C1719844;C1512806;C0036056;C0205437;C3272372,false;false;true;false;false,8776/22402
omega - $nmbr$ fa intake $nmbr$  d third,C1719844;C1512806;C0205437,false;false;false,8777/22402
mean ( sd ) pre - bronchodilator,C0444504;C2699239;C2599602;C2347634;C2348143,false;false;false;false;false,8778/22402
mean ( sd ) post - bronchodilator,C0444504;C2699239;C2347634;C2348143,false;false;false;false,8779/22402
former smoking,C0205156;C0037369;C0453996;C1881674;C0750523,false;true;true;false;false,8780/22402
former smoker,C0337671,false,8781/22402
egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8782/22402
egfr > $nmbr$ ml / min / $nmbr$ - $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8783/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8784/22402
egfr > $nmbr$ ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8785/22402
egfr < $nmbr$ ml / min / $nmbr$ - $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8786/22402
egfr < $nmbr$ ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8787/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ *,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8788/22402
egfr £ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8789/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ §,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,8790/22402
primary outcomes,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8791/22402
primary outcome !,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8792/22402
primary outcome,C0205225;C1274040;C0439612;C0439631,false;false;false;false,8793/22402
$nmbr$ vessel,C0005847,true,8794/22402
$nmbr$ vessels,C0005847,true,8795/22402
non - st - segment elevation mi,C1518422;C0520886;C3810814,false;false;false,8796/22402
non - st - segment elevation acs,C1518422;C0520886;C0742343;C4318612,false;false;true;false,8797/22402
rate ratio ( $nmbr$ % ci ),C0871208;C0456603;C0008107;C3259781;C1547037;C1521828,false;false;true;false;false;false,8798/22402
rate ratio ( $nmbr$ % cl ),C0871208;C0456603;C0596019;C1547037;C1521828,false;false;false;false;false,8799/22402
extensive colitisy,C0205231,false,8800/22402
extensive colitis,C0205231;C0009319;C1963084,false;true;false,8801/22402
lipid - lowering therapy — no . ( % ),C0585943,false,8802/22402
lipid - lowering therapy - no . ( % ),C0585943,false,8803/22402
patients with at least one concomitant disease *,C0030705;C0205447;C0243087,true;false;true,8804/22402
patients with at least one concomitant disease | |,C0030705;C0205447;C0243087,true;false;true,8805/22402
hyperlipidemia ( % ) §,C0020473;C0428465;C4555212,true;false;false,8806/22402
hyperlipidemia  %,C0020473;C0428465;C4555212,true;false;false,8807/22402
hyperlipidaemia ( % ),C0020473;C0428465;C4555212,true;false;false,8808/22402
hyperlipidemia ( % ),C0020473;C0428465;C4555212,true;false;false,8809/22402
diagnosed diabetes ( n = $nmbr$ ),C0011900;C0011847;C0011849,true;false;true,8810/22402
undiagnosed diabetes ( n = $nmbr$ ),C1408353;C0011847;C0011849,false;false;true,8811/22402
salmeterol ( n [ $nmbr$ ),C0073992,true,8812/22402
physician ' s judgment that vka inappropriate ],C0031831;C0022423;C0804815,true;true;false,8813/22402
physician ' s judgment that vka inappropriate,C0031831;C0022423;C0804815,true;true;false,8814/22402
female simva,C0043210;C0086287;C1705497;C1705498,true;true;false;false,8815/22402
male simva,C0086582;C1706180;C1706428;C1706429,true;false;false;false,8816/22402
western europe ( n = $nmbr$ ),C0043129,true,8817/22402
eastern europe ( n = $nmbr$ ),C0015177,true,8818/22402
elevated creatine kinase - mb ( > $nmbr$ u / l ),C0151576;C0024853;C0439339;C0205250;C0010290;C0523584;C3163633,false;true;false;false;true;false;false,8819/22402
elevated creatine kinase mb ( > $nmbr$ u / l ),C0151576;C0024853;C0439339;C0205250;C0010290;C0523584;C3163633,false;true;false;false;true;false;false,8820/22402
current tobacco use,C0521116;C0040335;C0543414;C0841002;C3853727;C1705970,false;false;true;false;false;false,8821/22402
no current tobacco use,C0521116;C0040335;C0543414;C0841002;C3853727;C1705970,false;false;true;false;false;false,8822/22402
bare metal,C0025552,true,8823/22402
bare - metal,C0025552,true,8824/22402
corticosteroid or azathioprine / $nmbr$ - mercaptopurine,C0001617;C3536709,true;false,8825/22402
corticosteroid - azathioprine / $nmbr$ - mercaptopurine,C0001617;C0004482;C0000618;C3536709,true;true;true;false,8826/22402
dapagliflozin $nmbr$ mg,C2353951;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8827/22402
empagliflozin $nmbr$ mg,C3490348;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8828/22402
ertugliflozin $nmbr$ mg,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8829/22402
ics / lama,C0815320;C0999593;C1416775;C4551720,false;false;false;true,8830/22402
ics / laba,C0815320;C4551720,false;true,8831/22402
ics + laba,C0815320;C4551720,false;true,8832/22402
duration of disease — yr,C0872146;C0439234,false;false,8833/22402
duration of disease — mo,C0872146;C0026544;C0332177,false;true;false,8834/22402
eze + statin,C0360714,true,8835/22402
pbo + statin,C0031962;C0360714,true;true,8836/22402
ze + statin,C0360714,true,8837/22402
coronary endpoint,C0018787;C2349179;C2826544,true;false;false,8838/22402
coronary end point,C0018787;C2349179;C2826544,true;false;false,8839/22402
patients with baseline crp concentration £ $nmbr$ mg / l,C0030705;C0168634;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285;C1442488,true;true;false;true;false;false;false;false;false,8840/22402
patients with baseline crp concentration < $nmbr$ mg / l,C0030705;C0168634;C3890735;C0086045;C0439268;C1446561;C3827302;C4048285;C1442488,true;true;false;true;false;false;false;false;false,8841/22402
none 一 no . ( % ),,,8842/22402
score  no . ( % ),C0449820;C4050231,false;false,8843/22402
score 一 no . ( % ),C0449820;C4050231,false;false,8844/22402
female simva ( „ = $nmbr$ },C0043210;C0086287;C1705497;C1705498,true;true;false;false,8845/22402
male simva ( „ = $nmbr$ },C0086582;C1706180;C1706428;C1706429,true;false;false;false,8846/22402
aspirin — no . ( % ),C0004057,true,8847/22402
aspirin 一 no . ( % ),C0004057,true,8848/22402
adas — cog score,C3539026;C0449820;C4050231,false;false;false,8849/22402
adas - cog score *,C3539026;C0449820;C4050231,false;false;false,8850/22402
troponin $nmbr$ at baseline *,C0041199;C0168634;C1442488,true;true;false,8851/22402
troponin $nmbr$ at baseline,C0041199;C0168634;C1442488,true;true;false,8852/22402
lower limb fracture,C0023216;C0016658;C0441994;C0596838;C1548802;C2003888,true;true;false;false;false;false,8853/22402
upper limb fractures,C1140618,true,8854/22402
upper limb fracture,C0178316,false,8855/22402
lower limb fractures,C0023216,true,8856/22402
inflix  yes,C0666743;C1549445;C1705108;C1710701,true;false;false;false,8857/22402
inflix  no,C0666743,true,8858/22402
east europe,C1707877;C0015176,false;true,8859/22402
e . europe,C0015176,true,8860/22402
western europe,C0043129,true,8861/22402
w . europe,C0015176,true,8862/22402
eastern europe,C0015177,true,8863/22402
w est europe,C3811127;C0015176;C3890902,false;true;false,8864/22402
eastern european,C0239309,false,8865/22402
general health,C0424575;C4018875,false;false,8866/22402
mental health,C0025353,true,8867/22402
canakinumab dose ( per mo ),C2718773;C0178602;C0026544;C0332177;C0869039;C1114758,true;false;true;false;false;false,8868/22402
canakinumab dose ( per month ),C2718773;C0178602;C0332177;C0439231;C0869039;C1114758,true;false;false;false;false;false,8869/22402
age ( years ) : < $nmbr$,C1510829,false,8870/22402
age ( years ) : > $nmbr$,C1510829,false,8871/22402
chd status §,C0280604;C0449438;C3542407,false;false;false,8872/22402
chd status,C0280604;C0449438;C3542407,false;false;false,8873/22402
rheumatoid factor positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,8874/22402
rheumatoid factor - positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660,true;false;false;false;false;false;false,8875/22402
priorheartfailure  %,,,8876/22402
prior heart failure yes,C0332152;C0018801;C1549445;C1705108;C1710701;C0018802;C4554158;C2826257,false;true;false;false;false;true;false;false,8877/22402
prior heart failure  %,C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,8878/22402
gender  male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,8879/22402
gender male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,8880/22402
metabolic syndrome * n = $nmbr$,C0524620,true,8881/22402
metabolic syndrome ( n = $nmbr$ ),C0524620,true,8882/22402
nonmetabolic syndrome ( n = $nmbr$ ),C0039082,true,8883/22402
bmi ( kg / m $nmbr$ ),C0578022;C1532718,false;false,8884/22402
bmi  kg / m $nmbr$,C0578022;C1532718,false;false,8885/22402
bmi  kg / m $nmbr$  n,C0578022;C1532718,false;false,8886/22402
bmi ( kg / m $nmbr$ ) *,C0578022;C1532718,false;false,8887/22402
baseline bmi < $nmbr$ kg / m $nmbr$,C0168634;C0578022;C1532718;C1442488,true;false;false;false,8888/22402
baseline bmi > $nmbr$ kg / m $nmbr$,C0168634;C0578022;C1532718;C1442488,true;false;false;false,8889/22402
duration of assigned regimen before surgery post - randomisation characteristic *,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,8890/22402
duration of assigned regimen before surgery post - randomisation characteristic * *,C0449238;C1516050;C0040808;C2945654;C1552601;C2926735,false;false;true;false;false;false,8891/22402
asa use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,8892/22402
no asa use at baseline,C0004057;C0042153;C0168634;C1442488;C0457083;C1947944;C3853627,true;true;true;false;false;false;false,8893/22402
ics use at baseline,C0815320;C4551720,false;true,8894/22402
female eze / simva ( „ = $nmbr$ },C0043210;C0086287;C1705497;C1705498,true;true;false;false,8895/22402
male eze / simva ( „ = $nmbr$ },C0086582;C1706180;C1706428;C1706429,true;false;false;false,8896/22402
body mass index  kg / m $nmbr$  mean + sd,C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,8897/22402
body mass index  kg / m $nmbr$  mean ( sd ),C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,8898/22402
body mass index  kg / m $nmbr$  mean ± sd,C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,8899/22402
abdominal obesity *,C0311277,true,8900/22402
abdominal obesity,C0311277,true,8901/22402
cohort $nmbr$ ( n = $nmbr$ ),C0009247;C0599755,true;false,8902/22402
cohort $nmbr$ ( n = $nmbr$ ) f,C0009247;C0016327;C0599755,true;true;false,8903/22402
age  median ( $nmbr$ th - $nmbr$ th percentiles )  y,C0001779;C0549183;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false;false,8904/22402
age  median ( $nmbr$ th — $nmbr$ th percentiles )  y,C0001779;C0549183;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false;false,8905/22402
baseline hba $nmbr$ c  %,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,8906/22402
baseline hba $nmbr$ c ( % ),C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,8907/22402
no aminosalicylates  n,C0368663,false,8908/22402
aminosalicylates * *,C0368663,false,8909/22402
aminosalicylates  n,C0368663,false,8910/22402
vildagliptin $nmbr$ mg qd,C1570906;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,8911/22402
vildagliptin $nmbr$ mg bid,C1570906;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,8912/22402
< $nmbr$ kg / m $nmbr$ ( n — $nmbr$ ),C1532718,false,8913/22402
> $nmbr$ kg / m $nmbr$ ( n — $nmbr$ ),C1532718,false,8914/22402
baseline ldl - c > $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mmol / lc,C0168634;C0439190;C1442488,true;false;false,8915/22402
baseline ldl - c $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mmol / lc,C0168634;C0439190;C1442488,true;false;false,8916/22402
methotrexate use,C0025677;C0042153;C0457083;C1947944,true;true;false;false,8917/22402
methotrexate user,C0025677;C1548600;C1706077,true;false;false,8918/22402
bare metal stent,C2825200,false,8919/22402
bare - metal stent,C2825200,false,8920/22402
other ( n = $nmbr$ ),C0369718;C0441922,false;false,8921/22402
other ( n — $nmbr$ ),C0369718;C0441922,false;false,8922/22402
amputationsa,,,8923/22402
amputation,C0002688;C0332840;C1546539,true;false;false,8924/22402
p — value for interaction,C1709380;C1704675,false;false,8925/22402
p - value for interaction *,C1709380;C1704675,false;false,8926/22402
p value for interactiont,C1709380,false,8927/22402
p value for interaction,C1709380;C1704675,false;false,8928/22402
p - value for interaction,C1709380;C1704675,false;false,8929/22402
p value for interaction ^,C1709380;C1704675,false;false,8930/22402
p value fo interactio,C1709380,false,8931/22402
waisthip ratio,C0205682;C0456603;C1547037,true;false;false,8932/22402
waist - hip ratio,C0205682,true,8933/22402
tnglycendes < median,,,8934/22402
tngtycerides a median,,,8935/22402
tngtycendes a median,,,8936/22402
tngtycerides < median,,,8937/22402
furosemide,C0016860,true,8938/22402
torsemide,C0076840,true,8939/22402
drinker ( % ) a,C0556338,false,8940/22402
drinker ( % ),C0556338,false,8941/22402
uncertain,C0087130;C4085655,true;false,8942/22402
uncerlain,,,8943/22402
mean diastolic blood pressure  mm hg,C0428886;C0012000;C0439475;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;false;true;false;false;false,8944/22402
mean systolic blood pressure  mm hg,C0428886;C0039155;C0439475;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;false;true;false;false;false,8945/22402
maximum cimt < median,C0806909;C0549183;C0876920;C2347635;C2348144;C2939193;C1552615;C2826546,false;false;false;false;false;false;false;false,8946/22402
maximum cimt a med an,C0806909;C1552615;C2826546,false;false;false,8947/22402
at clinic diastolic pressure > $nmbr$ mm hg,C0002424;C0428883;C0439475;C0442592,true;true;false;false,8948/22402
at clinic systolic pressure > $nmbr$ mm hg,C0002424;C0871470;C0439475;C0442592,true;true;false;false,8949/22402
at clinic systolic pressure < $nmbr$ mm hg,C0002424;C0871470;C0439475;C0442592,true;true;false;false,8950/22402
at clinic diastolic pressure < $nmbr$ mm hg,C0002424;C0428883;C0439475;C0442592,true;true;false;false,8951/22402
thiazolidinediones,C1257987;C3541957,true;false,8952/22402
thiazolidinedioneb,,,8953/22402
thiazolidinedione no,C0289779;C1257987;C3537039,true;true;false,8954/22402
thiazolidinedione,C0289779;C1257987;C3537039,true;true;false,8955/22402
thiazolidinedione yes,C0289779;C1549445;C1705108;C1710701;C1257987;C3537039,true;false;false;false;true;false,8956/22402
crcl < $nmbr$ ml / min,C1846718;C0439445,false;false,8957/22402
crcl > $nmbr$ ml / min,C1846718;C0439445,false;false,8958/22402
ecrcl < $nmbr$ ml / min,C0439445,false,8959/22402
stroke or transient ischemic attack,C0038454;C4554100,true;false,8960/22402
stroke / transient ischemic attack,C0038454;C4554100,true;false,8961/22402
hdl cholesterol  mmol / l  women  mean ± sd,C0023822;C1532563;C0043210;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;true;false;false;false;false;false,8962/22402
hdl cholesterol  mmol / l  men  mean ± sd,C0023822;C1532563;C0025266;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;true;false;false;false;false;false,8963/22402
disease duration > $nmbr$ years ( n = $nmbr$ ),C0872146;C0439234,false;false,8964/22402
disease duration b $nmbr$ years ( n = $nmbr$ ),C0872146;C0439234,false;false,8965/22402
bmi ( kg / rrr ),C0578022;C0022718;C0439209;C4054209,false;true;false;false,8966/22402
bmi ( kg / m ),C0578022;C1532718,false;false,8967/22402
anterior ( n  % ),C0205094,false,8968/22402
inferior ( n  % ),C0542339;C0678975,false;false,8969/22402
blood pressure — mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,8970/22402
blood pressure  mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,8971/22402
blood pressure — mmhg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,8972/22402
blood pressure  mm,C0005823;C4330985;C4554674;C1271104;C1272641,true;false;false;false;true,8973/22402
blood pressure ( mm hg ),C0005823;C0439475;C1271104;C1272641,true;false;false;true,8974/22402
blood pressure ( mmhg ),C0005823;C0439475;C1271104;C1272641,true;false;false;true,8975/22402
blood pressure  mmhg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,8976/22402
non - st - elevation mi,C1518422;C0520886;C3810814,false;false;false,8977/22402
non - st — elevation mi,C1518422;C0520886;C3810814,false;false;false,8978/22402
non - st - elevation ml,C1518422;C0520886;C0439526;C1705224;C3887665,false;false;false;false;false,8979/22402
$nmbr$ - $nmbr$ . $nmbr$ : overweight,C0497406,true,8980/22402
$nmbr$ - $nmbr$ - $nmbr$  overweight,C0497406,true,8981/22402
intention - to - treat with st - segment - elevation myocardial infarction,C0162425;C1283828,true;false,8982/22402
intention - to - treat without st - segment - elevation myocardial infarction,C0162425;C1283828,true;false,8983/22402
no history of cancer,C0455471,false,8984/22402
history of cancer,C0455471,false,8985/22402
antidiabetic agent,C0935929,true,8986/22402
antidiabetic agents,C0935929,true,8987/22402
age > = $nmbr$ years old,C1510829,false,8988/22402
age < $nmbr$ years old,C1510829,false,8989/22402
ics use at baseline : no,C0815320;C4551720,false;true,8990/22402
ics use at baseline : yes,C0815320;C4551720,false;true,8991/22402
crp $ $nmbr$ mg / l  n,C3890735;C0439268;C4048285,false;false;false,8992/22402
crp < $nmbr$ mg / l  n,C3890735;C0439268;C4048285,false;false;false,8993/22402
stent thrombosis *,C3897493,false,8994/22402
stent thrombosis,C3897493,false,8995/22402
high - dosage ics plus laba with baseline blood eosinophils > $nmbr$ cells per pl ( n = $nmbr$ ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,8996/22402
high - dosage ics plus laba with baseline blood eosinophils a $nmbr$ cells per pl ( n = $nmbr$ ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,8997/22402
high - dosage ics plus laba with baseline blood eosinophils < $nmbr$ cells per pl ( n = $nmbr$ ),C0205250;C0178602;C0815320;C4551720;C2986497;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;true;false;false;false;false;false;false;false,8998/22402
not hispanic or latino ( n = $nmbr$ ),C1518424,false,8999/22402
not hispanic or latino ( n — $nmbr$ ),C1518424,false,9000/22402
< $nmbr$ mg / dl simva,C0439269,false,9001/22402
> $nmbr$ mg / dl simva,C0439269,false,9002/22402
cardiovasculardeath,,,9003/22402
cardiovascular death !,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,9004/22402
cardiovascular death,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,9005/22402
mean body - mass index  kg / m $nmbr$,C0444504;C0005893;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,9006/22402
mean body mass index  kg / m $nmbr$,C0444504;C0005893;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,9007/22402
mean body mass index ( kg / m $nmbr$ ) *,C0444504;C0005893;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,9008/22402
mean body mass index ( kg / m $nmbr$ ),C0444504;C0005893;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;true;false;false,9009/22402
a $nmbr$ + e $nmbr$ ( n = $nmbr$ ),C1272460,false,9010/22402
a $nmbr$ / $nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,9011/22402
$nmbr$ - $nmbr$ ( n = $nmbr$ ),C0369718;C0441922,false;false,9012/22402
mean sd $nmbr$ - h asbp  mm hg,C0444504;C2699239;C0033727;C0439475;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,9013/22402
mean ± sd $nmbr$ - h adbp  mm hg,C0444504;C2699239;C0033727;C0168370;C0439475;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false;false,9014/22402
egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,9015/22402
egfr $nmbr$ – $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,9016/22402
$nmbr$ - $nmbr$ / month,C0332177;C0439231,false;false,9017/22402
$nmbr$ - $nmbr$ months,C0439231,false,9018/22402
with corticosteroid treatment < $nmbr$,C0001617;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3536709,true;true;true;false;false;false;false;false;false,9019/22402
with corticosteroid treatment > $nmbr$,C0001617;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3536709,true;true;true;false;false;false;false;false;false,9020/22402
postmenopausal  no hrt,C0232970,false,9021/22402
postmenopausal and no ht,C0232970,false,9022/22402
poslmenopausal  no ht,,,9023/22402
postmenopausal and no hrt,C0232970,false,9024/22402
poslmenopausal  ht,C0018510;C0677607,true;true,9025/22402
depression,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,9026/22402
depression ^,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,9027/22402
no depression,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,9028/22402
concomitant medications,C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9029/22402
concomitant medication,C0521115;C0013227;C3244316;C4284232,false;true;false;false,9030/22402
$nmbr$ blocker,,,9031/22402
( $nmbr$ - blockers,,,9032/22402
$nmbr$ blockers,,,9033/22402
( $nmbr$ blocker,,,9034/22402
/ $nmbr$ - blockers,,,9035/22402
$nmbr$ - blockers,,,9036/22402
no prior stroke / tia,C0332152;C0038454;C0007787;C0917805;C1054154;C4554100;C2826257,false;true;true;true;false;false;false,9037/22402
prior stroke / tia,C0332152;C0038454;C0007787;C0917805;C1054154;C4554100;C2826257,false;true;true;true;false;false;false,9038/22402
prior stroke or tia,C0332152;C0038454;C4554100;C2826257,false;true;false;false,9039/22402
cv entry criteria,C3538987;C1705654;C0243161;C4048877;C4318503,false;false;true;true;false,9040/22402
entry criteria,C1705654;C0243161,false;true,9041/22402
fev $nmbr$ / fvc  % a,C3714541,true,9042/22402
fev $nmbr$ / fvc  % *,C3714541,true,9043/22402
placebo  % > ( n / n ),C0032042;C1696465;C1706408,true;false;false,9044/22402
placebo  % ( n / n ),C0032042;C1696465;C1706408,true;false;false,9045/22402
mayo < $nmbr$  n,C0454788;C1077578,false;false,9046/22402
mayo $ $nmbr$  n,C0454788;C1077578,false;false,9047/22402
weight in kg  median ( iqr ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,9048/22402
weight - kg  median ( iqr ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,9049/22402
weight ( kg )  median ( iqr ),C0005910;C0022718;C0549183;C0876920;C2347635;C2348144;C2939193;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;false;true;false;false,9050/22402
prior myocardial infarction — no . ( % ),C0155668,false,9051/22402
prior myocardial infarction 一 no . ( % ),C0155668,false,9052/22402
baseline ics use : no,C0168634;C0815320;C4551720;C1442488,true;false;true;false,9053/22402
baseline ics use : yes,C0168634;C0815320;C4551720;C1442488,true;false;true;false,9054/22402
tg  median ( min  max ),C0337445;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,9055/22402
mtss  median ( min  max ),C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9056/22402
jsn  median ( min  max ),C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9057/22402
all - cause mortality or hf hospitalization,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9058/22402
all - cause mortality or hf hospitalization ^,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9059/22402
fbs < $nmbr$ mg / dl,C3812213;C0439269,false;false,9060/22402
fbs > = $nmbr$ mg / dl,C3812213;C0439269,false;false,9061/22402
amlodipine / valsartan $nmbr$ / $nmbr$ mg,C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9062/22402
amlodipine / wlsartan i $nmbr$ / $nmbr$ mg,C0051696;C0021966;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0221138,true;true;true;true;false;false;false;false;false;false,9063/22402
all - cause mortality,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9064/22402
all cause mortality,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,9065/22402
renal insufficiency / failure,C0035078;C0231179;C1963154;C0231174;C0680095;C1565489,true;false;false;false;false;true,9066/22402
renal insufficiency or failure,C0035078;C1565489,true;true,9067/22402
anticoagulants,C0003280,true,9068/22402
anti - coagulants,C0848112,false,9069/22402
anticoagulant,C0003280;C0848112;C3536711,true;false;false,9070/22402
oral corticosteroids,C0442027;C0001617;C3539185;C3540725;C3540726;C3540727;C4521986,false;true;false;false;false;false;false,9071/22402
oral corticosteroid,C0442027;C0001617;C3536709;C4521986,false;true;false;false,9072/22402
prior lower gi clinical event,C0332152;C0441994;C1708130;C0205210;C0441471;C4019010;C3539617;C4050121;C1548802;C2003888;C2826257,false;false;false;false;false;false;false;false;false;false;false,9073/22402
prior upper gi clinical event,C0332152;C0203057;C0205210;C0441471;C4019010;C2826257,false;false;false;false;false;false,9074/22402
complex anatomy ( n - $nmbr$  $nmbr$ ),C0439855;C0002808;C0700276;C1384516;C1704241,false;true;false;true;false,9075/22402
noncomplex anatomy ( n - $nmbr$  $nmbr$ ),C0002808;C0700276;C1384516,true;false;true,9076/22402
all cana,C1418845,false,9077/22402
all cancer,C0006826;C0998265;C1306459,true;false;false,9078/22402
ace inhibitors / arb,C0003015,true,9079/22402
ace inhibitor or arb,C0003015;C4541021,true;false,9080/22402
ace inhibitors and arb,C0003015,true,9081/22402
ace inhibitors or arb,C0003015,true,9082/22402
ace inhibitors or arbs,C0003015,true,9083/22402
ace inhibitors / arbs,C0003015;C3888198,true;false,9084/22402
physician ' s global assessment,C4050369,false,9085/22402
physician ' s global assessment !,C4050369,false,9086/22402
previous or current im use : no,C0205156;C1552607,false;false,9087/22402
previous or current cs use : no,C0205156;C1552607,false;false,9088/22402
nyha class  n ( % ) i,C1882083,false,9089/22402
nyha class  n ( % ),C1882083,false,9090/22402
nyha class  n ( % ) ii,C1882085,false,9091/22402
nyha class  ( % ),C1882083,false,9092/22402
baseline heart rate ( beat / min ),C0168634;C0425583;C0871208;C0702093;C1524029;C3813700;C1521828;C1442488,true;false;false;false;false;false;false;false,9093/22402
baseline heart rate ( beats / min ),C0168634;C0018810;C1442488,true;true;false,9094/22402
concomitant medications  %,C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9095/22402
concomitant medication | |,C0521115;C0013227;C3244316;C4284232,false;true;false;false,9096/22402
metabolic syndrome  ! n ( % ),C0524620,true,9097/22402
metabolic syndrome  n ( % ),C0524620,true,9098/22402
body weight ( kg ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9099/22402
body weight  %,C0005910;C1305866,true;false,9100/22402
body weight  kg,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9101/22402
body weight — kg,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9102/22402
bodyweight ( kg ),C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,9103/22402
body weighta  kg,C0242821;C0022718;C0439209;C4054209;C0460148;C1268086;C4082212,true;true;false;false;false;false;false,9104/22402
fev_ ( l ) :,C3714541,true,9105/22402
fvc  l,C3714541,true,9106/22402
fvc ( l ),C3714541,true,9107/22402
fvc ( l ) *,C3714541,true,9108/22402
no fracture history,C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,9109/22402
fracture history,C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,9110/22402
$nmbr$ to < $nmbr$ ml / min,C0439445,false,9111/22402
> $nmbr$ to < $nmbr$ ml / min,C0439445,false,9112/22402
$nmbr$ - < $nmbr$ ml / min,C0439445,false,9113/22402
$nmbr$ - $nmbr$ ml / min,C0439445,false,9114/22402
met criterion at blt ( n [ % ] ),C0428210;C0243161;C1563149;C1708627;C1550543;C4317104,false;true;false;false;false;false,9115/22402
met criterion at bl ( n [ % ] ),C0428210;C0243161;C0005918;C0006413;C1552663;C2827109;C1550543;C4317104,false;true;true;true;false;false;false;false,9116/22402
( % ) ( $nmbr$ . $nmbr$ ),,,9117/22402
( % ) ( $nmbr$ - $nmbr$ ),,,9118/22402
post - bronchodilator fev $nmbr$ reversibility  % a,C2599594;C3714541;C0449261,false;true;false,9119/22402
postbronchodilator fev $nmbr$ reversibility  %,C2599594;C3714541;C0449261,false;true;false,9120/22402
post - bronchodilator fev $nmbr$ reversibility  %,C2599594;C3714541;C0449261,false;true;false,9121/22402
cigarette smoking,C0239059;C0700219,false;true,9122/22402
cigarette smoker,C0337667,false,9123/22402
daily dose $nmbr$ mg n = $nmbr$,C2348070;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,9124/22402
daily dose > $nmbr$ mg n = $nmbr$,C2348070;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,9125/22402
female ( n = $nmbr$  $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,9126/22402
male ( n = $nmbr$  $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,9127/22402
hemoglobin ( g r $nmbr$ ),C1319312;C0205090;C0684010;C2603358,false;false;true;false,9128/22402
hemoglobin ( g $nmbr$ ! ),C1319312,false,9129/22402
with lipid - lowering agents,C0086440,true,9130/22402
without lipid - lowering agents,C0086440,true,9131/22402
macroalbuminuria,,,9132/22402
macroalbuminuriaf,,,9133/22402
microalbuminuria,C0730345,false,9134/22402
macro - albuminuria,C2984010;C0001925,false;true,9135/22402
micro - albuminuria,C0085672;C0001925;C1553035;C3811161;C4049106,false;true;false;false;false,9136/22402
egfr ( ml / min per $nmbr$ - $nmbr$ m $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,9137/22402
egfr ( ml / min per $nmbr$ - $nmbr$ m $nmbr$ ) t,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,9138/22402
macroalbuminuria — no . / total no . ( % ),,,9139/22402
microalbuminuria — no . / total no . ( % ),C0730345,false,9140/22402
chd simva,C0280604;C3542407,false;false,9141/22402
no chd simva,C0280604;C3542407,false;false,9142/22402
> $nmbr$ . $nmbr$ mu / l $ mmol / l,C0439342;C0439190,false;false,9143/22402
< $nmbr$ . $nmbr$ mu / l $ mmol / l,C0439342;C0439190,false;false,9144/22402
stage $nmbr$ a : > = $nmbr$ and < $nmbr$,C0205390;C1300072;C1306673,false;false;false,9145/22402
stage $nmbr$ b : > = $nmbr$ and < $nmbr$,C0441781,false,9146/22402
canakinumab  hscrp > $nmbr$ - $nmbr$ mg / l at $nmbr$ months ( n = $nmbr$ ),C2718773;C0439268;C0439231,true;false;false,9147/22402
canakinumab  hscrp < $nmbr$ - $nmbr$ mg / l at $nmbr$ months ( n = $nmbr$ ),C2718773;C0439268;C0439231,true;false;false,9148/22402
post - bronchodilator screening fev $nmbr$ ml,C2599594;C0220908;C3714541;C0439526;C1705224;C3887665;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;true;false;false;false;false;false,9149/22402
pre - bronchodilator screening fev $nmbr$ ml,C2599602;C0220908;C3714541;C0439526;C1705224;C3887665;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;true;false;false;false;false;false,9150/22402
duration of hypercholesterolaemia  mean ± sd ( year ),C0449238;C0020443;C0444504;C2699239;C0439234;C0439508;C2347634;C2348143;C1522133;C2926735,false;true;false;false;false;false;false;false;false;false,9151/22402
duration of hypercholesterolemia  mean ± sd ( years ),C0449238;C0020443;C0444504;C2699239;C0439234;C2347634;C2348143;C1522133;C2926735,false;true;false;false;false;false;false;false;false,9152/22402
< $nmbr$ with no historical count > $nmbr$,C1552658;C0750480;C1705566;C1552723;C2004062,false;false;false;false;false,9153/22402
< $nmbr$ with historical count > $nmbr$,C1552658;C0750480;C1705566;C1552723;C2004062,false;false;false;false;false,9154/22402
baseline hbalc > $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ) $nmbr$,C0168634;C3829066;C1442488,true;false;false,9155/22402
baseline hbalc < $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ) $nmbr$,C0168634;C3829066;C1442488,true;false;false,9156/22402
difference from placebo ( $nmbr$ % ci ),C1705241;C0032042;C0008107;C3259781;C1696465;C1706408;C1705242,false;true;true;false;false;false;false,9157/22402
difference from placebo * ( $nmbr$ % ci ),C1705241;C0032042;C0008107;C3259781;C1696465;C1706408;C1705242,false;true;true;false;false;false;false,9158/22402
central eosinophil count ( cells per pl ),C0205099;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879;C1879652,false;false;true;false;false;true;false;false,9159/22402
central eosinophil count ( cells per pl ) t,C0205099;C0200638;C0007584;C3897966;C4049765;C0007634;C0750879;C1879652,false;false;true;false;false;true;false;false,9160/22402
other anti - platelet agents,C0040616;C0005821,true;true,9161/22402
other antiplatelet agents,C0085826,true,9162/22402
other forms of atherosclerosis ^,C0348078;C0003850;C0004153;C0376315,false;true;true;true,9163/22402
other forms of atherosclerosis ’,C0348078;C0003850;C0004153;C0376315,false;true;true;true,9164/22402
race or ethnic group  no . ( % ),C0034510;C1706779;C3853635,true;false;false,9165/22402
race or ethnic group — no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,9166/22402
prior smoker,C0337671,false,9167/22402
prior stroke,C0332152;C0038454;C4554100;C2826257,false;true;false;false,9168/22402
no prior stroke,C0332152;C0038454;C4554100;C2826257,false;true;false;false,9169/22402
gender  n ( % ),C0079399;C1522384,true;true,9170/22402
gender  no . ( % ),C0079399;C1522384,true;true,9171/22402
coronary heart disease  n ( % ) b,C0010054;C0010068;C1956346,true;true;true,9172/22402
coronary heart disease  n ( % ) t,C0010054;C0010068;C1956346,true;true;true,9173/22402
mean ± s . d . fpg,C0444504;C2347634;C2348143,false;false;false,9174/22402
mean ( s . d . ) fpg,C0444504;C2347634;C2348143,false;false;false,9175/22402
troponin i ( pg / ml ),C0077401;C0439297,true;false,9176/22402
troponin t ( pg / ml ),C0077404;C0439297;C1420827,true;false;false,9177/22402
> $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,9178/22402
≥ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,9179/22402
< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,9180/22402
ischemia - driven revascularization,C0022116;C4321499,true;false,9181/22402
ischemia driven revascularization,C0022116;C4321499,true;false,9182/22402
timi minor,,,9183/22402
timi major,,,9184/22402
history of major microvascular disease  n ( % ),C0683519;C0205082;C0443258;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false;false,9185/22402
history of major macrovascular disease  n ( % ),C0683519;C0205082;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false,9186/22402
pre - bronchodilation fvc,C0439566;C3714541,false;true,9187/22402
post - bronchodilation fvc,C0439576;C3714541,false;true,9188/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ ),,,9189/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ),,,9190/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ ),,,9191/22402
history of macrovascular disease ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,9192/22402
history of microvascular disease ( % ),C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,9193/22402
patient characteristics,C0815172,false,9194/22402
patients ' characteristics,C0815172,false,9195/22402
treatment with anti - platelet drugs,C0039798;C2963157;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,9196/22402
treatment with antiplatelet drugs,C3469597,false,9197/22402
concomitant medications  * n ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9198/22402
concomitant medication  n ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,9199/22402
concomitant medications  n ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,9200/22402
fpg  mean ( sd )  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,9201/22402
fpg  mean ( sd )  mg / dlt,C0444504;C2699239;C0024671;C1413248;C3273706;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;true;false;false;true;false;false;false;false;false;false;false,9202/22402
one - vessel disease,C3275121,false,9203/22402
two - vessel disease,C0581375,false,9204/22402
ethnicity,C0015031;C0243103,true;true,9205/22402
ind / glyb n = $nmbr$,C4049864;C1415124,false;false,9206/22402
ind / gly n = $nmbr$,C4049864;C0017890;C0523677,false;true;false,9207/22402
non - hispanic / latino,C1518424;C0086528,false;true,9208/22402
not hispanic or latino,C1518424,false,9209/22402
not hispanic / latino,C1518424;C0086528,false;true,9210/22402
north american,C0425358;C2700615,false;false,9211/22402
north america,C0028405,true,9212/22402
south africa,C0037712,true,9213/22402
south american,C0425359,false,9214/22402
sou ti africa,C0039247;C0001737;C0040302;C1553045;C1704756,true;true;true;false;false,9215/22402
south america,C0037713,true,9216/22402
northamerica,,,9217/22402
bloodpressure  mean ( sd )  m m hg,C0428886;C2699239;C1709500;C0025424;C0428257;C2347108;C2347109;C2348272,true;false;false;true;false;false;false;false,9218/22402
blood pressure  mean ( sd )  mm hg,C0428886;C2699239;C0439475,true;false;false,9219/22402
tiotropium / olodaterol $nmbr$ . $nmbr$ / $nmbr$ mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9220/22402
tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9221/22402
tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ pg,C4032878;C0030827;C0072225;C1266240,true;true;true;false,9222/22402
diastolic bp  mmhg ( sd ),C0428883;C0439475;C2699239,true;false;false,9223/22402
systolic bp  mmhg ( sd ),C0871470;C0439475;C2699239,true;false;false,9224/22402
postamendment,,,9225/22402
preamendment,C1548596,false,9226/22402
fasting glucose — mg / dl,C0015663;C0017725;C0439269,true;true;false,9227/22402
fasting glucose ( mg / dl ),C0015663;C0017725;C0439269,true;true;false,9228/22402
mean systolic bp  mmhg  mean = sd,C0444504;C0871470;C0439475;C2699239;C2347634;C2348143,false;true;false;false;false;false,9229/22402
mean diastolic bp  mmhg  mean = sd,C0444504;C0428883;C0439475;C2699239;C2347634;C2348143,false;true;false;false;false;false,9230/22402
number of prior aeds  n ( % ) b,C0237753;C0332152;C0180309;C2826257;C0449788,false;false;true;false;false,9231/22402
number of prior aeds  n ( % ),C0237753;C0332152;C0180309;C2826257;C0449788,false;false;true;false;false,9232/22402
mean ( sd ) sdai *,C0444504;C2699239;C3871128;C2347634;C2348143,false;false;false;false;false,9233/22402
mean ( sd ) cdai *,C0444504;C2699239;C0683448;C1413248;C3273706;C2347634;C2348143,false;false;false;false;false;false;false,9234/22402
age > $nmbr$ years $nmbr$,C1510829,false,9235/22402
age < $nmbr$ years $nmbr$,C1510829,false,9236/22402
baseline systolic blood pressure ( mm hg ),C4274438;C0439475,false;false,9237/22402
baseline diastolic blood pressure ( mm hg ),C4274392;C0439475,false;false,9238/22402
adp antagonist,C0523452;C0231491,false;false,9239/22402
tnf antagonist,C1448177;C0231491,true;false,9240/22402
comorbidities,C0009488,true,9241/22402
co - morbidities,C0009488,true,9242/22402
vildagliptin $nmbr$ mg bid n = $nmbr$,C1570906;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9243/22402
vildagliptin $nmbr$ mg qd n = $nmbr$,C1570906;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,9244/22402
migraine with aura,C0154723,true,9245/22402
migraine without aura,C0338480,true,9246/22402
previous cancer,C0205156;C0006826;C0998265;C1306459;C1552607,false;true;false;false;false,9247/22402
previous cancerc,C0205156;C1552607,false;false,9248/22402
lipid - lowering drugs,C0086440,true,9249/22402
lipid - lowerinq druq,C0023779,true,9250/22402
lipid - lowering drug,C0086440,true,9251/22402
des type,C0011702;C0332307;C1547052;C4551552,true;false;false;true,9252/22402
acs type,C0742343;C0332307;C1547052;C4318612,true;false;false;false,9253/22402
fev $nmbr$ ( post - albuterol )  l,C3714541;C0687676;C0001927;C1704687;C3469826,true;false;true;false;false,9254/22402
fev $nmbr$  pre - albuterol  l,C3714541;C0332152;C0001927;C0740175;C2257086;C3669034,true;false;true;false;false;false,9255/22402
fev $nmbr$ ( pre - albuterol )  l,C3714541;C0332152;C0001927;C0740175;C2257086;C3669034,true;false;true;false;false;false,9256/22402
fev $nmbr$  post - albuterol  l,C3714541;C0687676;C0001927;C1704687;C3469826,true;false;true;false;false,9257/22402
p blockers ( % ),C0369773;C2603361,false;false,9258/22402
p - blocker ( % ),C0369773;C2603361,false;false,9259/22402
severe or very severe,C0205082;C4050465;C4050466,false;false;false,9260/22402
severe / very severea,C0205082;C0442824;C2984081;C4050465;C4050466,false;false;false;false;false,9261/22402
difference ( $nmbr$ % cl ),C1705241;C0596019;C1705242,false;false;false,9262/22402
difference ( $nmbr$ % ci ) *,C1705241;C0008107;C3259781;C1705242,false;true;false;false,9263/22402
$nmbr$ months,C0439231,false,9264/22402
$nmbr$ mentis,,,9265/22402
$nmbr$ mortis,,,9266/22402
> $nmbr$ months,C0439231,false,9267/22402
< $nmbr$ months,C0439231,false,9268/22402
$nmbr$ montlts,,,9269/22402
seated sbp  mean ( sd )  mmhg,C0277814;C0085805;C0444504;C2699239;C0439475;C2347634;C2348143;C1283233,true;true;false;false;false;false;false;false,9270/22402
seated dbp  mean ( sd )  mmhg,C0277814;C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799;C1283233,true;true;false;false;false;false;false;false;false;false,9271/22402
alcohol abuse,C0085762;C4050601,true;false,9272/22402
alcohol use,C0001948,true,9273/22402
> $nmbr$ microg / l,,,9274/22402
< $nmbr$ microg / l,,,9275/22402
tobacco abuse,C0040336,true,9276/22402
tobacco use,C0040335;C0543414;C0841002;C3853727,false;true;false;false,9277/22402
hospital stay ( days ),C3489408;C0439228,true;false,9278/22402
hospital stay  days,C3489408;C0439228,true;false,9279/22402
fev $nmbr$ — % of predicted value,C3714541;C0681842;C1522609;C1882327,true;false;false;false,9280/22402
fev $nmbr$ ( % of predicted value ),C3714541;C0681842;C1522609;C1882327,true;false;false;false,9281/22402
maternal history  n ( % ),C0559473,false,9282/22402
paternal history  n ( % ),C0424909,false,9283/22402
plp - c  mean ( sd )  mg / dl,C0034266;C0444504;C2699239;C0439269;C2347634;C2348143;C1175541;C1257874;C1705623,true;false;false;false;false;false;true;true;false,9284/22402
ldl - c  mean ( sd )  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,9285/22402
hdl - c  mean ( sd )  mg / dl,C3715113;C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false;false,9286/22402
$nmbr$ drinks / wk,C0452428,false,9287/22402
> $nmbr$ drinks / week,C0452428,false,9288/22402
$nmbr$ + drinks / wk,C0452428,false,9289/22402
> $nmbr$ drinks / wk,C0452428,false,9290/22402
prior hypertension yes,C0332152;C0020538;C1549445;C1705108;C1710701;C1963138;C2826257,false;true;false;false;false;false;false,9291/22402
prior hypertensiona yes,C0332152;C1549445;C1705108;C1710701;C2826257,false;false;false;false;false,9292/22402
drug - related ae *,C0013227;C0439849;C3887670;C0445223;C1254351,true;false;false;false;false,9293/22402
drug - related teaes *,C0013227;C0439849;C0445223;C1254351,true;false;false;false,9294/22402
subgroup p valuef,C1079230;C1515021,false;false,9295/22402
subgroup p value 本,C1079230;C1709380;C1515021,false;false;false,9296/22402
white ethnic origin,C0007457;C0015031;C0043157;C0220938,true;true;true;false,9297/22402
while ethnic origin,,,9298/22402
> $nmbr$ yr since menopause,C0439234,false,9299/22402
< $nmbr$ yr since menopause,C0439234,false,9300/22402
ls mean difference ( $nmbr$ % ci ),C0023668;C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,true;false;false;true;false;false;false;false,9301/22402
( mean difference  $nmbr$ % ci ),C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,false;false;true;false;false;false;false,9302/22402
( mean % difference  $nmbr$ % ci ),C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,false;false;true;false;false;false;false,9303/22402
reversibility : < $nmbr$ %,C0449261,false,9304/22402
reversibility : > $nmbr$ %,C0449261,false,9305/22402
male eze / simva,C0086582;C1706180;C1706428;C1706429,true;false;false;false,9306/22402
all ez / simva,C0206578,true,9307/22402
female eze / simva,C0043210;C0086287;C1705497;C1705498,true;true;false;false,9308/22402
glycated hemoglobin - % ’,C0017853,true,9309/22402
glycated hemoglobin  %,C0017853,true,9310/22402
glycated hemoglobin ( % ),C0017853,true,9311/22402
glycated hemoglobin — %,C0017853,true,9312/22402
glycated haemoglobin ( % ),C0017853,true,9313/22402
a $nmbr$ c ( mmol / mol ),C3829066,false,9314/22402
hba $nmbr$ c  mmol / mol,C0019016;C3829066;C1825777;C3538758,true;false;false;false,9315/22402
hba $nmbr$ c ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,9316/22402
arterial hypertension *,C0020538,true,9317/22402
arterial hypertension,C0020538,true,9318/22402
intervention,C0184661;C0886296;C1273869,true;false;false,9319/22402
interruption,C0332453;C1512900,false;false,9320/22402
waist circumference ( cm ),C0455829,true,9321/22402
waist circumference — cm,C0455829,true,9322/22402
waist circumference  ( cm ),C0455829,true,9323/22402
waist circumference  cm,C0455829,true,9324/22402
dbp ( mm hg )  median ( iqr ),C0536221;C0439475;C0549183;C0876920;C2347635;C2348144;C2939193;C3813197;C4281799,true;false;false;false;false;false;false;false;false,9325/22402
sbp ( mm hg )  median ( iqr ),C0085805;C0439475;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,9326/22402
total cholesterol  mg / dl,C0201950;C0439269;C0543421,false;false;false,9327/22402
total cholesterol — mg / dl,C0201950;C0439269;C0543421,false;false;false,9328/22402
total cholesterol ( mg / dl ),C0201950;C0439269;C0543421,false;false;false,9329/22402
toial cholcsierol ( mg / dl ),C0439269,false,9330/22402
total cholesterol  mg / dl ^,C0201950;C0439269;C0543421,false;false;false,9331/22402
no change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,9332/22402
% change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,9333/22402
> $nmbr$ ml / min,C0439445,false,9334/22402
£ $nmbr$ ml / min,C0439445,false,9335/22402
< $nmbr$ ml / min,C0439445,false,9336/22402
smoking history ( pack - years ),C1519384;C1277691,false;false,9337/22402
smoking history  pack - years,C1519384;C1277691,false;false,9338/22402
smoking history ( pack - yr ),C1519384;C1968515;C0439234;C2825051;C2828395,false;false;false;false;false,9339/22402
dm + ( aliskiren vs . placebo ),C0011816;C1120110;C3250443,true;true;false,9340/22402
dm - ( aliskiren vs . placebo ),C0011816;C1120110;C3250443,true;true;false,9341/22402
without beta blocker,C0001645,true,9342/22402
with beta blocker,C0001645,true,9343/22402
timi risk score !,C0035647;C0449820;C4050231;C4552904,true;false;false;false,9344/22402
timi risk score,C0035647;C0449820;C4050231;C4552904,true;false;false;false,9345/22402
timi risk score  %,C0035647;C0449820;C4050231;C4552904,true;false;false;false,9346/22402
angiotensin - converting enzyme inhibitor,C0003015;C2757044;C3536837;C4541021,true;false;false;false,9347/22402
angiotensin - converting - enzyme inhibitor,C0003015;C2757044;C3536837;C4541021,true;false;false;false,9348/22402
total asthma symptom score,C3533163;C0004096;C2984299,false;true;false,9349/22402
total asthma symptom score :,C3533163;C0004096;C2984299,false;true;false,9350/22402
diastolic bp  mmhg  mean ± sd,C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C0012000;C0488053,true;false;false;false;false;false;true;false,9351/22402
systolic bp  mmhg  mean ± sd,C0871470;C0439475;C0444504;C2699239;C2347634;C2348143;C0039155;C0488053,true;false;false;false;false;false;true;false,9352/22402
uric acid fertile $nmbr$ ( > $nmbr$ . $nmbr$ mg / dl ),C0041980;C0015895;C0439269,true;true;false,9353/22402
uric acid tertile $nmbr$ ( < $nmbr$ . $nmbr$ mg / dl ),C0041980;C0439269,true;false,9354/22402
uric acid tertile $nmbr$ ( > $nmbr$ . $nmbr$ mg / dl ),C0041980;C0439269,true;false,9355/22402
> $nmbr$ . $nmbr$ mmol / liter,C0439190;C0475211,false;false,9356/22402
> $nmbr$ . $nmbr$ mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,9357/22402
< $nmbr$ . $nmbr$ mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,9358/22402
< $nmbr$ . $nmbr$ mmol / liter,C0439190;C0475211,false;false,9359/22402
< $nmbr$ . $nmbr$ pmol / liter,C0439192;C0475211,false;false,9360/22402
age ( years ) - < median ( n = $nmbr$  $nmbr$ ),C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9361/22402
age ( years ) - > = median ( n = $nmbr$  $nmbr$ ),C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9362/22402
macrovascular disease  n ( % ),C0012634,true,9363/22402
microvascular disease  n ( % ),C0443258;C0012634,false;true,9364/22402
vorapaxar ( n = $nmbr$ . $nmbr$ ),C2974521,true,9365/22402
vorapaxar ( n = $nmbr$ $nmbr$ ),C2974521,true,9366/22402
vorapaxar ( n = $nmbr$  $nmbr$ ),C2974521,true,9367/22402
risk difference,C0035647;C1705241;C1705242;C4552904,true;false;false;false,9368/22402
lsm difference,C1705241;C1705242,false;false,9369/22402
aspirin ( n = $nmbr$  $nmbr$ ),C0004057,true,9370/22402
aspirin ( n = $nmbr$ $nmbr$ ),C0004057,true,9371/22402
rosuvastatin,C0965129,true,9372/22402
rosuvastatin +,C0965129,true,9373/22402
metformin use,C0025598;C0042153;C0457083;C1947944,true;true;false;false,9374/22402
no metformin use,C0025598;C0042153;C0457083;C1947944,true;true;false;false,9375/22402
copd severity  n ( % ) a,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,9376/22402
copd severity  n ( % ),C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,9377/22402
copd severity  n ( % ) *,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,9378/22402
prior revascularization,C0332152;C0581603;C2826257,false;false;false,9379/22402
pci revascularization,C4049621;C0581603,false;false,9380/22402
ldl - c : hdl - c,C3715113,false,9381/22402
ldl - c / hdl - c,C3715113,false,9382/22402
ldl - c / hdl - cx,C3715113,false,9383/22402
oral agents,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,9384/22402
two agents,C0205448;C0450442;C1254351;C1521826,false;false;false;false,9385/22402
ras agents,C0034678;C0450442;C1254351;C1521826;C0525678,true;false;false;false;true,9386/22402
mean ( sd ) fev $nmbr$ ( l ) pre - bronchodilator,C0444504;C2699239;C3714541;C2599602;C2347634;C2348143,false;false;true;false;false;false,9387/22402
mean ( sd ) fev $nmbr$ ( l ) post - bronchodilator,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,9388/22402
< $nmbr$ years simva ( n = $nmbr$ },C0439234,false,9389/22402
> $nmbr$ years simva ( „ = $nmbr$ },C0439234,false,9390/22402
bmi > $nmbr$ kg / m $nmbr$,C0578022;C1532718,false;false,9391/22402
bmi < $nmbr$ kg / m $nmbr$,C0578022;C1532718,false;false,9392/22402
bmi  x $nmbr$ kg / m $nmbr$,C0578022;C1532718,false;false,9393/22402
bmi > = $nmbr$ kg / m $nmbr$,C0578022;C1532718,false;false,9394/22402
bmi  median ( sd )  kg / m $nmbr$,C0578022;C0549183;C2699239;C1532718;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9395/22402
bmi  mean ( sd )  kg / m $nmbr$,C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,9396/22402
physical function,C0516981;C4049916,false;false,9397/22402
physical functioning,C0516981;C4049916,false;false,9398/22402
ldl - c ( mg / dl ),C0439269,false,9399/22402
hdl - c ( mg / dl ),C3715113;C0439269,false;false,9400/22402
hdl - c  mg / dl,C3715113;C0439269,false;false,9401/22402
ldl - c  mg / dl,C0439269,false,9402/22402
regular aspirin use,C0205272;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,9403/22402
no regular aspirin use,C0205272;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,9404/22402
> $nmbr$ beats / min,,,9405/22402
< $nmbr$ beats / min,,,9406/22402
antiplatelets,,,9407/22402
antiplatelet,,,9408/22402
characteristics,C1521970,false,9409/22402
characteristic,C1521970,false,9410/22402
hypokalemia,C0020621;C4553966,true;false,9411/22402
hvookalemia,,,9412/22402
hyperkalemiab,,,9413/22402
hungary,C0020174,true,9414/22402
surgery,C0038894;C0038895;C0543467;C1274039,false;true;true;true,9415/22402
baseline uacr < $nmbr$ mg / g,C0168634;C1300563;C1442488,true;false;false,9416/22402
baseline uacr > $nmbr$ mg / g,C0168634;C1300563;C1442488,true;false;false,9417/22402
insulin plus $nmbr$ oral agent,C0021641;C0442027;C0450442;C1254351;C1521826;C4521986;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false,9418/22402
insulin plus > $nmbr$ oral agent,C0021641;C0442027;C0450442;C1254351;C1521826;C4521986;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false,9419/22402
long - acting nitrates,C0205166;C0079613;C0028125;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;true;false;false;false,9420/22402
long acting nitratef,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,9421/22402
long - acting nitrate,C0205166;C0079613;C0028125;C0699857;C3848573;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;false;true;false;false;false,9422/22402
ischaemic aetiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,9423/22402
ischemic aetiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,9424/22402
systolic blood pressure  mean ( sd )  mm hga,C0488055;C0444504;C2699239;C4330985;C4554674;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;false;true;false;true;true,9425/22402
systolic blood pressure  mean ( sd )  mm hg,C0488055;C0444504;C2699239;C0439475;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,9426/22402
hscrp < $nmbr$ . $nmbr$ mg / l,C0439268,false,9427/22402
hscrp > $nmbr$ . $nmbr$ mg / l,C0439268,false,9428/22402
hscrp > $nmbr$ . $nmbr$ mga .,C0065879,true,9429/22402
hs - crp > $nmbr$ . $nmbr$ mg / l,C3890735;C0439268;C4048285,false;false;false,9430/22402
hs - crp < $nmbr$ . $nmbr$ mg / l,C3890735;C0439268;C4048285,false;false;false,9431/22402
hs - crp < $nmbr$ . $nmbr$ g / l,C3890735;C0439294;C0456615;C4048285,false;false;false;false,9432/22402
creatinine clearance  ml / min,C0812399;C0439445,false;false,9433/22402
creatine clearance  ml / min,C0373595;C0439445,false;false,9434/22402
creatinine clearance ( ml / min ),C0812399;C0439445,false;false,9435/22402
total cholesterol $nmbr$ < $nmbr$ mg / dl,C0201950;C0439269;C0543421,false;false;false,9436/22402
total cholesterol $nmbr$ > $nmbr$ mg / dl,C0201950;C0439269;C0543421,false;false;false,9437/22402
rosuvastatin  n ( rate ),C0965129;C0871208;C1521828,true;false;false,9438/22402
rosuvastatin n ( rate ) *,C0965129;C0871208;C1521828,true;false;false,9439/22402
rosuvastatin n ( rate ),C0965129;C0871208;C1521828,true;false;false,9440/22402
tiotropium / olodaterol $nmbr$ / $nmbr$ mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9441/22402
tiotropium + olodaterol $nmbr$ / $nmbr$ mg,C4032878;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9442/22402
tiotropium + olodaterol $nmbr$ / $nmbr$ pg,C4032878;C0030827;C0072225;C1266240,true;true;true;false,9443/22402
diastolic blood pressure,C0428883;C1305849,true;false,9444/22402
systolic blood pressure,C0488055;C0871470;C1306620,false;true;false,9445/22402
cardiac failure *,C0018801;C0018802,true;true,9446/22402
cardiac failure §,C0018801;C0018802,true;true,9447/22402
cardiac failure,C0018801;C0018802,true;true,9448/22402
major cardiovascular event,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,9449/22402
major cardiovascular event *,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,9450/22402
major cardiovascular events,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,9451/22402
no concomitant immunosuppressive and / or prior anti - tnf use,C0521115;C0021081,false;true,9452/22402
concomitant immunosuppressive and / or prior anti - tnf use,C0521115;C0021081,false;true,9453/22402
triglycerides - mg / dl * *,C0041004;C0439269,true;false,9454/22402
triglycerides ( mg / dl ) * *,C0041004;C0439269,true;false,9455/22402
$nmbr$ - $nmbr$ months  n ( % ),C0439231,false,9456/22402
$nmbr$ - < $nmbr$ months  n ( % ),C0439231,false,9457/22402
received $nmbr$ prior biologic therapies  n,C1514756;C0278947,false;false,9458/22402
received $nmbr$ prior biologic therapy  n,C1514756;C0278947,false;false,9459/22402
immunosuppressants onlyff,C0021081,true,9460/22402
immunosuppressants only,C0021081;C0205171;C1720467,true;false;false,9461/22402
mtx > $nmbr$ mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,9462/22402
mtx £ $nmbr$ mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,9463/22402
active smoking,C0205177;C0037369;C0453996;C1881674;C3853793;C3888249,false;true;true;false;false;false,9464/22402
active smoker,C0205177;C0337664;C3853793;C3888249,false;true;false;false,9465/22402
cardiovascular risk factors  no . ( % ),C0850624,false,9466/22402
cardiovascular risk factors  n ( % ),C0850624,false,9467/22402
demographic,C0011298,true,9468/22402
demographics,C0011298;C1704791,true;false,9469/22402
demography,C0011298,true,9470/22402
no stroke ( n = $nmbr$ ),C0038454;C4554100,true;false,9471/22402
any stroke ( n = $nmbr$ ),C0038454;C4554100,true;false,9472/22402
left main,C0205091;C0205225;C1542147;C0443246;C1552822,false;false;false;false;false,9473/22402
back pain,C0004604;C1963071;C4553945,true;false;false,9474/22402
neck pain,C0007859;C1963180;C4553909,true;false;false,9475/22402
rest pain,C0234253,false,9476/22402
< $nmbr$ mg / dl eze / simva,C0439269,false,9477/22402
> $nmbr$ mg / dl eze / simva,C0439269,false,9478/22402
no st depression or elevation,C0520887,false,9479/22402
st depression or elevation,C0520887,false,9480/22402
medication use at baseline  n ( % ),C0240320;C0168634;C1442488,false;true;false,9481/22402
medications at baseline  n ( % ),C0013227;C0168634;C1442488;C0802604;C2598133;C4284232,true;true;false;false;false;false,9482/22402
history of atrial fibrillation or fl utter,C0729790,false,9483/22402
history of atrial fibrillation / flutter,C0729790;C0016385;C2242390;C1998417;C0232197,false;false;false;false;false,9484/22402
statin without other llt,C0360714;C2347090,true;false,9485/22402
statin with other llt,C0360714;C2347090,true;false,9486/22402
< q $nmbr$ ( $nmbr$ ) — number / n ( % ),C0237753;C0449788,false;false,9487/22402
> q $nmbr$ ( $nmbr$ ) — number / n ( % ),C0237753;C0449788,false;false,9488/22402
time from qualifying mi  %,C0040223;C1514624;C3810814;C3541383,true;false;false;false,9489/22402
time from qualifying mi  yrs,C0040223;C1514624;C3810814;C3541383,true;false;false;false,9490/22402
prior history of ml or ischemic stroke,C0332152;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;false;false;true;false;false;false;false;false,9491/22402
prior history of mi or ischaemic stroke,C0332152;C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;false;true;false;false;false;false;false,9492/22402
hazard ratio ( $nmbr$ % confi dence interval ),C2985465;C1272706;C1552654;C1552713,false;false;false;false,9493/22402
hazard ratio ( $nmbr$ % confidence interval ),C2985465;C0009667,false;true,9494/22402
hazard ratio ( $nmbr$ % confidence interval ) *,C2985465;C0009667,false;true,9495/22402
with antiplatelets,,,9496/22402
without antiplatelets,,,9497/22402
range  ( min  max ),C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,9498/22402
range : min  max,C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,9499/22402
range ( min  max ),C1514721;C0702093;C1524029;C3813700;C2348147;C3542016,false;false;false;false;false;false,9500/22402
aml $nmbr$ mg / hctz $nmbr$ mg,C0023465;C1319635;C0020261;C0023467,true;false;true;true,9501/22402
om $nmbr$ mg / hctz $nmbr$ mg,C0028971;C1319635;C0020261;C1705272,true;false;true;false,9502/22402
insulin therapy,C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,true;true;true;false;false;false;false,9503/22402
noninsulin therapy,C0039798;C0087111;C1363945,true;true;false,9504/22402
mean ± sd  n,C0444504;C2699239;C2347634;C2348143,false;false;false;false,9505/22402
mean ± sd ( yr ),C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false,9506/22402
mean ± sd ( n ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9507/22402
stage $nmbr$ : > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0456533;C0439445,false;false,9508/22402
stage $nmbr$ : < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0456533;C0439445,false;false,9509/22402
median ( q $nmbr$  q $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9510/22402
median ( q $nmbr$ : q $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,9511/22402
bmi category ( % ),C0578022;C0683312;C3889287,false;false;false,9512/22402
age category ( % ),C0001779;C0683312;C3889287,false;false;false,9513/22402
supplementary oxygen,C0030054,true,9514/22402
supplemental oxygen,C4534306,false,9515/22402
fvc ( liters ),C3714541;C0475211,true;false,9516/22402
fvc — liters,C3714541;C0475211,true;false,9517/22402
> $nmbr$ years of age,C1510829,false,9518/22402
< $nmbr$ years of age,C1510829,false,9519/22402
$ $nmbr$ exacerbations,C4086268,false,9520/22402
$nmbr$ exacerbation,C4086268,false,9521/22402
> $nmbr$ exacerbations,C4086268,false,9522/22402
$nmbr$ exacerbations,C4086268,false,9523/22402
history of mi ( n = $nmbr$  $nmbr$ ),C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,9524/22402
no history of mi ( n = $nmbr$  $nmbr$ ),C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,9525/22402
vka therapy,C0039798;C0087111;C1363945,true;true;false,9526/22402
dual therapy,C0205173;C0039798;C0087111;C1363945;C1554184,false;true;true;false;false,9527/22402
egfr  mean ( sd )  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0444504;C2699239;C0439445;C0369637;C0441923;C2347634;C2348143;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,9528/22402
egfr  mean = sd  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0444504;C2699239;C0439445;C0369637;C0441923;C2347634;C2348143;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,9529/22402
nt - probnp ， pmol / h,C0669479;C0439192;C0033727;C0369286;C0441932;C0564385;C4528284;C0754710,true;false;true;false;false;false;false;true,9530/22402
nt - probnp  pmol / l ^,C0669479;C0439284;C0754710,true;false;true,9531/22402
nt - probnp  pmol / l,C0669479;C0439284;C0754710,true;false;true,9532/22402
antihypertensive,C0003364,true,9533/22402
antihypertensives,C0003364,true,9534/22402
gender  n ( % ) male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,9535/22402
gender  n [ % ] male,C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,9536/22402
ldl - c ( mmol / l  mean ),C1532563;C0444504;C2347634;C2348143,false;false;false;false,9537/22402
hdl - c ( mmol / l  mean ),C3715113;C1532563;C0444504;C2347634;C2348143,false;false;false;false;false,9538/22402
all patients ( « = $nmbr$ $nmbr$ ),C0030705,true,9539/22402
all patients ( n = $nmbr$  $nmbr$ ),C0030705,true,9540/22402
eastern europe ( % ),C0015177,true,9541/22402
western europe ( % ),C0043129,true,9542/22402
om $nmbr$ mg / aml $nmbr$ mg,C0028971;C1319635;C0023465;C0023467;C1705272,true;false;true;true;false,9543/22402
ischaemic heart disease,C0010054;C0151744,true;true,9544/22402
ischemic heart disease,C0010054;C0151744,true;true,9545/22402
hba $nmbr$ c  mean ( sd )  %,C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,9546/22402
hba $nmbr$ c  mean = sd  %,C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,9547/22402
hba $nmbr$ c  median ( sd )  %,C0019016;C0549183;C2699239;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false;false,9548/22402
asia pacific,C0003980,true,9549/22402
asia - pacific,C0003980,true,9550/22402
asia / pacific,C0003980,true,9551/22402
previous coronary revascularization,C0205156;C0877341;C1552607,false;false;false,9552/22402
previous coronary revascularisation,C0205156;C0877341;C1552607,false;false;false,9553/22402
corticosteroid use at baseline - no,C0239126;C0168634;C1442488,false;true;false,9554/22402
corticosteroid use at baseline - yes,C0239126;C0168634;C1549445;C1705108;C1710701;C1442488,false;true;false;false;false;false,9555/22402
fev $nmbr$ reversibility  % *,C3714541;C0449261,true;false,9556/22402
fev $nmbr$ reversibility  % b,C3714541;C0449261,true;false,9557/22402
serum triglycerides — mmol / liter,C0542495;C0439190;C0475211,false;false;false,9558/22402
serum triglycerides — pmol / liter,C0542495;C0439192;C0475211,false;false;false,9559/22402
angina pectoris,C0002962,true,9560/22402
angina pectoris 本,C0002962,true,9561/22402
angina pectoris *,C0002962,true,9562/22402
angina pectorisf,C0002962,true,9563/22402
alc > = $nmbr$ . $nmbr$ %,C1424945;C3811058,false;false,9564/22402
alc < $nmbr$ . $nmbr$ %,C1424945;C3811058,false;false,9565/22402
major bleeding,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,9566/22402
minor bleeding,C0026193;C0019080;C0205165,true;true;false,9567/22402
a from baselineb,,,9568/22402
a from baseline,C0168634;C1442488,true;false,9569/22402
bmi : < $nmbr$ . $nmbr$ kg / m $nmbr$,C0578022;C1532718,false;false,9570/22402
bmi : > $nmbr$ . $nmbr$ kg / m $nmbr$,C0578022;C1532718,false;false,9571/22402
mayo score  mean ( sd ),C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578,false;false;false;false;false;false;false;false,9572/22402
mayo score ( mean ± sd ),C0454788;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1077578,false;false;false;false;false;false;false;false,9573/22402
total ( n = $nmbr$ $nmbr$ ),C0439175;C0439810,false;false,9574/22402
total  n = $nmbr$ $nmbr$,C0439175;C0439810,false;false,9575/22402
total ( n = $nmbr$  $nmbr$ ),C0439175;C0439810,false;false,9576/22402
> median ( $nmbr$ . $nmbr$ years ) — number / n ( % ),C0549183;C0439234;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9577/22402
< median ( $nmbr$ . $nmbr$ years ) — number / n ( % ),C0549183;C0439234;C0237753;C0449788;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,9578/22402
difference vs placebo * *,C1705241;C1705242,false;false,9579/22402
difference vs placebo ',C1705241;C1705242,false;false,9580/22402
difference vs . placebo,C1705241;C1705242,false;false,9581/22402
difference vs placebo,C1705241;C1705242,false;false,9582/22402
avm % △ ( se ),C0003857;C0036919;C0279476,true;true;false,9583/22402
met % △ ( se ),C0428210;C0036919;C1550543;C4317104,false;true;false;false,9584/22402
chronic kidney diseased,C2364010,false,9585/22402
chronic kidney disease,C1561643;C4553188,true;false,9586/22402
estimated difference %,C0750572;C1705241;C1705242,false;false;false,9587/22402
estimated difference,C0750572;C1705241;C1705242,false;false;false,9588/22402
u . s . site,C0041703;C0205145;C1515974;C2825164,true;false;false;false,9589/22402
u . s . sites,C0041703;C0205145,true;false,9590/22402
history of diabetes ( n = $nmbr$ ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9591/22402
no history of diabetes ( n = $nmbr$ ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9592/22402
< $nmbr$ months  median ( min  max ),C0439231;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,9593/22402
> $nmbr$ months  median ( min  max ),C0439231;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,9594/22402
posterior circulation,C0205095;C0005775;C1516559,false;true;false,9595/22402
anterior circulation,C0205094;C0005775;C1516559,false;true;false,9596/22402
insulin yes,C0021641;C1549445;C1705108;C1710701;C1533581;C1579433;C3714501,true;false;false;false;false;false;false,9597/22402
insulin use,C0240016,false,9598/22402
insulin based,C0021641;C1533581;C1579433;C3714501,true;false;false;false,9599/22402
non - black race and ss > $nmbr$ ( n = $nmbr$ vs $nmbr$ ),C1518422;C0005680,false;true,9600/22402
non - black race and ss < $nmbr$ ( n = $nmbr$ vs $nmbr$ ),C1518422;C0005680,false;true,9601/22402
family history of diabetes ( % ) *,C1313937,false,9602/22402
family history of diabetes ( - ),C1313937,false,9603/22402
family history of diabetes ( + ),C1313937,false,9604/22402
duration of diabetes  years,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9605/22402
duration ofdiabetes — yr,C0449238;C0439234;C2926735,false;false;false,9606/22402
duration of diabetes ( years ),C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9607/22402
duration of diabetes — yr,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9608/22402
duration of diabetes  yrs,C0449238;C0011847;C0011849;C2926735,false;false;true;false,9609/22402
duration of diabetes ( y ),C0449238;C0011847;C0011849;C2926735,false;false;true;false,9610/22402
duration of diabetes ( years ) t,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9611/22402
duration diabetes ( years ),C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,9612/22402
at index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,9613/22402
index event,C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,9614/22402
moderate ckd,C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,9615/22402
moderate ’,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,9616/22402
moderatey,,,9617/22402
no moderate ckd,C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,9618/22402
moderate,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,9619/22402
weight < $nmbr$ . $nmbr$ kg  n,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,9620/22402
weight $ $nmbr$ . $nmbr$ kg  n,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,9621/22402
history of microvascular disease,C0683519;C0443258;C0730226;C0850708;C0944983,false;false;false;false;false,9622/22402
history of macrovascular disease,C0683519;C0730226;C0850708;C0944983,false;false;false;false,9623/22402
disease duration  years,C0872146;C0439234,false;false,9624/22402
disease duration ( years ),C0872146;C0439234,false;false,9625/22402
disease duration ( yr ),C0872146;C0439234,false;false,9626/22402
glycated hemoglobin  nonstandardized level — %,C0202054,false,9627/22402
glycated hemoglobin  standardized level — %,C0017853,true,9628/22402
baseline characteristics,C4684572,false,9629/22402
baseline characteristic,C0168634;C1442488,true;false,9630/22402
patients without chronic,C0030705;C0205191,true;false,9631/22402
patients with chronic,C0030705;C0205191,true;false,9632/22402
baseline egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,9633/22402
baseline egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ c,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,9634/22402
baseline egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,9635/22402
ldl - c  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9636/22402
tchdl - c  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,9637/22402
hdl - c  mean ( sd ),C3715113;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,9638/22402
symptomatic pad,C0231220;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false;false,9639/22402
symptomatic padt,C0231220,false,9640/22402
statin during admission,C0360714;C0184666;C0809949,true;false;false,9641/22402
no statin during admission,C0360714;C0184666;C0809949,true;false;false,9642/22402
rosuvastatin events / patients ( % ),C0965129;C0441471;C0030705;C3541888,true;false;true;false,9643/22402
rosuvastatin  events / patients ( % ),C0965129;C0441471;C0030705;C3541888,true;false;true;false,9644/22402
average weekly mtx dose ( mg / week ),C1510992;C0332174;C0366550;C0024671;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2825518,false;false;false;true;false;true;false;false;false;false;false;false,9645/22402
average weekly mtx dose ( mg / week ) t,C1510992;C0332174;C0366550;C0024671;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2825518,false;false;false;true;false;true;false;false;false;false;false;false,9646/22402
all teaes *,,,9647/22402
all teaes,,,9648/22402
mild teaes,C2945599,false,9649/22402
sbp  mean ± sd ( mmhg ),C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,9650/22402
dbp  mean ± sd ( mmhg ),C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,9651/22402
death ( all - cause ),C0011065;C1306577;C4082313;C4552775,true;false;false;false,9652/22402
death ( all cause ),C0011065;C1306577;C4082313;C4552775,true;false;false;false,9653/22402
q $nmbr$ : > $nmbr$ . $nmbr$ kg ( n = $nmbr$ vs $nmbr$ ),C0022718;C0439209;C4054209,true;false;false,9654/22402
q $nmbr$ : < $nmbr$ . $nmbr$ kg ( n = $nmbr$ vs $nmbr$ ),C0022718;C0439209;C4054209,true;false;false,9655/22402
> = $nmbr$ years ( placebo n = $nmbr$  $nmbr$  saxagliptin n = $nmbr$  $nmbr$ ),C0439234;C0032042;C1611934;C1696465;C1706408,false;true;true;false;false,9656/22402
< $nmbr$ years ( placebo n = $nmbr$  $nmbr$  saxagliptin n = $nmbr$  $nmbr$ ),C0439234;C0032042;C1611934;C1696465;C1706408,false;true;true;false;false,9657/22402
without psoriasis ( zi = $nmbr$  $nmbr$ ),C0033860;C0043476,true;true,9658/22402
without psoriasis ( n = $nmbr$  $nmbr$ ),C0033860,true,9659/22402
heart rate > $nmbr$ bpm,C0018810,true,9660/22402
heart rate < $nmbr$ bpm,C0018810,true,9661/22402
inferior,C0542339;C0678975,false;false,9662/22402
non - anterior,C1518422;C0205094,false;false,9663/22402
nonanterior,,,9664/22402
not anterior,C1518422;C0205094,false;false,9665/22402
anterior,C0205094,false,9666/22402
hyperlipidaemia,C0020473;C0428465;C4555212,true;false;false,9667/22402
hyperlipidemia,C0020473;C0428465;C4555212,true;false;false,9668/22402
hyperlipidemia ^,C0020473;C0428465;C4555212,true;false;false,9669/22402
left - sided colitisz,C0205091;C0443246,false;false,9670/22402
left sided colitis,C2887821,false,9671/22402
left - sided colitis,C2887821,false,9672/22402
nadroparin ( n = $nmbr$ ),C0206232,true,9673/22402
no nadroparin ( n = $nmbr$ ),C0206232,true,9674/22402
social functioning,C0037395,true,9675/22402
social function,C0037395,true,9676/22402
eze / simva,,,9677/22402
ez / simva,C0206578,true,9678/22402
aniagonisi,,,9679/22402
antagonist,C0231491,false,9680/22402
all - cause death n,C0015127;C0011065;C1306577;C4082313;C4552775;C1524003,true;true;false;false;false;false,9681/22402
all - cause death,C0015127;C0011065;C1306577;C4082313;C4552775;C1524003,true;true;false;false;false;false,9682/22402
family history of cancera,C0241889,true,9683/22402
family history of cancerf,C0241889,true,9684/22402
indacaterol $nmbr$ mg,C1722260;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9685/22402
indacaterol $nmbr$ pg,C1722260;C0030827;C0072225;C1266240,true;true;true;false,9686/22402
p  regional difference,C0369773;C0682132;C2603361,false;false;false,9687/22402
p  regional difference *,C0369773;C0682132;C2603361,false;false;false,9688/22402
liraglutide $nmbr$ . $nmbr$ mg  n = $nmbr$,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9689/22402
liraglutide $nmbr$ . $nmbr$ mg n = $nmbr$,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9690/22402
liraglutide $nmbr$ - $nmbr$ mg ( n = $nmbr$ ),C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9691/22402
liraglutide $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9692/22402
fev $nmbr$ pre - bronchodilator,C3714541;C2599602,true;false,9693/22402
fev $nmbr$ post - bronchodilator,C3714541,true,9694/22402
ace inhibitors / arbs  n ( % ),C0003015;C3888198,true;false,9695/22402
ace - inhibitors / arbs  n ( % ),C0003015;C3888198,true;false,9696/22402
increase creatinine  < $nmbr$ . $nmbr$ mg / dl,C0442805;C0010294;C0439269;C1561535,false;true;false;false,9697/22402
increase creatinine  > $nmbr$ . $nmbr$ mg / dl,C0442805;C0010294;C0439269;C1561535,false;true;false;false,9698/22402
> $nmbr$ . $nmbr$ ( % ),,,9699/22402
< $nmbr$ . $nmbr$ ( % ),,,9700/22402
baseline lipid and lipoprotein values,C0168634;C0023779;C1442488,true;true;false,9701/22402
baseline lipid / lipoprotem values,C0168634;C0023779;C0042295;C1442488,true;true;false;false,9702/22402
baseline lipid / lipoprotein values,C0168634;C0443602;C0042295;C1442488,true;false;false;false,9703/22402
previous stroke *,C0205156;C0038454;C4554100;C1552607,false;true;false;false,9704/22402
previous stroke,C0205156;C0038454;C4554100;C1552607,false;true;false;false,9705/22402
hypertension — no . ( % ),C0020538;C1963138,true;false,9706/22402
hypertension — no . ( % ) |,C0020538;C1963138,true;false,9707/22402
overall ( n = u $nmbr$ ),C0282416;C0439148;C1561607,true;false;false,9708/22402
overall ( n = $nmbr$ ),C0282416;C1561607,true;false,9709/22402
history of diabetes :,C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9710/22402
history of diabetes,C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,9711/22402
beta - blockers  n ( % ),C0001645,true,9712/22402
beta - blockers  ( % ),C0001645,true,9713/22402
history of hypertension *,C0455527,false,9714/22402
history of hypertension,C0455527,false,9715/22402
ischemic heart disease  ( % ),C0010054;C0151744,true;true,9716/22402
ischemic heart disease  n ( % ),C0010054;C0151744,true;true,9717/22402
ischaemic heart disease  n ( % ),C0010054;C0151744,true;true,9718/22402
patients receiving enl  no . ( % ),C0030705,true,9719/22402
patients receiving lcz  no . ( % ),C0030705,true,9720/22402
urinary albumin : creatinine ratioa ( mg / g ),C0455271;C1300563;C1318330,false;false;false,9721/22402
urinary albumin : creatinine ratio ( mg / g ),C0455271;C1300563;C1318330,false;false;false,9722/22402
indian ( american ) or alaska native,C1524069;C0596070,false;false,9723/22402
indian ( american ) or alaskan native,C1524069;C0596070,false;false,9724/22402
saxagliptin $nmbr$ mg,C1611934;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9725/22402
mssbp < $nmbr$ mmhg,C0439475,false,9726/22402
mssbp > $nmbr$ mmhg,C0439475,false,9727/22402
infarct localisation,C0021308;C0475264;C1744691,true;false;false,9728/22402
infarct localization,C0021308;C0475264;C1744691,true;false;false,9729/22402
placebo group ( n = $nmbr$ ),C0032042;C0441848;C1696465;C1706408,true;false;false;false,9730/22402
placebo group ( n = $nmbr$ ) f,C0032042;C0441848;C0016327;C1696465;C1706408,true;false;true;false;false,9731/22402
sjc ( $nmbr$ joints ),C0022417;C0392905,true;false,9732/22402
sjc ( / $nmbr$ joints ),C0022417;C0392905,true;false,9733/22402
tjc ( / $nmbr$ joints ),C0022417;C0392905,true;false,9734/22402
tjc ( $nmbr$ joints ),C0022417;C0392905,true;false,9735/22402
oral anticoagulants,C0354604,false,9736/22402
oral anticoagulant,C0354604,false,9737/22402
ischemia,C0022116;C4321499,true;false,9738/22402
ischaemic,C0475224,false,9739/22402
disease characteristics,C0599878,false,9740/22402
disease characteristics *,C0599878,false,9741/22402
nyha functional class,C1882083;C0205245;C0542341;C2700217,false;false;false;false,9742/22402
ara functional class,C0325983;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C2316832;C3890184;C4282437;C4321455,false;false;false;false;false;false;false;false;false;false;false,9743/22402
teaes ( > $nmbr$ % in any treatment group ) *,C0374505,false,9744/22402
teaes ( > $nmbr$ % in any treatment group ),C0374505,false,9745/22402
history myocardial infarction,C0155668;C1275835,false;false,9746/22402
history of myocardial infarction,C1275835,false,9747/22402
acq - $nmbr$ score *,C2919686,false,9748/22402
npi - $nmbr$ score *,C1412208;C1549728;C3539727,false;false;false,9749/22402
acq - $nmbr$ scoret,C2919686,false,9750/22402
$nmbr$ - h ppg ( mmol / l ),C2827804;C1418888,false;false,9751/22402
$nmbr$ - h ppg ( mmol / l ) *,C2827804;C1418888,false;false,9752/22402
$nmbr$ - h pg ( mmol / l ),C2827798;C0439190;C2827804;C0030827;C0072225;C1266240,false;false;false;true;true;false,9753/22402
fvc post - bronchodilator,C3714541,true,9754/22402
fvc pre - bronchodilator,C3714541;C2599602,true;false,9755/22402
baseline su dose < $nmbr$ / $nmbr$ maximal,C0168634;C0038642;C0178602;C0869039;C1114758;C1705534;C1442488,true;true;false;false;false;false;false,9756/22402
baseline su dose > $nmbr$ / $nmbr$ maximal,C0168634;C0038642;C0178602;C0869039;C1114758;C1705534;C1442488,true;true;false;false;false;false;false,9757/22402
mean sd ldl - c  mg / dl,C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false,9758/22402
mean sd hdl - c  mg / dl,C0444504;C2699239;C3715113;C0439269;C2347634;C2348143,false;false;false;false;false;false,9759/22402
laa closure,C0185003;C1521802,false;false,9760/22402
pfo closure,C0185003;C1521802,false;false,9761/22402
cdai < $nmbr$ . $nmbr$ *,C0683448;C1413248;C3273706,false;false;false,9762/22402
sdai < $nmbr$ . $nmbr$ *,C3871128,false,9763/22402
nyha class — no . ( % ) $,C1882083,false,9764/22402
nyha class — no . ( % ),C1882083,false,9765/22402
drug - eluting,C0013227;C1254351,true;false,9766/22402
drug eluting,C0013227;C1254351,true;false,9767/22402
homa - p,,,9768/22402
homa - ir,C0022065;C0022071;C1448132,true;true;true,9769/22402
no . of patients with psa,C0030705,true,9770/22402
no . of patients with ra,C0030705,true,9771/22402
no . of patients with as,C0030705,true,9772/22402
ng ( n = $nmbr$  $nmbr$ ),C0017887;C0028074,true;true,9773/22402
no ( n = $nmbr$  $nmbr$ ),C0369718;C0441922,false;false,9774/22402
$nmbr$ ( n = $nmbr$  $nmbr$ ),C0369718;C0441922,false;false,9775/22402
sf - $nmbr$ v $nmbr$ mcs  mean [ sd ],C0037712;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,9776/22402
sf - $nmbr$ v $nmbr$ pcs  mean [ sd ],C0037712;C1864389;C0444504;C2699239;C2347634;C2348143;C1882368,true;false;false;false;false;false;true,9777/22402
regular ppi use,C0205272;C0358591;C0871125;C3811894,false;true;true;false,9778/22402
no regular ppi use,C0205272;C0358591;C0871125;C3811894,false;true;true;false,9779/22402
hospitalization for acs,C0019993;C0742343;C4318612,true;true;false,9780/22402
hospitalization for,C0019993,true,9781/22402
hospitalization for hf,C0019993;C0018488;C1313497;C1538440;C3273279,true;true;true;false;false,9782/22402
pbo + mtx to mtx,C0031962;C0025677;C1417487,true;true;false,9783/22402
czp + mtx to mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,9784/22402
tg  mg / dl  mean ± sd,C0337445;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,9785/22402
tc  mg / dl  mean ± sd,C0039411;C0439269;C0444504;C2699239;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;false;true;true;true;false;false;false,9786/22402
tc  mg / dl  mean + sd,C0039411;C0439269;C0444504;C2699239;C2347634;C2348143;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;false;true;true;true;false;false;false,9787/22402
aiirocumab,,,9788/22402
alirocumab,C3491162,true,9789/22402
hispanic or latino ethnic groupf,C0086409,true,9790/22402
hispanic or latino ethnic group !,C0086409,true,9791/22402
hispanic or latino ethnic groupb,C0086409,true,9792/22402
hispanic or latino ethnic group *,C0086409,true,9793/22402
prior aspirin,C0332152;C0004057;C2826257,false;true;false,9794/22402
no prior aspirin,C0332152;C0004057;C2826257,false;true;false,9795/22402
medication  n ( % ),C0013227;C3244316;C4284232,true;false;false,9796/22402
medications  n ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,9797/22402
medication — no . ( % ),C0013227;C3244316;C4284232,true;false;false,9798/22402
medications . no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,9799/22402
medications  no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,9800/22402
eze + statin n = $nmbr$,C0360714,true,9801/22402
pbo + statin n = $nmbr$,C0031962;C0360714,true;true,9802/22402
incidence *,C0021149;C0220856,true;true,9803/22402
incidence  %,C0021149;C0220856,true;true,9804/22402
incidencea,,,9805/22402
asia  pacific and other,C0003980,true,9806/22402
asia pacific or other,C0003980,true,9807/22402
asia pacific and other,C0003980,true,9808/22402
apo b : apo a - i ratio,C0003593;C0085201;C0456603;C1547037;C1677784;C3252643,true;true;false;false;true;true,9809/22402
apob : apoal ratio,C0003593;C0456603;C1547037;C3252643,true;false;false;true,9810/22402
apob : apoa - l ratio,C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;false;false;true,9811/22402
saxa + met n = $nmbr$,,,9812/22402
dapa + met n = $nmbr$,,,9813/22402
patients with uncomplicated events,C0030705;C0443334;C0441471;C3541888,true;false;false;false,9814/22402
patients with complicated events,C0030705;C0231242;C0441471;C3541888,true;false;false;false,9815/22402
sf - $nmbr$ mcs  mean ± sd,C0037712;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,9816/22402
sf - $nmbr$ pcs  mean ± sd,C0037712;C1864389;C0444504;C2699239;C2347634;C2348143;C1882368,true;false;false;false;false;false;true,9817/22402
systolic blood pressure subgroups,C0488055;C1079230;C0871470;C1306620,false;false;true;false,9818/22402
diastolic blood pressure subgroups,C0428883;C1079230;C1305849,true;false;false,9819/22402
losartan  n / n ( % ),C0126174,true,9820/22402
valsartan  n / n ( % ),C0216784,true,9821/22402
persistent,C0205322;C0332996,false;false,9822/22402
persistent af,C0205322;C0344434;C4049859;C0332996,false;false;false;false,9823/22402
ukpds $nmbr$ - year risk score < $nmbr$ %,C0439234;C0035647;C0449820;C4050231;C4552904;C0439508,false;true;false;false;false;false,9824/22402
ukpds $nmbr$ - year risk score > $nmbr$ %,C0439234;C0035647;C0449820;C4050231;C4552904;C0439508,false;true;false;false;false;false,9825/22402
sirolimus - eluting,C0072980,true,9826/22402
everolimus - eluting,C0541315,true,9827/22402
immunosuppressants,C0021081,true,9828/22402
immunosuppressant ^ ^,C0021081,true,9829/22402
hdl - c  mg / dl  mean ± sd,C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,9830/22402
ldl - c  mg / dl  mean + sd,C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,9831/22402
ldl - c  mg / dl  mean ± sd,C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,9832/22402
hdl - c  mg / dl  mean + sd,C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,9833/22402
medication use,C0240320,false,9834/22402
medication,C0013227;C3244316;C4284232,true;false;false,9835/22402
education *,C0013621;C0013622;C0013658;C0039401,true;true;true;true,9836/22402
medications *,C0013227;C0802604;C2598133;C4284232,true;false;false;false,9837/22402
medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,9838/22402
sgrq total score * ( units ),C2964552;C0439148;C1519795;C3853603,false;false;false;false,9839/22402
sgrq total score  units,C2964552;C0439148;C1519795;C3853603,false;false;false;false,9840/22402
sgrq total score ( units ),C2964552;C0439148;C1519795;C3853603,false;false;false;false,9841/22402
weight  median ( sd )  kg,C0005910;C0549183;C2699239;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;false;false;true;false;false,9842/22402
weight  mean ( sd ) kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,9843/22402
weight  median ( iqr )  kg,C0005910;C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;true;false;false;false;false;false;false;true;false;false,9844/22402
weight  mean ( sd )  kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,9845/22402
diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . . .,C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9846/22402
diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . .,C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9847/22402
total no .,C0439175;C0439810,false;false,9848/22402
total body,C0229960,false,9849/22402
ind / gly ( n = $nmbr$ ),C4049864;C0017890;C0523677,false;true;false,9850/22402
ind + pbo ( n = $nmbr$ ),C4049864;C0031962,false;true,9851/22402
ind + gly ( n = $nmbr$ ),C4049864;C0017890;C0523677,false;true;false,9852/22402
score of $ $nmbr$  no . ( % ),C0449820;C4050231,false;false,9853/22402
score of # $nmbr$  no . ( % ),C0449820;C4050231,false;false,9854/22402
body - mass index ( kg / m ' ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,9855/22402
body - mass index ( kg / m - ) !,C0005893;C1532718;C0578022;C1305855,false;false;false;true,9856/22402
body - mass index ( kg / m - ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,9857/22402
time to treatment initiation ( min,C3494202;C0589507;C0702093;C1524029;C3813700;C1158830;C1704686,true;false;false;false;false;false;false,9858/22402
time to treatment initiation ( min ),C3494202;C0589507;C0702093;C1524029;C3813700;C1158830;C1704686,true;false;false;false;false;false;false,9859/22402
patients with microalbuminuria at baseline,C0030705;C0730345,true;false,9860/22402
patients with macroalbuminuria at baseline,C0030705,true,9861/22402
atrial fibrillation !,C0004238;C0344434;C1963067,true;false;false,9862/22402
atrial fibrillation  %,C0004238;C0344434;C1963067,true;false;false,9863/22402
atrial fibrillation,C0004238;C0344434;C1963067,true;false;false,9864/22402
atrial fibrillation ( % ),C0004238;C0344434;C1963067,true;false;false,9865/22402
prior tnf antagonist treatment - no,C1514463;C1448177;C0231491,false;true;false,9866/22402
prior tnf antagonist treatment - yes,C1514463;C1448177;C0231491;C1549445;C1705108;C1710701,false;true;false;false;false;false,9867/22402
pt baseline ( week $nmbr$ ),C0032743;C0168634;C0332174;C0439230;C1442488;C0699718,true;true;false;false;false;false,9868/22402
db baseline ( week $nmbr$ ),C1418892;C0168634;C0332174;C0439230;C1442488,false;true;false;false;false,9869/22402
odds ratio ( $nmbr$ % ci ),C0028873;C0008107;C3259781,true;true;false,9870/22402
odds ratio ( $nmbr$ % cl ),C0028873;C0596019,true;false,9871/22402
ethnicity  n ( % ),C0015031;C0243103,true;true,9872/22402
ethnicity  no . ( % ),C0015031;C0243103,true;true,9873/22402
ethnicity - no . ( % ),C0015031;C0243103,true;true,9874/22402
pacemaker  n ( % ),C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,9875/22402
pacemaker  ( % ),C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,9876/22402
physical examination,C0031809;C1744699,true;false,9877/22402
physical examinations,C0031809,true,9878/22402
ileum and colon,C0020885,true,9879/22402
ileum or colon,C0020885,true,9880/22402
killip class > ii ( % ),C2697845,false,9881/22402
killip class  n ( % ),C1881332,false,9882/22402
qrs < $nmbr$ msec,C0439223,false,9883/22402
qrs > $nmbr$ ms *,C2349943;C3539704;C3713294,false;false;true,9884/22402
hba $nmbr$ c  %  mean ( sd ) b,C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,9885/22402
hba $nmbr$ c  %  mean ( sd ),C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,9886/22402
hba $nmbr$ c  %  mean ± sd,C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,9887/22402
< $nmbr$ % blood eosinophils at baseline,C0014467;C0168634;C1442488,true;true;false,9888/22402
> $nmbr$ % blood eosinophils at baseline,C0014467;C0168634;C1442488,true;true;false,9889/22402
czp $nmbr$ mg ( n $nmbr$ ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,9890/22402
age ( median  iqr )  y,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9891/22402
age  median ( iqr )  y,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,9892/22402
atrial fibrillation / flutter,C0155709,false,9893/22402
atrial fibrillation or flutter,C0004238;C0344434;C1963067,true;false;false,9894/22402
metformin,C0025598,true,9895/22402
no metformin,C0025598,true,9896/22402
q wave,C0429089;C1305738,false;false,9897/22402
q wave mi,C0861151,false,9898/22402
q - wave mi,C0861151,false,9899/22402
hand fracture,C0435632,false,9900/22402
hip fracture,C0019557;C0149531;C4552776,true;false;false,9901/22402
canagliflozin ( n = $nmbr$ ),C2974540,true,9902/22402
empagliflozin ( n = $nmbr$ ),C3490348,true,9903/22402
smoking history,C1519384,false,9904/22402
post - bronchodilator fev $nmbr$ / fvc  %,C2599594;C3714541,false;true,9905/22402
postbronchodilator fev $nmbr$ / fvc  %,C2599594;C3714541,false;true,9906/22402
smoker ( % ),C0337664,true,9907/22402
smoker ( % ) a,C0337664,true,9908/22402
ast  u / l,C1415181;C0439339;C3891303,false;false;false,9909/22402
alt  u / l,C1266129;C0439339;C4553172,false;false;false,9910/22402
non - hdl - c  mmol / l,C1518422;C3715113;C1532563,false;false;false,9911/22402
non - hdl - c ( mmol / l ),C1518422;C3715113;C1532563,false;false;false,9912/22402
menopause and ht,C0025320;C0567312,true;false,9913/22402
menopause and hrt,C0025320;C0567312,true;false,9914/22402
minimum - maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,9915/22402
minimum : maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,9916/22402
patients < $nmbr$ %,C0030705,true,9917/22402
patients > $nmbr$ %,C0030705,true,9918/22402
women ( n = $nmbr$ vs $nmbr$ ),C0043210,true,9919/22402
men ( n = $nmbr$ vs $nmbr$ ),C0025266,true,9920/22402
men ( n = $nmbr$ $nmbr$ ),C0025266,true,9921/22402
diastolic — mean ( sd ) ( mm hg ),C0012000;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,9922/22402
systolic — mean ( sd ) ( mm hg ),C0039155;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,9923/22402
active cancer,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,9924/22402
no active cancer,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,9925/22402
ac tve cancer,C0001246;C0006826;C0998265;C1306459;C0003354;C1412573;C2000891;C3539770,true;true;false;false;true;false;true;false,9926/22402
physical activity  kcal / wk,C0015259;C0439259;C0332174;C0439230;C0026606,true;false;false;false;true,9927/22402
physical activity  kcal / wk *,C0015259;C0439259;C0332174;C0439230;C0026606,true;false;false;false;true,9928/22402
loop or thiazide diuretic,C0445022,false,9929/22402
loop or thiazide diuretic #,C0445022,false,9930/22402
alcohol use  drinks / wk,C0001948,true,9931/22402
alcohol use  drinks / wk *,C0001948,true,9932/22402
total population,C3258257,false,9933/22402
total population n,C3258257,false,9934/22402
interruption ( n = $nmbr$ ),C0332453;C1512900,false;false,9935/22402
intervention ( n = $nmbr$ ),C0184661;C0886296;C1273869,true;false;false,9936/22402
non - st - segment elevation myocardial infarction,C1536221;C0441635;C1536222;C3537184;C4255010;C1518422;C1536220,false;false;false;false;true;false;true,9937/22402
non — st - segment — elevation myocardial infarction,C1536221;C0441635;C1536222;C3537184;C4255010;C1518422;C1536220,false;false;false;false;true;false;true,9938/22402
% risk reduction ( $nmbr$ % ci ),C1137094;C0008107;C3259781,true;true;false,9939/22402
risk reduction ( $nmbr$ % cl ),C1137094;C0596019,true;false,9940/22402
use of beta - blocker,C1524063;C0001645,false;true,9941/22402
use of beta - blockers,C1524063;C0001645,false;true,9942/22402
hf hospitalization,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,9943/22402
hf hospitalization n,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,9944/22402
hospitalization,C0019993,true,9945/22402
r elative risk ( $nmbr$ % ci ),C0205090;C0233492;C0035647;C0008107;C3259781;C4552904;C0684010;C2603358,false;false;true;true;false;false;true;false,9946/22402
relative risk ( $nmbr$ % ci ),C0242492;C0008107;C3259781,true;true;false,9947/22402
relative risk ( $nmbr$ % cl ),C0242492;C0596019,true;false,9948/22402
> $nmbr$ . $nmbr$ ( n — $nmbr$ ),C0369718;C0441922,false;false,9949/22402
< $nmbr$ . $nmbr$ ( n — $nmbr$ ),C0369718;C0441922,false;false,9950/22402
mi > $nmbr$ months *,C3810814;C0439231,false;false,9951/22402
mi < $nmbr$ months *,C3810814;C0439231,false;false,9952/22402
> $nmbr$ months — number / n ( % ),C0439231;C0237753;C0449788,false;false;false,9953/22402
< $nmbr$ months — number / n ( % ),C0439231;C0237753;C0449788,false;false;false,9954/22402
all n = $nmbr$  $nmbr$,C0369718;C0441922,false;false,9955/22402
all n = $nmbr$ $nmbr$,C0369718;C0441922,false;false,9956/22402
any clinical or lesion rf for st,C0205210,false,9957/22402
no clinical or lesion rfs for st,C0205210,false,9958/22402
neuropathy,C0442874,false,9959/22402
nephropathy,C0022658,true,9960/22402
hba $nmbr$ c > $nmbr$ % ( n $nmbr$ $nmbr$ ),C0019016;C1825777;C3538758,true;false;false,9961/22402
hba $nmbr$ c < = $nmbr$ % ( n $nmbr$ $nmbr$ ),C0019016;C1825777;C3538758,true;false;false,9962/22402
am △ 士 s . e .,C3813124;C3890196;C4520798,false;false;false,9963/22402
ama 士 s . e .,C0002461;C0279755;C2825862,true;false;false,9964/22402
im or cs use : no,,,9965/22402
im and cs use : no,,,9966/22402
hdl $nmbr$ - c,C3715113,false,9967/22402
ldl $nmbr$ - c,,,9968/22402
at randomization,C0034656,true,9969/22402
randomization,C0034656,true,9970/22402
to randomization,C0034656,true,9971/22402
> $nmbr$ years simva,C0439234,false,9972/22402
< $nmbr$ years simva,C0439234,false,9973/22402
simvastatin $nmbr$ mg ( n = $nmbr$ ) *,C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9974/22402
simvastatin $nmbr$ mg ( n = $nmbr$ ),C0074554;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9975/22402
hispanic or latino ( n — $nmbr$ ),C0086409,true,9976/22402
hispanic or latino ( n = $nmbr$ ),C0086409,true,9977/22402
copd exacerbation : yes,C0740304;C1549445;C1705108;C1710701,false;false;false;false,9978/22402
copd exacerbation : no,C0740304,false,9979/22402
hdl cholesterol > $nmbr$ - $nmbr$ mmol / l,C0023822;C1532563;C0392885,true;false;false,9980/22402
ldl cholesterol < $nmbr$ - $nmbr$ mmol / l,C0023824;C1532563;C0202117,true;false;false,9981/22402
ldl cholesterol > $nmbr$ - $nmbr$ mmol / l,C0023824;C1532563;C0202117,true;false;false,9982/22402
hdl cholesterol < $nmbr$ - $nmbr$ mmol / l,C0023822;C1532563;C0392885,true;false;false,9983/22402
sex  female  n ( % ),C0086287,true,9984/22402
sex ( male )  n ( % ),C0086582,true,9985/22402
sex  male  n ( % ),C0086582,true,9986/22402
sex  male  no . ( % ),C0086582,true,9987/22402
adjusted p - value for interaction,C0456081;C1709380;C1704675,false;false;false,9988/22402
unadjusted p - value for interaction,C1439367;C1709380;C1704675,false;false;false,9989/22402
no chd eze / simva,C0280604;C3542407,false;false,9990/22402
chd eze / simva,C0280604;C3542407,false;false,9991/22402
aspirin use ( p = $nmbr$ - $nmbr$ t ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,9992/22402
aspirin use ( p = $nmbr$ - $nmbr$ 十 ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,9993/22402
dapagliflozin $nmbr$ mg ( n = $nmbr$ ),C2353951;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9994/22402
ertugliflozin $nmbr$ mg ( n = $nmbr$ ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9995/22402
empagliflozin $nmbr$ mg ( n = $nmbr$ ),C3490348;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,9996/22402
prior coronary artery bypass grafting,C0332152;C0010055;C2826257,false;true;false,9997/22402
prior coronary artery bypass graft,C0332152;C0010055;C1260596;C2826257,false;true;false;false,9998/22402
cholesterol ( mmol / l ),C0008377;C1532563,true;false,9999/22402
cholesterol  mmol / l,C0008377;C1532563,true;false,10000/22402
fev $nmbr$  litres ( pre ipratropium )  mean ( sd ),C3714541;C0475211;C0332152;C0027235;C0444504;C2699239;C2347634;C2348143;C0740175;C2257086;C3669034,true;false;false;true;false;false;false;false;false;false;false,10001/22402
fev $nmbr$  litres ( post ipratropium )  mean ( sd ),C3714541;C0475211;C0687676;C0027235;C0444504;C2699239;C2347634;C2348143;C1704687;C3469826,true;false;false;true;false;false;false;false;false;false,10002/22402
insulin ( pmol / l ),C0021641;C0439284;C1533581;C1579433;C3714501,true;false;false;false;false,10003/22402
insulin  pmol / l,C0021641;C0439284;C1533581;C1579433;C3714501,true;false;false;false;false,10004/22402
proprotein convertase subtil / kexin typ $nmbr$ ( ng / ml ) - baseline - < median ( n = $nmbr$  $nmbr$ ),C1100660;C0165249;C1414185;C0439275;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488;C3811813,true;true;false;false;true;false;false;false;false;false;false;false,10005/22402
proprotein convertase subtil / kexin typ $nmbr$ ( ng / ml ) - baseline - > = median ( n = $nmbr$  $nmbr$ ),C1100660;C0165249;C1414185;C0439275;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488;C3811813,true;true;false;false;true;false;false;false;false;false;false;false,10006/22402
( mmol / l ],C1532563,false,10007/22402
mmol / mol,C3829066,false,10008/22402
mmol / l,C1532563,false,10009/22402
wc ( cm ),C0013123;C2825512,true;false,10010/22402
rr ( cl ),C4554402;C0596019,false;false,10011/22402
patient ' s global assessment,C4054229,false,10012/22402
patient ' s global assessment !,C4054229,false,10013/22402
patient ' s global assessment of,C4054229,false,10014/22402
no epa group no . of events ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,10015/22402
epa group no . of events ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,10016/22402
nitrates  ( % ),C0028125;C0699857;C3848573,true;false;false,10017/22402
nitrates  n ( % ),C0028125;C0699857;C3848573,true;false;false,10018/22402
cox hr ( $nmbr$ % ci ),C1565830;C0008107;C3259781,true;true;false,10019/22402
cmh rr ( $nmbr$ % ci ),C4554402;C0008107;C3259781,false;true;false,10020/22402
coronary revascularization,C0877341,false,10021/22402
coronary revascularisation,C0877341,false,10022/22402
n - $nmbr$ pufa ( n = $nmbr$ ),C0369718;C0032615;C0441922,false;true;false,10023/22402
n - $nmbr$ - pufa ( n = $nmbr$ ),C0369718;C0032615;C0441922,false;true;false,10024/22402
antihypertensive agents,C0003364,true,10025/22402
antihypertensive agents *,C0003364,true,10026/22402
mean ( sd )  y,C0444504;C2699239;C2347634;C2348143,false;false;false;false,10027/22402
mean ( sd ) bmi,C0444504;C2699239;C0578022;C2347634;C2348143,false;false;false;false;false,10028/22402
non - high density lipoprotein ( mg / dl ) - baseline - > = median ( n = $nmbr$  $nmbr$ ),C1535899;C0439269;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,false;false;true;false;false;false;false;false;false,10029/22402
non - high density lipoprotein ( mg / dl ) - baseline - < median ( n = $nmbr$  $nmbr$ ),C1535899;C0439269;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,false;false;true;false;false;false;false;false;false,10030/22402
aldosterone blocker,C0002006,true,10031/22402
aldosterone blockers,C0002006,true,10032/22402
adjusted hr ( $nmbr$ % ci ),C0456081;C0008107;C3259781,false;true;false,10033/22402
adjusted hr ( $nmbr$ % cl ),C0456081;C0596019,false;false,10034/22402
cohort $nmbr$ ( uacr < $nmbr$ . $nmbr$ mg / g ),C0009247;C1300563;C0599755,true;false;false,10035/22402
cohort $nmbr$ ( uacr > $nmbr$ . $nmbr$ mg / g ),C0009247;C1300563;C0599755,true;false;false,10036/22402
no extensive colitis  n,C0205231;C0009319;C1963084,false;true;false,10037/22402
extensive colitis  n,C0205231;C0009319;C1963084,false;true;false,10038/22402
prior migraine,C0332152;C0149931;C2826257,false;true;false,10039/22402
prior migraine *,C0332152;C0149931;C2826257,false;true;false,10040/22402
primary endpoint death / mi / idr / st,C2986535;C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,false;true;false;true;false;false;false;false,10041/22402
primary end point : death / mi / idr / st,C2986535;C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,false;true;false;true;false;false;false;false,10042/22402
difference from placebo,C1705241;C0032042;C1696465;C1706408;C1705242,false;true;false;false;false,10043/22402
difference from placeboa,C1705241;C1705242,false;false,10044/22402
difference from placebo ¥,C1705241;C0032042;C1696465;C1706408;C1705242,false;true;false;false;false,10045/22402
standing after $nmbr$ minute change from baseline,C0231472;C0439232;C0392747;C0443172;C1705241;C4319952;C0700321;C0702093;C1282918;C2347166,true;false;false;false;false;false;false;false;false;false,10046/22402
standing after $nmbr$ minutes change from baseline,C0231472;C0439232;C0700321;C0702093;C1282918;C2347166,true;false;false;false;false;false,10047/22402
american indian or alaskan native,C0002460,true,10048/22402
american indian / alaska native,C0002460,true,10049/22402
american indian or alaska native,C0002460,true,10050/22402
multiracial,C1881928,false,10051/22402
multi - racial,C0439064;C0034510;C1706779;C3669213;C3853635;C3266262,false;true;false;false;false;true,10052/22402
aqlq ( s ) + $nmbr$ scored,C4055434,false,10053/22402
aqlq ( s ) + $nmbr$ scorets,C4055434,false,10054/22402
antiarrhythmic,C0003195;C3537142,true;false,10055/22402
anti arrhythmic,C0003195;C3537142,true;false,10056/22402
ct findings,C0007673;C2607943;C2926606;C3539655;C3540513;C3813556;C3888140,true;true;false;false;false;false;false,10057/22402
ecg findings,C0438154,false,10058/22402
lipoprotein ( a ) ( nmol / l ),C0065058;C0439282;C0125953;C1096202;C1439335,true;false;true;false;false,10059/22402
lipoprotein ( a ) ( mmol / l ),C0065058;C1532563;C0125953;C1096202;C1439335,true;false;true;false;false,10060/22402
baseline . mean _ sd  mg / dl,C0168634;C0444504;C2699239;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,10061/22402
baseline . mean _ sd . mg / mg,C0168634;C0444504;C2699239;C1319635;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,10062/22402
baseline . mean _ sd . mg / dl,C0168634;C0444504;C2699239;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,10063/22402
≤ $nmbr$ u / kg / day,C1532634,false,10064/22402
> $nmbr$ u / kg / day,C1532634,false,10065/22402
valsartan,C0216784,true,10066/22402
bosentan,C0252643,true,10067/22402
losartan,C0126174,true,10068/22402
history of stroke,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,10069/22402
history of stroke *,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,10070/22402
patients without syndesmophytes at baseline,C0030705;C0221690,true;false,10071/22402
patients with syndesmophytes at baseline,C0030705;C0221690,true;false,10072/22402
lipid - lowering,C0023779;C0441994;C2003888,true;false;false,10073/22402
lipid lowering,C0023779;C0441994;C2003888,true;false;false,10074/22402
stratum ii,C1710602;C4082587,false;false,10075/22402
stratum i,C0021966;C0221138,true;false,10076/22402
aapo $nmbr$ at rest  mm hg,C0035253;C0439475;C1622890,true;false;false,10077/22402
pao $nmbr$ at rest  mm hg,C0232555;C0035253;C0439475;C1622890;C1423784;C1427155;C4318615,false;true;false;false;false;false;false,10078/22402
mean ( s . d . ) systolic blood pressure  mm hg,C0428886;C0039155;C0439475;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;false;true;false;false;false,10079/22402
mean ( s . d . ) diastolic blood pressure  mm hg,C0428886;C0012000;C0439475;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;false;true;false;false;false,10080/22402
> $nmbr$ to < $nmbr$ h  n ( % ),C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,10081/22402
$nmbr$ to < $nmbr$ h  n ( % ),C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,10082/22402
coronary artery disease ^,C0010054;C0010068;C1956346,true;true;true,10083/22402
coronaiy artery disease,C0852949,false,10084/22402
coronary artery disease,C0010054;C0010068;C1956346,true;true;true,10085/22402
> o - $nmbr$ - i - i,C0483204;C0021966;C0221138,false;true;false,10086/22402
> o - $nmbr$ - ii,C0483204;C1710602;C4082587,false;false;false,10087/22402
egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  mean ( sd ),C1739039;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,10088/22402
egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  mean ± sd,C1739039;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,10089/22402
baseline fev $nmbr$,C0168634;C3714541;C1442488,true;true;false,10090/22402
baseline fev $nmbr$ #,C0168634;C3714541;C1442488,true;true;false,10091/22402
$nmbr$ ( n $nmbr$ $nmbr$ ),C0369718;C0441922,false;false,10092/22402
$nmbr$ mg ( n $nmbr$ $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10093/22402
respiratory rate  breaths / min,C0231832;C0439386;C0489258,true;false;false,10094/22402
respiratory rate ( breaths / min ),C0231832;C0439386;C0489258,true;false;false,10095/22402
karnofsky score < $nmbr$,C0206065,true,10096/22402
karnofsky score 竺 $nmbr$,C0206065,true,10097/22402
ldl - csmedian,,,10098/22402
ldl - c > median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10099/22402
non - hdl - c *,C1518422;C3715113,false;false,10100/22402
non - hdl - c,C1518422;C3715113,false;false,10101/22402
duration of pci — min,C0449238;C4049621;C0702093;C1524029;C3813700;C2926735,false;false;false;false;false;false,10102/22402
duration of pci  min,C0449238;C4049621;C0702093;C1524029;C3813700;C2926735,false;false;false;false;false;false,10103/22402
mean ( s . d . ) bmi  kg / m $nmbr$,C0444504;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false,10104/22402
mean ± s . d . bmi  kg / m $nmbr$,C0444504;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false,10105/22402
baselinec,,,10106/22402
( baseline ),C0168634;C1442488,true;false,10107/22402
baselineb,,,10108/22402
baseline,C0168634;C1442488,true;false,10109/22402
< $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ),C3829066,false,10110/22402
≥ $nmbr$ . $nmbr$ % ( ≥ $nmbr$ mmol / mol ),C3829066,false,10111/22402
inferior ( % ),C0542339;C0678975,false;false,10112/22402
anterior { % ),C0205094,false,10113/22402
age group  no . ( % ),C0027362;C2348001,true;false,10114/22402
age group  n ( % ),C0001779;C0441848,false;false,10115/22402
qualifying mi < $nmbr$ yrs prior,C1514624;C3810814,false;false,10116/22402
qualifying mi $ $nmbr$ yrs prior,C1514624;C3810814,false;false,10117/22402
hawaiian / pacific islander,C0337920;C0242191,true;true,10118/22402
hawaiian pacific islander,C0337920;C0242191,true;true,10119/22402
bl mean ( mmhg ),C0005918;C0444504;C0439475;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;false;true;false;false,10120/22402
bl mean ( cm ),C0005918;C0444504;C2347634;C2348143;C0006413;C1552663;C2827109,true;false;false;false;true;false;false,10121/22402
no or unknown,,,10122/22402
no / unknown,C0439673;C3541433;C4050014,false;false;false,10123/22402
loop diuretic,C0354100;C3536704,true;false,10124/22402
loop diuretics,C0354100,true,10125/22402
non diuretics,C1518422;C0012798,false;true,10126/22402
esam ( ng / ml ),C1424976;C0439275,false;false,10127/22402
ngal ( ng / ml ),C0215955;C0439275;C1416806;C2346625,true;false;false;false,10128/22402
fev $nmbr$ / fvc,C3714541,true,10129/22402
fev $nmbr$ / fvc %,C3714541,true,10130/22402
history of diabetes ( a ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,10131/22402
history of diabetes ( % ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,10132/22402
age : < $nmbr$ years ( n = $nmbr$ ),C1510829,false,10133/22402
age < $nmbr$ years ( n = $nmbr$ ),C1510829,false,10134/22402
age  years  mean ( range ),C1510829;C0444504;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,10135/22402
age  years : median ( range ),C1510829;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,10136/22402
metabolic syndrome ( % ) b,C0524620,true,10137/22402
metabolic syndrome ( % ),C0524620,true,10138/22402
peripheral artery disease — no . ( % ),C1704436;C4025272,true;false,10139/22402
peripheral - artery disease — no . ( % ),C1704436;C4025272,true;false,10140/22402
aiorvasiaiin,,,10141/22402
atorvastatin,C0286651,true,10142/22402
epa ( mol % ),C0027960;C0324740;C0439189;C1456781;C1824986;C3665593,true;true;false;false;false;false,10143/22402
aa  mol %,C0282379;C0027960;C0324740;C0439189;C1456781;C1824986;C3665593;C1235746;C1882141;C4554792,true;true;true;false;false;false;false;false;false;false,10144/22402
epa  mol %,C0027960;C0324740;C0439189;C1456781;C1824986;C3665593,true;true;false;false;false;false,10145/22402
cardiovasculardeath / myocardial infarction / stroke,C0027051;C0038454;C4554100;C0428953;C2926063;C3810814;C4552959,true;true;false;false;false;false;false,10146/22402
cardiovascular death / myocardial infarction / stroke,C0027051;C0011065;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775,true;true;false;false;false;false;false;false;false,10147/22402
m o nito ring treatment,C0369637;C0521164;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1260969;C1882954;C0441923,false;false;true;true;false;false;false;false;false;false;false;false,10148/22402
monitoring treatment,C0150369;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1283169,false;true;true;false;false;false;false;false;false,10149/22402
baseline focal seizure frequency / $nmbr$ days  median ( q $nmbr$  q $nmbr$ ),C0168634;C0751495;C0376249;C0439228;C0549183;C0876920;C2347635;C2348144;C2939193;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1442488,true;true;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,10150/22402
baseline focal seizure frequency / $nmbr$ days  median ( q $nmbr$ - q $nmbr$ ),C0168634;C0751495;C0376249;C0439228;C0549183;C0876920;C2347635;C2348144;C2939193;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1442488,true;true;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,10151/22402
thiazide diuretics,C0012802,true,10152/22402
thiazide diuretic,C0012802;C3536861,true;false,10153/22402
diabetes present $nmbr$ ( $nmbr$ . $nmbr$ ),C0011847;C0150312;C0449450;C0011849,false;false;false;true,10154/22402
diabetes absent $nmbr$ ( $nmbr$ . $nmbr$ ),C0011847;C0011849,false;true,10155/22402
baseline medication,C0168634;C0013227;C3244316;C4284232;C1442488,true;true;false;false;false,10156/22402
baseline cv medications,C0168634;C3538987;C0013227;C0802604;C2598133;C4284232;C4048877;C4318503;C1442488,true;false;true;false;false;false;true;false;false,10157/22402
baseline medications,C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,10158/22402
calcium aniagonisi,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,10159/22402
calcium antagonist,C0006684,true,10160/22402
calcium antagonists,C0006684,true,10161/22402
at qualifying event,C1514624;C0441471;C4019010,false;false;false,10162/22402
qualifying event,C1514624;C0441471;C4019010,false;false;false,10163/22402
$nmbr$ - $nmbr$ . $nmbr$ : obese class ii,C3853263,false,10164/22402
$nmbr$ - $nmbr$ . $nmbr$ : obese class i,C3853264,false,10165/22402
white race — no . ( % ) f,C0007457;C0043157;C0220938,true;true;false,10166/22402
white race — no . ( % ) : t,C0007457;C0043157;C0220938,true;true;false,10167/22402
white race — no . ( % ) :,C0007457;C0043157;C0220938,true;true;false,10168/22402
ileocolon,,,10169/22402
lleocolon,,,10170/22402
tiotropium $nmbr$ mg ( n = $nmbr$,C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10171/22402
tiotropium $nmbr$ mg ( n = $nmbr$ ),C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10172/22402
multi - vessel coronary artery disease,C1299432,false,10173/22402
multivessel coronary artery disease,C0010054;C0010068;C1956346,true;true;true,10174/22402
mean ± sd msdbp  mm hg,C0444504;C2699239;C0439475;C2347634;C2348143,false;false;false;false;false,10175/22402
mean sd mssbp  mm hg,C0444504;C2699239;C0439475;C2347634;C2348143,false;false;false;false;false,10176/22402
mean age  y ( sd ),C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,10177/22402
mean age ( y ) ( sd ),C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,10178/22402
age in $nmbr$ classes,C0001779;C0456387;C1518526;C1705943;C4019422,false;false;false;false;false,10179/22402
egfr in $nmbr$ classes,C1739039;C0456387;C1518526;C1705943;C4019422;C3811844;C3812682,true;false;false;false;false;false;false,10180/22402
heart rate  bpm,C0018810,true,10181/22402
heart rate — bpm,C0018810,true,10182/22402
heart rate ( bpm ),C0018810,true,10183/22402
biguanide ( metformin ),C0005382;C0025598;C3537187;C4317165,true;true;false;false,10184/22402
biguanides ( metformin ),C0005382;C0025598;C0360396;C3540012,true;true;false;false,10185/22402
naive : no,,,10186/22402
naive : yes,C1549445;C1705108;C1710701,false;false;false,10187/22402
no steroids ( n = $nmbr$ vs $nmbr$ ),C0038317,true,10188/22402
steroids ( n = $nmbr$ vs $nmbr$ ),C0038317,true,10189/22402
secondary ' outcomes,C0027627;C1274040;C0175668;C0205436,true;false;false;false,10190/22402
secondary outcomes,C0027627;C1274040;C0175668;C0205436,true;false;false;false,10191/22402
clopidogrel,C0070166,true,10192/22402
clopiodogrel,,,10193/22402
antiplatelet - onl group ( n = $nmbr$ ),C0441848,false,10194/22402
antiplatelet - only group ( n = $nmbr$ ),C0205171;C0441848;C1720467,false;false;false,10195/22402
myopathyt,,,10196/22402
myopathy,C0026848,true,10197/22402
baseline hdl - c in $nmbr$ classes,C0168634;C3715113;C0456387;C1518526;C1705943;C4019422;C1442488,true;false;false;false;false;false;false,10198/22402
baseline trl - c in $nmbr$ classes,C0168634;C0456387;C1518526;C1705943;C4019422;C1442488,true;false;false;false;false;false,10199/22402
with diabetes,C0011847;C0011849,false;true,10200/22402
without diabetes,C0011847;C0011849,false;true,10201/22402
treated vessel,C1522326;C0005847,false;true,10202/22402
treated vessel !,C1522326;C0005847,false;true,10203/22402
estimated glomerular filtration rate - ml / min / $nmbr$ . $nmbr$ m $nmbr$ tt,C3811844;C0439445;C0369637;C1452561;C4554543;C0441923,false;false;false;true;false;false,10204/22402
estimated glomerular filtration rate ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C3811844;C0439445;C0369637;C0441923,false;false;false;false,10205/22402
inferior or posterior,C0542339;C0678975,false;false,10206/22402
inferior / posterior,C0542339;C0205095;C0678975,false;false;false,10207/22402
weight > $nmbr$ kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,10208/22402
weight < $nmbr$ kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,10209/22402
systolic ( mean  sd ),C0039155;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,10210/22402
diastolic ( mean  sd ),C0012000;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,10211/22402
tertile $nmbr$ ( > $nmbr$ . $nmbr$ pg / ml ) n - $nmbr$,C0439297,false,10212/22402
tertile $nmbr$ ( < $nmbr$ . $nmbr$ ng / ml ) n - $nmbr$,C0439275,false,10213/22402
patients with egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ at baseline,C0030705;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;true;false;false;false;false;false,10214/22402
patients with egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ at baseline,C0030705;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;true;false;false;false;false;false,10215/22402
baseline hba $nmbr$ c > $nmbr$ . $nmbr$ %,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,10216/22402
baseline hba $nmbr$ c < $nmbr$ . $nmbr$ %,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,10217/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ % f,C0016327,true,10218/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ % t,C2603360,false,10219/22402
number of stents,C0237753;C0038257;C0449788,false;true;false,10220/22402
number of patients,C2360800,false,10221/22402
tjc ( $nmbr$ joints )  mean ( sd ),C0022417;C0444504;C2699239;C2347634;C2348143;C0392905,true;false;false;false;false;false,10222/22402
sjc ( $nmbr$ joints )  mean ( sd ),C0022417;C0444504;C2699239;C2347634;C2348143;C0392905,true;false;false;false;false;false,10223/22402
body mass index  median ( iqr ) b,C0005893;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;true,10224/22402
body mass index  median ( iqr ),C0005893;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;true,10225/22402
all other,,,10226/22402
all others,C1955473;C3539125,false;false,10227/22402
secondary *,C0027627;C0175668;C0205436,true;false;false,10228/22402
secondary pci,C0027627;C4049621;C0175668;C0205436,true;false;false;false,10229/22402
no . of prior aeds  n ( % ),C0332152;C0180309;C2826257,false;true;false,10230/22402
no . of prior aeds  c n ( % ),C0332152;C0180309;C2826257,false;true;false,10231/22402
( mean change  $nmbr$ % ci ),C0444504;C0392747;C0008107;C3259781;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,10232/22402
( mean % change  $nmbr$ % ci ),C0444504;C0392747;C0008107;C3259781;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,10233/22402
hazard ratiof,C0598697,false,10234/22402
hazard ratio,C2985465,false,10235/22402
prior myocardial infarction yes,C0155668;C1549445;C1705108;C1710701,false;false;false;false,10236/22402
prior myocardial infarction  %,C0155668,false,10237/22402
dpp - $nmbr$ inhibitor,C1414174;C1999216,false;false,10238/22402
dpp - $nmbr$ inhibitors,C1414174;C0243077,false;true,10239/22402
ldl - c / hdl - c ratio,C0428621,false,10240/22402
ldl - c : hdl - c ratio,C0428621,false,10241/22402
modified has - bled $ $nmbr$,C0392747;C3889737,false;false,10242/22402
modified has - bled < $nmbr$,C0392747;C3889737,false;false,10243/22402
subgroup,C1079230;C1515021,false;false,10244/22402
subgroups,C1079230,false,10245/22402
old stroke *,C1536121,false,10246/22402
new stroke *,C0205314;C0038454;C4554100,false;true;false,10247/22402
low risk,C3272281;C3538919,false;false,10248/22402
lower risk,C3272281;C3538919,false;false,10249/22402
high - intensity statin,C4081854;C0360714,false;true,10250/22402
high - intensity statin *,C4081854;C0360714,false;true,10251/22402
no high - intensity statin,C4081854;C0360714,false;true,10252/22402
smoker  ! n ( % ),C0337664,true,10253/22402
smokers  n ( % ),C0337664,true,10254/22402
ics use yes / no  %,C0815320;C4551720,false;true,10255/22402
ics use  yes / no %,C0815320;C4551720,false;true,10256/22402
ics use  yes / no  %,C0815320;C4551720,false;true,10257/22402
present smokerc,C0150312;C0449450,false;false,10258/22402
present smoker,C0150312;C0337664;C0449450,false;true;false,10259/22402
p - value ( int ),C1709380;C3272375,false;false,10260/22402
p value ( int ),C1709380;C3272375,false;false,10261/22402
alteplase,C0032143,true,10262/22402
reteplase,C0256103,true,10263/22402
western europe / australia,C0043128;C0015176;C0043129;C0004340,true;true;true;true,10264/22402
western europe and australia,C0043129,true,10265/22402
geographical region,C0017446,true,10266/22402
geographic region,C0017446,true,10267/22402
tiotropium $nmbr$ mg respimat ® ( n z $nmbr$ ),C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10268/22402
tiotropium $nmbr$ mg respimat ® ( n = $nmbr$ ),C0213771;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10269/22402
body - mass index > $nmbr$  n ( % ),C0005893;C0578022;C1305855,false;false;true,10270/22402
body mass index > $nmbr$  n ( % ),C0005893;C0578022;C1305855,false;false;true,10271/22402
pbo + mtx n = $nmbr$,C0031962;C0025677;C1417487,true;true;false,10272/22402
czp + mtx n = $nmbr$,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,10273/22402
ef < $nmbr$ % hfref ( n = $nmbr$  $nmbr$ % ),,,10274/22402
ef > $nmbr$ % hfpef ( n = $nmbr$  $nmbr$ % ),,,10275/22402
macroalbuminuria at baseline ( $nmbr$ % of patients treated ),C0168634;C0030705;C1442488,true;true;false,10276/22402
microalbuminuria at baseline ( $nmbr$ % of patients treated ),C0730345;C0168634;C0030705;C1442488,false;true;true;false,10277/22402
any coronary artery disease,C0010054;C0010068;C1956346,true;true;true,10278/22402
only coronary artery disease,C0205171;C0010054;C0010068;C1956346;C1720467,false;true;true;true;false,10279/22402
estimated gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,10280/22402
estimated gfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,10281/22402
female patients  n ( % ),C0150905,false,10282/22402
male patients  n ( % ),C0150904,false,10283/22402
history  pack - years,C0019664;C1277691;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,10284/22402
history ( pack - years ),C0019664;C1277691;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,10285/22402
duration of diabetes > $nmbr$ years,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,10286/22402
duration of diabetes < $nmbr$ years,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,10287/22402
structural heart disease §,C1290384,false,10288/22402
structural heart disease,C1290384,false,10289/22402
no family history of chd ( n = $nmbr$  $nmbr$ ),C0241889;C0280604;C3542407,true;false;false,10290/22402
family history of chd ( n = $nmbr$  $nmbr$ ),C0241889;C0280604;C3542407,true;false;false,10291/22402
subcortical wml load diameter  mm  mean ( sd ),C0815275;C1550025;C0552409;C4330985;C2699239;C4554674;C1704782;C1708715,false;false;false;false;false;false;false;false,10292/22402
subcortical wml load diameter  mm   mean ( sd ),C0815275;C1550025;C0552409;C4330985;C2699239;C4554674;C1704782;C1708715,false;false;false;false;false;false;false;false,10293/22402
etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . . ( . % . . ) . . . . . . . . . . .,C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10294/22402
etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . .,C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10295/22402
glycoprotein iib / iiia inhibitor,C0016011;C1999216,true;false,10296/22402
glycoprotein iib / iiia inhibitors,C0016011;C0243077,true;true,10297/22402
with acei / arb,C3888198,false,10298/22402
without acei / arb,C3888198,false,10299/22402
corticosteroid or immunosuppressant,C0001617;C3536709,true;false,10300/22402
corticosteroids and immunosuppressants,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,10301/22402
corticosteroid and immunosuppressant,C0001617;C3536709,true;false,10302/22402
egfr < $nmbr$ ml / min,C1739039;C0439445;C3811844;C3812682,true;false;false;false,10303/22402
egfr > $nmbr$ ml / min,C1739039;C0439445;C3811844;C3812682,true;false;false;false,10304/22402
st - segment — elevation myocardial infarction,C1536220,true,10305/22402
st - segment elevation myocardial infarction,C1536220,true,10306/22402
patients with psoriasis ( n = $nmbr$ ),C0030705;C0033860,true;true,10307/22402
patients without psoriasis ( n = $nmbr$ ),C0030705;C0033860,true;true,10308/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ mz,C1739039;C0439445;C0026655;C1705291;C3811844;C3812682,true;false;true;false;false;false,10309/22402
egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ mz,C1739039;C0439445;C0026655;C1705291;C3811844;C3812682,true;false;true;false;false;false,10310/22402
age > $nmbr$ years ( median ),C1510829,false,10311/22402
age < $nmbr$ years ( median ),C1510829,false,10312/22402
no . pts,C1419129;C2698747,false;false,10313/22402
no . men,C0025266,true,10314/22402
$nmbr$ mg qw $nmbr$ . $nmbr$ pt yrs,C0024671;C0043011;C0032743;C0699718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,10315/22402
$nmbr$ mg biw $nmbr$ . $nmbr$ pt yrs,C0024671;C0032743;C0699718;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,10316/22402
fasting plasma glucose ( mg / dl ),C0015663;C0202042;C0439269;C0455280,true;false;false;false,10317/22402
fasting plasma glucose — mg / dl,C0015663;C0202042;C0439269;C0455280,true;false;false;false,10318/22402
antidiabetic medications,C0935929,true,10319/22402
antidiabetic medication,C0935929,true,10320/22402
ldl - c ( median  iqr )  mg / dl,C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10321/22402
hdl - c ( median  iqr )  mg / dl,C3715113;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,10322/22402
nonischemic cardiomyopathy,C0878544,true,10323/22402
ischaemic cardiomyopathy,C0349782,false,10324/22402
ischemic cardiomyopathy,C0349782,false,10325/22402
no ilb / iiia inhibitors,C4697913;C0243077,false;true,10326/22402
ilb / iiia inhibitors,C4697913;C0243077,false;true,10327/22402
nontatal ml,C0439526;C1705224;C3887665,false;false;false,10328/22402
nonfatal ml,C0439526;C1705224;C3887665,false;false;false,10329/22402
no of events women men *,C0441471;C0043210;C0025266;C3541888,false;true;true;false,10330/22402
no of events womenmen *,C0441471;C3541888,false;false,10331/22402
demographic features,C0683970,false,10332/22402
demographic feature,C0683970,false,10333/22402
non - epa ( n = $nmbr$ ),C1518422,false,10334/22402
non - us ( n = $nmbr$ ),C1518422,false,10335/22402
heart failure *,C0018801;C0018802;C4554158,true;true;false,10336/22402
heart failure,C0018801;C0018802;C4554158,true;true;false,10337/22402
heart failurea,C0018787,true,10338/22402
acetylsalicylic acid,C0004057,true,10339/22402
acetyl - salicylic acid,C0004057,true,10340/22402
difference ( % ),C1705241;C1705242,false;false,10341/22402
difference ( se ),C1705241;C0036919;C1705242,false;true;false,10342/22402
exercise > once weekly,C0015259;C1522704,true;false,10343/22402
exercise > once weekly ?,C0015259;C1522704,true;false,10344/22402
$nmbr$ - $nmbr$ days ( % ),C0439228,false,10345/22402
$nmbr$ - $nmbr$ yr ( % ),C0439234,false,10346/22402
number stent > $nmbr$,C0237753;C0038257;C0449788,false;true;false,10347/22402
number ste  t > $nmbr$,C0237753;C1420459;C3811127;C0449788,false;false;false;false,10348/22402
most common concomitant aeds  d n ( % ),C0205393;C0205214;C0521115;C0180309;C1522138;C3245511,false;false;false;true;false;false,10349/22402
most common concomitant aeds  n ( % ),C0205393;C0205214;C0521115;C0180309;C1522138;C3245511,false;false;false;true;false;false,10350/22402
> $nmbr$ % to < $nmbr$ % ( > $nmbr$ to $nmbr$ mmol / mol ),C0040363;C3829066;C0041260;C1883351,true;false;true;false,10351/22402
> $nmbr$ % to < $nmbr$ % ( > $nmbr$ to < $nmbr$ mmol / mol ),C0040363;C3829066;C0041260;C1883351,true;false;true;false,10352/22402
baricitinib $nmbr$ mg ( n = $nmbr$ ),C4044947;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10353/22402
baricitinib $nmbr$ mg qd ( n = $nmbr$ ),C4044947;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,10354/22402
alcohol consumption,C0001948,true,10355/22402
alcohol consumption !,C0001948,true,10356/22402
sri response  %,C1420401;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,10357/22402
acr response  %,C1412134;C0871261;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false,10358/22402
endpoint / baseline,C2349179;C0168634;C1442488;C2826544,false;true;false;false,10359/22402
endpoint / baselinec,C2349179;C2826544,false;false,10360/22402
ranozaline,,,10361/22402
ranolazine,C0073633,true,10362/22402
left anterior descending coronary artery,C0226032,false,10363/22402
l eft anterior descending coronary artery,C0439394;C0451214;C0226032;C1706495;C3642217,false;false;false;false;false,10364/22402
renal subgroup,C0022646;C1079230;C1515021,true;false;false,10365/22402
female subgroup,C0043210;C1079230;C1515021;C0086287;C1705497;C1705498,true;false;false;true;false;false,10366/22402
ss < $nmbr$ ( n = $nmbr$ vs $nmbr$ ),C2699257;C3891295;C4551874,false;false;false,10367/22402
ss > $nmbr$ ( n = $nmbr$ vs $nmbr$ ),C2699257;C3891295;C4551874,false;false;false,10368/22402
transient ischemic attack,C0007787;C0917805,true;true,10369/22402
transient ischaemic attack,C0007787;C0917805,true;true,10370/22402
$nmbr$ mg ew n = $nmbr$,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10371/22402
$nmbr$ mg eow n = $nmbr$,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10372/22402
phgada ( mm ),C4330985;C4554674,false;false,10373/22402
ptgada ( mm ),C4330985;C4554674,false;false,10374/22402
patient ' s assessment of pain !,C0679830;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;true;true,10375/22402
patient ' s assessment of pain,C0679830;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;true;true,10376/22402
lama ( only monotherapy ),C0999593;C0205171;C1720467;C1416775,false;false;false;false,10377/22402
laba ( only monotherapy ),C0205171;C1720467,false;false,10378/22402
insulin glargine ( n = $nmbr$ ),C0907402,true,10379/22402
insulin glargine ( n = $nmbr$ ll ),C0907402,true,10380/22402
secukinumab  $nmbr$ mg ( n = $nmbr$ ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10381/22402
secukinumab $nmbr$ mg ( n = $nmbr$ ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,10382/22402
paroxysmal,C0205311,false,10383/22402
paroxysmal af,C0235480,true,10384/22402
history of major microvascular disease — no . ( % ),C0683519;C0205082;C0443258;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false;false,10385/22402
history of major macrovascular disease — no . ( % ),C0683519;C0205082;C0205164;C4318856;C4521762;C0730226;C0850708;C0944983,false;false;false;false;false;false;false;false,10386/22402
non - hdl cholesterol,C0729627;C1535899,false;false,10387/22402
non - hdl choleslerol,C1518422;C3715113,false;false,10388/22402
insulin treated,C0021641;C1533581;C1579433;C3714501,true;false;false;false,10389/22402
insulin - treated,C0021641;C1533581;C1579433;C3714501,true;false;false;false,10390/22402
msdbp  mmhg ( sd ),C0439475;C2699239,false;false,10391/22402
mssbp  mmhg ( sd ),C0439475;C2699239,false;false,10392/22402
no prior statin ( n = $nmbr$  $nmbr$ ),C0332152;C0360714;C2826257,false;true;false,10393/22402
prior statin ( n = $nmbr$  $nmbr$ ),C0332152;C0360714;C2826257,false;true;false,10394/22402
fev $nmbr$ ( liters ),C3714541;C0475211,true;false,10395/22402
fev $nmbr$ — liters,C3714541;C0475211,true;false,10396/22402
systolic,C0039155,true,10397/22402
diastolic,C0012000,true,10398/22402
czp + mtx ^ mtx,C0054841;C0025677;C1417487;C1861828;C1872109,true;true;false;true;true,10399/22402
pbo + mtx ^ mtx,C0031962;C0025677;C1417487,true;true;false,10400/22402
history of paroxysmal af,C0019664;C0235480;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,10401/22402
no history of paroxysmal af,C0019664;C0235480;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,10402/22402
stage $nmbr$ : > = $nmbr$,C0205390;C1300072;C1306673,false;false;false,10403/22402
stage $nmbr$ : < $nmbr$,C0205390;C1300072;C1306673,false;false;false,10404/22402
ato $nmbr$ mg and sim $nmbr$ ^ $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10405/22402
ato $nmbr$ mg and sim $nmbr$ - $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10406/22402
- - week $nmbr$ - -,C0332174;C0439230,false;false,10407/22402
- < — ■ bb — - ►,C0004739;C0332297,true;false,10408/22402
- hdl cholesterol,C0023822;C0392885,true;false,10409/22402
- ldl cholesterol,C0023824;C0202117,true;false,10410/22402
- median fasting serum glucose ( mg / dl ) ( iqr ),C0549183;C0015663;C0202041;C0439269;C3534430;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,10411/22402
- median pulse pressure ( mm hg ) ( iqr ),C0549183;C0949236;C0439475;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,10412/22402
- median tg ( iqr ),C0549183;C0337445;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10413/22402
- median urine acr ( mg / g ) ( iqr ),C0549183;C0042036;C1412134;C1300563;C1515941;C0042037;C2963137;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;true;false;false;false;false;false,10414/22402
- recurrent vte during overall study period,C1455761;C0630906;C0282416;C0557651;C0439531;C1948053;C2603343;C1561607;C2945760,false;true;true;false;false;false;false;false;false,10415/22402
- triglycerides,C0041004,true,10416/22402
- [ the null hypothesis is that there are no differences among subgroups  for age and time since randomization  the inter -,C4684719;C1079230;C0001779,false;false;false,10417/22402
- ° - $nmbr$  wom -,,,10418/22402
- $nmbr$ - $nmbr$ ( - $nmbr$ - $nmbr$ too $nmbr$ ),,,10419/22402
- $nmbr$ - $nmbr$ ( $nmbr$ % cl - $nmbr$ - $nmbr$ to - $nmbr$ - $nmbr$ ),C0596019,false,10420/22402
- $nmbr$ . $nmbr$ ( $nmbr$ % ci : - $nmbr$ . $nmbr$  - $nmbr$ . $nmbr$  n = $nmbr$ ),C0008107;C3259781,true;false,10421/22402
- $nmbr$ . $nmbr$ ( $nmbr$ % ci : - $nmbr$ . $nmbr$  - $nmbr$ . $nmbr$  n = $nmbr$ ) a - $nmbr$ . $nmbr$ %  * p = $nmbr$ . $nmbr$,C0008107;C3259781,true;false,10422/22402
- $nmbr$ placebo,C0032042;C1696465;C1706408,true;false;false,10423/22402
- $nmbr$ < flex fn f - score,C1570610;C0016327;C0449820;C4050231,true;true;false;false,10424/22402
- $nmbr$ . $nmbr$ < ls t - score,C0023668;C0449820;C4050231,true;false;false,10425/22402
- $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$  - c ) . $nmbr$ r,C0722969,false,10426/22402
- $nmbr$ . $nmbr$ < flex fn f - score < - $nmbr$,C1570610;C0016327;C0449820;C4050231,true;true;false;false,10427/22402
- $nmbr$ . $nmbr$ < ls t - score < — $nmbr$ . $nmbr$,C0023668;C0449820;C4050231,true;false;false,10428/22402
- $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) * ll,,,10429/22402
- $nmbr$ . $nmbr$ ± lno ^,,,10430/22402
- $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ § ti,C0039247;C0040302;C1553045;C1704756,true;true;false;false,10431/22402
- $nmbr$ . $nmbr$ ( $nmbr$ % ci : - $nmbr$ . $nmbr$  - $nmbr$ . $nmbr$  n = $nmbr$ ) * p = $nmbr$ . $nmbr$,C0008107;C3259781,true;false,10432/22402
- $nmbr$ . $nmbr$ to - $nmbr$ cm,,,10433/22402
- $nmbr$ - $nmbr$ ( $nmbr$ % cl - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ ),C0596019,false,10434/22402
- b - i -,C0021966;C0221138,true;false,10435/22402
- b - i —,C0021966;C0221138,true;false,10436/22402
- bi -,,,10437/22402
- f $nmbr$ . $nmbr$ ( - i - $nmbr$ . $nmbr$ ),C0016327;C0021966;C0221138,true;true;false,10438/22402
- major bleed,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,10439/22402
- o - oo $nmbr$ ( - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ ),C0483204,false,10440/22402
- o . os,C2673162,false,10441/22402
- o $nmbr$ o ( - $nmbr$ - loto - $nmbr$ - $nmbr$ ),C0483204,false,10442/22402
- oil,C0028908;C0032085;C1517288;C3541397,true;true;false;false,10443/22402
— no . ( % ),,,10444/22402
— $nmbr$ . $nmbr$ < fn t - score,C1570610;C0449820;C4050231,true;false;false,10445/22402
— $nmbr$ . $nmbr$ < fn t - score < — $nmbr$ . $nmbr$,C1570610;C0449820;C4050231,true;false;false,10446/22402
— b - h —,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,10447/22402
! amlodipine,C0051696,true,10448/22402
# pts,C1419129;C2698747,false;false,10449/22402
# $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10450/22402
$ race was determined by the investigator during the patient ' s interview .,C0034510;C1706779;C3853635,true;false;false,10451/22402
% - point difference ( $nmbr$ % ci ) c,C1552961;C1705241;C0008107;C3259781;C1705242;C2347617;C3714763,false;false;true;false;false;false;false,10452/22402
% \mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,10453/22402
% asthma control days {  #,C0004096;C0243148;C0439228;C1550141;C1882979;C2587213;C3274648;C4553389;C2984299,true;true;false;false;false;false;false;false;false,10454/22402
% bronchial reversibility ( sd ),C0205039;C0449261;C2699239;C1442216,false;false;false;false,10455/22402
% change ( mean ± se ),C0392747;C0444504;C0036919;C2347634;C2348143;C0443172;C1705241;C4319952,false;false;true;false;false;false;false;false,10456/22402
% change ( meanlse ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,10457/22402
% change ( meantse ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,10458/22402
% change ( median  q $nmbr$  q $nmbr$ ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,10459/22402
% change from baseline to week $nmbr$,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,10460/22402
% fhg,,,10461/22402
% hba $nmbr$ c ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,10462/22402
% improvement in dactylitis score at week $nmbr$  n,C2986411;C0239161;C0449820;C4050231,false;false;false;false,10463/22402
% improvement in enthesitis score at week $nmbr$  n,C2986411;C1282952;C0449820;C4050231,false;false;false;false,10464/22402
% of patients $nmbr$ . $nmbr$ $nmbr$ . $nmbr$,C0030705,true,10465/22402
% of predicted,C0681842;C1882327,false;false,10466/22402
% patients,C0030705,true,10467/22402
% phg,,,10468/22402
% predicted fev,C0681842;C3714541;C1882327,false;true;false,10469/22402
% predicted fev ^,C0681842;C3714541;C1882327,false;true;false,10470/22402
% predicted fev $nmbr$,C0681842;C3714541;C1882327,false;true;false,10471/22402
% predicted post - bronchodilator fev  ( sd ) ml,C0681842;C1882327,false;false,10472/22402
% predicted post - bronchodilator fev $nmbr$  mean ( sd )  l,C0681842;C1882327,false;false,10473/22402
% predicted pre - bd,C0681842;C0332152;C0005126;C2344255;C4050145;C0740175;C2257086;C3669034;C1882327,false;false;true;false;false;false;false;false;false,10474/22402
% predicted prebronchodilator fev $nmbr$  mean ( sd )  l,C0681842;C2599602;C3714541;C0444504;C2699239;C2347634;C2348143;C1882327,false;false;true;false;false;false;false;false,10475/22402
% predicted value ( sd ),C0681842;C1522609;C2699239;C1882327,false;false;false;false,10476/22402
% reduction,C0301630;C0392756;C1293152;C4551656,false;false;false;false,10477/22402
% reversibility,C0449261,false,10478/22402
% reversibility in fev ^ at,C0449261;C3714541,false;true,10479/22402
% risk reduction ( $nmbr$ % cl ),C1137094;C0596019,true;false,10480/22402
% stenosis ( core lab ),C0678234;C4684837;C1261287;C2632116,false;false;true;false,10481/22402
% stenosis ( investigator ),C0678234;C0035173;C1261287;C2632116,false;true;true;false,10482/22402
% to goal,C0018017;C1571704,true;false,10483/22402
% / year,C0439234;C0439508,false;false,10484/22402
% / yr,C0439234,false,10485/22402
& median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10486/22402
( $ $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C0439445;C0369637;C0441923,false;false;false,10487/22402
( % of group ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,10488/22402
( % of target ) ∗,C1521840;C2986546,false;false,10489/22402
( % )  $nmbr$ mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,10490/22402
(  $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C0439445;C0369637;C0441923,false;false;false,10491/22402
( : > blockers,,,10492/22402
( _ > $nmbr$ . $nmbr$ mmol / l ) hdl - c women : < $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l ) men : < $nmbr$ mg / dl,C3898312;C3715113;C0043210;C3539687;C0025266,false;false;true;false;true,10493/22402
( < $nmbr$ . $nmbr$ mmol / l ),C1532563,false,10494/22402
( < $nmbr$ mg / l ),C0439268,false,10495/22402
( < $nmbr$ ml / minute ) *,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,10496/22402
( ≥ $nmbr$ mg / l ),C0439268,false,10497/22402
( $nmbr$ patients ),C0030705,true,10498/22402
( $nmbr$ subjects ),C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,10499/22402
( $nmbr$ - blocker,,,10500/22402
( $nmbr$ - sitosterol ( p . mol / l ),C0037215;C0347982;C0220914,true;false;true,10501/22402
( $nmbr$ - $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C0439445;C0369637;C0441923,false;false;false,10502/22402
( $nmbr$ . $nmbr$ % )  values were not collected for $nmbr$ patients ( $nmbr$ . $nmbr$ % ) who were enrolled,C0042295,false,10503/22402
( $nmbr$ % ci ) a,C0008107;C3259781,true;false,10504/22402
( $nmbr$ % ci ) b,C0008107;C3259781,true;false,10505/22402
( $nmbr$ % ci ) c,C0008107;C3259781,true;false,10506/22402
( a ) aza treatment ( ref ),C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,10507/22402
( a ) bmi subgroups,C0578022;C1079230,false;false,10508/22402
( b ) age subgroups,C1304659;C0001779,false;false,10509/22402
( b ) aza treatment ( ref ),C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,10510/22402
( c ) ' ' kza treatment ( ref ),C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,10511/22402
( cells per pl ) t,C0007584;C3897966;C4049765;C0007634,true;false;false;true,10512/22402
( cm ),,,10513/22402
( composite endpoint ),C0205199;C2349179;C2826544;C1547335,false;false;false;false,10514/22402
( d ) aza treatment ( ref ),C0073187;C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0332173;C4484261,true;true;true;false;true;false;false;false;false;false;false;false,10515/22402
( e ) aza treatment ( ref ),C0004482;C0039798;C1425988;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,10516/22402
( fxs ),C0016667,true,10517/22402
( id,C0009450;C0600091;C1441613,true;false;false,10518/22402
( incl . uncertain ),C0268281;C1418854,true;false,10519/22402
( including hypertension ),C0332257,false,10520/22402
( interquartile range ) ( mm ),C1711350;C4330985;C4554674,false;false;false,10521/22402
( iqr ),,,10522/22402
( iqr ) — days,C0439228,false,10523/22402
( l ) t,C0439394;C1706495;C3642217,false;false;false,10524/22402
( mean + . sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,10525/22402
( mean ± sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,10526/22402
( median  h ),C0549183;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,10527/22402
( mg / dl ± sd ),C0439269;C2699239,false;false,10528/22402
( mg / dl ),C0439269,false,10529/22402
( min ) *,C0702093;C1524029;C3813700,false;false;false,10530/22402
( minimum - maximum ) focal seizure fre - quency / $nmbr$ days at baseline,C1524031;C0806909;C0751495;C1414819;C0439228;C0168634;C1442488;C1552615;C2826546;C1552614;C2826545,false;false;true;false;false;true;false;false;false;false;false,10531/22402
( mmol / l ),C1532563,false,10532/22402
( mu / l $ mmol / l ) b,C0439342;C0439190,false;false,10533/22402
( n = $nmbr$ ) ( n = $nmbr$ ),C0369718;C0441922,false;false,10534/22402
( n = $nmbr$ )  ' ( n = $nmbr$ ),C0369718;C0441922,false;false,10535/22402
( n = $nmbr$ l $nmbr$ ),C0369718;C0441922,false;false,10536/22402
( n = l $nmbr$ ),C0369718;C0441922,false;false,10537/22402
( ne  ne ),C0027608;C0028219;C3538705,true;true;false,10538/22402
( ngml ' ' ) total mean ipss score,C2964552;C0444504;C1019118;C1998280;C2827405;C3811063;C2347634;C2348143;C0439175;C3533236;C0439810,false;false;false;false;false;false;false;false;false;false;false,10539/22402
( nyha grade iii or iv ),C1275491;C0205617;C0450094;C0475271;C0687697;C3889290;C4050000;C4283820;C4283821;C4283822,false;false;false;false;false;false;false;false;false;false,10540/22402
( ofl ),,,10541/22402
( phase $nmbr$ dose - finding trial ),C0205390;C0178602;C0037088;C0008976;C0243095;C2825141;C0869039;C1114758;C1710475,false;false;true;true;false;false;false;false;false,10542/22402
( points ),C1552961;C2347617;C3714763,false;false;false,10543/22402
( range ),C1514721;C2348147;C3542016,false;false;false,10544/22402
( ref ),C1425988,false,10545/22402
( scale diabetes ),C0175659;C0011847;C0011849;C0349674;C1947916,true;false;true;false;false,10546/22402
( scale obesity and prediabetes ),C0175659;C0028754;C1963185;C0349674;C1947916,true;true;false;false;false,10547/22402
( sd ),C2699239,false,10548/22402
( sd ) l / min acq - $nmbr$ score  mean ( sd ),C2699239;C0702093;C2919686;C0449820;C0444504;C2347634;C2348143;C4050231;C1524029;C3813700,false;false;false;false;false;false;false;false;false;false,10549/22402
( se ),C0036919,true,10550/22402
( subgroup ),C1079230;C1515021,false;false,10551/22402
( tiotropium n = $nmbr$  placebo n,C0213771;C0032042;C1696465;C1706408,true;true;false;false,10552/22402
( tiotropium n = $nmbr$  placebo n =,C0213771;C0032042;C1696465;C1706408,true;true;false;false,10553/22402
( tiotropium n = $nmbr$ non - tiotropium n = $nmbr$ ),C0213771;C1518422,true;false,10554/22402
( tiotropium n = $nmbr$ non - tiotropium n = $nmbr$ $nmbr$,C0213771;C1518422,true;false,10555/22402
( total ses - cd score at,C2964552;C0007928;C0034283;C4552032,false;true;true;false,10556/22402
( week ),C0332174;C0439230,false;false,10557/22402
( women only ),C0043210;C0205171;C1720467,true;false;false,10558/22402
( years ),C0439234,false,10559/22402
( yes / no ),C1512698,false,10560/22402
* data are expr,C1511726;C3245479;C3714741,false;false;false,10561/22402
* eligibility risk factors  n ( % ) *,C0013893;C0035648;C1553898;C1548635,true;true;false;false,10562/22402
* hypercholesterolemia was defined as a low - density lipoprotein cholesterol level at enrollment of more than $nmbr$ mg per deciliter ( $nmbr$ . $nmbr$ mmol per liter ) after an overnight fast . † nonsustained ventricular tachycardia was defined as $nmbr$ or more consecutive ventricular beats at a heart rate of more than $nmbr$ beats per minute . ‡ to convert weight to kilograms  divide by $nmbr$ . $nmbr$ . § to convert values for creatinine to micromoles per liter  multiply by $nmbr$ . $nmbr$ . ¶ data for follow - up medication were available for $nmbr$ patients ( amiodarone  $nmbr$  placebo  $nmbr$  and icd  $nmbr$ ) . ace de - notes angiotensin - converting enzyme  and arb angiotensin ii – receptor blocker . ¿ p < $nmbr$ . $nmbr$ for the comparison among the groups,C0020443;C1522133;C0441889;C1516879;C1696073;C3888021;C0456079;C1547707;C2946261;C0475211;C0439583;C0015663;C0750194;C2919575;C0456962;C2985769;C1704788;C3539106;C0871208;C1521828;C0439209;C0439300;C1719797;C2911648;C1316572;C1317574;C0369773;C1707455;C2603361,true;false;false;false;false;false;false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,10563/22402
* non - black *,C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,10564/22402
* nonfatal ml,C0439526;C1705224;C3887665,false;false;false,10565/22402
* patient characterization data are reproduced from morrow et al . ( $nmbr$ ) .,C2707520;C1880022,false;false,10566/22402
* plus - minus values are means 士 sd . race or ethnic group was self - determined . the body - mass index is the weight in kilograms divided by,C0332288;C0042295;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0005910;C0439209;C0043100;C1305866;C1705104,false;false;false;false;true;false;false;false;true;false;true;false;false,10567/22402
* plus - minus values are means ± sd . there were no significant differences ( at,C0332288;C0042295,false;false,10568/22402
* plus – minus values are means ± sd . percentages may not total $nmbr$ because of rounding . the body - mass index is the weight in kilograms divided by the square of the height in meters . to convert the values for creatinine to micromoles per liter  multiply by $nmbr$ . $nmbr$ . ace denotes angiotensin - converting enzyme  cabg coronary - artery bypass grafting  nt - probnp n - terminal pro - b – type natriuretic peptide  nyha new york heart association  and pci percutaneous coro - nary intervention . † race was reported by the investigators . ‡ one patient in nyha class i was mistakenly included in the placebo group . § this category includes any angina - like symptoms at any time in the past  with no confirmation of diagnosis of coro - nary heart disease required . ¶ possible scores range from $nmbr$ to $nmbr$  with lower scores indicating a better quality of life . ∥ anemia was defined by world health organization criteria as a hemoglobin level of less than $nmbr$ g per deciliter in men and less than $nmbr$ g per deciliter in women . * * nt - probnp levels are influenced by a variety of factors  including age  sex  body - mass index  and renal function . no clinically useful normal range has been established . † † some patients were taking both loop and thiazide diuretics .,C0332288;C0042295;C0439175;C0332490;C0439810;C0005910;C0439209;C0043100;C1305866;C1705104;C0441074;C0475211;C1719797;C1452534;C4284014;C2911648;C0010055;C4284038;C1317554;C0205088;C1292769;C1705314;C1705315;C2825907;C0332307;C1144709;C1275491;C0027976;C0018787;C0004083;C0439849;C0596306;C0699792;C2709270;C3537020;C1547052;C0522523;C0184661;C0034510;C1706779;C3853635;C0886296;C1273869;C0205447;C0030705;C1882084;C0032042;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408;C0040223;C1444637;C4284302;C3541383;C0596672;C0040363;C0441994;C0449820;C1548802;C2003888;C0041260;C1883351;C0376558;C0002871;C1000483;C4554633;C1281911;C0025266;C1317554;C0441889;C2825907;C0001779;C0009253;C0005893;C0578022;C1305855;C0036864;C0079399;C0804628;C1314687;C1522384;C3827682;C0086715;C0445022,false;false;false;false;false;true;false;true;false;false;false;false;false;true;false;false;true;false;false;false;false;false;false;false;false;true;false;true;true;true;false;false;false;false;false;false;false;true;true;false;false;false;false;false;true;false;true;false;false;true;false;false;false;false;false;true;false;false;false;false;true;false;false;false;false;true;false;true;true;false;false;false;true;false;false;false;false;true;false;false;true;true;true;false;false;true;false;true;false,10569/22402
* the p ‐ value is from the test statistic for testing the interaction between the treatment group and diabetes group .,C1709380;C0039593;C0392366,false;false;false,10570/22402
* atherosclerotic coronary heart disease  ischaemic stroke or peripheral arterial disease . † n / n = number of people in phase $nmbr$ studies only . ‡ high ‐ intensity statins were defined as atorvastatin $nmbr$ to $nmbr$ mg  rosuvastatin $nmbr$ to $nmbr$ mg or simvastatin $nmbr$ mg daily .,C0010054;C0018787;C0948008;C0333482;C0010068;C1956346;C0012634;C0237753;C0027361;C0449788;C4081854;C0360714;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;true;true;true;false;true;false;false;true;true;true;false;false;false;false;false,10571/22402
* ci denotes confidence interval .,C0008107;C3259781,true;false,10572/22402
* data are expressed as median ± sd  except,C1511726;C3245479;C3714741,false;false;false,10573/22402
* data are given as percentage of subjects unless otherwise specified . ptca indicates percutaneous transluminal coronary angioplasty  cabg  coronary artery bypass graft  ace  angiotensin - converting enzyme  bmi  body mass index ( calculated as weight in kilograms divided by square of height in meters )  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  fpg  fasting plasma glucose  and fpi  fasting plasma insulin . tto convert cholesterol values to micromoles per liter  multiply by $nmbr$ . $nmbr$ . to convert triglycerides to micromoles per liter  multiply by $nmbr$ . $nmbr$ . to convert fpg to micromoles per liter  multiply by $nmbr$ . $nmbr$ . to convert fpi to picomoles per liter  multiply by $nmbr$ . $nmbr$ .,C1511726;C3245479;C3714741;C0205369;C2936173;C0185098;C0022709;C1305855;C0444686;C0005910;C0043100;C1305866;C1705104;C1441506;C0441074;C0023821;C0023824;C0023824;C0015663;C0202042;C0455280;C0015663;C0857690;C0041061;C0475211;C1719797;C2911648;C1719797;C2911648,false;false;false;false;true;false;true;true;false;true;true;false;false;false;false;true;true;true;true;false;false;true;false;true;false;false;false;false;false,10574/22402
* data reported as n ( % ) or median ( quartiles $nmbr$  $nmbr$ ) .,C1511726;C3245479;C3714741,false;false;false,10575/22402
* determined by investigator to be possibly  probably or definitely related to study drug tmyopathy defined as cpk > $nmbr$ x uln with associated muscle symptoms with no other plausible etiology ^ consecutive defined as two or more measurements at least one week apart or one measurement < $nmbr$ days after the last dose of study drug ( presumed consecutive ) § two patients had incomplete data to assess chd status simva = simvastatin  eze = ezetimibe  ae = adverse event  alt = alanine aminotransferase  ast = aspartate aminotransferase  cpk = creatine phosphokinase  uln = upper limit of normal,C0521095;C0035173;C0439849;C0445223;C0332281;C0026845;C0683368;C1457887;C4083049;C1704788;C0205448;C3539106;C0013175;C1516048;C1266129;C0805162;C1415181;C0010287;C1519815;C3891303;C4553172;C1519815,false;true;false;false;false;true;true;false;false;false;false;false;true;false;false;false;false;true;false;false;false;false,10576/22402
* interquartile range,C1711350,false,10577/22402
* other - europe ( n = $nmbr$ )  australia ( n = $nmbr$ ) and india ( n = $nmbr$ ) - the data from these regions were collapsed due to the small numbers,C0015176;C0004340;C1511726;C0017446;C0205147;C3245479;C3714741;C0237753;C0449788,true;true;false;true;false;false;false;false;false,10578/22402
* p < $nmbr$ . $nmbr$ for eze / simva ( pooled across doses ) vs . simva ( pooled across doses ) for the entire cohort data are presented as least squares mean ± standard error ( † median ± se for tg ) for the entire cohort and also for each selected subgroup simva = simvastatin  eze = ezetimibe  tc = total cholesterol  tg = triglycerides  hdl - c = high - density lipoprotein - cholesterol  non - hdl - c = non - high - density lipoprotein cholesterol  apo = apolipoprotein,C0369773;C2603361;C1709595;C0178602;C2349200;C4522255;C0023189;C0444504;C1710181;C0549183;C0036919;C0337445;C0876920;C2347635;C2348144;C2939193;C2347634;C2348143;C0439751;C0009247;C0599755;C0444667;C0074554;C1142985;C0039411;C0201950;C0337445;C0062152;C0041004;C3715113;C0543421;C0439175;C0023822;C0439810;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C1708438;C0023822;C1518422;C3715113;C0023821;C0729627;C0178587;C0003591;C0008377;C0065055,false;false;false;false;false;false;true;false;false;false;true;false;false;false;false;false;false;false;false;true;false;false;true;true;true;false;false;true;true;false;false;false;true;false;true;true;true;false;false;false;false;true;false;false;true;false;false;true;true;true,10579/22402
* p < $nmbr$ . $nmbr$ for between - treatment difference with same dose of simvastatin for entire cohort data are expressed as least squares mean ± standard error simva = simvastatin  eze = ezetimibe  chd = coronary heart disease,C0369773;C2603361;C0074554;C0439751;C0009247;C1511726;C3245479;C3714741;C0599755;C0444667;C0444504;C1710181;C0074554;C1142985;C0280604;C0018787;C3542407;C2347634;C2348143;C0012634,false;false;true;false;true;false;false;false;false;false;false;false;true;true;false;true;false;false;false;true,10580/22402
* p for heterogeneity of treatment effect between tertiles > $nmbr$ . $nmbr$ .,C0369773;C0019409;C1518681;C0242960;C2603361,false;false;false;true;false,10581/22402
* per $nmbr$ participant years . composite of first occurrence death ( all cause )  nonfatal ml  or nonfatal stroke . cardiovascular death excluding those classified as “ unable to determine . ”,C0679646;C0439234;C0205199;C0205435;C0243132;C0011065;C1306577;C4082313;C4552775;C1554210;C2745955;C1279901;C1547335;C2698741;C4554048;C0015127;C1524003;C0008902;C0566415;C1299582;C4048706;C4321405,false;false;false;false;true;true;false;false;false;false;false;false;false;false;false;true;false;true;false;false;false;false,10582/22402
* rate is number of events per $nmbr$ patient - years of follow - up . fthe p value for number of patients from log - rank  for total number of hospitalizations from permutation test . ^ by treatment comparing the,C0871208;C1521828;C0589120;C1709380;C2360800;C1522577;C1704685;C3274571;C1708728;C0667477;C0439175;C4086639;C0439810;C0699794;C2986775;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;false;false;false;false;false;false;false;false;true;false;false;false;false;false;true;true;false;false;false;false;false,10583/22402
* reported by physicians . † data are median ( iqr ) . all data are mean ( sd ) or number ( % ) unless otherwise indicated .,C1709908;C0031831;C1511726;C3245479;C3714741,false;true;false;false;false,10584/22402
* risk reduction  $nmbr$ percent confidence interval ( ci )  and p value are derived from cox models . for risk reductions  negative numbers indicate an increase in risk . † diabetes and hypertension were defined by clinical history . ‡ a family history was defined as having one or more first - degree relatives with either myocardial infarction or sudden death before the age of $nmbr$ . § hdl cholesterol levels are shown according to the median value ( $nmbr$ . $nmbr$ mg per deciliter [ $nmbr$ . $nmbr$ mmol per liter ] ) . ¶ triglyceride levels are shown according to the median value ( $nmbr$ mg per deciliter [ $nmbr$ . $nmbr$ mmol per liter ] ) . ¿ ldl cholesterol levels are shown according to the median value ( $nmbr$ mg per deciliter [ $nmbr$ . $nmbr$ mmol per liter ] ) and according to the values that divide the subjects into three equal groups ( < $nmbr$  $nmbr$ to $nmbr$  and > $nmbr$ mg per deciliter [ < $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$  and > $nmbr$ . $nmbr$ mmol per liter ] ) .,C1137094;C0439165;C0009667;C0008107;C3259781;C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0205447;C0439190;C0475211;C0428475;C0549183;C1522609;C0567349;C0439241;C2347285;C2348885;C0876920;C2347635;C2348144;C2939193;C0441889;C0439241;C0439190;C0475211;C0332849;C0439241,true;false;true;true;false;false;true;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,10585/22402
* subgroups were defined on the basis of variables assessed before randomization . the lipid levels represent the averages of the values measured four weeks before randomization and those measured at randomization . to convert values for cholesterol to millimoles per liter  multiply by $nmbr$ . $nmbr$  to convert values for triglycerides to millimoles per liter  multiply by $nmbr$ . $nmbr$ . ci denotes confidence interval  ldl low - density lipoprotein  and hdl high - density lipoprotein . tests for heterogeneity of treatment effect were undertaken across each of the subgroups . in addition  we performed tests for interaction between treatment and the following continuous base - line variables : age  total  ldl  and hdl cholesterol  and triglyceride levels . there was no evidence of significant heterogeneity of treat - ment effect in any prespecified subgroup ( p » $nmbr$ . $nmbr$ ) . † data were missing for three patients  two in the placebo group and one in the pravastatin group .,C1079230;C0034656;C0042295;C0034656;C1719797;C2911648;C0475211;C1719797;C0008107;C3259781;C2911648;C0023820;C1518681;C0332287;C1883712;C0231290;C0332282;C0008377;C0019409;C0242960;C1511726;C3245479;C3714741;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;true;false;true;false;false;false;false;true;false;false;true;false;false;false;false;false;true;false;true;false;false;false;false;false;true;false;false;false,10586/22402
* the $nmbr$ substrata with baseline ( bl ) ldl cholesterol $nmbr$ to $nmbr$ mg / dl and $nmbr$ to $nmbr$ mg / dl were combined to make $nmbr$ group with bl ldl cholesterol $nmbr$ to $nmbr$ mg / dl because of small numbers of patients included in the substrata with $nmbr$ to $nmbr$ mg / dl . † bl hdl cholesterol cutoffs were $nmbr$ or $nmbr$ mg / dl for men and $nmbr$ or $nmbr$ mg / dl for women . bars indicate se . bmi body mass index  e ezetimibe $nmbr$ mg  hdl - c hdl cholesterol  ldl - c ldl cholesterol  tg triglycerides,C0168634;C0005918;C0023824;C0202117;C0006413;C1552663;C2827109;C1442488;C3642216;C0005918;C0023824;C0439269;C0202117;C0006413;C1552663;C2827109;C2360800;C3642216;C0005918;C0023822;C1442160;C0392885;C0006413;C1552663;C2827109;C0025266;C1305855;C1142985;C0024671;C3715113;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0368910;C0337445,true;true;true;false;true;false;false;false;false;true;true;false;false;true;false;false;false;false;true;true;false;false;true;false;false;true;true;true;true;false;true;false;false;false;false;false;false;false,10587/22402
$nmbr$ - blocker,,,10588/22402
$nmbr$ step,C1261552;C1704379;C1705117;C2825408;C3814463,false;false;false;false;false,10589/22402
. $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10590/22402
. $nmbr$ kg mtx use,C0022718;C0025677;C0042153;C0457083;C1947944;C1417487;C0439209;C4054209,true;true;true;false;false;false;false;false,10591/22402
. $nmbr$ step or incident vitrectomy or photocoagulation,C1261552;C1704379;C1705117;C2825408;C3814463,false;false;false;false;false,10592/22402
/ \ge category,C1292300;C0683312;C3889287;C3538705,false;false;false;false,10593/22402
/ ’ interaction,C1704675,false,10594/22402
/ $nmbr$ - blocker,,,10595/22402
/ pl $nmbr$ $nmbr$,C3897966;C4049765,false;false,10596/22402
: mi  previous pci and chronic obstructive pulmonary disease .,C3810814;C0205156;C4049621;C1552607,false;false;false;false,10597/22402
? f ? n,C0016327,true,10598/22402
[ } ifrerence vs . placebo  % ( $nmbr$ % cl ),,,10599/22402
[ $nmbr$ . $nmbr$ mmol / l ] ),C1532563,false,10600/22402
[ $nmbr$ % ci ] *,C0008107;C3259781,true;false,10601/22402
[ cm ( female ) / cm ( male ) ],C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498,true;true;false;false;false;true;false;false,10602/22402
[ cm { female ) / cm { male ) ],C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498,true;true;false;false;false;true;false;false,10603/22402
[ kg / m ^ ],C1532718,false,10604/22402
[ min  max ],C0702093;C1524029;C3813700,false;false;false,10605/22402
[ no / yes ] ( % ),C1549445;C1705108;C1710701,false;false;false,10606/22402
[ sd ],C2699239,false,10607/22402
[ zi = $nmbr$ ] $nmbr$ ( $nmbr$ . $nmbr$ ),C0043476,true,10608/22402
\bl - sc n / n,C0005918;C0282380;C0006413;C1552663;C2827109,true;true;true;false;false,10609/22402
^ ≥ $nmbr$ % incidence in any treatment group in the overall safety population .,C0021149;C0374505;C0220856,true;false;true,10610/22402
^ $nmbr$ days,C0439228,false,10611/22402
^ $nmbr$ months,C0439231,false,10612/22402
^ $nmbr$ mm hg,C0439475,false,10613/22402
^ $nmbr$ mg / g  n ( % ),C1300563,false,10614/22402
^ $nmbr$ hrs,C1568891,true,10615/22402
^ $nmbr$ ml / min,C0439445,false,10616/22402
^ numbers do not always sum to group totals due to missing information for some variables . fbody mass index was calculated as weight in kilograms divided by the square of height in meters . ^ hypertension was defined as a self - reported systolic blood pressure > $nmbr$ mm hg  a diastolic blood pressure > $nmbr$ mm hg  or physician - diagnosed hypertension . § hyperlipidemia was defined as a self - reported total cholesterol > $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l ) or physician - diagnosed high cholesterol . | | diabetes was defined by self - report .,C0237753;C0449788;C4524803;C0439828;C0577559;C0600653;C0918012;C1552854;C1637833;C2986546;C0577573;C1096155;C1306372;C3152252;C3539882;C4283905;C0444686;C0005910;C0043100;C1305866;C1705104;C1441506;C0489786;C0441074;C0020538;C1963138;C0488055;C0439475;C0871470;C1306620;C0025424;C0428257;C2347108;C2347109;C2348272;C0681906;C0201950;C0439269;C1532563;C0543421;C2700446;C0011900;C0020443;C0011847;C0011849;C1522133,false;false;false;false;false;true;true;false;false;false;false;true;false;false;false;false;false;true;true;false;false;false;false;false;true;false;false;false;true;false;true;false;false;false;false;false;false;false;false;false;true;true;true;false;true;false,10617/22402
| : s blocker,C0565930;C2603362,false;false,10618/22402
| ? > - blocker ( n  % ),,,10619/22402
“ off ”,,,10620/22402
“ on ” with troublesome dyskinesia,C0013384,true,10621/22402
“ on ” without troublesome dyskinesia,C0013384,true,10622/22402
“ relative risk of outcome in acei group iw control group . bbaseline variables for models included : logarithm of age  reciprocal of serum creatinine  sbp  up excretion  treatment assignment and terms for studies $nmbr$  $nmbr$ $nmbr$ and $nmbr$ ( see footnotes of table $nmbr$ ) . other baseline variables considered for analysis ( p < $nmbr$ . $nmbr$ in univariate analysis ) included dp mean arterial pressure  type of antihypertensive regimen in the control group  planned duration of follow - up  whether or not the investigators were blinded  whether or not dietary advice was given and the year of publication .,C0242492;C1274040;C0441833;C0439828;C3161035;C0687744;C1257890;C1519504;C1705428;C1705429;C0201976;C0085805;C0221102;C0039798;C1516050;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0504085;C2699704;C0600061;C0947630;C0750591;C0002778;C0936012;C1524024;C0232108;C0332307;C0003364;C0040808;C2945654;C1547052;C1272641;C4288391;C0439234;C0034036;C0034037;C1704324;C0439508,true;false;false;false;false;false;true;false;false;false;false;true;false;true;false;true;false;false;false;false;false;false;false;false;false;false;false;false;true;false;false;true;true;false;false;true;false;false;true;true;false;false,10623/22402
£ $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,10624/22402
£ $nmbr$ . $nmbr$ yrs,,,10625/22402
£ $nmbr$ . $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,10626/22402
£ $nmbr$ . $nmbr$ mmol / l,C1532563,false,10627/22402
£ $nmbr$ mg / dl,C0439269,false,10628/22402
£ $nmbr$ % bsa psoriasis  no . ( % ),C0033860,true,10629/22402
£ $nmbr$ yr,C0439234,false,10630/22402
£ $nmbr$ m b ' m in,C1709500,false,10631/22402
£ $nmbr$ ml / minute,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,10632/22402
£ l $nmbr$ kg,C1637390,false,10633/22402
+ ics / + laba n z $nmbr$,C0815320;C4551720,false;true,10634/22402
< - $nmbr$ . $nmbr$ - vfx,,,10635/22402
< - $nmbr$ . $nmbr$ + vfx,,,10636/22402
< - $nmbr$ . $nmbr$ cm,,,10637/22402
< $nmbr$ . $nmbr$ tng > cll,C0023434,true,10638/22402
< $nmbr$ cells / ul $nmbr$ $nmbr$,C0439378,false,10639/22402
< $nmbr$ mg / dl eze / simva ( n = $nmbr$ ),C0439269,false,10640/22402
< $nmbr$ mg / dl simva ( n = $nmbr$ ),C0439269,false,10641/22402
< $nmbr$ st quartile,C0036056;C2828255;C3272372,true;false;false,10642/22402
< $nmbr$ mgday p . eq .,C0205163;C0439185,false;false,10643/22402
< $nmbr$ month n = $nmbr$,C0332177;C0439231,false;false,10644/22402
< $nmbr$ l / min,C0439393,false,10645/22402
< $nmbr$ . $nmbr$ yrs,,,10646/22402
< $nmbr$ years ( % ),C0439234,false,10647/22402
< $nmbr$ years eze / simva ( n = $nmbr$ ),C0439234,false,10648/22402
< $nmbr$ years simva ( n = $nmbr$ ),C0439234,false,10649/22402
< $nmbr$ . $nmbr$ min,C0702093;C1524029;C3813700,false;false;false,10650/22402
< median $nmbr$ . $nmbr$,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10651/22402
< = $nmbr$ yr,C0439234,false,10652/22402
< = € $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10653/22402
< = $nmbr$ year  n ( % ),C0439234;C0439508,false;false,10654/22402
< = $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10655/22402
< $nmbr$ . $nmbr$ ld,C0694649,false,10656/22402
< $nmbr$ mg / l ( n = $nmbr$ ),C0439268,false,10657/22402
< $nmbr$ . $nmbr$ ng / ml ( n = $nmbr$ ),C0439275,false,10658/22402
< $nmbr$ . $nmbr$ ng / l ( n = $nmbr$ ) n ( % ),C0439297,false,10659/22402
< $nmbr$ . $nmbr$ ng / l ( n = $nmbr$ ),C0439297,false,10660/22402
< $nmbr$ mg / dl *,C0439269,false,10661/22402
< $nmbr$ . $nmbr$ mm hg,C0439475,false,10662/22402
< $nmbr$ mm hg — no . ( % ),C0439475,false,10663/22402
< $nmbr$ / $nmbr$ mm hg +,C0439475,false,10664/22402
< $nmbr$ / $nmbr$ mmhg  ldl - c < $nmbr$ mg / dl,C0439475;C0439269,false;false,10665/22402
< $nmbr$ / $nmbr$ mm hg,C0439475,false,10666/22402
< $nmbr$ ml / s,C0439390,false,10667/22402
< $nmbr$ cells / mm ^,C0007584;C4330985;C4554674;C0007634,true;false;false;true,10668/22402
< $nmbr$ and no moderate or severe deformity ( n = $nmbr$ ),,,10669/22402
< $nmbr$ mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,10670/22402
< $nmbr$ mg / d peq,C0439422,false,10671/22402
< $nmbr$ mg / day,C0439422,false,10672/22402
< $nmbr$  kg / m $nmbr$,C1532718,false,10673/22402
< $nmbr$ — no . { % ),,,10674/22402
< $nmbr$ kg / m $nmbr$ ( n = $nmbr$ ),C1532718,false,10675/22402
< $nmbr$ ppb,C1415800,false,10676/22402
< $nmbr$ xuln,,,10677/22402
< $nmbr$ — no . ( % ),,,10678/22402
< $nmbr$ no . ( % ),,,10679/22402
< $nmbr$ crcl,C1846718,false,10680/22402
< $nmbr$ kg  mj ( reference ),C0022718;C0439254;C4284025;C0439209;C4054209,true;false;false;false;false,10681/22402
< $nmbr$ kg / m ^,C1532718,false,10682/22402
< $nmbr$ kg / ma $nmbr$,C0022718;C0024443;C3887485;C0439209;C4054209,true;true;false;false;false,10683/22402
< $nmbr$ ky / nr,,,10684/22402
< $nmbr$ mg dl ( reference ),C0439269;C1514811;C1706462,false;false;false,10685/22402
< $nmbr$ mg / g  n ( % ),C1300563,false,10686/22402
< $nmbr$ ml / min / $nmbr$ . $nmbr$ ni -,C0439445;C0028075;C2348274;C3869926;C3869927,false;true;false;false;false,10687/22402
< $nmbr$ ml / minute,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,10688/22402
< $nmbr$ % predicted,C0681842;C1882327,false;false,10689/22402
< $nmbr$ mlmin ) $nmbr$,,,10690/22402
< $nmbr$ meters,C0441074,false,10691/22402
< $nmbr$ mo  n ( % ),C0026544;C0332177,true;false,10692/22402
< $nmbr$ . $nmbr$ mu / l - mmol / l,C0439342;C0439190,false;false,10693/22402
< $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l ),C0439269;C1532563,false;false,10694/22402
< $nmbr$ ml / min / $nmbr$  $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,10695/22402
< $nmbr$ crcl  n ( % ),C1846718,false,10696/22402
< $nmbr$ ml / min — %,C0439445,false,10697/22402
< $nmbr$ ml / min ( n = $nmbr$ ),C0439445,false,10698/22402
< $nmbr$ mg / l,C0439268,false,10699/22402
< $nmbr$ weeks,C0439230,false,10700/22402
< $nmbr$ kg ' i ',C0022718;C0021966;C0221138;C0439209;C4054209,true;true;false;false;false,10701/22402
< $nmbr$ mi / min,C3810814;C0702093;C1524029;C3813700,false;false;false;false,10702/22402
< $nmbr$ ml min ’ $nmbr$ $nmbr$ . $nmbr$ m  $nmbr$,C0439445;C0369637;C0441923,false;false;false,10703/22402
< $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C0439445;C0369637;C0441923,false;false;false,10704/22402
< $nmbr$ ml / min / $nmbr$  $nmbr$ m ^,C0439445;C0369637;C0441923,false;false;false,10705/22402
< $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C0439445;C0369637;C0441923,false;false;false,10706/22402
< $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^ — no . { % ),C0439445;C0369637;C0441923,false;false;false,10707/22402
< $nmbr$ mlymin,,,10708/22402
< $nmbr$ yr — no . { % ),C0439234,false,10709/22402
< $nmbr$ y ( n = $nmbr$  $nmbr$ . $nmbr$ % ),,,10710/22402
< $nmbr$ y ears,C0013443;C0521421,true;false,10711/22402
< $nmbr$ yr ( n = $nmbr$ ),C0439234,false,10712/22402
< $nmbr$ yrs of age ( n = $nmbr$  $nmbr$ ),C0001779,false,10713/22402
< $nmbr$ yea ' s,,,10714/22402
< $nmbr$ kg  n ( % ),C0022718;C0439209;C4054209,true;false;false,10715/22402
< $nmbr$ . $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10716/22402
< $nmbr$ . $nmbr$ % ( < $nmbr$ mmol / mol ),C3829066,false,10717/22402
< $nmbr$ ml / minute ),C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,10718/22402
< $nmbr$ cm,,,10719/22402
< mean,C0444504;C2347634;C2348143,false;false;false,10720/22402
< median ( $nmbr$ year - old ),C0549183;C0439234;C0580836;C0439508;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,10721/22402
< median ( $nmbr$ days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10722/22402
< median { $nmbr$ days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10723/22402
< median prednisone dose  n ( % ),C0549183;C0032952;C0178602;C0869039;C1114758;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,10724/22402
★ reported by physicians . tdata are median ( iqr ) . all data are mean ( sd ) or number ( % ) unless otherwise indicated .,C1709908;C0031831,false;true,10725/22402
卞 at discharge .,C0012621;C0030685;C2926602,false;true;false,10726/22402
赛 $nmbr$ years,C0439234,false,10727/22402
= calcium channel blocker  bmi = body,C0006684;C0578022;C0242821;C0460148;C1268086;C4082212;C3536851;C4521885,true;false;true;false;false;false;false;false,10728/22402
= cerebrospinal fluid .,C0007806;C0007807,true;true,10729/22402
= ezetimibe  tc = triglycerides  hdl - c = lg / dl l > $nmbr$ . $nmbr$ mmol / l ] ) . to qualify as having,C1142985;C0039411;C0062152;C0023128;C3642216;C0439190;C0694651;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;true;true;false;false;false;true;true;true;false;false;false,10730/22402
= international prostate symptom score,C1998280,false,10731/22402
= placebo  eze : tes ( fc j > $nmbr$ rr $nmbr$ definition ) .,C0032042;C0076172;C2983605;C4554402;C1550452;C1704788;C3539107;C3888054;C1422793;C1696465;C1706408,true;true;false;false;false;false;false;false;false;false;false,10732/22402
= placebo  eze = ezetimibe  erol  apo = apolipoprotein  metabolic syndrome  patients were eans and percentage changes are,C0032042;C1142985;C0003591;C0524620;C0030705;C1696465;C1706408,true;true;true;true;true;false;false,10733/22402
≤   $nmbr$   mmol / mol ( $nmbr$ . $nmbr$ % )    n   ( % ),C3829066,false,10734/22402
≥   $nmbr$   mmol / mol ( $nmbr$ . $nmbr$ % )    n   ( % ),C3829066,false,10735/22402
≥ $nmbr$ ae,C3887670,false,10736/22402
≥ $nmbr$ sae,C1519255;C1622657;C4553214,false;false;false,10737/22402
≥ $nmbr$ teae,,,10738/22402
≤ $nmbr$   year,C0439234;C0439508,false;false,10739/22402
≥ $nmbr$  kg / m $nmbr$,C1532718,false,10740/22402
≤ $nmbr$ years,C0439234,false,10741/22402
≤ $nmbr$ mg / l,C0439268,false,10742/22402
≥ $nmbr$ . $nmbr$ % and < $nmbr$ . $nmbr$ %,,,10743/22402
≥ $nmbr$ yearsa,,,10744/22402
≥ $nmbr$ a ( n = $nmbr$ ),C0369718;C0441922,false;false,10745/22402
≥ $nmbr$ ml / min,C0439445,false,10746/22402
≥ $nmbr$ . $nmbr$ % and ≤ $nmbr$ . $nmbr$ %,,,10747/22402
= sia,C1225105;C1551538,false;false,10748/22402
> - $nmbr$ . $nmbr$ - vfx,,,10749/22402
> - $nmbr$ . $nmbr$ + vfx,,,10750/22402
> - $nmbr$ . $nmbr$ and < - $nmbr$ . $nmbr$,,,10751/22402
> - $nmbr$ cm,,,10752/22402
> $nmbr$ med at baseline cardiac disorder *,C4321267;C0168634;C0018799;C1442488,false;true;true;false,10753/22402
> $nmbr$ years vs .   ≤   $nmbr$ years,C0439234,false,10754/22402
> $nmbr$ mg / dl eze / simva ( „ = $nmbr$ ),C0439269,false,10755/22402
> $nmbr$ mg / dl simva ( „ = $nmbr$ ),C0439269,false,10756/22402
> $nmbr$ st and < $nmbr$ nd quartile,C0036056;C3272372,true;false,10757/22402
> $nmbr$ to   ≤   $nmbr$ years vs .   ≤   $nmbr$ years,C0439234,false,10758/22402
> $nmbr$ nd and < $nmbr$ rd quartile,,,10759/22402
> $nmbr$ . $nmbr$   vs . $nmbr$ . $nmbr$ to   ≤   $nmbr$ . $nmbr$,,,10760/22402
> $nmbr$ kg / m $nmbr$ smokers,C1532718;C0337664,false;true,10761/22402
> $nmbr$ cells / ul,C0439378,false,10762/22402
> $nmbr$ rd quartile,C0694666;C2828255;C4553350,false;false;false,10763/22402
> $nmbr$ and   ≤   $nmbr$   vs .   ≤   $nmbr$,,,10764/22402
> $nmbr$ to   ≤   $nmbr$   vs .   ≤   $nmbr$,,,10765/22402
> $nmbr$ and < $nmbr$ years,,,10766/22402
> $nmbr$ to s $nmbr$ yrs,C0040363;C0041260;C1883351,true;true;false,10767/22402
> $nmbr$ month n = $nmbr$,C0332177;C0439231,false;false,10768/22402
> $nmbr$ and   ≤   $nmbr$   vs   ≤   $nmbr$,,,10769/22402
> $nmbr$ years ( % ),C0439234,false,10770/22402
> $nmbr$ years eze / simva ( n = $nmbr$ ),C0439234,false,10771/22402
> $nmbr$ years old,C0439234,false,10772/22402
> $nmbr$ years simva ( n = $nmbr$ ),C0439234,false,10773/22402
> $nmbr$ years bmi,C0439234;C0578022,false;false,10774/22402
> $nmbr$ ml min ) $nmbr$,C0439445,false,10775/22402
> $nmbr$   vs .   ≤   $nmbr$,,,10776/22402
> is years,,,10777/22402
> median $nmbr$ . $nmbr$,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,10778/22402
>   $nmbr$ – <   $nmbr$   mmol / mol ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ % )    n   ( % ),C3829066,false,10779/22402
> = $nmbr$ kg / m $nmbr$,C1532718,false,10780/22402
> = $nmbr$ l / min,C0439393,false,10781/22402
> = $nmbr$ l_ / min,C0439393,false,10782/22402
> = $nmbr$ ml / mln,C0439526;C1417190;C3815103;C1705224;C3887665,false;false;false;false;false,10783/22402
> = $nmbr$ . $nmbr$ to < $nmbr$ ng / l ( n = $nmbr$ ) n ( % ),C0439297,false,10784/22402
> = $nmbr$ day s initial heparin treatment duration,C0332173;C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685;C0439228;C0439505,false;false;true;false;false;false;false;false;false;false;false,10785/22402
> = $nmbr$ days,C0439228,false,10786/22402
> = $nmbr$ to < $nmbr$ ng / l ( n = $nmbr$ ) n ( % ),C0439297,false,10787/22402
> = $nmbr$ mmhq,,,10788/22402
> = $nmbr$ ng / l ( n = $nmbr$ ) n ( % ),C0439297,false,10789/22402
> = $nmbr$ ng / l ( n = $nmbr$ ),C0439297,false,10790/22402
> = $nmbr$ kg / ma $nmbr$,C0022718;C0024443;C3887485;C0439209;C4054209,true;true;false;false;false,10791/22402
> = $nmbr$ mg / g,C1300563,false,10792/22402
> = $nmbr$ meters,C0441074,false,10793/22402
> = $nmbr$ years and < $nmbr$ years,C0439234,false,10794/22402
> = $nmbr$ ^ initial heparin treatment duration,C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false;false,10795/22402
> = $nmbr$ . $nmbr$ % ( > = $nmbr$ mmol / mol ),C3829066,false,10796/22402
> = $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,10797/22402
> = medan ( $nmbr$ year - old ),C0439234;C0580836;C0439508,false;false;false,10798/22402
> = median ( $nmbr$ days ),C0549183;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,10799/22402
> = medion ( $nmbr$ days ),C0439228,false,10800/22402
> $nmbr$ aes,C1412268;C2699274,false;false,10801/22402
> $nmbr$ aes leading to discontinuation,C1412268;C2699274,false;false,10802/22402
> $nmbr$ antihypertensive medication  no . ( % ),C0003364,true,10803/22402
> $nmbr$ drug - related,C0013227;C0439849;C0445223;C1254351,true;false;false;false,10804/22402
> $nmbr$ drug - related aes *,C0013227;C0439849;C1412268;C2699274;C0445223;C1254351,true;false;false;false;false;false,10805/22402
> $nmbr$ exacerbation in prev $nmbr$ m ( n = $nmbr$ ),C4086268;C1552852;C0369637;C0441923,false;false;false;false,10806/22402
> $nmbr$ glucose - lowering medication . no . ( % ),C0017725;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,10807/22402
> $nmbr$ oral antidiabetic medication,C0175795;C0935929;C0442027;C4521986,false;true;false;false,10808/22402
> $nmbr$ serious aes,C0205404;C1412268;C2699274,false;false;false,10809/22402
> $nmbr$ to < = $nmbr$ years  n ( % ),C0439234,false,10810/22402
> $nmbr$ to $nmbr$   years,C0439234,false,10811/22402
> $nmbr$ year,C0439234;C0439508,false;false,10812/22402
> $nmbr$ yr  n ( % ),C0439234,false,10813/22402
> $nmbr$ . $nmbr$ ng / ml ( n = $nmbr$ ),C0439275,false,10814/22402
> $nmbr$ / $nmbr$ lung fields,C0225759,false,10815/22402
> $nmbr$ da of capillary nonperfusion in the eyec,C0011318;C0006901;C0935624;C3668815,true;true;false;false,10816/22402
> $nmbr$ years to < $nmbr$ years,C0439234,false,10817/22402
> $nmbr$   years,C0439234,false,10818/22402
> $nmbr$ ng / l,C0439297,false,10819/22402
> $nmbr$ b ( $nmbr$ b to $nmbr$ a ),,,10820/22402
> $nmbr$ cm,,,10821/22402
> $nmbr$ months  n ( % ),C0439231,false,10822/22402
> $nmbr$ . $nmbr$ mm,C4330985;C4554674,false;false,10823/22402
> $nmbr$ ^ mol / liter — no . ( % ),C0347982,false,10824/22402
〉 $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C0439445;C0369637;C0441923,false;false;false,10825/22402
> $nmbr$ mm hg — no . ( % ),C0439475,false,10826/22402
> $nmbr$ ml / s,C0439390,false,10827/22402
> $nmbr$ at screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,10828/22402
> $nmbr$ per pl at screening,C3897966;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4049765,false;true;true;false;false;false;false;false;false,10829/22402
> $nmbr$ to < $nmbr$ cells / mm ^,C0007584;C4330985;C4554674;C0007634,true;false;false;true,10830/22402
> $nmbr$ to < $nmbr$ cells / mm ’,C0007584;C4330985;C4554674;C0007634,true;false;false;true,10831/22402
> $nmbr$ and < $nmbr$,,,10832/22402
> $nmbr$ and / or > $nmbr$ moderate or severe deformity  or both ( n = $nmbr$ ),,,10833/22402
> $nmbr$ antihypertensive medications,C0003364,true,10834/22402
> $nmbr$ chd risk factors,C0280604;C0035648;C1553898;C3542407,false;true;false;false,10835/22402
> $nmbr$ cv risk factors ^ or established atherosclerotic cv disease,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,10836/22402
> $nmbr$ mg / liter,C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,10837/22402
> $nmbr$ oads,,,10838/22402
> $nmbr$ symptom days per week,C1457887;C0677547;C3854129,false;false;false,10839/22402
〉 $nmbr$ years,C0439234,false,10840/22402
> $nmbr$ ( $nmbr$ ) drinks / day if male ( female ),C0452428,false,10841/22402
> $nmbr$ ( n = $nmbr$ l $nmbr$ ),C0369718;C0441922,false;false,10842/22402
> $nmbr$ mg / d peq,C0439422,false,10843/22402
> $nmbr$ mg / day,C0439422,false,10844/22402
> $nmbr$ - ^ $nmbr$ kg / m ’,C1532718,false,10845/22402
> $nmbr$ - s $nmbr$ kg / m ’,C0565930;C1532718;C2603362,false;false;false,10846/22402
> $nmbr$ - < $nmbr$ kg / m $nmbr$ ( n = $nmbr$ ),C1532718,false,10847/22402
> $nmbr$ - < s $nmbr$ kg / m ’,C0565930;C1532718;C2603362,false;false;false,10848/22402
> $nmbr$ to < $nmbr$ ppb,C1415800,false,10849/22402
> $nmbr$ . $nmbr$ pmol / liter,C0439192;C0475211,false;false,10850/22402
> $nmbr$ to < $nmbr$ uln,C0040363;C1519815;C0041260;C1883351,true;false;true;false,10851/22402
> $nmbr$ diseased vessels,C0005847,true,10852/22402
> $nmbr$ drinks / dav,C0452428,false,10853/22402
> $nmbr$ mg / l ( n = $nmbr$ ),C0439268,false,10854/22402
> $nmbr$ . $nmbr$   vs .   >   $nmbr$ . $nmbr$ and   ≤   $nmbr$ . $nmbr$,,,10855/22402
> $nmbr$ — no . { % ),,,10856/22402
> $nmbr$ ( moderate or high bleeding risk )  no . / total ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,10857/22402
> $nmbr$ days to $nmbr$ year ( n = $nmbr$ ),C0556972,false,10858/22402
> $nmbr$ kg nr,C0022718;C0027496;C3844738;C0439209;C4054209,true;true;false;false;false,10859/22402
> $nmbr$ kg / m ^,C1532718,false,10860/22402
> $nmbr$ kg / m ^ ( obesity ),C1532718;C0028754;C1963185,false;true;false,10861/22402
> $nmbr$ kg / m ’,C1532718,false,10862/22402
> $nmbr$ kg / m $nmbr$ ( n = $nmbr$ ),C1532718,false,10863/22402
> $nmbr$ ky / nr,,,10864/22402
> $nmbr$ to < $nmbr$ ml / min / l $nmbr$ nr,C1635169;C0702093;C0027496;C3844738;C1524029;C3813700,false;false;true;false;false;false,10865/22402
> $nmbr$ to < $nmbr$ mg dl,C0439269,false,10866/22402
> $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,10867/22402
> $nmbr$ to < $nmbr$ iu / l,C0439457,false,10868/22402
> $nmbr$ % predicted to < $nmbr$ % predicted,C0681842;C1882327,false;false,10869/22402
> $nmbr$ cells / mm ^,C0007584;C4330985;C4554674;C0007634,true;false;false;true,10870/22402
> $nmbr$ in previous,C0205156;C1552607,false;false,10871/22402
> $nmbr$ per pl in $nmbr$ months before screening,C3897966;C0439231;C4049765,false;false;false,10872/22402
> $nmbr$ kg / nr,C0022718;C0027496;C3844738;C0439209;C4054209,true;true;false;false;false,10873/22402
> $nmbr$ y pathogenesis  n ( % ),C0543483;C0699748,true;false,10874/22402
> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mu / l - mmol / l,C0439342;C0439190,false;false,10875/22402
> $nmbr$ - $nmbr$ yr,C0439234,false,10876/22402
> $nmbr$ ppb,C1415800,false,10877/22402
> $nmbr$ % predicted,C0681842;C1882327,false;false,10878/22402
> $nmbr$ % responder rate  n ( % ),C0871208;C1521828,false;false,10879/22402
> $nmbr$ % stenosis of major artery  n ( % ),C0038449;C0205082;C0205164;C4318856;C4521762,false;false;false;false;false,10880/22402
> $nmbr$ uln,C1519815,false,10881/22402
> $nmbr$ yearstos is years,,,10882/22402
> $nmbr$ mg / l,C0439268,false,10883/22402
> $nmbr$ weeks,C0439230,false,10884/22402
> $nmbr$ crcl,C1846718,false,10885/22402
> $nmbr$ kg body weight at randomization,C0022718;C0005910;C0034656;C1305866;C0242821;C2985844;C0460148;C1268086;C4082212;C0439209;C4054209,true;true;true;false;true;false;false;false;false;false;false,10886/22402
> $nmbr$ mg / dl ( > $nmbr$ . $nmbr$ mmol / l ) + +,C0439269;C1532563,false;false,10887/22402
> $nmbr$ mi / min,C3810814;C0702093;C1524029;C3813700,false;false;false;false,10888/22402
> $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ — no . ( % ),C0439445;C0369637;C0441923,false;false;false,10889/22402
> $nmbr$ ml / niin / l $nmbr$ ni -,C1635169;C0028075;C2348274;C3869926;C3869927,false;true;false;false;false,10890/22402
> $nmbr$ mlymin,,,10891/22402
> $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C0439445;C0369637;C0441923,false;false;false,10892/22402
> $nmbr$ to < $nmbr$ iiil / iiim / $nmbr$ . $nmbr$ m $nmbr$,C0369637;C0441923,false;false,10893/22402
> $nmbr$ years of age  n ( % ),C1510829,false,10894/22402
> $nmbr$ yr ( n = $nmbr$ ),C0439234,false,10895/22402
> $nmbr$ yr from the united states,C0439234;C0041703,false;true,10896/22402
> $nmbr$ yrs of age ( n = $nmbr$  $nmbr$ ),C0001779,false,10897/22402
> $nmbr$ to < $nmbr$ mg / dl,C0439269,false,10898/22402
> $nmbr$ . $nmbr$ mg / day  %,C0439422,false,10899/22402
> $nmbr$ yr — no . { % ),C0439234,false,10900/22402
> $nmbr$ iu / l,C0439457,false,10901/22402
> $nmbr$ ( n  % ) weight  kg,C0369718;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0441922,false;true;true;false;false;true;false;false;false,10902/22402
> $nmbr$ y ( n = $nmbr$  $nmbr$ . $nmbr$ % ),,,10903/22402
> $nmbr$ years or < $nmbr$ crcl  n ( % ),C0439234,false,10904/22402
> $nmbr$ yr — %,C0439234,false,10905/22402
> $nmbr$ . $nmbr$ bpm,,,10906/22402
> $nmbr$ bpm ( n = $nmbr$ ),,,10907/22402
> $nmbr$ %  n ( % of patients ),C0369718;C0030705;C0441922,false;true;false,10908/22402
> $nmbr$ . $nmbr$ mu / l - mmol / l,C0439342;C0439190,false;false,10909/22402
> $nmbr$ ( n  % ) chads $nmbr$ score,C0369718;C0007928;C1413373;C0441922,false;true;false;false,10910/22402
> $nmbr$ kg — no . ( % ),C0022718;C0439209;C4054209,true;false;false,10911/22402
> $nmbr$ ml / min ( n = $nmbr$ ),C0439445,false,10912/22402
> $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10913/22402
> $nmbr$ mg / dl baseline high - sensitivity crp,C0439269;C0168634;C1441604;C3890735;C4048285;C1442488,false;true;false;false;false;false,10914/22402
> $nmbr$ bpm ( n = $nmbr$ l $nmbr$ ),,,10915/22402
> $nmbr$ mg dl,C0439269,false,10916/22402
> $nmbr$ ml min - $nmbr$ $nmbr$ . $nmbr$ m ' $nmbr$,C0439445;C0369637;C0441923,false;false;false,10917/22402
> $nmbr$ ml / min per $nmbr$ . $nmbr$ m ^,C0439445;C0369637;C0441923,false;false;false,10918/22402
> $nmbr$ ml / min / $nmbr$ . $nmbr$,C0439445,false,10919/22402
> $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C0439445;C0369637;C0441923,false;false;false,10920/22402
> $nmbr$ . $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10921/22402
> $nmbr$ - $nmbr$ cm,,,10922/22402
> ii,,,10923/22402
> lto £ $nmbr$ symptom days per week,C1457887;C0677547;C3854129,false;false;false,10924/22402
> lto < $nmbr$ ( n = $nmbr$ ),,,10925/22402
> mean,C0444504;C2347634;C2348143,false;false;false,10926/22402
> ulnand < $nmbr$ ng / l,C0439297,false,10927/22402
> year $nmbr$,C0439234;C0439508,false;false,10928/22402
± sd .,C2699239,false,10929/22402
± standard deviation . triglyceride,C0871420;C0041004,false;true,10930/22402
« $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,10931/22402
» $nmbr$ years,C0439234,false,10932/22402
§ classes on the canadian cardiovascular society ( ccs ) scale range from i to iv,C0238884;C0007226;C0037455;C1879987;C0175659;C1514721;C2348147;C3542016;C0349674;C1947916;C3887460,false;true;true;false;true;false;false;false;false;false;false,10933/22402
† includes patients originally randomized to placebo who were switched to secukinumab per the study designs .   ‡ aes that occurred in at least $nmbr$ . $nmbr$ % of the patients in the any secukinumab group during the $nmbr$ ‐ week placebo ‐ controlled period and events with an eair of at least $nmbr$ . $nmbr$ cases per $nmbr$ patient ‐ years in the any secukinumab group during the entire treatment period . events listed according to preferred term in the medical dictionary for regulatory activities ( meddra version $nmbr$ . $nmbr$ )  sorted in descending order of eair in the any secukinumab group for the entire treatment period . the entire treatment period for safety data was from baseline to week $nmbr$ visit of the last patient enrolled in these studies . ae  adverse event  as  ankylosing spondylitis  eair  exposure adjusted incidence rates    n  number of randomized patients  sae  serious adverse event  urti  upper respiratory tract infection .,C0332257;C1552866;C2700399;C3179547;C0035171;C1412268;C2699274;C2983265;C2986888;C0030705;C0332174;C1706408;C0439531;C1948053;C0439230;C0868928;C1533148;C3179547;C0374505;C0439751;C0439531;C0441471;C3541888;C1948053;C0444667;C0680240;C1709637;C0012113;C2347664;C0441655;C1140263;C0333052;C2607870;C0439751;C0039798;C0439531;C0036043;C1511726;C3245479;C3714741;C1705187;C1948053;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0444667;C0332174;C1512346;C0439230;C3887670;C0877248;C0038013;C0274281;C0332157;C0871208;C2360800;C0034656;C1519255;C1622657;C4553214;C3815594;C1521828;C0041912,false;false;false;true;true;false;false;false;false;true;false;false;false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;true;false;false;false;false;false;false;true;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false;false;true;false;false;false;false;true;false;false;false;false;false;true,10934/22402
• $nmbr$ : death from any cause  major coronary event  or nonfatal stroke,C0011065;C1306577;C4082313;C4552775,true;false;false;false,10935/22402
• any mi,C3810814,false,10936/22402
• any stroke,C0038454;C4554100,true;false,10937/22402
• death from any cause,C0007465,true,10938/22402
• death from coronary heart disease,C0011065;C0010054;C0010068;C1956346;C1306577;C4082313;C4552775,true;true;true;true;false;false;false,10939/22402
• death from cv causes  major coronary event  or nonfatal stroke,C0011065;C3538987;C4048877;C4318503;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,10940/22402
• hemorrhagic stroke,C0553692,true,10941/22402
• hospitalization for unstable angina,C0019993;C0002965,true;true,10942/22402
• ii : death from coronary heart disease  nonfatal mi  coronary revascularization > $nmbr$ days,C1710602;C0011065;C0545743;C0018799;C3810814;C0581603;C0439228;C1306577;C4082313;C4552775;C4082587,false;true;false;true;false;false;false;false;false;false;false,10943/22402
• iii : death from cv causes  nonfatal mi  hospitalization for ua  all revascularization > $nmbr$ days  nonfatal stroke,C0439070;C0011065;C3538987;C4048877;C4318503;C1306577;C4082313;C4552775;C1705160,false;true;false;true;false;false;false;false;false,10944/22402
• ischemic stroke,C0948008,false,10945/22402
• ml with st - segment elevation,C0439526;C0520886;C1705224;C3887665,false;false;false;false,10946/22402
• ml without st - segment elevation,C0439526;C0520886;C1705224;C3887665,false;false;false;false,10947/22402
• unstable angina,C0002965,true,10948/22402
• urgent coronaiy revascularization > $nmbr$ days,C0439609;C0581603;C0439228;C3272275,false;false;false;false,10949/22402
• j . the body - mass index is the weight in kilograms divided by the square of the,,,10950/22402
$nmbr$ - $nmbr$ hours,C0439227,false,10951/22402
$nmbr$ - $nmbr$ ( o $nmbr$ - o - $nmbr$ ),C0483204,false,10952/22402
$nmbr$ - $nmbr$ ( $nmbr$ % cl $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ ),C0596019,false,10953/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ - o - $nmbr$ ),C0483204,false,10954/22402
$nmbr$ - $nmbr$ mm,C4330985;C4554674,false;false,10955/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ o - o - $nmbr$ ),C0483204,false,10956/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ - i - $nmbr$ ),C0483204;C0021966;C0221138,false;true;false,10957/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ - i - o $nmbr$ ),C0483204;C0021966;C0221138,false;true;false,10958/22402
$nmbr$ - $nmbr$ fo - $nmbr$ $nmbr$ - $nmbr$ ^,,,10959/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ s - o - $nmbr$ ),C0483204,false,10960/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ - o - $nmbr$ o ),C0483204,false,10961/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ i - o - $nmbr$ ),C0483204;C0021966;C0221138,false;true;false,10962/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ - $nmbr$ - oo ),C0483204,false,10963/22402
$nmbr$ - $nmbr$ fo - $nmbr$ - o - q ^ i,C0021966;C0221138,true;false,10964/22402
$nmbr$ - $nmbr$ { o - $nmbr$ - $nmbr$ - o $nmbr$ ),C0483204,false,10965/22402
$nmbr$ - $nmbr$ ( o $nmbr$ o - i - i $nmbr$ ),C0483204;C0021966;C0221138,false;true;false,10966/22402
$nmbr$ - $nmbr$ ( s $nmbr$ - $nmbr$ ) t,C0718146,false,10967/22402
$nmbr$ - $nmbr$ ( o - $nmbr$ s - i - $nmbr$ ),C0483204;C0021966;C0221138,false;true;false,10968/22402
$nmbr$ — $nmbr$ days,C0439228,false,10969/22402
$nmbr$ ( or $nmbr$  if female only ),,,10970/22402
$nmbr$ $nmbr$ fo $nmbr$ - $nmbr$ $nmbr$ ),,,10971/22402
$nmbr$ $nmbr$ ( o - $nmbr$ - i - o $nmbr$ ),C0483204;C0021966;C0221138,false;true;false,10972/22402
$nmbr$ or $nmbr$ — no . / total no . ( % ),,,10973/22402
$nmbr$ or $nmbr$  n ( % ),,,10974/22402
$nmbr$ or $nmbr$  no . / total no . ( % ),,,10975/22402
$nmbr$ to $nmbr$ symptom days per week,C1457887;C0677547;C3854129,false;false;false,10976/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . i $nmbr$ i ),C0021966;C0221138,true;false,10977/22402
$nmbr$ . $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10978/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) pty = $nmbr$,,,10979/22402
$nmbr$ . $nmbr$ vs $nmbr$ . $nmbr$,,,10980/22402
$nmbr$ . $nmbr$ $nmbr$ % ci : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ p = $nmbr$ . $nmbr$,C0008107;C3259781,true;false,10981/22402
$nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,10982/22402
$nmbr$ . $nmbr$ { $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) pty = $nmbr$,,,10983/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - l . l ),C3539687,false,10984/22402
$nmbr$ . $nmbr$ ( $nmbr$ % ci $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$,C0008107;C3259781,true;false,10985/22402
$nmbr$ . $nmbr$ { $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ } pty = $nmbr$,,,10986/22402
$nmbr$ . $nmbr$ ( $nmbr$ % ci $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ),C0008107;C3259781,true;false,10987/22402
$nmbr$ . $nmbr$ ( $nmbr$ % cl $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$,C0596019,false,10988/22402
$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . os ),C0229090;C0230028;C0262950;C0393706;C1561953,false;false;true;false;false,10989/22402
$nmbr$ . $nmbr$ to . $nmbr$ . i . iot,C0021966;C0006196;C0221138,true;true;false,10990/22402
$nmbr$ . i $nmbr$ ( $nmbr$ . $nmbr$ i - $nmbr$ . $nmbr$ ),C0021966;C0221138,true;false,10991/22402
$nmbr$ ( o - o $nmbr$ - o - $nmbr$ ),C0483204,false,10992/22402
$nmbr$ ( oo $nmbr$ - o . $nmbr$ ),,,10993/22402
$nmbr$ ( o - $nmbr$ - o - $nmbr$ ),C0483204,false,10994/22402
$nmbr$ ix,C0015491,true,10995/22402
$nmbr$ tob $nmbr$ months,C1420851;C0439231,false;false,10996/22402
$nmbr$ tob $nmbr$ months  n ( % ),C1420851;C0439231,false;false,10997/22402
$nmbr$ tol ( n = $nmbr$ ),,,10998/22402
$nmbr$ - $nmbr$ drinks / dav,C0452428,false,10999/22402
$nmbr$ - $nmbr$ / week ( n = $nmbr$ ),C0332174;C0439230,false;false,11000/22402
$nmbr$ - $nmbr$ / day,C0332173;C0439228;C0439505,false;false;false,11001/22402
$nmbr$ — — bh — i,C0004684;C0021966;C0221138;C0004952;C1412800;C2986890;C4284594;C4321407,true;true;false;true;false;false;false;false,11002/22402
$nmbr$ — e - h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,11003/22402
$nmbr$ — em,,,11004/22402
$nmbr$ ( $ $nmbr$ ml / min ),C0439445,false,11005/22402
$nmbr$ ( $nmbr$ si,,,11006/22402
$nmbr$ ( except for female alone ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,11007/22402
$nmbr$ ( ref ),C1425988,false,11008/22402
$nmbr$ abciximab ( n = $nmbr$ ),C0288672,true,11009/22402
$nmbr$ amlodipine - chlorthalidone,C0051696;C0008294,true;true,11010/22402
$nmbr$ antihypertensive medication,C0003364,true,11011/22402
$nmbr$ baricitinib $nmbr$ mg ■ baricitinib $nmbr$ mg,C4044947;C1319635,true;false,11012/22402
$nmbr$ chlorthalidone,C0008294,true,11013/22402
$nmbr$ chlorthalidone ( n = $nmbr$ ),C0008294,true,11014/22402
$nmbr$ chlorthalidone amlodipine,C0008294;C0051696,true;true,11015/22402
$nmbr$ cl ),C0596019,false,11016/22402
$nmbr$ day l,C0332173;C0439228;C0439505,false;false;false,11017/22402
$nmbr$ event  $nmbr$ . $nmbr$ per $nmbr$ py ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ),C0441471;C0030428;C3538810;C4019010,false;true;false;false,11018/22402
$nmbr$ exacerbation in prev $nmbr$ m ( n = $nmbr$ ),C4086268;C1552852;C0369637;C0441923,false;false;false;false,11019/22402
$nmbr$ is ( $nmbr$ . $nmbr$ ),,,11020/22402
$nmbr$ lisinopril,C0065374,true,11021/22402
$nmbr$ lisinopril - chlorthalidone,C0065374;C0008294,true;true,11022/22402
$nmbr$ low ( n = $nmbr$ ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,11023/22402
$nmbr$ med at baseline,C4321267;C0168634;C1442488,false;true;false,11024/22402
$nmbr$ mg ( $nmbr$  $nmbr$ . $nmbr$ % ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,11025/22402
$nmbr$ mg a,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,11026/22402
$nmbr$ month l,C0332177;C0439231,false;false,11027/22402
$nmbr$ n qi,C0369718;C0376586;C0441922,false;true;false,11028/22402
$nmbr$ n / n,C0369718;C0441922,false;false,11029/22402
$nmbr$ oad,,,11030/22402
$nmbr$ oam,,,11031/22402
$nmbr$ oral antidiabetic medication,C0175795;C0935929;C0442027;C4521986,false;true;false;false,11032/22402
$nmbr$ parameter,C0549193;C1704769;C2350001,false;false;false,11033/22402
$nmbr$ prior tnf antagonist failure  n ( % ) b,C0332152;C3887647;C0231491;C0231174;C0680095;C2826257,false;false;false;false;false;false,11034/22402
$nmbr$ standard ( n = $nmbr$ ),C1442989;C2828392,false;false,11035/22402
$nmbr$ t i,C2603360;C0021966;C0221138,false;true;false,11036/22402
$nmbr$ to $nmbr$ years,C0439234,false,11037/22402
$nmbr$ to $nmbr$ mg / l ( n = $nmbr$ ),C0439268,false,11038/22402
$nmbr$ year mean change from baseline,C0439234;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143;C0439508,false;false;false;true;false;false;false;false;false;false;false,11039/22402
$nmbr$ . $nmbr$ ( reference ),C1514811;C1706462,false;false,11040/22402
$nmbr$ . $nmbr$ ( referent ),C1706462,false,11041/22402
$nmbr$ . $nmbr$ ( ref . ),C1425988,false,11042/22402
$nmbr$ . $nmbr$ f $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ h,C0016327;C0033727;C0369286;C0441932;C0564385;C4528284,true;true;false;false;false;false,11043/22402
$nmbr$ . $nmbr$ ( fi . $nmbr$ ),C4050619,false,11044/22402
$nmbr$ . $nmbr$ % vs . $nmbr$ . $nmbr$ %,,,11045/22402
$nmbr$ . $nmbr$ - < $nmbr$ ng / l ( n = $nmbr$ ),C0439297,false,11046/22402
$nmbr$ - < $nmbr$ ng / l ( n = $nmbr$ ),C0439297,false,11047/22402
$nmbr$ - year risk for chd,C0439234;C1282512;C0439508,false;false;false,11048/22402
$nmbr$ - year risk of chd  % #,C0439234;C1282512;C0439508,false;false;false,11049/22402
$nmbr$ - year risk of chd  % # < $nmbr$ . $nmbr$,C0439234;C1282512;C0439508,false;false;false,11050/22402
$nmbr$ - yr rate / $nmbr$ participants,C0439234;C0871208;C0679646;C1521828,false;false;false;false,11051/22402
$nmbr$ μ g ( n = $nmbr$ ),C0439267,false,11052/22402
$nmbr$ mg empagliflozin,C0024671;C3490348;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11053/22402
$nmbr$ mg / d ( n = $nmbr$ ),C0439422,false,11054/22402
$nmbr$ mg / kg,C0439272,false,11055/22402
$nmbr$ ml / min,C0439445,false,11056/22402
$nmbr$ years or more,C0439234,false,11057/22402
$nmbr$ % ( - ito $nmbr$ ),C0022283,true,11058/22402
$nmbr$ % ( oto $nmbr$ ),,,11059/22402
$nmbr$ % participants,C0679646,false,11060/22402
$nmbr$ . $nmbr$ per $nmbr$ py,C0030428;C3538810,true;false,11061/22402
$nmbr$ - $nmbr$ mg / dl *,C0439269,false,11062/22402
$nmbr$ mg + mtx,C0024671;C0025677;C1417487;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,11063/22402
$nmbr$ mg / $nmbr$ mgb,C0024671;C0373680;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,11064/22402
$nmbr$ ml ( $nmbr$ to $nmbr$ ) ( n = $nmbr$ / $nmbr$ ),C0439526;C1705224;C3887665,false;false;false,11065/22402
$nmbr$ / $nmbr$ mga ( n = $nmbr$ ),C0065879,true,11066/22402
$nmbr$ ( mono ),C1551432;C1551969,false;false,11067/22402
$nmbr$ % ( ito $nmbr$ ),C0022283,true,11068/22402
$nmbr$ mg dabigatran,C0024671;C2348066;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11069/22402
$nmbr$ mg dabigatran ( n = $nmbr$ ),C0024671;C2348066;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11070/22402
$nmbr$ ( $nmbr$ % cl $nmbr$ to $nmbr$ ),C0596019,false,11071/22402
$nmbr$ < sbp < $nmbr$ mmhg n = $nmbr$,C0085805;C0439475,true;false,11072/22402
$nmbr$ b ( $nmbr$ b to > $nmbr$ a ),,,11073/22402
$nmbr$ carotid artery sites,C0007272;C0205145;C0162859,true;false;true,11074/22402
$nmbr$ mo  mean ( sd ) x,C0026544;C0444504;C2699239;C2347634;C2348143;C0332177,true;false;false;false;false;false,11075/22402
$nmbr$ ml ( $nmbr$ to $nmbr$ ) ( n - $nmbr$ / $nmbr$ ),C0439526;C1705224;C3887665,false;false;false,11076/22402
$nmbr$ ml ( $nmbr$ to $nmbr$ ) ( n = $nmbr$ / $nmbr$ ) §,C0439526;C1705224;C3887665,false;false;false,11077/22402
$nmbr$ to $nmbr$ mm hg,C0439475,false,11078/22402
$nmbr$ to < $nmbr$ mm hg — no . { % ),C0439475,false,11079/22402
$nmbr$ events,C0441471;C3541888,false;false,11080/22402
$nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mmhg,C0439475,false,11081/22402
$nmbr$ o - i $nmbr$ mm hg,C0483204;C0021966;C0439475;C0221138,false;true;false;false,11082/22402
$nmbr$ . $nmbr$ per $nmbr$ pyr,,,11083/22402
$nmbr$ [ $nmbr$ - $nmbr$ js,C1552154,false,11084/22402
$nmbr$ f $nmbr$ q % ),C0016327,true,11085/22402
$nmbr$ . $nmbr$ ( $nmbr$ % ci : $nmbr$ . $nmbr$  $nmbr$ . $nmbr$  n = $nmbr$ ),C0008107;C3259781,true;false,11086/22402
$nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mm hg,C0439475,false,11087/22402
$nmbr$ - year predicted risk ( % ) of,C0439234;C0439508,false;false,11088/22402
$nmbr$ min / time ),C0702093;C0040223;C3541383;C1524029;C3813700,false;true;false;false;false,11089/22402
$nmbr$ to < $nmbr$ cel,C0208736;C0346421;C0439237;C1413336,true;true;false;false,11090/22402
$nmbr$   mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,11091/22402
$nmbr$ . $nmbr$ i $nmbr$ . $nmbr$ ( n = $nmbr$ ),C0021966;C0221138,true;false,11092/22402
$nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ . $nmbr$ per $nmbr$ $nmbr$ . $nmbr$ per pyr $nmbr$ pyr,,,11093/22402
$nmbr$ . $nmbr$ per $nmbr$ $nmbr$ . $nmbr$ per $nmbr$ pyr pyr,,,11094/22402
$nmbr$ ( $nmbr$ . $nmbr$ ) ( continued ),C0549178,false,11095/22402
$nmbr$ ( only $nmbr$ distal ),C0205171;C0205108;C4522154;C1720467,false;false;false;false,11096/22402
$nmbr$ o / $nmbr$ o $nmbr$ ( $nmbr$ - $nmbr$ % ),C0483204,false,11097/22402
$nmbr$ f $nmbr$ l % $nmbr$,C0016327,true,11098/22402
$nmbr$ ( $nmbr$ s . s ),C0565930;C2603362,false;false,11099/22402
$nmbr$ < $nmbr$ s ) n $nmbr$ ( $nmbr$ . $nmbr$ ),C2986823,true,11100/22402
$nmbr$ - < $nmbr$ years,C0439234,false,11101/22402
$nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ . $nmbr$ per $nmbr$ pyr,,,11102/22402
$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) ],C0040363;C0041260;C1883351,true;true;false,11103/22402
$nmbr$ b ( $nmbr$ b to $nmbr$ a ),,,11104/22402
$nmbr$ st tertile ( < = $nmbr$ mg / dl [ < = $nmbr$ . $nmbr$ mmol / l ] ) b,C0036056;C0439269;C1532563;C3272372,true;false;false;false,11105/22402
$nmbr$ st : $nmbr$ - $nmbr$ . $nmbr$ pmol / l,C0036056;C0439284;C3272372,true;false;false,11106/22402
$nmbr$ - gi,C1708130;C3539617;C4050121,false;false;false,11107/22402
$nmbr$ - h pmg ( mmol / l ),C2827804,false,11108/22402
$nmbr$ - h pmg  mmol / l ( mean ± sd ),C2827804;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11109/22402
$nmbr$ - h postprandial c - peptide ( ng / ml ),C2827809;C0376674;C0006558,false;true;true,11110/22402
$nmbr$ - h postprandial insulin ( miu / ml ),C0033727;C0376674;C0021641;C0439457;C1533581;C1579433;C3714501;C0369286;C0441932;C0564385;C4528284,true;true;true;false;false;false;false;false;false;false;false,11111/22402
$nmbr$ - h postprandial proinsulin ( pmol / l ),C2827799;C0376674;C0033362;C3813208,false;true;true;false,11112/22402
$nmbr$ - hour postload glucose,C0439227;C0017725;C0564385,false;true;false,11113/22402
$nmbr$ - hour ppg  mmol / l,C0439227;C1418888;C1532563;C0564385,false;false;false;false,11114/22402
$nmbr$ - y kaplan - meier rate ( $nmbr$ % ci ),C0871208;C0008107;C3259781;C1521828,false;true;false;false,11115/22402
$nmbr$ — no . / total no . ( % ),C0439175;C0439810,false;false,11116/22402
$nmbr$ ( $nmbr$ to < $nmbr$ ml / min ),C0439445,false,11117/22402
$nmbr$ $nmbr$ to < $nmbr$ kg / m $nmbr$,C1532718,false,11118/22402
$nmbr$ hr after glucose challenge,C3840385,false,11119/22402
$nmbr$ oads,,,11120/22402
$nmbr$ or $nmbr$ d / mo,,,11121/22402
$nmbr$ or $nmbr$ d / wk,,,11122/22402
$nmbr$ or $nmbr$ step,,,11123/22402
$nmbr$ prior tnf antagonist failures  n ( % ) b,C0332152;C3887647;C0231491;C0231174;C0680095;C2826257,false;false;false;false;false;false,11124/22402
$nmbr$ yr . km rate,C0439234;C3887676;C0871208;C1521828,false;false;false;false,11125/22402
$nmbr$  no . / total no . ( % ),C0439175;C0439810,false;false,11126/22402
$nmbr$ . $nmbr$ ( ne  ne ),C0027608;C0028219;C3538705,true;true;false,11127/22402
$nmbr$ . $nmbr$ range $nmbr$ - $nmbr$,C1514721;C2348147;C3542016,false;false;false,11128/22402
$nmbr$ . $nmbr$  range $nmbr$ - $nmbr$,C1514721;C2348147;C3542016,false;false;false,11129/22402
$nmbr$ . $nmbr$ % vi . $nmbr$ . $nmbr$ %,C0205999,true,11130/22402
$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) [ $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) ],C0040363;C0041260;C1883351,true;true;false,11131/22402
$nmbr$ i - $nmbr$ - $nmbr$ ai,C0021966;C0003504;C4551710;C0221138,true;true;false;false,11132/22402
$nmbr$ mg  rosuvastatin $nmbr$ mg .,C1319635;C0965129,false;true,11133/22402
$nmbr$ . $nmbr$ ( ll . $nmbr$ ),,,11134/22402
$nmbr$ / $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,11135/22402
$nmbr$ mgrdl,,,11136/22402
$nmbr$ - $nmbr$ mmol / l,C1532563,false,11137/22402
$nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ . $nmbr$ per $nmbr$ . $nmbr$ per $nmbr$ pyr $nmbr$ pyr,,,11138/22402
$nmbr$ mm hg,C0439475,false,11139/22402
$nmbr$ kg / m $nmbr$,C1532718,false,11140/22402
$nmbr$ . $nmbr$ % vi  $nmbr$ . $nmbr$ %,C0205999,true,11141/22402
$nmbr$ mg / g  n ( % ),C1300563,false,11142/22402
$nmbr$ - < $nmbr$ kg / m $nmbr$,C1532718,false,11143/22402
$nmbr$ ( oh ) vitamin d ( ng / ml ),C0220853;C0014695;C0439275;C0042866;C2936842;C3537249;C3714503,true;true;false;true;false;false;false,11144/22402
$nmbr$ μ g bid ( n = $nmbr$ ),C0439267,false,11145/22402
$nmbr$ to < $nmbr$ — no . { % ),,,11146/22402
$nmbr$ < bmi < $nmbr$,C0578022,false,11147/22402
$nmbr$ ( io - $nmbr$ % ),C1046794;C3146236,false;false,11148/22402
$nmbr$ th — $nmbr$ th percentiles,C0039725;C1264641;C0039738;C1420718;C4282123;C4285344,true;false;true;false;false;false,11149/22402
$nmbr$ c . t,,,11150/22402
$nmbr$ a . g,C0439267,false,11151/22402
$nmbr$ hr prandial glucose ' * ’,C1998602;C0017725;C4553624,true;true;false,11152/22402
$nmbr$ i $nmbr$ ( $nmbr$ i . $nmbr$ ),C0021966;C0221138,true;false,11153/22402
$nmbr$ l . $nmbr$ ( l $nmbr$ . $nmbr$ l ),C3539687,false,11154/22402
$nmbr$ nd tertile ( > $nmbr$ to < = $nmbr$ mg / dl [ > $nmbr$ . $nmbr$ to < = $nmbr$ . $nmbr$ mmol / l ] ) c,C0439269,false,11155/22402
$nmbr$ nd : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ pmol / l,C0439284,false,11156/22402
$nmbr$ s . $nmbr$ ± s . $nmbr$,C0565930;C2603362,false;false,11157/22402
$nmbr$ - < $nmbr$ mo  n ( % ),C0026544;C0332177,true;false,11158/22402
$nmbr$ - $nmbr$ — no . / total no . ( % ),C0439175;C0439810,false;false,11159/22402
$nmbr$ - $nmbr$  no . / totalno . ( % ),,,11160/22402
$nmbr$ - polnt mace,C0349381;C0949745;C1445339,false;true;false,11161/22402
$nmbr$ - yr km mortality rate,C0439234;C3887676;C0026565;C0205848,false;false;true;true,11162/22402
$nmbr$ - yr %,C0439234,false,11163/22402
$nmbr$ – $nmbr$ months,C0439231,false,11164/22402
$nmbr$ ( moderate disease ),C0205081;C0012634;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,11165/22402
$nmbr$ blocker before admission,C0184666;C0809949,false;false,11166/22402
$nmbr$ coenzyme q $nmbr$ subgroups for time to first hospitalization ( number of patients variable ) .,C0041536;C1079230;C0040223;C3541383,true;false;true;false,11167/22402
$nmbr$ mo - $nmbr$ y,C0026544;C0332177,true;false,11168/22402
$nmbr$ . $nmbr$ ( lo - $nmbr$ . $nmbr$ ),C0206579;C1232424,true;false,11169/22402
$nmbr$ − $nmbr$ mg / g,C1300563,false,11170/22402
$nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,11171/22402
$nmbr$ - $nmbr$ ml min ) $nmbr$,C0439445,false,11172/22402
$nmbr$ - $nmbr$ ml / rain,C0439526;C0034640;C1705224;C3887665,false;true;false;false,11173/22402
$nmbr$ - $nmbr$ crcl,C1846718,false,11174/22402
$nmbr$ – ≤ $nmbr$ ml / min,C0439445,false,11175/22402
$nmbr$ days composite of death / new mi / urgent revascularization and definite st,C0205199;C0011065;C4689466;C3810814;C0439609;C0581603;C3272275;C1306577;C4082313;C4552775;C1547335,false;true;false;false;false;false;false;false;false;false;false,11176/22402
$nmbr$ days definite st,C0439228;C0439544;C0036056;C3272372;C1704787,false;false;true;false;false,11177/22402
$nmbr$ days new mi,C0439228;C0205314;C3810814,false;false;false,11178/22402
$nmbr$ days new mi or definite acute st,C0439228;C0205314;C3810814,false;false;false,11179/22402
$nmbr$ days stroke ( ischemic ),C0439228,false,11180/22402
$nmbr$ days until end of study ( landmark analysis ),C0444930;C2826182;C0002778;C0936012;C1524024;C2746065,false;false;false;false;true;false,11181/22402
$nmbr$ days urgent revascularization,C0439228;C0439609;C0581603;C3272275,false;false;false;false,11182/22402
$nmbr$ kg / m $nmbr$ or more,C1532718,false,11183/22402
$nmbr$ mg qd ( n = $nmbr$ ),C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,11184/22402
$nmbr$ to < $nmbr$ mumin,,,11185/22402
$nmbr$ to < $nmbr$ ml / min per $nmbr$ . $nmbr$ m ^,C0439445;C0369637;C0441923,false;false;false,11186/22402
$nmbr$ to < $nmbr$ ml / minute,C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665,false;false;false;false;false;false;false;false,11187/22402
$nmbr$ to less than $nmbr$,C0040363;C0041260;C1883351,true;true;false,11188/22402
$nmbr$ wk,C0332174;C0439230,false;false,11189/22402
$nmbr$ mg ld,C0024671;C0694649;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,11190/22402
$nmbr$ mg q $nmbr$ w,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,11191/22402
$nmbr$ q $nmbr$ w ( n = $nmbr$ ),,,11192/22402
$nmbr$ events [ $nmbr$ . $nmbr$ ],C0441471;C3541888,false;false,11193/22402
$nmbr$ . l ( $nmbr$ . l ),C3539687,false,11194/22402
$nmbr$ s f $nmbr$ ),C0565930;C0016327;C2603362,false;true;false,11195/22402
$nmbr$ ms score †,C2349943;C0449820;C4050231;C3539704;C3713294,false;false;false;false;true,11196/22402
$nmbr$ rd tertile ( > $nmbr$ mg / dl [ > $nmbr$ . $nmbr$ mmol / l ] ) d,C0694666;C0567349;C3642216;C2348885;C0439269;C0439190;C4553350,false;false;false;false;false;false;false,11197/22402
$nmbr$ rd : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ pmol / l,C0694666;C0439284;C4553350,false;false;false,11198/22402
$nmbr$ - $nmbr$ ( < $nmbr$ ml / min ),C0439445,false,11199/22402
$nmbr$ - $nmbr$ — no . ( % ),,,11200/22402
$nmbr$ - point mace ( $nmbr$ - point mace plus hospitalization for unstable angina ),C1552961;C2347617;C3714763,false;false;false,11201/22402
$nmbr$ ‐ point reduction in selena – sledai score  %,C1552961;C0301630;C0451528;C0392756;C1293152;C4551656;C2347617;C3714763,false;false;false;false;false;false;false;false,11202/22402
$nmbr$ - year cumulative incidence  % ( ci ),C0439234;C1511559;C0021149;C0008107;C3259781;C0220856;C0439508,false;false;true;true;false;true;false,11203/22402
$nmbr$ ( severe disease ),C1836348,false,11204/22402
$nmbr$ tcz + mtx,C0025677;C1417487,true;false,11205/22402
$nmbr$ tcz + mtx mtx,C0025677;C1417487,true;false,11206/22402
$nmbr$ week,C0332174;C0439230,false;false,11207/22402
$nmbr$ yrs l,,,11208/22402
$nmbr$ . $nmbr$ ± $nmbr$ . lf,C1416933;C2986618;C4554443,false;false;false,11209/22402
$nmbr$ - $nmbr$  cv disease ( n = $nmbr$  $nmbr$ ),C0007222,true,11210/22402
$nmbr$ / week ( n = $nmbr$ ),C0332174;C0439230,false;false,11211/22402
$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) ],C0040363;C0041260;C1883351,true;true;false,11212/22402
$nmbr$ / day,C0332173;C0439228;C0439505,false;false;false,11213/22402
$nmbr$ min twice / week,C0702093;C1720725;C0332174;C0439230;C1948050;C1524029;C3813700,false;false;false;false;false;false;false,11214/22402
$nmbr$ . $nmbr$ ± ii . $nmbr$,,,11215/22402
$nmbr$ - $nmbr$ ( men ),C0025266,true,11216/22402
$nmbr$ to < $nmbr$ ml / min / $nmbr$  $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,11217/22402
$nmbr$ . i ± ii . $nmbr$,C0021966;C1710602;C4082587;C0221138,true;false;false;false,11218/22402
$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) ],C0040363;C0041260;C1883351,true;true;false,11219/22402
$nmbr$ ( $nmbr$ cl ),C0596019,false,11220/22402
$nmbr$ . $nmbr$ ( io . i ),C1046794;C0021966;C0221138;C3146236,false;true;false;false,11221/22402
$nmbr$ s = scandinavian simvastatin survival study . $nmbr$ woscops = west of scotland coronary prevention study . $nmbr$ care = cholesterol and recurrent events . $nmbr$ post - cabg = post - coronary artery bypass graft . $nmbr$ afcaps / texcaps = air force / texas coronary atherosclerosis prevention study . $nmbr$ lipid = long - term intervention with pravastatin in ischaemic disease . $nmbr$ gissi prevention = gruppo italiano per lo studio della sopravvivenza nell ’ infarto miocardico . $nmbr$ lips = lescol intervention prevention study . $nmbr$ hps = heart protection study . $nmbr$ prosper = prospective study of pravastatin in the elderly at risk . $nmbr$ allhat - llt = antihypertensive and lipid - lowering treatment to prevent heart attack trial . $nmbr$ ascot - lla = anglo - scandinavian cardiac outcomes trial - lipid lowering arm . $nmbr$ alert = assessment of lescol in renal transplantation . $nmbr$ cards = collaborative atorvastatin diabetes study . $nmbr$ s = simvastatin . l = lovastatin . p = pravastatin . f = ﬂ uvastatin . a = atorvastatin . * mean duration of follow - up based on survival times within each trial . overall mean is weighted by trial - speci ﬁ c variances of logrank ( o – e ) for major vascular events . † all trials included dietary intervention : woscops  gissi prevention  lipid  $nmbr$ s  lips  and hps provided dietary advice  afcaps / texcaps  post - cabg  care  allhat  alert  cards  and prosper used american heart association ( aha ) step $nmbr$ diet and care intensi ﬁ ed to step $nmbr$ diet if ldl cholesterol $nmbr$ · $nmbr$ mmol / l ( $nmbr$ mg / dl ) . ‡ other chd includes patients with a history of other symptomatic chd but excludes those with a history of mi ( as already counted in mi column ) . § other vascular includes history of intracerebral bleed  transient ischaemic attack  ischaemic stroke  unknown stroke  and peripheral artery disease . ¶ none includes individuals without a history of mi  symptomatic chd  intracerebral bleed  transient ischaemic attack  ischaemic stroke  unknown stroke  or peripheral artery disease,C0565930;C0240951;C0074554;C0038952;C0557651;C1705493;C0036453;C2603343;C0220921;C2603362;C0150158;C1706420;C0008377;C0687676;C0010055;C0680782;C0039711;C1260596;C1704687;C3469826;C0010054;C0199176;C0023779;C0023981;C0184661;C0085542;C0886296;C1273869;C1706420;C2700409;C0018787;C1736144;C0475224;C0679698;C0206579;C1232424;C0242994;C0489835;C1545588;C0001792;C0035647;C2347090;C4552904;C1999167;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0018787;C0085565;C0008976;C0023779;C0441994;C0446516;C0239110;C0591720;C2004580;C3665546;C3669039;C4084853;C4553014;C3715044;C4553528;C2003888;C1522601;C0022671;C0439394;C0024027;C0085542;C0016327;C1706495;C3642217;C0589120;C1522577;C1704685;C3274571;C0282416;C0444504;C2347634;C2348143;C1561607;C0205082;C0005847;C0441471;C3541888;C1558950;C1801960;C0205164;C4318856;C4521762;C0012171;C0184661;C0199176;C0023759;C1706420;C2700409;C0886296;C1273869;C0420180;C0023779;C0086153;C1999230;C0204932;C0687676;C0010055;C1947933;C0239110;C2004580;C3665546;C3669039;C4084853;C4553014;C1704687;C3469826;C2930619;C3275277;C3898312;C3642216;C0019664;C0231220;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062;C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062;C0005847;C1558950;C1801960;C0038454;C4554100;C0019664;C3810814;C0231220;C0280604;C2937358;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062;C0948008;C0277793;C0439673;C3541433;C4050014;C1261512;C1304680;C0745413;C0038454;C4554100,false;false;true;true;false;false;true;false;true;false;false;false;true;false;true;false;true;false;false;false;true;false;true;true;true;true;false;false;false;true;true;false;false;false;true;false;true;false;false;true;true;false;false;false;true;true;false;false;false;false;false;true;true;true;true;false;true;false;true;false;false;false;false;false;false;false;false;false;true;false;true;true;true;false;false;false;false;false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false;true;true;false;true;false;true;false;false;false;true;true;false;false;false;true;false;false;false;false;false;false;false;false;false;true;false;false;false;true;false;false;false;true;false;false;false;false;true;false;true;false;false;false;false;true;false;false;true;false;true;false;false;false;true;false;true;false;false;false;false;false;false;false;false;false;false;false;false;true;false,11222/22402
$nmbr$ th : $nmbr$ . $nmbr$ - $nmbr$ pmol / l,C0039725;C0439284;C0039738;C1420718;C4282123;C4285344,true;false;true;false;false;false,11223/22402
$nmbr$ - $nmbr$ / week ( n = $nmbr$ ) $nmbr$ - $nmbr$ / week ( n = $nmbr$ ),C0332174;C0439230,false;false,11224/22402
$nmbr$ - asa compounds  n ( % ),C0004057;C0205198;C1706082;C3853627,true;false;false;false,11225/22402
$nmbr$ . $nmbr$ ( $nmbr$ . o - $nmbr$ . o ),C0483204,false,11226/22402
$nmbr$ . $nmbr$ ± l . l,C3539687,false,11227/22402
$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mm,C4330985;C4554674,false;false,11228/22402
$nmbr$ . $nmbr$ or more,,,11229/22402
$nmbr$ - $nmbr$ ml min  $nmbr$,C0439445,false,11230/22402
$nmbr$ - $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,11231/22402
$nmbr$ – < $nmbr$ ml / min,C0439445,false,11232/22402
$nmbr$ - < $nmbr$ kg,C0022718;C0439209;C4054209,true;false;false,11233/22402
$nmbr$ to < $nmbr$ m um in,C0369637;C0441923,false;false,11234/22402
$nmbr$ to < $nmbr$ ml / min ( n = $nmbr$ $nmbr$ ),C0439445,false,11235/22402
$nmbr$ to $nmbr$ y  n ( % ),,,11236/22402
$nmbr$ % decrease in womac pain score,C0392756;C0582148;C0547047,false;false;false,11237/22402
$nmbr$ . $nmbr$ ± b . b,,,11238/22402
$nmbr$ mg / $nmbr$ mgc,C0024671;C3888239;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,11239/22402
$nmbr$ kg / m ’,C1532718,false,11240/22402
$nmbr$ - $nmbr$ ( women ),C0043210,true,11241/22402
$nmbr$ . $nmbr$ ( i $nmbr$ . s ),C0021966;C0221138,true;false,11242/22402
$nmbr$ %  n ( % of patients ),C0369718;C0030705;C0441922,false;true;false,11243/22402
$nmbr$ . $nmbr$ ( $nmbr$ l . l ),C3539687,false,11244/22402
$nmbr$ ( $nmbr$ . $nmbr$ ) / $nmbr$ z ( $nmbr$ ze ),,,11245/22402
$nmbr$ tq - fi ' i,C3555502;C4050619;C0021966;C0221138,true;false;true;false,11246/22402
$nmbr$ fe black *,C3848561;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,11247/22402
$nmbr$ ii ( $nmbr$ . $nmbr$ ),,,11248/22402
$nmbr$ l ( l $nmbr$ ),C3539687,false,11249/22402
$nmbr$ l . $nmbr$ ( l $nmbr$ . $nmbr$ ),C3539687,false,11250/22402
$nmbr$ - mercaptopurine / azathioprine,C0000618;C0004482,true;true,11251/22402
$nmbr$ - min walk distance m,C0702093;C0429886;C0369637;C0441923;C1524029;C3813700,false;false;false;false;false;false,11252/22402
$nmbr$ - min walk distance  ft,C0702093;C0429886;C1881534;C3890579;C1524029;C3813700,false;false;false;false;false;false,11253/22402
$nmbr$ - up and / or aza at baseline,,,11254/22402
$nmbr$ - y incidence rate ( se ) per $nmbr$ participants,C1708485;C0036919;C0679646,false;true;false,11255/22402
$nmbr$ - y rate per $nmbr$ persons ( se )  n,C0871208;C0027361;C0036919;C1521828,false;true;true;false,11256/22402
$nmbr$ - year km %,C0439234;C3887676;C0439508,false;false;false,11257/22402
$nmbr$ days,C0439228,false,11258/22402
$nmbr$ mg / kgf ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,11259/22402
$nmbr$ mq / kq *,C0024853,true,11260/22402
$nmbr$ . $nmbr$ ( g . l ),C0439294;C0456615,false;false,11261/22402
$nmbr$ - $nmbr$  risk  not disease ( n = $nmbr$  $nmbr$ ),C0035647;C4552904,true;false,11262/22402
$nmbr$ to < $nmbr$ yr — no . { % ),C0439234,false,11263/22402
$nmbr$ to < $nmbr$ ml min ’ $nmbr$ $nmbr$ . $nmbr$ m ' $nmbr$,C0439445;C0369637;C0441923,false;false;false,11264/22402
$nmbr$ to < $nmbr$ ml / min / $nmbr$ - $nmbr$,C0439445,false,11265/22402
$nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C0439445;C0369637;C0441923,false;false;false,11266/22402
$nmbr$ to $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C0439445;C0369637;C0441923,false;false;false,11267/22402
$nmbr$ . $nmbr$ ( lo . i ),C0206579;C0021966;C0221138;C1232424,true;true;false;false,11268/22402
$nmbr$ ( $nmbr$ i . i ),C0021966;C0221138,true;false,11269/22402
$nmbr$ to < $nmbr$ yr — no . ( % ),C0439234,false,11270/22402
$nmbr$ to $nmbr$ y ( n = $nmbr$  $nmbr$ . $nmbr$ % ),,,11271/22402
$nmbr$ to $nmbr$ yr,C0439234,false,11272/22402
$nmbr$ years  n ( % ),C0439234,false,11273/22402
$nmbr$ yrs or more,,,11274/22402
$nmbr$ +  no . ( % ),,,11275/22402
$nmbr$ moto < $nmbr$ yr  n ( % ),C0439234,false,11276/22402
$nmbr$ mw distance  m,C0024548;C0012751;C0369637;C0441923;C0026385;C0556966,true;false;false;false;true;false,11277/22402
$nmbr$ mwt ( m ),C0369637;C0441923,false;false,11278/22402
$nmbr$ events  $nmbr$ . $nmbr$ per $nmbr$ py ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ),C0441471;C0030428;C3538810;C3541888,false;true;false;false,11279/22402
$nmbr$ . $nmbr$ % or more,,,11280/22402
$nmbr$ to < $nmbr$ bpm ( n = $nmbr$ ),C0040363;C0041260;C1883351,true;true;false,11281/22402
$nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ) ( continued ),C0549178,false,11282/22402
$nmbr$ - $nmbr$ y  n ( % ),,,11283/22402
$nmbr$ ( $nmbr$ j ) z $nmbr$ ( $nmbr$ . e,,,11284/22402
$nmbr$ . $nmbr$ ± o . lt,C0483204;C0023376;C0230426;C3887647;C4521399,false;true;false;false;false,11285/22402
$nmbr$ ± ll,,,11286/22402
$nmbr$ . $nmbr$ ± l . ot,C0439394;C1318464;C1418208;C1705587;C1706495;C3642217,false;true;false;false;false;false,11287/22402
$nmbr$ nil,C0442734,false,11288/22402
$nmbr$ . l ( $nmbr$ l . $nmbr$ ),C3539687,false,11289/22402
$nmbr$ tcz,,,11290/22402
$nmbr$ - $nmbr$ . $nmbr$ mm,C4330985;C4554674,false;false,11291/22402
$nmbr$ . ' ^ / $nmbr$ t $nmbr$ c } u,C2603360;C0439148,false;false,11292/22402
$nmbr$ - day cce,C0332173;C0439228;C0439505,false;false;false,11293/22402
$nmbr$ - day mortality,C0332173;C0026565;C0026566;C0439228;C0439505,false;true;true;false;false,11294/22402
$nmbr$ mg / $nmbr$ wk ( n = $nmbr$ ),C1881833,false,11295/22402
$nmbr$ or greater,,,11296/22402
$nmbr$ % ci $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$,C0008107;C3259781,true;false,11297/22402
$nmbr$ % ci $nmbr$,C0008107;C3259781,true;false,11298/22402
$nmbr$ % clf,C3540486;C4553190,false;false,11299/22402
$nmbr$ . $nmbr$ i $nmbr$ . $nmbr$ ( n = $nmbr$ ) a,C0021966;C0221138,true;false,11300/22402
a,,,11301/22402
a - blockers,,,11302/22402
α - glucosidase inhibitor,C1512211,false,11303/22402
a - glucosidase inhibitors,C1512211,false,11304/22402
a - glucosidase inhibitors ' $nmbr$,C1512211,false,11305/22402
a $nmbr$ years,C0439234,false,11306/22402
a cardiovascular death or hospitalization for heart failure,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,11307/22402
a compared w,C1707455,false,11308/22402
a compared wi,C1707455;C0043193;C1520135,false;true;false,11309/22402
a decrease of > $nmbr$ points in the cdai score,C0392756;C2924612;C0547047,false;false;false,11310/22402
a excludes two randomized patients with unknown diabetes status at baseline .,,,11311/22402
a median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,11312/22402
a new vertebral fractures ( mfas ),C0205314;C0080179;C1549796;C1549980,false;true;false;false,11313/22402
a prebronchodilator fevl ( % predicted ),C2599602,false,11314/22402
a reslizumab $nmbr$ . $nmbr$ mg / kg n / n,C1869620;C0439272,true;false,11315/22402
a severe hypoglycemia,C0205082;C0020615;C4553659;C4050465;C4050466,false;true;false;false;false,11316/22402
a stroke,C0038454;C4554100,true;false,11317/22402
a vs . c,,,11318/22402
a ) those receiving no inhaled pre - treatment maintenance medication,,,11319/22402
a  no vhd ( n = $nmbr$ $nmbr$ ),,,11320/22402
a . acr $nmbr$,C1412134;C1515941,false;false,11321/22402
a . beuralizuinab $nmbr$ ing q $nmbr$ w,,,11322/22402
a . overall and subgroups bv statin potency - -,C0282416;C1561607,true;false,11323/22402
a . primary composite outcome,C0205225;C0205199;C1274040;C1547335;C0439612;C0439631,false;false;false;false;false;false,11324/22402
a / aml ( n = $nmbr$ ),C0023465;C0023467,true;true,11325/22402
a / c,,,11326/22402
a / ga,C0016993,true,11327/22402
a : worldwide black and non - black patients,C0005680;C0027567;C0085756;C0439541,true;true;true;false,11328/22402
a $nmbr$ vs placebo,,,11329/22402
a $nmbr$ c [ n ( % ) ],C1272460,false,11330/22402
a $nmbr$ c < median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,11331/22402
a $nmbr$ c < $nmbr$ . $nmbr$ %,,,11332/22402
a $nmbr$ c > = median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,11333/22402
a $nmbr$ c  %,,,11334/22402
a $nmbr$ c  % ( mmol / mol ),C3829066,false,11335/22402
a $nmbr$ c > $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ %,,,11336/22402
a $nmbr$ c > $nmbr$ . $nmbr$ %,,,11337/22402
a $nmbr$ c > s . $nmbr$ - s . $nmbr$ %,,,11338/22402
a $nmbr$ . $nmbr$ ± $nmbr$ a . $nmbr$,,,11339/22402
aa,C0282379;C1235746;C1882141;C4554792,true;false;false;false,11340/22402
aa / g,C0282379;C0439267;C1235746;C1882141;C4554792,true;false;false;false;false,11341/22402
abaloparatide - sc  n ( % ),C4042342;C0282380,true;true,11342/22402
abatacept $nmbr$ / $nmbr$ ( n = $nmbr$ ),C1619966,true,11343/22402
abatacept ‡,C1619966,true,11344/22402
abbreviations : ace  angiotensin - converting enzyme  bmi  body mass index ( calculated as weight in kilograms divided by height in meters squared )  dm  diabetes mellitus  hba $nmbr$ c  hemoglobin a $nmbr$ c  hmg - coa  $nmbr$ - hydroxy - $nmbr$ - methylglutaryl coenzyme a . asome subjects took more than $nmbr$ oral anti - dm drug in addition to metformin  and thus the total number of concomitant oral anti - dm drugs in the columns exceed the “ n ” values in the colesevelam hydrochloride and placebo group headings . bsulfonylureas include chlorpropamide  glibenclamide  glimepiride  glipizide  and tolazamide . cthiazolidinediones include pioglitazone  pioglitazone hydrochloride  rosiglitazone  and rosiglitazone maleate . d - glucosidase inhibitors include acarbose or miglitol .,C0000723;C0022709;C1305855;C0005910;C0439209;C0043100;C1305866;C1705104;C0011849;C0019016;C0019046;C4553328;C1825777;C3538758;C0700307;C0009226;C0681850;C1550501;C1706203;C2349001;C2697811;C0011816;C0013227;C0332287;C0025598;C1254351;C3250443;C4288115;C0521115;C0029167;C0011816;C3250443;C0175795;C0304289;C1185738;C1706132;C0032042;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408;C0040372;C0073187;C1512211;C0332173;C4484261,true;true;true;true;false;true;false;false;true;true;true;false;false;false;false;true;false;false;false;false;false;true;true;false;true;false;false;false;false;true;true;false;false;false;false;false;true;false;false;true;false;false;false;false;false;true;true;false;false;false,11345/22402
abbreviations : ace  angiotensin - converting enzyme  iqr  interquartile range  ml  myocardial infarction . si conversion : to convert creatinine clearance to ml / s  multiply by $nmbr$ . $nmbr$ . * data are expressed as no . / total ( % ) unless otherwise specified . festimated using cockroft - gault equation . tthe timi risk score was used to categorize patients at low ( $nmbr$ - $nmbr$ )  intermediate ( $nmbr$ - $nmbr$ )  and high ( $nmbr$ - $nmbr$ ) risk . $nmbr$,C0000723;C0022709;C1514721;C0439526;C1705224;C3887665;C2348147;C3542016;C0021308;C0439836;C1719797;C1511726;C3245479;C3714741;C2911648;C0205369;C0035647;C4552904,true;true;false;false;false;false;false;false;true;false;false;false;false;false;false;false;true;false,11346/22402
abbreviations : acei  angiotensin - converting enzyme inhibitor  arb  angiotensin receptor blocker  bpm  beats per minute  ccb  calcium channel blocker  msdbp  mean sitting diastolic blood pressure  mssbp  mean sitting systolic blood pressure . values are no . ( % ) unless otherwise indicated . amean ± sd . bmore severe  > $nmbr$ and < $nmbr$ mm hg / > $nmbr$ and < $nmbr$ mm hg  less severe  > $nmbr$ and < $nmbr$ mm hg / > $nmbr$ and < $nmbr$ mm hg . blood pressure at baseline is with monotherapy ( ie  before switch to amlodipine / valsar - tan therapy ) .,C0000723;C0003015;C3888198;C0597357;C2757044;C3536837;C4541021;C0439385;C0006684;C0444504;C2347634;C2348143;C3536851;C4521885;C1319894;C0444504;C2347634;C2348143;C0042295;C0025424;C0428257;C2347108;C2347109;C2348272;C0014122;C0022067;C0439453;C1881173;C4554371,true;true;false;false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false;true;false;false;false;false;true;true;false;false;false,11347/22402
abbreviations : bmi  body mass index  cabg  coronary artery bypass graft  nsaids  nonsteroidal anti - inflammatory drugs  pci  percutaneous coronary interventions . * values expressed as number ( percentage ) unless otherwise indicated . percentages may not equal $nmbr$ due to rounding . fhistory of or currently taking antidiabetic or lipid - lowering medications . ^ history of or currently have elevated serum creatinine level but less than $nmbr$ mg / dl_ ( < $nmbr$ pmol / l ) . § patients with a history of skin  prostate  and other cancers with long survival expectancy were not excluded . | | lnsulin and / or oral hypoglycemics . ildata for women only ( n = $nmbr$ for calcium antagonist strategy and n = $nmbr$ for non - calcium antagonist strategy ) .,C0000723;C1305855;C0010055;C0003211;C1532338;C0042295;C0237753;C0439165;C1549488;C1561533;C0449788;C0205163;C0678226;C0332490;C3146286;C0600061;C0679831;C0444099;C0033572;C1123023;C4520765;C0205166;C0038952;C0679138;C0220921;C1706317;C0359086;C0043210;C0205171;C1720467;C0679199,true;true;true;true;true;false;false;false;false;false;false;false;false;false;false;false;false;false;true;true;false;false;true;true;true;false;false;true;false;false;false,11348/22402
abbreviations : chd  coronary heart disease  cl  confidence interval  ml  myocardial infarction  rr  relative risk . ^ defined as a composite end point comprising the first of any of these events : nonfatal ml  nonfatal stroke  or cardiovascular death . tp value for interaction < . $nmbr$ for major cardiovascular event . no other interactions are significant . ^ calculated as weight in kilograms divided by the square of height in meters . § hypertension was defined as a self - reported systolic blood pressure > $nmbr$ mm hg  a diastolic blood pressure > $nmbr$ mm hg  or physician - diagnosed hypertension . | | hyperlipidemia was defined as a self - reported total cholesterol > $nmbr$ mg / dl_ ( $nmbr$ . $nmbr$ mmol / l ) or physician - diagnosed high cholesterol . ^ diabetes defined by self - report . # calculated using the framingham risk score among $nmbr$ $nmbr$ women who provided a blood sample at baseline .,C0000723;C0010068;C0596019;C0009667;C0439526;C1705224;C3887665;C0021308;C4554402;C0242492;C2700400;C0038454;C4554100;C0205082;C1320716;C0205164;C4318856;C4521762;C0005910;C0439209;C0043100;C1305866;C1705104;C0441074;C0475209;C1706378;C0033095;C0439475;C0460139;C1306345;C4284008;C0031831;C0804815;C0201950;C0439269;C1532563;C0543421;C0008377;C0011847;C0011849;C0035647;C0449820;C0043210;C4050231;C4552904;C0168634;C1442488,true;true;false;true;false;false;false;true;false;true;false;true;false;false;false;false;false;false;true;false;true;false;false;false;false;false;true;false;false;false;false;true;false;false;false;false;false;true;false;true;true;false;true;false;false;true;false,11349/22402
abbreviations : da  disc area  e - etdrs  electronic early treatment diabetic retinopathy study  iop  intraocular pressure  oct  optical coherence tomography .,C0000723;C0011318;C0180459;C0017446;C0013850;C3161471;C0011884;C0021888;C0920367;C1547561;C4281784;C0205146;C1556138;C1705370;C2348299;C3668815,true;true;false;true;false;false;true;true;true;false;true;false;false;false;false;false,11350/22402
abbreviations : egfr = estimated glomerular filtration rate  imt = intimal medial thickness  lv = left ventricular . * two - sample comparison t - tests were calculated based on log - transformed variables . * * geometric mean with $nmbr$ % confidence interval in parenthesis .,C0000723;C1739039;C3811844;C0334121;C0162864;C0205098;C1280412;C1256463;C1704614;C4318736;C3812682;C0023128;C0225897;C0205448;C0370003;C1707455;C0871472;C2347026;C0731033;C1881413;C1527178;C1708728;C1510411;C0439828;C2986759;C2986775;C1705938,true;true;false;true;true;false;false;false;false;false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;false;false;false,11351/22402
abbreviations :   teae  treatment - emergent adverse event  gly  glycopyrrolate inhalation solution  bid  twice daily .,C0000723;C4684800;C0017890;C0017970;C1154181;C0585361;C0523677,true;false;true;true;false;false;false,11352/22402
abciximab - facilitated pci,C0288672;C4049621,true;false,11353/22402
abciximab vs . primary,C0288672,true,11354/22402
abl - sc mean,C0023139;C0282380;C0444504;C2347634;C2348143;C1704928;C3890208,true;true;false;false;false;false;false,11355/22402
abl - sc n / n,C0023139;C0282380;C1704928;C3890208,true;true;false;false,11356/22402
about $nmbr$ mg / l or more,C0439268,false,11357/22402
about $nmbr$ mg / l,C0439268,false,11358/22402
absence,C0332197;C1689985,false;false,11359/22402
absolute ( l ),C0205344,false,11360/22402
absolute decline in fvc > $nmbr$ % predicted,C0205344;C3714541,false;true,11361/22402
absolute decline in fvc > $nmbr$ % predicted or death  n ( % ),C0205344;C3714541,false;true,11362/22402
absolute difference estimate vs placebo ( $nmbr$ % ci ),C1549031;C0750572,false;false,11363/22402
absolute risk difference ( $nmbr$ % cl ),C1549031;C0035647;C0596019;C4552904;C1519101;C1705241;C1705242,false;true;false;false;false;false;false,11364/22402
absolute risk reduction ( $nmbr$ % ci )  % / y,C3179139;C0008107;C3259781,true;true;false,11365/22402
absolute risk reduction ( $nmbr$ % cl ) *,C3179139;C0596019,true;false,11366/22402
absolute risk reductions,C3179139,true,11367/22402
absolute time spent “ on ” with troublesome dyskinesia  h / day,C0439546,false,11368/22402
absolute time spent “ on ” without troublesome dyskinesia  h / day,C0439546,false,11369/22402
absolute time spent “ on ”  h / day,C0439546,false,11370/22402
absolutedifferenceestimate vs placebo ( $nmbr$ % ci ),,,11371/22402
access site,C0589360,false,11372/22402
accord acr < $nmbr$ - $nmbr$,C0680240;C1412134;C1515941,false;false;false,11373/22402
accord acr > $nmbr$ - $nmbr$,C0680240;C1412134;C1515941,false;false;false,11374/22402
accord primary  n ( % ),C0680240;C0205225;C0439612;C0439631,false;false;false;false,11375/22402
acd,C4554601,false,11376/22402
ace - i ( n  % ),C1452534;C0021966;C0221138;C4284014,true;true;false;false,11377/22402
ace ‐ i or arb,C1452534;C0021966;C0221138;C4284014,true;true;false;false,11378/22402
ace - i or arb  % ( n ),C1452534;C0021966;C0221138;C4284014,true;true;false;false,11379/22402
ace - inhibitor or arb ( % ),C0003015;C4541021,true;false,11380/22402
ace - inhibitors,C0003015,true,11381/22402
ace = angiotensin - converting enzyme  cabg = coronary artery bypass graft  ccsc = canadian cardiovascular society classification  mi = myocardial infarction  pci = percutaneous coronary,C0022709;C0010055;C0545743;C0189695;C3640258;C0027051,true;true;false;false;false;true,11382/22402
ace inhibitor / arb,C0003015;C3888198;C4541021,true;false;false,11383/22402
ace inhibitor and / or arb,C0003015;C4541021,true;false,11384/22402
ace inhibitor or arb use,C0003015;C4541021,true;false,11385/22402
ace inhibitor treatment,C0003015;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4541021,true;true;true;false;false;false;false;false;false,11386/22402
ace inhibitor use ( % ),C0003015;C0042153;C0457083;C1947944;C4541021,true;true;false;false;false,11387/22402
ace inhibitor  arb  or both,C0003015;C3888198;C4541021,true;false;false,11388/22402
ace inhibitor / arb therapy,C1444755;C3888198,false;false,11389/22402
ace inhibitor / arb  %,C0003015;C3888198;C4541021,true;false;false,11390/22402
ace inhibitors or angiotensin - receptor blockers,C0003015,true,11391/22402
ace or arb,C1452534;C4284014,true;false,11392/22402
ace / arb,C1452534;C3888198;C4284014,true;false;false,11393/22402
ace / arb use,C1452534;C3888198;C4284014,true;false;false,11394/22402
ace / arb users,C1452534;C3888198;C1706077;C4284014,true;false;false;false,11395/22402
ace = angiotensin - converting enzyme . arb = angiotensin receptor blockers .,C0022709;C3888198;C0597357,true;false;false,11396/22402
acei and / or arb,,,11397/22402
acei  n ( % ),,,11398/22402
acei / arb therapy  n ( % ),C3888198;C0039798;C0087111;C1363945,false;true;true;false,11399/22402
aceis,,,11400/22402
aceis  angiotensin - converting enzyme inhibitors  c  candesartan  des  drug - eluting stent  egfr  estimated glomerular filtration rate  hdl  high - density lipoprotein  ldl  low - density lipoprotein  nc  non - candesartan .,C0003015;C0717550;C0011702;C4551552;C2757044;C0038257;C1739039;C3811844;C3812682;C0023823;C0027964;C1518422;C0717550;C0028407;C0067895;C0265987,true;true;true;true;false;true;true;false;false;true;true;false;true;true;true;false,11401/22402
aceis  n ( % ),,,11402/22402
acetaminophen,C0000970;C2917659,true;false,11403/22402
aclidinium $nmbr$ pg,C2699757;C0030827;C0072225;C1266240,false;true;true;false,11404/22402
aclidinium $nmbr$ pg vs placebo,C2699757;C0030827;C0072225;C1266240,false;true;true;false,11405/22402
aclidinium $nmbr$   μ g ( n   =   $nmbr$ ) a,C2699757;C0439267,false;false,11406/22402
aclidinium $nmbr$   μ g ( n   =   $nmbr$ ) b,C2699757;C0439267,false;false,11407/22402
aclidinium $nmbr$   μ g ( n   =   $nmbr$ ),C2699757;C0439267,false;false,11408/22402
aclidinium $nmbr$   μ g bid ( n   =   $nmbr$ ),C2699757;C0439267,false;false,11409/22402
aclidinium / formoterol $nmbr$ / $nmbr$ pg twice daily,C2699757;C0060657;C0030827;C0585361;C0072225;C1266240,false;true;true;false;true;false,11410/22402
acpa positive,C1525410;C0439178;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false,11411/22402
acpa positive  no . ( % ),C1525410;C0439178;C1446409;C1514241;C2825490;C3812269;C1706063,false;false;false;false;false;false;false,11412/22402
acq - $nmbr$ score,C2919686,false,11413/22402
acq - $nmbr$ score ' ! ',C2919686,false,11414/22402
acq - $nmbr$ score  mean ( sd ) e,C2919686;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,11415/22402
acq - $nmbr$ score 本,C2919686,false,11416/22402
acq - $nmbr$ total score ∗,C2919686;C2964552,false;false,11417/22402
acq score  mean,C2919686;C0449820;C0444504;C2347634;C2348143;C4050231,false;false;false;false;false;false,11418/22402
acq $nmbr$ score  mean ( sd ),C2919686;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,11419/22402
acr ( mg / g )  mean ( sd ),C1412134;C1300563;C0444504;C2699239;C2347634;C2348143;C1515941,false;false;false;false;false;false;false,11420/22402
acr > $nmbr$ mg / g,C1412134;C1300563;C1515941,false;false;false,11421/22402
acr functional class  n ( % ),C1412134;C0205245;C0456387;C1518526;C1705943;C0542341;C2700217;C1515941,false;false;false;false;false;false;false;false,11422/22402
acr response by baseline mtx use  no . / total no . ( % ) acr $nmbr$,C1412134;C0871261;C0168634;C0025677;C1417487;C1442488;C1704632;C1706817;C2911692;C1515941,false;false;true;true;false;false;false;false;false;false,11423/22402
acr response by baseline weight,C1412134;C0871261;C1303013;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false;false,11424/22402
acr response  % acr $nmbr$,C1412134;C0871261;C1704632;C1706817;C2911692;C1515941,false;false;false;false;false;false,11425/22402
acr $nmbr$ week $nmbr$ responders  ( n = $nmbr$ ),C1412134;C0332174;C0439230;C1515941,false;false;false;false,11426/22402
acs ( n = $nmbr$  $nmbr$ ),C0742343;C4318612,true;false,11427/22402
acs event,C0742343;C0441471;C4019010;C4318612,true;false;false;false,11428/22402
acs management  no . ( % ),C0742343;C0001554;C0376636;C1273870;C3273539;C4318612,true;true;true;false;false;false,11429/22402
acs presentation,C0742343;C0449450;C4318612,true;false;false,11430/22402
act - $nmbr$,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,11431/22402
act total score ≥   $nmbr$,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,11432/22402
act total score   ≥   $nmbr$ and / or improvement from baseline   ≥   $nmbr$,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,11433/22402
act . $nmbr$,C0079613;C1704930;C1869853;C3890007;C4048375,true;false;true;false;false,11434/22402
action tested is between the continuous variable and treatment .,C0441472;C3266814,false;false,11435/22402
active,C0205177;C3853793;C3888249,false;false;false,11436/22402
active - control study,C2347179;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1706449;C0557651;C2603343,false;true;false;false;false;false;false;false;false;false,11437/22402
active canakinumab ( n   =   $nmbr$  $nmbr$ ),C0205177;C2718773;C3853793;C3888249,false;true;false;false,11438/22402
active cancer at any timeb,C0205177;C0006826;C0998265;C1306459;C3853793;C3888249,false;true;false;false;false;false,11439/22402
active cancer at baseline,C0205177;C0006826;C0168634;C1442488;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false;false,11440/22402
active cancer at randomisation,C0205177;C0006826;C0034656;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false,11441/22402
active cancer at randomization,C0205177;C0006826;C0034656;C0998265;C1306459;C3853793;C3888249,false;true;true;false;false;false;false,11442/22402
active comparatorb,C0205177;C3853793;C3888249,false;false;false,11443/22402
active pso wi $nmbr$ bsa > $nmbr$ %  n ( . % y,C0205177;C0043193;C1520135;C3853793;C3888249,false;true;false;false;false,11444/22402
active smokers,C0205177;C0337664;C3853793;C3888249,false;true;false;false,11445/22402
active treatment,C1704532,false,11446/22402
active vs placebo,C0205177;C3853793;C3888249,false;false;false,11447/22402
active   versus   placebo,C0205177;C3853793;C3888249,false;false;false,11448/22402
activities of daily living updrs subscore ( baseline )  mean ( sd ),C0001288;C3639721;C0168634;C0444504;C2699239;C2347634;C2348143;C1442488;C4050548,true;true;true;false;false;false;false;false;false,11449/22402
activity,C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false,11450/22402
activity ( range $nmbr$ - $nmbr$ )  mean ± sd,C0205177;C1514721;C0444504;C2699239;C2347634;C2348143;C2348147;C3542016;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false;false;false;false;false;false;false,11451/22402
activity limitation,C0205177;C0443288;C0449295;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false;false,11452/22402
actual ( l ),C0237400,false,11453/22402
actual or estimated weight  kg,C0237400,false,11454/22402
acuity - bleeding major / minor,C0750509,false,11455/22402
acuity major or,C0750509,false,11456/22402
acuity minor,C0750509,false,11457/22402
acute increase in serum creatinine,C1546542;C0442805;C0010294;C1561535;C0205178;C0201976;C0600061,false;false;true;false;false;false;false,11458/22402
acute medication intake ( days / month ),C0205178;C0013227;C1512806;C0556971;C3244316;C4284232,false;true;false;false;false;false,11459/22402
acute reperfusion,C0205178;C0035124;C0684253,false;true;false,11460/22402
acute stent thrombosis ( definite or probable ),C0205178;C3897493,false;false,11461/22402
adalimumab,C1122087,true,11462/22402
adamantane derivatives,C3653470,false,11463/22402
add - on to met,C1883712;C0428210;C1550543;C4317104,false;false;false;false,11464/22402
add - on to met + su $nmbr$,C1883712;C0428210;C0038642;C1705534;C1550543;C4317104,false;false;true;false;false;false,11465/22402
add - on to met + su,C1883712;C0428210;C0038642;C1705534;C1550543;C4317104,false;false;true;false;false;false,11466/22402
add - on to met $nmbr$,C1883712;C0428210;C1550543;C4317104,false;false;false;false,11467/22402
additional angiography,C1524062;C0002978,false;true,11468/22402
additional antihypertensive subgroup,C1524062;C0003364;C1079230;C1515021,false;true;false;false,11469/22402
additional endpoints,C1524062;C2349179,false;false,11470/22402
additional heparin,C1524062;C0019134;C0770546,false;true;false,11471/22402
additional radiographic findings at week $nmbr$,C1524062;C0444708;C2607943;C0332174;C0439230;C2926606;C3539655,false;false;true;false;false;false;false,11472/22402
additional subgroup analyses,C1524062;C2986480,false;false,11473/22402
adhere,C3714578,false,11474/22402
adherence > $nmbr$ %,C1510802,false,11475/22402
adherence to study regimen — no . ( % ),C1510802,false,11476/22402
adherence to study regimen — no . ( % ) ff,C1510802,false,11477/22402
adiusted hazard ratio *,C2985465,false,11478/22402
adj . hr ( $nmbr$ % cl ) a,C0001552;C0596019;C2826286,true;false;false,11479/22402
adjudicated mace $nmbr$,C0349381;C0949745;C1445339,false;true;false,11480/22402
adjusted $nmbr$ or ( $nmbr$ % cl ),C0456081,false,11481/22402
adjusted change from baseline,C0456081;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false,11482/22402
adjusted exacerbation rate ( per patient peryear ),C0456081;C4086268;C0871208;C0030705;C1521828,false;false;false;true;false,11483/22402
adjusted exacerbation rate { per patient peryear ),C0456081;C4086268;C0871208;C0030705;C1521828,false;false;false;true;false,11484/22402
adjusted for all baseline variables and interaction between acei and baseline upb,C0456081;C0168634;C0439828;C1442488,false;true;false;false,11485/22402
adjusted for all baseline variables  interaction between acei and baseline up  and declines in sbp and up,C0456081;C0168634;C0439828;C1704675;C1442488,false;true;false;false;false,11486/22402
adjusted for all baseline variables $nmbr$,C0456081;C0168634;C0439828;C1442488,false;true;false;false,11487/22402
adjusted hazard ratio ( $nmbr$ % ci ) †,C0456081;C2985465;C0008107;C3259781,false;false;true;false,11488/22402
adjusted hazard ratio ( $nmbr$ % cl ) *,C0456081;C2985465;C0596019,false;false;false,11489/22402
adjusted hazard ratio ≠ ( $nmbr$ % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,11490/22402
adjusted hazard ratio *,C0456081;C2985465,false;false,11491/22402
adjusted hazard ratio § ( $nmbr$ % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,11492/22402
adjusted hazard ratio ‡ ( $nmbr$ % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,11493/22402
adjusted hr ( $nmbr$ % ci ) * compared with no diabetes at bl or at year $nmbr$,C0456081;C0008107;C3259781,false;true;false,11494/22402
adjusted hr ( $nmbr$ % ci ) * comparing idm with bl,C0456081;C0008107;C1707455;C0270221;C0005918;C0006413;C1552663;C2827109;C3259781,false;true;false;false;true;true;false;false;false,11495/22402
adjusted hr losartan vs atenolol *,C0456081;C0126174,false;true,11496/22402
adjusted hr * ( $nmbr$ % ci ),C0456081;C0008107;C3259781,false;true;false,11497/22402
adjusted hr * ( $nmbr$ % cl ) pvalue,C0456081;C0596019,false;false,11498/22402
adjusted hr  $nmbr$ % ci,C0456081;C0008107;C3259781,false;true;false,11499/22402
adjusted mean ( se ),C0456081;C0444504;C0036919;C2347634;C2348143,false;false;true;false;false,11500/22402
adjusted mean ( se ) fevi auco_ $nmbr$  ml,C0456081;C0444504;C0036919;C0429706;C0439526;C1705224;C3887665;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false;false;false,11501/22402
adjusted mean ( se ) trough fevi  ml,C0456081;C0444504;C0036919;C0444506;C0429706;C0439526;C1705224;C3887665;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false;false;false;false,11502/22402
adjusted mean _ se change from baseline,C0456081;C0444504;C0036919;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;true;false;false;false;false;false;false,11503/22402
adjusted mean ± se change from baseline,C0456081;C0444504;C0036919;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;true;false;false;false;false;false;false,11504/22402
adjusted mean change ( kg ),C0456081;C0444504;C0392747;C0022718;C0439209;C4054209;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,11505/22402
adjusted mean change from baseline,C0456081;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false,11506/22402
adjusted mean change from baseline ( se ),C0456081;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;true;false;false;false;false;false;false,11507/22402
adjusted mean difference ( $nmbr$ % ci ),C0456081;C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,false;false;false;true;false;false;false;false,11508/22402
adjusted modelc hr  $nmbr$ % ci  p value,C0456081;C0008107;C1709380;C3259781,false;true;false;false,11509/22402
adjusted or ( $nmbr$ % ci ) b,C0456081,false,11510/22402
adjusted or ( $nmbr$ % ci ) c,C0456081,false,11511/22402
adjusted or ( $nmbr$ % cl ),C0456081,false,11512/22402
adjusted rate of fev $nmbr$   decline ( se )  ml / yr,C0456081;C0871208;C3714541;C0036919;C0439526;C0439234;C1705224;C3887665;C1521828,false;false;true;true;false;false;false;false;false,11513/22402
adjusted rate of hospitalized pneumonia events ( per patient - year )  mean ( $nmbr$ % ci ),C0456081;C0871208;C0701159;C0032285;C0441471;C3541888;C1521828,false;false;false;true;false;false;false,11514/22402
adjusted rate of pneumonia events ( per patient - year )  mean ( $nmbr$ % ci ),C0456081;C0871208;C0032285;C0441471;C3541888;C1521828,false;false;true;false;false;false,11515/22402
adjusted *   hr,C0456081,false,11516/22402
adjusted ∗   mean ( se ) ( ml ),C0456081;C0444504;C0036919;C0439526;C1705224;C3887665;C2347634;C2348143,false;false;true;false;false;false;false;false,11517/22402
adjusted ∗   mean of difference ( se ) ( ml ),C0456081;C0444504;C1705241;C0036919;C0439526;C1705224;C3887665;C1705242;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false,11518/22402
adjusted ⁎ hazard ratio ( $nmbr$ % ci ),C0456081;C2985465;C0008107;C3259781,false;false;true;false,11519/22402
adjustedahr,,,11520/22402
adjustedaor,,,11521/22402
adjustedb  c beta ( se ),C0330390;C0036919;C0439096;C2004068,false;true;false;false,11522/22402
administration of study - drug bolus — no . / total no . ( % ),C3161471;C0013227;C1186706;C1511237;C1705509;C3812160;C1254351;C0001554;C0013175;C1533734;C0557651;C0150270;C0262754;C3469597;C2603343,false;true;false;false;false;false;false;true;true;false;false;false;false;false;false,11523/22402
administration of study drug ( % ),C3161471;C0013227;C1254351;C0001554;C0013175;C1533734;C0557651;C0150270;C0262754;C3469597;C2603343,false;true;false;true;true;false;false;false;false;false;false,11524/22402
admission grace score,C0184666;C0809949,false;false,11525/22402
adolescents ( aged $nmbr$ - $nmbr$ y )  no . ( % ),C0205653,true,11526/22402
adults ( aged   ≥ $nmbr$ y )  no . ( % ),C0001675,true,11527/22402
advanced  n ( % ),C0205179,false,11528/22402
adverse event,C0877248,false,11529/22402
adverse events ( any grade ),C0877248;C1705413,false;false,11530/22402
adverse events leading to premature treatment discontinuation,C0877248;C1705413,false;false,11531/22402
ae ' ( per cm / s ),C3887670;C0439392,false;false,11532/22402
ae / a ratio ( per $nmbr$ . $nmbr$ unit ),C3887670,false,11533/22402
ae / e ' ratio ( per $nmbr$ unit ),C3887670;C0456603;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C1547037,false;false;false;false;false;false;false;false;false;false,11534/22402
aed inducer status,C0887457;C3898767;C0449438,true;false;false,11535/22402
aerobic exercise,C0001701,true,11536/22402
aes in ≥ $nmbr$ japanese patients in a study arm  n ( % ) §,C1412268;C0376247;C0030705;C1556094;C2699274,false;false;true;true;false,11537/22402
aes leading to,C1412268;C2699274,false;false,11538/22402
aes leading to discontinuation of study drugb,C1412268;C2699274,false;false,11539/22402
aes leading to dose reduction of study drugb,C1412268;C2699274,false;false,11540/22402
aes related to,C1412268;C2699274,false;false,11541/22402
aes *,C1412268;C2699274,false;false,11542/22402
aetiology of pah,C0015127;C0030123;C3203102;C4284467;C1314792;C1524003,true;true;true;false;true;false,11543/22402
af alone refers to atrial fi - brillation without coexisting cardiovascular conditions but with left atrial dilatation . ace denotes angiotensin - con - verting enzyme  hf heart failure  and lvd left ventricular dysfunction .,C0344434;C4049859;C0012634;C0348080;C1705253;C3864998;C0387288;C0014442;C0018801;C4521602,false;false;true;false;false;false;true;true;true;false,11544/22402
af duration  n ( % ),C0344434;C0449238;C2926735;C4049859,false;false;false;false,11545/22402
af first diagnosis > $nmbr$ years  n ( % ),C0344434;C0205435;C0011900;C0439234;C1704338;C1704656;C1279901;C4049859,false;false;true;false;true;false;false;false,11546/22402
af on baseline ecg  n ( % ),C0344434;C0168634;C1623258;C1442488;C4049859,false;true;true;false;false,11547/22402
af or atrial flutter !,C0344434;C4049859,false;false,11548/22402
af type,C0344434;C0332307;C1547052;C4049859,false;false;false;false,11549/22402
af type — no . ( % ),C0344434;C0332307;C1547052;C4049859,false;false;false;false,11550/22402
affected body - surface area > $nmbr$ % — no . { % ),C1879646;C0205148;C0392760;C0005902;C1314939,false;false;false;true;false,11551/22402
africa ! near east,C0001737;C1707877,true;false,11552/22402
africa or near east,C0001737,true,11553/22402
african american n = $nmbr$,C0085756,true,11554/22402
african american  n ( % ),C0085756,true,11555/22402
african american / black,C0085756;C0005680;C0027567;C0439541,true;true;true;false,11556/22402
african descent,C0027567,true,11557/22402
after bronchodilator use,C0006280;C0042153;C0457083;C1947944,true;true;false;false,11558/22402
ag,C0002037;C0051080;C0152305;C3888235,true;true;true;false,11559/22402
ag + gg,C0002037;C0017454;C0018370;C0051080;C0152305;C3888235,true;true;true;true;true;false,11560/22402
aga group,C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,11561/22402
age - mean ( sd ) years,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11562/22402
age — y  meantsd,C0001779,false,11563/22402
age — yr age group — no . ( % ),C0027362;C0439234;C2348001,true;false;false,11564/22402
age — yr race — no . ( % ) f,C0001779;C0439234,false;false,11565/22402
age & $nmbr$,C0001779,false,11566/22402
age ( median [ iqr ] )  y,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11567/22402
age ( median  years ),C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11568/22402
age ( p = o - $nmbr$ ),C0001779,false,11569/22402
age ( per $nmbr$ years ),C1510829,false,11570/22402
age ( sd )  y,C0001779;C2699239,false;false,11571/22402
age ( y ) [ mean - sd ],C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11572/22402
age ( y ) ∗,C0001779,false,11573/22402
age ( y )  mean ( range ),C0001779;C0444504;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,11574/22402
age ( y )  mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11575/22402
age ( y )  median ( min  max ),C0001779;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,11576/22402
age ( y )  median ( min  max },C0001779;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,11577/22402
age ( year )  mean ± sd,C0001779;C0439234;C0444504;C2699239;C2347634;C2348143;C0439508,false;false;false;false;false;false;false,11578/22402
age ( years ( s . d . ) ),C1510829,false,11579/22402
age ( years ) ( mean ± sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11580/22402
age ( years )  mean _ sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11581/22402
age ( years )  mean ± s . d .,C1510829;C0444504;C2347634;C2348143,false;false;false;false,11582/22402
age ( years )  mean   ±   sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11583/22402
age ( years )  median ( range ),C1510829;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,11584/22402
age ( years ) : mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11585/22402
age ( years ) a,C1510829,false,11586/22402
age ( years  sd ),C1510829;C2699239,false;false,11587/22402
age ( yr ) *,C0001779;C0439234,false;false,11588/22402
age ( yr )  mean ( sd ),C0001779;C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,11589/22402
age ( yr )  mean ( sd ) bmd t - score  mean ( sd ),C0001779;C0439234;C3533236;C2699239,false;false;false;false,11590/22402
age [ year ]  mean ± sda,C0001779;C0439234;C0444504;C0276477;C1428349;C1553165;C2347634;C2348143;C0439508,false;false;false;false;false;false;false;false;false,11591/22402
age [ years ],C1510829,false,11592/22402
age [ years ]  median ( range ),C1510829;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,11593/22402
age £ $nmbr$ years ( itt ) ( n = $nmbr$ ),C1510829,false,11594/22402
age < $nmbr$ gd lesion > $nmbr$ n = $nmbr$,C0001779;C0221198;C1546698,false;false;false,11595/22402
age < $nmbr$ gd lesion = $nmbr$ n = $nmbr$,C0001779;C0221198;C1546698,false;false;false,11596/22402
age < $nmbr$ years and bmi < $nmbr$ kg / m $nmbr$,C1510829,false,11597/22402
age < $nmbr$ years and bmi ≥ $nmbr$ kg / m $nmbr$,C1510829,false,11598/22402
age < $nmbr$ vears n = $nmbr$,C0001779,false,11599/22402
age < $nmbr$ years ( itt ) ( n = $nmbr$ ),C1510829,false,11600/22402
age < $nmbr$ years ( n = $nmbr$  $nmbr$ ),C1510829,false,11601/22402
age < $nmbr$ years  n ( % ),C1510829,false,11602/22402
age < $nmbr$ yr or > $nmbr$ yr,C0001779;C0439234,false;false,11603/22402
age < $nmbr$ : qvai $nmbr$ - sfc,C0001779;C4521536,false;false,11604/22402
age < $nmbr$ years ( n =,C1510829,false,11605/22402
age ≥ $nmbr$ years and bmi < $nmbr$ kg / m $nmbr$,C1510829,false,11606/22402
age ≥ $nmbr$ years and bmi ≥ $nmbr$ kg / m $nmbr$,C1510829,false,11607/22402
age ≥ $nmbr$ years,C1510829,false,11608/22402
age ≥ $nmbr$ years  n ( % ),C1510829,false,11609/22402
age ≥ $nmbr$ yearsa,C0001779,false,11610/22402
age >,C0001779,false,11611/22402
age > - median,C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11612/22402
age > $nmbr$ gd lesion > $nmbr$ n = $nmbr$,C0001779;C0221198;C1546698,false;false;false,11613/22402
age > $nmbr$ gd lesion = $nmbr$ n = $nmbr$,C0001779;C0221198;C1546698,false;false;false,11614/22402
age > $nmbr$ yr ( % ),C0001779;C0439234,false;false,11615/22402
age > $nmbr$ yr and elevated biomarkers,C0001779;C0439234,false;false,11616/22402
age > $nmbr$ yr and st - segment changes,C0001779;C0439234,false;false,11617/22402
age > $nmbr$ yr  elevated biomarkers  and st - segment changes,C0001779;C0439234;C0205250;C0005516;C3163633,false;false;false;true;false,11618/22402
age > $nmbr$ ( years ) t,C1510829,false,11619/22402
age > $nmbr$ vears n = $nmbr$,C0001779,false,11620/22402
age > $nmbr$ y ( % ),C0001779,false,11621/22402
age > $nmbr$ y *,C0001779,false,11622/22402
age > $nmbr$ yr — no . ( % ),C0001779;C0439234,false;false,11623/22402
age > $nmbr$ yr  no . ( % ),C0001779;C0439234,false;false,11624/22402
age > $nmbr$ : qvai $nmbr$ - sfc,C0001779;C4521536,false;false,11625/22402
age > $nmbr$ y  n / n ( % ),C0001779,false,11626/22402
age > $nmbr$ years ( itt ) ( n = $nmbr$ ),C1510829,false,11627/22402
age > $nmbr$ years ( n = $nmbr$ ),C1510829,false,11628/22402
age > $nmbr$ yrs  n ( % ),C0001779,false,11629/22402
age ± sd ( yrs ),C0001779;C2699239,false;false,11630/22402
age $nmbr$ $nmbr$ y,C0001779,false,11631/22402
age $nmbr$ years,C1510829,false,11632/22402
age $nmbr$ years ( n = $nmbr$ ),C1510829,false,11633/22402
age $nmbr$ * $nmbr$ yr,C0001779;C0439234,false;false,11634/22402
age $nmbr$ - $nmbr$ yr  elevated biomarkers  and previous vascular,C0001779;C0439234;C0205250;C0005516;C3163633,false;false;false;true;false,11635/22402
age $nmbr$ - $nmbr$ y ( n = $nmbr$ ),C0001779,false,11636/22402
age $nmbr$ - $nmbr$,C0001779,false,11637/22402
age $nmbr$ - $nmbr$ years ( itt ) ( n = $nmbr$ ),C1510829,false,11638/22402
age $nmbr$ - $nmbr$ years ( n = $nmbr$ ),C1510829,false,11639/22402
age $nmbr$ +,C0001779,false,11640/22402
age $nmbr$ + y,C0001779,false,11641/22402
age $nmbr$ + years,C1510829,false,11642/22402
age a $nmbr$,C0001779,false,11643/22402
age at asthma diagnosis years,C1828181;C0004096;C0439234;C2984299;C3173302,false;true;false;false;false,11644/22402
age at baseline ( years ),C1510829;C0168634;C1442488,false;true;false,11645/22402
age at baseline in years  mean ( sd ),C0001779;C0168634;C1442488,false;true;false,11646/22402
age at diagnosis < $nmbr$ years,C1828181;C0439234;C3173302,false;false;false,11647/22402
age at diagnosis of ln  years,C1828181;C0861352;C0439234;C1428884;C3714709;C3173302,false;false;false;false;false;false,11648/22402
age at diagnosis of sle  years,C1828181;C0024141;C0439234;C3173302,false;true;false;false,11649/22402
age at diagnosis s $nmbr$ years,C1828181;C0439234;C3173302,false;false;false,11650/22402
age at disease onset  n ( % ) *,C0206132;C0012634;C3870509,true;true;false,11651/22402
age at disease onset  years *,C0206132;C0012634;C0439234;C3870509,true;true;false;false,11652/22402
age at enrollment ( years )  mean ( sd ),C1510829;C1516879;C0444504;C2699239;C2347634;C2348143;C1696073;C3888021,false;false;false;false;false;false;false;false,11653/22402
age at entry ( years ),C1510829;C1705654,false;false,11654/22402
age at lipid randomization ( y ),C0001779;C0065033;C0034656,false;true;true,11655/22402
age at menopause ( yr ),C1625754;C0439234;C1629609,false;false;false,11656/22402
age at time of first seizure,C0001779;C0040223;C0205435;C0036572;C1959629;C4553401;C1279901;C3541383,false;true;false;true;false;false;false;false,11657/22402
age b $nmbr$ y ( n = $nmbr$ ),C0001779,false,11658/22402
age categories,C2916832,false,11659/22402
age categories ( y )  n ( % ),C2916832,false,11660/22402
age categories  n ( % ),C2916832,false,11661/22402
age category  n ( % ),C0001779;C0683312;C3889287,false;false;false,11662/22402
age category  n ( % ) < $nmbr$ years,C1510829;C0683312;C3889287,false;false;false,11663/22402
age category  n ( % ) :,C0001779;C0683312;C3889287,false;false;false,11664/22402
age cohort  no . ( % ),C2348001,false,11665/22402
age distribution,C0001782,true,11666/22402
age distribution  n ( % ),C0001782,true,11667/22402
age distribution  years  n ( % ),C1510829;C0520511;C1704711;C0001782;C0439234,false;false;true;true;false,11668/22402
age groiro : < $nmbr$ years,C1510829,false,11669/22402
age group — no . ( % ),C0027362;C2348001,true;false,11670/22402
age group ( ≥ $nmbr$ years ) — no . ( % ),C1510829;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0027362;C0439234;C2348001,false;false;false;true;false;false;false;true;false;false,11671/22402
age group ( ≥ $nmbr$ ) — no . ( % ),C0027362;C2348001,true;false,11672/22402
age group ( y ),C0001779;C0441858,false;false,11673/22402
age group $nmbr$,C0027362;C2348001,true;false,11674/22402
age groups,C0027362,true,11675/22402
age groups  n ( % ),C0001779;C0441848,false;false,11676/22402
age in years  mean,C1510829;C0444504;C2347634;C2348143,false;false;false;false,11677/22402
age in years  median ( iqr ),C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11678/22402
age is > $nmbr$ vrs  positive biomarkers  and no si . gni . fi . canr ecg changes,C0001779,false,11679/22402
age is > $nmbr$ vrs  significant ecg changes  and no positive bi . omark . ers,C0001779,false,11680/22402
age is > $nmbr$ vrs  significant ecg changes  and positive biomarkers,C0001779,false,11681/22402
age mean age  years sex,C1510829;C0444504;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C2347634;C2348143,false;false;true;true;true;false;false;true;false;false,11682/22402
age of asthma onset  years,C0206132;C0004096;C0439234;C2984299;C3175530,true;true;false;false;false,11683/22402
age of onset,C0206132;C3175530,true;false,11684/22402
age of onset < $nmbr$ years ( n = $nmbr$ ),C0206132;C0439234;C3175530,true;false;false,11685/22402
age of onset $nmbr$ years ( n = $nmbr$ ),C0206132;C0439234;C3175530,true;false;false,11686/22402
age range,C0001779;C1514721;C2348147;C3542016,false;false;false;false,11687/22402
age range  y,C0001779;C1514721;C2348147;C3542016,false;false;false;false,11688/22402
age s * $nmbr$ yr,C0001779;C0439234,false;false,11689/22402
age s $nmbr$ years ( n = $nmbr$  $nmbr$ ),C1510829,false,11690/22402
age s $nmbr$,C0001779,false,11691/22402
age subgroup  y,C0001779;C1079230;C1515021,false;false;false,11692/22402
age when diabetes first diagnosed ( years )  mean ( sd ),C0001779,false,11693/22402
age years geographic region,C1510829;C0017446,false;true,11694/22402
age yr  range,C0001779;C0439234;C1514721;C2348147;C3542016,false;false;false;false;false,11695/22402
age *,C0001779,false,11696/22402
age  mean ( range ) years,C1510829;C0444504;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,11697/22402
age  mean ( s . e . ),C0001779;C0444504;C2347634;C2348143,false;false;false;false,11698/22402
age  mean ( sd ) ( years ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11699/22402
age  mean ( sd ) years  n ( % ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11700/22402
age  mean ( sd )  y ethnicity  no . ( % ),C0001779;C0444504;C2699239;C0015031;C0243103;C2347634;C2348143,false;false;false;true;true;false;false,11701/22402
age  mean ( sd )  yearsa,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11702/22402
age  mean ( sd )  yr,C0001779;C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false;false,11703/22402
age  mean ± sd  y,C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11704/22402
age  mean years ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11705/22402
age  mean years ( sd ) ’ gender  n ( % ),C1510829;C0444504;C2699239;C0079399;C1522384;C2347634;C2348143,false;false;false;true;true;false;false,11706/22402
age  mean yr,C0001779;C0444504;C0439234;C2347634;C2348143,false;false;false;false;false,11707/22402
age  mean  years ( ± sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11708/22402
age  mean  yrs ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11709/22402
age  median ( $nmbr$ th  $nmbr$ th )  y,C0001779;C0549183;C0039725;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;true;false;false;false;false;false;false;false,11710/22402
age  median ( range ) ( years ),C1510829;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,11711/22402
age  median years,C1510829;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11712/22402
age  x,C0001779,false,11713/22402
age  y ( $nmbr$ th  $nmbr$ th percentiles ),C0001779;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344,false;true;false;true;false;false;false,11714/22402
age  y ( mean ± s . d . ),C0001779;C0444504;C2347634;C2348143,false;false;false;false,11715/22402
age  y ( mean ± sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11716/22402
age  y ( sd ),C0001779;C2699239,false;false,11717/22402
age  y < $nmbr$,C0001779,false,11718/22402
age  y gender  n ( % ),C0001779;C0079399;C1522384,false;true;true,11719/22402
age  y mean ( sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11720/22402
age  y  median ( q $nmbr$ – q $nmbr$ ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11721/22402
age  year ( median ),C0001779;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C0439508,false;false;false;false;false;false;false;false,11722/22402
age  years ( mean _ + sd ) sex  n ( % ) :,C1510829;C0444504;C2699239;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C2347634;C2348143,false;false;false;true;true;true;false;false;true;false;false,11723/22402
age  years ( mean = sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11724/22402
age  years ( mean ± sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11725/22402
age  years ( mean $nmbr$ sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11726/22402
age  years mean ( s . d . ),C1510829;C0444504;C2347634;C2348143,false;false;false;false,11727/22402
age  years mean ( sd ),C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11728/22402
age  years mean ± sd,C1510829;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11729/22402
age  years ^,C1510829,false,11730/22402
age  years “,C1510829,false,11731/22402
age  years $nmbr$ ',C1510829,false,11732/22402
age  yf $nmbr$ - $nmbr$,C0001779,false,11733/22402
age  yr  n ( % ),C0001779;C0439234,false;false,11734/22402
age  yrs ( mean ± sd ),C0001779;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,11735/22402
age  yrs  median ( iqr ),C0001779;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11736/22402
age  yt,C0001779;C1412122,false;false,11737/22402
age  years geographical distribution of patients,C1510829;C0681686;C0030705,false;false;true,11738/22402
age . y,C0001779,false,11739/22402
age . years,C1510829,false,11740/22402
age . . . . . . . . y ( n = $nmbr$ ),C0001779,false,11741/22402
age / gd lesion,C0001779;C0221198;C1546698,false;false;false,11742/22402
age\\yr,C0001779;C0439234,false;false,11743/22402
age   ≥ $nmbr$   y  n ( % ),C0001779,false,11744/22402
agea,,,11745/22402
aged ≥ $nmbr$ years,C0001779;C0439234;C0001792;C1999167,false;false;true;false,11746/22402
aged $nmbr$ y or older  n ( % ),C0001779;C0001792;C1999167,false;true;false,11747/22402
aged a $nmbr$ years,C0001779;C0001792;C1999167,false;true;false,11748/22402
aget  y,,,11749/22402
agi,C1299007,true,11750/22402
aha status at screeningb  n ( % ),C0050451;C0449438;C0772110,true;false;false,11751/22402
ai $nmbr$,C0003504;C4551710,true;false,11752/22402
aii participants ( n = $nmbr$ ),C1424250;C0679646;C2698414,false;false;false,11753/22402
aii patients ( n = $nmbr$ ),C1424250;C0030705;C2698414,false;true;false,11754/22402
ain  no . ( % ) * *,C0347129,false,11755/22402
ain  no . ( % ) “ *,C0347129,false,11756/22402
air ( n = $nmbr$ ),C0001861;C3536832,true;false,11757/22402
air + ig ( n = $nmbr$ ),C0001861;C0021027;C0305052;C0360506;C3536832,true;true;false;false;false,11758/22402
airway compromise,C4055482,false,11759/22402
airway reversibility  %,C0178987;C0449261;C0458827,false;false;false,11760/22402
airway reversibility  mean  %,C0178987;C0449261;C0444504;C2347634;C2348143;C0458827,false;false;false;false;false;false,11761/22402
alanine aminotransferase increased,C0001899;C0057041;C1415274;C3887708,true;true;false;false,11762/22402
alanine aminotransferase  u / l,C0001899;C0439339;C0057041;C1415274;C3887708,true;false;true;false;false,11763/22402
alav ( per ml ),C0439526;C1705224;C3887665,false;false;false,11764/22402
albiglutide ( n = $nmbr$ ),C2607479,true,11765/22402
albiglutide events / patients ( %,C2607479;C0441471;C0030705;C3541888,true;false;true;false,11766/22402
albumin - to - creatinine ratio ' i  /,C0486293;C0021966;C0221138;C1318293,false;true;false;false,11767/22402
albumin - to - creatinine ratio ( acr ),C0486293;C1412134;C1515941;C1318293,false;false;false;false,11768/22402
albumin  g / dl,C0001924;C0439267,true;false,11769/22402
albuminuria ( acr > $nmbr$ m . g / g ) at baseline to normoalbuminuria,C0001925;C1412134;C0369637;C1319635;C0168634;C1442488;C0441923;C1515941,true;false;false;false;true;false;false;false,11770/22402
albuminuria and previous maerovaseular disease plus established renal disease ( egfr $nmbr$ - $nmbr$ ml / min / l $nmbr$ in - with an uacr > $nmbr$ mg / g or egfr $nmbr$ - < $nmbr$ ml / inin / l $nmbr$ in - with any uacr mg / g ),C0001925;C1635169;C0702093;C1524029;C3813700;C1739039;C1635169;C3811844;C3812682,true;false;false;false;false;true;false;false;false,11771/22402
albuminuria and previous maerovaseular disease without established renal disease,C0001925,true,11772/22402
albuminuria progression,C0001925;C0242656;C0449258,true;true;false,11773/22402
albuminuria_p_interaction,C0001925;C1704675,true;false,11774/22402
alc ( % ),C1424945;C3811058,false;false,11775/22402
alc ( mmol / mol ),C1424945;C3829066;C3811058,false;false;false,11776/22402
alc < $nmbr$ . $nmbr$ % at baseline  n ( % ),C1424945;C0168634;C1442488;C3811058,false;true;false;false,11777/22402
alc > $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ %,C1424945;C3811058,false;false,11778/22402
alc at week $nmbr$ ( % ),C1424945;C0332174;C0439230;C3811058,false;false;false;false,11779/22402
alc at weeko ( % ),C1424945;C3811058,false;false,11780/22402
alc group ( % ),C1424945;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3811058,false;false;false;true;false;false;false;false,11781/22402
alcohol,C0001962;C0001975,true;true,11782/22402
alcohol < = $nmbr$ / wk,C0001962;C0332174;C0439230;C0001975,true;false;false;true,11783/22402
alcohol > $nmbr$ / wk,C0001962;C0332174;C0439230;C0001975,true;false;false;true,11784/22402
alcohol > $nmbr$ drinks per week,C0556297;C0332174;C0439230,false;false;false,11785/22402
alcohol consumption ( % ) < $nmbr$ drink / dav,C0556297;C0009830;C1947907;C0001948;C0452428,false;true;false;true;false,11786/22402
alcohol consumption ( yes ) ( n ),C0001948;C1549445;C1705108;C1710701,true;false;false;false,11787/22402
alcohol consumption at baseline,C0001948;C0168634;C1442488,true;true;false,11788/22402
alcohol consumption *,C0001948,true,11789/22402
alcohol consumption  no . ( % ),C0001948,true,11790/22402
alcohol drinker,C0001962;C0556338;C0001975,true;false;true,11791/22402
alcohol drinker  n ( % ),C0001962;C0556338;C0001975,true;false;true,11792/22402
alcohol intake never / rarely,C0001948;C2003901;C0522498,true;false;false,11793/22402
alcohol use ( %  > $nmbr$ / day ),C0001948;C0332173;C0439228;C0439505,true;false;false;false,11794/22402
alcohol use  n ( % ),C0001948,true,11795/22402
alcohol useb,C0001962;C0001975,true;true,11796/22402
alcohol usef  n ( % ),C0001962;C0001975,true;true,11797/22402
alcohol users  n ( % ),C0556297,false,11798/22402
alcohol ^,C0001962;C0001975,true;true,11799/22402
aldosterone receptor antagonists,C1579268,true,11800/22402
aldosterone use,C0002006;C0042153;C0457083;C1947944,true;true;false;false,11801/22402
alendronate,C0102118,true,11802/22402
alendronate ( n = $nmbr$ ),C0102118,true,11803/22402
algorithm $nmbr$,C0002045;C1553907,true;false,11804/22402
alirocumab $nmbr$ mg q $nmbr$ w,C3491162;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11805/22402
alirocumab $nmbr$ / $nmbr$ mg,C3491162;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11806/22402
alirocumab n = $nmbr$,C3491162,true,11807/22402
alive ( n = $nmbr$ ),C2584946;C4551704,false;false,11808/22402
all - baricitinib ra ( n = $nmbr$ ) *,C4044947;C3538806;C4048756,true;false;false,11809/22402
all - causa mortality,C3903827;C0026565;C0026566,false;true;true,11810/22402
all - cause death / stroke / see,C0015127;C0011065;C0038454;C4554100;C1306577;C4082313;C4552775;C1524003,true;true;true;false;false;false;false;false,11811/22402
all - cause mortalitv,C0015127;C1524003,true;false,11812/22402
all - cause mortality ( n = $nmbr$ ),C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,11813/22402
all - cause mortality ( no . of events ),C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,11814/22402
all - cause mortality ( per $nmbr$ person - years ),C0444868;C0015127;C0026565;C0027361;C0439234;C2347489;C0026566;C1524003;C3539085,false;true;true;true;false;false;true;false;false,11815/22402
all - cause mortality at $nmbr$ year,C0444868;C0015127;C0026565;C0439234;C0439508;C0026566;C1524003;C3539085,false;true;true;false;false;true;false;false,11816/22402
all ( n = $nmbr$  $nmbr$ ),C0369718;C0441922,false;false,11817/22402
all ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C0369718;C0441922,false;false,11818/22402
all bleed,,,11819/22402
all canakinumab,C2718773,true,11820/22402
all cause mortality or hosp . for worsening hf hs - crp < $nmbr$ . $nmbr$ mg / l,C0444868;C0015127;C0026565;C0026566;C1524003;C3539085,false;true;true;true;false;false,11821/22402
all death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,11822/22402
all diabetesd,,,11823/22402
all doses,C0178602,false,11824/22402
all doses ( n = $nmbr$ ),C0178602,false,11825/22402
all dulaglutide $nmbr$ . $nmbr$ mg + insulin lispro / insulin glargine ( n = $nmbr$ ),C3179549;C0024671;C0907402;C0293359;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;true;false;false;false;false;false,11826/22402
all itt sutajects,,,11827/22402
all major cardiovascular events,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,11828/22402
all men,C0025266,true,11829/22402
all mis,C0687670;C1333208;C1412384;C3538735,false;false;false;false,11830/22402
all mis *,C0687670;C1333208;C1412384;C3538735,false;false;false;false,11831/22402
all mn - na ï ve patients,C0026327;C0597484;C0042469;C0030705;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882;C0026405;C4285072,true;false;true;true;false;false;false;false;false;false;false;true;false,11832/22402
all non - mn,C1518422;C0026327;C0026405;C4285072,false;true;true;false,11833/22402
all noncompleters,,,11834/22402
all others eteed for $nmbr$ mg edoxaban dose at,C1955473;C4086581;C2975435;C3539125,false;false;true;false,11835/22402
all participants ( n = $nmbr$ ),C0679646,false,11836/22402
all participants history of cabg,C0679646;C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;true;false;false;false;false,11837/22402
all participants * ( n = $nmbr$ / $nmbr$ ),C0679646,false,11838/22402
all participants  mm hg : sbp  mean ( sd ),C0679646;C0439475;C0085805;C0444504;C2699239;C2347634;C2348143,false;false;true;false;false;false;false,11839/22402
all participants ^ ^ ( n = $nmbr$ / $nmbr$ ),C0679646,false,11840/22402
all participantsa,,,11841/22402
all participantst ( n = $nmbr$ / $nmbr$ ),,,11842/22402
all patients ( n $nmbr$ $nmbr$ ),C0030705,true,11843/22402
all patients ( n   =   $nmbr$ ) b,C0030705,true,11844/22402
all patients ( p < $nmbr$ . $nmbr$ ),C0030705,true,11845/22402
all patients ( p = $nmbr$ . $nmbr$ ),C0030705,true,11846/22402
all patients n = $nmbr$ $nmbr$,C0030705,true,11847/22402
all patients on maximally tolerated statin ± other llt,C0030705;C0360714,true;true,11848/22402
all patients  n =,C0030705,true,11849/22402
all patientsb,,,11850/22402
all randomized all - cause mortality,,,11851/22402
all randomized all - cause mortality or hospitalization for worsening hf ^,,,11852/22402
all randomized coronary end point,C0034656;C0018787;C2349179;C2826544;C3815594,true;true;false;false;false,11853/22402
all recurrent strokes,C1836785,false,11854/22402
all responders  ( n = $nmbr$ ),,,11855/22402
all strokes,,,11856/22402
all strokes *,,,11857/22402
all strokes  n ( % ),,,11858/22402
all subjects - n,,,11859/22402
all treatments,C0087111,true,11860/22402
all trials,C0008976,true,11861/22402
all with diabetes ( n = $nmbr$ ),C0011847;C0011849,false;true,11862/22402
all without diabetes ( n = $nmbr$ ),C0011847;C0011849,false;true,11863/22402
all women,C0043210,true,11864/22402
alleles,C0002085,true,11865/22402
allergic disease by historyb  n ( % ),C0020517;C0851444,true;false,11866/22402
allergic rhinitis,C1334103;C2607914;C4552864,false;true;false,11867/22402
allergic rhinitis — no . ( % ),C1334103;C2607914;C4552864,false;true;false,11868/22402
allergic rhinitis duration  mean ± sd  y *,C1334103;C0449238;C0444504;C2699239;C2347634;C2348143;C2926735;C2607914;C4552864,false;false;false;false;false;false;false;true;false,11869/22402
allopurinol,C0002144,true,11870/22402
allopurinol $nmbr$ / $nmbr$ mg daily n = $nmbr$,C0002144;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,11871/22402
allopurinol $nmbr$ / $nmbr$ mg n = $nmbr$,C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11872/22402
allopurinol $nmbr$ mg ( n = $nmbr$ ) +,C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11873/22402
allopurinolt,,,11874/22402
alogliptin,C1958126,true,11875/22402
alogliptin ( n = $nmbr$ ),C1958126,true,11876/22402
alogliptin $nmbr$ . $nmbr$ mg + pioglitazone ( n = $nmbr$ ),C3535925;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,11877/22402
alogliptin $nmbr$ mg + pioglitazone ( n = $nmbr$ ),C3535925;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,11878/22402
alogliptin  n ( % ),C1958126,true,11879/22402
alpha - blocker / other vasodilator,C0001641,true,11880/22402
alpha - blockers,C0001641,true,11881/22402
alpha blockers,C0001641,true,11882/22402
alpha glucosidase inhibitors,C1299007;C2756986;C3539108,true;false;false,11883/22402
alpha reductase inhibitors,C0439095;C0597153;C1655741;C2003941;C2350010,false;false;false;false;false,11884/22402
alprostadil ( n = $nmbr$ ),C0002335,true,11885/22402
alprostadil n / n,C0002335,true,11886/22402
alprostadil n / n %,C0002335,true,11887/22402
alt > $nmbr$ x uln on two consecutive visits,C1266129;C1519815;C0205448;C1707491;C0545082;C1512346;C4553172,false;false;false;false;false;false;false,11888/22402
alt increased,C1266129;C4553172,false;false,11889/22402
alt or ast > $nmbr$ x uln $nmbr$,C1266129;C4553172,false;false,11890/22402
alvedv ( per ml ),C0439526;C1705224;C3887665,false;false;false,11891/22402
alvef ( per $nmbr$ % ),,,11892/22402
alvesv ( per ml ),C0439526;C1705224;C3887665,false;false;false,11893/22402
alvmi ( per g / m $nmbr$ ),C0456715,false,11894/22402
am_ % delta,,,11895/22402
am_delta,,,11896/22402
amann whitney u test / wilcoxon sum rank test .,C0439148;C0683443;C1515051;C0667477;C0699794,false;false;false;true;false,11897/22402
ambition,C0870128,false,11898/22402
ambulatory sbp  difference vs placebo ( $nmbr$ % cl ),C0439841;C0085805;C1705241;C1705242,false;true;false;false,11899/22402
ambulatory sbp  n,C0439841;C0085805,false;true,11900/22402
amended dabigatran protocol,C1691222;C2348066;C0442711;C1507394;C1522729;C2348563;C2599718;C3715209;C4282383,false;true;false;false;false;false;true;false;false,11901/22402
america,C0002454,true,11902/22402
american,C0596070,false,11903/22402
american ‐ indian / alaska native,C0002460,true,11904/22402
american hispanic ( n   = $nmbr$ ),C0596070;C0086409,false;true,11905/22402
american indian or,C0002460,true,11906/22402
american indian or alaska native  :,C0002460,true,11907/22402
american indian or alaskan,C0002460,true,11908/22402
american indian  alaskan native  or aboriginal canadian,C0002460;C0238611,true;false,11909/22402
american indian / alaskan native,C0002460;C0238611,true;false,11910/22402
american indian / alaskan native  n ( % ),C0886378;C1524069;C0238611;C0002460;C0302891,false;false;false;true;false,11911/22402
american indian / native alaskan,C0002460;C0682125,true;true,11912/22402
americas * *,C0002454;C0596070,true;false,11913/22402
aminosalicylate,C0368663;C2825094,false;false,11914/22402
amiodarone ( n  % ),C0002598,true,11915/22402
amiodarone ote at baseline,C0002598;C0168634;C1442488,true;true;false,11916/22402
amiodarone use at baseline,C0002598;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,11917/22402
amiodarone use at baseline yes $nmbr$  $nmbr$,C0002598;C0042153;C0168634;C1549445;C1705108;C1710701;C1442488;C0457083;C1947944,true;true;true;false;false;false;false;false;false,11918/22402
amiodarone vs . placebo,C0002598,true,11919/22402
aml ( n = $nmbr$ ),C0023465;C0023467,true;true,11920/22402
aml $nmbr$ mg + hctz $nmbr$ mg,C0023465;C1319635;C0020261;C0023467,true;false;true;true,11921/22402
aml $nmbr$ mg + hctz $nmbr$ mg ( n = $nmbr$ ),C0023465;C1319635;C0020261;C0023467,true;false;true;true,11922/22402
aml vs . chl,C0023465;C0023467,true;true,11923/22402
aml vs . lis,C0023465;C0023467,true;true,11924/22402
amlodipine,C0051696,true,11925/22402
amlodipine $nmbr$ to $nmbr$ mg ( n = $nmbr$ ),C0051696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11926/22402
amlodipine and valsartan,C0051696,true,11927/22402
amlodipine vs chlorthalidone normal,C0051696,true,11928/22402
amlodipine vs chlorthalidone obese,C0051696,true,11929/22402
amlodipine vs chlorthalidone overweight,C0051696,true,11930/22402
amlodipine / chlorthalidone,C0051696;C0008294,true;true,11931/22402
amlodipine / lisinopril $nmbr$,C0051696;C0065374,true;true,11932/22402
amlodipine / lisinopril / chlorthalidone comparison,C0051696;C0065374;C0008294;C1707455,true;true;true;false,11933/22402
amlodipine / valsartan $nmbr$ to $nmbr$ / $nmbr$ mg ( n = $nmbr$ ),C1962523;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11934/22402
ampd $nmbr$,,,11935/22402
amputation — no . ( % ),C0002688;C0332840;C1546539,true;false;false,11936/22402
amputation due to diabetes — no . ( % ),C0678226;C0598284,false;false,11937/22402
amputations  n ( % ),C0002688,true,11938/22402
anacetrapib $nmbr$ mg,C2604745;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,11939/22402
analgesic medication  n ( % ),C0002771,true,11940/22402
analysis,C0002778;C0936012;C1524024,false;false;true,11941/22402
analysis compared with the pretreatment condition ( baseline )  n  ldl = low - density lipoprotein  csf = cerebrospinal fluid .,C0002778;C0936012;C1524024,false;false;true,11942/22402
anatomic extent of qualifying event  n ( % . ) x,C0220784;C0439792;C1514624;C0441471;C4019010,false;false;false;false;false,11943/22402
anatomical extent of qualifying event — no . ( % ) : t,C0220784;C0439792;C1514624;C0441471;C4019010,false;false;false;false;false,11944/22402
anatomy,C0002808;C0700276;C1384516,true;false;true,11945/22402
ancova result,C0814908;C1274040;C1546471;C2825142,false;false;false;false,11946/22402
and after pci  median ( iqr )  d,C4049621;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,11947/22402
and either an ace inhibitor or angiotension receptor blocker,,,11948/22402
and infusion,,,11949/22402
and microalbuminuria or macroalbuminuria,,,11950/22402
and physical examination,,,11951/22402
and vfx status,,,11952/22402
and / or aza at baseline,,,11953/22402
and / or discharge,,,11954/22402
anemia  %,C0002871;C1000483;C4554633,true;false;false,11955/22402
anemia  no . / total ( % ) ”,C0002871;C1000483;C4554633,true;false;false,11956/22402
anesthesiad  n ( % ),,,11957/22402
angina class iii or iv prior,C0264677,false,11958/22402
angina or acute mi,C0002962,true,11959/22402
angina or positive stress test,C0002962,true,11960/22402
angina with documented ischemia,C0002962;C1301725;C0022116;C4321499;C1609436,true;false;true;false;false,11961/22402
angina .,C0002962,true,11962/22402
angioedema ( adjudicated )  n ( % ),C0002994,true,11963/22402
angioedema present  n ( % ) {,C0002994;C0150312;C0449450,true;false;false,11964/22402
angioedema present  n ( % ) $nmbr$,C0002994;C0150312;C0449450,true;false;false,11965/22402
angiographic characteristics  no . ( % ),C0002978;C1521970,true;false,11966/22402
angioplasty,C0162577;C1548817,true;false,11967/22402
angiotensin -,C0003018;C4521302,true;false,11968/22402
angiotensin - converting - enzyme inhibitor or angiotensin -,C0003015;C2757044;C3536837;C4541021,true;false;false;false,11969/22402
angiotensin - converting enzyme inhibitor or angiotensin receptor blocker use ( mitt population ),C0003015;C2757044;C3536837;C4541021,true;false;false;false,11970/22402
angiotensin - converting enzyme inhibitor / angiotensin receptor blocker,C0003015;C0597357;C2757044;C3536837;C4541021,true;false;false;false;false,11971/22402
angiotensin - converting enzyme inhibitors,C0003015;C2757044,true;false,11972/22402
angiotensin - converting enzyme inhibitors ^,C0003015;C2757044,true;false,11973/22402
angiotensin - eonverting enzyme inhibitors,C0003018;C0014432;C1152555;C2756995;C4521302,true;true;false;false;false,11974/22402
angiotensin - eonverting enzyme inhibitors / angiotensin reeeptor bloekers,C0003018;C0014432;C1152555;C2756995;C4521302,true;true;false;false;false,11975/22402
angiotensin - receptor,C0034787;C1622222,true;true,11976/22402
angiotensin ii antagonists,C0003009;C0243076;C1366631;C3714928,true;true;false;false,11977/22402
angiotensin ii receptor blockers,C0521942;C2757003,true;false,11978/22402
angiotensin il - receptor blocker,C0034787;C0020898;C0021764;C0022271;C1622222;C0003018;C1149183;C4521302,true;true;true;true;true;true;false;false,11979/22402
angiotensin receptive blocker,C0003018;C0544683;C4521302,true;false;false,11980/22402
ankle - brachial index £ $nmbr$ . $nmbr$,C1328319;C3888326,true;false,11981/22402
ankle edema,C0235439,false,11982/22402
annanginal drugs ( $nmbr$ / l / s » $nmbr$ ) ^,C0013227;C3687832,true;false,11983/22402
annual asthma exacerbation rates,C0332181;C0349790;C0871208;C1521828,false;false;false;false,11984/22402
annual exacerbation rate,C0332181;C4086268;C0871208;C1521828,false;false;false;false,11985/22402
anorexigen use,C0042153;C0457083;C1947944,true;false;false,11986/22402
anterior infarct location,C0340293;C0450429;C1515974;C4284930;C4284931;C2349195,true;false;false;false;false;true,11987/22402
anterior mi,C3536746,false,11988/22402
anterior myocardial infarction — no . / total no . ( % ),C0340293,true,11989/22402
anterior or non - anterior ml,C0205094,false,11990/22402
anthropometrics  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,11991/22402
anti - anaemics,C0857322,false,11992/22402
anti - ccp antibodies *,C1624602;C1525410;C1704514;C4318437;C0003241,true;false;false;true;true,11993/22402
anti - ccp antibody - positive  n ( % ),C0432633;C1525410;C0741132;C1704514,false;false;false;false,11994/22402
anti - ccp positive,C4318437;C0439178;C1446409;C1514241;C2825490;C3812269,true;false;false;false;false;false,11995/22402
anti - dsdna ( > $nmbr$ iu / ml )  %,C0741099;C0439458,false;false,11996/22402
anti - dsdna positive,C0741099;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,11997/22402
anti - gad negative,C0270549;C0205160;C1513916;C2825415;C2825491;C3853545;C1414925,false;false;false;false;false;false;false,11998/22402
anti - gad negative ( n = $nmbr$ ),C0432633;C0270549;C0205160;C1513916;C2825415;C2825491;C3853545;C1414925,false;false;false;false;false;false;false;false,11999/22402
anti - gad positive,C0270549;C0439178;C1446409;C1514241;C2825490;C3812269;C1414925,false;false;false;false;false;false;false,12000/22402
anti - gad positive ( n = $nmbr$ ),C0432633;C0270549;C0439178;C1446409;C1514241;C2825490;C3812269;C1414925,false;false;false;false;false;false;false;false,12001/22402
anti - histamines,C0019590,true,12002/22402
anti ‐ hyperglycaemic agent  n ( % ),C0432633;C1321567,false;false,12003/22402
anti - hypertensive,C0003364,true,12004/22402
anti - hypertensive treatment history  n ( % ),C0432633;C0857121;C0039798;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;false;true;true;true;false;false;false;false;true;false;false;false;false;false,12005/22402
anti - hypertensives,C0003364,true,12006/22402
anti - p $nmbr$,,,12007/22402
anti ‐ platelet agents  n ( % ),C0432633;C0005821;C0450442;C1254351;C1521826,false;true;false;false;false,12008/22402
anti - thrombotics,C0087086,true,12009/22402
anti - tnf,C1448177,true,12010/22402
anti ‐ tnf ‐ na ï ve    n   ( % ),C0432633;C1448177;C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,false;true;false;true;false;false;false;false;false;false;false,12011/22402
anti - tnf ir,C1448177;C0022065;C0022071;C1448132,true;true;true;true,12012/22402
antiarrhythmic drugs    n   ( % ),C0003195,true,12013/22402
antiarrhythmics,C0003195,true,12014/22402
antibody binding level at baseline,C0428536;C1145667;C0168634;C1442488;C1167622;C1149306;C0441889;C0456079;C1547707;C2946261,false;false;true;false;false;false;false;false;false;false,12015/22402
anticholinergic drug,C0242896,true,12016/22402
anticholinergic use  n ( % ),C0242896;C0042153;C0457083;C1947944;C3537004,true;true;false;false;false,12017/22402
anticholinergics,C0242896;C3537307;C3540711,true;false;false,12018/22402
antidepressant,C0003289,true,12019/22402
antidiabetic drug,C0935929,true,12020/22402
antidiabetic drug ‘ i “ j ‘,C0935929;C0021966;C0221138,true;true;false,12021/22402
antihyperglycaemic medication at baseline,C0020616;C0013227;C0168634;C1442488;C3244316;C4284232,true;true;true;false;false;false,12022/22402
antihyperglycemic medications,C0020616;C0013227;C0802604;C2598133;C4284232,true;true;false;false;false,12023/22402
antihypertensive agent use,C0003364;C0042153;C0457083;C1947944,true;true;false;false,12024/22402
antihypertensive agents ( n per patient ),C0003364;C0030705,true;true,12025/22402
antihypertensive medication,C0003364,true,12026/22402
antihypertensive medication use  n ( % ),C0003364;C0042153;C0457083;C1947944,true;true;false;false,12027/22402
antihypertensive medication ),C0003364,true,12028/22402
antihypertensive medication $nmbr$ ',C0003364,true,12029/22402
antihypertensive randomization  no . ( % ) a,C0003364;C0034656,true;true,12030/22402
antihypertensive treatment  n ( % ),C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,12031/22402
antihypertensive treatments,C0003364;C0087111,true;true,12032/22402
antihypertensive use,C0003364;C0042153;C0457083;C1947944,true;true;false;false,12033/22402
antihypertensives ' *,C0003364,true,12034/22402
antihypertensives  n ( % ),C0003364,true,12035/22402
antimalarial,C0003374;C3536844;C4552582,true;false;false,12036/22402
antiplatelet agent n ( % ),C0085826,true,12037/22402
antiplatelet at randomization,C0034656,true,12038/22402
antiplatelet use,C0042153;C0457083;C1947944,true;false;false,12039/22402
antiplatelets agents,C0085826,true,12040/22402
antiplatelets  any,,,12041/22402
antiplateletsa,,,12042/22402
antithrombin,C0003438;C0003440;C4521254,true;true;false,12043/22402
antithrombotic,,,12044/22402
antithrombotic medications  n ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,12045/22402
antithrombotic use before enrollment  no . ( % ),C0042153;C1516879;C1696073;C3888021;C0457083;C1947944,true;false;false;false;false;false,12046/22402
antithrombotic ! i,C0021966;C0221138,true;false,12047/22402
any ( including corticosteroid ),,,12048/22402
any acuity bleeding,C0333276,false,12049/22402
any adverse event ( ae ),C0877248;C3887670,false;false,12050/22402
any adverse event leading to study drug discontinuation  n ( % ),C0877248,false,12051/22402
any ae,C3887670,false,12052/22402
any ae leading to discontinuation  n ( % ),C3887670,false,12053/22402
any ae  n ( % ) ‡,C3887670,false,12054/22402
any aes,C1412268;C2699274,false;false,12055/22402
any albuminuria,C0001925,true,12056/22402
any anti - hypertensive agent,C0003364,true,12057/22402
any antianginal drug !,C1874267;C0013227;C1254351;C3537168,false;true;false;false,12058/22402
any anticoagulant,C0003280;C0848112;C3536711,true;false;false,12059/22402
any antihypertensive agent,C0003364,true,12060/22402
any antihypertensive drug,C0003364,true,12061/22402
any bleeding,,,12062/22402
any blood,C0005767;C0005768;C0229664,true;true;false,12063/22402
any blood product transfusion,C0005841;C1514468;C1704444;C0281867;C0456388;C0199960;C1879316;C1547007,true;false;false;false;false;false;false;false,12064/22402
any bp - lowering agents ^,C0037623;C0441994;C0450442;C1254351;C1521826;C2003888;C1415692;C1708288;C4318478,true;false;false;false;false;false;false;false;false,12065/22402
any cardiovascular disease,C0007222,true,12066/22402
any cardiovascular diseased,C0007226;C3887460,true;false,12067/22402
any cause,C0015127;C1524003,true;false,12068/22402
any copd medication,C0024117;C0013227;C3244316;C4284232;C1412502;C3714496,true;true;false;false;false;false,12069/22402
any cough,C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,12070/22402
any cvd history ( % ),C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,12071/22402
any drug - related ae  n ( % ),C0013227;C0439849;C3887670;C0445223;C1254351,true;false;false;false;false,12072/22402
any dynamic st - segment shift,C0729333;C0429029;C0333051;C2347509,false;false;false;false,12073/22402
any early adverse event,C1279919;C0877248,false;false,12074/22402
any electrocardiographic abnormality — no . ( % ),C0522055,false,12075/22402
any glycoprotein iib / iiia inhibitor use,C0016011;C1999216;C0042153;C0457083;C1947944,true;false;true;false;false,12076/22402
any gusto bleeding,C0019080,true,12077/22402
any hba $nmbr$ c,C0019016;C1825777;C3538758,true;false;false,12078/22402
any lipid - lowering agent use,C0086440;C0042153;C0457083;C1947944,true;true;false;false,12079/22402
any llt other than nutraceuticals  n ( % ),C2347090;C1518478,false;true,12080/22402
any llt other than statins  n ( % ) b,C2347090;C0360714,false;true,12081/22402
any mi,C3810814,false,12082/22402
any other lipid ‐ lowering therapy  n ( % ),,,12083/22402
any overt bleed,C0019080,true,12084/22402
any peripheral revascularization,C0205100;C0581603,false;false,12085/22402
any placebo,C0032042;C1696465;C1706408,true;false;false,12086/22402
any prerandomization failure of an antiarrhythmic drug — no . ( % ),C0231174;C0003195;C0301380;C0680095,false;true;false;false,12087/22402
any pulmonary medication  n ( % ),C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268,true;true;false;false;false;false;false,12088/22402
any revascularization,C0581603,false,12089/22402
any sae,C1519255;C1622657;C4553214,false;false;false,12090/22402
any secukinumab ( n   = $nmbr$ ),C3179547,true,12091/22402
any serious ae  n ( % ),C0205404;C3887670,false;false,12092/22402
any serious teaes,C0205404,false,12093/22402
any severity,C0439793;C0522510,false;false,12094/22402
any site,C0205145;C1515974;C2825164,false;false;false,12095/22402
any stroke,C0038454;C4554100,true;false,12096/22402
any sulfonylurea,C0038766;C3536898,true;false,12097/22402
any teae,,,12098/22402
any teaes,,,12099/22402
any therapy — no . ( % ),C0039798;C0087111;C1363945,true;true;false,12100/22402
any thiazide diuretic,C0012802;C3536861,true;false,12101/22402
any thiazolidinedione,C0289779;C1257987;C3537039,true;true;false,12102/22402
any timi bleeding,,,12103/22402
any treatment - emergent ae,C0039798;C0750573;C3887670;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,12104/22402
any ulcerative colitis medication,C0009324;C0013227;C3244316;C4284232,true;true;false;false,12105/22402
any vascular diasease,C0005847;C1558950;C1801960,true;false;false,12106/22402
any vascular disease,C0042373,true,12107/22402
any vascular *   efficacy,C0005847;C1280519;C1707887;C1558950;C1801960,true;false;false;false;false,12108/22402
any vte - related death,C0630906;C0425043,true;false,12109/22402
any vte or vte - related death — no . ( % ),C0630906,true,12110/22402
aortic,C0003483,true,12111/22402
aortic - valve replacement,C0003506,false,12112/22402
aortic valve disease ( n = $nmbr$ $nmbr$ ),C1260873;C4553103,false;false,12113/22402
ap - value from an ancova with corresponding baseline lipid value as the covariate and with a effect for treatment group .,C0002680;C1522609;C0814908;C3887950,true;false;false;false,12114/22402
ap = $nmbr$ . $nmbr$  bp $nmbr$ . $nmbr$  cp = $nmbr$ . $nmbr$ . * the study - speci ﬁ c bp targets were sbp $nmbr$ mm hg and dbp $nmbr$ mm hg ( or sbp $nmbr$ mm hg and dbp $nmbr$ mm hg in those with dm ) . the ldl - c target was $nmbr$ mg / dl or $nmbr$ mg / dl  depending on risk factor status at baseline in accordance with ncep atp iii guidelines . odds ratio and p value calculated based on generalized linear mixed model with generalized estimating equations method that includes compound symmetry covariance matrix for subjects from the same site . an interaction between treatment effect and dm status was observed for bp goal attainment ( p = $nmbr$ . $nmbr$ ) and dual bp / ldl - c goal attainment ( p = $nmbr$ . $nmbr$ ) among patients with or without dm calculated based on a mixed - effects linear model ( not adjusted for differences in baseline values ) . abbreviations : bp  blood pressure  dbp  diastolic blood pressure  dm  diabetes mellitus  ldl - c  low - density lipoprotein cholesterol  ncep atp iii  national cholesterol education program – adult treatment panel iii  or  odds ratio  sbp  systolic blood pressure,C0002680;C0037623;C0006938;C4050020;C1415692;C1708288;C4318478;C3887950;C0085805;C0439475;C0025424;C0428257;C2347108;C2347109;C2348272;C1521840;C2986546;C0035648;C0449438;C0168634;C1442488;C2744579;C0439070;C0162791;C0028873;C0220845;C0282423;C1705160;C4552600;C0205246;C0023732;C0205430;C0750572;C0552449;C0025663;C0449851;C0871511;C3160715;C0445247;C0205145;C1515974;C2825164;C0680230;C0030705;C0011816;C3250443;C0456081;C1705241;C1705242;C0428883;C0011849;C0178587;C0065055;C2744579;C0439070;C3245503;C0086858;C4068104;C1705160;C4552600;C0001675;C0039798;C0441833;C0439070;C1705160;C1706365;C1999270;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1706450;C0033095;C0460139;C1306345;C4284008,true;true;true;false;false;false;false;false;true;false;true;false;false;false;false;false;false;true;false;true;false;true;false;true;true;true;true;false;false;false;true;false;false;false;true;false;false;false;false;false;false;false;false;true;true;false;false;false;false;true;true;false;true;true;false;false;true;false;false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;false;true;false;false;false,12115/22402
apasp ( per mmhg ),C0439475,false,12116/22402
apixaban $nmbr$ . $nmbr$ mg bid,C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12117/22402
apixaban $nmbr$ mg bid,C1831808;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12118/22402
aplxaban $nmbr$ . $nmbr$ mg bid,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,12119/22402
apo a - i ( mg / dl ) *,C0085201;C0439269;C1677784,true;false;true,12120/22402
apo a $nmbr$ ( mg / dl ),C0003592;C0439269;C0523508;C4553344;C4553379,true;false;false;false;false,12121/22402
apo a $nmbr$  mean ( sd ),C0003592;C0444504;C2699239;C2347634;C2348143;C0523508;C4553344;C4553379,true;false;false;false;false;false;false;false,12122/22402
apo a $nmbr$  mg / dl  mean ( sd ),C0003592;C0439269;C0444504;C2699239;C2347634;C2348143;C0523508;C4553344;C4553379,true;false;false;false;false;false;false;false;false,12123/22402
apo b ( mg / dl ),C0003593;C0439269;C3252643,true;false;true,12124/22402
apo b ( mg / dl ) * *,C0003593;C0439269;C3252643,true;false;true,12125/22402
apo b  mean ( sd ),C0003593;C0444504;C2699239;C2347634;C2348143;C3252643,true;false;false;false;false;true,12126/22402
apo b  mg / dl  mean ( sd ),C0003593;C0439269;C0444504;C2699239;C2347634;C2348143;C3252643,true;false;false;false;false;false;true,12127/22402
apo  apolipoprotein  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  tc  total cholesterol,C0003594;C0003591;C0011849;C3715113;C0392885;C0008377;C0023824;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C0428471,true;true;true;false;false;true;true;true;true;true;true;false;false;false;false,12128/22402
apo  apolipoprotein  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  tc  total cholesterol  tg  triglycerides . * includes agents acting on the renin - angiotensin system  beta blocking agents  calcium channel blockers  and diuretics . † median values [ standard deviation for medians calculated by ( q $nmbr$ q $nmbr$ ) / $nmbr$ . $nmbr$ ] . § includes cardiac glycosides  antiarrhythmics class i and iii  vasodilators used in cardiac diseases and other cardiac preparations . ‡ expressed as g / l .,C0003594;C0003591;C0011849;C3715113;C0023821;C0008377;C0202117;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C0428473;C0023824;C0201950;C0543421;C0041004;C0001645;C0006684;C2757014;C3541930;C0871420;C0549183;C0017977;C0003195;C0441885;C1319793;C2698967;C0012634,true;true;true;false;true;true;false;true;true;true;true;false;false;false;false;true;false;false;true;true;true;false;false;false;false;true;true;false;false;false;true,12129/22402
apoa - i,C0085201;C1677784,true;true,12130/22402
apoa $nmbr$  mg / dl,C0003592;C0439269;C0523508;C4553344;C4553379,true;false;false;false;false,12131/22402
apoal,,,12132/22402
apoal ( mg / dl ) *,C0439269,false,12133/22402
apob  g / l  mean ( sd ),C0003593;C0439294;C0444504;C2699239;C2347634;C2348143;C0456615;C3252643,true;false;false;false;false;false;false;true,12134/22402
apob : apoa - i,C0003593;C0085201;C1677784;C3252643,true;true;true;true,12135/22402
apob : apoa - i ratio,C0003593;C0085201;C0456603;C1547037;C1677784;C3252643,true;true;false;false;true;true,12136/22402
apob : apoa $nmbr$,C0003593;C0003592;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;true,12137/22402
apob : apoa $nmbr$ ratio,C0003593;C0003592;C0456603;C1547037;C0523508;C4553344;C4553379;C3252643,true;true;false;false;false;false;false;true,12138/22402
apob $nmbr$,C0003593;C3252643,true;true,12139/22402
apoe e $nmbr$ carriers  no . ( % ),C0003595;C0007294;C0523511;C1412481,true;true;false;false,12140/22402
apoe   ε $nmbr$ carrier,C0003595;C0007294;C0560175;C1325398;C1706209;C3273162;C0523511;C1412481,true;true;true;false;false;false;false;false,12141/22402
apolipoprotein,C0003591,true,12142/22402
apolipoprotein b $nmbr$  mg / dl,C0003593;C0439269,true;false,12143/22402
apolipoprotein b  mg / dl,C0003593;C0439269,true;false,12144/22402
aqlq score  mean,C4055434;C0449820;C0444504;C2347634;C2348143;C4050231,false;false;false;false;false;false,12145/22402
aqlq score  mean ( sd ),C4055434;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,12146/22402
aqlq ( s ) + $nmbr$ score  mean ( sd ) c  f,C4055434;C0449820;C0444504;C2699239;C0016327;C2347634;C2348143;C4050231,false;false;false;false;true;false;false;false,12147/22402
aqlq ( s ) + $nmbr$ score : §,C4055434;C0449820;C4050231,false;false;false,12148/22402
aqlq ( si + $nmbr$ score ’,C4055434;C0449820;C4050231,false;false;false,12149/22402
arb ( n  % ),C3888198,false,12150/22402
arb + ccb ( n = $nmbr$ ),C3888198;C0006684,false;true,12151/22402
arb = angiotensin ii receptor blocker  ccb,C3888198;C0521942;C0006684;C3536793,false;true;true;false,12152/22402
arb or ace inhibitor,C3888198,false,12153/22402
arb or ace inhibitor  n ( % ),C3888198,false,12154/22402
arbs or ace inhibitors,C3888198,false,12155/22402
ard ( $nmbr$ % cl ) per $nmbr$ patient - years,C1817569;C0596019;C0030705;C0439234;C1826411,false;false;true;false;false,12156/22402
ard per $nmbr$ $nmbr$ patient - years ( $nmbr$ % ci ),C1817569;C0030705;C0439234;C0008107;C3259781;C1826411,false;true;false;true;false;false,12157/22402
area of fluorescein leakage within the grid  mean ( sd )  dab,C0017446;C4476700;C0205146,true;false;false,12158/22402
area of retinal hemorrhage within the grid  mean ( sd )  dab,C0017446;C0035317;C0205146,true;true;false,12159/22402
area of retinal thickening within the grid  mean ( sd )  dab,C0017446;C1302690;C0205146,true;false;false,12160/22402
areas,C0205146;C4319729,false;false,12161/22402
arr ( % ),C2170357;C4084934,false;false,12162/22402
arteriai access,,,12163/22402
arterial hypertension  no . ( % ),C0020538,true,12164/22402
arthritis characteristics,C0003864;C1521970;C4552845,true;false;false,12165/22402
arthritis mutilans,C0702102,false,12166/22402
arvfac ( per $nmbr$ % ),,,12167/22402
as,,,12168/22402
as duration  y  mean ( sd ),C0449238;C0444504;C2699239;C2347634;C2348143;C2926735,false;false;false;false;false;false,12169/22402
as major component — no . ( % ),C0205082;C0449432;C1705248;C0205164;C4318856;C4521762,false;false;false;false;false;false,12170/22402
asa  n ( % ),C0004057;C3853627,true;false,12171/22402
asas $nmbr$ / $nmbr$    %,C0004057;C3853627,true;false,12172/22402
asas $nmbr$ / $nmbr$    n   ( % ),C0004057;C3853627,true;false,12173/22402
asas partial remission  %,C0004057;C1521726;C4552913;C4552914;C3853627,true;false;false;false;false,12174/22402
asas partial remission    n   ( % ),C0004057;C1521726;C4552913;C4552914;C3853627,true;false;false;false;false,12175/22402
asas $nmbr$,C0004057;C3853627,true;false,12176/22402
asas $nmbr$  %,C0004057;C3853627,true;false,12177/22402
asas $nmbr$    %,C0004057;C3853627,true;false,12178/22402
ascvd no prior ml,C3665365,false,12179/22402
ascvd * . n ( % ),C3665365,false,12180/22402
ascvd  b no . ( % ),C3665365,false,12181/22402
asdas - crp δ   ≥   $nmbr$ . $nmbr$,C3890735;C4048285,false;false,12182/22402
asdas - crp *,C3890735;C4048285,false;false,12183/22402
asdas - crp   <   $nmbr$ . $nmbr$,C3890735;C4048285,false;false,12184/22402
asdas inactive disease  %,C0544452,false,12185/22402
asia - pacific and south africa,C0003980,true,12186/22402
asia - pacific region and south africa,C0003980;C0017446;C0205147,true;true;false,12187/22402
asia ( excluding japan ),C0003980;C0332196;C0022341;C2828389,true;false;true;false,12188/22402
asia ( n = $nmbr$  $nmbr$ ),C0003980,true,12189/22402
asia and pacific islands,C0003980,true,12190/22402
asia pacific ( n = $nmbr$ ),C0003980,true,12191/22402
asia pacific and africa,C0003980,true,12192/22402
asia pacific and south africa,C0003980,true,12193/22402
asia #,C0003980,true,12194/22402
asian ( n   = $nmbr$ ),C0078988,true,12195/22402
asian ( n = $nmbr$  $nmbr$ ),C0078988,true,12196/22402
asian itt population by treatment group,C0078988;C1257890;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0032659;C0374505,true;true;true;true;false;false;false;false;false;true;false,12197/22402
asian itt population total ( n = $nmbr$ ),C0078988;C0032659;C0439175;C0439810;C1257890,true;true;false;false;true,12198/22402
asian / pacific islander  n ( % ),C0078988;C0242191,true;true,12199/22402
asians ( n = $nmbr$ ),C0078988,true,12200/22402
aslan,,,12201/22402
aspartate aminotransferase increased,C0004002,true,12202/22402
aspartate aminotransferase  u / l,C0004002;C0439339,true;false,12203/22402
aspirin ( % ),C0004057,true,12204/22402
aspirin ( any dose ),C0004057,true,12205/22402
aspirin ( n  % ),C0004057,true,12206/22402
aspirin ( n = $nmbr$ ) no . of participants with events ( % ),C0004057,true,12207/22402
aspirin $nmbr$  $nmbr$,C0004057,true,12208/22402
aspirin alone ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C0004057;C0205171;C0439044;C0679994,true;false;false;false,12209/22402
aspirin at baseline,C0004057;C0168634;C1442488,true;true;false,12210/22402
aspirin before admission,C0004057;C0184666;C0809949,true;false;false,12211/22402
aspirin dose at baseline  mg,C4696290;C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488;C0004057;C4086581,false;true;true;true;false;false;false;false;false;false;true;false,12212/22402
aspirin dose  mg / d,C4696290;C0439422,false;false,12213/22402
aspirin group ( n = $nmbr$ ),C0004057;C0441848,true;false,12214/22402
aspirin or other antiplatelet drug,C0004057,true,12215/22402
aspirin or other antiplatelet or anticoagulant agent,C0004057,true,12216/22402
aspirin orother antiplatelet drug,C0004057;C0013227;C1254351;C0085826,true;true;false;true,12217/22402
aspirin plus clopidogrel ( n = $nmbr$ ),C0004057;C0332287;C0070166,true;false;true,12218/22402
aspirin plus placebo ( n = $nmbr$ ),C0004057;C0332287;C0032042;C1696465;C1706408,true;false;true;false;false,12219/22402
aspirin use ( % ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,12220/22402
aspirin use ( p = $nmbr$ . $nmbr$ t ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,12221/22402
aspirin use at randomization,C0004057;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,12222/22402
aspirin use at randomization - n ( % ),C0004057;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,12223/22402
aspirin use before screening — no . { % ),C0004057;C0042153;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0457083;C1947944,true;true;true;true;false;false;false;false;false;false;false,12224/22402
aspirin use n ( % ),C0004057;C0042153;C0457083;C1947944,true;true;false;false,12225/22402
aspirin  no . ( % ),C0004057,true,12226/22402
aspirin / antiplatelet medication,C0004057;C0013227;C3244316;C4284232;C0085826,true;true;false;false;true,12227/22402
aspirin + dipyridamole,C0732279,true,12228/22402
aspirin + thienopyridine,C0004057;C1120149,true;true,12229/22402
asqol  ls mean change ± se,C0023668;C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false,12230/22402
asqol  ls mean change from baseline   ±   se,C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false,12231/22402
assessment of physical function ( $nmbr$ - $nmbr$  haq - di ),C0031809;C0031843;C3826998;C4321476;C0542341;C0700205;C1705273;C1261322;C0516981;C4049916;C1516048,true;true;false;false;false;false;false;false;false;false;false,12232/22402
assigned to placebo,C1516050;C0032042;C1696465;C1706408;C1552601,false;true;false;false;false,12233/22402
assigned to topiramate,C1516050;C1552601,false;false,12234/22402
assigned treatment by sex interaction,C1516050;C0039798;C0009253;C1704675;C0036864;C0079399;C0804628;C1314687;C1522384;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552601,false;true;true;false;true;true;false;false;true;true;false;false;false;false;false;false,12235/22402
associated with an atrial septal defect,C0332281;C0018817,false;true,12236/22402
ast > $nmbr$ x uln on two consecutive visits,C1415181;C1519815;C0205448;C1707491;C0545082;C1512346;C3891303,false;false;false;false;false;false;false,12237/22402
ast increased,C1415181;C3891303,false;false,12238/22402
asteria i / ii,C1093020;C0021966;C1710602;C4082587;C0221138,true;true;false;false;false,12239/22402
asthma - control status at randomization — no . ( % ),C0004096;C0243148;C0449438;C0034656;C1550141;C1882979;C2587213;C3274648;C4553389;C2984299,true;true;false;true;false;false;false;false;false;false,12240/22402
asthma - related health -,C0004096;C2984299,true;false,12241/22402
asthma exacerbations,C0349790,false,12242/22402
asthma symptoms in the past $nmbr$ weeks,C0004096;C0683368;C2987125;C1457887;C2984299,true;true;false;false;false,12243/22402
asubset of the ≥ $nmbr$ years subgroup .,C0439234;C1079230;C1515021,false;false;false,12244/22402
asui score  mean,,,12245/22402
asui score  mean ( sd ),,,12246/22402
asymmetric peripheral arthritis,C0332514;C0238694,false;false,12247/22402
at,,,12248/22402
at $nmbr$ years,C0439234,false,12249/22402
at any time,C0040223;C3541383,true;false,12250/22402
at baseline,C0168634;C1442488,true;false,12251/22402
at baseline — no . ( % ),C0168634;C1442488,true;false,12252/22402
at c change ( % ) *,C0392747;C0443172;C1705241;C4319952,false;false;false;false,12253/22402
at c data,C1511726;C3245479;C3714741,false;false;false,12254/22402
at end of follow - up,C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,12255/22402
at end of follow - up — no . ( % ),C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,12256/22402
at end of follow - up — no . / total no . ( % ),C0444930;C0589120;C1522577;C1704685;C3274571;C2746065,false;false;false;false;false;false,12257/22402
at femoral neck  mean ( sd ),C0015815;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,12258/22402
at increased fall risk ( n - $nmbr$ ),C4699158;C0085639;C0238715;C4553726;C0205217;C1268740;C0442805,false;false;false;false;false;false;false,12259/22402
at index event : no . ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,12260/22402
at or above median,,,12261/22402
at screening,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,12262/22402
at week $nmbr$,C0332174;C0439230,false;false,12263/22402
at weeks $nmbr$ and $nmbr$,C0439230,false,12264/22402
atenoioi ( n = $nmbr$ ),,,12265/22402
atenolol,C0004147,true,12266/22402
atenolol ( n = $nmbr$ ),C0004147,true,12267/22402
atenolol ( n = $nmbr$  $nmbr$ ),C0004147,true,12268/22402
atenolol ( no . = $nmbr$ ),C0004147,true,12269/22402
atenolol use at $nmbr$ month,C0004147;C0042153;C0332177;C0439231;C0457083;C1947944,true;true;false;false;false;false,12270/22402
atherectomy,C0162513,true,12271/22402
atherosclerosis,C0003850;C0004153,true;true,12272/22402
atherosclerotic cardiovascular disease *,C0004153,true,12273/22402
atherosclerotic cvd,C0333482;C0007222,false;true,12274/22402
atherosclerotic cvd §,C0333482;C0007222,false;true,12275/22402
atherosclerotic cvdj,C0333482,false,12276/22402
atherosclerotic vascular disease — no .,C0004153,true,12277/22402
atherosclerotic vascular disease history  n ( % ) t,C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,12278/22402
atherosclerotic vascular disease history  no . ( % ) ‡,C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,12279/22402
atherosclerotic vascular disease history †,C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,12280/22402
atherosclerotic vascular disease  n ( % ) §,C0004153,true,12281/22402
atherothrombotic infarction  n ( % ),C0021308,true,12282/22402
atherothrombotic stroke  n ( % ),C0038454;C4554100,true;false,12283/22402
atients with event,C0441471;C4019010,false;false,12284/22402
atm - locm,C3711796,true,12285/22402
atm - locus,C3711796;C1708726,true;false,12286/22402
atonic,C0541791,false,12287/22402
atopic,C0392707,false,12288/22402
atopic at baseline : yes,C0392707;C0168634;C1549445;C1705108;C1710701;C1442488,false;true;false;false;false;false,12289/22402
atopy ( n = $nmbr$  $nmbr$ ),C0392707;C3539705,false;false,12290/22402
atopy ( specific ige ) c  n ( % ),C0392707;C0205369;C1552740;C3539705,false;false;false;false,12291/22402
atopy by phadiatop test  n ( % ),C0392707;C1441070;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C3539705,false;false;false;false;false;false;false;false;false;false,12292/22402
atorvastatin ( n = $nmbr$  $nmbr$ ),C0286651,true,12293/22402
atorvastatin { n = $nmbr$  $nmbr$ ),C0286651,true,12294/22402
atorvastatin $nmbr$ mg and simvastatin $nmbr$ - $nmbr$ mg ( zi = $nmbr$ ),C0286651;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12295/22402
atorvastatin $nmbr$ mg ( zi = $nmbr$ ),C0286651;C0024671;C0043476;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,12296/22402
atorvastatinb,,,12297/22402
atrial fibrillation — no . ( % ),C0004238;C0344434;C1963067,true;false;false,12298/22402
atrial fibrillation on baseline ecg  n ( % ),C0344434;C0168634;C1442488,false;true;false,12299/22402
atrial fibrillation type  n ( % ),C0004238;C0332307;C1547052;C0344434;C1963067,true;false;false;false;false,12300/22402
atrial fibrillation    n   ( % ),C0004238;C0344434;C1963067,true;false;false,12301/22402
atrial fibrillation . no . ( % ),C0004238;C0344434;C1963067,true;false;false,12302/22402
attack ( % ),C0277793;C1261512;C1304680,false;false;false,12303/22402
attain,,,12304/22402
atv  atorvastatin  ldl - c  low - density lipoprotein cholesterol . * p - values pertain to treatment - by - stratum interaction test for stratum or treatment - by - subgroup interaction test for subgroups . ' multiplicity adjustments were not applied to this predefined subgroup analysis of ldl - c goal attainment   [ expressed as number of patients reaching ldl - c goal at week $nmbr$ / number of patients above goal at baseline  ^ treatment stratum was defined by intake of atv $nmbr$ or $nmbr$ mg .,C0210243;C0286651;C0023824;C1709380;C0674679;C1145759;C1334862;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1079230;C1704675;C0237455;C1515021;C1518422;C0680230;C0018017;C0332174;C2360800;C0439230;C1571704;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;true;true;false;true;true;false;false;false;false;false;false;false;false;false;false;false;true;false;false;false;false;true;true;false;false;false;false;false,12305/22402
atwo ‐ sample t ‐ test .,C0370003;C0871472;C2347026,false;false;false,12306/22402
atypical absence,C0595948,false,12307/22402
augment copd,C0205217,false,12308/22402
aunivariate logistic regression .,C0206031,true,12309/22402
austral ia / new zealand,C0020980;C0027978;C0324547;C0694634;C1947960,true;true;true;false;false,12310/22402
australia / new zealand / south africa,C4289954;C0037712,false;true,12311/22402
autonomic neuropathy,C0259749,false,12312/22402
available data,C0470187;C1511726;C3245479;C3714741,false;false;false;false,12313/22402
average daily dose,C1510992;C2348070;C2825518,false;false;false,12314/22402
avp pg / ml,C1098706;C0439297;C1568204;C1708407,true;false;true;false,12315/22402
aza ( n = $nmbr$ ),C0004482,true,12316/22402
azathioprine monotherapy,C0004482,true,12317/22402
azl - m,C0369637;C0441923,false;false,12318/22402
azl - m + hctz ( n = $nmbr$ ),C0369637;C0020261;C0441923,false;true;false,12319/22402
azl - m $nmbr$ mg ( n = $nmbr$ ),C0369637;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0441923,false;true;true;false;false;false;false;false;false,12320/22402
azl - m $nmbr$ mg + cld $nmbr$ mg,C0369637;C1319635;C0441923,false;false;false,12321/22402
azl - m $nmbr$ mg $nmbr$ - cld $nmbr$ mg ( n = l $nmbr$ ),C0369637;C2827881;C0441923,false;false;false,12322/22402
azl - m / cld ( n = $nmbr$ ),C0369637;C0441923,false;false,12323/22402
azl - m + cldb,C0369637;C0441923,false;false,12324/22402
azl - ma,C0024443;C3887485,true;false,12325/22402
b - blockers at baseline,C0168634;C1442488,true;false,12326/22402
b - blockers  n ( % ),,,12327/22402
b - natriuretic peptide . pg / ml,C0070338;C0597421;C0439297,true;false;false,12328/22402
b includes both ex - smokers and nonsmokers .,,,12329/22402
b mace,C0349381;C0949745;C1445339,false;true;false,12330/22402
b major cardiovascular events,C0205082;C1320716;C0205164;C4318856;C4521762,false;false;false;false;false,12331/22402
b nonsevere hypoglycemia,C0020615;C4553659,true;false,12332/22402
b pooled new and worsened vertebral fractures ( mfas ),,,12333/22402
b postbronchodilator fevl ( % predicted ),C2599594,false,12334/22402
b reslizumab $nmbr$ . $nmbr$ mg / kg n / n,C1869620;C0439272,true;false,12335/22402
b ) those on inhaled corticosteroids and long - acting bronchodilators as previous treatment use .,,,12336/22402
b  vhd ( n = $nmbr$ ),,,12337/22402
b . acr $nmbr$,C1412134;C1515941,false;false,12338/22402
b . benralizumab $nmbr$ mg q $nmbr$ w,C2982078;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12339/22402
b . i . d .  twice daily  cat  copd assessment test  copd  chronic obstructive pulmonary disease  fev $nmbr$    forced expiratory volume in $nmbr$   s  fvc  forced vital capacity  gold  global initiative for chronic obstructive lung disease  ics  inhaled corticosteroid  mcid  minimum clinically important difference  mmrc  modified medical research council  o . d .  once daily  sd  standard deviation  sgrq - c  st . george ’ s respiratory questionnaire for copd,C0152277;C0585361;C0007450;C4284282;C0325090;C0524517;C1443200;C3665481;C4050461;C0024117;C3714541;C0016529;C1306036;C3714541;C0018026;C0205246;C0424093;C0205191;C0549186;C2348867;C1304897;C0024115;C0815320;C0004048;C0001617;C4277733;C3536709;C4551720;C3826977;C0871420;C3826872;C1553316;C0521346;C0034394;C1546767;C0024117;C1412502;C3714496,false;false;true;false;false;true;false;false;false;true;true;true;false;true;true;false;false;false;false;false;false;true;false;true;true;true;false;true;false;false;false;false;false;true;false;true;false;false,12340/22402
b . myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,12341/22402
b : u . s . black and non - black patients,C0041703;C0005680;C0027567;C0085756;C0439541,true;true;true;true;false,12342/22402
b + a ( n = $nmbr$ ),,,12343/22402
b + h ( n = $nmbr$ ),C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,12344/22402
background aha therapy at screening  n,C1706907;C0050451;C0039798;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0087111;C1363945;C0772110,false;true;true;true;true;false;false;false;false;false;true;false;false,12345/22402
background aha therapy at screening  n ( % ) §,C1706907;C0050451;C0039798;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0087111;C1363945;C0772110,false;true;true;true;true;false;false;false;false;false;true;false;false,12346/22402
background aha therapy at screening  a,C1706907;C0050451;C0039798;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0087111;C1363945;C0772110,false;true;true;true;true;false;false;false;false;false;true;false;false,12347/22402
background aha therapy at screening  a   n ( % ),C1706907;C0050451;C0039798;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0087111;C1363945;C0772110,false;true;true;true;true;false;false;false;false;false;true;false;false,12348/22402
background laba use,C1706907;C0042153;C0457083;C1947944,false;true;false;false,12349/22402
background laba use - yes  n ( % ),C1706907;C0042153;C1549445;C1705108;C1710701;C0457083;C1947944,false;true;false;false;false;false;false,12350/22402
background lipid - lowering therapy,C1706907;C0585943,false;false,12351/22402
background lipid therapy per acc / aha definition    n   ( % ) a,C1706907;C0023767;C0039798;C4072694;C1550452;C1704788;C3539107;C3888054;C0087111;C1363945,false;true;true;false;false;false;false;false;true;false,12352/22402
background therapy,C1706907;C0039798;C0087111;C1363945,false;true;true;false,12353/22402
bacterial pneumonia,C0004626,true,12354/22402
bail ‐ out use of glycoprotein iib / iiia inhibitors,C0175673,false,12355/22402
barc types $nmbr$  $nmbr$  or $nmbr$,C0332307,false,12356/22402
baricitinib $nmbr$ / $nmbr$ mg,C4044947;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12357/22402
baricitinib $nmbr$ mg qd,C4044947;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,12358/22402
basal,C0205112,false,12359/22402
basal alone,C0205112;C0205171;C0439044;C0679994,false;false;false;false,12360/22402
basal insulin,C0650607,false,12361/22402
basal insulin doset,C0650607,false,12362/22402
basal only,C0205112;C0205171;C1720467,false;false;false,12363/22402
basal plus bolus,C0205112;C0332287;C1186706;C1511237;C1705509;C3812160,false;false;false;false;false;false,12364/22402
basdai question $nmbr$ score ( $nmbr$ - $nmbr$ )  mean ( sd ),C1998004,false,12365/22402
basdai responses at week $nmbr$,C1998004;C0871261;C0332174;C0439230,false;false;false;false,12366/22402
basdai score ( $nmbr$ - $nmbr$ )  mean ( sd ),C1998004,false,12367/22402
basdai score  mean ( sd ),C1998004,false,12368/22402
basdai  ls mean change from baseline   ±   se,C1998004;C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;true;false;false;true;true;false;false;false;false;false;false,12369/22402
basdai  mean change from baseline,C1998004;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false,12370/22402
basdai  total  mean ± sd,C1998004;C0439175;C0444504;C2699239;C2347634;C2348143;C0439810,false;false;false;false;false;false;false,12371/22402
basdai ⁎ ⁎,C1998004,false,12372/22402
basdai $nmbr$  n ( % ),C1998004,false,12373/22402
basdai $nmbr$  %,C1998004,false,12374/22402
base,C0002055;C0178499;C1880279,true;false;false,12375/22402
baseiine acei / arb,C3888198,false,12376/22402
baseiine aspirin,C0004057,true,12377/22402
baseiine ccb,C0006684,true,12378/22402
baseiine diuretic,,,12379/22402
baseiine statin,C0360714,true,12380/22402
baseline - adjusted hr,C0168634;C1442488,true;false,12381/22402
baseline - - mdrd,C0168634;C3839656;C1442488,true;false;false,12382/22402
baseline - ckd - epi,C0168634;C1561643;C0162734;C4281721;C1442488,true;true;true;false;false,12383/22402
baseline ( mmol / l ),C0168634;C1532563;C1442488,true;false;false,12384/22402
baseline ( sd ),C0168634;C2699239;C1442488,true;false;false,12385/22402
baseline ^ ste  mm,C0168634;C1420459;C4330985;C4554674;C3811127;C1442488,true;false;false;false;false;false,12386/22402
baseline £ std  mm,C0168634;C4330985;C4554674;C1442488,true;false;false;false,12387/22402
baseline $nmbr$ - hour mean sbp  mm hg,C0168634;C0439227;C0444504;C0085805;C0439475;C2347634;C2348143;C0564385;C1442488,true;false;false;true;false;false;false;false;false,12388/22402
baseline $nmbr$ - mlnute walk distance :,C0168634;C0429886;C1442488,true;false;false,12389/22402
baseline a $nmbr$ c ( % ),C0168634;C1442488,true;false,12390/22402
baseline a $nmbr$ c ( % ) [ lsm ( se ) ],C0168634;C0036919;C1442488,true;true;false,12391/22402
baseline abi  affected limb,C0168634;C1328319;C3888326;C1442488,true;true;false;false,12392/22402
baseline adas - cog $nmbr$,C0168634;C3539026;C1442488,true;false;false,12393/22402
baseline age,C0168634;C0001779;C1442488,true;false;false,12394/22402
baseline albuminuria,C0168634;C0001925;C1442488,true;true;false,12395/22402
baseline alc < $nmbr$ . $nmbr$ %,C0168634;C1424945;C3811058;C1442488,true;false;false;false,12396/22402
baseline alc category,C0168634;C1424945;C0683312;C3889287;C3811058;C1442488,true;false;false;false;false;false,12397/22402
baseline anti - hyperglycemic medications  n ( % ),C0168634;C0432633;C0013227;C0802604;C2598133;C4284232;C1442488,true;false;true;false;false;false;false,12398/22402
baseline asdas - crp,C0168634;C3890735;C4048285;C1442488,true;false;false;false,12399/22402
baseline aspirin use,C0168634;C0004057;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,12400/22402
baseline aspirin use strata,C0168634;C0004057;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,12401/22402
baseline basdai,C0168634;C1998004;C1442488,true;false;false,12402/22402
baseline basfi,C0168634;C1442488,true;false,12403/22402
baseline bii  mean ( sd ),C0168634;C1413059;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,12404/22402
baseline bmi,C0168634;C0578022;C1442488,true;false;false,12405/22402
baseline bmi ( kg / m ^ ),C0168634;C0578022;C1532718;C1442488,true;false;false;false,12406/22402
baseline bmi ( kg / m $nmbr$ ),C0168634;C0578022;C1532718;C1442488,true;false;false;false,12407/22402
baseline bnp concentration ( pg / ml ),C0168634;C0054015;C0086045;C0439297;C1446561;C3827302;C1095989;C1417808;C2982014;C1442488,true;true;true;false;false;false;false;false;false;false,12408/22402
baseline bp  mean ( sd ) *,C0168634;C0488053;C2699239;C1442488,true;false;false;false,12409/22402
baseline bsa  mean ( sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,12410/22402
baseline cardiovascular assessment,C4684571;C0007226;C3887460;C0168634;C0846600;C1442488,false;true;false;true;false;false,12411/22402
baseline cardiovascular medications  n ( % ),C0168634;C0007220;C1442488,true;true;false,12412/22402
baseline cdai  mean ( sd ),C0168634;C0683448;C0444504;C2699239;C2347634;C2348143;C1413248;C3273706;C1442488,true;false;false;false;false;false;false;false;false,12413/22402
baseline cdr - sb ( n   = $nmbr$ + $nmbr$ ),C0168634;C4521843;C0038111;C3811240;C1442488,true;false;true;false;false,12414/22402
baseline cha $nmbr$ ds $nmbr$ - vascb  c,C0168634;C1420648;C3714751;C1442488,true;false;false;false,12415/22402
baseline chads $nmbr$ a  c,C0168634;C0007928;C1413373;C1442488,true;true;false;false,12416/22402
baseline characteristics  mean ( sd ) a,C4684572;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,12417/22402
baseline ckd egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0168634;C1561643;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;true;false;false;false;false;false;false,12418/22402
baseline ckd egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0168634;C1561643;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;true;false;false;false;false;false;false,12419/22402
baseline concentration,C0168634;C0086045;C1446561;C3827302;C1442488,true;true;false;false;false,12420/22402
baseline concomitant cardiovascular medications,C0168634;C0521115;C0007220;C1442488,true;false;true;false,12421/22402
baseline crcl  ml / min,C0168634;C1846718;C0439445;C1442488,true;false;false;false,12422/22402
baseline creatinine  median ( range ) mg / dl,C0168634;C0010294;C0549183;C1514721;C0439269;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1561535;C1442488,true;true;false;false;false;false;false;false;false;false;false;false;false,12423/22402
baseline crohn ' s disease medications,C0168634;C0010346;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;true;false;false;false;false,12424/22402
baseline crp,C0168634;C3890735;C4048285;C1442488,true;false;false;false,12425/22402
baseline crp category ( mg / l ),C0168634;C3890735;C0683312;C0439268;C3889287;C4048285;C1442488,true;false;false;false;false;false;false,12426/22402
baseline crp levels < $nmbr$ mg / l,C0168634;C3890735;C0441889;C0439268;C4048285;C1442488,true;false;false;false;false;false,12427/22402
baseline crp levels ≥ $nmbr$ mg / l,C0168634;C3890735;C0441889;C0439268;C4048285;C1442488,true;false;false;false;false;false,12428/22402
baseline dad ( n   = $nmbr$ + $nmbr$ ),C0168634;C3641946;C1442488,true;false;false,12429/22402
baseline das $nmbr$  mean ( s . e . ),C0168634;C0051767;C0444504;C2347634;C2348143;C0057671;C1442488,true;true;false;false;false;true;false,12430/22402
baseline data,C0168634;C1511726;C3245479;C3714741;C1442488,true;false;false;false;false,12431/22402
baseline daytime nasal symptoms score  mean ± sd,C0168634;C0332169;C0231918;C1442488,true;false;false;false,12432/22402
baseline dbp,C0168634;C0536221;C3813197;C4281799;C1442488,true;true;false;false;false,12433/22402
baseline dbp  mean ± sd  mm hg,C0168634;C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799;C1442488,true;true;false;false;false;false;false;false;false;false,12434/22402
baseline demographics,C0168634;C0011298;C1704791;C1442488,true;true;false;false,12435/22402
baseline diabetes mellitus therapy  n ( % ),C0168634;C0948092;C1442488,true;false;false,12436/22402
baseline diastolic blood,C0168634;C0012000;C0005767;C0005768;C0229664;C1442488,true;true;true;true;false;false,12437/22402
baseline diastolic blood pressure  mean ( sd )  mm hg,C4274392;C0444504;C2699239;C0439475;C2347634;C2348143,false;false;false;false;false;false,12438/22402
baseline dipeptidyl peptidase $nmbr$,C0168634;C0022709;C1442488,true;true;false,12439/22402
baseline dlqi  mean ( sd ),C0168634;C3899393;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,12440/22402
baseline ecg with lvh  n ( % ),C0168634;C0232306;C1442488,true;false;false,12441/22402
baseline ecrcl $nmbr$ $nmbr$ ml / min,C0168634;C0439445;C1442488,true;false;false,12442/22402
baseline ecrcl k $nmbr$ to < $nmbr$ ml / min,C0168634;C0597277;C0439445;C1708601;C1442488,true;false;false;false;false,12443/22402
baseline ecro < $nmbr$ mumin,C0168634;C1442488,true;false,12444/22402
baseline ecrq $nmbr$ $nmbr$ to < $nmbr$ ml / min,C0168634;C0439445;C1442488,true;false;false,12445/22402
baseline ed severity * * :,C0168634;C3538926;C0439793;C0522510;C1442488,true;false;false;false;false,12446/22402
baseline egfr ( ml / min per $nmbr$ « $nmbr$ m ’ ),C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,12447/22402
baseline egfr < $nmbr$,C0168634;C1739039;C3811844;C3812682;C1442488,true;true;false;false;false,12448/22402
baseline egfr ≥ $nmbr$ to < $nmbr$,C0168634;C1739039;C3811844;C3812682;C1442488,true;true;false;false;false,12449/22402
baseline egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,12450/22402
baseline egfr  ml / min / $nmbr$ . $nmbr$   m $nmbr$,C0168634;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;true;false;false;false;false;false;false,12451/22402
baseline eosinophil < $nmbr$ cells / pl,C0168634;C0682547;C3897966;C4049765;C1442488,true;false;false;false;false,12452/22402
baseline eosinophil $nmbr$ cells / pl,C0168634;C0682547;C3897966;C4049765;C1442488,true;false;false;false;false,12453/22402
baseline estimated gfr,C0168634;C1442488,true;false,12454/22402
baseline factor,C0168634;C1521761;C2827422;C1442488,true;false;false;false,12455/22402
baseline fasting plasma glucose,C0168634;C0015663;C0202042;C0455280;C1442488,true;true;false;false;false,12456/22402
baseline fasting tgs  mg / dl,C0168634;C0015663;C1156212;C0439269;C1537574;C1442488,true;true;false;false;false;false,12457/22402
baseline fc - ldl - c,C0168634;C2983605;C1442488,true;false;false,12458/22402
baseline feature,C0168634;C1521970;C1706388;C2346469;C2348519;C1442488,true;false;false;false;false;false,12459/22402
baseline fev $nmbr$  median ( range )  l,C0168634;C3714541;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1442488,true;true;false;false;false;false;false;false;false;false;false,12460/22402
baseline fpg  mg / dl,C0168634;C0439269;C1442488,true;false;false,12461/22402
baseline free pcsk $nmbr$ level,C0168634;C0332296;C0441889;C0456079;C1547707;C2946261;C1880497;C1996904;C1442488,true;false;false;false;false;false;false;false;false,12462/22402
baseline geometric mean ( $nmbr$ ® / l ),C0168634;C2986759;C1442488,true;false;false,12463/22402
baseline gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C0168634;C0017654;C0439445;C0369637;C0441923;C1424601;C1442488,true;true;false;false;false;false;false,12464/22402
baseline glycated,C0168634;C1442488,true;false,12465/22402
baseline glycated hemoglobin ( % ),C0168634;C0017853;C1442488,true;true;false,12466/22402
baseline glycemic control,C0168634;C0005802;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1442488,true;true;true;false;false;false;false;false;false,12467/22402
baseline haq mean ( s . e . ),C0168634;C0102923;C0444504;C2347634;C2348143;C0451208;C1442488,true;true;false;false;false;false;false,12468/22402
baseline hba ^ c,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,12469/22402
baseline hba $nmbr$ c < $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,12470/22402
baseline hba $nmbr$ c ≤ median $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ),C0168634;C0019016;C0549183;C3829066;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758;C1442488,true;true;false;false;false;false;false;false;false;false;false,12471/22402
baseline hba $nmbr$ c ≥ $nmbr$ mmol / mol ( ≥ $nmbr$ . $nmbr$ % )  n ( % ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,12472/22402
baseline hba $nmbr$ c ≥ $nmbr$ . $nmbr$ % to < $nmbr$ . $nmbr$ % ( $nmbr$ – $nmbr$ mmol / mol ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,12473/22402
baseline hba $nmbr$ c ≥ $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ),C0168634;C0019016;C3829066;C1825777;C3538758;C1442488,true;true;false;false;false;false,12474/22402
baseline hba $nmbr$ c > median $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ),C0168634;C0019016;C0549183;C3829066;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758;C1442488,true;true;false;false;false;false;false;false;false;false;false,12475/22402
baseline hba $nmbr$ c concentration,C0168634;C0019016;C0086045;C1446561;C3827302;C1825777;C3538758;C1442488,true;true;true;false;false;false;false;false,12476/22402
baseline hba $nmbr$ c subgroup,C0168634;C0019016;C1079230;C1515021;C1825777;C3538758;C1442488,true;true;false;false;false;false;false,12477/22402
baseline hba $nmbr$ c ^,C0168634;C0019016;C1825777;C3538758;C1442488,true;true;false;false;false,12478/22402
baseline hbalc,C0168634;C1442488,true;false,12479/22402
baseline hbalc < $nmbr$ %,C0168634;C1442488,true;false,12480/22402
baseline hbalc > $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % ),C0168634;C3829066;C1442488,true;false;false,12481/22402
baseline hbalc > $nmbr$ % to < $nmbr$ %,C0168634;C1442488,true;false,12482/22402
baseline hbalc > $nmbr$ %,C0168634;C1442488,true;false,12483/22402
baseline hbalc ^,C0168634;C1442488,true;false,12484/22402
baseline hbalc ’,C0168634;C1442488,true;false,12485/22402
baseline hbi  mean ( sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,12486/22402
baseline hdl - c,C0168634;C3715113;C1442488,true;false;false,12487/22402
baseline hdl - c level ( n = $nmbr$ » $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl,C0168634;C3715113;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12488/22402
baseline hdl - c level ( n = $nmbr$ . $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl,C0168634;C3715113;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12489/22402
baseline hdl - c level ( n = $nmbr$  $nmbr$ ) s $nmbr$ . $nmbr$ mg / dl,C0168634;C3715113;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12490/22402
baseline hdl - c level ( n = s $nmbr$  $nmbr$ ) < $nmbr$ . $nmbr$ mg / dl,C0168634;C3715113;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12491/22402
baseline hdl - c  mg / dl,C0168634;C3715113;C0439269;C1442488,true;false;false;false,12492/22402
baseline hdl ‐ c  mg / dl,C0168634;C3715113;C0439269;C1442488,true;false;false;false,12493/22402
baseline height ( cm ),C0168634;C0489786;C1442488,true;false;false,12494/22402
baseline hemoglobin aj ^ values,C0168634;C0019046;C0004486;C0042295;C0230613;C1442488,true;true;true;false;true;false,12495/22402
baseline high - density lipoprotein cholesterol ( mg / dl ),C0168634;C0023822;C0439269;C1442488,true;true;false;false,12496/22402
baseline hstni,C0168634;C1442488,true;false,12497/22402
baseline ics,C0168634;C0815320;C4551720;C1442488,true;false;true;false,12498/22402
baseline ics > $nmbr$ pg per day ( fluticasone propionate dpi or equivalent ) and laba,C0168634;C0815320;C2827928;C0117996;C4551720;C1442488,true;false;false;true;true;false,12499/22402
baseline ics dose  n ( % ),C0168634;C0815320;C0178602;C0869039;C1114758;C4551720;C1442488,true;false;false;false;false;true;false,12500/22402
baseline if have $nmbr$ yr follow - up *,C0168634;C1442488,true;false,12501/22402
baseline ifg ( fpg $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mmol / l ) - n,C0168634;C1334085;C1532563;C1708411;C1442488,true;false;false;false;false,12502/22402
baseline in - check * ’ pifr ( l / min ),C0168634;C1283174;C0702093;C1524029;C3813700;C1555524;C4321547;C1442488,true;false;false;false;false;false;false;false,12503/22402
baseline inflammation markers,C0168634;C0021368;C0005516;C1442488,true;true;true;false,12504/22402
baseline insulin,C0168634;C0021641;C1533581;C1579433;C3714501;C1442488,true;true;false;false;false;false,12505/22402
baseline insulin dose ( u = kg ) [ lsm ( se ) ],C0168634;C0366513;C1300561;C0036919;C1442488,true;false;false;true;false,12506/22402
baseline ldl - c  mg / dl,C0168634;C0439269;C1442488,true;false;false,12507/22402
baseline ldl ‐ c  mg / dl,C0168634;C0439269;C1442488,true;false;false,12508/22402
baseline ldl ( mg % ),C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1442488,true;true;true;false;false;false;false;false;false,12509/22402
baseline ldl cholesterol ( derived ),C0168634;C0023824;C0202117;C1442488,true;true;false;false,12510/22402
baseline ldlc level ( n = $nmbr$  $nmbr$ ) > $nmbr$ . $nmbr$ mgzdl,C0168634;C1416822;C0441889;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false,12511/22402
baseline ldlc level ( n = $nmbr$  $nmbr$ ) ^ $nmbr$ . $nmbr$ mg / dl,C0168634;C1416822;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12512/22402
baseline ldlc level ( n = $nmbr$ . $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl,C0168634;C1416822;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12513/22402
baseline ldlc level ( n = $nmbr$  $nmbr$ ) s $nmbr$ . $nmbr$ mg / dl,C0168634;C1416822;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12514/22402
baseline lipid and apolipoprotein levels,C0168634;C0023779;C1442488,true;true;false,12515/22402
baseline lipid parameters  mg / dl  mmol / l or g / l,C0168634;C0023779;C0449381;C0439269;C1532563;C1442488,true;true;false;false;false;false,12516/22402
baseline lipid profile  mg / dl  mean ( sd ),C0168634;C0023779;C1979963;C0439269;C0444504;C2699239;C2347634;C2348143;C2003903;C1442488,true;true;false;false;false;false;false;false;false;false,12517/22402
baseline lipid therapy,C0168634;C0023779;C0039798;C0087111;C1363945;C1442488,true;true;true;true;false;false,12518/22402
baseline lipids,C0168634;C0023779;C1442488,true;true;false,12519/22402
baseline lipids  mg / dl,C0168634;C0023779;C0439269;C1442488,true;true;false;false,12520/22402
baseline lipoprotein ( a ) ( nmol / l )  median ( iqr ),C0168634;C0065058;C0439282;C0549183;C0876920;C2347635;C2348144;C2939193;C0125953;C1096202;C1439335;C1442488,true;true;false;false;false;false;false;false;true;false;false;false,12521/22402
baseline los angeles grade of eo  n ( % ),C0168634;C0024015;C1442488,true;true;false,12522/22402
baseline lp ( a )  mg / dl,C0168634;C0065058;C0439269;C1439335;C4553379;C1442488,true;true;false;false;false;false,12523/22402
baseline luts severity * :,C0168634;C0574785;C0439793;C0522510;C1442488,true;true;false;false;false,12524/22402
baseline luts severity  n ( % ) :,C0168634;C0574785;C0439793;C0522510;C1442488,true;true;false;false;false,12525/22402
baseline mayo score,C0168634;C0454788;C0449820;C4050231;C1077578;C1442488,true;false;false;false;false;false,12526/22402
baseline mdrd egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0168634;C3839656;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;false;true;false;false;false;false;false;false,12527/22402
baseline mdrd egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0168634;C3839656;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1442488,true;false;true;false;false;false;false;false;false,12528/22402
baseline mean ( sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,12529/22402
baseline mean ambulatory sbp  mm hg ( sd ) *,C0168634;C0444504;C0439841;C0085805;C0439475;C2699239;C2347634;C2348143;C1442488,true;false;false;true;false;false;false;false;false,12530/22402
baseline mean fev $nmbr$ ( sd )  ml,C0168634;C0444504;C3714541;C2699239;C0439526;C1705224;C3887665;C2347634;C2348143;C1442488,true;false;true;false;false;false;false;false;false;false,12531/22402
baseline mean seated sbp  mm hg ( sd ),C0168634;C0444504;C0277814;C0085805;C0439475;C2699239;C1283233;C2347634;C2348143;C1442488,true;false;true;true;false;false;false;false;false;false,12532/22402
baseline mean serum uric acid  pmol / l ( sd ),C0168634;C0444504;C0455272;C0439284;C2699239;C0700634;C2347634;C2348143;C1442488,true;false;false;false;false;false;false;false;false,12533/22402
baseline median,C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false,12534/22402
baseline medical therapy  n ( % ),C0168634;C0418981;C1442488,true;false;false,12535/22402
baseline medications ( % ),C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,12536/22402
baseline medications  n ( % ),C0168634;C0013227;C0802604;C2598133;C4284232;C1442488,true;true;false;false;false;false,12537/22402
baseline metformin,C0168634;C0025598;C1442488,true;true;false,12538/22402
baseline microalbumin : < $nmbr$,C0168634;C0201838;C2362049;C1442488,true;false;false;false,12539/22402
baseline monthly pos seizure rate,C0168634;C0332177;C1262869;C0036572;C0871208;C1521828;C1959629;C4553401;C3496112;C3496399;C1442488,true;false;true;true;false;false;false;false;false;false;false,12540/22402
baseline mtss subgroup,C0168634;C1079230;C1515021;C1442488,true;false;false;false,12541/22402
baseline mwd  m,C0168634;C0369637;C0441923;C1442488,true;false;false;false,12542/22402
baseline nbp,C0168634;C1442488,true;false,12543/22402
baseline non - hdl - ca,C0168634;C1518422;C3715113;C3887642;C1442488,true;false;false;true;false,12544/22402
baseline normoglycaemia ( fpg < $nmbr$ . $nmbr$ mmol / l ) - n,C0168634;C0580545;C1532563;C1442488,true;false;false;false,12545/22402
baseline normoglycemia,C0168634;C0580545;C1442488,true;false;false,12546/22402
baseline numberf of adm classes  n ( % ),C0168634;C0215825;C0456387;C1518526;C1705943;C4019422;C4521767;C1442488,true;true;false;false;false;false;false;false,12547/22402
baseline ocs use : yes,C0168634;C1442488,true;false,12548/22402
baseline of induction,C0168634;C0205263;C0857127;C1442488,true;false;false;false,12549/22402
baseline of induction )  n ( % ),C0168634;C0205263;C0857127;C1442488,true;false;false;false,12550/22402
baseline outcomes,C0168634;C1274040;C1442488,true;false;false,12551/22402
baseline parameter,C0168634;C0549193;C1704769;C2350001;C1442488,true;false;false;false;false,12552/22402
baseline pasi  mean ( sd ),C0168634;C4528685;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,12553/22402
baseline pava,C0168634;C0135567;C1442488,true;true;false,12554/22402
baseline pcsi < $nmbr$ a,C0168634;C1442488,true;false,12555/22402
baseline pfd  m,C0168634;C0016065;C0369637;C0441923;C1839454;C2827389;C3889643;C1442488,true;true;false;false;true;false;false;false,12556/22402
baseline pos frequency per $nmbr$ days,C0168634;C1262869;C0585290;C3496112;C3496399;C1442488,true;true;false;false;false;false,12557/22402
baseline post - bronchodilator fev $nmbr$   ( sd )  ml,C0168634;C2599594;C3714541;C2699239;C0439526;C1705224;C3887665;C1442488,true;false;true;false;false;false;false;false,12558/22402
baseline ppasi score  mean ( sd ),C0168634;C1442488,true;false,12559/22402
baseline prediabetes,C0168634;C0362046;C1442488,true;true;false,12560/22402
baseline prednisone or oral prednisone equivalent daily dose,C0168634;C0032952;C1442488,true;true;false,12561/22402
baseline presence of nasal polyps,C0168634;C0150312;C0027430;C0392148;C3854307;C1442488,true;false;true;false;false;false,12562/22402
baseline procedure  n ( % ),C0168634;C0184661;C2700391;C3274430;C3539779;C1442488,true;true;false;false;false;false,12563/22402
baseline pssi score  mean ( sd ),C0168634;C1442488,true;false,12564/22402
baseline ptga,C0168634;C1442488,true;false,12565/22402
baseline pulmonary medication  b n ( % ),C0168634;C0024109;C0013227;C3244316;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false,12566/22402
baseline pulmonary medications,C0168634;C0024109;C0013227;C0802604;C2598133;C4284232;C2707265;C2709248;C4522268;C1442488,true;true;true;false;false;false;false;false;false;false,12567/22402
baseline renal function ( eclcr ),C0168634;C0232804;C1442488,true;false;false,12568/22402
baseline risk factors,C0168634;C0035648;C1553898;C1442488,true;true;false;false,12569/22402
baseline rst - segment,C0168634;C1425219;C0441635;C1442488,true;false;false;false,12570/22402
baseline rst - segment elevation  mm,C0168634;C1425219;C0441635;C0439775;C4330985;C4554674;C0702240;C1442488,true;false;false;false;false;false;false;false,12571/22402
baseline sbp,C0168634;C0085805;C1442488,true;true;false,12572/22402
baseline sbp ( mm ),C0168634;C0085805;C4330985;C4554674;C1442488,true;true;false;false;false,12573/22402
baseline sbp { p = o - $nmbr$ ),C0168634;C0085805;C1442488,true;true;false,12574/22402
baseline sbp  mean ± sd  mm hg,C0168634;C0085805;C0444504;C2699239;C0439475;C2347634;C2348143;C1442488,true;true;false;false;false;false;false;false,12575/22402
baseline sedbp  mean ( sd )  mm hg §,C0168634;C0444504;C2699239;C0439475;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,12576/22402
baseline serum calcium level  n ( % ),C0168634;C0036785;C0728876;C1442488,true;false;false;false,12577/22402
baseline serum mg < $nmbr$ . $nmbr$ mmol / l,C0168634;C0229671;C0439268;C0439190;C0024671;C1532563;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1546774;C1550100;C1442488,true;true;false;false;true;false;true;false;false;false;false;false;false;false;false,12578/22402
baseline serum mg > = $nmbr$ . $nmbr$ mmol / l,C0168634;C0229671;C0439268;C0439190;C0024671;C1532563;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1546774;C1550100;C1442488,true;true;false;false;true;false;true;false;false;false;false;false;false;false;false,12579/22402
baseline serum urate ( mg / dl ) a,C0168634;C0455272;C0439269;C1442488,true;false;false;false,12580/22402
baseline sesbp  mean ( sd )  mm hg §,C0168634;C0444504;C2699239;C0439475;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,12581/22402
baseline shs ( $nmbr$ - $nmbr$ ),C0168634;C1442488,true;false,12582/22402
baseline sildenafil dose mg,C0168634;C0529793;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C1442488,true;true;false;true;true;false;false;false;false;false;false;false;false,12583/22402
baseline sitosterol / cholesterol,C0168634;C0037215;C0008377;C0220914;C1442488,true;true;true;true;false,12584/22402
baseline sitosterol / lathosterol,C0168634;C0037215;C0064673;C0220914;C1442488,true;true;true;true;false,12585/22402
baseline sitting dbp  * mm hg,C0168634;C0277814;C0536221;C0439475;C3813197;C4281799;C2584297;C4050224;C1442488,true;true;true;false;false;false;true;false;false,12586/22402
baseline sitting sbp  $nmbr$ mm hg,C0168634;C0277814;C0085805;C0439475;C2584297;C4050224;C1442488,true;true;true;false;true;false;false,12587/22402
baseline sjc  mean ( s . e . ),C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,12588/22402
baseline skin pain vas  mean ( sd ),C0168634;C0241136;C0042815;C0444504;C2699239;C2347634;C2348143;C3536884;C3827561;C1963195;C0444099;C1123023;C4520765;C1442488,true;false;true;false;false;false;false;true;false;false;false;true;false;false,12589/22402
baseline smoking status,C0168634;C1519386;C1442488,true;false;false,12590/22402
baseline spga  mean ( sd ),C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,true;false;false;false;false;false,12591/22402
baseline spirometry,C0168634;C0037981;C1442488,true;true;false,12592/22402
baseline statin,C0168634;C0360714;C1442488,true;true;false,12593/22402
baseline statin intensity,C0168634;C0360714;C0522510;C1442488,true;true;false;false,12594/22402
baseline statin use,C0168634;C0360714;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,12595/22402
baseline ste in worst lead  mm,C0168634;C1420459;C1522166;C0023175;C4330985;C4554674;C0181586;C1442948;C1522538;C2348269;C3275067;C3811127;C1442488,true;false;false;true;false;false;false;false;false;false;false;false;false,12596/22402
baseline sua  mean ± sd mg / dl,C0168634;C0444504;C2699239;C0439269;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,12597/22402
baseline subgroup,C0168634;C1079230;C1515021;C1442488,true;false;false;false,12598/22402
baseline sulfonylurea yes,C0168634;C0038766;C1549445;C1705108;C1710701;C3536898;C1442488,true;true;false;false;false;false;false,12599/22402
baseline symptom days perweek,C0168634;C1457887;C0439228;C3854129;C1442488,true;false;false;false;false,12600/22402
baseline systolic blood pressure  mean ( sd )  mm hg,C4274438;C0444504;C2699239;C0439475;C2347634;C2348143,false;false;false;false;false;false,12601/22402
baseline t - score at femoral neck  n ( % ),C0168634;C0449820;C0015815;C4050231;C1442488,true;false;true;false;false,12602/22402
baseline tava,C0168634;C1442488,true;false,12603/22402
baseline tbp,C0168634;C1442488,true;false,12604/22402
baseline tc  mg / dl,C0168634;C0039411;C0439269;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C1442488,true;true;false;true;true;true;false;false;false;false,12605/22402
baseline tg,C0168634;C0337445;C1442488,true;false;false,12606/22402
baseline tg < $nmbr$ . $nmbr$ mmol / l,C0168634;C0337445;C1532563;C1442488,true;false;false;false,12607/22402
baseline tg > $nmbr$ . $nmbr$ mmol / l,C0168634;C0337445;C1532563;C1442488,true;false;false;false,12608/22402
baseline tg level ( n = $nmbr$  $nmbr$ ) < $nmbr$ . $nmbr$ mg / dl,C0168634;C0337445;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12609/22402
baseline tg level ( n = $nmbr$  $nmbr$ ) s $nmbr$ . $nmbr$ mg / dl,C0168634;C0337445;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12610/22402
baseline tg level ( n = $nmbr$ . $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl,C0168634;C0337445;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12611/22402
baseline tg level { n = $nmbr$  $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl,C0168634;C0337445;C0441889;C0439269;C0456079;C1547707;C2946261;C1442488,true;false;false;false;false;false;false;false,12612/22402
baseline tg  ( mg / dl )  median ( iqr ),C0168634;C0337445;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488,true;false;false;false;false;false;false;false;false,12613/22402
baseline tjc  mean ( s . e . ),C0168634;C0444504;C2347634;C2348143;C1442488,true;false;false;false;false,12614/22402
baseline to eom placebo ( n = $nmbr$ ),C0168634;C0241886;C0032042;C1696465;C1706408;C1442488,true;false;true;false;false;false,12615/22402
baseline to year $nmbr$,C0168634;C0439234;C0439508;C1442488,true;false;false;false,12616/22402
baseline tophusa,C0168634;C1442488,true;false,12617/22402
baseline total ipss,C0168634;C0439175;C1019118;C1998280;C2827405;C3811063;C0439810;C1442488,true;false;false;false;false;false;false;false,12618/22402
baseline total ipss  mean ( sd ),C0168634;C0439175;C1019118;C0444504;C2699239;C2347634;C2348143;C1998280;C2827405;C3811063;C0439810;C1442488,true;false;false;false;false;false;false;false;false;false;false;false,12619/22402
baseline total pcsk $nmbr$ level,C0168634;C0439175;C0441889;C0456079;C1547707;C2946261;C0439810;C1442488,true;false;false;false;false;false;false;false,12620/22402
baseline triglycerides,C0168634;C0041004;C1442488,true;true;false,12621/22402
baseline triglycerides > $nmbr$ mg / dl and,C0168634;C0041004;C0439269;C1442488,true;true;false;false,12622/22402
baseline uas $nmbr$,C0168634;C1442488,true;false,12623/22402
baseline upgr > $nmbr$ gm / gm ( $nmbr$ mg / mmole ),C0168634;C0017480;C0567349;C2348885;C3854019;C1442488,true;true;false;false;true;false,12624/22402
baseline upgr  mg / mmole ( n = $nmbr$  $nmbr$  $nmbr$ ),C0168634;C0567349;C2348885;C1442488,true;false;false;false,12625/22402
baseline use of adm  n ( % ),C0168634;C1524063;C0215825;C4521767;C1442488,true;false;true;false;false,12626/22402
baseline variable,C0168634;C0439828;C4553760;C1442488,true;false;false;false,12627/22402
baseline vertebral fracture,C0168634;C0080179;C1442488,true;true;false,12628/22402
baseline vfx,C0168634;C1442488,true;false,12629/22402
baseline vitamin - d,C0168634;C0014695;C0042866;C2936842;C3537249;C3714503;C1442488,true;true;true;false;false;false;false,12630/22402
baseline weekly iss,C0168634;C0332174;C1740819;C1845118;C1442488,true;false;false;false;false,12631/22402
baseline who function class,C0168634;C1442488,true;false,12632/22402
baseline  % ( n ),C0168634;C1442488,true;false,12633/22402
baseline  mg / dl ( mmol / l ),C0168634;C0439269;C1532563;C1442488,true;false;false;false,12634/22402
baseline  no . ( % ),C0168634;C1442488,true;false,12635/22402
basfi *,,,12636/22402
batellna c - reective protein,C0033684,true,12637/22402
bb,C0004739;C0332297,true;false,12638/22402
bdi focal score $nmbr$,C0006448;C0205234;C0449820;C4050231;C0451022;C3714938;C3889415,true;false;false;false;false;false;false,12639/22402
beam values ( mg / dl )  mean ( sd ),C0338248;C0042295;C0439269;C0444504;C2699239;C2347634;C2348143;C2347880;C4521565,false;false;false;false;false;false;false;false;false,12640/22402
beam   <   $nmbr$   mg / dl at week $nmbr$  n ( % ),C0338248;C0439269;C0332174;C0439230;C2347880;C4521565,false;false;false;false;false;false,12641/22402
because of ae,C3887670,false,12642/22402
because of drug ‐ relateda   ae,C0013227;C3887670;C1254351,true;false;false,12643/22402
because of drug ‐ relateda   sae,C0013227;C1519255;C1622657;C4553214;C1254351,true;false;false;false;false,12644/22402
because of sae,C1519255;C1622657;C4553214,false;false;false,12645/22402
before a change to the enrollment form was implemented in august $nmbr$ . bnp,C0392747;C1516879;C0348078;C0376315;C1522492;C4255237;C1696073;C3888021;C0443172;C1705241;C4319952,false;false;false;true;false;false;false;false;false;false;false,12646/22402
before admission )  %,C0184666;C0809949,false;false,12647/22402
before bronchodilation — liters §,C1371299;C0475211;C3537072,false;false;false,12648/22402
before bronchodilator use,C0006280;C0042153;C0457083;C1947944,true;true;false;false,12649/22402
below median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,12650/22402
bempedoic,,,12651/22402
bempedoic acid ( n = $nmbr$ ),C3659310,true,12652/22402
benazepril - amlodipine group ( n = $nmbr$ ),C0053091;C0051696;C0441848,true;true;false,12653/22402
benazepril - hydrochlorothiazide group ( n = $nmbr$ ),C0717481;C0441848,false;false,12654/22402
benralizumab,C2982078,true,12655/22402
benralizumab $nmbr$ mg q $nmbr$ w,C2982078;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,12656/22402
benralizumab q $nmbr$ w ( n - $nmbr$ ),C2982078,true,12657/22402
benralizumab q $nmbr$ w ( n = $nmbr$ ),C2982078,true,12658/22402
benzodiazepine or bzra ‡,C0005064;C3536850;C4048284,true;false;true,12659/22402
beta - blocker n ( % ),C0001645,true,12660/22402
beta blocker use ( % ),C0001645;C0042153;C0457083;C1947944,true;true;false;false,12661/22402
beta blocker users,C0001645;C1706077,true;false,12662/22402
beta blocker  %,C0001645,true,12663/22402
beta blocker  n ( % ),C0001645,true,12664/22402
beta bloekers,C0330390;C0439096;C2004068,false;false;false,12665/22402
betablocker,C0001645,true,12666/22402
between - treatment comparison of percentage change from baseline in total hip bmd,C1299575;C1707455;C0439165;C1549488;C1561533,false;false;false;false;false,12667/22402
bi ( $nmbr$ . $nmbr$ ),,,12668/22402
biack,,,12669/22402
biack hispanic,C0086409,true,12670/22402
biack non - hispanic,,,12671/22402
biasp $nmbr$ bid,,,12672/22402
bifurcation lesion with side branch ≥ $nmbr$ . $nmbr$ mm stented,C0184906;C0221198;C0441987;C0205384;C4330985;C4554674;C1253959;C1881507;C2700383;C2826234;C1546698;C3146289,false;false;false;false;false;false;false;false;false;false;false;false,12673/22402
bifurcation per lesion ‡,C0184906;C0221198;C1546698;C3146289,false;false;false;false,12674/22402
biguanide,C0005382;C3537187;C4317165,true;false;false,12675/22402
biguanide use at baseline,C0005382;C0042153;C0168634;C1442488;C0457083;C1947944;C3537187;C4317165,true;true;true;false;false;false;false;false,12676/22402
biguanides ¶,C0005382;C0360396;C3540012,true;false;false,12677/22402
bii ( mean ± sd ),C1413059;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,12678/22402
bii score,C1413059,false,12679/22402
bilag a  b or c domain score  n ( % ),,,12680/22402
biochemical events,C0205474;C0441471;C3541888,false;false;false,12681/22402
biochemical measures  mean ( sd ),C0205474;C0079809;C0444504;C2699239;C2347634;C2348143;C1879489,false;true;false;false;false;false;false,12682/22402
biochemical parameters at randomization  mean,C0205474;C0449381;C0034656;C0444504;C2347634;C2348143,false;false;true;false;false;false,12683/22402
biolimus a $nmbr$ - eluting stent ¶,,,12684/22402
biologic,C0005515;C0205460,true;false,12685/22402
biological,C0005532;C0205460,true;false,12686/22402
biomarker high,C0005516,true,12687/22402
biomarker high ( periostin > $nmbr$ ng / ml or blood eosinophils > $nmbr$ cells per pl ) t,C0005516;C0205250;C0219433;C0439275;C1424662;C3812270;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,true;false;true;false;false;false;false;false;false;false;false;false,12688/22402
biomarker levels,C0005516;C0441889,true;false,12689/22402
biomarker low,C0005516,true,12690/22402
biomarkers at baseline,C0005516;C0168634;C1442488,true;true;false,12691/22402
biometric parameters,C0005544;C0449381;C2718322,true;false;false,12692/22402
bivalirudin ( n = $nmbr$  $nmbr$ ),C0168273,true,12693/22402
bivalirudin alone ( n = $nmbr$ ),C0168273;C0205171;C0439044;C0679994,true;false;false;false,12694/22402
bivalirudin plus glycoprotein iib / iiia inhibitors ( n = $nmbr$ ),C0168273;C0016011;C0243077,true;true;true,12695/22402
bivalirudin used,C0168273,true,12696/22402
bl,C0005918;C0006413;C1552663;C2827109,true;true;false;false,12697/22402
bl alc < $nmbr$ . $nmbr$ %,C0005918;C1424945;C3811058;C0006413;C1552663;C2827109,true;false;false;true;false;false,12698/22402
bl bm $nmbr$ < $nmbr$ kg / m ^,C0005918;C0006416;C1532718;C0006413;C1552663;C2827109,true;true;false;true;false;false,12699/22402
bl bmioo kg / m ^,C0005918;C1532718;C0006413;C1552663;C2827109,true;false;true;false;false,12700/22402
bl bml < $nmbr$ kg / m ^,C0005918;C1532718;C0006413;C1552663;C2827109,true;false;true;false;false,12701/22402
bl bml > $nmbr$ kg / m ^,C0005918;C1532718;C0006413;C1552663;C2827109,true;false;true;false;false,12702/22402
bl bml > $nmbr$ ke / m ^,C0005918;C0022558;C0369637;C0441923;C0006413;C1552663;C2827109,true;true;false;false;true;false;false,12703/22402
black ( n   = $nmbr$ ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,12704/22402
black ( n = $nmbr$ )  adjusted hazard ratio *,C0005680;C0456081;C2985465;C0027567;C0085756;C0439541,true;false;false;true;true;false,12705/22402
black hispanic,C1533017;C1533018,false;false,12706/22402
black hispanic - n ( % ),C1533017;C1533018,false;false,12707/22402
black non - hispanic,C1533017;C1518422;C1533018;C0005680;C1518424;C0027567;C0085756;C0439541,false;false;false;true;false;true;true;false,12708/22402
black non - hispanic - n ( % ),C1533017;C1518422;C1533018;C0005680;C1518424;C0027567;C0085756;C0439541,false;false;false;true;false;true;true;false,12709/22402
black or african,C0005680;C0027567;C0085756;C0439541,true;true;true;false,12710/22402
black or african ‐ american,C0005680;C0027567;C0085756;C0439541,true;true;true;false,12711/22402
black or african heritage,C0005680;C0027567;C0085756;C0439541,true;true;true;false,12712/22402
black or asian,C0005680;C0027567;C0085756;C0439541,true;true;true;false,12713/22402
black participants,C0005680;C0679646;C0027567;C0085756;C0439541,true;false;true;true;false,12714/22402
black region or country ( % ),C0005680;C0017446;C0205147;C0027567;C0085756;C0439541,true;true;false;true;true;false,12715/22402
black *,C0005680;C0027567;C0085756;C0439541,true;true;true;false,12716/22402
black  no . ( % ),C0005680;C0027567;C0085756;C0439541,true;true;true;false,12717/22402
black  non - hispanic,C1533017;C1518422;C1533018;C0005680;C1518424;C0027567;C0085756;C0439541,false;false;false;true;false;true;true;false,12718/22402
black /,C0005680;C0027567;C0085756;C0439541,true;true;true;false,12719/22402
black / af rican american,C0085756;C0344434;C4049859,true;false;false,12720/22402
black / african,C0337824,false,12721/22402
black / non - black,C0005680;C1518422;C0027567;C0085756;C0439541,true;false;true;true;false,12722/22402
bladder,C0005682;C4319531,true;false,12723/22402
blaek,,,12724/22402
blaek / afriean - ameriean,,,12725/22402
blaic < $nmbr$ . $nmbr$ %,,,12726/22402
blaic > $nmbr$ . $nmbr$ %,,,12727/22402
bleeding,C0019080,true,12728/22402
bleeding end points,C0019080;C2349179,true;false,12729/22402
bleeding events during first $nmbr$ days of treatmen,C0019080;C0441471;C0205435;C0439228;C1279901;C3541888,true;false;false;false;false;false,12730/22402
bleeding events during the entire study,C0019080;C0441471;C0439751;C0557651;C2603343;C0444667;C3541888,true;false;false;false;false;false;false,12731/22402
bleeding outcomes,C0019080;C1274040,true;false,12732/22402
blisibimod ( n = $nmbr$ ),C3713826,true,12733/22402
blocker,,,12734/22402
blood - glucose control,C3267174,false,12735/22402
blood bilirubin increased,C0005767;C0005437;C0005768;C0229664,true;true;true;false,12736/22402
blood eosinophil count — cells / mm ’,C0005773;C0200638;C4330985;C4554674;C0750879,true;false;false;false;false,12737/22402
blood eosinophil count cells / mm $nmbr$ no .,C0005773;C0200638;C4330985;C4554674;C0750879,true;false;false;false;false,12738/22402
blood eosinophil count  geometric mean ( sd loge scale ) cells / ll,C0014467,true,12739/22402
blood eosinophils  cells / ml,C0014467;C2699156,true;false,12740/22402
blood eosinophils  mean ( range )  cells / ml,C0014467;C0444504;C1514721;C2699156;C2348147;C3542016;C2347634;C2348143,true;false;false;false;false;false;false;false,12741/22402
blood eosinophils  mean ( range )  cells / mlb,C0005773;C0014467;C0444504;C1514721;C2348147;C3542016;C2347634;C2348143;C0200638;C0007584;C0007634,true;true;false;false;false;false;false;false;false;true;true,12742/22402
blood glucose - lowering drugs  excluding insulin  n ( % ),C0018938;C0017725;C0441994;C2003888;C0005802;C0013227;C3687832,true;true;false;false;true;true;false,12743/22402
blood glucose - lowering treatments  n ( % ),C0596197;C0017725;C0441994;C2003888;C0005802;C0087111,false;true;false;false;true;true,12744/22402
blood glucose lowering treatment,C0596197;C0017725;C0441994;C2003888;C0005802;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;false;true;true;true;false;false;false;false;false,12745/22402
blood pressure ( mm hg ) systolic,C0005823;C0439475;C1271104;C1272641,true;false;false;true,12746/22402
blood pressure ( mm hg ) *,C0005823;C0439475;C1271104;C1272641,true;false;false;true,12747/22402
blood pressure < $nmbr$ / $nmbr$ mmhg  n ( % ),C0005823;C0439475;C1271104;C1272641,true;false;false;true,12748/22402
blood pressure < $nmbr$ mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,12749/22402
blood pressure > $nmbr$ mm hg,C0005823;C0439475;C1271104;C1272641,true;false;false;true,12750/22402
blood pressure at baseline :,C0005823;C0168634;C1442488;C1271104;C1272641;C0005767;C0443150;C0005768;C0229664,true;true;false;false;true;true;false;true;false,12751/22402
blood pressure at entry ( mm   hg ),C0005823;C1705654;C0439475;C1271104;C1272641,true;false;false;false;true,12752/22402
blood pressure control *,C0005823;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1271104;C1272641,true;true;false;false;false;false;false;false;true,12753/22402
blood pressure eontrolt,C0005823;C1271104;C1272641,true;false;true,12754/22402
blood pressure in mm hg  mean ( sd ),C0428886;C0439475;C2699239;C0488053,true;false;false;false,12755/22402
blood pressure while seated — mm hg,C0005823;C1271104;C1272641,true;false;true,12756/22402
blood pressure  mean ( sd )  mm hg systolic,C0428886;C2699239;C0439475,true;false;false,12757/22402
blood pressure  mean ( sd )  mm hgt,C0428886;C2699239;C4330985;C4554674,true;false;false;false,12758/22402
blood pressure  mm hg  mean ( sd ),C0428886;C0439475;C2699239,true;false;false,12759/22402
blood pressure  mmhg systolic,C0005823;C0439475;C1271104;C1272641,true;false;false;true,12760/22402
blood pressure  mmhg  mean ( sd ),C0428886;C0439475;C2699239,true;false;false,12761/22402
blood pressure : systolic / diastolic ( mm hg ) ( mean  sd ),C2704328;C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12762/22402
blood urea nitrogen  mg / dl,C0005845;C0439269;C0600137,true;false;false,12763/22402
bm $nmbr$  kg / m $nmbr$ ( mean ± s . d . ),C0006416;C1275571;C0369637;C0444504;C2347634;C2348143;C0441923;C0022718;C0439493;C1513009;C0439209;C4054209,true;false;false;false;false;false;false;true;false;false;false;false,12764/22402
bmi - kg / m $nmbr$,C0578022;C1532718,false;false,12765/22402
bmi ( . kg / m - ) *,C0578022;C1532718,false;false,12766/22402
bmi ( kg / ( m ) $nmbr$ ),C0578022;C1532718,false;false,12767/22402
bmi ( kg / m ^ ),C0578022;C1532718,false;false,12768/22402
bmi ( kg / m ^ )  mean ( sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12769/22402
bmi ( kg / m ^ )  mean ± s . d .,C0578022;C1275571;C0369637;C0444504;C2347634;C2348143;C0441923;C0022718;C0439493;C1513009;C0439209;C4054209,false;false;false;false;false;false;false;true;false;false;false;false,12770/22402
bmi ( kg / m ’ ),C0578022;C1532718,false;false,12771/22402
bmi ( kg / m $nmbr$ ) ( mean ± sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12772/22402
bmi ( kg / m $nmbr$ ) ( sd ),C0578022;C1532718;C2699239,false;false;false,12773/22402
bmi ( kg / m $nmbr$ ) [ mean - sd ],C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12774/22402
bmi ( kg / m $nmbr$ )  mean ( sd ) a,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12775/22402
bmi ( kg / m $nmbr$ )  median ( range ),C0578022;C1532718;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,12776/22402
bmi ( kg / m $nmbr$ ) : mean ± sd,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12777/22402
bmi ( kg / m $nmbr$ ) a,C0578022;C1532718,false;false,12778/22402
bmi ( kg = m $nmbr$ ),C0578022;C1532718,false;false,12779/22402
bmi ( sd )  kg / m $nmbr$,C0578022;C2699239;C1532718,false;false;false,12780/22402
bmi [ kg / m $nmbr$ ],C0578022;C1532718,false;false,12781/22402
bmi £ $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12782/22402
bmi < $nmbr$ kg / m  ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12783/22402
bmi < $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12784/22402
bmi < $nmbr$ kg / m ^ ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12785/22402
bmi < $nmbr$ kg / m $nmbr$ ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12786/22402
bmi = body mass index  bnp = brain natriuretic peptide  dbp = diastolic blood pressure  gfr = glomerular filtration rate  hr = heart rate  iqr = interquartile range  kccq = kansas city cardiomyopathy questionnaire  n = number  nt = n - terminal  nyha = new york heart association  sbp = systolic blood pressure,C1305855;C0054015;C0536221;C3813197;C4281799;C1095989;C1417808;C2982014;C0005823;C0017654;C0018810;C1561549;C1424601;C1271104;C1272641;C1711350;C3476798;C3476086;C0237753;C0332126;C1449832;C3889152;C4050156;C4283901;C4284038;C0449788;C0205088;C1275491;C0027976;C0018787;C0004083;C0085805;C0039155;C0005767;C0005768;C0229664;C0439849;C0596306;C0699792;C1705314;C1705315;C0033095;C0460139;C1306345;C4284008,true;true;true;false;false;false;false;false;true;true;true;false;false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false;true;true;true;true;true;true;true;false;false;false;false;false;false;true;false;false;false,12787/22402
bmi > $nmbr$  n ( % ),C0578022,false,12788/22402
bmi > = $nmbr$ kg / m $nmbr$ population ( n = $nmbr$ ),C0578022;C1532718;C0032659;C1257890,false;false;true;true,12789/22402
bmi > $nmbr$ — no . { % ) $,C0578022,false,12790/22402
bmi > $nmbr$ kg / m ^ ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12791/22402
bmi > $nmbr$ kg / m $nmbr$ *,C0578022;C1532718,false;false,12792/22402
bmi > $nmbr$ kg / m $nmbr$  n ( % ),C0578022;C1532718,false;false,12793/22402
bmi > $nmbr$ obese,C0578022,false,12794/22402
bmi ¼ body mass index  hctz ¼ hydrochlorothiazide  msdbp ¼ mean sitting diastolic blood pressure  mssbp ¼ mean sitting systolic blood pressure  sd ¼ standard deviation,C1305855;C0020261;C0444504;C2347634;C2348143;C0428886;C0012727;C0205419;C1705236,true;true;false;false;false;true;false;false;false,12795/22402
bmi $nmbr$ - < $nmbr$ kg / m - ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12796/22402
bmi $nmbr$ - < $nmbr$ kg / m  ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12797/22402
bmi $nmbr$ - < $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12798/22402
bmi $nmbr$ - < $nmbr$ kg / m ^ ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12799/22402
bmi $nmbr$ - < $nmbr$ kg / ni - ( n = $nmbr$ / $nmbr$ ),C0578022;C0022718;C0028075;C2348274;C3869926;C3869927;C0439209;C4054209,false;true;true;false;false;false;false;false,12800/22402
bmi $nmbr$ – $nmbr$ overweight,C0578022;C0497406,false;true,12801/22402
bmi $nmbr$ - $nmbr$ - $nmbr$ - $nmbr$,C0578022,false,12802/22402
bmi $nmbr$ $nmbr$ - $nmbr$ $nmbr$,C0578022,false,12803/22402
bmi $nmbr$ - $nmbr$ - $nmbr$ $nmbr$,C0578022,false,12804/22402
bmi $nmbr$,C0578022,false,12805/22402
bmi a $nmbr$,C0578022,false,12806/22402
bmi categories  n ( % ),C0578022;C0683312,false;false,12807/22402
bmi category ( kg / m $nmbr$ ),C0578022;C0683312;C1532718;C3889287,false;false;false;false,12808/22402
bmi category  no . ( % ),C0578022;C0683312;C3889287,false;false;false,12809/22402
bmi distribution  n ( % ),C0578022;C0520511;C1704711,false;false;true,12810/22402
bmi group ( kg / m ^ ),C0578022;C0441847;C0022718;C0439209;C4054209;C0441833;C1532718;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false;false;false;true;false;false;false,12811/22402
bmi indicates body mass index  sbp  systolic blood pressure  dbp  lipoprotein ( a ) . ldl - c was calculated with the friedewald formula . ' hypertension and diabetes were based on physician diagnosis . ! smoker includes current and past smokers .,C0578022;C0065058;C0125953;C1096202;C1439335;C0020538;C1963138;C0521116;C1705970,false;true;true;false;false;true;false;false;false,12812/22402
bmi kg · m − $nmbr$,C0578022;C1532718,false;false,12813/22402
bmi o $nmbr$ kg / m $nmbr$  n ( % ),C0578022;C1532718,false;false,12814/22402
bmi   kg · m − $nmbr$,C0578022;C1532718,false;false,12815/22402
bmi # kg - m “ $nmbr$,C0578022;C1532718,false;false,12816/22402
bmi * ( kg / m $nmbr$ )  median ( q $nmbr$  q $nmbr$ ),C0578022;C1532718;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,12817/22402
bmi  body mass index  hrt  hormone replacement therapy  lvh  left ventricular hypertrophy  nsaids  nonsteroidal anti - inflammatory drugs  pvd  peripheral vascular disease  tia  transient ischemic attack . ahistory of and / or currently taking lipid - lowering or antidiabetic medications . bp < $nmbr$ . $nmbr$ for verapamil sustained - release ( sr ) vs . atenolol . chistory of or currently have elevated serum creatinine but less than $nmbr$ mg / dl . dblood pressure control defined as < $nmbr$ / $nmbr$ or < $nmbr$ / $nmbr$ in patients with diabetes or a history of renal insufficiency .,C1305855;C0282402;C0149721;C0340279;C0003211;C0085096;C4521226;C0012634;C0007787;C1515187;C0023779;C0441994;C2003888;C0030685;C0753208;C1709991;C3813610;C3890900;C3891546;C0391871;C0439180;C0680255;C1283071;C1963578;C0201976;C0600061;C1704788;C3539106;C0035078;C1565489,true;true;true;false;true;true;false;true;true;false;true;false;false;true;true;false;false;false;false;false;false;false;false;false;false;false;false;false;true;true,12818/22402
bmi  kg per m $nmbr$,C0578022;C1532718,false;false,12819/22402
bmi  kg / m ^,C0578022;C1532718,false;false,12820/22402
bmi  kg / m ^ *,C0578022;C1532718,false;false,12821/22402
bmi  kg / m ^  mean ( sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12822/22402
bmi  kg / m ^  mean ( sd ) ’,C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12823/22402
bmi  kg / m ’,C0578022;C1532718,false;false,12824/22402
bmi  kg / m $nmbr$ ( mean $nmbr$ sd ),C0578022;C1532718;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,12825/22402
bmi  kg / m $nmbr$ ( sd ),C0578022;C1532718;C2699239,false;false;false,12826/22402
bmi  kg / m $nmbr$ cholesterol  mg / dl,C0578022;C1532718;C0008377;C0439269,false;false;true;false,12827/22402
bmi  kg / m $nmbr$  mean,C0578022;C1532718;C0444504;C2347634;C2348143,false;false;false;false;false,12828/22402
bmi  kg / m $nmbr$  median ( iqr ),C0578022;C1532718;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,12829/22402
bmi  kg / m $nmbr$  n ( % ),C0578022;C1532718,false;false,12830/22402
bmi  mean ( sd ) ( kg / m $nmbr$ ),C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,12831/22402
bmi  mean ( sd ) kg / m $nmbr$,C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,12832/22402
bmi  mean ( sd )  kg / m ^,C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,12833/22402
bmi  mean ( sd )  kg / m $nmbr$ c,C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,12834/22402
bmi  mean ( sd )  kg / rn $nmbr$,C0578022;C0444504;C2699239;C0022718;C2827110;C3540639;C4281819;C0439209;C4054209;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,12835/22402
bmi  mean ± sd kg / m $nmbr$,C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,12836/22402
bmi  mean ± sd  kg / m $nmbr$,C0578022;C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,12837/22402
bmi  mean  kg / m $nmbr$,C0578022;C0444504;C1532718;C2347634;C2348143,false;false;false;false;false,12838/22402
bmi  mean  kg / m $nmbr$ ( ± sd ),C0578022;C0444504;C1532718;C2699239;C2347634;C2348143,false;false;false;false;false;false,12839/22402
bmi  median ( iqr )  kg / m $nmbr$,C0578022;C0549183;C1532718;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,12840/22402
bmi  n ( % ),C0578022,false,12841/22402
bmi  no . ( % ),C0578022,false,12842/22402
bmi : < $nmbr$ kg / nr,C0578022;C0022718;C0027496;C3844738;C0439209;C4054209,false;true;true;false;false;false,12843/22402
bmi : body mass index  dbp : diastolic blood pressure  gm : geometric mean  sbp : systolic blood pressure . the analysis was based on observed data without imputation on missing values . asubgroup of patients in whom $nmbr$ h urine was collected ( see materials and methods section ) .,C1305855;C0428883;C0017480;C3854019;C0428886;C0085805;C0039155;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C1441672;C1511726;C2699638;C3245479;C3714741;C0033727;C0042036;C0042037;C2963137;C0369286;C0441932;C0564385;C4528284;C0152060;C0700320;C1522472;C1552923;C1705191;C3714523,true;true;true;true;true;true;true;false;false;false;true;false;false;false;false;false;false;false;false;true;true;true;false;false;false;false;false;false;false;false;false;false;false,12844/22402
bmi > $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12845/22402
bmi > $nmbr$ kg / m $nmbr$ ( n = $nmbr$ / $nmbr$ ),C0578022;C1532718,false;false,12846/22402
bmia,,,12847/22402
bmij,,,12848/22402
bmit,,,12849/22402
bmp kg - m “ $nmbr$,C0053932;C1532718;C0279266;C4281808,true;false;false;false,12850/22402
bmultivariate logistic regression with variables forced in the modela,C0206031;C0439828,true;false,12851/22402
bnp — pg / ml,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,12852/22402
bnp — pg / ml  i,C0054015;C0439297;C0021966;C0221138;C0030827;C0023806;C0072225;C1266240;C1095989;C1417808;C2982014,true;false;true;false;true;true;true;false;false;false;false,12853/22402
bnp ( n = $nmbr$ ),C0054015;C1095989;C1417808;C2982014,true;false;false;false,12854/22402
bnp < $nmbr$ pg / ml n = $nmbr$,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,12855/22402
bnp > $nmbr$ pg / ml or nt pro - bnp > $nmbr$ pg / ml  n ( % ),C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,12856/22402
bnp > $nmbr$ pg / ml n = $nmbr$,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,12857/22402
bnp > $nmbr$ pg / ml  n   =   $nmbr$   $nmbr$,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,12858/22402
bnp > $nmbr$ pg / ml  n   =   $nmbr$   $nmbr$,C0054015;C0439297;C1095989;C1417808;C2982014,true;false;false;false;false,12859/22402
bnp indicates brain natriuretic peptide  and nyha  new york heart association .,C0054015;C1095989;C1417808;C2982014,true;false;false;false,12860/22402
bnp  * median ( iqr )  pg / ml,C0054015;C0549183;C0439297;C0876920;C2347635;C2348144;C2939193;C1095989;C1417808;C2982014,true;false;false;false;false;false;false;false;false;false,12861/22402
bnp / nt - probnp,C0054015;C0669479;C0754710;C1095989;C1417808;C2982014,true;true;true;false;false;false,12862/22402
bnp / ntbnp ( n = $nmbr$ ),C0054015;C1095989;C1417808;C2982014,true;false;false;false,12863/22402
bocf - iike imputation ( random . ) ( n = $nmbr$ ),C2984917;C2699638;C0034656;C0439605,false;false;true;false,12864/22402
body - mass index - ! ',C0005893;C0578022;C1305855,false;false;true,12865/22402
body - mass index — no . ( % ) : i :,C0005893;C0578022;C1305855,false;false;true,12866/22402
body - mass index ( kg / cm $nmbr$ ),C0005893;C4054689;C0578022;C1305855,false;false;false;true,12867/22402
body - mass index ( kg / m   $nmbr$ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,12868/22402
body - mass index ( kg / m ’ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,12869/22402
body - mass index ( kg / m $nmbr$ ) ( mean  sd ),C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12870/22402
body - mass index ( kg / m $nmbr$ ) *,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12871/22402
body - mass index ( kg / mq,C0005893;C0022718;C0024853;C0439209;C4054209;C0578022;C1305855,false;true;true;false;false;false;true,12872/22402
body - mass index \ kg / m $nmbr$,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12873/22402
body - mass index > $nmbr$ kg / nrn,C0005893;C0022718;C1425210;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;true,12874/22402
body - mass index ) ',C0005893;C0578022;C1305855,false;false;true,12875/22402
body - mass index  kg / m $nmbr$,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12876/22402
body - mass index  kq / nrn,C0005893;C1425210;C0578022;C1305855,false;false;false;true,12877/22402
body - mass index : ! : blood pressure — mm hg,C0005893;C0005823;C0439475;C1271104;C1272641;C0578022;C1305855,false;true;false;false;true;false;true,12878/22402
body - mass index ^,C0005893;C0578022;C1305855,false;false;true,12879/22402
body - mass index ^ :,C0005893;C0578022;C1305855,false;false;true,12880/22402
body - mass index ”,C0005893;C0578022;C1305855,false;false;true,12881/22402
body height ( cm ),C0005890;C0487985,true;false,12882/22402
body mass index - mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,12883/22402
body mass index ( bmi  kg / m $nmbr$ )  n ( % ) < $nmbr$ kg / m $nmbr$,C0005893;C0578022;C0022718;C1709500;C0439209;C4054209;C1305855,false;false;true;false;false;false;true,12884/22402
body mass index ( kg / m ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,12885/22402
body mass index ( kg / m ^ ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,12886/22402
body mass index ( kg / m ^ ) ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12887/22402
body mass index ( kg / m ’ ) ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12888/22402
body mass index ( kg / m “ ) ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12889/22402
body mass index ( kg / m $nmbr$ ) baseline systolic blood,C0005893;C1532718;C0168634;C0039155;C0005767;C0005768;C0229664;C1442488;C0578022;C1305855,false;false;true;true;true;true;false;false;false;true,12890/22402
body mass index ( kg / m $nmbr$ ) ∗,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12891/22402
body mass index ( kg / m $nmbr$ )  mean ( sd ) c,C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12892/22402
body mass index ( kg / ma ),C0005893;C0022718;C0024443;C3887485;C0439209;C4054209;C0578022;C1305855,false;true;true;false;false;false;false;true,12893/22402
body mass index ( kgm _ $nmbr$ ),C0005893;C0578022;C1305855,false;false;true,12894/22402
body mass index ( median,C0005893;C0549183;C0876920;C2347635;C2348144;C2939193;C0578022;C1305855,false;false;false;false;false;false;false;true,12895/22402
body mass index ( mg / m $nmbr$ ),C0005893;C0024671;C0369637;C0441923;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0578022;C1305855,false;true;false;false;true;false;false;false;false;false;false;true,12896/22402
body mass index [ kg / m $nmbr$ ]  mean ± sd,C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12897/22402
body mass index > $nmbr$ kg / m  n ( % ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,12898/22402
body mass index > $nmbr$ t,C0005893;C0578022;C1305855,false;false;true,12899/22402
body mass index blood pressure — mmhg,C0005893;C0005823;C0439475;C1271104;C1272641;C0578022;C1305855,false;true;false;false;true;false;true,12900/22402
body mass index group ( ≥ $nmbr$ kg / m $nmbr$ ) — no . ( % ),C0005893;C0441847;C0022718;C0439209;C4054209;C0441833;C1532718;C0687744;C1257890;C1519504;C1705428;C1705429;C0578022;C1305855,false;false;true;false;false;false;false;false;true;false;false;false;false;true,12901/22402
body mass index group ( kg / m $nmbr$ ) ≥ $nmbr$ kg / m $nmbr$ — no . ( % ),C0005893;C0441833;C0022718;C1709500;C0439209;C4054209;C0687744;C1257890;C1519504;C1705428;C1705429;C0578022;C1305855,false;false;true;false;false;false;false;true;false;false;false;false;true,12902/22402
body mass index mean kg / m $nmbr$ ( sd ),C0005893;C0444504;C1532718;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12903/22402
body mass index  kg / m ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12904/22402
body mass index  kg / m ^ ( meanisd ),C0005893;C1532718;C0578022;C1305855,false;false;false;true,12905/22402
body mass index  kg / m ^ mean ( sd ),C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12906/22402
body mass index  kg / m ^ ^,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12907/22402
body mass index  kg / m ’,C0005893;C1532718;C0578022;C1305855,false;false;false;true,12908/22402
body mass index  kg / m $nmbr$ ( mean ± sd ),C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12909/22402
body mass index  kg / m $nmbr$   ( sd ),C0005893;C1532718;C2699239;C0578022;C1305855,false;false;false;false;true,12910/22402
body mass index  kg / m $nmbr$  mean ( sd ) §,C0005893;C1532718;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12911/22402
body mass index  kg / rn \ mean ( sd ),C0005893;C0022718;C2827110;C0444504;C2699239;C2347634;C2348143;C3540639;C4281819;C0439209;C4054209;C0578022;C1305855,false;true;false;false;false;false;false;false;false;false;false;false;true,12912/22402
body mass index  mean ( sd ) ( kg m ) $nmbr$ ),C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12913/22402
body mass index  mean ( sd ) kg / m $nmbr$,C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12914/22402
body mass index  mean ( sd )  kg / m $nmbr$,C0005893;C0444504;C2699239;C1532718;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12915/22402
body mass index  mean kg / m ^ ( sd ),C0005893;C0444504;C1532718;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;false;true,12916/22402
body mass index / mean ( sd ),C0005893;C0444504;C2699239;C2347634;C2348143;C0578022;C1305855,false;false;false;false;false;false;true,12917/22402
body mass index ^,C0005893;C0578022;C1305855,false;false;true,12918/22402
body mass indexa,C0518010,false,12919/22402
body mass indexb,C0518010,false,12920/22402
body mass indexf,C0518010,false,12921/22402
body mass indexf  < $nmbr$,C0518010,false,12922/22402
body mass indext,C0518010,false,12923/22402
body weight ( change from baseline ),C0005911;C0168634;C1442488;C0392747;C1303013;C0443172;C1705241;C4319952,true;true;false;false;false;false;false;false,12924/22402
body weight ( kg ) *,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,12925/22402
body weight ( kg )  mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C1305866,true;true;false;false;false;false;false;false;false,12926/22402
body weight ( kg )  mean ± sd,C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C1305866,true;true;false;false;false;false;false;false;false,12927/22402
body weight at randomization,C0005910;C0034656;C1305866;C0242821;C2985844;C0460148;C1268086;C4082212,true;true;false;true;false;false;false;false,12928/22402
body weight at randonization { ixrs ),C0005910;C1305866,true;false,12929/22402
body weight reduction > $nmbr$ %,C0005910;C0301630;C0392756;C1293152;C4551656;C1305866;C0242821;C1262477;C0460148;C1268086;C4082212,true;false;false;false;false;false;true;true;false;false;false,12930/22402
body weight *,C0005910;C1305866,true;false,12931/22402
body weight  kg ( mean ± sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C1305866,true;true;false;false;false;false;false;false;false,12932/22402
body weight  kg ( sd ),C0005910;C0022718;C2699239;C0439209;C4054209;C1305866,true;true;false;false;false;false,12933/22402
body weight  kg ^,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,12934/22402
body weiqht,C0242821;C0460148;C1268086;C4082212,true;false;false;false,12935/22402
bodyweight  kg,C0005910;C0022718;C0439209;C4054209;C1305866,true;true;false;false;false,12936/22402
bolus,C1186706;C1511237;C1705509;C3812160,false;false;false;false,12937/22402
bolus alone,C1186706;C1511237;C1705509;C3812160,false;false;false;false,12938/22402
bolus and corrections,C1186706;C1511237;C1705509;C3812160,false;false;false;false,12939/22402
bolus and infusion,C1186706;C1511237;C1705509;C3812160,false;false;false;false,12940/22402
bolus insulin doseh,C1186706;C0021641;C1533581;C1579433;C3714501;C1511237;C1705509;C3812160,false;true;false;false;false;false;false;false,12941/22402
bolus of heparin given,C1186706;C0019134;C0770546;C1511237;C1705509;C3812160,false;true;false;false;false;false,12942/22402
bone erosion score  mean ( sd ),C0587240;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,12943/22402
bone fracture,C0016658,true,12944/22402
bone fracture due to fall,C0016658;C0678226;C0085639;C0238715;C4553726,true;false;false;false;false,12945/22402
bone mineral density ( g / cm $nmbr$ )  mean ( sd ),C0005938;C0439267;C0444504;C2699239;C2347634;C2348143;C0177804,true;false;false;false;false;false;false,12946/22402
bonferroni - adjusted p value  b vs a,C1879894;C1709380,false;false,12947/22402
bonferroni - adjusted p value  c vs a,C1879894;C1709380,false;false,12948/22402
bonferroni - adjusted p value  d vs a,C1879894;C1709380,false;false,12949/22402
boost intensify all ( pan - asian patient population ),C1511253;C1874596,false;false,12950/22402
boost intensify premix i ( global patient population ),C1511253;C1874596,false;false,12951/22402
borg dyspnea score who functional class  n ( % ),C0013404;C0449820;C4050231;C1963100,true;false;false;false,12952/22402
bosentan use :,C0252643;C0042153;C0457083;C1947944,true;true;false;false,12953/22402
both adalimumab groups ( n = $nmbr$ ),C1122087,true,12954/22402
both adalimumab groups ( n = $nmbr$ ) no baseline cd - related antibiotic use,C1122087,true,12955/22402
both adalimumab groups ( n = $nmbr$ ) baseline immunosuppressant use,C1122087,true,12956/22402
both adalimumab groups ( n = $nmbr$ ) baseline cd - related antibiotic use,C1122087,true,12957/22402
both iv vasodilator and inotrope,C0022326;C0042402;C3537240;C4265176,true;true;false;false,12958/22402
both unfractionated heparin and low - molecular - weight heparin,C0019134;C2825026,true;false,12959/22402
bowel stricturing  ' n ( % ),C0267465,false,12960/22402
bp - lowering treatment ( n = $nmbr$ ),C0037623;C0441994;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2003888;C1415692;C1708288;C4318478,true;false;true;true;false;false;false;false;false;false;false;false;false,12961/22402
bp - lowering treatments  n ( % ),C0037623;C0441994;C0087111;C2003888;C1415692;C1708288;C4318478,true;false;true;false;false;false;false,12962/22402
bp < $nmbr$ / $nmbr$  n ( % ),C0037623;C1415692;C1708288;C4318478,true;false;false;false,12963/22402
bp = blood pressure  egfr = estimated glomerular filtration rate ( men : $nmbr$ en : $nmbr$ x cr $nmbr$ . $nmbr$ x age $nmbr$ . $nmbr$ x $nmbr$ . $nmbr$ )  hdl = high - density lipoprotein .,C0005823;C1739039;C3811844;C3812682,true;true;false;false,12964/22402
bp and fasting glucose results,C0037623;C1415692;C1708288;C4318478,true;false;false;false,12965/22402
bp component ( mm hg ),C0037623;C0449432;C0439475;C1705248;C1415692;C1708288;C4318478,true;false;false;false;false;false;false,12966/22402
bp control,C0037623;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C1415692;C1708288;C4318478,true;true;false;false;false;false;false;false;false;false,12967/22402
bp goal attainment,C0037623;C0680230;C1415692;C1708288;C4318478,true;false;false;false;false,12968/22402
bp goal  no . ( % ),C0037623;C0018017;C1571704;C1415692;C1708288;C4318478,true;true;false;false;false;false,12969/22402
bp in pre - treated patients,C0037623;C1415692;C1708288;C4318478,true;false;false;false,12970/22402
bp variable  mm hg,C0037623;C0439828;C0439475;C4553760;C1415692;C1708288;C4318478,true;false;false;false;false;false;false,12971/22402
bp : blood pressure  ci : confidence interval  esrd : end - stage renal disease  hr  hazard ratio . all patients ( except patients with other race ) were included with missing covariates imputed . event : no . of patients with esrd  rate : event rate per $nmbr$ years of follow - up  pre - specified : a cox model with treatment group and region as covariates and baseline proteinuria level ( o or x $nmbr$ g / g ) as strata  adjusted : a multivariate cox model with treatment group  time - varying systolic and diastolic bp as covariates . pre - specified analysis and adjusted for time - varying bp,C0005823;C0008107;C0009667;C0022661;C0205088;C0035078;C2316810;C3259781;C0012634;C2985465;C0034510;C1706779;C3853635;C0030705;C0022661;C0871208;C0441471;C4019010;C1521828;C0035078;C2316810;C0017446;C0205147;C1319635;C0039798;C0441833;C0040223;C0039155;C3541383;C0687744;C1257890;C1519504;C1705428;C1705429;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2826245,true;true;true;true;false;true;false;false;true;false;true;false;false;true;true;false;false;false;false;true;false;true;false;false;true;false;true;true;false;false;true;false;false;false;true;false;false;false;false;false;false,12972/22402
bpearson ' s chi ‐ square test .,C0008041,true,12973/22402
bph - luts severity,C0005001;C0574785;C0439793;C0522510;C1704272,true;true;false;false;true,12974/22402
bph - related health status,C0005001;C1704272,true;true,12975/22402
brain volume  cm ',C1113695,false,12976/22402
brandomization was stratified by diabetic status .,,,12977/22402
breakfastb,,,12978/22402
bronchial reversibility %,C0205039;C0449261;C1442216,false;false;false,12979/22402
brv > $nmbr$ mg / day,C0155502;C0439422,true;false,12980/22402
brv $nmbr$   mg / day,C0155502;C0439422,true;false,12981/22402
brv $nmbr$ mg / day ( n =,C0155502;C0439422,true;false,12982/22402
brv overall,C0155502,true,12983/22402
brv overall ( n = $nmbr$ ),C0155502;C0282416;C1561607,true;true;false,12984/22402
brv overalla ( n = $nmbr$ ),C0155502,true,12985/22402
bsa ( % ),,,12986/22402
bsa ( % )  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,12987/22402
bsa affected  %,,,12988/22402
bsa involved  % $nmbr$,,,12989/22402
bsl hb  gl - $nmbr$,C1549954;C0019046;C0018229;C1423073;C1427674,false;true;true;false;false,12990/22402
bsl  baseline  cl  confidence interval  esrd  end - stage renal disease  hb  hemoglobin  hr  hazard ratio  k ( rate )  # of events per $nmbr$ patient - years of follow - up  yr  year . multivariate cox model with hemoglobin category and baseline urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin as covariates .,C1549954;C0168634;C0596019;C0009667;C0022661;C1442488;C0019046;C2985465;C0597277;C0871208;C0441471;C3541888;C1521828;C1708601;C0030705;C0439234;C0589120;C1565830;C3161035;C3274659;C3714583;C3853906;C1522577;C1704685;C3274571;C0019046;C0683312;C3889287;C0201976;C0600061,false;true;false;true;true;false;true;false;false;false;false;false;false;false;true;false;false;true;false;false;false;false;false;false;false;true;false;false;false;false,12991/22402
bsl  baseline  cl  confidence interval  esrd  end - stage renal disease  hb  hemoglobin  k ( rate )  # of events per $nmbr$ patient - years of follow - up  rrr  relative risk reduction  yr  year . ^ treatment effect of losartan versus placebo . interaction test between treatment group and hemoglobin group ( < $nmbr$ or > $nmbr$ g i - $nmbr$ ) . cmultivariate cox model with baseline log urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin as covariates . dmultivariate cox model with baseline log urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin and change in hemoglobin at year $nmbr$ as covariates .,C1549954;C0168634;C0596019;C0009667;C0022661;C1442488;C0019046;C0597277;C0871208;C0441471;C3541888;C1521828;C1708601;C0589120;C0242492;C0301630;C0439234;C1518681;C0439508;C0392756;C1293152;C4551656;C0080103;C1137094;C0205345;C1547039;C1522577;C1704685;C3274571;C0126174;C1626828;C1708728;C2986775;C0456603;C0201976;C0001924;C0600061;C0036773;C0010294;C1561535;C0728877;C0229671;C0486293;C4281686;C1546774;C1550100;C1547037;C0019046;C0439234;C0439508,false;true;false;true;true;false;true;false;false;false;false;false;false;false;true;false;false;false;false;false;false;false;true;true;false;false;false;false;false;true;false;false;false;false;false;true;false;true;true;false;false;true;false;false;false;false;false;true;false;false,12992/22402
bud $nmbr$ ptg n = $nmbr$,C2700462;C0039512;C1418830;C2945744,false;true;false;false,12993/22402
bud / fm $nmbr$ / $nmbr$ atg n = ^ $nmbr$,C2700462;C3540627;C3815109;C2945744,false;false;false;false,12994/22402
budesonide - formoterol ( n = $nmbr$ ),C1276807,false,12995/22402
budesonide - formoterol $nmbr$ ^ g + $nmbr$ . $nmbr$ ^ g ( n = $nmbr$ ),C1276807;C1319635,false;false,12996/22402
budesonide - formoterol $nmbr$ + $nmbr$ . $nmbr$ ^ g ( n = $nmbr$ ),C1276807;C0439267,false;false,12997/22402
budesonide ( n = $nmbr$ ),C0054201,true,12998/22402
budesonide ( symptom days a week ),C0054201;C1457887;C0439228;C3854129,true;false;false;false,12999/22402
budesonide { symptom days a week ),C0054201;C1457887;C0439228;C3854129,true;false;false;false,13000/22402
budesonide $nmbr$ ^ g ( n = $nmbr$ ),C0054201;C0439267,true;false,13001/22402
budesonide mmx $nmbr$ mg  ( n = $nmbr$ ),C0054201;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13002/22402
budesonide  n ( % ),C0054201,true,13003/22402
budesonide / formoterol fdc,C1276807;C0340427;C1413520;C3539652,false;true;false;false,13004/22402
bundle branch block,C0006384;C1879286,true;true,13005/22402
bw  kg,C0005910;C0022718;C0439209;C4054209;C0006041;C2986891,true;true;false;false;true;false,13006/22402
by baseline diabetic status,C0168634;C0241863;C0449438;C1442488,true;false;false;false,13007/22402
by cause of death,C0007465;C4050444,true;false,13008/22402
by genotyping,C1285573,false,13009/22402
by gfr stratum for all participants  ml / min per $nmbr$ . $nmbr$ m ’ !,C0017654;C0679646;C0439445;C1424601,true;false;false;false,13010/22402
by gfr stratum for diabetic participants  mt / min per $nmbr$ . $nmbr$ m ’ §,C0017654;C0241863;C0679646;C0702093;C1524029;C3813700;C1424601,true;false;false;false;false;false;false,13011/22402
by gfr stratum tor all participants  ml / min per $nmbr$ . $nmbr$ m ^ !,C0017654;C0076836;C1199517;C1419603;C3539732;C1424601,true;true;false;false;false;false,13012/22402
by gfr stratum tor diabetic participants  ml / min per $nmbr$ . $nmbr$ m ’ §,C0017654;C0076836;C0241863;C0679646;C0439445;C0369637;C0441923;C1199517;C1419603;C3539732;C1424601,true;true;false;false;false;false;false;false;false;false;false,13013/22402
by treatment arm,C1522541,false,13014/22402
by who / simon broome criteria,C0443058;C0243161,false;true,13015/22402
bypass graft §,C0185098,false,13016/22402
c - peptide  median ( q $nmbr$  q $nmbr$ )  nmol / l,C0006558;C0549183;C0439282;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,13017/22402
c - reactive protein ( high - sensitivity assay )  mitt = modified intent - to - treat  pbo cholesterol  cl = confidence intervals  hdl - c = high - density lipoprotein cholest = national cholesterol education program adult treatment panel y patients with diabetes ( fc > _ $nmbr$ mg / dl [ > $nmbr$ . $nmbr$ mmol / l ] ) . to qualify as having acteristics described in methods ( ncep atp iii definition )  + baseline values are rr d hs - crr for which medians are presented  * * p < $nmbr$ . $nmbr$  § p = $nmbr$ . $nmbr$  * p = $nmbr$ . $nmbr$ . nteractions were not statistically significant ( p > $nmbr$ . $nmbr$ ) .,C0006560;C1441604;C0005507;C0243073;C1510438;C1413716;C4048285;C0087111;C1292734;C1522326;C0065055;C3245503;C0150375;C0679841;C0001675;C1706450;C0030705;C0011847;C2983605;C3642216;C3898312;C0011849;C0168634;C0042295;C1442488;C0369773;C2603361,true;false;true;true;false;false;false;true;false;false;true;false;false;false;true;false;true;false;false;false;false;true;true;false;false;false;false,13018/22402
c - reactive protein concentration ( mg / l ),C0006560;C0086045;C0439268;C1446561;C3827302;C1413716;C4048285,true;true;false;false;false;false;false,13019/22402
c - reactive protein  u / l,C0006560;C0439339;C1413716;C4048285,true;false;false;false,13020/22402
c - reactive proteinc,C0205332,false,13021/22402
c clinical fractures ( fas ),C0205210;C0016658,false;true,13022/22402
c group ( n = $nmbr$ ),C0441848,false,13023/22402
c peptide  nmol / l * ',C0006558;C0439282,true;false,13024/22402
c  right - sided vhd ( n = $nmbr$ ),C0205090;C0444532,false;false,13025/22402
c . das $nmbr$ - crp < $nmbr$ . $nmbr$,C0051767;C3890735;C4048285;C0057671,true;false;false;true,13026/22402
c $nmbr$ ml decrease in trough fev $nmbr$,C0439526;C0392756;C0444506;C3714541;C0547047;C1705224;C3887665,false;false;false;true;false;false;false,13027/22402
c $nmbr$ - unit sgrq total score increase,C0439148;C2964552;C0442805;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603,false;false;false;false;false;false;false;false;false,13028/22402
c $nmbr$ e $nmbr$ fab bolus,C1186706;C1511237;C1705509;C3812160,false;false;false;false,13029/22402
c $nmbr$ e $nmbr$ fab bolus ( n = $nmbr$ ),C1186706;C1511237;C1705509;C3812160,false;false;false;false,13030/22402
c $nmbr$ e $nmbr$ fab bolus and infusion ( n = $nmbr$ ),C1186706;C1511237;C1705509;C3812160,false;false;false;false,13031/22402
ca - channel blockers  n ( % ),C3887642;C0870261,true;false,13032/22402
cabg — no . { % ),C0010055,true,13033/22402
cabg history,C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,13034/22402
cabg or angioplasty,C0010055,true,13035/22402
cabg or ptca ( % ),C0010055,true,13036/22402
cabg or valve,C0010055,true,13037/22402
cabg performed during index hospitalization,C0010055,true,13038/22402
cabg surgery by no . of vessels $nmbr$,C0010055;C0042381;C3714645,true;true;false,13039/22402
cabg :,C0010055,true,13040/22402
cad death,C1504769;C0011065;C1306577;C4082313;C4552775;C2239547;C3813548;C4284121,true;true;false;false;false;false;false;false,13041/22402
cad *,C1504769;C2239547;C3813548;C4284121,true;false;false;false,13042/22402
caffeine,C0006644;C0236734,true;false,13043/22402
caffeine consumption ( yes ) ( n ),C0948365;C1549445;C1705108;C1710701,false;false;false;false,13044/22402
caffeine consumption *,C0948365,false,13045/22402
caffeine user,C3532939,false,13046/22402
caffeine user  n ( % ),C3532939,false,13047/22402
caffeine users  n ( % ),C3532939,false,13048/22402
calcitonin,C0006668;C0770558;C1704385;C2825090;C4520796,true;false;false;false;false,13049/22402
calcium - channel blocker *,C0006684;C3536851;C4521885,true;false;false,13050/22402
calcium - channel blockersubgroup,C0006685,true,13051/22402
calcium channel blocker ( % ),C0006684;C3536851;C4521885,true;false;false,13052/22402
calcium channelantagonist,C0006675;C0006726;C2936886;C3540037;C3714611,true;true;false;false;false,13053/22402
calcium level,C0201925;C0428302,false;false,13054/22402
calculated annual decline  mean ± se,C0444686;C0332181;C0444504;C0036919;C2347634;C2348143;C1441506,false;false;false;true;false;false;false,13055/22402
caleitonin  ng / l  females mean ± sd,C0439297;C0086287;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,13056/22402
caleitonin  ng / l  males mean ± sd,C0439297;C0086582;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,13057/22402
caleium ehannel bloekers ( ccb ),C0006684,true,13058/22402
calima japan ( n = $nmbr$ ),C0022341,true,13059/22402
calima japandhigh - dosage ics / laba and baseline blood eosinophils > $nmbr$ cells / ml ( n = $nmbr$ ) y,C0178602;C0815320;C4551720;C2986497,false;false;true;false,13060/22402
calima overall ( n = $nmbr$ ),C0282416;C1561607,true;false,13061/22402
calima overalldhigh - dosage ics / laba and baseline blood eosinophils > $nmbr$ cells / ml ( n = $nmbr$ ),C0178602;C0815320;C4551720;C2986497,false;false;true;false,13062/22402
cana,C1418845,false,13063/22402
cana $nmbr$ mg ( n $nmbr$ $nmbr$ ),C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,13064/22402
cana $nmbr$ mg ( n - $nmbr$ ),C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,13065/22402
cana $nmbr$ mg ( n = $nmbr$ ) *,C1418845;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,13066/22402
cana $nmbr$ ( n = $nmbr$ ),C1418845,false,13067/22402
cana $nmbr$ / met ( n = $nmbr$ ),C1418845,false,13068/22402
canada or united states,C0006823,true,13069/22402
canagiiflozin,,,13070/22402
canagliflozin $nmbr$ mg vs sitagliptin $nmbr$ mg,C2974540;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13071/22402
canakinumab $nmbr$ mg,C2718773;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13072/22402
canakinumab dose,C2718773;C0178602;C0869039;C1114758,true;false;false;false,13073/22402
canakinumab  $nmbr$ - month on - treatment il - $nmbr$ below the median value ( < $nmbr$ . $nmbr$ ng / l ) ( n   =   $nmbr$ ),C2718773;C0332177;C0039798;C0020898;C0549183;C1522609;C0439297;C0876920;C2347635;C2348144;C2939193;C0021764;C0022271;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0439231,true;false;true;true;false;false;false;false;false;false;false;true;true;true;false;false;false;false;false;false,13074/22402
canakinumab  $nmbr$ month on - treatment il - $nmbr$ above the median value ( ≥ $nmbr$ . $nmbr$ ng / l ) ( n   =   $nmbr$ ),C2718773;C0332177;C0039798;C0020898;C0549183;C1522609;C0439297;C0876920;C2347635;C2348144;C2939193;C0021764;C0022271;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0439231,true;false;true;true;false;false;false;false;false;false;false;true;true;true;false;false;false;false;false;false,13075/22402
canakinumab  il - $nmbr$ lowest tertile,C2718773;C0020898;C1708760;C0021764;C0022271,true;true;false;true;true,13076/22402
canakinumab  il - $nmbr$ middle tertile,C2718773;C0020898;C0444598;C0549183;C1552826;C0021764;C0022271,true;true;false;false;false;true;true,13077/22402
canakinumab  il - $nmbr$ top tertilec,C2718773;C0020898;C1704458;C0021764;C0022271,true;true;false;true;true,13078/22402
cancer — no . ( % ),C0006826;C0998265;C1306459,true;false;false,13079/22402
cancer n ( % ),C0006826;C0998265;C1306459,true;false;false,13080/22402
cancer surgery,C0920424,false,13081/22402
cancer *,C0006826;C0998265;C1306459,true;false;false,13082/22402
cancer  fatal and nonfatal,C0006826;C0998265;C1306459,true;false;false,13083/22402
cancert,,,13084/22402
cangrelor dyspnoea vs no dyspnoea *,C1121991;C0013404;C1963100,true;true;false,13085/22402
cangrelor n / n ( % ),C1121991,true,13086/22402
canrenone ( n z $nmbr$ ),C0006882,true,13087/22402
canvas ( n = $nmbr$ ) : placebo ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ ),C3281223;C0032042;C1418845;C1319635;C1696465;C1706408,false;true;false;false;false;false,13088/22402
cardiac - biomarker status 一 no . / total no . ( % ) $,C1999091;C0005516;C2735302;C1271630;C0449438;C0018787;C0449442;C1522601,false;true;false;false;false;true;false;false,13089/22402
cardiac arrhythmia,C0003811;C0264886;C1560249,true;true;false,13090/22402
cardiac arrhythmia  n ( % ),C0003811;C0264886;C1560249,true;true;false,13091/22402
cardiac biomarker elevation,C1271630;C0439775;C0702240,false;false;false,13092/22402
cardiac biomarker  n ( % ),C1271630,false,13093/22402
cardiac catheterisation or pci for index event,C0018795,true,13094/22402
cardiac diseasec,C0018787;C1522601,true;false,13095/22402
cardiac disorder,C0018799,true,13096/22402
cardiac disorder  n ( % ) §,C0018799,true,13097/22402
cardiac disorders ( soc ),C0018799,true,13098/22402
cardiac enzyates raised,C0018787;C1522601,true;false,13099/22402
cardiac failure —,C0018801;C0018802,true;true,13100/22402
cardiac failurec,C0018787;C1522601,true;false,13101/22402
cardiac index  l • mn ' • m $nmbr$,C0428776;C0026327;C0369637;C0441923;C0026405;C4285072,false;true;false;false;true;false,13102/22402
cardiac medications during index hospitalization,C0428776;C0013227;C0019993;C0802604;C2598133;C4284232,false;true;true;false;false;false,13103/22402
cardiac medications during index hospitalization — no . ( % ),C0428776;C0013227;C0019993;C0802604;C2598133;C4284232,false;true;true;false;false;false,13104/22402
cardiac parameters,C0018787;C0449381;C1522601,true;false;false,13105/22402
cardiac procedure :,C1279986,false,13106/22402
cardiac resynchronization therapy n ( % ),C1167956,true,13107/22402
cardiac rhythm disorder at baseline no,C0264886;C0168634;C1442488,true;true;false,13108/22402
cardiac therapy,C3654025,false,13109/22402
cardio - renal risk,C0018787;C0022646;C0035647;C4552904,true;true;true;false,13110/22402
cardioembolic infarction  n ( % ),C0021308,true,13111/22402
cardiogenic shock during first $nmbr$ hr after randomization,C0036980;C0205435;C1279901,true;false;false,13112/22402
cardiomyopathy,C0878544,true,13113/22402
cardiothoracic ratio > $nmbr$ . $nmbr$,C4055270;C0456603;C1547037,false;false;false,13114/22402
cardiovascuiar mortaiity,,,13115/22402
cardiovascular and oral hypoglycemic drugs - no . ( % ),C0007226;C3887460,true;false,13116/22402
cardiovascular death ( n = $nmbr$ ),C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13117/22402
cardiovascular death and hospital admission for heart failure,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13118/22402
cardiovascular death or heart failure hospitalization,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13119/22402
cardiovascular death or hospitalization for heart failure,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13120/22402
cardiovascular death or hospitalized hf,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13121/22402
cardiovascular death or nonfatal myocardial infarction,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13122/22402
cardiovascular death *,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13123/22402
cardiovascular death  mi  or stroke,C0007226;C0011065;C3810814;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false;false,13124/22402
cardiovascular death  myocardial infarction  or stroke,C0007226;C0011065;C0027051;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775;C3887460,true;true;true;false;false;false;false;false;false;false;false,13125/22402
cardiovascular death  nonfatal myocardial infarction  nonfatal stroke,C0027051;C0011065;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775,true;true;false;false;false;false;false;false;false,13126/22402
cardiovascular death  nonfatal myocardial infarction  or nonfatal stroke,C0007226;C0011065;C0027051;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775;C3887460,true;true;true;false;false;false;false;false;false;false;false,13127/22402
cardiovascular death / hospitalization for heart failure,C0007226;C0011065;C3898876;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false;false,13128/22402
cardiovascular death ®,C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,13129/22402
cardiovascular disease ( n = $nmbr$ ),C0007222,true,13130/22402
cardiovascular disease history  n ( % ) *,C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,13131/22402
cardiovascular disease history ‡,C1880008;C0012634;C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0007226;C0683519;C3887460,false;true;true;true;true;false;false;false;false;true;false;false,13132/22402
cardiovascular disease n ( % ),C0007222,true,13133/22402
cardiovascular disease risk category,C1113685;C0683312;C3889287,false;false;false,13134/22402
cardiovascular disease *,C0007222,true,13135/22402
cardiovascular disorder,C0007222,true,13136/22402
cardiovascular disorder  n ( % ),C0007222,true,13137/22402
cardiovascular events,C1320716,false,13138/22402
cardiovascular history — no . ( % ),C1880008,false,13139/22402
cardiovascular hospitalisation §,C0007226;C0019993;C3887460,true;true;false,13140/22402
cardiovascular metabolic syndrome risk lactors,C0007226;C0524620;C0035647;C4552904;C3887460,true;true;true;false;false,13141/22402
cardiovascular mortality ( per $nmbr$ person - years ),C0007226;C0026565;C0027361;C0439234;C2347489;C0026566;C3887460,true;true;true;false;false;true;false,13142/22402
cardiovascular mortality or mi,C0007226;C0026565;C0026566;C3887460,true;true;true;false,13143/22402
cardiovascular mortality  mi  or revascularization,C0007226;C0026565;C3810814;C0026566;C3887460,true;true;false;true;false,13144/22402
cardiovascular risk factor — no . { % ),C0850624,false,13145/22402
cardiovascular risk factors — no . { % ),C0850624,false,13146/22402
cardiovascular risk factors alone ( n = $nmbr$ ),C0850624;C0205171;C0439044;C0679994,false;false;false;false,13147/22402
cardiovascular risk factors and history,C0850624,false,13148/22402
cardiovascular risk factors and history — no . ( % ),C0850624,false,13149/22402
cardiovascular risk factors and history ( % ),C0850624,false,13150/22402
cardiovascular risk  n ( % ),C0007226;C0035647;C4552904;C3887460,true;true;false;false,13151/22402
cardiovascular therapies — no . { % ),C0587038,false,13152/22402
care use,C1947933;C0042153;C0457083;C1947944,false;true;false;false,13153/22402
caribbean,C0043122;C0206155;C1331005,true;true;false,13154/22402
carisbamate $nmbr$  $nmbr$ mg ( n = $nmbr$ ),C1871983;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13155/22402
carisbamate $nmbr$ mg ( n = $nmbr$ ),C1871983;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13156/22402
carotid artery disease,C0007273,true,13157/22402
carotid artery stenosis  n ( % ),C0007282,true,13158/22402
carotid bulb sites,C0007281;C0205145,true;false,13159/22402
carotid endarterectomy,C0014099,true,13160/22402
carotid imt,C0741968;C0334121;C1704614;C4318736,false;true;false;false,13161/22402
carrier ( n = $nmbr$ ),C0007294;C0560175;C1325398;C1706209;C3273162,true;true;false;false;false,13162/22402
carvedilol,C0054836,true,13163/22402
carvedilol  % ( n ),C0054836,true,13164/22402
cases,C0868928;C1533148,false;false,13165/22402
casual plasma glucose ( mg / dl ),C0202042;C0439269;C0455280,false;false;false,13166/22402
cat > = $nmbr$ ( n = $nmbr$  $nmbr$ ),C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,13167/22402
cat > = $nmbr$,C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,13168/22402
cat score  mean ( sd ),C0007450;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;false;false;false;false;false;true;false;false;false;false,13169/22402
cat total score $nmbr$,C0007450;C2964552;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;false;true;false;false;false;false,13170/22402
cat . $nmbr$ n / n ( % ),C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,true;false;true;false;false;false;false,13171/22402
cataract,C0086543;C4555209,true;false,13172/22402
cataract removal,C0007389,true,13173/22402
catecholamines or corticosteroids without hospitalization,C0007412,true,13174/22402
categorical variables,C0683312;C0439828;C3889287,false;false;false,13175/22402
categorical variables . no . ( % ) * ’,C0683312;C0439828;C3889287,false;false;false,13176/22402
categories of urinary acr  ^ g / mg,C0683312;C0042027;C1412134;C1300563;C1515941;C1524119,false;true;false;false;false;false,13177/22402
category,C0683312;C3889287,false;false,13178/22402
category — no . / total no . ( % ),C0683312;C3889287,false;false,13179/22402
catheter site — femoral,C0449652,false,13180/22402
catheterization laboratory in,C0007430;C0022877;C3244292;C4283904,true;true;false;false,13181/22402
catheterization laboratory in center,C0007430;C0022877;C0205099;C4534362;C3244292;C4283904,true;true;false;false;false;false,13182/22402
caucasian $nmbr$,C0007457;C0043157,true;true,13183/22402
caucasian eze / simva ( n = $nmbr$ ),C0007457;C0043157,true;true,13184/22402
caucasian n = $nmbr$  $nmbr$,C0007457;C0043157,true;true,13185/22402
caucasian race,C0007457,true,13186/22402
caucasian race ( % ),C0007457,true,13187/22402
caucasian simva ( n = $nmbr$ ),C0007457;C0043157,true;true,13188/22402
caucasian  n ( % ) *,C0007457;C0043157,true;true,13189/22402
caucasians ( n = $nmbr$ ),C0007457;C0043157,true;true,13190/22402
causaslan,,,13191/22402
cause of death unknown,C0007465;C4050444,true;false,13192/22402
causes of dvt or pe — no . ( % ) ^ |,C0015127;C0149871;C2926618;C3899446;C1314792,true;true;false;false;true,13193/22402
causes of dvt or pe  n ( % ),C0015127;C0149871;C2926618;C3899446;C1314792,true;true;false;false;true,13194/22402
cbz - exposed,C0006949,true,13195/22402
cbz - naive,C0006949,true,13196/22402
cc,C0008318;C3538933,true;false,13197/22402
cclear < $nmbr$,,,13198/22402
cclear $nmbr$ - $nmbr$,,,13199/22402
cclear $nmbr$ +,,,13200/22402
ccq total score,C2964552,false,13201/22402
cd [ gemini $nmbr$ ] * ’,C0007928;C0034283;C4552032,true;true;false,13202/22402
cd complications,C0007928;C0009566;C1171258;C0034283;C4552032,true;false;true;true;false,13203/22402
cd duration  y,C0007928;C0449238;C2926735;C0034283;C4552032,true;false;false;true;false,13204/22402
cdai ( $nmbr$ - $nmbr$ ),C0683448;C1413248;C3273706,false;false;false,13205/22402
cdai > $nmbr$  n [ % ],C0683448;C1413248;C3273706,false;false;false,13206/22402
cdai score,C0683448;C1413248;C3273706,false;false;false,13207/22402
cdai score  mean ( s . d . ),C0683448;C1413248;C3273706,false;false;false,13208/22402
cdai score  mean ± sda,C0683448;C1413248;C3273706,false;false;false,13209/22402
cdai score  median ( min  max ),C0683448;C1413248;C3273706,false;false;false,13210/22402
cdai  mean [ sd ],C0683448;C0444504;C2699239;C2347634;C2348143;C1413248;C3273706,false;false;false;false;false;false;false,13211/22402
cdai §,C0683448;C1413248;C3273706,false;false;false,13212/22402
cdmard experience  n ( % ),C0237607;C0596545,false;false,13213/22402
celecoxib,C0538927,true,13214/22402
center,C0205099;C3810851,false;false,13215/22402
center - level ihr percent time in therapeutic range for warfarin subjects,C0205099;C0441889;C0439165;C1554109;C0087111;C0302350;C0040223;C0460097;C3541383;C0456079;C1547707;C2946261;C3810851,false;false;false;false;true;false;true;false;false;false;false;false;false,13216/22402
center level ttr,C0205099;C0441889;C0032923;C1421224;C0456079;C1547707;C2946261;C3810851,false;false;true;false;false;false;false;false,13217/22402
central and eastern europe,C0205099;C1879652,false;false,13218/22402
central and south america,C0205099;C1879652,false;false,13219/22402
central and south america and mexico,C0205099;C1879652,false;false,13220/22402
central eosinophil count,C0205099;C0200638;C0750879;C1879652,false;false;false;false,13221/22402
central or south america,C0205099;C1879652,false;false,13222/22402
central / eastern,C0205099;C1707877;C1879652,false;false;false,13223/22402
central / south,C0205099;C1710133;C1879652,false;false;false,13224/22402
central / south america,C0007674;C1710133;C0205099;C0037713;C1879652,true;false;false;true;false,13225/22402
central / south america and mexico,C0007674;C1710133;C0205099;C0037713;C1879652,true;false;false;true;false,13226/22402
centrally acting sympathomimetics,C3653511,false,13227/22402
centre,C0205099;C3810851,false;false,13228/22402
centrilobular emphysema,C0221227,true,13229/22402
cerebral,,,13230/22402
cerebral infarction,C0007785,true,13231/22402
cerebral ischemia,C0007785;C0917798,true;true,13232/22402
cerebrovascuiar disease,C0012634,true,13233/22402
cerebrovascular accident / tia,C0038454;C0007787;C0917805;C1054154,true;true;true;false,13234/22402
cerebrovascular disease n ( % ),C0007820,true,13235/22402
cerebrovascular disease  %,C0007820,true,13236/22402
cerebrovascular or peripheral arterial disease,C1880018,false,13237/22402
cerebrovascular or peripheral arterial disease    n   ( % ),C1880018,false,13238/22402
certolizumab group,C1872109;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,13239/22402
cfb at week $nmbr$,C0009002;C0332174;C0439230;C1824728,true;false;false;false,13240/22402
cfisher ' s exact test .,C2828393;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4050514,false;false;false;false;false;false;false;false;false,13241/22402
cgfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,13242/22402
cgfrby ckd - epi  ml / min / $nmbr$ . $nmbr$ m $nmbr$  median ( iqr ),C1561643;C0162734;C0439445;C0369637;C0549183;C0876920;C2347635;C2348144;C2939193;C0441923;C4281721,true;true;false;false;false;false;false;false;false;false;false,13243/22402
cgi - s  n ( % ) z :,C4526016,false,13244/22402
cgm use,C0042153;C0457083;C1947944,true;false;false,13245/22402
cha $nmbr$ s $nmbr$ score,C1420648;C0449820;C4050231,false;false;false,13246/22402
cha $nmbr$ ds $nmbr$ - vasc < $nmbr$,C1420648;C3714751,false;false,13247/22402
cha $nmbr$ ds $nmbr$ - vasc $nmbr$ - $nmbr$,C1420648;C3714751,false;false,13248/22402
cha $nmbr$ ds $nmbr$ - vasc $nmbr$ $nmbr$,C1420648;C3714751,false;false,13249/22402
cha $nmbr$ ds $nmbr$ - vasc score,C1420648;C3714751;C0449820;C4050231,false;false;false;false,13250/22402
cha $nmbr$ ds $nmbr$ - vasc score  mean ± sd,C1420648;C3714751;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false;false,13251/22402
cha $nmbr$ ds $nmbr$ - vasc score    n   ( % ),C1420648;C3714751;C0449820;C4050231,false;false;false;false,13252/22402
cha $nmbr$ ds $nmbr$ - vasc  mean ± sd,C1420648;C3714751;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,13253/22402
cha $nmbr$ ds $nmbr$ vasc score,C1420648;C3714751;C0449820;C4050231,false;false;false;false,13254/22402
cha $nmbr$ ds $nmbr$ vasc score ( % ),C1420648;C3714751;C0449820;C4050231,false;false;false;false,13255/22402
chad $nmbr$ > $nmbr$,C0007928;C1413373,true;false,13256/22402
chads - $nmbr$ score,C0007928;C1413373,true;false,13257/22402
chads score  n ( % ),C0007928;C1413373,true;false,13258/22402
chads $nmbr$ risk factors  n ( % ),C0007928;C0035648;C1553898;C1413373,true;true;false;false,13259/22402
chads $nmbr$ score > $nmbr$,C0007928;C1413373,true;false,13260/22402
chads $nmbr$ score $nmbr$,C0007928;C1413373,true;false,13261/22402
chads $nmbr$ score $nmbr$ - $nmbr$  n ( % ),C0007928;C1413373,true;false,13262/22402
chads $nmbr$ score per outcome stroke or systemic embolism,C0007928;C1413373,true;false,13263/22402
chads $nmbr$ score  mean ( ± sd ),C0007928;C1413373,true;false,13264/22402
chads $nmbr$ score  mean ± sd,C0007928;C1413373,true;false,13265/22402
chads $nmbr$ score  n ( % ),C0007928;C1413373,true;false,13266/22402
chads $nmbr$ scoret,C0007928;C1413373,true;false,13267/22402
chads $nmbr$   score    n   ( % ),C0007928;C1413373,true;false,13268/22402
chads $nmbr$  mean ± sd,C0007928;C0444504;C2699239;C2347634;C2348143;C1413373,true;false;false;false;false;false,13269/22402
chads $nmbr$ < $nmbr$,C0007928;C1413373,true;false,13270/22402
chads $nmbr$ components  n ( % ),C0007928;C0449432;C1413373,true;false;false,13271/22402
chads $nmbr$ scoref,C0007928;C1413373,true;false,13272/22402
chadsa < $nmbr$,,,13273/22402
chadsj < $nmbr$,,,13274/22402
chadsj > $nmbr$,,,13275/22402
chajdsa - vasc $nmbr$ - $nmbr$,,,13276/22402
chajdsj - vasc > $nmbr$,,,13277/22402
chajdsj - vasc $nmbr$ - $nmbr$,,,13278/22402
chajdsrvasc $nmbr$ - $nmbr$,,,13279/22402
change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,13280/22402
change from baseline in,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13281/22402
change from baseline in acq - $nmbr$,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13282/22402
change from baseline in acq - $nmbr$ score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13283/22402
change from baseline in aqlq { s ) score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13284/22402
change from baseline in fevj ( mb ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13285/22402
change from baseline in mean $nmbr$ - h dbp  mmhg,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13286/22402
change from baseline in mean $nmbr$ - h sbp  mmhg,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13287/22402
change from baseline in morning pef during weeks $nmbr$ - $nmbr$  mean l / min ( se ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13288/22402
change from baseline in post - bd,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13289/22402
change from baseline in pre - bd,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13290/22402
change from baseline in rescue medication use ( puffs per day ),C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13291/22402
change from baseline in sgrq,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13292/22402
change from baseline to final apbm,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13293/22402
change from baseline to week $nmbr$ in dlqi scorez,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13294/22402
change from baseline to week $nmbr$ in uas $nmbr$,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13295/22402
change from baseline to week $nmbr$ in weekly iss,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13296/22402
change from baseline to week $nmbr$ in weekly no . of hives score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13297/22402
change from baseline to week $nmbr$ in weekly size of largest hive score,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13298/22402
change from baseline to week $nmbr$,C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false,13299/22402
change from baseline  median ( iqr ),C0392747;C0168634;C0549183;C0876920;C2347635;C2348144;C2939193;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false;false;false;false;false;false,13300/22402
change from baseline  mg / dl  mean ( sd ),C0392747;C0168634;C0439269;C0444504;C2699239;C2347634;C2348143;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false;false;false;false;false;false,13301/22402
change from baseline  mmhg,C0392747;C0168634;C0439475;C1442488;C0443172;C1705241;C4319952,false;true;false;false;false;false;false,13302/22402
change in das $nmbr$ > $nmbr$ . $nmbr$,C0392747;C0051767;C0057671;C0443172;C1705241;C4319952,false;true;true;false;false;false,13303/22402
change in femoral neck bmd from fit baseline to flex baseline,C0392747;C0015815;C0443172;C1705241;C4319952,false;true;false;false;false,13304/22402
change in fpg $nmbr$ to month $nmbr$ ( mg / dl ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,13305/22402
change in hba $nmbr$ c $nmbr$ to month $nmbr$ ( % ),C0392747;C0019016;C1825777;C3538758;C0443172;C1705241;C4319952,false;true;false;false;false;false;false,13306/22402
change in hbalc after $nmbr$ weeks etd ( $nmbr$ % cl ),C0392747;C0443172;C1705241;C4319952,false;false;false;false,13307/22402
change in hdl ‐ c,C0392747;C3715113;C0443172;C1705241;C4319952,false;false;false;false;false,13308/22402
change in ldl ‐ c,C0392747;C0443172;C1705241;C4319952,false;false;false;false,13309/22402
change in lp ( a ),C0392747;C0065058;C1439335;C4553379;C0443172;C1705241;C4319952,false;true;false;false;false;false;false,13310/22402
change in nt - probnp at $nmbr$,C0392747;C0669479;C0754710;C0443172;C1705241;C4319952,false;true;true;false;false;false,13311/22402
change in pav  mean ( $nmbr$ % cl )  %,C0392747;C0058890;C0444504;C0596019;C2347634;C2348143;C0443172;C1705241;C4319952,false;true;false;false;false;false;false;false;false,13312/22402
change in psa ‐ modified shs  baseline to week $nmbr$ ‡,C0392747;C3810537;C3813209;C0443172;C1705241;C4319952,false;false;false;false;false;false,13313/22402
change in psa ‐ modified shs  baseline to week $nmbr$,C0392747;C3810537;C3813209;C0443172;C1705241;C4319952,false;false;false;false;false;false,13314/22402
change in retinal pathology,C0392747;C0035298;C0030664;C0205469;C0677042;C0443172;C1705241;C4319952,false;true;true;true;false;false;false;false,13315/22402
change in sbp,C0392747;C0085805;C0443172;C1705241;C4319952,false;true;false;false;false,13316/22402
change in sedbp  ls mean ( se ),C0392747;C0023668;C0444504;C0036919;C2347634;C2348143;C0443172;C1705241;C4319952,false;true;false;true;false;false;false;false;false,13317/22402
change in sesbp  ls mean ( se ),C0392747;C0023668;C0444504;C0036919;C2347634;C2348143;C0443172;C1705241;C4319952,false;true;false;true;false;false;false;false;false,13318/22402
change in tc,C0392747;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C0443172;C1705241;C4319952,false;true;true;true;true;false;false;false;false;false;false,13319/22402
change in tg,C0392747;C0337445;C0443172;C1705241;C4319952,false;false;false;false;false,13320/22402
change to week $nmbr$,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,13321/22402
change to week $nmbr$ *,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,13322/22402
change to week $nmbr$ * ’ ’,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,13323/22402
change to   week $nmbr$,C0392747;C0332174;C0439230;C0443172;C1705241;C4319952,false;false;false;false;false;false,13324/22402
change  mg / dl ( mmol / l ),C0392747;C0439269;C1532563;C0443172;C1705241;C4319952,false;false;false;false;false;false,13325/22402
changes at baseline,C0392747;C0168634;C1442488;C0443172,false;true;false;false,13326/22402
changes from baseline in mssbp and msdbp are shown as least - squares mean sem . * p $nmbr$ . $nmbr$ vs $nmbr$ y .,C0392747;C0168634;C1442488;C0443172,false;true;false;false,13327/22402
changes in serum creatinine  pmol / l,C0392747;C0201976;C0439284;C0600061;C0443172,false;false;false;false;false,13328/22402
changes in shs,C0392747;C0443172,false;false,13329/22402
characteristic ( a ),C1521970,false,13330/22402
characteristic age,C1521970;C0001779,false;false,13331/22402
characteristic age — yr,C1521970;C0001779;C0439234,false;false;false,13332/22402
characteristic age mean ± sd — yr,C1521970;C0001779;C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false;false;false,13333/22402
characteristic and treatment,C1521970,false,13334/22402
characteristic at baseline,C1521970;C0168634;C1442488,false;true;false,13335/22402
characteristic *,C1521970,false,13336/22402
characteristic  no . ( % ),C1521970,false,13337/22402
characteristic / outcome,C1521970;C1274040,false;false,13338/22402
characteristic ^,C1521970,false,13339/22402
characteristic_level,C1521970;C0441889;C0456079;C1547707;C2946261,false;false;false;false;false,13340/22402
characteristic_name,C1521970;C0027365;C1547383;C4522128,false;true;false;false,13341/22402
characteristic †,C1521970,false,13342/22402
characteristica,,,13343/22402
characteristics no . of participants,C1521970,false,13344/22402
characteristics *,C1521970,false,13345/22402
characteristicsa,,,13346/22402
charlson,,,13347/22402
charlson comobility score  n ( % ),C0449820;C4050231,false;false,13348/22402
charlson comorbidity index,C4546361,false,13349/22402
charlson comorbidity index  mean ( sd ),C4546361;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,13350/22402
charlson index ( % ),C0600653;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false,13351/22402
charm,C0849759,false,13352/22402
chd ( nonfatal mi + fatal chd ),C0280604;C3810814;C1302234;C1705232;C3542407,false;false;false;false;false,13353/22402
chd ( primary outcome ),C0280604;C0205225;C1274040;C0439612;C0439631;C3542407,false;false;false;false;false;false,13354/22402
chd + cl all,C0280604;C0596019;C3542407,false;false;false,13355/22402
chd at baseline,C0280604;C0168634;C1442488;C3542407,false;true;false;false,13356/22402
chd deaths,C0280604;C0011065;C1306577;C3542407,false;true;false;false,13357/22402
chd disease death,C0280604;C0012634;C0011065;C1306577;C4082313;C4552775;C3542407,false;true;true;false;false;false;false,13358/22402
chd eze / simva ( „ = $nmbr$ ),C0280604;C3542407,false;false,13359/22402
chd plus cerebral infarction,C0280604;C0007785;C3542407,false;true;false,13360/22402
chd risk factors #,C0280604;C0035648;C1553898;C3542407,false;true;false;false,13361/22402
chd simva ( „ = $nmbr$ ),C0280604;C3542407,false;false,13362/22402
chd  coronary heart disease  eze / simva  ezetimibe / simvastatin combination tablet  fpg  fasting plasma glucose  pvd  peripheral vascular disease,C0010068;C1532737;C0039225;C0015663;C0202042;C0085096;C0455280;C1705223;C4319774;C0074554,true;true;true;true;false;true;false;false;false;true,13363/22402
chd  total,C0280604;C0439175;C0439810;C3542407,false;false;false;false,13364/22402
chest discomfort,C0235710,false,13365/22402
chest x - ray,C0039985,false,13366/22402
chf score ( u ),C0018802;C0449820;C0439148;C4050231,true;false;false;false,13367/22402
chi - square p value,C1552646;C1709380,false;false,13368/22402
china / japan,C0008115;C0022341,true;true,13369/22402
china / tjapan,C0008115,true,13370/22402
chl,C0019829,true,13371/22402
chlor,C0308648,false,13372/22402
chloroquine,C0008269,true,13373/22402
chlorthalidone,C0008294,true,13374/22402
chlorthalidone ( n = $nmbr$ ),C0008294,true,13375/22402
chlorthalidone $nmbr$,C0008294,true,13376/22402
chlorthalidone group,C0008294;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,13377/22402
chlorthalidone vs amlodipine,C0008294,true,13378/22402
chlorthalidone vs doxazosin,C0008294,true,13379/22402
chlorthalidone vs lisinopril,C0008294,true,13380/22402
cholesterol,C0008377,true,13381/22402
cholesterol - mean ( sd  n ),C0008377;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,13382/22402
cholesterol ( ng / ml ),C0008377;C0439275,true;false,13383/22402
cholesterol ( nmol / l ),C0008377;C0439282,true;false,13384/22402
cholesterol  mg / dl,C0008377;C0439269,true;false,13385/22402
cholesterol  mg / dl total,C0201950;C0439269;C0543421,false;false;false,13386/22402
cholesterol  mg / dl  mean ( sd ) §,C0008377;C0439269;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,13387/22402
cholinesterase inhibitor use at baseline  no . ( % ),C0008425;C0042153;C0168634;C1442488;C0457083;C1947944;C3536756;C4521309,true;true;true;false;false;false;false;false,13388/22402
chondroitin,C0008454,true,13389/22402
chondroitin sulfate,C0008466,true,13390/22402
chronic bronchitis ( itt ) ( n = $nmbr$ ),C0008677,true,13391/22402
chronic bronchitis ( n = $nmbr$ ),C0008677,true,13392/22402
chronic bronchitist,C0205191,false,13393/22402
chronic cardiovascular disease  no . ( % ),C1290380,false,13394/22402
chronic kidney disease ( % ),C1561643;C4553188,true;false,13395/22402
chronic kidney disease  no . ( % ) t,C1561643;C4553188,true;false,13396/22402
chronic kidney disease †,C1561643;C4553188,true;false,13397/22402
chronic obstructive pulmonary,C0205191;C0549186;C0024109;C2707265;C2709248;C4522268,false;false;true;false;false;false,13398/22402
chronic obstructive pulmonary disease — no . ( % ),C0024117,true,13399/22402
chronic renal disease,C0022661;C1561643,true;true,13400/22402
chronic renal disease — no . ( % ),C0022661;C1561643,true;true,13401/22402
chronic renal insufficiency,C0403447;C1561643,true;true,13402/22402
chronic renal insufficiency  %,C0403447;C1561643,true;true,13403/22402
chronic sinusitis + nasal polypsd  n ( % ),C0149516;C0028429;C4520890,false;true;false,13404/22402
chronic treatment with aspirin,C0205191;C0039798;C0004057;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;true;false;false;false;false;false,13405/22402
chylomicron cholesterol,C0008731;C0008377;C1325761,true;true;false,13406/22402
chylomicron triglycerides,C0008731;C0041004;C1325761,true;true;false,13407/22402
ci = confidence interval  na = not applicable or not analyzed .,C0008107;C0009667;C0597484;C1272460;C1546968;C1879645;C4049872;C4552882;C3259781,true;true;false;false;false;false;false;false;false,13408/22402
ci  confidence interval  esrd  end - stage renal disease  n / n  number of patients who had an event / total number of patients . aadjusted with terms including treatment ( losartan or placebo )  geographic region  genotype  and the treatment  genotype interaction . bp value for treatment  genotype interaction ( i . e .  comparison of the losartan treatment effect between the $nmbr$ genotype groups ) .,C0008107;C0009667;C0022661;C3259781;C2360800;C0030705;C0233324;C1515273;C1705313;C2826302;C0017446;C0017431;C0205147;C0039798;C0017431;C1704675;C0683454;C1707455;C0126174;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1280500;C0017431;C1518681;C2348382,true;true;true;false;false;true;true;false;false;false;true;true;false;true;true;false;false;false;true;true;false;false;false;false;false;false;true;false;false,13409/22402
ciass i,C0021966;C0221138,true;false,13410/22402
ciass ll - iv,,,13411/22402
cigarette - smoking status — no . ( % ),C0239059;C0449438;C0700219;C0677453;C1519386;C1704760;C3890423,false;false;true;true;false;false;false,13412/22402
cigarette - smoking status ( % ),C0239059;C0449438;C0700219;C0677453;C1519386;C1704760;C3890423,false;false;true;true;false;false;false,13413/22402
cigarette smoker *,C0337667,false,13414/22402
cigarette smoker  no . ( % ),C0337667,false,13415/22402
cigarette smoking  n ( % ),C0239059;C0700219,false;true,13416/22402
ck > $nmbr$ x uln $nmbr$,C0009212;C1519815;C0010287;C1872855,true;false;true;true,13417/22402
ck > $nmbr$ xuln,C0009212;C0010287;C1872855,true;true;true,13418/22402
ckd ( egfr < $nmbr$ )  n ( % ),C1561643;C1739039;C3811844;C3812682,true;true;false;false,13419/22402
ckd n,C1561643,true,13420/22402
ckd prognosis by kdigo ' ',C1561643;C0033325;C3854082,true;true;false,13421/22402
ckd rate ( # events ),C1561643;C0871208;C0441471;C3541888;C1521828,true;false;false;false;false,13422/22402
ckd stage $nmbr$,C1561643;C0205390;C1300072;C1306673,true;false;false;false,13423/22402
ckd stage $nmbr$ ( % ),C1561643;C0205390;C1300072;C1306673,true;false;false;false,13424/22402
ckd stages,C1561643;C1306673,true;false,13425/22402
ckd *,C1561643,true,13426/22402
cl - $nmbr$ ],C0596019,false,13427/22402
class > ii,C0441886;C2698968,false;false,13428/22402
class $nmbr$,C0456387;C1518526;C1705943,false;false;false,13429/22402
class i or no symptoms,C0441885;C1319793;C2698967,false;false;false,13430/22402
class ii ( b - blockers ),C0441886;C2698968,false;false,13431/22402
class iii / iii - v,C0457166;C0439070;C1705160;C1880098,false;false;false;false,13432/22402
class iv glomerulonephritis,C0441888;C0017658;C2698970,false;true;false,13433/22402
class iv only,C0441888;C0205171;C1720467;C2698970,false;false;false;false,13434/22402
class iv / iv - v,C0457166;C0022326;C4265176;C1880098,false;true;false;false,13435/22402
class ll - iv,C0456387;C1518526;C1705943,false;false;false,13436/22402
class v only,C0457166;C0205171;C1720467;C1880098,false;false;false;false,13437/22402
classification of epilepsy type  n ( % ),C0008902;C0014544;C0332307;C1547052;C0008903;C0678229,true;true;false;false;true;false,13438/22402
cld $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,13439/22402
cld $nmbr$ mg ( n = l $nmbr$ ),C0439268,false,13440/22402
clean  n ( % ) a,C1947930,false,13441/22402
clinic research experience  n ( % ),C0008972;C0237607;C0596545,true;false;false,13442/22402
clinical and patient reported outcomes  % ( observed n ) unless otherwise indicated,C0205210,false,13443/22402
clinical atherosclerotic disease *,C0205210;C0333482;C0012634,false;false;true,13444/22402
clinical characteristics ( % ),C0683325,false,13445/22402
clinical characteristics  n ( % ),C0683325,false,13446/22402
clinical dementia rating sum of boxes  mean ( sd ) f,C0451074;C1515051;C0444504;C2699239;C1517104;C2347634;C2348143,true;false;false;false;false;false;false,13447/22402
clinical disease activity index,C3869583,false,13448/22402
clinical efficacy at week $nmbr$,C0087113;C0332174;C0439230,true;false;false,13449/22402
clinical endpoint,C2347784,false,13450/22402
clinical fracture,C0205210;C0016658,false;true,13451/22402
clinical or lesion rf for st,C0205210,false,13452/22402
clinical outcome,C0205210;C1274040,false;false,13453/22402
clinical remissione,C0205210,false,13454/22402
clinical responsed,C0205210,false,13455/22402
clinical variables  median ( iqr ),C0205210;C0439828;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,13456/22402
clinically relevant non,C2347946;C1518422,false;false,13457/22402
clonic,,,13458/22402
clopidogrel %,C0070166,true,13459/22402
clopidogrel ( n = $nmbr$ $nmbr$ ),C0070166,true,13460/22402
clopidogrel dyspnoea vs no dyspnoea *,C0070166;C0013404;C1963100,true;true;false,13461/22402
clopidogrel n / n ( % ),C0070166,true,13462/22402
clopidogrel n / n { % ),C0070166,true,13463/22402
clopidogrel or ticlopidine,C0070166,true,13464/22402
clopidogrel  $nmbr$ mg loading doset,C0070166;C0024671;C1708715;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,13465/22402
closure,C0185003;C1521802,false;false,13466/22402
clow - potency stratum : simvastatin $nmbr$ mg  pravastatin $nmbr$ mg  fluvastatin $nmbr$ mg  atorvastatin $nmbr$ mg  high - potency stratum : simvastatin $nmbr$ mg  atorvastatin,C2985073;C3245505;C0074554;C1319635;C0085542;C0082608;C0286651;C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;true;true;true;false;false;false;false;false;false;false,13467/22402
cluster $nmbr$ : diuretic ( n = $nmbr$ ),C1555715;C1704332,false;false,13468/22402
cluster $nmbr$ : reversible  no diuretic ( n = $nmbr$ ),C1555715;C1704332,false;false,13469/22402
cluster $nmbr$ : not reversible  no diuretic ( n = $nmbr$ ),C1555715;C1704332,false;false,13470/22402
cluster seizures,C1555715;C0036572;C1704332,false;true;false,13471/22402
cm,,,13472/22402
cmann whitney u test / wilcoxon sum rank test .,C0439148;C0683443;C1515051;C0667477;C0699794,false;false;false;true;false,13473/22402
cns systemic embolism,C3714787;C0205373;C0013922;C1704212,true;false;true;true,13474/22402
co - morbidities  n ( % ),C0009488,true,13475/22402
cochranemantelehaenszel ( repeated $nmbr$ . $nmbr$ % ci ) c,C0205341;C0008107;C3259781,false;true;false,13476/22402
coefficient,C1707429,false,13477/22402
coenzyme q $nmbr$ p  g / ml #,C0041536;C1300565,true;false,13478/22402
cognitive,C1516691,false,13479/22402
cognitive subscale on alzheimer ' s disease assessment scale  mean ( sd ) e,C1516691;C0450989;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,13480/22402
coiticosieroids at baseline,C0168634;C1442488,true;false,13481/22402
colchicine ( n = $nmbr$ ),C0009262,true,13482/22402
colectomy ( partial or total ),C0009274,true,13483/22402
colesevelam ( n = $nmbr$ ),C0541155,true,13484/22402
colesevelam hydrochloride group ( n = $nmbr$ ),C0541154;C0441848,true;false,13485/22402
college degree or higher,C0557806;C0441889;C0449286;C0542560;C2348088,false;false;false;false;false,13486/22402
college graduate or more,C0682187,false,13487/22402
colombia,C3245499,true,13488/22402
colon ' ses - cd score  mean ( sd ),C0009368;C0007928;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C0034283;C4552032;C3888384,true;true;false;false;false;false;false;false;true;false;false,13489/22402
colon only  ' n ( % ),C0009368;C0205171;C1720467;C3888384,true;false;false;false,13490/22402
colon only  n ( % ),C0009368;C0205171;C1720467;C3888384,true;false;false;false,13491/22402
colon or rectum,C0009368;C3888384,true;false,13492/22402
colonic area involved,C0009368;C0017446;C0205146,true;true;false,13493/22402
colonoscopy,C0009378;C1548837,true;false,13494/22402
combination,C0205195;C1947911;C3811910,false;false;false,13495/22402
combination ( n = $nmbr$ ),C0205195;C1947911;C3811910,false;false;false,13496/22402
combination treatment ifx + aza,C0205195;C0039798;C0020823;C0004482;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1947911;C3811910,false;true;true;true;true;false;false;false;false;false;false;false,13497/22402
combinationf,,,13498/22402
combinations of aspirin and ppi use ( p = $nmbr$ . $nmbr$ t ),C0453882;C0004057;C3539181;C3539182;C3539954;C3539955;C3539956;C3539957;C3539959;C3539960;C3539961;C3539962;C3539963;C3539964;C3539965;C3539966;C3539967;C3539968;C3539969;C3539970;C3539971;C3539972;C3539973;C3539974;C3539975;C3539976;C3539977;C3539978;C3539979;C3540026;C3540027;C3540028;C3540030;C3540031;C3540719;C3540720;C3540721;C3540722;C3540723;C3540724;C3540740;C3854036,false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,13499/22402
combined,C0205195,false,13500/22402
combined ( dutasteride / ta msu losi n ),C0205195;C0754659;C0039297;C0024776;C1412759;C1506978;C1705538;C3272501;C4553364,false;true;true;true;false;false;false;false;false,13501/22402
combined cardiac failure  cardiomyopathy or other cardiac disorder  n ( % ) luts severity  n ( % ),C0205195;C0018801;C0878544;C0018802,false;true;true;true,13502/22402
combined cardiac failure  cardiomyopathy or other cardiac disorders,C0205195;C0018801;C0878544;C0018802,false;true;true;true,13503/22402
combined chd,C0205195;C0280604;C3542407,false;false;false,13504/22402
combined cvd,C0205195;C0007222,false;true,13505/22402
combined end point,C0205195;C2349179;C2826544,false;false;false,13506/22402
combined end poir,C0205195;C0444930;C2746065,false;false;false,13507/22402
combined fatal / nonfatal outcomes,C0205195;C0206277,false;true,13508/22402
combined golimumab groups,C0205195;C2353893,false;true,13509/22402
combined infliximab,C0205195;C0666743,false;true,13510/22402
combined insulin / oral hypoglycaemic agent use,C0205195;C0240016;C0359086,false;false;false,13511/22402
combined ischaemic heart disease and / or cerebrovascular disorder *,C0205195;C0010054;C0151744,false;true;true,13512/22402
combined major macrovascular events  neohrodathv . and all - cause mortalitv ■,C0205195;C0205082;C0441471;C3541888;C0205164;C4318856;C4521762,false;false;false;false;false;false;false,13513/22402
combined major macrovascular events .,C0205195;C0205082;C0441471;C3541888;C0205164;C4318856;C4521762,false;false;false;false;false;false;false,13514/22402
combined statin and other lipid - lowering agent use,C0205195;C0360714,false;true,13515/22402
combined therapy ( / v = $nmbr$ )  $nmbr$ / $nmbr$,C0033972,true,13516/22402
combined therapy vsdutasteride,C0033972,true,13517/22402
combined therapy vsta msu iosin,C0033972;C0024776;C1412759,true;true;false,13518/22402
combo - facilitated pci,C4049621,false,13519/22402
combo vs . primary,,,13520/22402
commercially available fondaparinux,C0470187;C1098510,false;true,13521/22402
common carotid artery sites,C0007272;C0205145;C0162859,true;false;true,13522/22402
comorbid conditionsb,C0009488,true,13523/22402
comorbid illnesses,C0009488;C0221423,true;false,13524/22402
comorbidities ( % ),C0009488,true,13525/22402
comorbidities and concomitant medications,C0009488,true,13526/22402
comorbidities  no . ( % ),C0009488,true,13527/22402
comorbidities / concomitant medications,C0009488;C0521115;C0013227;C0802604;C2598133;C4284232,true;false;true;false;false;false,13528/22402
comorbidity  no . ( % ),C0009488,true,13529/22402
comparator,C1707454;C4553389;C4553390,false;false;false,13530/22402
comparison,C1707455,false,13531/22402
comparison : cat . $nmbr$ vs . cat . $nmbr$,C1707455;C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282,false;true;false;true;false;false;false;false,13532/22402
complete healinga,C0205197;C0725685;C3853530;C4283785,false;false;false;false,13533/22402
complete mayo clinic score  median ( min  max },C0205197;C0454788;C0002424;C0449820;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C4050231;C0442592;C1077578;C0725685;C3853530;C4283785,false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,13534/22402
completed previous febuxostat study,C2348557;C0205156;C0249529;C1552607,false;false;true;false,13535/22402
completed prior febuxostat studya,C0205197;C0332152;C0249529;C2826257;C3854010,false;false;true;false;false,13536/22402
component . for all instruments  higher scores indicate more severe disease . ara denotes american rheumatism association ( now called,C0449432;C4551823;C0205250;C0449820;C1705248,false;true;false;false;false,13537/22402
components,C0449432,false,13538/22402
components of primary composite end point — secondary end points,C1882460;C0205199;C4528314;C1547335,false;false;false;false,13539/22402
components of the first cid,C0449432;C0205435;C1707433;C1279901,false;false;false;false,13540/22402
composite,C0205199;C1547335,false;false,13541/22402
composite endpoint,C0205199;C2349179;C2826544;C1547335,false;false;false;false,13542/22402
composite endpoint ( a $nmbr$ c < $nmbr$ . $nmbr$ %  bp,C0205199;C2349179;C0037623;C1415692;C1708288;C4318478;C2826544;C1547335,false;false;true;false;false;false;false;false,13543/22402
composite index of insulin sensitivity ( isi ),C0205199;C0600653;C0920563;C4049919;C0918012;C1552854;C1637833;C2986546;C1547335,false;true;true;false;true;false;false;false;false,13544/22402
composite microvascular end point *,C0205199;C0443258;C2349179;C2826544;C1547335,false;false;false;false;false,13545/22402
composite ocular end point ^,C0205199;C0015392;C2349179;C2826544;C0042789;C0700042;C1299003;C4521296;C1547335,false;true;false;false;true;false;false;false;false,13546/22402
composite of $nmbr$ % reduction in egfr  end - stage kidney disease  or death from renal causes,C0205199;C0301630;C0392756;C1293152;C4551656;C1547335,false;false;false;false;false;false,13547/22402
composite of death / mi / stro ke / urgent revasc / definit e acute stent thrombosis,C0205199;C0011065;C0022558;C0439609;C0378365;C0155626;C3897493;C3272275;C1306577;C4082313;C4552775;C1547335,false;true;true;false;true;false;false;false;false;false;false;false,13548/22402
composite of death / mi / urg ent revasc,C0205199;C0011065;C3810814;C0919420;C3889152;C0378365;C1367721;C1705448;C1306577;C4082313;C4552775;C1547335,false;true;false;false;false;true;false;false;false;false;false;false,13549/22402
composite of doubling of serum creatinine  end - stage kidney disease  or death from renal causes,C0205199;C0205173;C0201976;C0205088;C0022658;C0600061;C1705764;C1547335,false;false;false;false;true;false;false;false,13550/22402
composite physiologic index §,C0205199;C0205463;C0600653;C0918012;C1552854;C1637833;C2986546;C1547335,false;false;true;true;false;false;false;false,13551/22402
composite vascular endpoint,C0205199;C0005847;C2349179;C2826544;C1558950;C1801960;C1547335,false;true;false;false;false;false;false,13552/22402
concentrations at baseline,C0086045;C0168634;C1442488,true;true;false,13553/22402
concern,C2699424,false,13554/22402
concomitant,C0521115,false,13555/22402
concomitant aeds  n ( % ),C0521115;C0180309,false;true,13556/22402
concomitant aedsb  n ( % ),C0521115,false,13557/22402
concomitant aedsb    n   ( % ),C0521115,false,13558/22402
concomitant antibiotic use  n [ % ],C0521115;C0003232;C0042153;C0457083;C1947944,false;true;true;false;false,13559/22402
concomitant anticoagulant  antithrombotic or nsaid  n ( % ),C0521115;C0003280;C0848112;C3536711,false;true;false;false,13560/22402
concomitant antiplatelet,C0521115,false,13561/22402
concomitant aspirin use,C0521115;C0004057;C0042153;C0457083;C1947944,false;true;true;false;false,13562/22402
concomitant cardiovascular therapy,C1707479;C0007226;C3887460;C0521115;C0587038,false;true;false;false;false,13563/22402
concomitant drug therapies  n ( % ),C0521115;C0013216,false;true,13564/22402
concomitant drug therapy at discharge,C1707479;C0013227;C0012621;C0030685;C2926602;C1254351;C0521115;C0013216;C0013217;C3850077;C0039798;C0087111;C1363945,false;true;false;true;false;false;false;true;true;true;true;true;false,13565/22402
concomitant dvt — no . ( % ) baseline nt - probnp — no . ( % ),C0521115;C0149871;C2926618;C3899446,false;true;false;false,13566/22402
concomitant dvt  n ( % ),C0521115;C0149871;C2926618;C3899446,false;true;false;false,13567/22402
concomitant lipid - lowering therapy ( any ),C0521115;C0585943,false;false,13568/22402
concomitant lipid - modifying therapy — no . { % ),C1707479;C0023779;C0392747,false;true;false,13569/22402
concomitant medication — no . { % ) | ace inhibitor,C0521115;C0013227;C3244316;C4284232,false;true;false;false,13570/22402
concomitant medication ( > $nmbr$ % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,13571/22402
concomitant medication use,C0521115;C0240320,false;false,13572/22402
concomitant medication  n ( % ) d,C0521115;C0013227;C3244316;C4284232,false;true;false;false,13573/22402
concomitant medication  n [ % ],C0521115;C0013227;C3244316;C4284232,false;true;false;false,13574/22402
concomitant medication  no . ( % ),C0521115;C0013227;C3244316;C4284232,false;true;false;false,13575/22402
concomitant medications — no . ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,13576/22402
concomitant medications ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,13577/22402
concomitant medications ( yes )  n ( % },C0521115;C0013227;C1549445;C1705108;C1710701;C0802604;C2598133;C4284232,false;true;false;false;false;false;false;false,13578/22402
concomitant medications after randomization,C0521115;C0013227;C0034656;C0802604;C2598133;C4284232,false;true;true;false;false;false,13579/22402
concomitant medications at baseline,C0521115;C0013227;C0168634;C1442488;C0802604;C2598133;C4284232,false;true;true;false;false;false;false,13580/22402
concomitant medications in > $nmbr$ % of subjects  no . ( % ),C0521115;C0013227;C0681850;C1550501;C1706203;C2349001;C2697811;C0802604;C2598133;C4284232,false;true;false;false;false;false;false;false;false;false,13581/22402
concomitant medications  no . ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,13582/22402
concomitant methotrexate use  n ( % ),C0521115;C0025677;C0042153;C0457083;C1947944,false;true;true;false;false,13583/22402
concomitant oads  n ( % ),C0521115,false,13584/22402
concomitant oral anti - dm drugs  no . ( % ) a,C0521115;C0029167;C0011816;C3250443;C0175795;C0304289,false;true;true;false;false;false,13585/22402
concomitant oral glucose - lowering agents  zz ( % ),C2347852;C0442027;C0017725;C0441994;C2347310;C2003888;C4521986,false;false;true;false;false;false;false,13586/22402
concomitant pd medications at baseline  n ( % ) c  d,C0521115;C4553228;C0013227;C0168634;C1442488;C0802604;C2598133;C4284232;C4553229,false;false;true;true;false;false;false;false;false,13587/22402
concomitant therapy  n [ % ],C1707479,false,13588/22402
concomitant treatment 一 no . ( % ),C0521115;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,13589/22402
concomitant treatments at randomization,C0521115;C0087111;C0034656,false;true;true,13590/22402
concomitant use of bosentan  n ( % ),C0521115;C1524063;C0252643,false;false;true,13591/22402
concomitant use of conventional synthetic dmard up to $nmbr$ mo — no . { % ) methotrexate,C0521115;C1524063;C0439858;C1883254;C0242708,false;false;false;false;true,13592/22402
concomitant use of corticosteroids,C0521115;C1524063;C0001617;C3539185;C3540725;C3540726;C3540727,false;false;true;false;false;false;false,13593/22402
concomitant use of mtx to week $nmbr$,C0521115;C1524063;C0025677;C1417487,false;false;true;false,13594/22402
concomitant use of nsaids to week $nmbr$,C0521115;C1524063;C0003211,false;false;true,13595/22402
concurrent illness,C0205420;C0221423,false;false,13596/22402
concurrent medications,C0205420;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,13597/22402
concurrent prednisolone,C0205420;C0032950,false;true,13598/22402
concurrent treatment at study entry — no . ( % ) * *,C0009247;C0039798;C1705654;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0205420;C0679827;C0557651;C2603343;C1521826;C3161471,true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,13599/22402
condition $nmbr$ ( $nmbr$ . $nmbr$ ),C0012634;C0348080;C1705253;C3864998,true;false;false;false,13600/22402
congestion *,C0700148;C2826600,false;false,13601/22402
congestive heart,C0742742;C0018787,false;true,13602/22402
congestive heart failure — no . ( % ) |,C0018802,true,13603/22402
congestive heart failure at randomisation,C0018802;C0034656,true;true,13604/22402
congestive heart failure §,C0018802,true,13605/22402
congestive heart failure †,C0018802,true,13606/22402
congestive hf,C0742742;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,13607/22402
conieosieroids and / or $nmbr$ - mp,,,13608/22402
connective - tissue disease,C0009782,true,13609/22402
connective tissue disease,C0009782,true,13610/22402
conservative strategy ( n = $nmbr$  $nmbr$ ),C0679199,false,13611/22402
constipation,C0009806;C1963087;C3641755;C4084722;C4084723;C4084724,true;false;false;false;false;false,13612/22402
continue thienopyridine n = $nmbr$,C0549178,false,13613/22402
continued use of gpa,C0549178;C1524063;C3495801;C4553145,false;false;true;false,13614/22402
continuous,C0549178,false,13615/22402
continuous lvef $nmbr$ treatment interaction,C0549178;C0428772;C0039798;C1704675;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0488728,false;false;true;false;true;false;false;false;false;false;false,13616/22402
continuous variables  mean ( sd ) ^,C0549178;C0439828;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,13617/22402
contrast angiography,C0009924;C0002978;C1979874,true;true;false,13618/22402
contrast used ( ml ) *,C0009924;C1979874,true;false,13619/22402
contrast volume > $nmbr$ ( ml ),C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,13620/22402
contrast volume > $nmbr$ ml,C0009924;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1979874,true;false;false;false;false;false;false;false;false,13621/22402
control = warfarin,C0243148;C0043031;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;false;false;false;false;false,13622/22402
control group,C0009932,true,13623/22402
control n = $nmbr$,C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,true;false;false;false;false;false,13624/22402
controlled : acq - $nmbr$ < $nmbr$ . $nmbr$,C2587213;C2919686;C2911690,false;false;false,13625/22402
controllertreatment before entry *,C1705654,false,13626/22402
contusion,C0009938,true,13627/22402
conventional agents *,C0439858;C0450442;C1254351;C1521826,false;false;false;false,13628/22402
converting enzyme inhibitor,C0014432;C0919438;C4521603,true;false;false,13629/22402
convulsion,C0036572;C4048158,true;true,13630/22402
copd - placebo ( $nmbr$ pt ) n . ( % ),C0024117;C0032042;C0032743;C0699718;C1696465;C1706408;C1412502;C3714496,true;true;true;false;false;false;false;false,13631/22402
copd - rosuvastatin ( $nmbr$ pt ) n . ( % ),C0024117;C0965129;C0032743;C0699718;C1412502;C3714496,true;true;true;false;false;false,13632/22402
copd ( % ),C0024117;C1412502;C3714496,true;false;false,13633/22402
copd duration  mean ( sd )  yr *,C0024117;C0449238;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735;C1412502;C3714496,true;false;false;false;false;false;false;false;false;false,13634/22402
copd exacerbation history in the previous year  n ( % ),C0740304;C0019664;C0205156;C0439234;C0439508;C1552607;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;false;false;false;true;false;false;false;false,13635/22402
copd history yrs,C0024117;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1412502;C3714496,true;true;true;false;false;false;false;false;false,13636/22402
copd medication taken for at least $nmbr$ months before study entry,C0024117;C0013227;C3244316;C4284232;C1412502;C3714496,true;true;false;false;false;false,13637/22402
copd severity stage ( gold ),C0024117;C0439793;C0205390;C0018026;C1304897;C1300072;C1306673;C0522510;C1412502;C3714496,true;false;false;true;false;false;false;false;false;false,13638/22402
copd severity  %,C0024117;C0439793;C0522510;C1412502;C3714496,true;false;false;false;false,13639/22402
copd severitya    n   ( % ),C0024117;C1412502;C3714496,true;false;false,13640/22402
copd severityy,C0024117;C1412502;C3714496,true;false;false,13641/22402
copd type,C0024117;C0332307;C1547052;C1412502;C3714496,true;false;false;false;false,13642/22402
copd worsening,C0024117;C0332271;C1457868;C1546960;C1412502;C3714496,true;false;false;false;false;false,13643/22402
copd    n   ( % ),C0024117;C1412502;C3714496,true;false;false,13644/22402
coping,C0009967,true,13645/22402
core cardiovascular endpoint,C0444669;C0007226;C2349179;C2826544;C3887460;C1167518;C1706352;C1882467;C3274653,false;true;false;false;false;false;false;false;false,13646/22402
core study to first infusion,C0444669;C0557651;C0205435;C0574032;C1827465;C1279901;C2603343;C1167518;C1706352;C1882467;C3274653,false;false;false;false;false;false;false;false;false;false;false,13647/22402
corneii product  mm - ms,C1514468;C4330985;C2349943;C3539704;C3713294;C4554674;C1704444,false;false;false;false;true;false;false,13648/22402
cornell index  pv,C0600653;C0030840;C0032463;C0918012;C1552854;C1637833;C2986546,true;true;true;true;false;false;false,13649/22402
cornell voltage - duration product ( mmxmsec ) *,C0598352;C0449238;C1514468;C1704444;C2926735,false;false;false;false;false,13650/22402
cornell voltage - duration product  mm × ms,C0598352;C0449238;C1514468;C4330985;C2349943;C3539704;C3713294;C4554674;C1704444;C2926735,false;false;false;false;false;false;true;false;false;false,13651/22402
cornell voltage - duration product  mm x ms,C0598352;C0449238;C1514468;C4330985;C2349943;C3539704;C3713294;C4554674;C1704444;C2926735,false;false;false;false;false;false;true;false;false;false,13652/22402
cornell voltage duration ( mv × ms ),C0598352;C0449238;C1454484;C2349943;C3539704;C3713294;C1705503;C4281602;C2926735,false;false;true;false;false;true;false;false;false,13653/22402
cornell voltage x duration product  mm x ms,C0598352;C0449238;C1514468;C4330985;C2349943;C3539704;C3713294;C4554674;C1704444;C2926735,false;false;false;false;false;false;true;false;false;false,13654/22402
coronar y - artery bypass grafting,C0450140;C0741847,false;false,13655/22402
coronar y artery disease,C0852949,false,13656/22402
coronarv arterv disease,C0012634,true,13657/22402
coronary - artery bypass grafting §,C0010055,true,13658/22402
coronary artery,C0205042,true,13659/22402
coronary artery bypass,C0010055,true,13660/22402
coronary artery bypass graft — no . ( % ),C0010055;C1260596,true;false,13661/22402
coronary artery bypass graft  n ( % ),C0010055;C1260596,true;false,13662/22402
coronary artery bypass grafting n ( % ),C0010055,true,13663/22402
coronary artery disease — no . ( % ),C0010054;C0010068;C1956346,true;true;true,13664/22402
coronary artery disease — no . ( % ) : c,C0010054;C0010068;C1956346,true;true;true,13665/22402
coronary artery disease ( n = $nmbr$ $nmbr$ ),C0010054;C0010068;C1956346,true;true;true,13666/22402
coronary artery disease *,C0010054;C0010068;C1956346,true;true;true,13667/22402
coronary artery disease  %,C0010054;C0010068;C1956346,true;true;true,13668/22402
coronary artery disease    n   ( % ),C0010054;C0010068;C1956346,true;true;true,13669/22402
coronary artery disease §,C0010054;C0010068;C1956346,true;true;true,13670/22402
coronary artery stenosis > $nmbr$ %,C0242231,true,13671/22402
coronary artery treated  no . ( % ),C0205042,true,13672/22402
coronary bypass surgery,C0010055,true,13673/22402
coronary events $nmbr$,C0741923,false,13674/22402
coronary heart disease — no . ( % ),C0010054;C0010068;C1956346,true;true;true,13675/22402
coronary heart disease  n ( % ) cardiovascular risk ( per protocol )  n ( % ) very high,C1277690;C0007226;C1698058;C0442711;C1507394;C1522729;C2348563;C2599718;C3715209;C4282383;C3887460,false;true;false;false;false;false;false;true;false;false;false,13676/22402
coronary procedure ( % of group ),C0018821;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1279986;C0018787;C2986530,true;false;false;true;false;false;false;false;true;false,13677/22402
coronary revascularisation §,C0877341,false,13678/22402
coronary syndrome . ci = confidence interval  hr = hazard ratio .,C0018787;C0039082;C0008107;C0009667;C2985465;C3259781,true;true;true;true;false;false,13679/22402
corticosteroid - free remissioni,C0001617;C0332296;C1880497;C1996904;C3536709,true;false;false;false;false,13680/22402
corticosteroid dose ( prednisone,C0001617;C0178602;C0032952;C0869039;C1114758;C3536709,true;false;true;false;false;false,13681/22402
corticosteroid use at randomization,C0239126;C0034656,false;true,13682/22402
corticosteroid use at randomization    n   ( % ),C0239126;C0034656,false;true,13683/22402
corticosteroid use  %,C0239126,false,13684/22402
corticosteroid use  n ( % ),C0239126,false,13685/22402
corticosteroids ' $nmbr$,C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,13686/22402
corticosteroids ( excluding budesonide ),C0001617;C3539185;C3540725;C3540726;C3540727,true;false;false;false;false,13687/22402
cortteosterom relrsclory status,C0449438,false,13688/22402
cough ( investigator reported ),C0010200;C0035173;C1961131;C3274924;C4084725;C4084726;C4084727,true;true;false;false;false;false;false,13689/22402
cough ( leading to study drug discontinuation ),C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,13690/22402
cough  n ( % ),C0010200;C1961131;C3274924;C4084725;C4084726;C4084727,true;false;false;false;false;false,13691/22402
covariate,,,13692/22402
covariates,,,13693/22402
cox - $nmbr$ selective inhibitor use,C0085387;C0036576;C0042153;C0457083;C1947944;C1707391,true;true;true;false;false;false,13694/22402
cr + crpnorr,C0201975;C3539604;C3711669;C4084730;C4553336;C4553337,false;false;true;false;false;false,13695/22402
cr + mh,C0201975;C0026514;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337,false;true;true;false;true;false;false;false,13696/22402
cr + mh + crpnorr,C0201975;C0026514;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337,false;true;true;false;true;false;false;false,13697/22402
cr imputation ( random . ) ( n = $nmbr$ ),C0201975;C2699638;C0034656;C0439605;C3539604;C3711669;C4084730;C4553336;C4553337,false;false;true;false;false;true;false;false;false,13698/22402
crcl ( ml / min ),C1846718;C0439445,false;false,13699/22402
crcl ( ml / min ) at randomization,C1846718;C0439445;C0034656,false;false;true,13700/22402
crcl ( sd ) ml / min,C1846718;C2699239;C0439445,false;false;false,13701/22402
crcl > $nmbr$ - < $nmbr$ ml / min,C1846718;C0439445,false;false,13702/22402
crcl $nmbr$ - $nmbr$,C1846718,false,13703/22402
crcl at baseline  ml / min,C1846718;C0168634;C0439445;C1442488,false;true;false;false,13704/22402
crcl at randomization - ml / min,C1846718;C0034656;C0439445,false;true;false,13705/22402
crcl at randomization  ml / min,C1846718;C0034656;C0439445,false;true;false,13706/22402
crcl of $nmbr$ - $nmbr$ ml min '  n ( % ),C1846718;C0439445,false;false,13707/22402
crcl  mean  ml / min ( ± sd ),C1846718;C0444504;C0439445;C2699239;C2347634;C2348143,false;false;false;false;false;false,13708/22402
crcl  median ( iqr )  ml / min,C1846718;C0549183;C0439445;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,13709/22402
crcl  ml / min,C1846718;C0439445,false;false,13710/22402
crcl  ml / min mean ( sd ),C1846718;C0439445;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,13711/22402
creatine clearance category,C0373595;C0683312;C3889287,false;false;false,13712/22402
creatine clearance category $nmbr$ to < $nmbr$ ml / min $nmbr$ / $nmbr$,C0373595;C0683312;C0439445;C3889287,false;false;false;false,13713/22402
creatinine,C0010294;C1561535,true;false,13714/22402
creatinine ( ^ mol / l ) ( median  iqr ),C0010294;C0347982;C0549183;C0876920;C2347635;C2348144;C2939193;C1561535,true;false;false;false;false;false;false;false,13715/22402
creatinine ( µ mol / l ),C0010294;C0347982;C1561535,true;false;false,13716/22402
creatinine ( mg / dl )  mean ( sd ),C0010294;C0439269;C0444504;C2699239;C2347634;C2348143;C1561535,true;false;false;false;false;false;false,13717/22402
creatinine ( p  mol / l ),C0010294;C0347982;C1561535,true;false;false,13718/22402
creatinine > $nmbr$ . $nmbr$ x baseline and above uln,C0010294;C0168634;C1442488;C1561535,true;true;false;false,13719/22402
creatinine > $nmbr$ x baseline,C0010294;C0168634;C1442488;C1561535,true;true;false;false,13720/22402
creatinine $nmbr$ . $nmbr$ mg / dl medications,C0010294;C0439269;C0013227;C0802604;C2598133;C4284232;C1561535,true;false;true;false;false;false;false,13721/22402
creatinine ciearance,C0010294;C1561535,true;false,13722/22402
creatinine clearance — ml / min,C0812399;C0439445,false;false,13723/22402
creatinine clearance ( ml / min )  mean ± sd,C0812399;C0439445;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,13724/22402
creatinine clearance < $nmbr$ ml / min — no . ( % ) weight < $nmbr$ kg — no . ( % ),C0812399;C0439445,false;false,13725/22402
creatinine clearance < $nmbr$ ml / min  no . / total ( % ),C0812399;C0439445,false;false,13726/22402
creatinine clearance > $nmbr$ to < $nmbr$ ml / min — no . ( % ) f,C0151280,false,13727/22402
creatinine clearance at randomization,C0812399;C0034656,false;true,13728/22402
creatinine clearance at randomization ( ixrs ),C0812399;C0034656,false;true,13729/22402
creatinine clearance category [ ml / min ],C0812399;C0683312;C0439445;C3889287,false;false;false;false,13730/22402
creatinine clearance  ml / min - $nmbr$ *,C0812399;C0439445,false;false,13731/22402
creatinine clearance  no . ( % ),C0812399,false,13732/22402
creatinine clearance  an   ( % ),C0812399,false,13733/22402
creatinine clearanceb  ml / min,C0010294;C0439445;C1561535,true;false;false,13734/22402
creatinine ratio,C0010294;C0456603;C1547037;C1561535,true;false;false;false,13735/22402
creatinine  mg / dl ( sd ),C0010294;C0439269;C2699239;C1561535,true;false;false;false,13736/22402
creatinine  mg / dl  mean,C0010294;C0439269;C0444504;C2347634;C2348143;C1561535,true;false;false;false;false;false,13737/22402
creatinine  mmol 八,C0010294;C0439190;C1561535,true;false;false,13738/22402
creatinine  pmol / l,C0010294;C0439284;C1561535,true;false;false,13739/22402
criterion,C0243161,true,13740/22402
criterion reached first  n ( % ),C0243161,true,13741/22402
critical site,C1511545;C0205145;C1515974;C2825164,false;false;false;false,13742/22402
crj,,,13743/22402
crohn ' s disease duration,C0010346;C0449238;C2926735,true;false;false,13744/22402
cromoglicate,C0010347,true,13745/22402
cross - clamp,C2828360;C0175721;C1883710;C3810601,false;false;false;false,13746/22402
crosuvastatin + fenofibric acid vs . rosuvastatin monotherapy .,C0060179,true,13747/22402
crp ( mg / dl  per unit ),C3890735;C0439269;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C3642216;C1638407;C0024671;C1532632;C0026410;C1960952;C2346927;C4321396;C4521761;C4048285,false;false;false;false;false;false;false;false;false;false;false;true;false;true;false;false;false;false;false,13748/22402
crp ( mg / l ),C3890735;C0439268;C4048285,false;false;false,13749/22402
crp ( mg / l ) ( cv ),C3890735;C0439268;C3538987;C4048877;C4318503;C4048285,false;false;false;true;false;false,13750/22402
crp ( mg / l ) [ b ]  median ( min - max ),C3890735;C0439420;C0549183;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,13751/22402
crp ( mg / l )  mean ( sd ),C3890735;C0439268;C0444504;C2699239;C2347634;C2348143;C4048285,false;false;false;false;false;false;false,13752/22402
crp ( mg / l )  n,C3890735;C0439268;C4048285,false;false;false,13753/22402
crp ( normal < $nmbr$ . $nmbr$ mg / dl ),C3890735;C0205307;C0439269;C0231683;C0439166;C2347086;C4553972;C4048285,false;false;false;false;false;false;false;false,13754/22402
crp [ mg / l ]  median,C3890735;C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,13755/22402
crp > $nmbr$ . $nmbr$ mg / dl  n ( % ),C3890735;C0439269;C4048285,false;false;false,13756/22402
crp > $nmbr$ mg / $nmbr$  n [ % ],C3890735;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4048285,false;true;true;false;false;false;false;false;false,13757/22402
crp level  mean ± sd mg / dl,C3890735;C0441889;C0444504;C2699239;C0439269;C2347634;C2348143;C0456079;C1547707;C2946261;C4048285,false;false;false;false;false;false;false;false;false;false;false,13758/22402
crp  mean [ sd ] mg / $nmbr$,C3890735;C0444504;C2699239;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143;C4048285,false;false;false;true;true;false;false;false;false;false;false;false;false,13759/22402
crp  mean mg / l ( sd ),C3890735;C0444504;C0439268;C2699239;C2347634;C2348143;C4048285,false;false;false;false;false;false;false,13760/22402
crp  median ( range ) mg / literl,C3890735;C0549183;C1514721;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;true;true;false;false;false;false;false;false;false;false;false;false;false;false,13761/22402
crp  median  mg / dl,C3890735;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,13762/22402
crp  mg / dl,C3890735;C0439269;C4048285,false;false;false,13763/22402
crp  mg / dl  mean ( sd ),C3890735;C0439269;C0444504;C2699239;C2347634;C2348143;C4048285,false;false;false;false;false;false;false,13764/22402
crp  mg / dl  median,C3890735;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C4048285,false;false;false;false;false;false;false;false,13765/22402
crp  mg / l *,C3890735;C0439268;C4048285,false;false;false,13766/22402
crp   ≤   uln,C3890735;C1519815;C4048285,false;false;false,13767/22402
crp   >   uln,C3890735;C1519815;C4048285,false;false;false,13768/22402
crpnonr ?,,,13769/22402
crt - p + d  n ( % ),,,13770/22402
crude,,,13771/22402
crude model hr ( $nmbr$ % ci ),C3161035;C0008107;C3259781;C3274659;C3714583;C3853906,false;true;false;false;false;false,13772/22402
crude rate,C0871208;C1521828,false;false,13773/22402
crusade bleeding score  mean ( sd ) ^,C0019080;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,true;false;false;false;false;false;false,13774/22402
crusade score,C0449820;C4050231,false;false,13775/22402
cryptogenic,C0332240,false,13776/22402
cryptogenic localization - related,C0332240;C0475264;C1744691,false;false;false,13777/22402
cs,C0010182;C0271160;C3540510;C4085345,true;false;false;false,13778/22402
cs and im,C0010182;C0271160;C3540510;C4085345,true;false;false;false,13779/22402
cs and imm,C0010182;C0271160;C3540510;C4085345,true;false;false;false,13780/22402
cs and is,C0010182;C0271160;C3540510;C4085345,true;false;false;false,13781/22402
cs only,C0010182;C0205171;C1720467;C0271160;C3540510;C4085345,true;false;false;false;false;false,13782/22402
csdmard otherthan methotrexate,C0025677,true,13783/22402
csdmard use at baseline ^,C0042153;C0168634;C1442488;C0457083;C1947944,true;true;false;false;false,13784/22402
csii,,,13785/22402
ct,C0007673;C3540513;C3813556;C3888140,true;false;false;false,13786/22402
ct ratio ( % ),C0007673;C0456603;C1547037;C3540513;C3813556;C3888140,true;false;false;false;false;false,13787/22402
ct ratio > $nmbr$ . $nmbr$,C0007673;C0456603;C1547037;C3540513;C3813556;C3888140,true;false;false;false;false;false,13788/22402
ct  calcitonin  cv  cardiovascular  egfr  estimated glomerular filtration rate  hbalc  glycated hemoglobin  h $nmbr$  histamine $nmbr$  iqr  interquartile range  n  number of patients  sd  standard deviation .,C0006668;C3538987;C0007226;C1739039;C3811844;C3812682;C3887460;C4048877;C4318503;C3666909;C0062408;C0033727;C0019588;C1711350;C0237753;C0449788;C0369286;C0441932;C0564385;C4528284;C0030705;C2699239;C0871420,true;false;true;true;false;false;false;true;false;false;true;true;true;false;false;false;false;false;false;false;true;false;false,13789/22402
ct + tt,C0007673;C1452561;C4554543;C3540513;C3813556;C3888140,true;true;false;false;false;false,13790/22402
ctd population subgroup,C1335071;C0032659;C1079230;C1515021;C1257890;C1442905,false;true;false;false;true;false,13791/22402
ctn - i  ng / ml,C0917591;C0021966;C0439275;C0221138,true;true;false;false,13792/22402
cu index test  n ( % ) $nmbr$,C1177210;C0600653;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0918012;C1552854;C1637833;C2986546;C2347872,false;true;false;false;false;false;false;false;false;true;false;false;false;false,13793/22402
cuban,C1553379,false,13794/22402
culprit vessel,C0005847,true,13795/22402
cumulative events,C1511559;C0441471;C3541888,false;false;false,13796/22402
cumulative incidence $nmbr$ years,C1511559;C0021149;C0439234;C0220856,false;true;false;true,13797/22402
cumulative incidence lyear,C1511559;C0021149;C0220856,false;true;true,13798/22402
cumulative nsaid score  mean   ±   sd,C1511559;C0003211;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C3536840,false;true;false;false;false;false;false;false;false,13799/22402
current ( n   = $nmbr$  $nmbr$ ),C0521116;C1705970,false;false,13800/22402
current alcohol drinking  n ( % ),C0521116;C0001948;C0556297;C1705970,false;true;false;false,13801/22402
current alcohol  n ( % ),C0521116;C0001962;C0001975;C1705970,false;true;true;false,13802/22402
current alendronate use,C0521116;C0102118;C0042153;C0457083;C1947944;C1705970,false;true;true;false;false;false,13803/22402
current angina,C0521116;C0002962;C1705970,false;true;false,13804/22402
current angina ( % ),C0521116;C0002962;C1705970,false;true;false,13805/22402
current cigarette smoker  n ( % ),C3173209;C0677453;C1704760;C3890423;C3241966;C0521116;C0337667;C1705970,false;true;false;false;false;false;false;false,13806/22402
current cigarette smoking  no . ( % ),C0521116;C0239059;C0700219;C1705970,false;false;true;false,13807/22402
current cigarette use,C0521116;C0694535;C1705970,false;false;false,13808/22402
current cigarette  n ( % ),C0521116;C0677453;C1704760;C3890423;C1705970,false;true;false;false;false,13809/22402
current corticosteroid use  n,C0521116;C0239126;C1705970,false;false;false,13810/22402
current dactylitis  n,C0521116;C0239161;C1705970,false;false;false,13811/22402
current enthesitis  n ( % ) ’,C0521116;C1282952;C1705970,false;false;false,13812/22402
current inhaled corticosteroid use,C0521116;C0004048;C0239126;C1705970,false;true;false;false,13813/22402
current laba use,C0521116;C0042153;C0457083;C1947944;C1705970,false;true;false;false;false,13814/22402
current lama use,C0521116;C0999593;C0042153;C0457083;C1947944;C1416775;C1705970,false;false;true;false;false;false;false,13815/22402
current lra use,C0521116;C1705970,false;false,13816/22402
current medication use,C0746467;C0042153;C0457083;C1947944;C0521116;C0240320;C1705970,false;true;false;false;false;false;false,13817/22402
current or former smoker,C0521116;C1705970,false;false,13818/22402
current or prior smoking  %,C0521116;C1705970,false;false,13819/22402
current oral corticosteroid use,C0521116;C1527415;C0001617;C3536709;C0442027;C0239126;C4521986;C1705970,false;false;true;false;false;false;false;false,13820/22402
current smoker — no . { % ),C3173209;C3241966,false;false,13821/22402
current smoker — no . ( % ) blood pressure — mm hg,C3173209;C3241966,false;false,13822/22402
current smoker — no . / total no . ( % ),C3173209;C3241966,false;false,13823/22402
current smoker »,C3173209;C3241966,false;false,13824/22402
current smoker ( n = $nmbr$  $nmbr$ ) former smoker ( n = $nmbr$  $nmbr$ ),C3173209;C0205156;C0750523;C3241966,false;false;false;false,13825/22402
current smoker at baseline    n   ( % ),C3173209;C0168634;C1442488;C3241966,false;true;false;false,13826/22402
current smoker at screening  n ( % ),C3173209;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3241966,false;true;true;false;false;false;false;false;false,13827/22402
current smoker at screeninga  n ( % ),C3173209;C3241966,false;false,13828/22402
current smoker  n ( % of patients ),C3173209;C0030705;C3241966,false;true;false,13829/22402
current smoker  n ( % ) post - bronchodilator screening,C3173209;C2599594;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3241966,false;false;true;true;false;false;false;false;false;false,13830/22402
current smoker  n ( % },C3173209;C3241966,false;false,13831/22402
current smoker  n [ % ],C3173209;C3241966,false;false,13832/22402
current smoker  n / n ( % ),C3173209;C3241966,false;false,13833/22402
current smoker  no . ( % ),C3173209;C3241966,false;false,13834/22402
current smokers ( itt ) ( n = $nmbr$ ),C3173209;C3241966,false;false,13835/22402
current smokers ( n = $nmbr$ ),C3173209;C3241966,false;false,13836/22402
current smokers  n ( % ) medicai history  n ( % ),C3173209;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3241966,false;true;true;false;false;false;false;false,13837/22402
current smokers    n   ( % ),C3173209;C3241966,false;false,13838/22402
current smoking ( % ),C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,13839/22402
current smoking  %,C0521116;C0037369;C0453996;C1881674;C1705970,false;true;true;false;false,13840/22402
current tobacco smoker,C3173209;C0040329;C0086707;C0740009;C3241966;C0521116;C4505217;C1705970,false;true;true;true;false;false;true;false,13841/22402
current tobacco smoker ( % ) qualifying event ( % ),C3173209;C0040329;C1514624;C0441471;C4019010;C0086707;C0740009;C3241966;C0521116;C4505217;C1705970,false;true;false;false;false;true;true;false;false;true;false,13842/22402
current use of hormone therapy,C2827774;C1524063;C0019932;C4521914;C0521116;C0279025;C1705970,false;false;true;false;false;false;false,13843/22402
current xanthine derivative use,C0521116;C0043314;C1527240;C0042153;C0457083;C1947944;C0043318;C1705970,false;true;false;true;false;false;true;false,13844/22402
currentd,,,13845/22402
currently on aha therapy,C0521116;C0050451;C0039798;C0087111;C1363945;C0772110,false;true;true;true;false;false,13846/22402
currently smoker,C0521116;C0337664,false;true,13847/22402
currently smokes,C0521116,false,13848/22402
cutoffs,C1442160,false,13849/22402
cv,C3538987;C4048877;C4318503,false;true;false,13850/22402
cv death or hf hosp .,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,13851/22402
cv death or hhf,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,13852/22402
cv death or ml,C3538987;C0011065;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;true;false,13853/22402
cv death  mi  or stroke,C3538987;C0011065;C3810814;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;true;false,13854/22402
cv death  mi  stroke,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,13855/22402
cv death  mi  stroke  or urgent coronary revascularization,C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;true;false;false;false;false;true;false,13856/22402
cv death  mi  stroke  recurrent ischemia,C3538987;C0011065;C3810814;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;true;false,13857/22402
cv death  ml or ischemic stroke,C3538987;C0011065;C0439526;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;false;true;false,13858/22402
cv death  ml  ischemic stroke  hospitalization for unstable angina  revascularization or heart failure,C3538987;C0011065;C0439526;C0948008;C0019993;C0002965;C0581603;C1705224;C3887665;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;true;true;false;false;false;false;false;false;true;false,13859/22402
cv death  myocardial infarction  stroke,C3538987;C0011065;C0027051;C0038454;C4554100;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;true;true;false;false;false;false;false;false;false;false;true;false,13860/22402
cv death  non - fatal mi or non - fatal stroke,C3538987;C0011065;C1518422;C1302234;C3810814;C1705232;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;false;false;false;false;false;false;false;true;false,13861/22402
cv disease,C0007222,true,13862/22402
cv disease history  no . ( % ) §,C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3538987;C0683519;C4048877;C4318503,true;true;true;false;false;false;false;false;false;true;false,13863/22402
cv endpoints n ( % ),C3538987;C2349179;C4048877;C4318503,false;false;true;false,13864/22402
cv historya,C3538987;C4048877;C4318503,false;true;false,13865/22402
cv medication,C3538987;C0013227;C3244316;C4284232;C4048877;C4318503,false;true;false;false;true;false,13866/22402
cv risk factors,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,13867/22402
cv risk factors and history,C3538987;C0035648;C1553898;C4048877;C4318503,false;true;false;true;false,13868/22402
cvd deaths,C0007222;C0011065;C1306577,true;true;false,13869/22402
cvd mortality,C0007222;C0026565;C0026566,true;true;true,13870/22402
cvd risk factors ( age > $nmbr$ ) ^ “ ^,C0007222;C0035648;C0001779;C1553898;C0035647;C0001783;C4552904,true;true;false;false;true;true;false,13871/22402
cvd without mi or stroke ( n = $nmbr$ ),C0007222;C3810814,true;false,13872/22402
cvd without miatroke,C0007222,true,13873/22402
cvd without ml / stroke,C0007222;C0439526;C0038454;C4554100;C1705224;C3887665,true;false;true;false;false;false,13874/22402
cvd without ml ^ troke,C0007222;C0439526;C1705224;C3887665,true;false;false;false,13875/22402
cvd  total,C0007222;C0439175;C0439810,true;false;false,13876/22402
cvd / mi / stroke,C0007222;C3810814;C0038454;C4554100,true;false;true;false,13877/22402
cvd / mi / stroke / revascularization / urgent vascular hospitalization,C0007222;C3810814;C0038454;C0581603;C0439609;C0005847;C0019993;C1558950;C1801960;C3272275;C4554100,true;false;true;false;false;true;true;false;false;false;false,13878/22402
cvd / mi / stroke / urgent coronary revascularization,C0007222;C3810814,true;false,13879/22402
cvd / mi / stroke / urgent vascular hospitalization,C0007222;C3810814,true;false,13880/22402
cvd / stroke / see,C0007222;C0038454;C4554100,true;true;false,13881/22402
cvdeath  ml  or ischemic stroke,C0439526;C1705224;C3887665,false;false;false,13882/22402
cwt  mean ( se )  mm,C0444504;C0036919;C4330985;C4554674;C2347634;C2348143,false;true;false;false;false;false,13883/22402
cyp $nmbr$ a $nmbr$,C1418793;C2634343,false;false,13884/22402
cyp $nmbr$ a $nmbr$ inhibitors,C1418793;C0243077;C2634343,false;true;false,13885/22402
cystitis,C0010692;C0600041;C1963088,true;false;false,13886/22402
cystoscopic procedure,C0560573;C0184661;C2700391;C3274430;C3539779,false;true;false;false;false,13887/22402
czech repumc,C0337799,false,13888/22402
czp $nmbr$ mg,C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,13889/22402
czp $nmbr$ mg ( n = $nmbr$ ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,13890/22402
czp $nmbr$ mg ( n = lll ),C0054841;C0024671;C1261077;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;false;true;false;false;false;false;false;true;true,13891/22402
czp $nmbr$ mg every $nmbr$ weeks ( n = $nmbr$ ),C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,13892/22402
czp $nmbr$ mg q $nmbr$ w,C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;false;false;false;true;true,13893/22402
czp baseline,C0054841;C0168634;C1442488;C1861828;C1872109,true;true;false;true;true,13894/22402
czp combined arms ( n = $nmbr$ ),C0054841;C0205195;C0206655;C0446516;C2681631;C3715044;C4553528;C1861828;C1872109,true;false;true;true;false;false;false;true;true,13895/22402
d,C0073187;C0332173;C4484261,true;false;false,13896/22402
d - value,C1522609,false,13897/22402
d ( $nmbr$ % ci ),C0073187;C0008107;C3259781;C0332173;C4484261,true;true;false;false;false,13898/22402
d $nmbr$ mg vs . warfarin,C0073187;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0332173;C4484261,true;true;true;false;false;false;false;false;false;false,13899/22402
d includes cardiac glycosides  antiarrhythmics classes i and iii  vasodilators used in cardiac disease and other cardiac preparations .,C0073187;C0332173;C4484261,true;false;false,13900/22402
d non - vertebral fragility fractures ( fas ),C0073187;C1518422;C0549207;C0302113;C0332173;C4484261,true;false;true;false;false;false,13901/22402
d population,C0073187;C0032659;C1257890;C0332173;C4484261,true;true;true;false;false,13902/22402
d  mitral stenosis vhd ( n = $nmbr$ ),C0073187;C0026269;C0264766;C0332173;C4484261,true;true;false;false;false,13903/22402
d / mi / idfvst,C0073187;C3810814;C0332173;C4484261,true;false;false;false,13904/22402
d $nmbr$ % ( n / n ),C0073187;C0332173;C4484261,true;false;false,13905/22402
d $nmbr$ vs warfarin,C0073187;C0332173;C4484261,true;false;false,13906/22402
d $nmbr$ vs warfarin rr ( $nmbr$ % ci  p value ),C0073187;C0332173;C4484261,true;false;false,13907/22402
dabigatran,C2348066,true,13908/22402
dabigatran ( n = $nmbr$ ),C2348066,true,13909/22402
dabigatran $nmbr$ mg,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13910/22402
dabigatran $nmbr$ mg ( n = $nmbr$ ),C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13911/22402
dabigatran $nmbr$ mg $nmbr$ mg % per yr,C2348066;C1319635;C0439234,true;false;false,13912/22402
dabigatran $nmbr$ mg bid,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13913/22402
dabigatran $nmbr$ mg bid ( n = $nmbr$ ),C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13914/22402
dabigatran $nmbr$ mg bid events / n ( % / y ),C2348066;C0024671;C0441471;C3541888;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;true;false;false;false;false;false,13915/22402
dabigatran $nmbr$ mg bid vs warfarin,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13916/22402
dabigatran $nmbr$ mg versus warfarin,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13917/22402
dabigatran $nmbr$   mg b . i . d .,C2348066;C0439422;C0021966;C0221138;C0024671;C0152277;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;true;false;true;false;false;false;false;false,13918/22402
dabigatran $nmbr$ mg versu swarfarin,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13919/22402
dabigatran $nmbr$ vs dabigatran $nmbr$ mg bid,C2348066,true,13920/22402
dabigatran $nmbr$ mg ( n = $nmbr$  $nmbr$ ),C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13921/22402
dabigatran group,C2348066;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,13922/22402
dabigatran  $nmbr$ mg,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13923/22402
dabigatran  $nmbr$ mg bid,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13924/22402
dabigatran  $nmbr$ mg twice daily,C2348066;C0024671;C0585361;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,13925/22402
dabigatran  $nmbr$ mg  vs . warfarin,C2348066;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,13926/22402
dabigatran $nmbr$ vs . warfarin p ( inter ),C2348066,true,13927/22402
dactylitis in > $nmbr$ digit,C3863761,false,13928/22402
dactylitis score,C0239161;C0449820;C4050231,false;false;false,13929/22402
dactylitis score ( $nmbr$ - $nmbr$ ),C0239161;C0449820;C4050231,false;false;false,13930/22402
dactylitis score ( $nmbr$ - $nmbr$ )  mean ( sd ),C0239161;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,13931/22402
dactylitis score ( $nmbr$ – $nmbr$ scale ),C0239161;C0449820;C0175659;C0349674;C1947916;C4050231,false;false;true;false;false;false,13932/22402
dactylitis score at baseline  median ( iqr ) week $nmbr$,C0239161;C0449820;C0168634;C0549183;C0332174;C0439230;C0876920;C2347635;C2348144;C2939193;C1442488;C4050231,false;false;true;false;false;false;false;false;false;false;false;false,13933/22402
dactylitis severity score ) score > $nmbr$ — no . { % ),C0239161;C0457451,false;false,13934/22402
dactylitis  % #,C0239161,false,13935/22402
daily “ off ” time  mean ± sd  h / dayf,C0332173;C0040223;C0444504;C2699239;C0033727;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143;C3541383,false;true;false;false;true;false;false;false;false;false;false;false,13936/22402
daily bowel movements,C0332173;C0011135,false;true,13937/22402
daily dose of inhaled glucocorticoid — no . ( % ) §,C2348070;C0004048;C0017710,false;true;true,13938/22402
daily dose of study medication prescribed,C2348070;C0013175,false;true,13939/22402
daily dose of vitamin d ( iu / day ),C2348070;C0014695;C0439465;C0042866;C2936842;C3537249;C3714503,false;true;false;true;false;false;false,13940/22402
daily exercise ( % ),C0332173,false,13941/22402
daily total dose of insulin — lu / kg,C2348070;C0021641;C0024171;C0022718;C0439209;C4054209;C0024176;C2697939;C1533581;C1579433;C3714501,false;true;true;true;false;false;true;false;false;false;false,13942/22402
dalteparin ( n = $nmbr$ ),C0206461,true,13943/22402
dapaglifloiin  n *,,,13944/22402
dapaglifloz . in  n,,,13945/22402
dapagliflozin,C2353951,true,13946/22402
dapagliflozin ( n = $nmbr$ ),C2353951,true,13947/22402
dapagliflozin $nmbr$ mg + insulin ( n   = $nmbr$ ),C2353951;C0024671;C0021641;C1533581;C1579433;C3714501;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;true;false;false;false;false;false,13948/22402
dapagliflozin $nmbr$ mg + insulin ( n = $nmbr$ ),C2353951;C0024671;C0021641;C1533581;C1579433;C3714501;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;true;false;false;false;false;false,13949/22402
dapagliflozin placebo no . of events / no . of patients,C2353951;C0032042;C1696465;C1706408,true;true;false;false,13950/22402
dapagliflozin  n *,C2353951,true,13951/22402
das $nmbr$ ‐ crp,C0051767;C3890735;C4048285;C0057671,true;false;false;true,13952/22402
das $nmbr$ - esr  mean ( sd ),C0051767;C3811131;C0444504;C2699239;C2347634;C2348143;C0057671,true;false;false;false;false;false;true,13953/22402
das $nmbr$ - esr  mean ± sd das $nmbr$ - esr remission  %,C0051767;C3811131;C0444504;C2699239;C0544452;C0687702;C2347634;C2348143;C0057671,true;false;false;false;false;false;false;false;true,13954/22402
das $nmbr$ - hscrp  mean ( sd ),C0051767;C0444504;C2699239;C2347634;C2348143;C0057671,true;false;false;false;false;true,13955/22402
das $nmbr$ ( crp )  mean ( sd ),C0051767;C3890735;C0444504;C2699239;C2347634;C2348143;C4048285;C0057671,true;false;false;false;false;false;false;true,13956/22402
das $nmbr$ score,C0051767;C0057671,true;true,13957/22402
das $nmbr$  mean ( sd ),C0051767;C0444504;C2699239;C2347634;C2348143;C0057671,true;false;false;false;false;true,13958/22402
das $nmbr$  mean ± sd,C0051767;C0444504;C2699239;C2347634;C2348143;C0057671,true;false;false;false;false;true,13959/22402
das $nmbr$  range $nmbr$ - $nmbr$  mean ( sd ),C0051767;C1514721;C0444504;C2699239;C2347634;C2348143;C2348147;C3542016;C0057671,true;false;false;false;false;false;false;false;true,13960/22402
data are expressed as n / total ( % ) unless otherwise speci ﬁ ed . systeme international unit conversion : to convert creatinine clearance to ml / s  multiply by $nmbr$ . $nmbr$ . * estimated with cockroft - gault equation  † at discharge . ace angiotensin - converting enzyme  cabg coronary artery bypass graft  ccsc canadian cardiovascular society classi ﬁ cation  mi myocardial infarction  pci percutaneous coronary intervention .,C1511726;C3245479;C3714741;C0439453;C0439836;C0565930;C1719797;C2911648;C2603362;C0022709;C0010055;C1516705;C0238884;C0007226;C0037455;C0007447;C0027051;C4049621;C3887460;C0018787;C0184661;C0886296;C1273869,false;false;false;false;false;false;false;false;false;true;true;false;false;true;true;true;true;false;false;true;true;false;false,13961/22402
data are expressed as n / total ( % ) unless otherwise specified . systeme international unit conversion : to convert creatinine clearance to ml / s  multiply by $nmbr$ . $nmbr$ . * estimated with cockroft - gault equation,C1511726;C3245479;C3714741;C0439453;C0439836;C1719797;C2911648,false;false;false;false;false;false;false,13962/22402
data are mean ( sd ) or n ( % ) . ace = angiotensin - converting enzyme  arb = angiotensin - receptor blocker . chf = congestive heart failure . * any use in $nmbr$ h before surgery except for aspirin which only required any use in the $nmbr$ days before surgery .,C1511726;C3245479;C3714741;C3888198;C0034787;C0018802;C1622222;C0033727;C0038894;C0038895;C0543467;C1274039;C0369286;C0441932;C0564385;C4528284;C0042153;C0439228;C0457083;C1947944,false;false;false;false;true;true;true;true;false;true;true;true;false;false;false;false;true;false;false;false,13963/22402
data are mean ( sd ) or number ( % ) . bmi = body - mass index . sbp = systolic blood pressure . dbp = diastolic blood pressure . lvef = left ventricular ejection fraction . hf = heart failure . ami = acute myocardial infarction . cabg = coronary artery bypass graft . pci = percutaneous coronary intervention . icd = implantable cardioverter de ﬁ brillator . copd = chronic obstructive pulmonary disease . ace = angiotensin - converting enzyme . arbs = angiotensin receptor blockers . * available for $nmbr$ patients ( $nmbr$ rosuvastatin  $nmbr$ placebo ) .,C1511726;C3245479;C3714741;C0085805;C0488055;C0428883;C0428772;C0488728;C0871470;C1306620;C0042508;C0018801;C0155626;C0010055;C1532338;C0021122;C0162589;C0011198;C0024117;C1452534;C4284014;C0017480;C3541240;C0521942;C0014442;C3888198;C4521602;C0815017;C0965129;C0032042;C1696465;C1706408,false;false;false;true;false;true;false;false;true;false;true;true;false;true;true;true;true;true;true;true;false;true;false;true;true;false;false;true;true;true;false;false,13964/22402
data are mean ( sd ) or number ( % ) . pufa = polyunsaturated fatty acids  bmi = body - mass index . sbp = systolic blood pressure . dbp = diastolic blood pressure . nyha = newyork heart association . lvef = left ventricular ejection fraction . hf = heartfailure . ami = acute myocardial infarction . cabg = coronary artery bypass graft . pci = percutaneous coronary intervention . icd = implantable cardioverter defibrillator . copd = chronic obstructive pulmonary disease . ace = angiotensin - converting enzyme . arbs = angiotensin receptor blockers . * available for $nmbr$ patients ( $nmbr$ n - $nmbr$ pufa  $nmbr$ placebo ) .,C1511726;C3245479;C3714741;C1305855;C0085805;C0488055;C0536221;C3813197;C4281799;C0871470;C1306620;C0005823;C1275491;C0018787;C0004083;C0428772;C2733342;C0488728;C0439849;C0596306;C0699792;C1271104;C1272641;C1264633;C0018801;C0155626;C0010055;C0205042;C1554103;C0185098;C1532338;C0021122;C0162589;C2825184;C0024117;C0022709;C3888198;C0521942;C0815017,false;false;false;true;true;false;true;false;false;true;false;true;false;true;true;false;false;false;false;false;false;false;true;false;true;false;true;true;false;false;true;true;true;false;true;true;false;true;true,13965/22402
data are mean ± standard deviation for continuous variables and number ( % ) for categoric variables . p,C1511726;C3245479;C3714741,false;false;false,13966/22402
data are number of patients ( % ) or hazard ratio ( $nmbr$ % cl )  p values are forthe test of heterogeneity . cad = coronary artery disease . bmi = body - mass index  which is weight in kg divided by the square of height in metres . ldl = low - density lipoprotein . hdl = high - density lipoprotein . there is a deficit of clinical data in some patients with the events .,C1511726;C3245479;C3714741;C0042295;C1305855;C0205120;C0489786;C1552595;C0023820;C0023821;C1516606;C0030705,false;false;false;false;true;false;false;false;true;true;false;true,13967/22402
data are number of patients ( % ) or mean ( sd )  unless otherwise indicated . cabg = coronary - artery bypass grafting . ptca = percutaneous transluminal coronary angioplasty  ldl = low - density lipoprotein . hdl = high - density lipoprotein . iqr = i nterquarti le range  hmg coa ri = $nmbr$ - hydroxy - $nmbr$ - methylglutaryl coenzyme a reductase inhibitor . bmi = body - mass index  which is weight in kg divided by the square of height in metres  * median ( iqr ) .,C1511726;C3245479;C3714741;C1444656;C0010055;C0545743;C0189695;C2936173;C0522523;C0522520;C1522231;C0162577;C0023823;C0023821;C1548817;C0021966;C0023190;C1514721;C0047420;C0035487;C0700307;C0009235;C1826843;C2348147;C3542016;C0439090;C1423767;C2697858;C0221138;C0597153;C1305855;C1655741;C0022718;C0439209;C4054209;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;true;false;false;false;true;true;true;false;true;true;false;true;true;false;true;false;false;false;false;false;false;false;false;true;false;true;false;false;false;false;false;false;false,13968/22402
data are presented as mean sd . * n $nmbr$ for ldl cholesterol . † n $nmbr$ for ldl cholesterol . ‡ signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p $nmbr$ . $nmbr$ . § signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p $nmbr$ . $nmbr$ . ¶ signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p $nmbr$ . $nmbr$ .,C1511726;C3245479;C3714741;C0369718;C0023824;C0202117;C0441922;C0871881;C0002780;C0168634;C0042295;C0871881;C0002780;C1442488;C1711260;C2348152,false;false;false;false;true;false;false;false;true;true;false;false;true;false;false;false,13969/22402
data are reported as n ( % ) . event rates in parentheses are kaplan - meier estimates ( % ) at $nmbr$ year . * cardiovascular ( cv ) death  myocardial infarction ( mi )  or recurrent ischemia . † cv death  mi  or severe recurrent ischemia,C1511726;C3245479;C3714741;C1720943;C0439234;C0007226;C3538987;C0011065;C0027051;C0428953;C2926063;C3810814;C4552959;C1306577;C4082313;C4552775;C4048877;C4318503;C3887460;C0439508;C3810814;C0022116;C4321499,false;false;false;true;false;true;false;true;true;false;false;false;false;false;false;false;true;false;false;false;false;true;false,13970/22402
data are reported as percentage or mean ± standard deviation  unless otherwise indicated . ng  normoglycemia  igm  impaired glucose metabolism  ldl  low - density lipoprotein  hdl  high - density lipoprotein  fpg  fasting plasma glucose . a median ( interquartile range ) . * p < $nmbr$ . $nmbr$ vs . ng . † p < $nmbr$ . $nmbr$ vs . ng .,C1511726;C3245479;C3714741;C1444656;C1154908;C0580545;C1706005;C0221099;C0017725;C0017887;C0596620;C0028074;C0178587;C0023820;C0023821;C0015663;C0202042;C0455280;C0549183;C1711350;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;true;true;false;true;false;true;true;true;false;false;false;false;false;false;false;false,13971/22402
data are reported as percentage or mean ± standard deviation  unless otherwise indicated . ng  normoglycemia  igm  impaired glucose metabolism  ldl  low - density lipoprotein  hdl  high - density lipoprotein  fpg  fasting plasma glucose . a median ( interquartile range ) . ‡ p < $nmbr$ . $nmbr$ vs . non - epa . § p < $nmbr$ . $nmbr$ vs . non - epa,C1511726;C3245479;C3714741;C1444656;C1154908;C0580545;C1706005;C0221099;C0017725;C0017887;C0596620;C0028074;C0178587;C0023820;C0023821;C0015663;C0202042;C0455280;C0549183;C1711350;C0876920;C2347635;C2348144;C2939193;C1518422,false;false;false;false;false;false;false;false;true;true;false;true;false;true;true;true;false;false;false;false;false;false;false;false;false,13972/22402
data presented as mean   ±   sd  unless otherwise specified    acopd severity is based on the gold $nmbr$ criteria [ $nmbr$ ]  gold $nmbr$ [ $nmbr$ ]    bon a scale of $nmbr$ – $nmbr$  with higher scores indicating worse health status  the mcid is a change of $nmbr$   units  on a scale of $nmbr$ – $nmbr$  with higher scores indicating more severe dyspnea  on a scale of $nmbr$ – $nmbr$  with higher scores indicating worse health status,C1511726;C3245479;C3714741;C0205250;C0449820;C0205250;C0449820;C0205250;C0449820,false;false;false;false;false;false;false;false;false,13973/22402
data represent number of patients ( % ) or mean ( standard deviation )  unless otherwise indicated . a self - reported information . bc physician - diagnosed diabetes or fasting plasma glucose ≥ $nmbr$ mg / dl or hemoglobin a $nmbr$ c ≥ $nmbr$ . $nmbr$ % . d physician - diagnosed hypertension or systolic blood pressure ≥ $nmbr$ mmhg or diastolic blood pressure ≥ $nmbr$ mmhg . median ( interquartile range ) . ldl  low - density lipoprotein  hdl  high - density lipoprotein  tg  triglyceride .,C1511726;C3245479;C3714741;C0073187;C0031831;C0804815;C0332173;C4484261;C0428883;C0439475;C0549183;C1711350;C0205251;C0178587;C1550472;C3890211;C4048187;C4321351;C4522223;C0876920;C2347635;C2348144;C2939193;C1305849;C0023820;C0062152;C0337445,false;false;false;true;true;false;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;true;true;false,13974/22402
data  ' ' n,C1511726;C3245479;C3714741,false;false;false,13975/22402
dates of recruitment,C0011008;C2949735;C2348077,true;false;true,13976/22402
day $nmbr$ oral glucocorticoid use — no . { % ),C0332173;C0442027;C0017710;C4521986;C0439228;C0439505,false;false;true;false;false;false,13977/22402
days between acs and rand,C0439228;C0742343;C4318612,false;true;false,13978/22402
days from acs to randomization,C0439228;C0742343;C4318612,false;true;false,13979/22402
days with heartburna ( days ),C0439228,false,13980/22402
daytime mean dbp ( abpm ) at week $nmbr$  mmhg,C0332169;C0444504;C0536221;C0332174;C0439475;C0439230;C3813197;C4281799;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,13981/22402
daytime mean sbp ( abpm ) at week $nmbr$  mmhg,C0332169;C0444504;C0085805;C0332174;C0439475;C0439230;C2347634;C2348143,false;false;true;false;false;false;false;false,13982/22402
daytime nasal symptoms score change from baseline  mean ± se,C0332169;C0231918,false;false,13983/22402
daytime symptoms more than twice per week,C0332169;C0683368;C1720725;C1948050;C1457887,false;true;false;false;false,13984/22402
dbp,C0536221;C3813197;C4281799,true;false;false,13985/22402
dbp ( mean over $nmbr$ h )  mmhg,C0536221;C0444504;C0033727;C0439475;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143;C3813197;C4281799,true;false;true;false;false;false;false;false;false;false;false;false,13986/22402
dbp ( mmghg )  mean ( sd ),C0536221;C0444504;C2699239;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false,13987/22402
dbp ( mmhg )  mean ( sd ),C0536221;C0439475;C0444504;C2699239;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,13988/22402
dbp ( office measurement )  mmhg,C0536221;C0442603;C0242485;C0439475;C3813197;C4281799,true;false;false;false;false;false,13989/22402
dbp ( sd ),C0536221;C2699239;C3813197;C4281799,true;false;false;false,13990/22402
dbp ( sd )  mm   hg,C0536221;C2699239;C0439475;C3813197;C4281799,true;false;false;false;false,13991/22402
dbp < $nmbr$ mmhg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,13992/22402
dbp ≥ $nmbr$ mmhg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,13993/22402
dbp > $nmbr$ or sbp > $nmbr$ mm hg laboratory determinations,C0536221;C3813197;C4281799,true;false;false,13994/22402
dbp $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) baseline lipid profile  mg / dl  mean ( sd ),C0536221;C0168634;C0023779;C1979963;C0439269;C0444504;C2699239;C2347634;C2348143;C2003903;C1442488;C3813197;C4281799,true;true;true;false;false;false;false;false;false;false;false;false;false,13995/22402
dbp at visit $nmbr$,C0536221;C0545082;C1512346;C2826704;C3813197;C4281799,true;false;false;false;false;false,13996/22402
dbp during the follow - up period ( mmhg ),C0536221;C0589120;C0439531;C0439475;C1948053;C1522577;C1704685;C3274571;C3813197;C4281799,true;false;false;false;false;false;false;false;false;false,13997/22402
dbp mm hg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,13998/22402
dbp  mean ( sd ),C0536221;C0444504;C2699239;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false,13999/22402
dbp  mean ( sd ) mm hg,C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,14000/22402
dbp  mm hg ( mean $nmbr$ h )  mean ( sd ),C0536221;C0456680;C0025424;C0444504;C2699239;C2347634;C2348143;C0428257;C2347108;C2347109;C2348272;C3813197;C4281799,true;false;true;false;false;false;false;false;false;false;false;false;false,14001/22402
dbp  mm hg ( office measurement )  mean ( sd ),C0536221;C0439475;C0442603;C0242485;C0444504;C2699239;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false;false;false,14002/22402
dbp  mm   hg,C0536221;C0439475;C3813197;C4281799,true;false;false;false,14003/22402
dbp  mm   hg ( sd ),C0536221;C0439475;C2699239;C3813197;C4281799,true;false;false;false;false,14004/22402
dbp . mean ( sd ) mm hg,C0536221;C0444504;C2699239;C0439475;C2347634;C2348143;C3813197;C4281799,true;false;false;false;false;false;false;false,14005/22402
dcct a $nmbr$ c,,,14006/22402
de,C0011198;C0017480;C3541240,true;true;false,14007/22402
de ( n = $nmbr$ ),C0011198;C0017480;C3541240,true;true;false,14008/22402
de $nmbr$ mg bid ( n - $nmbr$  $nmbr$ ),C0011198;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0017480;C3541240,true;true;true;false;false;false;false;false;true;false,14009/22402
de $nmbr$ n = $nmbr$,C0011198;C0017480;C3541240,true;true;false,14010/22402
dead ( n = $nmbr$ ),C0011065,true,14011/22402
death due to renal failure or sustained esrd,C0011065;C0678226;C0035078;C1963154;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,14012/22402
death due to renal failure ®,C0011065;C0678226;C0035078;C1963154;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,14013/22402
death from,C0011065;C1306577;C4082313;C4552775,true;false;false;false,14014/22402
death or disabling stroke,C0011065;C1306577;C4082313;C4552775,true;false;false;false,14015/22402
death or ich,C0011065;C1306577;C4082313;C4552775,true;false;false;false,14016/22402
death *,C0011065;C1306577;C4082313;C4552775,true;false;false;false,14017/22402
death  mi  idr  st  or gusto mod / sev bleeding,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,14018/22402
death  n ( % ),C0011065;C1306577;C4082313;C4552775,true;false;false;false,14019/22402
death  with pe not,C0011065;C0070939;C1880476;C4284304;C1306577;C4082313;C4552775,true;true;false;false;false;false;false,14020/22402
death / mi / idr / st,C0011065;C3810814;C0036056;C3272372;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,14021/22402
death / q - ml / stent thrombosis,C0011065;C0439526;C3897493;C1705224;C3887665;C1306577;C4082313;C4552775,true;false;false;false;false;false;false;false,14022/22402
death / q - mi / idr,C0011065;C3810814;C1306577;C4082313;C4552775,true;false;false;false;false,14023/22402
death / udmi / idr,C0011065;C1306577;C4082313;C4552775,true;false;false;false,14024/22402
deaths  n ( % ),C0011065;C1306577,true;false,14025/22402
deathsb,,,14026/22402
decline #   ml · yr − $nmbr$,C0439526;C0439234;C1705224;C3887665,false;false;false;false,14027/22402
deep - vein thrombosis only,C0149871;C0205171;C1720467,true;false;false,14028/22402
definite acute stent thrombosis,C0439544;C0205178;C3897493;C1704787,false;false;false;false,14029/22402
definite stent thrombosis,C0439544;C3897493;C1704787,false;false;false,14030/22402
definite / probable stent thrombosis,C0439544;C0033204;C3897493;C0332148;C1704787,false;true;false;false;false,14031/22402
delayed,C0205421;C1545665;C3272602,false;false;false,14032/22402
delayed - eptifibatide group ( n = $nmbr$ ),C0205421;C0253563;C0441848;C1545665;C3272602,false;true;false;false;false,14033/22402
delayed eptifibatide,C0205421;C0253563;C1545665;C3272602,false;true;false;false,14034/22402
delighted,C3830544,false,14035/22402
demographic $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ),C0011298,true,14036/22402
demographic and clinical,C0011298,true,14037/22402
demographic characteristic,C0011298;C1521970,true;false,14038/22402
demographic characteristics  mean ( sd )  unless otherwise stated,C0683970;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,14039/22402
demographic characteristics  mean ± sd unless otherwise indicated,C0683970;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,14040/22402
demographic data,C4684639,false,14041/22402
demographic factors,C0011292;C0011298,true;true,14042/22402
demographic variable,C0011298;C0439828;C4553760,true;false;false,14043/22402
demographic / disease characteristics at baseline,C0683970;C0012634;C0168634;C1442488;C0011298;C0599878;C4684572,false;true;true;false;true;false;false,14044/22402
demographics age ( years ),C0011298;C1510829;C1704791,true;false;false,14045/22402
demographics and clinical characteristics,C0011298;C1704791,true;false,14046/22402
denosumab ( n = $nmbr$ ) n ( % ),C1690432,true,14047/22402
denotes angiotensin - converting enzyme .,,,14048/22402
dense calcium,C0439794;C0006675;C0006726;C2936886;C3540037;C3714611,false;true;true;false;false;false,14049/22402
dense calcium  mm ’,C0439794;C0006675;C4330985;C4554674;C0006726;C2936886;C3540037;C3714611,false;true;false;false;true;false;false;false,14050/22402
dental procedure,C0011331,true,14051/22402
depression ®,C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,true;true;false;false;false;false;false;false,14052/22402
dermal,C0221928;C1522447,false;false,14053/22402
dermatitis atopic,C0011603,true,14054/22402
des implantation for restenosis  n ( % ),C0011702;C0021107;C0333186;C0029976;C4551552,true;false;false;true;true,14055/22402
des type at index procedure,C0011702;C0600653;C0455713;C0918012;C1552854;C1637833;C2986546;C4551552,true;true;false;true;false;false;false;true,14056/22402
descent,C0205386;C0680043,false;false,14057/22402
detected during tumor evaluation,C0442726;C0027651;C0220825;C1261322;C1578706;C3273930;C1511790,false;true;false;false;false;false;false,14058/22402
deterioration in renal function ( investigator reported ),C0868945;C0232804;C0035173,false;false;true,14059/22402
deviation  mm,C0012727;C4330985;C4554674;C0205419;C1705236,false;false;false;false;false,14060/22402
deviation  tg  triglyceride .,C0012727;C0041004;C0205419;C1705236,false;true;false;false,14061/22402
device = watchman filter,C0180860;C0335390,false;false,14062/22402
dexlansoprazole mr,C2348248;C0024485;C1417249;C2347167;C3254418;C4050513,true;true;false;false;true;false,14063/22402
dexlansoprazole mr ( n = $nmbr$ ),C2348248;C0024485;C1417249;C2347167;C3254418;C4050513,true;true;false;false;true;false,14064/22402
dexlansoprazole mr $nmbr$ mg  n = $nmbr$,C2348248;C0024485;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417249;C2347167;C3254418;C4050513,true;true;true;true;false;false;false;false;false;false;false;true;false,14065/22402
dexlansoprazole mr $nmbr$ mg qd,C2348248;C0024485;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417249;C2347167;C3254418;C4050513,true;true;true;false;true;false;false;false;false;false;false;false;true;false,14066/22402
dfisher ' s exact test .,C2828393;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4050514,false;false;false;false;false;false;false;false;false,14067/22402
dha ( n = $nmbr$ ),C0142831;C2348308,true;false,14068/22402
dha intake on food frequency questionnaire  mean ( sd )  mg / d,C0142831;C1286336;C0034394;C0444504;C2699239;C0439422;C2347634;C2348143;C1512806;C2986698;C2348308,true;false;true;false;false;false;false;false;false;false;false,14069/22402
diabetes - related medication use    n   ( % ),C0011847;C0439849;C0240320;C0445223;C0011849,false;false;false;false;true,14070/22402
diabetes ( n [ % ] ) *,C0011847;C0011849,false;true,14071/22402
diabetes ( n = $nmbr$ ),C0011847;C0011849,false;true,14072/22402
diabetes ( p = . $nmbr$ ),C0011847;C0011849,false;true,14073/22402
diabetes ( p = . o $nmbr$ ),C0011847;C0011849,false;true,14074/22402
diabetes ( p = . oo $nmbr$ ),C0011847;C0011849,false;true,14075/22402
diabetes at baseline,C0011847;C0168634;C1442488;C0011849,false;true;false;true,14076/22402
diabetes bl,C0011847;C0005918;C0006413;C1552663;C2827109;C0011849,false;true;true;false;false;true,14077/22402
diabetes classificationa,C0011847;C0011849,false;true,14078/22402
diabetes duration,C0011847;C0449238;C2926735;C0011849,false;false;false;true,14079/22402
diabetes duration ( y ),C0011847;C0449238;C2926735;C0011849,false;false;false;true,14080/22402
diabetes duration ( years ) *,C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,14081/22402
diabetes duration at baseline,C0011847;C0449238;C0168634;C1442488;C2926735;C0011849,false;false;true;false;false;true,14082/22402
diabetes duration mean ± sd,C0011847;C0449238;C0444504;C2699239;C2347634;C2348143;C2926735;C0011849,false;false;false;false;false;false;false;true,14083/22402
diabetes duration  y,C0011847;C0449238;C2926735;C0011849,false;false;false;true,14084/22402
diabetes duration  ycars “,C0011847;C0449238;C2926735;C0011849,false;false;false;true,14085/22402
diabetes duration  years ( mean ± sd ),C0011847;C0449238;C0439234;C0444504;C2699239;C2347634;C2348143;C2926735;C0011849,false;false;false;false;false;false;false;false;true,14086/22402
diabetes duration  years ^,C0011847;C0449238;C0439234;C2926735;C0011849,false;false;false;false;true,14087/22402
diabetes etiology,C0011847;C0015127;C1314792;C1524003;C0011849,false;true;true;false;true,14088/22402
diabetes history  mean ( sd )  years,C0011847;C0019664;C0444504;C2699239;C0439234;C2347634;C2348143;C0019665;C0262512;C0262926;C1705255;C2004062;C0011849,false;true;false;false;false;false;false;true;false;false;false;false;true,14089/22402
diabetes medication,C0011847;C0013227;C3244316;C4284232;C0011849,false;true;false;false;true,14090/22402
diabetes melitus,C0011847;C0011849,false;true,14091/22402
diabetes mellitus — no . / total no . ( % ),C0011849,true,14092/22402
diabetes mellitus ( type $nmbr$ )  n ( % ),C1320657,false,14093/22402
diabetes mellitus [ n ( % ) ],C0011849,true,14094/22402
diabetes mellitus 一 no . ( % ),C0011849,true,14095/22402
diabetes mellitus classification,C0011849;C0008902;C0008903;C0678229,true;true;true;false,14096/22402
diabetes mellitus duration ( sd )  y,C0011849;C0449238;C2699239;C2926735,true;false;false;false,14097/22402
diabetes mellitus duration  y,C0011849;C0449238;C2926735,true;false;false,14098/22402
diabetes mellitus duration  y ( sd ),C0011849;C0449238;C2699239;C2926735,true;false;false;false,14099/22402
diabetes mellitus n = $nmbr$  $nmbr$,C0011849,true,14100/22402
diabetes mellitus yes ( n  % ) hypertension,C0011849;C1549445;C0020538;C1963138;C1705108;C1710701,true;false;true;false;false;false,14101/22402
diabetes mellitus  n ( % ) yes,C0011849;C1549445;C1705108;C1710701,true;false;false;false,14102/22402
diabetes mellitus  n / n ( % ),C0011849,true,14103/22402
diabetes mellitus  n = $nmbr$,C0011849,true,14104/22402
diabetes mellitus  no . ( % ),C0011849,true,14105/22402
diabetes mellitus  no . / total no . ( % ),C0011849,true,14106/22402
diabetes mellitust,C0011847;C0011849,false;true,14107/22402
diabetes n ( % ),C0011847;C0011849,false;true,14108/22402
diabetes t,C0011847;C0011849,false;true,14109/22402
diabetes therapy at baseline ( alone or in combination ),C3274787;C0168634;C1442488;C3539002,false;true;false;false,14110/22402
diabetes type ii  n ( % ),C0011860,true,14111/22402
diabetes with no use of diabetes drugs,C0020616;C1524063,true;false,14112/22402
diabetes with use of oral diabetes drugs,C0020616;C1524063;C0442027;C4521986;C0011847;C0029167;C0175795;C0304289;C0011849,true;false;false;false;false;true;false;false;true,14113/22402
diabetes  no . ( % ) c,C0011847;C0011849,false;true,14114/22402
diabetes ^,C0011847;C0011849,false;true,14115/22402
diabetes | |,C0011847;C0011849,false;true,14116/22402
diabetes | | yes,C0011847;C1549445;C1705108;C1710701;C0011849,false;false;false;false;true,14117/22402
diabetesc,,,14118/22402
diabetese,,,14119/22402
diabetesh yes,C1549445;C1705108;C1710701,false;false;false,14120/22402
diabetesz,,,14121/22402
diabetic ( no ),C0241863,false,14122/22402
diabetic ( yes ),C0241863;C1549445;C1705108;C1710701,false;false;false;false,14123/22402
diabetic eye disease,C0342245,false,14124/22402
diabetic participants,C0241863;C0679646,false;false,14125/22402
diabetic participants !,C0241863;C0679646,false;false,14126/22402
diabetic status  n ( % ),C0241863;C0449438,false;false,14127/22402
diabetic subjects  n = $nmbr$,C0241863;C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false,14128/22402
diabetic therapy use  n ( % ) * no therapy,C0241863;C0039798;C0042153;C0457083;C1947944;C0087111;C1363945,false;true;true;false;false;true;false,14129/22402
diabetic  n ( % ),C0241863,false,14130/22402
diabetics - no ( n = $nmbr$  $nmbr$ ),C0241863,false,14131/22402
diabetics - yes ( n = $nmbr$  $nmbr$ ),C0241863;C1549445;C1705108;C1710701,false;false;false;false,14132/22402
diabetics ( n = $nmbr$ ),C0241863,false,14133/22402
diabetics • no ( n = $nmbr$  $nmbr$ ),C0241863,false,14134/22402
diagnoses / risk factors  n ( % ],C0011900;C0035648;C1553898,true;true;false,14135/22402
diagnosis — yr,C0011900;C0439234;C1704338;C1704656,true;false;true;false,14136/22402
diagnosis ( years ),C0011900;C0439234;C1704338;C1704656,true;false;true;false,14137/22402
diagnosis at study entry — no . ( % ),C1704656;C1705654;C4068481,false;false;false,14138/22402
diagnosis of diabetes  n ( % ),C0011900;C0011847;C0011849;C1704338;C1704656,true;false;true;true;false,14139/22402
diagnosis of hefh  n ( % ),C0011900;C1704338;C1704656,true;true;false,14140/22402
diagnostic catheterization,C0596429,false,14141/22402
diarrhoea,C0011991;C1963091;C3641756;C4084784;C4084802;C4085317,true;false;false;false;false;false,14142/22402
diary variables  mean ( sd ),C0376660;C0439828;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,14143/22402
diastoiic biood pressure  mm hg,C0033095;C0439475;C0460139;C1306345;C4284008,true;false;false;false;false,14144/22402
diastolic blood pressure > $nmbr$ mm hg,C0428883;C0439475;C1305849,true;false;false,14145/22402
diastolic blood pressure mmhg  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,14146/22402
diastolic blood pressure  ( mm hg ),C0428883;C0439475;C1305849,true;false;false,14147/22402
diastolic blood pressure  mm hg ( sd ),C0428883;C0439475;C2699239;C1305849,true;false;false;false,14148/22402
diastolic blood pressure  mm hg ^,C0428883;C0439475;C1305849,true;false;false,14149/22402
diastolic blood pressure  mm hq,C0428883;C4330985;C4554674;C1305849,true;false;false;false,14150/22402
diastolic blood pressure  mm   hg,C0428883;C0439475;C1305849,true;false;false,14151/22402
diastolic blood pressure  mmhg  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C1305849;C0012000;C0428886,true;false;false;false;false;false;false;true;true,14152/22402
diastolic blood pressure  and lp ( a ),C0428883;C1305849,true;false,14153/22402
diastolic bp,C0428883,true,14154/22402
diastolic bp ( mmhg ) *,C0428883;C0439475,true;false,14155/22402
diastolic bp  mm hg  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C0012000;C0488053,true;false;false;false;false;false;true;false,14156/22402
diastolic bp  mm   hg  mean ( sd ),C0428883;C0439475;C0444504;C2699239;C2347634;C2348143;C0012000;C0488053,true;false;false;false;false;false;true;false,14157/22402
diastolic bp  mmhg,C0428883;C0439475,true;false,14158/22402
diastolic pressure  mm hg,C0428883;C0439475,true;false,14159/22402
diastolic  mean ( sd )  mm hg,C0012000;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,14160/22402
diastolic  total,C0012000;C0439175;C0439810,true;false;false,14161/22402
diastolic  treated at baseline,C0012000,true,14162/22402
diclofenac ( n = $nmbr$ ),C0012091,true,14163/22402
diclofenac $nmbr$ mg ( n = $nmbr$ ) n ( % ),C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14164/22402
diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . n . . . ( . % . . ) . . . . . . . . . . .,C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14165/22402
diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . ( . % . . ) . . . . . . . . . . .,C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14166/22402
diclofenac $nmbr$ mg  n = $nmbr$  n ( % ),C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14167/22402
diclofenac group ( n = $nmbr$ $nmbr$ ),C0012091;C0441848,true;false,14168/22402
did not enrol into osler,,,14169/22402
did not meet atopy and ige $nmbr$ - $nmbr$ ku / lcriteriaa ( n = $nmbr$  $nmbr$ ),,,14170/22402
diet - controlled ( % ),C0743195,false,14171/22402
diet - i - pravastatin ( n = $nmbr$ ),C0012155;C0021966;C0085542;C0221138;C0012159;C1519433;C2983588;C3668949,true;true;true;false;true;false;false;false,14172/22402
diet diet + pravastatin event / patients ( $nmbr$ ooo / pt - y ),C0012155;C0085542;C0441471;C0030705;C0032743;C0699718;C4019010;C0012159;C1519433;C2983588;C3668949,true;true;false;true;true;false;false;true;false;false;false,14173/22402
diet ( n = $nmbr$ ),C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,14174/22402
diet $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ),C0012155;C0012159;C1519433;C2983588;C3668949,true;true;false;false;false,14175/22402
diet group,C0012155;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0012159;C1519433;C2983588;C3668949,true;false;false;true;false;false;false;true;false;false;false,14176/22402
diet + pravastatin $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ),C0012155;C0085542;C0012159;C1519433;C2983588;C3668949,true;true;true;false;false;false,14177/22402
dietary calcium intake  mean ( sd )  mg / d,C0489458;C0444504;C2699239;C0439422;C2347634;C2348143,false;false;false;false;false;false,14178/22402
diff_measure,,,14179/22402
diff_measure ( dm added this as table had multiple headings ),C0079809;C0011816;C3250443;C0242485,true;true;false;false,14180/22402
difference ( $nmbr$ % ci  p value ),C1705241;C0008107;C1709380;C3259781;C1705242,false;true;false;false;false,14181/22402
difference ( glargine - standard care ) lsm ± se ( mm / year ),C1705241;C0907402;C1442989;C1947933;C0036919;C4330985;C0439234;C0439508;C4554674;C2828392;C1705242,false;true;false;false;true;false;false;false;false;false;false,14182/22402
difference ( n - $nmbr$ fa - placebo ) lsm ± se ( mm / year ),C1705241;C0032042;C0036919;C4330985;C0439234;C0439508;C4554674;C1696465;C1706408;C1705242,false;true;true;false;false;false;false;false;false;false,14183/22402
difference $nmbr$ years - baseline,C1705241;C0439234;C0168634;C1442488;C1705242,false;false;true;false;false,14184/22402
difference $nmbr$ years - baseline *,C1705241;C0439234;C0168634;C1442488;C1705242,false;false;true;false;false,14185/22402
difference ff / vi versus uc  %,C1705241;C4554348;C0205999;C1705242,false;false;true;false,14186/22402
difference from placebo ( $nmbr$ % cl ),C1705241;C0032042;C0596019;C1696465;C1706408;C1705242,false;true;false;false;false;false,14187/22402
difference in ls mean vs placebo ( $nmbr$ % ci )  %,C1705241;C0023668;C0444504;C2347634;C2348143;C1705242,false;true;false;false;false;false,14188/22402
difference in ls mean vs placebo ( $nmbr$ % ci )  mmol / mol,C1705241;C0023668;C0444504;C2347634;C2348143;C1705242,false;true;false;false;false;false,14189/22402
difference in ls means ( $nmbr$ % ci ),C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,14190/22402
difference in ls means ( $nmbr$ % ci ) versus placebo,C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,14191/22402
difference in ls means ( $nmbr$ % ci ) a,C1705241;C0023668;C1704970;C0008107;C3259781;C1705242,false;true;false;true;false;false,14192/22402
difference in means,C1705241;C1704970;C1705242,false;false;false,14193/22402
difference in means ( $nmbr$ % cl ),C1705241;C1704970;C0596019;C1705242,false;false;false;false,14194/22402
difference in sbp between treatment,C1705241;C0085805;C1705242,false;true;false,14195/22402
difference mepo - pbo ( $nmbr$ % ci ),C1705241;C0031962;C0008107;C3259781;C1705242,false;true;true;false;false,14196/22402
difference vs ff $nmbr$ pg ( $nmbr$ % ci ),C1705241;C1705242,false;false,14197/22402
difference vs pbo,C1705241;C1705242,false;false,14198/22402
difference vs pbo ( $nmbr$ % ci ),C1705241;C1705242,false;false,14199/22402
difference vs placebo ( $nmbr$ % ci ),C1705241;C1705242,false;false,14200/22402
difference vs . placebo  % ( $nmbr$ % cl ),C1705241;C1705242,false;false,14201/22402
difference vs . placebo  kg ( $nmbr$ % cl ),C1705241;C1705242,false;false,14202/22402
differences between indacaterol + tiotropium versus tiotropium + placebo,C1705241;C1722260;C0213771;C1705242,false;true;true;false,14203/22402
differencevs . pbof,,,14204/22402
diffusion capacity of the lung for carbon monoxide  % predicted !,C0231971,false,14205/22402
digoxin n ( % ),C0012265,true,14206/22402
digoxin n = $nmbr$ ( $nmbr$ % ),C0012265,true,14207/22402
digoxin or digitalis glycoside,C0012265,true,14208/22402
digoxin or digitalis preparation,C0012265,true,14209/22402
digoxin or digitalis preparations,C0012265,true,14210/22402
digoxin scd  no . ( % / y ),C0012265,true,14211/22402
digoxin  %,C0012265,true,14212/22402
digoxin  % ( n ),C0012265,true,14213/22402
dihydropyridine ccbs,C0012315;C0006684;C0220821,true;true;true,14214/22402
dip joint arthritis,C0932510;C0003864;C4552845,false;true;false,14215/22402
dipeptidyl peptidase $nmbr$ inhibitor,C0003015;C2757044;C3536837,true;false;false,14216/22402
dipeptidyl peptidase $nmbr$ inhibitors,C0003015,true,14217/22402
dipyridamole alone,C0012582,true,14218/22402
direct stenting per lesion ‡,C0439851;C0038257;C0221198;C1546698;C2348535;C1947931,false;true;false;false;false;false,14219/22402
direction of hr,C0449738,false,14220/22402
disabling or fatal,,,14221/22402
disabling or fatal stroke,,,14222/22402
disabling stroke,C0038454;C4554100,true;false,14223/22402
discontinu - ation,,,14224/22402
discontinuation of ics / laba prior to baseline  n ( % ),C0457454;C0815320;C4551720;C1444662;C4552847,false;false;true;false;false,14225/22402
discontinuation of lama prior to baseline  n ( % ),C0457454;C0999593;C1416775;C1444662;C4552847,false;false;false;false;false,14226/22402
disease activity ( n ( % ) ),C1292728,false,14227/22402
disease and quality - of - life scores  mean ( sd ),C0012634,true,14228/22402
disease characteristics duration of psoriatic arthritis — yr,C0872146;C1521970;C0003872;C0439234;C0599878;C0449238;C2926735,false;false;true;false;false;false;false,14229/22402
disease characteristics  n ( % )  unless otherwise stated,C0599878,false,14230/22402
disease duration,C0872146,false,14231/22402
disease duration ( y )  median ( m / n  max ),C0872146;C0549183;C0369637;C0441923;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,14232/22402
disease duration ( years )  mean ± s . d .,C0872146;C0439234;C0444504;C2347634;C2348143,false;false;false;false;false,14233/22402
disease duration [ year ]  mean ± sda,C0872146;C0439234;C0444504;C0276477;C1428349;C1553165;C2347634;C2348143;C0439508,false;false;false;false;false;false;false;false;false,14234/22402
disease duration > $nmbr$ years  $nmbr$ [ % ] disease activity ‘ s,C1292728;C0449238;C0439234;C2926735;C0872146;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false;false;false;false;false,14235/22402
disease duration  mean [ sd ] years,C0872146;C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false;false,14236/22402
disease duration  y,C0872146,false,14237/22402
disease duration  y  mean ± sd,C0872146;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,14238/22402
disease duration  year ( median ),C0872146;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C0439508,false;false;false;false;false;false;false;false,14239/22402
disease duration  yrs  mean ( sd ),C0872146;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,14240/22402
disease extent  n ( % ),C0012634;C0439792,true;false,14241/22402
disease history,C0683519,false,14242/22402
disease localization ' ’  n ( % ),C0012634;C0475264;C1744691,true;false;false,14243/22402
disease localization  n ( % ),C0012634;C0475264;C1744691,true;false;false,14244/22402
disease severity,C0521117,false,14245/22402
disease site — no . ( % ) ^,C0012634;C0205145;C1515974;C2825164,true;false;false;false,14246/22402
disease site  n [ % ],C0012634;C0205145;C1515974;C2825164,true;false;false;false,14247/22402
disorders ( soc ),C0012634,true,14248/22402
disposition index,C0743223;C0600653;C0918012;C1552854;C1637833;C2986546;C1705555,false;true;true;false;false;false;false,14249/22402
disseminated tuberculosis,C0152915,false,14250/22402
distal,C0205108;C4522154,false;false,14251/22402
distal forearm,C0588203,false,14252/22402
distal lower,C0205108;C0441994;C1548802;C2003888;C4522154,false;false;false;false;false,14253/22402
distance to ldl - c goal,C0012751;C0018017;C1571704,false;true;false,14254/22402
distribution — no . { % ),C0520511;C1704711,false;true,14255/22402
distribution of metformin dose at randomization  n ( % ),C0520511;C0025598;C0178602;C0869039;C1114758;C1704711,false;true;false;false;false;true,14256/22402
diuretic ( any ),C0012798,true,14257/22402
diuretic agents,C0012798;C0450442;C1254351;C1521826,true;false;false;false,14258/22402
diuretic agents ( excluding antialdosterone ),C0012798;C0450442;C1254351;C1521826,true;false;false;false,14259/22402
diuretic n ( % ),C0012798,true,14260/22402
diuretic subgroup,C0012798;C1079230;C1515021,true;false;false,14261/22402
diuretic therapy,C0948575,false,14262/22402
diuretic use at baseline,C0012798;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,14263/22402
diuretics  %,C0012798,true,14264/22402
diuretics ^,C0012798,true,14265/22402
diureties,,,14266/22402
dlqi,C3899393,false,14267/22402
dlqi ( $nmbr$ - $nmbr$ )  mean ( sd ),C3899393;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,14268/22402
dlqi ( patients with £ $nmbr$ % bsa psoriasis ),C3899393;C0030705;C0033860,false;true;true,14269/22402
dlqi improvement from baseline to week $nmbr$,C3899393;C2986411;C0168634;C1442488,false;false;true;false,14270/22402
dlqi score,C3899393,false,14271/22402
dlqi §,C3899393,false,14272/22402
dm ( n = $nmbr$  $nmbr$ ),C0011816;C3250443,true;false,14273/22402
dm duration,C0011816;C0449238;C2926735;C3250443,true;false;false;false,14274/22402
dm duration  years,C0011816;C0449238;C0439234;C2926735;C3250443,true;false;false;false;false,14275/22402
dm or ckd *,C0011816;C3250443,true;false,14276/22402
dm or diabetic complications,C0011816;C3250443,true;false,14277/22402
dm  n ( % ),C0011816;C3250443,true;false,14278/22402
dmab ( n = $nmbr$ ),C0012411,true,14279/22402
dmard − ( n   =   $nmbr$ ),C0242708,true,14280/22402
dmard - biologic ir,C0242708;C0005515;C0022065;C0022071;C1448132;C0205460,true;true;true;true;true;false,14281/22402
dmard - ir,C0242708;C0022065;C0022071;C1448132,true;true;true;true,14282/22402
dmard - ir / anti - tnf - ir,C0242708;C0022065;C1448177;C0022071;C1448132,true;true;true;true;true,14283/22402
dmard at baseline,C0242708;C0168634;C1442488,true;true;false,14284/22402
dmard + ( n   =   $nmbr$ ),C0242708,true,14285/22402
documented hypoglycaemiac,C1301725;C1609436,false;false,14286/22402
documented mi,C1301725;C3810814;C1609436,false;false;false,14287/22402
door - to - balloon time — hr,C4296144,false,14288/22402
dopa and dopa derivativese,C0013023,true,14289/22402
dopamine agonist use  no . ( % ),C0178601;C3536925,true;false,14290/22402
dose ( iu ),C0178602;C0049272;C0439453;C0694756;C0869039;C1114758,false;true;false;false;false;false,14291/22402
dose ( mg / day ),C0178602;C0439422;C0869039;C1114758,false;false;false;false,14292/22402
dose ( mg / week ),C0178602;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,false;true;false;false;true;false;false;false;false;false;false;false,14293/22402
dose adjusted,C0178602;C0869039;C1114758,false;false;false,14294/22402
dose adjustment n ( % ),C2826232,false,14295/22402
dose adjustment reason < $nmbr$ kg,C2826286;C0022718;C0439209;C4054209,false;true;false;false,14296/22402
dose equivalent  mg ( sd ) ),C0178602;C0205163;C0024671;C2699239;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439185;C0869039;C1114758,false;false;true;false;true;false;false;false;false;false;false;false;false,14297/22402
dose ratio at week $nmbr$ ( $nmbr$ % cl ),C0178602;C0456603;C0332174;C0596019;C0439230;C1547037;C0869039;C1114758,false;false;false;false;false;false;false;false,14298/22402
dose reduced at randomization *,C0178602;C0869039;C1114758,false;false;false,14299/22402
dose reduction at randomization,C0178602;C0301630;C0034656;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;true;false;false;false;false;false,14300/22402
dose reduction at randomization — no . ( % )  i,C0178602;C0301630;C0034656;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;true;false;false;false;false;false,14301/22402
dose reduction at randomization  %,C0178602;C0301630;C0034656;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;true;false;false;false;false;false,14302/22402
dose reduction  n ( % ),C0178602;C0301630;C0392756;C1293152;C4551656;C0869039;C1114758,false;false;false;false;false;false;false,14303/22402
dose  mg,C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,false;true;true;false;false;false;false;false;false;false,14304/22402
dose / weight ( iu / kg ),C0178602;C0005910;C0439463;C0043100;C1305866;C1705104;C0869039;C1114758,false;true;false;true;false;false;false;false,14305/22402
dosing,,,14306/22402
double - dummy phase * *,C4684647;C0205390;C1710475,false;false;false,14307/22402
doubling of baseline serum creatinine or esrd rr ( ci ) “,C0205173;C0168634;C0201976;C0600061;C1442488;C1705764,false;true;false;false;false;false,14308/22402
doubling of creatinine,C0205173;C0010294;C1561535;C1705764,false;true;false;false,14309/22402
doubling of creatinine level,C0205173;C0428279;C1705764,false;false;false,14310/22402
doubling statin dose,C0205173;C0360714;C0178602;C0869039;C1114758;C1705764,false;true;false;false;false;false,14311/22402
doxazosin,C0114873,true,14312/22402
doxazosin group,C0114873;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,14313/22402
dpp - $nmbr$,C1414174,false,14314/22402
dpp ‐ $nmbr$ inhibitors,C1414174;C0243077,false;true,14315/22402
draining fistulae  n ( % ),C0544791,false,14316/22402
drinker ( $nmbr$ - $nmbr$ drinks / week ),C0556338,false,14317/22402
drinker ( $nmbr$ to $nmbr$ drinks / week ),C0556338;C0452428;C0332174;C0439230,false;false;false;false,14318/22402
drinker  n ( % ),C0556338,false,14319/22402
drinking,C0001948;C0684271,true;true,14320/22402
drinking  n ( % ) lipid values  mmol / l,C0001948;C0023779;C0042295;C1532563;C0684271,true;true;false;false;true,14321/22402
dronedarone,C0766326,true,14322/22402
dronedarone ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C0766326,true,14323/22402
drosuvastatin + fenofibric acid vs . fenofibric acid monotherapy .,C0060179,true,14324/22402
drug - related saes,C0013227;C0439849;C1519255;C1622657;C4553214;C0445223;C1254351,true;false;false;false;false;false;false,14325/22402
drug - related teaes,C0013227;C0439849;C0445223;C1254351,true;false;false;false,14326/22402
drug ‐ relateda,C0013227;C1254351,true;false,14327/22402
drug - relateda,C0013227;C1254351,true;false,14328/22402
drug and insulint,C0013227;C1254351,true;false,14329/22402
drug naive,C0013227;C1254351,true;false,14330/22402
drug therapy,C0013216;C0013217,true;true,14331/22402
drug therapy at admission — no . ( % ) aspirin,C0013216;C0184666;C0809949;C0013217,true;false;false;true,14332/22402
drug therapy  n ( % ),C0013216;C0013217,true;true,14333/22402
drug therapy  no . ( % ),C0013216;C0013217,true;true,14334/22402
drugs and toxins,C0013227;C3687832,true;false,14335/22402
dual antiplatelet therapy,C0205173;C1096021;C1554184,false;false;false,14336/22402
dual bp / ldl - c goal attainment,C0205173;C0037623;C0680230;C1415692;C1708288;C4318478;C1554184,false;true;false;false;false;false;false,14337/22402
dual i extension,C0205173;C0021966;C0231448;C1880641;C0221138;C1554184,false;true;false;false;false;false,14338/22402
dual ii,C0205173;C1710602;C4082587;C1554184,false;false;false;false,14339/22402
dual iv,C0205173;C0022326;C4265176;C1554184,false;true;false;false,14340/22402
due to ae,C3887670,false,14341/22402
due to drug - relateda ae,C0013227;C3887670;C1254351,true;false;false,14342/22402
due to drug - relateda sae,C0013227;C1519255;C1622657;C4553214;C1254351,true;false;false;false;false,14343/22402
due to ecg changes,C1623258,true,14344/22402
due to sae,C1519255;C1622657;C4553214,false;false;false,14345/22402
due worsening angina,C0678226;C0002965;C3146286,false;true;false,14346/22402
dulaglutide $nmbr$ . $nmbr$ mg,C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14347/22402
dulaglutide $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14348/22402
dulaglutide $nmbr$ . $nmbr$ mgf,C3179549;C1366394;C3712803;C3887684,true;true;true;false,14349/22402
dulaglutide $nmbr$ · $nmbr$ mg ( n = $nmbr$ ),C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14350/22402
dulaglutide $nmbr$ . $nmbr$ mg *,C3179549;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14351/22402
dupiiumab  $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14352/22402
dupilumab $nmbr$,C3660996,true,14353/22402
durable clinical remissionh,C0205210,false,14354/22402
durable clinical responseg,C0205210,false,14355/22402
duration,C0449238;C2926735,false;false,14356/22402
duration — yr,C0449238;C0439234;C2926735,false;false;false,14357/22402
duration < $nmbr$ year  n ( % ),C0449238;C0439234;C0439508;C2926735,false;false;false;false,14358/22402
duration > $nmbr$ to < $nmbr$ years  n ( % ),C0449238;C0439234;C2926735,false;false;false,14359/22402
duration > $nmbr$ years  n ( % ),C0449238;C0439234;C2926735,false;false;false,14360/22402
duration alendronate use  years ( meanisd ),C0449238;C0102118;C0042153;C0439234;C0457083;C1947944;C2926735,false;true;true;false;false;false;false,14361/22402
duration antiplatelet use as % of study duration ( sd ),C1881378;C0557651;C2699239;C2603343;C2826775,false;false;false;false;false,14362/22402
duration dm in dm ( years ),C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,14363/22402
duration of alendronate use  mean ( sd )  y,C1881378;C0102118;C0444504;C2699239;C2347634;C2348143;C2826775,false;true;false;false;false;false;false,14364/22402
duration of as  n ( % ),C0449238;C2926735,false;false,14365/22402
duration of as  years,C0449238;C2926735,false;false,14366/22402
duration of asthma — yr,C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,14367/22402
duration of asthma ( years ),C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,14368/22402
duration of asthma > $nmbr$ years,C0449238;C0004096;C0439234;C2984299;C2926735,false;true;false;false;false,14369/22402
duration of asthma,C0449238;C0004096;C2984299;C2926735,false;true;false;false,14370/22402
duration of asthma  y,C0449238;C0004096;C2984299;C2926735,false;true;false;false,14371/22402
duration of chf ( months ),C0449238;C0018802;C0439231;C2926735,false;true;false;false,14372/22402
duration of chronic kidney disease * ( years ),C0449238;C0205191;C0022658;C0439234;C2926735,false;false;true;false;false,14373/22402
duration of clopidogrel pretreatment — hr median,C0449238;C0070166;C1550147;C0549183;C0876920;C2347635;C2348144;C2939193;C2709094;C3539075;C3539076;C2926735,false;true;false;false;false;false;false;false;false;false;false;false,14374/22402
duration of copd ( yr ) f,C0449238;C0024117;C0439234;C0016327;C1412502;C3714496;C2926735,false;true;false;true;false;false;false,14375/22402
duration of crohn ’ s disease ( yrs ),C0449238;C0010346;C2926735,false;true;false,14376/22402
duration of current flare  median ( range ) months ( n = $nmbr$  $nmbr$  $nmbr$ ),C0449238;C0521116;C1517205;C0549183;C1514721;C0439231;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C3540542;C1705970;C2926735,false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,14377/22402
duration of diabetes — yr ^,C0449238;C0011847;C0439234;C0011849;C2926735,false;false;false;true;false,14378/22402
duration of diabetes < $nmbr$ yrs,C0449238;C0011847;C0011849;C2926735,false;false;true;false,14379/22402
duration of diabetes ( years )  mean ( sd ),C0449238;C0011847;C0439234;C0444504;C2699239;C2347634;C2348143;C0011849;C2926735,false;false;false;false;false;false;false;true;false,14380/22402
duration of diabetes ( years )  mean  ( sd ),C0449238;C0011847;C0439234;C0444504;C2699239;C2347634;C2348143;C0011849;C2926735,false;false;false;false;false;false;false;true;false,14381/22402
duration of diabetes in years  median ( iqr ),C0449238;C0011847;C0011849;C2926735,false;false;true;false,14382/22402
duration of diabetes mellitus,C0449238;C0011849;C2926735,false;true;false,14383/22402
duration of diabetes mellitus  median ( iqr )  y,C0449238;C0011849;C0549183;C0876920;C2347635;C2348144;C2939193;C2926735,false;true;false;false;false;false;false;false,14384/22402
duration of diabetes mellitus  y  mean ( sd ) §,C0449238;C0011849;C0444504;C2699239;C2347634;C2348143;C2926735,false;true;false;false;false;false;false,14385/22402
duration of diabetes microvascular disease — no . ( % ),C0011847;C0443258;C0872146;C0011849,false;false;false;true,14386/22402
duration of diabetes  y,C0449238;C0011847;C0011849;C2926735,false;false;true;false,14387/22402
duration of diabetes  y  mean ( sd ),C0449238;C0011847;C0444504;C2699239;C2347634;C2348143;C0011849;C2926735,false;false;false;false;false;false;true;false,14388/22402
duration of diabetes  years  mean ( sd ),C0449238;C0011847;C0439234;C0444504;C2699239;C2347634;C2348143;C0011849;C2926735,false;false;false;false;false;false;false;true;false,14389/22402
duration of diabetes  years  median ( iqr ),C0449238;C0011847;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C0011849;C2926735,false;false;false;false;false;false;false;false;true;false,14390/22402
duration of disease — yr ^ mean,C0872146;C0439234;C0444504;C2347634;C2348143,false;false;false;false;false,14391/22402
duration of disease ( y )  median ( min  max },C0872146;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,14392/22402
duration of disease ( years ),C0872146;C0439234,false;false,14393/22402
duration of disease ( yr ),C0872146;C0439234,false;false,14394/22402
duration of disease before baseline,C0872146,false,14395/22402
duration of disease since,C0872146,false,14396/22402
duration of disease  n ( % ),C0872146,false,14397/22402
duration of disease  y,C0872146,false,14398/22402
duration of dm - years,C0449238;C0011816;C0439234;C3250443;C2926735,false;true;false;false;false,14399/22402
duration of epilepsy  mean ( sd )  years,C0449238;C0014544;C0444504;C2699239;C0439234;C2347634;C2348143;C2926735,false;true;false;false;false;false;false;false,14400/22402
duration of epilepsy  years,C0449238;C0014544;C0439234;C2926735,false;true;false;false,14401/22402
duration of heart failure ( years ),C0449238;C0018801;C0439234;C0018802;C4554158;C2926735,false;true;false;true;false;false,14402/22402
duration of hf  y,C0449238;C0018488;C1313497;C1538440;C3273279;C2926735,false;true;true;false;false;false,14403/22402
duration of infusion after pci — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,14404/22402
duration of infusion before cabg — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,14405/22402
duration of infusion before pci — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,14406/22402
duration of infusion during medical management — hr,C0449238;C0574032;C1827465;C2926735,false;false;false;false,14407/22402
duration of macular edema  mo,C0449238;C0024440;C0026544;C0332177;C0271051;C2926735,false;true;true;false;true;false,14408/22402
duration of oral antidiabetic treatment  y  mean ( sd ),C0444921;C0442027;C0935929;C0444504;C2699239;C2347634;C2348143;C4521986,false;false;true;false;false;false;false;false,14409/22402
duration of paod ( years )  mean ± sd,C0449238;C0439234;C0444504;C2699239;C2347634;C2348143;C2926735,false;false;false;false;false;false;false,14410/22402
duration of pci ( min )  median,C0449238;C4049621;C0702093;C0549183;C0876920;C2347635;C2348144;C2939193;C1524029;C3813700;C2926735,false;false;false;false;false;false;false;false;false;false;false,14411/22402
duration of previous use of vka  months,C1881378;C0205156;C0439231;C1552607;C2826775,false;false;false;false;false,14412/22402
duration of prior alendronate use  months,C1881378;C0332152;C0102118;C0439231;C2826257;C2826775,false;false;true;false;false;false,14413/22402
duration of prior statin therapy ^,C0444917;C0332152;C0360714;C2826257,false;false;true;false,14414/22402
duration of procedure,C2346509,false,14415/22402
duration of psoriasis ( years )  mean ( sd ),C0449238;C0033860;C0439234;C0444504;C2699239;C2347634;C2348143;C2926735,false;true;false;false;false;false;false;false,14416/22402
duration of qualifying atrial fibrillation » $nmbr$ days — no . ( % ),C0449238;C1514624;C0004238;C0439228;C0344434;C1963067;C2926735,false;false;true;false;false;false;false,14417/22402
duration of ra,C0449238;C3538806;C4048756;C2926735,false;false;false;false,14418/22402
duration of ra  mean ± sd years,C0449238;C3538806;C0444504;C2699239;C0439234;C2347634;C2348143;C4048756;C2926735,false;false;false;false;false;false;false;false;false,14419/22402
duration of rat  years,C0449238;C0034693;C0439234;C0034721;C2926735,false;true;false;true;false,14420/22402
duration of study - drug administration — hr,C2348354;C0013175,false;true,14421/22402
duration of sulphonylurea use ( months )  mean ± s . d .,C1881378;C0038766;C0439231;C0444504;C2347634;C2348143;C3536898;C2826775,false;true;false;false;false;false;false;false,14422/22402
duration of symptoms > $nmbr$ min,C0436359;C0702093;C1524029;C3813700,false;false;false;false,14423/22402
duration of t $nmbr$ d  y,C0449238;C2926735,false;false,14424/22402
duration of total exposure to study treatment  weeks,C0439175;C2826870;C0439810,false;false;false,14425/22402
duration of treatment in the healing study  n,C0444921,false,14426/22402
duration of type $nmbr$ diabetes,C0449238;C1320657;C2926735,false;false;false,14427/22402
duration of type $nmbr$ diabetes categories  n ( % ),C1547660;C1320657,false;false,14428/22402
duration of type $nmbr$ diabetes mellitus  years,C0449238;C1320657;C0439234;C2926735,false;false;false;false,14429/22402
duration of type $nmbr$ diabetes  years,C0449238;C1320657;C0439234;C2926735,false;false;false;false,14430/22402
duration since diagnosis ( years ),C0449238;C2926735,false;false,14431/22402
during overall study period,C0282416;C0557651;C0439531;C1948053;C2603343;C1561607,true;false;false;false;false;false,14432/22402
dutasteride,C0754659,true,14433/22402
dutasteride ( n = $nmbr$ ),C0754659,true,14434/22402
dutasteride ( w = $nmbr$ )  $nmbr$ / $nmbr$,C0754659,true,14435/22402
dynamic measure of β - cell function ( ϕ s ) ( change from baseline ) – assessed for mmtt subset only,C0729333;C0079809;C0007613;C0392747;C0443172;C1705241;C4319952;C0242485,false;true;true;false;false;false;false;false,14436/22402
dysfunction  ef = erectile function  iief = i,C0031847;C0030847;C0031843;C3641331;C0021966;C0221138;C0542341;C0700205;C1705273;C0277785;C3887504;C3887505,true;true;true;false;true;false;false;false;false;false;false;false,14437/22402
dysglycaemia or mets,C1960636,false,14438/22402
dysglycemic categories  n ( % ),C1960636;C0683312,false;false,14439/22402
dyslipidaemia — no . ( % ),C0242339,true,14440/22402
dyslipidaemia including hypercholesterol — no . ( % ),C0242339,true,14441/22402
dyslipidaemiaj,,,14442/22402
dyslipidemia — no . { % ),C0242339,true,14443/22402
dyspnea,C0013404;C1963100,true;false,14444/22402
dyspnea – mmrc grade  n ( % ),C0013404;C3826977;C0441800;C0919553;C3244287;C1963100,true;false;false;false;false;false,14445/22402
dyspnea t,C0013404;C1963100,true;false,14446/22402
dyspnea  % ( frequent / continuous ),C0013404;C0332183;C0549178;C1963100,true;false;false;false,14447/22402
dyspnea  frequent / continuous,C0013404;C0332183;C0549178;C1963100,true;false;false;false,14448/22402
dyspnoea ( n = $nmbr$ ),C0013404;C1963100,true;false,14449/22402
e - rs total scoreb,C0035970;C0439175;C0439810;C3714753;C3813325,true;false;false;false;false,14450/22402
e ( characteristic n,C1521970,false,14451/22402
e europe,C0015176,true,14452/22402
e major non - vertebral fragility fractures ( fas ),C0205082;C1518422;C0549207;C0302113;C0205164;C4318856;C4521762,false;false;true;false;false;false;false,14453/22402
e / a ratio,C0456603;C1547037,false;false,14454/22402
e / e ' ( septal ),,,14455/22402
e $nmbr$ + a $nmbr$,,,14456/22402
e $nmbr$ ( n = $nmbr$ ),,,14457/22402
e $nmbr$ / s $nmbr$ ( n = $nmbr$ ),C3846405,false,14458/22402
e $nmbr$ / s $nmbr$ vs e $nmbr$,C3846405,false,14459/22402
e $nmbr$ / s $nmbr$ vs s $nmbr$,C3846405,false,14460/22402
eacit - e total score ) |,C2964552,false,14461/22402
early,C1279919,false,14462/22402
early - eptifibatide group ( n = $nmbr$ ),C1279919;C0253563;C0441848,false;true;false,14463/22402
early clopidogrel intended,C1279919;C0070166,false;true,14464/22402
early crohn ' s disease *,C1279919;C0010346,false;true,14465/22402
early death,C1836407,false,14466/22402
early eptifibatide,C1279919;C0253563,false;true,14467/22402
early ichaem ic stroke,C1279919;C0020750;C0038454;C4554100;C4554818,false;true;true;false;false,14468/22402
early invasive strategy ( n = $nmbr$  $nmbr$ ),C1279919;C0205281;C0679199;C1334278,false;false;false;false,14469/22402
early invasive *,C1279919;C0205281;C1334278,false;false;false,14470/22402
early invasive $nmbr$,C1279919;C0205281;C1334278,false;false;false,14471/22402
early load,C1279919,false,14472/22402
early routine,C1279919;C0205547,false;false,14473/22402
early use intended,C1279919,false,14474/22402
early  n ( % ),C1279919,false,14475/22402
ease - $nmbr$,C1331418,false,14476/22402
east asia,C0015631,true,14477/22402
east asian,C1707877;C0078988,false;true,14478/22402
eastern and central europe,C1707877,false,14479/22402
eastern europe ( n   = $nmbr$  $nmbr$ ),C0015177,true,14480/22402
eastern europe and africa,C0015177,true,14481/22402
eastern europe  africa,C0001741;C0015176;C0015177;C0001737,true;true;true;true,14482/22402
ecfr ( ml / min per $nmbr$ - $nmbr$ m ’ ),C0439445;C0369637;C0441923,false;false;false,14483/22402
ecfr  ml / min per $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,14484/22402
ecg - lvh ( cornell ),C0232306,false,14485/22402
ecg - lvh ( sokolow - lyon ),C0232306,false,14486/22402
ecg abnormality at entry,C0522055;C1705654,false;false,14487/22402
ecg and imaging data,C1623258,true,14488/22402
ecg at time of qualifying symptoms,C1623258;C0040223;C1514624;C0683368;C1457887;C3541383,true;true;false;true;false;false,14489/22402
ecg atrial fibrillation  n ( % ),C1623258;C0004238;C0344434;C1963067,true;true;false;false,14490/22402
ecg changes ( % ) t,C1623258,true,14491/22402
ecg left ventricular,C1623258,true,14492/22402
eczema,C0013595;C4553957,true;false,14493/22402
ed > $nmbr$ yr  no . ( % ),C3538926;C0439234,false;false,14494/22402
ed characteristics,C3538926;C1521970,false;false,14495/22402
ed duration,C3538926;C0449238;C2926735,false;false;false,14496/22402
ed duration > $nmbr$ yr  n ( % ),C3538926;C0449238;C0439234;C2926735,false;false;false;false,14497/22402
ed duration  visit $nmbr$ * *,C3538926;C0449238;C0545082;C1512346;C2826704;C2926735,false;false;false;false;false;false,14498/22402
ed etiology  no . ( % ),C3538926;C0015127;C1314792;C1524003,false;true;true;false,14499/22402
ed history  n ( % yes ),C3538926;C0019664;C1549445;C1705108;C1710701;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;false;false;false;true;false;false;false;false,14500/22402
ed severity * *  n ( % ) :,C3538926;C0439793;C0522510,false;false;false,14501/22402
ed severity  no . ( % ) a,C3538926;C0439793;C0522510,false;false;false,14502/22402
ed severity  visit $nmbr$ * *,C3538926;C0439793;C0545082;C1512346;C2826704;C0522510,false;false;false;false;false;false,14503/22402
ed therapy,C3538926;C0039798;C0087111;C1363945,false;true;true;false,14504/22402
ed visit related to exacerbation  n ( % ),C3538926;C0545082;C1512346;C2826704,false;false;false;false,14505/22402
eda  %,C0162359;C1539327;C3539920;C3887494,true;false;false;false,14506/22402
edema peripheral,C0013604;C1717255,true;false,14507/22402
edema  % z,C0013604;C1717255,true;false,14508/22402
edema  n ( % ),C0013604;C1717255,true;false,14509/22402
edo,,,14510/22402
edoxaban,C2975435,true,14511/22402
edoxaban ( n = $nmbr$ ),C2975435,true,14512/22402
edoxaban at randomization  n ( % ),C2975435;C0034656,true;true,14513/22402
edoxaban dose adjusted at randomisation  n ( % ) *,C2975435;C0178602;C0869039;C1114758,true;false;false;false,14514/22402
edoxaban higher dose vs warfarin,C2975435;C0444956,true;false,14515/22402
edoxaban lower dose vs warfarin,C2975435,true,14516/22402
edoxaban n = $nmbr$,C2975435,true,14517/22402
edoxaban n = $nmbr$ n / n ( % ),C2975435,true,14518/22402
edoxaban n / n  rate ( % ),C2975435;C0871208;C1521828,true;false;false,14519/22402
edoxaban vs . warfarin,C2975435,true,14520/22402
edoxaban warfarin,C2975435;C0043031,true;true,14521/22402
edss stratification . no . ( % ),C0451246;C1514983;C3887783,false;false;false,14522/22402
educ > $nmbr$ y,,,14523/22402
educ $nmbr$ - $nmbr$ y,,,14524/22402
educ ssy,,,14525/22402
education,C0013621;C0013622;C0013658;C0039401,true;true;true;true,14526/22402
education — no . ( % ),C0013621;C0013622;C0013658;C0039401,true;true;true;true,14527/22402
education ( % ),C0013621;C0013622;C0013658;C0039401,true;true;true;true,14528/22402
education ( years ),C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,14529/22402
education < $nmbr$ y,C0013621;C0013622;C0013658;C0039401,true;true;true;true,14530/22402
education > $nmbr$ y,C0013621;C0013622;C0013658;C0039401,true;true;true;true,14531/22402
education > $nmbr$ yr ( % ),C0013621;C0439234;C0013622;C0013658;C0039401,true;false;true;true;true,14532/22402
education $nmbr$ to $nmbr$ y,C0013621;C0013622;C0013658;C0039401,true;true;true;true,14533/22402
education in years  mean,C0013621;C0439234;C0444504;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;true;true;true,14534/22402
education in years  mean ( sd ),C0013621;C0439234;C0444504;C2699239;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;false;true;true;true,14535/22402
education level,C0013621;C0013658,true;true,14536/22402
education  mean ( sd ) years,C0013621;C0444504;C2699239;C0439234;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;false;true;true;true,14537/22402
education  mean ( sd )  y,C0013621;C0444504;C2699239;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;true;true;true,14538/22402
education  mean ( sd )  ya,C0013621;C0444504;C2699239;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;true;true;true,14539/22402
education  y,C0013621;C0013622;C0013658;C0039401,true;true;true;true,14540/22402
education  y  mean ( sd ),C0013621;C0444504;C2699239;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;true;true;true,14541/22402
education  years  mean ( sd ),C0013621;C0439234;C0444504;C2699239;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;false;true;true;true,14542/22402
education  yrs  mean ( sd ),C0013621;C0444504;C2699239;C2347634;C2348143;C0013622;C0013658;C0039401,true;false;false;false;false;true;true;true,14543/22402
eduglinozin $nmbr$ mg vs placebo / glimepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14544/22402
ef ( % )  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,14545/22402
ef < $nmbr$ % ( n $nmbr$ $nmbr$ ),,,14546/22402
ef < $nmbr$ % ( n = $nmbr$  $nmbr$ ),,,14547/22402
ef < $nmbr$ % n = $nmbr$,,,14548/22402
ef > $nmbr$ % ( n = $nmbr$  $nmbr$ ),,,14549/22402
ef > $nmbr$ % n = $nmbr$,,,14550/22402
ef > $nmbr$ % ( n $nmbr$ $nmbr$ ),,,14551/22402
ef $nmbr$ - $nmbr$ . $nmbr$ % ( n $nmbr$ $nmbr$ ),,,14552/22402
ef b $nmbr$ %,,,14553/22402
ef domain,C1880389;C1883221;C3541951,false;false;false,14554/22402
effect estimate,C1280500;C0750572;C1518681;C2348382,false;false;false;false,14555/22402
effect of covariates on slopes,C1280500;C1518681;C2348382,false;false;false,14556/22402
effect of ranolazine compared with placebo on angina and recurrent ischemia,C1280500;C0073633;C1518681;C2348382,false;true;false;false,14557/22402
effect size !,C0814843,false,14558/22402
effect size ^,C0814843,false,14559/22402
efficacy end points,C1280519;C2349179;C1707887,false;false;false,14560/22402
efficacy endpoint,C1280519;C2349179;C2826544;C1707887,false;false;false;false,14561/22402
efficacy endpoints *,C1280519;C2349179;C1707887,false;false;false,14562/22402
efficacy measures,C1280519;C1707887,false;false,14563/22402
efficacy parameter,C1280519;C0549193;C1704769;C2350001;C1707887,false;false;false;false;false,14564/22402
efficacy variable,C1280519;C0439828;C4553760;C1707887,false;false;false;false,14565/22402
efficacy    n   ( % ) a,C1280519;C1707887,false;false,14566/22402
egfr — mean ( sd  n ),C1739039;C0444504;C2699239;C2347634;C2348143;C3811844;C3812682,true;false;false;false;false;false;false,14567/22402
egfr — ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14568/22402
egfr — ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14569/22402
egfr ( mdrd )  ml min − $nmbr$ $nmbr$ . $nmbr$   m − $nmbr$,C1739039;C3839656;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,14570/22402
egfr ( mdrd )  ml / min / $nmbr$ . $nmbr$ m * *,C1739039;C3839656;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,14571/22402
egfr ( mdrd )  n ( % ),C1739039;C3839656;C3811844;C3812682,true;false;false;false,14572/22402
egfr ( ml / min per $nmbr$ - $nmbr$ kg / m ^ ),C1739039;C0439402;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14573/22402
egfr ( ml / min per $nmbr$ - $nmbr$ m ^ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14574/22402
egfr ( ml / min per $nmbr$ - $nmbr$ m ’ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14575/22402
egfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14576/22402
egfr ( ml / min per $nmbr$ ^ $nmbr$ m ' ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14577/22402
egfr ( ml / min per $nmbr$ + $nmbr$ m ”,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14578/22402
egfr ( ml / min per $nmbr$ · $nmbr$ m $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14579/22402
egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  mean ( sd ),C1739039;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,14580/22402
egfr  $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14581/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$,C1739039;C0439445;C3811844;C3812682,true;false;false;false,14582/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14583/22402
egfr < $nmbr$ . $nmbr$ ( vs egfr > $nmbr$ ),C1739039;C3811844;C3812682,true;false;false,14584/22402
egfr < $nmbr$ ml / min  n ( % ),C1739039;C0439445;C3811844;C3812682,true;false;false;false,14585/22402
egfr < $nmbr$ ml / min per $nmbr$ ^ $nmbr$ m ',C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14586/22402
egfr < $nmbr$ ml / min per $nmbr$ · $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14587/22402
egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14588/22402
egfr ≥ $nmbr$ ml / min per $nmbr$ · $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14589/22402
egfr ≥ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14590/22402
egfr ≥ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14591/22402
egfr > $nmbr$  n ( % ),C1739039;C3811844;C3812682,true;false;false,14592/22402
egfr > $nmbr$ ml / min per $nmbr$ ^ $nmbr$ m ',C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14593/22402
egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14594/22402
egfr > $nmbr$ ml / min  n ( % ),C1739039;C0439445;C3811844;C3812682,true;false;false;false,14595/22402
egfr $nmbr$ ml / min / $nmbr$ . $nmbr$,C1739039;C0439445;C3811844;C3812682,true;false;false;false,14596/22402
egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$,C1739039;C0439445;C3811844;C3812682,true;false;false;false,14597/22402
egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m *,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14598/22402
egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14599/22402
egfr $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ( vs egfr > $nmbr$ ),C1739039;C3811844;C3812682,true;false;false,14600/22402
egfr $nmbr$ to < $nmbr$ ml / min  n ( % ),C1739039;C0439445;C3811844;C3812682,true;false;false;false,14601/22402
egfr $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14602/22402
egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ’,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14603/22402
egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14604/22402
egfr and albuminuria,C1739039;C3811844;C3812682,true;false;false,14605/22402
egfr by creatinine ( ml / min per $nmbr$ · $nmbr$ m $nmbr$ ),C1739039;C0010294;C0439445;C1561535;C3811844;C3812682,true;true;false;false;false;false,14606/22402
egfr by creatinine ( ml / min per $nmbr$ · $nmbr$ m $nmbr$  geometric mean [ se ] ),C1739039;C0010294;C0439445;C1561535;C3811844;C3812682,true;true;false;false;false;false,14607/22402
egfr by cystatin c ( ml / min per $nmbr$ · $nmbr$ m $nmbr$  geometric mean [ se ] ),C1739039;C0071744;C0439445;C1413772;C3811844;C3812682,true;true;false;false;false;false,14608/22402
egfr by cystatin c ( ml / min per $nmbr$ · $nmbr$ m $nmbr$  mean [ se ] ),C1739039;C0071744;C0439445;C1413772;C3811844;C3812682,true;true;false;false;false;false,14609/22402
egfr category,C1739039;C0683312;C3889287;C3811844;C3812682,true;false;false;false;false,14610/22402
egfr category ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  n ( % ),C1739039;C0683312;C0439445;C0369637;C0441923;C3889287;C3811844;C3812682,true;false;false;false;false;false;false;false,14611/22402
egfr crcl ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$,C1739039;C1846718;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,14612/22402
egfr from the mdrd equation ( sd )  ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$,C1739039;C3839656;C0552449;C2699239;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false,14613/22402
egfr in ml / min / $nmbr$ . $nmbr$ m ^  median ( iqr ),C1739039;C0439445;C0369637;C0549183;C0876920;C2347635;C2348144;C2939193;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false;false,14614/22402
egfr s $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14615/22402
egfr s $nmbr$ o ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14616/22402
egfr   < $nmbr$   ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14617/22402
egfr   ≥ $nmbr$   ml / min / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14618/22402
egfr  mean ± sd,C1739039;C0444504;C2699239;C2347634;C2348143;C3811844;C3812682,true;false;false;false;false;false;false,14619/22402
egfr  ml • mn ' • $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439526;C0026327;C0369637;C0441923;C0026405;C4285072;C1705224;C3887665;C3811844;C3812682,true;false;true;false;false;true;false;false;false;false;false,14620/22402
egfr  ml / kg per $nmbr$ . $nmbr$ m $nmbr$,C1739039;C1300574;C0369637;C0441923;C0439526;C1532718;C1705224;C3887665;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,14621/22402
egfr  ml / min per $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14622/22402
egfr  ml / min per $nmbr$ . $nmbr$ m $nmbr$  mean ( sd ),C1739039;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,14623/22402
egfr  ml / min per $nmbr$ · $nmbr$ m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14624/22402
egfr  ml / min / $nmbr$ . $nmbr$ m ^,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14625/22402
egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mdrd ),C1739039;C0439445;C0369637;C3839656;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,14626/22402
egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mdrd )  mean ( sd ),C1739039;C0439445;C0369637;C3839656;C0444504;C2699239;C2347634;C2348143;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false;false,14627/22402
egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( sd ),C1739039;C0439445;C0369637;C2699239;C0441923;C3811844;C3812682,true;false;false;false;false;false;false,14628/22402
egfr  ml / min / $nmbr$ . $nmbr$   m $nmbr$,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14629/22402
egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  ‡,C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14630/22402
egfr  ml / min / bsa,C1739039;C0439445;C3811844;C3812682,true;false;false;false,14631/22402
egfr  ml / minute / $nmbr$ . $nmbr$ m $nmbr$,C1739039;C0439526;C0439232;C0369637;C0441923;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false;false;false;false,14632/22402
egfr  n ( % ) normal ( egfr > $nmbr$ ml / min / em ^ ),C1739039;C0205307;C0439445;C0231683;C0439166;C2347086;C4553972;C3811844;C3812682,true;false;false;false;false;false;false;false;false,14633/22402
egfr_p_interaction,C1739039;C1704675;C3811844;C3812682,true;false;false;false,14634/22402
egfr +  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mean ± sd ),C1739039;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923;C3811844;C3812682,true;false;false;false;false;false;false;false;false;false,14635/22402
egfr ‡ ( ml / min per $nmbr$ · $nmbr$ m $nmbr$ ),C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,true;false;false;false;false;false,14636/22402
either ocs use  nasal polyps  pre - bd fvc < $nmbr$ % of predicted or age at diagnosis sl $nmbr$ years,C3844638,false,14637/22402
ejection fraction — mean ± sd,C0489482;C0444504;C2699239;C2347634;C2348143;C2700378,false;false;false;false;false;false,14638/22402
ejection fraction ( % ),C0489482;C2700378,false;false,14639/22402
ejection fraction ( mean ),C0489482;C0444504;C2347634;C2348143;C2700378,false;false;false;false;false,14640/22402
ejection fraction group,C0489482;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2700378,false;false;false;true;false;false;false;false,14641/22402
ejection fraction *,C0489482;C2700378,false;false,14642/22402
ejection fraction  %,C0489482;C2700378,false;false,14643/22402
ejection fraction  mean ( sd )  %,C0489482;C0444504;C2699239;C2347634;C2348143;C2700378,false;false;false;false;false;false,14644/22402
el  n ( % ),C1416870;C1447747;C1823249;C3811107;C3811848;C3815598,false;true;false;false;false;false,14645/22402
elderly,C0001792;C1999167,true;false,14646/22402
elderly patients ( n — $nmbr$ ),C0870602,false,14647/22402
elective peripheral revascularization,C0206058;C0205100;C0581603;C0439608,true;false;false;false,14648/22402
elective procedure,C0747973,false,14649/22402
elective surgery,C0206058,true,14650/22402
electrocardiogram,C0013798;C1547122;C1623258,true;false;true,14651/22402
electrocardiograph results  no . ( % ),C0013798;C0180600;C1623258,true;true;true,14652/22402
electrocardiography,C0013798;C1623258,true;true,14653/22402
elevated baseline crp,C0742906;C0168634;C1442488,false;true;false,14654/22402
elevated biomarkers and st - segment changes,C0205250;C0005516;C3163633,false;true;false,14655/22402
elevated bnp,C0205250;C0054015;C1095989;C1417808;C2982014;C3163633,false;true;false;false;false;false,14656/22402
elevated bnp  > $nmbr$ pg / ml ( n = $nmbr$  $nmbr$ ),C0205250;C0054015;C0439297;C1095989;C1417808;C2982014;C3163633,false;true;false;false;false;false;false,14657/22402
elevated cholesterol,C0020443,true,14658/22402
elevated crp  n ( % ),C0742906,false,14659/22402
elevated high - sensitivity crp — no . { % ) * *,C0742906;C1441604,false;false,14660/22402
elevated natriuretic peptide level ( n = $nmbr$ ),C0205250;C1144709;C0441889;C0456079;C1547707;C2946261;C2709270;C3537020;C3163633,false;true;false;false;false;false;false;false;false,14661/22402
elevated natriuretic peptides in previous $nmbr$ days — no . ( % ) $,C0205250;C1144709;C0205156;C0439228;C1552607;C3163633,false;true;false;false;false;false,14662/22402
elevated natriuretic peptides in previous $nmbr$ days — no . ( % ) : ! :,C0205250;C1144709;C0205156;C0439228;C1552607;C3163633,false;true;false;false;false;false,14663/22402
elevated non - hdl cholesterol,C0205250;C0729627;C1535899;C3163633,false;false;false;false,14664/22402
elevated serum creatinine ( > $nmbr$ . $nmbr$ mg / dl_ ),C0700225;C0439269,false;false,14665/22402
elevated serum creatinine  > $nmbr$ . $nmbr$ mg / dl,C0700225;C0439269,false;false,14666/22402
elevated symptomatic serum creatinine  hypotension > $nmbr$ . $nmbr$ mg / dl,C0700225;C0231220;C0020649;C0439269;C3163620,false;false;true;false;false,14667/22402
elevated troponin — %,C0205250;C0041199;C3163633,false;true;false,14668/22402
elevated vs normalb,C0205250;C3163633,false;false,14669/22402
elevated vs . normalb,C0205250;C3163633,false;false,14670/22402
elevated vs . normalc,C0205250;C3163633,false;false,14671/22402
elevation of cardiac biomarker levels — no . / total no . ( % ),C0439775;C1271630;C0441889;C0702240,false;false;false;false,14672/22402
elevation of cardiac biomarker levels or st - seg - ment deviation > $nmbr$ mm — no . / total no . ( % ),C0439775;C1271630;C0441889;C0702240,false;false;false;false,14673/22402
elevation of troponin levels — no . / total no . ( % ),C0439775;C0041199;C0441889;C0702240,false;true;false;false,14674/22402
eligibility risk factors,C0013893;C0035648;C1553898;C1548635,true;true;false;false,14675/22402
eligibility risk factors — n ( % ) :,C0013893;C0035648;C1553898;C1548635,true;true;false;false,14676/22402
eligibility risk factors !,C0013893;C0035648;C1553898;C1548635,true;true;false;false,14677/22402
eligibility risk factors  % t ascvo,C0013893;C0035648;C1553898;C1548635,true;true;false;false,14678/22402
eligibility risk factors  no . ( % ) t,C0013893;C0035648;C1553898;C1548635,true;true;false;false,14679/22402
eligibility risk factors /,C0013893;C0035648;C1553898;C1548635,true;true;false;false,14680/22402
eligibility risk factors :,C0013893;C0035648;C1553898;C1548635,true;true;false;false,14681/22402
eligibility risk factors ’ ),C0013893;C0035648;C1553898;C1548635,true;true;false;false,14682/22402
eligibility risk factorsa,C0013893;C0035647;C4552904;C1548635,true;true;false;false,14683/22402
eligibility strata,C0013893;C1548635,true;false,14684/22402
eligibility stratum,C0013893;C1548635,true;false,14685/22402
elms  n ( % ),C0330531;C2980688,true;false,14686/22402
embolism,C0013922;C1704212,true;true,14687/22402
emotional function,C0013987;C0031843;C0542341;C0700205;C1705273;C0849912,true;true;false;false;false;false,14688/22402
empa,C2699863,false,14689/22402
empagiiflozin $nmbr$ mg,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14690/22402
empaglifiozin $nmbr$ mg ( w = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14691/22402
empaglifiozin $nmbr$ . $nmbr$ mg ( w = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14692/22402
empagliflozin ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C3490348,true,14693/22402
empagliflozin ( n   =   $nmbr$ ),C3490348,true,14694/22402
empagliflozin $nmbr$ mg / day ( n = $nmbr$ ),C3490348;C0439422,true;false,14695/22402
empagliflozin n with event / n,C3490348;C0441471;C4019010,true;false;false,14696/22402
empagliflozin pooled ( n = $nmbr$ ),C3490348;C1709595;C2349200;C4522255,true;false;false;false,14697/22402
empagllflozin,,,14698/22402
empagllflozln,,,14699/22402
emphysema ( itt ) ( n = $nmbr$ ),C0013990;C0034067,true;true,14700/22402
emphysema ( n = $nmbr$ ),C0013990;C0034067,true;true,14701/22402
empty,C1880497,false,14702/22402
end - point ( sd ),C2349179;C2699239;C2826544,false;false;false,14703/22402
end - stage renal disease,C0022661;C2316810,true;false,14704/22402
end of trial,C0444930;C0008976;C2746065,false;true;false,14705/22402
endoscopic disease severity,C0014245;C0521117;C0442418,true;false;false,14706/22402
endoscopy subscore  n ( % ),C0014245,true,14707/22402
endpoint *,C2349179;C2826544,false;false,14708/22402
endpoints,C2349179,false,14709/22402
enox,C3147679,false,14710/22402
enoxaparin ( n = $nmbr$  $nmbr$ ),C0206460,true,14711/22402
enoxaparin $nmbr$ mg ( n = $nmbr$  $nmbr$ ),C0206460;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14712/22402
enoxaparin only,C0206460;C0205171;C1720467,true;false;false,14713/22402
enrolled from re - cover ii study — no . ( % ),C4684790,false,14714/22402
enrolled from re - cover study — no . ( % ),C4684790,false,14715/22402
enrolled in russia or georgia,C4684790;C0035970,false;true,14716/22402
enrolled in the americas,C4684790;C0002454;C0596070,false;true;false,14717/22402
enrolled into osler,C4684790,false,14718/22402
enrollment in lmwh substudy,C1516879;C0019139;C3536766;C1696073;C3888021,false;true;false;false;false,14719/22402
enrollment strata : prior hospitalization,C1516879;C0332152;C0019993;C2826257;C1696073;C3888021,false;false;true;false;false;false,14720/22402
enrollment to randomization,C1516879;C0034656;C1696073;C3888021,false;true;false;false,14721/22402
enrolment through hf,C1516879;C0018488;C1313497;C1538440;C3273279;C1696073;C3888021,false;true;true;false;false;false;false,14722/22402
enrope + sonth afriea,,,14723/22402
entacapone,C0165921,true,14724/22402
enthesitis score ( mases  $nmbr$ - $nmbr$ )  mean ( sd ),C1282952;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,14725/22402
enthesitis score at baseline  median ( iqr ) week $nmbr$,C1282952;C0449820;C0168634;C0549183;C0332174;C0439230;C0876920;C2347635;C2348144;C2939193;C1442488;C4050231,false;false;true;false;false;false;false;false;false;false;false;false,14726/22402
enthesitis score *,C1282952;C0449820;C4050231,false;false;false,14727/22402
enthesitis  % §,C1282952,false,14728/22402
entire evaluable cohort,C0439751;C1516986;C0009247;C0599755;C0444667,false;false;true;false;false,14729/22402
entocort ec ( n = $nmbr$ ),C1170256,false,14730/22402
entry category,C1705654;C0683312;C3889287,false;false;false,14731/22402
entry criteria ( % ),C1705654;C0243161,false;true,14732/22402
entry hip fracture location  n ( % ),C1705654;C3260017,false;false,14733/22402
environmental stimuli,C0450025,false,14734/22402
eo,C0332120,false,14735/22402
eo severity by la classification at baseline ( baseline of the healing study )  n ( % ),C0332120;C0439793;C1881447;C0522510,false;false;false;false,14736/22402
eos count ( cells / pl ),C1623465;C0750480;C0007584;C3897966;C4049765;C0007634;C1705566;C1861303,false;false;true;false;false;true;false;true,14737/22402
eosinoohil count,C0750480;C1705566,false;false,14738/22402
eosinophil counf cells pl ',C0682547;C3897966;C4049765,false;false;false,14739/22402
eosinophil count,C0200638;C0750879,false;false,14740/22402
eosinophil count ( cells / pl )  median ( range ) c,C0200638;C0007584;C3897966;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C4049765;C0007634;C0750879,false;true;false;false;false;false;false;false;false;false;false;false;true;false,14741/22402
eosinophil high,C0014467,true,14742/22402
eosinophil low,C0014467,true,14743/22402
eosinophils,C0014467;C0200638,true;false,14744/22402
eosinophils ( cells / ll ) inclusion criteria  n ( % ),C0682547,false,14745/22402
eosinophils £ $nmbr$ % ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14746/22402
eosinophils £ $nmbr$ % ( n = $nmbr$ ),C0014467;C0200638,true;false,14747/22402
eosinophils < $nmbr$ $nmbr$ x $nmbr$ * $nmbr$ / l ( n = $nmbr$ ),C0014467;C0200638,true;false,14748/22402
eosinophils < $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14749/22402
eosinophils < $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( n = $nmbr$ ),C0014467;C0200638,true;false,14750/22402
eosinophils < $nmbr$ . $nmbr$ x $nmbr$ * $nmbr$ ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14751/22402
eosinophils < $nmbr$ . $nmbr$ x $nmbr$ * $nmbr$ ( n = $nmbr$ ),C0014467;C0200638,true;false,14752/22402
eosinophils < $nmbr$ % ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14753/22402
eosinophils < $nmbr$ % ( n = $nmbr$ ),C0014467;C0200638,true;false,14754/22402
eosinophils > $nmbr$ $nmbr$ x $nmbr$ * $nmbr$ / $nmbr$ ( n = $nmbr$ ),C0014467;C0200638,true;false,14755/22402
eosinophils > $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14756/22402
eosinophils > $nmbr$ . $nmbr$ x $nmbr$ ' ^ ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14757/22402
eosinophils > $nmbr$ . $nmbr$ x $nmbr$ * $nmbr$ ( n = $nmbr$ ),C0014467;C0200638,true;false,14758/22402
eosinophils > $nmbr$ . $nmbr$ x $nmbr$ ^ ^ ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14759/22402
eosinophils > $nmbr$ % ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14760/22402
eosinophils > $nmbr$ % ( n = $nmbr$ ),C0014467;C0200638,true;false,14761/22402
eosinophils $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( n = $nmbr$ ),C0014467;C0200638,true;false,14762/22402
eosinophils $nmbr$ % ( itt ) ( n = $nmbr$ ),C0014467;C0200638,true;false,14763/22402
eosinophils $nmbr$ % ( n - $nmbr$ ),C0014467;C0200638,true;false,14764/22402
epilepsy drug,C0014544;C0013227;C1254351,true;true;false,14765/22402
epilepsy with grand mal seizures on awakening,C0014549;C0494475,true;true,14766/22402
epistaxis,C0014591;C4554627,true;false,14767/22402
eplerenone ( n   = $nmbr$ ),C0961485,true,14768/22402
eq - $nmbr$ d - $nmbr$   l  no pain or discomfortc,C0205163;C0439185,false;false,14769/22402
eq - $nmbr$ d - $nmbr$   l  no pain or discomfortf,C0205163;C0439185,false;false,14770/22402
eq - $nmbr$ d mobility,C0205163;C0080078;C0425245;C0449580;C4318935;C0439185,false;true;false;false;false;false,14771/22402
eq - $nmbr$ dprofile - mobility  n ( % ),C0205163;C0080078;C0425245;C0449580;C4318935;C0439185,false;true;false;false;false;false,14772/22402
eq $nmbr$ da health index status score,C0205163;C0011318;C0018759;C0600653;C0449820;C4050231;C0918012;C1552854;C1637833;C2986546;C3668815;C0439185,false;true;true;true;false;false;true;false;false;false;false;false,14773/22402
er visit,C3810541;C0545082;C1512346;C2826704;C3811131,false;false;false;false;false,14774/22402
era,C1521863;C3495919,true;false,14775/22402
era and pde - $nmbr$ i,C1521863;C3495919,true;false,14776/22402
erd *  n ( % ),,,14777/22402
erectile dysfunction,C0242350;C1961100,true;false,14778/22402
erectile function  ipss,C0030847;C0031843;C1019118;C1998280;C2827405;C3811063;C0542341;C0700205;C1705273,true;true;false;false;false;false;false;false;false,14779/22402
erlugliflozin $nmbr$ mg vs placebo / glimepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14780/22402
erosion score ( $nmbr$ – $nmbr$ scale ),C0333307;C0449820;C0175659;C0349674;C1947916;C4050231;C1880549;C1959609;C3887524,false;false;true;false;false;false;false;false;false,14781/22402
erosion score  mean ± sd,C0333307;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C1880549;C1959609;C3887524,false;false;false;false;false;false;false;false;false;false,14782/22402
erosion  mean ± sd,C0333307;C0444504;C2699239;C2347634;C2348143;C1880549;C1959609;C3887524,false;false;false;false;false;false;false;false,14783/22402
ertuglifldzin $nmbr$ mg vs placebo / glinepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14784/22402
ertugliflozin,C4079805,true,14785/22402
ertugliflozin $nmbr$ mg ( n $nmbr$ $nmbr$ ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14786/22402
ertugliflozin $nmbr$ mg vs placebo / giimepiride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14787/22402
ertugliflozin $nmbr$ mg vs placebo / glimepiride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14788/22402
ertugliflozin $nmbr$ mg vs placebo / glirneplride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14789/22402
ertugliflozin $nmbr$   mg,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14790/22402
ertugliflozin $nmbr$   mg ( n   =   $nmbr$ ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14791/22402
ertugliflozin $nmbr$ mg ( n   =   $nmbr$ ),C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14792/22402
ertugliflozin $nmbr$ mg vs placebo / glinepiride,C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14793/22402
ertuglrflozin $nmbr$ mg vs placebo / glimepiride,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,14794/22402
erysipelas,C0014733,true,14795/22402
erythrocyte sedimentation rate ( mm / h ),C1176468;C0456680;C1619634,false;false;true,14796/22402
esophageal hiatal hernia *,C3489393,true,14797/22402
esr,C3811131,false,14798/22402
esr ( mm / h )  mean ( sd ),C3811131;C0456680;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,14799/22402
esr ( mm / h )  median ( min - max ),C3811131;C3642211;C0033727;C0549183;C0876920;C2347635;C2348144;C2939193;C0369286;C0441932;C0564385;C4528284;C0456680;C0702093;C1524029;C3813700,false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false,14800/22402
esr ( mm / hour ),C3811131;C4330985;C0439227;C0564385;C4554674,false;false;false;false;false,14801/22402
esr ( mm / hour  per unit ),C3811131;C4330985;C0456685;C4554674,false;false;false;false,14802/22402
esr  mean ± sd mg / dl,C3811131;C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false;false,14803/22402
esr  median ( range ) mm / hour,C3811131;C0549183;C1514721;C4330985;C0439227;C0564385;C4554674;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false;false;false,14804/22402
esrd ',C0022661;C0035078;C2316810,true;true;false,14805/22402
esrd only rr ( ci ) “,C0022661;C0205171;C4554402;C0008107;C3259781;C1720467;C0035078;C2316810,true;false;false;true;false;false;true;false,14806/22402
esrd or $nmbr$ % decline in gfr,C0022661;C0035078;C2316810,true;true;false,14807/22402
esrd or $nmbr$ % dedine in gfr,C0022661;C0035078;C2316810,true;true;false,14808/22402
esrd *,C0022661;C0035078;C2316810,true;true;false,14809/22402
established atherosclerotic cardiovascular disease — no . { % ),C0443211;C0004153;C1272684,false;true;false,14810/22402
established atherosclerotic disease — no . { % ),C0443211;C0333482;C0012634;C1272684,false;false;true;false,14811/22402
established cvd / chronic kidney disease ( age > $nmbr$ ) ^ * ’,C0443211;C0007222;C1561643;C0001779;C4553188;C1272684,false;true;true;false;false;false,14812/22402
established maerovaseular disease and albuminuria,C0443211;C0012634;C1272684,false;true;false,14813/22402
established renal disease ( egfr $nmbr$ - < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^ with any uacr mg / g or egfr > $nmbr$ - $nmbr$ ml / inin / l $nmbr$ m $nmbr$ with an uacr > $nmbr$ mg / g ) without previous maerovaseular and albuminuria disease,C0443211;C0022658;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C1272684;C1300563;C1300563;C0205156;C1552607,false;true;true;false;false;false;false;false;false;false;false;false;false,14814/22402
established renal disease *,C0443211;C0022658;C1272684,false;true;false,14815/22402
estimate,C0750572,false,14816/22402
estimate ( $nmbr$ % ci ),C0750572;C0008107;C3259781,false;true;false,14817/22402
estimate ( $nmbr$ % cl ),C0750572;C0596019,false;false,14818/22402
estimated creatinine clearance — ml / min  i,C0750572;C0812399;C0023806;C0702093;C1524029;C3813700;C0439445;C0021966;C0221138,false;false;true;false;false;false;false;true;false,14819/22402
estimated creatinine clearance — ml / min §,C0750572;C0812399;C0439445,false;false;false,14820/22402
estimated creatinine clearance ( ml / min ),C0750572;C0812399;C0439445,false;false;false,14821/22402
estimated creatinine clearance < $nmbr$ ml / mint,C0750572;C0812399;C0439526;C0452249;C0522467;C1337213;C1576800;C3890003;C1705224;C3887665,false;false;false;false;true;false;false;false;false;false,14822/22402
estimated creatinine clearance  !,C0750572;C0812399,false;false,14823/22402
estimated creatinine clearancet,C0750572;C0010294;C1561535,false;true;false,14824/22402
estimated cv risk at baseline,C3538987;C1519101;C0168634;C1442488;C4048877;C4318503,false;false;true;false;true;false,14825/22402
estimated gfr — ml / min / $nmbr$ . $nmbr$ m ^ |,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,14826/22402
estimated gfr — ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,14827/22402
estimated gfr — no . ( % ) ^ |,C0750572;C0017654;C1424601,false;true;false,14828/22402
estimated gfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ )  mean ( sd ),C0750572;C0017654;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923;C1424601,false;true;false;false;false;false;false;false;false;false,14829/22402
estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,14830/22402
estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ) lipid baseline lipid profile,C0750572;C0017654;C0439445;C0369637;C0023779;C0168634;C1979963;C2003903;C1442488;C0441923;C1424601,false;true;false;false;true;true;false;false;false;false;false,14831/22402
estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  mean ( sd ),C0750572;C0017654;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923;C1424601,false;true;false;false;false;false;false;false;false;false,14832/22402
estimated gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^ — no . ( % ),C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,14833/22402
estimated gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  no . ( % ),C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,14834/22402
estimated gfr at baseline  ml • min $nmbr$,C0750572;C0017654;C0168634;C0439445;C1442488;C1424601,false;true;true;false;false;false,14835/22402
estimated gfr  mean ( sd )  mlvmin per $nmbr$ . $nmbr$ m ^ *,C0750572;C0017654;C0444504;C2699239;C0369637;C0441923;C2347634;C2348143;C1424601,false;true;false;false;false;false;false;false;false,14836/22402
estimated gfr  ml / min,C0750572;C0017654;C0439445;C1424601,false;true;false;false,14837/22402
estimated gfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0750572;C0017654;C0439445;C0369637;C0441923;C1424601,false;true;false;false;false;false,14838/22402
estimated gfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$   of body - surface area,C0750572;C0017654;C0439445;C0369637;C0489451;C0017446;C0205146;C0441923;C1424601,false;true;false;false;false;true;false;false;false,14839/22402
estimated gfr ^,C0750572;C0017654;C1424601,false;true;false,14840/22402
estimated glomerular filtration rate — ml / min / $nmbr$ . $nmbr$ m ^,C3811844;C0439445;C0369637;C0441923,false;false;false;false,14841/22402
estimated glomerular filtration rate — ml / min / $nmbr$ . $nmbr$ m $nmbr$,C3811844;C0439445;C0369637;C0441923,false;false;false;false,14842/22402
estimated glomerular filtration rate — ml / min / $nmbr$ . $nmbr$ m $nmbr$ of body - surface area §,C3811844;C0439445;C0369637;C0489451;C0017446;C0205146;C0441923,false;false;false;false;true;false;false,14843/22402
estimated glomerular filtration rate — no . ( % ),C3811844,false,14844/22402
estimated glomerular filtration rate ( mdrd )  ml · min $nmbr$ · $nmbr$ . $nmbr$ m $nmbr$,C3811844;C3839656;C0439445;C0369637;C0441923,false;false;false;false;false,14845/22402
estimated glomerular filtration rate ( mdrd )  ml · min $nmbr$ · $nmbr$ . $nmbr$ m $nmbr$ *,C3811844;C3839656;C0439445;C0369637;C0441923,false;false;false;false;false,14846/22402
estimated glomerular filtration rate < $nmbr$,C3811844,false,14847/22402
estimated glomerular filtration rate  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C3811844;C0439445;C0369637;C0441923,false;false;false;false,14848/22402
estimated glomerular filtration rate  ml / min / $nmbr$ . $nmbr$ m $nmbr$  mean ( sd ) §,C3811844;C0439445;C0369637;C0444504;C2699239;C2347634;C2348143;C0441923,false;false;false;false;false;false;false;false,14849/22402
estimated glomerular filtration rate ^,C3811844,false,14850/22402
estimated glomerular filtration rate | |,C3811844,false,14851/22402
estimated glomerular filtration rate §,C3811844,false,14852/22402
estimated mean,C0750572;C0444504;C2347634;C2348143,false;false;false;false,14853/22402
estimated mean $nmbr$ % cl,C0750572;C0444504;C0596019;C2347634;C2348143,false;false;false;false;false,14854/22402
estimated means and treatment differences ( % ),C0750572;C1704970,false;false,14855/22402
estimated number of pack - years,C0750572;C0237753;C1277691;C0449788,false;false;false;false,14856/22402
estimated proportions ( % ) and odds ratios,C0750572;C1709707,false;false,14857/22402
estimated treatment difference ( % ),C0750572;C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;false;true;false;false;false;false;false,14858/22402
estradiol ( e $nmbr$ ) ( pmol / l ),C0014912;C0439284,true;false,14859/22402
estradiol ( pmol / l ),C0014912;C0439284,true;false,14860/22402
estradiol quartiles,C0014912;C2828255,true;false,14861/22402
estrogen,C0014939;C2936882;C4542544,true;false;false,14862/22402
estrogen ( ' % ? ),C0014939;C2936882;C4542544,true;false;false,14863/22402
estrogen supplementation,C0014939;C0242297;C2936882;C4542544,true;false;false;false,14864/22402
estrogen supplementation -,C0014939;C0242297;C2936882;C4542544,true;false;false;false,14865/22402
etd : − $nmbr$ . $nmbr$ [ − $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     =   $nmbr$ . $nmbr$,C1180255;C0008107;C3259781,false;true;false,14866/22402
etd : − $nmbr$ . $nmbr$ [ − $nmbr$ . $nmbr$  − $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     <   $nmbr$ . $nmbr$,C1180255;C0008107;C3259781,false;true;false,14867/22402
etd : − $nmbr$ . $nmbr$ [ − $nmbr$ . $nmbr$  − $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     <   $nmbr$ . $nmbr$,C1180255;C0008107;C3259781,false;true;false,14868/22402
ethnic background,C0015031,true,14869/22402
ethnic minority group — no . ( % ),C0015031;C0026192;C1879937;C0680174,true;true;false;false,14870/22402
ethnic origin white,C0015031;C0007457;C0043157;C0220938,true;true;true;false,14871/22402
ethnic origin *,C0015031,true,14872/22402
ethnicity - - hispanic or latino,C0015031;C0086409;C0243103,true;true;true,14873/22402
ethnicity t,C0015031;C0243103,true;true,14874/22402
ethnicity  %,C0015031;C0243103,true;true,14875/22402
ethnicity  hispanic / latino  n ( % ),C0015031;C0086409;C0086528;C0243103,true;true;true;true,14876/22402
ethnicity  n ( % ) *,C0015031;C0243103,true;true,14877/22402
ethnicity  n ( % ) :,C0015031;C0243103,true;true,14878/22402
ethnicity  n ( % ) b,C0015031;C0243103,true;true,14879/22402
ethnicity  not hispanic / latino    n   ( % ),C0015031;C0243103,true;true,14880/22402
ethnicity $nmbr$ ',C0015031;C0243103,true;true,14881/22402
ethnieity,,,14882/22402
etiology,C0015127;C1314792;C1524003,true;true;false,14883/22402
etiology ( % ),C0015127;C1314792;C1524003,true;true;false,14884/22402
etiology  n ( % ),C0015127;C1314792;C1524003,true;true;false,14885/22402
etiology    n   ( % ),C0015127;C1314792;C1524003,true;true;false,14886/22402
etoricoxib ( n = $nmbr$ ),C0972314,true,14887/22402
etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . . ( . % . . ) . . . . . . . . . . . .,C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14888/22402
etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . . ( . % . . ) . . . . . . . . . . . . .,C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14889/22402
etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . . .,C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14890/22402
etoricoxib $nmbr$ mg  n = $nmbr$  n ( % ),C0972314;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14891/22402
etoricoxib group ( n = $nmbr$ $nmbr$ ),C0972314;C0441848,true;false,14892/22402
etr : $nmbr$ . $nmbr$ [ $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     =   $nmbr$ . $nmbr$,C0008107;C3259781,true;false,14893/22402
eu,C0015179;C3665627,true;false,14894/22402
europe ( including south africa ),C0015176,true,14895/22402
europe ( plus south africa ),C0015176;C0332287;C0037712,true;false;true,14896/22402
europe $nmbr$ ( n = $nmbr$  $nmbr$ ),C0015176,true,14897/22402
europe $nmbr$ ¶,C0015176,true,14898/22402
europe $nmbr$ +,C0015176,true,14899/22402
europe and russia,C0015176,true,14900/22402
european or arab,C0239307;C1535514,false;false,14901/22402
evening,C0587117,false,14902/22402
evening mealb,C0587117,false,14903/22402
event ( p = $nmbr$ . $nmbr$ o + ),C0441471;C4019010,false;false,14904/22402
event during on -,C0441471;C4019010,false;false,14905/22402
event during overall,C0441471;C0282416;C1561607;C4019010,false;true;false;false,14906/22402
event incidence / n,C0441471;C0021149;C0220856;C4019010,false;true;true;false,14907/22402
event number,C0441471;C0237753;C0449788;C4019010,false;false;false;false,14908/22402
event rate ( per $nmbr$,C0441471;C0871208;C1521828;C4019010,false;false;false;false,14909/22402
event rate ( % / vr ),C0441471;C0871208;C3476815;C1521828;C4019010,false;false;false;false;false,14910/22402
event rate ( % / year ),C0441471;C0871208;C0439234;C0439508;C1521828;C4019010,false;false;false;false;false;false,14911/22402
event rate ( per $nmbr$ person - years ),C0441471;C0871208;C0027361;C0439234;C2347489;C1521828;C4019010,false;false;true;false;false;false;false,14912/22402
event rate ( per $nmbr$ person years ),C0441471;C0871208;C0027361;C0439234;C2347489;C1521828;C4019010,false;false;true;false;false;false;false,14913/22402
event rates per $nmbr$ patient - years ( $nmbr$ % ci ),C0441471;C0871208;C0030705;C0439234;C0008107;C3259781;C1521828;C4019010,false;false;true;false;true;false;false;false,14914/22402
event  n ( % ),C0441471;C4019010,false;false,14915/22402
event / patients in group ( incidence / $nmbr$ person - year ),C0441471;C0030705;C0441833;C0021149;C0027361;C0439234;C0439508;C2347489;C0220856;C0687744;C1257890;C1519504;C1705428;C1705429;C4019010,false;true;false;true;true;false;false;false;true;false;true;false;false;false;false,14916/22402
event { n ( % ),C0441471;C4019010,false;false,14917/22402
events consistent with genital infection,C0441471;C3541888,false;false,14918/22402
events consistent with uti,C0441471;C3541888,false;false,14919/22402
events consistent with volume depletion,C0441471;C3541888,false;false,14920/22402
events requiring assistance,C0441471;C3541888,false;false,14921/22402
events  n ( % ),C0441471;C3541888,false;false,14922/22402
events  n ( % / y ),C0441471;C3541888,false;false,14923/22402
events / patient - year ( n ),C0441471;C0030705;C0439234;C0439508;C3541888,false;true;false;false;false,14924/22402
ever,,,14925/22402
ever been on a vka,,,14926/22402
every day,C0332173;C0439228;C0439505,false;false;false,14927/22402
evolocumab,C3529352,true,14928/22402
evolocumab ( n = $nmbr$ ),C3529352,true,14929/22402
evolocumab + soc ( n = $nmbr$ ),C3529352,true,14930/22402
evomab,,,14931/22402
evomab + soc,,,14932/22402
ex - drinker,C0337679,false,14933/22402
ex - smokers ( itt ) ( n = $nmbr$ ),C0337671;C4555205,false;true,14934/22402
ex - smokers ( n = $nmbr$ ),C0337671;C4555205,false;true,14935/22402
ex - smokers : qvai $nmbr$ - sfc,C0337671;C4521536;C4555205,false;false;true,14936/22402
exacerbation historyh  n ( % ),C4086268,false,14937/22402
exacerbation in previous year,C4086268;C0205156;C0439234;C0439508;C1552607,false;false;false;false;false,14938/22402
exacerbation rate per year,C4086268;C0871208;C0439234;C0439508;C1521828,false;false;false;false;false,14939/22402
exacerbation within $nmbr$ mo  %,C4086268;C0026544;C0332177,false;true;false,14940/22402
exacerbation within previous $nmbr$ mo  no . ( % ),C4086268;C0205156;C0026544;C0332177;C1552607,false;false;true;false;false,14941/22402
exacerbations in past $nmbr$ mo — no . ( % ),C4086268;C1444637;C0026544;C0332177;C4284302,false;false;true;false;false,14942/22402
exacerbations in previous $nmbr$ mo ( n )  mean ( sd ),C4086268;C0205156;C0026544;C0444504;C2699239;C2347634;C2348143;C0332177;C1552607,false;false;true;false;false;false;false;false;false,14943/22402
exacerbations in previous year requiring hospitalization and / or ed visit  n ( % ),C4086268;C0205156;C0439234;C0019993;C0439508;C1552607,false;false;false;true;false;false,14944/22402
exacerbations in previous year requiring hospitalization  n ( % ),C4086268;C0205156;C0439234;C0019993;C0439508;C1552607,false;false;false;true;false;false,14945/22402
exacerbations in the past $nmbr$ months n,C4086268;C4331910,false;false,14946/22402
exacerbations in the prev . year : $nmbr$,C4086268;C1552852;C0439234;C0439508,false;false;false;false,14947/22402
exacerbations in the year before study,C4086268;C0439234;C0439508,false;false;false,14948/22402
exacerbations requiring hospitalisation ( past year ) ( % ),C4086268,false,14949/22402
exacerbations requiring oral steroids / antibiotics ( past year ) ( % ),C4086268,false,14950/22402
exact - pro total score  mean ( sd ),C2828393;C0033382;C2964552;C0444504;C2699239;C2347634;C2348143;C0523852;C2987124;C4050514,false;true;false;false;false;false;false;false;true;false,14951/22402
exact ( b ),C2828393;C4050514,false;false,14952/22402
exenatide ± oad,C0167117,true,14953/22402
exenatide er,C0167117;C3810541;C3811131,true;false;false,14954/22402
exercise status,C0015259;C0449438;C1522704,true;false;false,14955/22402
exercise  n ( % ),C0015259;C1522704,true;false,14956/22402
exlertl ot disease,C1318464;C0012634;C1418208;C1705587,true;true;false;false,14957/22402
expanded cv endpoint,C0205229;C3538987;C2349179;C2826544;C4048877;C4318503,false;false;false;false;true;false,14958/22402
expanded mace,C0205229;C0349381;C0949745;C1445339,false;false;true;false,14959/22402
experience ( n  % ),C0237607;C0596545,false;false,14960/22402
experienced,C0237607;C0596545,false;false,14961/22402
experimental intervention group ( n = $nmbr$ ),C1517586;C0184661;C0441848;C0886296;C1273869,false;true;false;false;false,14962/22402
experimental treatment group,C0949266;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2585119,true;false;false;true;false;false;false;false,14963/22402
exploratory cardiovascular and death outcomes,C0007226;C3887460,true;false,14964/22402
exploratory kidney and microvascular outcomes,C0022646;C0227665,true;false,14965/22402
exposed,C0332157,false,14966/22402
exposure to study drug — days,C0332157;C0013175;C0439228,false;true;false,14967/22402
exsmoker,C0337671;C4555205,false;true,14968/22402
extended - release niacin plus statin ( n = $nmbr$ ),C1707968;C0027996;C0332287;C0360714;C1142562,false;true;false;true;false,14969/22402
extended cardiovascular endpoint,C0231448;C0007226;C2349179;C2826544;C3887460;C0231449;C0439792,false;true;false;false;false;false;false,14970/22402
extensive  n ( % ),C0205231,false,14971/22402
extensive / pancolitis,C0205231;C0868908,false;false,14972/22402
extenswe,,,14973/22402
extent of index dvt ' ( n  % of dvt patients ' ),C0439792;C0600653;C0149871;C0030705;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;true;false;false;false,14974/22402
extent of index pe ' ( n  % of pe patients ),C0439792;C0600653;C0070939;C0030705;C1880476;C4284304;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;true;false;false;false,14975/22402
extracranial,C0580586,false,14976/22402
ez / simva $nmbr$ / $nmbr$ mg,C0206578;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14977/22402
eze = ezetimibe $nmbr$ mg  pooled sinva = simvastatin pooled across doses  pooled eze / sinva = ezetimibe / simvastatin tablet pooled across doses  bni = body mass index  ldl - c = low - density lipoprotein cholesterol  t g = triglycerides  t c = total cholesterol  hdl - c = high - density lipoprotein cholesterol  apo — apolipoprotein  c rp — c - neactive protein  rlp - c = remnant - like particle - cholesterol .,C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1532737;C0039225;C1705223;C4319774;C0577559;C0600653;C0023824;C0439267;C0918012;C1552854;C1637833;C2986546;C0577573;C1096155;C1306372;C3152252;C3539882;C4283905;C0041004;C0201950;C0023821;C0543421;C0008377;C0003594;C0003591;C0031529;C0033684;C4054077;C1538326;C3541325;C3891451;C0674390,true;true;true;false;false;false;false;false;true;true;false;false;false;true;true;false;true;false;false;false;false;true;false;false;false;false;true;false;true;false;true;true;true;true;true;false;false;false;false;true,14978/22402
eze / simva ( n = $nmbr$ ),,,14979/22402
eze / simva  $nmbr$ / $nmbr$ mg + feno  $nmbr$ mg dn = $nmbr$ ) ',C1319635;C1333964;C1707618,false;false;false,14980/22402
eze / simva  $nmbr$ / $nmbr$ mg + feno  $nmbr$ mg dn = $nmbr$ ),C1319635;C1333964;C1707618,false;false;false,14981/22402
eze / simva  $nmbr$ / $nmbr$ mg dn = $nmbr$ c $nmbr$ ),C0024671;C1333964;C1707618;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;false;false;false;false,14982/22402
eze / simva  $nmbr$ / $nmbr$ mg dr = $nmbr$ ),C0024671;C0013014;C0031831;C1707664;C2348314;C3540849;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;true;false;false;false;false;false,14983/22402
ezetimibe $nmbr$ mg ( n — $nmbr$ ),C1142985;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,14984/22402
ezetimibe  n ( % ),C1142985,true,14985/22402
ezetimibe / simvastatin group,C1532737;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,14986/22402
f - plasma glucose  mmol / l,C0016327;C0202042;C1532563;C0455280,true;false;false;false,14987/22402
f $nmbr$ vs placebo,C0016327,true,14988/22402
facial psoriasis  n ( % ),C1276112,false,14989/22402
facilitated pci ( n = $nmbr$ ),C4049621,false,14990/22402
facit - f,C3272505,false,14991/22402
facit - f score,C3272505;C0449820;C4050231,false;false;false,14992/22402
factor,C1521761;C2827422,false;false,14993/22402
factor absent,C1521761;C2827422,false;false,14994/22402
factor at baseline,C1521761;C0168634;C1442488;C2827422,false;true;false;false,14995/22402
factor present,C1521761;C0150312;C0449450;C2827422,false;false;false;false,14996/22402
factor *,C1521761;C2827422,false;false,14997/22402
factors dabigatran,C1521761;C2348066;C2827422,false;true;false,14998/22402
factors dabigatran event incidence / n,C1521761;C2348066;C0441471;C0021149;C0220856;C4019010;C2827422,false;true;false;true;true;false;false,14999/22402
factors that confer a,C1521761;C2827422,false;false,15000/22402
failure,C0231174;C0680095,false;false,15001/22402
fair control ( $nmbr$ - $nmbr$ . $nmbr$ ),C2911689;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,false;true;false;false;false;false;false,15002/22402
fair or poor,C2911689,false,15003/22402
fair / poor,C2911689;C0032854;C0542537;C2700379,false;true;false;false,15004/22402
fall in last $nmbr$ mo,C0085639;C0026544;C0332177;C0238715;C4553726,false;true;false;false;false,15005/22402
fall in last $nmbr$ months ( % ),C0085639;C0439231;C0238715;C4553726,false;false;false;false,15006/22402
familial,C0015576;C0241888,true;false,15007/22402
familv historv of cad,C1504769;C2239547;C3813548;C4284121,true;false;false;false,15008/22402
family history of diabetes mellitus — no . ( % ),C0260526;C1313937,false;false,15009/22402
family history of diabetes mellitus — no . { % ),C0260526;C1313937,false;false,15010/22402
family history of myocardial infarction prior to age $nmbr$  %,C0455406,false,15011/22402
family history of premature chd * *,C0241889;C0151526;C0280604;C3542407;C0205252;C4018905,true;true;false;false;false;false,15012/22402
family history of premature coronary heart disease,C0260520;C0151526;C0205252;C4018905;C1313980;C2317524,false;true;false;false;false;false,15013/22402
family history of premature heart disease,C0850707;C0151526;C0018787;C0205252;C4018905,false;true;true;false;false,15014/22402
family history ot chd  n ( % ),C0241889;C1318464;C0280604;C3542407;C1418208;C1705587,true;true;false;false;false;false,15015/22402
famotidine $nmbr$ mg ( n = $nmbr$ ),C0015620;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15016/22402
fas,,,15017/22402
fas  range $nmbr$ - $nmbr$  mean ( sd ),C1514721;C0444504;C2699239;C2347634;C2348143;C2348147;C3542016,false;false;false;false;false;false;false,15018/22402
faster aspart,C0015663;C0123677;C0456962;C2985769,true;false;false;false,15019/22402
faster aspart ( mealtime ),C0015663;C0123677;C0587119;C0456962;C2985769,true;false;true;false;false,15020/22402
faster aspart   +   basal,C0015663;C0123677;C0205112;C0456962;C2985769,true;false;false;false;false,15021/22402
fasting,C0015663,true,15022/22402
fasting blood glucose > $nmbr$ mg / dl ( > $nmbr$ . $nmbr$ mmol / l ),C0428568;C0439269;C1532563;C1261430,false;false;false;false,15023/22402
fasting blood glucose  mean ( sd )  mg / dlt,C0428568;C0444504;C2699239;C0024671;C1413248;C3273706;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143;C1261430,false;false;false;true;false;false;true;false;false;false;false;false;false;false;false,15024/22402
fasting c - peptide ( ng / ml ),C0015663;C0006558;C0439275,true;true;false,15025/22402
fasting glucose,C0015663;C0017725,true;true,15026/22402
fasting glucose > $nmbr$ mg / dl  n ( % ),C0015663;C0017725;C0439269,true;true;false,15027/22402
fasting glucose > $nmbr$ mg / dl *,C0015663;C0017725;C0439269,true;true;false,15028/22402
fasting glucose level  mg / dl,C0202045;C0439269,false;false,15029/22402
fasting glucose mg / dl diabetes classification,C0015663;C0017725;C0439269;C0011847;C0008902;C0008903;C0678229;C0011849,true;true;false;false;true;true;false;true,15030/22402
fasting glucose *,C0015663;C0017725,true;true,15031/22402
fasting glucose  mean ( sd )  mg / dl,C0015663;C0017725;C0444504;C2699239;C0439269;C2347634;C2348143,true;true;false;false;false;false;false,15032/22402
fasting glucose  mg / dl,C0015663;C0017725;C0439269,true;true;false,15033/22402
fasting glucose  mg / dl ',C0015663;C0017725;C0439269,true;true;false,15034/22402
fasting glucose  mg / dl  mean ( sd ) §,C0015663;C0017725;C0439269;C0444504;C2699239;C2347634;C2348143,true;true;false;false;false;false;false,15035/22402
fasting indices,C0015663;C4033634,true;false,15036/22402
fasting insulin ( miu / ml ),C0015663;C0021641;C0439457;C1533581;C1579433;C3714501,true;true;false;false;false;false,15037/22402
fasting insulin  iiiu / ml  mean ± sd,C0015663;C0021641;C0439526;C0444504;C2699239;C2347634;C2348143;C1705224;C3887665;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false;false;false;false;false,15038/22402
fasting insulin  pmol / l ( mean ± sd ),C0015663;C0021641;C0439284;C0444504;C2699239;C2347634;C2348143;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false;false;false,15039/22402
fasting insulin  * median ( iqr )  gu / ml,C0015663;C0021641;C0549183;C0120446;C0439526;C1705224;C3887665;C3887515;C0876920;C2347635;C2348144;C2939193;C1533581;C1579433;C3714501,true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,15040/22402
fasting lipids ( mmol / $nmbr$ ),C0015663;C0023779;C0439190,true;true;false,15041/22402
fasting plasma glucose — mmol / liter,C0015663;C0202042;C0439190;C0475211;C0455280,true;false;false;false;false,15042/22402
fasting plasma glucose ( change from baseline ),C0583513;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false,15043/22402
fasting plasma glucose ( mg / dl ) $nmbr$,C0015663;C0202042;C0439269;C0455280,true;false;false;false,15044/22402
fasting plasma glucose ( mmol / l ) $nmbr$,C0015663;C0202042;C1532563;C0455280,true;false;false;false,15045/22402
fasting plasma glucose categories  n ( % ),C0015663;C0202042;C0683312;C0455280,true;false;false;false,15046/22402
fasting plasma glucose in mmol / l ( median ( q $nmbr$  q $nmbr$ ) [ n ] ),C0583513;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,15047/22402
fasting plasma glucose *,C0015663;C0202042;C0455280,true;false;false,15048/22402
fasting plasma glucose  mg / dl,C0015663;C0202042;C0439269;C0455280,true;false;false;false,15049/22402
fasting plasma glucose  mg / dl  mean ( sd ),C0015663;C0202042;C0439269;C0444504;C2699239;C2347634;C2348143;C0455280,true;false;false;false;false;false;false;false,15050/22402
fasting proinsulin ( pmol / l ),C0015663;C0033362;C0439284;C3813208,true;true;false;false,15051/22402
fasting serum glucose — mg / dl * *,C0015663;C0202041;C0439269;C3534430,true;false;false;false,15052/22402
fasting serum glucose ( mg / dl ),C0015663;C0202041;C0439269;C3534430,true;false;false;false,15053/22402
fasting serum glucose level  mean ( sd )  mg / dl,C0202045;C0229671;C0444504;C2699239;C0439269;C2347634;C2348143;C1546774;C1550100;C0015663;C0583332,false;true;false;false;false;false;false;false;false;true;false,15054/22402
fasting serum glucose  mean ( sd ) mg / dl,C0015663;C0202041;C0444504;C2699239;C0439269;C2347634;C2348143;C3534430,true;false;false;false;false;false;false;false,15055/22402
fasting serum glucose  mmol / l  median ( q $nmbr$  q $nmbr$ ),C0015663;C0202041;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193;C3534430,true;false;false;false;false;false;false;false;false,15056/22402
fasting tgs  median ( q $nmbr$ : q $nmbr$ ),C0015663;C1156212;C0549183;C0876920;C2347635;C2348144;C2939193;C1537574,true;false;false;false;false;false;false;false,15057/22402
fasting triglyceride level  mean ( sd )  mg / dl,C0015663;C0428475;C0444504;C2699239;C0439269;C2347634;C2348143,true;false;false;false;false;false;false,15058/22402
fasting triglycerides,C0015663;C0041004,true;true,15059/22402
fasting triglycerides > $nmbr$ mg / dl *,C0015663;C0041004;C0439269,true;true;false,15060/22402
fasting triglycerides  mean ( sd ) mg / dl,C0015663;C0041004;C0444504;C2699239;C0439269;C2347634;C2348143,true;true;false;false;false;false;false,15061/22402
fasting triglycerides  mean ( sd )  mg / dl,C0015663;C0041004;C0444504;C2699239;C0439269;C2347634;C2348143,true;true;false;false;false;false;false,15062/22402
fasting triglycerides  mg / dl,C0015663;C0041004;C0439269,true;true;false,15063/22402
fatal,C1302234;C1705232,false;false,15064/22402
fatal & nonfatal ccvd,C1302234;C1705232,false;false,15065/22402
fatal & nonfatal hospitalized heart failure,C1302234;C0701159;C0018801;C0018802;C4554158;C1705232,false;false;true;true;false;false,15066/22402
fatal & nonfatal hospitalized stroke,C1302234;C0701159;C0038454;C4554100;C1705232,false;false;true;false;false,15067/22402
fatal aes,C1302234;C1412268;C2699274;C1705232,false;false;false;false,15068/22402
fatal bleed,C1302234;C0019080;C1705232,false;true;false,15069/22402
fatal bleeding,C1302234;C0019080;C1705232,false;true;false,15070/22402
fatal chd + nonfatal ml,C1302234;C0280604;C0439526;C1705224;C3887665;C3542407;C1705232,false;false;false;false;false;false;false,15071/22402
fatal chd and nonfatal mia,C1302234;C0280604;C3542407;C1705232,false;false;false;false,15072/22402
fatal myocardial infarction,C1302234;C0027051;C0428953;C2926063;C3810814;C4552959;C1705232,false;true;false;false;false;false;false,15073/22402
fatal or non - fatal myocardial infarction,C1302234;C1705232,false;false,15074/22402
fatal or non - fatal stroke,C1302234;C1705232,false;false,15075/22402
fatal or nonfatal myocardial infarction,C1302234;C1705232,false;false,15076/22402
fatal or nonfatal stroke,C1302234;C1705232,false;false,15077/22402
fatal or nonlatal myocardial inlarctlon,C1302234;C1705232,false;false,15078/22402
fatal or nonlatal stroke,C1302234;C1705232,false;false,15079/22402
fatal stroke,C1302234;C0038454;C4554100;C1705232,false;true;false;false,15080/22402
fatal / nonfatal mi  n ( % ),C1302234;C3810814;C1705232,false;false;false,15081/22402
fatal / nonfatal ml,C1302234;C0439526;C1705224;C3887665;C1705232,false;false;false;false;false,15082/22402
fatal / nonfatal stroke,C1302234;C0038454;C4554100;C1705232,false;true;false;false,15083/22402
fatal / nonfatal stroke  n ( % ),C1302234;C0038454;C4554100;C1705232,false;true;false;false,15084/22402
fatigue ( range $nmbr$ - $nmbr$ ),C0015672;C1514721;C2348147;C3542016;C3463815;C4050243;C4554645,true;false;false;false;false;false;false,15085/22402
fatty acid group ( n = $nmbr$ ),C0015684;C0441848,true;false,15086/22402
favors favors amlodipine chlorthalidone,C0309049,false,15087/22402
favors favors lisinopril chlorthalidone,C0309049,false,15088/22402
favors amlodipine favors chlorthalidone,C0309049;C0051696;C0008294,false;true;true,15089/22402
favors comparator,C0309049;C1707454;C4553389;C4553390,false;false;false;false,15090/22402
favors dabigatran,C0309049;C2348066,false;true,15091/22402
favors ff / vi favors placebo,C0309049;C4554348;C0205999,false;false;true,15092/22402
favors ffa / i favors placebo,C0309049;C0015688;C0021966;C0032042;C1696465;C1706408;C0221138,false;true;true;true;false;false;false,15093/22402
favors lisinopril favors chlorthalidone,C0309049;C0065374;C0008294,false;true;true,15094/22402
fbg ( mg / dl ),C0439269,false,15095/22402
fbg ( mmol / l ),C1532563,false,15096/22402
fbg baseline,C0168634;C1442488,true;false,15097/22402
fbg  mmol / l,C1532563,false,15098/22402
fc > $nmbr$ mg / dl ( > _ $nmbr$ . $nmbr$ mmol / l ) or history of diabetes,C2983605;C0439269;C1532563,false;false;false,15099/22402
fcal  mg / g  mean ± sd,C1300563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15100/22402
fdc $nmbr$ / $nmbr$ pg,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,15101/22402
fdc $nmbr$ / $nmbr$ pg vs aclidinium $nmbr$ pg,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,15102/22402
fdc $nmbr$ / $nmbr$ pg vs formoterol $nmbr$ pg,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,15103/22402
fdc $nmbr$ / $nmbr$ pg vs placebo,C0340427;C0030827;C0072225;C1266240;C1413520;C3539652,true;true;true;false;false;false,15104/22402
fdc $nmbr$ / $nmbr$   μ g ( n   =   $nmbr$ ),C0340427;C0439267;C1413520;C3539652,true;false;false;false,15105/22402
feature,C1521970;C1706388;C2346469;C2348519,false;false;false;false,15106/22402
febuxostat,C0249529,true,15107/22402
febuxostat $nmbr$ mg,C0249529;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15108/22402
febuxostat $nmbr$ mg ( n = $nmbr$ ),C0249529;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15109/22402
febuxostat $nmbr$ mg daily n = $nmbr$,C0249529;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,15110/22402
febuxostat $nmbr$ mg n = $nmbr$,C0249529;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15111/22402
febuxostat $nmbr$ mg daily n = $nmbr$ % ( n / n ),C0249529;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,15112/22402
febuxostat $nmbr$ mg daily n = $nmbr$ n ( % ),C0249529;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,15113/22402
feet,C0016504;C0347981,true;false,15114/22402
femaie,,,15115/22402
female - n ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,15116/22402
female — no . ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,15117/22402
female ( n   = $nmbr$  $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,15118/22402
female ( n = lll $nmbr$ ),C0043210;C1261077;C0086287;C1705497;C1705498,true;false;true;false;false,15119/22402
female $nmbr$,C0043210;C0086287;C1705497;C1705498,true;true;false;false,15120/22402
female acr definition  ^ g / mg,C0043210;C1412134;C1550452;C0439267;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1704788;C3539107;C3888054;C1515941;C0086287;C1705497;C1705498,true;false;false;false;true;true;false;false;false;false;false;false;false;false;false;true;false;false,15121/22402
female eze / simva ( n = $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,15122/22402
female gender ( % ),C0086287,true,15123/22402
female gender n ( % ),C0086287,true,15124/22402
female n ( % ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,15125/22402
female participants who are ≥ $nmbr$ years postmenopausal,C0043210;C0679646;C0086287;C1705497;C1705498,true;false;true;false;false,15126/22402
female patients ^,C0150905,false,15127/22402
female race white,C0043210;C0034510;C0007457;C0043157;C0220938;C1706779;C3853635;C0086287;C1705497;C1705498,true;true;true;true;false;false;false;true;false;false,15128/22402
female sex — no . { % ),C0086287,true,15129/22402
female sex — %,C0086287,true,15130/22402
female sex — no . ( % ) race — no . ( % ) f,C0086287,true,15131/22402
female sex  n ( % of patients ),C0086287;C0030705;C0150905;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C0043210;C0150831;C1705497;C1705498,true;true;false;true;true;true;false;false;true;true;false;false;false,15132/22402
female sex  no . ( % ),C0086287,true,15133/22402
female sex  no . / total ( % ),C0086287,true,15134/22402
female simva ( n = $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,15135/22402
female subjects ( n = $nmbr$ ),C0043210;C0086287;C1705497;C1705498,true;true;false;false,15136/22402
female  n ( % ) race  n ( % ),C0043210;C0034510;C1706779;C3853635;C0086287;C1705497;C1705498,true;true;false;false;true;false;false,15137/22402
female / male ( % ),C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498,true;true;false;false;false;true;false;false,15138/22402
female : ≥ $nmbr$ years postmenopausal,C0043210;C0439234;C0086287;C1705497;C1705498,true;false;true;false;false,15139/22402
female : perimenopausal or < $nmbr$ years postmenopausal,C0043210;C0086287;C1705497;C1705498,true;true;false;false,15140/22402
female : premenopausal,C0043210;C0086287;C1705497;C1705498,true;true;false;false,15141/22402
females ( itt ) ( n = $nmbr$ ),C0086287,true,15142/22402
females ( n = $nmbr$ ),C0086287,true,15143/22402
females only,C0086287;C0205171;C1720467,true;false;false,15144/22402
females  < $nmbr$ . $nmbr$,C0086287,true,15145/22402
females  < $nmbr$,C0086287,true,15146/22402
females  > $nmbr$ . $nmbr$,C0086287,true,15147/22402
females  > $nmbr$,C0086287,true,15148/22402
females  n ( % ),C0086287,true,15149/22402
femalesex,,,15150/22402
femoral access,C0015811;C0444454;C1554204,true;false;false,15151/22402
femoral neck ( n = $nmbr$  $nmbr$ ) bmd ( g / cm $nmbr$ ) ( sd ),C0015815;C0439267;C2699239,true;false;false,15152/22402
femoral neck bmd ( g / cm $nmbr$ ),C0015815;C0439267,true;false,15153/22402
femoral neck bmd t - score,C0015815;C0449820;C4050231,true;false;false,15154/22402
femoral neck f - score at flex baseline,C0015815;C0016327;C0449820;C0168634;C1442488;C4050231,true;true;false;true;false;false,15155/22402
femoral neck t - score,C0015815;C0449820;C4050231,true;false;false,15156/22402
femoral neck t - score ( mean = sd ),C0015815;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,true;false;false;false;false;false;false,15157/22402
femoral neckc,C0015811,true,15158/22402
femoralneck t - scorebybaselinevfxstatus,,,15159/22402
feno — ppb,C1415800,false,15160/22402
feno  $nmbr$ dn = $nmbr$ ),C1333964;C1707618,false;false,15161/22402
feno  $nmbr$ mg dn = $nmbr$ ),C0024671;C1333964;C1707618;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;true;false;false;false;false;false,15162/22402
fenofibrate ( n = $nmbr$ ),C0033228,true,15163/22402
fenofibric acid - $nmbr$ - low - dose statin,C0060179;C0445550;C0360714;C1708745,true;false;true;false,15164/22402
fenofibric acid - i - moderate - dose statin,C0060179;C0021966;C1709056;C0360714;C0221138,true;true;false;true;false,15165/22402
fenofibric acid - i - low - dose statin,C0060179;C0021966;C0445550;C0360714;C1708745;C0221138,true;true;false;true;false;false,15166/22402
fenofibric acid   n   =   $nmbr$,C0060179,true,15167/22402
fev auc i $nmbr$ h,C3714541;C0376690;C0021966;C0033727;C0369286;C0441932;C0564385;C4528284;C0221138,true;true;true;true;false;false;false;false;false,15168/22402
fev,C3714541,true,15169/22402
fev  % predicted,C3714541,true,15170/22402
fev  < $nmbr$ % predicted,C3714541,true,15171/22402
fev  > $nmbr$ % predicted,C3714541,true,15172/22402
fev $nmbr$,C3714541,true,15173/22402
fev $nmbr$ % predicted at baseline,C3714541,true,15174/22402
fev $nmbr$ % predicted normal,C3714541,true,15175/22402
fev $nmbr$ ( l ) pre - bronchodilator,C3714541;C2599602,true;false,15176/22402
fev $nmbr$ ( l )  mean ( sd ),C3714541;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15177/22402
fev $nmbr$ at week $nmbr$  mean ml ( se ) difference mepo - pbo ( $nmbr$ % ci ),C3714541;C0332174;C0444504;C0036919;C1705241;C0031962;C2348025;C1705242;C2347634;C2348143;C0439230,true;false;false;true;false;true;false;false;false;false;false,15178/22402
fev $nmbr$ auc $nmbr$ mine $nmbr$ h,C3714541;C0376690,true;true,15179/22402
fev $nmbr$ pre - bronchodilator ( % predicted normal )  mean ( sd ) c  d,C3714541;C2599602,true;false,15180/22402
fev $nmbr$ pre - bronchodilator ( l )  mean ( sd ) c,C3714541;C2599602;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,15181/22402
fev $nmbr$ prebronchodilator [ % pn ]  mean ± sd,C3714541;C2599602;C0219433;C0444504;C2699239;C2347634;C2348143;C1549735;C3541307;C4049640;C4049767,true;false;true;false;false;false;false;false;false;false;false,15182/22402
fev $nmbr$ prebronchodilator [ l ]  mean ± sd,C3714541;C2599602;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,15183/22402
fev $nmbr$   % of predicted normal post - bronchodilator,C0520835;C0681842;C2599594;C1882327,false;false;false;false,15184/22402
fev $nmbr$   at baseline ( randomization ) ∗,C3714541;C0168634;C0034656;C1442488,true;true;true;false,15185/22402
fev $nmbr$   at screening ∗,C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;true;false;false;false;false;false,15186/22402
fev $nmbr$ % predicted ( sd ),C3714541;C0681842;C2699239;C1882327,true;false;false;false,15187/22402
fev $nmbr$ % predicted < $nmbr$ %,C3714541,true,15188/22402
fev $nmbr$ % predicted ≥ $nmbr$ %,C3714541,true,15189/22402
fev $nmbr$ % predicted  mean ( sd ),C3714541;C0681842;C0444504;C2699239;C2347634;C2348143;C1882327,true;false;false;false;false;false;false,15190/22402
fev $nmbr$ % reversibility ( sd ),C3714541;C0449261;C2699239,true;false;false,15191/22402
fev $nmbr$  % predicted  mean ( sd ),C3714541;C0681842;C0444504;C2699239;C2347634;C2348143;C1882327,true;false;false;false;false;false;false,15192/22402
fev $nmbr$  l prebronchodilator fev $nmbr$  % predicted,C3714541;C2599602,true;false,15193/22402
fev $nmbr$  l  mean ( sd ),C3714541;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15194/22402
fev $nmbr$  mean ( sd ) pre - bd fev $nmbr$ / fvc,C3714541;C0444504;C2699239;C0332152;C0005126;C2344255;C4050145;C0740175;C2257086;C3669034;C2347634;C2348143,true;false;false;false;true;false;false;false;false;false;false;false,15195/22402
fev $nmbr$  mean  % predicted,C3714541;C0444504;C2347634;C2348143,true;false;false;false,15196/22402
fev $nmbr$  mean  l,C3714541;C0444504;C2347634;C2348143,true;false;false;false,15197/22402
fev $nmbr$ / fvc at baseline ( randomization ) ( % ) ∗,C3714541;C0168634;C0034656;C1442488,true;true;true;false,15198/22402
fev $nmbr$ / fvc prebronchodilator  mean ± sd,C3714541;C2599602;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,15199/22402
fev $nmbr$ / fvc ratio  %,C3714541;C0456603;C1547037,true;false;false,15200/22402
fev $nmbr$ / fvc  mean ( sd ),C3714541;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15201/22402
fevi percent predicted ( % ),C0429706;C0439165;C0849974;C1561566;C4528367,false;false;false;false;false,15202/22402
fevi reversibility — %,C3830088,false,15203/22402
fevi  l,C0429706;C0849974;C1561566;C4528367,false;false;false;false,15204/22402
fevi / fvc ( % ),C0802741;C3815113,false;false,15205/22402
fevi $nmbr$ l,C0429706;C0849974;C1561566;C4528367,false;false;false;false,15206/22402
fevj % predicted !  t,C0681842;C1882327,false;false,15207/22402
fevt : fvc ratio — % |,C0016529;C3714541;C0456603;C1547037,true;true;false;false,15208/22402
ff - $nmbr$ % ( - $nmbr$ %  $nmbr$ % ),C4554348,false,15209/22402
ff – $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % ),C4554348;C0008107;C3259781,false;true;false,15210/22402
ff $nmbr$ % ( - $nmbr$ %  $nmbr$ % ),C4554348,false,15211/22402
ff $nmbr$   µ g,C4554348;C0439267,false;false,15212/22402
ff $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % ),C4554348;C0008107;C3259781,false;true;false,15213/22402
ff mdi,C4554348;C0993596;C1839839;C4049613,false;true;true;false,15214/22402
ff / vi,C4554348;C0205999,false;true,15215/22402
ff / vi – $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % ),C4554348;C0205999;C0008107;C3259781,false;true;true;false,15216/22402
ff / vi ( n   =   $nmbr$ ),C4554348;C0205999,false;true,15217/22402
ff / vi $nmbr$ . $nmbr$,C4554348;C0205999,false;true,15218/22402
ff / vi $nmbr$ % ( - $nmbr$ %  $nmbr$ % ),C4554348;C0205999,false;true,15219/22402
ff / vi $nmbr$ / $nmbr$   µ g,C4554348;C0205999;C0439267,false;true;false,15220/22402
ff / vi $nmbr$ % ( $nmbr$ % ci $nmbr$ – $nmbr$ % ),C4554348;C0205999;C0008107;C3259781,false;true;true;false,15221/22402
ff / vi $nmbr$ % ( $nmbr$ %  $nmbr$ % ),C4554348;C0205999,false;true,15222/22402
ffa / i,C0015688;C0021966;C0221138,true;true;false,15223/22402
fg > $nmbr$,C0016703;C0439214;C2348814,true;false;false,15224/22402
fgf - $nmbr$ high / < $nmbr$ elevated biomarkers,C0016026;C0205250;C0005516;C3163633;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false,15225/22402
fgf - $nmbr$ high / > $nmbr$ elevated biomarkers,C0016026;C0205250;C0005516;C3163633;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false,15226/22402
fgf - $nmbr$ high / egfr < $nmbr$,C0016026;C0205250;C1739039;C3811844;C3812682;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false;false,15227/22402
fgf - $nmbr$ high / egfr > $nmbr$,C0016026;C0205250;C1739039;C3811844;C3812682;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C0919505,true;false;true;false;false;false;false;false;false;false;false;false,15228/22402
fgf - $nmbr$ low / < $nmbr$ elevated biomarkers,C0016026;C0205251;C0205250;C0005516;C3163633;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;false;true;false;false;false;false;false;false;false,15229/22402
fgf - $nmbr$ low / > $nmbr$ elevated biomarkers,C0016026;C0205251;C0205250;C0005516;C3163633;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;false;true;false;false;false;false;false;false;false,15230/22402
fgf - $nmbr$ low / egfr < $nmbr$,C0016026;C0205251;C1739039;C3811844;C3812682;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;true;false;false;false;false;false;false;false;false,15231/22402
fgf - $nmbr$ low / egfr > $nmbr$,C0016026;C0205251;C1739039;C3811844;C3812682;C1550472;C3890211;C4048187;C4321351;C4522223;C0919505,true;false;true;false;false;false;false;false;false;false;false,15232/22402
fibrate or other lipid - lowering agent,,,15233/22402
fibrillation / flutter ),C0232197;C0016385;C2242390,false;false;false,15234/22402
fibrin - specilic,C0015982,true,15235/22402
fibrinolysist,,,15236/22402
fibrinolytic,C0040044,true,15237/22402
fibrinolytic agent — no . ( % ) : t,C0016018,true,15238/22402
fibrinolytic agent before randomisation,C0016018;C0034656,true;true,15239/22402
fibrinolytic agents before or after entry,C0016018,true,15240/22402
fibrinolytic therapy — no . ( % ),C0040044,true,15241/22402
fibrinolytics,C0040044,true,15242/22402
fibrofatty,,,15243/22402
fibrofatty  mm ^,C4330985;C4554674,false;false,15244/22402
fibrous,C0016059;C0439709,true;false,15245/22402
fibrous  mm ’,C0016059;C4330985;C4554674;C0439709,true;false;false;false,15246/22402
figure $nmbr$ least squares ( ls ) mean differences between ro ﬂ umilast and placebo in ( a ) pre - and ( b ) postbronchodilator fev $nmbr$ in the itt population and subpopulations . copd  chronic obstructive pulmonary disease  fev $nmbr$  forced expiratory volume in $nmbr$ s  ics  inhaled corticosteroid  itt  intent to treat  laba  long - acting b $nmbr$ - agonist .,C0032042;C0332152;C0740175;C2257086;C3669034;C1696465;C1706408;C0032659;C1257890;C0016529;C0815320;C0004048;C0001617;C3536709;C4551720;C1306036;C0040363;C0041260;C1883351,true;false;false;false;false;false;false;true;true;true;false;true;true;false;true;false;true;true;false,15247/22402
final,C0205088;C1546485;C3853528,false;false;false,15248/22402
final ( mg / dl ),C0205088;C0439269;C1546485;C3853528,false;false;false;false,15249/22402
final a $nmbr$ c ( % ),C0205088;C1546485;C3853528,false;false;false,15250/22402
final analysis ( all patients ),C0205088;C0002778;C0936012;C1524024;C1546485;C3853528,false;false;false;true;false;false,15251/22402
final mean,C0205088;C0444504;C2347634;C2348143;C1546485;C3853528,false;false;false;false;false;false,15252/22402
final timi flow grade < $nmbr$,C0205088;C3272266;C0441800;C0919553;C3244287;C1546485;C3853528,false;false;false;false;false;false;false,15253/22402
first co - primary,C0205435;C3245499;C1279901,false;true;false,15254/22402
first cv hospitalization,C0205435;C3538987;C0019993;C4048877;C4318503;C1279901,false;false;true;true;false;false,15255/22402
first diagnosed,C0205435;C1279901,false;false,15256/22402
first disease - progression outcome to occur §,C0205435;C0679250;C0242656;C0449258;C3542417;C1274040;C1335499;C1947900;C4552808;C1279901,false;false;true;false;false;false;false;false;false;false,15257/22402
first dose admin . $nmbr$ - $nmbr$ h / $nmbr$ - $nmbr$ h post onset of symptoms,C0205435;C4084955;C0033727;C0439568;C4086878;C0369286;C0441932;C0564385;C4528284;C1279901,false;false;true;false;false;false;false;false;false;false,15258/22402
first episode of atrial fibrillation ( vs . recurrent episode ) — no . ( % ) f,C0205435;C0332189;C0004238;C0344434;C1963067;C1279901,false;false;true;false;false;false,15259/22402
first hospitalization for chf or cv death,C0205435;C0019993;C0018802;C1279901,false;true;true;false,15260/22402
first medical contact in ambulance,C0205435;C0199168;C0332158;C0002422;C3846685;C0337611;C1705415;C3812666;C0205476;C1279901,false;false;false;true;false;false;false;false;false;false,15261/22402
first serum creatinine,C0205435;C0201976;C0600061;C1279901,false;false;false;false,15262/22402
first year *,C0205435;C0439234;C0439508;C1279901,false;false;false;false,15263/22402
fistula  ' n ( % ),C0016169,true,15264/22402
fl ( $nmbr$ . $nmbr$ ),C1300812;C1708024,false;false,15265/22402
fl ( $nmbr$ b ),C1300812;C1708024,false;false,15266/22402
flecainide,C0016229,true,15267/22402
flex ain ' ’,C0347129,false,15268/22402
flex aln ^,C0729594;C2681220,false;false,15269/22402
flex baseline bmd t - score at femoral neck ( meanisd ),C0168634;C0449820;C0015815;C4050231;C1442488,true;false;true;false;false,15270/22402
flex baseline bmd t - score at lumbar spine ( meanisd ),C0168634;C0449820;C0024091;C3887615;C4050231;C1442488,true;false;true;false;false;false,15271/22402
flex baseline bmd t score,C0168634;C0449820;C4050231;C1442488,true;false;false;false,15272/22402
flex baseline bmd  g / cm ^ ( meanisd ),C0168634;C0439267;C1442488,true;false;false,15273/22402
flex baseline bmd  mean ( sd )  g / cm $nmbr$,C0168634;C0444504;C2699239;C0439267;C2347634;C2348143;C1442488,true;false;false;false;false;false;false,15274/22402
flex fn f - score < - $nmbr$ . $nmbr$,C1570610;C0016327;C0449820;C4050231,true;true;false;false,15275/22402
flex pbo ®,C0031962,true,15276/22402
fluticasone - salmeterol ( n = $nmbr$ ),C0939232,true,15277/22402
fluticasone alone ( n = $nmbr$ ),C0082607;C0205171;C0439044;C0679994,true;false;false;false,15278/22402
fluticasone propionate / salmeterol fdc,C1622832;C0340427;C1413520;C3539652,true;true;false;false,15279/22402
fn t - score < — $nmbr$ . $nmbr$,C1570610;C0449820;C4050231,true;false;false,15280/22402
fn t - score < = - $nmbr$ . $nmbr$ ( % ),C1570610;C0449820;C4050231,true;false;false,15281/22402
focal,C0205234,false,15282/22402
follow - up,C0589120;C1522577;C1704685;C3274571,false;false;false;false,15283/22402
follow - up in - trial at $nmbr$ yr,C0589120;C0008976;C0439234;C1522577;C1704685;C3274571,false;true;false;false;false;false,15284/22402
fondaparinux — no . ( % ),C1098510,true,15285/22402
fondaparinux ( n = $nmbr$  $nmbr$ ),C1098510,true,15286/22402
fondaparinux ( n = $nmbr$ ),C1098510,true,15287/22402
for baseline hemoglobin $nmbr$ g $nmbr$ ’,C0168634;C1319312;C1442488,true;false;false,15288/22402
for baseline hemoglobin < $nmbr$ g $nmbr$ ',C0168634;C1319312;C1442488,true;false;false,15289/22402
for combined hemoglobin groups,C0205195;C0019046,false;true,15290/22402
for patients not using personal cgm,C0030705,true,15291/22402
for patients using personal cgm,C0030705,true,15292/22402
forearm,C0016536,true,15293/22402
former ( n   = $nmbr$  $nmbr$ ),C0205156;C0750523,false;false,15294/22402
former smoker — no . ( % ),C0337671,false,15295/22402
former smoker — no . { % ),C0337671,false,15296/22402
former smoker ( n = $nmbr$  $nmbr$ ),C0337671,false,15297/22402
former smokers,C0337671,false,15298/22402
former / current smoker ( n = $nmbr$ $nmbr$ ),C0337671;C0521116;C1705970;C0205156;C3173209;C3241966;C0750523,false;false;false;false;false;false;false,15299/22402
formoterol $nmbr$ gg ( n = $nmbr$ ),C0060657;C0017454;C0018370,true;true;true,15300/22402
formoterol $nmbr$ pg,C0060657;C0030827;C0072225;C1266240,true;true;true;false,15301/22402
formoterol $nmbr$ pg vs placebo,C0060657;C0030827;C0072225;C1266240,true;true;true;false,15302/22402
formoterol $nmbr$   μ g ( n   =   $nmbr$ ),C0060657;C0439267,true;false,15303/22402
formoterol tiotropium n = $nmbr$ non - tiotropium n = $nmbr$,C0060657;C0213771;C1518422,true;true;false,15304/22402
fp,C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,15305/22402
fp ( n   = $nmbr$  $nmbr$ ),C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,15306/22402
fp versus no ics,C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,15307/22402
fp versus other ics,C0016704;C1419068;C1419906;C3541238;C3541412,true;false;false;false;false,15308/22402
fpci vs . ppci in men,,,15309/22402
fpci vs . ppci in women,,,15310/22402
fpg,,,15311/22402
fpg ( mmol / $nmbr$ ),C0439190,false,15312/22402
fpg ( mmol / l )  mean ( sd ),C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15313/22402
fpg ( mmol / l )  mean ± s . d .,C0439433;C0444504;C2347634;C2348143,false;false;false;false,15314/22402
fpg change ( mg / dl ) *,C0392747;C0439269;C0443172;C1705241;C4319952,false;false;false;false;false,15315/22402
fpg data ',C1511726;C3245479;C3714741,false;false;false,15316/22402
fpg month $nmbr$ ( mg / dl ),C0332177;C0439269;C0439231,false;false;false,15317/22402
fpg ( mg / dl ) x,C0439269,false,15318/22402
fpg  ( mg / dl ),C0439269,false,15319/22402
fpg  ( mmol / l ),C1532563,false,15320/22402
fpg  mean ( sd )  mg / dlf,C0444504;C2699239;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false;false,15321/22402
fpg  median ( q $nmbr$  q $nmbr$ )  mmol / l,C0549183;C1532563;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,15322/22402
fpg  mg / dl  mean ± sd,C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15323/22402
fpg  mmol / l ( mean ± sd ),C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15324/22402
fpg  mmol / l  mean ( sd ),C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15325/22402
fpg  mmol / la,C0439190;C0023031;C0023749;C0230347;C2346906;C4553351,false;true;true;false;false;false,15326/22402
fpi  gu / ml ( pmol / l ),C0120446;C1635169;C0439192;C0439526;C0439284;C1705224;C3887665;C3887515,true;false;false;false;false;false;false;false,15327/22402
fpi  m - u / ml ( pmol / l ),C0456616;C0439340;C0439192;C1880521;C2945590;C0369637;C0439284;C0441923,false;false;false;false;false;false;false;false,15328/22402
fpi  mean ( sd )  pu / rnff,C0444504;C2699239;C0018387;C2347634;C2348143,false;false;true;false;false,15329/22402
fracture history  n ( % ),C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15330/22402
fracture status prevalent vertebral fractured,C0016658;C0449438;C0033105;C0549207;C4554413;C0220900,true;false;true;true;false;true,15331/22402
fractures,C0016658,true,15332/22402
framingham risk score,C3166866;C0035647;C0449820;C4050231;C4552904,false;true;false;false;false,15333/22402
framingham risk score ( % ),C3166866;C0035647;C0449820;C4050231;C4552904,false;true;false;false;false,15334/22402
framingham risk score *,C3166866;C0035647;C0449820;C4050231;C4552904,false;true;false;false;false,15335/22402
framingham risk score  arbitrary units,C3166866;C0035647;C0449820;C0439183;C4050231;C4552904,false;true;false;false;false;false,15336/22402
freedom from gtc seizures  n ( % ),C1299590,false,15337/22402
freqency of events,C0441471;C3541888,false;false,15338/22402
frequency of events,C0376249;C0441471;C3541888;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352,true;false;false;false;false;false;false;false;false,15339/22402
frequent exacerbator,C0332183,false,15340/22402
frequent or continuous,C0332183,false,15341/22402
fsg ( mg / dl ),C0439269,false,15342/22402
fsg  mg / dl ( mean ± sd ),C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15343/22402
fsn score  mean ± sd,C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false,15344/22402
full analysis set  n,C0443225;C0002778;C0036849;C1442518;C1705195;C0936012;C1524024,false;false;true;false;false;false;true,15345/22402
furosemide equivalent  mg / kg,C0016860;C0205163;C0439272;C0439185,true;false;false;false,15346/22402
fvc,C3714541,true,15347/22402
fvc % predicted !  t,C3714541,true,15348/22402
fvc < $nmbr$ % predicted,C3714541,true,15349/22402
fvc > $nmbr$ % predicted,C3714541,true,15350/22402
fvc change,C3714541;C0392747;C0443172;C1705241;C4319952,true;false;false;false;false,15351/22402
fvc ∗,C3714541,true,15352/22402
fvc  % predicted,C3714541,true,15353/22402
fvc  % predicted  mean ( sd ),C3714541,true,15354/22402
fvc  l  mean ( sd ),C3714541;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15355/22402
fvc  ml,C3714541;C0439526;C1705224;C3887665,true;false;false;false,15356/22402
g,C0439267,false,15357/22402
g - blockers,C0439267,false,15358/22402
g + c,C0439267,false,15359/22402
ga,C0016993,true,15360/22402
ga / a,C0016993,true,15361/22402
gained bmd,C1517378,false,15362/22402
gait,C0016928,true,15363/22402
gamma glutamyltransferase  u / l,C0017040;C0439339,true;false,15364/22402
gastroenteritis,C0017160,true,15365/22402
gastrointestinal ( gi ) disorders,C0017178;C1708130;C3539617;C4050121,true;false;false;false,15366/22402
gastrointestinal area involved  n / total n ( % ),C0521362;C0017446;C0205146,false;true;false,15367/22402
gastrointestinal bleeding,C0017181,true,15368/22402
gastrointestinal disorders,C0017178,true,15369/22402
gastrointestinal event,C0521362;C0441471;C4019010,false;false;false,15370/22402
gastrointestinal major bleed,C0017181;C0205082;C0205164;C4318856;C4521762,true;false;false;false;false,15371/22402
gaviscon da ( n = $nmbr$ ),C0061146;C0011318;C3668815,true;true;false,15372/22402
gemfibrozil ( n = $nmbr$,C0017245,true,15373/22402
gendar,,,15374/22402
gender - male  n ( % ),C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,15375/22402
gender - n ( % ),C0079399;C1522384,true;true,15376/22402
gender ( female : male  % ),C0079399;C0043210;C0086582;C1706180;C1706428;C1706429;C0086287;C1705497;C1705498;C1522384,true;true;true;false;false;false;true;false;false;true,15377/22402
gender ( m / f )  ( % ),C0079399;C1306057;C1522384,true;false;true,15378/22402
gender ( male )  n ( % ),C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,15379/22402
gender ( male / female ) ( number ),C0079399;C0086582;C0043210;C0237753;C0449788;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1522384,true;true;true;false;false;true;false;false;false;false;false;true,15380/22402
gender [ n ( % ) ],C0079399;C1522384,true;true,15381/22402
gender female,C0079399;C0043210;C0086287;C1705497;C1705498;C1522384,true;true;true;false;false;true,15382/22402
gender n ( % ),C0079399;C1522384,true;true,15383/22402
gender  male ( % ),C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,15384/22402
gender  male  n ( % ),C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,15385/22402
gender  male / female,C0079399;C0086582;C0043210;C0086287;C1705497;C1705498;C1706180;C1706428;C1706429;C1522384,true;true;true;true;false;false;false;false;false;true,15386/22402
gender  n ( % ],C0079399;C1522384,true;true,15387/22402
gender    n   ( % men ),C0079399;C0025266;C1522384,true;true;true,15388/22402
gender    n   ( % ),C0079399;C1522384,true;true,15389/22402
gender :,C0079399;C1522384,true;true,15390/22402
gender : male    n   ( % ),C0079399;C0086582;C1706180;C1706428;C1706429;C1522384,true;true;false;false;false;true,15391/22402
gene,C0017337,true,15392/22402
gene / chr / snp,C0017337;C0043459;C0752046;C1527094;C1861559;C3890034;C4050175,true;true;true;false;true;false;false,15393/22402
general allergic events,C0205246;C0700624;C0441471;C3541888;C3812897;C3891294;C4521767,false;false;false;false;false;false;false,15394/22402
general alone,C0205246;C0205171;C0439044;C0679994;C3812897;C3891294;C4521767,false;false;false;false;false;false;false,15395/22402
general anaesthesia,C0002915;C2930406,true;false,15396/22402
general health ( self - reported ),C0424575;C4018875,false;false,15397/22402
general health  self - reported,C0424575;C4018875,false;false,15398/22402
generalized,C0205246,false,15399/22402
genetic subgroup,C0017296;C1079230;C1515021;C0314603,true;false;false;false,15400/22402
genital mycotic infections male $nmbr$,C0740330;C0086582;C1706180;C1706428;C1706429,false;true;false;false;false,15401/22402
genotype,C0017431,true,15402/22402
genotype - by - treatment interaction p values *,C0017431;C0039798;C1704675;C1709380;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;true;false;false;false;false;false,15403/22402
genotype - specific treatment effect hazard ratio ( $nmbr$ % ci ),C0017431;C0205369;C1518681;C2985465;C0008107;C3259781;C1552740,true;false;false;false;true;false;false,15404/22402
gentype,,,15405/22402
geo graphic region : asia,C0017454;C0017446;C0003980;C0205147,true;true;true;false,15406/22402
geographic region  n ( % ),C0017446,true,15407/22402
geographic region ?,C0017446,true,15408/22402
geographic region ^,C0017446,true,15409/22402
geographical location  n ( % ),C4545686,false,15410/22402
geometric anti - dsdna antibody binding level,C0449829;C2355607;C1145667;C0441889;C0456079;C1547707;C2946261;C1167622;C2746079,false;false;false;false;false;false;false;false;false,15411/22402
geometric c $nmbr$ concentration  mg / dl,C0449829;C0086045;C0439269;C1446561;C3827302,false;true;false;false;false,15412/22402
geometric mean blood eosinophil count on loge scale — cells / ^ ljj,C2986759;C0200638;C2697934;C0175659;C0349674;C1947916,false;false;false;true;false;false,15413/22402
geometric mean ige on loge scale — u / ml,C2986759;C2697934;C0175659;C0439340;C1880521;C2945590;C0349674;C1947916,false;false;true;false;false;false;false;false,15414/22402
geometric mean ofcrp — mg / liter ( range ),C2986759;C0024671;C0475211;C1514721;C2348147;C3542016;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;false;false;true;false;false;false;false;false,15415/22402
geometric mean uacr,C2986759,false,15416/22402
gertder,,,15417/22402
getgoal - l - asia,C0003980,true,15418/22402
getgoal - s,,,15419/22402
gff mdi,C0993596;C1839839;C4049613,true;true;false,15420/22402
gfr ( ckd - epi ),C0017654;C1561643;C0162734;C4281721;C1424601,true;true;true;false;false,15421/22402
gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0017654;C0439445;C0369637;C0441923;C1424601,true;false;false;false;false,15422/22402
gfr < $nmbr$,C0017654;C1424601,true;false,15423/22402
gfr > $nmbr$,C0017654;C1424601,true;false,15424/22402
gfr $nmbr$ $nmbr$,C0017654;C1424601,true;false,15425/22402
gfr $nmbr$ - $nmbr$,C0017654;C1424601,true;false,15426/22402
gg,C0017454;C0018370,true;true,15427/22402
ggt increased,C1415053,false,15428/22402
gi bleed,C1708130;C3539617;C4050121,false;false;false,15429/22402
gi major bleeding,C0017181;C0205082;C0205164;C4318856;C4521762,true;false;false;false;false,15430/22402
giargine,,,15431/22402
giimepiride ± oad,,,15432/22402
glacial $nmbr$,,,15433/22402
glargine $nmbr$,C0907402,true,15434/22402
glargine allocation,C0907402;C1706778,true;false,15435/22402
glargine n ( n / loopy ),C0907402,true,15436/22402
glatiramer acetate  no . ( % ),C0289884,true,15437/22402
glimepiride,C0061323,true,15438/22402
glipizide ( n = $nmbr$ ),C0017642,true,15439/22402
global trial population,C0205246;C0008976;C0032659;C1257890;C2348867,false;true;true;true;false,15440/22402
glp - $nmbr$ analogue,C0018301;C0243071;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,15441/22402
glp - $nmbr$ receptor agonist,C0018301;C4543206;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,15442/22402
glp - $nmbr$ receptor agonists,C0018301;C4543206;C1422069;C1425391;C1539338;C2350813,true;false;false;false;false;true,15443/22402
glu $nmbr$ asp g . t,C0125690;C0439267,true;false,15444/22402
glucagon - like peptide - $nmbr$ receptor agonist,C0014361;C4543206,true;false,15445/22402
glucocorticoid ],C0017710,true,15446/22402
glucocorticoids at baseline,C0017710;C0168634;C1442488;C3540777;C3540778,true;true;false;false;false,15447/22402
glucocorticoids combined with immunosuppressive agents,C0017710;C3540777;C3540778,true;false;false,15448/22402
glucosamine,C0017718,true,15449/22402
glucosamine + chondroitin sulfate,C0017720;C0008454;C0876712;C0038720;C0474702;C0475337;C3536965;C0017718;C0008466,true;true;false;true;false;false;false;true;true,15450/22402
glucose - lowering medication,C0017725;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,15451/22402
glucose - lowering medications,C0017725;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888,true;false;true;false;false;false;false,15452/22402
glucose - lowering therapies — no . { % ),C0017725;C0441994;C0087111;C2003888,true;false;true;false,15453/22402
glucose - lowering therapy,C0017725;C0441994;C0039798;C0087111;C1363945;C2003888,true;false;true;true;false;false,15454/22402
glucose - lowering therapy - no . ( % ),C0017725;C0441994;C0039798;C0087111;C1363945;C2003888,true;false;true;true;false;false,15455/22402
glucose - lowering therapy  n ( % ),C0017725;C0441994;C0039798;C0087111;C1363945;C2003888,true;false;true;true;false;false,15456/22402
glucose — mmol / liter,C0017725;C0439190;C0475211,true;false;false,15457/22402
glucose in urine    ≥ $nmbr$ +,C0004076,false,15458/22402
glucose  mg / dl  mean,C0017725;C0439269;C0444504;C2347634;C2348143,true;false;false;false;false,15459/22402
glucose  non - fasting or random ( nmol / l ),C0017725,true,15460/22402
glulisine + oad,,,15461/22402
glulisine monotherapy,,,15462/22402
gly,C0017890;C0523677,true;false,15463/22402
gly ( $nmbr$ . $nmbr$ pg b . i . d . ) n = $nmbr$,C1415124;C0030827;C0152277;C0072225;C1266240,false;true;false;true;false,15464/22402
gly $nmbr$ μ g bid,C0017890;C0439267;C0523677,true;false;false,15465/22402
glycaemic control ( hba $nmbr$ c )  n ( % ),C0005802;C0243148;C0019016;C1825777;C3538758;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;true;false;false;false;false;false;false;false,15466/22402
glycaemic control group,C0005802;C0009932,true;true,15467/22402
glycaemic parameters,C0005802;C0449381,true;false,15468/22402
glycated haemoglobin  %,C0017853,true,15469/22402
glycated hemoglobin — % -,C0017853,true,15470/22402
glycated hemoglobin  %  mean ( sd ),C0017853;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15471/22402
glycated hemoglobin | |,C0017853,true,15472/22402
glycemic characteristics,C0005802;C1521970,true;false,15473/22402
glycemic indexes,C1136206,true,15474/22402
glycemic status,C1320980,false,15475/22402
glycemic status f,C1320980;C0016327,false;true,15476/22402
glycemic variability  mmol / lc,C0005802;C2827666;C0439190,true;false;false,15477/22402
glyceryl trinitrate infusion,C0017887;C0574032;C1827465,true;false;false,15478/22402
glycohemoglobin  %,C0202054;C0696092,false;false,15479/22402
glycohemoglobin  %  mean ( sd ),C0202054;C0444504;C2699239;C2347634;C2348143;C0696092,false;false;false;false;false;false,15480/22402
glycoprotein iib / iiia inhibitor use before angiography,C0016011;C1999216;C0042153;C0002978;C0457083;C1947944,true;false;true;true;false;false,15481/22402
glycoprotein iib / iiia inhibitort,C0016011,true,15482/22402
glycoprotein llb / illa inhibitor,C0017968;C1999216,true;false,15483/22402
glycoprotein llb / llia inhibitor,C0017968;C1999216,true;false,15484/22402
glycoprotein llb / llla receptor inhibitor,C0017968;C0597357;C1999216,true;false;false,15485/22402
glycopyrrolate / glycopyrrolate / eflow cs $nmbr$ meg eflow cs $nmbr$ meg ( n = $nmbr$ ) ( n = $nmbr$ ),C0017970;C0010182;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345,true;true;true;true;true;false;false;false,15486/22402
glycopyrrolate / eflow cs $nmbr$ meg ( n = $nmbr$ ),C0017970;C0010182;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345,true;true;true;true;true;false;false;false,15487/22402
glyeated haemoglobin,C0019046,true,15488/22402
gm,C0017480;C3854019,true;true,15489/22402
gm  geometric mean  gmr  geometric mean ratio over baseline  uacr  urinary albumimcreatinine ratio . % reduction : $nmbr$ x ( $nmbr$ — ratio of gmr for losartan versus gmr for placebo ) . amean of change  with change calculated as difference between time indicated and baseline as measured for each participant  difference of changes between treatment groups . cp - values compare differences from no change .,C0017480;C2986759;C1522544;C0456603;C0168634;C1442488;C1547037;C1704695;C3854019;C1273442;C0301630;C1522544;C1704695;C0392756;C1293152;C4551656;C1442103;C1547049;C0679646;C1705241;C0392747;C0443172;C1705242;C2698741;C4554048;C1707455,true;false;true;false;true;false;false;false;true;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false,15490/22402
gmi ( men ),C0025266,true,15491/22402
gmi ( women ),C0043210,true,15492/22402
gmr,C1522544;C1704695,true;false,15493/22402
goal,C0018017;C1571704,true;false,15494/22402
gold $nmbr$ ( « = $nmbr$ ),C0018026;C1304897,true;false,15495/22402
gold $nmbr$ - $nmbr$,C0018026;C1304897,true;false,15496/22402
gold $nmbr$ - $nmbr$ ( « = $nmbr$ ),C0018026;C1304897,true;false,15497/22402
gold $nmbr$ - $nmbr$ ( n = $nmbr$ ),C0018026;C1304897,true;false,15498/22402
gold classification,C0018026;C0008902;C0008903;C0678229;C1304897,true;true;true;false;false,15499/22402
gold grade $nmbr$,C0018026;C0441800;C0919553;C3244287;C1304897,true;false;false;false;false,15500/22402
gold grade $nmbr$ and ics non - users at screening,C0018026;C0441800;C0919553;C3244287;C1304897,true;false;false;false;false,15501/22402
gold grade $nmbr$ and ics users at screening,C0018026;C0441800;C0919553;C3244287;C1304897,true;false;false;false;false,15502/22402
gold grades $nmbr$ - $nmbr$ ( percent - predicted fev ( )  n,C0018026;C1304897,true;false,15503/22402
gold group,C0018026;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1304897,true;false;false;true;false;false;false;false,15504/22402
gold group a,C0018026;C0441835;C4522145;C1304897,true;false;false;false,15505/22402
gold group b,C0018026;C4522078;C1304897,true;false;false,15506/22402
gold group c,C0018026;C0441837;C1304897,true;false;false,15507/22402
gold group d,C0018026;C0441838;C1304897,true;false;false,15508/22402
gold group  n ( % ),C0018026;C0441848;C1304897,true;false;false,15509/22402
gold groups a - d using mmrcb,C0018026;C1304897,true;false,15510/22402
gold stage ( % ) : c,C0018026;C0441785;C1304897,true;false;false,15511/22402
gold stage  n ( % ),C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,15512/22402
gold stage  nf * ( % ),C0018026;C0205390;C1300072;C1306673;C1304897,true;false;false;false;false,15513/22402
golden - $nmbr$ and - $nmbr$,,,15514/22402
golden - $nmbr$,,,15515/22402
golimumab,C2353893,true,15516/22402
golimumab $nmbr$ mg ( n = $nmbr$ ),C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15517/22402
golimumab $nmbr$ mg / kg + mtx,C2353893;C0439272;C0025677;C1417487,true;false;true;false,15518/22402
golimumab $nmbr$ / $nmbr$ mg,C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15519/22402
golimumab $nmbr$ mg ( n = $nmbr$ ) †,C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15520/22402
golimumab $nmbr$ mg / $nmbr$ mgt,C2353893;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,15521/22402
golimumab combined ( n = $nmbr$ ),C2353893;C0205195,true;false,15522/22402
goncomitant treatment with age inhibitors / angiotensin,C0039798;C0001779;C0243077;C0003018;C4521302;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;true;false;true;false;false;false;false;false,15523/22402
good,C0205170,false,15524/22402
good control ( < $nmbr$ ),C0205170;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389,false;true;false;false;false;false;false,15525/22402
good / moderate response,C0205170;C4085643,false;false,15526/22402
gout history  mean ± sd years,C0018099;C0019664;C0444504;C2699239;C0439234;C2347634;C2348143;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false;false;true;false;false;false;false,15527/22402
gp iib / iiia inhibitor before pci — no . ( % ),C0016011;C1999216;C4049621,true;false;false,15528/22402
gp iib / iiia inhibitor used,C0016011;C1999216,true;false,15529/22402
gp iib / iiia inhibitors,C0016011;C0243077,true;true,15530/22402
gp mdi,C1705010;C0993596;C1839839;C4049613;C3811116,false;true;true;false;false,15531/22402
gpifo ' llia inhibitor use before angography,C1999216;C0042153;C0457083;C1947944,false;true;false;false,15532/22402
gpiib - iiia inhibitors,C0016011;C0243077,true;true,15533/22402
grade > $nmbr$,C0441800;C0919553;C3244287,false;false;false,15534/22402
grade $nmbr$ ( moderate copd )  n ( % ),C0441800;C0919553;C3244287,false;false;false,15535/22402
grade $nmbr$ ( severe copd )  n ( % ),C0441800;C0919553;C3244287,false;false;false,15536/22402
grade of hypertension,C0441800;C0020538;C1963138;C0919553;C3244287,false;true;false;false;false,15537/22402
graft,C0181074;C0332835;C1961139,false;true;false,15538/22402
graft  pci  percutaneous coronary intervention  tia  transient,C0181074;C1532338;C0007787;C0917805;C1054154;C0332835;C1961139,false;true;true;true;false;true;false,15539/22402
granulating  n ( % ) a,,,15540/22402
grip strength < meidan,C0429271;C2598165,false;false,15541/22402
grip strength > = median,C0429271;C0549183;C0876920;C2347635;C2348144;C2939193;C2598165,false;false;false;false;false;false;false,15542/22402
group,C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,15543/22402
group b ( low risk  more symptoms )  n ( % ),C0441848;C3272281;C0683368;C1457887;C3538919,false;false;true;false;false,15544/22402
group d ( high risk  more symptoms )  n ( % ),C0441848;C0332167;C0683368;C1457887;C3272283;C4050568;C4319571,false;false;true;false;false;false;false,15545/22402
group difference,C0441833;C1705241;C1705242;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;false;false;true;false;false;false,15546/22402
groups,C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429,false;false;true;false;false;false;false,15547/22402
grs,C1412761;C3539564,false;false,15548/22402
gt,C1435727;C1704693;C2697657,true;false;false,15549/22402
gt + tt,C1435727;C1452561;C4554543;C1704693;C2697657,true;true;false;false;false,15550/22402
gusto - bleeding severe / moderate,,,15551/22402
gusto moderate bleeding / ich,C0205081;C0019080;C0019191;C3272597;C3281105;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false;false,15552/22402
gusto moderate or severe,,,15553/22402
gusto moderate / severe bleed,,,15554/22402
gusto moderate / severe bleeding,,,15555/22402
gusto severe bleed,C0205082;C0019080;C4050465;C4050466,false;true;false;false,15556/22402
gusto severe or,,,15557/22402
gusto severe / moderate,C1299393,false,15558/22402
h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,15559/22402
h dl cholesterol < $nmbr$ mg / dl,C0033727;C3539687;C0008377;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0369286;C0441932;C0564385;C4528284,true;false;true;true;true;false;false;false;false;false;false;false;false;false,15560/22402
h pylori serology *,C0079488;C0036745;C0220911;C0455278,true;true;false;false,15561/22402
h . pylori status  n ( % ),C0079488;C0449438,true;false,15562/22402
h $nmbr$ - receptor antagonist,C0033727;C4543207;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false;false,15563/22402
h $nmbr$ blocker ( n  % ) long - term vka therapy,C0033727;C0443252;C0039798;C0087111;C1363945;C0369286;C0441932;C0564385;C4528284,true;false;true;true;false;false;false;false;false,15564/22402
h $nmbr$ receptor antagonist,C0033727;C4543207;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false;false,15565/22402
haematological,C0018943;C0200627,true;false,15566/22402
haemoglobin ( mg / dl ),C0019046;C0439269,true;false,15567/22402
haemorrhagic stroke,C0553692,true,15568/22402
haemorrhagic stroke — no . ( % ),C0553692,true,15569/22402
hale,,,15570/22402
hand,C0018563;C1552914,true;false,15571/22402
hands,C0018563;C1552914,true;false,15572/22402
haplotype,C0018591,true,15573/22402
haq - di ( $nmbr$ - $nmbr$ ),C3826998;C4321476,false;false,15574/22402
haq - di ( range $nmbr$ - $nmbr$ ),C3826998;C1514721;C2348147;C3542016;C4321476,false;false;false;false;false,15575/22402
haq - di improvement from baseline to week $nmbr$,C3826998;C2986411;C0168634;C1442488;C4321476,false;false;true;false;false,15576/22402
haq - di mcide,C3826998;C4321476,false;false,15577/22402
haq - di score ( $nmbr$ - $nmbr$ )  mean ( sd ),C3826998;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C4321476,false;false;false;false;false;false;false;false,15578/22402
haq - di  mean [ sd ],C3826998;C0444504;C2699239;C2347634;C2348143;C4321476,false;false;false;false;false;false,15579/22402
haq - di  range $nmbr$ - $nmbr$  mean ( sd ),C3826998;C1514721;C0444504;C2699239;C2347634;C2348143;C2348147;C3542016;C4321476,false;false;false;false;false;false;false;false;false,15580/22402
haq alternative disability score,C0102923;C1523987;C0231170;C0449820;C4050231;C0451208,true;false;false;false;false;false,15581/22402
haq di,C3826998;C4321476,false;false,15582/22402
haq di ( range $nmbr$ - $nmbr$ ),C3826998;C1514721;C2348147;C3542016;C4321476,false;false;false;false;false,15583/22402
haq di score ( $nmbr$ - $nmbr$ ),C3826998;C0449820;C4050231;C4321476,false;false;false;false,15584/22402
haq di score ( range $nmbr$ - $nmbr$ )  mean ± sd,C3826998;C0449820;C1514721;C0444504;C2699239;C2347634;C2348143;C2348147;C3542016;C4050231;C4321476,false;false;false;false;false;false;false;false;false;false;false,15585/22402
haq pain scale  mean,C0102923;C1504479;C0444504;C2347634;C2348143;C0451208,true;false;false;false;false;false,15586/22402
haq pain score,C0102923;C0582148;C0451208,true;false;false,15587/22402
haq score,C0102923;C0451208,true;false,15588/22402
haq score ( $nmbr$ – $nmbr$ scale ),C0102923;C0449820;C0175659;C0349674;C1947916;C4050231;C0451208,true;false;true;false;false;false;false,15589/22402
hard mace,C0018599;C0349381;C0949745;C1445339,true;false;true;false,15590/22402
harzar ratio ( $nmbr$ % ci ),C0456603;C0008107;C3259781;C1547037,false;true;false;false,15591/22402
harzard ratio ( $nmbr$ % ci ),C0456603;C0008107;C3259781;C1547037,false;true;false;false,15592/22402
has - bled > $nmbr$,,,15593/22402
has - bled $nmbr$ - $nmbr$,,,15594/22402
has - bled score,,,15595/22402
has - bled score > $nmbr$,,,15596/22402
has - bled score ’,,,15597/22402
has - bledo,,,15598/22402
hazard inleraction,C0598697,false,15599/22402
hazard interaction,C0598697;C1704675,false;false,15600/22402
hazard ratio ( $nmbr$ % c,C2985465,false,15601/22402
hazard ratio ( $nmbr$ % ci ) - j -,C2985465;C0008107;C3259781,false;true;false,15602/22402
hazard ratio ( $nmbr$ % ci ) for adjudicated type $nmbr$ diabetes,C2985465;C0008107;C1320657;C3259781,false;true;false;false,15603/22402
hazard ratio ( $nmbr$ % ci ) vs . placebo,C2985465;C0008107;C3259781,false;true;false,15604/22402
hazard ratio ( $nmbr$ % ci ) $nmbr$ with vs . without psoriasis,C2985465;C0008107;C3259781,false;true;false,15605/22402
hazard ratio ( $nmbr$ % cl ) nateglinide vs . placebo,C2985465;C0596019;C0903898,false;false;true,15606/22402
hazard ratio ( $nmbr$ % cl ) valsartan vs . placebo,C2985465;C0596019;C0216784,false;false;true,15607/22402
hazard ratio ( $nmbr$ % cl ) *,C2985465;C0596019,false;false,15608/22402
hazard ratio ( $nmbr$ % cl ],C2985465;C0596019,false;false,15609/22402
hazard ratio [ $nmbr$ % cl ],C2985465;C0596019,false;false,15610/22402
hazard ratio [ $nmbr$ % ci ],C2985465;C0008107;C3259781,false;true;false,15611/22402
hazard ratio $nmbr$ ),C2985465,false,15612/22402
hazard ratio and $nmbr$ % confidence interval,C2985465,false,15613/22402
hazard ratio for cardiovascular death,C2985465;C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,false;true;true;false;false;false;false,15614/22402
hazard ratio glp - $nmbr$ analogue vs placebo [ $nmbr$ % cl ],C2985465;C0018301;C0243071;C1422069;C1425391;C1539338;C2350813,false;true;false;false;false;false;true,15615/22402
hazard ratio vs . placebo,C2985465,false,15616/22402
hazard ratio with,C2985465,false,15617/22402
hazard ratio with dabigatran  $nmbr$ mg ( $nmbr$ % cl ),C2985465;C2348066;C0024671;C0596019;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;true;false;false;false;false;false,15618/22402
hazard ratio with high ( $nmbr$ % cl ),C2985465;C0205250;C0596019;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,15619/22402
hazard ratio with low ( $nmbr$ % cl ),C2985465;C0205251;C0596019;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,15620/22402
hazard ratio * ( and $nmbr$ % ci ),C2985465,false,15621/22402
hazard ratio  umec / vi vs . tio ( $nmbr$ % ci ),C2985465;C0205999,false;true,15622/22402
hazard ratio $nmbr$,C2985465,false,15623/22402
hazard . ratio . ( $nmbr$ % ci ) . . . . . . . . . .,C2985465;C0008107;C3259781,false;true;false,15624/22402
hb decrease ≥ $nmbr$ g / dl,C3843510;C0392756;C3642216;C0547047;C0019046;C0439267,false;false;false;false;true;false,15625/22402
hb  g / dl,C3843510;C3642216;C0019046;C0439267,false;false;true;false,15626/22402
hba   ( % ),C0019016;C1825777;C3538758,true;false;false,15627/22402
hba $nmbr$ c — % cholesterol — mmol / l,C0019016;C0008377;C1532563;C1825777;C3538758,true;true;false;false;false,15628/22402
hba $nmbr$ c % ( range ),C0019016;C1514721;C2348147;C3542016;C1825777;C3538758,true;false;false;false;false;false,15629/22402
hba $nmbr$ c ( % patients < $nmbr$ . $nmbr$ % ),C0019016;C0030705;C1825777;C3538758,true;true;false;false,15630/22402
hba $nmbr$ c ( % ) *,C0019016;C1825777;C3538758,true;false;false,15631/22402
hba $nmbr$ c ( % )  mean ( sd ),C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,15632/22402
hba $nmbr$ c ( change from baseline ),C0019016;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C1825777;C3538758,true;false;true;false;false;false;false;false;false,15633/22402
hba $nmbr$ c ( mmol / mol [ se ] ),C0019016;C3829066;C0036919;C1825777;C3538758,true;false;true;false;false,15634/22402
hba $nmbr$ c ( sd )  %,C0019016;C2699239;C1825777;C3538758,true;false;false;false,15635/22402
hba $nmbr$ c ( sd )  mmol / mol,C0019016;C2699239;C3829066;C1825777;C3538758,true;false;false;false;false,15636/22402
hba $nmbr$ c \n,C0019016;C1825777;C3538758,true;false;false,15637/22402
hba $nmbr$ c < $nmbr$ . $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,15638/22402
hba $nmbr$ c < $nmbr$ . $nmbr$ %  bp < $nmbr$ / $nmbr$ mm hg  ldl - c < $nmbr$ mg / dl,C0019016;C0037623;C0439475;C0439269;C1415692;C1708288;C4318478;C1825777;C3538758,true;true;false;false;false;false;false;false;false,15639/22402
hba $nmbr$ c < $nmbr$ % level,C0019016;C0441889;C0456079;C1547707;C2946261;C1825777;C3538758,true;false;false;false;false;false;false,15640/22402
hba $nmbr$ c ≤ $nmbr$ . $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,15641/22402
hba $nmbr$ c ≤ $nmbr$ . $nmbr$ % without gi adverse reactions,C0019016;C1708130;C0559546;C3539617;C4050121;C1825777;C3538758,true;false;false;false;false;false;false,15642/22402
hba $nmbr$ c > $nmbr$ . $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,15643/22402
hba $nmbr$ c > $nmbr$ % level,C0019016;C0441889;C0456079;C1547707;C2946261;C1825777;C3538758,true;false;false;false;false;false;false,15644/22402
hba $nmbr$ c > $nmbr$ · $nmbr$ %,C0019016;C1825777;C3538758,true;false;false,15645/22402
hba $nmbr$ c $nmbr$ weeks,C0019016;C0439230;C1825777;C3538758,true;false;false;false,15646/22402
hba $nmbr$ c at baseline,C0019016;C0168634;C1442488;C1825777;C3538758,true;true;false;false;false,15647/22402
hba $nmbr$ c at baseline :,C0019016;C0168634;C1442488;C1825777;C3538758,true;true;false;false;false,15648/22402
hba $nmbr$ c categories  n ( % ),C0019016;C0683312;C1825777;C3538758,true;false;false;false,15649/22402
hba $nmbr$ c category,C0019016;C0683312;C3889287;C1825777;C3538758,true;false;false;false;false,15650/22402
hba $nmbr$ c distribution at baseline,C0019016;C0520511;C0168634;C1442488;C1704711;C1825777;C3538758,true;false;true;false;true;false;false,15651/22402
hba $nmbr$ c in % ( median ( q $nmbr$  q $nmbr$ ) [ n ] ),C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,15652/22402
hba $nmbr$ c month $nmbr$ ( % ),C0019016;C0332177;C0439231;C1825777;C3538758,true;false;false;false;false,15653/22402
hba $nmbr$ c strata,C0019016;C1825777;C3538758,true;false;false,15654/22402
hba $nmbr$ c tx difference vs pbo  median change from baseline ( se ) $nmbr$,C0019016;C0041403;C1705241;C1705242;C1825777;C3538758,true;true;false;false;false;false,15655/22402
hba $nmbr$ c   ( % ),C0019016;C1825777;C3538758,true;false;false,15656/22402
hba $nmbr$ c   ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,15657/22402
hba $nmbr$ c   at randomization,C0019016;C0034656;C1825777;C3538758,true;true;false;false,15658/22402
hba $nmbr$ c   baseline ( % ),C0019016;C0168634;C1442488;C1825777;C3538758,true;true;false;false;false,15659/22402
hba $nmbr$ c ( % ) ( median ( iqr ),C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,15660/22402
hba $nmbr$ c  % ( mean ± sd ) [ range ],C0019016;C0444504;C2699239;C1514721;C2348147;C3542016;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false;false;false;false,15661/22402
hba $nmbr$ c  % ( mean $nmbr$ sd ),C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,15662/22402
hba $nmbr$ c  % [ mmol / mol ],C0019016;C3829066;C1825777;C3538758,true;false;false;false,15663/22402
hba $nmbr$ c  % *,C0019016;C1825777;C3538758,true;false;false,15664/22402
hba $nmbr$ c  %  median ( q $nmbr$  q $nmbr$ ),C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,15665/22402
hba $nmbr$ c  % d,C0019016;C1825777;C3538758,true;false;false,15666/22402
hba $nmbr$ c  ( % ),C0019016;C1825777;C3538758,true;false;false,15667/22402
hba $nmbr$ c  ( mmol / mol ),C0019016;C3829066;C1825777;C3538758,true;false;false;false,15668/22402
hba $nmbr$ c  < $nmbr$ . $nmbr$,C0019016;C1825777;C3538758,true;false;false,15669/22402
hba $nmbr$ c  > $nmbr$ . $nmbr$,C0019016;C1825777;C3538758,true;false;false,15670/22402
hba $nmbr$ c  $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$,C0019016;C1825777;C3538758,true;false;false,15671/22402
hba $nmbr$ c  baseline mean hba $nmbr$ c  % ( sd ),C0019016;C0168634;C0444504;C2699239;C2347634;C2348143;C1442488;C1825777;C3538758,true;true;false;false;false;false;false;false;false,15672/22402
hba $nmbr$ c  difference vs placebo ( $nmbr$ % cl ),C0019016;C1705241;C1705242;C1825777;C3538758,true;false;false;false;false,15673/22402
hba $nmbr$ c  mean ( sd ),C0019016;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,15674/22402
hba $nmbr$ c  median ( q $nmbr$ – q $nmbr$ ),C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,15675/22402
hba $nmbr$ c  median ( q $nmbr$  q $nmbr$ )  %,C0019016;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false,15676/22402
hba $nmbr$ c  mmol / mol ( mean ),C0019016;C3829066;C0444504;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false,15677/22402
hba $nmbr$ c  mmol / mol  mean ( sd ),C0019016;C3829066;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;false;false;false;false;false;false;false,15678/22402
hba $nmbr$ c  mmol / mol  median ( q $nmbr$  q $nmbr$ ),C0019016;C3829066;C0549183;C0876920;C2347635;C2348144;C2939193;C1825777;C3538758,true;false;false;false;false;false;false;false;false,15679/22402
hba $nmbr$ c  mmol / mold,C0019016;C0439190;C0369241;C1825777;C3538758,true;false;true;false;false,15680/22402
hba $nmbr$ c  mmol / mole,C0019016;C3829066;C1825777;C3538758,true;false;false;false,15681/22402
hba $nmbr$ c  n,C0019016;C1825777;C3538758,true;false;false,15682/22402
hba $nmbr$ ca  %  mean ± sd,C0019016;C3887642;C0444504;C2699239;C2347634;C2348143;C1825777;C3538758,true;true;false;false;false;false;false;false,15683/22402
hbai,,,15684/22402
hbaic ( % )  mean ± s . d .,C0444504;C2347634;C2348143,false;false;false,15685/22402
hbaic group ( % ),C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,false;false;true;false;false;false,15686/22402
hbaie ( % ),,,15687/22402
hbaie ( % ) mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,15688/22402
hbaie  %,,,15689/22402
hbaj ( - ( %  mmol / mol ),C3829066,false,15690/22402
hbajc ( mmol / mol ) mean ± sd,C3829066;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15691/22402
hbalc,,,15692/22402
hbalc ( mmol / mol ),C3829066,false,15693/22402
hbalc £ $nmbr$ mmol / mol ( £ $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),C3829066,false,15694/22402
hbalc £ $nmbr$ mmol / mol ( < $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),C3829066,false,15695/22402
hbalc £ $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),C3829066,false,15696/22402
hbalc < $nmbr$ mmol / mol ( < $nmbr$ . $nmbr$ % ) at week $nmbr$,C3829066;C0332174;C0439230,false;false;false,15697/22402
hbalc < $nmbr$ % ( $nmbr$ mmol / mol ),C3829066,false,15698/22402
hbalc < $nmbr$ mmol / mol ( £ $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),C3829066,false,15699/22402
hbalc < $nmbr$ mmol / mol ( < $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),C3829066,false,15700/22402
hbalc < $nmbr$ %,,,15701/22402
hbalc > $nmbr$ - < $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),C3829066,false,15702/22402
hbalc > $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),C3829066,false,15703/22402
hbalc > $nmbr$ %,,,15704/22402
hbalc a $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ ),,,15705/22402
hbalc in %  median ( iqr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,15706/22402
hbalc  %  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,15707/22402
hbalc  mmol / mol,C3829066,false,15708/22402
hbau  %,,,15709/22402
hc,C0020268;C0262499;C1413512,true;false;false,15710/22402
hcru ( a ),,,15711/22402
hctz - hydrochlorothiazide . * data were missing for some patients .,C0020261;C1511726;C3245479;C3714741,true;false;false;false,15712/22402
hctz = hydrochlorothiazide . * based on a ' / _ $nmbr$ test  t data were missing for some patients .,C0020261,true,15713/22402
hd ( n = $nmbr$ ),,,15714/22402
hd edoxaban vs warfarin,C2975435,true,15715/22402
hder *,C3898895,false,15716/22402
hdl - c ( mg / dl ) *,C3715113;C0439269,false;false,15717/22402
hdl - c < $nmbr$ mg / dl,C3715113;C0439269,false;false,15718/22402
hdl - c < $nmbr$ mg / dl  no . ( % ),C3715113;C0439269,false;false,15719/22402
hdl - c < $nmbr$ mg / dl_,C3715113;C0439269,false;false,15720/22402
hdl - c > $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l ),C3715113;C0439269;C1532563,false;false;false,15721/22402
hdl - c at baseline .,C3715113;C0168634;C1442488,false;true;false,15722/22402
hdl - c level  < $nmbr$ mg / dld,C3715113;C0441889;C0024671;C1414063;C2826331;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0456079;C1547707;C2946261,false;false;true;false;false;true;false;false;false;false;false;false;false;false,15723/22402
hdl - c level  mean ( sd )  mg / dl,C3715113;C0441889;C0444504;C2699239;C0439269;C2347634;C2348143;C0456079;C1547707;C2946261,false;false;false;false;false;false;false;false;false;false,15724/22402
hdl - c level  mg / dl,C3715113;C0441889;C0439269;C0456079;C1547707;C2946261,false;false;false;false;false;false,15725/22402
hdl - c   high - density lipoprotein cholesterol    ldl - c   low - density lipoprotein cholesterol    sestandard error    tg   triglycerides .,C0023822;C0858892;C0743559;C0337445;C1608199,true;false;false;false;false,15726/22402
hdl - c  mg / dl  mean ( sd ),C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,15727/22402
hdl - c  mmol / l  mean ( sd ),C3715113;C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,15728/22402
hdl - c  $nmbr$ mg / dl  n ( % ),C3715113;C0439269,false;false,15729/22402
hdl - c < $nmbr$ mg / dl . n ( % ),C3715113;C0439269,false;false,15730/22402
hdl - cholesterol  mean ( sd ) mg / dl,C0023822;C0444504;C2699239;C0439269;C2347634;C2348143;C0392885,true;false;false;false;false;false;false,15731/22402
hdl - cholesterol  mg / dl  mean ( sd ),C0023822;C0439269;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;false;false;false;false;false,15732/22402
hdl - cholesterol  mmol / l,C0023822;C1532563;C0392885,true;false;false,15733/22402
hdl - cholesterol  mmol / le,C0023822;C0439190;C0023190;C0439090;C1423767;C2697858;C0392885,true;false;true;false;false;false;false,15734/22402
hdl — female,C3715113;C0043210;C0086287;C1705497;C1705498,false;true;true;false;false,15735/22402
hdl — male,C3715113;C0086582;C1706180;C1706428;C1706429,false;true;false;false;false,15736/22402
hdl < $nmbr$ mg / dl,C3715113;C0439269,false;false,15737/22402
hdl cholesterol ( mmol / l ) ( median  iqr ),C0023822;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193;C0392885,true;false;false;false;false;false;false;false,15738/22402
hdl cholesterol ( mmol / l )  mean ( sd ),C0023822;C1532563;C0444504;C2699239;C2347634;C2348143;C0392885,true;false;false;false;false;false;false,15739/22402
hdl cholesterol ( sd )  mg / dl,C0023822;C2699239;C0439269;C0392885,true;false;false;false,15740/22402
hdl cholesterol < $nmbr$ mg / dl *,C0023822;C0439269;C0392885,true;false;false,15741/22402
hdl cholesterol level,C0023822;C0441889;C0456079;C1547707;C2946261;C0392885;C3715113;C0201950;C0428466,true;false;false;false;false;false;false;false;false,15742/22402
hdl cholesterol mean,C0023822;C0444504;C2347634;C2348143;C0392885,true;false;false;false;false,15743/22402
hdl cholesterol  mean ( sd )  mg / dl,C0023822;C0444504;C2699239;C0439269;C2347634;C2348143;C0392885,true;false;false;false;false;false;false,15744/22402
hdl cholesterol  mmol / lt,C0023822;C0439190;C0023376;C0230426;C3887647;C4521399;C0392885,true;false;true;false;false;false;false,15745/22402
hdl cholesterol ^ :,C0023822;C0392885,true;false,15746/22402
hdl  mean ( sd )  mg / dl,C3715113;C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false;false,15747/22402
hdl $nmbr$,C3715113,false,15748/22402
hdlcholesterol,,,15749/22402
hdm n = $nmbr$,,,15750/22402
health - care use rate ( peryear ),C0814514;C0871208;C1521828,false;false;false,15751/22402
health practices,C0018684,true,15752/22402
healthy weight,C3898900;C0005910;C0043100;C1305866;C1705104,false;true;true;false;false,15753/22402
heart - rate group at baseline,C0018810;C0441833;C0168634;C1442488;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;true;false;false;true;false;false;false,15754/22402
heart failure — no . / total no . ( % ),C0018801;C0018802;C4554158,true;true;false,15755/22402
heart failure ( nyha ii ‐ iii )  n ( % ),C0018801;C1275491;C1710602;C0439070;C1705160;C4082587;C0018802;C4554158,true;false;false;false;false;false;true;false,15756/22402
heart failure ( treated / hospitalized / fatal ),C0018801;C0018802;C4554158,true;true;false,15757/22402
heart failure $nmbr$ yr before admission,C0018801;C0439234;C0184666;C0809949;C0018802;C4554158,true;false;false;false;true;false,15758/22402
heart failure at entry  no . ( % ),C0018801;C1705654;C0018802;C4554158,true;false;true;false,15759/22402
heart failure history,C0018801;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C0018802;C4554158,true;true;true;false;false;false;false;true;false,15760/22402
heart failure hospitalisation or cv death,C3898876,false,15761/22402
heart failure hospitalizations,C3898876,false,15762/22402
heart failure  hospitalized or fatal,C0018801;C0018802;C4554158,true;true;false,15763/22402
heart failure  n ( % ),C0018801;C0018802;C4554158,true;true;false,15764/22402
heart failure  no . / total no . ( % ),C0018801;C0018802;C4554158,true;true;false,15765/22402
heart failure  ci  confidence interval .,C0018801;C0008107;C0009667;C3259781;C0018802;C4554158,true;true;true;false;true;false,15766/22402
heart failure ‡,C0018801;C0018802;C4554158,true;true;false,15767/22402
heart rate ( bpm ) *,C0018810,true,15768/22402
heart rate ( bpm $nmbr$ ) *  * *,C0018810,true,15769/22402
heart rate ( median $nmbr$ . $nmbr$ },C0018810;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,15770/22402
heart rate ( min − $nmbr$ ),C0018810;C0702093;C1524029;C3813700,true;false;false;false,15771/22402
heart rate ( sd ),C0018810;C2699239,true;false,15772/22402
heart rate ( sd )  bpm,C0018810;C2699239,true;false,15773/22402
heart rate ( sd )  bpm blood pressure  mm hg,C0018810;C2699239;C0005823;C0439475;C1271104;C1272641,true;false;true;false;false;true,15774/22402
heart rate 一 beats / min,C0018810,true,15775/22402
heart rate at baseline ( bpm,C0018810;C0168634;C1442488,true;true;false,15776/22402
heart rate at baseline  bpm,C0018810;C0168634;C1442488,true;true;false,15777/22402
heart rate at rest — beats / min,C0018810;C0035253;C1622890,true;true;false,15778/22402
heart rate  / min,C0018810;C0702093;C1524029;C3813700,true;false;false;false,15779/22402
heart rate  beats per minute,C0018810,true,15780/22402
heart rate  bpm  mean ( sd ),C0018810;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15781/22402
heart rate  mean ( sd ),C0018810;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15782/22402
heart rate  mean ( sd )  bpm ( n = $nmbr$ $nmbr$ ),C0018810;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,15783/22402
heart rate  min_ $nmbr$ ( mean ),C0018810;C0702093;C0444504;C2347634;C2348143;C1524029;C3813700,true;false;false;false;false;false;false,15784/22402
heartburn severity during the run - in periodt,C0018834;C0439793;C3274438;C0522510,true;false;false;false,15785/22402
heat failure,C0018837;C0231174;C0680095,true;false;false,15786/22402
height '  cm,C0489786,false,15787/22402
height ( cm ) ( mean ± sd ),C0489786;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15788/22402
height ( cm )  mean ( s . e . ),C0489786;C0439392;C0444504;C2347634;C2348143,false;false;false;false;false,15789/22402
height ( cm )  mean ( sd ) a,C0489786;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15790/22402
height in meters .,C0489786;C0441074,false;false,15791/22402
height loss,C0424641,false,15792/22402
height loss ( cm ),C0424641,false,15793/22402
height  cm ( mean ± s . d . ),C0489786;C0439392;C0444504;C2347634;C2348143,false;false;false;false;false,15794/22402
height  cm  mean ( sd ),C0489786;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15795/22402
height  mean ( sd )  cm,C0489786;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,15796/22402
helicobacter pylori - negative  n ( % ),C4688581,false,15797/22402
helicobacter pylori infection ( + ) ( n ),C0850666,false,15798/22402
hematocrit  %,C0018935;C0518014,true;false,15799/22402
hemodynamic parameters at baseline in the patients enrolled in the hemodynamic substudy,C0019010;C0449381;C0168634;C1442488;C4281788,true;false;true;false;false,15800/22402
hemoglobin - a $nmbr$ c ( % ) ' • ■ * *,C0019020;C3889898,true;false,15801/22402
hemoglobin level  %,C0019029;C1314664,false;false,15802/22402
hemoglobin ( < $nmbr$ men  ， : : $nmbr$ women ),C0019046;C0025266;C0043210,true;true;true,15803/22402
hemoglobin ( g / l ),C0635222;C0439267;C0019046;C0439294;C0456615,true;false;true;false;false,15804/22402
hemoglobin 一 g / dl,C1319312;C3642216;C0019046;C0439267,false;false;true;false,15805/22402
hemoglobin a    ( % ),C0019016,true,15806/22402
hemoglobin a ^ c  %,C0019020;C3889898,true;false,15807/22402
hemoglobin a $nmbr$ c,C0019020;C3889898,true;false,15808/22402
hemoglobin a $nmbr$ c ( % ),C0019020;C3889898,true;false,15809/22402
hemoglobin a $nmbr$ c  %,C0019020;C3889898,true;false,15810/22402
hemoglobin a $nmbr$ c  mean ( sd )  %,C0019020;C0444504;C2699239;C2347634;C2348143;C3889898,true;false;false;false;false;false,15811/22402
hemoglobin aj ^ ( % ),C0019046;C0004486;C0230613,true;true;true,15812/22402
hemoglobin ale *,C0019046;C0678386;C2632076,true;false;false,15813/22402
hemoglobin ale  %  median ( iqr ),C0019046;C0678386;C0549183;C0876920;C2347635;C2348144;C2939193;C2632076,true;false;false;false;false;false;false;false,15814/22402
hemoglobin category,C0019046;C0683312;C3889287,true;false;false,15815/22402
hemorrhagic,C0333275,false,15816/22402
heparin + tirofiban ( n = $nmbr$ ),C0019134;C0247025;C0770546,true;true;false,15817/22402
heparin ± tirofiban ( n = $nmbr$ ),C0019134;C0247025;C0770546,true;true;false,15818/22402
heparin alone ( n = $nmbr$ ),C0019134;C0205171;C0439044;C0679994;C0770546,true;false;false;false;false,15819/22402
heparin at randomization,C0019134;C0034656;C0770546,true;true;false,15820/22402
heparin dose regimen,C0019134;C2348331;C0770546,true;false;false,15821/22402
heparin plus a gpi ( n = $nmbr$ ),C0019134;C1415351;C0770546,true;false;false,15822/22402
heparin plus gpi ( n = $nmbr$  $nmbr$ ),C0019134;C0332287;C1415351;C0770546,true;false;false;false,15823/22402
heparin plus tirofiban ( n = $nmbr$ ),C0019134;C0332287;C0247025;C0770546,true;false;true;false,15824/22402
heparin use,C0239945,false,15825/22402
heparin  fondaparinux or brvalirudin use between - oex event,C0019134;C1098510;C0770546,true;true;false,15826/22402
heparins and fondaparinux,C0019134,true,15827/22402
hepatic disorders,C0023895,true,15828/22402
heterogeneity or trend p vaiue,C0019409;C0242960,false;true,15829/22402
heterogeneity or trend p value,C0019409;C0242960,false;true,15830/22402
heterozygous familial hypercholesterolemia,C0342882,false,15831/22402
heterozygous familial hypercholesterolemia †,C0342882,false,15832/22402
hf,C0018488;C1313497;C1538440;C3273279,true;true;false;false,15833/22402
hf ' without known reduced ef,C0018488;C0205309;C0392756;C1313497;C1538440;C3273279,true;false;false;true;false;false,15834/22402
hf cause,C0018488;C0015127;C1524003;C1313497;C1538440;C3273279,true;true;false;true;false;false,15835/22402
hf duration  y  n ( % ),C0018488;C0449238;C2926735;C1313497;C1538440;C3273279,true;false;false;true;false;false,15836/22402
hf hosp .,C0018488;C1313497;C1538440;C3273279,true;true;false;false,15837/22402
hf hospitalisation,C0018488;C0019993;C1313497;C1538440;C3273279,true;true;true;false;false,15838/22402
hf signs and symptoms,C0018488;C0220912;C0220913;C0311392;C1313497;C1538440;C3273279,true;true;false;false;true;false;false,15839/22402
hf symptoms and signs,C0018488;C0683368;C1457887;C1313497;C1538440;C3273279,true;true;false;true;false;false,15840/22402
hf without known reduced ef,C0018488;C0205309;C0392756;C1313497;C1538440;C3273279,true;false;false;true;false;false,15841/22402
hf without known reduced ef ( n = $nmbr$ ),C0018488;C0205309;C0392756;C1313497;C1538440;C3273279,true;false;false;true;false;false,15842/22402
hf  total,C0018488;C0439175;C0439810;C1313497;C1538440;C3273279,true;false;false;true;false;false,15843/22402
hfref,,,15844/22402
hfref ( n = $nmbr$ ),,,15845/22402
hhf ( n = $nmbr$ ),,,15846/22402
hiatal hernia ( yes ) ( n ),C3489393;C1549445;C1705108;C1710701,true;false;false;false,15847/22402
high - density lipoprotein cholesterol — mg / dl,C0023822;C0439269,true;false,15848/22402
high - density lipoprotein cholesterol metabolic syndrome  patients were to,C0023822;C0524620;C0030705,true;true;true,15849/22402
high - density lipoprotein cholesterol  mg / dl,C0023822;C0439269,true;false,15850/22402
high - density lipoprotein ],C0023821,true,15851/22402
high - dose arb ( n = $nmbr$ ),C0444956;C3888198,false;false,15852/22402
high - dose edoxaban,C0444956;C2975435,false;true,15853/22402
high - dose edoxaban ( n = $nmbr$ ),C0444956;C2975435,false;true,15854/22402
high - dose edoxaban vs warfarin,C0444956;C2975435,false;true,15855/22402
high - intensity statin use,C4081854;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,15856/22402
high ‐ intensity statins ‡,C4081854;C0360714,false;true,15857/22402
high - risk,C0332167;C3272283;C4050568;C4319571,false;false;false;false,15858/22402
high - school graduate,C0870649;C1549971,false;false,15859/22402
high - school graduate or ged,C0870649;C1549971,false;false,15860/22402
high - sensitivity c - reactive protein — mg / liter |,C1441604;C0006560;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285,false;true;true;false;true;false;false;false;false;false;false;false,15861/22402
high - sensitivity c - reactive protein ( mg / l ),C1441604;C0006560;C0439268;C1413716;C4048285,false;true;false;false;false,15862/22402
high - sensitivity c - reactive protein stratification,C1441604;C0006560;C1514983;C1413716;C4048285,false;true;false;false;false,15863/22402
high - sensitivity c - reactive protein  mg / l,C1441604;C0006560;C0439268;C1413716;C4048285,false;true;false;false;false,15864/22402
high ( >   uln and   ≤   $nmbr$ xuln ) ( n   =   $nmbr$ ),C0205250;C1519815;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,15865/22402
high ( > $nmbr$ % ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15866/22402
high ( > $nmbr$ ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15867/22402
high ( > $nmbr$ kg / m ^ ) baseline bmi,C0205250;C1532718;C0168634;C0578022;C1442488;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false;false,15868/22402
high ( > $nmbr$ )  %,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15869/22402
high ( > $nmbr$ . $nmbr$ u / ml ),C0205250;C0439340;C1880521;C2945590;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false;false,15870/22402
high ( > $nmbr$ % ) baseline hbalc,C0205250;C0168634;C1442488;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false,15871/22402
high ( > uln ),C0205250;C1519815;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,15872/22402
high ( $nmbr$ % ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15873/22402
high ( $nmbr$ - $nmbr$ ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15874/22402
high ( i $nmbr$ kg / m $nmbr$ ) baseline bmi,C0205250;C0021966;C1532718;C0168634;C0578022;C1442488;C0221138;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;true;false;false;false;false;false;false;false;false;false,15875/22402
high ( i $nmbr$ % ) baseline hba $nmbr$ c,C0205250;C0021966;C0168634;C0019016;C1825777;C3538758;C1442488;C0221138;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;true;false;false;false;false;false;false;false;false;false;false,15876/22402
high ( n = $nmbr$ ),C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15877/22402
high blood pressure,C0020538;C2926615,true;false,15878/22402
high cardiovascular risk  n ( % ) ^,C0332167;C0007226;C3887460;C3272283;C4050568;C4319571,false;true;false;false;false;false,15879/22402
high crp and esr,C0205250;C3890735;C4048285;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,15880/22402
high crp or esr,C0205250;C3890735;C4048285;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false,15881/22402
high cv risk,C0332167;C3538987;C4048877;C4318503;C3272283;C4050568;C4319571,false;false;true;false;false;false;false,15882/22402
high dose,C0444956,false,15883/22402
high fracture risk stratum,C0332167;C0016658;C3272283;C4050568;C4319571,false;true;false;false;false,15884/22402
high microalbuminuria to macroalbuminuria ( n = $nmbr$ ),C0205250;C0730345;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,15885/22402
high nafld fibrosis score ( nfs > $nmbr$ . $nmbr$ ),C0205250;C0400966;C1954436;C1555018;C1954437;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false;false;false,15886/22402
high nfs nfs > $nmbr$ . $nmbr$ ( n = $nmbr$ ),C0205250;C1513839;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,15887/22402
high normal ( n = $nmbr$ ),C0205250;C0205307;C0231683;C0439166;C2347086;C4553972;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false;false;false;false;false,15888/22402
high risk ( - ics ),C0332167;C0815320;C4551720;C3272283;C4050568;C4319571,false;false;true;false;false;false,15889/22402
high risk ( ? ics ),C0332167;C0815320;C4551720;C3272283;C4050568;C4319571,false;false;true;false;false;false,15890/22402
high risk ( > $nmbr$ ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,15891/22402
high risk ( n $nmbr$ $nmbr$ ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,15892/22402
high risk for diabetes *,C0332167;C0011847;C0011849;C3272283;C4050568;C4319571;C0205250;C1171304;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;true;false;false;false;false;false;false;false;false;false;false;false,15893/22402
high risk of diabetes,C0332167;C0011847;C0011849,false;false;true,15894/22402
high risk *  %,C0332167;C3272283;C4050568;C4319571,false;false;false;false,15895/22402
high trs : $nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ ),C0205250;C0266427;C0968917;C1150746;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;true;false;false;false;false;false;false;false,15896/22402
high tt > $nmbr$ . $nmbr$ ( n = $nmbr$ ),C0205250;C1452561;C4554543;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;true;false;false;false;false;false;false;false,15897/22402
high vs . normalb,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15898/22402
high vs . normalc,C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false,15899/22402
higher - dose,C0444956,false,15900/22402
higher - dose edoxaban ( n = $nmbr$ )  n ( % / y ),C0444956;C2975435,false;true,15901/22402
higher - dose edoxaban vs warfarin,C0444956;C2975435,false;true,15902/22402
higher - target group ( n = $nmbr$ ),C0205250;C1521840;C0441848;C2986546,false;false;false;false,15903/22402
higher dose,C0444956,false,15904/22402
higher dose edoxaban regimen,C0205250;C2348331;C2975435,false;false;true,15905/22402
higher risk ( n = $nmbr$ ),C0332167;C3272283;C4050568;C4319571,false;false;false;false,15906/22402
highest,C1522410,false,15907/22402
highjj,,,15908/22402
highly sensitive,C0439822,false,15909/22402
highly sensitive responder ( n = $nmbr$ ),C0439822,false,15910/22402
highly sensitive responders ( n = $nmbr$ ),C0439822,false,15911/22402
hip,C0019552;C0022122;C1505163;C3538851;C4284725,true;true;true;false;false,15912/22402
hip + $nmbr$ vertebral fractures,C0019557;C0549207;C0019552;C0080179;C0022122;C1505163;C3538851;C4284725,true;true;true;true;true;true;false;false,15913/22402
hip + nonvertebral + vertebral,C0019552;C0549207;C0022122;C1505163;C3538851;C4284725,true;true;true;true;false;false,15914/22402
hip + other nonvertebral fractures,C0019552;C0022122;C1505163;C3538851;C4284725,true;true;true;false;false,15915/22402
hip fracture + > $nmbr$,C0019557;C0149531;C4552776,true;false;false,15916/22402
hip fracture only,C0019557;C0205171;C1720467;C0149531;C4552776,true;false;false;false;false,15917/22402
hip  femur,C0019552;C0015811;C0022122;C1505163;C3538851;C4284725,true;true;true;true;false;false,15918/22402
hip  wrist  or spine *,C0019552;C0043262;C1322271;C0022122;C1505163;C3538851;C4284725,true;true;true;true;true;false;false,15919/22402
hispanic ( n = $nmbr$ l $nmbr$ ),C0086409,true,15920/22402
hispanic ethnic group — no . { % ) ’ i ',C0086409;C0015031;C1879937,true;true;false,15921/22402
hispanic ethnic group — no . ( % ) : t,C0086409;C0015031;C1879937,true;true;false,15922/22402
hispanic ethnicity  n ( % ),C0086409;C0015031;C0243103,true;true;true,15923/22402
hispanic or non - hispanic ethnic group — no . ( % ) f,C0086409,true,15924/22402
hispanic / latino ( n = $nmbr$ ),C0086409;C0086528,true;true,15925/22402
hispanic / latino ethnicity,C0086409;C0086528;C0015031;C0243103,true;true;true;true,15926/22402
hispanic / non - hispanic,C0086409;C1518422,true;false,15927/22402
hispanie / latino,C0086528,true,15928/22402
histamine - $nmbr$ - receptor antagonist,C0019590;C4521896,true;false,15929/22402
histor y of congestive heart failure — no . ( % ),C0018802,true,15930/22402
histor y of heart failure,C0018801;C0018802;C4554158,true;true;false,15931/22402
histor y of myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,15932/22402
histor y of stable angina,C0340288,true,15933/22402
histor y of unstable angina,C0002965,true,15934/22402
history chd,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,15935/22402
history congestive heart failure,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15936/22402
history coronary,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,15937/22402
history coronary revascularization,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,15938/22402
history mi or stroke,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,15939/22402
history of ( % ),C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,15940/22402
history of > $nmbr$ previous vte ( excluding index event ),C0019664;C0205156;C0630906;C0332196;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C2828389;C1552607;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;true;false;false;false;false;false;true;false;false;false;false,15941/22402
history of amputation  n ( % ),C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,15942/22402
history of amputation  no . ( % ),C0019664;C0002688;C0332840;C1546539;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;true;false;false;false;false,15943/22402
history of asthma - related intubation — no . ( % ),C0455544,false,15944/22402
history of atrial fibrillation and / or flutter,C0729790,false,15945/22402
history of atrial fibrillation or flutter,C0729790,false,15946/22402
history of bowel resection ( ref ),C0019664;C0741614;C1425988;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,15947/22402
history of bowel resections  n ( % ),C0019664;C0741614;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,15948/22402
history of cad / mi,C0019664;C1504769;C3810814;C2239547;C3813548;C4284121;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false;true;false;false;false;false,15949/22402
history of cardiovascular disease — no . ( % ),C0455539,false,15950/22402
history of cardiovascular disease — no . { % ),C0455539,false,15951/22402
history of carotid disease - n ( % ),C0683519;C0741968;C0730226;C0850708;C0944983,false;false;false;false;false,15952/22402
history of cerebrovascular disease — no . { % ),C0585890,false,15953/22402
history of chd at baseline,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,15954/22402
history of chd at baseline d  g,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,15955/22402
history of chd at baseline  no . ( % ),C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,15956/22402
history of chd at baseline §,C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;false;false;false;false,15957/22402
history of chf - n ( % ),C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15958/22402
history of chf before index event,C0019664;C0018802;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15959/22402
history of chf  nyha class ii or iii — no . ( % ),C0019664;C0018802;C1882085;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,15960/22402
history of clinical fracture ( > $nmbr$ years old ),C1272071;C0205210;C0439234,false;false;false,15961/22402
history of clinical fracture ( > $nmbr$ years ),C1272071;C0205210;C0439234,false;false;false,15962/22402
history of coronary,C0019664;C0018787;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15963/22402
history of coronary arteiy disease,C0683519;C0018787;C0730226;C0850708;C0944983,false;true;false;false;false,15964/22402
history of coronary artery disease,C1881055,false,15965/22402
history of coronary artery disease - n ( % ),C1881055,false,15966/22402
history of coronary artery disease — no . { % ),C1881055,false,15967/22402
history of coronary heart disease at,C0683519;C0018787;C0730226;C0850708;C0944983,false;true;false;false;false,15968/22402
history of coronary heart disease  no . ( % ),C0683519;C0018787;C0730226;C0850708;C0944983,false;true;false;false;false,15969/22402
history of coronary revascularization d,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,15970/22402
history of coronary revascularization  no . ( % ),C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,15971/22402
history of crohn ' s disease surgery  n ( % ),C0455610;C0010346,false;true,15972/22402
history of cvd,C0019664;C0007222;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15973/22402
history of cvd and of cv risk factors - no . ( % ),C0019664;C0007222;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15974/22402
history of cvd  n ( % ),C0019664;C0007222;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15975/22402
history of diabetes - n ( % ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,15976/22402
history of diabetes { p = $nmbr$ * $nmbr$ ),C0019664;C0011847;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;true;false;false;false;false,15977/22402
history of diabetes mellitus ( n = $nmbr$ ),C0455488,false,15978/22402
history of diabetes mellitus  no . ( % ),C0455488,false,15979/22402
history of diabetes nyha class,C0019664;C0011847;C1882083;C0011849;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;true;true;false;false;false;false,15980/22402
history of diagnosed hypertension n ( % ),C0455527;C0011900,false;true,15981/22402
history of diagnosed hypertension prior to randomization  n ( % ),C0455527;C0011900,false;true,15982/22402
history of disease refractory to treatment with tnf antagonist — no . ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,15983/22402
history of dyslipidaemia,C0019664;C0242339;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15984/22402
history of dyslipidemia,C0019664;C0242339;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15985/22402
history of elms  n ( % ),C0019664;C0330531;C2980688;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,15986/22402
history of extra - intestinal manifestations of ibd,C0019664;C1883702;C0021853;C1280464;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,15987/22402
history of falls,C1561668;C2919132,false;false,15988/22402
history of falls in year before randomization,C1561668;C2919132,false;false,15989/22402
history of fistulising disease  n [ % ],C0683519;C0730226;C0850708;C0944983,false;false;false;false,15990/22402
history of fistulizing disease  n ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,15991/22402
history of fistullzing disease  n ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,15992/22402
history of h pylori eradication *,C0019664;C0079488;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15993/22402
history of heart failure — no . { % ),C0455531,false,15994/22402
history of heart failure at baseline,C0455531,false,15995/22402
history of heart failure  no . ( % ),C0455531,false,15996/22402
history of hf hospitalization,C0551577;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,15997/22402
history of hf or lvef b $nmbr$ % with index event  no . ( % ),C0019664;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;true;false;false;false;false,15998/22402
history of htn  %,C0019664;C0020538;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,15999/22402
history of hypertension - n ( % ),C0455527,false,16000/22402
history of hypertension  no . ( % ),C0455527,false,16001/22402
history of hypertension . no . ( % ),C0455527,false,16002/22402
history of hypertension ^  %,C0455527,false,16003/22402
history of impaired renal function  no . ( % ),C0019664;C1565489;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,16004/22402
history of lvh on echocardiogram,C0019664;C0149721;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,16005/22402
history of lvh on electrocardiogram,C0019664;C0149721;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;false;false,16006/22402
history of macrovascular disease at baseline  n ( % ),C0683519;C0730226;C0850708;C0944983,false;false;false;false,16007/22402
history of mi or stroke,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16008/22402
history of mi or stroke d,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16009/22402
history of mi or stroke history of coronary,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16010/22402
history of mi or stroke  n ( % ),C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16011/22402
history of mi or stroke  no . ( % ),C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16012/22402
history of ml at baseline,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,16013/22402
history of ml before index event,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,16014/22402
history of ml or stroke,C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;false;false;false,16015/22402
history of non - hemor - rhagic stroke,C0019664;C1518422;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,16016/22402
history of omalizumab treatment :,C0019664;C0966225;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;true;false;false;false;false;false;true;false;false;false;false,16017/22402
history of osteoporotic fracture  n ( % ) a,C4075937,false,16018/22402
history of oxygen use - yes  n ( % ),C0019664;C0030054;C1524063;C1549445;C1705108;C1710701;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false;true;false;false;false;false,16019/22402
history of parental myocardial,C0019664;C0030551;C0027061;C1522564;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;true;false;false;false;false,16020/22402
history of pci or cabg before index event,C0019664;C4049621;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16021/22402
history of peripheral arterial disease,C0683519;C0205100;C0003842;C0221464;C0730226;C0850708;C0944983,false;false;true;false;false;false;false,16022/22402
history of peripheral artery disease — no . { % ),C0683519;C0489868;C0730226;C0850708;C0944983,false;false;false;false;false,16023/22402
history of postmenopausal fracture *,C1272071;C0232970,false;false,16024/22402
history of pvd,C4534349,false,16025/22402
history of pvd  no . ( % ),C4534349,false,16026/22402
history of smoking,C1519384,false,16027/22402
history of stroke at baseline,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16028/22402
history of stroke or tia - n ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16029/22402
history of stroke * *,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16030/22402
history of stroke / see / tia  n ( % ),C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16031/22402
history of stroke / see / tia,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16032/22402
history of stroke †,C0019664;C0038454;C4554100;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16033/22402
history of strokea,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,16034/22402
history of thyroid disease  n ( % ),C0683519;C0040132;C3540038;C0730226;C0850708;C0944983,false;true;false;false;false;false,16035/22402
history of tnf antagonist treatment failure — no . ( % ) * *,C0019664;C1448177;C0231491;C0162643;C0235828;C0521983;C1547544;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;true;false;false;false;false,16036/22402
history of upper,C0019664;C1282910;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16037/22402
history of upper gi events ( perforations  ulcers and bleeding ) n ( % ),C0019664;C0203057;C0441471;C0549099;C0041582;C3541888;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;true;false;true;false;false;false;false,16038/22402
history of upper gl events ( perforations  ulcers  bleeding )  n ( % ),C0019664;C1282910;C0018229;C0441471;C0549099;C0041582;C3541888;C1423073;C1427674;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;true;false;false;false;true;false;false;false;false,16039/22402
history of venous,C0019664;C0042449;C0348013;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,16040/22402
history ol chd at baselines,C0019664;C0280604;C0168634;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;true;false;false;false;false,16041/22402
history ol coronary revascularization *,C0019664;C0877341;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16042/22402
history ol mi or stroke,C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,16043/22402
history ot chd  n ( % ),C0019664;C1318464;C0280604;C3542407;C1418208;C1705587;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false;true;false;false;false;false,16044/22402
history / presence of tophi,C0019664;C0150312;C0221248;C0392148;C3854307;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;false;false;false;true;false;false;false;false,16045/22402
hit - $nmbr$ score,C0272285;C0449820;C4050231;C0332159;C1708373,false;false;false;false;false,16046/22402
hl 土 $nmbr$ . $nmbr$,C1453952;C4085347,true;false,16047/22402
hla - b $nmbr$,C0019737;C0550853;C1415561,true;false;false,16048/22402
hla - b $nmbr$ positive at baseline  n ( % ),C0019737;C0439178;C0168634;C1442488;C1446409;C1514241;C2825490;C3812269;C0550853;C1415561,true;false;true;false;false;false;false;false;false;false,16049/22402
hla ‐ b $nmbr$ positive    n   ( % ),C1426226;C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false,16050/22402
hla - b $nmbr$  n ( % ) ⁎ ⁎,C1426226,false,16051/22402
hmg - coa reductase inhibitors,C0360714;C2756999;C3539119,true;false;false,16052/22402
ho,C0019905;C1832110;C3889614,true;false;false,16053/22402
ho active cancer,C0019905;C0205177;C0006826;C0998265;C1306459;C3853793;C3888249;C1832110;C3889614,true;false;true;false;false;false;false;false;false,16054/22402
hoehn & yahr stage,C0205390;C1300072;C1306673,false;false;false,16055/22402
hoehn & yahr stage ( “ off ” )  n ( % ),C0205390;C1300072;C1306673,false;false;false,16056/22402
hoehn & yahr stage ( “ on ” )  n ( % ),C0205390;C1300072;C1306673,false;false;false,16057/22402
hoehn and yahr stage ( baseline )  mean ( sd ),C0205390;C0168634;C0444504;C2699239;C2347634;C2348143;C1442488;C1300072;C1306673,false;true;false;false;false;false;false;false;false,16058/22402
homa - b,,,16059/22402
homa - ir index,C0022065;C0600653;C0918012;C1552854;C1637833;C2986546;C0022071;C1448132,true;true;true;false;false;false;true;true,16060/22402
homa - ir score,C0022065;C0449820;C4050231;C0022071;C1448132,true;false;false;true;true,16061/22402
homa - ir  mean ( sd ),C0022065;C0444504;C2699239;C2347634;C2348143;C0022071;C1448132,true;false;false;false;false;true;true,16062/22402
homa_ % b  median ( q $nmbr$  q $nmbr$ )  %,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,16063/22402
homa_ir tx difference vs pbo  median change from baseline ( se ) $nmbr$,C0022065;C0041403;C1705241;C1705242;C0022071;C1448132,true;true;false;false;true;true,16064/22402
homa_ir  median ( q $nmbr$  q $nmbr$ )  % / $nmbr$,C0022065;C0549183;C0876920;C2347635;C2348144;C2939193;C0022071;C1448132,true;false;false;false;false;false;true;true,16065/22402
hong kong,C0019907;C2987742,true;false,16066/22402
hordic,,,16067/22402
hormone therapy use,C0279025;C0042153;C0457083;C1947944,false;true;false;false,16068/22402
hormones,C0019932,true,16069/22402
hospitaiization for angina,C0002962,true,16070/22402
hospitaiization for heart faiiure,C0018787,true,16071/22402
hospital admission for heart failure,C0184666;C0018801;C0018802;C4554158,false;true;true;false,16072/22402
hospitalisation,C0019993,true,16073/22402
hospitalisation for heart failure,C3898876,false,16074/22402
hospitalisation related to exacerbation  n ( % ),C0019993,true,16075/22402
hospitalization for acute limb ischemia,C0019993;C0205178;C2945695,true;false;false,16076/22402
hospitalization for heart failure n ( % ),C3898876,false,16077/22402
hospitalization for heart failure or cv,C3898876,false,16078/22402
hospitalization for heart failure or cv death,C3898876,false,16079/22402
hospitalization for unstable ap,C0019993;C0443343;C0002680;C3887950;C1883468,true;false;true;false;false,16080/22402
hospitalization for / due to,C0019993,true,16081/22402
hospitalization in previous year with management of heart failure,C0019993;C0205156;C0439234;C0439508;C1552607,true;false;false;false;false,16082/22402
hospitalization in previous year with management of heart failure as major component — no . ( % ),C0019993;C0205156;C0439234;C0439508;C1552607,true;false;false;false;false,16083/22402
hospitalization in the past $nmbr$ months prior to baseline,C0019993;C4331910,true;false,16084/22402
hospitalization stratum  n ( % ),C0019993,true,16085/22402
hospitalization to enrollment,C0019993;C1516879;C1696073;C3888021,true;false;false;false,16086/22402
hospitalization  n ( % ),C0019993,true,16087/22402
hospitalizations,C0019993,true,16088/22402
hospitalized,C0701159,false,16089/22402
hospitalized angina,C0701159;C0002962,false;true,16090/22402
hospitalized exacerbation rates,C0701159;C4086268;C0871208;C1521828,false;false;false;false,16091/22402
hospitalized for an exacerbation,C0701159;C4086268,false;false,16092/22402
hospitalized heart failure,C0701159;C0018801;C0018802;C4554158,false;true;true;false,16093/22402
hospitalized hf,C0701159;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,16094/22402
hospitalized hf !,C0701159;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,16095/22402
hospitalized pneumonia events  n,C0701159;C0032285;C0441471;C3541888,false;true;false;false,16096/22402
hospitalized without airway compromise,C0701159;C4055482,false;false,16097/22402
hospitalized !,C0701159,false,16098/22402
hospitalized / fatal heart failure,C0701159;C1302234;C0018801;C0018802;C4554158;C1705232,false;false;true;true;false;false,16099/22402
hot climate subset,C0178683;C1515021,false;false,16100/22402
hr ( $nmbr$ % c ! ),,,16101/22402
hr ( $nmbr$ % ci ) *,C0008107;C3259781,true;false,16102/22402
hr ( $nmbr$ % ci )  multivariate cox proportional - hazard regression,C0008107;C1565830;C0205351;C0598697;C0684320;C0684321;C1836830;C3259781,true;true;false;false;false;true;false;false,16103/22402
hr ( $nmbr$ % ci )  univariate cox proportional - hazard regression,C0008107;C1565830;C0205351;C0598697;C0684320;C0684321;C1836830;C3259781,true;true;false;false;false;true;false;false,16104/22402
hr ( $nmbr$ % cl ) = $nmbr$ $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$  $nmbr$ ),C0596019,false,16105/22402
hr ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ b ( $nmbr$  $nmbr$ . $nmbr$ ),C0596019,false,16106/22402
hr ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ $nmbr$ ),C0596019,false,16107/22402
hr ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ $nmbr$  $nmbr$ . $nmbr$ ),C0596019,false,16108/22402
hr ( $nmbr$ % cl ) pvalue,C0596019,false,16109/22402
hr ( $nmbr$ s % a ),,,16110/22402
hr ( $nmbr$ s % ci ),C0008107;C3259781,true;false,16111/22402
hr ( adjusteda ),,,16112/22402
hr ( b . p . m . ),C0369637;C0441923,false;false,16113/22402
hr ( bpm ),,,16114/22402
hr [ $nmbr$ % ci ),C0008107;C3259781,true;false,16115/22402
hr $nmbr$ - $nmbr$ ( $nmbr$ % cl $nmbr$ - $nmbr$ - $nmbr$ ),C0596019,false,16116/22402
hr $nmbr$ - $nmbr$ ( $nmbr$ % cl $nmbr$ - $nmbr$ - $nmbr$ - $nmbr$ ),C0596019,false,16117/22402
hr $nmbr$ . $nmbr$,,,16118/22402
hr $nmbr$ . $nmbr$ ( $nmbr$ % cl $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$ *,C0596019,false,16119/22402
hr and $nmbr$ % ci *,,,16120/22402
hr is < $nmbr$ if pravastatin is better than diet alone,,,16121/22402
hr vs control ( $nmbr$ % cl ) *,,,16122/22402
hr vs placebo ( $nmbr$ % ci ),,,16123/22402
hr vs . warfarin ( $nmbr$ % ci ),,,16124/22402
hr with edoxaban ( $nmbr$ % ci ),C2975435;C0008107;C3259781,true;true;false,16125/22402
hr * or rr †,,,16126/22402
hr * or rr † ( $nmbr$ % ci ),,,16127/22402
hr  ( $nmbr$ % ci ),C0008107;C3259781,true;false,16128/22402
hr  ( $nmbr$ % cl ),C0596019,false,16129/22402
hr  bpm,,,16130/22402
hr  bpm ( sd ),C2699239,false,16131/22402
hr : $nmbr$ . $nmbr$ ( $nmbr$ % cl : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$,C0596019,false,16132/22402
hr ‡,,,16133/22402
hradj ( $nmbr$ % ci ),C0008107;C3259781,true;false,16134/22402
hradjusted ( $nmbr$ % ci ) b,C0008107;C3259781,true;false,16135/22402
hrg,C1437978;C1705020,true;false,16136/22402
hrql mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,16137/22402
hrt use,C0282402;C0042153;C0457083;C1947944,true;true;false;false,16138/22402
hs - crp mg / l,C3890735;C0439268;C4048285,false;false;false,16139/22402
hs - crp _ = $nmbr$ . $nmbr$ mg / l,C3890735;C0439268;C4048285,false;false;false,16140/22402
hs - crp < $nmbr$ . $nmbr$ nlg l,C3890735;C4048285,false;false,16141/22402
hs - crp j $nmbr$ . $nmbr$ mg / l,C3890735;C0439268;C4048285,false;false;false,16142/22402
hs graduate / ged,C0588053;C1880947;C1547183,false;false;false,16143/22402
hscrp ( mg / l )  median ( first  third quartiles ),C0439268;C0549183;C0205435;C0205437;C2828255;C1279901;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,16144/22402
hscrp ( mg / l )  median ( min – max ),C0439420;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,16145/22402
hscrp ( mg / l )  median ( minimum ‒ maximum ),C0439268;C0549183;C1524031;C0806909;C1552615;C2826546;C1552614;C2826545;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false;false,16146/22402
hscrp ( post - baseline / baseline ratio )  ls mean   ±   se,C0687676;C0168634;C0456603;C0023668;C0444504;C0036919;C2347634;C2348143;C1547037;C1442488;C1704687;C3469826,false;true;false;true;false;true;false;false;false;false;false;false,16147/22402
hscrp at baseline,C0168634;C1442488,true;false,16148/22402
hscrp level,C0441889;C0456079;C1547707;C2946261,false;false;false;false,16149/22402
hscrp range  mg / l,C1514721;C0439268;C2348147;C3542016,false;false;false;false,16150/22402
hscrp  exp ls mean change ± se ‡,C1417055;C0023668;C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,false;true;false;false;true;false;false;false;false;false,16151/22402
hscrp  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,16152/22402
hscrp  median ( iqr )  mg / l,C0549183;C0439268;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,16153/22402
hscrp  mg / l  median ( min – max ),C0439420;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,16154/22402
hvpercholesterolemia,,,16155/22402
hvpertension,,,16156/22402
hx cabg,C0262926;C0010055;C3814444,false;true;false,16157/22402
hx mi or stroke,C0262926;C3810814;C3814444,false;false;false,16158/22402
hx of diabetes  n ( % ),C0262926;C0011847;C0011849;C3814444,false;false;true;false,16159/22402
hydroxychloroquine,C0020336,true,16160/22402
hydroxychloroquine treatment §,C0020336;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,16161/22402
hypercholesterolaemia ( % ),C0020443;C1522133,true;false,16162/22402
hypercholesterolemia ( % ),C0020443;C1522133,true;false,16163/22402
hypercholesterolemia  no . ( % ),C0020443;C1522133,true;false,16164/22402
hyperkalaemia,C0020461;C4552983,true;false,16165/22402
hyperkalaemia ( investigator reported ),C0020461;C0035173;C4552983,true;true;false,16166/22402
hyperkalaemia ( serum potassium > $nmbr$ . $nmbr$ mmol / l ),C0020461;C0302353;C1532563;C0543465;C4552983,true;false;false;false;false,16167/22402
hyperkalemia * ’,C0020461;C4552983,true;false,16168/22402
hyperkalemia  n ( % ),C0020461;C4552983,true;false,16169/22402
hyperlipidaemia therapy use  n ( % ) * no lipid - lowering agent therapy,C0020473;C0039798;C0042153;C0457083;C1947944;C0087111;C1363945;C0428465;C4555212,true;true;true;false;false;true;false;false;false,16170/22402
hyperlipidaemia  n ( % ) yes,C0020473;C1549445;C1705108;C1710701;C0428465;C4555212,true;false;false;false;false;false,16171/22402
hyperlipidemia — no . / total no . ( % ),C0020473;C0428465;C4555212,true;false;false,16172/22402
hyperlipidemia | |,C0020473;C0428465;C4555212,true;false;false,16173/22402
hyperlipidemia | | yes,C0020473;C1549445;C1705108;C1710701;C0428465;C4555212,true;false;false;false;false;false,16174/22402
hyperlipidemia  n / n ( % ),C0020473;C0428465;C4555212,true;false;false,16175/22402
hyperlipidemia §,C0020473;C0428465;C4555212,true;false;false,16176/22402
hyperlipidemia § yes,C0020473;C1549445;C1705108;C1710701;C0428465;C4555212,true;false;false;false;false;false,16177/22402
hyperlipidmemia,,,16178/22402
hypersensitivity  n ( % ),C0020517;C0520946,true;false,16179/22402
hypertension ( > $nmbr$ / $nmbr$ mm hg or taking,C0020538;C0439475;C1963138,true;false;false,16180/22402
hypertension ( bp > $nmbr$ / $nmbr$ mmhg or using antihypertensive medication ),C0020538;C0037623;C0439475;C1415692;C1708288;C4318478;C1963138,true;true;false;false;false;false;false,16181/22402
hypertension 一 no . ( % ),C0020538;C1963138,true;false,16182/22402
hypertension at baseline,C0020538;C0168634;C1442488;C1963138,true;true;false;false,16183/22402
hypertension n ( % ),C0020538;C1963138,true;false,16184/22402
hypertension requiring medical treatment,C0020538;C1963138,true;false,16185/22402
hypertension requiring treatment,C0578998,false,16186/22402
hypertension severity at baseline  n ( % ),C4013784;C0168634;C1442488,false;true;false,16187/22402
hypertension  n ( % ) yes,C0020538;C1549445;C1705108;C1710701;C1963138,true;false;false;false;false,16188/22402
hypertension  n / n ( % ),C0020538;C1963138,true;false,16189/22402
hypertension  no . / total no . ( % ) medications in use at baseline  no . / total no . ( % ),C0020538;C1963138,true;false,16190/22402
hypertension  receiving treatment  n ( % ),C0578998;C1514756,false;false,16191/22402
hypertension    n   ( % ),C0020538;C1963138,true;false,16192/22402
hypertension / yes,C0020538;C1549445;C1705108;C1710701;C1963138,true;false;false;false;false,16193/22402
hypertension ^,C0020538;C1963138,true;false,16194/22402
hypertension § yes,C0020538;C1549445;C1705108;C1710701;C1963138,true;false;false;false;false,16195/22402
hypertrophy per ecg ( n = $nmbr$ $nmbr$ ),C0020564;C1623258,true;true,16196/22402
hypertrophy  n ( % ),C0020564,true,16197/22402
hypoglycaemiad  %,,,16198/22402
hypoglycaemic therapy,C0020616;C0039798;C0087111;C1363945,true;true;true;false,16199/22402
hypoglycemia ^,C0020615;C4553659,true;false,16200/22402
hypoglycemiat,,,16201/22402
hypoglycemic agent,C0020616,true,16202/22402
hypokalaemia,C0020621;C4553966,true;false,16203/22402
hyponatremia,C0020625;C4553967,true;false,16204/22402
hyponatremic ( < $nmbr$ meq / l ) at baseline,C0857122;C0439375;C0168634;C1442488,false;false;true;false,16205/22402
hypotension  n ( % ),C0020649;C3163620,true;false,16206/22402
hypovolaemia,C0546884,true,16207/22402
hzard ratio,C0456603;C1547037,false;false,16208/22402
i - $nmbr$ mg / d ( n = $nmbr$ ),C0152277;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0021966;C0439422;C0221138,false;true;true;false;false;false;false;false;true;false;false,16209/22402
i - ^ w « - i - $nmbr$,C0021966;C0221138,true;false,16210/22402
i - h,C0021966;C0033727;C0369286;C0441932;C0564385;C4528284;C0221138,true;true;false;false;false;false;false,16211/22402
i ( $nmbr$ . i ),C0021966;C0221138,true;false,16212/22402
i $nmbr$ . $nmbr$ vs $nmbr$ . $nmbr$,C0021966;C0221138,true;false,16213/22402
i amiodarone,C0021966;C0002598;C0221138,true;true;false,16214/22402
i intensive  $nmbr$ mg of atorvastatin ( n = $nmbr$ ),C0021966;C0162425;C0024671;C0286651;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0522510;C1283828;C1550453;C0221138,true;true;true;true;true;false;false;false;false;false;false;false;false;false,16215/22402
i lisinopril ( n = $nmbr$ ),C0021966;C0065374;C0221138,true;true;false,16216/22402
i moderate  $nmbr$ mg of pravastatin ( n = $nmbr$ ),C0021966;C0205081;C0024671;C0085542;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1881878;C4049705;C4049706;C4085643;C4321335;C0221138,true;false;true;true;true;false;false;false;false;false;false;false;false;false;false;false,16217/22402
i no . of events,C0021966;C0221138,true;false,16218/22402
i or ii,C0021966;C0221138,true;false,16219/22402
i placebo,C0021966;C0032042;C1696465;C1706408;C0221138,true;true;false;false;false,16220/22402
i placebo ( n = $nmbr$ ),C0021966;C0032042;C1696465;C1706408;C0221138,true;true;false;false;false,16221/22402
i rosuvastatin ( n = $nmbr$ ),C0021966;C0965129;C0221138,true;true;false,16222/22402
i u - uj,C0021966;C0439148;C0221138,true;false;false,16223/22402
i vitamin e,C0683454;C0042890;C0021966;C0042874;C3714803;C0221138,false;true;true;true;false;false,16224/22402
i vitamin e ( n = $nmbr$ ),C0683454;C0042890;C0021966;C0042874;C3714803;C0221138,false;true;true;true;false;false,16225/22402
i with mets ( n = $nmbr$ ),C0021966;C0812270;C1705694;C2939420;C0221138,true;false;false;false;false,16226/22402
i without mets ( n = $nmbr$ ),C0021966;C0812270;C1705694;C2939420;C0221138,true;false;false;false;false,16227/22402
i . $nmbr$ ( $nmbr$ . $nmbr$ - i . $nmbr$ ),C0021966;C0221138,true;false,16228/22402
i . $nmbr$ i ( $nmbr$ . $nmbr$ - i . $nmbr$ ),C0021966;C0221138,true;false,16229/22402
i $nmbr$ ( i $nmbr$ . $nmbr$ ),C0021966;C0221138,true;false,16230/22402
i $nmbr$ ( i $nmbr$ . i ),C0021966;C0221138,true;false,16231/22402
i $nmbr$ i $nmbr$ ± $nmbr$,C0021966;C0221138,true;false,16232/22402
i $nmbr$ ± $nmbr$ i,C0021966;C0221138,true;false,16233/22402
i $nmbr$ ± $nmbr$ ii,C0021966;C1710602;C4082587;C0221138,true;false;false;false,16234/22402
i $nmbr$ i ( i $nmbr$ . $nmbr$ ),C0021966;C0221138,true;false,16235/22402
i $nmbr$ ± i $nmbr$,C0021966;C0221138,true;false,16236/22402
i $nmbr$ years of age,C0021966;C1510829;C0221138,true;false;false,16237/22402
i $nmbr$ i ± i $nmbr$,C0021966;C0221138,true;false,16238/22402
i $nmbr$ i,C0021966;C0221138,true;false,16239/22402
ib ( $nmbr$ . $nmbr$ ),C2744579;C3890035;C4283819,true;false;false,16240/22402
ibdq total score,C2964552,false,16241/22402
ibs ( $nmbr$ . $nmbr$ ),C0022104;C0432306,true;true,16242/22402
ibuprofen,C0020740,true,16243/22402
ica stenosis $nmbr$ % - $nmbr$ % f,C0201519;C0678234;C0016327;C1261287;C2632116,false;false;true;true;false,16244/22402
icd or crt - d,C0021122,true,16245/22402
icd vs . placebo,C0021122,true,16246/22402
icd  %,C0021122,true,16247/22402
icd / crt - d  n ( % ),C0021122,true,16248/22402
ich,C0019191;C3272597;C3281105,true;false;false,16249/22402
icosapent ethyl ( events / n ( % ) ),C0058978;C0441471;C3541888,true;false;false,16250/22402
ics ( tiotropium n = $nmbr$  placebo n = $nmbr$ ),C0815320;C0213771;C0032042;C1696465;C1706408;C4551720,false;true;true;false;false;true,16251/22402
ics ? laba ( free or fdc ),C0815320;C4551720,false;true,16252/22402
ics dose of stable maintenance treatment ( μ g ) ∗  †,C0815320;C0178602;C0205360;C0814469;C0439267;C1547311;C0869039;C1114758;C3714445;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4551720,false;false;false;false;false;false;false;false;false;true;true;false;false;false;false;false;true,16253/22402
ics no laba,C0815320;C4551720,false;true,16254/22402
ics non - users,C0815320;C1518422;C1706077;C4551720,false;false;false;true,16255/22402
ics non - users at screening,C0815320;C1518422;C1706077;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4551720,false;false;false;true;true;false;false;false;false;false;true,16256/22402
ics non - users : qvai $nmbr$ - sfc,C0815320;C1518422;C1706077;C4521536;C4551720,false;false;false;false;true,16257/22402
ics nonusers  n ( % ),C0815320;C4551720,false;true,16258/22402
ics plus laba,C0815320;C4551720,false;true,16259/22402
ics subset,C0815320;C1515021;C4551720,false;false;true,16260/22402
ics use at enrollment  mean  mg / d,C0815320;C4551720,false;true,16261/22402
ics use at screening,C0815320;C4551720,false;true,16262/22402
ics use at screeningg  n ( % ),C0815320;C4551720,false;true,16263/22402
ics use no,C0815320;C4551720,false;true,16264/22402
ics use yes,C0815320;C4551720,false;true,16265/22402
ics users,C0815320;C1706077;C4551720,false;false;true,16266/22402
ics users at baseline  %,C0815320;C1706077;C0168634;C1442488;C4551720,false;false;true;false;true,16267/22402
ics users at screening,C0815320;C1706077;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4551720,false;false;true;true;false;false;false;false;false;true,16268/22402
ics users : qvai $nmbr$ - sfc,C0815320;C1706077;C4521536;C4551720,false;false;false;true,16269/22402
ics  n ( % ),C0815320;C4551720,false;true,16270/22402
ics  no laba  n ( % ),C0815320;C4551720,false;true,16271/22402
ics / laba subset,C0815320;C1515021;C4551720,false;false;true,16272/22402
ics / laba therapy  n ( % ),C0815320;C0039798;C0087111;C1363945;C4551720,false;true;true;false;true,16273/22402
ics / labd,C0815320;C0396059;C4551720,false;true;true,16274/22402
ics  no laba ( tiotropium n = $nmbr$  placebo n = $nmbr$ ),C0815320;C4551720,false;true,16275/22402
icsa plus laba  n ( % ),C0332287,false,16276/22402
icsf,,,16277/22402
ideg,,,16278/22402
idegasp – biasp $nmbr$,,,16279/22402
idegasp bid,,,16280/22402
ideglira,C4308663,true,16281/22402
idiopathic / familial,C0332240;C0015576;C0241888,false;true;false,16282/22402
idiopathica,,,16283/22402
idm,C0270221,false,16284/22402
iee at baseline : < $nmbr$ iu / l,C0168634;C0439457;C1442488,true;false;false,16285/22402
ifg pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ ),C1334085;C0031962;C1708411,false;true;false,16286/22402
ifx treatment,C0020823;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,16287/22402
ig ( n = $nmbr$ ),C0021027;C0305052;C0360506,true;false;false,16288/22402
iga $nmbr$ / $nmbr$,C2825347,false,16289/22402
iga mod $nmbr$ score  n ( % ),C2825347;C0011860;C0449820;C4050231,false;true;false;false,16290/22402
ige ( ku / l )  median ( range ) c,C0439340;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,16291/22402
ige high ( > $nmbr$ ku / l  n = $nmbr$  $nmbr$ ),C0205250;C0439340;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209,false;false;false;false;false;false;false;false,16292/22402
igehigh ( > i $nmbr$ ku / l  n = i  $nmbr$ ),C0021966;C0439340;C0221138,true;false;false,16293/22402
igelow ( < $nmbr$ ku / l  n = $nmbr$  $nmbr$ ),C0439340,false,16294/22402
igelow ( < i $nmbr$ ku / l  n = i  $nmbr$ ),C0021966;C0439340;C0221138,true;false;false,16295/22402
igelow ( n = $nmbr$  $nmbr$ ),,,16296/22402
igg ( > $nmbr$ . $nmbr$ g / l )  %,C0439294;C0456615,false;false,16297/22402
igl ( n = $nmbr$ ),C0021037;C0314619;C2247518,true;false;false,16298/22402
iglar ( n   =   $nmbr$ ),,,16299/22402
iglarlixi ( n   =   $nmbr$ ),,,16300/22402
igt or ifg,,,16301/22402
igt / ifg,C1334085;C1708411,false;false,16302/22402
ihd,C0151744,true,16303/22402
ii $nmbr$ amlodipine - lisinopril - chlorthalidone chlorthalidone,C1710602;C0051696;C0065374;C0008294;C4082587,false;true;true;true;false,16304/22402
ii ( $nmbr$ ),,,16305/22402
ii = $nmbr$,,,16306/22402
ii chiorthaiidone amiodipine,C1710602;C4082587,false;false,16307/22402
ii lisinopril,C1710602;C0065374;C4082587,false;true;false,16308/22402
ii lisinopril i,C1710602;C0065374;C0021966;C0221138;C4082587,false;true;true;false;false,16309/22402
ii . $nmbr$ ( $nmbr$ . $nmbr$ ) $nmbr$,,,16310/22402
ii / iii,C1710602;C0439070;C1705160;C4082587,false;false;false;false,16311/22402
ii $nmbr$ ( i $nmbr$ . $nmbr$ ),C1710602;C0021966;C0221138;C4082587,false;true;false;false,16312/22402
ii $nmbr$ ( ii . $nmbr$ ),C1710602;C4082587,false;false,16313/22402
ii $nmbr$ ± $nmbr$,,,16314/22402
iief - ef domain score  visit $nmbr$ * *,C3641331;C1880389;C0449820;C0545082;C1512346;C2826704;C4050231;C1883221;C3541951,false;false;false;false;false;false;false;false;false,16315/22402
iief - ef domain score  visit $nmbr$ y,C3641331;C1880389;C0449820;C0545082;C1512346;C2826704;C4050231;C1883221;C3541951,false;false;false;false;false;false;false;false;false,16316/22402
iii ( $nmbr$ ),C0439070;C1705160,false;false,16317/22402
iii and iv,C0439070;C1705160,false;false,16318/22402
iii or iv,C0439070;C1705160,false;false,16319/22402
ijb ^,,,16320/22402
il - $nmbr$ range  ng / l,C0020898;C1514721;C0439297;C2348147;C3542016;C0021764;C0022271,true;false;false;false;false;true;true,16321/22402
ileocolonic ( both ileum and colon ),,,16322/22402
ileum and colon  ' n ( % ),C0020885,true,16323/22402
ileum and colon  n ( % ),C0020885,true,16324/22402
ileum only  n ( % ),C0020885;C0205171;C1720467,true;false;false,16325/22402
ileum ses - cd score  mean ( sd ),C0020885;C0007928;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C0034283;C4552032,true;true;false;false;false;false;false;false;true;false,16326/22402
ill -,C0231218,false,16327/22402
im - uniti,,,16328/22402
im on ] y,,,16329/22402
image only,C1704254;C0205171;C1720467;C1704922;C3542466,false;false;false;false;false,16330/22402
imaged artery,C1704254;C0003842;C0226004;C1704922;C3542466,false;true;false;false;false,16331/22402
imaging data  mean ( sd ),C0011923;C1511726;C0444504;C2699239;C2347634;C2348143;C3245479;C3714741;C0079595,true;false;false;false;false;false;false;false;false,16332/22402
imm,C0205470,false,16333/22402
imm only,C0205470;C0205171;C1720467,false;false;false,16334/22402
immobilization — no . ( % ),C0020944;C4048292,true;false,16335/22402
immunomodulators,C0001551;C0005525;C1527392,true;true;true,16336/22402
immunomodulatory drugs,C0013227;C3687832,true;false,16337/22402
immunosuppressant ^,C0021081,true,16338/22402
immunosuppressive agents at baseline,C0021081;C0168634;C1442488,true;true;false,16339/22402
immunosuppressive use  n ( % ),C0021081;C0042153;C0457083;C1947944,true;true;false;false,16340/22402
impacts,C1825598;C4049986,false;false,16341/22402
impaired cognitive,C0338656,true,16342/22402
impaired cognitive function ( spmsq > $nmbr$ ) . n - $nmbr$ n ( % ) participants with the event of interest,C0221099;C0009240;C0679646;C0441471;C0543488;C4019010;C0392335;C4050130,false;true;false;false;false;false;false;false,16343/22402
impaired fasting giucose levei ( n = $nmbr$ ),C0221099,false,16344/22402
impaired fasting glucose,C1272092,false,16345/22402
impaired fasting glucose ( > $nmbr$ mg / dl ) ( % ),C1272092;C0439269,false;false,16346/22402
impaired fasting glucose §,C1272092,false,16347/22402
impaired fasting glucosex,C0221099,false,16348/22402
impaired renal function §,C1565489,true,16349/22402
impaired renal function †,C1565489,true,16350/22402
implantable cardioverter - defibrillator n ( % ),C0162589;C2825184,true;false,16351/22402
implanted cardioverter defibrillator,C0021102;C0810516;C2828363,false;false;false,16352/22402
improvement from baseline ≥   $nmbr$,C2986411;C0168634;C1442488,false;true;false,16353/22402
imputed,C2699638,false,16354/22402
in,,,16355/22402
in - clinic uas $nmbr$,C0150312;C0002424;C0442592;C0332285;C1707101,false;true;false;false;false,16356/22402
in - clinic uask,C0150312;C0002424;C0442592;C0332285;C1707101,false;true;false;false;false,16357/22402
in - hospital medication,C0019994;C0013227;C3244316;C4284232;C1510665,true;true;false;false;false,16358/22402
in - trial $nmbr$ - year rates per $nmbr$ ( se ) total events / number at risk,C0150312;C0008976;C0439234;C1264674;C0036919;C0439175;C0441471;C3541888;C0439810;C0871208;C4288115;C1521828;C0439508;C0332285;C1707101,false;true;false;false;true;false;false;false;false;false;false;false;false;false;false,16359/22402
in - trial and post - trial $nmbr$ - year rates per $nmbr$ ( se ) total events / number at risk,C0150312;C0008976;C0332285;C1707101,false;true;false;false,16360/22402
in - trial nonfatal or fatal stroke n = $nmbr$  $nmbr$,C0150312;C0008976;C0332285;C1707101,false;true;false;false,16361/22402
in extension study,C0231448;C0557651;C2603343;C1880641,false;false;false;false,16362/22402
in hospital ticagrelor,C0019994;C1999375;C1510665,true;true;false,16363/22402
in patients with a history of chronic angina who have presented with an acute,C0679831;C0205191;C0002962,false;false;true,16364/22402
in previous year  mean ( sd ),C0205156;C0439234;C0444504;C2699239;C2347634;C2348143;C0439508;C1552607,false;false;false;false;false;false;false;false,16365/22402
in remission at maintenance study baseline,C0544452;C0024501;C0557651;C0168634;C1442488;C2603343;C0687702,false;true;false;true;false;false;false,16366/22402
in the spironolactone group and $nmbr$ patients in the placebo group .,C0037982;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,16367/22402
in therapeutic range for warfarin subjects,C0460097;C0043031,false;true,16368/22402
in thirds,,,16369/22402
inadequate response ' ^,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,16370/22402
inadequate response ' ’ ',C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,16371/22402
inadequate response ( > $nmbr$ months mmf / ggs ),C0205412;C0871261;C0439231;C0083765;C0209368;C3848524;C1704632;C1706817;C2911692;C0439856,false;false;false;true;true;true;false;false;false;false,16372/22402
inadequate response or intolerance to > $nmbr$ anti - tnfdrug,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,16373/22402
inappropriate,C1548788;C3537135;C3542467,false;false;false,16374/22402
incidence of each outcome,C0021149;C1274040;C0220856,true;false;true,16375/22402
incidence rate ( n ),C1708485,false,16376/22402
incidence rate ( n ) a,C1708485,false,16377/22402
incidence rate ( per $nmbr$ person - yr ),C1708485;C0027361;C0439234;C2347489,false;true;false;false,16378/22402
incidence rate difference  linagliptin - placebo ( $nmbr$ % cl ),C1708485;C1705241;C2746078;C0032042;C0596019;C1696465;C1706408;C1705242,false;false;true;true;false;false;false;false,16379/22402
incidence rate no . ( / $nmbr$ person - years ),C1708485,false,16380/22402
incidence rate of cv events  n ( % ),C1708485;C3538987;C0441471;C3541888;C4048877;C4318503,false;false;false;false;true;false,16381/22402
incidence rate per $nmbr$ person years,C1708485;C0027361;C0439234;C2347489,false;true;false;false,16382/22402
incidence rate *,C1708485,false,16383/22402
incidence  ° / o ( $nmbr$ / $nmbr$ cl ),C0021149;C0596019;C0220856,true;false;true,16384/22402
incidence  $nmbr$ person - year,C0021149;C0027361;C0439234;C0439508;C2347489;C0220856,true;true;false;false;false;true,16385/22402
incidence ^,C0021149;C0220856,true;true,16386/22402
incident dm or change in,C1551358;C0011816;C3250443,false;true;false,16387/22402
incident or worsening nephropathy,C1551358,false,16388/22402
included in analysis,C0332257;C0002778;C0936012;C1524024,false;false;false;true,16389/22402
included in this study ( n = $nmbr$ ),C0332257;C0557651;C2603343,false;false;false,16390/22402
inclusion criteria,C1512693,false,16391/22402
inclusion findings ( % ),C0007637;C2607943;C2926606;C3539655;C1512693,true;true;false;false;false,16392/22402
inconsistent fao ( n [ $nmbr$ ),C0442809;C0016457,false;false,16393/22402
incontinence episodes / $nmbr$ h,C0021167;C0332189;C0033727;C0369286;C0441932;C0564385;C4528284,false;false;true;false;false;false;false,16394/22402
increase in serum creatinine,C0442805;C0201976;C0600061,false;false;false,16395/22402
increased - risk for thrombotic cardiovascular,C4699158;C0087086;C0007226;C3887460,false;true;true;false,16396/22402
increased risk for falls,C4699158;C0000921;C0085639;C1849142;C0035647;C4552904,false;true;false;false;true;false,16397/22402
increased risk for thrombotic cardiovascular event ^  n ( % ),C0205217;C0087086;C1273410;C0442805,false;true;false;false,16398/22402
indacaterol / glycopyrronium $nmbr$ / $nmbr$   μ g o . d .,C1722260;C3814772;C0439417,true;false;false,16399/22402
indeterminate nfs - $nmbr$ . $nmbr$ < nfs < $nmbr$ . $nmbr$ ! n = $nmbr$ ),C0205258;C1513839,false;false,16400/22402
index acs — no . ( % ),C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;true;false;false;false,16401/22402
index acs ( % ),C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546,true;true;false;true;false;false;false,16402/22402
index acute coronary syndrome — no . { % ),C0600653;C0948089;C0918012;C1552854;C1637833;C2986546,true;true;true;false;false;false,16403/22402
index event information,C0600653;C0441471;C1533716;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;false;true;false;false;false,16404/22402
index event  n / n ( % ),C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,16405/22402
index events,C0600653;C0441471;C3541888;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,16406/22402
index events : dvt n ( % ),C0600653;C0441471;C0149871;C2926618;C3899446;C3541888;C0918012;C1552854;C1637833;C2986546,true;false;true;false;false;false;true;false;false;false,16407/22402
index events : pe ± dvt n ( % ),C0600653;C0441471;C0070939;C0149871;C2926618;C3899446;C1880476;C4284304;C3541888;C0918012;C1552854;C1637833;C2986546,true;false;true;true;false;false;false;false;false;true;false;false;false,16408/22402
index inclusion acute coronary syndrome,C0600653;C0007637;C0948089;C1512693;C0918012;C1552854;C1637833;C2986546,true;true;true;false;true;false;false;false,16409/22402
index pe : event during,C0600653;C0070939;C0441471;C4019010;C1880476;C4284304;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false;false;true;false;false;false,16410/22402
index percutaneous coronary intervention,C0600653;C1532338;C0918012;C1552854;C1637833;C2986546,true;true;true;false;false;false,16411/22402
indian subpopulation,C1524069;C1257890,false;true,16412/22402
indication,C0392360;C3146298,false;false,16413/22402
individual endpoints,C0027361;C2349179;C0237401,true;false;false,16414/22402
individuals with normoglycaemia,C0027361;C0580545;C0237401,true;false;false,16415/22402
individuals with pre - diabetes  n ( % ),C0027361;C0362046;C0237401,true;true;false,16416/22402
individuals with prediabetes,C0027361;C0362046;C0237401,true;true;false,16417/22402
individuals with t $nmbr$ dm ( scale diabetes ),C0027361;C0011816;C0175659;C0011847;C0011849;C0349674;C1947916;C3250443;C0237401,true;true;true;false;true;false;false;false;false,16418/22402
individuals with type $nmbr$ diabetes  n ( % ),C0027361;C1320657;C0237401,true;false;false,16419/22402
indomethacin,C0021246,true,16420/22402
inducing,C0205263,false,16421/22402
induction study treatment,C4049995;C0557651;C2603343;C0205263;C1521826;C0857127,false;false;false;false;false;false,16422/22402
infarct - related vessel ( % ),C0021308,true,16423/22402
infarct location anterior,C0021308;C0450429;C1515974;C4284930;C4284931,true;false;false;false;false,16424/22402
infarct on brain imaging ^,C0751955,true,16425/22402
infarct size,C0021308;C0456389,true;false,16426/22402
infarct territory ( % ),C0021308;C1301808;C2983136,true;false;false,16427/22402
infarction ( yr ) history of congestive heart failure ( % ),C0021308;C0439234;C0455531;C0742742,true;false;false;false,16428/22402
infected  n ( % ) a,C0439663,false,16429/22402
infections,C3714514,true,16430/22402
infections and infestations,C3714514,true,16431/22402
inferior mi *  %,C0340305;C3542426,true;false,16432/22402
inflammatory bowel disease,C0021390,true,16433/22402
infliiimab i,C0021966;C0221138,true;false,16434/22402
infliximab combination therapy,C4076075;C0205195;C1947911;C3811910;C0666743;C0009429;C0556895,false;false;false;false;true;true;false,16435/22402
infliximab monotherapy,C0666743,true,16436/22402
inflotmas io mgluj versus piecew,C1046794;C3146236,false;false,16437/22402
influenza,C0021400;C0021403,true;true,16438/22402
infrequent exacerbator,C0521114,false,16439/22402
inguinal hernia repair,C0021446,false,16440/22402
inhaled corticosteroid,C0004048;C0001617;C3536709,true;true;false,16441/22402
inhaled corticosteroid - yes  n ( % ),C0004048;C0001617;C1549445;C1705108;C1710701;C3536709,true;true;false;false;false;false,16442/22402
inhaled ^,C0004048,true,16443/22402
inhaledb,,,16444/22402
inhibitor,C1999216,false,16445/22402
inhibitors — no . { % ) se - $nmbr$ physical functioning score ^ ^,C0243077,true,16446/22402
inhixanab $nmbr$ mgikg versus piacom,,,16447/22402
initial heparin — no . ( % ) §,C0205265;C0019134;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false,16448/22402
initial heparin treatment duration,C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false;false,16449/22402
initial heparin treatment duration on or after randomization,C0205265;C0019134;C0444921;C3259042;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false;false,16450/22402
initial symptomatic pe,C0205265;C0231220;C0070939;C1880476;C4284304;C1279901;C1555582;C1705685,false;false;true;false;false;false;false;false,16451/22402
initial timi flow grade $nmbr$,C0205265;C3272266;C0441800;C0919553;C3244287;C1279901;C1555582;C1705685,false;false;false;false;false;false;false;false,16452/22402
initial treatment randomization,C0205265;C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1279901;C1555582;C1705685,false;true;true;true;false;false;false;false;false;false;false;false,16453/22402
initial type of heparin treatment received,C0205265;C0019134;C0455708;C0770546;C1279901;C1555582;C1705685,false;true;false;false;false;false;false,16454/22402
initiated use during double - blind treatment period,C1548602;C0042153;C0013072;C0039798;C0439531;C1948053;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0457083;C1947944;C1704686,false;true;true;true;false;false;true;false;false;false;false;false;false;false;false,16455/22402
injectable anti ‐ hyperglycaemic  n ( % ),C1272883;C0432633,false;false,16456/22402
injection - site reaction  n ( % ),C0151735;C4551923,true;false,16457/22402
inotropic agent,C0304509,false,16458/22402
insufficient,C0205412;C0231180;C0439856,false;false;false,16459/22402
insuiin giargine ± oad,,,16460/22402
insulin - dependent diabetes mellitus,C0011854,true,16461/22402
insulin - naive  n ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,16462/22402
insulin - requiring diabetes,C0021641;C0011847;C0011849;C1533581;C1579433;C3714501,true;false;true;false;false;false,16463/22402
insulin - treated diabetes  %,C0021641;C1533581;C1579433;C3714501,true;false;false;false,16464/22402
insulin - treated dm,C0021641;C1533581;C1579433;C3714501,true;false;false;false,16465/22402
insulin — / tu / ml,C0021641;C0041400;C0439526;C1705224;C3887665;C1532464;C2700314;C3811255;C1533581;C1579433;C3714501,true;true;false;false;false;false;false;false;false;false;false,16466/22402
insulin ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,16467/22402
insulin + metformin,C0021641;C0025598;C1533581;C1579433;C3714501,true;true;false;false;false,16468/22402
insulin + oral antidiabetic medication ( s ),C0021641;C0175795;C0935929;C0442027;C4521986;C1533581;C1579433;C3714501,true;false;true;false;false;false;false;false,16469/22402
insulin administration,C0199782,false,16470/22402
insulin aspart,C0123677;C1708521,false;true,16471/22402
insulin aspart ( mealtime ),C0123677;C0587119;C1708521,false;true;true,16472/22402
insulin at baseline,C0021641;C0168634;C1442488;C1533581;C1579433;C3714501,true;true;false;false;false;false,16473/22402
insulin detemir,C0537270,true,16474/22402
insulin dose — lu / day,C0366513;C0024171;C0332173;C0439228;C0439505;C0024176;C2697939,false;true;false;false;false;true;false,16475/22402
insulin dose ( iu / day )  median,C0366513;C0439465;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,16476/22402
insulin dose ( lu / day ),C0366513;C0024171;C0332173;C0439228;C0439505;C0024176;C2697939,false;true;false;false;false;true;false,16477/22402
insulin dose ( u ),C0366513;C0439148,false;false,16478/22402
insulin dose  u,C0366513;C0439148,false;false,16479/22402
insulin glargin arm,C0021641;C0446516;C3715044;C4553528;C1533581;C1579433;C3714501,true;true;false;false;false;false;false,16480/22402
insulin glargine + insulin lispro ( award - $nmbr$  n = $nmbr$ ),C0293359;C0907402;C0004446,true;true;true,16481/22402
insulin glargine dose at screening visit  iu,C0366513;C0907402;C0220908;C0545082;C0049272;C0439453;C0694756;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0178602;C0869039;C1114758,false;true;true;false;true;false;false;false;false;true;false;false;false;false;false;false;false;false,16482/22402
insulin glargine slope lsm ± se ( mm / year ),C0907402;C0807955;C0036919;C4330985;C0439234;C0439508;C4554674,true;false;true;false;false;false;false,16483/22402
insulin glargine   ±   oad,C0907402,true,16484/22402
insulin glargine   ±   oad   +   > bd prandial,C0907402;C0005126;C2344255;C4050145,true;true;false;false,16485/22402
insulin glargine   ±   oad   +   bd prandial,C0907402;C0005126;C2344255;C4050145,true;true;false;false,16486/22402
insulin glargine   ±   oad   +   od prandial,C0907402;C0229089;C0439164;C1512019;C3273373;C3665488,true;false;false;false;true;true,16487/22402
insulin lispro mix $nmbr$,C0293359;C0205430;C1421951;C1720722;C4553942,true;false;false;false;false,16488/22402
insulin secretagogue,C0021641;C4704833;C1533581;C1579433;C3714501,true;true;false;false;false,16489/22402
insulin therapy  n ( % ),C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,true;true;true;false;false;false;false,16490/22402
insulin therapy  n ( % ) 本,C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501,true;true;true;false;false;false;false,16491/22402
insulin treatment,C0745343,false,16492/22402
insulin treatment  n ( % ),C0745343,false,16493/22402
insulin type  n ( % ),C0457592,false,16494/22402
insulin use at baseline,C0240016;C0168634;C1442488,false;true;false,16495/22402
insulin use    n   ( % ),C0240016,false,16496/22402
insulin  median ( q $nmbr$  q $nmbr$ )  pmol / l,C0021641;C0549183;C0439284;C0876920;C2347635;C2348144;C2939193;C1533581;C1579433;C3714501,true;false;false;false;false;false;false;false;false;false,16497/22402
insulin  n ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,16498/22402
insulin + metformin + sulphonylureas,C0021641;C0025598;C0038766;C1533581;C1579433;C3714501,true;true;true;false;false;false,16499/22402
insulin + sulphonylureas,C0021641;C0038766;C1533581;C1579433;C3714501,true;true;false;false;false,16500/22402
insulinogenic index ( dinsulino_ $nmbr$ o min / dglucoseo - $nmbr$ o min ),C0600653;C0702093;C1524029;C3813700;C0918012;C1552854;C1637833;C2986546,true;false;false;false;true;false;false;false,16501/22402
insulins,C0021641;C3537244;C4049919,true;true;false,16502/22402
insulins and analogs,C0021641;C3537244;C4049919,true;true;false,16503/22402
integrated analysis set ( n = $nmbr$ ),C1158478;C0002778;C0936012;C1524024;C1705422,false;false;false;true;false,16504/22402
intensification of antianginal therapy,C1511484;C1874267;C3537168,false;false;false,16505/22402
intensity of rest pain ( mmvas )  mean ± sd,C0522510;C0234253;C0444504;C2699239;C2347634;C2348143;C0035253;C1320357;C4085211;C1622890,false;false;false;false;false;false;true;false;false;false,16506/22402
intensity of statin therapy,C0522510;C1278454,false;false,16507/22402
intensity of statin therapy at baseline — no . { % ),C0522510;C1278454,false;false,16508/22402
intensity $nmbr$,C0522510,false,16509/22402
intensive ( n = $nmbr$ ),C0162425;C0522510;C1283828;C1550453,true;false;false;false,16510/22402
intensive blood glucose control,C0162425;C3267174;C0522510;C1283828;C1550453,true;false;false;false;false,16511/22402
intensive bp lowering  < $nmbr$ mm hg ( n = $nmbr$ ),C0162425;C0037623;C0441994;C0439475;C2003888;C1415692;C1708288;C4318478;C0522510;C1283828;C1550453,true;true;false;false;false;false;false;false;false;false;false,16512/22402
intensive glycemia lowering,C0162425;C0005802;C0441994;C2003888;C0522510;C1283828;C1550453,true;true;false;false;false;false;false,16513/22402
intensive therapy ( n = $nmbr$ ),C0162425;C0039798;C0087111;C1363945;C0522510;C1283828;C1550453,true;true;true;false;false;false;false,16514/22402
intent - to - treat population,C0162425;C0087111;C0032659;C1257890;C1292734;C1522326;C1283828;C1550453,true;true;true;true;false;false;false;false,16515/22402
intent to use direct thrombin,C0162425;C1283828;C1550453,true;false;false,16516/22402
intent to use glycoprotein iib / iiia inhibitor,C0162425;C1283828;C1550453,true;false;false,16517/22402
intention to treat,C0162425;C1283828,true;false,16518/22402
inter . p - value,C0205103;C1548610,false;false,16519/22402
interaction,C1704675,false,16520/22402
interaction between treatment and baseline bmi category,C1704675;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;false;false;false;false;false,16521/22402
interaction j $nmbr$ - valuet,C1704675,false,16522/22402
interaction p - vaiue,C1704675,false,16523/22402
interaction p - value *,C1704675;C1709380,false;false,16524/22402
interaction p - valuef,C1704675,false,16525/22402
interaction p = $nmbr$ . $nmbr$,C1704675,false,16526/22402
interaction p vaiue,C1704675,false,16527/22402
interaction p value $nmbr$ . $nmbr$,C1704675;C1709380,false;false,16528/22402
interaction p value !,C1704675;C1709380,false;false,16529/22402
interaction p value ∗,C1704675;C1709380,false;false,16530/22402
interaction p value *,C1704675;C1709380,false;false,16531/22402
interaction p values are as follows : amlodipine vs . chlorthalidone : age  p = $nmbr$ . $nmbr$  gender  p = $nmbr$ . $nmbr$  race  p = $nmbr$ . $nmbr$  history of chd  p = $nmbr$ . $nmbr$  history of diabetes  p = $nmbr$ . $nmbr$ . lisinopril vs . chlorthalidone : age  p = $nmbr$ . $nmbr$  gender  p = $nmbr$ . $nmbr$  race  p = $nmbr$ . $nmbr$  history of chd  p = $nmbr$ . $nmbr$  history of diabetes  p = $nmbr$ . $nmbr$ . peripheral arterial disease refers to in - trial hospitalization or lower extremity revascularization procedure .,C1704675;C1709380;C0369773;C0079399;C0034510;C0019664;C0280604;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062;C1706779;C3853635;C1522384;C2603361;C0011847;C0065374;C0011849;C0034510;C0019664;C0280604;C0011847;C0011849;C3542407;C0019665;C0262512;C0262926;C1705255;C2004062;C1706779;C3853635;C0085096;C1704436;C0015385;C0581603;C0184661;C2700391;C3274430;C3539779,false;false;false;true;true;true;false;false;true;false;false;false;false;false;false;true;false;false;true;true;true;true;false;false;true;false;true;false;false;false;false;false;false;true;true;true;false;true;false;false;false,16532/22402
interaction pf,C1704675;C3815179,false;false,16533/22402
interaction : treatment by psoriasis p valueb,C1704675;C3258078,false;false,16534/22402
intercourse satisfac -,C0009253,true,16535/22402
interim analysis,C4684691,false,16536/22402
interim analysis ( all patients ),C4684691,false,16537/22402
intermediate - acting,C0205103;C1550465;C2827755;C3889971,false;false;false;false,16538/22402
intermediate ( $nmbr$ )  %,C0205103;C1550465;C2827755;C3889971,false;false;false;false,16539/22402
intermediate ( $nmbr$ - $nmbr$ ),C0205103;C1550465;C2827755;C3889971,false;false;false;false,16540/22402
intermediate / long - acting + fast - acting,C0205103;C0205166;C0079613;C0015663;C0456962;C2985769;C1704930;C1869853;C3890007;C4048375;C1706317;C1550465;C2827755;C3889971,false;false;true;true;false;false;false;true;false;false;false;false;false;false,16541/22402
internal carotid artery sites,C0007276;C0205145,true;false,16542/22402
interquartile range — ml / min,C1711350;C0439445,false;false,16543/22402
intertrochanteric,C0745355,false,16544/22402
interval between clinical evaluation and initiation of treatment — no . ( % ),C1272706;C1261322;C4084924;C1552654;C1552713;C0205210;C2826267,false;false;false;false;false;false;false,16545/22402
interval from symptom onset to qualifying ecg obtained in the er — hr,C1272706;C4086878;C1552654;C1552713,false;false;false;false,16546/22402
interval of > $nmbr$ yr since diagnosis of type $nmbr$ diabetes — no . ( % ),C1272706;C0439234;C1552654;C1552713,false;false;false;false,16547/22402
intervention .,C0184661;C0886296;C1273869,true;false;false,16548/22402
interventional or surgical procedures,C0184661;C3274035,true;false,16549/22402
intestinal area involved — no . ( % ),C0021853;C0017446;C0205146,true;true;false,16550/22402
intolerance,C0231199;C1744706;C2355652,false;false;false,16551/22402
intolerance ',C0231199;C1744706;C2355652,false;false;false,16552/22402
intolerance ®,C0231199;C1744706;C2355652,false;false;false,16553/22402
intra - abdominal abscess ( past ),C0243001;C1444637;C4284302,true;false;false,16554/22402
intracerebral,C0442111,false,16555/22402
intracranial,C0524466,false,16556/22402
intracranial bleed,C0151699,true,16557/22402
intracranial bleeding,C0151699,true,16558/22402
intracranial disease of major artery disease t,C0752138;C0012634;C0205082;C0205164;C4318856;C4521762,true;true;false;false;false;false,16559/22402
intracranial hemorrhage,C0151699;C4554169,true;false,16560/22402
intracranial hemorrhage  n ( % ),C0151699;C4554169,true;false,16561/22402
intracranial hemorrhage †,C0151699;C4554169,true;false,16562/22402
intravenous ( n = $nmbr$ ),C0348016,false,16563/22402
intravenous anticoagulant during hospitalisation *,C0348016;C0003280;C0019993;C0848112;C3536711,false;true;true;false;false,16564/22402
intravenous anticoagulant prior to pre - pci angiography,C0348016;C0003280;C0332152;C4049621;C0002978;C0740175;C2257086;C3669034;C0848112;C3536711,false;true;false;false;true;false;false;false;false;false,16565/22402
intravenous vasoactive drugs  % y,C0683092;C1980011,false;false,16566/22402
inversion,C0021943;C0021945;C1705687;C2349984,true;false;false;false,16567/22402
investigations,C1261322,false,16568/22402
investigator - defined drug - related aes,C0035173,true,16569/22402
investigator - reported aes,C0035173;C0684224;C1412268;C2699274;C0700287;C4319718,true;true;false;false;false;false,16570/22402
involved gastrointestinal,C1314939;C0521362,false;false,16571/22402
involved gl areas,C1879646;C0018229;C1423073;C1427674,false;true;false;false,16572/22402
iop - lowering medication,C0578862;C0441994;C0013227;C3244316;C4284232;C2003888,false;false;true;false;false;false,16573/22402
iop  mm hg,C0578862;C0439475,false;false,16574/22402
ipeated - measures state examinatioi,C0079809;C1879489,true;false,16575/22402
ipf,C0034069;C1800706,true;true,16576/22402
ipss,C1019118;C1998280;C2827405;C3811063,false;false;false;false,16577/22402
ipss - s,C1019118;C1998280;C2827405;C3811063,false;false;false;false,16578/22402
ipss - v,C1019118;C1998280;C2827405;C3811063,false;false;false;false,16579/22402
ipss ( ls mean ± se ),C1019118;C0023668;C0444504;C0036919;C2347634;C2348143;C1998280;C2827405;C3811063,false;true;false;true;false;false;false;false;false,16580/22402
ipss ( mean ± sd ),C1019118;C0444504;C2699239;C2347634;C2348143;C1998280;C2827405;C3811063,false;false;false;false;false;false;false;false,16581/22402
ipss ( unit ),C1019118;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C1998280;C2827405;C3811063,false;false;false;false;false;false;false;false;false;false;false,16582/22402
ipss categories,C1019118;C0683312;C1998280;C2827405;C3811063,false;false;false;false;false,16583/22402
ipss hrql,C1019118;C1998280;C2827405;C3811063,false;false;false;false,16584/22402
ipss qol,C1019118;C0518214;C1998280;C2827405;C3811063,false;false;false;false;false,16585/22402
ipss qol ( ls,C1019118;C0518214;C0023668;C1998280;C2827405;C3811063,false;false;true;false;false;false,16586/22402
ipss storage subscore,C1019118;C0337174;C1698986;C1753314;C1998280;C2827405;C3811063,false;false;false;false;false;false;false,16587/22402
ipss total score,C1019118;C2964552;C1998280;C2827405;C3811063,false;false;false;false;false,16588/22402
ipss voiding subscore,C1019118;C1998280;C2827405;C3811063,false;false;false;false,16589/22402
ipss  “ / o,C1019118;C1998280;C2827405;C3811063,false;false;false;false,16590/22402
iqr,,,16591/22402
irr = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ ) $nmbr$ . $nmbr$,C4082285,true,16592/22402
irregular or ulcerated ica plaquef,C0205271,false,16593/22402
irritative subscore,C0441723;C1706307;C2700617,false;false;false,16594/22402
is domain luts severity ( % ),,,16595/22402
is only,,,16596/22402
ischaemic ( n = $nmbr$ ),C0475224,false,16597/22402
ischaemic dilated cardiomyopathy,C1960867,false,16598/22402
ischaemic etiology n ( % ),C0475224;C0015127;C1314792;C1524003,false;true;true;false,16599/22402
ischaemic heart disease or cerebrovascular disorder  n ( % ),C0010054;C0151744,true;true,16600/22402
ischaemic or unknown stroke,C0475224,false,16601/22402
ischaemic skin lesions,C0475224;C0037284,false;false,16602/22402
ischaemic stroke,C0948008,false,16603/22402
ischaemic stroke  n ( % ),C0948008,false,16604/22402
ischemia on cecg ( % ),C0022116;C4321499,true;false,16605/22402
ischemic,C0475224,false,16606/22402
ischemic cause,C0475224;C0015127;C1524003,false;true;false,16607/22402
ischemic etiology,C0475224;C0015127;C1314792;C1524003,false;true;true;false,16608/22402
ischemic etiology ( % ),C0475224;C0015127;C1314792;C1524003,false;true;true;false,16609/22402
ischemic etiology  %,C0475224;C0015127;C1314792;C1524003,false;true;true;false,16610/22402
ischemic heart disease ( % ),C0010054;C0151744,true;true,16611/22402
ischemic heart disease *,C0010054;C0151744,true;true,16612/22402
ischemic heart disease  no . ( % ),C0010054;C0151744,true;true,16613/22402
ischemic heart failure etiology,C0475224;C0018801;C0015127;C1314792;C1524003;C0018802;C4554158,false;true;true;true;false;true;false,16614/22402
ischemic hf etiology,C0475224;C0018488;C0015127;C1314792;C1524003;C1313497;C1538440;C3273279,false;true;true;true;false;true;false;false,16615/22402
ischemic hf  % ( n ),C0475224;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,16616/22402
ischemic outcomes,C0475224;C1274040,false;false,16617/22402
ischemic stroke ( % ),C0948008,false,16618/22402
ischemic stroke ( incl . uncertain ),C0948008,false,16619/22402
ischemic stroke or see,C0948008,false,16620/22402
ischemic stroke subtype,C0948008;C0449560,false;false,16621/22402
isehemie heart disease,C0018799,true,16622/22402
ish,,,16623/22402
ish status  n ( % ),C0449438,false,16624/22402
isoiated systoiic hypertension *,C0020538;C1963138,true;false,16625/22402
isolated systolic hypertension,C0745133,false,16626/22402
isolated systolic hypertension  n ( ' % >,C0745133,false,16627/22402
isolated systolic hypertension ^,C0745133,false,16628/22402
isolated systolic hypertension ⁎,C0745133,false,16629/22402
isolated upper gastrointestinal disease behavior  n ( % ),C0205409;C0810300;C0004927;C2707008;C1548221,false;false;true;false;false,16630/22402
it $nmbr$ . $nmbr$,,,16631/22402
itca $nmbr$ $nmbr$ mg / day ( n = $nmbr$ ),C0165330;C0439422,true;false,16632/22402
itch nrs,C0033774;C2240043;C4050142;C1422257,true;false;false;false,16633/22402
itch nrs $nmbr$ ( v = $nmbr$ ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,16634/22402
itch nrs $nmbr$ - $nmbr$ ( at = $nmbr$ ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,16635/22402
itch nrs $nmbr$ - $nmbr$ ( v = $nmbr$ ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,16636/22402
itch nrs $nmbr$ - $nmbr$ ( . \ ' = $nmbr$ ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,16637/22402
itch nrs $nmbr$ - $nmbr$ ( a ' = $nmbr$ ),C0033774;C2240043;C4050142;C1422257,true;false;false;false,16638/22402
item,C1551338;C4554251,false;false,16639/22402
ith vs . without ),,,16640/22402
itt cohort  overall study period,C0009247;C0599755,true;false,16641/22402
itt patients  n ( % ),C0030705,true,16642/22402
itt population  n,C0032659;C1257890,true;true,16643/22402
iuss score  mean ( sd ),C0439453,false,16644/22402
iv - $nmbr$ mg,C0022326;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C4265176,true;true;true;false;false;false;false;false;false,16645/22402
iv ( $nmbr$ ),C0022326;C4265176,true;false,16646/22402
iv inotropic drug,C1971835,false,16647/22402
iv vasodilator,C0022326;C0042402;C3537240;C4265176,true;true;false;false,16648/22402
ivabradine,C0257190,true,16649/22402
ivc ( n = $nmbr$ ),C4085887,false,16650/22402
ixekizumab every $nmbr$ weeks ( n = $nmbr$ ),C3489764,true,16651/22402
ization — no . ( % ),,,16652/22402
j $nmbr$ - blocker  % ( n ),,,16653/22402
j $nmbr$ - blocker,,,16654/22402
j $nmbr$ coefficient,C1707429,false,16655/22402
japanese subgroup ( n = $nmbr$ ),C0376247;C1079230;C1515021;C1556094,false;false;false;true,16656/22402
japanese subpopulation,C0376247;C1257890;C1556094,false;true;true,16657/22402
joint space narrowing score  mean ( sd ),C1859695;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,16658/22402
joint swelling  effusion  or both on clinical examination,C1253936;C0013604;C0038999;C1963136;C4554335;C0152031;C0013687;C2317432,true;true;false;false;false;false;false;false,16659/22402
js $nmbr$ - agonists,C1552154;C0243192;C2987634,false;true;false,16660/22402
jsn score,C0449820;C4050231,false;false,16661/22402
jsn score ( $nmbr$ – $nmbr$ scale ),C0449820;C0175659;C0349674;C1947916;C4050231,false;true;false;false;false,16662/22402
jsn  mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,16663/22402
jugular venous distension  n ( % ),C0425687,false,16664/22402
jugular venous distention > $nmbr$ cm,C0425687,false,16665/22402
juvenile myoclonic epilepsy,C0270853,true,16666/22402
jvd $ $nmbr$ cm h $nmbr$ o  %,C0425687;C0455483,false;false,16667/22402
jvp $ $nmbr$ cm h $nmbr$ o,C0455483,false,16668/22402
jvp ( 〉 $nmbr$ cm ),,,16669/22402
k - m % n,C0597277;C0369637;C0441923;C1708601,false;false;false;false,16670/22402
k  mmol / l,C0597277;C1532563;C1708601,false;false;false,16671/22402
kaplan - meier rates  %,C0871208;C1521828,false;false,16672/22402
kaplan - meier rates  % i i,C0871208;C0021966;C0221138;C1521828,false;true;false;false,16673/22402
key secondary end points,C0027627;C2349179;C0175668;C0205436,true;false;false;false,16674/22402
key : fc = fasting glucose  bp = * this category did not include ar have $nmbr$ of the indicated charac,C2983605;C0015663;C0017725;C0037623;C1415692;C1708288;C4318478,false;true;true;true;false;false;false,16675/22402
kg,C0022718;C0439209;C4054209,true;false;false,16676/22402
kg / m $nmbr$,C1532718,false,16677/22402
kg / m $nmbr$ ),C1532718,false,16678/22402
kidney disease ( usrds ),C0022658,true,16679/22402
killip ciass,,,16680/22402
killip class — no . / total no . ( % ) i,C1881332,false,16681/22402
killip class > $nmbr$  no . ( % ),C1881332,false,16682/22402
killip class > i  %,C2697844,false,16683/22402
killip class $nmbr$,C1881332,false,16684/22402
killip class $nmbr$ / $nmbr$,C1881332,false,16685/22402
killip class ii - iv  n ( % ),C2697847;C1710602;C4082587;C2697845;C0022326;C4265176,false;false;false;false;true;false,16686/22402
killip class ii  iii  or iv — %,C2697846;C1710602;C4082587;C2697845;C0439070;C1705160,false;false;false;false;false;false,16687/22402
killip class iv at randomization,C2697847;C0034656,false;true,16688/22402
killip class *,C1881332,false,16689/22402
killip class  n ( % ) i,C1881332,false,16690/22402
kl $nmbr$ ( % ),C1366480;C1416656;C1704887,false;false;false,16691/22402
km event ( % ) at $nmbr$ y,C3887676;C0441471;C4019010,false;false;false,16692/22402
km rate ( % ),C3887676;C0871208;C1521828,false;false;false,16693/22402
km rates { % ) e / s,C3887676;C0871208;C1521828,false;false;false,16694/22402
km rates { % ) p / s,C3887676;C0871208;C0234833;C0722388;C1521828,false;false;false;false;false,16695/22402
knee,C0022742;C0022745;C1963703,true;true;false,16696/22402
knees ( n ),C0022742,true,16697/22402
known duration,C0205309;C0449238;C2926735,false;false;false,16698/22402
known duration of t $nmbr$ dm  y,C0205309;C0449238;C0011816;C3250443;C2926735,false;false;true;false;false,16699/22402
known duration of type $nmbr$ diabetes,C0205309;C0449238;C1320657;C2926735,false;false;false;false,16700/22402
l,C0439394;C1706495;C3642217,false;false;false,16701/22402
l ( < l ),C3539687,false,16702/22402
l compared wi,C0439394;C1707455;C0043193;C1520135;C1706495;C3642217,false;false;true;false;false;false,16703/22402
l compared wit,C0439394;C1706495;C3642217,false;false;false,16704/22402
l eft anterior descending,C0439394;C0451214;C0205094;C0205386;C1547177;C1706495;C3642217,false;false;false;false;false;false;false,16705/22402
l vs . c,C0439394;C1706495;C3642217,false;false;false,16706/22402
l . i ( $nmbr$ . $nmbr$ ),C0439394;C0021966;C0221138;C1706495;C3642217,false;true;false;false;false,16707/22402
l . l ± $nmbr$ . $nmbr$,C3539687,false,16708/22402
l / c,C0439394;C1706495;C3642217,false;false;false,16709/22402
l $nmbr$ - $nmbr$ vs placebo,C0439394;C1706495;C3642217,false;false;false,16710/22402
l $nmbr$ - $nmbr$ vs l $nmbr$ - $nmbr$ - $nmbr$,C0439394;C1706495;C3642217,false;false;false,16711/22402
la diameter,C0023031;C1301886;C0023749;C0230347;C2346906;C4553351,true;false;true;false;false;false,16712/22402
la grade a  n ( % ) f,C0023031;C0023749;C0230347;C2346906;C4553351,true;true;false;false;false,16713/22402
la grade b  n ( % ) f,C1881342;C0016327,false;true,16714/22402
laa closure ( n = $nmbr$ ),C0185003;C1521802,false;false,16715/22402
laba ( inhaled )  d   n ( % ),,,16716/22402
laba ( tiotropium n = $nmbr$  placebo n = $nmbr$ ),C0213771;C0032042;C1696465;C1706408,true;true;false;false,16717/22402
laba or lama,,,16718/22402
laba plus ics ( tiotropium n = $nmbr$  placebo n = $nmbr$ ),C0332287;C0815320;C0213771;C0032042;C1696465;C1706408;C4551720,false;false;true;true;false;false;true,16719/22402
laba plus ics  n ( % ),C0332287;C0815320;C4551720,false;false;true,16720/22402
laba use at enrolment,C0042153;C1516879;C1696073;C3888021;C0457083;C1947944,true;false;false;false;false;false,16721/22402
laba  n ( % ),,,16722/22402
laba  no ics  n ( % ),,,16723/22402
laba / ics #,C0815320;C4551720,false;true,16724/22402
laba / lama / ics,C0999593;C0815320;C4551720;C1416775,false;false;true;false,16725/22402
laba   +   ics,C0815320;C4551720,false;true,16726/22402
labd alone,C0396059,true,16727/22402
laboratory determinations,C0022877;C0680730;C3244292;C4283904,true;false;false;false,16728/22402
laboratory evaluations,C0022877;C0220825;C3244292;C4283904,true;false;false;false,16729/22402
laboratory investigations,C0022877;C1261322;C3244292;C4283904,true;false;false;false,16730/22402
laboratory parameters  median ( iqr ),C0022877;C0449381;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904,true;false;false;false;false;false;false;false;false,16731/22402
laboratory testing,C0022885,false,16732/22402
laboratory tests,C0022885,false,16733/22402
laboratory values in patients with history of diabetes,C0022877;C0042295;C0030705;C3244292;C4283904,true;false;true;false;false,16734/22402
labs at randomization,C0587081;C0034656,false;true,16735/22402
lack of effectiveness,C0235828,false,16736/22402
lack of efficacy,C0235828,false,16737/22402
lack of efficacy with > $nmbr$ anti - interleukin $nmbr$,C0235828,false,16738/22402
lack of efficacy with > $nmbr$ bdmard,C0235828,false,16739/22402
lacunar infarction  n ( % ),C0333559,true,16740/22402
lad artery,C0003842;C0226004,true;false,16741/22402
lama ( tiotropium )  b   n ( % ),C0999593;C0213771;C1416775,false;true;false,16742/22402
lama use  n ( % ),C0999593;C0042153;C0457083;C1947944;C1416775,false;true;false;false;false,16743/22402
lamad,,,16744/22402
lansoprazole ( n = $nmbr$ ),C0050940,true,16745/22402
lansoprazole $nmbr$ mg qd,C0050940;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,16746/22402
laparoscopic cholecystectomy,C0162522,true,16747/22402
large / very large,C0549177;C0442824;C2984081,false;false;false,16748/22402
last infusion in the horizon - pft,C1517741;C0574032;C0024119;C0053122;C0279232;C1827465,false;false;true;true;false;false,16749/22402
last study visit,C1517741,false,16750/22402
late load,C0205087,false,16751/22402
lathosterol ( jimol / l ),C0064673,true,16752/22402
lathosterol / total c ( | imol / mmol ),C0064673;C0439175;C0439190;C0439810,true;false;false;false,16753/22402
latin,,,16754/22402
latin american subgroup,C1553378;C1079230;C1515021,false;false;false,16755/22402
latin ameriea,,,16756/22402
latino,C0086528,true,16757/22402
lav ( ml ),C0019682;C0439526;C1705224;C3887665,true;false;false;false,16758/22402
lavolta $nmbr$,,,16759/22402
lavolta ii,C1710602;C4082587,false;false,16760/22402
lb,,,16761/22402
lc  n = $nmbr$,,,16762/22402
lce — l - dopa / carbidopa / entacapone  lc — l - dopa / carbidopa  pd — parkinson disease  updrs — rating scale  adl — activities of daily living  pdq - $nmbr$ — parkinson disease questionnaire .,C1423759;C0353697;C0165921;C4553228;C4553229;C3273355;C0030567;C3639721;C0681889;C0001288;C1521736;C0030567;C0034394;C1521736,false;true;true;false;false;false;true;true;false;true;false;true;true;false,16763/22402
lce  n = $nmbr$,C1423759;C3273355,false;false,16764/22402
lcl,C3658298,true,16765/22402
lcz $nmbr$,,,16766/22402
lcz $nmbr$ treatment  n ( % ),C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,16767/22402
ld,C0694649,false,16768/22402
ld edoxaban vs warfarin,C0694649;C2975435,false;true,16769/22402
ldi - b > $nmbr$ ( n = $nmbr$ ),,,16770/22402
ldi  mean ( sd ) a,C0444504;C2699239;C2347634;C2348143,false;false;false;false,16771/22402
ldi  mean [ sd ] b,C0444504;C2699239;C2347634;C2348143,false;false;false;false,16772/22402
ldi $nmbr$,,,16773/22402
ldl - c ( calculated )  mean ( sd ),,,16774/22402
ldl - c ( calculated )  mg / dl  mean ( sd ),,,16775/22402
ldl - c ( measured )  mean ( sd ),,,16776/22402
ldl - c ( mg / dl ) * *,C0439269,false,16777/22402
ldl - c < $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l ),C0439269;C1532563,false;false,16778/22402
ldl - c > $nmbr$ mg / dl,C0439269,false,16779/22402
ldl - c $nmbr$ - $nmbr$ mg / dl,C0439269,false,16780/22402
ldl - c at baseline :,C0168634;C1442488,true;false,16781/22402
ldl - c goal attainment,C0680230,false,16782/22402
ldl - c in mmol / l ( baseline : mean ( sd ) [ n ]  wk $nmbr$ and change : mean ( se ) [ n ] ),C1532563;C0168634;C0444504;C2699239;C0332174;C0439230;C2347634;C2348143;C1442488,false;true;false;false;false;false;false;false;false,16783/22402
ldl - c in mmol / l ( mean ± sd for baseline [ n ]  mean ± se for week $nmbr$ [ n ] ),C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,16784/22402
ldl - c level  mean ( sd )  mg / dl,C0441889;C0444504;C2699239;C0439269;C2347634;C2348143;C0456079;C1547707;C2946261,false;false;false;false;false;false;false;false;false,16785/22402
ldl - c level  mg / dl,C0441889;C0439269;C0456079;C1547707;C2946261,false;false;false;false;false,16786/22402
ldl - c   *   ( mmol / l ),C1532563,false,16787/22402
ldl - c  mg / dl *,C0439269,false,16788/22402
ldl - c  mmol / l ( sd ),C1532563;C2699239,false;false,16789/22402
ldl - c  mmol / l  mean ( sd ),C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,16790/22402
ldl - c / hdl - c ratio  mean ( sd ),C0428621;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,16791/22402
ldl - c < $nmbr$ mg / dl  no . ( % ),C0439269,false,16792/22402
ldl - cholesterol  mean ( sd ) mg / dl,C0023824;C0444504;C2699239;C0439269;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,16793/22402
ldl - cholesterol  mg / dl  mean ( sd ),C0023824;C0439269;C0444504;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,16794/22402
ldl - cholesterol  mmol / l,C0023824;C1532563;C0202117,true;false;false,16795/22402
ldl - cholesterol  mmol / lf,C0023824;C0439190;C1416933;C2986618;C4554443;C0202117,true;false;false;false;false;false,16796/22402
ldl - to - hdl cholesterol ratio  mean ( sd ),C0428621;C0008377;C0444504;C2699239;C2347634;C2348143;C1171408,false;true;false;false;false;false;false,16797/22402
ldl cholesterol - lowering therapy,C0023824;C0441994;C0039798;C0087111;C1363945;C2003888;C0202117,true;false;true;true;false;false;false,16798/22402
ldl cholesterol ( mmol / l ) ( median  iqr ),C0023824;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193;C0202117,true;false;false;false;false;false;false;false,16799/22402
ldl cholesterol ( mmol / l )  mean ( sd ),C0023824;C1532563;C0444504;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,16800/22402
ldl cholesterol ( sd )  mg / dl,C0023824;C2699239;C0439269;C0202117,true;false;false;false,16801/22402
ldl cholesterol level,C0023824;C0441889;C0456079;C1547707;C2946261;C0201950;C0202117;C0428466,true;false;false;false;false;false;false;false,16802/22402
ldl cholesterol mean,C0023824;C0444504;C2347634;C2348143;C0202117,true;false;false;false;false,16803/22402
ldl cholesterol  mean ( sd )  mg / dl,C0023824;C0444504;C2699239;C0439269;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,16804/22402
ldl cholesterol  mmol / l  mean ( sd ) §,C0023824;C1532563;C0444504;C2699239;C2347634;C2348143;C0202117,true;false;false;false;false;false;false,16805/22402
ldl cholesterol  mmol / lt,C0023824;C0439190;C0023376;C0230426;C3887647;C4521399;C0202117,true;false;true;false;false;false;false,16806/22402
ldl cholesterol ^ :,C0023824;C0202117,true;false,16807/22402
ldl / hdl cholesterol ratio  mean ( sd ) §,C0428621;C0008377;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,16808/22402
ldl : hdl ratio,C0428621,false,16809/22402
ldlc,C1416822,false,16810/22402
ldlc : hdlc,C1416822;C1704429,false;true,16811/22402
leader,,,16812/22402
leading to death,C0332152;C0011065;C1306577;C4082313;C4552775;C1522538,false;true;false;false;false;false,16813/22402
leading to discontinuation,C0332152;C0457454;C1444662;C4552847;C1522538,false;false;false;false;false,16814/22402
leading to study drug discontinuation,C0332152;C1522538,false;false,16815/22402
leading to study withdrawal,C0332152;C1522538,false;false,16816/22402
least - squares mean difference ( $nmbr$ % ci ) *,C0023189;C0444504;C1705241;C0008107;C3259781;C1705242;C2347634;C2348143,true;false;false;true;false;false;false;false,16817/22402
least - squares mean difference ( $nmbr$ % cl ),C0023189;C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,true;false;false;false;false;false;false,16818/22402
least squares mean between - treatment difference ( $nmbr$ % ci ),C0023189;C0444504;C0039798;C1705241;C0008107;C3259781;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2347634;C2348143,true;false;true;false;true;false;false;true;false;false;false;false;false;false;false,16819/22402
lebrikizumab $nmbr$ mg,C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16820/22402
lebrikizumab $nmbr$ mg ( n = $nmbr$ ),C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16821/22402
lebrikizumab $nmbr$ - $nmbr$ mg,C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16822/22402
lebrikizumab $nmbr$ - $nmbr$ mg ( n = $nmbr$ ),C2981360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16823/22402
leeds dactylitis index - basic  mean ( sd ) ’ ' ^,C0239161;C0600653;C1527178;C0444504;C2699239;C2347634;C2348143;C0918012;C1552854;C1637833;C2986546,false;true;false;false;false;false;false;true;false;false;false,16824/22402
leeds enthesitis index  mean ( sd ) ’ ’ * ’,C0451148;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,16825/22402
leeds enthesitis index ^ score > $nmbr$ — no . { % ),C0451148,false,16826/22402
leflunomide,C0063041,true,16827/22402
left,C0205091;C0443246;C1552822,false;false;false,16828/22402
left anterior descending artery,C0226032,false,16829/22402
left main coronary artery bifurcation,C3898614,false,16830/22402
left main disease  n ( % ),C0205091;C0205225;C0012634;C1542147;C0443246;C1552822,false;false;true;false;false;false,16831/22402
left main treated,C0205091;C0205225;C1522326;C1542147;C0443246;C1552822,false;false;false;false;false;false,16832/22402
left shoulder,C0524469,false,16833/22402
left side  n ( % ),C0205091,false,16834/22402
left ventricular ejection fraction — % §,C0428772;C0488728,false;false,16835/22402
left ventricular ejection fraction ( % ),C0428772;C0488728,false;false,16836/22402
left ventricular ejection fraction within previous $nmbr$ mo — no . / total no . ( % ) $nmbr$,C0428772;C0205156;C0026544;C0332177;C1552607;C0488728,false;false;true;false;false;false,16837/22402
left ventricular ejection fraction  %,C0428772;C0488728,false;false,16838/22402
left ventricular ejection fraction  % *,C0428772;C0488728,false;false,16839/22402
left ventricular hypertrophy * *,C0149721;C3484363,true;false,16840/22402
left ventricular systolic dysfunction  n ( % ),C1277187;C1963159;C4553199,false;false;false,16841/22402
legend,C2729544,false,16842/22402
legs only,C1140621;C0205171;C1720467,true;false;false,16843/22402
lei > $nmbr$ ( n = $nmbr$ ),C0023401;C0428209,true;false,16844/22402
lei  mean ( sd ),C0023401;C0444504;C2699239;C2347634;C2348143;C0428209,true;false;false;false;false;false,16845/22402
lei  mean [ sd ] c,C0023401;C0444504;C2699239;C2347634;C2348143;C0428209,true;false;false;false;false;false,16846/22402
lei $nmbr$,C0023401;C0428209,true;false,16847/22402
lelt ventricular hypertrophy *,C0340279,false,16848/22402
lesion length ≥ $nmbr$ mm,C0221198;C1444754;C4330985;C4554674;C1706316;C1546698,false;false;false;false;false;false,16849/22402
lesion ( s ),C0221198;C1546698,false;false,16850/22402
lesions treated per patient,C0221198,false,16851/22402
less severe oa symptoms at baseline,C0439092;C0436345;C0029408;C0168634;C1442488;C3887876;C0547044,false;false;true;true;false;false;false,16852/22402
less than $nmbr$ y ears,C0439092;C0013443;C0521421,false;true;false,16853/22402
less than $nmbr$,C0439092,false,16854/22402
less than $nmbr$ kg / m $nmbr$,C0439092;C1532718,false;false,16855/22402
less than $nmbr$ . $nmbr$ %,C0439092,false,16856/22402
less than high school,C0439092;C0599395;C0683862;C0870649,false;false;false;false,16857/22402
less than median,C0439092;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,16858/22402
leukopenia,C0023530;C0750394,true;false,16859/22402
leukotriene modifier,C0023545;C0205349;C1514623;C1516451;C3542952,true;false;false;false;false,16860/22402
lev - exposed,C0023556,true,16861/22402
lev ( n   =   $nmbr$ ),C0023556,true,16862/22402
lev status,C0023556;C0449438,true;false,16863/22402
level of renal impairment ',C0441889;C1565489;C0456079;C1547707;C2946261,false;true;false;false;false,16864/22402
level of thyroperoxidase antibody at baseline,C0441889;C0487652;C1318460;C0456079;C1547707;C2946261;C0021965;C0428536;C1364508;C1429427;C3272921,false;false;false;false;false;false;true;false;false;true;false,16865/22402
levodopa dose  mean ± sd  mg / day,C0023570;C0178602;C0444504;C2699239;C0439422;C2347634;C2348143;C0869039;C1114758,true;false;false;false;false;false;false;false;false,16866/22402
levosimendan ( n   = $nmbr$ ),C0246904,true,16867/22402
li $nmbr$ ( $nmbr$ . $nmbr$ ),C0023617;C3495095,true;false,16868/22402
lieum only  n ( % ),C0205171;C1720467,false;false,16869/22402
life - threatening,C1546953;C2826244;C3537125,false;false;false,16870/22402
life - threatening bleed,C1546953;C0019080;C2826244;C3537125,false;true;false;false,16871/22402
life - threatening bleeding  disabling stroke  and death,C1546953;C0019080;C0038454;C4554100;C2826244;C3537125,false;true;true;false;false;false,16872/22402
lifestyle behaviors,C0023676;C0004927;C0677505,true;true;false,16873/22402
lifestyle behaviours,C0023676;C0004927;C0677505,true;true;false,16874/22402
likelihood test,C0033204;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,true;false;false;false;false;false;false;false,16875/22402
limb,C0015385,true,16876/22402
limb amputation,C0002689,false,16877/22402
limited,C0439801;C2674459;C3542948;C4050251,false;false;false;false,16878/22402
limited to left side of colon,C0439801;C0227388;C2674459;C3542948;C4050251,false;false;false;false;false,16879/22402
linagliptin ( n = $nmbr$ ) ',C2746078,true,16880/22402
linear regression,C0023733;C2346679,true;false,16881/22402
lioid trial participants,C1997894;C2242969,false;false,16882/22402
lipc,C1416867,false,16883/22402
lipid - lowering drug * *,C0086440,true,16884/22402
lipid - lowering drugs  n ( % ),C0086440,true,16885/22402
lipid ‐ lowering therapies  n ( % ),C0585943,false,16886/22402
lipid - modulating drug,C0023779;C0443264;C0013227;C1254351,true;false;true;false,16887/22402
lipid concentrations,C0023779;C0086045,true;true,16888/22402
lipid concentrations total cholesterol ( mmol / l ),C0023779;C0086045;C0201950;C1532563;C0543421,true;true;false;false;false,16889/22402
lipid levels — mg / dlj total cholesterol,C0428460;C0024671;C0201950;C0543421;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;true;false;false;false;false;false,16890/22402
lipid lowering agent n ( % ),C0086440,true,16891/22402
lipid lowering agents,C0086440,true,16892/22402
lipid lowering drugs,C0086440,true,16893/22402
lipid lowering therapy,C0585943,false,16894/22402
lipid measure *,C0023779;C0079809;C0242485,true;true;false,16895/22402
lipid measures at baseline — mg / dl,C0023779,true,16896/22402
lipid medication  n ( % ),C0023779;C0013227;C3244316;C4284232,true;true;false;false,16897/22402
lipid modifiers,C0023779;C4284280,true;false,16898/22402
lipid parameters,C0023779;C0449381,true;false,16899/22402
lipid parameters  mg / dl  mean ( sd ),C0023779;C0449381;C0439269;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false;false,16900/22402
lipid treatment,C0023779;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,16901/22402
lipid trial participants,C0023779;C1997894;C2242969,true;false;false,16902/22402
lipid trial participants - n ( % ),C0023779;C1997894;C2242969,true;false;false,16903/22402
lipid trial participants #,C0023779;C1997894;C2242969,true;false;false,16904/22402
lipid trial participants  no . ( % ),C0023779;C1997894;C2242969,true;false;false,16905/22402
lipid trial participantsk,C0023779;C0008976,true;true,16906/22402
lipid trial participantss,C0023779;C0008976,true;true,16907/22402
lipid values,C0023779;C0042295,true;false,16908/22402
lipid values  mean ( sd ),C0023779;C0042295;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,16909/22402
lipids,C0023779,true,16910/22402
lipids — mg / dl,C0023779;C0439269,true;false,16911/22402
lipids medications,C0023779;C0013227;C0802604;C2598133;C4284232,true;true;false;false;false,16912/22402
lipids  mean ( sd )  mg / dlf,C0023779;C0444504;C2699239;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false;false,16913/22402
lipoprotein ( a )  median ( qi  q $nmbr$ )  nmol / l,C0065058;C0549183;C0376586;C0439282;C0876920;C2347635;C2348144;C2939193;C0125953;C1096202;C1439335,true;false;true;false;false;false;false;false;true;false;false,16914/22402
lira,C1555441,false,16915/22402
liraglutide ( « = $nmbr$ ),C1456408,true,16916/22402
liraglutide ( $nmbr$ . $nmbr$ mg ) ± oad,C1456408;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16917/22402
liraglutide $nmbr$ - $nmbr$ mg mean ( n ),C1456408;C0024671;C0444504;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;true;false;false;false;false;false,16918/22402
liraglutide n ( % ),C1456408,true,16919/22402
lis,C2247545,false,16920/22402
lisinopril,C0065374,true,16921/22402
lisinopril ( n = $nmbr$ ),C0065374,true,16922/22402
lisinopril cvd total,C0065374;C0007222;C0439175;C0439810,true;true;false;false,16923/22402
lisinopril vs amlodipineb,C0065374,true,16924/22402
lisinopril vs chlorthalidone,C0065374,true,16925/22402
lisinopril vs chlorthalidone normal,C0065374,true,16926/22402
lisinopril vs chlorthalidone obese,C0065374,true,16927/22402
lisinopril vs chlorthalidone overweight,C0065374,true,16928/22402
lisinopril / chlorthalidone,C0065374;C0008294,true;true,16929/22402
lisrs,,,16930/22402
lithe,,,16931/22402
lived alone,C1548795;C0205171;C0439044;C0679994;C1634625;C2982691,false;false;false;false;false;false,16932/22402
liver disorder,C0023895,true,16933/22402
lixi,,,16934/22402
lixisenatide,C2973895,true,16935/22402
lixisenatide ( n = $nmbr$ ),C2973895,true,16936/22402
lixisenatide ( n = $nmbr$ o ),C2973895,true,16937/22402
ll ( $nmbr$ ),,,16938/22402
ll  n ( % ),,,16939/22402
ll $nmbr$ ( $nmbr$ ),,,16940/22402
lll / iv,C1261077;C0022326;C4265176,false;true;false,16941/22402
llpasi $nmbr$,,,16942/22402
llraglutide $nmbr$ - $nmbr$ mg mean ( n ),C0024671;C0444504;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;false;false;true;false;false;false;false;false,16943/22402
lm $nmbr$ $nmbr$,C1261082;C1551056,false;false,16944/22402
lm $nmbr$ bid ( n = $nmbr$ ),C1261082;C1551056,false;false,16945/22402
lmwh within $nmbr$ days before randomization — no . / total no . ( % ),C0019139;C0439228;C3536766,true;false;false,16946/22402
lo ( lo - lo ),C0206579;C1232424,true;false,16947/22402
loading dose of clopidogrel or ticlopidine,C3714444;C0070166,false;true,16948/22402
local eosinophil count,C0205276;C0200638;C0750879,false;false;false,16949/22402
local eosinophil count [ cells / µ l ]  median ( range ),C0205276;C0200638;C0347983;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C0750879,false;false;false;false;false;false;false;false;false;false;false;false,16950/22402
local eosinophil count [ cells / ml ]  median ( range ),C0205276;C0200638;C2699156;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C0750879,false;false;false;false;false;false;false;false;false;false;false;false,16951/22402
locally advanced,C1517927,false,16952/22402
location of infarction — no . ( % ) §,C0450429;C0021308;C1515974;C4284930;C4284931,false;true;false;false;false,16953/22402
log - rank,C1708728;C0667477;C0699794;C2986775,false;true;false;false,16954/22402
log - rank p value,C1708728;C0667477;C1709380;C0699794;C2986775,false;true;false;false;false,16955/22402
logistic regression,C0206031,true,16956/22402
lone atrial fibrillation — no . ( % ) §,C0340489,false,16957/22402
long - acting nitrate agents,C0205166;C0079613;C0028125;C0450442;C1254351;C1521826;C0699857;C3848573;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;false;false;false;false;true;false;false;false,16958/22402
long - acting  intermediate / long - acting + fast - acting,C0205166;C0079613;C0205103;C0015663;C0456962;C2985769;C1550465;C2827755;C3889971;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false;false;false;false;true;false;false;false,16959/22402
long - acting ^,C0205166;C0079613;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;false;true;false;false;false,16960/22402
long - standing persistent,C0205166;C0231472;C0205322;C0332996;C1706317,false;true;false;false;false,16961/22402
long - term treatment with aspirin — no . / total no . ( % ),C0023977;C0004057,true;true,16962/22402
long - term vitamin k antagonist,C0443252;C1096489;C2267235,false;false;false,16963/22402
long - term vka therapy,C0443252;C0039798;C0087111;C1363945,false;true;true;false,16964/22402
long - term warfarin ( n = $nmbr$ ),C0443252;C0043031,false;true,16965/22402
long ( > $nmbr$ years ) duration of diabetes,C0439591;C0439234;C0011847;C0011849,false;false;false;true,16966/22402
long ( > $nmbr$ mm ) stenting yes ( n = $nmbr$ ),C0205166;C4330985;C0038257;C1549445;C1705108;C1710701;C2348535;C4554674;C1706317,false;false;true;false;false;false;false;false;false,16967/22402
long ( i $nmbr$ years ) duration of diabetes,C0439591;C0021966;C0439234;C0011847;C0011849;C0221138,false;true;false;false;true;false,16968/22402
long term ( n = $nmbr$ ) +,C0443252,false,16969/22402
long term vka therapy,C0443252;C0039798;C0087111;C1363945,false;true;true;false,16970/22402
long term *,C0443252,false,16971/22402
loop diuretic use,C0354100;C0042153;C0457083;C1947944;C3536704,true;true;false;false;false,16972/22402
loop diureties,C0445022,false,16973/22402
loop or thiazide diuretic ^,C0445022,false,16974/22402
lor ii,C1416897;C1710602;C4082587;C1416899;C2986770,false;false;false;false;false,16975/22402
losartan ( n = $nmbr$  $nmbr$ ),C0126174,true,16976/22402
losartan ( n = $nmbr$ ),C0126174,true,16977/22402
loss of response,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,16978/22402
loss of response ‘ s,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,16979/22402
loss of response ®,C1517945;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,16980/22402
lost bmd,C0745777;C3815882,false;false,16981/22402
low - ceiling diuretic,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,16982/22402
low - density lipoprotein choles -,C0023823,true,16983/22402
low - density lipoprotein cholesterol — mg / dlf,C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,16984/22402
low - density lipoprotein ^,C0023823,true,16985/22402
low - dose aspirin use at baseline,C2608320;C0042153;C0168634;C1442488;C0457083;C1947944,false;true;true;false;false;false,16986/22402
low - dose aspirin use strata * n ( % ),C2608320;C0042153;C0457083;C1947944,false;true;false;false,16987/22402
low - dose aspirin use . strata *  n ( % ),C2608320;C0042153;C0457083;C1947944,false;true;false;false,16988/22402
low - dose edoxaban,C0445550;C2975435;C1708745,false;true;false,16989/22402
low - dose edoxaban ( n = $nmbr$ ),C0445550;C2975435;C1708745,false;true;false,16990/22402
low - dose edoxaban vs warfarin,C0445550;C2975435;C1708745,false;true;false,16991/22402
low - medium microalbuminuria ( n = $nmbr$ ),C0205251;C0009458;C0730345;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false;false;false;false;false,16992/22402
low - molecular - weight heparin — no . ( % ),C0019139;C3536766,true;false,16993/22402
low - molecular - weight heparin only,C0019139;C0205171;C1720467;C3536766,true;false;false;false,16994/22402
low - molecular - weight only,C0041667;C1521991;C0205171;C1720467;C0205251;C0026385;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;false;false;false;true;false;false;false;false;false,16995/22402
low - trauma fracture since age $nmbr$  n ( % ),C0521170,true,16996/22402
low ( < $nmbr$ kg / m ^ ) baseline bmi,C0205251;C1532718;C0168634;C0578022;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;true;false;false;false;false;false;false;false,16997/22402
low ( < $nmbr$ kg / m $nmbr$ ) baseline bmi,C0205251;C1532718;C0168634;C0578022;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;true;false;false;false;false;false;false;false,16998/22402
low ( < $nmbr$ % ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,16999/22402
low ( < $nmbr$ % ) baseline hba $nmbr$ c,C0205251;C0168634;C0019016;C1825777;C3538758;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;true;false;false;false;false;false;false;false;false,17000/22402
low ( < $nmbr$ % ) baseline hbalc,C0205251;C0168634;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false,17001/22402
low ( > $nmbr$ . $nmbr$ and < $nmbr$ ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,17002/22402
low ( $nmbr$ - $nmbr$ )  %,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,17003/22402
low ( $nmbr$ - $nmbr$ ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,17004/22402
low ( n = $nmbr$ ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,17005/22402
low { < $nmbr$ % ),C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,17006/22402
low body weight ( < $nmbr$ kg ),C0041667;C0022718;C0439209;C4054209,true;true;false;false,17007/22402
low c $nmbr$ ( < $nmbr$ . $nmbr$ g / l ),C0205251;C0439294;C0456615;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false,17008/22402
low c $nmbr$ ( < $nmbr$ mg / dl )  %,C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false,17009/22402
low c $nmbr$ / c $nmbr$ and anti - dsdna,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,17010/22402
low complement / anti - dsdna positive ( n = $nmbr$ ),C3897137;C0432633;C0012854;C0439178;C1446409;C1514241;C2825490;C3812269;C0311474,false;false;true;false;false;false;false;false;true,17011/22402
low dose,C0445550;C1708745,false;false,17012/22402
low dose combination therapy,C0445550;C0009429;C0556895;C1708745,false;true;false;false,17013/22402
low hdl - c,C0151691,false,17014/22402
low hdl cholesterol * |,C0151691,false,17015/22402
low nafld fibrosis score ( nfs < - $nmbr$ . $nmbr$ ),C0205251;C0400966;C1954436;C1555018;C1954437;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false,17016/22402
low nfs nfs < - $nmbr$ . $nmbr$ ( n = $nmbr$ ),C0205251;C1513839;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false,17017/22402
low normal ( n = $nmbr$ ),C0205251;C0205307;C0231683;C0439166;C2347086;C4553972;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false;false;false;false;false;false,17018/22402
low or moderate,C0205251;C1550472;C3890211;C4048187;C4321351;C4522223,false;false;false;false;false;false,17019/22402
low renin ( pra < $nmbr$ . $nmbr$ ng / ml / h ) ( n = $nmbr$ ),C0855389;C0633231;C1533072;C4050009;C1141951;C1419788;C3274822;C3669212;C4283900,false;true;false;false;false;false;false;false;false,17020/22402
low risk ( - ics ),C3272281;C0815320;C4551720;C3538919,false;false;true;false,17021/22402
low risk ( ? ics ),C3272281;C0815320;C4551720;C3538919,false;false;true;false,17022/22402
low risk ( n $nmbr$ $nmbr$ ),C3272281;C3538919,false;false,17023/22402
low to medium microalbuminuria ( n = $nmbr$ ),C0205251;C0009458;C0730345;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false;false;false;false;false;false;false,17024/22402
low trs : $nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ ),C0205251;C0266427;C0968917;C1150746;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;true;false;false;false;false;false;false,17025/22402
low tt < $nmbr$ . $nmbr$ ( n = $nmbr$ ),C0205251;C1452561;C4554543;C1550472;C3890211;C4048187;C4321351;C4522223,false;true;false;false;false;false;false;false,17026/22402
lower - dose,C0445550;C1708745,false;false,17027/22402
lower - limb angioplasty or bypass surgery,C0745788,false,17028/22402
lower - target group ( n = $nmbr$ ),C0441994;C1521840;C0441848;C2986546;C1548802;C2003888,false;false;false;false;false;false,17029/22402
lower dose,C0445550;C1708745,false;false,17030/22402
lower dose edoxaban regimen,C0441994;C2348331;C2975435;C1548802;C2003888,false;false;true;false;false,17031/22402
lower limbs,C0023216,true,17032/22402
lower risk ( n = $nmbr$ ),C3272281;C3538919,false;false,17033/22402
lower tertile : b $nmbr$ . $nmbr$,C0441994;C1548802;C2003888,false;false;false,17034/22402
lowest,C1708760,false,17035/22402
lowest activated clotting,C1708760;C1879547;C0005778;C1328723,false;false;true;false,17036/22402
lowest normal ( n = $nmbr$ ),C1708760;C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,17037/22402
lowest tertile ( range  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / dl  mean ± sd  $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ mg / dl ),C1708760;C1514721;C0024671;C3539687;C0444504;C2699239;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016,false;false;true;false;false;false;false;false;true;false;false;false;false;false;false;false,17038/22402
lp ( a ) ( μ mol / l ),C0065058;C0347982;C1439335;C4553379,true;false;false;false,17039/22402
lp ( a )  median ( q $nmbr$ : q $nmbr$ ),C0065058;C0549183;C0876920;C2347635;C2348144;C2939193;C1439335;C4553379,true;false;false;false;false;false;false;false,17040/22402
lp ( a )  mg / dl  median ( q $nmbr$ : q $nmbr$ ),C0065058;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C1439335;C4553379,true;false;false;false;false;false;false;false;false,17041/22402
lp ( a )  nmol / l  mean ( sd ),C0065058;C0439282;C0444504;C2699239;C2347634;C2348143;C1439335;C4553379,true;false;false;false;false;false;false;false,17042/22402
lpa  mg / dl,C1096202;C0439269;C1439335;C3539666;C4049711;C4553379,false;false;false;false;false;false,17043/22402
lrg,C1428862,false,17044/22402
ls - mean difference between treatment groups ( $nmbr$ % ci ),C0023668;C0444504;C1705241;C0374505;C0008107;C3259781;C1705242;C0039798;C2347634;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2348143,true;false;false;false;true;false;false;true;false;true;false;false;false;false;false;false,17045/22402
ls - mean difference ® ( $nmbr$ % cl ),C0023668;C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,true;false;false;false;false;false;false,17046/22402
ls mean ( $nmbr$ % ci ),C0023668;C0444504;C0008107;C3259781;C2347634;C2348143,true;false;true;false;false;false,17047/22402
ls mean ( $nmbr$ % ci )  %,C0023668;C0444504;C0008107;C3259781;C2347634;C2348143,true;false;true;false;false;false,17048/22402
ls mean ( $nmbr$ % ci )  mmol / mol,C0023668;C0444504;C0008107;C3829066;C3259781;C2347634;C2348143,true;false;true;false;false;false;false,17049/22402
ls mean ( $nmbr$ % ci ) a,C0023668;C0444504;C0008107;C3259781;C2347634;C2348143,true;false;true;false;false;false,17050/22402
ls mean [ $nmbr$ % ci ] treatment difference vs placebo,C0023668;C0444504;C0008107;C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3259781;C2347634;C2348143,true;false;true;true;false;false;true;false;false;false;false;false;false;false;false,17051/22402
ls mean ± se,C0023668;C0444504;C0036919;C2347634;C2348143,true;false;true;false;false,17052/22402
ls mean change,C0023668;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;false;false;false;false,17053/22402
ls mean change ( se ),C0023668;C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false,17054/22402
ls mean change from baseline,C0023668;C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;false;false;false;false;false,17055/22402
ls mean change from baseline ( se ),C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false,17056/22402
ls mean change from baseline ( se )  %,C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;true;false;false;false;false;false;false,17057/22402
ls mean change from baseline  ml ( se ) a,C0023668;C0444504;C0392747;C0168634;C0439526;C0036919;C1705224;C3887665;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;true;false;true;false;false;false;false;false;false;false;false,17058/22402
ls mean difference ( $nmbr$ % cl ),C0023668;C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,true;false;false;false;false;false;false,17059/22402
ls mean difference ( se ),C0023668;C0444504;C1705241;C0036919;C1705242;C2347634;C2348143,true;false;false;true;false;false;false,17060/22402
ls mean difference vs placebo ( $nmbr$ % ci ),C0023668;C0444504;C1705241;C1705242;C2347634;C2348143,true;false;false;false;false;false,17061/22402
ls mean treatment difference ( $nmbr$ % ci ),C0023668;C0444504;C0039798;C1705241;C0008107;C3259781;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2347634;C2348143,true;false;true;false;true;false;false;true;false;false;false;false;false;false;false,17062/22402
ls means difference ( $nmbr$ % ci ) a,C0023668;C1704970;C1705241;C0008107;C3259781;C1705242,true;false;false;true;false;false,17063/22402
ls t - score < — $nmbr$ . $nmbr$,C0023668;C0449820;C4050231,true;false;false,17064/22402
ls / ul $nmbr$ $nmbr$,C0023668;C1300557,true;false,17065/22402
lsm difference ( $nmbr$ % cl ),C1705241;C0596019;C1705242,false;false;false,17066/22402
lta ( max response to $nmbr$ pm adp ) defined hpr ( % patients ),C2611142;C0030266;C0523452;C4049155,false;true;false;false,17067/22402
ltg - exposed,C1420817;C4521367;C4521846,false;false;false,17068/22402
ltg - naive,C1420817;C4521367;C4521846,false;false;false,17069/22402
ltg subgroup  n = $nmbr$,C1420817;C1079230;C1515021;C4521367;C4521846,false;false;false;false;false,17070/22402
ltt other than statin,C0360714,true,17071/22402
lue for interaction,C1704675,false,17072/22402
lumbar,C0024090,true,17073/22402
lumbar spine bmd t -,C0024091;C3887615,true;false,17074/22402
lunchb,,,17075/22402
lung,C0024109,true,17076/22402
lung infection,C0876973;C4552950,false;false,17077/22402
lung neoplasm malignant,C0024121,true,17078/22402
luts = lower urinary tract symptoms  is =,C0574785,true,17079/22402
luts severity,C0574785;C0439793;C0522510,true;false;false,17080/22402
luts / bph characteristics,C0574785;C0005001;C1521970;C1704272,true;true;false;true,17081/22402
lv diastolic dysfunction  n ( % ),C0023128;C0520863;C0731033;C1881413,true;false;true;false,17082/22402
lv ejection fraction > $nmbr$ % and < $nmbr$ %,C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,17083/22402
lv ejection fraction  % ( n = $nmbr$ ),C0023128;C0489482;C2700378;C0731033;C1881413,true;false;false;true;false,17084/22402
lv ejection fractionb,C0023128;C0302131;C0336969;C0812388;C0731033;C1881413,true;false;false;false;true;false,17085/22402
lv function,C0023128;C0031843;C0542341;C0700205;C1705273;C0731033;C1881413,true;true;false;false;false;true;false,17086/22402
lv function > $nmbr$ . $nmbr$ and < $nmbr$ . $nmbr$  n ( % ) medications  n ( % of patients ),C0023128;C0031843;C0542341;C0700205;C1705273;C0731033;C1881413,true;true;false;false;false;true;false,17087/22402
lv heart structure,C0023128;C0018787;C0731033;C1881413,true;true;true;false,17088/22402
lv hypertrophy per ecg,C0232306,false,17089/22402
lv mass index ( mg / m $nmbr$ ),C0455825;C0600653;C0024671;C0369637;C0441923;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;true;false;false;false;false;false;true;false;false;false,17090/22402
lv systolic dysfunction  n ( % ),C0023128;C0749225;C0731033;C1881413,true;false;true;false,17091/22402
lvedv ( ml ),C0439526;C1705224;C3887665,false;false;false,17092/22402
lvef — no . ( % )  i,C0428772;C0488728,false;false,17093/22402
lvef ( mean ± sd ),C0428772;C0444504;C2699239;C2347634;C2348143;C0488728,false;false;false;false;false;false,17094/22402
lvef ( u ),C0428772;C0439148;C0488728,false;false;false,17095/22402
lvef < $nmbr$ . $nmbr$,C0428772;C0488728,false;false,17096/22402
lvef ≤ $nmbr$ %  n   =   $nmbr$   $nmbr$ a,C0428772;C0488728,false;false,17097/22402
lvef ≤ $nmbr$ %  n   =   $nmbr$   $nmbr$ ) a,C0428772;C0488728,false;false,17098/22402
lvef ^ $nmbr$ . $nmbr$ and nyha class ii  iii at baseline,C0428772;C0488728,false;false,17099/22402
lvesv ( ml ),C0439526;C1705224;C3887665,false;false;false,17100/22402
lvh - n = $nmbr$,C0149721,true,17101/22402
lvh ( from echocardiogram ),C0149721;C0013516;C2243117,true;true;false,17102/22402
lvh ( from electrocardiogram ),C0149721;C0013798;C1547122;C1623258,true;true;false;true,17103/22402
lvh + n = $nmbr$,C0149721,true,17104/22402
lvh by ecg,C0232306,false,17105/22402
lvh by ecg ( minnesota code ),C0232306;C0026183;C0009219;C0805701;C3889831,false;true;true;false;false,17106/22402
lvh by ecg or echo . n ( % ),C0232306,false,17107/22402
lvh by ecg or echocardiography  no ( % ),C0232306,false,17108/22402
lvh by ecg or echocardiographyd,C0232306,false,17109/22402
lvh by ecg / echo,C0232306;C0058928;C1655045,false;true;false,17110/22402
lvh by ecgt blood pressure  mm hg,C0149721;C0005823;C0439475;C1271104;C1272641,true;true;false;false;true,17111/22402
lvh by echo or ecg,C0149721;C0058928;C1655045,true;true;false,17112/22402
lvh by echocardiogram,C0149721;C0013516;C2243117,true;true;false,17113/22402
lvh by echocardiography,C0149721;C0013516,true;true,17114/22402
lvh by electrocardiogram,C0149721;C0013798;C1547122;C1623258,true;true;false;true,17115/22402
lvh by electrocardiogram  n ( % ),C0149721;C0013798;C1547122;C1623258,true;true;false;true,17116/22402
lvh by minnesota code,C0149721;C0026183;C0009219;C0805701;C3889831,true;true;true;false;false,17117/22402
lvh by minnesota code  no . ( % ),C0149721;C0026183;C0009219;C0805701;C3889831,true;true;true;false;false,17118/22402
lvh on ecg,C0232306,false,17119/22402
lyear mean change from baseline,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,17120/22402
lymphadenopathy,C0497156;C4282165,true;false,17121/22402
m $nmbr$ s,C0439493;C1513009,false;false,17122/22402
mab,C0003250;C0369637,true;false,17123/22402
macce ( % ) abciximab placebo,C0288672;C0032042;C1696465;C1706408,true;true;false;false,17124/22402
macce ( death  mi  stroke ),C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775,true;false;true;false;false;false;false,17125/22402
mace category  n ( % ) [ ir ],C0349381;C0683312;C0022065;C0022071;C1448132;C3889287;C0949745;C1445339,false;false;true;true;true;false;true;false,17126/22402
mace +,C0349381;C0949745;C1445339,false;true;false,17127/22402
macroalbuminuria — no . ( % ) drug therapy — no . ( % ),,,17128/22402
macroalbuminuria ( uacr > $nmbr$ ),,,17129/22402
maf,,,17130/22402
main effect baseline hormone,C0205225;C1280500;C0168634;C0019932;C4521914;C1442488;C1518681;C2348382;C1542147,false;false;true;true;false;false;false;false;false,17131/22402
main etiology of heart failure,C0205225;C0015127;C0018801;C0018802;C4554158;C1314792;C1524003;C1542147,false;true;true;true;false;true;false;false,17132/22402
maintenance ocs use  n ( % ),C0024501,true,17133/22402
maintenance use — no . ( % ),C0024501,true,17134/22402
major adverse cardiovascular events,C0205082;C0877248;C0007226;C3887460;C1705413;C0205164;C4318856;C4521762,false;false;true;false;false;false;false;false,17135/22402
major amputationsb,C0205082;C0205164;C4318856;C4521762,false;false;false;false,17136/22402
major and crnm bleeds,C0205082;C0205164;C4318856;C4521762,false;false;false;false,17137/22402
major bleed,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,17138/22402
major bleeding ( mb ),C0205082;C0019080;C0024853;C0205164;C4318856;C4521762,false;true;true;false;false;false,17139/22402
major bleeding $nmbr$ to $nmbr$,C0205082;C0019080;C0205164;C4318856;C4521762,false;true;false;false;false,17140/22402
major coronary disease event ( fatal / non - fatal mi ),C0205082;C0741923;C0012634;C1302234;C1518422;C3810814;C1705232;C0010068;C0441471;C4019010;C1956346;C0205164;C4318856;C4521762,false;false;true;false;false;false;false;true;false;false;true;false;false;false,17141/22402
major coronary event,C0205082;C0741923;C0205164;C4318856;C4521762,false;false;false;false;false,17142/22402
major gl bleeding,C0205082;C0018229;C0019080;C1423073;C1427674;C0205164;C4318856;C4521762,false;true;true;false;false;false;false;false,17143/22402
major macrovascular events,C0205082;C0441471;C3541888;C0205164;C4318856;C4521762,false;false;false;false;false;false,17144/22402
major or clinically relevant non - major bleed,C0205082;C0205164;C4318856;C4521762,false;false;false;false,17145/22402
major or clinically relevant non - major bleeding,C0205082;C0205164;C4318856;C4521762,false;false;false;false,17146/22402
major secondary end pointf,C0205082;C0027627;C0444930;C2746065;C0175668;C0205436;C0205164;C4318856;C4521762,false;true;false;false;false;false;false;false;false,17147/22402
major st depression or,C0041696;C0036056;C3272372;C1269683;C0205082;C0520887;C0205164;C4318856;C4521762,true;true;false;true;false;false;false;false;false,17148/22402
major st depression or t - wave,C0041696;C0036056;C3272372;C1269683;C0205082;C0520887;C0205164;C4318856;C4521762,true;true;false;true;false;false;false;false;false,17149/22402
major st depression or t - wave inversion,C0041696;C0036056;C3272372;C1269683;C0205082;C0520887;C0205164;C4318856;C4521762,true;true;false;true;false;false;false;false;false,17150/22402
major surgery,C0679637,false,17151/22402
major / crnm bleed,C0205082;C0205164;C4318856;C4521762,false;false;false;false,17152/22402
male ( n   = $nmbr$  $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,17153/22402
male acr definition  ^ . g / mg,C0086582;C1412134;C1550452;C0439267;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1704788;C3539107;C3888054;C1515941;C1706180;C1706428;C1706429,true;false;false;false;true;true;false;false;false;false;false;false;false;false;false;false;false;false,17154/22402
male eze / simva ( n = $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,17155/22402
male gender    n   ( % ),C0086582;C1706180,true;false,17156/22402
male patients *,C0150904,false,17157/22402
male sex — no . { % ),C0086582,true,17158/22402
male sex — no . ( % ) medical history — no . / total no . ( % ),C0086582,true,17159/22402
male sex ( % ) race or ethnic group ( % ) f,C0086582;C0034510;C1706779;C3853635,true;true;false;false,17160/22402
male sex \ no . ( % ),C0086582,true,17161/22402
male sex  n [ % ],C0086582,true,17162/22402
male sex  no . / total no . ( % ),C0086582,true,17163/22402
male sex ^,C0086582,true,17164/22402
male simva ( n = $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,17165/22402
male subjects ( n = $nmbr$  $nmbr$ ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,17166/22402
male vs . female,C0086582;C1706180;C1706428;C1706429,true;false;false;false,17167/22402
male *  n ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,17168/22402
male  % ( n ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,17169/22402
male  n,C0086582;C1706180;C1706428;C1706429,true;false;false;false,17170/22402
male    n   ( % ),C0086582;C1706180;C1706428;C1706429,true;false;false;false,17171/22402
males ( itt ) ( n = $nmbr$ ),C0086582,true,17172/22402
males ( n = $nmbr$ ),C0086582,true,17173/22402
males [ n ( % ) ],C0086582,true,17174/22402
males  %,C0086582,true,17175/22402
males  < $nmbr$ . $nmbr$,C0086582,true,17176/22402
males  < $nmbr$,C0086582,true,17177/22402
males  > $nmbr$ . $nmbr$,C0086582,true,17178/22402
males  > $nmbr$,C0086582,true,17179/22402
males  n ( % ),C0086582,true,17180/22402
malignancy death,C0006826;C0011065;C1306577;C4082313;C4552775;C1306459;C4282132,true;true;false;false;false;false;false,17181/22402
management distribution,C0001554;C0520511;C1704711;C0376636;C1273870;C3273539,true;false;true;true;false;false,17182/22402
mar ( itt ) ( n = $nmbr$ ),C3829202;C4255469,false;false,17183/22402
mar imputation ( random . ) ( n = $nmbr$ ),C3829202;C2699638;C0034656;C0439605;C4255469,false;false;true;false;false,17184/22402
married,C0024841;C0555047,true;false,17185/22402
mass index,C0577559;C0600653;C0918012;C1552854;C1637833;C2986546;C0577573;C1096155;C1306372;C3152252;C3539882;C4283905,false;true;true;false;false;false;false;true;false;false;false;false,17186/22402
mate !,C0682323;C1260875,false;false,17187/22402
maximum,C0806909;C1552615;C2826546,false;false;false,17188/22402
mayo clinic score  mean ± sd,C0454788;C0002424;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C0442592;C1077578,false;true;false;false;false;false;false;false;false;false,17189/22402
mayo clinic scoreb,C0454788;C0002424;C0442592;C1077578,false;true;false;false,17190/22402
mayo score ( $nmbr$ - $nmbr$ ),C0454788;C0449820;C4050231;C1077578,false;false;false;false,17191/22402
mbes / crbesb  n / n ( % ),,,17192/22402
mbes / crbesc,,,17193/22402
mbesb  n / n ( % ),,,17194/22402
mbesc  n / n ( % ),,,17195/22402
mcs score,,,17196/22402
mcs score ( $nmbr$ – $nmbr$ scale ),,,17197/22402
mdi,C0993596;C1839839;C4049613,true;true;false,17198/22402
mdrd - egfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C3839656;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,false;true;false;false;false;false;false,17199/22402
mdrd egfr geometric mean ( cv % )  a  b ml /,C3839656;C1739039;C2986759;C3538987;C0439526;C1705224;C3887665;C4048877;C4318503;C3811844;C3812682,false;true;false;false;false;false;false;true;false;false;false,17200/22402
mdrd egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C3839656;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682,false;true;false;false;false;false;false,17201/22402
mean — %,C0444504;C2347634;C2348143,false;false;false,17202/22402
mean — mg / dl,C0444504;C0439269;C2347634;C2348143,false;false;false;false,17203/22402
mean — ml / min,C0444504;C0439445;C2347634;C2348143,false;false;false;false,17204/22402
mean — ml / min / $nmbr$ . $nmbr$ m ^,C0444504;C0439445;C0369637;C0441923;C2347634;C2348143,false;false;false;false;false;false,17205/22402
mean — mm hg,C0444504;C0439475;C2347634;C2348143,false;false;false;false,17206/22402
mean % change in fn bmd,C0444504;C0392747;C1570610;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,17207/22402
mean % predicted value prebronchodilation,C0444504;C2347634;C2348143,false;false;false,17208/22402
mean ( = sd ) days since,C0444504;C2699239;C0439228;C2347634;C2348143,false;false;false;false;false,17209/22402
mean ( ± s . d . ),C0444504;C2347634;C2348143,false;false;false,17210/22402
mean ( ± sd ) baseline score,C3533236;C2699239;C0168634;C1442488,false;false;true;false,17211/22402
mean ( ± sd ) change from,C0444504;C2699239;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false,17212/22402
mean ( $nmbr$ th to $nmbr$ thquartile ) bnp ( pg / ml ),C0444504;C0039725;C0054015;C0439297;C1095989;C1417808;C2982014;C0039738;C1420718;C4282123;C4285344;C2347634;C2348143,false;true;true;false;false;false;false;true;false;false;false;false;false,17213/22402
mean ( $nmbr$ % ci ) change from $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ mg  %,C0444504;C0008107;C0392747;C0443172;C1705241;C4319952;C3259781;C2347634;C2348143,false;true;false;false;false;false;false;false;false,17214/22402
mean ( $nmbr$ % ci ) change from $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ mg  % ‐ points,C0444504;C0008107;C0392747;C0443172;C1705241;C4319952;C3259781;C2347634;C2348143,false;true;false;false;false;false;false;false;false,17215/22402
mean ( median ) mtx dose  mg / week,C0444504;C0549183;C0366550;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0876920;C2347635;C2348144;C2939193;C2347634;C2348143,false;false;false;true;false;false;true;false;false;false;false;false;false;false;false;false;false;false,17216/22402
mean ( s . d . ) baseline fpg  mmol / l,C0444504;C0168634;C1532563;C1442488;C2347634;C2348143,false;true;false;false;false;false,17217/22402
mean ( s . d . ) baseline hba $nmbr$ c  %,C0444504;C0168634;C0019016;C1825777;C3538758;C1442488;C2347634;C2348143,false;true;true;false;false;false;false;false,17218/22402
mean ( s . d . ) duration of t $nmbr$ dm  years,C0444504;C0449238;C0011816;C0439234;C3250443;C2926735;C2347634;C2348143,false;false;true;false;false;false;false;false,17219/22402
mean ( s . d . ) metformin dose †  mg / day,C0444504;C0025598;C0178602;C0439422;C0869039;C1114758;C2347634;C2348143,false;true;false;false;false;false;false;false,17220/22402
mean ( s . d . ) weight  kg,C0444504;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C2347634;C2348143,false;true;true;false;false;true;false;false;false;false,17221/22402
mean ( sd on loge scale ) u / ml,C0444504;C2699239;C2697934;C0175659;C0439340;C1880521;C2945590;C0349674;C1947916;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,17222/22402
mean ( sd ) % of predicted normal eevi,C0444504;C2699239;C0681842;C0205307;C0231683;C0439166;C2347086;C4553972;C1882327;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false,17223/22402
mean ( sd ) % of predicted normal fev $nmbr$,C0444504;C2699239;C0681842;C0520835;C1882327;C2347634;C2348143,false;false;false;false;false;false;false,17224/22402
mean ( sd ) % of predicted normal fevi,C0444504;C2699239;C0681842;C0205307;C0429706;C0849974;C1561566;C4528367;C0231683;C0439166;C2347086;C4553972;C1882327;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,17225/22402
mean ( sd ) % reversibility fev $nmbr$ at,C0444504;C2699239;C0449261;C3714541;C2347634;C2348143,false;false;false;true;false;false,17226/22402
mean ( sd ) ( years ),C0444504;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false,17227/22402
mean ( sd ) [ range ] duration of epilepsy  years,C0444504;C2699239;C1514721;C0449238;C0014544;C0439234;C2926735;C2348147;C3542016;C2347634;C2348143,false;false;false;false;true;false;false;false;false;false;false,17228/22402
mean ( sd ) $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,17229/22402
mean ( sd ) age,C0444504;C2699239;C0001779;C2347634;C2348143,false;false;false;false;false,17230/22402
mean ( sd ) age  y,C0444504;C2699239;C0001779;C2347634;C2348143,false;false;false;false;false,17231/22402
mean ( sd ) age  y race  n ( % ) *,C0444504;C2699239;C0001779;C0034510;C1706779;C3853635;C2347634;C2348143,false;false;false;true;false;false;false;false,17232/22402
mean ( sd ) anthropometry,C0444504;C2699239;C0003188;C2347634;C2348143,false;false;true;false;false,17233/22402
mean ( sd ) baseline,C0444504;C2699239;C0168634;C1442488;C2347634;C2348143,false;false;true;false;false;false,17234/22402
mean ( sd ) bmd in g / cm $nmbr$,C0444504;C2699239;C0439267;C2347634;C2348143,false;false;false;false;false,17235/22402
mean ( sd ) bmi  kg / m $nmbr$,C0444504;C2699239;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false;false,17236/22402
mean ( sd ) calcium intake in mg daily,C0444504;C2699239;C0489458;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;false;true;false;true;false;false;false;false;false;false;false,17237/22402
mean ( sd ) change from pre - to post - bronchodilator fev $nmbr$  l,C0444504;C2699239;C0392747;C2599602;C0687676;C3714541;C1704687;C3469826;C0332152;C2599594;C0740175;C2257086;C3669034;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false,17238/22402
mean ( sd ) change from pre - to post - bronchodilator fevi  ml,C0444504;C2699239;C2599602;C0687676;C3481639;C0439526;C1705224;C3887665;C1704687;C3469826;C0332152;C2599594;C0740175;C2257086;C3669034;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,17239/22402
mean ( sd ) change from pre - to post - bronchodilator fevi  nil,C0444504;C2699239;C2599602;C0687676;C3481639;C0442734;C1704687;C3469826;C0332152;C2599594;C0740175;C2257086;C3669034;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,17240/22402
mean ( sd ) duration of smoking  pack - years,C0444504;C2699239;C0449238;C0037369;C1277691;C0453996;C1881674;C2926735;C2347634;C2348143,false;false;false;true;false;true;false;false;false;false,17241/22402
mean ( sd ) duration of t $nmbr$ dm  y,C0444504;C2699239;C0449238;C0011816;C3250443;C2926735;C2347634;C2348143,false;false;false;true;false;false;false;false,17242/22402
mean ( sd ) e - etdrs visual acuity letter score ( snellen equivalent ),C3533236;C2699239;C0042812;C1096774;C0183370;C0205163;C0439185;C2360551,false;false;true;true;false;false;false;false,17243/22402
mean ( sd ) eevi  ml,C0444504;C2699239;C0439526;C1705224;C3887665;C2347634;C2348143,false;false;false;false;false;false;false,17244/22402
mean ( sd ) egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0444504;C2699239;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,17245/22402
mean ( sd ) fev $nmbr$  l,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,17246/22402
mean ( sd ) fev $nmbr$ / fvc  %,C0444504;C2699239;C3714541;C2347634;C2348143,false;false;true;false;false,17247/22402
mean ( sd ) fev $nmbr$ postbronchodilator  l,C0444504;C2699239;C3714541;C2599594;C2347634;C2348143,false;false;true;false;false;false,17248/22402
mean ( sd ) fevi  ml,C0444504;C2699239;C0429706;C0439526;C1705224;C3887665;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false,17249/22402
mean ( sd ) fevi / evc  %,C0444504;C2699239;C0429706;C0013903;C0429711;C1414479;C0849974;C1561566;C4528367;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false,17250/22402
mean ( sd ) fevi / fvc  %,C0444504;C2699239;C0802741;C3815113;C2347634;C2348143,false;false;false;false;false;false,17251/22402
mean ( sd ) hba $nmbr$ c level  %,C0444504;C2699239;C0019016;C0441889;C0456079;C1547707;C2946261;C1825777;C3538758;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false;false,17252/22402
mean ( sd ) hba $nmbr$ c  %,C0444504;C2699239;C0019016;C1825777;C3538758;C2347634;C2348143,false;false;true;false;false;false;false,17253/22402
mean ( sd ) improvement from baseline to week $nmbr$ in basdai,C0444504;C2699239;C2986411;C0168634;C1442488;C2347634;C2348143,false;false;false;true;false;false;false,17254/22402
mean ( sd ) improvement from baseline to week $nmbr$ in basdai questions *,C0444504;C2699239;C2986411;C0168634;C1442488;C2347634;C2348143,false;false;false;true;false;false;false,17255/22402
mean ( sd ) nonstudy eye e - etdrs visual acuity letter score,C3533236;C2699239;C0015392;C0042812;C1096774;C2360551;C0700042,false;false;true;true;true;false;false,17256/22402
mean ( sd ) postbronchodilator fev $nmbr$ % predicted,C0444504;C2699239;C2599594;C3714541;C2347634;C2348143,false;false;false;true;false;false,17257/22402
mean ( sd ) postbronchodilator fev $nmbr$ reversibility  %,C0444504;C2699239;C2599594;C3714541;C0449261;C2347634;C2348143,false;false;false;true;false;false;false,17258/22402
mean ( sd ) postbronchodilator fev $nmbr$ / fvc  %,C0444504;C2699239;C2599594;C3714541;C2347634;C2348143,false;false;false;true;false;false,17259/22402
mean ( sd ) values are presented for all variables  except medical history  race or ethnic group  and sex ( n  % ) and urinary albumin / creatinine ratio ( median ( range ) ) . abody mass index is the weight in kilograms divided by the square of the height in meters . bto convert values to micromoles per liter  multiply by $nmbr$ . $nmbr$ . estimated using the modified equation from the modification of diet in renal disease study . dto convert values to millimoles per liter  multiply by $nmbr$ . $nmbr$ . eto convert values to millimoles per liter  multiply by $nmbr$ . $nmbr$ . ^ to convert values to millimoles per liter  multiply by $nmbr$ . $nmbr$ .,C0444504;C2699239;C0042295;C2347634;C2348143;C0019664;C0034510;C1706779;C3853635;C0019665;C0262512;C0262926;C1705255;C2004062;C0486293;C0549183;C1514721;C0577559;C0600653;C0918012;C1552854;C1637833;C2986546;C0577573;C1096155;C1306372;C3152252;C3539882;C4283905;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1318293;C0005910;C0439209;C0043100;C1305866;C1705104;C0441074;C0750572;C0457987;C0557651;C0724655;C2603343;C0475211;C1719797;C2911648;C0475211;C1719797;C2911648;C1719797;C2911648,false;false;false;false;false;true;true;false;false;true;false;false;false;false;false;false;false;false;true;true;false;false;false;false;true;false;false;false;false;false;false;false;false;false;false;false;true;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,17260/22402
mean ( sd ) years daily ocs use  n ( % ),C0444504;C2699239;C0439234;C0332173;C2347634;C2348143,false;false;false;false;false;false,17261/22402
mean ( sd ) % predicted normal fev $nmbr$,C0444504;C2699239;C2347634;C2348143,false;false;false;false,17262/22402
mean ( sd )  kg / m $nmbr$,C0444504;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false,17263/22402
mean ( sd )  mg / kg $nmbr$,C0444504;C2699239;C0439272;C2347634;C2348143,false;false;false;false;false,17264/22402
mean ( sd )  mmhg,C0444504;C2699239;C0439475;C2347634;C2348143,false;false;false;false;false,17265/22402
mean ( sd )  ng / ml £,C0444504;C2699239;C0439275;C2347634;C2348143,false;false;false;false;false,17266/22402
mean ( sd ) d,C0444504;C2699239;C2347634;C2348143,false;false;false;false,17267/22402
mean ( se ) $nmbr$ - year rates per $nmbr$ population,C0036919;C0439234;C0871208;C2347634;C1521828;C0439508,true;false;false;false;false;false,17268/22402
mean ( se ) auc ^ p l,C0444504;C0036919;C0376690;C2347634;C2348143,false;true;true;false;false,17269/22402
mean ( se ) auc $nmbr$ - $nmbr$  l,C0444504;C0036919;C0376690;C2347634;C2348143,false;true;true;false;false,17270/22402
mean ( se ) trough l,C0444504;C0036919;C0444506;C2347634;C2348143,false;true;false;false;false,17271/22402
mean ( se ) trough  l,C0444504;C0036919;C0444506;C2347634;C2348143,false;true;false;false;false,17272/22402
mean ± s . d .,C0444504;C2347634;C2348143,false;false;false,17273/22402
mean ± sd age ( y ) mean bmi category ( % ),C0444504;C2699239;C0001779;C0578022;C0683312;C3889287;C2347634;C2348143,false;false;false;false;false;false;false;false,17274/22402
mean ± sd mg ( n = $nmbr$  $nmbr$  $nmbr$ ),C0444504;C2699239;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143,false;false;true;true;false;false;false;false;false;false;false,17275/22402
mean ± sd unless otherwise indicated,C0444504;C2699239;C2347634;C2348143,false;false;false;false,17276/22402
mean ± se,C0444504;C0036919;C2347634;C2348143,false;true;false;false,17277/22402
mean ± se ) bii ( ls mean ± se ),C0444504;C0036919;C1413059;C0023668;C2347634;C2348143,false;true;false;true;false;false,17278/22402
mean ±   sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,17279/22402
mean $nmbr$ - h dbp +,C0444504;C0033727;C0536221;C3813197;C4281799;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;true;true;false;false;false;false;false;false;false;false,17280/22402
mean $nmbr$ - h sbp *,C0444504;C0033727;C0085805;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,false;true;true;false;false;false;false;false;false,17281/22402
mean acq - $nmbr$ score at randomization  !,C0444504;C2919686;C2347634;C2348143,false;false;false;false,17282/22402
mean acq - $nmbr$ scores,C0444504;C2919686;C2347634;C2348143,false;false;false;false,17283/22402
mean age — yr ( range ),C0444504;C0001779;C0439234;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false;false,17284/22402
mean age ( range ) — yr,C0444504;C0001779;C1514721;C0439234;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false;false,17285/22402
mean age ( sd ),C0444504;C0001779;C2699239;C2347634;C2348143,false;false;false;false;false,17286/22402
mean age ( sd )  yr,C0444504;C0001779;C2699239;C0439234;C2347634;C2348143,false;false;false;false;false;false,17287/22402
mean age ( y ),C0444504;C0001779;C2347634;C2348143,false;false;false;false,17288/22402
mean age ( years  sd ),C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,17289/22402
mean age ( yr ),C0444504;C0001779;C0439234;C2347634;C2348143,false;false;false;false;false,17290/22402
mean age 士 s . d .  year,C0444504;C0001779;C0439234;C0439508;C2347634;C2348143,false;false;false;false;false;false,17291/22402
mean age ± s . d .  year,C0444504;C0001779;C0439234;C0439508;C2347634;C2348143,false;false;false;false;false;false,17292/22402
mean age ± s . d .  years,C0444504;C1510829;C2347634;C2348143,false;false;false;false,17293/22402
mean age  y,C0444504;C0001779;C2347634;C2348143,false;false;false;false,17294/22402
mean age  y ( range ),C0444504;C0001779;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,17295/22402
mean age  y : ( range ),C0444504;C0001779;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,17296/22402
mean age  years ( range ),C0444504;C1510829;C1514721;C2348147;C3542016;C2347634;C2348143,false;false;false;false;false;false;false,17297/22402
mean age  years ± sd,C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,17298/22402
mean age ± sd ( years ),C0444504;C1510829;C2699239;C2347634;C2348143,false;false;false;false;false,17299/22402
mean alc  %,C0444504;C1424945;C3811058;C2347634;C2348143,false;false;false;false;false,17300/22402
mean aqlq total score t,C3533236;C4055434;C0439175;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false;false,17301/22402
mean arterial pressure  baseline,C0428886;C0168634;C1442488,true;true;false,17302/22402
mean arterial pressure  difference,C0428886;C1705241;C1705242,true;false;false,17303/22402
mean arterial pressure  last,C0428886,true,17304/22402
mean asui scored,C0444504;C2347634;C2348143,false;false;false,17305/22402
mean baseline ( n ),C0444504;C0168634;C1442488;C2347634;C2348143,false;true;false;false;false,17306/22402
mean baseline bmi,C0444504;C0168634;C0578022;C1442488;C2347634;C2348143,false;true;false;false;false;false,17307/22402
mean baseline ei score,C0444504;C0168634;C0022067;C1414370;C2348481;C1442488;C2347634;C2348143,false;true;true;false;false;false;false;false,17308/22402
mean baseline nasal congestion score,C3533236;C0168634;C0027424;C4554631;C1442488,false;true;false;false;false,17309/22402
mean baseline ucdai score,C0444504;C0168634;C1442488;C2347634;C2348143,false;true;false;false;false,17310/22402
mean blood eosinophil count ( cells per pl ),C0444504;C0200638;C3897966;C4049765;C2347634;C2348143,false;false;false;false;false;false,17311/22402
mean blood pressure at screening visit ( mm hg ),C0428886;C0220908;C0545082;C0439475;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0488053,true;true;false;false;false;false;true;false;false;false;false;false;false,17312/22402
mean blood pressure  mm hg,C0428886;C0439475;C0488053,true;false;false,17313/22402
mean bm $nmbr$ ± s . d .  kg / m $nmbr$,C0444504;C0006416;C1532718;C2347634;C2348143,false;true;false;false;false,17314/22402
mean bmd ( = sd )  g / cm $nmbr$,C0444504;C2699239;C0439267;C2347634;C2348143,false;false;false;false;false,17315/22402
mean bmi ( sd ),C0444504;C0578022;C2699239;C2347634;C2348143,false;false;false;false;false,17316/22402
mean bmi ( sd )  kg / m $nmbr$,C0444504;C0578022;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,17317/22402
mean bmi ± s . d .  kg / m ^,C0444504;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false,17318/22402
mean bmi ± s . d .  kg / m $nmbr$,C0444504;C0578022;C1532718;C2347634;C2348143,false;false;false;false;false,17319/22402
mean bmi  kg / m $nmbr$ ± sd,C0444504;C0578022;C1532718;C2699239;C2347634;C2348143,false;false;false;false;false;false,17320/22402
mean bmi ± sd ( kg / m $nmbr$ ),C0444504;C0578022;C2699239;C1532718;C2347634;C2348143,false;false;false;false;false;false,17321/22402
mean bmii 士 s . d .  kg / m $nmbr$,C0444504;C1532718;C2347634;C2348143,false;false;false;false,17322/22402
mean body - mass index ( = sd )  kg / m $nmbr$,C0444504;C0005893;C2699239;C1532718;C0578022;C1305855;C2347634;C2348143,false;false;false;false;false;true;false;false,17323/22402
mean body - mass index ( kg / mq,C0444504;C0005893;C0022718;C0024853;C0439209;C4054209;C0578022;C1305855;C2347634;C2348143,false;false;true;true;false;false;false;true;false;false,17324/22402
mean body - mass index  kg / m $nmbr$ ( sd ) *,C0444504;C0005893;C1532718;C2699239;C0578022;C1305855;C2347634;C2348143,false;false;false;false;false;true;false;false,17325/22402
mean body - mass index  kg / m $nmbr$   ( sd ) *,C0444504;C0005893;C1532718;C2699239;C0578022;C1305855;C2347634;C2348143,false;false;false;false;false;true;false;false,17326/22402
mean body - mass indexj,C0444504;C0518010;C2347634;C2348143,false;false;false;false,17327/22402
mean body weight  kg ( range ),C0444504;C0005910;C0022718;C1514721;C2348147;C3542016;C0439209;C4054209;C1305866;C2347634;C2348143,false;true;true;false;false;false;false;false;false;false;false,17328/22402
mean change from baseline in acq overall score ( sd ) *,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,17329/22402
mean change from baseline in fev $nmbr$ % predicted  % ( sd ) *,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,17330/22402
mean change from baseline in the number of,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,17331/22402
mean change from baseline  %,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,17332/22402
mean change from baseline  % ‐ points,C0444504;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false,17333/22402
mean change in acq score,C3533236;C0392747;C2919686;C0443172;C1705241;C4319952,false;false;false;false;false;false,17334/22402
mean change in dbp from baseline  mg / dl  mean ( sd ),C0444504;C0392747;C0536221;C3813197;C4281799;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,17335/22402
mean change in fev $nmbr$,C0444504;C0392747;C3714541;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,17336/22402
mean change in radiographic end points shs  mean ± sd,C0444504;C0392747;C0444708;C2349179;C2699239;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false,17337/22402
mean change in sbp from baseline  mmhg  mean ( sd ),C0444504;C0392747;C0085805;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;true;false;false;false;false;false,17338/22402
mean change in sgrq,C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false,17339/22402
mean change in total updrs scores adjusted according to baseline updrs,C3533236;C0392747;C0439175;C3639721;C0439810;C0443172;C1705241;C4319952;C0444504;C2964552;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false;false,17340/22402
mean change ‘ s in fasting blood glucose [ mg / dl ( mmol / l ) ],C0444504;C0392747;C0428568;C2827883;C3642216;C1532563;C1261430;C0443172;C1705241;C4319952;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false;false,17341/22402
mean copd duration  y ( sd ),C0444504;C0024117;C0449238;C2699239;C2926735;C1412502;C3714496;C2347634;C2348143,false;true;false;false;false;false;false;false;false,17342/22402
mean crp level  mg / l ( sd ),C0444504;C3890735;C0441889;C0439268;C2699239;C0456079;C1547707;C2946261;C4048285;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false,17343/22402
mean daily dose ( range ) — mg  i,C0444504;C2348070;C1514721;C0024671;C0021966;C0221138;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2348147;C3542016;C2347634;C2348143,false;false;false;true;true;false;true;false;false;false;false;false;false;false;false;false,17344/22402
mean diastolic blood pressure ( sd )  mm hg,C0428886;C0012000;C2699239;C0439475;C0488053;C0444504;C0428883;C1305849;C2347634;C2348143,true;true;false;false;false;false;true;false;false;false,17345/22402
mean difference ( $nmbr$ % cl ),C0444504;C1705241;C0596019;C1705242;C2347634;C2348143,false;false;false;false;false;false,17346/22402
mean dose ' ’,C0444504;C0178602;C0869039;C1114758;C2347634;C2348143,false;false;false;false;false;false,17347/22402
mean dose ( sd ) ( mg / day ),C0444504;C0178602;C2699239;C0439422;C0869039;C1114758;C2347634;C2348143,false;false;false;false;false;false;false;false,17348/22402
mean dose ( sd ) ( mg / week ),C0444504;C0178602;C2699239;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C2347634;C2348143,false;false;false;true;false;false;true;false;false;false;false;false;false;false;false;false,17349/22402
mean doseb,C0444504;C2347634;C2348143,false;false;false,17350/22402
mean duration of pd  yr,C0444504;C0449238;C4553228;C0439234;C4553229;C2926735;C2347634;C2348143,false;false;false;false;false;false;false;false,17351/22402
mean duration of surgery ± sd  min,C0444504;C0449238;C0038894;C2699239;C0702093;C1524029;C3813700;C0038895;C0543467;C1274039;C2926735;C2347634;C2348143,false;false;false;false;false;false;false;true;true;true;false;false;false,17352/22402
mean duration offollow - up ( years ) *,C0444504;C0449238;C0439234;C2926735;C2347634;C2348143,false;false;false;false;false;false,17353/22402
mean fecal calprotectin level  mg / g stool ( sd ),C0444504;C0015733;C0950624;C0441889;C1300563;C2699239;C0183622;C0456079;C1547707;C2946261;C1335798;C1366582;C2347634;C2348143,false;true;true;false;false;false;false;false;false;false;false;false;false;false,17354/22402
mean femoral neck t score,C3533236;C0015815,false;true,17355/22402
mean fpg  mmol / l,C0444504;C1532563;C2347634;C2348143,false;false;false;false,17356/22402
mean glycated hemoglobin reduction during characteristic follow - up ( $nmbr$ % ci ) percent,C0444504;C0017853;C1521970;C0589120;C0520870;C0439165;C1522577;C1704685;C3274571;C2347634;C2348143,false;true;false;false;false;false;false;false;false;false;false,17357/22402
mean hba $nmbr$ c ± s . d .  %,C0444504;C0019016;C1825777;C3538758;C2347634;C2348143,false;true;false;false;false;false,17358/22402
mean hba $nmbr$ c  %,C0444504;C0019016;C1825777;C3538758;C2347634;C2348143,false;true;false;false;false;false,17359/22402
mean hba $nmbr$ c  mmol / mol †,C0444504;C0019016;C3829066;C1825777;C3538758;C2347634;C2348143,false;true;false;false;false;false;false,17360/22402
mean hbaic = • = s . d .  %,C0444504;C2347634;C2348143,false;false;false,17361/22402
mean ics ( fluticasone propionate dpi or equivalent  pg per day ),C0444504;C0815320;C0117996;C4551720;C2347634;C2348143,false;false;true;true;false;false,17362/22402
mean ics use at enrolment ( pg ) *,C0444504;C0815320;C4551720;C2347634;C2348143,false;false;true;false;false,17363/22402
mean iief ef score mean iief domain score by bmi ( < $nmbr$ / < $nmbr$ to < $nmbr$ / < $nmbr$ kg / m $nmbr$ ),C3533236;C3641331;C1880389;C0578022;C1883221;C3541951,false;false;false;false;false;false,17364/22402
mean ipss qol ( sd ),C0444504;C1019118;C0518214;C2699239;C1998280;C2827405;C3811063;C2347634;C2348143,false;false;false;false;false;false;false;false;false,17365/22402
mean ipss  storage sub - score ( sd ),C3533236;C1019118;C0337174;C0542339;C2699239;C1264637;C1698986;C1753314;C1998280;C2827405;C3811063,false;false;false;false;false;false;false;false;false;false;false,17366/22402
mean ipss  voiding subscore ( sd ),C0444504;C1019118;C1998280;C2827405;C3811063;C2347634;C2348143,false;false;false;false;false;false;false,17367/22402
mean lipid difference ( mg / dl ) hdl - c,C0444504;C0023779;C1705241;C0439269;C3715113;C1705242;C2347634;C2348143,false;true;false;false;false;false;false;false,17368/22402
mean lumbar spine t score,C3533236;C0024091;C3887615,false;true;false,17369/22402
mean lvef,C0444504;C0428772;C0488728;C2347634;C2348143,false;false;false;false;false,17370/22402
mean mmrc grade  units ( sd ),C0444504;C3826977;C0441800;C0439148;C2699239;C1519795;C3853603;C0919553;C3244287;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false;false,17371/22402
mean mmse score,C3533236;C0451306,false;true,17372/22402
mean no . agents ( sd ) other medications,C0444504;C2347634;C2348143,false;false;false,17373/22402
mean number of antihypertensive medication at last visit   ‡,C0444504;C0237753;C0003364;C0449788;C2347634;C2348143,false;false;true;false;false;false,17374/22402
mean number of antihypertensive medications at $nmbr$ year   *,C0444504;C1718138;C0003364;C2347634;C2348143,false;false;true;false;false,17375/22402
mean number of caes in past $nmbr$ months ( number per patient ) ] |,C0444504;C0237753;C0449788;C2347634;C2348143,false;false;false;false;false,17376/22402
mean number of clinically significant asthma exacerbations †,C0444504;C0237753;C0237881;C0349790;C0750502;C1546944;C0449788;C2347634;C2348143,false;false;false;false;false;false;false;false;false,17377/22402
mean number of combined visits / hospitalizations †,C0444504;C4086639;C0205195;C0545082;C1512346;C2347634;C2348143,false;false;false;false;false;false;false,17378/22402
mean number of exacerbations in previous y ( sd ),C0444504;C0237753;C4086268;C0449788;C2347634;C2348143,false;false;false;false;false;false,17379/22402
mean number of puffs per day,C0444504;C0237753;C1533107;C0449788;C2347634;C2348143,false;false;false;false;false;false,17380/22402
mean of jsw ( mm ),C0444504;C4330985;C4554674;C2347634;C2348143,false;false;false;false;false,17381/22402
mean of maximum cimt  mean ( sd )  mm,C0444504;C0806909;C2699239;C4330985;C4554674;C1552615;C2826546;C2347634;C2348143,false;false;false;false;false;false;false;false;false,17382/22402
mean of mean cimt  mean ( sd )  mm,C0444504;C2699239;C4330985;C4554674;C2347634;C2348143,false;false;false;false;false;false,17383/22402
mean or n,C0444504;C2347634;C2348143,false;false;false,17384/22402
mean percentage change from baseline to final visit,C0444504;C0439165;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C1549488;C1561533;C2347634;C2348143,false;false;false;true;false;false;false;false;false;false;false;false,17385/22402
mean pga score ± sd,C3533236;C0016410;C2699239;C3541266;C4050369,false;true;false;false;false,17386/22402
mean postbronchodilatora fev $nmbr$  % predicted ( sd ),C0444504;C3714541;C0681842;C2699239;C1882327;C2347634;C2348143,false;true;false;false;false;false;false,17387/22402
mean prebronchodilation ( l ),C0444504;C2347634;C2348143,false;false;false,17388/22402
mean proportion ( % ),C0444504;C1709707;C2347634;C2348143,false;false;false;false,17389/22402
mean pulmonary artery pressure  mm hg,C3854605;C0439475,false;false,17390/22402
mean qmax score by bmi ( < $nmbr$ / < $nmbr$ to < $nmbr$ / < $nmbr$ kg / m $nmbr$ ),C3533236;C0578022,false;false,17391/22402
mean reversibility ( % ),C0444504;C0449261;C2347634;C2348143,false;false;false;false,17392/22402
mean score ( min  max range ),C3533236;C0702093;C1514721;C2348147;C3542016;C1524029;C3813700,false;false;false;false;false;false;false,17393/22402
mean selena - sledai score ± sd,C0444504;C0451528;C2347634;C2348143,false;false;false;false,17394/22402
mean serum cholesterol  mg / dl,C0444504;C0587184;C0439269;C2347634;C2348143,false;false;false;false;false,17395/22402
mean serum creatinine  mg / dl,C0444504;C0201976;C0439269;C0600061;C2347634;C2348143,false;false;false;false;false;false,17396/22402
mean serum potassium  mg / dl,C0444504;C0302353;C0439269;C0543465;C2347634;C2348143,false;false;false;false;false;false,17397/22402
mean sgrq total score,C3533236;C0439175;C0439810;C0444504;C2964552;C2347634;C2348143,false;false;false;false;false;false;false,17398/22402
mean sitting diastolic blood pressure,C0444504;C1319894;C2347634;C2348143,false;false;false;false,17399/22402
mean sitting systolic blood pressure,C0444504;C2347634;C2348143,false;false;false,17400/22402
mean slicc damage index score ± sd,C3533236;C0010957;C0600653;C2699239;C0918012;C1552854;C1637833;C2986546;C1883709,false;false;true;false;true;false;false;false;false,17401/22402
mean stent diameter per lesion  mm ( sd ) †,C0038257;C0552409;C0221198;C4330985;C2699239;C4554674;C1546698,true;false;false;false;false;false;false,17402/22402
mean stents per lesion ( sd ) ‡,C0444504;C0038257;C0221198;C2699239;C1546698;C2347634;C2348143,false;true;false;false;false;false;false,17403/22402
mean systolic blood pressure ( sd )  mm hg,C0428886;C0039155;C2699239;C0439475;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;false;false;true;false;false;false,17404/22402
mean systolic blood pressure  mm hg ( sd ),C0428886;C0039155;C0439475;C2699239;C0488053;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143,true;true;false;false;false;false;false;true;false;false;false,17405/22402
mean systolic pressure gradient,C4687744;C0039155,false;true,17406/22402
mean time since as diagnosis  years  mean ± sd,C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,17407/22402
mean time since asthma,C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,17408/22402
mean time since diagnosis ( years ),C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,17409/22402
mean time since diagnosis  y,C0444504;C0040223;C3541383;C2347634;C2348143,false;true;false;false;false,17410/22402
mean time to first oral dose postsurgeryh  hr,C0444504;C0040223;C0205435;C0442027;C0178602;C0869039;C1114758;C4521986;C1279901;C3541383;C2347634;C2348143,false;true;false;false;false;false;false;false;false;false;false;false,17411/22402
mean time to first subcutaneous injectiong  h in relation to surgery  hr,C0444504;C0040223;C0205435;C0443315;C0033727;C0369286;C0441932;C0564385;C4528284;C1279901;C3541383;C2347634;C2348143,false;true;false;false;true;false;false;false;false;false;false;false;false,17412/22402
mean total ipss ( sd ),C0444504;C0439175;C1019118;C2699239;C1998280;C2827405;C3811063;C0439810;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false,17413/22402
mean total ipss mean ipss by bmi ( < $nmbr$ / < $nmbr$ to < $nmbr$ / < $nmbr$ kg / m $nmbr$ ),C0444504;C0439175;C1019118;C0578022;C1998280;C2827405;C3811063;C0439810;C2347634;C2348143,false;false;false;false;false;false;false;false;false;false,17414/22402
mean total serum psa,C0444504;C2986589;C0229671;C1546774;C1550100;C2347634;C2348143,false;false;true;false;false;false;false,17415/22402
mean total stent length per lesion  mm ( sd ) ‡,C0444504;C0439175;C0038257;C1444754;C0221198;C4330985;C2699239;C4554674;C1546698;C1706316;C0439810;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false;false;false;false,17416/22402
mean treatment exposure  wk,C0444504;C0039798;C0274281;C0332174;C0439230;C0332157;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2347634;C2348143,false;true;false;false;false;false;true;false;false;false;false;false;false;false,17417/22402
mean wall thickness ( cm ),C4054557;C0677535,false;false,17418/22402
mean years since menopause,C0444504;C0439234;C2347634;C2348143,false;false;false;false,17419/22402
mean   ±   sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,17420/22402
mean  mg / dl,C0444504;C0439269;C2347634;C2348143,false;false;false;false,17421/22402
mean  ml ( sd ),C0444504;C0439526;C2699239;C1705224;C3887665;C2347634;C2348143,false;false;false;false;false;false;false,17422/22402
mean  sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,17423/22402
mean_delta,C0444504;C0439097;C1705241;C3146239;C3538806;C3540585;C3815527;C2347634;C2348143,false;false;false;false;false;false;false;false;false,17424/22402
mean 土 sd ( n ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,17425/22402
mean ± sd  n ( % ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,17426/22402
measure,C0079809;C0242485,true;false,17427/22402
measures,C0079809;C1879489,true;false,17428/22402
measures ( % ),C0079809;C1879489,true;false,17429/22402
measures ( mmol / l ),C0079809;C0242485;C1879489,true;false;false,17430/22402
measures of lung function,C0079809;C0035245;C1879489,true;true;false,17431/22402
medal,C0524670,true,17432/22402
meddra smq,C1140263,false,17433/22402
median — ml / min,C0549183;C0439445;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,17434/22402
median — ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0549183;C0439445;C0369637;C0441923;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,17435/22402
median ( $nmbr$ th  $nmbr$ th percentile ),C0549183;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;true;false;true;false;false;false;false;false;false;false,17436/22402
median ( $nmbr$ % ci ) time to weekly iss mid response up to week $nmbr$ ( wk ) f,C0549183;C0008107;C0332174;C1740819;C0034746;C1845118;C3259781;C0876920;C2347635;C2348144;C2939193,false;true;false;false;true;false;false;false;false;false;false,17437/22402
median ( interquartile range ),C0549183;C1711350;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,17438/22402
median ( interquartile range ) — yr,C0549183;C1711350;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,17439/22402
median ( iq range ),C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,17440/22402
median ( iqr ) — yr,C0549183;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,17441/22402
median ( iqr ) change from baseline to week $nmbr$ in psa - modified total shs score,C0549183;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false,17442/22402
median ( iqr ) mean $nmbr$ sdchange from baseline to week $nmbr$ by weight group and mtx use : weight,C0549183;C0444504;C0168634;C1442488;C2347634;C2348143;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false,17443/22402
median ( iqr )  h,C0549183;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,17444/22402
median ( minimum – maximum ) focal seizure frequency / $nmbr$   days at baseline,C0549183;C1524031;C0806909;C0751495;C0376249;C0439228;C0168634;C1442488;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352;C0205234;C0149775;C1552615;C2826546;C1552614;C2826545;C0876920;C2347635;C2348144;C2939193,false;false;false;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,17445/22402
median ( q $nmbr$ – q $nmbr$ ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,17446/22402
median ( range ) duration of asthma ( y ),C0549183;C1514721;C0449238;C0004096;C2984299;C2926735;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false;false;false,17447/22402
median ( range ) duration of asthma ( years ),C0549183;C1514721;C0449238;C0004096;C0439234;C2984299;C2926735;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false;false;false;false,17448/22402
median ( range ) duration of hospital stayi  d,C0549183;C1514721;C0449238;C0019994;C1510665;C2926735;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;true;false;false;false;false;false;false;false;false,17449/22402
median ( range ) total ige level ( iuml ~ ’ ) $nmbr$,C0549183;C1514721;C0439175;C0441889;C0456079;C1547707;C2946261;C0439810;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false;false;false;false,17450/22402
median ( range ) treatment duration  d,C0549183;C1514721;C0444921;C3259042;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,17451/22402
median age — yr,C0549183;C0001779;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,17452/22402
median age [ interquartile range ] — yr,C0549183;C0001779;C1711350;C0439234;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,17453/22402
median age  y ( range ),C0549183;C0001779;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,17454/22402
median age  years ( iqr ),C0549183;C1510829;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,17455/22402
median blood eosinophil count ( cells per pl ) t,C0549183;C0200638;C3897966;C4049765;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,17456/22402
median bnp ( iqr ) – pg / ml,C0549183;C0054015;C0439297;C1095989;C1417808;C2982014;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,17457/22402
median body mass index  kg / m $nmbr$ ( range ),C0549183;C0005893;C1532718;C1514721;C2348147;C3542016;C0578022;C1305855;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;true;false;false;false;false,17458/22402
median body weight ( kg ),C3821165;C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104;C0549183;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;true;false;false;false;false;false;false;false,17459/22402
median c - reactive protein — mg / liter,C0549183;C0006560;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1413716;C4048285;C0876920;C2347635;C2348144;C2939193,false;true;true;false;true;false;false;false;false;false;false;false;false;false;false;false,17460/22402
median cardiac troponin t ( iqr ) 一 pg / ml,C0549183;C3538889;C0439297;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,17461/22402
median crcl — ml / min,C0549183;C1846718;C0439445;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false,17462/22402
median crohn ' s disease duration  y ( range ),C0549183;C0010346;C0449238;C1514721;C2348147;C3542016;C2926735;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false;false,17463/22402
median delay ( h ) §,C0549183;C0205421;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false,17464/22402
median dose ( range ) ' ’,C0549183;C0178602;C1514721;C2348147;C3542016;C0869039;C1114758;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false,17465/22402
median dose ( range ) b,C0549183;C0178602;C1514721;C2348147;C3542016;C0869039;C1114758;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false;false,17466/22402
median duration of chf — mo,C0549183;C0449238;C0018802;C0026544;C0332177;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;true;true;false;false;false;false;false;false,17467/22402
median duration of diabetes ( yr ),C0549183;C0449238;C0011847;C0439234;C0011849;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false,17468/22402
median duration of study - drug administration ( iqr ) — days,C0549183;C2348354;C0013175;C0439228;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false,17469/22402
median duration oftype $nmbr$ diabetes ( iqr ) — yr,C0549183;C0449238;C0011847;C0439234;C0011849;C2926735;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false,17470/22402
median egfr ( interquartile range ),C0549183;C1739039;C1711350;C3811844;C3812682;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false,17471/22402
median fecal calprotectin — mg / kg gi areas involved — no . ( % ),C0549183;C0015733;C0950624;C0439272;C1708130;C0205146;C4319729;C3539617;C4050121;C1335798;C1366582;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false;false;false;false;false;false,17472/22402
median feno ( ppb ) f,C0549183;C1415800;C0016327;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false,17473/22402
median infusions — no . ( range ),C0549183;C0574032;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,17474/22402
median m / kg $nmbr$ ( iqr ),C0549183;C0369637;C0022718;C0439209;C4054209;C0441923;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false,17475/22402
median nt - probnp ( iqr ) – pg / ml,C0549183;C0669479;C0439297;C0754710;C0876920;C2347635;C2348144;C2939193,false;true;false;true;false;false;false;false,17476/22402
median of jsw,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,17477/22402
median pasi score { range ) ' i  i ',C0549183;C4528685;C0449820;C1514721;C0021966;C0221138;C2348147;C3542016;C4050231;C0876920;C2347635;C2348144;C2939193,false;false;false;false;true;false;false;false;false;false;false;false;false,17478/22402
median seconds,C0549183;C0457385;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,17479/22402
median serum periostin ( ng / ml ) t,C0549183;C0229671;C0219433;C0439275;C1424662;C3812270;C1546774;C1550100;C0876920;C2347635;C2348144;C2939193,false;true;true;false;false;false;false;false;false;false;false;false,17480/22402
median time delay ( interquartile range ) — min,C0549183;C0522486;C1711350;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false;false,17481/22402
median time from index acute coronary syndrome to randomization ( iqr ) — mo,C0549183;C0040223;C0600653;C0948089;C0918012;C1552854;C1637833;C2986546;C3541383;C0876920;C2347635;C2348144;C2939193,false;true;true;true;true;false;false;false;false;false;false;false;false,17482/22402
median time in therapeutic range for warfarin recipients  %,C0549183;C1554109;C0087111;C0302350;C0040223;C0460097;C3541383;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false,17483/22402
median time to event ( weeks ),C0549183;C0040223;C0441471;C0439230;C4019010;C3541383;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false;false;false;false,17484/22402
median triglyceride ( mg / dl ),C0549183;C0041004;C0439269;C0876920;C2347635;C2348144;C2939193,false;true;false;false;false;false;false,17485/22402
median  iqr ),C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,17486/22402
median  mg / dl,C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,17487/22402
median  ml,C0549183;C0439526;C1705224;C3887665;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,17488/22402
median  range,C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,17489/22402
median  y ( range ),C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false,17490/22402
median §,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,17491/22402
medians ( iqr ),C0549183,false,17492/22402
medical and lifestyle history,C0199168;C0205476,false;false,17493/22402
medical historv,C0199168;C0205476,false;false,17494/22402
medical history — %,C0262926;C1704706,false;false,17495/22402
medical history and risk factors  no . / total ( % ) *,C0262926;C1704706,false;false,17496/22402
medical history at randomization — no . ( % ),C0262926;C0034656;C1704706,false;true;false,17497/22402
medical history before index acute coronary syndrome — no . { % ),C0262926;C0600653;C0948089;C0918012;C1552854;C1637833;C2986546;C1704706,false;true;true;true;false;false;false;false,17498/22402
medical history of cv disease or heart failure  n ( % ),C0262926;C0007222,false;true,17499/22402
medical history  n ( % of patients ),C0679831;C1369882;C1609576,false;false;false,17500/22402
medical history    n   ( % ),C0262926;C1704706,false;false,17501/22402
medical history . no . ( % ),C0262926;C1704706,false;false,17502/22402
medical history : cancer,C0262926;C0006826;C0998265;C1306459;C1704706,false;true;false;false;false,17503/22402
medical management only — no . { % ),C0199168;C0001554;C0205171;C1720467;C0376636;C1273870;C3273539;C0205476,false;true;false;false;true;false;false;false,17504/22402
medical therapy before admission,C0418981;C0184666;C0809949,false;false;false,17505/22402
medical therapy before randomization — no . / total no . ( % ),C0418981;C0034656,false;true,17506/22402
medical therapy during index hospitalization — %,C0418981;C0600653;C0019993;C0918012;C1552854;C1637833;C2986546,false;true;true;true;false;false;false,17507/22402
medical treatment  n ( % ),C0679624,false,17508/22402
medication $nmbr$ ( $nmbr$ . $nmbr$ ),C0013227;C3244316;C4284232,true;false;false,17509/22402
medication at entry ( % ),C0013227;C1705654;C3244316;C4284232,true;false;false;false,17510/22402
medication at randomization,C0013227;C0034656;C3244316;C4284232,true;true;false;false,17511/22402
medication at randomization  %,C0013227;C0034656;C3244316;C4284232,true;true;false;false,17512/22402
medication at randomization  n ( % ),C0013227;C0034656;C3244316;C4284232,true;true;false;false,17513/22402
medication at time of randomization,C0013227;C0040223;C0034656;C3541383;C3244316;C4284232,true;true;true;false;false;false,17514/22402
medication at time of randomization — no . ( % ),C0013227;C0040223;C0034656;C3541383;C3244316;C4284232,true;true;true;false;false;false,17515/22402
medication continued into double - blind treatment period,C0013227;C3244316;C4284232,true;false;false,17516/22402
medication in use at the baseline,C0013227;C3244316;C4284232,true;false;false,17517/22402
medication use — no . { % ),C0013227;C3244316;C4284232,true;false;false,17518/22402
medication use ( % ),C0240320,false,17519/22402
medication use ( % ) aspirin,C0240320;C0004057,false;true,17520/22402
medication use at baseline - n ( % ),C0240320;C0168634;C1442488,false;true;false,17521/22402
medication use at entry ( % ),C0240320;C1705654,false;false,17522/22402
medication use before enrollment  no . ( % ),C0240320;C1516879;C1696073;C3888021,false;false;false;false,17523/22402
medication use  n ( % ),C0240320,false,17524/22402
medication use  no . / total no . ( % ),C0013227;C3244316;C4284232,true;false;false,17525/22402
medication useb,C0013227;C3244316;C4284232,true;false;false,17526/22402
medications — no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,17527/22402
medications — no . { % ) * *,C0013227;C0802604;C2598133;C4284232,true;false;false;false,17528/22402
medications ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,17529/22402
medications antihypertensive drugs,C0013227;C0003364;C0802604;C2598133;C4284232,true;true;false;false;false,17530/22402
medications at baselinet,C0013227;C0802604;C2598133;C4284232,true;false;false;false,17531/22402
medications at enrollment  n ( % ) :,C0013227;C1516879;C1696073;C3888021;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,17532/22402
medications at enrolment,C0013227;C1516879;C1696073;C3888021;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,17533/22402
medications at the time of randomization — no . ( % ),C0013227;C0040223;C0034656;C3541383;C0802604;C2598133;C4284232,true;true;true;false;false;false;false,17534/22402
medications at time of randomization — no . ( % ),C0013227;C0040223;C0034656;C3541383;C0802604;C2598133;C4284232,true;true;true;false;false;false;false,17535/22402
medications during hospitalization or at discharge,C0013227;C0019993;C0802604;C2598133;C4284232,true;true;false;false;false,17536/22402
medications for crohn ' s disease taken at baseline — no . ( % ),C0013227;C0010346;C0802604;C2598133;C4284232,true;true;false;false;false,17537/22402
medications in the hospital after randomization — no . ( % ),C0013227;C0019994;C1510665;C0802604;C2598133;C4284232,true;true;false;false;false;false,17538/22402
medications in use at baseline — no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,17539/22402
medications in use at baseline — no . / total no . ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,17540/22402
medications in use at baseline  n ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,17541/22402
medications  n,C0013227;C0802604;C2598133;C4284232,true;false;false;false,17542/22402
medications  n ( % of patients ),C0013227;C0030705;C0802604;C2598133;C4284232,true;true;false;false;false,17543/22402
medium normal ( n = $nmbr$ ),C0009458;C0205307;C0231683;C0439166;C2347086;C4553972;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;false;false;false;false;false;false;false;false;false;false,17544/22402
meglitinides ( glinides ),C0065880;C3537178;C1579432,true;false;false,17545/22402
meloxicam,C0083381,true,17546/22402
memantine use at baseline  no . ( % ),C0025242;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,17547/22402
men ( n [ % ] ),C0025266,true,17548/22402
men ( n 二 $nmbr$ ),C0025266,true,17549/22402
men ( n  % ),C0025266,true,17550/22402
men with ed ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C0025266;C3538926,true;false,17551/22402
men without ed ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C0025266;C3538926,true;false,17552/22402
men  n ( % ) *,C0025266,true,17553/22402
men  no . ( % ),C0025266,true,17554/22402
men  total ( n = $nmbr$ ),C0025266;C0439175;C0439810,true;false;false,17555/22402
men    n   ( % ),C0025266,true,17556/22402
men : < $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l ),C0025266;C0439269;C1532563,true;false;false,17557/22402
men : qvai $nmbr$ - sfc,C0025266;C4521536,true;false,17558/22402
menopausal status and hormone therapy use,C1513126,false,17559/22402
menopausal status and hormone therapy use premenopausal,C1513126,false,17560/22402
mensa,,,17561/22402
ment,C0084844;C1538994,true;false,17562/22402
mental activities updrs subscore ( baseline )  mean ( sd ),C0229992;C0441655;C3639721;C0168634;C0444504;C2699239;C2347634;C2348143;C1442488,false;false;true;true;false;false;false;false;false,17563/22402
mental status,C0278060,false,17564/22402
mental status ( baseline spmsq scores )  n ( % ),C0278060;C0168634;C1442488,false;true;false,17565/22402
mepo ( n = $nmbr$ ),,,17566/22402
mepolizumab,C0969324,true,17567/22402
mepolizumab $nmbr$ mg ( n = $nmbr$ ),C0969324;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,17568/22402
merformin,,,17569/22402
mesalamine use  n ( % ) a,C0127615;C0042153;C0457083;C1947944,true;true;false;false,17570/22402
met atopy and ige $nmbr$ - $nmbr$ ku / l criteria  ( n = $nmbr$ ),C0428210;C0392707;C3539705;C1550543;C4317104,false;false;false;false;false,17571/22402
met / su / tzd,C0428210;C0038642;C1705534;C1550543;C4317104,false;true;false;false;false,17572/22402
met / tzd,C0428210;C1550543;C4317104,false;false;false,17573/22402
metabolic syndrome — no . ( % ) !,C0524620,true,17574/22402
metabolic syndrome — no . ( % ) ^,C0524620,true,17575/22402
metabolic syndrome — no . ( % ) $nmbr$,C0524620,true,17576/22402
metabolic syndrome  n / n ( % ) *,C0524620,true,17577/22402
metabolic syndromeb,C0311400;C1524026;C2707259,false;false;false,17578/22402
metabolism and nutrition,C0025519;C0025520,true;true,17579/22402
metastatic,C0036525;C1522484;C4085632,false;true;false,17580/22402
metformin - dose,C0025598;C0178602;C0869039;C1114758,true;false;false;false,17581/22402
metformin ( hdm ),C0025598,true,17582/22402
metformin ( n $nmbr$ $nmbr$ ),C0025598,true,17583/22402
metformin ? pioglitazone,C1635037,false,17584/22402
metformin ? su,C0025598;C0038642;C1705534,true;true;false,17585/22402
metformin + su,C0025598;C0038642;C1705534,true;true;false,17586/22402
metformin + su + tzd,C0025598;C0038642;C1705534,true;true;false,17587/22402
metformin ± other oral anti - dm drugs,C0025598,true,17588/22402
metformin • pioglitazone,C1635037,false,17589/22402
metformin alone,C0025598,true,17590/22402
metformin dose,C0025598;C0178602;C0869039;C1114758,true;false;false;false,17591/22402
metformin monotherapy,C0025598,true,17592/22402
metformin only,C0025598;C0205171;C1720467,true;false;false,17593/22402
metformin open - label *,C0025598,true,17594/22402
metformin use  n ( % ),C0025598;C0042153;C0457083;C1947944,true;true;false;false,17595/22402
metformin  n ( % ),C0025598,true,17596/22402
metformin + sulphonylureas,C0025598;C0038766,true;true,17597/22402
metforminmonotherapy,,,17598/22402
method of assessing ejection fraction,C0025663;C1516048;C0302131;C1264633;C0336969;C0812388;C0449851;C0871511,true;false;false;false;false;false;false;false,17599/22402
method of insulin administration,C0025663;C0199782;C0449851;C0871511,true;false;false;false,17600/22402
methotrexate alone ^,C0025677,true,17601/22402
methotrexate dose on day $nmbr$ — mg per wl < $nmbr$,C0025677;C0178602;C0439422;C0869039;C1114758;C0332173;C4086581;C0439228;C0439505,true;false;false;false;false;false;false;false;false,17602/22402
methotrexate dose | |  mg,C0025677;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758,true;false;true;true;false;false;false;false;false;false;false,17603/22402
methotrexate plus other csdmardfl,C0025677,true,17604/22402
methotrexate treatment !,C0746573,false,17605/22402
methotrexate use at baseline,C0025677;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,17606/22402
methotrexate use at randomization,C0025677;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,17607/22402
methotrexate use at randomization    n   ( % ),C0025677;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,17608/22402
methylxanthines,C0066447,true,17609/22402
metoprolol ( n = $nmbr$ $nmbr$ ),C0025859,true,17610/22402
mets pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ ),C0812270;C0031962;C1705694;C2939420,false;true;false;false,17611/22402
mets  n ( % ),C0812270;C1705694;C2939420,false;false;false,17612/22402
mexican,C0240339,false,17613/22402
mexico  central / south america,C0025885;C0007674;C1710133;C0205099;C0037713;C1879652,true;true;false;false;true;false,17614/22402
mfns ( n = $nmbr$ ),,,17615/22402
mg daily ),C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,17616/22402
mg / day,C0439422,false,17617/22402
mg / dl fpg ( mmol / l ),C0439269;C1532563,false;false,17618/22402
mg / dl  mean ± sd,C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,17619/22402
mg / g,C1300563,false,17620/22402
mg / mmol,C0567349;C2348885,false;false,17621/22402
mh + crpnorr,C0026514;C2930980,true;true,17622/22402
mhi,,,17623/22402
mi — no . ( % ),C3810814,false,17624/22402
mi ( fatal / nonfatal ),C3810814;C1302234;C1705232,false;false;false,17625/22402
mi *,C3810814,false,17626/22402
mi  n ( % ),C3810814,false,17627/22402
micral test result,C0456984;C0587081,false;false,17628/22402
micro - or macroalbuminuria  n ( % ) §,C0085672;C1553035;C3811161;C4049106,false;false;false;false,17629/22402
micro - or macroalbuminuria  no . ( % ),C0085672;C1553035;C3811161;C4049106,false;false;false;false,17630/22402
micro / macroaibuminuria,C0085672;C1553035;C3811161;C4049106,false;false;false;false,17631/22402
micro / macroalbuminuria,C0085672;C1553035;C3811161;C4049106,false;false;false;false,17632/22402
microalbuminuria — no . ( % ),C0730345,false,17633/22402
microalbuminuria ( uacr $nmbr$ – $nmbr$ ),C0730345,false,17634/22402
microalbuminuria or macroalbuminuria §,C0730345,false,17635/22402
microalbuminuria  mg / g cr,C0730345;C1300563;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337,false;false;false;false;true;false;false;false,17636/22402
microvascular complicationsb,C0443258,false,17637/22402
microvascular disease history,C0443258;C0683519,false;false,17638/22402
microvascular disease history  n ( % ),C0443258;C0683519,false;false,17639/22402
microvascular disease history  no . ( % ),C0443258;C0683519,false;false,17640/22402
microvascular disease *,C0443258;C0012634,false;true,17641/22402
microvascular outcome,C0443258;C1274040,false;false,17642/22402
micturitions / $nmbr$ h,C0042034;C0033727;C0369286;C0441932;C0564385;C4528284,true;true;false;false;false;false,17643/22402
midas score,C1309950;C1423498;C4049617,true;false;false,17644/22402
middle,C0444598;C0549183;C1552826,false;false;false,17645/22402
middle east  africa  or asia - pacific,C0026068;C0001737;C0444598;C0001741;C0549183;C1552826,true;true;false;true;false;false,17646/22402
middle tertile : > $nmbr$ . $nmbr$ to b $nmbr$ . $nmbr$,C0444598;C0549183;C1552826,false;false;false,17647/22402
migraine duration ( h ),C0149931;C0449238;C0033727;C0369286;C0441932;C0564385;C4528284;C2926735,true;false;true;false;false;false;false;false,17648/22402
migraine occurrence ( days / month ),C0149931;C0243132;C0556971;C1554210;C2745955,true;true;false;false;false,17649/22402
migraine severity score,C0149931;C0457451,true;false,17650/22402
mild - to - moderate ( ipss < $nmbr$ ),C1299392;C1019118;C1998280;C2827405;C3811063,false;false;false;false;false,17651/22402
mild ( < $nmbr$ ),C2945599,false,17652/22402
mild ( $nmbr$ - $nmbr$ ),C2945599,false,17653/22402
mild ( $nmbr$ – $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % ),C2945599;C0439445;C0369637;C0441923,false;false;false;false,17654/22402
mild ( fev  > $nmbr$ % predicted ),C2945599;C3714541,false;true,17655/22402
mild ( iief - ef $nmbr$ - $nmbr$ ),C2945599;C3641331,false;false,17656/22402
mild ( ipss < $nmbr$ ),C2945599;C1019118;C1998280;C2827405;C3811063,false;false;false;false;false,17657/22402
mild ( n = $nmbr$ ),C2945599,false,17658/22402
mild ( n $nmbr$ = $nmbr$ ) $nmbr$,C2945599,false,17659/22402
mild decrease ( $nmbr$ - < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C2945599;C0392756;C0439445;C0369637;C0441923;C0547047,false;false;false;false;false;false,17660/22402
mild decrease in gfr ( $nmbr$ - $nmbr$ ml / mln per $nmbr$ . $nmbr$ m ^ ),C2945599;C0392756;C0017654;C0439526;C1417190;C3815103;C1705224;C3887665;C1424601;C0547047,false;false;true;false;false;false;false;false;false;false,17661/22402
mild dysfunction ( crcl > $nmbr$ - $nmbr$ ml / min  n = $nmbr$ [ $nmbr$ . $nmbr$ % ] ),C3274775;C1846718;C0439445,false;false;false,17662/22402
mild ed,C2945599;C3538926,false;false,17663/22402
mild ed severe ed,C2945599;C3538926;C0205082;C4050465;C4050466,false;false;false;false;false,17664/22402
mild impairment,C2945599;C0221099;C0684336,false;false;false,17665/22402
mild impairment ( £ $nmbr$ to,C2945599;C0221099;C0684336,false;false;false,17666/22402
mild impairment ( $nmbr$ to $nmbr$ ml / min ),C2945599;C0221099;C0439445;C0684336,false;false;false;false,17667/22402
mild impairment ( egfr $nmbr$ - $nmbr$ ml / min / m ^ ),C2945599;C0221099;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0684336,false;false;true;false;false;false;false;false;false,17668/22402
mild impairment ( egfr $nmbr$ – $nmbr$ )  n ( % ),C2945599;C0221099;C1739039;C3811844;C3812682;C0684336,false;false;true;false;false;false,17669/22402
mild impairment  < $nmbr$ to < $nmbr$,C2945599;C0221099;C0684336,false;false;false,17670/22402
mild or no dysfunction ( crcl > $nmbr$ ml / min  n = $nmbr$ $nmbr$  [ $nmbr$ . $nmbr$ % ] ),C2945599,false,17671/22402
mild reduction in egfr,C2945599;C0301630;C1739039;C3811844;C3812682;C0392756;C1293152;C4551656,false;false;true;false;false;false;false;false,17672/22402
mild to moderate renal impairment *,C1299392;C1565489,false;true,17673/22402
mild / moderate ( ipss < $nmbr$ ),C1299392;C1019118;C1998280;C2827405;C3811063,false;false;false;false;false,17674/22402
mildlydecreased baseline gfr ( $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C0168634;C0017654;C0439445;C0369637;C0441923;C1424601;C1442488,true;true;false;false;false;false;false,17675/22402
min - ’,C0702093;C1524029;C3813700,false;false;false,17676/22402
min - max,C0702093;C1524029;C3813700,false;false;false,17677/22402
min – max,C0702093;C1524029;C3813700,false;false;false,17678/22402
min per $nmbr$ . $nmbr$ m $nmbr$,C0702093;C0369637;C0441923;C1524029;C3813700,false;false;false;false;false,17679/22402
mineralcorticoid receptor antagonist,C4543207,false,17680/22402
mineralocorticoid receptor antagonist n ( % ),C1579268,true,17681/22402
mini - mental state examination  mean ( sd ) d,C0451306;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,17682/22402
minimum,C1524031;C1552614;C2826545,false;false;false,17683/22402
minimum — maxim um,C1524031;C0024968;C1552614;C2826545,false;true;false;false,17684/22402
minimum — maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,17685/22402
minimum  maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,17686/22402
minimum / maximum,C1524031;C0806909;C1552615;C2826546;C1552614;C2826545,false;false;false;false;false;false,17687/22402
minor bleed,C0026193;C0019080;C0205165,true;true;false,17688/22402
minor surgery,C0038904,true,17689/22402
minor / major,C0026193;C0205082;C0205164;C4318856;C4521762;C0205165,true;false;false;false;false;false,17690/22402
minority,C0026192,true,17691/22402
minutes from pre - pci angiography to post - pci angiography  median ( iqr ),C0439232;C0332152;C4049621;C0002978;C0740175;C2257086;C3669034;C0700321;C0702093;C1282918;C2347166,false;false;false;true;false;false;false;false;false;false;false,17692/22402
minutes from prehospital ecg to pci  median ( iqr ),C0439232;C1623258;C0700321;C0702093;C1282918;C2347166,false;true;false;false;false;false,17693/22402
minutes from symptom onset to prehospital ecg  median ( iqr ),C0439232;C4086878;C0700321;C0702093;C1282918;C2347166,false;false;false;false;false;false,17694/22402
missing ed duration ( y ),C1551393;C3538926;C0449238;C2926735;C1705492;C3272743,false;false;false;false;false;false,17695/22402
missing *,C1551393;C1705492;C3272743,false;false;false,17696/22402
missing  n ( % ) a,C1551393;C1705492;C3272743,false;false;false,17697/22402
mitral valve disease ( n = $nmbr$ $nmbr$ ),C0026265;C4553832,false;false,17698/22402
mitt population ( n = $nmbr$ ),C0032659;C1257890,true;true,17699/22402
mixed,C0205430;C3160715,false;false,17700/22402
mixed ( itt ) ( n = $nmbr$ ),C0205430;C3160715,false;false,17701/22402
mixed ( n = $nmbr$ ),C0205430;C3160715,false;false,17702/22402
mixed hispanic,C0205430;C0086409;C3160715,false;true;false,17703/22402
mmf ( n = $nmbr$ ),C0083765;C0209368;C3848524,true;true;true,17704/22402
mmol / l [ n ],C1532563,false,17705/22402
mmol / l ),C1532563,false,17706/22402
mmp - $nmbr$  median ( iqr )  gg / l,C0623362;C0549183;C0017454;C0018370;C0876920;C2347635;C2348144;C2939193;C0919336,true;false;true;true;false;false;false;false;false,17707/22402
mmrc dyspnea scale score : t : t,C3826977;C0013404;C4049715;C1963100,false;true;false;false,17708/22402
mmrm estimates  ls mean ( se )  [ $nmbr$ % ci ],,,17709/22402
mmse = mini - mental state examination  adas — cog = alzhei -,C0451306;C3539026,true;false,17710/22402
mn - na ï ve population,C0026327;C0597484;C0042469;C0032659;C1257890;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882;C0026405;C4285072,true;false;true;true;true;false;false;false;false;false;false;false;true;false,17711/22402
mn population,C0026327;C0032659;C1257890;C0026405;C4285072,true;true;true;true;false,17712/22402
mn population  n,C0026327;C0032659;C1257890;C0026405;C4285072,true;true;true;true;false,17713/22402
mnapsi,,,17714/22402
mnapsi  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,17715/22402
mnapsi  mean [ sd ] d,C0444504;C2699239;C2347634;C2348143,false;false;false;false,17716/22402
mod / sev exacerbation rate,C0011860;C0439793;C4086268;C0871208;C1521828;C0458216;C2983285,true;false;false;false;false;false;false,17717/22402
mod / sev exacerbation rates,C0011860;C0439793;C4086268;C0871208;C1521828;C0458216;C2983285,true;false;false;false;false;false;false,17718/22402
model  n,C3161035;C3274659;C3714583;C3853906,false;false;false;false,17719/22402
model $nmbr$,C3161035;C3274659;C3714583;C3853906,false;false;false;false,17720/22402
model $nmbr$ +,C3161035;C3274659;C3714583;C3853906,false;false;false;false,17721/22402
model $nmbr$ t,C3161035;C3274659;C3714583;C3853906,false;false;false;false,17722/22402
model $nmbr$ §,C3161035;C3274659;C3714583;C3853906,false;false;false;false,17723/22402
moderate - intensity statin,C4081855;C0360714,false;true,17724/22402
moderate - intensity statin use,C4081855;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,17725/22402
moderate - to -,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17726/22402
moderate - to - severe copd exacerbation,C1299393;C0740304,false;false,17727/22402
moderate severe ( n = $nmbr$ ) ( n = $nmbr$ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17728/22402
moderate ( > $nmbr$ and < $nmbr$ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17729/22402
moderate ( > $nmbr$ % . < $nmbr$ % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17730/22402
moderate ( $nmbr$ % . < $nmbr$ % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17731/22402
moderate ( $nmbr$ – $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % ),C0205081;C0439445;C0369637;C0441923;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false,17732/22402
moderate ( $nmbr$ % < fev  < $nmbr$ % predicted ),C0205081;C3714541;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,17733/22402
moderate ( $nmbr$ - $nmbr$ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17734/22402
moderate ( $nmbr$ < ipss < $nmbr$ ),C0205081;C1019118;C1998280;C2827405;C3811063;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false;false,17735/22402
moderate ( iief - ef $nmbr$ - $nmbr$ ),C0205081;C3641331;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false,17736/22402
moderate ( iief - ef $nmbr$ - $nmbr$ )  n ( % ),C0205081;C3641331;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false,17737/22402
moderate ( ipss < $nmbr$ ) ( n = $nmbr$ ),C0205081;C1019118;C1998280;C2827405;C3811063;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false;false,17738/22402
moderate ( n = $nmbr$ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17739/22402
moderate ( n $nmbr$ = $nmbr$ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17740/22402
moderate ( s $nmbr$ % . < $nmbr$ % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17741/22402
moderate chronic kidney disease,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17742/22402
moderate copd,C0205081;C0024117;C1412502;C3714496;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false;false,17743/22402
moderate cord * : qva $nmbr$ - sfc,C0205081;C1550235;C4521536;C1706500;C3489532;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;true;false;false;false;false;false,17744/22402
moderate decrease ( $nmbr$ - < $nmbr$ mlymin per $nmbr$ . $nmbr$ m $nmbr$ ),C0205081;C0392756;C0369637;C0441923;C0547047;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false;false,17745/22402
moderate disease,C0205081;C0012634;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false,17746/22402
moderate dysfunction ( crcl $nmbr$ - $nmbr$ ml / min  n = $nmbr$ [ $nmbr$ . $nmbr$ % ] ),C3274776;C1846718;C0439445,false;false;false,17747/22402
moderate impairment,C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false,17748/22402
moderate impairment ( $nmbr$ to $nmbr$ ml / min ),C0205081;C0221099;C0439445;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false;false,17749/22402
moderate impairment ( egfr $nmbr$ - $nmbr$ ml / min / m ^ ),C0205081;C0221099;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;false;false;false;false;false;false;false;false;false;false;false,17750/22402
moderate impairment ( egfr $nmbr$ – $nmbr$ )  n ( % ),C0205081;C0221099;C1739039;C3811844;C3812682;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;true;false;false;false;false;false;false;false;false,17751/22402
moderate impairment  < $nmbr$ to < $nmbr$,C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false,17752/22402
moderate or severe decrease in gfr ( < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17753/22402
moderate or severe decrease in gfr { < $nmbr$ ml / mln per $nmbr$ . $nmbr$ m ^ ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17754/22402
moderate or severe impairment,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17755/22402
moderate or severe renal disease  n ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17756/22402
moderate or severe renal disease  b   n ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17757/22402
moderate renal impairment  n ( % ) *,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17758/22402
moderate risk ( > $nmbr$ - $nmbr$ ),C0205081;C0035647;C4552904;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,17759/22402
moderate severity,C0205081;C0439793;C0522510;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false;false;false,17760/22402
moderate trs : $nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ ),C0205081;C0266427;C0968917;C1150746;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;true;false;false;false;false;false;false,17761/22402
moderate  gold $nmbr$,C0205081;C0018026;C1304897;C1881878;C4049705;C4049706;C4085643;C4321335,false;true;false;false;false;false;false;false,17762/22402
moderate / low,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17763/22402
moderate / severe exacerbation,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17764/22402
moderate / severe exacerbations  patient subgroups  n ( % ),C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17765/22402
moderate / severe reduction in egfr,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,17766/22402
moderatex,,,17767/22402
moderatez,,,17768/22402
modi fied la grade *,C0342276;C0023031;C0441800;C0919553;C3244287;C0023749;C0230347;C2346906;C4553351,true;true;false;false;false;true;false;false;false,17769/22402
modified hachinski ischemia scale  mean ( sd ) c,C0392747;C0022116;C0175659;C0444504;C2699239;C2347634;C2348143;C0349674;C1947916;C4321499;C3889737,false;true;true;false;false;false;false;false;false;false;false,17770/22402
modified has - bled > $nmbr$,C0392747;C3889737,false;false,17771/22402
modified has - bled score  mean ± sd,C0392747;C3889737,false;false,17772/22402
modified total sharp score,C0392747;C2964552;C1444775;C1539835;C3890003;C3889737,false;false;false;false;false;false,17773/22402
monoamine oxidase b inhibitors,C2917290;C3653412,false;false,17774/22402
monotherapy $nmbr$,,,17775/22402
monteiukast,,,17776/22402
monteiukast ( n = $nmbr$ ),,,17777/22402
monteiukast vs placebo,,,17778/22402
month $nmbr$ subgroup x treatment interaction p - value,C0332177;C1079230;C0039798;C1704675;C1709380;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1515021;C0439231,false;false;true;false;false;true;false;false;false;false;false;false;false,17779/22402
months from qualifying stroke *   ( % ),C0439231;C1514624;C0038454;C4554100,false;false;true;false,17780/22402
morning,C0332170,false,17781/22402
morning peak expiratory flow — liters / min,C0332170;C1518922;C0475211;C0702093;C1524029;C3813700,false;false;false;false;false;false,17782/22402
morning stiffness duration  min,C0457086;C0449238;C0702093;C1524029;C3813700;C2926735,false;false;false;false;false;false,17783/22402
morning stiffness severity  $nmbr$ - $nmbr$ scale,C0457086;C0439793;C0175659;C0349674;C1947916;C0522510,false;false;true;false;false;false,17784/22402
morphometric vertebral,C0200760;C0549207,false;true,17785/22402
mortality,C0026565;C0026566,true;true,17786/22402
mortality outcomes,C0026565;C1274040;C0026566,true;false;true,17787/22402
most common aes in any group,C0205393;C0205214;C1412268;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2699274;C1522138;C3245511,false;false;false;false;false;true;false;false;false;false;false;false,17788/22402
most common aes ‡,C0205393;C0205214;C1412268;C2699274;C1522138;C3245511,false;false;false;false;false;false,17789/22402
most frequent aesa,C0205393;C0332183,false;false,17790/22402
most frequent gi disorders,C0205393;C0332183;C1708130;C0012634;C3539617;C4050121,false;false;false;true;false;false,17791/22402
most frequent infections,C0205393;C0239998,false;false,17792/22402
most frequent non - infectious teaesb,C0205393;C0239998;C1518422,false;false;false,17793/22402
most frequent serious teaes,C0205393;C0332183;C0205404,false;false;false,17794/22402
mostly dissatisfied,C0205393;C0750554,false;false,17795/22402
mostly satisfied,C0205393;C0750554,false;false,17796/22402
motor updrs subscore ( baseline )  mean ( sd ),C1513492;C3639721;C0168634;C0444504;C2699239;C2347634;C2348143;C1442488;C1705994,false;true;true;false;false;false;false;false;false,17797/22402
mouth ulceration,C0149745,true,17798/22402
mra regimen ( n - $nmbr$ ),C0243032;C0040808;C2945654;C1609165;C3891069,true;true;false;true;false,17799/22402
mra use,C0243032;C1609165;C3891069,true;true;false,17800/22402
mras,C1335594;C1367476,true;false,17801/22402
mrf,C0312443;C1412879,false;false,17802/22402
ms < $nmbr$  n [ % ],C2349943;C3539704;C3713294,false;false;true,17803/22402
ms $nmbr$ - $nmbr$  n [ % ],C2349943;C3539704;C3713294,false;false;true,17804/22402
ms  mean [ sd ],C2349943;C0444504;C2699239;C2347634;C2348143;C3539704;C3713294,false;false;false;false;false;false;true,17805/22402
msdbp ( mm hg ),C0439475,false,17806/22402
msdbp ± sd  mmhg,C2699239;C0439475,false;false,17807/22402
msfc timed $nmbr$ - foot walk test .,,,17808/22402
mssbp ( mm hg ),C0439475,false,17809/22402
mssbp ± sd  mmhg,C2699239;C0439475,false;false,17810/22402
mtss at,,,17811/22402
mtss at baseline observed case,C0168634;C1442488,true;false,17812/22402
mtss  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,17813/22402
mtx - ir,C0025677;C0022065;C0022071;C1448132;C1417487,true;true;true;true;false,17814/22402
mtx ( n ),C0025677;C1417487,true;false,17815/22402
mtx + other csdmards,C0025677;C1417487,true;false,17816/22402
mtx + other csomards,C0025677;C1417487,true;false,17817/22402
mtx + othetcsdmards,C0025677;C1417487,true;false,17818/22402
mtx < $nmbr$ mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,17819/22402
mtx ≤ $nmbr$ mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,17820/22402
mtx ≥ $nmbr$ mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,17821/22402
mtx > $nmbr$ – $nmbr$ mg / week,C0025677;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;true;false;false;true;false;false;false;false;false;false,17822/22402
mtx > $nmbr$ and si $nmbr$ mg / week,C0025677;C1417487,true;false,17823/22402
mtx at baseline,C0025677;C0168634;C1442488;C1417487,true;true;false;false,17824/22402
mtx at baseline  n ( % ),C0025677;C0168634;C1442488;C1417487,true;true;false;false,17825/22402
mtx average weekly dose  mg / week  mean ( sd ),C0366550;C1510992;C0332174;C0024671;C0444504;C2699239;C2347634;C2348143;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2825518,false;false;false;true;false;false;false;false;false;true;false;false;false;false;false;false,17826/22402
mtx dose > $nmbr$ mg / week  %,C0366550;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;false;false;true;false;false;false;false;false,17827/22402
mtx ir,C0025677;C0022065;C0022071;C1448132;C1417487,true;true;true;true;false,17828/22402
mtx naive or free,C0025677;C1417487,true;false,17829/22402
mtx only,C0025677;C0205171;C1720467;C1417487,true;false;false;false,17830/22402
mtx plus infliximab,C0025677;C0332287;C0666743;C1417487,true;false;true;false,17831/22402
mtx plus placebo,C0025677;C0332287;C0032042;C1696465;C1706408;C1417487,true;false;true;false;false;false,17832/22402
mtx sio mg / week,C0025677;C1039355;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1417487,true;false;true;false;false;true;false;false;false;false;false;false,17833/22402
mtx use at baseline,C0025677;C0042153;C0168634;C1442488;C0457083;C1947944;C1417487,true;true;true;false;false;false;false,17834/22402
mtx use at randomization  n ( % ),C0025677;C0042153;C0034656;C0457083;C1947944;C1417487,true;true;true;false;false;false,17835/22402
mucosal healingc n / n ( % ),C0026724,true,17836/22402
mucosal healingf,C0026724,true,17837/22402
multiple risk factors,C0439064;C0035648;C1553898,false;true;false,17838/22402
multiracial or other,C1881928,false,17839/22402
multivariable,,,17840/22402
multivariable adjusted hr ( $nmbr$ % ci ),C0456081;C0008107;C3259781,false;true;false,17841/22402
multivariable adjusted model hr ( $nmbr$ % ci ),C0456081;C3161035;C0008107;C3259781;C3274659;C3714583;C3853906,false;false;true;false;false;false;false,17842/22402
multivariable or ( $nmbr$ % ci )  p value *,,,17843/22402
multivariate logistic modelb,C0242415,true,17844/22402
multivessel coronary - artery bypass grafting,C0010055,true,17845/22402
multivessel disease — no . ( % ),C0012634,true,17846/22402
multivessel disease  no . ( % ),C0012634,true,17847/22402
multivitamin use yes,C0301532;C0042153;C1549445;C1705108;C1710701;C0457083;C1947944,false;true;false;false;false;false;false,17848/22402
multivitamins,C0301532;C3714835,false;false,17849/22402
mycophenolate ( any derivative ),C0883242,false,17850/22402
myocardiai infarction,C0021308,true,17851/22402
myocardial infarction ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,17852/22402
myocardial infarction before index acs — no . ( % ),C0027051;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C0428953;C2926063;C3810814;C4552959,true;true;true;false;true;false;false;false;false;false;false;false,17853/22402
myocardial infarction n ( % ),C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,17854/22402
myocardial infarction / cabg / pci,C0027051;C0010055;C4049621;C0428953;C2926063;C3810814;C4552959,true;true;false;false;false;false;false,17855/22402
myocardial infarction :,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,17856/22402
myocardial infarction §,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,17857/22402
myoclonic,,,17858/22402
n - $nmbr$ allocation,C0369718;C1706778;C0441922,false;false;false,17859/22402
n - $nmbr$ fatty acids,C0369718;C0015684;C0441922,false;true;false,17860/22402
n - $nmbr$ fatty acids slope lsm ± se ( mm / year ),C0369718;C0015684;C0441922,false;true;false,17861/22402
n - $nmbr$ fatty acit,C0369718;C0441922,false;false,17862/22402
n - terminal pro - bnp — pg / ml §,C0669479;C0439297,true;false,17863/22402
n ( % of patients ),C0369718;C0030705;C0441922,false;true;false,17864/22402
n ( % ) blood pressure - mean ( sd ) mm hg,C0369718;C0428886;C2699239;C0439475;C0441922,false;true;false;false;false,17865/22402
n ( % ) liraglutide $nmbr$ placebo,C0369718;C1456408;C0032042;C1696465;C1706408;C0441922,false;true;true;false;false;false,17866/22402
n ( % ) patients with risk faetors for cv disease aged > $nmbr$,C0369718;C0030705;C0035647;C4552904;C0441922,false;true;true;false;false,17867/22402
n ( % ) responders,C0369718;C0441922,false;false,17868/22402
n ( % ) unless otherwise specified,C0369718;C0441922,false;false,17869/22402
n ( iqr ),C0369718;C0441922,false;false,17870/22402
n ( lesions ),C0369718;C0441922,false;false,17871/22402
n ( stented lesions ),C0369718;C0441922,false;false,17872/22402
n = $nmbr$ t,C0369718;C0441922,false;false,17873/22402
n america,C0369718;C0002454;C0441922,false;true;false,17874/22402
n events ( % ),C0369718;C0441471;C3541888;C0441922,false;false;false;false,17875/22402
n events / n subjects,C0369718;C0441471;C3541888;C0441922,false;false;false;false,17876/22402
n events / n at risk,C0369718;C0441471;C3541888;C0441922,false;false;false;false,17877/22402
n nt,C0369718;C0332126;C1449832;C3889152;C4050156;C4283901;C4284038;C0441922,false;false;true;false;false;false;false;false,17878/22402
n observed,C0369718;C0441922,false;false,17879/22402
n participants,C0369718;C0679646;C0441922,false;false;false,17880/22402
n t % ),C0369718;C0441922,false;false,17881/22402
n . a .,C1272460,false,17882/22402
n / a,C1272460,false,17883/22402
n / n   ( % ),C0369718;C0441922,false;false,17884/22402
n / n ( % / yr ),C0369718;C0439234;C0441922,false;false;false,17885/22402
n / r,C0369718;C0205090;C0684010;C2603358;C0441922,false;false;true;false;false,17886/22402
n + v ( n = $nmbr$ ),C0369718;C0441922,false;false,17887/22402
n = $nmbr$ lesions,C0369718;C0441922,false;false,17888/22402
na,C0597484;C1272460;C1546968;C1879645;C4049872;C4552882,false;false;false;false;false;false,17889/22402
nail involvement  %,C0027342;C1314939;C1432728;C3538766,true;false;true;false,17890/22402
naire can range from $nmbr$ to $nmbr$ for the alternative disability portion and from $nmbr$ to $nmbr$ for the pain portion . scores for the medical outcomes,C0040363;C0041260;C1883351;C0199168;C1274040;C0205476,true;true;false;false;false;false,17891/22402
naive,,,17892/22402
naive ( no treatment for current flare ),,,17893/22402
nap,C0870935;C1423800;C4283878,false;false;false,17894/22402
naproxen,C0027396,true,17895/22402
napsi score ( $nmbr$ - $nmbr$ ) of target fingernail,,,17896/22402
napsit,,,17897/22402
nasal polyposis or chronic rhinosinusitis — no . { % ),C0027430,true,17898/22402
nasal polyps at baseline : yes,C0027430;C0168634;C1549445;C1705108;C1710701;C1442488,true;true;false;false;false;false,17899/22402
nasal polyps  n ( % ),C0027430,true,17900/22402
nateglinide ( n = $nmbr$ ),C0903898,true,17901/22402
nateglinide and repaglinide,C0903898,true,17902/22402
nateglinide n / n,C0903898,true,17903/22402
native american or alaska native,C0282204;C1515945,true;false,17904/22402
native american or alaskan native,C0282204;C1515945,true;false,17905/22402
native hawaiian or,C0337920,true,17906/22402
native hawaiian or other pacific,C0337920,true,17907/22402
native hawaiian / pacific islander,C0337920;C0242191,true;true,17908/22402
nausea and / or vomiting adverse events,C0027497;C1963179;C2984057;C3829611;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767,true;false;false;false;false;false;false;false;false;false;false;false,17909/22402
nbp,,,17910/22402
nc,C0027964;C0028407;C0067895;C0265987,true;true;true;false,17911/22402
nc group ( n = $nmbr$ ),C0027964;C0441848;C0028407;C0067895;C0265987,true;false;true;true;false,17912/22402
ncep atp - iii metabolic syndrome features  n ( % ),C2744579;C0439070;C0524620;C1705160;C4552600,true;false;true;false;false,17913/22402
nct $nmbr$,,,17914/22402
nd,,,17915/22402
nd not due to swelling or ich,,,17916/22402
ne,C0027608;C0028219;C3538705,true;true;false,17917/22402
nebivolol ( n = $nmbr$ ),C0068475,true,17918/22402
necessitating hospitalization in previous year — no . ( % ),C0019993;C0205156;C0439234;C0439508;C1552607,true;false;false;false;false,17919/22402
necrosis  n ( % ) a,C0027540;C1334928,true;false,17920/22402
necrotic core,C0027540;C0444669;C1167518;C1706352;C1882467;C3274653,true;false;false;false;false;false,17921/22402
necrotic core  mm ^,C0027540;C0444669;C4330985;C4554674;C1167518;C1706352;C1882467;C3274653,true;false;false;false;false;false;false;false,17922/22402
need for $nmbr$ ng edoxaban dose at,C0027552;C0017887;C2975435;C0178602;C0869039;C1114758;C0028074;C0686904,true;true;true;false;false;false;true;false,17923/22402
negative ctnl ( n = $nmbr$  $nmbr$ ),C0205160;C1513916;C2825415;C2825491;C3853545,false;false;false;false;false,17924/22402
neither cs nor imm,C0010182;C0271160;C3540510;C4085345,true;false;false;false,17925/22402
neither deep - vein thrombosis nor pulmonary embolism ^,C0149871,true,17926/22402
neither deep - vein thrombosis nor pulmonary embolism §,C0149871,true,17927/22402
neither pe nor dvt,C0070939;C1880476;C4284304,true;false;false,17928/22402
neither unfractionated heparin nor low - molecular - weight heparin,C0019134;C2825026,true;false,17929/22402
neohrodathv . and all - cause mortalitv,,,17930/22402
nerd,,,17931/22402
nesiritide ( n = $nmbr$ ),C0054015,true,17932/22402
nesiritide  % z,C0054015,true,17933/22402
net clinical benefit *,C1456447;C4684590;C3853572;C3887809;C3890893,true;false;false;false;false,17934/22402
net clinical benefit : cv death  mi  stroke  gusto moderate / severe bleeding,C1456447;C4684590;C3538987;C0011065;C3810814;C0038454;C4554100;C1306577;C4082313;C4552775;C4048877;C4318503;C3853572;C3887809;C3890893,true;false;false;true;false;true;false;false;false;false;true;false;false;false;false,17935/22402
net clinical benefit : on - treatment vte or major bleeding,C1456447;C1516635;C0814225;C0630906;C4684590;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3853572;C3887809;C3890893,true;false;false;true;false;true;true;false;false;false;false;false;false;false;false,17936/22402
net composite,C1456447;C0205199;C1547335;C3853572;C3887809;C3890893,true;false;false;false;false;false,17937/22402
net ep $nmbr$,C1456447;C1880476;C4321526;C3853572;C3887809;C3890893,true;false;false;false;false;false,17938/22402
network,C0150775;C1513822;C1705739;C1882071,true;false;false;false,17939/22402
neuraxial alonee,C3714787,true,17940/22402
neuraxial anaesthesia,C3714787;C0002903;C0002912;C0002930;C4049933,true;true;true;true;false,17941/22402
neurocognitive disorders,C0029227;C4041080,true;true,17942/22402
neurologicai events,C0441471;C3541888,false;false,17943/22402
neuropathy — no . ( % ),C0442874,false,17944/22402
neutropenia,C0023530;C0027947;C0853697,true;true;false,17945/22402
never been on a vka,C2003901,false,17946/22402
never drink,C2003901,false,17947/22402
never nsaid,C2003901;C0003211;C3536840,false;true;false,17948/22402
never or past,C2003901,false,17949/22402
never smoked — no . ( % ),C2003901,false,17950/22402
never took alendronate,C2003901,false,17951/22402
new - onset atrial fibrillation,C0741281,false,17952/22402
new - onset diabetes,C0746890;C0011847;C0011849,false;false;true,17953/22402
new - onset diabetes §,C0746890;C0011847;C0011849,false;false;true,17954/22402
new diabetes,C0205314;C0011847;C0011849,false;false;true,17955/22402
new hf medication,C0205314;C0018488;C0013227;C3244316;C4284232;C1313497;C1538440;C3273279,false;true;true;false;false;true;false;false,17956/22402
new or worsenina neohrodathv,C0205314,false,17957/22402
new or worsentna neohrodathv,C0205314,false,17958/22402
new use of gpa,C0205314;C1524063;C3495801;C4553145,false;false;true;false,17959/22402
new york heart association class,C1882083,false,17960/22402
newly diagnosed asthma ( n ),C0750546;C0011900;C0004096;C2984299,false;true;true;false,17961/22402
nfs < - $nmbr$ . $nmbr$ ( low ),C1555018,false,17962/22402
nfs > $nmbr$ . $nmbr$ ( high ),C1555018,false,17963/22402
niacin ( n = $nmbr$ ),C0027996;C1142562,true;false,17964/22402
niacin  n ( % ),C0027996;C1142562,true;false,17965/22402
niacin + statin,C0027996;C0360714;C1142562,true;true;false,17966/22402
nice classification of copd severity of obstruction  n ( % ) [ $nmbr$ ],C4087029;C0008902;C0024117;C0439793;C0028778;C1882136;C0522510;C1412502;C3714496;C0008903;C0678229,false;true;true;false;false;false;false;false;false;true;false,17967/22402
night - time awakenings in past $nmbr$ weeks ( sd ) *,C0860510;C2987125;C2699239,false;false;false,17968/22402
night - time awakenings in past $nmbr$ weeks prior to baseline,C0860510;C2987125,false;false,17969/22402
nighttime mean dbp ( abpm ) at week $nmbr$  mmhg,C0240526;C0444504;C0536221;C0332174;C0439475;C0439230;C3813197;C4281799;C2347634;C2348143,false;false;true;false;false;false;false;false;false;false,17970/22402
nighttime mean sbp ( abpm ) at week $nmbr$  mmhg,C0240526;C0444504;C0085805;C0332174;C0439475;C0439230;C2347634;C2348143,false;false;true;false;false;false;false;false,17971/22402
nih stroke scale,C1697238;C3484372,false;false,17972/22402
nihss score,C1697238,false,17973/22402
nilvadipine,C0132512,true,17974/22402
nintedanib ( n   =   $nmbr$ ),C2930789,true,17975/22402
nintedanib ( n = $nmbr$ ),C2930789,true,17976/22402
nitrate ( oral or intravenous ),C0028125;C0699857;C3848573,true;false;false,17977/22402
nitrate ( oral or topical ),C0028125;C0699857;C3848573,true;false;false,17978/22402
nitrates ( % ),C0028125;C0699857;C3848573,true;false;false,17979/22402
nitratesf,,,17980/22402
nkf stage,,,17981/22402
no - ckd intensive ( n = $nmbr$ ),C1561643;C0162425;C0522510;C1283828;C1550453,true;true;false;false;false,17982/22402
no - ckd standard ( n = $nmbr$ ),C1561643;C1442989;C2828392,true;false;false,17983/22402
no $nmbr$  $nmbr$,,,17984/22402
no ( $nmbr$ . $nmbr$ ),,,17985/22402
no ( reference ),C1514811;C1706462,false;false,17986/22402
no ace inhibitor / arb,C0003015;C3888198;C4541021,true;false;false,17987/22402
no active cancer center - level inr percent time,C0205177;C1513817;C0441889;C0525032;C0439165;C0040223;C3541383;C1704538;C0456079;C1547707;C2946261;C3853793;C3888249,false;false;false;true;false;true;false;false;false;false;false;false;false,17988/22402
no alcohol consumption  on average,C0001948;C1510992;C2825518,true;false;false,17989/22402
no amiodarone,C0002598,true,17990/22402
no antihypertensive medication,C0003364,true,17991/22402
no apparent heart disease,C0750489;C0018799,false;true,17992/22402
no asa,C0004057;C3853627,true;false,17993/22402
no aspirin at baseline,C0004057;C0168634;C1442488,true;true;false,17994/22402
no atopy ( n = $nmbr$ ),C0392707;C3539705,false;false,17995/22402
no atrial fibrillation,C0004238;C0344434;C1963067,true;false;false,17996/22402
no baseline characteristics,C4684572,false,17997/22402
no baseline immunosuppressant use,C0168634;C0021081;C0042153;C0457083;C1947944;C1442488,true;true;true;false;false;false,17998/22402
no body weight at randomization ( ixrs ),C0005910;C0034656;C1305866;C0242821;C2985844;C0460148;C1268086;C4082212,true;true;false;true;false;false;false;false,17999/22402
no cad / mi,C1504769;C3810814;C2239547;C3813548;C4284121,true;false;false;false;false,18000/22402
no cardiovascular disease ( n = $nmbr$ ),C0007222,true,18001/22402
no cardiovascular disorder $nmbr$ ',C0007222,true,18002/22402
no cases,C0868928;C1533148,false;false,18003/22402
no chd at baseline,C0280604;C0168634;C1442488;C3542407,false;true;false;false,18004/22402
no chd eze / simva ( n = $nmbr$ ),C0280604;C3542407,false;false,18005/22402
no chd simva ( „ = $nmbr$ ),C0280604;C3542407,false;false,18006/22402
no ckd,C1561643,true,18007/22402
no ckd ( % ),C1561643,true,18008/22402
no ckd n,C1561643,true,18009/22402
no ckd rate ( # events ),C1561643;C0871208;C0441471;C3541888;C1521828,true;false;false;false;false,18010/22402
no colchicine ( n = $nmbr$ ),C0009262,true,18011/22402
no concomitant antiplatelet,C0521115,false,18012/22402
no cs and imm,C0010182;C0271160;C3540510;C4085345,true;false;false;false,18013/22402
no cs and is,C0010182;C0271160;C3540510;C4085345,true;false;false;false,18014/22402
no culprit vessel identified,C0005847,true,18015/22402
no cv event ( n = $nmbr$  $nmbr$ ),C3538987;C0441471;C4019010;C4048877;C4318503,false;false;false;true;false,18016/22402
no cvd,C0007222,true,18017/22402
no diabetes ( n = $nmbr$  $nmbr$ ),C0011847;C0011849,false;true,18018/22402
no diabetes ( p = . $nmbr$ ),C0011847;C0011849,false;true,18019/22402
no diabetes ( p = . o $nmbr$ ),C0011847;C0011849,false;true,18020/22402
no digoxin n = $nmbr$ $nmbr$ ( $nmbr$ % ),C0012265,true,18021/22402
no digoxin scd  no . ( % / y ),C0012265,true,18022/22402
no diuretic therapy,C0948575,false,18023/22402
no dm,C0011816;C3250443,true;false,18024/22402
no dm ( n = $nmbr$  $nmbr$ ),C0011816;C3250443,true;false,18025/22402
no draining fistulas *,C0544791,false,18026/22402
no dysglycaemia or mets pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ ),C1960636,false,18027/22402
no dyspnoea ( n = $nmbr$ ),C0013404;C1963100,true;false,18028/22402
no ef data | |,C1511726;C3245479;C3714741,false;false;false,18029/22402
no estrogen,C0014939;C2936882;C4542544,true;false;false,18030/22402
no gi bleed,C1708130;C3539617;C4050121,false;false;false,18031/22402
no glucocorticoids at baseline,C0017710;C0168634;C1442488;C3540777;C3540778,true;true;false;false;false,18032/22402
no glucose lowering drugs,C0017725;C0441994;C0013227;C3687832;C2003888,true;false;true;false;false,18033/22402
no heart failure,C0018801;C0018802;C4554158,true;true;false,18034/22402
no history of bowel resections,C0019664;C0741614;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,18035/22402
no history of extra - intestinal manifestations of ibd ( ref ),C0019664;C1883702;C0021853;C1280464;C1425988;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;true;false;false;false;false,18036/22402
no history of heart failure at baseline,C0455531,false,18037/22402
no history of hf,C0019664;C0018488;C1313497;C1538440;C3273279;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;true;false;false;true;false;false;false;false,18038/22402
no history of tnf antagonist treatment — no . ( % ),C0019664;C1448177;C0231491;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;true;false;false;false;false;false;true;false;false;false;false,18039/22402
no hospitalization in the past $nmbr$ months prior to baseline ( ref ),C0019993;C4331910,true;false,18040/22402
no hx of hf ( n = $nmbr$ ),C0262926;C0018488;C1313497;C1538440;C3273279;C3814444,false;true;true;false;false;false,18041/22402
no ics,C0815320;C4551720,false;true,18042/22402
no immunosuppressive agents at baseline,C0021081;C0168634;C1442488,true;true;false,18043/22402
no in - trial stroke n = $nmbr$  $nmbr$,C0150312;C0008976;C0038454;C4554100;C0332285;C1707101,false;true;true;false;false;false,18044/22402
no incident dm or change in fg > $nmbr$,C1551358;C0011816;C3250443,false;true;false,18045/22402
no increased risk for falls,C4699158;C0000921;C0085639;C1849142;C0035647;C4552904,false;true;false;false;true;false,18046/22402
no inducer at core study entry,C3898767;C0444669;C0557651;C1705654;C2603343;C1167518;C1706352;C1882467;C3274653,false;false;false;false;false;false;false;false;false,18047/22402
no infarct visible,C0021308,true,18048/22402
no laba  no ics  n ( % ),,,18049/22402
no laba  no ics ( tiotropium n = $nmbr$  placebo n = $nmbr$ ),,,18050/22402
no longer met study criteria,C0205166;C0428210;C0557651;C0243161;C2603343;C1550543;C4317104;C1706317,false;false;false;true;false;false;false;false,18051/22402
no metabolic syndrome,C0524620,true,18052/22402
no methotrexate  hydroxychloroquine  or sulfasalazine treatment,C0025677;C0020336,true;true,18053/22402
no mtx at baseline,C0025677;C0168634;C1442488;C1417487,true;true;false;false,18054/22402
no mtx use at baseline,C0025677;C0042153;C0168634;C1442488;C0457083;C1947944;C1417487,true;true;true;false;false;false;false,18055/22402
no nasal polyps,C0027430,true,18056/22402
no new a or and no more than $nmbr$ new bilag b domain score  %,C0205314,false,18057/22402
no new erosions among patients with ≥ $nmbr$ uninvolved joint at baseline ¶,C0205314;C0333307;C0030705;C1959609,false;false;true;false,18058/22402
no new jsn among patients with ≥ $nmbr$ uninvolved joint at baseline ¶,C0205314;C0030705,false;true,18059/22402
no nonsevere hypoglycemia,C0020615;C4553659,true;false,18060/22402
no oam,,,18061/22402
no ocs,,,18062/22402
no ocs use  no nasal polyps  pre - bd fvc s $nmbr$ % of predicted and age at diagnosis < $nmbr$ years,,,18063/22402
no of events / total n ( % ),C0441471;C0439175;C0439810;C3541888,false;false;false;false,18064/22402
no op  no vfx,,,18065/22402
no op  vfx,,,18066/22402
no oral antidiabetic medication,C0175795;C0935929;C0442027;C4521986,false;true;false;false,18067/22402
no p value for ischemia ischemia hr ( $nmbr$ % ci ) interaction,C1709380;C0022116;C0008107;C1704675;C3259781;C4321499,false;true;true;false;false;false,18068/22402
no pah - specific therapy,C0030123;C0205369;C0039798;C0087111;C1363945;C1552740;C3203102;C4284467,true;false;true;true;false;false;true;false,18069/22402
no polyvascular disease ( n = $nmbr$ $nmbr$ ),C0012634,true,18070/22402
no polyvascular disease * ( n = $nmbr$ $nmbr$ ),C0012634,true,18071/22402
no ppi,C0358591;C0871125;C3811894,true;true;false,18072/22402
no pretreatment,C1550147;C2709094;C3539075;C3539076,false;false;false;false,18073/22402
no previous cd related surgery $nmbr$,C0205156;C0007928;C0034283;C4552032;C1552607,false;true;true;false;false,18074/22402
no previous copd medication,C0205156;C0024117;C0013227;C3244316;C4284232;C1412502;C3714496;C1552607,false;true;true;false;false;false;false;false,18075/22402
no previous diagnosis of diabetes mellitus,C0332132;C0011849,false;true,18076/22402
no previous ischemic stroke / tia ( n = $nmbr$ $nmbr$  $nmbr$ . $nmbr$ % ),C0205156;C0948008;C0007787;C0917805;C1054154;C1552607,false;false;true;true;false;false,18077/22402
no previous myocardial infarction $nmbr$ / $nmbr$,C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,18078/22402
no previous stroke or tia ( n = $nmbr$ ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,18079/22402
no previous stroke ortia,C0205156;C0038454;C4554100;C1552607,false;true;false;false,18080/22402
no previous stroke / tia,C0205156;C0038454;C0007787;C0917805;C1054154;C4554100;C1552607,false;true;true;true;false;false;false,18081/22402
no previous treatment with infliximab,C0205156;C0039798;C0666743;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,18082/22402
no prior admc,C0332152;C2826257,false;false,18083/22402
no prior angina ( n = $nmbr$  $nmbr$ ),C0332152;C0002962;C2826257,false;true;false,18084/22402
no prior cvd,C0332152;C0007222;C2826257,false;true;false,18085/22402
no prior dm,C0332152;C0011816;C3250443;C2826257,false;true;false;false,18086/22402
no prior hf ( n = $nmbr$  $nmbr$ ),C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,18087/22402
no prior hf hospitalization ( n   = $nmbr$  $nmbr$ ),C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,18088/22402
no prior hf n = $nmbr$,C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,18089/22402
no prior htn ( n = $nmbr$  $nmbr$ ),C0332152;C0020538;C2826257,false;true;false,18090/22402
no prior mi ( n = $nmbr$  $nmbr$ ),C0332152;C3810814;C2826257,false;false;false,18091/22402
no prior mi n = $nmbr$,C0332152;C3810814;C2826257,false;false;false,18092/22402
no prior oma use,C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,18093/22402
no prior oma use ( n = $nmbr$ ),C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,18094/22402
no prior revascularization ( n = $nmbr$  $nmbr$ ),C0332152;C0581603;C2826257,false;false;false,18095/22402
no prior stroke ( n = $nmbr$ ),C0332152;C0038454;C4554100;C2826257,false;true;false;false,18096/22402
no prior tnf inhibitor exposure,C0332152;C1448177;C1999216;C0274281;C0332157;C2826257,false;true;false;false;false;false,18097/22402
no reperfusion,C0035124;C0684253,true;false,18098/22402
no resistant htn n = $nmbr$  $nmbr$,C0332325;C0020538;C1514892;C1550464;C2827757,false;true;false;false;false,18099/22402
no revascularisation,C0581603,false,18100/22402
no revascularization for index acs event  no . ( % ),C0581603;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false;true;false;false;false,18101/22402
no severe hypoglycemia,C0205082;C0020615;C4553659;C4050465;C4050466,false;true;false;false;false,18102/22402
no statin group,C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,18103/22402
no steroid use at baseline ( ref ),C0281991;C0168634;C1425988;C1442488,false;true;false;false,18104/22402
no stsd > $nmbr$ mm on admission ( n = $nmbr$  $nmbr$ ),C4330985;C0184666;C0809949;C4554674,false;false;false;false,18105/22402
no treatment or antihistamines only,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,18106/22402
no vhd,,,18107/22402
no vhd event rate / year ( n ),C0441471;C0871208;C0439234;C0439508;C1521828;C4019010,false;false;false;false;false;false,18108/22402
no vka at randomization,C0034656,true,18109/22402
no worsening in pga  %,C0332271;C0016410;C3541266;C4050369;C1457868;C1546960,false;true;false;false;false;false,18110/22402
no . ( % ) ',,,18111/22402
no . ( % ) $nmbr$ ( $nmbr$ ),,,18112/22402
no . ( % ) of individuals *,C0027361;C0237401,true;false,18113/22402
no . ( % ) of patients with ≥ $nmbr$ % bsa affected,C0030705,true,18114/22402
no . ( % ) of patients with atrial tachyarrhythmia,C0030705,true,18115/22402
no . ( % ) of patients with fingernail involvement,C0030705,true,18116/22402
no . ( % ) of patients with stroke,C0030705,true,18117/22402
no . *,,,18118/22402
no . copies gly $nmbr$ - glu $nmbr$ - $nmbr$ c,C1948062;C0068000,false;true,18119/22402
no . fingernails,C0222001,true,18120/22402
no . japanese,C0376247;C1556094,false;true,18121/22402
no . needed to treat ( $nmbr$ % cl ) *,,,18122/22402
no . of,,,18123/22402
no . of ' signs or symptoms of chff,C0220912;C0220913;C0311392,true;false;false,18124/22402
no . of $nmbr$ - mg tablets of acetaminophen,C0024671;C1243102;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;false;false;false;false;false,18125/22402
no . of agents,C0450442;C1254351;C1521826,false;false;false,18126/22402
no . of background glucose - lowering therapies  no . ( % ),C1706907;C0017725;C0441994;C0087111;C2003888,false;true;false;true;false,18127/22402
no . of cardiovascular events ( cardiovascular events / $nmbr$ person - years ),C1320716;C0027361;C0439234;C2347489,false;true;false;false,18128/22402
no . of deaths,C0011065;C1306577,true;false,18129/22402
no . of diseased vessels ( % of group ),C0005847;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,18130/22402
no . of drugs,C0013227;C3687832,true;false,18131/22402
no . of events ( rate ),C0441471;C0871208;C1521828;C3541888,false;false;false;false,18132/22402
no . of events / patients % / yr,C0441471;C0030705;C0439234;C3541888,false;true;false;false,18133/22402
no . of events / sample size,C0441471;C3541888,false;false,18134/22402
no . of events / sample size i i,C0441471;C3541888,false;false,18135/22402
no . of events / total no . $nmbr$ % ),C0441471;C3541888,false;false,18136/22402
no . of events / totol no . ( % ),C0441471;C3541888,false;false,18137/22402
no . of exacerbations in past year,C4086268,false,18138/22402
no . of hospitalised patients,C0030705,true,18139/22402
no . of infusions,C0574032,false,18140/22402
no . of moderate or severe exacerbations in previous,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,18141/22402
no . of pack - yr,C1968515;C0439234;C2825051;C2828395,false;false;false;false,18142/22402
no . of participants,C0679646,false,18143/22402
no . of participants ( % ),C0679646,false,18144/22402
no . of patients with events ( % ),C0030705,true,18145/22402
no . of patients / no . of events ( % ) $nmbr$ / $nmbr$ ( $nmbr$ ) $nmbr$ / $nmbr$ ( $nmbr$ ),C0030705,true,18146/22402
no . of previous biologic dmards — no . ( % ),C0205156;C4055380;C1552607,false;false;false,18147/22402
no . of previous ciu / csu medications,C0205156;C0578870;C0013227;C0802604;C2598133;C4284232;C1552607,false;false;true;false;false;false;false,18148/22402
no . of previous ciu / csu medications  mean ( median ),C0205156;C0578870;C0013227;C0444504;C0549183;C0876920;C2347635;C2348144;C2939193;C2347634;C2348143;C0802604;C2598133;C4284232;C1552607,false;false;true;false;false;false;false;false;false;false;false;false;false;false;false,18149/22402
no . of previous csdmards  n ( % ),C0205156;C1552607,false;false,18150/22402
no . of previous tne inhibitors,C0205156;C3896585;C0243077;C1552607,false;false;true;false,18151/22402
no . of prior aeds  n ( % ) $nmbr$ - $nmbr$,C0332152;C0180309;C2826257,false;true;false,18152/22402
no . of prior aedsd,C0332152;C2826257,false;false,18153/22402
no . of risk factors for venous thromboembolism  no . ( % ),C0035648;C1553898,true;false,18154/22402
no . of strokes / no . of patients in category ( and % ),C0038454,true,18155/22402
no . of vessels treated,C0005847,true,18156/22402
no . of vessels with > $nmbr$ % stenosis,C0005847,true,18157/22402
no . patients ( % ),C0030705,true,18158/22402
no . patients with,C0030705,true,18159/22402
no . previous alpha - blocker use,C0205156;C0001641;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,18160/22402
no . previous dmard  mean ( sd ),C0205156;C0242708;C0444504;C2699239;C2347634;C2348143;C1552607,false;true;false;false;false;false;false,18161/22402
no . randomized,C0034656;C3815594,true;false,18162/22402
no . with visit,C0545082;C1512346;C2826704,false;false;false,18163/22402
no . women,C0043210,true,18164/22402
no . / total,C0439175;C0439810,false;false,18165/22402
no . / total no . ( % ),C0439175;C0439810,false;false,18166/22402
no . / total no . ( % ) t,C0439175;C0439810,false;false,18167/22402
no . / total 	 no . ( % ),C0439175;C0439810,false;false,18168/22402
no . a,,,18169/22402
nocad / mi,C3810814,false,18170/22402
nocturia episodes / $nmbr$ h,C0028734;C0332189;C0033727;C0369286;C0441932;C0564385;C4528284,true;false;true;false;false;false;false,18171/22402
nocturnal back pain  $nmbr$ – $nmbr$ mm vas  mean ± sd,C1970122;C4330985;C0042815;C0444504;C2699239;C2347634;C2348143;C3536884;C3827561;C4554674,false;false;true;false;false;false;false;true;false;false,18172/22402
nocturnal symptoms in past week,C0240526;C0683368;C2987125;C1457887,false;true;false;false,18173/22402
noirecerving,,,18174/22402
noliecervrig,,,18175/22402
nominal change,C0392747;C0443172;C1705241;C4319952,false;false;false;false,18176/22402
nominal p vs placebo,,,18177/22402
non - / ex - drinker,C0457801,false,18178/22402
non - / ex - tobacco user,C1518422;C3853727,false;false,18179/22402
non - asian,C1518422;C0078988,false;true,18180/22402
non - asian ( n = $nmbr$ $nmbr$ ),C1518422;C0078988,false;true,18181/22402
non - biological systemic,C0445097;C0205373,false;false,18182/22402
non - black participants,C1518422;C0005680;C0679646;C0027567;C0085756;C0439541,false;true;false;true;true;false,18183/22402
non - cabg related bleeding at $nmbr$ h,C1518422;C0010055,false;true,18184/22402
non - cana ( n = $nmbr$ ),C1518422;C1418845,false;false,18185/22402
non - cardiovascular mortality,C1518422;C0007226;C0026565;C0026566;C3887460,false;true;true;true;false,18186/22402
non - carrier ( n = $nmbr$ ),C2986416,false,18187/22402
non - caucasian eze / simva ( n = $nmbr$ ),C1518422;C0007457;C0043157,false;true;true,18188/22402
non - caucasian simva ( n = $nmbr$ ),C1518422;C0007457;C0043157,false;true;true,18189/22402
non - cvd deaths,C1518422;C0007222;C0011065;C1306577,false;true;true;false,18190/22402
non - cvd mortality,C1518422;C0007222;C0026565;C0026566,false;true;true;true,18191/22402
non - diabetic ( n = $nmbr$ ),C1518422;C0241863,false;false,18192/22402
non - diabetic subjects  n = $nmbr$,C1518422;C0241863;C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false,18193/22402
non - diabetics ( n = $nmbr$ ),C1518422;C0241863,false;false,18194/22402
non - dihydropyridine ccbs,C1518422;C0012315;C0006684;C0220821,false;true;true;true,18195/22402
non - early crohn ' s disease,C1518422;C1279919;C0010346,false;false;true,18196/22402
non - east asian §,C1518422;C1707877;C0078988,false;false;true,18197/22402
non - east asianf,C1518422;C1707877,false;false,18198/22402
non ‐ elderly,C1518422;C0001792;C1999167,false;true;false,18199/22402
non - fatal ml,C1518422;C1302234;C0439526;C1705224;C3887665;C1705232,false;false;false;false;false;false,18200/22402
non ‐ haemorrhagic stroke — no . ( % ),C1518422;C0333275,false;false,18201/22402
non - hdl - c ( mg / dl ) * *,C1518422;C3715113;C0439269,false;false;false,18202/22402
non - hdl - c  mean ( sd ),C1518422;C3715113;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,18203/22402
non - hdl - c  mg / dl  mean ( sd ),C1518422;C3715113;C0439269;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false;false,18204/22402
non - hdl - c  mmol / l  mean ( sd ),C1518422;C3715113;C1532563;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false;false,18205/22402
non ‐ hdl cholesterol,C0729627;C1535899,false;false,18206/22402
non - hdl cholesterol j,C0729627;C1535899,false;false,18207/22402
non - hdlc,C1518422;C1704429,false;true,18208/22402
non - hishnic,C1518422,false,18209/22402
non - hispanic and latino,C1518424,false,18210/22402
non - hispanic black or african - american,C1518424;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,18211/22402
non - hispanic or latino,C1518424,false,18212/22402
non - hispanic  non - latino,C1518424;C0086528,false;true,18213/22402
non - hispanicwhite,C1518422,false,18214/22402
non - inhaled steroid use  n ( % ),C1518422;C0586793,false;false,18215/22402
non - insulin treated dm,C1518422;C0021641;C1522326;C0011816;C3250443;C1533581;C1579433;C3714501,false;true;false;true;false;false;false;false,18216/22402
non - ischaemic ( n = $nmbr$ ),C1518422;C0475224,false;false,18217/22402
non - ischaemic dilated cardiomyopathy,C1518422;C1960867,false;false,18218/22402
non - ischemic,C1518422;C0475224,false;false,18219/22402
non - lad artery,C1518422;C0003842;C0226004,false;true;false,18220/22402
non - mets,C1518422;C0812270;C1705694;C2939420,false;false;false;false,18221/22402
non - mtx csdmards,C1518422;C0025677;C1417487,false;true;false,18222/22402
non - pci intravenous unfractionated heparin,C1518422;C4049621;C0354566,false;false;false,18223/22402
non - q - wave myocardial infarction,C0542269;C3537181,false;false,18224/22402
non - rheumatic valvular heart disease,C1518422;C0264757,false;false,18225/22402
non - rollover,C1518422;C0517067;C0543436,false;false;false,18226/22402
non - severe hypoglycaemia,C1518422;C0205082;C0020615;C4553659;C4050465;C4050466,false;false;true;false;false;false,18227/22402
non - smokers receiving lipid - lowering drugs  p blockers  and either an ace inhibitor or angiotension receptor blocker,C0337672;C4554605,false;true,18228/22402
non - smokers receiving lipid lowering drugs  ( $nmbr$ blockers  and either an ace inhibitor or angiotension receptor blocker,C0337672;C4554605,false;true,18229/22402
non - spondylitis,C1518422;C0038012,false;true,18230/22402
non - st - segment elevation,C1518422;C0520886,false;false,18231/22402
non - statin ( n = $nmbr$ ),C1518422;C0360714,false;true,18232/22402
non - steroidal anti - inflammatory drugs,C0003211,true,18233/22402
non - tiotropium,C1518422;C0213771,false;true,18234/22402
non - transient risk factors for recurrent vte  n ( % ),C0439597;C0040704;C0035648;C0630906;C1553898;C0205374,false;true;true;true;false;false,18235/22402
non - trial antiplatelet,C1518422;C0008976,false;true,18236/22402
non - trial p blocker,C1518422;C0008976,false;true,18237/22402
non - trial treatment during hospital stay,C1518422;C0008976;C0039798;C3489408;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;true;true;true;false;false;false;false;false,18238/22402
non - united states,C1518422;C0041703,false;true,18239/22402
non - us,C1518422,false,18240/22402
non - user $nmbr$,C1518422;C1548600;C1706077,false;false;false,18241/22402
non cns embolism,C1518422;C3714787;C0013922;C1704212,false;true;true;true,18242/22402
non stent thrombosis - related mi,C1518422;C3897493,false;false,18243/22402
non usa,C1518422;C0041703,false;true,18244/22402
non white,C1518422;C0007457;C0043157;C0220938,false;true;true;false,18245/22402
nonblack,,,18246/22402
nonblack ( n = $nmbr$ ),,,18247/22402
nonblack ( n = $nmbr$ )  adjusted hazard ratio *,C0456081;C2985465,false;false,18248/22402
nonblack participants,C0679646,false,18249/22402
nonblack race — no . ( % ) f,,,18250/22402
noncardiac death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,18251/22402
noncardiovascular death,C0011065;C1306577;C4082313;C4552775,true;false;false;false,18252/22402
noncompliant,C0457432,false,18253/22402
noncurrent smoker,C0337664,true,18254/22402
nondiabetes,,,18255/22402
nondiabetic participants !,C0679646,false,18256/22402
nondisabling  nonfatal stroke,C0038454;C4554100,true;false,18257/22402
none ( n = $nmbr$ ),C0369718;C0441922,false;false,18258/22402
none at baseline,C0168634;C1442488,true;false,18259/22402
none or diet,,,18260/22402
none or seldom,,,18261/22402
nonfatai myocardiai infarction,C0021308,true,18262/22402
nonfatal,,,18263/22402
nonfatal mi ( n = $nmbr$ ),C3810814,false,18264/22402
nonfatal mi + fatal chdt,C3810814;C1302234;C1705232,false;false;false,18265/22402
nonfatal myocardiail infarction,C0021308,true,18266/22402
nonfatal myocardial infarction,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,18267/22402
nonfatal myocardial infarction ®,C0027051;C0428953;C2926063;C3810814;C4552959,true;false;false;false;false,18268/22402
nonfatal stroke ( n = $nmbr$ ),C0038454;C4554100,true;false,18269/22402
nonfatal stroke ®,C0038454;C4554100,true;false,18270/22402
nonglycemic cardiovascular risk factors,C0850624,false,18271/22402
noninducing,,,18272/22402
nonischemic,,,18273/22402
nonischemic cardiomyopathy — no . ( % ),C0878544,true,18274/22402
nonobese ( < $nmbr$ kg / nr ),C0022718;C0027496;C3844738;C0439209;C4054209,true;true;false;false;false,18275/22402
nonreversible,,,18276/22402
nonsevere hypoglycemia,C0020615;C4553659,true;false,18277/22402
nonsmoker  n ( % ),C0337672;C0425293;C4554605,false;false;true,18278/22402
nontraumatic leg or foot amputation,C0023216;C1140621,true;true,18279/22402
nonuser,,,18280/22402
nonvertebral,,,18281/22402
noppi,,,18282/22402
nordic,C0331873,false,18283/22402
nordic countries,C0036273,true,18284/22402
normai fasting giucose levei ( n = $nmbr$ ),,,18285/22402
normal - high renin ( pra > $nmbr$ . $nmbr$ ng / ml / h ) ( n = $nmbr$ ),C0205307;C0855390;C0633231;C1533072;C4050009;C1141951;C1419788;C3274822;C3669212;C4283900;C0231683;C0439166;C2347086;C4553972,false;false;true;false;false;false;false;false;false;false;false;false;false;false,18286/22402
normal ( £ $nmbr$ ml / minute ),C0205307;C0439526;C0439232;C0700321;C0702093;C1282918;C2347166;C1705224;C3887665;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false;false;false;false;false;false,18287/22402
normal ( < $nmbr$ . $nmbr$ u / ml ),C0205307;C0439340;C1880521;C2945590;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false,18288/22402
normal ( ≤   uln ) n   =   $nmbr$,C0205307;C1519815;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,18289/22402
normal ( ≥ $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % ),C0205307;C0439445;C0369637;C0441923;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false,18290/22402
normal ( > $nmbr$ ml / min ),C0205307;C0439445;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,18291/22402
normal ( > $nmbr$ mlvmin per $nmbr$ . $nmbr$ m $nmbr$ ),C0205307;C0369637;C0441923;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false,18292/22402
normal ( bmi < $nmbr$ ),C4229017,false,18293/22402
normal ( egfr ≥ $nmbr$ )  n ( % ),C0205307;C1739039;C3811844;C3812682;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,18294/22402
normal acr ( < $nmbr$ mg / mg ) at baseline to albuminuria ( acr > $nmbr$ mg / g ),C0205307;C1412134;C1319635;C0168634;C1442488;C1515941;C0231683;C0439166;C2347086;C4553972,false;false;false;true;false;false;false;false;false;false,18295/22402
normal albuminuria ( uacr < $nmbr$ ),C0205307;C0001925;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false,18296/22402
normal baseline crp,C0205307;C0168634;C3890735;C4048285;C1442488;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false;false,18297/22402
normal bnp  ^ $nmbr$ pg / ml ( n = $nmbr$  $nmbr$ ),C0205307;C0054015;C0439297;C1095989;C1417808;C2982014;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false;false;false,18298/22402
normal cognitive,C2712133,false,18299/22402
normal cognitive function ( spmsq < $nmbr$ ) . n - $nmbr$ . $nmbr$ n ( % ) participants with the event of interest,C1276356;C0009240;C0679646;C0441471;C4019010;C0392335;C4050130,false;true;false;false;false;false;false,18300/22402
normal coronary angiography,C0853522,false,18301/22402
normal crp and,C0205307;C3890735;C4048285;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false,18302/22402
normal egfr ( $nmbr$ < egfr < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) at baseline to high egfr ( > $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C0205307;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false;false;false;false,18303/22402
normal function ( crcl > $nmbr$ ml / min  n = $nmbr$ [ $nmbr$ . $nmbr$ % ] ),C4296962;C1846718;C0439445,false;false;false,18304/22402
normal function or mild impairment,C4296962,false,18305/22402
normal hba $nmbr$ c  n = $nmbr$,C0205307;C0019016;C1825777;C3538758;C0231683;C0439166;C2347086;C4553972,false;true;false;false;false;false;false;false,18306/22402
normal left ventricular ejection fraction — no . ( % ) j,C1535947;C0205091;C0443246;C1552822;C0205307;C0428772;C0488728;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false;false;false;false,18307/22402
normal or high egfr ( > $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) at baseline to low egfr ( < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18308/22402
normal or increased baseline gfr ( > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18309/22402
normal or increased egfr,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18310/22402
normal or increased gfr ( > $nmbr$ ml / mln per $nmbr$ . $nmbr$ m ^ ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18311/22402
normal or mild ( iief - ef $nmbr$ - $nmbr$ )  n ( % ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18312/22402
normal responder,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18313/22402
normal responder ( n = $nmbr$ ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18314/22402
normal responders ( n = $nmbr$ ),C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18315/22402
normal study termination,C0205307;C0557651;C1549081;C1692758;C2603343;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false;false;false;false,18316/22402
normal weight ( bmi < $nmbr$ ),C4229017;C0005910;C0043100;C1305866;C1705104;C2712185;C0578022,false;true;true;false;false;false;false,18317/22402
normal  < $nmbr$,C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false,18318/22402
normalfunction or mild impairment,,,18319/22402
normalized volume measures,C1882115;C0449468;C1690016;C1705102;C2700258,false;false;false;false;false,18320/22402
normalized womac score,C1882115;C0449820;C4050231,false;false;false,18321/22402
normoalbuminuria,,,18322/22402
normoalbuminuria — no . ( % ),,,18323/22402
normoalbuminuria ( uacr < $nmbr$ mg / g ),C1300563,false,18324/22402
normoalbuminuria  no . ( % ),,,18325/22402
normoalbuminuria §,,,18326/22402
normoglycaemic individuals  n ( % ),C0580545;C0027361;C0237401,false;true;false,18327/22402
normoglycemia,C0580545,false,18328/22402
normoglycemic,C0580545,false,18329/22402
normoglycemic ^,C0580545,false,18330/22402
normoglycemic {,C0580545,false,18331/22402
normonatremic ( > $nmbr$ meq / l ) at baseline,C0439375;C0168634;C1442488,false;true;false,18332/22402
normotensive ( n = $nmbr$ ),C2712122,false,18333/22402
north,C1709269,false,18334/22402
north america ( n = $nmbr$ ),C0028405,true,18335/22402
north america ( plus america and new zealand ),C0028405;C0332287,true;false,18336/22402
north america *,C0028405,true,18337/22402
north america / oceania,C0028405;C0282279;C4085681,true;true;false,18338/22402
north ameriea,C1709269,false,18339/22402
nos $nmbr$ $nmbr$ c . t  n ( % ),C0326287;C1518425,false;false,18340/22402
nos $nmbr$ $nmbr$ a . g  n ( % ),C0326287;C1518425,false;false,18341/22402
nos $nmbr$ glu $nmbr$ asp g . t  n ( % ),C0326287;C0125690;C0439267;C1518425,false;true;false;false,18342/22402
not assessable,C1883425,false,18343/22402
not collected ^,C1518422,false,18344/22402
not estimable,C1518422,false,18345/22402
not hispanic,C1518424,false,18346/22402
not hispanic / latino ( n = $nmbr$  $nmbr$ ),C1518424;C0086528,false;true,18347/22402
not hispanie / latino,C1518422;C0086528,false;true,18348/22402
not on an aha,C1518422;C0050451;C0772110,false;true;false,18349/22402
not on metformin,C1518422;C0025598,false;true,18350/22402
not perfused,C1518422,false,18351/22402
not present at screening  but within previous year,C1518422,false,18352/22402
not receiving,C1518422,false,18353/22402
not severe,C4316743,false,18354/22402
not tested,C1518422,false,18355/22402
notatincreased fall risk ( n - $nmbr$  $nmbr$ ),C1268740,false,18356/22402
notes :,C1317574,false,18357/22402
nothfref,,,18358/22402
np tercile $nmbr$ ( bnp < $nmbr$ pg / ml  nt - probnp < $nmbr$ pg / ml ) ( n - $nmbr$ ),C0065827;C0054015;C0439297;C4284038;C1317554;C2825907;C1095989;C1417808;C2982014;C1706141;C3887659,true;true;false;false;false;false;false;false;false;false;false,18359/22402
np tercile $nmbr$ ( bnp > $nmbr$ pg / ml  nt - probnp > $nmbr$  $nmbr$ pg / ml ) ( n - $nmbr$ ),C0065827;C0054015;C0439297;C4284038;C1317554;C2825907;C1095989;C1417808;C2982014;C1706141;C3887659,true;true;false;false;false;false;false;false;false;false;false,18360/22402
nph,C0020258;C0027442,true;true,18361/22402
nptercile $nmbr$ ( bnp $nmbr$ - $nmbr$ pg / ml  nt - probnp $nmbr$ - $nmbr$  $nmbr$ pg / ml ) ( n - $nmbr$ ),C0054015;C0439297;C4284038;C1317554;C2825907;C1095989;C1417808;C2982014,true;false;false;false;false;false;false;false,18362/22402
nsaid   at   least   once,C0003211;C3536840,true;false,18363/22402
nste acs,C0742343;C4318612,true;false,18364/22402
nstemi ( n = $nmbr$  $nmbr$ ),C3537184;C4255010,false;true,18365/22402
nt - pro - bnp,C0669479;C0754710,true;true,18366/22402
nt - pro - bnp — pmol / literf,C0669479;C0439192;C0754710,true;false;true,18367/22402
nt - probnp — pg / ml,C0669479;C0439297;C0754710,true;false;true,18368/22402
nt - probnp values were reported in $nmbr$ of $nmbr$ patients enrolled in this stratum,C0669479;C0042295;C0754710,true;false;true,18369/22402
nt - probnp  median pg / ml,C0669479;C0549183;C0439297;C0876920;C2347635;C2348144;C2939193;C0754710,true;false;false;false;false;false;false;true,18370/22402
nt - probnp  pmol / h,C0669479;C0439192;C0033727;C0369286;C0441932;C0564385;C4528284;C0754710,true;false;true;false;false;false;false;true,18371/22402
nt - probnp $nmbr$ pmol - l - $nmbr$,C0669479;C0439284;C0754710,true;false;true,18372/22402
nt estimated,C0332126;C1449832;C3889152;C4050156;C4283901;C4284038,false;true;false;false;false;false,18373/22402
nt probnp > $nmbr$ ng / ml n ( % ) §,C4284038;C1317554;C0439275;C2825907,false;false;false;false,18374/22402
ntbnp ( n = $nmbr$ ),,,18375/22402
nteraction p value,C1709380,false,18376/22402
nternational index of,C0600653;C0918012;C1552854;C1637833;C2986546,true;true;false;false;false,18377/22402
ntprobnp ( pg / ml ),C0669479;C0439297;C0754710,true;false;true,18378/22402
numab,,,18379/22402
number ( % ) of patients,C2360800,false,18380/22402
number and % of participants with events  and incidence rate per $nmbr$ person - year,C0237753;C0449788,false;false,18381/22402
number of “ off ” periods,C0237753;C0449788,false;false,18382/22402
number of agents,C0237753;C0450442;C1254351;C1521826;C0449788,false;false;false;false;false,18383/22402
number of antihypertensive agent reported,C0237753;C0003364;C0449788,false;true;false,18384/22402
number of antihypertensive medications at study entry,C1718138;C0003364,false;true,18385/22402
number of antihypertensive medications used  n ( % ) no antihypertensive therapy,C1718138;C0003364,false;true,18386/22402
number of antihypertensive medications  n ( % ),C1718138;C0003364,false;true,18387/22402
number of arterial beds involved,C0237753;C0003842;C0004916;C0221464;C0449788,false;true;true;false;false,18388/22402
number of clinically significant asthma exacerbations in last year prior to baseline,C0237753;C0237881;C0349790;C0750502;C1546944;C0449788,false;false;false;false;false;false,18389/22402
number of co - aeds  n ( % ),C0237753;C3245499;C0180309;C0449788,false;true;true;false,18390/22402
number of concomitant aedsc,C0237753;C0521115;C0449788,false;false;false,18391/22402
number of copd exacerbations in the previous year    n   ( % ),C0237753;C0740304;C0449788,false;false;false,18392/22402
number of copd exacerbations within $nmbr$ months  mean ( sd ),C0237753;C0740304;C0449788,false;false;false,18393/22402
number of diseased vessels  mean ( sd ),C0237753;C0005847;C0444504;C2699239;C2347634;C2348143;C0449788,false;true;false;false;false;false;false,18394/22402
number of draining fistulae per patient  n,C0237753;C0544791;C0449788,false;false;false,18395/22402
number of er visits in last year prior to baseline,C0237753;C3810541;C3811131;C0449788,false;false;false;false,18396/22402
number of events,C4330837,false,18397/22402
number of events ( annualised rate [ % ] ),C4330837,false,18398/22402
number of events  event per $nmbr$ person - years,C4330837,false,18399/22402
number of exacerbations in previous $nmbr$ months,C0237753;C4086268;C0449788,false;false;false,18400/22402
number of exacerbations in previous $nmbr$   months,C0237753;C4086268;C0449788,false;false;false,18401/22402
number of exacerbations in previous year  mean ( sd ),C0237753;C4086268;C0449788,false;false;false,18402/22402
number of exacerbations in the $nmbr$ months before screening,C0237753;C4086268;C0449788,false;false;false,18403/22402
number of exacerbations in the last $nmbr$ months,C0237753;C4086268;C0449788,false;false;false,18404/22402
number of exacerbations in the last $nmbr$ months  mean ± sd,C0237753;C4086268;C0449788,false;false;false,18405/22402
number of hospitalizations in last year prior to baseline,C4086639,false,18406/22402
number of implanted stents  n  mean ( sd ),C0237753;C0522776;C0444504;C2699239;C2347634;C2348143;C0449788,false;false;false;false;false;false;false,18407/22402
number of lesions  n ( % ) a,C0449791,false,18408/22402
number of medications  n ( % ),C1718138,false,18409/22402
number of pack years,C0237753;C1277691;C0449788,false;false;false,18410/22402
number of participants with an event,C0237753;C0679646;C0449788,false;false;false,18411/22402
number of patients ( % ) or mean ± sd,C2360800,false,18412/22402
number of patients randomized,C2360800,false,18413/22402
number of patients with available data,C2360800,false,18414/22402
number of patients with dose available,C2360800,false,18415/22402
number of patients with events,C2360800,false,18416/22402
number of patients with exacerbations in the previous $nmbr$ months  n ( % ),C2360800,false,18417/22402
number of people ( n ),C0237753;C0027361;C0449788,false;true;false,18418/22402
number of prevalent vertebral fractures,C0237753;C0033105;C0080179;C0220900;C0449788,false;true;true;true;false,18419/22402
number of previous anti - tnf treatments for psa  n ( % ),C0237753;C0205156;C1448177;C0087111;C1552607;C0449788,false;false;true;true;false;false,18420/22402
number of previous reported aeds,C0237753;C0205156;C0684224;C0180309;C0700287;C4319718;C1552607;C0449788,false;false;true;true;false;false;false;false,18421/22402
number of previous tnfa inhibitors,C0237753;C0205156;C1448177;C0243077;C1710304;C1552607;C0449788,false;false;true;true;false;false;false,18422/22402
number of prior aeds,C0237753;C0332152;C0180309;C2826257;C0449788,false;false;true;false;false,18423/22402
number of prior aeds    n   ( % ),C0237753;C0332152;C0180309;C2826257;C0449788,false;false;true;false;false,18424/22402
number of subjects in analysis,C0237753;C0681850;C1550501;C1706203;C2349001;C2697811;C0449788,false;false;false;false;false;false;false,18425/22402
number of swollen joints ( $nmbr$ - $nmbr$ ),C0449813;C0038999,false;false,18426/22402
number of swollen joints ( $nmbr$ - $nmbr$ )  mean ( sd ),C0449813;C0038999;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,18427/22402
number of swollen joints ( $nmbr$ assessed ),C0449813;C0038999,false;false,18428/22402
number of target vessels,C0237753;C0449618;C0449788,false;false;false,18429/22402
number of tender joints ( $nmbr$ - $nmbr$ ),C0449813;C0234234,false;false,18430/22402
number of tender joints ( $nmbr$ - $nmbr$ )  mean ( sd ),C0449813;C0234234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false;false,18431/22402
number of tender joints ( $nmbr$ assessed ),C0449813;C0234234,false;false,18432/22402
number of treated lesions ( per patient ),C0449791;C1522326,false;false,18433/22402
number of treated patients,C2360800;C1522326,false;false,18434/22402
number of visits  mean ± sd,C1549755;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,18435/22402
number of visits  median,C1549755,false,18436/22402
number ol ( % ) patients > $nmbr$ years,C0237753;C0030705;C0439234;C0449788,false;true;false;false,18437/22402
number randomized,C0237753;C0449788,false;false,18438/22402
numbera,,,18439/22402
numbers of events ( % ) :,C4330837,false,18440/22402
nutraceuticals  n ( % ),C1518478,true,18441/22402
nvf at flex baseline - $nmbr$ < flex fn t - score,C0168634;C1570610;C0449820;C4050231;C1442488,true;true;false;false;false,18442/22402
nx *,C0445085,false,18443/22402
nyha,C1275491,false,18444/22402
nyha chf class,C1882083;C0018802,false;true,18445/22402
nyha class ( when patient was last in stable condition,C1882083,false,18446/22402
nyha class ii ( n = $nmbr$ ),C1882085,false,18447/22402
nyha class iii or iv  n ( % ),C1882086,false,18448/22402
nyha class iii  % ( n ),C1882086,false,18449/22402
nyha class iii / iv,C0278962,false,18450/22402
nyha classes iii - iv,C0278962,false,18451/22402
nyha functional class ( % ),C1882083;C0205245;C0542341;C2700217,false;false;false;false,18452/22402
nyha functional class $nmbr$,C1882083;C0205245;C0542341;C2700217,false;false;false;false,18453/22402
nyha functional class at randomization,C1882083;C0205245;C0034656;C0542341;C2700217,false;false;true;false;false,18454/22402
nyha functional class i,C1882084;C0205245;C0542341;C2700217,false;false;false;false,18455/22402
nyha functional class iii,C1882086;C0205245;C0542341;C2700217,false;false;false;false,18456/22402
nyha functional class iii ( % ),C1882086;C0205245;C0542341;C2700217,false;false;false;false,18457/22402
nyha functional classification — no . ( % ),C1275491;C0205245;C0542341;C2700217,false;false;false;false,18458/22402
nyha functional classification — no . ( % ) i,C1275491;C0205245;C0542341;C2700217,false;false;false;false,18459/22402
nyha iii or iv § ( n = $nmbr$ $nmbr$ ),C1275491;C0439070;C1705160,false;false;false,18460/22402
nyha iv  %,C1275491;C0022326;C4265176,false;true;false,18461/22402
nyha ll / lll patients with lvef < $nmbr$ . $nmbr$ at baseline,C1275491,false,18462/22402
nyha_class,C1882083,false,18463/22402
o,C0483204,false,18464/22402
o - oi $nmbr$ ( - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ ),C0483204;C0029118;C0029434,false;true;true,18465/22402
o - oo $nmbr$ ( - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ ),C0483204,false,18466/22402
o $nmbr$ o ( oo $nmbr$ - o - $nmbr$ o ),C0483204,false,18467/22402
o $nmbr$ kg  n ( % ),C0483204;C0022718;C0439209;C4054209,false;true;false;false,18468/22402
oab - q score  mean ( sd ),C3641332;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,18469/22402
oab therapy,C0039798;C0087111;C1363945,true;true;false,18470/22402
oac experienced  bn   ( % ),,,18471/22402
oad at screening  n ( % ),C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,18472/22402
oad history  years,C0019664;C0439234;C0019665;C0262512;C0262926;C1705255;C2004062,true;false;true;false;false;false;false,18473/22402
oad use  n ( % ),C0042153;C0457083;C1947944,true;false;false,18474/22402
oam,,,18475/22402
oam use [ n ( % ) ],C0042153;C0457083;C1947944,true;false;false,18476/22402
oascvd,,,18477/22402
oat,C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,18478/22402
oat ( n   =   $nmbr$ ),C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,18479/22402
obese ( > $nmbr$ kg / m ^ $nmbr$ ),C0028754;C1532718,true;false,18480/22402
obese ( > $nmbr$ kg / m $nmbr$ ) b,C0028754;C1532718,true;false,18481/22402
obese ( bmi £ $nmbr$ ),C0028754;C0578022,true;false,18482/22402
obese ( bmi > $nmbr$ kg / m $nmbr$ ),C0028754;C0578022;C1532718,true;false;false,18483/22402
obesity ( bmi £ $nmbr$ kg / m $nmbr$ ),C0028754;C0578022;C1532718;C1963185,true;false;false;false,18484/22402
obesity *,C0028754;C1963185,true;false,18485/22402
obesity * ( bm $nmbr$ > $nmbr$ kg / m $nmbr$ ),C0028754;C0006416;C1532718;C1963185,true;true;false;false,18486/22402
observation,C0302523;C0700325;C1964257;C3889687,true;true;false;false,18487/22402
observed,C1441672,false,18488/22402
observed case,C1441672;C0868928;C1706255;C1706256,false;false;false;false,18489/22402
obstructive subscore,C0549186,false,18490/22402
ocn,C1412791;C2347392,false;false,18491/22402
ocs at baseline,C0168634;C1442488,true;false,18492/22402
ocs dose *  mean ( sd ),C0178602;C0444504;C2699239;C2347634;C2348143;C0869039;C1114758,false;false;false;false;false;false;false,18493/22402
ocs maintained / increased,,,18494/22402
ocs reduced / stopped,,,18495/22402
ocs use,,,18496/22402
ocs  n ( % ),,,18497/22402
oct center point thickness  pm,C3828732;C0205099;C1552961;C1280412;C2347617;C3714763;C3810851,false;false;false;false;false;false;false,18498/22402
octi,,,18499/22402
octi & mate $nmbr$,C0682323;C1260875,false;false,18500/22402
odds ‐ ratio ( $nmbr$ % ci ),C0028873;C0008107;C3259781,true;true;false,18501/22402
odds ratio and $nmbr$ % cl,C0028873,true,18502/22402
odds ratios ( $nmbr$ % ci ),C0028873;C0008107;C3259781,true;true;false,18503/22402
of patients meeting criterion / total no . of patients,C0030705,true,18504/22402
of t $nmbr$ dm ( years ),C2603360;C0011816;C0439234;C3250443,false;true;false;false,18505/22402
of variation )  iu,C0205419;C0049272;C0439453;C0694756,false;true;false;false,18506/22402
off - pump,C1518543;C0182537,false;false,18507/22402
ohs graduate,C0268353;C1861455,true;true,18508/22402
oil,C0028908;C0032085;C1517288;C3541397,true;true;false;false,18509/22402
ol / l ),,,18510/22402
olaemia  n ( % ),,,18511/22402
older subjects ( aged > $nmbr$ years ',C0580836,false,18512/22402
olmesartan along with ccb ( n - $nmbr$ ),C1098320;C0006684,true;true,18513/22402
olmesartan along with diuretic ( n - $nmbr$ ),C1098320;C0012798,true;true,18514/22402
olmesartan medoxomil $nmbr$ mg ( n = $nmbr$ ),C0386393;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18515/22402
olmesartan medoxomil $nmbr$ mg / hctz $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C0386393;C1319635;C0020261,true;false;true,18516/22402
olodaterol,C2934193,true,18517/22402
olodaterol $nmbr$ $nmbr$ | ig tiotropium n = $nmbr$ non - tiotropium n = $nmbr$,C4032878;C0021027;C1518422;C0305052;C0360506,true;true;false;false;false,18518/22402
olodaterol $nmbr$ gg ( n = $nmbr$ ),C2934193;C0017454;C0018370,true;true;true,18519/22402
olodaterol $nmbr$ jig,C2934193,true,18520/22402
olodaterol $nmbr$ | ig tiotropium n = $nmbr$ non - tiotropium n = $nmbr$,C4032878;C0021027;C1518422;C0305052;C0360506,true;true;false;false;false,18521/22402
olodaterol $nmbr$ pg,C2934193;C0030827;C0072225;C1266240,true;true;true;false,18522/22402
olodaterol sgg,C2934193,true,18523/22402
om $nmbr$ mg + aml $nmbr$ mg + hctz $nmbr$ mg,C0028971;C1319635;C0023465;C0020261;C0023467;C1705272,true;false;true;true;true;false,18524/22402
om $nmbr$ mg + aml $nmbr$ mg + hctz $nmbr$ mg ( n = $nmbr$ ),C0028971;C1319635;C0023465;C0020261;C0023467;C1705272,true;false;true;true;true;false,18525/22402
om $nmbr$ mg / aml $nmbr$ mg ( n = $nmbr$ ),C0028971;C1319635;C0023465;C0023467;C1705272,true;false;true;true;false,18526/22402
om $nmbr$ mg / hctz $nmbr$ mg ( n = $nmbr$ ),C0028971;C1319635;C0020261;C1705272,true;false;true;false,18527/22402
om $nmbr$ / aml $nmbr$ / hctz $nmbr$ . $nmbr$ mg,C0028971;C0023465;C0020261;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0023467;C1705272,true;true;true;true;true;false;false;false;false;false;true;false,18528/22402
om $nmbr$ / aml $nmbr$ / hctz $nmbr$ mg,C0028971;C0023465;C0020261;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0023467;C1705272,true;true;true;true;true;false;false;false;false;false;true;false,18529/22402
om $nmbr$ / aml $nmbr$ / hctz $nmbr$ . $nmbr$ mg *,C0028971;C0023465;C0020261;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0023467;C1705272,true;true;true;true;true;false;false;false;false;false;true;false,18530/22402
oma / oat,C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,18531/22402
oma / oat ( n   =   $nmbr$ ),C0028753;C0331496;C0939905;C3539067;C3897364,false;true;false;false;false,18532/22402
omalizumab,C0966225,true,18533/22402
omalizumab $nmbr$ mg ( n [ $nmbr$ ),C0966225;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,18534/22402
omega - $nmbr$ fa ( n = $nmbr$ ),C1719844,false,18535/22402
omega - $nmbr$ fatty acids,C1719844;C0015684,false;true,18536/22402
omeract - oarsi response,C0871261;C1704632;C1706817;C2911692,false;false;false;false,18537/22402
on - pump,C3842462,false,18538/22402
on antihypertensive medication at baseline  n ( % ) ‡,C0003364;C0168634;C1442488,true;true;false,18539/22402
on antihypertensive treatment  n ( % ),C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,18540/22402
on aspirin at baseline,C0004057;C0168634;C1442488,true;true;false,18541/22402
on bp medication  n ( % ),C0037623;C0013227;C3244316;C4284232;C1415692;C1708288;C4318478,true;true;false;false;false;false;false,18542/22402
on maximum tolerated medications ( % ) median ( $nmbr$ th to $nmbr$ th quartile ) sua ( mg / dl ),C0806909;C0013227;C0549183;C0039725;C2828255;C0439269;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193;C0802604;C2598133;C4284232;C1552615;C2826546,false;true;false;true;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false,18543/22402
on metformin ir or metformin xr $nmbr$   mg / d,C0025598;C0022065;C0022071;C1448132,true;true;true;true,18544/22402
on non ‐ metformin aha,C1518422;C0025598;C0050451;C0772110,false;true;true;false,18545/22402
on oac at time of randomisation  n ( % ),C0040223;C0034656;C3541383,true;true;false,18546/22402
on or after e ^ andomization,,,18547/22402
on statins at baseline,C0360714;C0168634;C1442488,true;true;false,18548/22402
on step - $nmbr$ drug  %,C1261552;C0013227;C1254351;C1704379;C1705117;C2825408;C3814463,false;true;false;false;false;false;false,18549/22402
on steroid at baseline,C0038317;C0168634;C1442488,true;true;false,18550/22402
one antihypertensive medication,C0205447;C0003364,false;true,18551/22402
one at baseline,C0205447;C0168634;C1442488,false;true;false,18552/22402
one lesion,C0205447;C0221198;C1546698,false;false;false,18553/22402
one or more exacerbations,C0205447,false,18554/22402
one or more medications,C0205447,false,18555/22402
ongoing atopic or allergic condition — no . { % ),C0549178;C0392707,false;false,18556/22402
onset $nmbr$ [ $nmbr$ ],C0206132;C0332162,true;false,18557/22402
ontario and mcmaster universities osteoarthritis index ( womac ) can range from $nmbr$ to $nmbr$ for the pain subscale  $nmbr$ to $nmbr$ for the stiffness,C0029040,true,18558/22402
op concomitant medications ( % ),C0521115;C0013227;C0802604;C2598133;C4284232,false;true;false;false;false,18559/22402
op  no vfx,,,18560/22402
op  vfx,,,18561/22402
opaqb physical function score,C4483112;C0031843;C0542341;C0700205;C1705273;C0516981;C0449820;C4050231;C4049916,false;true;false;false;false;false;false;false;false,18562/22402
open - label phase ( baseline = week $nmbr$ ),C1709323;C0205390;C0168634;C0332174;C0439230;C1442488;C1710475,false;false;true;false;false;false;false,18563/22402
open - label population,C1709323;C0032659;C1257890,false;true;true,18564/22402
operative procedure,C0543467;C0677612,true;false,18565/22402
ophthalmologic events,C0029087;C0441471;C3541888;C0205481,true;false;false;false,18566/22402
option,C1518601;C1550456,false;false,18567/22402
or,,,18568/22402
or ( $nmbr$ % ci ) a,,,18569/22402
or ( $nmbr$ % cl ) = $nmbr$ $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ $nmbr$ ),,,18570/22402
or ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ $nmbr$ . $nmbr$ . $nmbr$ ),,,18571/22402
or ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ ),,,18572/22402
or ( $nmbr$ % cl ) = $nmbr$ $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ $nmbr$ ),,,18573/22402
or ( itt ) ( n = $nmbr$ ),,,18574/22402
or [ $nmbr$ % cl ],,,18575/22402
or death,,,18576/22402
or esrd,,,18577/22402
or for cana vs pbo ( $nmbr$ % ci ) | |,C1418845,false,18578/22402
or for cana vs pbo ( $nmbr$ % ci ) §,C1418845,false,18579/22402
or morbidity and mortality,,,18580/22402
or no microalbuminuria or macroalbuminuria,,,18581/22402
or per unit for continuous variables,C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603,false;false;false;false;false;false;false,18582/22402
or primary outcome,,,18583/22402
or raloxifene,,,18584/22402
or severe,,,18585/22402
or taking antihypertensive medication,,,18586/22402
or ulcerations  ® n ( % ),,,18587/22402
or  $nmbr$ . $nmbr$ ( $nmbr$ % cl  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ),,,18588/22402
or  $nmbr$ . $nmbr$ ( $nmbr$ % cl  $nmbr$ . $nmbr$ — $nmbr$  $nmbr$ ),,,18589/22402
or : $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ )  p = $nmbr$ . $nmbr$,,,18590/22402
or 、 ( $nmbr$ % ci ),,,18591/22402
or = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ ) < $nmbr$ . $nmbr$,,,18592/22402
or = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ ) $nmbr$ . $nmbr$,,,18593/22402
oradj ( $nmbr$ % ci ),C0008107;C3259781,true;false,18594/22402
oral ( % ),C0442027;C4521986,false;false,18595/22402
oral agent,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,18596/22402
oral agent and / or insulin therapy,C0442027;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false,18597/22402
oral anti - dm drug status  no . ( % ),C0029167;C0011816;C0449438;C3250443;C0175795;C0304289,true;true;false;false;false;false,18598/22402
oral anticoagulant n ( % ),C0354604,false,18599/22402
oral antihyperglycaemic  n ( % ),C0359086,false,18600/22402
oral corticosteroid dose ( mg / day ),C0442027;C0001617;C0178602;C0439422;C0869039;C1114758;C3536709;C4521986,false;true;false;false;false;false;false;false,18601/22402
oral corticosteroid use at baseline,C1527415;C0001617;C0168634;C1442488;C3536709;C0442027;C0239126;C4521986,false;true;true;false;false;false;false;false,18602/22402
oral corticosteroid use at enrolmentt,C1527415;C0001617;C3536709;C0442027;C0239126;C4521986,false;true;false;false;false;false,18603/22402
oral corticosteroid use  n ( % ),C1527415;C0001617;C3536709;C0442027;C0239126;C4521986,false;true;false;false;false;false,18604/22402
oral diabetic agent,C0442027;C0241863;C0450442;C1254351;C1521826;C4521986,false;false;false;false;false;false,18605/22402
oral fi - blockers,C0442027;C4050619;C4521986,false;false;false,18606/22402
oral glucocorticoid dose  mg ( prednisone equivalent ),C0442027;C0017710;C0178602;C0024671;C0032952;C0205163;C0439185;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C4521986,false;true;false;true;true;false;false;true;false;false;false;false;false;false;false;false,18607/22402
oral glucocorticoid use,C1527415;C0017710,false;true,18608/22402
oral hypoglycemic agents,C0359086,false,18609/22402
oral hypoglycemic agentsj,C0359086,false,18610/22402
oral hypoglycemics hormone replacement,C0359086;C0282402,false;true,18611/22402
oral or other systemic corticosteroid,C0442027;C4521986,false;false,18612/22402
oral β - adrenergics  n ( % ),C0442027;C0001637;C4521986,false;true;false,18613/22402
oralb,,,18614/22402
organic,C0747055,false,18615/22402
origin [ n ( % ) ],C0079946;C0439659;C1550512,false;false;false,18616/22402
original dabigatran protocol,C0205313;C2348066;C0442711;C1507394;C1522729;C2348563;C2599718;C3715209;C4282383;C2347409,false;true;false;false;false;false;true;false;false;false,18617/22402
oropharyngeal pain,C2363731;C4554669,false;false,18618/22402
ors ( $nmbr$ % cis ) :,C0069590;C1963718,true;false,18619/22402
orthopnea,C0085619,false,18620/22402
orthopnea  frequent / continuous,C0085619;C0332183;C0549178,false;false;false,18621/22402
orthostatic test *,C0231472;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,true;false;false;false;false;false;false;false,18622/22402
os domain,C0229090;C1880389;C1883221;C3541951;C0230028;C0262950;C0393706;C1561953,false;false;false;false;false;true;false;false,18623/22402
osmotic diuresis - related aes,C0232823;C0439849;C1412268;C2699274;C0445223,false;false;false;false;false,18624/22402
osteoporosis drug,C0029456;C0013227;C1254351;C4554622,true;true;false;false,18625/22402
osteoprotegerin decreased,C0538161;C1308614;C1336645,true;true;false,18626/22402
other ' i ',C0021966;C0221138,true;false,18627/22402
other ( % ) diabetes ( interaction : p = $nmbr$ . $nmbr$ ),C0011847;C1704675;C0011849,false;false;true,18628/22402
other ( n   = $nmbr$ ),C0369718;C0441922,false;false,18629/22402
other ( n = $nmbr$  $nmbr$ ),C0369718;C0441922,false;false,18630/22402
other ( n = $nmbr$  $nmbr$ ],C0369718;C0441922,false;false,18631/22402
other { n = $nmbr$ ),C0369718;C0441922,false;false,18632/22402
other anti - hypertensive,C0003364,true,18633/22402
other antihypertensive drug,C0003364,true,18634/22402
other antihypertensive medications,C0003364,true,18635/22402
other antithrombotic medication for index event — no . ( % ),C0013227;C0600653;C0441471;C4019010;C0918012;C1552854;C1637833;C2986546;C3244316;C4284232,true;true;false;false;true;false;false;false;false;false,18636/22402
other ascvd,C3665365,false,18637/22402
other ascvd  no . ( % ),C3665365,false,18638/22402
other atherosclerotic,C0333482,false,18639/22402
other atherosclerotic cvd,C0333482;C0007222,false;true,18640/22402
other atherosclerotic cvd st depression on,C0333482;C0007222;C0520887,false;true;false,18641/22402
other atherosclerotic cvd * *,C0333482;C0007222,false;true,18642/22402
other atherosclerotic cvdd  e,C0333482;C1859330,false;true,18643/22402
other blood glucose - lowering agents,C0005802;C0441994;C0450442;C1254351;C1521826;C2003888,true;false;false;false;false;false,18644/22402
other blood pressure - lowering drugs,C0003364,true,18645/22402
other bp drug,C0037623;C0013227;C1254351;C1415692;C1708288;C4318478,true;true;false;false;false;false,18646/22402
other bph - luts therapy,C0005001;C0574785;C0039798;C0087111;C1363945;C1704272,true;true;true;true;false;true,18647/22402
other climate subset,C0008946;C1515021,true;false,18648/22402
other clinical characteristics,C0683325,false,18649/22402
other combination,C0205195;C1947911;C3811910,false;false;false,18650/22402
other diagnostic procedure *,C0430022;C1546908,false;false,18651/22402
other diuretic,C0012798,true,18652/22402
other dmards,C0242708,true,18653/22402
other drug therapy  n ( % ),C0013216;C0013217,true;true,18654/22402
other end points,C2349179,false,18655/22402
other glucose - lowering drugs,C0017725;C0441994;C0013227;C3687832;C2003888,true;false;true;false;false,18656/22402
other glucose status,C0017725;C0449438,true;false,18657/22402
other hypoglycemic agent  n ( % ),C0020616,true,18658/22402
other ics,C0815320;C4551720,false;true,18659/22402
other ics versus no ics,C0815320;C4551720,false;true,18660/22402
other individual and exploratory end points,C0027361;C0237401,true;false,18661/22402
other lipid - lowering medication,C0023779;C0441994;C0013227;C3244316;C4284232;C2003888,true;false;true;false;false;false,18662/22402
other lipid lowering drugs,C0086440,true,18663/22402
other medical history  no . ( % ),C0262926;C1704706,false;false,18664/22402
other medications,C0013227;C0802604;C2598133;C4284232,true;false;false;false,18665/22402
other medications at enrollment,C0013227;C1516879;C1696073;C3888021;C0802604;C2598133;C4284232,true;false;false;false;false;false;false,18666/22402
other n ( % ),C0369718;C0441922,false;false,18667/22402
other osteoporosis medication,C0029456;C0013227;C3244316;C4284232;C4554622,true;true;false;false;false,18668/22402
other outcomes,C1274040,false,18669/22402
other pacific islander,C0242191,true,18670/22402
other plain vitamin preparations,C0042890,true,18671/22402
other prespecified end points,C2349179,false,18672/22402
other race,C0034510;C1706779;C3853635,true;false;false,18673/22402
other race  n ( % ),C0034510;C1706779;C3853635,true;false;false,18674/22402
other selected aes,C1707391;C1412268;C2699274,false;false;false,18675/22402
other stent,C0038257,true,18676/22402
other steroids,C0038317,true,18677/22402
other treatment assignment,C0039798;C1516050;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,18678/22402
other uc - related gi surgical procedure,,,18679/22402
other vascular disease ( cvd or pad )  %,C0042373;C0007222,true;true,18680/22402
other vasodilators §,C0042402,true,18681/22402
other * ( n = $nmbr$ ),C0369718;C0441922,false;false,18682/22402
other * ’,,,18683/22402
other  no . ( % ),,,18684/22402
other / mixed ( n = $nmbr$ ),C0205430;C3160715,false;false,18685/22402
other / multiple,C0439064,false,18686/22402
other : :,,,18687/22402
other ^,,,18688/22402
other ® region — no . ( % ),C0017446;C0205147,true;false,18689/22402
other †,,,18690/22402
othera,,,18691/22402
otherc,,,18692/22402
otherd,,,18693/22402
otherf,,,18694/22402
otherj ^ :,,,18695/22402
others  classes i and iiic,C1955473;C0441885;C1319793;C2698967;C3539125,false;false;false;false;false,18696/22402
othert,,,18697/22402
othery ethnicity  n ( % ),C0015031;C0243103,true;true,18698/22402
othery ethnicity  n ( % ) *,C0015031;C0243103,true;true,18699/22402
outcome - variant,C1274040;C0205419,false;false,18700/22402
outcome ( n  % },C1274040,false,18701/22402
outcome according to no . of risk factors for vte,C1274040;C0680240;C0035648;C1553898,false;false;true;false,18702/22402
outcome according to primary cancer site — no . / total no . ( % ),C1274040;C0680240;C0872338,false;false;false,18703/22402
outcome according to renal function level ( in ml / min ),C1274040;C0680240;C0232804;C0441889;C0456079;C1547707;C2946261;C0022646;C0935587,false;false;false;false;false;false;false;true;false,18704/22402
outcome according to stage of cancer — no . / total no . ( % ),C1274040;C0680240;C0027646,false;false;true,18705/22402
outcome and metabolizer phenotype,C1274040,false,18706/22402
outcome measure,C0086749,true,18707/22402
outcome severity,C1274040;C0439793;C0522510,false;false;false,18708/22402
outcome type,C1274040;C0332307;C1547052,false;false;false,18709/22402
outcome_subgroup,C1274040;C1079230;C1515021,false;false;false,18710/22402
outcomes,C1274040,false,18711/22402
outcomes by treatment ( spironolactone vs placebo ),C0085415;C0037982,true;true,18712/22402
outcomes during accord,C1274040;C0680240,false;false,18713/22402
ovary,C0029939;C0227898,true;false,18714/22402
over past $nmbr$ years  n ( % ),C4086728,false,18715/22402
overaii,,,18716/22402
overaii ( n = $nmbr$ ),,,18717/22402
overal event rate,C0441471;C0871208;C1521828;C4019010,false;false;false;false,18718/22402
overall ( $nmbr$  $nmbr$ ),C0282416;C1561607,true;false,18719/22402
overall ( itt ) ( n = $nmbr$ ),C0282416;C1561607,true;false,18720/22402
overall ( per protocol ) ( n = $nmbr$ ),C0282416;C1698058;C1561607,true;false;false,18721/22402
overall ( pp ) ( n = $nmbr$ ),C0282416;C0030375;C0063017;C4319755;C1561607,true;true;true;false;false,18722/22402
overall ( w = $nmbr$ )  $nmbr$ / $nmbr$,C0282416;C1561607,true;false,18723/22402
overall analysis,C0282416;C0002778;C0936012;C1524024;C1561607,true;false;false;true;false,18724/22402
overall cohort ( post hoc analysis excluding metformin users ),C0282416;C0086027;C0687676;C0332196;C0025598;C1706077;C2828389;C1704687;C3469826;C1561607,true;true;false;false;true;false;false;false;false;false,18725/22402
overall cohort ( primary analysis ),C0282416;C0086027;C0205225;C0439612;C0439631;C1561607,true;true;false;false;false;false,18726/22402
overall ctd,C0282416;C1335071;C1442905;C1561607,true;false;false;false,18727/22402
overall dlqi score,C0282416;C3899393;C1561607,true;false;false,18728/22402
overall dlqi score $nmbr$,C0282416;C3899393;C1561607,true;false;false,18729/22402
overall early - morning copd symptom severity scorec,C0282416;C1279919;C0332170;C0024117;C1319166;C1412502;C3714496;C1561607,true;false;false;true;false;false;false;false,18730/22402
overall efficacy,C0282416;C1280519;C1707887;C1561607,true;false;false;false,18731/22402
overall freedom population ( n = $nmbr$ ),C0282416;C0016694;C0032659;C1257890;C1561607,true;true;true;true;false,18732/22402
overall mortality,C0282416;C0026565;C0026566;C1561607,true;true;true;false,18733/22402
overall n ( n / loopy ),C0282416;C1561607,true;false,18734/22402
overall night - time copd symptom severity scorec,C0282416;C0240526;C0024117;C1319166;C1412502;C3714496;C1561607,true;false;true;false;false;false;false,18735/22402
overall pea population,C0282416;C0030738;C0032659;C1257890;C0069964;C0070939;C1262903;C3257529;C1561607,true;true;true;true;true;true;true;false;false,18736/22402
overall population ( n - $nmbr$ ),C0282416;C0032659;C1257890;C1561607,true;true;true;false,18737/22402
overall population ( n = $nmbr$ $nmbr$ ) : non - cana ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ ),C0282416;C0032659;C1518422;C1418845;C1319635;C1257890;C1561607,true;true;false;false;false;true;false,18738/22402
overall population ( n = $nmbr$ ),C0282416;C0032659;C1257890;C1561607,true;true;true;false,18739/22402
overall study period,C0282416;C1561607,true;false,18740/22402
overall study population,C0282416;C2348561;C1561607,true;false;false,18741/22402
overall treatment effect,C0282416;C1518681;C1561607,true;false;false,18742/22402
overall vero population,C0282416;C0032659;C1257890;C1561607,true;true;true;false,18743/22402
overall  n = $nmbr$,C0282416;C1561607,true;false,18744/22402
overall  qvai $nmbr$ - sfc,C0282416;C4521536;C1561607,true;false;false,18745/22402
overall ® $nmbr$ . $nmbr$,C0282416;C1561607,true;false,18746/22402
overally,,,18747/22402
overweight,C0497406,true,18748/22402
overweight ( bmi £ $nmbr$ to < $nmbr$ ),C0497406;C0578022,true;false,18749/22402
overweight ( bmi = $nmbr$ - $nmbr$ . $nmbr$ ),C0497406;C0578022,true;false,18750/22402
oxypurinol ( n = $nmbr$ ),C0030086,true,18751/22402
p ' value,C1709380,false,18752/22402
p - blocker intake at randomisation ( n = $nmbr$ ),C0369773;C1512806;C0034656;C2603361,false;false;true;false,18753/22402
p - blocker use,C0369773;C0042153;C0457083;C1947944;C2603361,false;true;false;false;false,18754/22402
p - blockers ( % ),C0369773;C2603361,false;false,18755/22402
p - blocking agents  selective,C0369773;C0233660;C0450442;C1254351;C1521826;C0332206;C2603361,false;false;false;false;false;false;false,18756/22402
p - for interaetion,C0369773;C2603361,false;false,18757/22402
p - gp inhibitor,C3898062,false,18758/22402
p - gp use,C0369773;C1705010;C0042153;C0457083;C1947944;C3811116;C2603361,false;false;true;false;false;false;false,18759/22402
p - heterogeneity,C0369773;C0019409;C0242960;C2603361,false;false;true;false,18760/22402
p - int .,C0369773;C3272375;C2603361,false;false;false,18761/22402
p - inte faction,C0369773;C2603361,false;false,18762/22402
p - inter,C0369773;C2603361,false;false,18763/22402
p - sitosterol / lathosterol,C0369773;C0037215;C0064673;C0220914;C2603361,false;true;true;true;false,18764/22402
p - sitosterol / total c ( | imol / mmol ),C0369773;C0037215;C0439175;C0439190;C0439810;C0220914;C2603361,false;true;false;false;false;true;false,18765/22402
p ‐ value,C1709380,false,18766/22402
p - value ( ■ nt ),C1709380;C0332126;C1449832;C3889152;C4050156;C4283901;C4284038,false;false;true;false;false;false;false,18767/22402
p - value ( ancova treatment difference ) a,C1709380;C0814908;C0039798;C1705241;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;false;true;false;false;true;false;false;false;false;false,18768/22402
p - value ( interaction ) ≠,C1709380;C1704675,false;false,18769/22402
p - value ( overall ),C1709380;C0282416;C1561607,false;true;false,18770/22402
p - value ( trend ),C1709380;C1521798;C4554533,false;false;false,18771/22402
p - value ( vs placebo ),C1709380,false,18772/22402
p - value d $nmbr$ mg vs . warfarin,C1709380;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,18773/22402
p - value for,C1709380,false,18774/22402
p - value for east asian versus non - east asian *,C1709380;C1707877;C0078988,false;false;true,18775/22402
p - value for interaction $nmbr$ :,C1709380;C1704675,false;false,18776/22402
p - value for trend across categories,C1709380;C1521798;C4554533,false;false;false,18777/22402
p - value low vs . high nfs ^,C1709380,false,18778/22402
p - value n / n ( % ),C1709380,false,18779/22402
p - value vs . placebo,C1709380,false,18780/22402
p ‐ value *,C1709380,false,18781/22402
p - value },C1709380,false,18782/22402
p - value ‘ ’,C1709380,false,18783/22402
p - value ¶,C1709380,false,18784/22402
p - value $nmbr$,C1709380,false,18785/22402
p - valueb,C0369773;C2603361,false;false,18786/22402
p ( $nmbr$ % cl ),C0369773;C0596019;C2603361,false;false;false,18787/22402
p ( inter - action ),C0369773;C0205103;C0441472;C3266814;C1548610;C2603361,false;false;false;false;false;false,18788/22402
p ( women vs men ),C0369773;C0043210;C2603361,false;true;false,18789/22402
p . b * int,C1539794;C3272375,false;false,18790/22402
p . b “ int,C1539794;C3272375,false;false,18791/22402
p $nmbr$ interaction women vs men,C0369773;C1704675;C0043210;C2603361,false;false;true;false,18792/22402
p between age groups,C0369773;C0027362;C2603361;C0001779;C0441849;C1959644,false;true;false;false;false;false,18793/22402
p blocker before admission,C0369773;C0184666;C0809949;C2603361,false;false;false;false,18794/22402
p blocker *,C0369773;C2603361,false;false,18795/22402
p blockersubgroup,C0369773;C2603361,false;false,18796/22402
p for inter - act,C0369773;C2603361,false;false,18797/22402
p for interaction between rhtn and no rhtn and treatmenta,C0369773;C1704675;C2603361,false;false;false,18798/22402
p for trend,C0369773;C1521798;C4554533;C2603361,false;false;false;false,18799/22402
p for trend -,C0369773;C1521798;C4554533;C2603361,false;false;false;false,18800/22402
p int . f,C0369773;C3272375;C0016327;C2603361,false;false;true;false,18801/22402
p inter,C0369773;C2603361,false;false,18802/22402
p interaction = $nmbr$ . $nmbr$,C0369773;C1704675;C2603361,false;false;false,18803/22402
p j $nmbr$ * trend,C1518835;C1521798;C4554533,false;false;false,18804/22402
p vaiue,C0369773;C2603361,false;false,18805/22402
p vaiue ( interaction ),C0369773;C1704675;C2603361,false;false;false,18806/22402
p value ( inter ),C1709380,false,18807/22402
p value ( interaction ),C1709380;C1704675,false;false,18808/22402
p value ( nominal ),C1709380,false,18809/22402
p value ( vs . previous time point ),C1709380,false,18810/22402
p value between groups,C1709380;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C1522609;C0441849,false;false;false;true;false;false;false;false;false;false,18811/22402
p value by gt,C1709380;C1435727;C1704693;C2697657,false;true;false;false,18812/22402
p value f,C1709380;C0016327,false;true,18813/22402
p value for,C1709380,false,18814/22402
p value for dm vs . no dm,C4086240,false,18815/22402
p value for heterogeneity （ rosiglitazone versus glyburide ）,C1709380;C0019409;C0289313;C0242960,false;false;true;true,18816/22402
p value for heterogeneity （ rosiglitazone versus metformin ）,C1709380;C0019409;C0289313;C0242960,false;false;true;true,18817/22402
p value for interaction - dosage with dabigatran  $nmbr$ mg,C1709380;C1704675;C0178602;C2986497,false;false;false;false,18818/22402
p value for interaction ( age continuous ),C1709380;C1704675;C0001779,false;false;false,18819/22402
p value for interaction ( age groups ) *,C1709380;C1704675;C0027362,false;false;true,18820/22402
p value for interaction by region,C1709380;C1704675,false;false,18821/22402
p value for interaction  dosage with dabigatran  $nmbr$ mg,C1709380;C1704675;C0178602;C2986497,false;false;false;false,18822/22402
p value for interaction ®,C1709380;C1704675,false;false,18823/22402
p value for interaction ® vertebral fracture at flex baseline :,C1709380;C1704675;C0080179,false;false;true,18824/22402
p value for trend *,C1709380;C1521798;C4554533,false;false;false,18825/22402
p value heart failure vs no heart failure,C1709380;C0018801;C0018802;C4554158,false;true;true;false,18826/22402
p value interaction,C1709380;C1704675,false;false,18827/22402
p value within category,C1709380;C0683312;C3889287,false;false;false,18828/22402
p value *  placebo group p value *  hyponatremia normonatremic group  tolvaptan vs hyponatremic vs placebo,C1709380;C0032042;C0441833;C0020625;C1176308;C4553967;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408,false;true;false;true;true;false;false;true;false;false;false;false;false,18829/22402
p value ∥,C1709380,false,18830/22402
p value § ® ( w,C1709380,false,18831/22402
p valueb,C0369773;C2603361,false;false,18832/22402
p valuec,C0369773;C2603361,false;false,18833/22402
p valuej ',C0369773;C2603361,false;false,18834/22402
p valuer,C0369773;C0401806;C2603361,false;false;false,18835/22402
p   value,C1709380,false,18836/22402
p   value for interaction,C1709380;C1704675,false;false,18837/22402
p   values for interaction,C1709380;C1704675,false;false,18838/22402
p   values of interaction,C1709380;C1704675,false;false,18839/22402
p   vs . placebo,C0369773;C2603361,false;false,18840/22402
p ( inter ),C0369773;C2603361,false;false,18841/22402
p ) atients with > $nmbr$ exacerbations resulting in emergency department visit,C0369773;C4086268;C2603361,false;false;false,18842/22402
p . o ),C0369773;C2603361,false;false,18843/22402
p / interaction,C0369773;C1704675;C2603361,false;false;false,18844/22402
p < $nmbr$ . $nmbr$ ) between the study groups in any of the baseline characteristics . ace,C0369773;C0681848;C2603361;C0557651;C0441849;C1959644;C2603343,false;false;false;false;false;false;false,18845/22402
p $nmbr$ vs no treatment $nmbr$,C0369773;C2603361,false;false,18846/22402
p $nmbr$ y $nmbr$ antagonist,C0369773;C0231491;C2603361,false;false;false,18847/22402
p $nmbr$ y $nmbr$ antagonists,C0369773;C0243076;C2603361,false;true;false,18848/22402
p $nmbr$ min twice / week,C0369773;C0702093;C1720725;C0332174;C0439230;C1948050;C1524029;C3813700;C2603361,false;false;false;false;false;false;false;false;false,18849/22402
p $nmbr$ z $nmbr$ ( n = $nmbr$ ),C0369773;C2603361,false;false,18850/22402
p $nmbr$ vs placebo,C0369773;C2603361,false;false,18851/22402
p $nmbr$ vs usual care,C0369773;C2603361,false;false,18852/22402
pacemaker — no . ( % ),C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,18853/22402
pacemaker or icd,C0030163;C0810633;C1546728;C3275122;C3853703,true;false;false;false;false,18854/22402
pacific,,,18855/22402
pack - years ( iqr ),C1277691,false,18856/22402
pack years,C1277691,false,18857/22402
paclitaxel - eluting stent use  n ( % ),C0144576;C0038257;C0042153;C0457083;C1947944,true;true;true;false;false,18858/22402
pad details  n ( % ),C0182158;C0332568;C3540603;C3669270;C3814046;C4319657,false;false;false;false;false;false,18859/22402
pah - ctd,C0030123;C1335071;C1442905;C3203102;C4284467,true;false;false;true;false,18860/22402
pah - mctd / ctd - other,C0030123;C0026272;C1335071;C1442905;C3203102;C4284467,true;true;false;false;true;false,18861/22402
pah - sle,C0030123;C0024141;C3203102;C4284467,true;true;true;false,18862/22402
pah - ssc,C0030123;C3897657;C3203102;C4284467,true;false;true;false,18863/22402
pah etiology,C0030123;C0015127;C1314792;C1524003;C3203102;C4284467,true;true;true;false;true;false,18864/22402
pah etiology :,C0030123;C0015127;C1314792;C1524003;C3203102;C4284467,true;true;true;false;true;false,18865/22402
pah therapy at baseline,C0030123;C0039798;C0168634;C1442488;C0087111;C1363945;C3203102;C4284467,true;true;true;false;true;false;true;false,18866/22402
pain vas ( range $nmbr$ - $nmbr$ )  mean ± sd,C0042815;C1514721;C0444504;C2699239;C2347634;C2348143;C2348147;C3542016,true;false;false;false;false;false;false;false,18867/22402
pain vas  mean change from baselinea,C0042815;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;false;false;false;false,18868/22402
pain vas  mean change from baselined,C0042815;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;false;false;false;false,18869/22402
pain vas  range $nmbr$ - $nmbr$ mm  mean ( sd ),C0042815;C1514721;C4330985;C0444504;C2699239;C2347634;C2348143;C4554674;C2348147;C3542016,true;false;false;false;false;false;false;false;false;false,18870/22402
pain  $nmbr$ - $nmbr$ mm vas,C0042815;C4330985;C4554674,true;false;false,18871/22402
pain  mm,C0030193;C4330985;C4554674;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,true;false;false;false;false;false;false;false;false;false;false,18872/22402
pairwise comparison,C1707455,false,18873/22402
pancreas,C0030274,true,18874/22402
panel a,C0441833;C1706365;C1999270,false;false;false,18875/22402
panel b,C0441833;C1706365;C1999270,false;false;false,18876/22402
parameter ( mg / dl ),C0549193;C0439269;C1704769;C2350001,false;false;false;false,18877/22402
parameter at baseline,C0549193;C0168634;C1442488;C1704769;C2350001,false;true;false;false;false,18878/22402
parameter mean ± s . d .,C0549193;C0444504;C2347634;C2348143;C1704769;C2350001,false;false;false;false;false;false,18879/22402
parameter statistics,C0681933,false,18880/22402
parameter  % ( $nmbr$ % ci ),C0549193;C0008107;C3259781;C1704769;C2350001,false;true;false;false;false,18881/22402
parameter  n ( % ),C0549193;C1704769;C2350001,false;false;false,18882/22402
parameter / variable,C0549193;C0439828;C4553760;C1704769;C2350001,false;false;false;false;false,18883/22402
parameters,C0449381,false,18884/22402
parameters at baseline,C0449381;C0168634;C1442488,false;true;false,18885/22402
parental history of mi before age $nmbr$ y,C0030551;C0019664;C3810814;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,18886/22402
parental history of ml before age $nmbr$ y yes,C0030551;C0019664;C0439526;C1705224;C3887665;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;true;false;false;false;false,18887/22402
parental history of myocardial infarction before age $nmbr$ y,C0030551;C1275835,true;false,18888/22402
parental history of myocardial infarction before age $nmbr$ y yes,C0030551;C1275835,true;false,18889/22402
parenteral anticoagulation,C0030547;C0003281;C2917212;C2919015;C3537050;C4522267,true;false;false;false;false;false,18890/22402
paresthesia,C0030554;C4553220,true;false,18891/22402
paroxysmal ( n  % ),C0205311,false,18892/22402
paroxysmal atrial fibrillation — no . ( % ),C0235480;C4050122,true;false,18893/22402
paroxysmal nocturnal dyspnea,C1956415,true,18894/22402
paroxysmal !,C0205311,false,18895/22402
paroxysmal  n ( % ),C0205311,false,18896/22402
partial mayo score,C0728938;C0454788;C0449820;C4050231;C1077578;C1550516,false;false;false;false;false;false,18897/22402
participant - reported hypertension — no . { % ),C0679646;C2698741;C4554048,false;false;false,18898/22402
participants,C0679646,false,18899/22402
participants at baseline  n,C0679646;C0168634;C1442488,false;true;false,18900/22402
participants randomized,C0679646,false,18901/22402
participants taking insulin,C0679646,false,18902/22402
participants with a history of cabg,C0679646;C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;true;false;false;false;false,18903/22402
participants with an event per $nmbr$ patient - years,C0679646;C0441471;C4019010,false;false;false,18904/22402
participants with heart failure,C0679646;C0018801;C0018802;C4554158,false;true;true;false,18905/22402
participants with hf at baseline,C0679646;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,18906/22402
participants with metabolic syndrome,C0679646;C0524620,false;true,18907/22402
participants without a history of cabg,C0679646;C0019664;C0010055;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;true;false;false;false;false,18908/22402
participants without heart failure,C0679646;C0018801;C0018802;C4554158,false;true;true;false,18909/22402
participants without hf at baseline,C0679646;C0018488;C1313497;C1538440;C3273279,false;true;true;false;false,18910/22402
participants without metabolic syndrome,C0679646;C0524620,false;true,18911/22402
participants  n,C0679646,false,18912/22402
participants  no . ( % ),C0679646,false,18913/22402
participated in a previous febuxostat studyb  n ( % ),C0205156;C0249529;C1552607,false;true;false,18914/22402
partner  n ( % yes ),C0682323;C1549445;C1705108;C1710701;C3887537,false;false;false;false;false,18915/22402
pasi,C4528685,false,18916/22402
pasi # $nmbr$ at week $nmbr$,C4528685;C0332174;C0439230,false;false;false,18917/22402
pasi [ c ]  median ( min - max ),C4528685;C0549183;C0702093;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,18918/22402
pasi $nmbr$,C4528685,false,18919/22402
pasi response by baseline mtx use  no . / total no . ( % ) * pasi $nmbr$,C4528685;C0871261;C0168634;C0025677;C1417487;C1442488;C1704632;C1706817;C2911692,false;false;true;true;false;false;false;false;false,18920/22402
pasi response by baseline weight  no . / total no . ( % ) * pasi $nmbr$,C4528685;C0871261;C1303013;C1704632;C1706817;C2911692,false;false;false;false;false;false,18921/22402
pasi score,C4528685;C0449820;C4050231,false;false;false,18922/22402
pasi score ( $nmbr$ - $nmbr$ ),C4528685;C0449820;C4050231,false;false;false,18923/22402
pasi score ( $nmbr$ - $nmbr$ )  mean ( sd ),C4528685;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,18924/22402
pasi score ( $nmbr$ - $nmbr$ ) d,C4528685;C0449820;C4050231,false;false;false,18925/22402
pasi score ( $nmbr$ – $nmbr$ scale ),C4528685;C0449820;C0175659;C0349674;C1947916;C4050231,false;false;true;false;false;false,18926/22402
pasi score  mean ( sd ),C4528685;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false;false,18927/22402
pasi score $nmbr$,C4528685;C0449820;C4050231,false;false;false,18928/22402
pasi  mean ( sd ),C4528685;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,18929/22402
pasi  median ( range ) * *,C4528685;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,18930/22402
pasi $nmbr$ a,C4528685,false,18931/22402
pasi $nmbr$  no . / total no . ( % ) $nmbr$,C4528685,false,18932/22402
pasia,,,18933/22402
passive smoker,C0425309,false,18934/22402
past cardiovascular history  no . ( % ),C0332119;C0007226;C3887460;C1444637;C1880008;C4284302,false;true;false;false;false;false,18935/22402
past or nonsmoker ( n = $nmbr$ ),C1444637;C4284302,false;false,18936/22402
past smoker,C1444637;C0337664;C4284302,false;true;false,18937/22402
past treatment for paod,C2945691,false,18938/22402
patient ' s ga  $nmbr$ - $nmbr$ mm vas,C0030705;C0016993;C4330985;C0042815;C3536884;C3827561;C4554674,true;true;false;true;true;false;false,18939/22402
patient ' s global assessment of disease status score,C4054229;C3176928;C0449820;C4050231,false;false;false;false,18940/22402
patient ' s global assessment of response to therapy score,C4054229;C0871261;C1704632;C1706817;C2911692,false;false;false;false;false,18941/22402
patient ' s history of :,C0679831;C1369882,false;false,18942/22402
patient - reported hypertension — no . { % ),C0030705,true,18943/22402
patient - reported outcomes,C2987124,true,18944/22402
patient - years ) hr ( unadjusted ),C0030705;C0439234,true;false,18945/22402
patient assessment of arthritis pain  mm,C0679830;C4317006;C4330985;C4554674,false;false;false;false,18946/22402
patient assessment of disease activity  mm,C0679830;C1292728;C4330985;C4554674,false;false;false;false,18947/22402
patient assessment of pain ( $nmbr$ - $nmbr$ cm  vas ),C0679830;C0042815,false;true,18948/22402
patient assessment of pain ( $nmbr$ - $nmbr$ mm )  mean ( sd ),C0679830;C0030193;C4330985;C0444504;C2699239;C2347634;C2348143;C4554674;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132;C0030705;C0030198,false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;true;true,18949/22402
patient characteristic,C0030705,true,18950/22402
patient characteristics at randomization,C0815172;C0034656,false;true,18951/22402
patient classification,C0030705;C0008902;C0008903;C0678229,true;true;true;false,18952/22402
patient demographics age — yr,C4698447;C0011298;C0439234;C1704791,false;true;false;false,18953/22402
patient global assessment of disease,C4054229;C0012634,false;true,18954/22402
patient global assessment of disease activity ( $nmbr$ - $nmbr$ cm  vas ),C4054228;C0042815;C3536884;C3827561,false;true;true;false,18955/22402
patient global assessment of disease activity  mean ( sd ),C4054228;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,18956/22402
patient population,C0030705;C0032659;C1257890,true;true;true,18957/22402
patient status after wake - up  % of days patient woke :,C0449437;C1170730;C0439228,false;false;false,18958/22402
patient years,C0030705;C0439234,true;false,18959/22402
patients ( full analysis sety )  n,C0030705;C0443225;C0002778;C0936012;C1524024,true;false;false;false;true,18960/22402
patients ( treated set * )  n,C0030705,true,18961/22402
patients < $nmbr$ y,C0030705,true,18962/22402
patients < $nmbr$ y *,C0030705,true,18963/22402
patients > $nmbr$ y,C0030705,true,18964/22402
patients > $nmbr$ y *,C0030705,true,18965/22402
patients aged > $nmbr$ y  no  ( ss ),C0030705,true,18966/22402
patients analyzed  n,C0030705,true,18967/22402
patients assessed,C0030705,true,18968/22402
patients in analysis  n,C0030705;C0002778;C0936012;C1524024,true;false;false;true,18969/22402
patients in the placebo group  nt - probnp values were reported for $nmbr$ patients,C0030705;C0032042;C0441833;C0669479;C0042295;C0754710;C0687744;C1257890;C1519504;C1705428;C1705429;C1696465;C1706408,true;true;false;true;false;true;false;true;false;false;false;false;false,18970/22402
patients included in analysis,C0030705,true,18971/22402
patients meeting the criteria to receive $nmbr$ mg of,C0030705,true,18972/22402
patients not receiving mtx  n =,C0030705,true,18973/22402
patients not receiving statin,C0030705,true,18974/22402
patients on antihypertensive medications  n ( % ) | |,C0030705;C0003364,true;true,18975/22402
patients on atorvastatin  rosuvastatin  or simvastatin at,C0030705;C0286651;C0965129,true;true;true,18976/22402
patients per $nmbr$ patient - years,C0030705;C0439234,true;false,18977/22402
patients randomised  n,C0030705,true,18978/22402
patients randomized  n,C0030705,true,18979/22402
patients randomized  no .,C0030705,true,18980/22402
patients randomly assigned,C0030705,true,18981/22402
patients receiving $nmbr$ mg of edoxaban at randomization — no . ( % ) f,C0030705,true,18982/22402
patients receiving any uc medication  n ( % ),C0030705,true,18983/22402
patients receiving immunotherapy  no . ( % ),C0030705,true,18984/22402
patients receiving mtx,C0030705,true,18985/22402
patients receiving mtx  n =,C0030705,true,18986/22402
patients receiving statin,C0030705,true,18987/22402
patients taking mtx  n ( % ),C0030705,true,18988/22402
patients taking mtx  no . ( % ),C0030705,true,18989/22402
patients taking oral corticosteroids at baseline  n ( % ),C0030705,true,18990/22402
patients total no .,C0030705,true,18991/22402
patients treated and operated  n ( % ),C0030705,true,18992/22402
patients treated with atenoloi ( n = $nmbr$ ),C0030705,true,18993/22402
patients treated with losartan ( n = $nmbr$ ),C0030705,true,18994/22402
patients who did not use insulin pump,C0030705,true,18995/22402
patients who had ulcerations at,C0030705,true,18996/22402
patients who received $nmbr$ drug,C0030705,true,18997/22402
patients who received $nmbr$ or $nmbr$ drugs,C0030705,true,18998/22402
patients who used insulin pump,C0030705,true,18999/22402
patients with $ $nmbr$ dactylitis digit at week $nmbr$ enthesitis,C0030705;C3863761,true;false,19000/22402
patients with $ $nmbr$ % bsa at baseline  no .,C0030705,true,19001/22402
patients with > $nmbr$ exacerbation in previous $nmbr$ months,C0030705;C4086268,true;false,19002/22402
patients with > $nmbr$ exacerbation requiring admission to hospital in the $nmbr$ months before screening,C4086268;C0030673,false;true,19003/22402
patients with > $nmbr$ exacerbation requiring er visit or admission to hospital in the $nmbr$ months before screening,C1512346;C4086268;C3810541;C3811131,false;false;false;false,19004/22402
patients with > $nmbr$ co - aeds,C0030705;C3245499;C0180309,true;true;true,19005/22402
patients with > $nmbr$ % bsa,C0030705,true,19006/22402
patients with > $nmbr$ % bsa psoriasis skin involvement  n ( % ),C0030705;C0033860;C0444099;C1314939;C1123023;C4520765,true;true;false;false;true;false,19007/22402
patients with $nmbr$ co - aed,C0030705;C3245499;C0887457,true;true;true,19008/22402
patients with $nmbr$ co - aeds,C0030705;C3245499;C0180309,true;true;true,19009/22402
patients with a prior mi or stroke at baseline,C0030705;C0332152;C3810814;C2826257,true;false;false;false,19010/22402
patients with an event per $nmbr$ patient - years,C0030705;C0441471;C4019010,true;false;false,19011/22402
patients with ascvd but no prior ml hr ( $nmbr$ % cl ),C0030705;C3665365,true;false,19012/22402
patients with bp $ $nmbr$ / $nmbr$ mmhg ( abpm ) at baseline  nt,C0030705;C0037623;C0439475;C1415692;C1708288;C4318478,true;true;false;false;false;false,19013/22402
patients with cardiac disorders  n ( % ) §,C0741926;C0012634;C0030705;C0018799,false;true;true;true,19014/22402
patients with cardiac disorders  n ( % ) c,C0741926;C0012634;C0030705;C0018799,false;true;true;true,19015/22402
patients with change from baseline in psa - modified total shs score # $nmbr$,C0030705;C0392747;C0443172;C1705241;C4319952,true;false;false;false;false,19016/22402
patients with change from baseline in total psa ‐ modified shs ≤ $nmbr$,C0030705;C0392747;C0443172;C1705241;C4319952,true;false;false;false;false,19017/22402
patients with clinically evident vascular disease,C0030705;C3887511;C0042373,true;false;true,19018/22402
patients with dactylitis,C0030705;C0239161,true;false,19019/22402
patients with dactylitis at baseline  no .,C0030705;C0239161,true;false,19020/22402
patients with dactylitis at week $nmbr$  n ( % ),C0030705;C0239161,true;false,19021/22402
patients with dactylitis  no . ( % ),C0030705;C0239161,true;false,19022/22402
patients with dactylitisa,C0030705,true,19023/22402
patients with deep - vein thrombosis only,C0030705;C0149871;C0205171;C1720467,true;true;false;false,19024/22402
patients with diabetes,C0030705;C0011847;C0011849,true;false;true,19025/22402
patients with diabetes mellitus ( n = $nmbr$ ),C0030705;C0011849,true;true,19026/22402
patients with digits with dactylitis  n ( % ),C0030705;C0582802,true;false,19027/22402
patients with dm ( n = $nmbr$ ),C0030705;C0011816;C3250443,true;true;false,19028/22402
patients with dm vs . patients without dm,C0030705;C0011816;C3250443,true;true;false,19029/22402
patients with draining fistulae at baseline [ n = $nmbr$ ],C0030705;C0544791,true;false,19030/22402
patients with early cd ( n = $nmbr$ ),C0030705;C1279919;C0007928;C0034283;C4552032,true;false;true;true;false,19031/22402
patients with eligible ses - cd score,C0030705;C1548635;C0007928;C0449820;C4050231;C0034283;C4552032,true;false;true;false;false;true;false,19032/22402
patients with endpoin t  n ( % ),C0030705,true,19033/22402
patients with enthesitis,C0030705;C1282952,true;false,19034/22402
patients with enthesitis ( lei > $nmbr$ ),C0030705;C1282952;C0023401;C0428209,true;false;true;false,19035/22402
patients with enthesitis at baseline  no .,C0030705;C1282952,true;false,19036/22402
patients with enthesitis at week $nmbr$ radiographic progression § change from baseline to week $nmbr$ in psa - modified total shs score,C0030705;C1282952,true;false,19037/22402
patients with enthesitis at week $nmbr$  n ( % ),C0030705;C1282952,true;false,19038/22402
patients with enthesitis  n ( % ),C0030705;C1282952,true;false,19039/22402
patients with enthesitis  no . ( % ),C0030705;C1282952,true;false,19040/22402
patients with eot data  n,C2707520,false,19041/22402
patients with established cv disease aged > $nmbr$ years .,C0030705;C0443211;C0007222;C1510829;C1272684,true;false;true;false;false,19042/22402
patients with evaluable endoscopy,C2986511;C0014245,false;true,19043/22402
patients with event ( n  % ),C0030705;C0441471;C4019010,true;false;false,19044/22402
patients with event / patients analysed,C0030705;C0441471;C4019010,true;false;false,19045/22402
patients with event / analyzed,C0030705;C0441471;C4019010,true;false;false,19046/22402
patients with fingernail involvement,C0030705;C0222001;C1314939,true;true;false,19047/22402
patients with glycated hemoglobin < $nmbr$ . $nmbr$ % and no severe hypoglycemia or diabetic ketoacidosis,C0030705;C0017853,true;true,19048/22402
patients with glycated hemoglobin > $nmbr$ . $nmbr$ % and > $nmbr$ episode of severe hypoglycemia *,C0030705;C0017853,true;true,19049/22402
patients with glycated hemoglobin > $nmbr$ . $nmbr$ % and > $nmbr$ episode ofdiabetic ketoacidosis *,C0030705;C0017853,true;true,19050/22402
patients with hospitalized pneumonia events  n ( % ),C0870668;C0032285;C0441471;C3541888,false;true;false;false,19051/22402
patients with improvement $ $nmbr$ . $nmbr$,C0030705;C2986411,true;false,19052/22402
patients with level > $nmbr$ pg / ml,C0030705;C0441889;C0439297;C0456079;C1547707;C2946261,true;false;false;false;false;false,19053/22402
patients with low ( < $nmbr$ mg / dl ) c $nmbr$,C0030705;C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223,true;false;false;false;false;false;false;false,19054/22402
patients with measurement,C0030705;C0242485,true;false,19055/22402
patients with microvascular complications  n ( % ),C0030705;C0443258;C0009566;C1171258,true;false;false;true,19056/22402
patients with mild pain ( womac pain score  $nmbr$ - $nmbr$ ),C0030705;C0278138;C0449820;C4050231;C4522280;C2945599;C0582148,true;false;false;false;false;false;false,19057/22402
patients with moderate - to - severe pain ( womac pain score  $nmbr$ - $nmbr$ ),C0030705;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,true;false;false;false;false;false;false,19058/22402
patients with nail psoriasis ( mnapsi > $nmbr$ ),C0030705;C0406322,true;false,19059/22402
patients with negative anti - dsdna,C0030705;C0205160;C0741099;C1513916;C2825415;C2825491;C3853545,true;false;false;false;false;false;false,19060/22402
patients with no prior cvd ( primary,C0030705;C0332152;C0007222;C2826257,true;false;true;false,19061/22402
patients with only mrf hr ( $nmbr$ % cl ),C0030705;C0205171;C0312443;C0596019;C1412879;C1720467,true;false;false;false;false;false,19062/22402
patients with perianal fistulae  n [ % ],C0030705;C0267561,true;false,19063/22402
patients with pneumonia event  n ( % ) #,C0030705;C0032285;C0441471;C4019010,true;true;false;false,19064/22402
patients with pneumonia events  n ( % ) #,C0030705;C0032285;C0441471;C3541888,true;true;false;false,19065/22402
patients with pneumonia resulting in death  n ( % ),C0030705;C0032285,true;true,19066/22402
patients with possible new dm at randomization ( fpg > $nmbr$ - $nmbr$ ),C0030705;C0332149;C0205314;C0011816;C3250443;C1705910;C2362652,true;false;false;true;false;false;false,19067/22402
patients with possible new dm at randomization ( hba $nmbr$ c > $nmbr$ . $nmbr$ - $nmbr$ % ),C0030705;C0332149;C0205314;C0011816;C3250443;C1705910;C2362652,true;false;false;true;false;false;false,19068/22402
patients with prior dmard use  n ( % ) a,C0030705;C0332152;C0242708;C0042153;C0457083;C1947944;C2826257,true;false;true;true;false;false;false,19069/22402
patients with prior ml hr ( $nmbr$ % cl ),C0030705;C0332152;C0439526;C0596019;C1705224;C3887665;C2826257,true;false;false;false;false;false;false,19070/22402
patients with psoriasis ( bsa ≥   $nmbr$ % ),C0030705;C0033860,true;true,19071/22402
patients with psoriasis > $nmbr$ % of body surface area,C0030705;C0033860;C0489451;C0017446;C0205146,true;true;false;true;false,19072/22402
patients with pulmonary embolism,C0030705;C0034065,true;true,19073/22402
patients with radiographic erosion  n / n ( % ),C0030705;C0444708;C0333307;C1880549;C1959609;C3887524,true;false;false;false;false;false,19074/22402
patients with remission,C1277626,false,19075/22402
patients with serum $nmbr$ ( oh ) d ≥   $nmbr$ . $nmbr$ and <   $nmbr$   ng / ml    n / n   ( % ),C0030705;C0229671;C0220853;C1546774;C1550100,true;true;true;false;false,19076/22402
patients with specific disease characteris -,C0683521;C0205369;C1552740,false;false;false,19077/22402
patients with specific disease characteristics  n ( % ),C0030705;C0205369;C0599878;C1552740,true;false;false;false,19078/22402
patients with supplemental vitamin d dose of $nmbr$ iu / day starting at screeningc    n   ( % ),C0030705;C0420176;C0178602;C0439465;C0439659;C0869039;C1114758;C3541352,true;false;false;false;false;false;false;false,19079/22402
patients with weekly iss mid response  n ( % ) v,C0030705;C0332174;C1740819;C0871261;C1704632;C1706817;C2911692;C1845118,true;false;false;false;false;false;false;false,19080/22402
patients without,C0030705,true,19081/22402
patients without a prior mi or stroke at baseline,C0030705;C0332152;C3810814;C2826257,true;false;false;false,19082/22402
patients without clinically evident vascular disease,C0030705;C3887511;C0042373,true;false;true,19083/22402
patients without diabetes,C0030705;C0011847;C0011849,true;false;true,19084/22402
patients without diabetes mellitus ( n = $nmbr$ ),C0030705;C0011849,true;true,19085/22402
patients without dm ( n = $nmbr$  $nmbr$ ),C0030705;C0011816;C3250443,true;true;false,19086/22402
patients without dm ( n = $nmbr$ ),C0030705;C0011816;C3250443,true;true;false,19087/22402
patients without draining fistulae at baseline [ n = $nmbr$ ],C0030705;C0544791,true;false,19088/22402
patients  n ( % ),C0030705,true,19089/22402
patients  n / n ( % ) a,C0030705,true,19090/22402
patients  no .,C0030705,true,19091/22402
patients    n   ( % ),C0030705,true,19092/22402
patients / events n,C0030705;C0441471;C3541888,true;false;false,19093/22402
patientswith bp $ $nmbr$ / $nmbr$ mmhg ( abpm ) at baseline  nt,C0037623;C0439475;C0168634;C0332126;C1449832;C3889152;C4050156;C4283901;C4284038;C1442488;C1415692;C1708288;C4318478,true;false;true;false;true;false;false;false;false;false;false;false;false,19094/22402
patientswith bp  $nmbr$ / $nmbr$ mmhg ( abpm ) at baseline  n §,C0037623;C0439475;C0168634;C1442488;C1415692;C1708288;C4318478,true;false;true;false;false;false;false,19095/22402
pb,C1415801;C3819255,false;false,19096/22402
pbo - adjusted ls mean change,C0031962;C0456081;C0023668;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;true;false;false;false;false;false;false;false,19097/22402
pbo - adjusted ls mean change ( se ),C0031962;C0456081;C0023668;C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;true;false;false;true;false;false;false;false;false,19098/22402
pbo - sc every other week ( n = $nmbr$ ),C0031962;C0282380,true;true,19099/22402
pbo ( n - $nmbr$ ),C0031962,true,19100/22402
pbo ( n   =   $nmbr$ ),C0031962,true,19101/22402
pbo czp $nmbr$ mg q $nmbr$ w week $nmbr$ ( n = $nmbr$ ),C0031962;C0054841;C0024671;C0332174;C0439230;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109,true;true;true;false;false;true;false;false;false;false;false;true;true,19102/22402
pbo n = $nmbr$,C0031962,true,19103/22402
pbo to czp week $nmbr$ dose combined,C0031962;C0054841;C0332174;C0178602;C0869039;C1114758;C0439230;C1861828;C1872109,true;true;false;false;false;false;false;true;true,19104/22402
pbo  no . ( % ) ^,C0031962,true,19105/22402
pbo  no . ( o / o ) ^ ’,C0031962,true,19106/22402
pci — no . { % ),C4049621,false,19107/22402
pci alone ( n = $nmbr$ ),C4049621;C0205171;C0439044;C0679994,false;false;false;false,19108/22402
pci duration,C4049621;C0449238;C2926735,false;false;false,19109/22402
pci history,C4049621;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,19110/22402
pci indication,C4049621;C0392360;C3146298,false;false;false,19111/22402
pci performed,C4049621,false,19112/22402
pci postindex event,C4049621;C0441471;C4019010,false;false;false,19113/22402
pci / thrombolysis at randomization,C4049621;C0520997;C0034656,false;false;true,19114/22402
pci :,C4049621,false,19115/22402
pci = percutaneous coronary intervention . cabg = coronary - artery bypass graft . for hope > $nmbr$ mg / l  for europa > $nmbr$ mg / l or on a lipid - lowering treatment  for peace  data are mean ( sd ) . data are mean ( sd ) unless otherwise indicated .,C4049621;C0522523;C0545743;C0184661;C0010055;C0189695;C0886296;C1273869;C0392347;C2827881;C0242751;C0023779;C0441994;C0039798;C0680443;C1511726;C3245479;C3714741;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C2003888,false;false;false;true;true;false;false;false;true;false;true;true;false;true;false;false;false;false;true;false;false;false;false;false;false,19116/22402
pcr after acs,C0032520;C0742343;C4318612;C3853643;C4050242,true;true;false;false;false,19117/22402
pcs score,C1864389;C1882368,false;true,19118/22402
pcs score ( $nmbr$ – $nmbr$ scale ),C1864389;C1882368,false;true,19119/22402
pde - $nmbr$ i,C0021966;C0221138,true;false,19120/22402
pde - $nmbr$ i monotherapy,C0021966;C0221138,true;false,19121/22402
pde $nmbr$ inhibitors,C0031638,true,19122/22402
pdq - $nmbr$,,,19123/22402
pe and dvt,C0070939;C1880476;C4284304,true;false;false,19124/22402
pe only,C0070939;C0205171;C1720467;C1880476;C4284304,true;false;false;false;false,19125/22402
pe with / without dvt,C0070939;C1880476;C4284304,true;false;false,19126/22402
peak fev $nmbr$ ( $nmbr$ - $nmbr$ h )   response,C0444505;C3714541;C0033727;C0871261;C1704632;C1706817;C2911692;C0369286;C0441932;C0564385;C4528284,false;true;true;false;false;false;false;false;false;false;false,19127/22402
peak systolic pressure gradient,C4687747;C0039155,false;true,19128/22402
pedal edema  slight / moderate / marked,C0574002;C2937276;C0205081;C0522501;C1706089;C1881878;C4049705;C4049706;C4085643;C4321335;C2945599;C4050469,false;false;false;false;false;false;false;false;false;false;false;false,19129/22402
pef at baseline  l_ / min,C0030771;C0168634;C0702093;C1524029;C3813700;C1442488;C1518922;C1542834,true;true;false;false;false;false;false;false,19130/22402
pef !,C0030771;C1518922;C1542834,true;false;false,19131/22402
pefam   ( l / min ) ∗,C0702093;C1524029;C3813700,false;false;false,19132/22402
pefpm   ( l / min ) ∗,C0702093;C1524029;C3813700,false;false;false,19133/22402
penetrating no . of resections  n ( % ),C0205321,false,19134/22402
people with diabetes n = $nmbr$,C0027361;C0011847;C0011849,true;false;true,19135/22402
people without diabetes n = $nmbr$,C0027361;C0011847;C0011849,true;false;true,19136/22402
pepsinogen i / ii ratio,C0030915;C0456603;C1547037;C0523817,true;false;false;false,19137/22402
per body weight  u / kg,C0005910;C1300561;C1305866,true;false;false,19138/22402
percent activity impairment due to asthma,C0439167;C0221099;C0678226;C0004096;C2984299;C0684336,false;false;false;true;false;false,19139/22402
percent atheroma volume at baseline,C1690016;C0264956;C0168634;C1442488;C3887614,false;true;true;false;false,19140/22402
percent change from baseline at week $nmbr$,C3272907,false,19141/22402
percent change from baseline to week $nmbr$ in auc ( mean  sem ),C3272907,false,19142/22402
percent impairment while working due to asthma,C0439165;C0221099;C0684336,false;false;false,19143/22402
percent improvement  baseline to week $nmbr$  median ( iqr ),C0439165;C2986411;C0168634;C0332174;C0549183;C0876920;C2347635;C2348144;C2939193;C0439230;C1442488,false;false;true;false;false;false;false;false;false;false;false,19144/22402
percent of predicted normal value,C1882327;C0205307;C0231683;C0439166;C2347086;C4553972,false;false;false;false;false;false,19145/22402
percent of predicted value before bronchodilation ^,C1882327,false,19146/22402
percent of the time that inr was in the therapeutic range,C0439165;C0040223;C3541383,false;true;false,19147/22402
percent overall work impairment due to asthma,C0439165,false,19148/22402
percent stenosis [ core lab ],C0439165;C0678234;C4684837;C1261287;C2632116,false;false;false;true;false,19149/22402
percent stenosis [ investigator ],C0439165;C0678234;C0035173;C1261287;C2632116,false;false;true;true;false,19150/22402
percent work time missed due to asthma,C0439165;C0043227;C0040223;C3541383,false;true;true;false,19151/22402
percentage,C0439165;C1549488;C1561533,false;false;false,19152/22402
percentage of bsa involved,C0439165;C1549488;C1561533,false;false;false,19153/22402
percentage of females,C0439165;C0086287;C1549488;C1561533,false;true;false;false,19154/22402
percentage of fevj reversibility,C0439165;C0449261;C1549488;C1561533,false;false;false;false,19155/22402
percentage of p,C0439165;C1549488;C1561533,false;false;false,19156/22402
percentage of patients receiving dose adjustment,C0439165;C0030705;C1549488;C1561533,false;true;false;false,19157/22402
percentage of patients with event,C0439165;C0030705;C1549488;C1561533,false;true;false;false,19158/22402
percentage of predicted pre - bronchodilator fev ^,C0439165;C0681842;C2599602;C3714541;C1882327;C1549488;C1561533,false;false;false;true;false;false;false,19159/22402
percentage points,C0439165;C1549488;C1561533,false;false;false,19160/22402
percentage unless otherwise noted . cabg indicates coronary artery bypass graft  lvh  left ventricular hypertrophy  nsaids  nonsteroidal antiinflammatory drugs  pvd  peripheral vascular disease  tia  transient ischemic attack . ‘ history of hypercholesterolemia or reporting use of lipid - lowering medications at baseline . thistory of or currently have elevated serum creatinine level < $nmbr$ mg / dl . tbased on participant history or review of chart .,C0439165;C1549488;C1561533;C0149721;C0003211;C0085096;C4521226;C0042373;C0007787;C0455536;C0020443;C1522133;C0917805;C1054154;C0700287;C1524063;C0023779;C0441994;C0013227;C0802604;C2598133;C4284232;C2003888;C0679646;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C2698741;C4554048,false;false;false;true;true;true;false;true;true;false;true;false;true;false;false;false;true;false;true;false;false;false;false;false;true;true;false;false;false;false;false;false,19161/22402
percentages,C0439165;C1549488;C1561533,false;false;false,19162/22402
percentages of patients with event,C0439165;C0030705;C1549488;C1561533,false;true;false;false,19163/22402
percutaneous coronary intervention done *,C1532338,true,19164/22402
percutaneous coronary intervention n ( % ),C1532338,true,19165/22402
percutaneous coronary intervention or coronary - artery bypass grafting for index acute coronary syndrome — no . { % ),C1532338,true,19166/22402
percutaneous coronary intervention  n ( % ),C1532338,true,19167/22402
percutaneous coronary intervention §,C1532338,true,19168/22402
percutaneous transluminal coronary angioplasty,C2936173,true,19169/22402
peri - operative cabg participants :,C0347985;C1882154;C0010055;C0679646,false;false;true;false,19170/22402
perianal gi tract,C0442158;C0017189,false;true,19171/22402
perianal  n ( % ),C0442158,false,19172/22402
perindopril - indapamide,C1273169,true,19173/22402
period ii,C0439531;C1710602;C4082587;C1948053,false;false;false;false,19174/22402
periostin,C0219433;C1424662;C3812270,true;false;false,19175/22402
periostin high,C0219433;C1424662;C3812270,true;false;false,19176/22402
periostin low,C0219433;C1424662;C3812270,true;false;false,19177/22402
peripherai arteriai disease,C0012634,true,19178/22402
peripheral - artery stenosis,C4025272,false,19179/22402
peripheral angioplasty,C0205100;C0162577;C1548817,false;true;false,19180/22402
peripheral arterial disease — no . ( % ),C0085096;C1704436,true;true,19181/22402
peripheral arterial disease ( n = $nmbr$ $nmbr$ ),C0085096;C1704436,true;true,19182/22402
peripheral arterial disease §,C0085096;C1704436,true;true,19183/22402
peripheral arterial stenosis,C4025272,false,19184/22402
peripheral artery disease - -,C1704436;C4025272,true;false,19185/22402
peripheral artery disease 一 no . ( % ),C1704436;C4025272,true;false,19186/22402
peripheral artery diseaseb,C0489868,false,19187/22402
peripheral limb vascular efficacy,C0150936;C0015385;C1280519;C1707887;C0947487,false;true;false;false;false,19188/22402
peripheral revascularisation,C0205100;C0581603,false;false,19189/22402
peripheral sensory neuropathy,C0151313;C4554142,false;false,19190/22402
periprocedural medications  n ( % ),C0013227;C0802604;C2598133;C4284232,true;false;false;false,19191/22402
permanent ( n  % ),C0205355,false,19192/22402
permanent af,C0205355;C0344434;C4049859,false;false;false,19193/22402
permanent users,C0205355;C1706077,false;false,19194/22402
permanent users  n,C0205355;C1706077,false;false,19195/22402
permanent  n ( % ),C0205355,false,19196/22402
persisent,,,19197/22402
persistent ( n  % ),C0205322;C0332996,false;false,19198/22402
persistent af  n ( % ),C0205322;C0344434;C4049859;C0332996,false;false;false;false,19199/22402
persistent faod ( n [ $nmbr$ ),C0205322;C0332996,false;false,19200/22402
persistent faol ( n [ $nmbr$ ),C0205322;C0332996,false;false,19201/22402
persistent *,C0205322;C0332996,false;false,19202/22402
persistent  n ( % ),C0205322;C0332996,false;false,19203/22402
persistent / permanent,C0205322;C0205355;C0332996,false;false;false,19204/22402
person - years,C0027361;C0439234;C2347489,true;false;false,19205/22402
pervious cerebrovascular event,C0205326;C1880018;C0441471;C4019010,false;false;false;false,19206/22402
pfor trend,C1151635;C1521798;C4554533,false;false;false,19207/22402
pga score ( range ),C0016410;C0449820;C1514721;C2348147;C3542016;C4050231;C3541266;C4050369,true;false;false;false;false;false;false;false,19208/22402
pga score  mean ( sd ),C0016410;C0449820;C0444504;C2699239;C2347634;C2348143;C4050231;C3541266;C4050369,true;false;false;false;false;false;false;false;false,19209/22402
pgi - s  n ( % ) y :,C0523816;C1333690;C1412792;C1704947;C2975867;C3810522;C4522133,false;false;false;false;true;false;false,19210/22402
phakic,,,19211/22402
pharmacological therapy for hf,C0013217;C0018488;C1313497;C1538440;C3273279,true;true;true;false;false,19212/22402
pharyngitis,C0031350;C4553308,true;false,19213/22402
phenobarbital,C0031412,true,19214/22402
phosphatase  mean ( sd )  ng / ' mlf,C0031678;C0444504;C2699239;C0017887;C0066495;C0028074;C2347634;C2348143;C1149880;C4522024,true;false;false;true;true;true;false;false;false;false,19215/22402
phototherapy,C0031765,true,19216/22402
phototherapy previous systemic treatment  n ( % ),C0031765;C0205156;C0678812;C1552607,true;false;false;false,19217/22402
physical activity ( hours walking / wk ),C0015259;C0439227;C0026606,true;false;true,19218/22402
physical activity  kcal / wk < $nmbr$,C0015259;C0439259;C0332174;C0439230;C0026606,true;false;false;false;true,19219/22402
physical characteristics,C0031809;C1521970;C0205485;C1509143,true;false;false;false,19220/22402
physician ' s assessment of disease activity ( vas )  mm,C0031831;C1261322;C1292728;C0042815;C0456681;C3536884;C3827561;C1516048;C0804815,true;false;false;true;false;true;false;false;false,19221/22402
physician ' s ga  $nmbr$ - $nmbr$ mmvas,C0031831;C0016993;C0804815,true;true;false,19222/22402
physician ' s global assessment of disease status score,C4050369;C3176928;C0449820;C4050231,false;false;false;false,19223/22402
physician global assessment of disease,C4050369;C0012634,false;true,19224/22402
physician global assessment of disease activity ( $nmbr$ - $nmbr$ cm  vas ),C4050369;C0042815;C3536884;C3827561,false;true;true;false,19225/22402
physician global assessment of disease activity  mean ( sd ),C4050369;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,19226/22402
pi,C0122626;C0429863;C3537219;C3539772,true;false;false;false,19227/22402
piacebo,,,19228/22402
piacebo ( n = $nmbr$ ) no . of participants with events ( % ),,,19229/22402
pifr l / min,C0702093;C1524029;C3813700,false;false;false,19230/22402
pinteraction for treatment and history of heart failure,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,19231/22402
pinteraction = $nmbr$ . $nmbr$,,,19232/22402
pioglitazone dose  mean ( sd )  mg,C0071097;C0178602;C0444504;C2699239;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C2347634;C2348143;C0869039;C1114758,true;false;false;false;true;true;false;false;false;false;false;false;false;false;false,19233/22402
pioglitazone group ( n = $nmbr$ ),C0071097;C0441848,true;false,19234/22402
pioglitazone only,C0071097;C0205171;C1720467,true;false;false,19235/22402
piroxicam,C0031990,true,19236/22402
pla « = $nmbr$,C0456170,false,19237/22402
pla n = $nmbr$,C0456170,false,19238/22402
place !,C0442504;C1533810;C1704765;C1882509,false;false;false;false,19239/22402
placebo - control study,C0683952,false,19240/22402
placebo ‐ controlled period,C1706408;C0439531;C1948053,false;false;false,19241/22402
placebo |,C0032042;C1696465;C1706408,true;false;false,19242/22402
placebo $nmbr$ o $nmbr$,C0032042;C1696465;C1706408,true;false;false,19243/22402
placebo  ( n = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19244/22402
placebo ( « = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19245/22402
placebo ( » = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19246/22402
placebo ( $nmbr$ = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19247/22402
placebo ( $nmbr$  $nmbr$ . $nmbr$ % ),C0032042;C1696465;C1706408,true;false;false,19248/22402
placebo ( events / n ( % ) ),C0032042;C0441471;C3541888;C1696465;C1706408,true;false;false;false;false,19249/22402
placebo ( n — $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19250/22402
placebo ( n : $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19251/22402
placebo ( n = $nmbr$ ) †,C0032042;C1696465;C1706408,true;false;false,19252/22402
placebo ( n = $nmbr$ ) i -,C0032042;C1696465;C1706408,true;false;false,19253/22402
placebo ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C0032042;C1696465;C1706408,true;false;false,19254/22402
placebo ( n = $nmbr$ ) ',C0032042;C1696465;C1706408,true;false;false,19255/22402
placebo ( n = $nmbr$ ) n ( % ),C0032042;C1696465;C1706408,true;false;false,19256/22402
placebo ( n = $nmbr$ i $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19257/22402
placebo ( n $nmbr$ $nmbr$  $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19258/22402
placebo ( n   = $nmbr$  $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19259/22402
placebo ( n   = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19260/22402
placebo ( n   =   $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19261/22402
placebo ( n   =   $nmbr$  $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19262/22402
placebo ( n   =   $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19263/22402
placebo ( n   =   $nmbr$ ) a,C0032042;C1696465;C1706408,true;false;false,19264/22402
placebo ( n   =   $nmbr$ ) b,C0032042;C1696465;C1706408,true;false;false,19265/22402
placebo ( n = l $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19266/22402
placebo ( symptom days a week ),C0032042;C1457887;C0439228;C3854129;C1696465;C1706408,true;false;false;false;false;false,19267/22402
placebo ( w = $nmbr$ ),C0032042;C1696465;C1706408,true;false;false,19268/22402
placebo + glimepiride,C0032042;C0061323;C1696465;C1706408,true;true;false;false,19269/22402
placebo + insulin ( n   = $nmbr$ ),C0032042;C0021641;C1533581;C1579433;C3714501;C1696465;C1706408,true;true;false;false;false;false;false,19270/22402
placebo + insulin ( n = $nmbr$ ),C0032042;C0021641;C1533581;C1579433;C3714501;C1696465;C1706408,true;true;false;false;false;false;false,19271/22402
placebo + insulin glargine ( award - $nmbr$  n = $nmbr$ ),C0032042;C0907402;C0004446;C1696465;C1706408,true;true;true;false;false,19272/22402
placebo + pioglitazone ( n = $nmbr$ ),C0032042;C0071097;C1696465;C1706408,true;true;false;false,19273/22402
placebo $nmbr$ . $nmbr$,C0032042;C1696465;C1706408,true;false;false,19274/22402
placebo $nmbr$  $nmbr$,C0032042;C1696465;C1706408,true;false;false,19275/22402
placebo analysed ( % ),C0032042;C1696465;C1706408,true;false;false,19276/22402
placebo arm,C0032042;C0446516;C3715044;C4553528;C1696465;C1706408,true;true;false;false;false;false,19277/22402
placebo diabetes n = $nmbr$,C0032042;C0011847;C0011849;C1696465;C1706408,true;false;true;false;false,19278/22402
placebo dn = $nmbr$ ),C0032042;C1333964;C1707618;C1696465;C1706408,true;false;false;false;false,19279/22402
placebo dr = $nmbr$ ),C0032042;C0013014;C0031831;C1707664;C2348314;C3540849;C1696465;C1706408,true;true;true;false;false;false;false;false,19280/22402
placebo events / patients (,C0032042;C0441471;C0030705;C3541888;C1696465;C1706408,true;false;true;false;false;false,19281/22402
placebo group ( n = $nmbr$ ) ’ j ',C0032042;C0441844;C1696465;C1706408,true;false;false;false,19282/22402
placebo km %,C0032042;C3887676;C1696465;C1706408,true;false;false;false,19283/22402
placebo mdi,C0032042;C0993596;C1839839;C4049613;C1696465;C1706408,true;true;true;false;false;false,19284/22402
placebo mean,C0032042;C0444504;C2347634;C2348143;C1696465;C1706408,true;false;false;false;false;false,19285/22402
placebo mean change ( sd ),C0032042;C0444504;C0392747;C2699239;C0443172;C1705241;C4319952;C2347634;C2348143;C1696465;C1706408,true;false;false;false;false;false;false;false;false;false;false,19286/22402
placebo mortality rate  events per $nmbr$ person - y,C0032042;C0026565;C0441471;C0027361;C2347489;C3541888;C0205848;C1696465;C1706408,true;true;false;true;false;false;true;false;false,19287/22402
placebo n,C0032042;C1696465;C1706408,true;false;false,19288/22402
placebo n ( rate ) $nmbr$,C0032042;C0871208;C1521828;C1696465;C1706408,true;false;false;false;false,19289/22402
placebo n / n,C0032042;C1696465;C1706408,true;false;false,19290/22402
placebo no diabetes n = $nmbr$,C0032042;C1696465;C1706408,true;false;false,19291/22402
placebo no . ( $nmbr$ - y km % ),C0032042;C1696465;C1706408,true;false;false,19292/22402
placebo patients / events n,C0032042;C0030705;C0441471;C3541888;C1696465;C1706408,true;true;false;false;false;false,19293/22402
placebo plus statin ( n = $nmbr$ ),C0032042;C0332287;C0360714;C1696465;C1706408,true;false;true;false;false,19294/22402
placebo slope lsm ± se ( mm / year ),C0032042;C0807955;C0036919;C4330985;C0439234;C0439508;C4554674;C1696465;C1706408,true;false;true;false;false;false;false;false;false,19295/22402
placebo tiotropium n = $nmbr$ non - tiotropium n = $nmbr$,C0032042;C0213771;C1518422;C1696465;C1706408,true;true;false;false;false,19296/22402
placebo to ustekinumab $nmbr$ mgt,C0032042;C1608841;C1696465;C1706408,true;true;false;false,19297/22402
placebo tolvaptan ( $nmbr$ mg ) ( n $nmbr$ $nmbr$ ) ( n $nmbr$ $nmbr$ ),C0032042;C1176308;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1696465;C1706408,true;true;true;true;false;false;false;false;false;false;false,19298/22402
placebo ( n = $nmbr$ )  n ( % ),C0032042;C1696465;C1706408,true;false;false,19299/22402
placebo * ( add on to basal insulin ),C0032042;C1883712;C0650607;C1696465;C1706408,true;false;false;false;false,19300/22402
placebo  $nmbr$ . $nmbr$ ml ( n = $nmbr$ ),C0032042;C0439526;C1705224;C3887665;C1696465;C1706408,true;false;false;false;false;false,19301/22402
placebo  n,C0032042;C1696465;C1706408,true;false;false,19302/22402
placebo  n = l $nmbr$,C0032042;C1696465;C1706408,true;false;false,19303/22402
placebo  n *,C0032042;C1696465;C1706408,true;false;false,19304/22402
placebo  n   =   $nmbr$,C0032042;C1696465;C1706408,true;false;false,19305/22402
placebo /,C0032042;C1696465;C1706408,true;false;false,19306/22402
placebo / rosu vastatin,C0032042;C1099881;C1696465;C1706408,true;true;false;false,19307/22402
placebo / simva,C0032042;C1696465;C1706408,true;false;false,19308/22402
placebo + statin,C0032042;C0360714;C1696465;C1706408,true;true;false;false,19309/22402
placebo → golimumab $nmbr$ mg / $nmbr$ mga  b,C0032042;C2353893;C0024671;C0065879;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1696465;C1706408,true;true;true;true;true;false;false;false;false;false;false;false,19310/22402
placebo §,C0032042;C1696465;C1706408,true;false;false,19311/22402
placebofigolimumab $nmbr$ mg / $nmbr$ mgt,C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,19312/22402
plaeebo,,,19313/22402
plasma cholesterol — mg / dl,C0858034;C0439269,false;false,19314/22402
plasma creatine  mg / dl,C0032105;C0010286;C0439269;C1550098;C4521445,true;true;false;false;false,19315/22402
plasma dha  mean ( sd ) weight  %,C0032105;C0142831;C0444504;C2699239;C0005910;C0043100;C1305866;C1705104;C2347634;C2348143;C2348308;C1550098;C4521445,true;true;false;false;true;true;false;false;false;false;false;false;false,19316/22402
plasma glucose — mmol per liter,C0202042;C0439190;C0475211;C0455280,false;false;false;false,19317/22402
plasma glucose $nmbr$ hr after glucose load — mmol / liter,C0202042;C1550025;C0439190;C0475211;C1704782;C1708715;C0455280,false;false;false;false;false;false;false,19318/22402
plasma lipids ( mg / dl ) $nmbr$ total cholesterol mean,C0858034;C0023779;C0439269;C0444504;C2347634;C2348143,false;true;false;false;false;false,19319/22402
plasma lipoproteins  mmol / l,C0032105;C0023820;C1532563;C1550098;C4521445,true;true;false;false;false,19320/22402
plasma triglyceride — mg / dl,C0032105;C0041004;C0439269;C1550098;C4521445,true;true;false;false;false,19321/22402
platelet aggregation inhibitors excluding heparin,C0032177,true,19322/22402
platelet aggregation inhibitors  n ( % ),C0032177,true,19323/22402
platelets xlooo / mm ^,C0005821;C4330985;C4554674;C0443116;C1963076,true;false;false;false;false,19324/22402
pleased,C3829994;C4264468,false;false,19325/22402
plus – minus values are means ± sd . cabg denotes coronary - artery by - pass graft  ptca percutaneous transluminal coronary angioplasty  and ace angiotensin - converting enzyme . hypertension and diabetes were de - fined by clinical history . a more complete list of base - line characteristics is given in rubins et al . $nmbr$ † nitrates includes all preparations except as - needed nitroglycerin . ‡ any antianginal drug includes any nitrate ( as defined above )  calcium - channel blocker  or beta - blocker . § the body - mass index is the weight in kilograms divided by the square of the height in meters . ¶ to convert values for cholesterol to millimoles per liter  multiply by $nmbr$ . $nmbr$ . to convert values for triglycerides to millimoles per liter  multiply by $nmbr$ . $nmbr$ .,C0332288;C0042295;C0006448;C0030125;C0181074;C2936173;C0332835;C1961139;C1820373;C2828386;C3854028;C4321248;C4522126;C0006539;C0022709;C0020538;C1963138;C1452534;C0205210;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1879745;C0017887;C0885378;C1883728;C0005893;C0578022;C1305855;C0205120;C0489786;C1552595;C0008377;C0439190;C0042295;C0041004,false;false;true;true;false;true;true;false;false;false;false;false;false;true;true;true;false;true;false;true;true;false;false;false;false;false;true;false;false;false;false;true;false;false;false;true;false;false;true,19326/22402
pnd,C1417807;C1956415;C4552608,false;true;false,19327/22402
pneumonia,C0032285,true,19328/22402
pneumonia events  n,C0032285;C0441471;C3541888,true;false;false,19329/22402
pollen exposure,C0032385;C0274281;C0332157;C0795585;C1320238,true;false;false;false;false,19330/22402
pollent < $nmbr$,,,19331/22402
pollent s $nmbr$,,,19332/22402
polyarticular arthritis  no rheumatoid nodules,C0162323,true,19333/22402
polyvascular disease ( n = $nmbr$ ),C0012634,true,19334/22402
polyvascular disease and no type $nmbr$ diabetes ( n = $nmbr$ ),C0012634,true,19335/22402
polyvascular disease and type $nmbr$ diabetes ( n = $nmbr$ ),C0012634,true,19336/22402
polyvascular disease * ( n = $nmbr$ ),C0012634,true,19337/22402
polyvascular disease * and type $nmbr$ diabetes status,C0012634,true,19338/22402
polyvascular disease * status,C3176928,false,19339/22402
pool of fh i and ii studies,C0337051;C1260386;C1509144;C2349200,false;true;false;false,19340/22402
pool of long term ( hefh patients only ) and high fh,C0337051;C0443252;C0030705;C0205171;C1720467;C1509144;C2349200,false;false;true;false;false;false;false,19341/22402
pooled analysis of sustain $nmbr$ — $nmbr$ trials,C1709595;C0002778;C0936012;C1524024;C2349200;C4522255,false;false;false;true;false;false,19342/22402
pooled analysis sample,C1709595;C0002778;C0936012;C1524024;C1303103;C2349200;C4522255,false;false;false;true;false;false;false,19343/22402
pooled itt,C1709595;C2349200;C4522255,false;false;false,19344/22402
pooled non - canvas studies ( n = $nmbr$ ) : non - cana ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ ),C1709595;C1518422;C3281223;C2349200;C4522255,false;false;false;false;false,19345/22402
pooled pah - mctd and pah,C1709595;C0030123;C0026272;C3203102;C4284467;C2349200;C4522255,false;true;true;true;false;false;false,19346/22402
pooled placebo,C1709595;C0032042;C1696465;C1706408;C2349200;C4522255,false;true;false;false;false;false,19347/22402
pooled secukinumab,C1709595;C3179547;C2349200;C4522255,false;true;false;false,19348/22402
pooled trials * n = $nmbr$,C1709595;C0008976;C2349200;C4522255,false;true;false;false,19349/22402
poor compliance / noncompliance,C0032646;C0376405;C0457432,false;true;false,19350/22402
poor outcome at $nmbr$ months,C3806166;C0439231,false;false,19351/22402
population,C0032659;C1257890,true;true,19352/22402
positive atopic status,C0439178;C0392707;C0449438;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false;false,19353/22402
positive ctnl ( n = $nmbr$ ),C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false,19354/22402
positive cu index test,C0439178;C1177210;C0600653;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0918012;C1552854;C1637833;C2986546;C2347872;C1446409;C1514241;C2825490;C3812269,false;false;true;false;false;false;false;false;false;false;true;false;false;false;false;false;false;false;false,19355/22402
positive cu index test  z n ( % ),C0439178;C1177210;C0600653;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C0918012;C1552854;C1637833;C2986546;C2347872;C1446409;C1514241;C2825490;C3812269,false;false;true;false;false;false;false;false;false;false;true;false;false;false;false;false;false;false;false,19356/22402
positive for hla - b $nmbr$  n ( % ),C0439178;C0019737;C0550853;C1415561;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false;false,19357/22402
positive hla - b $nmbr$ status  n ( % ),C0439178;C1426226;C0449438;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false;false;false,19358/22402
positive orthostatic test },C0439178;C0231472;C0022885;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false;false;false;false;false;false;false;false,19359/22402
positive troponin i or t  no . ( % ),C0439178;C0077401;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false,19360/22402
positive troponin or ck - mb,C0439178;C0041199;C1446409;C1514241;C2825490;C3812269,false;true;false;false;false;false,19361/22402
positive vs . negative,C0439178;C1446409;C1514241;C2825490;C3812269,false;false;false;false;false,19362/22402
post - albuterol % predicted fev $nmbr$ mean ( sd ) e,C0687676;C0001927;C1704687;C3469826,false;true;false;false,19363/22402
post - bronchodilator fev i reversibility  % b,C2599594;C3714541;C0021966;C0449261;C0221138,false;true;true;false;false,19364/22402
post - bronchodilator fev  % predicted,C2599594;C3714541,false;true,19365/22402
post - bronchodilator fev  ( l ),C2599594;C3714541,false;true,19366/22402
post - bronchodilator fev  reversibility,C2599594;C3714541;C0449261,false;true;false,19367/22402
post - bronchodilator fev  / fvc,C2599594;C3714541,false;true,19368/22402
post - bronchodilator fev $nmbr$ at screening,C2599594;C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;true;false;false;false;false;false,19369/22402
post - bronchodilator fev $nmbr$ ml,C2599594;C3714541;C0439526;C1705224;C3887665,false;true;false;false;false,19370/22402
post - bronchodilator fev $nmbr$ % predictedb,C2599594;C3714541,false;true,19371/22402
post - bronchodilator fev $nmbr$  % predicted of normal value,C2599594;C3714541,false;true,19372/22402
post - bronchodilator fev $nmbr$  % predicted  mean ( sd ),C2599594;C3714541;C0681842;C0444504;C2699239;C2347634;C2348143;C1882327,false;true;false;false;false;false;false;false,19373/22402
post - bronchodilator fev $nmbr$  % predicted  mean ( sd ) c,C2599594;C3714541;C0681842;C0444504;C2699239;C2347634;C2348143;C1882327,false;true;false;false;false;false;false;false,19374/22402
post - bronchodilator fev $nmbr$  l  mean ( sd ),C2599594;C3714541;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,19375/22402
post - bronchodilator fev $nmbr$  l  mean ( sd ) c,C2599594;C3714541;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,19376/22402
post - bronchodilator fev $nmbr$  mean ( sd )  l,C2599594;C3714541;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,19377/22402
post - bronchodilator fev $nmbr$ / fvc ratio  mean ( sd ),C2599594;C3714541;C0456603;C0444504;C2699239;C2347634;C2348143;C1547037,false;true;false;false;false;false;false;false,19378/22402
post - bronchodilator fevi  n ( % ),C2599594;C0429706;C0849974;C1561566;C4528367,false;false;false;false;false,19379/22402
post - bronchodilator fevi $nmbr$ % predicted,C2599594;C0849974;C1561566;C4528367,false;false;false;false,19380/22402
post - bronchodilator fevx ( l ),C2599594,false,19381/22402
post - bronchodilator screening,C2599594;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,19382/22402
post - dose,C0439568,false,19383/22402
post - procedure,C3272301,false,19384/22402
post - salbutamol fev $nmbr$ ( l ) b  mean ( sd ),C0687676;C0001927;C3714541;C0444504;C2699239;C2347634;C2348143;C1704687;C3469826,false;true;true;false;false;false;false;false;false,19385/22402
post - salbutamol fev $nmbr$ / fvcb  mean ( sd ),C0687676;C0001927;C3714541;C0444504;C2699239;C2347634;C2348143;C1704687;C3469826,false;true;true;false;false;false;false;false;false,19386/22402
post erior - anterior spine,C0687676;C0205094;C0037949;C2752558;C1704687;C3469826,false;false;true;false;false;false,19387/22402
post fev $nmbr$,C0687676;C3714541;C1704687;C3469826,false;true;false;false,19388/22402
post fev $nmbr$   % pred,C0687676;C3714541;C1704687;C3469826,false;true;false;false,19389/22402
post fvc,C0687676;C3714541;C1704687;C3469826,false;true;false;false,19390/22402
post fvc % pred,C0687676;C3714541;C1704687;C3469826,false;true;false;false,19391/22402
post hoc analysis,C0687676;C0002778;C0936012;C1524024;C1704687;C3469826,false;false;false;true;false;false,19392/22402
post svc,C0687676;C0231957;C1704687;C3469826,false;false;false;false,19393/22402
postbaseline binding antibodies,C1145667;C0003241;C1167622,false;true;false,19394/22402
postbaseline new - onset diabetes - n ( % ),C0746890;C0011847;C0011849,false;false;true,19395/22402
postbronchodilator $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ),C2599594,false,19396/22402
postbronchodilator fevj ( % predicted ),C2599594,false,19397/22402
postdose fev / fvc at screening,C0439568;C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;true;false;false;false;false;false,19398/22402
postoperative use of p - blocker,C0032790;C1524063,true;false,19399/22402
postprandial indices,C0376674;C4033634,true;false,19400/22402
potassium - sparing diuretic,C0304490;C3536751,true;false,19401/22402
potassium — mg / dl,C0032821;C0439269;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,19402/22402
potassium ( mg / dl ),C0032821;C0439269;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,19403/22402
potassium at admission  mmol / l - $nmbr$,C0032821;C0184666;C1532563;C0809949;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false,19404/22402
potassium  meq / dl  mean,C0032821;C1532568;C0444504;C2347634;C2348143;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false;false;false;false,19405/22402
potassium  meq / l,C0032821;C0439375;C0202194;C0304475;C0597277;C3714637,true;false;false;false;false;false,19406/22402
potent phosphorylated glycoprotein inhibitor use,C3245505;C0017968;C1999216;C0042153;C0457083;C1947944,false;true;false;true;false;false,19407/22402
potential injection site reactions,C3245505;C0151735,false;true,19408/22402
potential predictor,C3245505;C2698872,false;false,19409/22402
ppbc score  mean ( sd ),C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false,19410/22402
ppci,,,19411/22402
ppg post - meal test  mmol / l,C1418888;C0376674;C0022885;C1532563;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;true;false;false;false;false;false;false;false;false,19412/22402
ppi,C0358591;C0871125;C3811894,true;true;false,19413/22402
ppi or h $nmbr$ receptor antagonist  n ( % ),C0358591;C0871125;C3811894,true;true;false,19414/22402
ppi use,C0358591;C0871125;C3811894,true;true;false,19415/22402
ppi use ( p = $nmbr$ . $nmbr$ t ),C0358591;C0871125;C3811894,true;true;false,19416/22402
ppi use at baseline,C0358591;C0871125;C3811894,true;true;false,19417/22402
ppi use within $nmbr$ months of randomization,C0358591;C0871125;C3811894,true;true;false,19418/22402
pr / virgin islands  n ( % ),C0279759;C0042752;C0279766;C1418864;C3538934;C3538935;C3889640;C4048189;C4082178;C4082184;C4085573;C4552913;C4552914,false;true;false;false;false;false;false;false;false;false;false;false;false,19419/22402
pra  median ( min  max )  ng / ml / h,C0633231;C0549183;C2827900;C0033727;C0369286;C0441932;C0564385;C4528284;C0702093;C1533072;C4050009;C1524029;C3813700;C0876920;C2347635;C2348144;C2939193;C1141951;C1419788;C3274822;C3669212;C4283900,true;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false,19420/22402
pravastatin ( n = $nmbr$ ),C0085542,true,19421/22402
pravastatin n = $nmbr$,C0085542,true,19422/22402
pravastatin sodium,C0700474,true,19423/22402
pravastatin vs usual care,C0085542,true,19424/22402
pre - bd fvc < $nmbr$ % of predicted,C0332152;C0005126;C3714541;C0681842;C1882327;C2344255;C4050145;C0740175;C2257086;C3669034,false;true;true;false;false;false;false;false;false;false,19425/22402
pre - bd fvc s $nmbr$ % of predicted,C0332152;C0005126;C3714541;C0681842;C1882327;C2344255;C4050145;C0740175;C2257086;C3669034,false;true;true;false;false;false;false;false;false;false,19426/22402
pre - bronchodilator fef $nmbr$ . $nmbr$ ( ml / s ) baseline blood eosinophil count,C2599602;C0439390;C0168634;C0014467;C0750480;C1705566;C0005767;C0200638;C0750879;C0005768;C0229664;C1442488,false;false;true;true;false;false;true;false;false;true;false;false,19427/22402
pre - bronchodilator fev i ( l ),C2599602;C3714541;C0021966;C0221138,false;true;true;false,19428/22402
pre - bronchodilator fev  % predicted,C2599602;C3714541,false;true,19429/22402
pre - bronchodilator fev  ( l ),C2599602;C3714541,false;true,19430/22402
pre - bronchodilator fev ^ ( l ),C2599602;C3714541,false;true,19431/22402
pre - bronchodilator fevi change,C2599602;C0849974;C1561566;C4528367,false;false;false;false,19432/22402
pre - bronchodilator fevi / fvc  %,C2599602;C0802741;C3815113,false;false;false,19433/22402
pre - bronchodilator fevj,C2599602,false,19434/22402
pre - bronchodilator fevr % pred,C2599602;C1708033,false;false,19435/22402
pre - bronchodilator fevr l,C2599602;C1708033,false;false,19436/22402
pre - bronchodilator fvc ’ % pred,C2599602;C3714541,false;true,19437/22402
pre - bronchodilator mean ( sd ) fev $nmbr$  . l,C2599602;C0444504;C2699239;C3714541;C2347634;C2348143,false;false;false;true;false;false,19438/22402
pre - bronchodilator screening,C2599602;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,false;true;true;false;false;false;false;false,19439/22402
pre - dose,C0439565;C3812758,false;false,19440/22402
pre - hospital ticagrelor ( n = $nmbr$ ),C0332152;C0019994;C1999375;C1510665;C0740175;C2257086;C3669034,false;true;true;false;false;false;false,19441/22402
pre - procedure,C3272300,false,19442/22402
pre - specified trial endpoints,C2826245,false,19443/22402
pre - treatedforhypertension [ n ( % ) ],C0332152;C0740175;C2257086;C3669034,false;false;false;false,19444/22402
pre - treatment [ n ( % ) ] c,C1550147;C2709094;C3539075;C3539076,false;false;false;false,19445/22402
pre – diabetes mellitus,C0362046,true,19446/22402
pre – diabetes mellitus  n = $nmbr$,C0362046,true,19447/22402
pre fev $nmbr$,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,19448/22402
pre fev $nmbr$   % pred,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,19449/22402
pre fvc,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,19450/22402
pre fvc % pred,C0332152;C3714541;C0740175;C2257086;C3669034,false;true;false;false;false,19451/22402
pre hospital ticagrelor,C0332152;C0019994;C1999375;C1510665;C0740175;C2257086;C3669034,false;true;true;false;false;false;false,19452/22402
pre svc,C0332152;C0231957;C0740175;C2257086;C3669034,false;false;false;false;false,19453/22402
prebronchodilator fev $nmbr$,C2599602;C3714541,false;true,19454/22402
prebronchodilator fev $nmbr$ ( %,C2599602;C3714541,false;true,19455/22402
prebronchodilator fev $nmbr$  mean ( sd )  l,C2599602;C3714541;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,19456/22402
prebronchodilator fevi — liters,C2599602;C0429706;C0475211;C0849974;C1561566;C4528367,false;false;false;false;false;false,19457/22402
prebronchodilator fevi ( % predicted ),C2599602;C0849974;C1561566;C4528367,false;false;false;false,19458/22402
prebronchodilator fevj ( % predicted ),C2599602,false,19459/22402
prediabetese,,,19460/22402
predicted normal ) t,C0681842;C0205307;C0231683;C0439166;C2347086;C4553972;C1882327,false;false;false;false;false;false;false,19461/22402
predictive factor,C0683956,false,19462/22402
prednisone - equivalent dose  mg,C0032952;C0205163;C0178602;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0869039;C1114758;C0439185,true;false;false;true;true;false;false;false;false;false;false;false;false,19463/22402
prednisone or equivalent dose ( mg / day ),C0032952,true,19464/22402
predominant cardiac diagnosis — no . ( % ),C1542147;C0018787;C0011900;C1704338;C1704656;C1522601,false;true;true;true;false;false,19465/22402
predose fev -  at randomization,C0439565;C3714541;C0034656;C3812758,false;true;true;false,19466/22402
predose fev / fvc,C0439565;C3714541;C3812758,false;true;false,19467/22402
predose fev ^ at screening,C0439565;C3714541;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3812758,false;true;true;true;false;false;false;false;false;false,19468/22402
predose fev $nmbr$ ( l ) *,C0439565;C3714541;C3812758,false;true;false,19469/22402
predose fvc ( l ),C0439565;C3714541;C3812758,false;true;false,19470/22402
predose fvc ( l ) *,C0439565;C3714541;C3812758,false;true;false,19471/22402
preferred term  %,C1709637;C2347664,false;false,19472/22402
pregnancy,C0032961,true,19473/22402
premature discontinuation,C0151526;C0457454;C1444662;C4552847;C0205252;C4018905,true;false;false;false;false;false,19474/22402
premature treatment discontinuation,C0151526;C0039798;C0457454;C1444662;C4552847;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0205252;C4018905,true;true;false;false;false;true;false;false;false;false;false;false;false,19475/22402
premenopausal  %,C0279752,false,19476/22402
premixed insulin only ( % ),C0021641;C0205171;C1720467;C1533581;C1579433;C3714501,true;false;false;false;false;false,19477/22402
premixed insulin with oads ( % ),C0021641;C1533581;C1579433;C3714501,true;false;false;false,19478/22402
preoperative p - blocker use yes,C0445204;C0042153;C1549445;C1705108;C1710701;C0457083;C1947944,false;true;false;false;false;false;false,19479/22402
preoperative use p - blocker,C0445204;C0042153;C0457083;C1947944,false;true;false;false,19480/22402
prerandomization pci,C4049621,false,19481/22402
presence of angioedema at baseline,C0150312;C0002994;C0392148;C3854307,false;true;false;false,19482/22402
presence of dactylitis,C0150312;C0239161;C0392148;C3854307,false;false;false;false,19483/22402
presence of enthesitis,C0150312;C1282952;C0392148;C3854307,false;false;false;false,19484/22402
presence of tophi,C0150312;C0221248;C0392148;C3854307,false;false;false;false,19485/22402
presence of tophi  n ( % ),C0150312;C0221248;C0392148;C3854307,false;false;false;false,19486/22402
present at screening,C0150312;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C0449450,false;true;true;false;false;false;false;false;false,19487/22402
presentation to tertiary care hospital — %,C0449450;C0337954,false;false,19488/22402
presentation *,C0449450,false,19489/22402
presenting condition  n ( % ),C0449450;C0012634;C0348080;C1705253;C3864998,false;true;false;false;false,19490/22402
presenting history or diagnosis — no . ( % ),C0449450;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,19491/22402
prespecified medical conditions  n ( % ) f,C0199168;C0012634;C0016327;C0348080;C1705253;C3864998;C0205476,false;true;true;false;false;false;false,19492/22402
prespecified subgroup analyses,C2986480,false,19493/22402
prespecified subgroups,C1079230,false,19494/22402
pressure ( mm hg ),C0033095;C0439475;C0460139;C1306345;C4284008,true;false;false;false;false,19495/22402
pressure,C0033095;C0460139;C1306345;C4284008,true;false;false;false,19496/22402
prestudy treatment ( % ) a,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,19497/22402
prestudy treatment status,C0749659,false,19498/22402
pretreatment hdl - c,C1550147;C3715113;C2709094;C3539075;C3539076,false;false;false;false;false,19499/22402
pretreatment triglycerides,C1550147;C0041004;C2709094;C3539075;C3539076,false;true;false;false;false,19500/22402
prevalent cvd,C0033105;C0007222;C0220900,true;true;true,19501/22402
prevalent kidney disease ( egfr < $nmbr$ ml / min / usm ^ or maeroalbuminuria uacr > $nmbr$ mg / g ),C0033105;C0022658;C1739039;C0439445;C3811844;C3812682;C0220900,true;true;true;false;false;false;true,19502/22402
prevalent vertebral fracture,C0033105;C0080179;C0220900,true;true;true,19503/22402
prevalent vertebral fracture status,C0033105;C0080179;C0449438;C0220900,true;true;false;true,19504/22402
prevalent vertebral fracture  n ( % ),C0033105;C0080179;C0220900,true;true;true,19505/22402
prevention )  n ( % ) patients on llt ( other than statin )  n ( % ),C0199176;C0030705;C2347090;C1706420;C2700409,false;true;false;false;true,19506/22402
previous $nmbr$ - ari use ( % ),C0205156;C1412533;C4521376;C1552607,false;false;false;false,19507/22402
previous $nmbr$ ari use,C0205156;C1412533;C4521376;C1552607,false;false;false;false,19508/22402
previous a - blocker,C0205156;C1552607,false;false,19509/22402
previous a - blocker use,C0205156;C1552607,false;false,19510/22402
previous af,C0205156;C0344434;C4049859;C1552607,false;false;false;false,19511/22402
previous analgesic products n ( % ),C0205156;C0002771;C1552607,false;true;false,19512/22402
previous anti - inflammatory / antirheumatic products n ( % ),C0205156;C0432633;C0333348;C0003191;C1514468;C1552607,false;false;false;true;false;false,19513/22402
previous antihypertensive treatment,C0205156;C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,19514/22402
previous antihypertensive treatment — no . ( % ),C0205156;C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,19515/22402
previous antiparkinson medication  no . ( % ),C0205156;C0003405;C1552607,false;true;false,19516/22402
previous bdmard received,C0205156;C1552607,false;false,19517/22402
previous cad  n ( % ),C0205156;C1504769;C2239547;C3813548;C4284121;C1552607,false;true;false;false;false;false,19518/22402
previous cancer — no . ( % ),C0205156;C0006826;C0998265;C1306459;C1552607,false;true;false;false;false,19519/22402
previous cardiovascular event — no . ( % ),C0205156;C1320716;C1552607,false;false;false,19520/22402
previous cardiovascular event ( % ),C0205156;C1320716;C1552607,false;false;false,19521/22402
previous cd related surgery ( ref ) a,C0205156;C0007928;C0034283;C4552032;C1552607,false;true;true;false;false,19522/22402
previous chf  n ( % ),C0205156;C0018802;C1552607,false;true;false,19523/22402
previous chronic kidney disease,C0205156;C1561643;C4553188;C1552607,false;true;false;false,19524/22402
previous clinical stroke or tia,C0205156;C0205210;C0038454;C4554100;C1552607,false;false;true;false;false,19525/22402
previous clinical stroke or transient ischemic attack ( % ),C0205156;C0205210;C0038454;C4554100;C1552607,false;false;true;false;false,19526/22402
previous congestive heart failure — no . ( % ),C0205156;C0018802;C1552607,false;true;false,19527/22402
previous congestive heart failure ( % ),C0205156;C0018802;C1552607,false;true;false,19528/22402
previous coronary artery bypass graft,C2144990,false,19529/22402
previous coronary artery bypass grafting,C2144990,false,19530/22402
previous coronary artery bypass surgery  no . ( % ),C2144990,false,19531/22402
previous coronary heart disease,C0205156;C0010054;C0010068;C1956346;C1552607,false;true;true;true;false,19532/22402
previous coronary procedure ( % of group ),C0205156;C0018821;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1279986;C0018787;C2986530;C1552607,false;true;false;false;true;false;false;false;false;true;false;false,19533/22402
previous cv events,C0205156;C3538987;C0441471;C3541888;C4048877;C4318503;C1552607,false;false;false;false;true;false;false,19534/22402
previous cvd ^,C0205156;C0007222;C1552607,false;true;false,19535/22402
previous diabetes mellitus,C0205156;C0011849;C1552607,false;true;false,19536/22402
previous diagnosis,C0332132,false,19537/22402
previous digoxin use,C0205156;C0012265;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,19538/22402
previous digoxin use ( % ),C0205156;C0012265;C0042153;C0457083;C1947944;C1552607,false;true;true;false;false;false,19539/22402
previous disease and drug use,C0205156;C0012634;C1552607,false;true;false,19540/22402
previous dm,C0205156;C0011816;C3250443;C1552607,false;true;false;false,19541/22402
previous dm  n ( % ),C0205156;C0011816;C3250443;C1552607,false;true;false;false,19542/22402
previous dmards  mean ± sd,C0205156;C0242708;C0444504;C2699239;C2347634;C2348143;C1552607,false;true;false;false;false;false;false,19543/22402
previous events  no . ( % ),C0205156;C0441471;C3541888;C1552607,false;false;false;false,19544/22402
previous exposure to a vitamin k antagonist — no . ( % ) current or former never,C0205156;C0332157;C0042839;C0597277;C0231491;C1708601;C0087161;C2825076;C3714656;C1552607,false;false;true;false;false;false;true;false;false;false,19545/22402
previous exposure to biologic systemic psoriasis therapyb ( yes )  n ( % ),C0205156;C0332157;C0005515;C0205373;C0033860;C1549445;C1705108;C1710701;C0205460;C1552607,false;false;true;false;true;false;false;false;false;false,19546/22402
previous exposure to non - biologic systemic psoriasis therapyb ( yes )  n ( % ),C0205156;C0332157;C1518422;C0005515;C0205373;C0033860;C1549445;C1705108;C1710701;C0205460;C1552607,false;false;false;true;false;true;false;false;false;false;false,19547/22402
previous exposure to systemic psoriasis therapyb ( yes )  n ( % ),C0205156;C0332157;C0205373;C0033860;C1549445;C1705108;C1710701;C1552607,false;false;false;true;false;false;false;false,19548/22402
previous heart failure — no . ( % ),C0205156;C0018801;C0018802;C4554158;C1552607,false;true;true;false;false,19549/22402
previous history of cardiovascular events,C2004062;C0007226;C3887460,false;true;false,19550/22402
previous hospital admission for heart failure,C0205156;C0184666;C0018801;C0018802;C4554158;C1552607,false;false;true;true;false;false,19551/22402
previous hospitalization for heart failure,C0205156;C3898876;C1552607,false;false;false,19552/22402
previous hospitalization for unstable angina,C0205156;C0019993;C0002965;C1552607,false;true;true;false,19553/22402
previous htn  n ( % ),C0205156;C0020538;C1552607,false;true;false,19554/22402
previous hypersensitivity reaction — no . ( % ),C0205156;C0020517;C1552607,false;true;false,19555/22402
previous ics alone,C0205156;C0815320;C4551720;C1552607,false;false;true;false,19556/22402
previous ics only,C0205156;C0815320;C0205171;C1720467;C4551720;C1552607,false;false;false;false;true;false,19557/22402
previous ics / labd,C0205156;C0815320;C0396059;C4551720;C1552607,false;false;true;true;false,19558/22402
previous infarction,C0205156;C0021308;C1552607,false;true;false,19559/22402
previous infarction ( % of group ),C0205156;C0021308;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1552607,false;true;false;false;true;false;false;false;false,19560/22402
previous infliximab therapy | |,C0205156;C4076075;C1552607,false;false;false,19561/22402
previous intervention ( % ),C0205156;C0184661;C0886296;C1273869;C1552607,false;true;false;false;false,19562/22402
previous ischemic heart disease — no . ( % ),C0205156;C0010054;C0151744;C1552607,false;true;true;false,19563/22402
previous ischemic stroke / tia ( n = $nmbr$  $nmbr$ . $nmbr$ % ),C0205156;C0948008;C0007787;C0917805;C1054154;C1552607,false;false;true;true;false;false,19564/22402
previous labd alone,C0205156;C0396059;C1552607,false;true;false,19565/22402
previous labd only,C0205156;C0396059;C0205171;C1720467;C1552607,false;true;false;false;false,19566/22402
previous lev only,C0205156;C0023556;C0205171;C1720467;C1552607,false;true;false;false;false,19567/22402
previous mi ( % ),C0205156;C3810814;C1552607,false;false;false,19568/22402
previous mi  %,C0205156;C3810814;C1552607,false;false;false,19569/22402
previous ml or abnormal angiogram,C0205156;C0439526;C1705224;C3887665;C1552607,false;false;false;false;false,19570/22402
previous myocardial infarction  no . ( % ),C0205156;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;true;false;false;false;false;false,19571/22402
previous myocardiaunfarction,C0205156;C1552607,false;false,19572/22402
previous number of ciu / csu medications,C0205156;C1718138;C0578870;C1552607,false;false;false;false,19573/22402
previous oral antidiabetic medication use  n ( % ),C0205156;C1527415;C0935929;C1552607,false;false;true;false,19574/22402
previous pde $nmbr$ - i therapy  no . ( % ),C0205156;C0021966;C0039798;C0087111;C1363945;C0221138;C1552607,false;true;true;true;false;false;false,19575/22402
previous pde $nmbr$ inhibitors,C0205156;C0031638;C1552607,false;true;false,19576/22402
previous percutaneous coronary intervention  %,C0205156;C1532338;C1552607,false;true;false,19577/22402
previous renal disease  n ( % ),C0205156;C0022658;C1552607,false;true;false,19578/22402
previous revascularization,C0205156;C0581603;C1552607,false;false;false,19579/22402
previous segments resection ( s ) *,C0205156;C2987624;C1552607,false;false;false,19580/22402
previous smoker,C0337671,false,19581/22402
previous smokers,C0337671,false,19582/22402
previous stroke 一 no . ( % ),C0205156;C1552607,false;false,19583/22402
previous stroke or tia ( n = $nmbr$ ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,19584/22402
previous stroke or tia  n ( % ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,19585/22402
previous stroke or tl a,C0205156;C0038454;C4554100;C1552607,false;true;false;false,19586/22402
previous stroke or tl a $nmbr$ - $nmbr$,C0205156;C0038454;C4554100;C1552607,false;true;false;false,19587/22402
previous stroke or transient ischemic attack — no . / total,C0205156;C0038454;C4554100;C1552607,false;true;false;false,19588/22402
previous stroke or transient ischemic attack  no . / total no . ( % ),C0205156;C0038454;C4554100;C1552607,false;true;false;false,19589/22402
previous stroke ortia,C0205156;C0038454;C4554100;C1552607,false;true;false;false,19590/22402
previous stroke ortia $nmbr$ - $nmbr$,C0205156;C0038454;C4554100;C1552607,false;true;false;false,19591/22402
previous stroke yes ( n  % ) previous myocardial infarction,C0205156;C3841753;C0027051;C0428953;C2926063;C3810814;C4552959;C1552607,false;false;true;false;false;false;false;false,19592/22402
previous stroke / tia,C0205156;C0038454;C0007787;C0917805;C1054154;C4554100;C1552607,false;true;true;true;false;false;false,19593/22402
previous systemic treatment  n ( % ),C0205156;C0678812;C1552607,false;false;false,19594/22402
previous therapies  n ( % ),C0205156;C0087111;C1552607,false;true;false,19595/22402
previous therapy,C0205156;C0039798;C0087111;C1363945;C1552607,false;true;true;false;false,19596/22402
previous treatment in the healing study  n ( % ),C0205156;C0043240;C1521826;C3161471;C0205249;C1552607,false;true;false;false;false;false,19597/22402
previous treatment with infliximab,C0205156;C0039798;C0666743;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;true;false;false;false;false;false;false,19598/22402
previous treatment ?,C0205156;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1552607,false;true;true;false;false;false;false;false;false,19599/22402
previous use of biologic systemic therapy  n ( % ),C0205156;C1524063;C0005527;C0205373;C0005515;C1515119;C0205460;C1552607,false;false;true;false;true;false;false;false,19600/22402
previous use of niacin or niaspan §,C0205156;C1524063;C0027996;C1142562;C1552607,false;false;true;false;false,19601/22402
previous use of nonbiologic systemic therapy  n ( % ),C0205156;C1524063;C1515119;C1552607,false;false;false;false,19602/22402
previous use of other biologic agents in addition to tne,C0205156;C1524063;C0005515;C1552607,false;false;true;false,19603/22402
previous use of systemic steroids for ciu / csu,C0205156;C0281991;C0205373;C1552607,false;false;false;false,19604/22402
previous use of systemic steroids  n ( % ),C0205156;C0281991;C0205373;C1552607,false;false;false;false,19605/22402
previous use of vitamin k antagonist for > $nmbr$ days — no . ( % ),C0205156;C1524063;C1096489;C2267235;C1552607,false;false;false;false;false,19606/22402
previous vka use,C0205156;C0042153;C0457083;C1947944;C1552607,false;true;false;false;false,19607/22402
previous vka use ( stratified randomization ),C0205156;C0042153;C4687737;C0457083;C1947944;C1552607,false;true;false;false;false;false,19608/22402
previous vte,C0205156;C0630906;C1552607,false;true;false,19609/22402
previous vte n ( % ),C0205156;C0630906;C1552607,false;true;false,19610/22402
previous vte  n ( % ),C0205156;C0630906;C1552607,false;true;false,19611/22402
previously failed anti - tnf treatment  no . ( % ),,,19612/22402
previously untreated isolated systolic hypertension,C0332155;C0745133,false;false,19613/22402
primary - prevention cohort,C0033144;C0009247;C0599755,true;true;false,19614/22402
primary analysis,C0205225;C0002778;C0936012;C1524024;C0439612;C0439631,false;false;false;true;false;false,19615/22402
primary and secondary prevention subgroups  adjusted for age  gender  hypertension  diabetes mellitus  and smoking . hr indicates hazard ratio  $nmbr$ % cl  $nmbr$ % confidence interval  tia  transient ischemic attack .,C0205225;C0439612;C0439631;C0011849;C1272706;C0007787;C1552654;C1552713,false;false;false;true;false;true;false;false,19616/22402
primary cardiovascular endpoint,C2986535;C0007226;C3887460,false;true;false,19617/22402
primary cause of chf,C0205225;C0015127;C0018802;C1524003;C0439612;C0439631,false;true;true;false;false;false,19618/22402
primary cause of heart failure,C0205225;C0015127;C0018801;C0018802;C4554158;C1524003;C0439612;C0439631,false;true;true;true;false;false;false;false,19619/22402
primary composite end point ‡,C2986535;C0205199;C1547335,false;false;false,19620/22402
primary composite end points,C0205225;C0205199;C2349179;C1547335;C0439612;C0439631,false;false;false;false;false;false,19621/22402
primary composite endpoint ‡,C2986535;C0205199;C1547335,false;false;false,19622/22402
primary composite ^,C0205225;C0205199;C1547335;C0439612;C0439631,false;false;false;false;false,19623/22402
primary cv endpoint,C2986535;C3538987;C4048877;C4318503,false;false;true;false,19624/22402
primary efficacy outcome,C0205225;C1280519;C1274040;C1707887;C0439612;C0439631,false;false;false;false;false;false,19625/22402
primary end - point,C2986535,false,19626/22402
primary end point |,C2986535,false,19627/22402
primary end point *,C2986535,false,19628/22402
primary end points,C0205225;C2349179;C0439612;C0439631,false;false;false;false,19629/22402
primary endpoint :,C2986535,false,19630/22402
primary endpoint ^,C2986535,false,19631/22402
primary endpoint ’,C2986535,false,19632/22402
primary endpoint $nmbr$,C2986535,false,19633/22402
primary hemorrhagic stroke,C0205225;C0553692;C0439612;C0439631,false;true;false;false,19634/22402
primary indication,C1549995,false,19635/22402
primary ischemic stroke,C0205225;C0948008;C0439612;C0439631,false;false;false;false,19636/22402
primary mace endpoint,C2986535;C0349381;C0949745;C1445339,false;false;true;false,19637/22402
primary nonresponse,C0205225;C0439612;C0439631,false;false;false,19638/22402
primary outcome ( $nmbr$ - point mace ),C0205225;C1274040;C1552961;C0349381;C0949745;C1445339;C2347617;C3714763;C0439612;C0439631,false;false;false;false;true;false;false;false;false;false,19639/22402
primary outcome plus revascularization or nonfatal hf,C0205225;C1274040;C0332287;C0581603;C0439612;C0439631,false;false;false;false;false;false,19640/22402
primary outcome ! ( n = $nmbr$ ),C0205225;C1274040;C0439612;C0439631,false;false;false;false,19641/22402
primary outcome : $nmbr$ % decrease in womac pain score,C0205225;C1274040;C0392756;C0582148;C0547047;C0439612;C0439631,false;false;false;false;false;false;false,19642/22402
primary pcit,C0205225;C0439612;C0439631,false;false;false,19643/22402
primary safety outcome -,C0205225;C0036043;C1274040;C1705187;C0439612;C0439631,false;true;false;false;false;false,19644/22402
primary study joint  n ( % ),C0205225;C0557651;C0022417;C0392905;C1706309;C2603343;C0439612;C0439631,false;false;true;false;false;false;false;false,19645/22402
primary target vessel ( % ),C0205225;C0449618;C0439612;C0439631,false;false;false;false,19646/22402
primary / key efficacy endpoint,C1709665;C1280519;C2349179;C2826544;C1707887,false;false;false;false;false,19647/22402
prior a - blocker use,C0332152;C2826257,false;false,19648/22402
prior acbi or arb use,C0332152;C2826257,false;false,19649/22402
prior admb,C0332152;C2826257,false;false,19650/22402
prior aeds  ≥ $nmbr$  n ( % ),C0332152;C0180309;C2826257,false;true;false,19651/22402
prior analgesic products  n ( % ),C0332152;C0002771;C2826257,false;true;false,19652/22402
prior angina ( n = $nmbr$  $nmbr$ ),C0332152;C0002962;C2826257,false;true;false,19653/22402
prior angina pectoris,C0332152;C0002962;C2826257,false;true;false,19654/22402
prior angina pectoris — no . / total no . ( % ),C0332152;C0002962;C2826257,false;true;false,19655/22402
prior angina  n / n ( % ),C0332152;C0002962;C2826257,false;true;false,19656/22402
prior angiography showing stenosis ≥ $nmbr$ %  n   =   $nmbr$   $nmbr$ a,C0332152;C0002978;C2826257,false;true;false,19657/22402
prior anti - tnf exposure,C0332152;C1448177;C0274281;C0332157;C2826257,false;true;false;false;false,19658/22402
prior anti - tnf failure,C0332152;C1448177;C0231174;C0680095;C2826257,false;true;false;false;false,19659/22402
prior anti - tnf treatment,C1514463;C1448177,false;true,19660/22402
prior antiinflammatory / antirheumatic products  n ( % ),C0332152;C0003209;C0003191;C1514468;C1515999;C2826257,false;true;true;false;false;false,19661/22402
prior aortocoronary bypass surgery — no . ( % ),C0455610;C0010055,false;true,19662/22402
prior aspirin use,C0332152;C0004057;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,19663/22402
prior bb plus acbi plus arb use,C0332152;C0004739;C0332287;C3888198;C0042153;C0457083;C1947944;C0332297;C2826257,false;true;false;false;true;false;false;false;false,19664/22402
prior bisphosphonate usage,C0332152;C0012544;C0457083;C2267018;C2826257,false;true;false;false;false,19665/22402
prior bp use,C0332152;C0037623;C0042153;C0457083;C1947944;C1415692;C1708288;C4318478;C2826257,false;true;true;false;false;false;false;false;false,19666/22402
prior cabg surgery,C0455610;C0010055,false;true,19667/22402
prior cabg  %,C0332152;C0010055;C2826257,false;true;false,19668/22402
prior cad,C0332152;C1504769;C2239547;C3813548;C4284121;C2826257,false;true;false;false;false;false,19669/22402
prior cardiovascular event,C0332152;C1320716;C2826257,false;false;false,19670/22402
prior chf,C0332152;C0018802;C2826257,false;true;false,19671/22402
prior chf  %,C0332152;C0018802;C2826257,false;true;false,19672/22402
prior clinical fracture ( since age $nmbr$ ),C0332152;C0205210;C0016658;C2826257,false;false;true;false,19673/22402
prior conventional synthetic dmards  n ( % ),C0332152;C0439858;C1883254;C0242708;C2826257,false;false;false;true;false,19674/22402
prior copd medication,C0332152;C0024117;C0013227;C3244316;C4284232;C1412502;C3714496;C2826257,false;true;true;false;false;false;false;false,19675/22402
prior copd medicationa  n ( % ),C0332152;C0024117;C1412502;C3714496;C2826257,false;true;false;false;false,19676/22402
prior coronary intervention or coronary artery bypass grafting,C0332152;C0018787;C0184661;C0886296;C1273869;C2826257,false;true;true;false;false;false,19677/22402
prior coronary revascularization — no . { % ),C0332152;C0877341;C2826257,false;false;false,19678/22402
prior coronary revascularization  n / n ( % ),C0332152;C0877341;C2826257,false;false;false,19679/22402
prior coronary revascularization  no . ( % ),C0332152;C0877341;C2826257,false;false;false,19680/22402
prior corticosteroid treatment,C1514463;C0001617;C3536709,false;true;false,19681/22402
prior cv history,C0332152;C3538987;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4048877;C4318503;C2826257,false;false;true;true;false;false;false;false;true;false;false,19682/22402
prior cvd,C0332152;C0007222;C2826257,false;true;false,19683/22402
prior ed therapy,C1514463;C3538926,false;false,19684/22402
prior electrical cardioversion for af ( n = $nmbr$ $nmbr$ ),C0332152;C0013778;C0344434;C4049859;C0542380;C2826257,false;true;false;false;false;false,19685/22402
prior gestational diabetes,C0332152;C0085207;C2826257,false;true;false,19686/22402
prior heart failure — no . { % ),C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,19687/22402
prior heart failure  n / n ( % ),C0332152;C0018801;C0018802;C4554158;C2826257,false;true;true;false;false,19688/22402
prior hf ( n = $nmbr$  $nmbr$ ),C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,19689/22402
prior hf hospitalization,C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,19690/22402
prior hf hospitalization ( n = $nmbr$ ),C0332152;C0018488;C0019993;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,19691/22402
prior hf n = $nmbr$,C0332152;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;false;false;false,19692/22402
prior history of bleeding on oac,C0332152;C0019664;C0019080;C0019665;C0262512;C0262926;C1705255;C2004062;C2826257,false;true;true;true;false;false;false;false;false,19693/22402
prior hospitalization for hf  %,C0332152;C0019993;C0018488;C1313497;C1538440;C3273279;C2826257,false;true;true;true;false;false;false,19694/22402
prior hospitalizations  n ( % ),C0332152;C0019993;C2826257,false;true;false,19695/22402
prior htn ( n = $nmbr$  $nmbr$ ),C0332152;C0020538;C2826257,false;true;false,19696/22402
prior hypertension,C0332152;C0020538;C1963138;C2826257,false;true;false;false,19697/22402
prior immunosuppressant failure,C0332152;C0021081;C0231174;C0680095;C2826257,false;true;false;false;false,19698/22402
prior immunosuppressant failurec,C0332152;C0021081;C2826257,false;true;false,19699/22402
prior immunosuppressive exposure  n ( % ),C0332152;C0021081;C0274281;C0332157;C2826257,false;true;false;false;false,19700/22402
prior infarction,C0332152;C0021308;C2826257,false;true;false,19701/22402
prior insulin use ( years ),C0332152;C0240016;C0439234;C2826257,false;false;false;false,19702/22402
prior lev,C0332152;C0023556;C2826257,false;true;false,19703/22402
prior lev treatment    n   ( % ),C1514463;C0023556,false;true,19704/22402
prior medication use  n ( % ),C0332152;C0240320;C2826257,false;false;false,19705/22402
prior mesalazine use *,C0332152;C0127615;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,19706/22402
prior mi ( n = $nmbr$  $nmbr$ ),C0332152;C3810814;C2826257,false;false;false,19707/22402
prior mi diagnosis :,C0332132;C3810814,false;false,19708/22402
prior mi n = $nmbr$,C0332152;C3810814;C2826257,false;false;false,19709/22402
prior mi within $nmbr$ y  no . ( % ),C0332152;C3810814;C2826257,false;false;false,19710/22402
prior mi  %,C0332152;C3810814;C2826257,false;false;false,19711/22402
prior mi  n / n ( % ),C0332152;C3810814;C2826257,false;false;false,19712/22402
prior ml or stroke at baseline,C0332152;C0439526;C1705224;C3887665;C2826257,false;false;false;false;false,19713/22402
prior ml / stroke,C0332152;C0439526;C0038454;C4554100;C1705224;C3887665;C2826257,false;false;true;false;false;false;false,19714/22402
prior ms treatment with ifn - beta or glatiramer acetate . no . ( % ),C1514463;C2349943;C0015980;C3539704;C3713294,false;false;true;false;true,19715/22402
prior myocardial infarction — no . { % ),C0155668,false,19716/22402
prior myocardial infarction — no . / total no . ( % ),C0155668,false,19717/22402
prior myocardial infarction ( % ),C0155668,false,19718/22402
prior myocardial infarction  no . / total no . ( % ),C0155668,false,19719/22402
prior myocardial intarction,C0332152;C0027061;C1522564;C2826257,false;true;false;false,19720/22402
prior non - cns se,C0332152;C1518422;C3714787;C0036919;C2826257,false;false;true;true;false,19721/22402
prior non - haemorrhagic stroke,C0332152;C1518422;C0553692;C2826257,false;false;true;false,19722/22402
prior nonvertebral fracture,C0332152;C0016658;C2826257,false;true;false,19723/22402
prior nonvertebral fracture at age > $nmbr$ years,C0332152;C0016658;C1510829;C2826257,false;true;false;false,19724/22402
prior nsaid use,C0332152;C0003211;C0042153;C0457083;C1947944;C3536840;C2826257,false;true;true;false;false;false;false,19725/22402
prior nsaid  n ( % ) a,C0332152;C0003211;C3536840;C2826257,false;true;false;false,19726/22402
prior oabg surgery,C0455610,false,19727/22402
prior oac,C0332152;C2826257,false;false,19728/22402
prior oad :,C0332152;C2826257,false;false,19729/22402
prior oma use,C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,19730/22402
prior oma use ( n = $nmbr$ ),C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,19731/22402
prior pad,C0332152;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657;C2826257,false;false;false;false;false;false;false;false,19732/22402
prior pci or cabg,C0332152;C4049621;C2826257,false;false;false,19733/22402
prior pci  %,C0332152;C4049621;C2826257,false;false;false,19734/22402
prior percutaneous coronary intervention — no . / total no . ( % ),C0332152;C1532338;C2826257,false;true;false,19735/22402
prior ptca or cabg,C0332152;C2936173;C2826257,false;true;false,19736/22402
prior revascularization ( % ),C0332152;C0581603;C2826257,false;false;false,19737/22402
prior revascularization ( n = $nmbr$  $nmbr$ ),C0332152;C0581603;C2826257,false;false;false,19738/22402
prior statin use ( n = $nmbr$ ),C0332152;C0360714;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,19739/22402
prior stroke ( % ),C0332152;C0038454;C4554100;C2826257,false;true;false;false,19740/22402
prior stroke ( n = $nmbr$ ),C0332152;C0038454;C4554100;C2826257,false;true;false;false,19741/22402
prior stroke or tia  %,C0332152;C0038454;C4554100;C2826257,false;true;false;false,19742/22402
prior stroke or tza,C0332152;C0038454;C4554100;C2826257,false;true;false;false,19743/22402
prior stroke / mi  n ( % ),C0332152;C0038454;C3810814;C4554100;C2826257,false;true;false;false;false,19744/22402
prior sulfasalazine use *,C0332152;C0036078;C0042153;C0457083;C1947944;C2826257,false;true;true;false;false;false,19745/22402
prior surgery for cd  n ( % ),C0455610;C0007928;C0034283;C4552032,false;true;true;false,19746/22402
prior surgery for cd  n [ % ],C0455610;C0007928;C0034283;C4552032,false;true;true;false,19747/22402
prior therapy with omalizumab : yes,C1514463;C0966225;C1549445;C1705108;C1710701,false;true;false;false;false,19748/22402
prior thienopyridine ( - ),C0332152;C1120149;C2826257,false;true;false,19749/22402
prior thienopyridine ( + ),C0332152;C1120149;C2826257,false;true;false,19750/22402
prior tia,C0332152;C0007787;C0917805;C1054154;C2826257,false;true;true;false;false,19751/22402
prior tnf antagonist failure  n [ % ],C0332152;C1448177;C0231491;C0231174;C0680095;C2826257,false;true;false;false;false;false,19752/22402
prior tnf antagonist failure  n ( % ) b,C0332152;C3887647;C0231491;C0231174;C0680095;C2826257,false;false;false;false;false;false,19753/22402
prior tnf antagonist  n [ % ] ‘ *,C0332152;C1448177;C0231491;C2826257,false;true;false;false,19754/22402
prior tnf inhibitor exposure,C0332152;C1448177;C1999216;C0274281;C0332157;C2826257,false;true;false;false;false;false,19755/22402
prior tnf inhibitor exposure  no . ( % ),C0332152;C1448177;C1999216;C0274281;C0332157;C2826257,false;true;false;false;false;false,19756/22402
prior transient ischaemic,C0332152;C0040704;C0475224;C0205374;C2826257,false;true;false;false;false,19757/22402
prior transient ischemic attack,C0332152;C0007787;C0917805;C2826257,false;true;true;false,19758/22402
prior treatment — no . ( % ),C1514463,false,19759/22402
prior urate lowering therapies  n ( % ),C1514463;C0729829;C0441994;C2003888;C0935936,false;false;false;false;true,19760/22402
prior use of osteoporosis medications,C0332152;C1524063;C0029456;C0013227;C0802604;C2598133;C4284232;C4554622;C2826257,false;false;true;true;false;false;false;false;false,19761/22402
prior use of osteoporosis medications  n ( % ),C0332152;C1524063;C0029456;C0013227;C0802604;C2598133;C4284232;C4554622;C2826257,false;false;true;true;false;false;false;false;false,19762/22402
prior use of synthetic dmards,C0332152;C1524063;C1883254;C0242708;C2826257,false;false;false;true;false,19763/22402
prior use of synthetic dmards  n ( % ),C0332152;C1524063;C1883254;C0242708;C2826257,false;false;false;true;false,19764/22402
prior vka experience,C0332152;C0237607;C0596545;C2826257,false;false;false;false,19765/22402
prior vka use for > $nmbr$ d  %,C0332152;C0042153;C0457083;C1947944;C2826257,false;true;false;false;false,19766/22402
pro - active intervention,C0033382;C0205177;C0184661;C0886296;C1273869;C3853793;C3888249;C0523852;C2987124,true;false;true;false;false;false;false;false;true,19767/22402
probable stent thrombosis,C0033204;C3897493;C0332148,true;false;false,19768/22402
probenecid,C0033209,true,19769/22402
procedures after discharge — no . ( % ),C0025664;C0012621;C0030685;C2926602;C0184661;C2700391;C3538935,true;false;true;false;true;false;false,19770/22402
procedures in the hospital — no . ( % ),C0025664;C0019994;C1510665;C0184661;C2700391;C3538935,true;true;false;true;false;false,19771/22402
progression of albuminuria,C0242656;C0001925;C0449258,true;true;false,19772/22402
progression to diabetes,C1735364,false,19773/22402
propafenone,C0033429,true,19774/22402
propionic acid derivatives,C0033482;C0695274;C3540752,true;false;false,19775/22402
proportion,C1709707,false,19776/22402
proportion ( % ) of individuals • control alirocumab,C1709707;C0027361;C0237401,false;true;false,19777/22402
proportion ( % ) of individuals a alirocumab • placebo,C1709707;C0027361;C0237401,false;true;false,19778/22402
proportion of angioedema - free days from week $nmbr$ to week $nmbr$ x,C1709707;C0002994;C0332296;C0439228;C1880497;C1996904,false;true;false;false;false;false,19779/22402
proportion of patients who achieved acr $nmbr$ n / n ( % ),C1709707;C0030705,false;true,19780/22402
proportion of patients with trough fevi > $nmbr$ ml above baseline  n ( % ),C1709707;C0030705,false;true,19781/22402
proportion of responders n / n ( % ),C1709707,false,19782/22402
proportion taking pulmonary medications ( % ) b,C1709707,false,19783/22402
proportions  n ( % ),C1709707,false,19784/22402
prostate biopsy,C0194804,false,19785/22402
prostate volume ( cm $nmbr$ ),C1441416,false,19786/22402
prostate volume ( ml ),C1441416;C0439526;C1705224;C3887665,false;false;false;false,19787/22402
protein in urine    ≥ $nmbr$ +,C0033687,true,19788/22402
proteinuria ( > $nmbr$ g / $nmbr$ h )  %,C0033687;C0560020;C1962972;C4554346,true;false;false;false,19789/22402
proton pump inhibitor,C0358591;C3536754;C4521480,true;false;false,19790/22402
proton pump inhibitor ( n  % ),C0358591;C3536754;C4521480,true;false;false,19791/22402
proximal,C0205107;C4489236,false;false,19792/22402
proximal gi tract,C0205107;C0017189;C4489236,false;true;false,19793/22402
proximal gl tract  n ( % ),C0205107;C0018229;C1185740;C1423073;C1427674;C4489236,false;true;false;false;false;false,19794/22402
psa - modified mases score ( $nmbr$ - $nmbr$ ),C3810537;C0392747;C3889737;C3813209,false;false;false;false,19795/22402
psa ‐ modified mases score ( $nmbr$ – $nmbr$ scale ),C3810537;C0392747;C3889737;C3813209,false;false;false;false,19796/22402
psa - modified shs of hands & feet $nmbr$ ( $nmbr$ - $nmbr$ ),C3810537;C0392747;C0018563;C0016504;C0347981;C1552914;C3889737;C3813209,false;false;true;true;false;false;false;false,19797/22402
psa ‐ modified shs of hands and feet,C3810537;C0392747;C0018563;C1552914;C3889737;C3813209,false;false;true;false;false;false,19798/22402
psa - modified shs ( $nmbr$ - $nmbr$ ),C3810537;C0392747;C3889737;C3813209,false;false;false;false,19799/22402
psa ( ng / ml ),C3810537;C0439275;C3813209,false;false;false,19800/22402
psa duration ( years ),C3810537;C0449238;C0439234;C2926735;C3813209,false;false;false;false;false,19801/22402
psa duration ( years )  mean ( sd ),C3810537;C0449238;C0439234;C0444504;C2699239;C2347634;C2348143;C2926735;C3813209,false;false;false;false;false;false;false;false;false,19802/22402
psa level  ng / ml,C4086720;C0439275,false;false,19803/22402
psa pain ( vas ),C3810537;C0042815;C3813209,false;true;false,19804/22402
psa reported  n ( % ),C3810537;C3813209,false;false,19805/22402
psa subtypes  n ( % ),C3810537;C0449560;C3813209,false;false;false,19806/22402
psa  ng / ml  mean ( sd ),C3810537;C0439275;C0444504;C2699239;C2347634;C2348143;C3813209,false;false;false;false;false;false;false,19807/22402
psaqol,,,19808/22402
psoriasis ( n =,C0033860,true,19809/22402
psoriasis > $nmbr$ % of bsa,C0033860,true,19810/22402
psoriasis bsa > $nmbr$ %  n ( % ),C0033860,true,19811/22402
psoriasis characteristics,C0033860;C1521970,true;false,19812/22402
psoriasis duration ( years )  mean ( sd ),C0033860;C0449238;C0439234;C0444504;C2699239;C2347634;C2348143;C2926735,true;false;false;false;false;false;false;false,19813/22402
psoriasis duration  years,C0033860;C0449238;C0439234;C2926735,true;false;false;false,19814/22402
psoriatic arthritis,C0003872,true,19815/22402
psychoactivesd,,,19816/22402
psychogenic,C0458006,false,19817/22402
psycholeptics,C3653516,false,19818/22402
pt . years = $nmbr$,C0032743;C0439234;C0699718,true;false;false,19819/22402
ptga ( $nmbr$ - $nmbr$ cm vas ),C0042815;C3536884;C3827561,true;true;false,19820/22402
ptga of disease activity ( $nmbr$ ‒ $nmbr$ mm )  mean ( sd ) †,C1292728;C4330985;C0444504;C2699239;C2347634;C2348143;C4554674,false;false;false;false;false;false;false,19821/22402
ptga ⁎ ⁎ ⁎,,,19822/22402
ptrend across doses,C0178602,false,19823/22402
pts,C1419129;C2698747,false;false,19824/22402
ptx $nmbr$ ( ng / ml ),C0030899;C0439275,true;false,19825/22402
puerto rican,C0034043,true,19826/22402
pulmonary congestion ( cxr ),C0242073;C0006888;C0039985,false;true;false,19827/22402
pulmonary embolism only,C0034065;C0205171;C1720467,true;false;false,19828/22402
pulmonary embolisma  n / n ( % ),C0024109;C2707265;C2709248;C4522268,true;false;false;false,19829/22402
pulmonary embolismb  n / n ( % ),C0024109;C2707265;C2709248;C4522268,true;false;false;false,19830/22402
pulmonary function tests ( post - bronchodilator )  mean ( sd ),C0024119;C2599594;C0444504;C2699239;C2347634;C2348143;C2598152,true;false;false;false;false;false;false,19831/22402
pulmonary medication during baseline ! ',C0024109;C0013227;C0168634;C1442488;C3244316;C4284232;C2707265;C2709248;C4522268,true;true;true;false;false;false;false;false;false,19832/22402
pulmonary medications ( % ),C0024109;C0013227;C0802604;C2598133;C4284232;C2707265;C2709248;C4522268,true;true;false;false;false;false;false;false,19833/22402
pulmonary vascular resistance  dyne • s • cm $nmbr$,C0456261;C0308914;C0600130;C0488644,true;false;false;false,19834/22402
pulse — beats / min,C0232117;C0391850;C1947910,true;false;false,19835/22402
pulse in beats / minute  mean ( sd ),C0232117;C0439385;C0444504;C2699239;C2347634;C2348143;C0391850;C1947910,true;false;false;false;false;false;false;false,19836/22402
pulse pressure ( median $nmbr$ . $nmbr$ ],C0949236;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,19837/22402
pulse pressure ( mm hg ),C0949236;C0439475,true;false,19838/22402
pulse pressure ( mmhg ),C0949236;C0439475,true;false,19839/22402
pulse rate ( mean $nmbr$ h )  bpm *,C0232117;C0444504;C0033727;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,true;false;true;false;false;false;false;false;false,19840/22402
pulse rate  bpm ( mean $nmbr$ h )  mean ( sd ) *,C0232117;C0444504;C0033727;C2699239;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,true;false;true;false;false;false;false;false;false;false,19841/22402
pulse  beats / min,C0232117;C0391850;C1947910,true;false;false,19842/22402
pump,C0182537,false,19843/22402
pure motor hemiparesis,C2247561;C1513492;C0018989;C1705994,false;false;true;false,19844/22402
pure sensory stroke,C2247561;C0445254;C0038454;C4554100,false;false;true;false,19845/22402
pv  ml,C0030840;C0439526;C1705224;C3887665;C0032463,true;false;false;false;true,19846/22402
pvalue ∗,,,19847/22402
pvaluefor interaction $nmbr$ - $nmbr$,C1704675,false,19848/22402
pvaluefor trend,C1521798;C4554533,false;false,19849/22402
pvr volume  ml  mean ( sd ),C0242852;C0449468;C0439526;C0444504;C2699239;C2347634;C2348143;C1705224;C3887665;C1690016;C1705102;C2700258;C0456261;C1419141,true;false;false;false;false;false;false;false;false;false;false;false;true;false,19850/22402
pvr  ml,C0242852;C0439526;C1705224;C3887665;C0456261;C1419141,true;false;false;false;true;false,19851/22402
pyrexia,C0015967,true,19852/22402
q ( q $nmbr$ \,,,19853/22402
q wave in the infarct territory at baseline *  %,C0429089;C0021308;C1301808;C2983136;C1305738,false;true;false;false;false,19854/22402
q waves in the infarct territory at baseline *  %,C0429089;C0021308;C1301808;C2983136;C1305738,false;true;false;false;false,19855/22402
q $nmbr$ - q $nmbr$,,,19856/22402
q $nmbr$ ( n   = $nmbr$ ),,,19857/22402
q $nmbr$ w ( n $nmbr$ $nmbr$ ),,,19858/22402
q $nmbr$ w ( n = $nmbr$ ),,,19859/22402
qids - sr $nmbr$,C4331197,false,19860/22402
qmax ( ml / s ),C0439390,false,19861/22402
qmax category  n ( % ) :,C0683312;C3889287,false;false,19862/22402
qmax  ml / s,C0439390,false,19863/22402
qmax  ml / s  mean ( sd ),C0439390;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,19864/22402
qmaxi rn l / s,C2827110;C3540639;C4281819,false;false;false,19865/22402
qol,C0518214,false,19866/22402
qol due to urinary symptoms,C0518214;C0678226;C0426359,false;false;false,19867/22402
qrs $ $nmbr$ ms ( $nmbr$ % cl ) ( n - $nmbr$ ),C2349943;C0596019;C3539704;C3713294,false;false;false;true,19868/22402
qrs < $nmbr$ ms ( $nmbr$ % cl ) ( n - $nmbr$  $nmbr$ ),C2349943;C0596019;C3539704;C3713294,false;false;false;true,19869/22402
qrs > $nmbr$ ms  % ( n ),C2349943;C3539704;C3713294,false;false;true,19870/22402
qrs duration  ms,C0429025;C2349943;C3539704;C3713294;C0488377,false;false;false;true;false,19871/22402
qrs width  ms,C0487742;C2349943;C3539704;C3713294,false;false;false;true,19872/22402
qtc > $nmbr$ n = $nmbr$,,,19873/22402
qtc < $nmbr$ n = $nmbr$,,,19874/22402
qualifying acs event — no . ( % ),C1514624;C0742343;C0441471;C4019010;C4318612,false;true;false;false;false,19875/22402
qualifying events,C1514624;C0441471;C3541888,false;false;false,19876/22402
qualifying high - risk features — %,C1514624,false,19877/22402
qualifying index event as pe,C1514624;C0600653;C0441471;C0070939;C1880476;C4284304;C4019010;C0918012;C1552854;C1637833;C2986546,false;true;false;true;false;false;false;true;false;false;false,19878/22402
qualifying risk factor,C1514624;C0035648,false;true,19879/22402
qualifying risk factor — no . ( % ),C1514624;C0035648,false;true,19880/22402
qualifying risk factor  n ( % ),C1514624;C0035648,false;true,19881/22402
qualifying risk factors — no . ( % ),C1514624;C0035648;C1553898,false;true;false,19882/22402
qualifying symptomatic event  n ( % ) a,C1514624,false,19883/22402
quartiles of fgf - $nmbr$ ( ru / ml ),C2828255;C0016026;C0035970;C0439526;C1705224;C3887665;C1425796;C0919505,false;true;true;false;false;false;false;false,19884/22402
question $nmbr$ ( fatigue / tiredness ),C1522634;C0015672;C4553152;C3463815;C4050243;C4554645,false;true;false;false;false;false,19885/22402
question $nmbr$ ( neck / back / hip pain ),C1522634;C0007859;C0004600;C0019552;C0022122;C1505163;C3538851;C4284725;C0205095;C0460009;C1995000;C1963180;C4553909;C0027530;C0004604;C1963071;C4553945;C0019559;C4551516;C3159206,false;true;true;true;true;true;false;false;false;false;false;false;false;true;true;false;false;false;false;false,19886/22402
question $nmbr$ ( pain / swelling in joints other than neck / back / hips ),C1522634;C0003862;C0013604;C0038999,false;true;true;false,19887/22402
question $nmbr$ ( discomfort from any areas tender to touch / pressure ),C1522634;C2364135;C0205146;C0234234;C0152054;C0439815;C0702221;C4319729,false;false;false;false;true;false;true;false,19888/22402
question $nmbr$ ( morning stiffness since arising ),C1522634;C0457086,false;false,19889/22402
question $nmbr$ ( length of morning stiffness since arising ),C1522634;C1444754;C0457086;C1706316,false;false;false;false,19890/22402
quintile ( n ),C1508496,false,19891/22402
quintile $nmbr$ ( $nmbr$ . $nmbr$ % - $nmbr$ . $nmbr$ % ) ( n = $nmbr$ ),C1508496,false,19892/22402
quintile  range  mg / dl,C1508496;C1514721;C0439269;C2348147;C3542016,false;false;false;false;false,19893/22402
qva $nmbr$ / $nmbr$ pg once daily ( n = $nmbr$ ),C0030827;C0332173;C0072225;C1266240,true;false;true;false,19894/22402
qveral,,,19895/22402
r - tpa,C0032143,true,19896/22402
r ight coronary,C0205090;C0684010;C2603358,false;true;false,19897/22402
r wave in avl ( mm ),C0429091;C0449216;C4330985;C4554674,false;false;false;false,19898/22402
ra - beam,C3538806;C0338248;C2347880;C4521565;C4048756,false;false;false;false;false,19899/22402
ra duration ( years )  mean ( s . e . ),C3538806;C0449238;C0439234;C0444504;C2347634;C2348143;C2926735;C4048756,false;false;false;false;false;false;false;false,19900/22402
ra ndosii zat ion,C3538806;C0022023;C1700702;C4048756,false;true;false;false,19901/22402
raas inhibitor,C1999216,false,19902/22402
raas inhibitors,C0243077,true,19903/22402
race - nonwhite,C0034510;C1706779;C3853635,true;false;false,19904/22402
race - n ( % ),C0034510;C1706779;C3853635,true;false;false,19905/22402
race — no . ( % ) : t,C0034510;C1706779;C3853635,true;false;false,19906/22402
race — no . { % ) ' i ',C0034510;C1706779;C3853635,true;false;false,19907/22402
race — no . { % ) - i -,C0034510;C1706779;C3853635,true;false;false,19908/22402
race — no . / total no . ( % ) f,C0034510;C1706779;C3853635,true;false;false,19909/22402
race ( % white ),C0034510;C1706779;C3853635,true;false;false,19910/22402
race ( % ) white,C0034510;C1706779;C3853635,true;false;false,19911/22402
race ( % ) *,C0034510;C1706779;C3853635,true;false;false,19912/22402
race ( non - white ) ( % ),C0034510;C1706779;C3853635,true;false;false,19913/22402
race ( p = o - $nmbr$ ),C0034510;C1706779;C3853635,true;false;false,19914/22402
race ( white  n [ % ] ),C0034510;C1706779;C3853635,true;false;false,19915/22402
race or ethnic group — no . ( % ) : t,C0034510;C1706779;C3853635,true;false;false,19916/22402
race or ethnic group — no . { % ) ■ ' ( white,C0034510;C1706779;C3853635,true;false;false,19917/22402
race or ethnic group ( % ) f,C0034510;C1706779;C3853635,true;false;false,19918/22402
race or ethnic group  n ( % ) *,C0034510;C1706779;C3853635,true;false;false,19919/22402
race or ethnic origin,C0034510;C1706779;C3853635,true;false;false,19920/22402
race or ethnicity,C0034510;C1706779;C3853635,true;false;false,19921/22402
race white,C0034510;C1706779;C3853635,true;false;false,19922/22402
race  % white,C0034510;C1706779;C3853635,true;false;false,19923/22402
race  asian  n ( % ),C0034510;C1706779;C3853635,true;false;false,19924/22402
race  black or african - american  n ( % ),C0034510;C1706779;C3853635,true;false;false,19925/22402
race  n ( % ) white,C0034510;C0007457;C0043157;C0220938;C1706779;C3853635,true;true;true;false;false;false,19926/22402
race  n ( % ) *,C0034510;C1706779;C3853635,true;false;false,19927/22402
race  n ( % ) :,C0034510;C1706779;C3853635,true;false;false,19928/22402
race  n ( % ) ’,C0034510;C1706779;C3853635,true;false;false,19929/22402
race  n ( % ) +,C0034510;C1706779;C3853635,true;false;false,19930/22402
race  n ( % ) a,C0034510;C1706779;C3853635,true;false;false,19931/22402
race  n ( % ) t,C0034510;C1706779;C3853635,true;false;false,19932/22402
race  n ( % ) y,C0034510;C1706779;C3853635,true;false;false,19933/22402
race  n ( % ],C0034510;C1706779;C3853635,true;false;false,19934/22402
race  no . ( % ) white,C0034510;C1706779;C3853635,true;false;false,19935/22402
race  no . ( % ) *,C0034510;C1706779;C3853635,true;false;false,19936/22402
race  no . ( % ) b,C0034510;C1706779;C3853635,true;false;false,19937/22402
race  no . ( % ) c,C0034510;C1706779;C3853635,true;false;false,19938/22402
race  no . / total ( % ),C0034510;C1706779;C3853635,true;false;false,19939/22402
race  white ( % ),C0034510;C1706779;C3853635,true;false;false,19940/22402
race  white  n ( % of patients ),C0034510;C1706779;C3853635,true;false;false,19941/22402
race  white    n   ( % ),C0034510;C1706779;C3853635,true;false;false,19942/22402
race    n   ( % ),C0034510;C1706779;C3853635,true;false;false,19943/22402
race  * ’ n ( % ),C0034510;C1706779;C3853635,true;false;false,19944/22402
race / ethnicity  % white non - hispanic,C0034510;C0015031;C1533020;C1518422;C1533021;C0007457;C1518424;C0043157;C0220938;C0243103;C1706779;C3853635,true;true;false;false;false;true;false;true;false;true;false;false,19945/22402
race / ethnicity  no . ( % ) *,C0034510;C0015031;C0243103;C1706779;C3853635,true;true;true;false;false,19946/22402
race / ethnicity  zz ( % ),C0034510;C0015031;C2347310;C0243103;C1706779;C3853635,true;true;false;true;false;false,19947/22402
race :,C0034510;C1706779;C3853635,true;false;false,19948/22402
race : white,C0034510;C1706779;C3853635,true;false;false,19949/22402
race_white  %,C0034510;C1706779;C3853635,true;false;false,19950/22402
race §,C0034510;C1706779;C3853635,true;false;false,19951/22402
racec  n ( % ),C4287599,false,19952/22402
racey  z,,,19953/22402
racial category,C0034510;C0683312;C3889287;C1706779;C3669213;C3853635,true;false;false;false;false;false,19954/22402
radiate,C0332301,false,19955/22402
radiographic progression based on change from baseline > sdc,C0444708;C0242656;C0449258,false;true;false,19956/22402
radionuclide ventriculography,C0017200;C0034610,true;true,19957/22402
raee,,,19958/22402
rales,C0034642;C0240859,true;false,19959/22402
ramus,C3538818,false,19960/22402
randomised patients ( n ),C0030705,true,19961/22402
randomised patients with > $nmbr$ % bsa psoriasis skin involvement at baseline,C0030705;C0033860;C0444099;C1314939;C1123023;C4520765,true;true;false;false;true;false,19962/22402
randomised patients with basdai assessment at baseline and week $nmbr$  n,C1998004;C0679830,false;false,19963/22402
randomised patients with dactylitis at baseline,C0030705;C0239161,true;false,19964/22402
randomised patients with enthesitis at baselinet,C0030705;C1282952,true;false,19965/22402
randomised patients with spondylitis at baseline  n,C0030705;C0038012,true;true,19966/22402
randomization - to - angiography,C0034656;C0002978,true;true,19967/22402
randomization - to - angiography distribution time,C0034656;C0002978;C0681683,true;true;false,19968/22402
randomization group,C0034656;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,19969/22402
randomization to,C0034656,true,19970/22402
randomization to end of study,C0034656,true,19971/22402
randomization to first balloon inflation  min,C0034656;C0205435;C0336867;C0021398;C0702093;C1524029;C3813700;C1318493;C0441144;C1279901,true;false;false;true;false;false;false;false;false;false,19972/22402
randomization ),C0034656,true,19973/22402
randomization  n ( % ),C0034656,true,19974/22402
randomize,,,19975/22402
randomized < $nmbr$ hr after presentation — %,C0034656;C0449450;C3815594,true;false;false,19976/22402
randomized group by subgroup interaction,C0034656;C0441833;C1079230;C1704675;C1515021;C0687744;C1257890;C1519504;C1705428;C1705429;C3815594,true;false;false;false;false;false;true;false;false;false;false,19977/22402
randomized patients,C0034656;C0030705;C3815594,true;true;false,19978/22402
randomized to canakinumab $nmbr$ mg,C0034656;C3815594,true;false,19979/22402
randomized to receive aspirin yes,C0034656;C3815594,true;false,19980/22402
randomized to receiveaspirin,C0034656;C3815594,true;false,19981/22402
randomized treatment,C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3815594,true;true;true;false;false;false;false;false;false,19982/22402
randomized treatment  % ( n ),C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3815594,true;true;true;false;false;false;false;false;false,19983/22402
randomized treatments  n ( % ),C0034656;C0087111;C3815594,true;true;false,19984/22402
randomized  double - blind reversal phase ( baseline = week $nmbr$ ),C0034656;C3815594,true;false,19985/22402
randomly assigned to ace,,,19986/22402
randomly assigned to calcium channel blocker,,,19987/22402
randomly assigned to diuretic,,,19988/22402
range ed etiology ( n ),C1514721;C3538926;C0015127;C1314792;C1524003;C2348147;C3542016,false;false;true;true;false;false;false,19989/22402
range iga modified $nmbr$ score  n ( % ),C1514721;C2825347;C2348147;C3542016,false;false;false;false,19990/22402
range of sbp,C1514721;C0085805;C2348147;C3542016,false;true;false;false,19991/22402
range race  n ( % ),C1514721;C0034510;C1706779;C3853635;C2348147;C3542016,false;true;false;false;false;false,19992/22402
rank based on treatment   =   placebo,C0667477;C0699794,true;false,19993/22402
rankin scale ≥ $nmbr$,C0451405,false,19994/22402
ranolazine ( n $nmbr$ $nmbr$ ),C0073633,true,19995/22402
ranolazine n = $nmbr$,C0073633,true,19996/22402
ranolazine  n   =   $nmbr$,C0073633,true,19997/22402
ranotazine vs . placebo km failure rate,,,19998/22402
rash,C0015230,true,19999/22402
rate,C0871208;C1521828,false;false,20000/22402
rate - control group ( n = $nmbr$ ),C0489879;C0441848,false;false,20001/22402
rate ( % per year ),C0871208;C0439234;C0439508;C1521828,false;false;false;false,20002/22402
rate ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ),C0871208;C0439445;C0369637;C0441923;C1521828,false;false;false;false;false,20003/22402
rate difference ( events / year ),C0871208;C1705241;C0441471;C0439234;C0439508;C3541888;C1705242;C1521828,false;false;false;false;false;false;false;false,20004/22402
rate difference ( lebrikizumab - placebo ),C0871208;C1705241;C2981360;C0032042;C1696465;C1706408;C1705242;C1521828,false;false;true;true;false;false;false;false,20005/22402
rate estimate ( $nmbr$ % ci ),C0871208;C0750572;C0008107;C3259781;C1521828,false;false;true;false;false,20006/22402
rate in all participants  % / y,C0871208;C0679646;C1521828,false;false;false,20007/22402
rate of non - progression ( defined as cfb in mtss £ $nmbr$ )  n / n ( % ) *,C0871208;C3839460;C1521828,false;false;false,20008/22402
rate of non - progression ( defined as cfb in mtss £ $nmbr$ . $nmbr$ )  n / n ( % ) *,C0871208;C3839460;C1521828,false;false;false,20009/22402
rate of oral or systemic corticosteroid,C0871208;C0442027;C4521986;C1521828,false;false;false;false,20010/22402
rate of sares,C0871208;C1521828,false;false,20011/22402
rate per $nmbr$ - patient - years ( control vs alirocumab ) *,C0871208;C0030705;C0439234;C1521828,false;true;false;false,20012/22402
rate per $nmbr$ - patient - years ( control vs alirocumab ) i,C0871208;C0030705;C0439234;C1521828,false;true;false;false,20013/22402
rate per $nmbr$ patient - years,C0871208;C0030705;C0439234;C1521828,false;true;false;false,20014/22402
rate ratio ( lebrikizumab vs placebo  $nmbr$ % cl ),C0871208;C0456603;C2981360;C1547037;C1521828,false;false;true;false;false,20015/22402
rate ratio { $nmbr$ % cl ),C0871208;C0456603;C0596019;C1547037;C1521828,false;false;false;false;false,20016/22402
rate ratio mepo / pbo ( $nmbr$ % ci ),C0871208;C0456603;C0031962;C0008107;C3259781;C1547037;C1521828,false;false;true;true;false;false;false,20017/22402
rate ratio vs placebo ( $nmbr$ % ci ),C0871208;C0456603;C1547037;C1521828,false;false;false;false,20018/22402
rate reduction ( % ),C0871208;C0301630;C0392756;C1293152;C4551656;C1521828,false;false;false;false;false;false,20019/22402
rate ( % / year ),C0871208;C0439234;C0439508;C1521828,false;false;false;false,20020/22402
rate  % / y,C0871208;C1521828,false;false,20021/22402
rate / $nmbr$ pyo,C0871208;C0033809;C1521828,false;true;false,20022/22402
rate †,C0871208;C1521828,false;false,20023/22402
rate ‡,C0871208;C1521828,false;false,20024/22402
rates,C0871208;C1521828,false;false,20025/22402
ratet,,,20026/22402
ratet n ( % ),,,20027/22402
ratio mepo / pbo ( $nmbr$ % ci ),C0456603;C0031962;C0008107;C3259781;C1547037,false;true;true;false;false,20028/22402
ratio of fev $nmbr$ to fvc ( % ),C0456603;C3714541;C1547037,false;true;false,20029/22402
ratio of ldl to hdl cholesterol,C0456603;C1547037,false;false,20030/22402
ratio of urinary albumin ( mg ) to creatinine ( g ),C0456603;C2362049;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1547037,false;false;true;true;false;false;false;false;false;false,20031/22402
ratio of urinary albumin ( mg ) to creatinine ( g ) median,C0456603;C2362049;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1547037,false;false;true;true;false;false;false;false;false;false,20032/22402
ratio to baseline in eosinophil count at week $nmbr$  geometric mean ( se on loge scale ) cells / ll,C0456603;C0168634;C1442488;C1547037,false;true;false;false,20033/22402
ratio to baseline in total ige at week $nmbr$  geometric mean ( se on loge scale ) u / ml,C0456603;C0168634;C1442488;C1547037,false;true;false;false,20034/22402
re - cover $nmbr$ dabigatran,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,20035/22402
re - cover $nmbr$ warfarin,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,20036/22402
re - cover ii,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,20037/22402
re - cover / re - cover ii,C0556581;C0180153;C1999244;C3888055;C2986904,false;false;false;false;false,20038/22402
re - medy,C0556581;C2986904,false;false,20039/22402
reason for discontinuation of previous tnfa inhibitor,C0392360;C0457454;C0205156;C1448177;C1999216;C1710304;C1552607;C1444662;C4552847,false;false;false;true;false;false;false;false;false,20040/22402
rec . ischemia,C1424025;C0022116;C4321499;C2606415,false;true;false;true,20041/22402
rec . ischemia leading to hosp,C1424025;C0022116;C4321499;C2606415,false;true;false;true,20042/22402
received antihypertensive within last $nmbr$ days  n ( % ),C1514756;C0003364;C0439228,false;true;false,20043/22402
received drug - eluting stent,C1514756;C1322815,false;true,20044/22402
received first loading dose,C1514756;C0205435;C3714444;C1279901,false;false;false;false,20045/22402
receiving antihypertensive,C1514756,false,20046/22402
receiving antihypertensive treatment -,C1514756,false,20047/22402
receiving antihypertensive treatment  n ( % ) blood pressure  mm hg  mean ( sd ),C1514756,false,20048/22402
recent cardiovascular eventf,C0332185;C0007226;C3887460,false;true;false,20049/22402
recent cardioversion ( within $nmbr$ days before randomization ) — no . ( % ),C0332185;C0013778;C0439228,false;true;false,20050/22402
recent treatment ( < $nmbr$ months mmf / ggs ),C0332185;C0039798;C0439231;C0083765;C0209368;C3848524;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;true;true;true;true;false;false;false;false;false,20051/22402
recent use of allopurinol ( within $nmbr$ days of,C0332185;C1524063;C0002144,false;false;true,20052/22402
receptor blocker,C0597357,false,20053/22402
receptor blockers,C0597357,false,20054/22402
receptor blockers  n ( % ),C0597357,false,20055/22402
recervini },,,20056/22402
recervng,,,20057/22402
recurrent hf,C1455761;C0018488;C1313497;C1538440;C3273279;C2945760,false;true;true;false;false;false,20058/22402
reduced hdl cholesterol,C0151691,false,20059/22402
reduction in odds %,C0301630;C0392756;C1293152;C4551656,false;false;false;false,20060/22402
reduction in risk % ( $nmbr$ % ci ),C1137094;C0008107;C3259781;C0035647;C0520870;C4552904,true;true;false;true;false;false,20061/22402
reduction of hba $nmbr$ c from baseline ≥ $nmbr$ . $nmbr$ %,C0301630;C0019016;C1825777;C3538758;C0392756;C1293152;C4551656,false;true;false;false;false;false;false,20062/22402
ref .,C1425988,false,20063/22402
ref §,C1425988,false,20064/22402
reference,C1514811;C1706462,false;false,20065/22402
referent,C1706462,false,20066/22402
refractory to corticosteroids  n ( % ),C0205269;C0001617;C3539185;C3540725;C3540726;C3540727,false;true;false;false;false;false,20067/22402
regadenoson ( n = $nmbr$ ),C1698215,true,20068/22402
region - north america,C0017446;C0028405;C0205147,true;true;false,20069/22402
region - n ( % ),C0017446;C0205147,true;false,20070/22402
region — no . { % ),C0017446;C0205147,true;false,20071/22402
region north america,C0017446;C0028405;C0205147,true;true;false,20072/22402
region ( us ),C0017446;C0205147,true;false,20073/22402
region 一 no . ( % ),C0017446;C0205147,true;false,20074/22402
region n ( % ),C0017446;C0205147,true;false,20075/22402
region of enrollment — no . ( % ),C0017446;C1516879;C1696073;C3888021;C0205147,true;false;false;false;false,20076/22402
region of residence ( p = $nmbr$ $nmbr$ ),C0017446;C0237096;C0205147,true;false;false,20077/22402
region of the world,C0017446;C2700280;C0205147,true;false;false,20078/22402
region of world — no . ( % ),C0017446;C2700280;C0205147,true;false;false,20079/22402
region ofenrollment — %,C0017446;C0205147,true;false,20080/22402
region ofthe world,C0017446;C2700280;C0205147,true;false;false,20081/22402
region united states,C0017446;C0041703;C0205147,true;true;false,20082/22402
region *,C0017446;C0205147,true;false,20083/22402
region  n ( % ) a,C0017446;C0205147,true;false,20084/22402
region  no . ( % ),C0017446;C0205147,true;false,20085/22402
region  no . ( % ) c,C0017446;C0205147,true;false,20086/22402
region  no . / total ( % ),C0017446;C0205147,true;false,20087/22402
region    n   ( % ),C0017446;C0205147,true;false,20088/22402
region :,C0017446;C0205147,true;false,20089/22402
regions  n ( % ),C0017446;C0205147,true;false,20090/22402
regiont,,,20091/22402
related to study druga,C0439849;C0445223,false;false,20092/22402
relative risk ( $nmbr$ % cl ) comparing icd therapy and placebo using a linear interaction term in the model ( shfmxicd ) *,C0242492;C0596019;C1707455;C0021122;C0039798;C0087111;C1363945,true;false;false;true;true;true;false,20093/22402
relative risk { $nmbr$ % ci ),C0242492;C0008107;C3259781,true;true;false,20094/22402
relative risk comparing icd therapy and placebo,C0242492;C1707455;C0021122;C0039798;C0087111;C1363945,true;false;true;true;true;false,20095/22402
relative risk vs . placebo ( $nmbr$ % cl ),C0242492,true,20096/22402
relative risk * ( $nmbr$ % cl ),C0242492;C0596019,true;false,20097/22402
relative risk ® ' ( $nmbr$ % cl ),C0242492;C0596019,true;false,20098/22402
relative risk ® ( $nmbr$ % cl ),C0242492;C0596019,true;false,20099/22402
relative wall thickness,C0080103;C0677535;C1280412;C0205345;C1547039,true;false;false;false;false,20100/22402
remaining patients,C1527428;C0030705,false;true,20101/22402
remission by : baseline duration of steroid,C0814126;C0168634;C0038317;C1442488,false;true;true;false,20102/22402
remission by : baseline steroid doses,C0544452;C0168634;C0038317;C0178602;C1442488;C0687702,false;true;true;false;false;false,20103/22402
remission component of variable,C0544452;C0449432;C0439828;C4553760;C1705248;C0687702,false;false;false;false;false;false,20104/22402
renal biopsy class,C0194073;C0456387;C1518526;C1705943,false;false;false;false,20105/22402
renal composite *,C0022646;C0205199;C1547335,true;false;false,20106/22402
renal disease,C0022658,true,20107/22402
renal disease ),C0022658,true,20108/22402
renal failure,C0035078;C1963154,true;false,20109/22402
renal function ( egfr ) according to mdrd  n ( % ),C0232804;C1739039;C0680240;C3839656;C3811844;C3812682,false;true;false;false;false;false,20110/22402
renal function ( ml / min ),C0232804;C0439445,false;false,20111/22402
renal function at randomization,C0232804;C0034656,false;true,20112/22402
renal function *,C0232804,false,20113/22402
renal function  bn ( % ),C0232804;C0005005;C0034700;C1706574;C4551963,false;true;true;false;false,20114/22402
renal function : ! : n ( % ),C0232804,false,20115/22402
renal functiona,C0022646,true,20116/22402
renal functionb,C0022646,true,20117/22402
renal functionc  n ( % ),C0022646,true,20118/22402
renal impairment ( crcl < $nmbr$ ml / min ),C1565489;C1846718;C0439445,true;false;false,20119/22402
renal impairment *,C1565489,true,20120/22402
renal impairmentf,C0022646,true,20121/22402
renal insufficiency *,C0035078;C1565489,true;true,20122/22402
renin - angiotensin - aldosterone system blocker,C0086907,true,20123/22402
renin - angiotensin system inhibitor use,C0035096;C1999216;C0042153;C0457083;C1947944;C2984247,true;false;true;false;false;false,20124/22402
renin – angiotensin system inhibitor,C0035096;C1999216;C2984247,true;false;false,20125/22402
renin inhibitor,C1960108;C3537174;C4521920,false;false;false,20126/22402
repaired congenital shunts,C0205340;C0009678;C0232180;C0542331;C1442858;C1744681,false;true;false;false;false;false,20127/22402
repaired s - p shunts,C0205340,false,20128/22402
required corticosteroid and / or antibiotic ( without hospitalization ),C1514873;C0001617;C3536709,false;true;false,20129/22402
required hospitalization,C1708385,false,20130/22402
requiring assistance,C0018896;C1269765,true;false,20131/22402
rescue medication use  inh / d {,C0240320;C0022209,false;true,20132/22402
rescue medication use  mean inhalations / previous $nmbr$ d,C0240320;C0444504;C0004048;C0205156;C1552607;C0354922;C2347634;C2348143,false;false;true;false;false;false;false;false,20133/22402
rescue use : mean no . of inhalations / d,C0042153;C0444504;C2347634;C2348143;C0457083;C1947944,true;false;false;false;false;false,20134/22402
resection performed — no . { % ),C0015252;C0728940,false;false,20135/22402
residence in asia  n ( % ),C0237096;C0003980,false;true,20136/22402
resistant htn n = $nmbr$,C0332325;C0020538;C1514892;C1550464;C2827757,false;true;false;false;false,20137/22402
resistant htn : placebo n = $nmbr$,C0332325;C0020538;C0032042;C1696465;C1706408;C1514892;C1550464;C2827757,false;true;true;false;false;false;false;false,20138/22402
resistant htn : spiro n = $nmbr$,C0332325;C0020538;C1514892;C1550464;C2827757,false;true;false;false;false,20139/22402
reslizumab,C1869620,true,20140/22402
reslizumab ( n = $nmbr$ ),C1869620,true,20141/22402
reslizumab $nmbr$ . $nmbr$   mg / kg ( n   = $nmbr$ ),C1869620;C0439272,true;false,20142/22402
reslizumab $nmbr$ . $nmbr$ mg / kg ( n = $nmbr$ ),C1869620;C0439272,true;false,20143/22402
resllzumab,,,20144/22402
respiratory medication taken at baseline  n ( % ),C0418986,false,20145/22402
responder analyses ( achieving alc < $nmbr$ . $nmbr$ % ),C0002778;C0936012;C1524024,false;false;true,20146/22402
rest angina but not past $nmbr$ h,C0002965;C0152172,true;false,20147/22402
rest angina past $nmbr$ h,C0002965;C1444637;C0033727;C0369286;C0441932;C0564385;C4528284;C4284302;C0152172,true;false;true;false;false;false;false;false;false,20148/22402
rest ofthe world,C0035253;C2700280;C1622890,true;false;false,20149/22402
rest ofworld,C0035253;C1622890,true;false,20150/22402
restriction in normal activities in the past $nmbr$ weeks,C0443288;C4697852,false;false,20151/22402
retinopathy — no . ( % ),C0035309;C1962966,true;false,20152/22402
revascularisation  n ( % ),C0581603,false,20153/22402
revascularization history,C0581603;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,false;true;true;false;false;false;false,20154/22402
revascularization in $nmbr$ days,C0581603;C0439228,false;false,20155/22402
reversibility — %,C0449261,false,20156/22402
reversibility ( % )  median ( range ) c,C0449261;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,20157/22402
reversibility [ % ]  median ( range ),C0449261;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false;false;false;false,20158/22402
reversibility < $nmbr$ % ( itt ) ( n = $nmbr$ ),C0449261,false,20159/22402
reversibility < $nmbr$ % ( n = $nmbr$ ),C0449261,false,20160/22402
reversibility > $nmbr$ % ( itt ) ( n = $nmbr$ ),C0449261,false,20161/22402
reversibility > $nmbr$ % ( n = $nmbr$ ),C0449261,false,20162/22402
reversibility s $nmbr$ % ( itt ) ( n = $nmbr$ ),C0449261,false,20163/22402
reversibility stratum *,C0449261,false,20164/22402
reversibility to salbutamolc  d  mean ( sd ),C0449261;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20165/22402
reversibility ’ ' %,C0449261,false,20166/22402
reversible,C0205343,false,20167/22402
reversible to albuterolc  d  n ( % ),C0205343,false,20168/22402
reversible to bronchodilator  b %,C0205343;C0006280,false;true,20169/22402
revive i,,,20170/22402
revive ii,,,20171/22402
rf - positive  > $nmbr$ iu / ml  %,C0035448;C0439178;C0439458;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false;false,20172/22402
rf ( mg / dl ),C0035448;C0439269;C0201660;C0748398;C1547111,true;false;false;false;false,20173/22402
rf ( mg / dl  per unit ),C0035448;C0439269;C0439148;C0439453;C1509845;C1519795;C1704753;C1880519;C3853603;C3642216;C1638407;C0024671;C1532632;C0026410;C1960952;C2346927;C4321396;C4521761;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false;false;false;true;false;true;false;false;false;false;false;false;false,20174/22402
rf and acpa negative  n ( % ),C0035448;C0201660;C0748398;C1547111,true;false;false;false,20175/22402
rf and acpa positive  n ( % ),C0035448;C0201660;C0748398;C1547111,true;false;false;false,20176/22402
rf negative and acpa positive  n ( % ),C0035448;C0205160;C1513916;C2825415;C2825491;C3853545;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,20177/22402
rf positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,20178/22402
rf positive and acpa negative  n ( % ),C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,20179/22402
rf positive  no . ( % ),C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,20180/22402
rf  % positive,C0035448;C0439178;C1446409;C1514241;C2825490;C3812269;C0201660;C0748398;C1547111,true;false;false;false;false;false;false;false;false,20181/22402
rhabdomyolysis  myopathy  or elevated creatine phosphokinase > $nmbr$ x upper limit of normal ( n = $nmbr$ ),C0035410;C0026848;C4552660,true;true;false,20182/22402
rheumatoid factor and acpa positive,C0035448;C0201660,true;false,20183/22402
rheumatoid factor or acpa positive  or both,C0035448;C0201660,true;false,20184/22402
rheumatoid factor !,C0035448;C0201660,true;false,20185/22402
rhinitis,C0035455,true,20186/22402
rhythm - control group ( n = $nmbr$ ),C0871269;C0243148;C0441848;C1550141;C1882979;C2587213;C3274648;C4553389;C1523018;C3828331,false;true;false;false;false;false;false;false;false;false,20187/22402
rib,C0035561,true,20188/22402
right ventricular dysfunction — no . / total no . ( % ) §,C0242707;C1556315,true;false,20189/22402
right ventricular dysfunction  n / n ( % ) j,C0242707;C1556315,true;false,20190/22402
risedronate ( n   =   $nmbr$ ),C0246719,true,20191/22402
risedronate ( n = $nmbr$ ),C0246719,true,20192/22402
risedronate n / n ( % ),C0246719,true,20193/22402
risk ratio [ $nmbr$ % cl ],C0028873;C0596019;C0242492,true;false;true,20194/22402
risk at,C0035647;C4552904,true;false,20195/22402
risk categories,C0035647;C0683312;C4552904,true;false;false,20196/22402
risk factor,C0035648,true,20197/22402
risk factor for venous thromboembolism  no . ( % ),C3495424;C1521761;C2827422;C3496592,false;false;false;false,20198/22402
risk factors — no . ( % ),C0035648;C1553898,true;false,20199/22402
risk factors ( % of group ),C0035648;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1553898,true;false;false;true;false;false;false;false,20200/22402
risk factors ( % ),C0035648;C1553898,true;false,20201/22402
risk factors and diabetes status ( % ),C0035648;C1553898,true;false,20202/22402
risk factors and medical history,C0035648;C1553898,true;false,20203/22402
risk factors for stroke,C0035648;C0038454;C4554100;C1553898,true;true;false;false,20204/22402
risk factors  no . ( % ),C0035648;C1553898,true;false,20205/22402
risk level at admission,C2923839;C0184666;C0809949,false;false;false,20206/22402
risk marker and model,C1519104,false,20207/22402
risk model endpoint,C0035647;C3161035;C2349179;C2826544;C3274659;C3714583;C3853906;C4552904,true;false;false;false;false;false;false;false,20208/22402
risk of moderate / severe exacerbations,C0332166;C0205082;C4086268;C4050465;C4050466,false;false;false;false;false,20209/22402
risk stratum,C0035647;C4552904,true;false,20210/22402
rivaroxaban ( n   = $nmbr$ ),C1739768,true,20211/22402
rivaroxaban $nmbr$ . $nmbr$ mg bid + aspirin $nmbr$ mg od,C1739768;C1319635;C0004057;C0229089;C0439164;C1512019;C3273373;C3665488,true;false;true;false;false;false;true;true,20212/22402
rivaroxaban alone ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C1739768;C0205171;C0439044;C0679994,true;false;false;false,20213/22402
rivaroxaban plus,C1739768,true,20214/22402
rivaroxaban plus aspirin ( $nmbr$ % cl ),C1739768;C0332287;C0004057;C0596019,true;false;true;false,20215/22402
rivaroxaban plus aspirin ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$,C1739768;C0332287;C0004057,true;false;true,20216/22402
rivaroxaban +,C1739768,true,20217/22402
rofecoxib,C0762662,true,20218/22402
roflumilast ( n = $nmbr$  $nmbr$ ),C0965618,true,20219/22402
rolofylline ( n = $nmbr$ ),C0166128,true,20220/22402
rolofylline $nmbr$ mg ( n = $nmbr$ ),C0166128;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20221/22402
rolofylline n,C0166128,true,20222/22402
rolofylline rx,C0166128;C1425688;C1521941;C2709207,true;false;false;false,20223/22402
rosigiitazone ± oad,,,20224/22402
rosiglitazone $nmbr$ mg daik,C0289313;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20225/22402
rosiglitazone $nmbr$ mg daily,C0289313;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,20226/22402
rosiglitazone versus glyburide,C0289313,true,20227/22402
rosiglitazone versus metformin,C0289313,true,20228/22402
rosuva  rosuvastatin  sd  standard deviation  t $nmbr$ dm  type $nmbr$ diabetes mellitus .,C0965129;C2699239;C0871420;C0011849;C0332307;C1547052;C0011816;C1320657;C3250443,true;false;false;true;false;false;true;false;false,20229/22402
rosuvastain + fenofibric acid   n   =   $nmbr$,C0060179,true,20230/22402
rosuvastatin ( n = $nmbr$  $nmbr$ ),C0965129,true,20231/22402
rosuvastatin ( n = $nmbr$ . $nmbr$ ),C0965129,true,20232/22402
rosuvastatin + fenofibric acid,C0965129;C0060179,true;true,20233/22402
rosuvastatin n ( rate ) $nmbr$,C0965129;C0871208;C1521828,true;false;false,20234/22402
rosuvastatin   n   =   $nmbr$,C0965129,true,20235/22402
rotablator use  n ( % ),C1260867;C0042153;C0457083;C1947944,false;true;false;false,20236/22402
rotigotine ( n = $nmbr$ ),C1700683;C4318637,true;true,20237/22402
rotigotine n = $nmbr$,C1700683;C4318637,true;true,20238/22402
row * n = $nmbr$,C1552840;C1552846,false;false,20239/22402
row §,C1552840;C1552846,false;false,20240/22402
rr ( $nmbr$ % ci ) c,C4554402;C0008107;C3259781,false;true;false,20241/22402
rr ( $nmbr$ % cl ) p value,C4554402;C0596019;C1709380,false;false;false,20242/22402
rr ( $nmbr$ % cl ) [ / ’ value ],C4554402;C0596019;C1522609,false;false;false,20243/22402
rr $nmbr$ - $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$  $nmbr$ ) ’,,,20244/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) *,,,20245/22402
rr $nmbr$ . $nmbr$ < $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) *,,,20246/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ),,,20247/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ ),,,20248/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ },,,20249/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) * *,,,20250/22402
rr $nmbr$ . $nmbr$,,,20251/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$,,,20252/22402
rr reduction  $nmbr$ / $nmbr$ ( $nmbr$ / $nmbr$ cl ),C4554402;C0301630;C0596019;C0392756;C1293152;C4551656,false;false;false;false;false;false,20253/22402
rr ( $nmbr$ aci ) [ p value ],C4554402;C0814206;C1709380;C1510682;C2346870;C4050575,false;false;false;false;false;false,20254/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ - $nmbr$ . $nmbr$ . $nmbr$ ) *,,,20255/22402
rr $nmbr$ . $nmbr$ ( $nmbr$ - $nmbr$  $nmbr$ . $nmbr$ ),,,20256/22402
rro . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ ),,,20257/22402
rro $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ),,,20258/22402
rs - breathlessnessb,C0035970;C3714753;C3813325,true;false;false,20259/22402
rs - chest symptomsd,C0035970;C0817096;C1527391;C3714753;C3813325,true;true;false;false;false,20260/22402
rs - cough & sputumc,C0035970;C0010200;C1961131;C3274924;C4084725;C4084726;C4084727;C3714753;C3813325,true;true;false;false;false;false;false;false;false,20261/22402
rs - totala,C0035970;C3714753;C3813325,true;false;false,20262/22402
rs $nmbr$,C0035970;C3714753;C3813325,true;false;false,20263/22402
rs $nmbr$ & rs $nmbr$,C0035970;C3714753;C3813325,true;false;false,20264/22402
rs $nmbr$ ( aa ) & rs $nmbr$,C0035970;C0282379;C1235746;C1882141;C4554792;C3714753;C3813325,true;true;false;false;false;false;false,20265/22402
rs $nmbr$ ( ac ) & rs $nmbr$,C0035970;C0001246;C0003354;C1412573;C2000891;C3539770;C3714753;C3813325,true;true;true;false;true;false;false;false,20266/22402
rs $nmbr$ ( cc ) & rs $nmbr$,C0035970;C0008318;C3538933;C3714753;C3813325,true;true;false;false;false,20267/22402
ruled out non - fatal pe with or,C1446409,false,20268/22402
russia and georgia,C0035970,true,20269/22402
russia / georgia,C0035970;C0017452;C0017454,true;true;true,20270/22402
rv and pulmonary vascular,C0035190;C3889272,true;false,20271/22402
rvalue,,,20272/22402
rvalue for interaction,C1704675,false,20273/22402
rvfac ( % ),,,20274/22402
rvw,,,20275/22402
s - asa compounds at baseline,C0010139;C0004057;C0168634;C1442488;C3853627;C0043474,true;true;true;false;false;true,20276/22402
s ( s $nmbr$,C0565930;C2603362,false;false,20277/22402
s $nmbr$ mmhg,C0565930;C0439475;C2603362,false;false;false,20278/22402
s $nmbr$ yrs,C0565930;C2603362,false;false,20279/22402
s arm,C0565930;C0446516;C3715044;C4553528;C2603362,false;true;false;false;false,20280/22402
s fs $nmbr$,C0565930;C1517317;C3814419;C2603362,false;false;false;false,20281/22402
s median,C0565930;C0549183;C0876920;C2347635;C2348144;C2939193;C2603362,false;false;false;false;false;false;false,20282/22402
s wave in v $nmbr$ ( mm ),C4301968;C0456681,false;false,20283/22402
s / se  mb or death,C0565930;C0036919;C0024853;C2603362,false;true;true;false,20284/22402
s $nmbr$ ( n = $nmbr$ ),C2986823,true,20285/22402
s $nmbr$ mg / mmol,C0565930;C0567349;C2348885;C2603362,false;false;false;false,20286/22402
s $nmbr$ - $nmbr$ vs placebo,C0565930;C0032042;C1696465;C1706408;C2603362,false;true;false;false;false,20287/22402
s $nmbr$ kg / m ^,C0565930;C1532718;C2603362,false;false;false,20288/22402
s $nmbr$ exacerbations,C0565930;C4086268;C2603362,false;false;false,20289/22402
s $nmbr$ vs placebo,C0565930;C0032042;C1696465;C1706408;C2603362,false;true;false;false;false,20290/22402
s $nmbr$ . $nmbr$ mg / mmol,C0565930;C0567349;C2348885;C2603362,false;false;false;false,20291/22402
s $nmbr$ years ( n = $nmbr$ ),C2986823;C0439234,true;false,20292/22402
s $nmbr$ years,C0565930;C0439234;C2603362,false;false;false,20293/22402
s $nmbr$ ml / min,C0565930;C0439445;C2603362,false;false;false,20294/22402
s $nmbr$ ( $nmbr$ . s ),C0565930;C2603362,false;false,20295/22402
s $nmbr$ - $nmbr$ - s $nmbr$ . $nmbr$ %,C0565930;C2603362,false;false,20296/22402
s $nmbr$ months,C0565930;C0439231;C2603362,false;false;false,20297/22402
sa acs,C0036243;C0742343;C4318612;C0038702;C1539696;C1825840;C3539736;C4521691,true;true;false;true;false;false;false;false,20298/22402
saba ( inhaled )  c   n ( % ),,,20299/22402
saba use in past $nmbr$ days,C0042153;C1444637;C0439228;C4284302;C0457083;C1947944,true;false;false;false;false;false,20300/22402
saba use  occasions / weekt,C0042153;C0457083;C1947944,true;false;false,20301/22402
sabae,,,20302/22402
sack,,,20303/22402
sacral and / or lumbar,C0036037,true,20304/22402
saes,C1519255;C1622657;C4553214,false;false;false,20305/22402
safety population,C0036043;C0032659;C1257890;C1705187,true;true;true;false,20306/22402
safety variable,C0036043;C0439828;C4553760;C1705187,true;false;false;false,20307/22402
safety  %,C0036043;C1705187,true;false,20308/22402
safety    n   ( % ) b,C0036043;C1705187,true;false,20309/22402
sal ( n   = $nmbr$  $nmbr$ ),C0036140;C0037494;C0206136,true;true;true,20310/22402
salbutamol  %,C0001927,true,20311/22402
salmeterol,C0073992,true,20312/22402
salmeterol ( n = $nmbr$ ),C0073992,true,20313/22402
salmeterol / fluticasone $nmbr$ / $nmbr$ pg twice daily,C0939232;C0030827;C0585361;C0072225;C1266240,true;true;false;true;false,20314/22402
salmeterol / fluticasone $nmbr$ / $nmbr$   μ g b . i . d .,C0939232;C0086706,true;true,20315/22402
sama  b   n ( % ),C1075468,false,20316/22402
samac,,,20317/22402
sample size,C0242618,true,20318/22402
sample size ( n ),C0242618,true,20319/22402
sample size  n,C0242618,true,20320/22402
sample size  n ( % ) by treatment,C0242618;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0037793;C0456389,true;true;true;false;false;false;false;false;true;false,20321/22402
sample sizea,C0370003;C2347026,false;false,20322/22402
sample statistics,C2348149,false,20323/22402
saudi arabia,C0036243,true,20324/22402
saxa $nmbr$ mg ( n $nmbr$ $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,20325/22402
saxa $nmbr$ mg $nmbr$ metformin ( n $nmbr$ $nmbr$ ),C0024671;C0025598;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20326/22402
saxagiiptin,,,20327/22402
saxagliptin ( n = $nmbr$ ),C1611934,true,20328/22402
sbp,C0085805,true,20329/22402
sbp ( mean over $nmbr$ h )  mmhg,C0085805;C0444504;C0033727;C0439475;C0369286;C0441932;C0564385;C4528284;C2347634;C2348143,true;false;true;false;false;false;false;false;false;false,20330/22402
sbp ( mmghg )  mean ( sd ),C0085805;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,20331/22402
sbp ( mmhg ) *,C0085805;C0439475,true;false,20332/22402
sbp ( mmhg )  mean ( sd ),C0085805;C0439475;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,20333/22402
sbp ( office measurement )  mmhg,C0085805;C0442603;C0242485;C0439475,true;false;false;false,20334/22402
sbp ( sd ),C0085805;C2699239,true;false,20335/22402
sbp ( sd )  mm   hg,C0085805;C2699239;C0439475,true;false;false,20336/22402
sbp < $nmbr$ mm hg,C0085805;C0439475,true;false,20337/22402
sbp < $nmbr$ mmhg,C0085805;C0439475,true;false,20338/22402
sbp < $nmbr$ mm hg and dbp < $nmbr$ mm hg $nmbr$ / $nmbr$,C0085805;C0439475,true;false,20339/22402
sbp ≥ $nmbr$ mmhg,C0085805;C0439475,true;false,20340/22402
sbp > $nmbr$ mmhg n = $nmbr$,C0085805;C0439475,true;false,20341/22402
sbp > $nmbr$ mm hg and / or dbp > $nmbr$ mm hg $nmbr$ / $nmbr$,C0085805;C0439475,true;false,20342/22402
sbp > $nmbr$ mmhg,C0085805;C0439475,true;false,20343/22402
sbp > $nmbr$ mmhg or dbp > $nmbr$ mmhg,C0085805;C0439475,true;false,20344/22402
sbp at baseline,C0085805;C0168634;C1442488,true;true;false,20345/22402
sbp at visit $nmbr$,C0085805;C0545082;C1512346;C2826704,true;false;false;false,20346/22402
sbp during the follow - up period ( mmhg ),C0085805;C0589120;C0439531;C0439475;C1948053;C1522577;C1704685;C3274571,true;false;false;false;false;false;false;false,20347/22402
sbp  baseline,C0085805;C0168634;C1442488,true;true;false,20348/22402
sbp  difference,C0085805;C1705241;C1705242,true;false;false,20349/22402
sbp  last,C0085805,true,20350/22402
sbp  mean ( sd ) mm hg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,20351/22402
sbp  mm hg ( mean $nmbr$ h )  mean ( sd ),C0085805;C0456680;C0025424;C0444504;C2699239;C2347634;C2348143;C0428257;C2347108;C2347109;C2348272,true;false;true;false;false;false;false;false;false;false;false,20352/22402
sbp  mm hg ( office measurement )  mean ( sd ),C0085805;C0439475;C0442603;C0242485;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false;false;false,20353/22402
sbp  mm   hg,C0085805;C0439475,true;false,20354/22402
sbp  mm   hg,C0085805;C0439475,true;false,20355/22402
sbp  mm   hg ( sd ),C0085805;C0439475;C2699239,true;false;false,20356/22402
sbp  systolic blood pressure  sd  standard deviation  dbp  diastolic blood pressure  b . p . m .  beats per minute  mi  myocardial infarction  tia  transient ischaemic attack .,C0085805;C0488055;C2699239;C0871420;C0536221;C0012000;C3813197;C4281799;C0871470;C1306620;C0033095;C0369637;C0441923;C0460139;C1306345;C4284008;C0007787,true;false;false;false;true;true;false;false;true;false;true;false;false;false;false;false;true,20357/22402
sbp  difference vs placebo ( $nmbr$ % cl ),C0085805;C1705241;C1705242,true;false;false,20358/22402
sbp . mean ( sd ) mm hg,C0085805;C0444504;C2699239;C0439475;C2347634;C2348143,true;false;false;false;false;false,20359/22402
sbp / dbp ( mmhg ),C0085805;C0536221;C0439475;C3813197;C4281799,true;true;false;false;false,20360/22402
sbp / dbp mean,C0085805;C0536221;C0444504;C2347634;C2348143;C3813197;C4281799,true;true;false;false;false;false;false,20361/22402
sbp < $nmbr$ mmhg n = $nmbr$,C0085805;C0439475,true;false,20362/22402
sbp < median ( n = $nmbr$ o $nmbr$ ),C0085805;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,20363/22402
sbp > median ( n = $nmbr$ ),C0085805;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,20364/22402
sbp > $nmbr$ mm hg,C0085805;C0439475,true;false,20365/22402
sbp > $nmbr$ mnn hg,C0085805;C0025424;C0428257;C2347108;C2347109;C2348272,true;true;false;false;false;false,20366/22402
sc belimumab $nmbr$ mg ( n = $nmbr$ ),C0282380;C1723401;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;true;false;false;false;false;false,20367/22402
scale — cognitive portion  ldl — low -,C0175659;C1516691;C0449719;C0349674;C1947916,true;false;false;false;false,20368/22402
scalp psoriasis  n ( % ),C0406326,false,20369/22402
scarring on renal biopsy,C1700247;C0005558;C0220797;C0008767;C0194073;C2004491,false;true;true;true;false;true,20370/22402
scd ( % ),,,20371/22402
scdbp  mean ( sd )  mmhgf,C0444504;C2699239;C2347634;C2348143,false;false;false;false,20372/22402
schwab & england score,C0014282,true,20373/22402
score,C0449820;C4050231,false;false,20374/22402
score ( > $nmbr$ ) at $nmbr$ monthsb unadjusted or,C0449820;C4050231,false;false,20375/22402
score > $nmbr$ . $nmbr$,C0449820;C4050231,false;false,20376/22402
score $nmbr$ . $nmbr$,C0449820;C4050231,false;false,20377/22402
score at week $nmbr$  mean ( se ) difference mepo - pbo ( $nmbr$ % ci ),C0332174;C3533236;C0036919;C1705241;C0031962;C0008107;C3259781;C1705242;C0439230,false;false;true;false;true;true;false;false;false,20378/22402
score distribution :,C0449820;C0520511;C1704711;C4050231,false;false;true;false,20379/22402
score improvement  baseline to week $nmbr$  median ( iqr ),C0449820;C2986411;C0168634;C0332174;C0549183;C0876920;C2347635;C2348144;C2939193;C0439230;C1442488;C4050231,false;false;true;false;false;false;false;false;false;false;false;false,20380/22402
score on asthma control questionnaire * *,C4706265,false,20381/22402
score on st . george ' s respiratory questionnaire ^ ^,C3472502,false,20382/22402
screening ( visit $nmbr$ ),C0220908;C0545082;C1512346;C2826704;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;false;true;false;false;false;false;false,20383/22402
screening and baseline lung function characteristics,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,20384/22402
screening fev $nmbr$   % predicted,C0220908;C3714541;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;true;false;false;false;false;false,20385/22402
screening  l,C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;true;false;false;false;false;false,20386/22402
screening  mean ( sd ) morning pef  mean,C0220908;C0444504;C2699239;C0332170;C0030771;C1518922;C1542834;C2347634;C2348143;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164,true;false;false;false;true;false;false;false;false;true;false;false;false;false;false,20387/22402
scsbp  mean ( sd )  mmhge,C0444504;C2699239;C2347634;C2348143,false;false;false;false,20388/22402
sd = standard deviation  bmi = body mass index  ed = erectile,C2699239;C0871420;C1305855;C3538926,false;false;true;false,20389/22402
sd of sbp,C2699239;C0085805,false;true,20390/22402
sd or %,C2699239,false,20391/22402
sd  standard,C2699239;C1442989;C2828392,false;false;false,20392/22402
sdai ( $nmbr$ - $nmbr$ ),C3871128,false,20393/22402
sdc ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ng / ml ),C1419891;C0439275;C3273112,false;false;false,20394/22402
sdc ( ng / ml ),C1419891;C0439275;C3273112,false;false;false,20395/22402
se,C0036919,true,20396/22402
seated sbp  n,C0277814;C0085805;C1283233,true;true;false,20397/22402
second co - primary,C0205436;C3245499;C0457385;C0565930;C1561503;C1705190,false;true;false;false;false;false,20398/22402
second serum creatinine,C0205436;C0201976;C0600061;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false,20399/22402
second year !,C0205436;C0439234;C0439508;C0457385;C0565930;C1561503;C1705190,false;false;false;false;false;false;false,20400/22402
secondary - prevention cohort,C0679699;C0009247;C0599755,true;true;false,20401/22402
secondary cardiovascular endpoint,C4528314;C0007226;C3887460,false;true;false,20402/22402
secondary end points,C0027627;C2349179;C0175668;C0205436,true;false;false;false,20403/22402
secondary end points $nmbr$,C0027627;C2349179;C0175668;C0205436,true;false;false;false,20404/22402
secondary end points ii,C0027627;C2349179;C1710602;C4082587;C0175668;C0205436,true;false;false;false;false;false,20405/22402
secondary end points iii,C0027627;C2349179;C0439070;C1705160;C0175668;C0205436,true;false;false;false;false;false,20406/22402
secondary endpoints :,C4528314,false,20407/22402
secondary iii *,C0027627;C0439070;C1705160;C0175668;C0205436,true;false;false;false;false,20408/22402
secondary ip,C0027627;C1308226;C4049997;C0175668;C0205436,true;true;false;false;false,20409/22402
secondary kidney composite outcome,C0027627;C0022646;C0205199;C1274040;C1547335;C0227665;C0175668;C0205436,true;true;false;false;false;false;false;false,20410/22402
secondary mace endpoint,C4528314;C0349381;C0949745;C1445339,false;false;true;false,20411/22402
secondary nonresponse,C0027627;C0175668;C0205436,true;false;false,20412/22402
secondary outcome,C0027627;C1274040;C0175668;C0205436,true;false;false;false,20413/22402
secondary p,C0027627;C0175668;C0205436,true;false;false,20414/22402
section $nmbr$ a,C0152060;C0700320;C1522472;C1552923;C1705191;C3714523,false;false;false;false;false;false,20415/22402
section $nmbr$ b,C0152060;C0700320;C1522472;C1552923;C1705191;C3714523,false;false;false;false;false;false,20416/22402
section $nmbr$ c,C0152060;C0700320;C1522472;C1552923;C1705191;C3714523,false;false;false;false;false;false,20417/22402
secukinumab $nmbr$ mg ( n $nmbr$ $nmbr$ ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20418/22402
secukinumab $nmbr$   mg,C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20419/22402
secukinumab $nmbr$   mg ( n   =   $nmbr$ ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20420/22402
secukinumab $nmbr$   mg no load ( n   =   $nmbr$ ),C3179547;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20421/22402
secukinumab pooled †   ( n   = $nmbr$ ),C3179547;C1709595;C2349200;C4522255,true;false;false;false,20422/22402
sedbp ( mmhg ) [ mean _sd ] d,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20423/22402
sedbp ( mmhg ) [ mean_ sd ] a,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20424/22402
seizure frequency during $nmbr$ ‐ week baseline  median ( range ),C0149775;C0332174;C0168634;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C1442488;C0439230,false;false;true;false;false;false;false;false;false;false;false;false;false,20425/22402
seizure history  n ( % ),C0036572;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1959629;C4553401,true;true;true;false;false;false;false;false;false,20426/22402
seizure types reported during baselinee,C0036572;C0332307;C1959629;C4553401,true;false;false;false,20427/22402
selected clinical characteristics,C1707391;C0683325,false;false,20428/22402
selected key secondary efficacy endpoints,C1707391;C4528314;C1280519;C1707887,false;false;false;false,20429/22402
selective vascular history,C0036576;C0005847;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C1558950;C1801960;C1707391,true;true;true;true;false;false;false;false;false;false;false,20430/22402
selena - sledai > $nmbr$  %,C0451528,false,20431/22402
selena - sledai activity  n ( % ),C0451528;C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939,false;false;false;false;false;false;false;false,20432/22402
selena - sledai mean score ( sd ),C0451528;C3533236;C2699239,false;false;false,20433/22402
selena - sledai total score,C0451528;C2964552,false;false,20434/22402
selexipag patients / events n,C2000145;C0030705;C0441471;C3541888,true;true;false;false,20435/22402
selexipag vs placebo hazard ratio ( $nmbr$ % cl ),C2000145,true,20436/22402
self - rated health status,C0036588;C0871208;C0018759;C1551994,true;false;true;false,20437/22402
self - reported descent  n ( % ),C0681906;C2700446,false;true,20438/22402
semaglutide,C3885068,true,20439/22402
semaglutide ( n = $nmbr$ ),C3885068,true,20440/22402
semaglutide $nmbr$ . $nmbr$ mg,C3885068;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20441/22402
semaglutide exposure  nmol / l,C3885068;C0274281;C0439282;C0332157,true;false;false;false,20442/22402
semuloparin ( n = $nmbr$ ),C2700104,true,20443/22402
sensitive,C0020517;C0332324;C1522640,true;false;false,20444/22402
sensitive responder ( n = $nmbr$ ),C0020517;C0332324;C1522640,true;false;false,20445/22402
sensitive responders ( n = $nmbr$ ),C0020517;C0332324;C1522640,true;false;false,20446/22402
sensitivity analyses,C0020517;C0002778;C0936012;C1524024;C0036667;C0312418;C0427965;C1511883;C1522640;C2346484;C2349185,true;false;false;true;true;false;false;false;false;false;false,20447/22402
sensorimotor stroke,C0038454;C4554100,true;false,20448/22402
serious,C0205404,false,20449/22402
serious aes,C0205404;C1412268;C2699274,false;false;false,20450/22402
serious decline in kidney function *,C0205404;C0232804,false;false,20451/22402
serious decline in kidney function $nmbr$,C0205404;C0232804,false;false,20452/22402
serious gi disorder,C0205404;C1708130;C0012634;C3539617;C4050121,false;false;true;false;false,20453/22402
serious infections,C0205404;C3714514,false;true,20454/22402
serious teaes,C0205404,false,20455/22402
serms,C0732611,true,20456/22402
seropositivity status  n,C0521143;C0449438,false;false,20457/22402
sertraline,C0074393;C0524265,true;false,20458/22402
serum $nmbr$ - hydroxyvitamin d  ng / ml,C0229671;C0020337;C0439275;C1546774;C1550100,true;true;false;false;false,20459/22402
serum $nmbr$ ( oh ) d concentrations  ng / ml  mean ( sd ),C0683149;C0220853;C0439275;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false;false,20460/22402
serum albumin - adjusted calcium ( mg / dl ),C0036773;C0728877,true;false,20461/22402
serum albumin concentration  g / l,C0683149;C0001924;C0439294;C0456615;C0036773;C0086045;C1446561;C3827302;C0728877;C0229671;C0486291;C1546774;C1550100,false;true;false;false;true;true;false;false;false;true;false;false;false,20462/22402
serum albumin  g / l,C0036773;C0439294;C0456615;C0728877,true;false;false;false,20463/22402
serum biochemistry potassium  mmol / l,C0302353;C0005477;C1532563;C0543465,false;true;false;false,20464/22402
serum bone - specific alkaline,C0229671;C0262950;C0205369;C1979842;C1552740;C1546774;C1550100,true;true;false;false;false;false;false,20465/22402
serum c - terminal telopeptide of,C0229671;C1707271;C1546774;C1550100,true;false;false;false,20466/22402
serum calcium  mmol / l,C0036785;C1532563;C0728876,false;false;false,20467/22402
serum cholesterol  mean ( sd ) mg / dl,C0587184;C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false;false,20468/22402
serum cholesterol  mean ( sd )  mg / dl,C0587184;C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false;false,20469/22402
serum cholesterol  mg / dl,C0587184;C0439269,false;false,20470/22402
serum creatinine - mean ( sd  n ),C0201976;C0444504;C2699239;C2347634;C2348143;C0600061,false;false;false;false;false;false,20471/22402
serum creatinine — mg / dl | |,C0201976;C0439269;C0600061,false;false;false,20472/22402
serum creatinine > $nmbr$ / xmol / l  n ( % ) | |,C0201976;C0600061,false;false,20473/22402
serum creatinine concentration and randomization to losartan,C0683149;C0010294;C1561535;C0201976;C0086045;C1446561;C3827302;C0600061,false;true;false;false;true;false;false;false,20474/22402
serum creatinine level,C0600061,false,20475/22402
serum creatinine level  mean ( sd )  mg / dl,C0600061;C0444504;C2699239;C0439269;C2347634;C2348143,false;false;false;false;false;false,20476/22402
serum creatinine  / xmol / l | |,C0201976;C0600061,false;false,20477/22402
serum creatinine  ≥ $nmbr$ . $nmbr$ mg / dl,C0201976;C0439269;C0600061,false;false;false,20478/22402
serum creatinine  μ mol / l,C0201976;C0347982;C0600061,false;false;false,20479/22402
serum creatinine  gmol / ' l  mean ( sd ),C0201976;C0444504;C2699239;C2347634;C2348143;C0600061,false;false;false;false;false;false,20480/22402
serum creatinine  mean ( sd ) mg / dl,C0201976;C0444504;C2699239;C0439269;C2347634;C2348143;C0600061,false;false;false;false;false;false;false,20481/22402
serum creatinine  mean ( sd )  mg / dl,C0201976;C0444504;C2699239;C0439269;C2347634;C2348143;C0600061,false;false;false;false;false;false;false,20482/22402
serum creatinine  mg / dl  mean ( sd ),C0201976;C0439269;C0444504;C2699239;C2347634;C2348143;C0600061,false;false;false;false;false;false;false,20483/22402
serum creatinine . mg / dl,C0201976;C0439269;C0600061,false;false;false,20484/22402
serum ctx - $nmbr$  ng / ml  median ( iqr ),C0229671;C0010377;C0439275;C0549183;C0876920;C2347635;C2348144;C2939193;C0631180;C3539598;C1546774;C1550100,true;true;false;false;false;false;false;false;true;false;false;false,20485/22402
serum ctx i ( ng / ml ),C0229671;C0631180;C0439275;C1546774;C1550100,true;true;false;false;false,20486/22402
serum fg  mg / dl,C0229671;C1638318;C3642216;C0016703;C0439269;C0439214;C2348814;C1546774;C1550100,true;false;false;true;false;false;false;false;false,20487/22402
serum gastrint  pg / ml,C0229671;C0439297;C1546774;C1550100,true;false;false;false,20488/22402
serum glucose ( mmol / l ),C0202041;C1532563;C3534430,false;false;false,20489/22402
serum glucose ( mg / dl ),C0202041;C0439269;C3534430,false;false;false,20490/22402
serum mg < $nmbr$ . $nmbr$ mmol / l ( hypomagnesemia ),C0229671;C0439268;C0439190;C0151723;C4552839;C0024671;C1532563;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1546774;C1550100,true;false;false;false;false;true;false;true;false;false;false;false;false;false;false,20491/22402
serum mg > $nmbr$ . $nmbr$ mmol / l ( normal mg / hvpermagnesemia ),C0229671;C2827881;C0439190;C0205307;C0231683;C0439166;C2347086;C4553972;C1546774;C1550100,true;false;false;false;false;false;false;false;false;false,20492/22402
serum n - propeptide of type $nmbr$ collagen,C0229671;C1709708;C0332307;C0009325;C1547052;C1875696;C1546774;C1550100,true;false;false;true;false;false;false;false,20493/22402
serum pepsinogen i / iit,C0229671;C0077923;C0523816;C1546774;C1550100,true;true;false;false;false,20494/22402
serum phosphate  mmol / l,C0036820;C1532563,false;false,20495/22402
serum potassium 一 mmol / liter,C0302353;C0439190;C0475211;C0543465,false;false;false;false,20496/22402
serum potassium level  mean ( sd )  meq / l,C0302353;C0444504;C2699239;C0439375;C2347634;C2348143;C0543465,false;false;false;false;false;false;false,20497/22402
serum potassium  > $nmbr$ . $nmbr$ mmol / l,C0302353;C1532563;C0543465,false;false;false,20498/22402
serum potassium  mean ( sd ) mmol / l,C0302353;C0444504;C2699239;C1532563;C2347634;C2348143;C0543465,false;false;false;false;false;false;false,20499/22402
serum sodium — mmol / liter,C0523891;C0439190;C0475211,false;false;false,20500/22402
serum sodium  meq / l,C0523891;C0439375,false;false,20501/22402
serum sodium . meq / l,C0523891;C0439375,false;false,20502/22402
serum total ige  iu / ml,C1441420;C0439458,false;false,20503/22402
serum urate ( mg / dl ),C0455272;C0439269,false;false,20504/22402
serum urate ( mg / dl )  n ( % ),C0455272;C0439269,false;false,20505/22402
serum urea nitrogen  mg / dl,C0856666;C0028158;C0439269;C1550581;C0229671;C0600137;C1291218;C3683557;C1546774;C1550100,false;true;false;false;true;false;false;false;false;false,20506/22402
serum uric acid  difference vs placebo ( $nmbr$ % cl ),C0455272;C1705241;C1705242;C0700634,false;false;false;false,20507/22402
serum uric acid  n,C0455272;C0700634,false;false,20508/22402
serum values,C0229671;C0042295;C1546774;C1550100,true;false;false;false,20509/22402
serum values ^,C0229671;C0042295;C1546774;C1550100,true;false;false;false,20510/22402
serum vitamin d ( nmol / l ),C0229671;C0014695;C0439282;C0042866;C2936842;C3537249;C3714503;C1546774;C1550100,true;true;false;true;false;false;false;false;false,20511/22402
ses - cd  mean ( sd ),C0007928;C0444504;C2699239;C2347634;C2348143;C0034283;C4552032,true;false;false;false;false;true;false,20512/22402
sesbp ( mmhg ) [ mean - sd ] d,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20513/22402
sesbp ( mmhg ) [ mean _sd ] a,C0439475;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20514/22402
severe ( < $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % ),C0205082;C0439445;C0369637;C0441923;C4050465;C4050466,false;false;false;false;false;false,20515/22402
severe ( > $nmbr$ ),C0205082;C4050465;C4050466,false;false;false,20516/22402
severe ( fev  < $nmbr$ % predicted ),C0205082;C3714541;C4050465;C4050466,false;true;false;false,20517/22402
severe ( iief - ef < $nmbr$ ),C0205082;C3641331;C4050465;C4050466,false;false;false;false,20518/22402
severe ( iief - ef $nmbr$ - $nmbr$ )  n ( % ),C0205082;C3641331;C4050465;C4050466,false;false;false;false,20519/22402
severe ( ipss > $nmbr$ ),C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466,false;false;false;false;false;false;false,20520/22402
severe ( ipss > $nmbr$ ) age group,C0205082;C1019118;C0027362;C2348001;C1998280;C2827405;C3811063;C4050465;C4050466,false;false;true;false;false;false;false;false;false,20521/22402
severe ( ipss > $nmbr$ ) ( n = $nmbr$ ),C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466,false;false;false;false;false;false;false,20522/22402
severe ( itt ) ( n = $nmbr$ ),C0205082;C4050465;C4050466,false;false;false,20523/22402
severe ( n $nmbr$ = $nmbr$ ),C0205082;C4050465;C4050466,false;false;false,20524/22402
severe aes,C0205082;C1412268;C2699274;C4050465;C4050466,false;false;false;false;false,20525/22402
severe copd,C0205082;C0024117;C1412502;C3714496;C4050465;C4050466,false;true;false;false;false;false,20526/22402
severe cord * : qvai $nmbr$ - sfc,C0205082;C1550235;C4521536;C1706500;C3489532;C4050465;C4050466,false;false;false;false;true;false;false,20527/22402
severe disease,C1836348,false,20528/22402
severe ed,C0205082;C3538926;C4050465;C4050466,false;false;false;false,20529/22402
severe episodes in previous year — no . / patient,C0205082;C0332189;C0205156;C0439234;C0439508;C1552607;C4050465;C4050466,false;false;false;false;false;false;false;false,20530/22402
severe exacerbations,C0205082;C4086268;C4050465;C4050466,false;false;false;false,20531/22402
severe hyperkalemia ' s,C0205082;C0020461;C4552983;C4050465;C4050466,false;true;false;false;false,20532/22402
severe hyperkalemia ‘ s,C0205082;C0020461;C4552983;C4050465;C4050466,false;true;false;false;false,20533/22402
severe hypoglycemia,C0205082;C0020615;C4553659;C4050465;C4050466,false;true;false;false;false,20534/22402
severe impairment ( egfr < $nmbr$ ml / min / m ^ ),C0205082;C0221099;C1739039;C0439445;C0369637;C0441923;C3811844;C3812682;C0684336;C4050465;C4050466,false;false;true;false;false;false;false;false;false;false;false,20535/22402
severe impairment ( egfr < $nmbr$ )  n ( % ),C0205082;C0221099;C1739039;C3811844;C3812682;C0684336;C4050465;C4050466,false;false;true;false;false;false;false;false,20536/22402
severe oa symptoms at baselined,C0436345;C0029408;C3887876,false;true;false,20537/22402
severe oab subgroup,C0205082;C1079230;C1515021;C4050465;C4050466,false;false;false;false;false,20538/22402
severe or very severe smoking status,C0205082;C4050465;C4050466,false;false;false,20539/22402
severe recurrent ischemia,C0205082;C1455761;C0022116;C4321499;C2945760;C4050465;C4050466,false;false;true;false;false;false;false,20540/22402
severe to end - stage impairment ( $nmbr$ ml / min ),C0205082;C0205088;C0221099;C0439445;C0684336;C4050465;C4050466,false;false;false;false;false;false;false,20541/22402
severe  gold $nmbr$,C0205082;C0018026;C1304897;C4050465;C4050466,false;true;false;false;false,20542/22402
severe / life threatening,C0205082;C1546953;C2826244;C3537125;C4050465;C4050466,false;false;false;false;false;false,20543/22402
severe / life ttireatening,C0205082;C0376558;C4050465;C4050466,false;true;false;false,20544/22402
severe / lite threatening,C0205082;C4050465;C4050466,false;false;false,20545/22402
severe / moderate,C1299393,false,20546/22402
severity of copda  airflow limitation  n ( % ),C0439793;C0231999;C0443288;C0449295;C0522510,false;false;false;false;false,20547/22402
severity of copda  combined assessment of copd  n ( % ),C0439793;C0522510,false;false,20548/22402
severity of heartburnb,C0439793;C0522510,false;false,20549/22402
severity ofhypertension [ n ( % ) ] b,C0439793;C0522510,false;false,20550/22402
severitya,,,20551/22402
sex — no . / total no . ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20552/22402
sex ( male ),C0086582,true,20553/22402
sex ( male )  %,C0086582,true,20554/22402
sex ( male  % ),C0086582,true,20555/22402
sex ( male / female ),C0086287;C0086582;C1706180;C1706428;C1706429;C0043210;C1705497;C1705498,true;true;false;false;false;true;false;false,20556/22402
sex ( male / female ) ( n ),C0086287;C0086582;C1706180;C1706428;C1706429;C0043210;C1705497;C1705498,true;true;false;false;false;true;false;false,20557/22402
sex ( men / women ),C0009253;C0025266;C0043210;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;true;false;false;true,20558/22402
sex ( no . ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20559/22402
sex ( p = $nmbr$ ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20560/22402
sex ( women  men ),C0009253;C0043210;C0025266;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;true;false;false;true,20561/22402
sex ( women  n [ % ] ),C0009253;C0043210;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;true;false;false;true,20562/22402
sex m / f,C0009253;C1306057;C0036864;C0079399;C0804628;C1314687;C1522384,true;false;true;true;false;false;true,20563/22402
sex  %,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20564/22402
sex  % male,C0086582,true,20565/22402
sex  female  %,C0086287,true,20566/22402
sex  female    n   ( % ),C0086287,true,20567/22402
sex  n ( % ) *,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20568/22402
sex  n ( % ) b,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20569/22402
sex  no  ( % ),C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20570/22402
sex  no . ( % ) male,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20571/22402
sexually active,C0241028,false,20572/22402
sexually active with female,C0241028;C0043210;C0086287;C1705497;C1705498,false;true;true;false;false,20573/22402
sexually active $nmbr$ ( % ),C0241028,false,20574/22402
sexy,C0009253;C0036864;C0079399;C0804628;C1314687;C1522384,true;true;true;false;false;true,20575/22402
sf - $nmbr$ mcs score,C0037712,true,20576/22402
sf - $nmbr$ pcs score,C0037712;C1864389;C1882368,true;false;true,20577/22402
sf - $nmbr$ bodily pain  mean change from baselineb,C0037712;C3890602;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;false;false;false;false;false,20578/22402
sf - $nmbr$ bodily pain  mean change from baselinee,C0037712;C3890602;C0444504;C0392747;C0443172;C1705241;C4319952;C2347634;C2348143,true;false;false;false;false;false;false;false;false,20579/22402
sf ‐ $nmbr$ health survey,C0037712;C0018762,true;true,20580/22402
sf - $nmbr$ mcs,C0037712,true,20581/22402
sf - $nmbr$ pcs,C0037712;C1864389;C1882368,true;false;true,20582/22402
sf ‐ $nmbr$ pcs  ls mean change ± se,C0037712;C1864389;C0023668;C0444504;C0392747;C0036919;C0443172;C1705241;C4319952;C2347634;C2348143;C1882368,true;false;true;false;false;true;false;false;false;false;false;true,20583/22402
sf - $nmbr$ pcs  ls mean change from baseline   ±   se,C0037712;C1864389;C0023668;C0444504;C0392747;C0168634;C0036919;C1442488;C0443172;C1705241;C4319952;C2347634;C2348143;C1882368,true;false;true;false;false;true;true;false;false;false;false;false;false;true,20584/22402
sf - $nmbr$ summary scores,C0037712;C1552616;C1706244,true;false;false,20585/22402
sfc ( n   = $nmbr$  $nmbr$ ),C4521536,false,20586/22402
sfc $nmbr$ / $nmbr$ pg twice daily ( n = $nmbr$ ),C4521536;C0030827;C0585361;C0072225;C1266240,false;true;false;true;false,20587/22402
sgrq - c total scoreb,C3826872;C0439175;C0439810,false;false;false,20588/22402
sgrq responder ( % ),,,20589/22402
sgrq score  mean ( sd ),C0449820;C0444504;C2699239;C2347634;C2348143;C4050231,false;false;false;false;false;false,20590/22402
sgrq scores  mean ( sd ),,,20591/22402
sgrq total score $nmbr$,C2964552,false,20592/22402
shared epitope  a % positive,C0237876;C0003316;C1522138,false;true;false,20593/22402
shfm annual mortality,C0332181;C0026565;C0026566,false;true;true,20594/22402
short ( < $nmbr$ years ) duration of diabetes,C0439593;C0439234;C0011847;C0011849,false;false;false;true,20595/22402
short term ( n = $nmbr$ ) +,C0443303,false,20596/22402
short term ^,C0443303,false,20597/22402
shs ( $nmbr$ - $nmbr$  per $nmbr$ score ),C0449820;C4050231,false;false,20598/22402
shs  mean ± sd,C0444504;C2699239;C2347634;C2348143,false;false;false;false,20599/22402
si . gni . fi . canr ecg changes  positive biomarkers  and age < $nmbr$ vrs,C4050619;C1623258,false;true,20600/22402
significant worsening in kccq clinical,C0237881;C0332271;C3476798;C1457868;C1546960;C0750502;C1546944,false;false;false;false;false;false;false,20601/22402
significant worsening in kccq clinical score ( ≥ $nmbr$ ) at $nmbr$ mo †,C0332271;C3476798;C2826293;C0449820;C4050231;C1457868;C1546960,false;false;false;false;false;false;false,20602/22402
sildenafil ( n = $nmbr$ ),C0529793,true,20603/22402
silodosin $nmbr$ mg ( n = $nmbr$ ),C1870115;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20604/22402
simva ( n = $nmbr$ ),,,20605/22402
simvastatin ( n = $nmbr$ . $nmbr$ ),C0074554,true,20606/22402
simvastatin ( n = $nmbr$  $nmbr$ ),C0074554,true,20607/22402
single - vessel disease,C0037179;C0042373;C0087136;C0205171,true;true;true;false,20608/22402
single vessel coronary artery disease †,C0581374,false,20609/22402
single vessel coronary artery diseasea,C0265903;C0005847,false;true,20610/22402
sinus tracts / perforation  ' ^ n ( % ),C0854572;C1185740;C0544791;C0549099;C1881710,false;false;false;false;false,20611/22402
sirius,,,20612/22402
sirolimus - eluting stent use  n ( % ),C0072980;C0038257;C0042153;C0457083;C1947944,true;true;true;false;false,20613/22402
sita $nmbr$ mg ( n = $nmbr$ ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,20614/22402
sitagliptin $nmbr$,C1565750,true,20615/22402
sitagliptin $nmbr$ $nmbr$ . $nmbr$ 士 $nmbr$ . $nmbr$ $nmbr$ - h postprandial plasma glucose ( ppg ) ( mmol / l ),C1565750;C2827804;C0376674;C0202042;C1418888;C0455280,true;false;true;false;false;false,20616/22402
sitagliptin $nmbr$ $nmbr$ . $nmbr$ 士 $nmbr$ . $nmbr$ fasting plasma glucose ( fpg ) ( mmol / l ),C1565750;C0015663;C0202042;C1532563;C0455280,true;true;false;false;false,20617/22402
sitagliptin ± oad,C1565750,true,20618/22402
sitting blood pressure — mmhg,C0580946;C0439475,false;false,20619/22402
sitting diastolic blood pressure ( mm hg ),C1319894;C0439475,false;false,20620/22402
sitting systolic blood pressure ( mm hg ),C0277814;C2584297;C4050224,true;true;false,20621/22402
six - minute walk distance  m,C3900196;C0012751;C0369637;C0441923,false;false;false;false,20622/22402
six - study placebo - controlled set,C0205452;C0557651;C1706408;C0036849;C1442518;C1705195;C2603343,false;false;false;true;false;false;false,20623/22402
size ( cm $nmbr$ ) ( mean ± standard deviation ),C0456389;C1828170;C1442989;C2828392;C0444504;C0871420;C2347634;C2348143,false;false;false;false;false;false;false;false,20624/22402
size of left atrium normal — no . ( % ) £,C0456389;C0225860,false;true,20625/22402
sjc  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,20626/22402
sk . $nmbr$,,,20627/22402
sl $nmbr$ mm hg,C0439475,false,20628/22402
sle markers  n ( % ),C0024141;C0005516,true;true,20629/22402
sleep,C0037313,true,20630/22402
sleeping problems in the past $nmbr$ weeks ( % ),C0700201;C2987125,true;false,20631/22402
small / medium,C0700321;C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,false;true;false;false;false;false;false;false,20632/22402
smedian prednisone dose  n ( % ),C0032952;C0178602;C0869039;C1114758,true;false;false;false,20633/22402
smi :,,,20634/22402
smmse,,,20635/22402
smmse < $nmbr$,,,20636/22402
smoker at baseline,C0337664;C0168634;C1442488,true;true;false,20637/22402
smoker or ex - smoker  n ( % ),C0337664,true,20638/22402
smoker  %,C0337664,true,20639/22402
smoker  n ( % ),C0337664,true,20640/22402
smokers  no . ( % ),C0337664,true,20641/22402
smokers : qva $nmbr$ - $nmbr$ fc,C0337664;C2983605,true;false,20642/22402
smoking ' ! ',C0037369;C0453996;C1881674,true;true;false,20643/22402
smoking ( % ),C0037369;C0453996;C1881674,true;true;false,20644/22402
smoking ( current ),C0037369;C0521116;C1705970;C0453996;C1881674,true;false;false;true;false,20645/22402
smoking ( during the previous month ),C2114448;C0332177;C0439231,false;false;false,20646/22402
smoking classification  n ( % ),C0037369;C0008902;C0008903;C0678229;C0453996;C1881674,true;true;true;false;true;false,20647/22402
smoking consumption pack - years,C0425291;C1277691,false;false,20648/22402
smoking history ( pack - years ) ∗,C1519384;C1277691,false;false,20649/22402
smoking history  r ( % ),C1519384;C0205090;C0684010;C2603358,false;false;true;false,20650/22402
smoking history    n   ( % ),C1519384,false,20651/22402
smoking pack - yearsa,C0037369;C1968515;C2825051;C2828395;C0453996;C1881674,true;false;false;false;true;false,20652/22402
smoking pack - yearsb  n ( % ),C0037369;C1968515;C2825051;C2828395;C0453996;C1881674,true;false;false;false;true;false,20653/22402
smoking pack year ( years ) ^,C0037369;C1277691;C0439234;C0439508;C0453996;C1881674,true;false;false;false;true;false,20654/22402
smoking status — no . { % ),C1519386,false,20655/22402
smoking status ( ongoing ) ( n ),C1519386;C0549178,false;false,20656/22402
smoking status ( previous ) ( n ),C1519386;C0205156;C1552607,false;false;false,20657/22402
smoking status current,C1519386;C0521116;C1705970,false;false;false,20658/22402
smoking status current smoker ( n = $nmbr$ ),C1519386;C3173209;C3241966,false;false;false,20659/22402
smoking status  n ( % ) *,C1519386,false,20660/22402
smoking status  n [ % ] ®,C1519386,false,20661/22402
smoking status . no . ( % ),C1519386,false,20662/22402
smoking * ( > $nmbr$ pack - years ),C0037369;C1277691;C0453996;C1881674,true;false;true;false,20663/22402
smoking  mean,C0037369;C0444504;C2347634;C2348143;C0453996;C1881674,true;false;false;false;true;false,20664/22402
smoking  n ( % ),C0037369;C0453996;C1881674,true;true;false,20665/22402
smokingb,,,20666/22402
snp,C0752046;C1527094,true;false,20667/22402
so,C0037640,true,20668/22402
so $nmbr$ %,C0037640,true,20669/22402
soc,,,20670/22402
socalone ( n = $nmbr$ ),,,20671/22402
social interaction,C0037420,true,20672/22402
sodium - glucose cotransporter $nmbr$ inhibitor,C0037473;C0017725;C1999216;C0597484;C3541959;C3714642,true;true;false;false;false;false,20673/22402
sodium  meq / l,C0037473;C0439375;C0597484;C3541959;C3714642,true;false;false;false;false,20674/22402
sokoiow - lyon voitage  mv,C1454484;C1705503;C4281602,true;false;false,20675/22402
sokolow - lyon ( mm ) *,C4330985;C4554674,false;false,20676/22402
sokolow - lyon voltage  mm,C0598352;C4330985;C4554674,false;false;false,20677/22402
sokolow - lyon  mm,C4330985;C4554674,false;false,20678/22402
sokolow – lyon voltage ( mv ),C0598352;C1454484;C1705503;C4281602,false;true;false;false,20679/22402
solifenacin ( n = $nmbr$ ),C1099677,true,20680/22402
some college,C0557806,false,20681/22402
some college / tech,C0557806;C1826596,false;false,20682/22402
some walking,,,20683/22402
somnolence,C0013144;C2830004;C4553740,false;true;false,20684/22402
sotagliflozin,C3896939,true,20685/22402
sotagliflozin ( n = $nmbr$ ),C3896939,true,20686/22402
sotagliflozin $nmbr$ mg ( n = $nmbr$ ),C3896939;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,20687/22402
source,C0449416;C1705919;C4521696,false;false;false,20688/22402
south africa / south america,C0037713;C0001737;C0037712;C0002454,true;true;true;true,20689/22402
south america ( n = $nmbr$ ),C0037713,true,20690/22402
south asia,C0037723;C1519427,true;false,20691/22402
south or central america,C1710133,false,20692/22402
south or central american,C1710133,false,20693/22402
south ! central america,C0037713;C0205099;C1879652;C1710133;C0007674,true;false;false;false;true,20694/22402
south  n ( % ),C1710133,false,20695/22402
southern europe,C0037724,true,20696/22402
southern hemisphere,C1710133;C0205139,false;false,20697/22402
spain,C0037747,true,20698/22402
spain ( n = $nmbr$ ),C0037747,true,20699/22402
special interest categories,C0205555;C0543488;C0683312,false;false;false,20700/22402
specific syndromes,C0205369;C0039082;C1558916;C1552740,false;true;false;false,20701/22402
spga > $nmbr$,,,20702/22402
spine,C0037949;C2752558,true;false,20703/22402
spine *,C0037949;C2752558,true;false,20704/22402
spirometric values at baseline,C0037981;C0042295;C0168634;C1442488;C0183441,true;false;true;false;false,20705/22402
spirometry,C0037981,true,20706/22402
spirometry after bronchodilation §,C0037981;C1371299;C3537072,true;false;false,20707/22402
spirono ( n = $nmbr$ ),,,20708/22402
spondylitis,C0038012,true,20709/22402
spondylitis with peripheral arthritis,C0038012;C0238694,true;false,20710/22402
sprint acr < $nmbr$ - $nmbr$,C1412134;C1515941,false;false,20711/22402
sprint acr > $nmbr$ - $nmbr$,C1412134;C1515941,false;false,20712/22402
sri ‐ $nmbr$ response rate  %,C1420401;C0237629,false;false,20713/22402
β - blocker,,,20714/22402
β ‐ blocker,,,20715/22402
β - blockers,,,20716/22402
β blocker,,,20717/22402
β blockers,,,20718/22402
ss years,C2699257;C0439234;C3891295;C4551874,false;false;false;false,20719/22402
ssed as ls means,C0023668;C1704970,true;false,20720/22402
ssomgdayp . eq .,C0205163;C0439185,false;false,20721/22402
st - depression and t - wave inversion,C0520887,false,20722/22402
st - depression only,C0520887;C0205171;C1720467,false;false;false,20723/22402
st - segment depression > $nmbr$ mm,C0520887;C4330985;C4554674,false;false;false,20724/22402
st - segment depression > $nmbr$ mm — no . ( % ),C0520887;C4330985;C4554674,false;false;false,20725/22402
st - segment depression or t - wave inversion on ecg,C0520887,false,20726/22402
st - segment deviation > $nmbr$ mm — no . / total no . ( % ),C1114722;C0441635;C4330985;C4554674;C1116089;C0429029;C0012727;C0205419;C1705236;C0036056;C0429066;C3272372,false;false;false;false;false;false;false;false;false;true;false;false,20727/22402
st - segment deviation timi risk score  %,C1114722;C0441635;C0035647;C0449820;C4050231;C4552904;C1116089;C0429029;C0012727;C0205419;C1705236;C0036056;C0429066;C3272372,false;false;true;false;false;false;false;false;false;false;false;true;false;false,20728/22402
st - segment elevation,C0520886,false,20729/22402
st ‐ str ≥ $nmbr$ % post pci,C0036056;C0687676;C4049621;C1704687;C3469826;C3272372,true;false;false;false;false;false,20730/22402
st ‐ str ≥ $nmbr$ % pre ‐ ci,C0036056;C0332152;C0008107;C3259781;C0740175;C2257086;C3669034;C3272372,true;false;true;false;false;false;false;false,20731/22402
st - t wave,C0036056;C0429103;C3272372,true;false;false,20732/22402
st - t wave abnormality d,C0036056;C1839341;C3272372,true;false;false,20733/22402
st - t wave changes,C0036056;C0429103;C3272372,true;false;false,20734/22402
st - t wave  n ( % ),C0036056;C0429103;C3272372,true;false;false,20735/22402
st - t wave  no . ( % ),C0036056;C0429103;C3272372,true;false;false,20736/22402
st - t waveft,C0036056;C3272372,true;false,20737/22402
st - t wavett,C0036056;C3272372,true;false,20738/22402
st depression ( without st elevation ),C0520887;C0439775;C0702240;C0011570;C0520886;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827,false;false;false;true;false;true;false;false;false;false;false;false,20739/22402
st depression > $nmbr$ mm,C0520887;C4330985;C4554674,false;false;false,20740/22402
st elevation,C0520886,false,20741/22402
st george ' s respiratory questionnaire total score !,C3472502;C0439175;C0439810,false;false;false,20742/22402
st segment depression,C0520887,false,20743/22402
st segment elevation,C0520886,false,20744/22402
st / t wave,C0036056;C0429103;C3272372,true;false;false,20745/22402
stable angina ( n = $nmbr$  $nmbr$ ),C0340288,true,20746/22402
stable angina  n ( % ),C0340288,true,20747/22402
stable coronary artery disease,C0205360;C0010054;C0010068;C1956346;C1547311,false;true;true;true;false,20748/22402
stage $nmbr$ ckd egfr > $nmbr$ ml / ( n = $nmbr$ ),C0205390;C1300072;C1306673,false;false;false,20749/22402
stage $nmbr$ ckd egfr $nmbr$ to $nmbr$ ml / min ( n = $nmbr$ ),C0205390;C1300072;C1306673,false;false;false,20750/22402
stage $nmbr$ a ckd cohort ( post hoc analysis excluding metformin users ),C0205390;C1300072;C1306673,false;false;false,20751/22402
stage $nmbr$ a ckd cohort ( secondary analysis ),C0205390;C1300072;C1306673,false;false;false,20752/22402
stage i ( gfr > $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) and stage v ( gfr < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) were not considered because they included only $nmbr$ and $nmbr$ patient  respectively . chf  congestive,C0441766;C0017654;C0439445;C0369637;C0441923;C1424601;C0023806;C0702093;C0007591;C0456533;C1524029;C3813700;C0021966;C0221138;C0017654;C0439445;C0369637;C0441923;C1424601;C0332257,false;true;false;false;false;false;true;false;true;false;false;false;true;false;true;false;false;false;false;false,20753/22402
stage ii,C0441767,false,20754/22402
stage iii,C0441771,false,20755/22402
stage iv,C0205390;C1300072;C1306673,false;false;false,20756/22402
stage of pda,C0205390;C0013274;C0226047;C4282128;C1300072;C1306673,false;true;false;false;false;false,20757/22402
standard,C1442989;C2828392,false;false,20758/22402
standard allocation,C1442989;C1706778;C2828392,false;false;false,20759/22402
standard bp lowering  < $nmbr$ mm hg ( n = $nmbr$ ),C1442989;C0037623;C0441994;C0439475;C2003888;C1415692;C1708288;C4318478;C2828392,false;true;false;false;false;false;false;false;false,20760/22402
standard care slope lsm ± se ( mm / year ),C1442989;C1947933;C0807955;C0036919;C4330985;C0439234;C0439508;C4554674;C2828392,false;false;false;true;false;false;false;false;false,20761/22402
standard therapy ( n = $nmbr$ ),C2936643,true,20762/22402
standard treatment ( n - $nmbr$ ),C4684780,false,20763/22402
standardized mean difference,C0444504;C1705241;C1705242;C2347634;C2348143,false;false;false;false;false,20764/22402
standardized total hip bmd ( g / cm $nmbr$ ),C0439175;C0019552;C0439267;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;false;true;true;false;false;false,20765/22402
statin ( % ),C0360714,true,20766/22402
statin + ezetimibe,C0360714;C1142985,true;true,20767/22402
statin + ezetimibe ( n = $nmbr$ . $nmbr$ ),C0360714;C1142985,true;true,20768/22402
statin + ezetimibe { n = $nmbr$  $nmbr$ ),C0360714;C1142985,true;true,20769/22402
statin + fibrate or niacin,C0360714,true,20770/22402
statin and / or ezetimibe,C0360714,true,20771/22402
statin and / or other lipid - lowering agent therapy,C0360714,true,20772/22402
statin group,C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,20773/22402
statin intensity per acc / ahac,C0360714;C0522510;C0175754;C0282160;C3541413,true;false;true;true;false,20774/22402
statin intolerant *,C0360714;C0231200,true;false,20775/22402
statin medication,C0360714;C0013227;C3244316;C4284232,true;true;false;false,20776/22402
statin only ( n = $nmbr$  $nmbr$ ),C0360714;C0205171;C1720467,true;false;false,20777/22402
statin potency medium ( n = $nmbr$ ),C0360714;C3245505;C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283,true;false;true;false;false;false;false;false;false,20778/22402
statin use — no . { % ),C0360714,true,20779/22402
statin use ( % ),C0360714;C0042153;C0457083;C1947944,true;true;false;false,20780/22402
statin use at baseline :,C0360714;C0042153;C0168634;C1442488;C0457083;C1947944,true;true;true;false;false;false,20781/22402
statin users,C0360714;C1706077,true;false,20782/22402
statin ( s ),C0360714,true,20783/22402
statin  % ( n ),C0360714,true,20784/22402
statin + er niacin ( n = $nmbr$ ),C0360714;C3810541;C0027996;C1142562;C3811131,true;false;true;false;false,20785/22402
statin + placebo ( n = $nmbr$ ),C0360714;C0032042;C1696465;C1706408,true;true;false;false,20786/22402
stating,C1301808;C1442792;C3148680,false;false;false,20787/22402
statins used during follow - up,C0360714,true,20788/22402
statins  n ( % ),C0360714,true,20789/22402
statins  no . ( % ),C0360714,true,20790/22402
statistic * *,C2348149;C2828391,false;false,20791/22402
statisticd,,,20792/22402
statistics,C0038215;C0600673,false;true,20793/22402
status ( spmsq < $nmbr$,C0449438,false,20794/22402
status ( spmsq > $nmbr$,C0449438,false,20795/22402
std n ( n / loopy ),,,20796/22402
stent thrombosis - related mi,C3897493,false,20797/22402
stent thrombosis arc definite / probable,C3897493;C0439544;C0033204;C0332148;C1704787,false;false;true;false;false,20798/22402
stent thrombosis or mi,C3897493,false,20799/22402
stented lesions,C0038257;C0221198,true;false,20800/22402
stented vessel,C0183521,false,20801/22402
steroid - free cr - $nmbr$,C0038317;C0332296;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337;C1880497;C1996904,true;false;false;false;true;false;false;false;false;false,20802/22402
steroid - free remission,C0038317;C0332296;C0544452;C0687702;C1880497;C1996904,true;false;false;false;false;false,20803/22402
steroid - sparing remission *,C0038317;C0544452;C0687702,true;false;false,20804/22402
steroid use at baseline ( mg / day ),C0281991;C0168634;C0439422;C1442488,false;true;false;false,20805/22402
steroid use  %,C0281991,false,20806/22402
steroids  n ( % ),C0038317,true,20807/22402
still taking alendronate at study entry  n ( % ),,,20808/22402
stomach,C0038351;C3714551,true;false,20809/22402
storage subscore,C0337174;C1698986;C1753314,false;false;false,20810/22402
strain ( % ),C0080194;C0456178;C1518614;C2987481,true;false;false;false,20811/22402
strata modelb hr  $nmbr$ % ci  p value,C0008107;C1709380;C3259781,true;false;false,20812/22402
stratification factor : menopausal status  n ( % ),C1514984;C1513126,false;false,20813/22402
stratification factors,C1514984,false,20814/22402
stratified by,C0205363,false,20815/22402
stratified hazard ratio ( $nmbr$ % ci ),C0205363;C2985465;C0008107;C3259781,false;false;true;false,20816/22402
stratified log - rank p value,C0205363;C1708728;C0667477;C1709380;C0699794;C2986775,false;false;true;false;false;false,20817/22402
stratified log - rank   p   value,C0205363;C1708728;C0667477;C1709380;C0699794;C2986775,false;false;true;false;false;false,20818/22402
stratum,,,20819/22402
stratum $nmbr$ : inadequate response or intolerance to $nmbr$ - $nmbr$ bdmards of same moa,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,20820/22402
stratum $nmbr$ : inadequate response or intolerance to > $nmbr$ bdmards of same moa or > $nmbr$ of multiple moa,C0205412;C0871261;C1704632;C1706817;C2911692;C0439856,false;false;false;false;false;false,20821/22402
stratum *,,,20822/22402
stratum  n ( % ),,,20823/22402
stroke ( fatal / nonfatal ),C0038454;C4554100,true;false,20824/22402
stroke and tia  n ( % ),C0038454;C4554100,true;false,20825/22402
stroke any,C0038454;C4554100,true;false,20826/22402
stroke at entry,C0038454;C1705654;C4554100,true;false;false,20827/22402
stroke deaths,C0038454;C0011065;C1306577;C4554100,true;true;false;false,20828/22402
stroke n ( % ),C0038454;C4554100,true;false,20829/22402
stroke non - fatal,C0038454;C4554100,true;false,20830/22402
stroke of atherosclerotic origin,C0038454;C0333482;C0079946;C0439659;C1550512;C4554100,true;false;false;false;false;false,20831/22402
stroke or,C0038454;C4554100,true;false,20832/22402
stroke or cerebrovascular disease,C0038454;C4554100,true;false,20833/22402
stroke or se ( s / se ),C0038454;C4554100,true;false,20834/22402
stroke or see,C0038454;C4554100,true;false,20835/22402
stroke or systemic,C0038454;C4554100,true;false,20836/22402
stroke or systemic embolism,C0038454;C4554100,true;false,20837/22402
stroke ortia,C0038454;C4554100,true;false,20838/22402
stroke subtype,C0038454;C0449560;C4554100,true;false;false,20839/22402
stroke  fatal and nonfatal,C0038454;C4554100,true;false,20840/22402
stroke  see  or cv death,C0038454;C4554100,true;false,20841/22402
stroke  see  or death,C0038454;C4554100,true;false,20842/22402
stroke  total,C0038454;C4554100,true;false,20843/22402
stroke / embolism,C0038454;C0013922;C1704212;C4554100,true;true;true;false,20844/22402
stroke / m $nmbr$,C0038454;C0369637;C0441923;C4554100,true;false;false;false,20845/22402
stroke / m l / hf hospitalization,C0038454;C0456616;C0018488;C0019993;C1313497;C1538440;C3273279;C4554100,true;false;true;true;true;false;false;false,20846/22402
stroke / non -,C0038454;C4554100,true;false,20847/22402
stroke / se,C0038454;C0036919;C4554100,true;true;false,20848/22402
stroke / see,C0038454;C4554100,true;false,20849/22402
strokezsee,,,20850/22402
structural,C0678594,false,20851/22402
structural heart disease — no . ( % ) f,C1290384,false,20852/22402
stsd > $nmbr$ mm on admission ( n = $nmbr$  $nmbr$ ),C4330985;C0184666;C0809949;C4554674,false;false;false;false,20853/22402
study $nmbr$ . $nmbr$,C0557651;C2603343,false;false,20854/22402
study $nmbr$ - item short - form general health survey ( sf - $nmbr$ ) can range from $nmbr$ to $nmbr$ for the physical component and from $nmbr$ to $nmbr$ for the mental,C0557651;C1551338;C1282927;C0348078;C3481509;C0037712;C0376315;C1522492;C4255237;C1806781;C2350002;C4554251;C2603343;C0040363;C0031809;C0449432;C1705248;C0205485;C1509143;C0041260;C1883351;C0229992,false;false;false;false;false;true;true;false;false;false;false;false;false;true;true;false;false;false;false;true;false;false,20855/22402
study drug,C0013175,true,20856/22402
study druga,C0557651;C2603343,false;false,20857/22402
study eye characteristics,C1568011;C0015392;C0700042,true;true;false,20858/22402
study medication  pre - dose,C0557651;C0013227;C3244316;C4284232;C2603343,false;true;false;false;false,20859/22402
study period fatal pe,C0557651;C0439531;C1302234;C0070939;C1880476;C4284304;C1705232;C1948053;C2603343,false;false;false;true;false;false;false;false;false,20860/22402
study population,C2348561,false,20861/22402
study treatment,C1521826,false,20862/22402
study treatment — no . / total no . ( % ),C1521826,false,20863/22402
su,C0038642;C1705534,true;false,20864/22402
su monotherapy,C0038642;C1705534,true;false,20865/22402
su  n ( % ),C0038642;C1705534,true;false,20866/22402
su / met,C0038642;C1705534,true;false,20867/22402
su / tzd,C0038642;C1705534,true;false,20868/22402
sua < $nmbr$ . $nmbr$,,,20869/22402
subcutaneous ( n = $nmbr$ ),C0443315,false,20870/22402
subcutaneous injections,C0021499,true,20871/22402
subcutaneous unfractionated heparin,C0353681,false,20872/22402
subdural / epidural,C0038541;C0228134;C0812144,true;true;false,20873/22402
subgoup_name,C0027365;C1547383;C4522128,true;false;false,20874/22402
subgroup $nmbr$,C1079230;C1515021,false;false,20875/22402
subgroup analyses,C2986480,false,20876/22402
subgroup analysis : change from baseline in hba $nmbr$ c at week $nmbr$ per baseline hba $nmbr$ c category,C2986480;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952,false;false;true;false;false;false;false,20877/22402
subgroup based on :,C1079230;C1515021,false;false,20878/22402
subgroup level,C1079230;C0441889;C0456079;C1547707;C2946261;C1515021,false;false;false;false;false;false,20879/22402
subgroup levels,C1079230;C0441889;C1515021,false;false;false,20880/22402
subgroup name / level,C1079230;C0027365;C0441889;C0456079;C1547707;C2946261;C1547383;C4522128;C1515021,false;true;false;false;false;false;false;false;false,20881/22402
subgroup no .,C1079230;C1515021,false;false,20882/22402
subgroup overall,C1079230;C0282416;C1561607;C1515021,false;true;false;false,20883/22402
subgroup p - value $nmbr$,C1079230;C1709380;C1515021,false;false;false,20884/22402
subgroup p value !,C1079230;C1709380;C1515021,false;false;false,20885/22402
subgroup sex,C1079230;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C1515021,false;true;true;true;false;false;true;false,20886/22402
subgroup statistics,C1079230;C0038215;C0600673;C1515021,false;false;true;false,20887/22402
subgroup treatment,C1079230;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C1515021,false;true;true;false;false;false;false;false;false,20888/22402
subgroup w . r . t . re - cover,C1079230;C0232024;C0556581;C0180153;C1999244;C3888055;C2986904;C1515021,false;false;false;false;false;false;false;false,20889/22402
subgroup_level,C1079230;C0441889;C0456079;C1547707;C2946261;C1515021,false;false;false;false;false;false,20890/22402
subgroupt,,,20891/22402
subject disposition  n ( % ),C0681850;C0743223;C1705555;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false,20892/22402
subject group,C0681850;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1550501;C1706203;C2349001;C2697811,false;false;false;true;false;false;false;false;false;false;false,20893/22402
subjects,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,20894/22402
subjects ( n ),C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,20895/22402
subjects n,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,20896/22402
subjects stratified by baseline pra,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,20897/22402
subjects who did not receive labd prior to the study,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,20898/22402
subjects who did receive labd prior to the study,C0681850;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false,20899/22402
subjects with imputed value for end ‐ of ‐ treatment body weight,C0681850;C2699638;C1522609;C1550501;C1706203;C2349001;C2697811,false;false;false;false;false;false;false,20900/22402
subjects with prevalent vertebral fracture  n ( % ) prevalent vertebral fracture,C0681850;C0033105;C0080179;C0220900;C1550501;C1706203;C2349001;C2697811,false;true;true;true;false;false;false;false,20901/22402
subpopulation,C1257890,true,20902/22402
subpopulation analyses according to baseline hba $nmbr$ c,C0441837;C0002778;C0680240;C0168634;C0019016;C1825777;C3538758;C1442488;C0936012;C1524024,false;false;false;true;true;false;false;false;false;true,20903/22402
subpopulation analyses according to bmi,C1514228;C0680240;C0578022,false;false;false,20904/22402
subscale  and $nmbr$ to $nmbr$ for the function subscale  normalized scores can range from $nmbr$ to $nmbr$ . scores for the health assessment question -,,,20905/22402
subsets,C1515021,false,20906/22402
subtrochanteric,,,20907/22402
sudden cardiac death §,C0085298,true,20908/22402
sudden death,C0011071;C1964022;C4554103,true;false;false,20909/22402
sufficient,C0205410,false,20910/22402
suit index  nmol / mmol,C0600653;C1532564;C1533073;C0918012;C1552854;C1637833;C2986546,true;false;false;true;false;false;false,20911/22402
suit quartile $nmbr$ ( b $nmbr$ . $nmbr$ nmol / mmol ) ( n = $nmbr$ ),C2828255;C1532564;C1533073,false;false;false,20912/22402
suit quartile $nmbr$ ( > $nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ nmol / mmol ) ( n = $nmbr$ ),C2828255;C1532564;C1533073,false;false;false,20913/22402
suit quartile $nmbr$ ( > $nmbr$ . $nmbr$ nmol / mmol ) ( n = $nmbr$ ),C2828255;C1532564;C1533073,false;false;false,20914/22402
sulfasalazine treatment,C0036078;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,20915/22402
sulfasalazine use at randomization,C0036078;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,20916/22402
sulfasalazine use at randomization    n   ( % ),C0036078;C0042153;C0034656;C0457083;C1947944,true;true;true;false;false,20917/22402
sulfonylurea use at baseline,C0038766;C0042153;C0168634;C1442488;C0457083;C1947944;C3536898,true;true;true;false;false;false;false,20918/22402
sulfonylureas,C0038766;C3653359,true;false,20919/22402
sulfonylureasb,,,20920/22402
sulphonamides  urea derivatives,C0038760;C0041942;C0243072,true;true;true,20921/22402
sulphonylureas only,C0038766;C0205171;C1720467,true;false;false,20922/22402
sun - $nmbr$ ( $nmbr$ ),C0038817;C0376223,true;true,20923/22402
supplementary table $nmbr$ . change from baseline in urine albumin - to - creatinine ratio by hba $nmbr$ c at baseline in patients with normoalbuminuria microalbuminuria and macroalbuminuria .,C0039224;C0392747;C0168634;C1442488;C0443172;C1705241;C4319952;C1706074;C0456603;C0019016;C1825777;C3538758;C1547037;C0730345,false;false;true;false;false;false;false;true;false;true;false;false;false;false,20924/22402
surgical repair of vsd or pda > $nmbr$ - year duration,C0374711;C0018818,false;true,20925/22402
suspected myocardial infarction,C0332147;C0027051;C0428953;C2926063;C3810814;C4552959;C0750491,false;true;false;false;false;false;false,20926/22402
sustain,C0443318;C2732140,false;false,20927/22402
sustain $nmbr$,C0443318;C2732140,false;false,20928/22402
sustain $nmbr$ : semaglutide vs . placebo,C0443318;C2732140,false;false,20929/22402
sustain $nmbr$ : semaglutide vs . sitagliptin $nmbr$ mg,C0443318;C2732140,false;false,20930/22402
sustain $nmbr$ : semaglutide vs . exenatide er $nmbr$ . $nmbr$ mg,C0443318;C2732140,false;false,20931/22402
sustain $nmbr$ : semaglutide vs . iglar,C0443318;C2732140,false;false,20932/22402
sustain $nmbr$ : semaglutide add ‐ on to insulin vs . placebo,C0443318;C2732140,false;false,20933/22402
sustained decrease of > $nmbr$ % in egfr ®,C0443318;C0392756;C0547047,false;false;false,20934/22402
sustained esrd  death due to kidney failure  or sustained decrease of > $nmbr$ % in egfr from baseline,C0443318;C0022661;C0011065;C0678226;C0035078;C1306577;C4082313;C4552775;C2316810,false;true;true;false;true;false;false;false;false,20935/22402
sustained mucosal healingc,C0443318;C0026724,false;true,20936/22402
sustained mucosal healingc n / n ( % ),C0443318;C0026724,false;true,20937/22402
swollen - joint count ( of $nmbr$ joints assessed ) — no .,C0451521,false,20938/22402
swollen joint count,C0451521,false,20939/22402
swollen joint count ( $nmbr$ - $nmbr$ joints ),C0451521,false,20940/22402
swollen joint count ( $nmbr$ – $nmbr$ joints )  mean ( sd ),C0451521;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20941/22402
swollen joint count ( $nmbr$ — $nmbr$  per swollen joint ),C0451521,false,20942/22402
swollen joint count ( $nmbr$ )  mean ( sd ),C0451521;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20943/22402
swollen joint count ( $nmbr$ joints )  mean ( sd ) ’,C0451521;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20944/22402
swollen joint count ( range $nmbr$ - $nmbr$ joints ),C0451521;C1514721;C2348147;C3542016,false;false;false;false,20945/22402
swollen joint count of $nmbr$ joints,C0451521,false,20946/22402
swollen joints ( $nmbr$ - joint count )  mean ± sd,C0451521;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,20947/22402
swollen joints > $nmbr$  n ( % ),C0152031,false,20948/22402
symmetric t - wave inversions,C0332516;C0520888;C2699744,false;false;false,20949/22402
symmetric t wave inversions,C0332516;C0520888;C2699744,false;false;false,20950/22402
symptom - free days in the past $nmbr$ weeks ( % ),C1457887;C0332296;C0677547;C1444637;C4284302;C0439228;C2987125;C1880497;C1996904;C3854129,false;false;false;false;false;false;false;false;false;false,20951/22402
symptom bother,C1457887;C3854129,false;false,20952/22402
symptom duration  months,C1457887;C0449238;C0439231;C2926735;C3854129,false;false;false;false;false,20953/22402
symptom onset - to - randomization,C4086878;C0034656,false;true,20954/22402
symptom onset to enrollment,C4086878;C1516879;C1696073;C3888021,false;false;false;false,20955/22402
symptom onset to hospital arrival  median ( iqr )  h,C4086878;C0019994;C1555577;C0549183;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193;C1706079;C1510665,false;true;false;false;true;false;false;false;false;false;false;false;false;false;false,20956/22402
symptom onset to hospitalization,C4086878;C0019993,false;true,20957/22402
symptom onset to pci  h,C4086878;C4049621;C0033727;C0369286;C0441932;C0564385;C4528284,false;false;true;false;false;false;false,20958/22402
symptomatic,C0231220,false,20959/22402
symptomatic deep - vein thrombosis,C0231220;C0149871,false;true,20960/22402
symptomatic heart fail,C0231220;C0018787,false;true,20961/22402
symptomatic hypoglycaemia,C0231220;C0020615;C4553659,false;true;false,20962/22402
symptomatic hypotension,C0231220;C0020649;C3163620,false;true;false,20963/22402
symptomatic hypotension ( sbp < $nmbr$ mmhg ),C0231220;C0020649;C0085805;C0439475;C3163620,false;true;true;false;false,20964/22402
symptomatic hypotension with sbp < $nmbr$ mm   hg,C0231220;C0020649;C0085805;C0439475;C3163620,false;true;true;false;false,20965/22402
symptomatic ich,C0231220;C0019191;C3272597;C3281105,false;true;false;false,20966/22402
symptomatic infarct swelling,C0231220;C0021308;C0013604;C0038999,false;true;true;false,20967/22402
symptomatic localization - related,C0231220;C0475264;C1744691,false;false;false,20968/22402
symptomatic pe,C0231220;C0070939;C1880476;C4284304,false;true;false;false,20969/22402
symptomatic remissionb n / n ( % ),C0231220,false,20970/22402
symptomaticb,,,20971/22402
symptoms mean ( sd ),C0683368;C0444504;C2699239;C2347634;C2348143;C1457887,true;false;false;false;false;false,20972/22402
symptoms of atrial fibrillation in the $nmbr$ months before randomization — no . ( % ),C0683368;C0004238;C0344434;C1963067;C1457887,true;true;false;false;false,20973/22402
symptoms onset to first balloon inflation  min,C4086878;C0205435;C0336867;C0021398;C0702093;C1524029;C3813700;C1318493;C0441144;C1279901,false;false;false;true;false;false;false;false;false;false,20974/22402
syncope,C0039070;C3541349;C4554644,true;false;false,20975/22402
syndrome  n ( % ),C0039082,true,20976/22402
sys : ns dia : < $nmbr$ . $nmbr$,C1425041;C0038944;C1706546;C1112705;C1705982,false;true;false;false;false,20977/22402
systemic corticosteroids — no . ( % ),C4053960,false,20978/22402
systemic corticosteroids  n ( % ),C4053960,false,20979/22402
systemic embolism,C0205373;C0013922;C1704212,false;true;true,20980/22402
systemic glucocorticoid use at randomization  n ( % ),C0205373;C0017710;C0042153;C0034656;C0457083;C1947944,false;true;true;true;false;false,20981/22402
systemic hypertension,C0020538,true,20982/22402
systemic sle medications  n ( % ),C0205373;C0024141;C0013227;C0802604;C2598133;C4284232,false;true;true;false;false;false,20983/22402
systoiic biood pressure  mm hg,C0033095;C0439475;C0460139;C1306345;C4284008,true;false;false;false;false,20984/22402
systolic blood pressure — mmhg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,20985/22402
systolic blood pressure ( change from baseline ),C0392747;C4274438;C0443172;C1705241;C4319952,false;false;false;false;false,20986/22402
systolic blood pressure ( median $nmbr$ . $nmbr$ ),C0488055;C0549183;C0876920;C2347635;C2348144;C2939193;C0871470;C1306620,false;false;false;false;false;false;true;false,20987/22402
systolic blood pressure ( mmhg )  mean ± sd,C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,20988/22402
systolic blood pressure < $nmbr$ mm hg and diastolic,C0488055;C0439475;C0871470;C1306620,false;false;true;false,20989/22402
systolic blood pressure > $nmbr$ mm hg — no . ( % ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,20990/22402
systolic blood pressure > $nmbr$ mm hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,20991/22402
systolic blood pressure > $nmbr$ mm hg  n ( % ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,20992/22402
systolic blood pressure > $nmbr$ mm hg or diastolic,C0488055;C0439475;C0871470;C1306620,false;false;true;false,20993/22402
systolic blood pressure mmhg  mean ( sd ),C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,20994/22402
systolic blood pressure  ( mm hg ),C0488055;C0439475;C0871470;C1306620,false;false;true;false,20995/22402
systolic blood pressure  mm hg ( sd ),C0488055;C0439475;C2699239;C0871470;C1306620,false;false;false;true;false,20996/22402
systolic blood pressure  mm hg ^,C0488055;C0439475;C0871470;C1306620,false;false;true;false,20997/22402
systolic blood pressure  mm hq,C0488055;C4330985;C4554674;C0871470;C1306620,false;false;false;true;false,20998/22402
systolic blood pressure  mm   hg,C0488055;C0439475;C0871470;C1306620,false;false;true;false,20999/22402
systolic blood pressure  mmhg *,C0488055;C0439475;C0871470;C1306620,false;false;true;false,21000/22402
systolic blood pressure  mmhg  mean ( sd ),C0488055;C0439475;C0444504;C2699239;C2347634;C2348143;C0871470;C1306620;C0039155;C0428886,false;false;false;false;false;false;true;false;true;true,21001/22402
systolic blood pressure ^,C0488055;C0871470;C1306620,false;true;false,21002/22402
systolic bp,C0871470,true,21003/22402
systolic bp ( mmhg ) *,C0871470;C0439475,true;false,21004/22402
systolic bp at baseline :,C0871470;C0168634;C1442488,true;true;false,21005/22402
systolic bp  mm hg ( mean ) nyha class,C0871470;C0439475;C0444504;C1882083;C2347634;C2348143;C0039155;C0488053,true;false;false;false;false;false;true;false,21006/22402
systolic bp  mm hg  mean ( sd ),C0871470;C0439475;C0444504;C2699239;C2347634;C2348143;C0039155;C0488053,true;false;false;false;false;false;true;false,21007/22402
systolic bp  mm   hg  mean ( sd ),C0871470;C0439475;C0444504;C2699239;C2347634;C2348143;C0039155;C0488053,true;false;false;false;false;false;true;false,21008/22402
systolic bp  mmhg,C0871470;C0439475,true;false,21009/22402
systolic bp  mmhg  mean ( sd ),C0871470;C0439475;C0444504;C2699239;C2347634;C2348143;C0039155;C0488053,true;false;false;false;false;false;true;false,21010/22402
systolic pressure — mm hg,C0871470;C0439475,true;false,21011/22402
systolic pressure at ankle level ( mmhg )  mean ± sd,C0871470;C0003086;C0441889;C0439475;C0444504;C2699239;C2347634;C2348143;C0456079;C1547707;C2946261;C0003087;C0039155;C0445074,true;true;false;false;false;false;false;false;false;false;false;true;true;false,21012/22402
systolic pressure  mm hg,C0871470;C0439475,true;false,21013/22402
systolic  mean ( sd )  mm hg h,C0039155;C0444504;C2699239;C0456680;C0025424;C0428257;C2347108;C2347109;C2348272;C2347634;C2348143,true;false;false;false;true;false;false;false;false;false;false,21014/22402
systolic  total,C0039155;C0439175;C0439810,true;false;false,21015/22402
systolic  treated at baseline,C0039155,true,21016/22402
t,C2603360,false,21017/22402
t - jj ( $nmbr$ - $nmbr$ ),C2603360,false,21018/22402
t - score at femoral neck,C3854607;C0015815,false;true,21019/22402
t - score categories lumbar spineb,C3854607;C0683312;C0024090,false;false;true,21020/22402
t - wave inversion,C0520888,false,21021/22402
t - wave inversion only,C0520888;C0205171;C1720467,false;false;false,21022/22402
t ( n = $nmbr$  $nmbr$ ),C2986835,false,21023/22402
t $nmbr$ . $nmbr$ mg,C2603360;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;true;true;false;false;false;false;false,21024/22402
t wave inversion,C0520888,false,21025/22402
t $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ng / ml ),C2603360;C0439275,false;false,21026/22402
t $nmbr$ lesion volume  mm ',C2603360;C0221198;C0449468;C4330985;C4554674;C1690016;C1705102;C2700258;C1546698,false;false;false;false;false;false;false;false;false,21027/22402
t $nmbr$ d duration  years,C2603360;C0449238;C0439234;C2926735,false;false;false;false,21028/22402
ta,C0039297;C1506978;C1705538;C3272501;C4553364,true;false;false;false;false,21029/22402
ta ( n = $nmbr$ ),C0039297;C1506978;C1705538;C3272501;C4553364,true;false;false;false;false,21030/22402
table $nmbr$ baseline characteristics of total study sample and stratified by treatment assignment and testosterone levela,C0039224;C4684572;C0947343;C0370003;C2347026;C0168634;C1315074;C1442488;C1706074,false;false;false;false;false;true;false;false;true,21031/22402
table $nmbr$ . characteristics of patients treated with losartan and atenolol *,C0039224;C0815172;C1706074,false;false;true,21032/22402
table $nmbr$ . characteristics of the patients at baseline . *,C0039224;C0815172;C1706074,false;false;true,21033/22402
table $nmbr$ . selected baseline characteristics of the study patients . *,C0039224;C1706074,false;true,21034/22402
table_group,C0039224;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1706074,false;false;false;true;false;false;false;true,21035/22402
taci,C0666480;C1425349;C4284230,true;false;false,21036/22402
tadalafil,C1176316,true,21037/22402
tadalafil $nmbr$ mg n = $nmbr$,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21038/22402
tadalafil $nmbr$ . $nmbr$ mg,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21039/22402
tadalafil $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21040/22402
tadalafil $nmbr$ . $nmbr$ mg n = $nmbr$,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21041/22402
tadalafil $nmbr$ mg,C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21042/22402
tadalafil $nmbr$ mg ( n = $nmbr$ ),C1176316;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21043/22402
tadalafil $nmbr$ mg mean change ( sd ),C1176316;C0024671;C0444504;C0392747;C2699239;C0443172;C1705241;C4319952;C2347634;C2348143;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false;false;false;false;true;false;false;false;false;false,21044/22402
tah ( n = $nmbr$ ),C0404079,false,21045/22402
taking antihypertensive medication at baseline  no . ( % ) e,C1515187,false,21046/22402
taking antihypertensive treatment at,C1515187,false,21047/22402
taking calcium supplements at baseline  n ( % ),C1515187;C0006675;C0006726;C2936886;C3540037;C3714611,false;true;true;false;false;false,21048/22402
taking statins  n ( % ) a,C1515187;C0360714,false;true,21049/22402
tamong those enrolling via bnp stratum . the study - qualifying bnp or,,,21050/22402
tamsulosin,C0257343,true,21051/22402
tamsulosin ( n = $nmbr$ ),C0257343,true,21052/22402
tamsulosin ( w = $nmbr$ )  $nmbr$ / $nmbr$,C0257343,true,21053/22402
tamsulosin $nmbr$ . $nmbr$ mg ( n = $nmbr$ ),C0257343;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21054/22402
tamsulosin $nmbr$ . $nmbr$ mg vs . placebo,C0257343;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21055/22402
tamsulosin $nmbr$ . $nmbr$ mg vs . $nmbr$ . $nmbr$ mg,C0257343;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21056/22402
tanezumab ( all doses combined ),C2346819,true,21057/22402
tanezumab ( all doses combined ) + nsaida,C2346819,true,21058/22402
tanezumab $nmbr$ mg,C2346819;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21059/22402
tanezumab $nmbr$ mg + nsaid,C2346819;C0024671;C0003211;C3536840;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,21060/22402
tanezumab $nmbr$ . $nmbr$ mg,C2346819;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21061/22402
tanezumab $nmbr$ . $nmbr$ mg + nsaid,C2346819;C0024671;C0003211;C3536840;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;true;false;false;false;false;false,21062/22402
target nail napsi score ( $nmbr$ – $nmbr$ scale ),C1521840;C0027342;C1432728;C3538766;C2986546,false;true;true;false;false,21063/22402
target vessel,C0449618,false,21064/22402
tass ’,C0559483,true,21065/22402
tbp,,,21066/22402
tc ( mg / dl ),C0039411;C0439269;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;true;true;true;false;false;false,21067/22402
tc level  mean ( sd ) mg / dl,C0039411;C0441889;C0444504;C2699239;C0439269;C2347634;C2348143;C0456079;C1547707;C2946261;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;false;false;false;false;false;false;false;false;false;true;true;true;false;false;false,21068/22402
tc : hdlc,C0039411;C1704429;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122,true;true;true;true;true;false;false;false,21069/22402
tcomparison of proportion of patients with nyha class lll / iv heart failure .,C1709707;C0030705,false;true,21070/22402
tcz - sc $nmbr$ mg every other week ( n = $nmbr$ ),C0282380;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21071/22402
tcz $nmbr$ mg / kg n = $nmbr$,C0439272,false,21072/22402
tcz + mtx ( n ),C0025677;C1417487,true;false,21073/22402
tdi e ' ( septal ) ( cm / sec ),C0205976;C0442004;C0439392;C2674784;C3714807,true;false;false;false;false,21074/22402
teaes in a $nmbr$ % of individuals,C0027361;C0237401,true;false,21075/22402
teaes leading to discontinuation of study drug,,,21076/22402
teaes of special interest,C0205555;C0543488,false;false,21077/22402
teaes reported by ≥ $nmbr$ % patients in the overall brv group    n   ( % ),,,21078/22402
teaes  cases per $nmbr$ - patient years ( ci ),C0868928;C0030705;C0439234;C0008107;C3259781;C1533148,false;true;false;true;false;false,21079/22402
temporal data and management strategy,C0442043;C1511726;C3245479;C3714741;C2362314,false;false;false;false;false,21080/22402
temporary factors,C0205374;C1521761;C2827422;C1548539;C3245481,false;false;false;false;false,21081/22402
temporary risk factor,C0205374;C0035648;C1548539;C3245481,false;true;false;false,21082/22402
tender - or painful - joint count ( of $nmbr$ joints assessed ) — no .,C0234234,false,21083/22402
tender joint count,C0451530,false,21084/22402
tender joint count ( $nmbr$ - $nmbr$  per tender joint ),C0451530,false,21085/22402
tender joint count ( $nmbr$ - $nmbr$ joints ),C0451530,false,21086/22402
tender joint count ( $nmbr$ – $nmbr$ joints )  mean ( sd ),C0451530;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,21087/22402
tender joint count ( $nmbr$ )  mean ( sd ),C0451530;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,21088/22402
tender joint count ( $nmbr$ joints )  mean ( sd ) ’,C0451530;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,21089/22402
tender joint count ( range $nmbr$ - $nmbr$ joints ),C0451530;C1514721;C2348147;C3542016,false;false;false;false,21090/22402
tender joint count of $nmbr$ joints,C0451530,false,21091/22402
tender joints ( $nmbr$ - joint count )  mean ± sd,C0451530;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,21092/22402
tenecteplase and pci ( n = $nmbr$ ),C0872913,true,21093/22402
teriparatide ( n   =   $nmbr$ ),C0070093,true,21094/22402
teriparatide n / n ( % ),C0070093,true,21095/22402
terlile $nmbr$,,,21096/22402
terrible,C3827840,false,21097/22402
tertiary,C0205372,false,21098/22402
tertiary amines,C3653356,false,21099/22402
tertiary end points,C0205372;C2349179,false;false,21100/22402
tertiary endpoints :,C0205372;C2349179,false;false,21101/22402
tertile $nmbr$ : $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ),,,21102/22402
tertile of total cholesterol at baseline  mean ( sd )  mmol / l,C0201950;C0543421,false;false,21103/22402
test for interaction,C0022885;C1704675;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false,21104/22402
test for interaction ( p value ),C0022885;C1704675;C1709380;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false;false,21105/22402
test for interaction between treatment and race,C0022885;C1704675;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false,21106/22402
test for trend,C0022885;C1521798;C4554533;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false;false,21107/22402
testing order,C0039593;C1705175;C1705176;C1705177;C1705178;C1882348;C3889825;C4284072;C0392366,false;false;false;false;false;false;false;false;false,21108/22402
testosterone ( nmol / l ),C0039601;C0439282,true;false,21109/22402
testosterone ( tt ) ( nmol / l ),C0039601;C1452561;C0439282;C4554543,true;true;false;false,21110/22402
testosterone level ( nmol / l ),C0428412;C0439282;C0523912,false;false;false,21111/22402
tests for categoric,C0589061,false,21112/22402
texcaps,,,21113/22402
tg ( mg / dl ),C0337445;C0439269,false;false,21114/22402
tg  triglycerides . * median values ( standard deviation for medians ) .,C0041004;C0399532;C0042295;C1442989;C0549183;C2828392,true;false;false;false;false;false,21115/22402
th ( $nmbr$ % ),C0039725;C0039738;C1420718;C4282123;C4285344,true;true;false;false;false,21116/22402
th c,C0039725;C0039738;C1420718;C4282123;C4285344,true;true;false;false;false,21117/22402
the american college of rheumatology ) .,C0596070;C0557806;C0035452,false;false;true,21118/22402
the metabolic syndrome ^,C0524620,true,21119/22402
the netherlands  australia  new zealand  and south africa,C0027778;C4289954,true;false,21120/22402
the plot shows hazard ratios and $nmbr$ % confidence intervals for the primary outcome  with patients stratified according to eight sub - groups prespecified in the statistical analysis plan . no heterogeneity was observed for these subgroups .,C0205225;C1547647;C0439612;C0439631;C0871424;C1079230,false;false;false;false;false;false,21121/22402
the square of the height in meters . patient ' s and physician ' s global assessment scores can range from $nmbr$ to $nmbr$ . scores for the western,C0205120;C0489786;C1552595;C4050369;C0449820;C1705493,false;false;false;false;false;false,21122/22402
the test for heterogeneity ( interaction ) indicates whether the treatment effect varied significantly among the sub - groups . the hochberg method was applied to each of the two comparisons of the treatment groups . bmi denotes body - mass index ( the weight in kilograms divided by the square of the height in meters ) .,C0022885;C0019409;C1704675;C0242960;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744;C4048755;C0205448;C1707455;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C0332849;C0205120;C0489786;C1552595,false;false;false;true;false;false;false;false;false;false;false;false;false;true;true;false;false;false;false;false;false;false;true;false;false;false;false;false;false;false;false,21123/22402
therapies,C0087111,true,21124/22402
therapy,C0039798;C0087111;C1363945,true;true;false,21125/22402
therapy - fatigue ( facit - f  $nmbr$ - $nmbr$ ),C0039798;C0015672;C3272505;C3463815;C4050243;C4554645;C0087111;C1363945,true;true;false;false;false;false;true;false,21126/22402
therapy use,C0039798;C0042153;C0457083;C1947944;C0087111;C1363945,true;true;false;false;true;false,21127/22402
thiazide diuretic *,C0012802;C3536861,true;false,21128/22402
thiazide users,C0541746;C1706077,true;false,21129/22402
thiazolidinedione use at baseline,C0289779;C0042153;C0168634;C1442488;C0457083;C1947944;C1257987;C3537039,true;true;true;false;false;false;true;false,21130/22402
thiazolidinediones *,C1257987;C3541957,true;false,21131/22402
thiazolidinedionesc,,,21132/22402
thienopyridine alone,C1120149,true,21133/22402
thienopyridine at baseline,C1120149;C0168634;C1442488,true;true;false,21134/22402
thienopyridine at discharge,C1120149;C0012621;C0030685;C2926602,true;false;true;false,21135/22402
thienopyridine + dipyridamole,C1120149;C0012582,true;true,21136/22402
third yeart,C0205437,false,21137/22402
this study,C0557651;C2603343,false;false,21138/22402
three - point mace,C0205449;C1552961;C0349381;C0949745;C1445339;C2347617;C3714763,false;false;false;true;false;false;false,21139/22402
three or more lesions,C0205449,false,21140/22402
thromboaspiration,,,21141/22402
thromboembolism,C0040038,true,21142/22402
thrombolysis,C0520997,false,21143/22402
thrombolytic agents,C0016018,true,21144/22402
thrombus aspiration done per lesion †,C0087086;C0220787;C0349707;C0700198;C2712334;C2827071;C0302148;C3146237,true;false;false;false;false;false;false;false,21145/22402
thyroid disease,C0040128,true,21146/22402
thyroid hormone,C0040135;C4522017,true;false,21147/22402
tia  n ( % ),C0007787;C0917805;C1054154,true;true;false,21148/22402
ticagrelor $nmbr$ mg,C1999375;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21149/22402
ticagrelor $nmbr$ mg diabetes n = $nmbr$,C1999375;C0024671;C0011847;C0011849;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;true;false;false;false;false;false,21150/22402
ticagrelor $nmbr$ mg km %,C1999375;C0024671;C3887676;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,21151/22402
ticagrelor $nmbr$ mg no diabetes n = $nmbr$,C1999375;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21152/22402
ticagrelor in ‐ hosp ( n = $nmbr$ ),C1999375,true,21153/22402
ticagrelor pre ‐ hosp ( n = $nmbr$ ),C1999375;C0332152;C0740175;C2257086;C3669034,true;false;false;false;false,21154/22402
tier $nmbr$ aes,C1412268;C2699274,false;false,21155/22402
time - to - first - infusion from hip surgery ( days )  n ( % ),C0040223;C0205435;C0574032;C1827465;C1279901;C3541383,true;false;false;false;false;false,21156/22402
time - to - first infusion,C0040223;C0205435;C0574032;C1827465;C1279901;C3541383,true;false;false;false;false;false,21157/22402
time ( sec ) *,C0040223;C0565930;C3541383,true;false;false,21158/22402
time between index acs and randomization — days,C0040223;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C3541383,true;true;true;false;true;false;false;false;false,21159/22402
time between index acs and randomization ( days ),C0040223;C0600653;C0742343;C4318612;C0918012;C1552854;C1637833;C2986546;C3541383,true;true;true;false;true;false;false;false;false,21160/22402
time from acute coronary syndrome to randomization ( days ),C0040223;C0948089;C3541383,true;true;false,21161/22402
time from end of fit  years ( meanisd ),C1522314;C0036572;C0439234;C2349186;C4048158;C4553125,false;true;false;false;true;false,21162/22402
time from fibrinolytic therapy to study - drug administration — no . / total no . ( % ),C0206209;C0040044;C0013175;C0040223;C0557651;C0013216;C1611232;C3665478;C2603343;C3541383;C0040227;C0150270;C3469597;C2349982,true;true;true;true;false;true;true;false;false;false;true;false;false;false,21163/22402
time from hospital admission to enrollment,C0040223;C0019994;C1959907;C1510665;C3541383,true;true;false;false;false,21164/22402
time from hospitalization to randomization — hr,C0040223;C0019993;C3541383,true;true;false,21165/22402
time from index acs event to randomisation ( days ),C0040223;C0600653;C0742343;C0441471;C4019010;C4318612;C0918012;C1552854;C1637833;C2986546;C3541383,true;true;true;false;false;false;true;false;false;false;false,21166/22402
time from ld to pci  min  median ( q $nmbr$ – q $nmbr$ ),C0040223;C0694649;C3541383,true;false;false,21167/22402
time from onset of pain to randomization — hr,C0449244;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132,false;true;false;false;false;false;false;false;false;false,21168/22402
time from onset of symptoms to presentation — hr,C1320528,false,21169/22402
time from onset of symptoms to start of fibrinolytic therapy — hr,C1320528,false,21170/22402
time from pah diagnosis months,C0030123;C0011900;C0556969;C1704338;C1704656;C3203102;C4284467,true;true;false;true;false;true;false,21171/22402
time from parkinson ’ s disease diagnosis in months  mean ( sd ),C0040223;C0030567;C0011900;C1704338;C1704656;C3541383,true;true;true;true;false;false,21172/22402
time from presentation to randomization — hr,C0040223;C0449450;C3541383,true;false;false,21173/22402
time from psoriatic arthritis diagnosis [ a ]  years,C0040223;C0003872;C0011900;C1704338;C1704656;C3541383,true;true;true;true;false;false,21174/22402
time from qualifying ecg to balloon inflation,C0040223;C1514624;C1623258;C3541383,true;false;true;false,21175/22402
time from ra diagnosis  years  median,C0556970;C3538806;C0011900;C1704338;C1704656;C4048756,false;false;true;true;false;false,21176/22402
time from randomization to cabg — hr,C0040223;C0034656;C3541383,true;true;false,21177/22402
time from randomization to coronary angiography — hr,C0040223;C0034656;C3541383,true;true;false,21178/22402
time from randomization to pci — hr,C0040223;C0034656;C3541383,true;true;false,21179/22402
time from randomization to study - drug administration — hr,C0206209;C0034656;C0013175;C0040227;C0150270;C3469597;C2349982,true;true;true;true;false;false;false,21180/22402
time from randomization to study - drug initiation — hr,C0040223;C0034656;C0013175;C0589507;C1158830;C1704686;C3541383;C0040227;C0013227;C1254351;C2349982,true;true;true;false;false;false;false;true;true;false;false,21181/22402
time from sx onset to baseline ecg  min,C1519428;C0449244;C3539997;C3815196,false;false;true;false,21182/22402
time from symptom onset of ra  years  median,C1320528;C3538806;C0439234;C4048756,false;false;false;false,21183/22402
time from symptom onset to balloon inflation,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,21184/22402
time from symptom onset to enrollment,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,21185/22402
time from symptom onset to start of fibrinolytic therapy — hr,C0040223;C4086878;C3541383;C1457887;C0449244;C3854129,true;false;false;false;false;false,21186/22402
time from symptoms to randomization  h,C0040223;C0683368;C1457887;C3541383,true;true;false;false,21187/22402
time from  median ( iqr )  h,C0040223;C0549183;C0033727;C0369286;C0441932;C0564385;C4528284;C0876920;C2347635;C2348144;C2939193;C3541383,true;false;true;false;false;false;false;false;false;false;false;false,21188/22402
time in therapeutic range,C1554109;C0087111;C0302350;C0040223;C0460097;C3541383,false;true;false;true;false;false,21189/22402
time in therapeutic range  median ( iqr )  %,C1554109;C0087111;C0549183;C0876920;C2347635;C2348144;C2939193;C0302350;C0040223;C0460097;C3541383,false;true;false;false;false;false;false;false;true;false;false,21190/22402
time in trial,C0040223;C3541383,true;false,21191/22402
time intervals,C0872291,false,21192/22402
time point,C2348792,false,21193/22402
time sample drawn ( h ),C0040223;C3541383,true;false,21194/22402
time since as diagnosis ( years )  mean ( sd ),C0040223;C3541383,true;false,21195/22402
time since as diagnosis ( years )  mean   ±   sd,C0040223;C3541383,true;false,21196/22402
time since asthma,C0040223;C3541383,true;false,21197/22402
time since asthma diagnosis [ years ]  median ( range ),C0040223;C3541383,true;false,21198/22402
time since asthma diagnosis years,C0040223;C3541383,true;false,21199/22402
time since bph diagnosis ( years ),C0040223;C3541383,true;false,21200/22402
time since cabg,C0040223;C3541383,true;false,21201/22402
time since diagnosis of ciu / csu ( years ) $nmbr$,C0040223;C3541383,true;false,21202/22402
time since diagnosis of ciu / csuf ( y ),C0040223;C3541383,true;false,21203/22402
time since diagnosis of copd  years,C0040223;C3541383,true;false,21204/22402
time since diagnosis of diabetes ( years ) ( median  iqr ),C0040223;C3541383,true;false,21205/22402
time since diagnosis of diabetes  mean ( sd ),C0040223;C3541383,true;false,21206/22402
time since diagnosis of diabetes  n ( % ),C0040223;C3541383,true;false,21207/22402
time since diagnosis of ln  years,C0040223;C3541383,true;false,21208/22402
time since diagnosis of pah years #,C0040223;C3541383,true;false,21209/22402
time since diagnosis of psa ( years )  mean ( sd ),C0040223;C3541383,true;false,21210/22402
time since diagnosis of sle  years,C0040223;C3541383,true;false,21211/22402
time since diagnosis of t $nmbr$ dm,C0040223;C3541383,true;false,21212/22402
time since diagnosis of t $nmbr$ dm  y  n ( % ),C0040223;C3541383,true;false,21213/22402
time since diagnosis of type $nmbr$ diabetes mellitus,C0040223;C3541383,true;false,21214/22402
time since diagnosis  years,C0040223;C3541383,true;false,21215/22402
time since end of fit  mean ( sd )  y,C0040223;C3541383,true;false,21216/22402
time since epilepsy diagnosis ( years ),C0040223;C3541383,true;false,21217/22402
time since first luts ( years ),C0040223;C3541383,true;false,21218/22402
time since first psoriasis diagnosis ( y )  mean ( sd ),C0040223;C3541383,true;false,21219/22402
time since ipf diagnosisa  mean years ( sd ),C0040223;C3541383,true;false,21220/22402
time since last dose of,C0946444,false,21221/22402
time since most recent myocardial,C0040223;C3541383,true;false,21222/22402
time since onset ( h ),C0040223;C3541383,true;false,21223/22402
time since pd diagnosis  mean ± sd,C0040223;C3541383,true;false,21224/22402
time since primary diagnosis,C0040223;C3541383,true;false,21225/22402
time since prior alendronate use  n ( % ),C0040223;C3541383,true;false,21226/22402
time since psa onset  mean years ( sd ),C0040223;C3541383,true;false,21227/22402
time since psoriasis diagnosis  years $nmbr$,C0040223;C3541383,true;false,21228/22402
time since rheumatoid arthritis diagnosis  years,C0040223;C3541383,true;false,21229/22402
time since start insulin ( years ),C0040223;C3541383,true;false,21230/22402
time since start of fit  mean ( sd )  y,C0040223;C3541383,true;false,21231/22402
time since start of fit  years ( meanisd ),C0040223;C3541383,true;false,21232/22402
time to all - cause death up to end of the study,C0040223;C0007465;C3541383;C0015127;C1301931;C1524003,true;true;false;true;false;false,21233/22402
time to angiography — hr,C0040223;C0002978;C3541383,true;true;false,21234/22402
time to death due to pah or hospitalization due to pah up to the end of the treatment periodd,C1301931,false,21235/22402
time to first cv hospitalization or death from any cause,C0040223;C0205435;C3538987;C0019993;C4048877;C4318503;C1279901;C3541383,true;false;false;true;true;false;false;false,21236/22402
time to first exacerbation,C0040223;C0205435;C4086268;C1279901;C3541383,true;false;false;false;false,21237/22402
time to first inhaled corticosteroid ( % ),C0040223;C0205435;C0004048;C0001617;C3536709;C1279901;C3541383,true;false;true;true;false;false;false,21238/22402
time to first morbidity / mortality event up to the end of the treatment periodd,C0040223;C0205435;C0026538;C0026565;C0441471;C4019010;C0026566;C0220880;C1279901;C3541383,true;false;true;true;false;false;true;true;false;false,21239/22402
time to first oral or systemic corticosteroid ( % ),C0040223;C0205435;C0442027;C4521986;C1279901;C3541383,true;false;false;false;false;false,21240/22402
time to first sare * ( % ),C0040223;C0205435;C1279901;C3541383,true;false;false;false,21241/22402
time to randomization ( h ),C0040223;C0034656;C0033727;C0369286;C0441932;C0564385;C4528284;C3541383,true;true;true;false;false;false;false;false,21242/22402
time to rx,C0040223;C1425688;C1521941;C2709207;C3541383,true;false;false;false;false,21243/22402
time to treatment  h,C3494202;C0033727;C0369286;C0441932;C0564385;C4528284,true;true;false;false;false;false,21244/22402
time  mean ( sd )  min procedure,C0040223;C0444504;C2699239;C0702093;C0184661;C2700391;C3274430;C3539779;C1524029;C3813700;C2347634;C2348143;C3541383,true;false;false;false;true;false;false;false;false;false;false;false;false,21245/22402
timi - bleeding major / minor,,,21246/22402
timi ≥ $nmbr$,,,21247/22402
timi ≥ $nmbr$ and spoke,,,21248/22402
timi ≥ $nmbr$ and spoke and time ≤ $nmbr$ h,,,21249/22402
timi clinically significant,,,21250/22402
timi flow grade $nmbr$ of mi culprit vessel post ‐ pci,C3272266;C0441800;C0005847;C0856742;C4049621;C0919553;C3244287,false;false;true;false;false;false;false,21251/22402
timi flow grade $nmbr$ of mi culprit vessel pre ‐ pci,C3272266;C0441800;C3810814;C0005847;C0919553;C3244287,false;false;false;true;false;false,21252/22402
timi flow ‡,C3272266,false,21253/22402
timi major or,,,21254/22402
timi major / minor bleeding,C4441842;C0019080,false;true,21255/22402
timi minor bleeding,C0026193;C0019080;C0205165,true;true;false,21256/22402
timi non - cabg major,C1518422;C0010055,false;true,21257/22402
timi risk score — %,C0035647;C0449820;C4050231;C4552904,true;false;false;false,21258/22402
timi risk score — no . / total no . ( % ) : c,C0035647;C0449820;C4050231;C4552904,true;false;false;false,21259/22402
timi risk score — no . / total no . ( % ) f,C0035647;C0449820;C4050231;C4552904,true;false;false;false,21260/22402
timi risk score > $nmbr$  %,C0035647;C0449820;C4050231;C4552904,true;false;false;false,21261/22402
timi risk score > $nmbr$  n ( % ),C0035647;C0449820;C4050231;C4552904,true;false;false;false,21262/22402
timi risk score category — no . ( % ),C0035647;C0449820;C0683312;C3889287;C4050231;C4552904,true;false;false;false;false;false,21263/22402
timi risk score *,C0035647;C0449820;C4050231;C4552904,true;false;false;false,21264/22402
timi risk score  n / n ( % ),C0035647;C0449820;C4050231;C4552904,true;false;false;false,21265/22402
timi risk scoret,,,21266/22402
tio,,,21267/22402
tio ( n $nmbr$ $nmbr$ ),,,21268/22402
tio $nmbr$ | ig ( n = $nmbr$ ),C0021027;C0305052;C0360506,true;false;false,21269/22402
tio i $nmbr$ mcg ( n = $nmbr$ ),C0021966;C0439211;C3463985;C0221138,true;false;false;false,21270/22402
tion  os = overall satisfaction  qmax = maximal urinary flow rate .,C0229090;C4086680;C0429784;C0230028;C0262950;C0393706;C1561953,false;false;false;false;true;false;false,21271/22402
tiotropium + olodaterol $nmbr$ / $nmbr$,C4032878,true,21272/22402
tiotropium $nmbr$ meg ( n = $nmbr$ ),C0213771;C0024489;C0025175;C0072225,true;true;true;true,21273/22402
tiotropium $nmbr$ . $nmbr$ μ g ( n   = $nmbr$ ),C0213771;C0439267,true;false,21274/22402
tiotropium $nmbr$ . $nmbr$ pg,C0213771;C0030827;C0072225;C1266240,true;true;true;false,21275/22402
tiotropium $nmbr$ . $nmbr$   μ g ( n   =   $nmbr$ ),C0213771;C0439267,true;false,21276/22402
tiotropium $nmbr$ pg,C0213771;C0030827;C0072225;C1266240,true;true;true;false,21277/22402
tiotropium $nmbr$   μ g ( n   =   $nmbr$ ),C0213771;C0439267,true;false,21278/22402
tiotropium salmeterol no . of patients / total no .,C0213771;C0073992,true;true,21279/22402
tiotropium vs . salmeterol,C0213771,true,21280/22402
tj ( $nmbr$ - $nmbr$ ),C0039247,true,21281/22402
tj ( $nmbr$ % ),C0039247,true,21282/22402
tjc  mean ( sd ),C0444504;C2699239;C2347634;C2348143,false;false;false;false,21283/22402
tk,C0041405;C0220928;C4050092,true;true;false,21284/22402
tlmi risk score,C0035647;C0449820;C4050231;C4552904,true;false;false;false,21285/22402
tnf - failure patientsa,C1448177;C0231174;C0680095,true;false;false,21286/22402
tnf - failurea,C1448177,true,21287/22402
tnf - ir,C1448177;C0022065;C0022071;C1448132,true;true;true;true,21288/22402
tnf - na ï ve,C1448177;C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,true;false;true;false;false;false;false;false;false;false,21289/22402
tnf - naive patientsa,C1448177,true,21290/22402
tnf - naivea,C1448177,true,21291/22402
tnf antagonist - exposed,C1448177;C0231491,true;false,21292/22402
tnf antagonist - failure population ( n - $nmbr$ ),C1448177;C0231491;C0231174;C0032659;C1257890;C0680095,true;false;false;true;true;false,21293/22402
tnf antagonist - naive ' ’,C1448177;C0231491,true;false,21294/22402
tnf antagonist - naive subgroup ( n - $nmbr$ ),C1448177;C0231491;C1079230;C1515021,true;false;false;false,21295/22402
tnf antagonist - naive ®,C1448177;C0231491,true;false,21296/22402
tnfi - exposed †,,,21297/22402
tnfi - ir,C0022065;C0022071;C1448132,true;true;true,21298/22402
tnfi - naive,,,21299/22402
tnfi - na ï ve,C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,false;true;false;false;false;false;false;false;false,21300/22402
tnfi - na ï ve  n ( % ),C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,false;true;false;false;false;false;false;false;false,21301/22402
tni ultrapositive ≥ $nmbr$ . $nmbr$ µ g / l  n   =   $nmbr$   $nmbr$,C0077401;C0439294;C0456615,true;false;false,21302/22402
tni ultrapositive  ≥ $nmbr$ . $nmbr$ µ g / l  n   =   $nmbr$   $nmbr$,C0077401;C0439294;C0456615,true;false;false,21303/22402
tobacco use  n ( % ),C0040335;C0543414;C0841002;C3853727,false;true;false;false,21304/22402
tobacco use  yes  n ( % ),C0040335;C1549445;C1705108;C1710701;C0543414;C0841002;C3853727,false;false;false;false;true;false;false,21305/22402
tobacco user,C3853727,false,21306/22402
tofacitinib,C2930696,true,21307/22402
tofacitinib $nmbr$ mg bid ( n = $nmbr$ ),C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21308/22402
tofacitinib $nmbr$ mg bid ( n   = $nmbr$ ),C2930696;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21309/22402
tolvaptan,C1176308,true,21310/22402
tolvaptan ( n = $nmbr$ ),C1176308,true,21311/22402
tonic,C3543842,false,21312/22402
tonic – clonic,C3543842,false,21313/22402
took prior antihyperglycemic agent ( any ),C1515187,false,21314/22402
tophi present  n ( % ),C0221248,false,21315/22402
topical,C0332237,false,21316/22402
topical non - prescription,C0332237;C1518422;C0033080;C1521941,false;false;true;false,21317/22402
topical prescription,C0332237;C0033080;C1521941,false;true;false,21318/22402
toricoxib $nmbr$ mg n = $nmbr$ ) ( % ),C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;false;false;false;false,21319/22402
totai mortaiity,,,21320/22402
total - c,C0439175;C0439810,false;false,21321/22402
total - hip bmd t - score,C2964552;C0019552;C0022122;C1505163;C3538851;C4284725,false;true;true;true;false;false,21322/22402
total ( n [ $nmbr$ ),C0439175;C0439810,false;false,21323/22402
total ( n $nmbr$ $nmbr$ ),C0439175;C0439810,false;false,21324/22402
total ( n   = $nmbr$ ),C0439175;C0439810,false;false,21325/22402
total ( n ),C0439175;C0439810,false;false,21326/22402
total ( n   =   $nmbr$ ),C0439175;C0439810,false;false,21327/22402
total ( v = $nmbr$  $nmbr$ ),C0439175;C0439810,false;false,21328/22402
total > atients,C0439175;C0439810,false;false,21329/22402
total $nmbr$,C0439175;C0439810,false;false,21330/22402
total aim ‐ high study,C0439175;C1947946;C0205250;C0557651;C2603343;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C2744535;C2948600;C3540471;C3540472;C3890193;C0439810,false;false;false;false;false;false;false;false;false;false;false;true;false;false;false;false;false,21331/22402
total asthma symptom score  mean ± sd ‡,C3533163;C0004096;C0444504;C2699239;C2347634;C2348143;C2984299,false;true;false;false;false;false;false,21332/22402
total asthma symptom score  mean ± sdz,C3533163;C0004096;C0444504;C2347634;C2348143;C2984299,false;true;false;false;false;false,21333/22402
total back pain score ( $nmbr$ – $nmbr$   mm scale )  mean   ±   sd,C2964552;C0004604;C4330985;C0175659;C0444504;C2699239;C2347634;C2348143;C0349674;C1947916;C4554674;C1963071;C4553945,false;true;false;true;false;false;false;false;false;false;false;false;false,21334/22402
total back pain  $nmbr$ – $nmbr$ mm vas  mean ± sd,C0439175;C0004600;C0042815;C4330985;C0444504;C2699239;C2347634;C2348143;C4554674;C0205095;C0460009;C1995000;C0439810,false;true;true;false;false;false;false;false;false;false;false;false;false,21335/22402
total basdai score  mean ( sd ),C0439175;C1998004;C0439810,false;false;false,21336/22402
total basdai score  mean   ±   sd,C0439175;C1998004;C0439810,false;false;false,21337/22402
total baseline insulin dose,C2986497;C0168634;C0021641;C1533581;C1579433;C3714501;C1442488;C0439175;C0366513;C0439810,false;true;true;false;false;false;false;false;false;false,21338/22402
total bilirubin > $nmbr$ x uln $nmbr$,C0005437;C1519815;C0368753,true;false;false,21339/22402
total bilirubin  mg / dl,C0005437;C0439269;C0368753,true;false;false,21340/22402
total bleeding,C0232100,true,21341/22402
total bleeds,C0232100,true,21342/22402
total by treatment,C0439175;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0439810,false;true;true;false;false;false;false;false;false,21343/22402
total c ( mg / dl ) *,C0439175;C0439269;C0439810,false;false;false,21344/22402
total c / hdl - c ratio * *,C0439175;C3715113;C0456603;C1547037;C0439810,false;false;false;false;false,21345/22402
total carmelina population,C3258257,false,21346/22402
total cholesterol ( mmol / l )  mean ( sd ),C0201950;C1532563;C0444504;C2699239;C2347634;C2348143;C0543421,false;false;false;false;false;false;false,21347/22402
total cholesterol ( sd )  mg / dl,C0201950;C2699239;C0439269;C0543421,false;false;false;false,21348/22402
total cholesterol level  mg / dl,C0878805;C0439269;C1445957,false;false;false,21349/22402
total cholesterol  mean ( sd ),C0201950;C0444504;C2699239;C2347634;C2348143;C0543421,false;false;false;false;false;false,21350/22402
total cholesterol  mean ( sd )  mg / dl,C0201950;C0444504;C2699239;C0439269;C2347634;C2348143;C0543421,false;false;false;false;false;false;false,21351/22402
total cholesterol  mg / dl  ^,C0201950;C0439269;C0543421,false;false;false,21352/22402
total cholesterol  mg / dl  mean ( sd ),C0201950;C0439269;C0444504;C2699239;C2347634;C2348143;C0543421,false;false;false;false;false;false;false,21353/22402
total cholesterol  mmol / l ( sd ),C0201950;C1532563;C2699239;C0543421,false;false;false;false,21354/22402
total cholesterol  mmol / l  mean ( sd ),C0201950;C1532563;C0444504;C2699239;C2347634;C2348143;C0543421,false;false;false;false;false;false;false,21355/22402
total cholesterol  mmol / le,C0201950;C0439190;C0023190;C0439090;C1423767;C2697858;C0543421,false;false;true;false;false;false;false,21356/22402
total cholesterol  mmol / lt,C0201950;C0439190;C0023376;C0230426;C3887647;C4521399;C0543421,false;false;true;false;false;false;false,21357/22402
total cholesterol ^,C0201950;C0543421,false;false,21358/22402
total cigarette pack - years  mean ( sd ),C0439175;C1303175;C0444504;C2699239;C2347634;C2348143;C0439810,false;false;false;false;false;false;false,21359/22402
total cohort,C0439175;C0009247;C0599755;C0439810,false;true;false;false,21360/22402
total daily dose of ics  mean  μ gc,C2348070;C0815320;C0444504;C3537453;C4281799;C2347634;C2348143;C4551720,false;false;false;false;false;false;false;true,21361/22402
total daily insulin dose ( lu / kg ),C2348070;C0021641;C0024171;C0022718;C0439209;C4054209;C0024176;C2697939;C1533581;C1579433;C3714501,false;true;true;true;false;false;true;false;false;false;false,21362/22402
total daily insulin dose ( u / day ),C2348070;C0021641;C0456683;C1533581;C1579433;C3714501,false;true;false;false;false;false,21363/22402
total daily insulin dose  u,C2348070;C0021641;C0439148;C1533581;C1579433;C3714501,false;true;false;false;false;false,21364/22402
total daily insulin dose  units / kgt,C2348070;C0021641;C0439148;C1519795;C3853603;C1533581;C1579433;C3714501,false;true;false;false;false;false;false;false,21365/22402
total death,C0439175;C0011065;C1306577;C4082313;C4552775;C0439810,false;true;false;false;false;false,21366/22402
total deaths,C0439175;C0011065;C1306577;C0439810,false;true;false;false,21367/22402
total deaths  n,C0439175;C0011065;C1306577;C0439810,false;true;false;false,21368/22402
total events  n,C0439175;C0441471;C3541888;C0439810,false;false;false;false,21369/22402
total feet score,C2964552;C0016504;C0347981,false;true;false,21370/22402
total gadolinium - enhancing lesion count . no . ( % ),C0439175;C1333400;C0439810,false;false;false,21371/22402
total glucose mg / dl,C0439175;C0017725;C0439269;C0439810,false;true;false;false,21372/22402
total hands score,C0439175;C0018563;C1552914;C0439810,false;true;false;false,21373/22402
total hip ( n = $nmbr$  $nmbr$ ) bmd ( g / cm $nmbr$ ) ( sd ),C0439175;C0019552;C0439267;C2699239;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;false;false;true;true;false;false;false,21374/22402
total hip bmd ( g / cm $nmbr$ ),C0439175;C0019552;C0439267;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;false;true;true;false;false;false,21375/22402
total hip bmd t - score,C2964552;C0019552;C0022122;C1505163;C3538851;C4284725,false;true;true;true;false;false,21376/22402
total hip bmi ) t - score,C2964552;C0019552;C0578022;C0022122;C1505163;C3538851;C4284725,false;true;false;true;true;false;false,21377/22402
total hip or knee replacement,C0439175;C0019552;C0022122;C1505163;C3538851;C4284725;C0439810,false;true;true;true;false;false;false,21378/22402
total hipc,C0439175;C0439810,false;false,21379/22402
total ics dose at entry  / xg / d,C2986497;C0815320;C1705654;C0017209;C1292284;C1421532;C4551720,false;false;false;true;false;false;true,21380/22402
total ige — lu / ml,C0439175;C2697941;C0439810,false;false;false,21381/22402
total ige levelx ( iu / ml )  median ( range ),C0439175;C0439458;C0549183;C1514721;C2348147;C3542016;C0876920;C2347635;C2348144;C2939193;C0439810,false;false;false;false;false;false;false;false;false;false;false,21382/22402
total ige  geometric,C0439175;C0439810,false;false,21383/22402
total included in combined analysis,C0439175;C0439810,false;false,21384/22402
total ipss,C0439175;C1019118;C1998280;C2827405;C3811063;C0439810,false;false;false;false;false;false,21385/22402
total length of implanted stents  mm  mean ( sd ),C0439175;C0449462;C0021102;C4330985;C0444504;C2699239;C2347634;C2348143;C4554674;C2828363;C0439810,false;false;false;false;false;false;false;false;false;false;false,21386/22402
total macular volume  mean ( sd )  mm $nmbr$,C0449468;C0332574;C0444504;C2699239;C4330985;C4554674;C2347634;C2348143,false;false;false;false;false;false;false;false,21387/22402
total mayo score,C2964552;C0454788;C1077578,false;false;false,21388/22402
total mortality all,C0439175;C0026565;C0026566;C0439810,false;true;true;false,21389/22402
total n,C0439175;C0439810,false;false,21390/22402
total n   =   $nmbr$,C0439175;C0439810,false;false,21391/22402
total n $nmbr$,C0439175;C0439810,false;false,21392/22402
total no . $nmbr$,C0439175;C0439810,false;false,21393/22402
total no . of events ( % of participants ) / total no . of participants,C0439175;C0439810,false;false,21394/22402
total no . of events / total no . of participants,C0439175;C0439810,false;false,21395/22402
total no . of events / participants,C0439175;C0439810,false;false,21396/22402
total number of events / participants,C0439175;C4330837;C0679646;C0439810,false;false;false;false,21397/22402
total number of patients,C0439175;C2360800;C0439810,false;false;false,21398/22402
total phase $nmbr$ pooled ( n = $nmbr$ ),C0439175;C0205390;C1710475;C0439810,false;false;false;false,21399/22402
total psa ‐ modified shs,C2986589;C0392747;C3889737,false;false;false,21400/22402
total randomised ( n ),C0439175;C0439810,false;false,21401/22402
total randomized,C0439175;C0439810,false;false,21402/22402
total randomized  n,C0439175;C0034656;C3815594;C0439810,false;true;false;false,21403/22402
total resolution of dactylitisb,C0439175;C1514893;C1706463;C2699488;C0439810,false;false;false;false;false,21404/22402
total resolution of enthesitisc,C0439175;C1514893;C1706463;C2699488;C0439810,false;false;false;false;false,21405/22402
total resolution of nail psoriasisd,C0439175;C1514893;C0027342;C1432728;C3538766;C1706463;C2699488;C0439810,false;false;true;true;false;false;false;false,21406/22402
total sample = $nmbr$ ( % ),C0439175;C0370003;C2347026;C0439810,false;false;false;false,21407/22402
total score ( $nmbr$ – $nmbr$ scale ),C2964552;C0175659;C0349674;C1947916,false;true;false;false,21408/22402
total score < $nmbr$,C2964552,false,21409/22402
total score > $nmbr$,C2964552,false,21410/22402
total score §,C2964552,false,21411/22402
total scores ( total score range : $nmbr$ - $nmbr$ ),C2964552;C1514721;C2348147;C3542016,false;false;false;false,21412/22402
total sgrq mean total score ( sd ),C2964552;C0444504;C2699239;C2347634;C2348143;C0439175;C3533236;C0439810,false;false;false;false;false;false;false;false,21413/22402
total sgrq score,C0439175;C0439810,false;false,21414/22402
total study itt population ( n = $nmbr$ ),C3258257;C0557651;C2603343;C0439175;C2348561;C0439810,false;false;false;false;false;false,21415/22402
total subjects,C0439175;C0681850;C1550501;C1706203;C2349001;C2697811;C0439810,false;false;false;false;false;false;false,21416/22402
total time of fondaparinux treatment before,C0439175;C0040223;C1098510;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C3541383;C0439810,false;true;true;true;true;false;false;false;false;false;false;false,21417/22402
total updrs score ( baseline )  mean ( sd ),C0439175;C3639721;C0439810,false;true;false,21418/22402
total updrs score ( range  $nmbr$ — $nmbr$ ) y,C0439175;C3639721;C0439810,false;true;false,21419/22402
total vdh - s score,C2964552,false,21420/22402
total vdh - s score ( $nmbr$ - $nmbr$ ) ( n ),C2964552,false,21421/22402
total !,C0439175;C0439810,false;false,21422/22402
total ! by baseline diabetic status,C0439175;C0168634;C0241863;C0449438;C1442488;C0439810,false;true;false;false;false;false,21423/22402
totalhdl cholesterol ratio,C0008377;C0456603;C1547037,true;false;false,21424/22402
toward,,,21425/22402
tpasi $nmbr$,,,21426/22402
tpm - exposed,C0076829,true,21427/22402
tpm - naive,C0076829,true,21428/22402
tpm subgroup  n = $nmbr$,C0076829;C1079230;C1515021,true;false;false,21429/22402
tr jet velocity ( m / sec ),C0108801;C0336862;C0439830;C0439493;C1547053;C1539482;C1705610;C1872943;C3811249;C3811250;C3814152,true;false;false;false;false;false;false;true;false;false;false,21430/22402
trait,C0599883,false,21431/22402
trandolapril,C0076891,true,21432/22402
trandolapril ( n = $nmbr$ ),C0076891,true,21433/22402
transaminases increased,C0002594;C0919834,true;false,21434/22402
transfemoral,,,21435/22402
transfusion,C0005841;C0199960;C1879316,true;false;false,21436/22402
transfusion ≥ $nmbr$ units rbcs or whole blood,C0005841;C0439148;C0014792;C1519795;C3853603;C0199960;C1879316,true;false;true;false;false;false;false,21437/22402
transfusions,C0005841;C0199960;C1879316,true;false;false,21438/22402
transient,C0040704;C0205374,true;false,21439/22402
transient ischaemic attack — no . ( % ),C0007787;C0917805,true;true,21440/22402
transient ischemic attack ( % ) type of lacunar syndrome ( % ),C0007787;C0332307;C3178801;C1547052;C0917805,true;false;true;false;true,21441/22402
transient st elevation,C0040704;C0520886;C0205374,true;false;false,21442/22402
transradial,,,21443/22402
treated at baseline,C1522326;C0168634;C1442488,false;true;false,21444/22402
treated at baseline  mean ( sd )  mm hg,C1522326;C0168634;C0444504;C2699239;C0439475;C2347634;C2348143;C1442488,false;true;false;false;false;false;false;false,21445/22402
treated at baseline  mm hg : sbp  mean ( sd ),C1522326;C0168634;C0439475;C0085805;C0444504;C2699239;C2347634;C2348143;C1442488,false;true;false;true;false;false;false;false;false,21446/22402
treated for hypertension  %,C1522326;C0020538;C1963138,false;true;false,21447/22402
treated lesions ‡,C1522326;C0221198,false;false,21448/22402
treated patients with baseline and $nmbr$ post - baseline ef ﬁ cacy measurement  bp value for treatment group comparison ( proactive intervention vs usual care ) was calculated based on a $nmbr$ - sample t test for continuous variables and chi - square test for categorical variables  cbp values were measured at baseline ( week $nmbr$ )  whereas information on all of the other variables listed was collected during screening . abbreviations : bmi  body mass index  bp  blood pressure  chd  coronary heart disease  crucial  cluster randomized usual care vs caduet investigation assessing long - term - risk  dbp  diastolic blood pressure  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  sd  standard deviation  sbp  systolic blood pressure  tc  total cholesterol  tg  triglyceride .,C0332293;C0030705;C0168634;C1442488;C0037623;C1522609;C0374505;C1707455;C0184661;C0886296;C1273869;C0039798;C2986530;C0087111;C0441833;C0237403;C0687744;C1257890;C1519504;C1522326;C1533734;C1705169;C1705428;C1705429;C3538994;C3887704;C1415692;C1708288;C4318478;C1947933;C0549178;C0439828;C0042295;C1305855;C0005823;C0280604;C0018787;C3542407;C0012641;C0443252;C0035647;C0428883;C0011849;C4552904;C0023822;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223;C0065055;C2699239;C0871420;C0085805;C0488055;C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122;C0871470;C1306620;C0201950;C0041004;C0543421,false;true;true;false;true;false;false;false;true;false;false;true;false;true;false;false;false;true;false;false;false;false;false;false;false;false;false;false;false;false;false;false;false;true;true;false;true;false;true;false;true;true;true;false;true;false;false;false;false;false;false;true;false;false;true;false;true;true;true;true;false;false;false;true;false;false;true;false,21449/22402
treated vessel ( s ),C1522326;C0005847,false;true,21450/22402
treated with atenolol ( n = $nmbr$ ),C0332293;C0004147,false;true,21451/22402
treated with laba  %,C0332293,false,21452/22402
treated with losartan ( n = $nmbr$ ),C0332293;C0126174,false;true,21453/22402
treatment - by - subgroup interaction,C0039798;C1079230;C1704675;C1515021;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,21454/22402
treatment - by - subgroup interaction  p = $nmbr$ . $nmbr$,C0039798;C1079230;C1704675;C1515021;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,21455/22402
treatment ( de vs warfarin ) by thrombophilia interaction,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,21456/22402
treatment after randomization  in the single - dummy phase — days ],C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,21457/22402
treatment and parameter,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,21458/22402
treatment arm ( zoledronate ) ( % ),C1522541;C0392938,false;true,21459/22402
treatment at baseline,C0039798;C0168634;C1442488;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,21460/22402
treatment at randomisation,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,21461/22402
treatment before catheterization,C0039798;C0007430;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,21462/22402
treatment before randomization — days,C0039798;C0034656;C0439228;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,21463/22402
treatment before randomization  %,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,21464/22402
treatment by subgroup interaction,C0039798;C1079230;C1704675;C1515021;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,21465/22402
treatment comparison,C0039798;C1707455;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,21466/22402
treatment comparison ( mg / day ) t,C0039798;C1707455;C0439422;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;true;false;false;false;false;false,21467/22402
treatment diff . vs tio ( $nmbr$ % ci ),C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,21468/22402
treatment difference % ( $nmbr$ % cl ),C0039798;C1705241;C0596019;C1705242;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;false;false;true;false;false;false;false;false,21469/22402
treatment duration before randomization — days,C0444921;C0034656;C0439228;C3259042,false;true;false;false,21470/22402
treatment duration mean ( sd ),C0444921;C0444504;C2699239;C2347634;C2348143;C3259042,false;false;false;false;false;false,21471/22402
treatment during or after catheterization,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,21472/22402
treatment effect ( hr ),C1518681,false,21473/22402
treatment for latent tuberculosis ^,C0039798;C1609538;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0205275;C0749724,true;true;true;false;false;false;false;false;false;false,21474/22402
treatment glargine,C0039798;C0907402;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,21475/22402
treatment group  on - treatment il - $nmbr$ threshold,C0039798;C0441833;C0020898;C0449864;C0021764;C0022271;C0687744;C1257890;C1519504;C1705428;C1705429;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;true;true;false;true;false;false;false;true;false;false;false;false;false,21476/22402
treatment groups  n ( % ),C0039798;C0441848;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;false;false;false;false;false,21477/22402
treatment period index dvt : event,C0039798;C0439531;C0600653;C0149871;C0441471;C4019010;C2926618;C3899446;C0918012;C1552854;C1637833;C2986546;C1948053;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;false;true;true;false;false;false;false;true;false;false;false;false;true;false;false;false;false;false,21478/22402
treatment randomization,C0039798;C0034656;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;false;false,21479/22402
treatment throughout study,C1521826;C3161471,false;false,21480/22402
treatment with any blood - pressure -,C0596197;C0033095;C0460139;C1306345;C4284008;C0039798;C0005823;C1271104;C1272641;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,false;true;false;false;false;true;true;false;true;true;false;false;false;false;false,21481/22402
treatment with sulphonylurea + biguanide  n ( % ),C0039798;C0038766;C0005382;C3537187;C4317165;C3536898;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;true;false;false;false;false;false,21482/22402
treatment with sulphonylurea + biguanide  n { % ),C0039798;C0038766;C0005382;C3537187;C4317165;C3536898;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;true;false;false;false;true;false;false;false;false;false,21483/22402
treatment with sulphonylurea  n ( % ),C0039798;C0038766;C3536898;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,21484/22402
treatment  n ( % ),C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,21485/22402
treatment   ×   lipid interaction,C0039798;C0023779;C1704675;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;true;false;false;false;false;false,21486/22402
treatments at randomisation,C0087111;C0034656,true;true,21487/22402
triacylglycerol  mmol / l  mean ( sd ),C0041004;C1532563;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,21488/22402
triacylglycerol  mmol / le,C0041004;C0439190;C0023190;C0439090;C1423767;C2697858,true;false;true;false;false;false,21489/22402
trial,C0008976,true,21490/22402
trial $nmbr$,C0008976,true,21491/22402
trial completers,C0008976,true,21492/22402
triglyceride ( mg / dl ) $nmbr$,C0041004;C0439269,true;false,21493/22402
triglyceride level,C0428475,false,21494/22402
triglyceride  mg / dl  mean ( sd ),C0041004;C0439269;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,21495/22402
triglycerides — mg / dl ^,C0041004;C0439269,true;false,21496/22402
triglycerides — mg / dl | |,C0041004;C0439269,true;false,21497/22402
triglycerides — mmol / l,C0041004;C1532563,true;false,21498/22402
triglycerides ( mmol / l ) ( median  iqr ),C0041004;C1532563;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,21499/22402
triglycerides ( mmol / l )  mean ( sd ),C0041004;C1532563;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,21500/22402
triglycerides ( sd )  mg / dl,C0041004;C2699239;C0439269,true;false;false,21501/22402
triglycerides > $nmbr$ mg / dl ( > $nmbr$ . $nmbr$ mmol / l ),C0041004;C0439269;C1532563,true;false;false,21502/22402
triglycerides at baseline,C0041004;C0168634;C1442488,true;true;false,21503/22402
triglycerides level  mg / dl,C0428475;C0439269,false;false,21504/22402
triglycerides mean,C0041004;C0444504;C2347634;C2348143,true;false;false;false,21505/22402
triglycerides  median ( iqr )  mg / dl,C0041004;C0549183;C0439269;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,21506/22402
triglycerides  median ( q $nmbr$ : q $nmbr$ ),C0041004;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false,21507/22402
triglycerides  median ( qi  q $nmbr$ )  mmol / l,C0041004;C0549183;C0376586;C1532563;C0876920;C2347635;C2348144;C2939193,true;false;true;false;false;false;false;false,21508/22402
triglycerides  mg / dl  median ( q $nmbr$ : q $nmbr$ ),C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193,true;false;false;false;false;false;false,21509/22402
triglycerides  mmol / l  mean ( sd ),C0041004;C1532563;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false;false,21510/22402
triglycerides  mmol / l ®,C0041004;C1532563,true;false,21511/22402
triglycerides  * mmol / l,C0041004;C1532563,true;false,21512/22402
troponin,C0041199,true,21513/22402
troponin ( - ),C0041199,true,21514/22402
troponin ( + ),C0041199,true,21515/22402
troponin negative ( n = $nmbr$ ),C0041199;C0205160;C1513916;C2825415;C2825491;C3853545,true;false;false;false;false;false,21516/22402
troponin positive ( n = $nmbr$ ),C0041199;C0439178;C1446409;C1514241;C2825490;C3812269,true;false;false;false;false;false,21517/22402
trough fev  response ( l ) i,C0444506;C3714541;C0871261;C0021966;C0221138;C1704632;C1706817;C2911692,false;true;false;true;false;false;false;false,21518/22402
trough fev | response ( l ),C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,21519/22402
trough fev $nmbr$,C0444506;C3714541,false;true,21520/22402
trough fev $nmbr$   response,C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,21521/22402
trough fvc response ( l ),C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,21522/22402
trough fvc response ( l ) !,C0444506;C3714541;C0871261;C1704632;C1706817;C2911692,false;true;false;false;false;false,21523/22402
trough seated dbp ( mmhg ) a,C0444506;C0277814;C0536221;C0439475;C3813197;C4281799;C1283233,false;true;true;false;false;false;false,21524/22402
trough seated hr ( bpm ) a,C0444506;C0277814;C1283233,false;true;false,21525/22402
trough seated sbp ( mmhg ) a,C0444506;C0277814;C0085805;C0439475;C1283233,false;true;true;false;false,21526/22402
tt,C1452561;C4554543,true;false,21527/22402
ttf - fv,C1332112;C1705840;C4087167,false;false;false,21528/22402
ttr ( warfarin arm only ),C0032923;C0043031;C0446516;C0205171;C1720467;C3715044;C4553528;C1421224,true;true;true;false;false;false;false;false,21529/22402
two - dimensional echocardiography,C0013524,true,21530/22402
two - sided p - value for hetero - geneity,C0205448;C0441987;C1709380,false;false;false,21531/22402
two lesions,C0205448;C0221198,false;false,21532/22402
two or more,C0205448,false,21533/22402
two or more antihypertensive medications,C0205448,false,21534/22402
two or more at baseline,C0205448,false,21535/22402
type,C0332307;C1547052,false;false,21536/22402
type $nmbr$ collagen  mean ( sd )  ng / ml £,C0332307;C0009325;C0444504;C2699239;C0439275;C2347634;C2348143;C1547052,false;true;false;false;false;false;false;false,21537/22402
type $nmbr$ diabetes — no . ( % ),C1320657,false,21538/22402
type $nmbr$ diabetes — no . ( % ) §,C1320657,false,21539/22402
type $nmbr$ diabetes — no . { % ) §,C1320657,false,21540/22402
type $nmbr$ diabetes meiiitus,C1320657,false,21541/22402
type $nmbr$ diabetes mellitus,C1320657,false,21542/22402
type $nmbr$ diabetes mellitus ' $nmbr$ ',C1320657,false,21543/22402
type $nmbr$ diabetes mellitus  n ( % ),C1320657,false,21544/22402
type $nmbr$ diabetes mellitusa,C1320657,false,21545/22402
type $nmbr$ diabetes pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ ),C1320657;C0031962,false;true,21546/22402
type $nmbr$ diabetes *,C1320657,false,21547/22402
type $nmbr$ diabetes  no . ( % ),C1320657,false,21548/22402
type $nmbr$ diabetes . n ( % ),C1320657,false,21549/22402
type b $nmbr$ / c lesions  n ( % ),C4264484,false,21550/22402
type ia,C0332307;C0020980;C0694634;C1947960;C1547052,false;true;false;false;false,21551/22402
type ib,C0332307;C2744579;C3890035;C4283819;C1547052,false;true;false;false;false,21552/22402
type ic,C0332307;C0020750;C4554818;C1547052,false;true;false;false,21553/22402
type ii diabetes,C0011860,true,21554/22402
type of af,C0332307;C0344434;C4049859;C1547052,false;false;false;false,21555/22402
type of af  n ( % ),C0332307;C0344434;C4049859;C1547052,false;false;false;false,21556/22402
type of antihypertensive medication use among patients using antihypertensive medications  n ( % ),C0332307;C0003364;C1524063;C1547052,false;true;false;false,21557/22402
type of atrial fibrillation,C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,21558/22402
type of atrial fibrillation - n ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,21559/22402
type of atrial fibrillation — no . / total no . ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,21560/22402
type of atrial fibrillation ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,21561/22402
type of atrial fibrillation ( n = $nmbr$ $nmbr$ ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,21562/22402
type of atrial fibrillation  n ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,21563/22402
type of atrial fibrillation  no . / total no . ( % ),C0332307;C0004238;C0344434;C1963067;C1547052,false;true;false;false;false,21564/22402
type of basal insulin  n ( % ),C0332307;C0650607;C1547052;C0205112;C0457592,false;false;false;false;false,21565/22402
type of event :,C1561488,false,21566/22402
type of hospital care,C0332307;C0259945;C1547052,false;false;false,21567/22402
type of hospitalization,C3177060,false,21568/22402
type of index event — no . ( % ),C1561488;C0600653;C0918012;C1552854;C1637833;C2986546,false;true;true;false;false;false,21569/22402
type of insulin,C0457592,false,21570/22402
type of insulin therapy — no . ( % ) $nmbr$,C0457592;C0039798;C0087111;C1363945,false;true;true;false,21571/22402
type of intervention,C3274412,false,21572/22402
type of lipid - lowering regimen,C0332307;C0023779;C0441994;C0040808;C2945654;C2003888;C1547052,false;true;false;true;false;false;false,21573/22402
type of ml  no . ( % ),C0332307;C0439526;C1705224;C3887665;C1547052,false;false;false;false;false,21574/22402
type of reference treatment strategy,C1514811;C0455708;C0679199;C1706462,false;false;false;false,21575/22402
type of surgery cabg,C0332307;C0038894;C0010055;C0038895;C0543467;C1274039;C1547052,false;false;true;true;true;true;false,21576/22402
type of surgery cabg only,C0332307;C0038894;C0010055;C0205171;C1720467;C0038895;C0543467;C1274039;C1547052,false;false;true;false;false;true;true;true;false,21577/22402
type of tnf antagonist failure  n ( % ) ' ’,C0332307;C1448177;C0231491;C0231174;C0680095;C1547052,false;true;false;false;false;false,21578/22402
type of tnf antagonist failure  n ( “ / o ) ”,C0332307;C1448177;C0231491;C0231174;C0680095;C1547052,false;true;false;false;false;false,21579/22402
type of tnf failure  n ( % ) b,C0332307;C3887647;C0231174;C0680095;C1547052,false;false;false;false;false,21580/22402
type / no . of valves repaired / replaced mitral,C0332307;C1547052,false;false,21581/22402
types of antihypertensive medications at $nmbr$ year   †,C0332307;C0003364,false;true,21582/22402
types of antihypertensive medications at last visit   §,C0332307;C0003364,false;true,21583/22402
u . s . black patients,C0041703;C0005680;C0030705;C0027567;C0085756;C0439541,true;true;true;true;true;false,21584/22402
u . s . non - black patients,C0041703;C1829939;C0005680;C0027567;C0085756;C0439541,true;false;true;true;true;false,21585/22402
ua ( n = $nmbr$ ),C0041580;C0042014,true;true,21586/22402
uacr,,,21587/22402
uacr — mg / g  median ( iqr ),C1300563;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,21588/22402
uacr ( mg / g  median [ iqr ] ),C1300563;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,21589/22402
uacr   < $nmbr$   mg / mmol ∗,C0567349;C2348885,false;false,21590/22402
uacr   ≥ $nmbr$   mg / mmol ∗,C0567349;C2348885,false;false,21591/22402
uacr *  mg / g ( q $nmbr$  q $nmbr$ ),C1300563,false,21592/22402
uacr  median ( iqr )  mg / g,C0549183;C1300563;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,21593/22402
uacr  mg / g  median ( $nmbr$ th − $nmbr$ th percentile ),C1300563;C0549183;C0039725;C1264641;C0039738;C1420718;C4282123;C4285344;C0876920;C2347635;C2348144;C2939193,false;false;true;false;true;false;false;false;false;false;false;false,21594/22402
uacr  mg / g  median ( iqr ),C1300563;C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false;false,21595/22402
uacr  n ( % ) †,,,21596/22402
uacr  pg / mg,C1627892,false,21597/22402
uas $nmbr$ {,,,21598/22402
uas $nmbr$,,,21599/22402
uc,,,21600/22402
uc ( n   =   $nmbr$ ),,,21601/22402
uc [ gemini $nmbr$ ] ‘,,,21602/22402
uc disease duration ( y ),C0872146,false,21603/22402
uc disease durslion,C0012634,true,21604/22402
uc history,C0019664;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;false;false;false,21605/22402
ucl,,,21606/22402
udy entry,C1705654,false,21607/22402
ufh only,C0205171;C1720467,false;false,21608/22402
ugt induction status : as randomizeda  n ( % ),C1420188;C0205263;C0449438;C0857127;C4284131,false;false;false;false;false,21609/22402
ugt induction status : per aeda  n ( % ),C1420188;C0205263;C0449438;C0857127;C4284131,false;false;false;false;false,21610/22402
uistekinumab,,,21611/22402
ulcer,C0041582;C3887532,true;false,21612/22402
ulcer  n ( % ) a,C0041582;C3887532,true;false,21613/22402
ulpasi $nmbr$,,,21614/22402
umec $nmbr$ . $nmbr$ | ig ( n = $nmbr$ ),C0021027;C0305052;C0360506,true;false;false,21615/22402
umec $nmbr$ . $nmbr$ mcg ( n = $nmbr$ ),C0439211;C3463985,false;false,21616/22402
umec / vi $nmbr$ . $nmbr$ / $nmbr$,C0205999,true,21617/22402
umec / vi $nmbr$ . $nmbr$ / $nmbr$ ( n $nmbr$ $nmbr$ ),C0205999,true,21618/22402
umied,,,21619/22402
unacceptable side effects,C1883420;C0001688;C0877248;C0879626,false;true;false;false,21620/22402
unadjusted $nmbr$ - y risk per $nmbr$ population = se ( adjusted rate ),C1439367;C0242444;C0036919;C0456081;C0871208;C1521828;C2987720,false;true;true;false;false;false;false,21621/22402
unadjusted hazard ratio ( $nmbr$ % ci ),C1439367;C2985465;C0008107;C3259781,false;false;true;false,21622/22402
unadjusted hazard ratio ( $nmbr$ % cl ),C1439367;C2985465;C0596019,false;false;false,21623/22402
unadjusted hr ( $nmbr$ % ci ) for $nmbr$ sd increment,C1439367;C0008107;C2699239;C1705117;C3259781,false;true;false;false;false,21624/22402
unadjusted hr ( $nmbr$ % ci ) for $nmbr$ standard deviation increment,C1439367;C0008107;C0871420;C1705117;C3259781,false;true;false;false;false,21625/22402
unadjusted hr ( $nmbr$ % ci ) a,C1439367;C0008107;C3259781,false;true;false,21626/22402
unadjusted model hr  $nmbr$ % ci  p value,C1439367;C3161035;C0008107;C1709380;C3259781;C3274659;C3714583;C3853906,false;false;true;false;false;false;false;false,21627/22402
unadjusted p value,C1439367;C1709380,false;false,21628/22402
unadjusteda beta ( se ),C0330390;C0036919;C0439096;C2004068,false;true;false;false,21629/22402
unclassified,C0205426;C1546437;C2347854;C4085229,false;false;false;false,21630/22402
uncontrolled on basal insulin,C0205318;C0650607,false;false,21631/22402
uncontrolled on oad ( s ),C0205318,false,21632/22402
uncontrolled : acq - $nmbr$ > $nmbr$ . $nmbr$,C0205318;C2919686,false;false,21633/22402
uncover - $nmbr$,,,21634/22402
underlying disease,C4067746;C0012634,false;true,21635/22402
undetermined,C0205258;C3536725;C4082977,false;false;false,21636/22402
undetermined etiology  n ( % ),C0478157,false,21637/22402
undeterminedc,,,21638/22402
undiagnosed diabetes mellitus,C1408353;C0011849,false;true,21639/22402
undiagnosed diabetes mellitus  n = $nmbr$,C1408353;C0011849,false;true,21640/22402
unfractionated heparin — no . ( % ),C0019134;C2825026,true;false,21641/22402
unfractionated heparin ( n = $nmbr$  $nmbr$ ),C0019134;C2825026,true;false,21642/22402
unfractionated heparin only,C0019134;C0205171;C1720467;C2825026,true;false;false;false,21643/22402
unfractionated heparin or enoxaparin plus glycoprotein iib / iiia inhibitors ( n = $nmbr$ ),C0019134;C2825026,true;false,21644/22402
unfractionated heparin within $nmbr$ hr before randomization — no . / total no . ( % ),C0019134;C2825026,true;false,21645/22402
unfractionated only,C0205171;C1720467,false;false,21646/22402
unhappy,C1688635,false,21647/22402
unified parkinson disease,C1548174;C0030567;C1521736;C1706076,false;true;false;false,21648/22402
united states ( n   = $nmbr$  $nmbr$ ),C0041703,true,21649/22402
united states and canada,C0041703,true,21650/22402
united states  canada,C0041703;C0006823,true;true,21651/22402
uniti - $nmbr$,,,21652/22402
uniti - $nmbr$ and uniti - $nmbr$ im - uniti,,,21653/22402
univariable,,,21654/22402
univariable or ( $nmbr$ % ci )  p value *,,,21655/22402
univariate logistic modela,C0242415,true,21656/22402
unknown — no . { % ),C0439673;C3541433;C4050014,false;false;false,21657/22402
unknown ( % ),C0439673;C3541433;C4050014,false;false;false,21658/22402
unknown / missing,C0439673;C3541433;C4050014,false;false;false,21659/22402
unprovoked vte n ( % ),C0630906,true,21660/22402
unrelated to effectiveness,C0445356;C1280519;C4553491;C1704623,false;false;false;false,21661/22402
unstable,C0443343;C1883468,false;false,21662/22402
unstable angina ( n = $nmbr$  $nmbr$ ),C0002965,true,21663/22402
unstable angina requiring hospitalization,C0002965;C0019993,true;true,21664/22402
unstable but no rest angina,C0443343;C1883468,false;false,21665/22402
untreated,C0332155,false,21666/22402
untreated at baseline,C0332155;C0168634;C1442488,false;true;false,21667/22402
untreated at baseline  mean ( sd )  mm hg,C0332155;C0168634;C0444504;C2699239;C0439475;C2347634;C2348143;C1442488,false;true;false;false;false;false;false;false,21668/22402
untreated at baseline  mm hg : sbp  mean ( sd ),C0332155;C0168634;C0439475;C0085805;C0444504;C2699239;C2347634;C2348143;C1442488,false;true;false;true;false;false;false;false;false,21669/22402
upa $nmbr$ mg qd,C0042071;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1706177,true;true;false;true;false;false;false;false;false;false,21670/22402
upadacitinib $nmbr$ mg ( n = l $nmbr$ ),C0439268,false,21671/22402
upcr  n ( % ),,,21672/22402
updrs iii ( motor ),C3639721;C0439070;C1513492;C1705994;C1705160,true;false;false;false;false,21673/22402
updrs score,C3639721,true,21674/22402
updrs total ( ii + iii ),C3639721;C0439175;C1710602;C0439070;C1705160;C4082587;C0439810,true;false;false;false;false;false;false,21675/22402
updrs  part ii ( adl ),C3639721;C0449719;C1710602;C0001288;C1420005;C4082587;C1709471,true;false;false;true;false;false;false,21676/22402
updrs  part iii ( motor ),C3639721;C0449719;C0439070;C1513492;C1705994;C1705160;C1709471,true;false;false;false;false;false;false,21677/22402
uplift ® population,C0032659;C1257890,true;true,21678/22402
upper abdominal pain,C0232492,false,21679/22402
upper gastrointestinal tract,C3203348,true,21680/22402
upper limb,C1140618,true,21681/22402
upper limbs,C1140618,true,21682/22402
upper respiratory tract inflammation,C0877266,false,21683/22402
upper tertile : > $nmbr$ . $nmbr$,C1282910,false,21684/22402
ups score  mean ( sd ),C0334463;C3542434,true;false,21685/22402
ure,,,21686/22402
urgency episodes / $nmbr$ h,C0439609;C0332189;C0033727;C0369286;C0441932;C0564385;C4528284,false;false;true;false;false;false;false,21687/22402
urgent peripheral revascularization,C0439609;C0205100;C0581603;C3272275,false;false;false;false,21688/22402
urgent revascularisation due to unstable angina,C0439609;C0581603;C0678226;C0002965;C3272275,false;false;false;true;false,21689/22402
urgent revascularizati on,C0439609;C3272275,false;false,21690/22402
urgent revascularization because of unstable angina,C0439609;C0581603;C0002965;C3272275,false;false;true;false,21691/22402
urgent surgery,C2188405,false,21692/22402
urgent vascular hospitalization,C0439609;C0005847;C0019993;C1558950;C1801960;C3272275,false;true;true;false;false;false,21693/22402
urinary acr,C0042027;C1412134;C1515941;C1524119,true;false;false;false,21694/22402
urinary acr ( mg / mmol ),C0042027;C1412134;C0567349;C2348885;C1515941;C1524119,true;false;false;false;false;false,21695/22402
urinary albumin - to - creatinine ratio — no . ( % ) §,C0455271;C1318330,false;false,21696/22402
urinary albumin - to - creatinine ratio §,C0455271;C1318330,false;false,21697/22402
urinary albumin : creatinine ratio ^,C0455271;C1318330,false;false,21698/22402
urine acr ( mg / mmol ),C0042036;C1412134;C0567349;C2348885;C1515941;C0042037;C2963137,true;false;false;false;false;true;false,21699/22402
urine acr < median,C0042036;C1412134;C0549183;C0876920;C2347635;C2348144;C2939193;C1515941;C0042037;C2963137,true;false;false;false;false;false;false;false;true;false,21700/22402
urine acr > = median,C0042036;C1412134;C0549183;C0876920;C2347635;C2348144;C2939193;C1515941;C0042037;C2963137,true;false;false;false;false;false;false;false;true;false,21701/22402
urine acr geometric mean ( cv % )  a  b mg / g,C0042036;C1412134;C2986759;C3538987;C1300563;C4048877;C4318503;C1515941;C0042037;C2963137,true;false;false;false;false;true;false;false;true;false,21702/22402
urine albumin - to - ereatinine ratio,C1273442;C0001924;C0042038;C0456603;C1547037;C0587185;C2362049,false;true;false;false;false;false;false,21703/22402
urine albumin / creatinine ( mg / mmol ),C0455271;C0567349;C2348885;C1318330,false;false;false;false,21704/22402
urine albumin / creatinine ratio  mg / mmol,C0455271;C0567349;C2348885;C1318330,false;false;false;false,21705/22402
urine p / cr,C0042036;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337;C0042037;C2963137,true;false;false;true;false;false;false;true;false,21706/22402
urine qmax  ml / s,C0042036;C0439390;C0042037;C2963137,true;false;true;false,21707/22402
urticaria,C0042109;C1559188,true;false,21708/22402
us n = $nmbr$,C0369718;C0441922,false;false,21709/22402
us site,C0205145;C1515974;C2825164,false;false;false,21710/22402
us w = $nmbr$,,,21711/22402
usa ( n = $nmbr$  $nmbr$ ),C0041703,true,21712/22402
usa / canada,C0041703;C0006823,true;true,21713/22402
use ( % ),C0042153;C0457083;C1947944,true;false;false,21714/22402
use at baseline,C0042153;C0168634;C1442488;C0457083;C1947944,true;true;false;false;false,21715/22402
use at baseline  n,C0042153;C0168634;C1442488;C0457083;C1947944,true;true;false;false;false,21716/22402
use of ace inhibitors / arbs  n ( % ),C1524063;C0003015;C3888198,false;true;false,21717/22402
use of anti - hypertensive agents  n ( % ) *,C1524063;C0432633;C0857121;C0450442;C1254351;C1521826,false;false;false;false;false;false,21718/22402
use of antiplatelet agents — no . / total no . ( % ),C1524063;C0085826,false;true,21719/22402
use of antiplatelet agents  n ( % ),C1524063;C0085826,false;true,21720/22402
use of aspirin at time of qualifying event ( % ),C1524063;C0004057,false;true,21721/22402
use of cgm ( yes ),C1524063;C1549445;C1705108;C1710701,false;false;false;false,21722/22402
use of cgm interaction test p - value ^ =,C1524063;C1704675;C0022885;C1709380;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744,false;false;false;false;false;false;false;false;false;false,21723/22402
use of clopidogrel,C1524063;C0070166,false;true,21724/22402
use of diuretics  n ( % ),C1524063;C0012798,false;true,21725/22402
use of h $nmbr$ bloekers  n ( % ),C1524063;C0033727;C0369286;C0441932;C0564385;C4528284,false;true;false;false;false;false,21726/22402
use of high - dose inhaled glucocorticoid — no . { % ),C1524063;C0444956,false;false,21727/22402
use of ics at baseline  %,C1524063;C0815320;C4551720,false;false;true,21728/22402
use of inhaled glucocorticoids at baseline,C1524063;C0004048;C0017710;C3540777;C3540778,false;true;true;false;false,21729/22402
use of loop diuretics,C1524063;C0354100,false;true,21730/22402
use of low - dose aspirin ( < $nmbr$,C1524063;C2608320,false;false,21731/22402
use of low - dose aspirin ( < $nmbr$ mg daily ),C1524063;C2608320;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,false;false;true;false;true;false;false;false;false;false,21732/22402
use of medication for pah,C1524063;C0013227;C3244316;C4284232,false;true;false;false,21733/22402
use of medication from randomization through $nmbr$ hr — no . / total no . ( % ),C1524063;C0013227;C3244316;C4284232,false;true;false;false,21734/22402
use of methotrexate at randomization —,C1524063;C0025677,false;true,21735/22402
use of oral glucocorticoids,C1524063;C0442027;C0017710;C3540777;C3540778;C4521986,false;false;true;false;false;false,21736/22402
use of pci or thrombolysis within one day of randomization,C1524063;C4049621,false;false,21737/22402
use of proton inhibitors  n ( % ),C1524063;C0033727;C0243077,false;true;true,21738/22402
use of statin at any follow - up visit ( % ),C1524063;C0360714,false;true,21739/22402
use of systemic glucocorticoid at random -,C1524063;C0205373;C0017710,false;false;true,21740/22402
use of ticagrelor,C1524063;C1999375,false;true,21741/22402
use of verapamil or quinidine,C1524063;C0042523,false;true,21742/22402
used,C1273517,false,21743/22402
user,C1548600;C1706077,false;false,21744/22402
using alendronate at baseline ( % ),C1524063,false,21745/22402
using hrt or raloxifene at baseline ( % ),C1524063,false,21746/22402
usteki,,,21747/22402
ustekinu,,,21748/22402
ustekinumab,C1608841,true,21749/22402
ustekinumab ' ’ ( n = $nmbr$ ),C1608841,true,21750/22402
ustekinumab $nmbr$ mg ( n = $nmbr$ ),C1608841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21751/22402
ustekinumab combined,C1608841,true,21752/22402
ustekinumab ® ( n = $nmbr$ ),C1608841,true,21753/22402
usual care,C3538928;C1947933,false;false,21754/22402
utis,C0042029,true,21755/22402
uveitis,C0042164;C1963266,true;false,21756/22402
v $nmbr$ ( n = $nmbr$,,,21757/22402
valdecoxib,C0913246,true,21758/22402
valsartan n / n,C0216784,true,21759/22402
value for nteraction,C1522609,false,21760/22402
values are mean ± sd  median [ quartile range ]  or % . ace indicates angiotensin - converting enzyme  arb  angiotensin receptor blocker  bnp  b - type natriuretic peptide  bp  blood pressure  bun  blood urea nitrogen  lvef  left ventricular ejection fraction  and nt - probnp  n - terminal pro - b - type natriuretic peptide .,C0042295;C0022709;C3888198;C0597357;C0054015;C0332307;C1547052;C1095989;C1417808;C2982014;C1452534;C1144709;C0005823;C0600137;C0428772;C0488728;C1291218;C3683557;C2709270;C3537020;C0428772;C0488728;C0054015;C1095989,false;true;false;false;true;false;false;false;false;false;true;true;true;false;false;false;false;false;false;false;false;false;true;false,21761/22402
values are presented as mean sd unless stated otherwise . data shown are for the randomized population . * body mass index values were missing from $nmbr$ patients in the aliskiren group and $nmbr$ patients in the hydrochlorothiazide group . † obesity was defined as body mass index $nmbr$ kg / m $nmbr$ . ‡ metabolic syndrome was defined according to the third report of the national cholesterol education program expert panel on detection  evaluation  and treatment of high blood cholesterol in adults ( adult treatment panel iii ) criteria $nmbr$ as any $nmbr$ of the following : waist circumference $nmbr$ cm for men or $nmbr$ cm for women  triglycerides $nmbr$ mg / dl  high - density lipoprotein cholesterol $nmbr$ mg / dl for men or $nmbr$ mg / dl for women  mssbp $nmbr$ mm hg or msdbp $nmbr$ mm hg  fasting glucose $nmbr$ mg / dl . § by medical history . aliskiren  n $nmbr$  hydrochlorothiazide  n $nmbr$ .,C0042295;C1547282;C0020261;C0441833;C0028754;C1963185;C0687744;C1257890;C1519504;C1705428;C1705429;C0600653;C1532718;C0524620;C0918012;C1552854;C1637833;C2986546;C0205437;C1511790;C0220825;C1261322;C0001675;C0039798;C0441833;C0439070;C0243161;C1705160;C1706365;C1999270;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C0231290;C0332282;C0041004;C0024671;C3539687;C0023822;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0025266;C0439475;C0015663;C0017725;C0439269;C0262926;C1704706;C2241628,false;false;true;false;true;false;false;true;false;false;false;true;false;true;true;false;false;false;false;false;false;false;true;true;false;false;true;false;false;false;true;false;false;false;false;false;false;false;true;true;false;true;true;false;false;false;false;false;true;false;true;true;false;false;false;false,21762/22402
values expressed as mean sd or number ( percent ) . * two patients were missing values for body mass index . † other forms of atherosclerosis are peripheral arterial disease  abdom - inal aortic aneurysm  symptomatic carotid artery disease  transient isch - emic attack  and stroke . ‡ family history of premature chd de ﬁ ned as chd in male ﬁ rst - degree relative aged $nmbr$ years or female ﬁ rst - degree relative $nmbr$ years . § blood pressure $nmbr$ / $nmbr$ mm hg  on antihypertensive medication  or diagnosis of hypertension based on medical history . n number of randomly assigned patients  ncep atp national cholesterol education program adult treatment panel .,C0042295;C0003850;C0004153;C0007273;C0040704;C0277793;C1261512;C1304680;C0205374;C0019664;C0151526;C0280604;C0011198;C1518340;C0017480;C3541240;C3542407;C0205252;C4018905;C0019665;C0262512;C0262926;C1705255;C2004062;C1425219;C0441889;C0080103;C0001779;C0439234;C0001792;C1999167;C0205345;C1547039;C0449286;C0542560;C2348088;C0439234;C0005823;C0439475;C0003364;C1271104;C1272641;C0020538;C1963138;C1516050;C0030688;C2744579;C3245503;C0008377;C0679841;C0001675;C1706450;C4552600;C1552601;C0441833;C1706365;C1999270,false;true;true;true;true;false;false;false;false;true;true;false;true;false;true;false;false;false;false;true;false;false;false;false;false;false;true;false;false;true;false;false;false;false;false;false;false;true;false;true;false;true;true;false;false;true;true;false;true;false;true;false;false;false;false;false;false,21763/22402
values were calculated using t tests for continuous variables and chi - square,C0042295,false,21764/22402
values were reported for $nmbr$ patients in the spironolactone group and $nmbr$,C0042295,false,21765/22402
valve repair / replacement only,C0184252;C0043240;C0035139;C0205171;C1720467;C0559956;C1555302;C4553149;C0374711;C4319951;C1186983;C1704414;C3888056,false;true;true;false;false;false;false;false;false;false;false;false;false,21766/22402
valve repair / replacement with or without cabg,C0184252;C0043240;C0035139;C0559956;C1555302;C4553149;C0374711;C4319951;C1186983;C1704414;C3888056,false;true;true;false;false;false;false;false;false;false;false,21767/22402
valve replacement / repair with or without cabg,C0184252;C0035139;C0043240;C0374711;C4319951;C0559956;C1555302;C4553149;C1186983;C1704414;C3888056,false;true;true;false;false;false;false;false;false;false;false,21768/22402
valvular disease  mitral,C3258293,false,21769/22402
valvular heart disease,C0018824;C1963123,true;false,21770/22402
valvular heart disease — no . ( % ),C0018824;C1963123,true;false,21771/22402
valvular heart disease  n ( % ),C0018824;C1963123,true;false,21772/22402
varespladib,C2713485,true,21773/22402
variable ' ! ',C0439828;C4553760,false;false,21774/22402
variable demographic characteristics,C0439828;C0683970;C4553760,false;false;false,21775/22402
variable_level,C0439828;C0441889;C0456079;C1547707;C2946261;C4553760,false;false;false;false;false;false,21776/22402
variables,C0439828,false,21777/22402
variables *,C0439828,false,21778/22402
variables .,C0439828,false,21779/22402
variables $nmbr$,C0439828,false,21780/22402
vascular access site †,C0750138;C0205145;C1515974;C2825164;C0005847;C0589360;C1558950;C1801960,false;false;false;false;true;false;false;false,21781/22402
vascular accidents  n ( % ),C0005847;C0000924;C1558950;C1801960,true;true;false;false,21782/22402
vascular death,C0005847;C0011065;C1306577;C4082313;C4552775;C1558950;C1801960,true;true;false;false;false;false;false,21783/22402
vascular disease,C0042373,true,21784/22402
vascular disease ( % of group ),C0042373;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429,true;false;false;true;false;false;false,21785/22402
vascular risk score — no . { % ) ^,C0005847;C0035647;C4552904;C1558950;C1801960,true;true;false;false;false,21786/22402
vascular risk score |,C0005847;C0035647;C0449820;C4050231;C4552904;C1558950;C1801960,true;true;false;false;false;false;false,21787/22402
vascular risk score *,C0005847;C0035647;C0449820;C4050231;C4552904;C1558950;C1801960,true;true;false;false;false;false;false,21788/22402
vasodilator,C0042402;C3537240,true;false,21789/22402
vasodilator therapy,C0042402;C0039798;C0087111;C1363945;C3537240,true;true;true;false;false,21790/22402
vasp pri - defined hpr ( % patients ),C0255567;C0034044;C1826843;C3539761;C3539762;C1421428,true;true;false;false;false;false,21791/22402
vdz n = \ $nmbr$,,,21792/22402
vdz n = $nmbr$,,,21793/22402
vdz / pbo [ n = $nmbr$ ],C0031962,true,21794/22402
vdz / pla n = $nmbr$,C0456170,false,21795/22402
vdz / vdz [ n = $nmbr$ ],,,21796/22402
vedolizumab cohort $nmbr$ ( n = $nmbr$ ),C2742797;C0009247;C0599755,true;true;false,21797/22402
vedolizumab n = $nmbr$,C2742797,true,21798/22402
vein bypass stented,C0042449;C0741847,true;false,21799/22402
verapamil ( n  % ),C0042523,true,21800/22402
verapamil sr ( no . = $nmbr$ ),C1527129,false,21801/22402
verifynow pru - defined hpr ( % patients ),C1704788;C1337105;C0030705;C3539106,false;false;true;false,21802/22402
versus tiotropium $nmbr$ pg tiotropium + olodaterol $nmbr$ - $nmbr$ / $nmbr$ pg,,,21803/22402
versus tiotropium $nmbr$ pg tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ pg,,,21804/22402
vertebral fracture and / or t score - $nmbr$ . $nmbr$,C0080179,true,21805/22402
vertebral fracture and / or t score s - $nmbr$ . $nmbr$,C0080179,true,21806/22402
vertebral fractures at baseline,C0080179;C0168634;C1442488,true;true;false,21807/22402
very elderly patients ( n - $nmbr$ ),C0442824;C0870602;C2984081,false;false;false,21808/22402
very g ood / ex cellent,C0442824;C0439267;C4267693;C2984081,false;false;false;false,21809/22402
very good or excellent,C3641222,false,21810/22402
very high,C0442804;C4321397,false;false,21811/22402
very high ( >   $nmbr$ xuln ) n   =   $nmbr$,C0442804;C4321397,false;false,21812/22402
very high vs . normal,C0442804;C4321397,false;false,21813/22402
very high vs . normalb,C0442804;C4321397,false;false,21814/22402
very severe ( itt ) ( n = $nmbr$ ),C3641272;C4050419,false;false,21815/22402
very severe copd,C3641272;C0024117;C1412502;C3714496;C4050419,false;true;false;false;false,21816/22402
very severe  gold $nmbr$,C3641272;C0018026;C1304897;C4050419,false;true;false;false,21817/22402
vhd,,,21818/22402
vhd event rate / year ( n ),C0441471;C0871208;C0439234;C0439508;C1521828;C4019010,false;false;false;false;false;false,21819/22402
vi - $nmbr$ % ( - $nmbr$ %  $nmbr$ % ),C0205999,true,21820/22402
vi – $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % ),C0205999;C0008107;C3259781,true;true;false,21821/22402
vi $nmbr$ % ( - $nmbr$ %  $nmbr$ % ),C0205999,true,21822/22402
vi $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % ),C0205999;C0008107;C3259781,true;true;false,21823/22402
vi $nmbr$ % ( $nmbr$ % ci $nmbr$ – $nmbr$ % ),C0205999;C0008107;C3259781,true;true;false,21824/22402
vi $nmbr$   µ g,C0205999;C0439267,true;false,21825/22402
viidagliptin $nmbr$ mg daily + glimepiride,C0024671;C0332173;C0061323;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;false;true;true;false;false;false;false;false,21826/22402
vildagliptin + metformin ( vldm ),C1570906;C0025598,true;true,21827/22402
vildagliptin $nmbr$ mg daily,C1570906;C0024671;C0332173;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;false;false;false;false;false,21828/22402
vildagliptin $nmbr$ mg daily + glimepiride,C1570906;C0024671;C0332173;C0061323;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;false;true;true;false;false;false;false;false,21829/22402
visit,C0545082;C1512346;C2826704,false;false;false,21830/22402
visit $nmbr$ blood pressures :,C0545082;C1272641;C1512346;C2826704,false;true;false;false,21831/22402
visit $nmbr$ dbp  mm hg,C0545082;C0536221;C0439475;C3813197;C4281799;C1512346;C2826704,false;true;false;false;false;false;false,21832/22402
visit $nmbr$ sbp  mm hg,C0545082;C0085805;C0439475;C1512346;C2826704,false;true;false;false;false,21833/22402
vital signs  mean ( sd ),C0150404;C0444504;C2699239;C2347634;C2348143;C0518766,false;false;false;false;false;true,21834/22402
vitamin c,C0003968;C2349136;C3714687;C4522080,true;false;false;false,21835/22402
vitamin d §,C0014695;C0042866;C2936842;C3537249;C3714503,true;true;false;false;false,21836/22402
vitamin k antagonist experienced  n ( % ),C1096489;C2267235,false;false,21837/22402
vitamin k antagonist experiencedk ( n = $nmbr$ $nmbr$ ),C1096489;C2267235,false;false,21838/22402
vitamin k antagonist naive,C1096489;C2267235,false;false,21839/22402
vitamins,C0042890;C3540032;C3714649,true;false;false,21840/22402
vka ( n   = $nmbr$ ),,,21841/22402
vka at randomization,C0034656,true,21842/22402
vka experienced,,,21843/22402
vka naive,,,21844/22402
vka naive  n ( % ),,,21845/22402
vka naxve,,,21846/22402
vldl - c,C0523560,false,21847/22402
vldm n = $nmbr$,,,21848/22402
voided volume  ml,C0042034;C0449468;C0439526;C1705224;C3887665;C1690016;C1705102;C2700258;C1552835,true;false;false;false;false;false;false;false;false,21849/22402
voiding subscore,C0042034;C4067975,true;false,21850/22402
volume change  mm ^,C0449468;C0392747;C4330985;C4554674;C0443172;C1705241;C4319952;C1690016;C1705102;C2700258,false;false;false;false;false;false;false;false;false;false,21851/22402
volume depletion - related aes,C0546884;C0439849;C1412268;C2699274;C0445223,true;false;false;false;false,21852/22402
volumetric bmd by qct,C0445383;C0412669,false;false,21853/22402
voluntary,C0439656;C3543419,false;false,21854/22402
vonoprazan $nmbr$ mg n = $nmbr$,C4080009;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761,true;true;true;false;false;false;false;false,21855/22402
vorapaxar,C2974521,true,21856/22402
vorapaxar ( n = $nmbr$ ),C2974521,true,21857/22402
vorapaxar no . ( $nmbr$ - y km % ),C2974521,true,21858/22402
vorapaxar placebo,C2974521;C0032042;C1696465;C1706408,true;true;false;false,21859/22402
vorapaxar ( n = $nmbr$ )  n ( % ),C2974521,true,21860/22402
vs . placebo,,,21861/22402
vs . warfarin,,,21862/22402
vte / vte - related deathsa  n / n ( % ),C0630906;C0439849;C0445223,true;false;false,21863/22402
vte / vte - related deathsb  n / n ( % ),C0630906;C0439849;C0445223,true;false;false,21864/22402
w europe,C0015176,true,21865/22402
w hite,,,21866/22402
wafarin,,,21867/22402
wafarin event incidence / n,C0441471;C0021149;C0220856;C4019010,false;true;true;false,21868/22402
waist circumference — cmj,C0455829,true,21869/22402
waist circumference ( cm ) : mean ± sd,C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,21870/22402
waist circumference women : > $nmbr$ in ( $nmbr$ cm ) men : > $nmbr$ in ( $nmbr$ cm ) tc $nmbr$ c $nmbr$ mg / dl,C0455829;C0043210;C0025266,true;true;true,21871/22402
waist circumference  cm  mean ( sd ),C0455829;C0444504;C2699239;C2347634;C2348143,true;false;false;false;false,21872/22402
waist circumference .,C0455829,true,21873/22402
waist / hip < median,C0230097;C0019552;C0549183;C0876920;C2347635;C2348144;C2939193;C0022122;C1505163;C3538851;C4284725,false;true;false;false;false;false;false;true;true;false;false,21874/22402
waist : hip ratio,C0205682,true,21875/22402
waisvhip > = median,C0549183;C0876920;C2347635;C2348144;C2939193,false;false;false;false;false,21876/22402
walk for exercise,C0080331;C0015259;C1522704,true;true;false,21877/22402
walk for exercise ( % ),C0080331;C0015259;C1522704,true;true;false,21878/22402
walking,C0080331;C4283795;C4321241;C4321242,true;false;false;false,21879/22402
war,C0043027,true,21880/22402
warf,C0043031,true,21881/22402
warfarin % ( n / n ),C0043031,true,21882/22402
warfarin ( % ),C0043031,true,21883/22402
warfarin ( n - $nmbr$  $nmbr$ ),C0043031,true,21884/22402
warfarin ( n = $nmbr$ )  n ( % / y ),C0043031,true,21885/22402
warfarin ( s $nmbr$ % cl ),C0043031;C0596019,true;false,21886/22402
warfarin events / n ( % / y ),C0043031;C0441471;C3541888,true;false;false,21887/22402
warfarin n = $nmbr$,C0043031,true,21888/22402
warfarin n = $nmbr$ n / n ( % ),C0043031,true,21889/22402
warfarin n / n  rate ( % ),C0043031;C0871208;C1521828,true;false;false,21890/22402
we recorded no significant interactions for any subgroup analysis . nyha = new york heart association . lvef = left ventricular ejection fraction . ' $nmbr$ % cl was calculated by cox proportional hazards model . tmedian value . data for total cholesterol were available for $nmbr$ patients ( $nmbr$ rosuvastatin  $nmbr$ placebo ) .,C0027976;C0018787;C0004083;C0428772;C0596019;C0439849;C0596306;C0699792;C0201950;C0543421,true;true;true;false;false;false;false;false;false;false,21891/22402
we recorded no significant interactions for any subgroup analysis . pufa = polyunsaturated fatty acids . nyha = new york heart association . lvef = left ventricular ejection fraction . * $nmbr$ % cl was calculated with a cox proportional hazards model . tmedian value . data for total cholesterol were available for $nmbr$ patients ( $nmbr$ n - $nmbr$ pufa  $nmbr$ placebo ) .,C0032615;C1275491;C0027976;C0018787;C0004083;C0428772;C0488728;C0439849;C0596306;C0699792;C0042508;C0596019;C0018623;C1704610;C0201950;C0543421;C0030705;C0032615;C0032042;C1696465;C1706408,true;false;true;true;true;false;false;false;false;false;true;false;true;false;false;false;true;true;true;false;false,21892/22402
week,C0332174;C0439230,false;false,21893/22402
week - $nmbr$ changea,C0332174;C4349366;C0439230,false;false;false,21894/22402
week $nmbr$ — mg / liter,C0332174;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;false;true;false;false;false;false;false;false,21895/22402
week $nmbr$ czp $nmbr$ mg q $nmbr$ w,C0332174;C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109;C0439230,false;true;true;true;false;false;false;false;false;true;true;false,21896/22402
week $nmbr$ czp $nmbr$ mg q $nmbr$ w ( n = $nmbr$ ),C0332174;C0054841;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1861828;C1872109;C0439230,false;true;true;true;false;false;false;false;false;true;true;false,21897/22402
week $nmbr$ czp dose combined,C0332174;C0054841;C0178602;C0869039;C1114758;C1861828;C1872109;C0439230,false;true;false;false;false;true;true;false,21898/22402
week $nmbr$ czp dose combined ( n   =   $nmbr$ ),C0332174;C0054841;C0178602;C0869039;C1114758;C1861828;C1872109;C0439230,false;true;false;false;false;true;true;false,21899/22402
week $nmbr$ mayo endoscopy subscorea,C0332174;C0454788;C0014245;C1077578;C0439230,false;false;true;false;false,21900/22402
week $nmbr$ mean ± sem,C0332174;C0444504;C2347634;C2348143;C0439230,false;false;false;false;false,21901/22402
week $nmbr$ - baseline,C0332174;C0168634;C1442488;C0439230,false;true;false;false,21902/22402
week $nmbr$ — mg / liter ^,C0332174;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;false;true;false;false;false;false;false;false,21903/22402
week $nmbr$ mean + sem,C0332174;C0444504;C2347634;C2348143;C0439230,false;false;false;false;false,21904/22402
week $nmbr$ outcome,C0332174;C1274040;C0439230,false;false;false,21905/22402
week $nmbr$ outcomes,C0332174;C1274040;C0439230,false;false;false,21906/22402
week $nmbr$ overall population,C0332174;C0282416;C0032659;C1257890;C1561607;C0439230,false;true;true;true;false;false,21907/22402
week $nmbr$ responders  ( n = $nmbr$ ),C0332174;C0439230,false;false,21908/22402
week $nmbr$ ( before ee ),C0332174;C0439230,false;false,21909/22402
week $nmbr$ crp,C0332174;C3890735;C4048285;C0439230,false;false;false;false,21910/22402
week $nmbr$ ( non - ee responders ),C0332174;C1518422;C0439230,false;false;false,21911/22402
week $nmbr$ mean ( sd ),C0332174;C0444504;C2699239;C2347634;C2348143;C0439230,false;false;false;false;false;false,21912/22402
week $nmbr$ % of patients,C0332174;C0030705;C0439230,false;true;false,21913/22402
week $nmbr$ ( mmol / l ),C0332174;C1532563;C0439230,false;false;false,21914/22402
week $nmbr$ ertugliflozin $nmbr$ mg vs placebo,C0332174;C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;true;true;false;false;false;false;false;false,21915/22402
week $nmbr$ ertugliflozin $nmbr$   mg vs . placebo,C0332174;C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;true;true;false;false;false;false;false;false,21916/22402
week $nmbr$ ertugliflozin $nmbr$ mg vs . placebo,C0332174;C4079805;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0439230,false;true;true;true;false;false;false;false;false;false,21917/22402
week $nmbr$  % ( n ),C0332174;C0439230,false;false,21918/22402
week $nmbr$  % ( n ) #,C0332174;C0439230,false;false,21919/22402
week $nmbr$  % ( n ) # or for cana vs pbo ( $nmbr$ % ci ) | |,C0332174;C0439230,false;false,21920/22402
week $nmbr$  % ( n ) * *,C0332174;C0439230,false;false,21921/22402
week $nmbr$  % ( n ) ^,C0332174;C0439230,false;false,21922/22402
week $nmbr$  % ( n ) | | or for cana vs pbo ( $nmbr$ % ci ) §,C0332174;C0439230,false;false,21923/22402
week $nmbr$  % ( n ) §,C0332174;C0439230,false;false,21924/22402
week $nmbr$  % ( n ) $nmbr$,C0332174;C0439230,false;false,21925/22402
week $nmbr$  % ( n ) $nmbr$ or for cana vs pbo ( $nmbr$ % ci ) | |,C0332174;C0439230,false;false,21926/22402
week $nmbr$  % ( n ) j,C0332174;C0439230,false;false,21927/22402
week $nmbr$ *,C0332174;C0439230,false;false,21928/22402
week $nmbr$ * ’ ’,C0332174;C0439230,false;false,21929/22402
week $nmbr$ / et,C0332174;C0439230,false;false,21930/22402
week $nmbr$ a,C0332174;C0439230,false;false,21931/22402
week and,C0332174;C0439230,false;false,21932/22402
week o ( baseline ) mean 士 sd,C0332174;C0168634;C0444504;C2699239;C2347634;C2348143;C1442488;C0439230,false;true;false;false;false;false;false;false,21933/22402
week   $nmbr$,C0332174;C0439230,false;false,21934/22402
weekly iss {,C0332174;C1740819;C1845118,false;false;false,21935/22402
weekly iss $nmbr$,C0332174;C1740819;C1845118,false;false;false,21936/22402
weekly number of hives score {,C0332174;C0237753;C0042109;C0449788,false;false;true;false,21937/22402
weekly number of hives score $nmbr$,C0332174;C0237753;C0042109;C0449788,false;false;true;false,21938/22402
weekly size of largest hives score {,C0332174;C0456389;C0443228;C0042109,false;false;false;true,21939/22402
weeko mean + sem,C0444504;C2347634;C2348143,false;false;false,21940/22402
weeks,C0439230,false,21941/22402
weeks_measured,C0439230,false,21942/22402
weight — kg cardiovascular history — no . ( % ),C0005910;C0022718;C1880008;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;true;false;false,21943/22402
weight # $nmbr$ kg,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21944/22402
weight ( kg ) ( mean ± sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,21945/22402
weight ( kg ) bmi ( kg / m $nmbr$ ),C0005910;C1319635;C0578022;C0369637;C0441923;C0043100;C1305866;C1705104,true;false;false;false;false;true;false;false,21946/22402
weight ( kg ) *,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21947/22402
weight ( kg )  mean ( s . e . ),C0005910;C1275571;C0444504;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;false;false;true;false;false,21948/22402
weight ( kg )  mean   ±   sd,C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,21949/22402
weight ( kg )  median ( m / n  max ),C0005910;C1532718;C0549183;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;false;false;false;false;false;true;false;false,21950/22402
weight ( kg ) 十,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21951/22402
weight ( kg ) a,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21952/22402
weight ( kg }  median ( min  max },C0005910;C1532757;C0549183;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;false;false;false;false;false;true;false;false,21953/22402
weight ( median [ iqr ] )  kg,C0005910;C0549183;C0022718;C0439209;C4054209;C0876920;C2347635;C2348144;C2939193;C0043100;C1305866;C1705104,true;false;true;false;false;false;false;false;false;true;false;false,21954/22402
weight [ kg ],C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21955/22402
weight < $nmbr$ kg  n ( % ),C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21956/22402
weight $nmbr$ +,C0005910;C0043100;C1305866;C1705104,true;true;false;false,21957/22402
weight $nmbr$ - $nmbr$,C0005910;C0043100;C1305866;C1705104,true;true;false;false,21958/22402
weight at baseline,C1303013,false,21959/22402
weight at randomization ( kg ),C2985844;C0022718;C0439209;C4054209,false;true;false;false,21960/22402
weight category,C0005910;C0683312;C3889287;C0043100;C1305866;C1705104,true;false;false;true;false;false,21961/22402
weight group  no . ( % ),C0005910;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;true;false;false,21962/22402
weight in kg ( baseline : mean ( sd ) [ n ]  wk $nmbr$ and change : mean ( se ) [ n ] ),C0022718;C1303013;C0444504;C2699239;C0332174;C0439230;C2347634;C2348143;C0439209;C4054209,true;false;false;false;false;false;false;false;false;false,21963/22402
weight of < $nmbr$ kg  n ( % ),C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21964/22402
weight  kg ( mean ± s . d . ),C0005910;C1275571;C0444504;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;false;false;true;false;false,21965/22402
weight  kg ( mean $nmbr$ sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,21966/22402
weight  kg blood pressure  mm hg,C0005910;C0022718;C0005823;C0439475;C1271104;C1272641;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;true;false;false;true;false;false;true;false;false,21967/22402
weight  kg duration of pah  n ( % ),C0005910;C0022718;C0449238;C0030123;C3203102;C4284467;C2926735;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;true;true;false;false;false;false;true;false;false,21968/22402
weight  kg mean ( sd ),C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,21969/22402
weight  kg  mean ± sd,C0005910;C0022718;C0444504;C2699239;C2347634;C2348143;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;false;false;false;false;true;false;false,21970/22402
weight  kg $nmbr$,C0005910;C0022718;C0439209;C4054209;C0043100;C1305866;C1705104,true;true;false;false;true;false;false,21971/22402
weight  mean ( sd ) ( kg ),C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,21972/22402
weight  mean ( sd ) lbs .,C0005910;C0444504;C2699239;C0439219;C3161851;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;false;false;false;false;true;false;false,21973/22402
weight  mean ( sd )  kgb,C0005910;C0444504;C2699239;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;false;false;true;false;false,21974/22402
weight  mean ± sd kg,C0005910;C0444504;C2699239;C0022718;C0439209;C4054209;C2347634;C2348143;C0043100;C1305866;C1705104,true;false;false;true;false;false;false;false;true;false;false,21975/22402
weight ^,C0005910;C0043100;C1305866;C1705104,true;true;false;false,21976/22402
weight < $nmbr$,C0005910;C0043100;C1305866;C1705104,true;true;false;false,21977/22402
west europe,C1705493;C0015176,false;true,21978/22402
western,C1705493,false,21979/22402
western europe ( n   = $nmbr$  $nmbr$ ),C0043129,true,21980/22402
western europe plus other,C0043129,true,21981/22402
western europe  australia  new zealand,C0043129;C4289954,true;false,21982/22402
western europe  australia  new zealand  and middle east,C0043129;C4289954,true;false,21983/22402
western europe  australia  new zealand  middle eai,C0043129;C4289954;C0444598;C0549183;C1552826,true;false;false;false;false,21984/22402
western europe  australia  new zealand  middle east,C0043129;C4289954;C0026068,true;false;true,21985/22402
while,,,21986/22402
white ( n   = $nmbr$  $nmbr$ ),C0007457;C0043157;C0220938,true;true;false,21987/22402
white ( n = $nmbr$  $nmbr$ ),C0007457;C0043157;C0220938,true;true;false,21988/22402
white blood cell count  cellsx $nmbr$,C0023508;C0427512,true;false,21989/22402
white hispanic,C1533020;C1533021,false;false,21990/22402
white hispanic - n ( % ),C1533020;C1533021,false;false,21991/22402
white mtx ( n ),C0007457;C0025677;C1417487;C0043157;C0220938,true;true;false;true;false,21992/22402
white non - hispanic,C1533020;C1518422;C1533021;C0007457;C1518424;C0043157;C0220938,false;false;false;true;false;true;false,21993/22402
white non - hispanic - n ( % ),C1533020;C1518422;C1533021;C0007457;C1518424;C0043157;C0220938,false;false;false;true;false;true;false,21994/22402
white or caucasian  n ( % ),C0007457;C0043157;C0220938,true;true;false,21995/22402
white race — no . ( % ) y left ventricular ejection fraction — %,C0007457;C0043157;C0220938,true;true;false,21996/22402
white race — no . { % ) ' i ',C0007457;C0043157;C0220938,true;true;false,21997/22402
white race — no . { % ) - i -,C0007457;C0043157;C0220938,true;true;false,21998/22402
white race — no . { % ) $,C0007457;C0043157;C0220938,true;true;false,21999/22402
white race — no . { % ) t,C0007457;C0043157;C0220938,true;true;false,22000/22402
white race ( n = $nmbr$ $nmbr$ ),C0007457;C0043157,true;true,22001/22402
white tcz + mtx ( n ),C0007457;C0025677;C1417487;C0043157;C0220938,true;true;false;true;false,22002/22402
white  n ( % ) medical history  n ( % ),C0007457;C0262926;C1704706;C0043157;C0220938,true;false;false;true;false,22003/22402
white  n / n ( % ),C0007457;C0043157;C0220938,true;true;false,22004/22402
white  no . ( % ),C0007457;C0043157;C0220938,true;true;false,22005/22402
white  non - hispanic,C1533020;C1518422;C1533021;C0007457;C1518424;C0043157;C0220938,false;false;false;true;false;true;false,22006/22402
whiteb,,,22007/22402
who fc ii symptoms at baseline $nmbr$,C2983605;C1710602;C0683368;C0168634;C1442488;C1457887;C4082587,false;false;true;true;false;false;false,22008/22402
who fc ii symptoms at baselinef,C2983605;C1710602;C0683368;C1457887;C4082587,false;false;true;false;false,22009/22402
who functional class,C0205245;C0456387;C1518526;C1705943;C0542341;C2700217,false;false;false;false;false;false,22010/22402
whole cohort,C0444667;C0009247;C0599755,false;true;false,22011/22402
with any stent,C0038257,true,22012/22402
with aspirin ( n = $nmbr$  $nmbr$ ),C0004057,true,22013/22402
with baseline crp level of > $nmbr$ mg / liter,C0168634;C3890735;C0441889;C0024671;C0475211;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C0456079;C1547707;C2946261;C4048285;C1442488,true;false;false;true;false;true;false;false;false;false;false;false;false;false;false;false,22014/22402
with baseline vertebral fracture,C0168634;C0080179;C1442488,true;true;false,22015/22402
with cerebrovascular disease,C0007820,true,22016/22402
with ckd ( $nmbr$ ),C1561643,true,22017/22402
with ckd intensive ( n = $nmbr$ ),C1561643;C0162425;C0522510;C1283828;C1550453,true;true;false;false;false,22018/22402
with ckd standard ( n = $nmbr$ ),C1561643;C1442989;C2828392,true;false;false,22019/22402
with concomitant ics,C0521115;C0815320;C4551720,false;false;true,22020/22402
with des,C0011702;C4551552,true;true,22021/22402
with dm,C0011816;C3250443,true;false,22022/22402
with dm ( n proactive intervention ( n = $nmbr$ a ),C0011816;C0184661;C0886296;C1273869;C3250443,true;true;false;false;false,22023/22402
with dyspnoea,C0013404;C1963100,true;false,22024/22402
with events ( % ),C0441471;C3541888,false;false,22025/22402
with higher classes indicating greater limitations on physical activity owing to,C0205250;C0456387;C1518526;C1705943;C4019422,false;false;false;false;false,22026/22402
with highest bwa,C1522410;C0006041,false;true,22027/22402
with highest hba $nmbr$ cc,C1522410;C0019016;C0008318;C3538933;C1825777;C3538758,false;true;true;false;false;false,22028/22402
with ics  n ( % ),C0815320;C4551720,false;true,22029/22402
with long - acting j $nmbr$ - agonists,C0205166;C0079613;C0243192;C2987634;C1704930;C1869853;C3890007;C4048375;C1706317,false;true;true;false;false;true;false;false;false,22030/22402
with lowest bwb,C1708760,false,22031/22402
with lowest hba $nmbr$ cd,C1708760;C0019016;C0007928;C0034283;C4552032;C1825777;C3538758,false;true;true;true;false;false;false,22032/22402
with metabolic syndrome,C0524620,true,22033/22402
with mets,C0812270;C1705694;C2939420,false;false;false,22034/22402
with prior mi / stroke ( n = $nmbr$ ),C0332152;C3810814;C0038454;C4554100;C2826257,false;false;true;false;false,22035/22402
with rehospitalization  urgent coronary revascularization,C0439609;C0877341;C3272275,false;false;false,22036/22402
with tamsulosin,C0257343,true,22037/22402
with tiotropium,C0213771,true,22038/22402
with treatment,C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704,true;true;false;false;false;false;false,22039/22402
withdrawals  n / n ( % ),C1710677;C2349954;C2825032;C3812880;C4049634,false;false;false;false;false,22040/22402
withdrew consent,C2349954,false,22041/22402
within $nmbr$ h after first procedure,C0033727;C0205435;C0184661;C2700391;C3274430;C3539779;C1279901;C0369286;C0441932;C0564385;C4528284,true;false;true;false;false;false;false;false;false;false;false,22042/22402
without aspirin ( n = $nmbr$  $nmbr$ ),C0004057,true,22043/22402
without baseline vertebral fracture,C0168634;C0080179;C1442488,true;true;false,22044/22402
without cerebrovascular disease,C0007820,true,22045/22402
without ckd ( $nmbr$ ),C1561643,true,22046/22402
without concomitant ics,C0521115;C0815320;C4551720,false;false;true,22047/22402
without dm,C0011816;C3250443,true;false,22048/22402
without dvt dvt alone,C0149871;C2926618;C3899446,true;false;false,22049/22402
without dyspnoea,C0013404;C1963100,true;false,22050/22402
without hx of hf,C0262926;C0018488;C1313497;C1538440;C3273279;C3814444,false;true;true;false;false;false,22051/22402
without hypertension at baseline to hypertension,C0020538;C0168634;C1442488;C1963138,true;true;false;false,22052/22402
without metabolic syndrome,C0524620,true,22053/22402
without mets,C0812270;C1705694;C2939420,false;false;false,22054/22402
without psoriasis ( n = $nmbr$ ),C0033860,true,22055/22402
without tamsulosin,C0257343,true,22056/22402
wml load at follow - up mri stratified by baseline severity of wml load,C1550025;C0589120;C0024485;C1824234;C3890166;C1522577;C1704685;C3274571;C1704782;C1708715,false;false;true;false;false;false;false;false;false;false,22057/22402
womac function score,C0031843;C0449820;C4050231;C0542341;C0700205;C1705273,true;false;false;false;false;false,22058/22402
womac pain score,C0582148,false,22059/22402
womac stiffness score,C0427008;C0449820;C4050231,false;false;false,22060/22402
women ( % ),C0043210,true,22061/22402
women ( n ( % ) ),C0043210,true,22062/22402
women ( n = $nmbr$ ) events,C0043210;C0441471;C3541888,true;false;false,22063/22402
women ethnic origin,C0043210;C0015031,true;true,22064/22402
women t,C0043210,true,22065/22402
women taking estrogen,C0043210,true,22066/22402
women : < $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l ),C0043210;C0439269;C1532563,true;false;false,22067/22402
women  qva $nmbr$ - sfc,C0043210;C4521536,true;false,22068/22402
womens,,,22069/22402
worldwide black patients,C0005680;C0030705;C0027567;C0085756;C0439541,true;true;true;true;false,22070/22402
worldwide non - black patients,C1829939;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,22071/22402
wrist,C0043262;C1322271,true;true,22072/22402
wt  second  median,C1883559;C0205436;C0549183;C0876920;C2347635;C2348144;C2939193;C0457385;C0565930;C1561503;C1705190;C2700323,false;false;false;false;false;false;false;false;false;false;false;false,22073/22402
x cr $nmbr$ . $nmbr$ x age,C0201975;C0001779;C3539604;C3711669;C4084730;C4553336;C4553337,false;false;false;true;false;false;false,22074/22402
x ? = $nmbr$ - $nmbr$  p = $nmbr$ - $nmbr$,,,22075/22402
x ? = $nmbr$ - l  p = $nmbr$ - $nmbr$,,,22076/22402
x ? = l - $nmbr$  p = $nmbr$ - $nmbr$,,,22077/22402
x $nmbr$  n ( % ),,,22078/22402
x $nmbr$ = $nmbr$ - $nmbr$  p = $nmbr$ - $nmbr$,,,22079/22402
x $nmbr$ = $nmbr$ - l  p = $nmbr$ - $nmbr$,,,22080/22402
x $nmbr$ = $nmbr$  p = $nmbr$ - $nmbr$,,,22081/22402
x $nmbr$ years,C0439234,false,22082/22402
xanthine,C0043314;C0043318,true;true,22083/22402
xanthines  b   n ( % ),C0043318;C3541955,true;false,22084/22402
xanthinesg,,,22085/22402
xho  p = o - $nmbr$,C4050013,false,22086/22402
xi = ° - ° $nmbr$,C1720296,false,22087/22402
xi = $nmbr$ - $nmbr$  p = $nmbr$ - $nmbr$,C1720296,false,22088/22402
xi = $nmbr$ . $nmbr$,C1720296,false,22089/22402
xi = $nmbr$ - $nmbr$,C1720296,false,22090/22402
xi = $nmbr$,C1720296,false,22091/22402
xi = $nmbr$ - $nmbr$  p = $nmbr$ - l,C1720296,false,22092/22402
xi = $nmbr$ - $nmbr$  p = o - l,C1720296,false,22093/22402
xi = $nmbr$ - $nmbr$  p = $nmbr$,C1720296,false,22094/22402
xi = $nmbr$ - l  p = $nmbr$ - $nmbr$,C1720296,false,22095/22402
xi = l ’ $nmbr$  p = $nmbr$ - $nmbr$,C1720296,false,22096/22402
xi = o - $nmbr$  p = o - $nmbr$,C1720296,false,22097/22402
xi = oo  p = o - $nmbr$,C1720296,false,22098/22402
yaa,,,22099/22402
year - $nmbr$,C0439234;C0439508,false;false,22100/22402
year from randomization,C0439234;C0034656;C0439508,false;true;false,22101/22402
year of publication of primary results,C0439234;C0034036;C0205225;C1274040;C1546471;C2825142;C0439612;C0439631;C0034037;C1704324;C0439508,false;true;false;false;false;false;false;false;true;false;false,22102/22402
year  n ( % ),C0439234;C0439508,false;false,22103/22402
yearl,,,22104/22402
years ( mean ± sd ),C0439234;C0444504;C2699239;C2347634;C2348143,false;false;false;false;false,22105/22402
years ( sd ),C0439234;C2699239,false;false,22106/22402
years duration oa,C0439234;C0449238;C0029408;C3887876;C2926735,false;false;true;false;false,22107/22402
years male gender  n ( % ),C0439234;C0086582;C1706180,false;true;false,22108/22402
years modified hoehn and yahr stage  n ( % ),C0439234,false,22109/22402
years of education *,C0439234;C0013621;C0013622;C0013658;C0039401,false;true;true;true;true,22110/22402
years of education  mean ( sd ),C0439234;C0013621;C0444504;C2699239;C2347634;C2348143;C0013622;C0013658;C0039401,false;true;false;false;false;false;true;true;true,22111/22402
years of follow - up  mean ( sd ) [ maximum ],C0439234;C0589120;C0444504;C2699239;C0806909;C1552615;C2826546;C2347634;C2348143;C1522577;C1704685;C3274571,false;false;false;false;false;false;false;false;false;false;false;false,22112/22402
years since diagnosis,C0439234,false,22113/22402
years since diagnosis of type $nmbr$ diabetes  n ( % ),C0439234,false,22114/22402
years since diagnosis  mean,C0439234,false,22115/22402
years since last gout flare,C0439234,false,22116/22402
years since mi ( median,C0439234,false,22117/22402
years since pd diagnosis  mean ± sd,C0439234,false,22118/22402
years since symptom onset,C0439234,false,22119/22402
years with gout,C0439234;C0018099,false;true,22120/22402
years with gout  mean ± sd,C0439234;C0018099;C0444504;C2699239;C2347634;C2348143,false;true;false;false;false;false,22121/22402
years with gouty arthritis,C0439234;C0003868,false;true,22122/22402
years ),C0439234,false,22123/22402
years  n ( % ) smoking  n ( % ) current,C0439234;C0037369;C0521116;C1705970;C0453996;C1881674,false;true;false;false;true;false,22124/22402
yes ( % ) weight [ kg ] ( interaction : p = $nmbr$ . $nmbr$ ),C1549445;C0005910;C0022718;C1704675;C0439209;C4054209;C0043100;C1305866;C1705104;C1705108;C1710701,false;true;true;false;false;false;true;false;false;false;false,22125/22402
yes ( any ),C1549445;C1705108;C1710701,false;false;false,22126/22402
yes ( n  % ),C1549445;C1705108;C1710701,false;false;false,22127/22402
yes vs . no,C1549445;C1705108;C1710701,false;false;false,22128/22402
yes  $nmbr$ $nmbr$ y,C1549445;C1705108;C1710701,false;false;false,22129/22402
yes  o $nmbr$ cm,C1549445;C1705108;C1710701,false;false;false,22130/22402
yes  r $nmbr$ y,C1549445;C1705108;C1710701,false;false;false,22131/22402
yes  z $nmbr$ cm,C1549445;C1705108;C1710701,false;false;false,22132/22402
younger subjects ( aged < $nmbr$ years ),C0332239,false,22133/22402
zoledronic acid,C0257685,true,22134/22402
zoledronic acid ( n = $nmbr$ ),C0257685,true,22135/22402
zoledronic acid arm,C0257685;C0446516;C3715044;C4553528,true;true;false;false,22136/22402
zt = $nmbr$,,,22137/22402
placebo - ezetimibe $nmbr$ / simvastatin $nmbr$ - fenofibrate $nmbr$ - ezetimibe $nmbr$ / simvastatin $nmbr$ / ezetimibe $nmbr$,C0032042;C1532737;C0033228;C1696465;C1706408,true;true;true;false;false,22138/22402
l - dopa / carbidopa - l - dopa / carbidopa / entacapone,C0353697;C0165921,true;true,22139/22402
arb - arb / ccb,C3888198;C0006684,false;true,22140/22402
other - candesartan,C0717550,true,22141/22402
benazepril / hydrochlorothiazide - benazepril / amlodipine,C0717481;C0051696,false;true,22142/22402
atenolol - losartan,C0004147;C0126174,true;true,22143/22402
amlodipine - amlodipine / valsartan,C1962523,true,22144/22402
mycophenolate mofetil - cyclophosphamide,C0209368;C0010583,true;true,22145/22402
atorvastatin - pravastatin,C0286651;C0085542,true;true,22146/22402
placebo - abatacept $nmbr$ / $nmbr$ - abatacept $nmbr$ / $nmbr$,C0032042;C1619966;C1696465;C1706408,true;true;false;false,22147/22402
bivalirudin - heparin plus gpi,C0168273;C0019134;C1415351;C0770546,true;true;false;false,22148/22402
olmesartan / ccb - olmesartan / diuretic,C1098320;C0006684,true;true,22149/22402
comparator - linagliptin,C1707454;C2746078;C4553389;C4553390,false;true;false;false,22150/22402
placebo - linagliptin,C0032042;C2746078;C1696465;C1706408,true;true;false;false,22151/22402
placebo - dexlansoprazole,C0032042;C2348248;C1696465;C1706408,true;true;false;false,22152/22402
placebo - carisbamate $nmbr$ mg - carisbamate $nmbr$ mg,C0032042;C1871983;C1319635;C1696465;C1706408,true;true;false;false;false,22153/22402
ezetimibe / simvastatin - double dose statin - rosuvastatin,C1532737;C0205173;C0178602;C0360714;C0965129;C0869039;C1114758;C1705764;C1705765,true;false;false;true;true;false;false;false;false,22154/22402
stent / abciximab - stent / placebo,C0038257;C0288672;C0032042;C1696465;C1706408,true;true;true;false;false,22155/22402
insulin lispro mix $nmbr$ / lispro mix $nmbr$ - insulin glargine / insulin lispro,C0293359,true,22156/22402
ideglira - ideg - lira,C4308663;C1555441,true;false,22157/22402
placebo - ideglira,C0032042;C4308663;C1696465;C1706408,true;true;false;false,22158/22402
ideglira - ideg,C4308663,true,22159/22402
budesonide - budesonide / formoterol,C1276807,false,22160/22402
placebo - vonoprazan $nmbr$ - vonoprazan $nmbr$,C0032042;C4080009;C1696465;C1706408,true;true;false;false,22161/22402
fluticasone - fluticasone / salmeterol,C0939232,true,22162/22402
febuxostat - febuxostat / lesinurad $nmbr$ - febuxostat / lesinurad $nmbr$,C0249529;C3886073,true;true,22163/22402
telmisartan / amlodipine - telmisartan / amlodipine / hydrochlorothiazide,C0939233;C0051696;C2733369;C0020261,true;true;true;true,22164/22402
chlorthalidone - amlodipine - lisinopril,C0008294;C0051696;C0065374,true;true;true,22165/22402
placebo - famotidine $nmbr$ - famotidine $nmbr$,C0032042;C0015620;C1696465;C1706408,true;true;false;false,22166/22402
air insulin - insulin glargine - air insulin / insulin glargine,C0001861;C0907402;C3536832,true;true;false,22167/22402
olmesartan $nmbr$ - olmesartan $nmbr$ / hydrochlorothiazide $nmbr$ . $nmbr$,C1098320;C0020261,true;true,22168/22402
sdc $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ng / ml,C1419891;C0439275;C3273112,false;false;false,22169/22402
hf symptomatic improvement,C0018488;C0231220;C2986411;C1313497;C1538440;C3273279,true;false;false;true;false;false,22170/22402
hf symptom unchanged,C0018488;C1457887;C3854129;C1313497;C1538440;C3273279,true;false;false;true;false;false,22171/22402
hf symptom worsened,C0018488;C1457887;C3854129;C1313497;C1538440;C3273279,true;false;false;true;false;false,22172/22402
cv death / hf hospitalization,C3538987;C0011065;C0018488;C0019993;C1313497;C1538440;C3273279;C1306577;C4082313;C4552775;C4048877;C4318503,false;true;true;true;true;false;false;false;false;false;true;false,22173/22402
vertebral fracture,C0080179,true,22174/22402
nonvertebral fracture,C0016658,true,22175/22402
mortality  shock or congestive heart failure within $nmbr$ days,C0026565;C0036974;C0026566,true;true;true,22176/22402
main accord endpoint,C0205225;C0680240;C2349179;C2826544;C1542147,false;false;false;false;false,22177/22402
fatal / nonfatal mi ( excluding silent mi ),C1302234;C3810814;C1705232,false;false;false,22178/22402
cardiovascular death or nonfatal mi ( excluding silent mi ),C0007226;C0011065;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false,22179/22402
cardiovascular death  nonfatal mi ( excluding silent mi )  or stroke,C0007226;C0011065;C3810814;C1306577;C4082313;C4552775;C3887460,true;true;false;false;false;false;false,22180/22402
combined efficacy and safety endpoint,C0205195;C1280519;C1707887,false;false;false,22181/22402
mean change from baseline bp at week $nmbr$,C0392747;C0168634;C0488053;C1442488;C0443172;C1705241;C4319952;C0444504;C1268766;C2347634;C2348143,false;true;false;false;false;false;false;false;false;false;false,22182/22402
median change in atheroma volume  %,C0549183;C0392747;C0264956;C0449468;C1690016;C1705102;C2700258;C0443172;C1705241;C4319952;C0876920;C2347635;C2348144;C2939193,false;false;true;false;false;false;false;false;false;false;false;false;false;false,22183/22402
nonvertebral fractures,C0016658,true,22184/22402
clinical vertebral fractures,C0205210;C0080179,false;true,22185/22402
complete clinical response at week $nmbr$,C0205197;C3853530;C4283785,false;false;false,22186/22402
death or mi at $nmbr$ days,C0011065;C1306577;C4082313;C4552775,true;false;false;false,22187/22402
$nmbr$ - year mortality,C0439234;C0026565;C0026566;C0439508,false;true;true;false,22188/22402
net adverse clinical events at day $nmbr$,C1456447;C0877248;C0205210;C0332173;C0439228;C0439505;C1705413;C3853572;C3887809;C3890893,true;false;false;false;false;false;false;false;false;false,22189/22402
adas - cog,C3539026,false,22190/22402
cdr - sob,C4521843;C0013404,false;true,22191/22402
adcs - adl,C3641947,false,22192/22402
npi,C1412208;C1549728;C3539727,false;false;false,22193/22402
proportion of > = $nmbr$ % responder rates,C1709707;C0871208;C1521828,false;false;false,22194/22402
ldl - c concentration,C0086045;C1446561;C3827302,true;false;false,22195/22402
non - hdlc concentration,C1518422;C1704429;C0086045;C1446561;C3827302,false;true;true;false;false,22196/22402
hdlc - concentration,C1704429;C0086045;C1446561;C3827302,true;true;false;false,22197/22402
apolipoprotein a,C0003592;C0523508,true;false,22198/22402
apolipoprotein b,C0003593,true,22199/22402
complete ulcer healing at week $nmbr$,C0205197;C0333293;C0332174;C0439230;C0725685;C3853530;C4283785,false;false;false;false;false;false;false,22200/22402
major amputations at week $nmbr$,C0205082;C0002688;C0332174;C0439230;C0205164;C4318856;C4521762,false;true;false;false;false;false;false,22201/22402
mean percentage of nights without heartburn,C0444504;C0439165;C0240526;C1549488;C1561533;C2347634;C2348143,false;false;false;false;false;false;false,22202/22402
new or worsening vertebral fracture at $nmbr$ months,C0205314,false,22203/22402
new vertebral fracture at $nmbr$ months,C0205314;C0080179;C0439231,false;true;false,22204/22402
seizure reduction from baseline,C0036572;C0301630;C0168634;C1442488;C0392756;C1293152;C4551656;C1959629;C4553401,true;false;true;false;false;false;false;false;false,22205/22402
apolipoprotein a - i,C0085201;C1677784,true;true,22206/22402
hba $nmbr$ c at week $nmbr$,C0019016;C0332174;C0439230;C1825777;C3538758,true;false;false;false;false,22207/22402
primary endpoint at $nmbr$ days,C2986535;C0439228,false;false,22208/22402
primary endpoint at $nmbr$ months,C2986535;C0439231,false;false,22209/22402
dual i extension - end of trial hba $nmbr$ c,C0205173;C0021966;C0231448;C0444930;C0008976;C0019016;C1825777;C3538758;C2746065;C1880641;C0221138;C1554184,false;true;false;false;true;true;false;false;false;false;false;false,22210/22402
dual iv - end of trial hba $nmbr$ c,C0205173;C0444972;C0444930;C0008976;C0019016;C1825777;C3538758;C2746065;C1554184,false;false;false;true;true;false;false;false;false,22211/22402
dual ii - end of trial hba $nmbr$ c,C0205173;C0444967;C0444930;C0008976;C0019016;C1825777;C3538758;C2746065;C1554184,false;false;false;true;true;false;false;false;false,22212/22402
proportion of days without heartburn at week $nmbr$  percentage,C1709707;C0439228,false;false,22213/22402
first severe asthma exacerbation,C0205435;C0581126;C4086268;C0205082;C0349790;C4050465;C4050466;C1279901,false;false;false;false;false;false;false;false,22214/22402
change in fev $nmbr$ at week $nmbr$,C0392747;C3714541;C0443172;C1705241;C4319952,false;true;false;false;false,22215/22402
serum ua < $nmbr$ mg / dl by month $nmbr$,C0229671;C0041580;C0439269;C0332177;C0439231;C0042014;C1546774;C1550100,true;true;false;false;false;true;false;false,22216/22402
control of sitting bp at week $nmbr$,C0243148;C0277814;C0037623;C1415692;C1708288;C4318478;C2584297;C4050224;C1550141;C1882979;C2587213;C3274648;C4553389,true;true;true;false;false;false;true;false;false;false;false;false;false,22217/22402
rate of atrial fibrillation,C0871208;C0004238;C0344434;C1963067;C1521828,false;true;false;false;false,22218/22402
combined $nmbr$ - year cvd,C0205195;C0439234;C0007222;C0439508,false;false;true;false,22219/22402
percentage of days without heartburn,C0439165;C0439228;C1549488;C1561533,false;false;false;false,22220/22402
bp goal at week $nmbr$,C0037623;C0018017;C0332174;C0439230;C1571704;C1415692;C1708288;C4318478,true;true;false;false;false;false;false;false,22221/22402
previous use of digoxin,C0205156;C1524063;C0012265;C1552607,false;false;true;false,22222/22402
cardiothoracic ratio,C4055270;C0456603;C1547037,false;false;false,22223/22402
retinal severity change,C0035298;C0439793;C0392747;C0443172;C1705241;C4319952;C0522510,true;false;false;false;false;false;false,22224/22402
serum uric acid  mg / dl,C0455272;C0439269;C0700634,false;false;false,22225/22402
concomitant statin use,C0521115;C0360714;C0042153;C0457083;C1947944,false;true;true;false;false,22226/22402
study protocol,C1507394;C2348563;C2599718,false;false;true,22227/22402
concomitant mao - b inhibitor use,C0521115;C0595265;C0042153;C0457083;C1947944;C2917433,false;false;true;false;false;false,22228/22402
ckd at baseline,C1561643;C0168634;C1442488,true;true;false,22229/22402
cvd  ckd,C0007222;C1561643,true;true,22230/22402
acei use,,,22231/22402
beta blocker use,C0001645;C0042153;C0457083;C1947944,true;true;false;false,22232/22402
nitrate use,C0028125;C0042153;C0457083;C1947944;C0699857;C3848573,true;true;false;false;false;false,22233/22402
sirolimus eluting stent,C0072980;C0038257,true;true,22234/22402
vessel disease,C0042373,true,22235/22402
kilip class,C0456387;C1518526;C1705943,false;false;false,22236/22402
time to randomisation from symptom onset ( h ),C0040223;C0034656;C3541383,true;true;false,22237/22402
time from symptoms onset to $nmbr$ st balloon inflation ( h ),C0683368;C0449244;C1457887,true;false;false,22238/22402
time from randomisation to $nmbr$ st balloon inflation ( h ),C0040223;C0034656;C3541383,true;true;false,22239/22402
first medical contact,C0205435;C0199168;C0332158;C0337611;C1705415;C3812666;C0205476;C1279901,false;false;false;false;false;false;false;false,22240/22402
stent placement,C0522776,false,22241/22402
previous mi and t $nmbr$ dm,C0205156;C3810814;C1552607,false;false;false,22242/22402
baseline peripheral artery disease,C0168634;C1704436;C4025272;C1442488,true;true;false;false,22243/22402
fibrinolytic agent given,C0016018,true,22244/22402
shock risk indext,C0036974;C0035647;C4552904,true;true;false,22245/22402
aetiology,C0015127;C1314792;C1524003,true;true;false,22246/22402
baseline $nmbr$ - min walk distance m,C0168634;C0702093;C0429886;C0369637;C0441923;C1524029;C3813700;C1442488,true;false;false;false;false;false;false;false,22247/22402
baseline who functional class,C0168634;C1442488,true;false,22248/22402
age at baseline years,C1510829;C0168634;C1442488,false;true;false,22249/22402
diabetes and untreated hypertension,C0011847;C0011849,false;true,22250/22402
clinically evident vascular disease,C3887511;C0042373,false;true,22251/22402
ethnicity  location,C0015031;C0450429;C1515974;C4284930;C4284931;C0243103,true;false;false;false;false;true,22252/22402
alcohol intake  drinks / week,C0001948,true,22253/22402
history of statin use,C0019664;C0360714;C1524063;C0019665;C0262512;C0262926;C1705255;C2004062,true;true;false;true;false;false;false;false,22254/22402
low - density lipoprotein  mg / dl,C0023823;C0439269,true;false,22255/22402
high - density lipoprotein  mg / dl,C0023821;C0439269,true;false,22256/22402
baseline bmd t score at femoral neck,C0168634;C0449820;C0015815;C4050231;C1442488,true;false;true;false;false,22257/22402
prior treatment status,C1514463;C0449438;C0332152;C0749659;C2826257,false;false;false;false;false,22258/22402
inclusion diagnosis,C0007637;C0011900;C1704338;C1704656;C1512693,true;true;true;false;false,22259/22402
modified braunwald class,C0392747;C0456387;C1518526;C1705943;C3889737,false;false;false;false;false,22260/22402
high - risk criterion,C0332167;C0243161;C3272283;C4050568;C4319571,false;true;false;false;false,22261/22402
cadillac score,C0449820;C4050231,false;false,22262/22402
arterial access site,C3272298,false,22263/22402
vessels with stenosis > $nmbr$ %,C0679403,false,22264/22402
stent type implanted,C0038257;C0332307;C1547052,true;false;false,22265/22402
heparin pre - randomization,C0019134;C0332152;C0034656;C0740175;C2257086;C3669034;C0770546,true;false;true;false;false;false;false,22266/22402
p $nmbr$ y $nmbr$ inhibitor loading dos,C0369773;C1999216;C1708715;C1428722;C2603361,false;false;false;false;false,22267/22402
p $nmbr$ y $nmbr$ inhibitor maintenance,C0369773;C1999216;C0024501;C2603361,false;false;true;false,22268/22402
primary management strategy,C0205225;C0001554;C0679199;C0376636;C1273870;C3273539;C0439612;C0439631,false;true;false;true;false;false;false;false,22269/22402
clinical dementia rating score,C4304227,false,22270/22402
cholinesterase inhibitor use,C0008425;C0042153;C0457083;C1947944;C3536756;C4521309,true;true;false;false;false;false,22271/22402
apolipoprotein e carrier,C0003595;C0007294;C0560175;C1325398;C1706209;C3273162,true;true;true;false;false;false,22272/22402
prior exposure to levetiracetam,C0332152;C0274281;C0377265;C3693636;C0332157;C2826257,false;false;true;false;false;false,22273/22402
prior exposure to carbamazepine,C0332152;C0274281;C0006949;C0006950;C0682993;C0332157;C2826257,false;false;true;false;false;false;false,22274/22402
prior exposure to topiramate,C0332152;C0274281;C0076829;C0332157;C2826257,false;false;true;false;false,22275/22402
prior exposure to lamotrigine,C0332152;C0274281;C0064636;C0524166;C0332157;C2826257,false;false;true;false;false;false,22276/22402
thienopyridine use,C1120149;C0042153;C0457083;C1947944,true;true;false;false,22277/22402
intent to use gp iib / iiia,C0162425;C1283828;C1550453,true;false;false,22278/22402
intent to use dti,C0162425;C1283828;C1550453,true;false;false,22279/22402
troponin or ckmb value,C0041199,true,22280/22402
timi score,,,22281/22402
investigator - reported hypoglycaemia,C0035173,true,22282/22402
nocturnal heartburn severity,C0240526;C0018834;C0439793;C0522510,false;true;false;false,22283/22402
concurrent medication,C0205420;C0013227;C3244316;C4284232,false;true;false;false,22284/22402
antiepileptic drug type at baseline,C0003299;C0332307;C0168634;C1442488;C1547052;C3537002;C0457591,true;false;true;false;false;false;false,22285/22402
cardiogenic shock,C0036980,true,22286/22402
type of mi,C0332307;C3810814;C1547052,false;false;false,22287/22402
target vessel diameter,C0449618;C1301886,false;false,22288/22402
onset of chest pain,C0206132;C0024902;C0332162,true;true;false,22289/22402
received pci,C1514756;C4049621,false;false,22290/22402
acei or arb pre - randomisation,,,22291/22402
acei or arb post - randomisation,,,22292/22402
bb after randomisation,C0004739;C0034656;C0332297,true;true;false,22293/22402
acei / arb and bb after randomisation,C3888198,false,22294/22402
pulsed blood pressure,C0232108,false,22295/22402
admission crcl,C0184666;C1846718;C0809949,false;false;false,22296/22402
admission k  mmol / l,C0184666;C0597277;C1532563;C1708601;C0809949,false;false;false;false;false,22297/22402
randomisation,C0034656,true,22298/22402
nerd grade,C0441800;C0919553;C3244287,false;false;false,22299/22402
asthma control,C0004096;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389;C2984299,true;true;false;false;false;false;false;false,22300/22402
eosinophil count ( cells / microlitre ),C0200638;C0439378;C0750879,false;false;false,22301/22402
baseline uric acid,C0168634;C0041980;C1442488,true;true;false,22302/22402
disease stage,C0699749,false,22303/22402
chronic heart failure class ii - iii,C0018802;C0441887;C1710602;C4082587;C2698969;C0441886;C0439070;C1705160;C2698968;C0264716,true;false;false;false;false;false;false;false;false;false,22304/22402
prior mi / stroke,C0332152;C3810814;C0038454;C4554100;C2826257,false;false;true;false;false,22305/22402
cardiovascular status,C0007226;C0449438;C3887460,true;false;false,22306/22402
egfr  ml / min ( mdrd ),C1739039;C0439445;C3839656;C3811844;C3812682,true;false;false;false;false,22307/22402
diabetic retinopathy at baseline,C0011884;C0168634;C1442488,true;true;false,22308/22402
type of reflux disease,C0457464;C0232483;C1882919;C4317146,false;false;false;false,22309/22402
number of symptom days per week,C0237753;C1457887;C0439228;C3854129;C0449788,false;false;false;false;false,22310/22402
cardiac surgery type,C0018821;C0332307;C1547052;C0524727,true;false;false;true,22311/22402
baseline egfr,C0168634;C1739039;C3811844;C3812682;C1442488,true;true;false;false;false,22312/22402
hiatus hernia,C3489393,true,22313/22402
h . pylori infection,C0850666,false,22314/22402
hypertension severity,C0020538;C0439793;C0522510;C1963138,true;false;false;false,22315/22402
> $nmbr$ or incident vitrectomy or photocoagulation,,,22316/22402
stage $nmbr$ ( cockcroft - gault ),C0205390;C1300072;C1306673,false;false;false,22317/22402
stage $nmbr$ ( four - variable modification of diet in kidney disease ),C0205390;C1300072;C1306673,false;false;false,22318/22402
western eu  australia  new zealand,C0043128;C0015179;C0027978;C0324547;C3665627;C1705493;C4289954,true;true;true;true;false;false;false,22319/22402
eastern eu,C1707877;C0015179;C3665627,false;true;false,22320/22402
< - $nmbr$ . $nmbr$,,,22321/22402
> - $nmbr$ . $nmbr$,,,22322/22402
yes  yes,C1549445;C1705108;C1710701,false;false;false,22323/22402
yes  no,C1512698,false,22324/22402
no  yes,C1549445;C1705108;C1710701,false;false;false,22325/22402
no  no,,,22326/22402
< = $nmbr$,,,22327/22402
ii - iii,C1710602;C0439070;C1705160;C4082587,false;false;false;false,22328/22402
pci - hospital,C4049621;C0019994;C1510665,false;true;false,22329/22402
non - pci hospital / ambulance,C1518422;C4049621;C0019994;C0002422;C3846685;C1510665,false;false;true;true;false;false,22330/22402
non - european,C1518422;C0239307;C1535514,false;false;false,22331/22402
< $nmbr$ . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$,C0439445;C0369637;C0441923,false;false;false,22332/22402
ipah / fpah / drug and toxin,C0152171;C1419079;C0013227;C1254351,false;false;true;false,22333/22402
repaired congenital shunt,C0205340;C0009678;C0232180;C0542331;C1442858;C1744681,false;true;false;false;false;false,22334/22402
black  worldwide,C0005680;C0027567;C0085756;C0439541,true;true;true;false,22335/22402
non - black  worldwide,C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,22336/22402
black  us,C0005680;C0027567;C0085756;C0439541,true;true;true;false,22337/22402
non - black  us,C1518422;C0005680;C0027567;C0085756;C0439541,false;true;true;true;false,22338/22402
past or nonsmoker,C1444637;C4284302,false;false,22339/22402
> - $nmbr$ . $nmbr$ to < - $nmbr$ . $nmbr$,C0040363;C0041260;C1883351,true;true;false,22340/22402
na ï ve,C0597484;C0042469;C3714652;C4321495;C1272460;C1546968;C1879645;C4049872;C4552882,false;true;false;false;false;false;false;false;false,22341/22402
recent,C0332185,false,22342/22402
inadequate,C0205412;C0439856,false;false,22343/22402
non - q - wave ml,C1518422;C0429089;C0439526;C1705224;C3887665;C1305738,false;false;false;false;false;false,22344/22402
no rest angina,C0002965;C0152172,true;false,22345/22402
rest angina,C0002965;C0152172,true;false,22346/22402
no antianginal drug,C1874267;C0013227;C1254351;C3537168,false;true;false;false,22347/22402
$nmbr$ antianginal drug,C1874267;C0013227;C1254351;C3537168,false;true;false;false,22348/22402
$nmbr$ antianginal drugs,C1874267;C0013227;C3687832;C3537168,false;true;false;false,22349/22402
intermediate risk,C3640764,false,22350/22402
single vessel disease,C0037179;C0042373;C0087136;C0205171,true;true;true;false,22351/22402
at least one drug - eluting stent,C0205447;C1322815,false;true,22352/22402
all bare metal stents,C2825200,false,22353/22402
prasugrel or ticagrelor,C1620287,true,22354/22402
non - lad,C1518422,false,22355/22402
pci procedure,C4049621;C0184661;C2700391;C3274430;C3539779,false;true;false;false;false,22356/22402
non pci procedure,C1518422;C4049621;C0184661;C2700391;C3274430;C3539779,false;false;true;false;false;false,22357/22402
non europe,C1518422;C0015176,false;true,22358/22402
< mild,C2945599,false,22359/22402
mild - < moderate,C1299392,false,22360/22402
moderate - < severe,C0205081;C1881878;C4049705;C4049706;C4085643;C4321335,false;false;false;false;false;false,22361/22402
severe - very severe,C0205082;C0442824;C2984081;C4050465;C4050466,false;false;false;false;false,22362/22402
enzyme inducing,C0014442;C4521602,true;false,22363/22402
non - enzyme inducing,C1518422;C0014442;C4521602,false;true;false,22364/22402
< = $nmbr$ . $nmbr$ mm,C4330985;C4554674,false;false,22365/22402
> = $nmbr$ h,C0033727;C0369286;C0441932;C0564385;C4528284,true;false;false;false;false,22366/22402
< = $nmbr$ ml / min,C0439445,false,22367/22402
pre - hospital,C0332152;C0019994;C1510665;C0740175;C2257086;C3669034,false;true;false;false;false;false,22368/22402
in - hospital,C0019994;C1510665,true;false,22369/22402
< = $nmbr$ %,,,22370/22402
russia / ukraine / belarus,C0035970;C0041580;C0006539,true;true;true,22371/22402
poor  tried previous glucocorticoid / non - laba,C0032854;C0205156;C0017710;C1518422;C1552607;C0542537;C2700379,true;false;true;false;false;false;false,22372/22402
poor  tried previous glucocorticoid + laba,C0032854;C0205156;C0017710;C1552607;C0542537;C2700379,true;false;true;false;false;false,22373/22402
good  tried previous glucocorticoid + laba,C0205170;C0205156;C0017710;C1552607,false;false;true;false,22374/22402
good  tried previous glucocorticoid,C0205170;C0205156;C0017710;C1552607,false;false;true;false,22375/22402
> = $nmbr$ mg / dl,C0439269,false,22376/22402
advanced,C0205179,false,22377/22402
< = $nmbr$ . $nmbr$ %,,,22378/22402
established disease,C0443211;C0012634;C1272684,false;true;false,22379/22402
risk factors only,C0035648;C0205171;C1720467;C1553898,true;false;false;false,22380/22402
pre - mixed insulin,C0332152;C0205430;C3160715;C0740175;C2257086;C3669034,false;false;false;false;false;false,22381/22402
yes  proliferative,C1549445;C1705108;C1710701,false;false;false,22382/22402
yes  non - proliferative,C1549445;C1705108;C1710701,false;false;false,22383/22402
yes  unknown,C1549445;C1705108;C1710701,false;false;false,22384/22402
erosive reflux disease,C0439679;C0232483;C0012634;C1882919;C4317146,false;false;true;false;false,22385/22402
gastrooesophageal reflux disease,C0017168;C4553201,true;false,22386/22402
> $nmbr$  < = $nmbr$,,,22387/22402
non - cabg or combined,C1518422;C0010055,false;true,22388/22402
tx,C0041403,true,22389/22402
tx $nmbr$,C0041403,true,22390/22402
amlodipione - chlorthalidone,C0008294,true,22391/22402
lisinopril - chlorthalidone,C0065374;C0008294,true;true,22392/22402
famotidine $nmbr$ - famotidine $nmbr$,C0015620,true,22393/22402
placebo - famotidine $nmbr$,C0032042;C0015620;C1696465;C1706408,true;true;false;false,22394/22402
air insulin - air insulin / insulin glargine,C0001861;C0907402;C3536832,true;true;false,22395/22402
insulin glargine - air insulin / insulin glargine,C0907402;C0001861;C3536832,true;true;false,22396/22402
placebo - vonoprazan $nmbr$,C0032042;C4080009;C1696465;C1706408,true;true;false;false,22397/22402
febuxostat - febuxostat / lesinurad $nmbr$,C0249529;C3886073,true;true,22398/22402
or_value,,,22399/22402
or $nmbr$,,,22400/22402
or $nmbr$ _value,,,22401/22402
